diff options
Diffstat (limited to 'wqflask/maintenance')
| -rw-r--r-- | wqflask/maintenance/dataset/20140110_Megan/C57BL-6JxC57BL-6NJF2.geno | 69 | ||||
| -rw-r--r-- | wqflask/maintenance/dataset/20140110_Megan/conf.ini | 5 | ||||
| -rw-r--r-- | wqflask/maintenance/dataset/20140110_Megan/run.sh | 1 | ||||
| -rw-r--r-- | wqflask/maintenance/dataset/about.txt (renamed from wqflask/maintenance/dataset/calculation/correlation/about.txt) | 0 | ||||
| -rw-r--r-- | wqflask/maintenance/dataset/bxdphenotypes.txt | 3899 | ||||
| -rw-r--r-- | wqflask/maintenance/dataset/calculation/__init__.py | 0 | ||||
| -rw-r--r-- | wqflask/maintenance/dataset/calculation/correlation/__init__.py | 0 | ||||
| -rw-r--r-- | wqflask/maintenance/dataset/conf.ini (renamed from wqflask/maintenance/dataset/calculation/correlation/conf.ini) | 0 | ||||
| -rw-r--r-- | wqflask/maintenance/dataset/correlations.py (renamed from wqflask/maintenance/dataset/calculation/correlation/correlations.py) | 0 | ||||
| -rw-r--r-- | wqflask/maintenance/dataset/datastructure.py (renamed from wqflask/maintenance/dataset/datastructure/datastructure.py) | 0 | ||||
| -rw-r--r-- | wqflask/maintenance/dataset/datastructure/__init__.py | 0 | ||||
| -rw-r--r-- | wqflask/maintenance/dataset/db.py (renamed from wqflask/maintenance/dataset/utilities/db.py) | 0 | ||||
| -rw-r--r-- | wqflask/maintenance/dataset/fetch.py (renamed from wqflask/maintenance/dataset/utilities/fetch.py) | 0 | ||||
| -rw-r--r-- | wqflask/maintenance/dataset/genotypes/__init__.py | 0 | ||||
| -rw-r--r-- | wqflask/maintenance/dataset/genotypes_load.py (renamed from wqflask/maintenance/dataset/genotypes/genotypes_load.py) | 0 | ||||
| -rw-r--r-- | wqflask/maintenance/dataset/phenotypes.py (renamed from wqflask/maintenance/dataset/phenotypes/phenotypes.py) | 0 | ||||
| -rw-r--r-- | wqflask/maintenance/dataset/phenotypes/__init__.py | 0 | ||||
| -rw-r--r-- | wqflask/maintenance/dataset/probesets.py (renamed from wqflask/maintenance/dataset/probesets/probesets.py) | 0 | ||||
| -rw-r--r-- | wqflask/maintenance/dataset/probesets/__init__.py | 0 | ||||
| -rw-r--r-- | wqflask/maintenance/dataset/run.sh (renamed from wqflask/maintenance/dataset/calculation/correlation/run.sh) | 0 | ||||
| -rw-r--r-- | wqflask/maintenance/dataset/test.py (renamed from wqflask/maintenance/dataset/utilities/test.py) | 0 | ||||
| -rw-r--r-- | wqflask/maintenance/dataset/utilities/__init__.py | 0 |
22 files changed, 3974 insertions, 0 deletions
diff --git a/wqflask/maintenance/dataset/20140110_Megan/C57BL-6JxC57BL-6NJF2.geno b/wqflask/maintenance/dataset/20140110_Megan/C57BL-6JxC57BL-6NJF2.geno new file mode 100644 index 00000000..f0c05a3a --- /dev/null +++ b/wqflask/maintenance/dataset/20140110_Megan/C57BL-6JxC57BL-6NJF2.geno @@ -0,0 +1,69 @@ +###Created by M.K.Mulligan 04242013
+###B=C57BL/6J; N=C57BL/6NJ; H=heterozygous or N on the X chromosome for males; U=No call
+@name:C57BL-6JxC57BL-6NJF2
+@B=C57BL/6J; N=C57BL/6NJ; H=heterozygous; U=No call
+@type:intercross
+@mat:B
+@pat:N
+@het:H
+@unk:U
+Chr Locus cM Mb C57BL/6J C57BL/6NJ JxNJ0000 JxNJ0751 JxNJ0752 JxNJ0753 JxNJ0783 JxNJ0801 JxNJ0802 JxNJ0804 JxNJ0806 JxNJ0807 JxNJ0809 JxNJ0810 JxNJ0811 JxNJ0812 JxNJ0813 JxNJ0814 JxNJ0815 JxNJ0816 JxNJ0817 JxNJ0818 JxNJ0819 JxNJ0820 JxNJ0822 JxNJ0823 JxNJ0824 JxNJ0826 JxNJ0828 JxNJ0829 JxNJ0830 JxNJ0831 JxNJ0832 JxNJ0833 JxNJ0834 JxNJ0835 JxNJ0836 JxNJ0837 JxNJ0838 JxNJ0839 JxNJ0840 JxNJ0841 JxNJ0842 JxNJ0843 JxNJ0844 JxNJ0845 JxNJ0846 JxNJ0847 JxNJ0848 JxNJ0849 JxNJ0850 JxNJ0851 JxNJ0852 JxNJ0853 JxNJ0854 JxNJ0855 JxNJ0856 JxNJ0857 JxNJ0858 JxNJ0859 JxNJ0860 JxNJ0861 JxNJ0862 JxNJ0863 JxNJ0864 JxNJ0865 JxNJ0866 JxNJ0867 JxNJ0868 JxNJ0869 JxNJ0870 JxNJ0871 JxNJ0872 JxNJ0873 JxNJ0874 JxNJ0875 JxNJ0876 JxNJ0877 JxNJ0878 JxNJ0879 JxNJ0880 JxNJ0881 JxNJ0882 JxNJ0883 JxNJ0884 JxNJ0885 JxNJ0886 JxNJ0887 JxNJ0888 JxNJ0889 JxNJ0890 JxNJ0891 JxNJ0892 JxNJ0894 JxNJ0895 JxNJ0896 JxNJ0897 JxNJ0898 JxNJ0899 JxNJ0900 JxNJ0901 JxNJ0902 JxNJ0903 JxNJ0904 JxNJ0905 JxNJ0906 JxNJ0907 JxNJ0909 JxNJ0911 JxNJ0912 JxNJ0913 JxNJ0914 JxNJ0915 JxNJ0916 JxNJ0917 JxNJ0918 JxNJ0919 JxNJ0920 JxNJ0921 JxNJ0922 JxNJ0924 JxNJ0925 JxNJ0926 JxNJ0927 JxNJ0928 JxNJ0929 JxNJ0930 JxNJ0931 JxNJ0932 JxNJ0933 JxNJ0934 JxNJ0935 JxNJ0936 JxNJ0937 JxNJ0938 JxNJ0939 JxNJ0940 JxNJ0941 JxNJ0942 JxNJ0943 JxNJ0953 JxNJ0954 JxNJ0955 JxNJ0956 JxNJ0957 JxNJ0958 JxNJ0959 JxNJ0961 JxNJ0963 JxNJ0964 JxNJ0965 JxNJ0966 JxNJ0967 JxNJ0968 JxNJ0969 JxNJ0970 JxNJ0971 JxNJ0972 JxNJ0973 JxNJ0974 JxNJ0976 JxNJ0977 JxNJ0978 JxNJ0979 JxNJ0980 JxNJ0981 JxNJ0982 JxNJ0983 JxNJ0984 JxNJ0985 JxNJ0987 JxNJ0988 JxNJ0989 JxNJ0990 JxNJ0991 JxNJ0992 JxNJ0993 JxNJ0994 JxNJ0995 JxNJ0996 JxNJ0997 JxNJ0998 JxNJ0999 JxNJ1000
+1 1-59904011 x 59.904011 B N N H N N H B H N B N H H H H B H N N H H N B H H N N B H N H H H H N H B H H B H H H N B H H H H N H B N H H H H H H N H N H H N H N H H B H H H N H B H N B H B B H H N H H H N H H H H H H H N B H B B B H N B N B H N B B H H B B H H B H B N B N B N N N B B H H B H H H B H B N H N N H B H H B H H H B B H H N H H H B N N H N N B B N N H N B H N H B H H H B B H N H
+1 1-90703267 x 90.703267 B N N N N N H H H N H H H H H H H H N N H H H B H H H N B N N H B H H H H H H H B H H H N B H N N H N H B N H H H H H N N N H H H H H B H H B H N N N H B H H H H B N H H N H H B H H H B H H H H N B N H B B H N B N B H N B H H B H B H H H H B N H H H N H H B B H H N H H H B H H H H N N H B H H B N H H B B H H N H H H H H H H H N H B N H H N B N N N B H H H B B H N H
+1 rs51237371 x 183.248134 B N H N H N N B B N H H H H H H N N B H N H H B B H H H B H N H B B N N N N B N B H B H N N H H H B N H B H B H H B H H H H H H N H H B H H H N H N H H B H N B H H H N H N H H H H B B B H H N H H H H N N B H B B H B H H B N H H B H B H H H H H H B N H B H B N H H H B B B H B N B H H N N N N H B H H H H H H N N H N H H H H H B H H N B B H B B B N H H H H N B H H H N
+2 2-24042711 x 24.042711 B N H H B B B H H N N H H H H N H B N B H H B H H H H N N B H H B B H B B H B B H N B H N N N H H B N H N B N H H H B H B B H N B B H H H H N B N H H H H H U B H H H H H H N H H H H B B N H H H H N B B B H N H H H H H H N H N B H H B H B N N H H H H N N N H H N H U N H B H H B H H H H N H N N H H H N B H N B H H H H B N H H H N B B B N N B H N N H H H H N N H H B B
+2 2-59889445 x 59.889445 B N H N B B B H H N H N N H H H N H N B N B H B N B H N N H H H H H N H B H B N N N B H N H N H B B N H H B N H H H B H B H H N B B B H B H N B N H N N H H H B H H H H N N H N H B H B B N H B H H H H B B H H H H H H H H N H N B H B H N B N N H H H H N N N N N H B H N H H H H B H H B H H N N N B H B N H H N B H H H H B N H H H H H H B H N H H N H H B H H H N H N H B
+2 2-152607139 x 152.607139 B N H N H B H N N N H N H H B N H H N N N H B H N H B H N H N B H N N H B B B H H H B H N B B H B H H H H H H H H H B B B H H B B B B H N N H B N B H N N H H B H H B H N N H H N N B B B H N B H N H N B H H H B N N H N H N N B B H H N N N H H H N N H N N H N N H B H H B N H H B N H B H B H B H B B B H B H H H H H H H H H N H B H B H N N H H N H H H B B H H H H H H H
+3 rs30751697 x 54.718828 B N H B N H H H B H B H H H B H N H N B H N N B H H B N B B H N H B B H N H H N H H B H H H H H N B H H H B B H N H H N N N H H N N B N B B N H H H H H H H H H B H H N H N H N H H N B H B N B B H B H B B H B H H H H H B H H N B B H B H H H N H B B N N H H H H B B H H H H N N H H N H B B H B B H B N H B H N H H N H H B H B H B H H N B B H H B B B N H N N H B B H H N
+3 rs13474735 x 95.538799 B N H B N H H H H H B H N B B H N H N H B N N B H N H H B B H H H B H H H H H N H H B B B H H H N B H N B B B H N H B N H H H H H H B N H H N H H H H H H B N H B H H N H H H H H H N H H H N B B N B H H B H B H B B H N B H H H H H H B H H N N H B B H N H H H H B H H H H H H N B H N H B H H B B N H N H B H N H H N H B H N B N B H H H B B N B B B H N H N N H B H N H N
+3 3-159474065 x 159.474065 B N B N N B H B N H N H H N B B N N N H B H H B B H H B H B H H B B N H H N N H N H H B H N H B H H H N H H H N H H B N H H H H H H H N H H B N B H N H B B N B H B H B H B B H H B H H N B N B H N H H B H N N B B B N N H N H N N H N B B N H H B B B B B H B B B N N N H H N H H H B H B B H B H H H N H B B N H N H B B H N H B N H H B B N N N B N H B N H H H B B H N H H
+4 rs13460207 x 21.800831 B N H H H H N B H H N N H H B H N N N H B H N H N B B H U B H B H H H N B B H B H B H B N H H H H N B H H B H N H B B H B H N N H N B B N N H N N N H H N N U H H H H N N B B H H H N H N H B B B H H H H H H B H H B H B B H B H H N H H H H B H H H H B N U H H B B B U U N H H B N B N H N H N H N N H B H B H N B N N H H N B H N N H N N B H H H B H H N H N H B H H B U B
+4 rs46850777 x 40.752043 B N B N B H N B H H N N B B B H N N H B B H B H N B B H N B H B B N H N B B H B H B H B N H B H H N B B H B H H H B N H B H N H H N H B N N H N N N H H N H H H H H H N N B B H H H N H N H H B B H H H H H H B H H B H H H H B N H N B H H H B H H H H B N B H H B B B H N N H H B N B N H N H N H N N B H H B H N B N N H H N B H N H B N N H H H H H B H N H N H B H H B H B
+4 rs32865425 x 124.331809 B N B N H N B H H H N H H H B H B H H B H H B H H B H N H B H B H H H N H B H B B B N B N H B H H N H H B H B H H B N H H H N N H N H B N H H H H H H N H H B N H H H B H H B H H H N B H H H B H H B N N H B H H H N N H N H B N B B B B B N H H B H H B N H N B H B B H H H N H H B B H H N H N N N N B N B H H N N H H N N N B N H H B H N H H N H N H B H N H N B H H H H H
+4 4-137777588 x 137.777588 B N H N H N B H B H H B H N H H B H H H H H H H H H H H H B H B N H H H B H H H H B N B H B H H H H H H B H B B H B N H H H H N H N H H N H H H H B H N H H B N H H H H H H B H N H N B H N B B H B B N H H B N B H N H B N H B N B B N B B N H H B H H B N H N B H H H H H H N H H B B H H N H H N N N B N B H H H N H H B N N B N B H B H H H H H H N N H H N H N B H H N H H
+4 rs32407463 x 150.05969 B N H H H N B N B B H B H N N H H H H H H H H H H H H H U H H B N B B H B H H N H B H B H B H H H H H H B H B B H B H H H H H N H N H H H H H H H B B N B H U N N B H H B H B H N H N B H N B B H B B N H H H N B H N H B N H B N B B N B B N H B B H H B N H N H H H H U H H H N H B B B N N N H N B N H N B H H H N H H B N N B N B N B H H H H H B H N H H H N N B H B N U H
+5 rs33209545 x 60.224881 B N B H H H N H H B H N H H B H H H N H N B N H H N B H H H H B H H B N N H B H N H H B H B B N B H N H H H H H H B N N H H B H H H N H B H H B H N B H H H H N H B B H N N B N H H B H N H H B B H H H N N H N H B H H H H H N H B N H H B N B N N H H B B B N B B N H B N H H B H H H B B H N B B N H B N B N B N H B H H N N N N N N H N H N N H H N H H H H H H H H H B H B
+5 rs29547790 x 71.32277 B N H H H H H H H B H N H H B H H H H H N B H H H N B H H H H B H H B N N H B H N H H B H B B N B B N H H H H H H B N N H H B H H H N H B H H B B N B H H H H N N B B H N N B N H H H H N H H B B H H H N H H H H B H H H H H N H B N H H B N B N N H H B B B H B B H B B N H B B H H H B B H N B B H B B H B N B N H B H H N N N N N N H N H N N H H N N H H H H H H N H B H B
+5 5-90204376 x 90.204376 B N H H H H H B H B H N H H B H H H H H N H N H H N B H H N H B H H B N N H B H N H H B H H B N H B N H H H N H H B N H H H B H H H N N B H H B B N B H H H N N N H B B N H B N H B H H N H H B B B H H N H H H H H H H H H H N H B N H H B N H N N H H B B H H B B H B U U H H B H H N H B H N B B H B B H B N B H H B H H N N N N H N H N H N N H N N N H B B H H H N H B H B
+5 rs3719791 x 132.016906 B N H H H B B B H B B H H H B H B N H H H N N H H N B H H N H H N H H H N H B H N H H B B H B H H B N N H H N N N H N H H N H H H N H N H B H B H N H H N B H B N H H H H H B N N B N B H N H B B B B H N B N H B H H N H N H N H H N B B H N H N N H H B B H H H B H B B N H H H N B H H H B H H B H B B B H H H N H B H H H N N H B B H N H B N B H H N H N B H H H N H B H B
+5 rs33404968 x 149.838448 B N H H B H B H H H B N N H B H B H H H H N N H H N B H B N H N N H N H H H B H N H H B B N B H N B N N B B H H N H H H H N H H H N B N N B H H H N N H H H N B B N H N B H B N N H N B B H B B H N H B H B N B B H B N B N H N H H N B B H N H N H H H B B H H N B H B H N H H H N B H N H B H N H H H B H H H H N H B H H H H N H H B B N H B N B H H H H H B H H B N H H H H
+6 rs30899669 x 39.350455 B N H N B H H B B B B N B H N B B B B H H H N B N H B B B H H H H H H B B N H N N H B N H H B N H H H H H H H B H N H B N N H N N H N H B N N H H H H B N N B H H B H N H H N H H H B H B H N N B H H H H H B B H B H H N N N H H B H H B H B N H N H H B N B N H B H H H B H H H B H H H B H B B B N N B N H B H B B B N H H N B H H H B B N N H H B N H H H H B H N H B N B N
+6 6-90109621 x 90.109621 B N N N B B N B B B B N B B N H H H B B H H N B H N B B B H H N H H H H B N B N N H H N H N B N H H H H H H N B H H B H N H H N N H H N H N H N N H N B N H H H H B N N H H H H B H H H B H H H B H H H H H B B H H H B N H N H B N B N H B H N H N N N N N B N N B H H N B H H H H B B H H H H B B B N N H B B N B H H H H H H H H H H H H N B H N H N B N B N H H N H B H H N
+6 rs30119689 x 145.19523 B N N N H B N B H H B H H B B N B H B N H N N B H H H B B B H N N H N N H N H H N N N H H H H N H H H H H H N B N N B H H B H H N H H N H H N H N B N H N H H H H B N N B H H B B B B H H H H B B B B H B B B N H H B B N B B H H N H H H H N N B H N H N N H H B H B B N H H B H B B B H N N B B H B B N H H B B H H H B B B H H H N H N N B H N N H H H N B N N B N N B B N B
+7 rs3148686 x 31.091494 B N N H H B B H H H H H B H N N H B H N H H H H H N H H B H H H N H B H N H B B H N H B B H N H N H H H N H H N H H H H H H H B H H H B N H B H N H H H B H B H B N H H N B H H N H H N N H H H B N B B H H B B H N H H N H H N N N B H H B N H H H H N B B H B H B B N N B H N H H H H H H B B B H N B H H H B B N H H B N H H N B H H N B H H B H H H B B N B H H N H N H H N
+7 rs50155421 x 63.386662 B N H H N H B H H H B H B N N N H B H H H H B H H H H H H B H H N H B H H B B H H N H B B B N B H H N H N H B N H B N B H H H B H H B B N H B H H H H H H H B H B N N H N H N B H H H B H B H H H H B B H H H B B N B H N H H N N N B H H B N H H B H H B B H H B B B H U H H N H H H B H H H B H H N B H H H H B H H N H N B H N B H H N H H H B H H H N B N B H H N H N H H N
+7 7-127278693 x 127.278693 B N H B N H B B B H B N B N H H H B H H N N B B B B H B H H N H H N N H H H B H B H H H B B H H H H H N N B H N B H N H B N N H H N H H N H H H B H H B N B H H H N H N H H H B H H H B H B N B H H H H B H H H B H H H N H H B N H B H B H H H H B H H H B H H B H N B H H H N H H H H H B H H H N N B H N N H H H B N N N B H N H H B N H H N B B B H N H N H N B H H N H N H
+8 8-14127388 x 14.127388 B N N H H H H N H B N H N B B H H B H N H H H N B B H H N B H H H B B H B H N H H H H N H H H B B H H B N N H N H B N N H H N H H H B H B N H H N H N H H N H H N N H H B H H B N H H H H B H N H B N N N H H N H N N H H H H H N N H B B B H H H N H B H H H B H B B N N H B H B B B H B H B H N B N B N H B N H B H N H H H H H B H H H H H H H N N H H N B H N H H H N H H H
+8 8-61604358 x 61.604358 B N N H H H B N H H H H N H B B H H H N H H H H H H B B H B B H N H B H H H N H H N H H N H H H H N B B H N N N B H N H H B N H N H B H N H H H H H N H H N H H H N H B H H N H H H H H H H H N H B N H N H H N N N N N H B H B H N H B B H H H N B H B B H B B H B H N H H H B H H B H B N H H N B H B N H B H H B H H H N H H N H N H H H B H H N B N H N H B N H B N H H N N
+8 8-87889078 x 87.889078 B N N H H H B H H H B H N H B B H H H N B H N H H H B U U B B B N H B H H H N H H H H H N B B N H N B H H N N N B H H H H B N H N N B H N H H H B H N H B N U H H N H B H B N H B H H H H H H N H B N U N H H N N N N N H B H B B N H B B H H N H B H B B H U B H B N N U U H B H N B H H N H H N B H B H H H B H N H H H N H N N N N H H H H H H N B N H N H B H H B N B H U N
+8 8-122469661 x 122.469661 B N N N U B H B H H B U B H H U H H H H N H B U H H B U U N B U U N H U N H H H H N B H B B N N B H N H H H H N B H U H H U N H H H B H N H H B B B N H B H U H H B B H H B B H H B H H H H N N N H N U H H B N H N N H H H H B B N H H B H B N H B H B H H U N H H H N U U H B H N B B B H N H N H H B H B H B H N B H B H N N N N H H B H N H B N H H N N H B H H B H H H U N
+9 9-3994759 x 3.994759 B N B N N H N H H N B B H N B H B N H H N N B H N H H H H H H H H B N B H H H H H B H H H N H H H B B N B B B H H H H B B H B H H H H B N H N H N B N H H H N H B N B H H H B B H H H N N H B H B H N B N B N H H H H H H H H H B B N N B H H H H H H H B H H H N H H B B N H B H B H H B N N H H H H B N H B N B N H H H H H H H N B H H N H H B H B H H H B B N H B N H B B H
+9 9-24935069 x 24.935069 B N B H N B N H N N B B H N B H B H H H N N B N N H H H H H H H N B N B H N H H B B H H H N H N H B B N B B B H H H H B B B B H B H H B N H N N H B N H H H N H B H B B H N B B H H H N N H B H B H N B N B N H H H N N H H H H B B H N B H H B H H H H B H H H N H N B B N H B H B H N H N N H H B H B N H B N B H H H N H B H H N B H B N H H H H B H H H B B N H B N N H B H
+9 rs30522453 x 86.11453 B N B H H B N B N H B N B H H B B H B H N H N N B B N H N H H N N H H B H N N N H H H H N H H H H N B B B B H B B H H N H B H H B H H H H H N N H B H B H B H H H H H B B H H B N H H B H N B N H N H N H B H B N H H H B N N N N H N N B H H H H H H B H H H N N N H H H B B H N H B H H H B B N B H H N N B B H H H N N B B N H H B H B H H N H H B H H N H B N H H N H N U H
+9 rs49019729 x 119.926025 B N B N H H N B B B H H N H H B H H H N N H N B B B N H H H H N N H H H H H N N H B H H N H H H H N N B B H N B B H B N B B H H H N H B N H H B H N B B H B H B B H H B H H B H N B B N H N B H N N B N H H H H H H B H H H H N H H N H H N H H H H H B N N H N N H H H H B B H H H H H N H B B N N B H B N H B H H H N H B H N H H B B B H H H H H H N H H B H H H H N B N H H
+10 rs29330320 x 29.332472 B N N B N N H H N B B U N B B U B B B N N H N N B B B U U N H N H H H H H H N B B H B H B B H B H N N H N N B H H B U N H H H N B H H H H B H B H H N N H N U N H B N H H B B H H H H H N H N H H H H H N H B H N B B B H H N B B H N H B H H N B B N H H B N B B N B N U U H H H H H H B B B N H H H H N B H B N B H H B B H H H H H H N B B B B N N H B H B H H H B H B N U H
+10 rs13480628 x 66.700922 B N N B N N H H N B B H N B B H H B B H N B H N B B B B N N B N H H H H N N N B B N B H B B H B H N N H N N B B H H B H B H H N B N N H H B B B H H N H H N H N H B N H B H B H H H H H N H N H H H B H N H B H N H B B H H N B B H H H B H H N B B N H H H N H B N B N H H H H H B H H B B B N H H H H N B H B N H B H B H H H H H N H H B B H B N H H B H B H H H H N H H U H
+10 10-87554578 x 87.554578 B N N B H N H H N B B B N H B H H B B H N B H N B B H H N B B N B H H H N N N B B N B N H H H B N N N H N N B B H H B H B N H N B N N N B B B B H H N B H N B N H B N H B H B H H H H H N H N N H H B B N H B N N H H H H H H B B H H H B H H N B B N B H H N H H N B H H B H N H B H H B B B N H H H H N B H B N H B H B H H H H H N H H H B H B N H H H H B H N N H N H H B H
+11 rs48169870 x 30.575691 B N B U U H H H B H H U N H B U N B H N B H N U H H N U U H H U U B B U H U H H B H H B B H B N H H H B H H B H H B U U H H B B B H H N H B N H B B H H B B U H H U N N B N H H B H B B B B N H H H H U H H H H B H H H H N N H N H H H U U B H N H B B U H H U H N H B U U H H N N N N N H H H H B H B H H B H H N H B H H H U H H H H B B H N H N H B B H H N N B H N H H U N
+11 11-46036117 x 46.036117 B N H N H H H B H H H N N H B N N B H N B H N H H N N B H H H B B B H N H N B H B H H B B N B H H H H B H H B H H H N H H N B B B H H N N B N H B B H H B H N H N N N N H N H H B H H B B B N H H H H B H B H H H H N H H N N N N H H H N N B H N H B H H H H N H H H B B N H H N N N N N N B H H B H H H H B H H H H B H H H H H H H H B B H N H H H B B H N N N B H N H H H N
+11 rs6268547 x 62.886983 B N H H H H H B H H H N N H B N N B H N H B H B N N H B H B H B B B N N H N H H B H H B H N B B H H H B H H B H H H N H H H B H B H H N N H N H B B H H H H N H N N N N H N B H B H H B B B N H H H H B H B H H H H N N B N H N B N H H N N B H N H B H H N B B H H H B H N H H N H N N N N H H H B H H H H H H H B H H H H H H H H H H B H H N H B H B B H N N H B H N N B H H
+11 11-90341985 x 90.341985 B N H B H H H B H H N N N N B N N H H H H B H B N N B B H B H H B B N N H H H H B H H B H N B H H H N N H H H H N H N H H B H N B H H B H H N H B H B H H H N H H H H N H H B H B H H H H H N H H H B B H B H H H H N H B N H N B N H B N H B H N B N H H N B B H H N B H N B H N H N N H N N H H H H H H B H H H H H H H H H H H B H H B H H H H B B B B H N N H H H N N B H B
+11 rs49027247 x 120.168102 B N H B H H H H H H N H N N H H N N B H H H H B N N H B N B N H B B N N H H H N B H H H H H B H H N N N B H H H N B H H H B N N H N B B H H N H H N B N N B N N H B B N H H H N H N H H H N H H B H B B H N H H B H N B B H N N H H N H N H H H H B N H H H H B H H H H H N B H H H H H B H N B N H B N H H B H H B H H H B B N N B N H H H B B H H B H B B H H H H B N N B H B
+12 rs29165094 x 29.094628 B N H N B B H H H H B B H B N B H N N H H H N H H H N B N N N B H H B H N H H H B N N B H B H H H B N B H H N H B H B H N H H H N N H N H H B H H B N N B B N N N B B N B B H N B H H N H N H H H H H N H H N H H H B B B N B B H H N H H H H H N B N N H H N H N B B N H N N H N B H H B B H H B B H H N N B H H H H H H B N H N B H B B N B H B N B B H H H B B H B N H N H N
+12 12-92834114 x 92.834114 B N H H B H H H N H B B H N N N B N N H H B N H H N H B H H N H N B B H N H N H B N H B H B N H N H H B B N B H B H H B B H H H H N H H H H H H H B H N B H N H N B B N B B H N B N H H H B N B H H B B H B N N H H B B B N B B N H N B H N B H N B N N H H H H H H B H B N N H H N H H H H H B H H H N N H H N B H H N B H B N H B N B H N B H H N B H H H H H B H B H H B B H
+13 rs29248623 x 52.853421 B N N N B H H N B H N N H N B B H H B N H B B B H N H H N B H H H H H H H N H B H H H H B H N N N H B H H H N H H H H B B H H H N H N H H B H H N H N N B H H H H B N B H H H B N B N H B N B H N H H N B N N H H N N B H N B H H H H B H N N B N N H H H H B B B N H H N H N H H B H B H H N N N B B H B N H B N N N H B N H N H B B N H B N B H B B N B N H B H B N H H N H B
+13 rs29622109 x 88.566525 B N H H B H B H H H N N H N B B B N B N N H H B H N B U U B H N N N H N H N H B H H H H B H N N N H B B H H H B H H H B B B B B N H N H H B N H N H N H B H U N B B N B H H H B N B N H H N B H H H H H B N N H H N N B H N H H B B N B H H H N N N H H H H U B B H B H U B N H H B B B H H N H N B B H B H B B H H N H B N B N N H B N H H N H B B B N B N H B H B N H H N U B
+13 rs29235721 x 119.932328 B N H B B B B H H H H N H N B H H N B N N H H H H N B B N H H N N N B N H H H B H H H H B H H N N H B H B H B B B B N H B B B B N B N N N N N H N N H H B H B H B B H H N H B H N N N N N H H H B H H B H N N N H H H B H H N H B B N B N H H H N N N H H H H H B B B N B B H B B B B H N H N H N B H B B H H B N H H H H H H H N H B N N N N N H H H N H B H H N H H H H H H B
+14 14-91246882 x 91.246882 B N H N U H B H H H H N N H B B H N H H H B H H H N H H B B H N H B B N B H H B H B H H B N H H H N B B B N H B H B B B B N B H B H B B H B H N H H N H N B B B H B B H N H N B N B N N H B B N B N B B N N H H N B H H N N H H B B N H B H H H H H N N H N B N B H N B B U H B N B H B H H H H H H H B B B N H H N B B H H N H B H H H H H H B H H B H B N B B H B H H B H H B
+14 14-117002819 x 117.002819 B N H H H H B B H H H N H H B B H N B H H B H H N H H H B B H N H N H N B H H H H B H H B H H H H N B B H B H B B B B B B N B H B H B B B B B N H H B N H H H H H B B H N H N B N B N N N B B N B N H H N N H H H H B H N N H H B B N N B H B H H N N H H N B N B H N H B H B H N B H B H H H H H H H B B B N B H B B B B H N N B H H H H H H B B H B H H N H B N B H H B N H H
+15 15-11266138 x 11.266138 B N N H H B N N B H H B H H N N H B H H H H H H H B H U U H H B B N H B B N H N H N N H H H H H B B H B N N H H H B B N H B B H N B N H H N B H N B B N H H U N H B H N B N B H B H B H H H B N B H H N N B B B N N H H B N H H B H H H B B B N H H H B H H U H N B N B U U H N N B B H B B H N H H H H N N H H H N B B N H H B H H H H H N B N N H N H H H H N N H B H H H U H
+16 16-35291630 x 35.29163 B N H H B B H H H H B H H H H H B H N B H H H B H B H H H H H N H B H B N H H N N B H N H H N H B N B N H H B H B H B H H H N H B H H N H B N H B H N H B H N N H H H H N B H N H B H H B N H H N H B N H B H B N H H H B N N N N B B H N H B N N N N N B B H H H B N H H B H H B H N B N H N H H H H H B N N H B N B H N B H H B B N N H N H B B B H N H N N N B B N N H B N B
+16 rs48691087 x 60.954442 B N H H B B B H H H H H H H H N B H H B H H H B H H H H H H H N H B H B N B H N H B H N H H N H B H H N H H B B B N B H H H N H B N H N H H N H H H N B B B N N H H H N N H H N H B H H B H H H N H B N H B H H N B H H B H N N N H B H N H B N N N H N B B H B H B H H H B H H H B H B N H N N N N H H B N N H B N B N N B H N H B N N H H B B B B H N H N N N B B N H H B N H
+16 rs4217166 x 90.181254 B N H H U B B B H H H U H H H U B H H B H H H U H H H U U B H N U B N B N B H N U H H N B H H N B H H H N N H U B H U H H U H N B N U H H H H H H H N B B B U N N U H N N H B N B B H H H B H H N N H U H B H H H B B B B H N N N H H N N U H N N N H H B H U U H B H H U U U B H B B B N B N N N N N H H H H H B H B N N B H N H B H N H H B H B B H N H N N N B H H H H H U H
+17 rs46703123 x 26.991191 B N H B H N H B H H N B B H B H H N B N B N N H H H N H B H N B N H H H H H H N H H H H N N N H H N H H H H H N H B N H H B H H N H H H B H H H N H H B B H N H N B H H H N B H H N H H H H H B B H H H N B N B H B N H H H B N B N H H B N B B H B H N N N N B N H H H N B H H N H B H H B N B B B H H B H B B H N N H B H H H N H H H N H B B H N H H B N B N H H H N N N B H
+17 rs33387924 x 68.102223 B N H H H N H B N H H H H H B H B H H N H N B N H H N N B H H N N B H N N B B B H N N H N H H H H N H H H H B N B B H H N H B H N H H H B B B B N B H H B B H B H B H N B N H H N N N B H B H B B B H H N B H H B H H H H N B N B B H H N N B H H B H N H N B H H H N H H H N H N H B H H H N B N B B N B B N B H H N H B H H H H H H N N B H N B N B H B H H H B H N H N N B H
+17 rs50807504 x 90.107756 B N H H H N H H N H B H U N B N B B H H H N B N H N N N B N H N H H B N N B B H N N H H N B H H B B N H H H B B B N H B N N H N N N H B B H B H N H H H H B B B H B B N H H H H H N H B B B N B N B H H B B H N H H H B H N N N N B H H N H B N B H H H H H B H H B N H H H H H N N B H H H N B N B H N B B N H H N N N B H H H H B N N N H H N B N B N B H H B B H H H H H B N
+18 18-90618149 x 90.618149 B N H N H N H B H H N B N B H H N B H H H N H H B N H N H H H H N H H N H H N B N N B B H N H N B H H H N B H H N H H H B H H N N B B N H H H H N N B B H B H B B H N H H H H N H H H H N B N H B B H H H N B H H B N N N H H H B H H N H B H N B N B H H N H H B H H N N H H H N N N B H B N B H H H H B B H N N H B H B H H H H B H H H H B N H B H B H H H B N H N B N B N H
+X X-61565614 x 61.565614 B N B B H H B B H H B H B H B B H B H B H B N B B B B H H H B B H B B H H B B H B H H H B B H H H B B H H H B H B H H B B H H H H B B B H H B H H B H B H H H H B B B H H H H H H H B B H B B H H H B H B H B B H B H B B H B B B B H H H H H H H B H B B H B H H B H H H H H B B B N B H B H H H B H B H B B H H B H B H H H H B H B B B H H B B B H H H H B H H H H B H B H B
+X X-87964774 x 87.964774 B N B B H H B B H H B H B H B B H B H B H B N B B B B U U H B B H B B H H B B H B B H H B B H H H B B H H H B H B H H B B B H H H B B B H H B H H B H B H B H H B B H H H H H H H H B B H B B H H H B H B H H H H B B B H H B B B B H H H H H H H B H H B H H H H B B H B U H B B B N B H B H H B B H B H B B H H H H B H B H H B H B B B H H B B B H H H H B H H H H B H B U B
+X X-149209478 x 149.209478 B N H B H B H B H H B H B H B B H B H B H H N H H H B H B B H B H H B B B B B H B B B H H B B H H B B H H H B H B B H B H B H B H B H H B B B H H B H H H B B H B B H H H H H H H H B H H B H H H H B H B H H H H B B B H B H H B B H H H H H H H B H H B H H B H B B H B B H B B B B N H B H H B H H B B H H B H H H B H B B B B H H B B H B H H B H B B B H B B H H H B H B B
diff --git a/wqflask/maintenance/dataset/20140110_Megan/conf.ini b/wqflask/maintenance/dataset/20140110_Megan/conf.ini new file mode 100644 index 00000000..866373c2 --- /dev/null +++ b/wqflask/maintenance/dataset/20140110_Megan/conf.ini @@ -0,0 +1,5 @@ +[configuration] +speciesId = 12 +inbredsetid = 13 +genoFreezeId = 14 +genofile = C57BL-6JxC57BL-6NJF2.geno
\ No newline at end of file diff --git a/wqflask/maintenance/dataset/20140110_Megan/run.sh b/wqflask/maintenance/dataset/20140110_Megan/run.sh new file mode 100644 index 00000000..44e96fd7 --- /dev/null +++ b/wqflask/maintenance/dataset/20140110_Megan/run.sh @@ -0,0 +1 @@ +/usr/bin/python ../code/genotypes_load.py conf.ini
\ No newline at end of file diff --git a/wqflask/maintenance/dataset/calculation/correlation/about.txt b/wqflask/maintenance/dataset/about.txt index a12f8c47..a12f8c47 100644 --- a/wqflask/maintenance/dataset/calculation/correlation/about.txt +++ b/wqflask/maintenance/dataset/about.txt diff --git a/wqflask/maintenance/dataset/bxdphenotypes.txt b/wqflask/maintenance/dataset/bxdphenotypes.txt new file mode 100644 index 00000000..39277747 --- /dev/null +++ b/wqflask/maintenance/dataset/bxdphenotypes.txt @@ -0,0 +1,3899 @@ +id Original_description Pre_publication_description Post_publication_description D2B6F1 B6D2F1 C57BL/6J DBA/2J BXD1 BXD2 BXD5 BXD6 BXD8 BXD9 BXD11 BXD12 BXD13 BXD14 BXD15 BXD16 BXD18 BXD19 BXD20 BXD21 BXD22 BXD23 BXD24A BXD24 BXD25 BXD27 BXD28 BXD29 BXD30 BXD31 BXD32 BXD33 BXD34 BXD35 BXD36 BXD37 BXD38 BXD39 BXD40 BXD41 BXD42 BXD43 BXD44 BXD45 BXD46 BXD47 BXD48 BXD49 BXD50 BXD51 BXD52 BXD53 BXD54 BXD55 BXD56 BXD57 BXD58 BXD59 BXD60 BXD61 BXD62 BXD63 BXD64 BXD65 BXD66 BXD67 BXD68 BXD69 BXD70 BXD71 BXD72 BXD73 BXD74 BXD75 BXD76 BXD77 BXD78 BXD79 BXD80 BXD81 BXD82 BXD83 BXD84 BXD85 BXD86 BXD87 BXD88 BXD89 BXD90 BXD91 BXD92 BXD93 BXD94 BXD95 BXD96 BXD97 BXD98 BXD99 BXD100 BXD101 BXD102 BXD103 +10001 Original post publication description: Cerebellum weight [mg] None Central nervous system, morphology: Cerebellum weight [mg] x x x x 61.4 49.0 62.5 53.1 59.1 53.9 53.1 45.9 48.4 49.4 47.4 56.3 53.6 50.1 48.2 50.6 53.8 48.6 x 54.9 49.6 47.4 51.5 50.2 53.6 49.7 56.0 52.1 53.7 49.7 44.5 x 51.1 54.9 49.9 x 59.4 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10002 Original post publication description: Central nervous system, morphology: Cerebellum weight after adjustment for covariance with brain size [mg] None Central nervous system, morphology: Cerebellum weight after adjustment for covariance with brain size [mg] x x x x 54.1 50.1 53.3 55.1 57.3 51.2 53.6 46.8 50.6 49.3 45.7 52.5 52.0 51.1 52.4 49.0 51.6 50.7 x 55.5 52.6 53.1 53.5 53.2 58.7 50.8 53.3 51.9 54.1 52.3 46.1 x 51.8 57.0 48.6 x 56.6 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10003 Original post publication description: Central nervous system, morphology: Brain weight, male and female adult average, unadjusted for body weight, age, sex [mg] None Central nervous system, morphology: Brain weight, male and female adult average, unadjusted for body weight, age, sex [mg] x x x x 483.0 403.0 501.0 403.0 438.0 448.0 408.0 405.0 392.0 414.0 437.0 450.0 429.0 409.0 374.0 437.0 435.0 394.0 x 408.0 385.0 359.0 394.0 385.0 365.0 403.0 439.0 445.0 439.0 417.0 427.0 x 436.0 423.0 455.0 x 469.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10004 Original post publication description: Central nervous system, morphology: Cerebellum volume [mm^3] None Central nervous system, morphology: Cerebellum volume [mm^3] x x x x 49.8 45.5 62.9 x 55.1 47.3 50.6 43.8 47.9 47.1 44.5 x 47.5 46.4 43.2 x 50.4 43.1 x 50.7 45.1 43.5 47.7 40.9 47.9 46.0 55.1 48.2 50.4 46.9 40.9 x 45.5 50.6 44.9 x 53.4 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10005 Original post publication description: Central nervous system, morphology: Cerebellum volume, adjusted for covariance with brain size [mm^3] None Central nervous system, morphology: Cerebellum volume, adjusted for covariance with brain size [mm^3] x x x x 46.0 44.9 52.5 x 54.3 45.8 49.0 42.6 48.3 45.0 41.6 x 47.8 45.8 45.8 x 48.0 43.9 x 52.2 46.6 49.3 49.3 46.0 52.6 46.8 51.5 47.7 51.0 48.2 42.5 x 45.8 52.6 44.2 x 51.1 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10006 Original post publication description: Central nervous system, morphology: Cerebellum internal granule layer (IGL) volume without adjustment [mm^3] None Central nervous system, morphology: Cerebellum internal granule layer (IGL) volume without adjustment [mm^3] x x x x 20.3 15.0 23.0 x 22.7 18.8 19.5 16.4 18.6 15.8 15.2 x 18.6 18.5 14.5 x 21.6 16.4 x 21.1 17.3 16.9 18.9 14.9 17.8 16.5 21.2 19.5 18.7 17.6 14.6 x 16.8 18.9 18.1 x 21.7 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10007 Original post publication description: Central nervous system, morphology: Internal granule layer (IGL) of the cerebellum volume, adjusted for sex, age, body and brain weight [mm3] None Central nervous system, morphology: Internal granule layer (IGL) of the cerebellum volume, adjusted for sex, age, body and brain weight [mm3] x x x x 18.7 14.8 18.7 x 22.4 18.1 18.9 16.0 18.8 14.9 14.0 x 18.8 18.3 15.9 x 20.6 16.8 x 21.8 17.9 19.3 19.5 17.0 19.8 16.9 19.7 19.3 18.9 18.2 15.3 x 16.9 19.8 17.8 x 20.8 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10008 Original post publication description: Phencyclidine response (7.5 mg/kg ip), locomotor response, difference in activity (PCP minus saline) between 1 hr test periods [cm] None Phencyclidine response (7.5 mg/kg ip), locomotor response, difference in activity (PCP minus saline) between 1 hr test periods [cm] x x 5525.0 5062.0 4897.0 4616.0 612.0 4695.0 982.0 441.0 10276.0 10420.0 8905.0 2267.0 2620.0 3237.0 2999.0 6160.0 12184.0 688.0 4218.0 8182.0 x 1165.0 6391.0 1159.0 245.0 2633.0 2805.0 5463.0 3298.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10009 Original post publication description: Phencyclidine response (7.5 mg/kg ip), locomotor activity from 0-60 min after PCP injection [cm] None Phencyclidine response (7.5 mg/kg ip), locomotor activity from 0-60 min after PCP injection [cm] x x 6180.0 5274.0 6307.0 5459.0 1487.0 5691.0 3709.0 1499.0 10922.0 12818.0 2999.0 2743.0 3011.0 4322.0 3763.0 6456.0 11556.0 1873.0 4541.0 7795.0 x 1426.0 7287.0 2635.0 684.0 4337.0 3938.0 6035.0 4701.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10010 Original post publication description: Saline control response (dose 0.9%, ip), locomotor activity from 0-60 min after injection (just prior to injection of phencyclidine) [cm] None Saline control response (dose 0.9%, ip), locomotor activity from 0-60 min after injection (just prior to injection of phencyclidine) [cm] x x 605.0 273.0 2029.0 957.0 361.0 1062.0 1980.0 1184.0 718.0 2416.0 245.0 560.0 532.0 1123.0 751.0 209.0 659.0 1294.0 609.0 1615.0 x 284.0 988.0 443.0 442.0 1847.0 1037.0 663.0 1598.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10011 Original post publication description: Amphetamine response (5 mg/kg ip), locomotor response, difference in activity (amphetamine minus saline) between 1 hr test periods [cm] None Amphetamine response (5 mg/kg ip), locomotor response, difference in activity (amphetamine minus saline) between 1 hr test periods [cm] x x 4844.0 7801.0 13196.0 4389.0 6627.0 8699.0 2973.0 8065.0 2881.0 2461.0 5670.0 4267.0 9238.0 414.0 4438.0 8887.0 4821.0 9263.0 6573.0 5800.0 x 10645.0 8489.0 15450.0 4772.0 4507.0 4413.0 5166.0 6022.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10012 Original post publication description: Amphetamine response (5 mg/kg ip), locomotor activity from 0-60 min after injection [cm] None Central nervous system, pharmacology, behavior: Amphetamine response (5 mg/kg ip), locomotor activity from 0-60 min after injection [cm] x x 6251.0 7137.0 14117.0 4990.0 6820.0 10392.0 4061.0 9382.0 3238.0 3389.0 6222.0 5243.0 9746.0 1756.0 5539.0 9105.0 5021.0 10467.0 6910.0 6730.0 x 10844.0 10070.0 15944.0 5005.0 5479.0 5925.0 5533.0 6867.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10013 Original post publication description: Saline control response (dose 0.9%, ip), locomotor activity from 0-60 min after injection (just prior to injection of 5 mg/kg amphetamine) [cm] None Central nervous system, pharmacology, behavior: Saline control response (dose 0.9%, ip), locomotor activity from 0-60 min after injection (just prior to injection of 5 mg/kg amphetamine) [cm] x x 841.0 431.0 996.0 911.0 423.0 1795.0 798.0 1465.0 413.0 1090.0 582.0 592.0 645.0 1565.0 1195.0 201.0 314.0 1370.0 642.0 688.0 x 202.0 1789.0 586.2 277.0 1074.0 1143.0 460.0 1003.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10014 Original post publication description: Ca2+ stimulated ecto-ATPase activity [umolPi /mg protein/hr] None Central nervous system, pharmacology, behavior: Calcium (Ca2+) stimulated ecto-ATPase (NTPase) activity in brain microsomes (monogenic trait mapping to Chr 2 at 25 Mb at Entpd8) [umolPi /mg protein/hr] x x 8.15 4.13 4.13 6.55 4.03 7.03 4.73 4.03 7.15 4.32 4.11 4.52 6.54 7.84 7.86 7.74 x 4.02 4.24 x x 4.43 3.83 7.32 8.07 7.32 4.61 4.33 3.33 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10015 Original post publication description: Mg2+ stimulated ecto-ATPase activity [umolPi /mg protein/hr] None Central nervous system, pharmacology, behavior: Magnesium (Mg2+) stimulated ecto-ATPase (NTPase) activity in brain microsomes (monogenic trait mapping to Chr 2 at 25 Mb at Entpd8) [umolPi /mg protein/hr] x x 10.12 4.61 4.81 8.41 4.61 8.31 5.11 4.7 8.39 4.71 4.43 4.83 8.33 9.72 9.64 10.51 x 4.2 5.14 x x 5.02 4.63 9.03 9.72 9.52 4.92 4.84 3.91 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10016 Original post publication description: Morphine response (dose ip), hypothermia [slope of drug response curve] None Central nervous system, pharmacology, metabolism: Morphine response (variable doses, ip), hypothermia [slope of drug-response curve] x -7.65 -4.58 -7.01 -7.06 -5.75 -6.33 -4.88 -7.36 -2.93 x -2.02 -3.43 -3.75 -1.88 -1.31 -4.53 x x -2.73 -2.12 -5.29 x -3.54 -6.06 -5.82 -7.5 -6.06 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10017 Original post publication description: Morphine response (dose ip), analgesia, slope of the drug response curve (DRC) [units] None Central nervous system, behavior, pharmacology: Morphine response (dose ip), analgesia, slope of the drug response curve (DRC) [units] x 42.9 26.8 59.7 50.1 63.4 30.0 30.5 62.7 27.6 x 33.9 25.8 31.2 25.5 36.7 39.1 x x 15.2 10.9 44.3 x 59.8 35.4 46.3 34.7 24.3 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10018 Original post publication description: Morphine response (dose mg/kg ip), Straub tail test, slope of the drug response curve DRC [units] None Morphine response (dose mg/kg ip), Straub tail test, slope of the drug response curve DRC [units] x 0.78 0.94 0.25 1.37 1.04 1.07 0.94 0.42 0.75 x 0.81 0.94 1.37 0.91 0.73 0.98 x x 0.48 0.61 1.2 x 0.35 0.75 1.16 1.24 0.75 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10019 Original post publication description: Body temperature following control saline injection [degree C] None Central nervous system, pharmacology, metabolism: Body temperature following saline injection, control for morphine response [degree C] x 38.2 37.5 37.7 38.1 37.0 37.2 38.3 37.4 37.3 x 38.4 37.8 37.6 36.6 37.0 38.4 x x 36.8 37.3 37.5 x 37.5 37.9 38.5 37.8 38.8 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10020 Original post publication description: Pain response, morphine, amphetamine, and saline responses, hot plate latency after saline control injection [seconds] None Pain response, morphine, amphetamine, and saline responses, hot plate latency after saline control injection [seconds] x 19.1 20.2 21.3 22.0 19.5 11.8 8.8 31.0 18.0 x 14.1 11.6 12.8 13.0 11.9 20.0 x x 13.8 16.1 12.2 x 13.5 15.0 15.5 22.9 9.8 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10021 Original post publication description: Saline control response (vehicle ip), open field activity after (unpublished means from same series of studies as reported in Belknap & Crabbe, 1992 ANYAS 654:311-323) [units] None Central nervous system, behavior: Saline control response (vehicle ip), open field activity after injection (unpublished data from same series of studies as reported in Belknap and Crabbe, 1992 ANYAS 654:311-323) [units] x x 15.44 6.39 9.34 12.15 9.24 15.25 8.4 8.675 x 14.49 6.43 11.84 7.315 10.25 12.72 x x 7.95 8.3 5.925 x 6.945 8.26 8.58 5.25 12.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10022 Original post publication description: Central nervous system, gustatory system: Saccharin sweet taste response, saccharin preference versus water ratio [%] None Central nervous system, gustatory system: Saccharin sweet taste response, saccharin preference versus water ratio [%] x x 96.0 59.0 74.0 82.0 90.0 91.0 57.0 60.0 x 77.0 57.0 85.0 82.0 86.0 77.0 x x 61.0 61.0 79.0 x 91.0 64.0 76.0 87.0 83.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10023 Original post publication description: Central nervous system, gustatory system: Saccharin sweet taste water consumption (BXD5 value of 1228 units winsorized to 700 units) [mg/kg/day] None Central nervous system, gustatory system: Saccharin sweet taste water consumption (BXD5 value of 1228 units winsorized to 700 units) [mg/kg/day] x x 677.0 294.0 333.0 473.0 700.0 519.0 267.0 286.0 x 475.0 253.0 601.0 457.0 458.0 436.0 x x 354.0 264.0 380.0 x 500.0 477.0 358.0 469.0 450.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10024 Original post publication description: Handling-induced convulsions (HIC) baseline scores [units] None Central nervous system, pharmacology, behavior: Handling-induced convulsions (HIC) baseline scores [units] x x 0.6995 0.3415 1.6835 2.0565 1.17045 0.3985 1.146 1.8895 x 0.6495 1.581 1.928 0.1625 0.4835 0.4165 x x 0.7105 0.6315 x x 0.091 0.125 1.5725 0.625 0.0985 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10025 Original post publication description: Nitrous oxide response, withdrawal handling-induced convulsion score (HIC) area under the curve [units] None Central nervous system, pharmacology, behavior: Nitrous oxide response, withdrawal handling-induced convulsion score (HIC) area under the curve [units] x x 5.68 13.24 6.85 1.17 15.6 4.57 5.35 20.0 x 2.2 10.15 2.55 1.0 1.33 3.8 x x 8.87 3.36 x x 6.5 6.67 9.0 6.94 5.62 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10026 Original post publication description: Nitrous oxide response, withdrawal handling-induced convulsion score (HIC), corrected peak level [units] None Central nervous system, pharmacology, behavior: Nitrous oxide response, withdrawal handling-induced convulsion score (HIC), corrected peak level [units] x x 1.4 2.94 1.41 0.44 3.4 1.28 1.31 4.17 x 0.62 2.2 0.88 0.3 0.39 0.73 x x 2.09 0.79 x x 1.71 1.56 2.0 1.35 1.35 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10027 Original post publication description: Nitrous oxide response, withdrawal handling-induced convulsion (HIC) score, difference between treated and baseline untreated [units] None Central nervous system, pharmacology, behavior: Nitrous oxide response, withdrawal handling-induced convulsion (HIC) score, difference between treated and baseline untreated [units] x x 6.067 12.635 9.533 0.333 14.131 4.252 7.821 15.977 x 0.807 8.35 2.4717 0.55 1.0467 3.55 x x 9.337 4.243 x x 6.727 6.447 7.213 9.137 5.57 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10028 Original post publication description: Ethanol response, acute withdrawal severity measured as the difference in handling-induced convulsion (HIC) from the saline control group (unpublished values from the same series of studies reported in Belknap et al. 1993 Behav Genetics 23:213-222) [ None Ethanol response, acute withdrawal severity measured as the difference in handling-induced convulsion (HIC) from the saline control group (unpublished values from the same series of studies reported in Belknap et al. 1993 Behav Genetics 23:213-222) [ x x 5.227 14.08 8.6 9.303 7.9 1.91 3.05 6.27 x 1.78 5.07 5.6 3.11 6.3 4.06 x x 8.47 5.707 x x 2.21 6.047 6.696 5.5 1.49 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10029 Original post publication description: Morphine response (16 mg/kg), analgesia relative to maximum possible effect [%] None Central nervous system, pharmacology, nociception: Morphine response (16 mg/kg), analgesia relative to maximum possible effect [%] x x 13.0 82.0 63.0 73.0 45.0 16.0 72.0 50.0 x 10.0 20.0 23.0 32.0 25.0 33.0 x x 18.0 12.0 60.0 x 80.0 30.0 55.0 45.0 18.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10030 Original post publication description: Naloxone ([3H]-naloxone) Bmax concentration (binding maximum) [pM] None Central nervous system, pharmacology, nociception: Naloxone ([3H]-naloxone) Bmax concentration (binding maximum) [pM/mg] x x 84.0 95.0 x 104.0 90.0 92.0 95.0 100.0 x 90.0 90.0 83.0 x 76.0 84.0 x x 83.0 74.0 88.0 x 86.0 92.0 90.0 103.0 86.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10031 Original post publication description: Morphology, metabolism: Body weight of adult males [g] None Morphology, metabolism: Body weight of adult males [g] x x 25.5 25.5 27.6 28.4 26.1 25.0 26.4 27.1 x 25.2 29.3 30.4 27.8 26.75 29.0 x x 28.4 25.1 24.3 x 25.0 24.7 25.2 26.3 24.7 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10032 Original post publication description: Central nervous system, morphology: Brain weight in young adult males [mg] None Central nervous system, morphology: Brain weight in young adult males [mg] x x 465.0 339.0 450.0 390.0 477.0 361.0 421.0 419.0 x 412.0 403.0 439.0 429.0 436.0 427.0 x x 409.0 431.0 432.0 x 380.0 394.0 381.0 389.0 375.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10033 Original post publication description: Central nervous system, morphology: Brain to body weight ratio [ratio] None Central nervous system, morphology: Brain to body weight ratio [ratio] x x 0.0183 0.0134 0.0163 0.0138 0.0183 0.145 0.016 0.0154 x 0.0164 0.0138 0.0145 0.0155 0.0163 0.0149 x x 0.0145 0.0172 0.0179 x 0.0153 0.0161 0.0152 0.0148 0.0153 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10034 Original post publication description: Infectious disease, immune function: Salmonella typhimurium bacteria strain LT2-Z growth from livers and spleens 6 days post inoculation with 10^2 CFU [log10 CFU] None Infectious disease, immune system: Salmonella typhimurium bacterial strain LT2-Z growth from livers and spleens 6 days post inoculation with 10^2 CFU (figure 3, filled circles) [log10 CFU] x x 4.92 5.55 4.14 5.29 6.79 4.12 4.69 4.95 4.89 4.57 5.42 5.17 x 3.04 5.61 x x x x 3.78 x 5.52 x x 4.82 3.06 4.69 x 3.78 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10035 Original post publication description: Infectious disease, immune function: Salmonella typhimurium bacteria strain WB500 from livers and spleens 6 days post inoculation with 10^2 CFU [log10 CFU] None Infectious disease, immune system: Salmonella typhimurium bacterial strain WB500 from livers and spleens 6 days post inoculation with 10^2 CFU (figure 3 open circles) [log10 CFU] x x 6.67 5.04 4.29 7.74 7.64 3.96 4.69 6.75 7.84 6.61 5.27 8.16 x 3.69 7.78 x x x x 4.08 x 6.46 x x 4.86 3.86 5.16 x 3.91 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10036 Original post publication description: Infectious disease, immune function: Salmonella typhimurium bacteria strain SR-11 from livers and spleens 6 days post inoculation with 10^2 CFU [log10 CFU] None Infectious disease, immune system: Salmonella typhimurium bacterial strain SR-11, net growth in livers and spleens 6 days after inoculation with 10^2 CFU (figure 5, triangles, Itk/Nramp1/Slc11a1-associated) [log10 CFU] x x 8.01 6.23 5.28 7.35 7.81 5.58 4.86 7.92 7.46 7.54 5.38 x x 7.27 8.04 x x x x 5.27 x 8.05 x x 6.31 5.62 5.57 x 5.42 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10037 Original post publication description: Central nervous system, behavior: Activity level, total distance travelled day 1 of novel environment [cm] None Central nervous system, behavior: Activity level, total distance travelled day 1 of novel environment [cm] x x 1405.0 1530.0 2132.0 1416.0 946.0 1882.0 954.0 1740.0 1090.0 1703.0 x 1325.0 x 1542.0 1716.0 1543.0 x 1273.0 855.0 x x 914.0 1155.0 1004.0 925.0 x 1422.0 x 1817.0 1138.0 1364.0 1367.0 x x 1084.0 859.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10038 Original post publication description: Central nervous system, behavior: Activity level, distance travelled (day 1 total distance-day 3 total distance) [cm] None Central nervous system, behavior: Activity level, distance travelled (day 1 total distance-day 3 total distance) [cm] x x 310.0 -92.0 398.0 269.0 385.0 394.0 53.1 -347.0 355.0 388.0 x -74.7 x 293.0 -362.0 95.0 x -236.0 -21.0 x x 70.0 195.0 -262.0 -84.0 x -12.0 x 405.0 -165.0 -13.0 459.0 x x -280.0 322.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10040 Original post publication description: Ethanol response, blood ethanol concentration (BEC) at recovery of righting reflex (retro-orbital sinus sample) [mg/ml] None Central nervous system, pharmacology, behavior: Ethanol response, blood ethanol concentration (BEC) at recovery of righting reflex (retro-orbital sinus sample) [mg/ml] x x 3.915 3.58 3.788 3.46 3.966 3.453 3.971 x 3.894 3.406 3.837 3.846 3.899 3.446 3.547 3.266 x 3.581 3.406 4.084 x 3.813 3.651 4.121 4.002 3.757 4.129 3.634 3.843 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10041 Original post publication description: Ethanol response (2.5 g/kg ip), duration of loss of righting reflex [minutes] None Central nervous system, pharmacology, behavior: Ethanol response (2.5 g/kg ip), duration of loss of righting reflex [minutes] x x 88.222 87.254 130.45 172.442 114.3 131.204 93.668 x 82.472 176.828 148.655 94.72 122.329 124.98 182.56 194.169 x 132.467 155.08 111.9 x 138.067 113.967 161.538 118.362 122.59 56.071 124.086 178.463 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10042 Original post publication description: Ethanol response (2.5 g/kg ip), ataxia, screen test sensitivity measured as the latency to fall, saline response minus ethanol response [seconds] None Central nervous system, pharmacology, behavior: Ethanol response (2.5 g/kg ip), ataxia, screen test sensitivity measured as the latency to fall, saline response minus ethanol response [seconds] x x 45.155 16.107 43.169 43.434 27.264 33.383 42.943 35.512 16.804 41.471 36.536 36.324 36.524 46.496 40.204 30.813 x 35.676 27.141 25.203 x 21.797 32.526 28.99 39.616 49.821 24.452 46.511 40.265 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10043 Original post publication description: Infectious disease, immune function: Ectromelia virus-induced mortality in males [3 = resistant, 2 = intermediate, 1 = susceptible, table 1 column 1, ordinal scale] None Infectious disease, immune system: Ectromelia virus-induced mortality in males [3 = resistant, 2 = intermediate, 1 = susceptible, table 1 column 1, ordinal scale] x 3.0 3.0 1.0 2.0 3.0 1.0 3.0 3.0 1.0 2.0 3.0 2.0 2.0 3.0 2.0 3.0 3.0 x 3.0 2.0 3.0 x 1.0 2.0 3.0 3.0 3.0 3.0 2.0 1.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10044 Original post publication description: Infectious disease, immune function: Ectromelia virus-induced mortality [3 = resistant, 1 = both intermediate and susceptible, major gene model, ordinal scale] None Infectious disease, immune system: Ectromelia virus-induced mortality [3 = resistant, 1 = both intermediate and susceptible, ordinal scale] x 3.0 3.0 1.0 3.0 3.0 1.0 3.0 3.0 1.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0 x 3.0 3.0 3.0 x 1.0 3.0 3.0 3.0 3.0 3.0 3.0 1.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10045 Original post publication description: Body temperature (baseline control for quinpirole study) [degrees C] None Metabolism: Body temperature (baseline control for quinpirole study) [degrees C] x x 38.711 38.687 x 38.851 38.724 38.69 39.37 38.721 39.227 38.958 38.581 38.645 38.565 38.369 38.192 38.247 x 39.009 39.074 38.79 x 38.453 39.183 38.67 38.7 39.449 38.46 38.168 39.068 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10046 Original post publication description: Quinpirole dopaminergic D2 and D3 receptor response (1 mg/kg ip), hypothermia 60 min after injection on day 1 measured as change from baseline temperature [degrees C] None Central nervous system, pharmacology, behavior: Quinpirole dopaminergic D2 and D3 receptor response (1 mg/kg ip), hypothermia 60 min after injection on day 1 measured as change from baseline temperature [degrees C] x x -1.622 -5.043 x -3.847 -1.144 -3.634 -4.746 -4.374 -1.224 -2.074 -0.874 -2.673 -1.127 -2.798 -1.573 -6.465 x -3.295 -1.781 -3.488 x -2.557 -2.4 -3.615 -6.767 -2.089 -3.831 -1.115 -3.967 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10047 Original post publication description: Quinpirole dopaminergic D2 and D3 receptor response (1 mg/kg ip), hypothermia tolerance, day 2 compared to day 1 [degrees C] None Central nervous system, pharmacology, behavior: Quinpirole dopaminergic D2 and D3 receptor response (1 mg/kg ip), hypothermia tolerance, day 2 compared to day 1 [degrees C] x x -0.242 -0.735 x -0.918 -0.18 -1.153 -1.407 -1.184 -0.34 -0.056 -0.202 -0.386 0.03 -0.768 -0.636 -2.019 x -0.754 -0.542 -1.215 x -0.457 -0.692 -0.688 -2.167 -0.461 -1.024 -0.226 -1.718 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10048 Original post publication description: Quinpirole dopaminergic D2 and D3 receptor response (1 mg/kg ip), hypothermia tolerance, day 3 compared to day 1 [degrees C] None Central nervous system, pharmacology, behavior: Quinpirole dopaminergic D2 and D3 receptor response (1 mg/kg ip), hypothermia tolerance, day 3 compared to day 1 [degrees C] x x -0.758 -1.652 x -1.472 -0.262 -2.213 -2.151 -1.412 -0.636 -0.234 -0.139 -0.978 -0.296 -1.374 -1.015 -3.181 x -1.102 -0.936 -1.321 x -1.038 -0.575 -0.528 -2.867 -1.222 -0.569 -0.39 -2.197 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10049 Original post publication description: Saline baseline response (ip, for quinpirole study), locomotion after injection [cm] None Central nervous system, pharmacology, behavior: Saline baseline response (ip, for quinpirole study), locomotion after injection [cm] x x 4856.45 3130.0 x 3465.56 2872.5 4197.17 3103.19 3973.81 1348.96 4790.5 2741.05 4112.67 4431.0 2289.59 4913.86 3254.37 x 3430.68 2475.78 2849.41 x 1952.25 4462.47 2008.57 2237.4 6160.66 3338.65 3182.64 4400.74 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10050 Original post publication description: Quinpirole dopaminergic D2 and D3 receptor response (0.01 mg/kg ip), locomotion change relative to baseline [cm] None Central nervous system, pharmacology, behavior: Quinpirole dopaminergic D2 and D3 receptor response (0.01 mg/kg ip), locomotion change relative to baseline [cm] x x -2878.27 -843.33 x -1327.56 -1165.64 -2840.87 -1098.64 -1016.06 -735.08 -3267.53 -1597.27 -956.22 -1714.36 -999.5 -2063.09 -1038.57 x -1214.11 -1095.88 -902.82 x -848.6 -1845.5 -459.14 -786.2 -2773.6 -914.67 -1319.57 -1696.27 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10051 Original post publication description: Quinpirole dopaminergic D2 and D3 receptor response (0.03 mg/kg ip), locomotion change relative to baseline [cm] None Central nervous system, pharmacology, behavior: Quinpirole dopaminergic D2 and D3 receptor response (0.03 mg/kg ip), locomotion change relative to baseline [cm] x x -2963.64 -1541.71 x -1777.94 -1658.43 -2678.6 -1934.9 -1839.38 -808.92 -3388.47 -1582.0 -2256.11 -2761.92 -1368.38 -2667.27 -2029.77 x -1945.8 -1501.44 -1162.07 x -1158.05 -1969.09 -717.06 -1669.6 -3768.1 -1573.64 -1691.86 -2403.35 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10052 Original post publication description: Quinpirole dopaminergic D2 and D3 receptor response (0.03 mg/kg ip), vertical activity (rears) change relative to baseline [n beam breaks] None Central nervous system, pharmacology, behavior: Quinpirole dopaminergic D2 and D3 receptor response (0.03 mg/kg ip), vertical activity (rears) change relative to baseline [n beam breaks] x -216.857 -184.5 -180.286 x x -66.56 -79.571 -137.2 -168.2 -120.875 -74.833 -201.2 -104.545 -120.333 -120.167 -115.38 -83.273 x -148.308 -179.4 -77.625 x -78.267 -29.1 -162.909 -20.25 -89.2 -123.714 -157.27 -107.714 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10053 Original post publication description: Quinpirole dopaminergic D2 and D3 receptor response (0.01 mg/kg ip), vertical activity (rears) change relative to baseline [n beam breaks] None Central nervous system, pharmacology, behavior: Quinpirole dopaminergic D2 and D3 receptor response (0.01 mg/kg ip), vertical activity (rears) change relative to baseline [n beam breaks] x x -124.267 -77.33 x -27.375 -57.286 -164.4 -101.636 -86.125 -54.615 -150.53 -105.091 -23.333 -52.182 -64.0 -20.364 -88.571 x -62.667 -31.875 -72.706 x -33.1 -126.25 9.571 -32.0 -102.1 -49.5 -55.333 -153.273 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10054 Original post publication description: Saline baseline response (ip, for quinpirole study), vertical activity (rears) after injection [n beam breaks] None Central nervous system, behavior: Saline baseline response (ip, control for quinpirole study), vertical activity (rears, beam breaks) after injection [n] x x 277.448 356.462 x 173.882 167.357 263.933 330.952 357.313 114.48 273.0 195.545 214.556 220.783 184.235 249.455 272.741 x 296.737 99.813 214.813 x 84.85 299.158 118.467 136.8 282.0 335.217 210.048 380.095 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10055 Original post publication description: Ethanol withdrawal handling induced convulsions, 2-12 hours after 4 g/kg 20% v/v EtOH, Area Under Curve None Ethanol withdrawal handling induced convulsions, 2-12 hours after 4 g/kg 20% v/v EtOH, Area Under Curve x x 6.8 15.5 14.5 13.0 14.2 2.7 7.9 18.7 x 5.0 16.4 10.4 4.3 7.0 4.5 x x 9.3 9.8 x x 2.5 6.4 11.1 6.7 1.5 x 0.0 6.4 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10056 Original post publication description: Hematopoietic stem cell pool size [cobblestone area-forming cells per 10e5 bone marrow cells] None Immune system, development: Hematopoietic stem cell pool size [cobblestone area-forming cells per 10e5 bone marrow cells] x x x x 3.1 11.1 3.2 4.3 3.11 9.1 10.9 1.01 x 6.0 10.0 3.97 6.9 x x 3.25 9.5 x x x 7.3 9.2 2.86 6.2 x 2.34 4.42 6.19 9.6 x x x 2.2 x 6.8 x 3.02 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10057 Original post publication description: Infectious disease, immune function: BCG-induced anergy (delayed type hypersensitivity) in footpad increments [mm] None Immune system: BCG-induced anergy (delayed type hypersensitivity) in footpad increments [mm] x x x x x 0.22 x x 0.14 x x 0.79 0.79 0.15 0.48 x x 0.15 0.86 x x 0.3 x x x x x 0.24 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10058 Original post publication description: Immune system, blood: Peripheral blood lymphocytes, percentage of B cells [B220 %] None Immune system, blood: Peripheral blood lymphocytes, percentage of B cells [B220 %] x 63.7 67.0 46.1 60.0 64.0 49.0 38.0 58.0 61.0 44.0 61.0 55.0 67.0 53.0 34.0 44.0 60.0 9.0 48.0 58.0 39.0 x 44.0 69.0 53.0 56.0 52.0 49.0 61.0 46.0 58.0 46.0 42.0 54.0 44.0 43.0 49.0 63.0 x 50.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10059 Original post publication description: Immune function, blood: Peripheral blood lymphocytes, percentage of CD4+ T cells [%] None Immune system, cardiovascular system: Peripheral blood lymphocytes, percentage of CD4+ T cells [%] x 14.9 13.3 18.3 20.0 9.0 25.0 18.0 14.0 14.0 18.0 16.0 12.0 6.0 16.0 19.0 11.0 10.0 25.0 13.0 19.0 15.0 x 20.0 11.0 11.0 10.0 15.0 16.0 7.0 12.0 12.0 20.0 18.0 16.0 21.0 18.0 19.0 11.0 x 12.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10060 Original post publication description: Immune function, blood: Peripheral blood lymphocytes, percentage of CD8+ T cells [%] None Immune system, cardiovascular system: Peripheral blood lymphocytes, percentage of CD8+ T cells [%] x 8.9 7.7 5.9 7.7 6.1 11.5 9.0 6.4 11.7 7.1 7.1 5.6 2.5 7.5 14.6 7.1 6.4 25.4 6.9 10.0 9.0 x 8.0 4.5 13.5 6.9 11.7 11.7 6.7 5.4 8.4 7.3 15.7 9.6 14.9 15.7 9.0 7.3 x 7.6 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10061 Original post publication description: Polymorphonuclear leukocyte number (PMN) after aerosolized LPS exposure [PMN/ml (x103)] None Polymorphonuclear leukocyte number (PMN) after aerosolized LPS exposure [PMN/ml (x103)] x x 132.5 425.0 260.9 405.0 78.3 413.7 311.3 213.5 224.2 195.0 304.2 199.1 301.7 764.5 204.3 64.3 890.0 273.9 399.1 x x 126.1 250.0 153.0 265.2 x 307.0 250.0 202.6 264.3 140.0 x 302.6 x 286.1 304.3 223.9 x 320.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10062 Original post publication description: Tumor necrosis factor (TNF)-alpha level in lung after aerosolized lipopolysaccharide (LPS) exposure [pg/ml] None Tumor necrosis factor (TNF)-alpha level in lung after aerosolized lipopolysaccharide (LPS) exposure [pg/ml] x x 508.6 1462.9 1671.4 454.3 1722.9 750.0 980.0 634.3 368.3 1520.0 397.1 876.3 374.3 1000.0 1182.9 1305.7 2035.7 1807.1 1668.6 x x 182.9 1128.6 1157.1 1829.4 x 1860.1 434.3 868.6 828.6 1634.3 x 1505.7 x 474.3 300.3 400.0 x 1036.6 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10063 Original post publication description: Ethanol response, withdrawal-associated handling-induced convulsions (HIC) after a 72 hr exposure to ethanol vapor (with Pyrazole injections to inhibit EtOH metabolism) [seizure severity area under the 25-hr curve] None Central nervous system, pharmacology, behavior: Ethanol response, withdrawal-associated handling-induced convulsions (HIC) after a 72 hr exposure to ethanol vapor (with Pyrazole injections to inhibit EtOH metabolism) [seizure severity area under the 25-hr curve] x x 42.65 77.11 58.0 83.25 72.21 33.65 54.75 74.69 65.24 48.41 66.86 49.03 29.78 36.19 30.38 7.19 x 56.1 58.57 78.33 x 68.42 59.71 58.86 46.93 14.77 70.25 5.5 57.88 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10064 Original post publication description: Ethanol response, area under the 25-hr curve for withdrawal following 72 hr exposure to air. Pyrazole injections were given daily to inhibit EtOH metabolism. Handling-induced convulsions (HIC) were scored hourly for 10 hr and again at hrs 24 and 25 [seizure severity] None Ethanol response, area under the 25-hr curve for withdrawal following 72 hr exposure to air. Pyrazole injections were given daily to inhibit EtOH metabolism. Handling-induced convulsions (HIC) were scored hourly for 10 hr and again at hrs 24 and 25 [seizure severity] x x 9.9 15.54 29.19 7.72 39.0 1.71 38.58 24.0 6.06 24.33 35.38 4.28 2.21 2.67 3.5 0.0 x 10.85 13.57 4.83 x 3.19 0.67 8.31 5.33 0.08 31.22 0.22 0.29 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10065 Original post publication description: Ethanol response (1.5 g/kg ip loading dose and 68.1 mg/kg pyrazole), chronic withdrawal, handling-induced convulsion score (HIC) corrected for response to pyrazole alone (difference between strain mean values for AREA25 and PYRAREA25) [seizure severity] None Ethanol response (1.5 g/kg ip loading dose and 68.1 mg/kg pyrazole), chronic withdrawal, handling-induced convulsion score (HIC) corrected for response to pyrazole alone (difference between strain mean values for AREA25 and PYRAREA25) [seizure severity] x x 32.75 61.57 29.01 75.53 33.21 31.94 16.17 50.69 59.17 24.08 31.48 44.76 27.56 33.52 26.88 7.19 x 45.25 45.0 73.5 x 65.24 59.05 50.56 41.6 14.69 39.03 5.28 57.58 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10066 Original post publication description: Ethanol response (1.5 g/kg), blood ethanol concentration (BEC) normalization data set (BEC was stabilized to ~1.5 mg EtOH/ml blood using daily pyrazole injections) [mg/ml] None Ethanol response (1.5 g/kg), blood ethanol concentration (BEC) normalization data set (BEC was stabilized to ~1.5 mg EtOH/ml blood using daily pyrazole injections) [mg/ml] x x 1.51 1.5 1.51 1.53 1.48 1.47 1.49 1.52 1.5 1.51 1.54 1.5 1.53 1.49 1.49 1.49 x 1.5 1.48 1.34 x 1.49 1.59 1.51 1.5 1.49 1.54 1.51 1.51 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10067 Original post publication description: Ethanol response (2 g/kg ip), hypothermia at 30 and 60 min after injection [degrees C] None Ethanol response (2 g/kg ip), hypothermia at 30 and 60 min after injection [degrees C] x x 2.0 1.63 1.15 1.34 2.37 2.26 1.23 2.64 x 1.27 1.3 1.62 0.88 0.85 1.44 x x 1.39 1.63 x x 1.33 1.86 0.88 1.1 1.91 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10068 Original post publication description: Ethanol response (3 g/kg ip), hypothermia at 30 and 60 min after injection [degrees C] None Ethanol response (3 g/kg ip), hypothermia at 30 and 60 min after injection [degrees C] x x 3.1 1.6 2.08 2.47 3.17 2.9 1.8 3.33 x 2.92 2.58 1.73 2.53 1.91 2.23 x x 1.79 3.17 x x 1.86 2.39 3.15 2.19 2.45 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10069 Original post publication description: Ethanol response (4 g/kg ip), hypothermia at 30 and 60 min after injection [degrees C] None Ethanol response (4 g/kg ip), hypothermia at 30 and 60 min after injection [degrees C] x x 3.4 2.93 2.33 2.53 3.65 3.48 2.11 3.47 x 2.98 3.73 3.9 3.23 1.83 2.71 x x 2.74 2.77 x x 2.4 2.07 4.29 2.31 2.92 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10070 Original post publication description: Ethanol response (2 g/kg ip), hypothermia after injection [degrees C] None Central nervous system, pharmacology, metabolism: Ethanol response (2 g/kg ip), hypothermia after injection [degrees C] x x 0.5 0.56 0.01 0.23 0.04 0.69 0.1 0.41 x 0.22 0.25 0.6 0.02 -0.05 -0.19 x x 0.07 -0.5 x x -0.16 0.3 -0.11 -0.42 0.75 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10071 Original post publication description: Ethanol response (3 g/kg ip), hypothermia after injection [degrees C] None Central nervous system, pharmacology, behavior: Ethanol response (3 g/kg ip), hypothermia after injection [degrees C] x x 0.91 -0.06 0.32 0.57 -0.02 0.44 0.18 0.69 x 0.7 0.16 -0.1 0.99 0.34 0.37 x x -0.73 0.18 x x -1.12 0.51 0.49 0.51 0.18 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10072 Original post publication description: Ethanol response (4 g/kg ip), hypothermia after injection [degrees C] None Central nervous system, pharmacology, metabolism: Ethanol response (4 g/kg ip), hypothermia after injection [degrees C] x x 0.78 0.92 -0.1 0.35 0.68 0.86 -0.14 0.03 x 0.36 0.67 1.28 1.14 -0.11 0.47 x x 0.5 0.34 x x -0.44 0.6 -0.72 0.57 0.38 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10073 Original post publication description: Ethanol response (10% v/v in water), acceptance of ethanol under thirst motivation in a single-bottle (no choice) test following 24 hr water deprivation, total 24 hr ethanol intake relative to previous water intake in 20-24 week-old males [ratio] None Ethanol response (10% v/v in water), acceptance of ethanol under thirst motivation in a single-bottle (no choice) test following 24 hr water deprivation, total 24 hr ethanol intake relative to previous water intake in 20-24 week-old males [ratio] x x 0.75 0.29 0.44 x 1.09 0.07 0.53 x 0.67 0.67 x 0.34 0.49 0.73 x 0.66 x 0.5 x 0.82 x 0.44 0.08 x 0.04 0.63 0.18 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10074 Original post publication description: Ethanol response (10% v/v in water), acceptance of ethanol under thirst motivation in a single-bottle (no choice) test following 24 hr water deprivation, total 24 hr ethanol intake in 20-24 week-old males [g/kg] None Central nervous system, pharmacology, behavior: Ethanol response (10% v/v in water), acceptance of ethanol under thirst motivation in a single-bottle (no choice) test following 24 hr water deprivation, total 24 hr ethanol intake in 20-24 week-old males [g/kg] x x 12.6 3.36 3.52 x 9.95 1.32 10.89 x 13.34 8.9 x 8.29 7.65 9.34 x 10.21 x 12.66 x 10.78 x 2.43 1.03 x 0.68 4.81 2.34 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10075 Original post publication description: Saline response (saline injection ip), open field activity in 20-24 week-old males (control for ethanol trait 10077) [beam crossings] None Central nervous system, pharmacology, behavior: Saline response (saline injection ip), open field activity in 20-24 week-old males (control for ethanol trait 10077) [beam crossings] x x 155.0 132.0 175.0 182.0 240.0 152.0 113.0 x 79.0 141.0 127.0 152.0 104.0 158.0 131.0 166.0 x 171.0 x 159.0 x 125.0 x 134.0 89.0 171.0 95.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10076 Original post publication description: Ethanol response (2.5 g/kg ip), distance run in the grid test, 10-12 min after injection in 20-24 week-old males [n beam crossings] None Ethanol response (2.5 g/kg ip), distance run in the grid test, 10-12 min after injection in 20-24 week-old males [n beam crossings] x x 83.0 335.0 264.0 155.0 178.0 144.0 171.0 x 133.0 317.0 121.0 245.0 117.0 252.0 150.0 268.0 x 251.0 x 204.0 x 154.0 x 187.0 170.0 226.0 233.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10077 Original post publication description: Ethanol response (1.33 g/kg ip), open field activity in 20-24 week-old males tested under dim light, 10-13 min after injection of saline (day 1) and ethanol (day 2), difference in number of beam crossings relative to saline control injection [n] None Ethanol response (1.33 g/kg ip), open field activity in 20-24 week-old males tested under dim light, 10-13 min after injection of saline (day 1) and ethanol (day 2), difference in number of beam crossings relative to saline control injection [n] x x -72.0 203.0 89.0 -27.0 -62.0 -8.0 58.0 x 54.0 176.0 -6.0 93.0 13.0 94.0 19.0 102.0 x 80.0 x 45.0 x 29.0 x 53.0 81.0 55.0 138.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10078 Original post publication description: Ethanol response (2.5 g/kg ip), ataxia on grid test, 10 to 12 min after injection in 24-28 week-old males, foot fall errors/distance run in the apparatus [n/distance] None Ethanol response (2.5 g/kg ip), ataxia on grid test, 10 to 12 min after injection in 24-28 week-old males, foot fall errors/distance run in the apparatus [n/distance] x x 2.58 1.84 1.66 2.4 x 2.28 5.43 x x x x x x x x 3.18 x x x x x 2.25 x x 1.84 x 2.5 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10079 Original post publication description: Ethanol response (3 day exposure to 8-11 g/kg ethanol in vapor chamber with pyrazole 1 mM/kg/day),handling-induced convulsion (HIC) withdrawal severity score (15x 1 hour measurements) in 24-28 week-old males, first experimental replication (Table 4) [area under curve] None Ethanol response (3 day exposure to 8-11 g/kg ethanol in vapor chamber with pyrazole 1 mM/kg/day),handling-induced convulsion (HIC) withdrawal severity score (15x 1 hour measurements) in 24-28 week-old males, first experimental replication (Table 4) [area under curve] x x 14.5 29.0 x 34.5 x x x x 23.75 21.13 x 22.83 16.0 x x x x 7.5 x x x x x 32.5 x x 25.33 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10080 Original post publication description: Ethanol response (3 day exposure to 8-11 g/kg ethanol in vapor chamber with pyrazole 1 mM/kg/day),handling-induced convulsion (HIC) withdrawal severity score (15x 1 hour measurements) in 24-28 week-old males, second experimental replication (Table 4) [area under curve] None Ethanol response (3 day exposure to 8-11 g/kg ethanol in vapor chamber with pyrazole 1 mM/kg/day),handling-induced convulsion (HIC) withdrawal severity score (15x 1 hour measurements) in 24-28 week-old males, second experimental replication (Table 4) [area under curve] x x x x 28.3 29.83 x 11.83 x x 41.3 x x 25.88 11.75 x x x x x x 15.0 x 28.17 x 35.3 x 5.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10081 Original post publication description: Ethanol response (3 day exposure to 8-11 g/kg ethanol in vapor chamber with pyrazole 1 mM/kg/day),handling-induced convulsion (HIC) withdrawal severity score (15x 1 hour measurements) in 24-28 week-old males, third experimental replication (Table 4) [area under curve] None Central nervous system, pharmacology, behavior: Ethanol response (3 day exposure to 8-11 g/kg ethanol in vapor chamber with pyrazole 1 mM/kg/day), withdrawal severity score (15x 1 hour measurements) handling-induced convulsion (HIC) in 24-28 week-old males, third experimental replication (Table 4) [area under curve] x x 11.83 28.0 19.43 x x 13.64 x x x x x x x x 8.0 x x x x x x 22.75 x 7.5 9.83 4.0 23.67 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10082 Original post publication description: Ethanol response (4 g/kg ip), hypothermia tolerance (positive scores) or sensitization (negative scores), difference between day 3 and day 1 [degrees C] None Central nervous system, behavior, pharmacology: Ethanol response (4 g/kg ip), hypothermia tolerance (positive scores) or sensitization (negative scores), day 3 minus day 1, in young adult females (50 to 123 days) [degrees C] x x 0.78 0.922 -0.097 0.354 0.679 0.863 -0.136 0.025 0.356 0.363 0.667 1.278 1.139 -0.108 0.465 0.559 x 0.5 0.343 x x -0.444 0.6 -0.722 0.573 0.381 1.031 x 0.972 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10083 Original post publication description: Ethanol response (3 g/kg), hypothermia tolerance (positive scores) or sensitization (negative scores), difference between day 3 and day 1 [degrees C] None Central nervous system, behavior, pharmacology: Ethanol response (3 g/kg ip), hypothermia tolerance (positive scores) or sensitization (negative scores), day 3 minus day 1, in young adult females (50 to 123 days) [degrees C] x x 0.907 -0.058 0.316 0.569 -0.023 0.439 0.181 0.687 -0.003 0.697 0.164 -0.1 0.991 0.338 0.366 0.759 x -0.727 0.178 x x -1.122 0.505 0.492 5.13 0.179 0.464 x 0.229 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10084 Original post publication description: Ethanol response (2 g/kg), hypothermia tolerance (positive scores) or sensitization (negative scores), day 3 minus day 1 [degrees C] None Central nervous system, behavior, pharmacology: Ethanol response (2 g/kg), hypothermia tolerance (positive scores) or sensitization (negative scores), day 3 minus day 1, in young adult females (50 to 123 days) [degrees C] x x 0.495 0.564 0.014 0.225 0.035 0.692 0.103 0.408 0.008 2.17 0.252 0.597 0.019 -0.053 -0.189 0.153 x 0.066 -0.503 x x -0.161 0.295 -0.108 -0.424 0.752 0.019 x 0.444 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10085 Original post publication description: Ethanol response, hypothermia (4 g/kg ip) [degrees C] None Central nervous system, behavior, pharmacology: Ethanol response (4 g/kg ip), hypothermia in young adult females (50 to 123 days) relative to baseline rectal body temperature (positive scores = hypothermia) [degrees C] x x 3.96 2.934 2.233 2.528 3.651 3.479 2.109 3.467 1.514 2.979 3.73 3.9 3.323 1.826 2.71 2.549 x 2.742 2.769 x x 2.403 2.067 4.285 2.312 2.922 2.101 x 3.086 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10086 Original post publication description: Ethanol response (3 g/kg), hypothermia [degrees C] None Central nervous system, behavior, pharmacology: Ethanol response (3 g/kg ip), hypothermia in young adult females (50 to 123 days) relative to baseline rectal body temperature (positive scores = hypothermia) [degrees C] x x 3.1 1.601 2.083 2.467 3.174 2.904 1.797 3.331 1.008 2.921 2.583 1.733 2.528 1.909 2.225 2.654 x 1.793 3.167 x x 1.856 2.386 3.146 2.192 2.449 1.595 x 2.363 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10087 Original post publication description: Ethanol response (2 g/kg), hypothermia [degrees C] None Central nervous system, behavior, pharmacology: Ethanol response (2 g/kg ip), hypothermia in young adult females (50 to 123 days) relative to baseline rectal body temperature (positive scores = hypothermia) [degrees C] x x 2.0 1.628 1.153 1.344 2.374 2.255 1.231 2.642 0.594 1.27 1.296 1.617 0.875 0.853 1.439 1.038 x 1.394 1.631 x x 1.328 1.861 0.877 1.096 1.908 0.602 x 1.492 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10088 Original post publication description: Ethanol response (2 mg/kg ip), acute difference in locomotion between experimental ethanol-condidtioned and saline control group of males [activity counts/min] None Central nervous system, pharmacology, behavior: Ethanol response (2 g/kg ip), acute difference in locomotion between experimental ethanol-condidtioned and saline control group of males [activity counts/min] x x 28.869 75.2 42.207 20.144 36.412 15.49 85.832 49.069 52.4 2.147 43.093 58.071 18.172 15.048 44.434 x x 50.538 33.052 x x 28.221 68.007 38.566 23.353 31.488 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10089 Original post publication description: Ethanol response (2 mg/kg ip), locomotor tolerance or sensitization in males [difference between activity after fourth ethanol trial and first trial] None Central nervous system, pharmacology, behavior: Ethanol response (2 g/kg ip), locomotor tolerance or sensitization in males [difference between activity after fourth ethanol trial and first trial] x x -59.094 26.921 -44.237 -26.048 -22.375 -47.387 -10.206 15.869 -37.031 -23.027 -19.28 -30.107 -15.159 -29.042 -1.931 x x 10.117 -2.704 x x 7.3 -34.855 34.772 -15.973 -4.218 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10090 Original post publication description: Ethanol response (2 mg/kg ip), conditioned place preference (CPP) for the ethanol-paired grid compartment in experimental group males [percentage time on ethanol-paired floor during 30 min test] None Ethanol response (2 g/kg ip), conditioned place preference (CPP) for the ethanol-paired grid compartment in experimental group males [percentage time on ethanol-paired floor during 30 min test] x x 58.316 59.618 65.087 62.43 54.588 63.214 59.001 60.163 78.344 57.973 59.701 55.239 64.039 61.564 57.696 x x 49.491 65.529 x x 74.6 49.865 66.859 54.526 53.349 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10091 Original post publication description: Saline control response (vehicle ip) of ethanol-treated (2 mg/kg ip) males, locomotion 1-5 min after saline injection, trial 4 (experimental group, prior ethanol exposure) [activity counts per min] None Saline control response (vehicle ip) of ethanol-treated (2 mg/kg ip) males, locomotion 1-5 min after saline injection, trial 4 (experimental group, prior ethanol exposure) [activity counts per min] x x 39.9 53.5 54.6 36.9 27.3 40.4 29.7 52.8 24.1 33.8 23.8 42.7 37.6 28.2 68.8 x x 47.6 35.7 x x 32.4 49.8 34.0 37.8 124.7 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10092 Original post publication description: Ethanol response (2 mg/kg ip), locomotion from 1-5 min after injection, conditioning trial 1 in males [activity counts per min] None Ethanol response (2 g/kg ip), locomotion from 1-5 min after injection, conditioning trial 1 in males [activity counts per min] x x 116.7 138.9 134.6 93.7 76.8 97.8 134.0 122.6 98.1 68.1 89.4 124.6 64.1 60.7 128.0 x x 104.2 80.0 x x 67.0 150.7 98.6 75.3 175.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10093 Original post publication description: Floor preference baseline, time on grid textured floor for experimental group of males [sec/min] None Floor preference baseline, time on grid textured floor for experimental group of males [sec/min] x x 38.5 42.8 31.0 37.8 27.9 31.4 33.5 47.3 25.8 37.1 26.8 40.2 30.1 21.2 52.2 x x 39.9 26.0 x x 22.9 36.2 42.3 32.7 88.7 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10094 Original post publication description: Locomotion from 1-5 min after a single saline i.p. injection for the control group of males [activity/min] None Locomotion from 1-5 min after a single saline i.p. injection for the control group of males [activity/min] x x 132.9 66.0 101.1 77.5 57.0 117.9 52.1 85.7 50.2 87.0 68.1 80.6 47.4 44.8 93.1 x x 56.3 46.1 x x 46.9 81.8 54.3 49.0 141.7 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10095 Original post publication description: Saline control response (vehicle, ip), locomotion of control group from 1-5 min after injection on trial 1 [activity/min] None Saline control response (vehicle, ip), locomotion of control group from 1-5 min after injection on trial 1 [activity/min] x x 75.9 48.0 74.4 58.5 35.2 81.0 50.6 67.5 37.2 60.4 37.1 52.2 44.5 37.8 75.9 x x 57.2 45.0 x x 35.4 62.8 58.3 41.2 135.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10096 Original post publication description: Locomotion from 1-5 min after a saline injection for the control group of males on trial 4 [activity/min] None Central nervous system, pharmacology, behavior: Locomotion from 1-5 min after a saline injection for the control group of males on trial 4 [activity/min] x x 37.8 39.3 41.9 26.4 22.9 38.7 28.6 41.2 14.9 35.9 15.4 33.9 33.6 25.5 58.2 x x 41.6 30.2 x x 20.5 36.8 22.1 30.2 97.5 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10097 Original post publication description: Ethanol response (2 mg/kg ip), conditioned place preference (CPP) for the ethanol-paired grid compartment in experimental group males [s/min] None Ethanol response (2 g/kg ip), conditioned place preference (CPP) for the ethanol-paired grid compartment in experimental group males [s/min] x x 35.6 36.0 43.7 40.9 32.1 38.6 36.2 36.1 50.5 35.7 33.7 35.7 36.1 40.5 34.5 x x 31.0 36.3 x x 45.7 33.8 43.5 31.2 34.5 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10098 Original post publication description: Ethanol response (2 mg/kg ip), conditioned place preference (CPP) for the ethanol-paired hole floor in experimental group males [s/min] None Ethanol response (2 g/kg ip), conditioned place preference (CPP) for the ethanol-paired hole floor in experimental group males [s/min] x x 25.6 24.4 26.0 25.8 26.6 22.8 22.5 24.0 16.0 26.1 22.1 29.4 19.4 26.4 253.0 x x 31.5 17.4 x x 16.2 33.7 23.0 25.7 30.5 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10099 Original post publication description: Saline control response (vehicle ip), habituation, locomotion from 1-5 min after a single saline injection for the experimental group of males [activity/min] None Central nervous system, behavior: Saline control response (vehicle ip), habituation, locomotion from 1-5 min after a single saline injection for the experimental group of males [activity/min] x x 116.2 65.1 116.0 83.7 54.9 106.7 47.4 76.6 50.4 91.5 60.0 97.6 53.0 48.3 87.1 x x 52.1 48.4 x x 47.3 85.8 49.9 44.5 146.4 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10100 Original post publication description: Locomotion from 1-5 min after a single saline ip injection of saline vehicle for the experimental group on trial 1 [activity counts per min] None Locomotion from 1-5 min after a single saline ip injection of saline vehicle for the experimental group on trial 1 [activity counts per min] x x 87.8 63.7 92.4 73.5 40.4 82.3 48.1 73.6 45.7 66.0 46.3 66.6 45.9 45.7 83.5 x x 53.6 47.0 x x 38.8 8.7 60.1 51.9 143.6 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10101 Original post publication description: Floor preference baseline, intrinsic preference for the grid-textured floor for the control group of males [s/min] None Central nervous system, behavior: Floor preference baseline, intrinsic preference for the grid-textured floor for the control group of males [s/min] x x 29.6 33.4 31.3 35.2 26.9 33.7 28.6 32.4 30.7 26.5 24.7 29.7 25.6 27.3 31.3 x x 28.8 23.2 x x 38.0 31.5 31.6 32.1 31.5 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10102 Original post publication description: Ethanol response (2 mg/kg ip), locomotion from 1-5 min after injection, conditioning trial 4 in males [activity counts per min] None Ethanol response (2 g/kg ip), locomotion from 1-5 min after injection, conditioning trial 4 in males [activity counts per min] x x 57.6 165.8 90.4 67.6 54.4 50.4 123.7 138.5 61.0 45.1 70.1 94.5 49.0 31.7 126.0 x x 114.3 77.3 x x 74.3 115.8 133.4 59.3 170.8 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10103 Original post publication description: Floor preference baseline, intrinsic preference for the grid-textured floor for the control group of males [s/min] None Floor preference baseline, intrinsic preference for the grid-textured floor for the control group of males [s/min] x x 41.5 40.2 29.4 30.1 29.3 31.4 33.4 43.8 29.0 40.0 30.6 40.7 29.5 24.1 48.0 x x 37.9 26.6 x x 20.9 34.8 38.3 31.7 66.8 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10104 Original post publication description: Ethanol response (2 mg/kg ip), locomotor tolerance or sensitization in males, difference between experimental group (two prior exposures to ethanol) and saline control group on fourth conditioning day [activity counts/min] None Central nervous system, pharmacology, behavior: Ethanol response (2 g/kg ip), locomotor tolerance or sensitization in males, difference between experimental group (two prior exposures to ethanol) and saline control group on fourth conditioning day [activity counts/min] x x 17.954 112.444 36.212 30.788 27.695 10.331 94.338 85.444 37.384 11.907 46.397 52.106 11.656 3.311 57.404 x x 67.04 41.583 x x 41.868 66.298 99.001 21.788 46.616 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10105 Original post publication description: Saline control response (0.9% ip), activity habituation in males [4th saline injection trial activity minus first saline activity trial activity] None Saline control response (0.9% ip), activity habituation in males [4th saline injection trial activity minus first saline activity trial activity] x x -47.925 -10.243 -37.8 -36.568 -13.088 -41.865 -18.465 -20.793 -21.569 -32.167 -22.473 -23.9 -8.386 -17.503 -14.676 x x -6.034 -11.252 x x -6.357 -32.848 -26.041 -14.067 -18.888 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10106 Original post publication description: Central nervous system, morphology: Striatum cholinergic neurons, section 11 [number/section] None Central nervous system, morphology: Striatum cholinergic neurons, section 11 [number/section] x x 60.0 86.0 72.0 75.0 80.0 69.0 92.0 80.0 73.0 52.0 74.0 66.0 70.0 64.0 68.0 93.0 86.0 71.0 85.0 68.0 x 99.0 96.0 x 80.0 62.0 72.0 75.0 95.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10107 Original post publication description: Striatum cholinergic neurons section 14 [number of neurons] None Striatum cholinergic neurons section 14 [number of neurons] x x 91.0 116.0 104.0 103.0 103.0 117.0 122.0 124.0 115.0 89.0 101.0 94.0 93.0 86.0 132.0 129.0 139.0 110.0 111.0 93.0 x 111.0 139.0 x 130.0 97.0 97.0 109.0 145.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10108 Original post publication description: Striatum cholinergic neurons section 17 [number of neurons] None Central nervous system, morphology: Striatum cholinergic neurons section 17 [n neurons/section] x x 110.0 135.0 133.0 117.0 124.0 130.0 174.0 142.0 138.0 125.0 127.0 131.0 117.0 127.0 174.0 161.0 159.0 127.0 129.0 130.0 x 156.0 166.0 x 140.0 148.0 137.0 139.0 152.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10109 Original post publication description: Striatum cholinergic neurons section 20 [number of neurons] None Striatum cholinergic neurons section 20 [number of neurons] x x 105.0 134.0 109.0 106.0 115.0 125.0 135.0 132.0 125.0 117.0 123.0 136.0 116.0 133.0 134.0 153.0 143.0 122.0 135.0 120.0 x 138.0 156.0 x 116.0 142.0 117.0 124.0 137.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10110 Original post publication description: Striatum cholinergic neurons section 22 [number of neurons] None Central nervous system, morphology: Striatum cholinergic neurons section 22 [n neurons/section] x x 70.0 89.0 76.0 67.0 62.0 75.0 97.0 82.0 95.0 72.0 60.0 72.0 65.0 70.0 75.0 71.0 76.0 66.0 82.0 76.0 x 83.0 85.0 x 70.0 102.0 74.0 87.0 85.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10111 Original post publication description: Striatum cholinergic neurons section 24 [number of neurons] None Striatum cholinergic neurons section 24 [number of neurons] x x 47.0 67.0 40.0 52.0 51.0 49.0 48.0 44.0 52.0 46.0 47.0 44.0 42.0 48.0 46.0 62.0 46.0 47.0 53.0 44.0 x 52.0 51.0 x 44.0 61.0 45.0 58.0 54.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10112 Original post publication description: Life span, longevity [days] (RWW winsorized outliers BXD2, BXD14, and DBA2J from 400, 500, and 175 days, respectively) None Life span, longevity [days] (RWW winsorized outliers BXD2, BXD14, and DBA2J from 400, 500, and 175 days, respectively) x x 675.0 365.0 600.0 450.0 525.0 690.0 660.0 825.0 750.0 740.0 x 500.0 800.0 650.0 740.0 900.0 x x 740.0 760.0 x 840.0 x 715.0 760.0 700.0 740.0 580.0 420.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10113 Original post publication description: Quiescent stem cells in old mice-cobblestone area forming cells (CAFC) day 35 frequency in bone marrow [105 BM cells] None Immune system, aging: Quiescent stem cells in aged mice, cobblestone area forming cells (CAFC) at day 35 in culture, frequency in bone marrow [10^5 BM cells] x x 1.5 3.0 1.5 x x 2.0 x 3.5 8.0 2.0 x 3.0 2.0 2.5 2.5 2.0 2.0 x x 2.0 x 2.0 1.0 2.0 3.0 0.5 3.0 3.3 3.5 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10114 Original post publication description: Immune system, aging: Proliferative activity of hematopoietic stem cells, quiescent HSCs in aged mice, cobblestone area forming cells (CAFC) on day 35, frequency in bone marrow [CAFC per 10e5 bone marrow cells] None Immune system, aging: Proliferative activity of hematopoietic stem cells, quiescent HSCs in aged mice, cobblestone area forming cells (CAFC) on day 35, frequency in bone marrow [CAFC per 10e5 bone marrow cells] x x 4.0 1.0 1.0 x x 12.0 x 11.5 2.0 4.5 x 7.0 21.0 3.3 6.0 3.3 4.0 x x 2.5 x 2.5 6.0 4.0 4.0 0.1 6.5 2.0 3.5 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10115 Original post publication description: Stem cell cycling, change in day 7 cobblestone area forming cell (CAFC) frequency during aging [%CAFC] None Immune system, aging: Stem cell cycling, change in day 7 cobblestone area forming cell (CAFC) frequency during aging [%CAFC] x x 110.0 100.0 125.0 x x 110.0 x 102.0 98.0 105.0 x 125.0 75.0 110.0 110.0 102.0 104.0 x x 103.0 x 120.0 100.0 104.0 105.0 90.0 120.0 85.0 80.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10116 Original post publication description: Immune system, aging: Proliferative activity of hematopoietic stem cells, day 21 cobblestone area forming cell (CAFC) frequency change, [% CAFC] None Immune system, aging: Proliferative activity of hematopoietic stem cells, day 21 cobblestone area forming cell (CAFC) frequency change, [% CAFC] x x 180.0 82.0 90.0 x x 200.0 x 120.0 80.0 125.0 x 130.0 340.0 108.0 130.0 92.0 130.0 x x 115.0 x 70.0 110.0 110.0 108.0 60.0 125.0 75.0 108.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10117 Original post publication description: Immune system, aging: Proliferative activity of hematopoietic stem cells, change in quiescent HSC percentage (cobblestone area-forming cells day 35 of culture) at 20 months [% CAFC] None Immune system, aging: Proliferative activity of hematopoietic stem cells, change in quiescent HSC percentage (cobblestone area-forming cells day 35 of culture) at 20 months [% CAFC] x x 190.0 75.0 103.0 x x 420.0 x 190.0 50.0 130.0 x 130.0 800.0 108.0 130.0 110.0 125.0 x x 110.0 x 108.0 240.0 125.0 110.0 20.0 135.0 80.0 102.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10118 Original post publication description: Stem cell frequency, cobblestone area-forming cell assay count (CAFC) on day 35 [CAFC per 100000 cells] None Immune system, development: Stem cell frequency, cobblestone area-forming cell assay count (CAFC) on day 35 [CAFC per 100000 cells] x x 1.2 3.3 1.0 3.4 2.9 1.6 2.1 3.5 8.22 1.6 0.9 2.6 2.1 2.4 2.3 2.1 1.9 2.2 2.2 1.8 x 1.8 1.2 1.8 2.5 0.5 2.5 2.8 2.9 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10119 Original post publication description: Hemopoietic stem cell cycling day 7 [% CAFC] None Immune system, aging: Hemopoietic stem cell cycling day 7 in culture [% CAFC] x x 8.0 20.0 36.0 12.6 31.0 31.0 13.0 2.0 29.0 16.0 26.0 18.0 22.0 34.0 13.0 2.0 0.8 32.0 6.0 12.6 x 7.8 0.8 12.8 24.0 19.0 0.8 56.0 34.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10120 Original post publication description: Chlordiazepoxide 10 mg/kg induced locomotor response distance traveled, 0-5 min time interval [cm] None Central nervous system, pharmacology, behavior: Chlordiazepoxide 10 mg/kg induced locomotor response distance traveled, 0-5 min time interval [cm] x x -696.0 -81.0 -716.0 x -40.0 -9.0 -284.0 197.0 919.0 112.0 -509.0 -594.0 216.0 7.0 668.0 335.0 744.0 76.0 787.0 -113.0 x 739.0 -39.0 -413.0 387.0 742.0 204.0 328.0 299.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10121 Original post publication description: Chlordiazepoxide response (10 mg/kg), induced locomotor response distance traveled, 5-10 min time interval [cm] None Chlordiazepoxide response (10 mg/kg), induced locomotor response distance traveled, 5-10 min time interval [cm] x x -459.0 863.0 -248.0 x -487.0 -36.0 -18.0 -1623.0 1166.0 1306.0 -451.0 132.0 -1104.0 1377.0 10.0 -39.0 510.0 -246.0 -448.0 256.0 x 174.0 -86.0 -497.0 409.0 1909.0 -590.0 527.0 500.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10122 Original post publication description: Chlordiazepoxide locomotor response, 10-15 min after injection (10 mg/kg) [cm/5 min] None Chlordiazepoxide locomotor response, 10-15 min after injection (10 mg/kg) [cm/5 min] x x -69.0 875.0 -462.0 x -846.0 -137.0 -285.0 -2600.0 518.0 477.0 -642.0 443.0 -1036.0 1013.0 266.0 -403.0 453.0 -520.0 -743.0 104.0 x -390.0 -110.0 -555.0 9.0 903.0 -28.0 774.0 419.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10123 Original post publication description: Chlordiazepoxide response (10 mg/kg ip), locomotion from 15-20 min after injection [cm] None Chlordiazepoxide response (10 mg/kg ip), locomotion from 15-20 min after injection [cm] x x 297.0 857.0 -817.0 x -705.0 -358.0 -425.0 -2564.0 319.0 -383.0 -888.0 268.0 -835.0 814.0 367.0 -828.0 -40.0 -354.0 -622.0 825.0 x -351.0 -132.0 -1058.0 -340.0 1059.0 -312.0 233.0 504.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10124 Original post publication description: Chlordiazepoxide 10 mg/kg induced locomotor response distance traveled, 5-20 min time interval [cm] None Chlordiazepoxide 10 mg/kg induced locomotor response distance traveled, 5-20 min time interval [cm] x x -231.0 2595.0 -1526.0 x -2039.0 -531.0 -727.0 -6786.0 2002.0 1401.0 -1981.0 843.0 -2974.0 3204.0 643.0 -1270.0 923.0 -1119.0 -1812.0 1185.0 x -567.0 -327.0 -2110.0 78.0 3870.0 -930.0 1534.0 1423.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10125 Original post publication description: Ethanol induced locomotor response distance traveled, 0-5 min time interval [cm] None Central nervous system, pharmacology, behavior: Ethanol induced locomotor response distance traveled, 0-5 min time interval [cm] x x 208.0 2284.0 1274.0 x 323.0 -208.0 1182.0 289.0 308.0 1819.0 925.0 146.0 943.0 1845.0 2042.0 1786.0 1423.0 1228.0 481.0 109.0 x 683.0 698.0 447.0 486.0 155.0 983.0 414.0 1073.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10126 Original post publication description: Ethanol induced locomotor response distance traveled, 5-10 min time interval [cm] None Ethanol induced locomotor response distance traveled, 5-10 min time interval [cm] x x 536.0 1689.0 533.0 x -144.0 -504.0 1387.0 -2024.0 459.0 2298.0 392.0 288.0 -119.0 1884.0 2243.0 264.0 2291.0 1904.0 -1116.0 -138.0 x -281.0 -378.0 1689.0 566.0 1038.0 902.0 671.0 515.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10127 Original post publication description: Ethanol induced locomotor response distance traveled, 10-15 min time interval [cm] None Ethanol induced locomotor response distance traveled, 10-15 min time interval [cm] x x 356.0 1094.0 182.0 x -824.0 -1115.0 1344.0 -2458.0 599.0 1244.0 282.0 -354.0 -324.0 1555.0 2235.0 -357.0 1742.0 1693.0 -591.0 -450.0 x -319.0 -634.0 800.0 749.0 799.0 758.0 908.0 766.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10128 Original post publication description: Ethanol induced locomotor response distance traveled, 15-20 min time interval [cm] None Central nervous system, pharmacology, behavior: Ethanol induced locomotor response distance traveled, 15-20 min time interval [cm] x x 215.0 739.0 639.0 x -936.0 -1376.0 1147.0 -2107.0 578.0 1495.0 -308.0 -857.0 -420.0 1416.0 1799.0 -606.0 1234.0 1406.0 -528.0 -173.0 x -380.0 -711.0 319.0 515.0 142.0 1065.0 1225.0 851.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10129 Original post publication description: Ethanol induced locomotor response distance traveled, 5-20 min time interval [cm] None Ethanol induced locomotor response distance traveled, 5-20 min time interval [cm] x x 1107.0 3522.0 1354.0 x -1905.0 -2995.0 3879.0 -6588.0 1636.0 5037.0 366.0 -923.0 -864.0 4855.0 6277.0 -717.0 5267.0 5003.0 -2235.0 -761.0 x -979.0 -1722.0 2808.0 1829.0 1980.0 2725.0 2805.0 2132.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10130 Original post publication description: Saline control locomotor response, distance traveled, 0-5 min time interval [cm] None Saline control locomotor response, distance traveled, 0-5 min time interval [cm] x x 5131.0 2170.0 4018.0 x 1876.0 2893.0 1784.0 3817.0 1647.0 3998.0 2876.0 3481.0 1086.0 1603.0 3117.0 2888.0 2713.0 1929.0 1926.0 2511.0 x 2317.0 2391.0 2194.0 1449.0 4543.0 2128.0 2099.0 1559.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10131 Original post publication description: Activity level, locomotion after a saline injection, distance traveled, 5-10 min time interval [cm] None Activity level, locomotion after a saline injection, distance traveled, 5-10 min time interval [cm] x x 3595.0 1894.0 2908.0 x 1767.0 2469.0 1807.0 3533.0 1333.0 2730.0 2356.0 2640.0 892.0 1752.0 3032.0 2900.0 2367.0 2200.0 1859.0 1864.0 x 1854.0 2316.0 1925.0 1645.0 4018.0 2143.0 2266.0 1789.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10132 Original post publication description: Saline control response (dose ip), locomotion from 10-15 min after injection [cm] None Saline control response (dose ip), locomotion from 10-15 min after injection [cm] x x 2783.0 1582.0 2391.0 x 1442.0 2302.0 1753.0 2865.0 1166.0 2391.0 1806.0 2433.0 865.0 1612.0 2775.0 2625.0 1868.0 1852.0 1430.0 1573.0 x 1418.0 1752.0 1691.0 1476.0 3395.0 1850.0 2013.0 1657.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10133 Original post publication description: Saline-induced locomotor response distance traveled, 15-20 min time interval [cm] None Saline-induced locomotor response distance traveled, 15-20 min time interval [cm] x x 2580.0 1317.0 1964.0 x 1420.0 2272.0 1656.0 2531.0 1268.0 2084.0 2148.0 2658.0 954.0 1383.0 2642.0 2442.0 1794.0 1781.0 1347.0 1351.0 x 1340.0 1594.0 1797.0 1519.0 3083.0 1598.0 1775.0 1770.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10134 Original post publication description: Saline induced locomotor response, distance traveled, 5-20 min time interval [cm] None Saline induced locomotor response, distance traveled, 5-20 min time interval [cm] x x 8958.0 4793.0 7263.0 x 4629.0 7043.0 5216.0 8929.0 3767.0 7204.0 6311.0 7731.0 2710.0 4747.0 8449.0 7966.0 6029.0 5833.0 4636.0 4787.0 x 4612.0 5663.0 5413.0 4640.0 10496.0 5590.0 6055.0 5215.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10135 Original post publication description: Ethanol acceptance-male raw mean consumption (Same data as Rodriguez et al, 1994 with outliers removed and 2 strains added) [g/kg body weight] None Central nervous system, pharmacology, behavior: Ethanol acceptance (10% in tap water after 24 hr water deprivation), raw mean consumption of adult males (same data as Rodriguez et al, 1994 with outliers removed and two strains added) [g/kg body weight] x x x x 16.1 14.96 15.26 13.48 11.28 9.47 16.78 14.75 10.03 10.4 x 14.77 7.08 10.92 x 16.47 14.66 x x 4.85 13.25 12.06 11.73 15.57 9.38 15.58 11.02 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10136 Original post publication description: Ethanol response (X% po), acceptance by females, raw mean consumption (same data as in Rodriguez et al., 1994 with outliers removed and two strains added) [g/kg body weight] None Central nervous system, pharmacology, behavior: Ethanol response (10% v/v in tap water), acceptance by females (74-91 days of age), consumption after 24 hr of water deprivation (same data as in Rodriguez et al., 1994 with outliers removed and two strains added) [g/kg body weight] x x x x 15.99 15.76 18.53 17.07 12.59 12.75 18.78 16.25 14.75 18.84 x 21.47 13.51 15.41 x 18.35 15.7 x x 10.1 13.48 10.88 9.63 17.43 12.82 18.18 11.05 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10137 Original post publication description: Ethanol response, acceptance, male residual (same data as Rodriguez et al, 1994 with outliers removed and two strains added) [g/kg body weight] None Central nervous system, pharmacology, behavior: Ethanol response (10% in tap water), voluntary consumption after 24 hr water deprivation, acceptance, male residual values (same data as Rodriguez et al, 1994 with outliers removed and two strains added) [g/kg body weight] x x x x 2.97 1.98 0.46 -0.36 0.39 -1.53 1.82 1.44 -2.28 -4.46 x -1.97 -4.42 -1.83 x 1.78 1.72 x x -4.4 1.77 2.29 2.79 1.49 -1.67 1.0 1.15 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10138 Original post publication description: Ethanol response, acceptance level, female residual (same data as in Rodriguez et al, 1994 with outliers removed and two strains added) [g/kg body weight] None Central nervous system, pharmacology, behavior: Ethanol response (10% v/v in tap water), acceptance by 74-91 day old females after 24 hr water deprivation, residuals (same data as in Rodriguez et al, 1994 with outliers removed and two strains added) [g/kg body weight] x x x x -1.54 -1.0 1.56 1.29 -1.72 -0.34 0.79 -0.37 1.28 5.12 x 4.83 2.02 1.35 x 0.58 -0.87 x x 0.09 -2.14 -3.95 -4.98 0.26 -0.21 1.0 -3.08 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10139 Original post publication description: Ethanol preference, male raw mean consumption (same data as Rodriguez et al, 1994 with outliers removed and two strains added) [g/kg body weight] None Central nervous system, pharmacology, behavior: Ethanol response (10% v/v in tap water), preference, young male (53-67 days) consumption using two-bottle choice (same data as Rodriguez et al, 1994 with outliers removed and two strains added) [g/kg body weight] x x x x 3.31 3.6 3.68 4.66 3.82 2.68 5.75 4.82 1.97 2.27 x 4.09 2.22 4.43 x 4.46 3.68 x x 2.22 6.54 5.64 5.53 5.04 3.01 8.01 2.37 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10140 Original post publication description: Ethanol preference-female raw mean consumption (Same data as Rodriguez et al, 1994 with outliers removed and 2 strains added) [g/kg body weight] None Central nervous system, pharmacology, behavior: Ethanol response (10% v/v in tap water), consumption preference using two bottle choice in young adult females (53-67 days) (same data as Rodriguez et al, 1994 with outliers removed and two strains added) [g/kg body weight] x x x x 5.36 6.48 4.09 6.73 4.91 2.96 5.02 4.82 2.25 3.49 x 11.03 4.05 4.98 x 4.62 4.19 x x 3.18 6.9 8.38 6.59 3.84 4.78 10.44 2.22 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10141 Original post publication description: Ethanol response, preference of males, residual mean (same data as Rodriguez et al, 1994 with outliers removed and two strains added) [g/kg body weight] None Central nervous system, pharmacology, behavior: Ethanol response (10% v/v in tap water), preference of young males (53-67 days) using two-bottle choice, residuals (same data as Rodriguez et al, 1994 with outliers removed and two strains added) [g/kg body weight] x x x x -0.81 -1.05 0.16 -0.1 -0.09 -0.31 1.79 0.96 -0.68 -0.97 x -1.18 0.49 0.69 x 0.69 0.11 x x -0.88 1.7 0.1 0.83 1.64 -0.83 1.5 -0.27 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10142 Original post publication description: Ethanol preference-female residual mean (Same data as Rodriguez et al, 1994 with outliers removed and 2 strains added) [g/kg body weight] None Central nervous system, pharmacology, behavior: Ethanol preference (10% in tap water), consumption in females using two-bottle choice, residual mean over a two week test period (same data as Rodriguez et al, 1994 with outliers removed and two strains added) [g/kg body weight] x x x x 0.88 1.7 -0.77 0.85 -0.1 -0.87 -1.98 -1.22 -0.85 0.09 x 5.75 0.7 -0.66 x -1.05 -0.67 x x -0.17 -0.92 1.49 -0.18 -2.43 0.61 1.09 -1.29 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10143 Original post publication description: Sleep need, slow wave sleep delta EEG power after 6 hrs sleep deprivation [%] None Central nervous system, physiology: Sleep need, slow wave sleep delta EEG power after 6 hrs sleep deprivation [%] x x 223.133 179.452 168.304 148.551 223.583 197.68 198.379 155.447 161.296 156.793 166.24 130.001 166.624 179.251 x 189.507 133.289 147.317 172.023 169.368 x 165.23 187.284 168.229 144.83 153.054 149.713 138.458 132.991 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10144 Original post publication description: Ethanol response (dose ip), ethanol-induced ataxia following first of five injections (initial sensitivity), onset threshold [mg/kg] None Central nervous system, pharmacology, behavior: Ethanol response (variable dose ip), ethanol-induced ataxia following first of five injections (initial sensitivity), onset threshold [mg/kg] x x 1.44 0.4 1.21 1.09 0.8 1.03 0.77 1.16 0.88 0.94 0.71 0.8 0.41 1.22 1.28 0.98 x 1.07 0.49 0.9 x 0.72 1.07 0.8 0.69 1.37 1.03 1.15 0.44 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10145 Original post publication description: Ethanol response (dose route), maximal threshold to ethanol induced ataxia [mg/ml] None Ethanol response (dose route), maximal threshold to ethanol induced ataxia [mg/ml] x x 2.62 3.47 3.75 2.94 2.75 2.21 3.13 3.63 3.24 2.63 3.27 2.65 2.66 2.88 2.86 2.81 x 2.93 3.28 3.12 x 3.26 3.17 2.67 3.21 2.91 3.52 2.57 3.49 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10146 Original post publication description: Ethanol response (dose route), tolerance, difference between ethanol induced ataxia (maximal threshold) minus onset threshold None Central nervous system, pharmacology, behavior: Ethanol response (escalating dose given ip), tolerance, difference between ethanol induced ataxia (maximal threshold blood ethanol concentration BEC) minus onset threshold [mg/ml] x x 1.18 3.07 2.54 1.85 1.95 1.19 2.36 2.47 2.36 1.69 2.56 1.85 2.25 1.66 1.58 1.83 x 1.86 2.79 2.22 x 2.54 2.1 1.87 2.52 1.54 2.49 1.42 3.05 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10147 Original post publication description: Ethanol response (dose route), tolerance measured as the fold-increase to ethanol-induced ataxia [ratio of maximal threshold divided by onset threshold] None Central nervous system, pharmacology, behavior: Ethanol response (iv?), tolerance measured as the fold-increase of blood ethanol concentration (BEC) to ethanol-induced ataxia [ratio of tolerance BEC level over initial BEC ataxia level] x x 1.82 8.68 3.1 2.7 3.44 2.16 4.06 3.13 3.68 2.8 4.61 3.31 6.49 2.36 2.23 2.87 x 2.74 6.69 3.47 x 4.53 2.96 3.34 4.65 2.12 3.42 2.23 7.93 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10148 Original post publication description: Life history, aging: Life span, longevity [days] None Life history, aging: Life span, longevity (authors excluded BXD13 (176 days) due to seizures, and BXD31 (577 days), and BXD32 (440 days) due to poor marker coverage. RWW reinstated all strains and winsorized BXD13 to 439 days) [days] x x x x 594.0 479.0 528.0 687.0 617.0 816.0 750.0 738.0 439.0 493.0 798.0 642.0 742.0 904.0 x x 743.0 763.0 x 835.0 x 711.0 765.0 703.0 737.0 577.0 440.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10149 Original post publication description: Hepatic lipid peroxidation (LPO) levels [malondialdehyde (MDA)/mg] None Liver, metabolism, aging: Hepatic lipid peroxidation (LPO) levels in 2-month-old males [malondialdehyde (MDA)/mg] x x 21.7 30.1 30.2 43.2 26.9 40.1 34.6 44.3 37.3 51.0 x 44.4 x 32.7 22.3 40.1 x 33.1 36.3 x x 42.8 24.7 26.3 57.0 x 28.4 x 24.7 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10150 Original post publication description: Immune function: Thymic T-cell response to anti-CD3-induced proliferation None Immune system: Thymic T-cell response to anti-CD3-induced proliferation x x x x 17.99 29.53 2.84 34.51 43.11 4.2 27.22 2.66 33.2 7.65 2.37 4.86 17.19 3.07 1.83 3.29 5.07 40.15 x 22.96 17.36 27.61 5.54 5.04 31.48 47.96 8.45 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10151 Original post publication description: Ethanol response (10% in water po), total fluid intake during 4-day forced 10% ethanol exposure period [total mls/day] None Central nervous system, pharmacology, behavior: Ethanol response (10% in water po), total fluid intake during 4-day forced 10% ethanol exposure period [total mls/day] x x 5.23 4.96 6.39 x x 4.65 6.07 x 4.38 x x x x 5.39 x x x x x x x x x x 5.09 x x x 6.62 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10152 Original post publication description: Fluid intake (total) during free choice ethanol period [ml/day] None Central nervous system, pharmacology, behavior: Fluid intake (total) during free choice ethanol period [ml/day] x x 6.06 6.64 2.5 x x 5.26 7.04 x 6.02 x x x x 6.35 x x x x x x x x x x 5.89 x x x 7.19 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10153 Original post publication description: Ethanol response (10% in water, po), preference during 3-week free choice period using two bottle choice test for males [mls 10% ethanol/mls total fluid] None Central nervous system, pharmacology, behavior: Ethanol response (10% in water, po), preference during 3-week free choice period using two bottle choice test for males [mls 10% ethanol/mls total fluid] x x 0.83 0.16 0.27 x x 0.83 0.24 x 0.43 x x x x 0.79 x x x x x x x x x x 0.24 x x x 0.16 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10154 Original post publication description: Ethanol response (10% in water po), preference during free choice period for females using two bottle choice [mls 10 % ethanol/mls total fluid] None Central nervous system, pharmacology, behavior: Ethanol response (10% in water po), preference during free choice period for females using two bottle choice [mls 10 % ethanol/mls total fluid] x x 0.81 0.14 0.48 x x 0.71 0.46 x 0.29 x x x x 0.63 x x x x x x x x x x 0.45 x x x 0.19 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10155 Original post publication description: Ethanol response (10% in water, po), consumption during 3-week free choice period using two bottle choice test for males [gm ethanol/kg body weight/day] None Central nervous system, pharmacology, behavior: Ethanol response (10% in water, po), consumption during 3-week free choice period using two bottle choice test for males [gm ethanol/kg body weight/day] x x 14.8 3.8 5.2 x x 12.9 4.4 x 9.5 x x x x 13.3 x x x x x x x x x x 4.5 x x x 7.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10156 Original post publication description: Ethanol response (10% in water, po), consumption during free choice period for females using two-bottle choice [gms ethanol/kg body weight/day] None Central nervous system, pharmacology, behavior: Ethanol response (10% in water, po), consumption during free choice period for females using two-bottle choice [gms ethanol/kg body weight/day] x x 20.5 3.7 12.2 x x 17.5 9.1 x 7.2 x x x x 17.1 x x x x x x x x x x 9.2 x x x 4.7 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10157 Original post publication description: Morphology: Body weight [g] None Morphology: Body weight [g] x x 23.5 22.9 22.6 x x 21.4 23.9 x 20.5 x x x x 23.5 x x x x x x x x x x 23.3 x x x 22.7 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10158 Original post publication description: Ethanol response (10% in water po), ethanol preference ratio using a two bottle choice test [ratio of 10% ethanol/total fluid] None Central nervous system, pharmacology, behavior: Ethanol response (10% in water po), ethanol preference ratio using a two bottle choice test [ratio of 10% ethanol/total fluid] x x 0.82 0.15 0.35 x x 0.76 0.38 x 0.37 x x x x 0.71 x x x x x x x x x x 0.37 x x x 0.18 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10159 Original post publication description: Ethanol response (10% in water po), voluntary consumption ratio using a two bottle choice test [gms ethanol/kg body weight] None Central nervous system, pharmacology, behavior: Ethanol response (10% in water po), voluntary consumption ratio using a two bottle choice test [gms ethanol/kg body weight] x x 17.4 3.7 8.0 x x 15.1 8.7 x 8.5 x x x x 15.2 x x x x x x x x x x 7.4 x x x 5.1 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10160 Original post publication description: Catalase activity in liver [uMol] None Liver, pharmacology, protein expression: Catalase activity in liver [uMol] x x 68.4 115.9 71.1 x x 76.2 0.0 x 130.9 x x x x 106.8 x x x x x x x x x x 121.6 x x x 136.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10161 Original post publication description: Catalase activity in brain [nMol] None Central nervous system, pharmacology, protein expression: Catalase activity in brain [nMol] x x 517.0 750.1 785.8 x x 627.3 0.0 x 660.0 x x x x 636.7 x x x x x x x x x x 615.1 x x x 795.8 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10162 Original post publication description: Pharmacology, metabolism: Aldehyde dehydrogenase (ALDH) activity in liver [nMol NADH produced/minute/milligram of protein] None Liver, pharmacology, metabolism, protein expression: Aldehyde dehydrogenase (ALDH) activity in liver [nMol NADH produced/minute/milligram of protein] x x 23.6 21.6 14.1 x x 15.3 15.0 x 12.4 x x x x 15.7 x x x x x x x x x x 21.3 x x x 13.6 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10163 Original post publication description: Aldehyde dehydrogenase (ALDH) activity in brain [nMol NADH produced/minute/milligram of protein] None Central nervous system, pharmacology, protein expression: Aldehyde dehydrogenase (ALDH) activity in brain [nMol NADH/min/mg protein] x x 1.89 2.02 0.57 x x 1.47 0.59 x 0.95 x x x x 1.43 x x x x x x x x x x 3.1 x x x 1.34 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10164 Original post publication description: Home cage activity after saline injection None Central nervous system, behavior: Home cage activity level 10-14 week old males after saline injection [n quadrant crossings/1 min] x x 13.25 8.375 11.75 8.625 10.75 15.5 11.25 11.375 8.375 7.88889 6.0 10.75 8.0 11.875 10.5 12.0 x 7.5 11.375 15.75 x 1.77778 17.125 11.5 7.5 13.5 9.125 8.625 20.75 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10165 Original post publication description: Methamphetamine response (4 mg/kg ip), locomotor activity difference from saline [quadrant crossings/min] None Central nervous system, behavior, pharmacology: Methamphetamine response (4 mg/kg i.p.), locomotor activity difference from saline in 10-14 week males [n quadrant crossings/min] x x 21.625 18.7679 47.25 35.9306 41.5 19.25 7.0 33.125 8.5 31.8986 19.875 13.125 35.75 18.125 21.875 31.5 x 34.375 9.5 10.125 x 13.8472 15.5 22.0 25.5 33.75 10.375 30.0 14.75 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10166 Original post publication description: Activity difference from saline for 8 mg/kg methamphetamine [quadrant crossings/min] None Central nervous system, behavior, pharmacology: Methamphetamine response (8 mg/kg i.p.), activity difference from saline in 10-14 week males [n quadrant crossings/min] x x 11.375 17.0 49.875 24.4861 43.125 1.7 7.25 14.25 6.125 27.4861 31.5 15.25 16.25 4.375 16.5 26.125 x 28.7857 5.5 -0.875 x 25.3472 9.375 40.625 11.5 12.125 23.4306 37.375 7.375 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10167 Original post publication description: Methamphetamine response, difference in locomotion between methamphetamine (16 mg/kg) and saline [quadrant crossings/min] None Central nervous system, behavior, pharmacology: Methamphetamine response (16 mg/kg i.p.), difference in locomotion relative saline in 10-14 week males [quadrant crossings/min] x x -8.75 3.79167 6.625 -0.875 8.25 -12.75 -9.13889 -2.0 -5.75 -2.88889 6.875 3.625 -7.14286 -2.0 4.875 -6.85714 x -1.75 -4.125 -7.25 x 25.4444 -13.3472 8.0 -1.75 -7.7 11.25 4.25 -4.25 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10168 Original post publication description: Methamphetamine response (16 mg/kg ip), frequency of sterotyped chewing events [n/min] None Central nervous system, behavior, pharmacology: Methamphetamine response (16 mg/kg i.p.), frequency of sterotyped chewing events 33 min after injection in 10-14 week males [n/min] x x 2.25 8.375 0.0 1.88889 1.375 7.3 8.25 5.75 4.875 5.04167 0.125 2.22222 9.625 0.875 4.5 7.375 x 1.44643 2.875 3.375 x 1.40278 0.0 3.875 2.275 2.125 0.0833333 2.125 -0.125 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10169 Original post publication description: Methamphetamine response (4 mg/kg ip), body temperature change after after injection [degree C] None Central nervous system, metabolism, pharmacology: Methamphetamine response (4 mg/kg i.p.), body temperature change 48 min after injection in 10-14 week males [change degree C] x x 0.0125 -1.00357 0.832143 -0.461111 0.2375 -3.725 -2.05 0.425 0.0625 0.588889 -0.180357 -1.5625 0.55 -1.2125 0.3625 -0.1375 x -1.4375 -0.4875 -1.8375 x -1.35278 -0.275 -0.7375 -1.5375 -0.5375 -0.279167 0.125 -0.7625 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10170 Original post publication description: Methamphetamine response (8 mg/kg ip), body temperature change after after injection [degree C] None Central nervous system, metabolism, pharmacology: Methamphetamine response (8 mg/kg i.p.), body temperature change 48 min after injection in 10-14 week males [change degree C] x x -0.3375 -0.0875 1.3 0.294444 0.675 -2.3 -0.7625 1.1875 0.225 1.02639 0.357143 0.8 1.775 -1.1125 1.2375 0.425 x 0.253571 0.0125 -0.6375 x -0.0652778 -0.125 0.525 -0.85 1.3 -1.26806 0.825 -0.3625 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10171 Original post publication description: Methamphetamine response (16 mg/kg ip), body temperature change after after injection [degree C] None Central nervous system, metabolism, pharmacology: Methamphetamine response (16 mg/kg i.p.), body temperature change 48 min after injection in 10-14 week males [change degree C] x x 0.1625 0.258333 1.05 1.5375 1.095 -0.15 0.680556 1.4 0.75 1.05139 0.432143 0.8875 1.13036 1.1875 1.2625 1.39821 x 1.05 0.325 1.1375 x 0.377778 0.791667 0.725 1.2 2.3525 -0.1 1.2375 1.0125 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10172 Original post publication description: Brain methamphetamine levels after 8 mg/kg methamphetamine [micrograms/gm] None Central nervous system, pharmacology: Brain methamphetamine levels after 8 mg/kg methamphetamine in 10-14 week males [micrograms/gm] x x 2.0 2.5 3.8 1.5 2.1 1.9 2.9 2.5 2.7 2.7 2.7 3.8 2.8 1.8 2.1 2.9 x 2.1 1.8 2.3 x 1.9 0.8 2.0 2.7 2.0 2.5 2.8 2.1 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10173 Original post publication description: Climbing scores after 16 mg/kg i.p. methamphetamine injection [quadrant crossings/min] None Central nervous system, behavior, pharmacology: Methamphetamine response (16 mg/kg, i.p.), climbing scores of 10-14 week females 1 hr period after injection [ordinal scale 0=on floor, 1=two paws up; 3=climbing] x x 2.3 0.6 0.1 -0.8 1.5 -0.8 0.3 x -0.1 0.7 2.6 -1.0 -0.7 2.0 -0.3 0.4 x 0.1 3.3 0.7 x 0.8 0.6 0.6 1.0 -1.4 2.6 -0.8 1.6 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10174 Original post publication description: Methamphetamine response (4 mg/kg ip), brain concentration after injection [micrograms/gm] None Central nervous system, pharmacology: Methamphetamine response (4 mg/kg ip), brain concentration after injection in 10-14 week males [micrograms/gm] x x 0.5 0.8 1.1 0.5 0.7 0.7 0.9 0.5 0.5 0.8 0.8 1.1 0.9 0.5 0.2 0.8 x 0.6 0.6 0.7 x 0.5 0.5 0.8 0.5 0.4 0.4 1.4 0.8 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10175 Original post publication description: Ethanol response (2 g/kg ip): metabolism rate of ethanol [mg/ml/hr] None Metabolism, pharmacology: Ethanol response (2 g/kg i.p.), metabolism rate of ethanol [mg/ml/hr] x x -0.72 -0.92 -0.79 -0.8 -0.68 -0.64 -0.82 -0.8 -0.87 -0.64 -0.83 -0.95 -0.97 -0.76 -0.73 -0.82 x -0.84 -0.84 -0.97 x -0.92 -0.77 -0.96 -0.77 -1.0 -0.63 -0.68 -0.73 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10176 Original post publication description: Ethanol response (3 g/kg ip), rate of metabolism, beta [mg/ml/hr] None Metabolism, pharmacology: Ethanol response (3 g/kg i.p.), rate of metabolism, beta [mg/ml/hr] x x -0.69 -0.83 -0.71 -0.72 -0.71 -0.69 -0.88 -0.85 -0.8 -0.51 -0.74 -0.85 -0.83 -0.67 -0.72 -0.73 x -0.85 -0.75 -0.88 x -0.86 -0.74 -0.92 -0.76 -0.83 -0.59 -0.62 -0.65 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10177 Original post publication description: Ethanol response (2 g/kg ip), blood ethanol concentration (BEC) 60 min after injection [mg/ml] None Pharmacology: Ethanol response (2 g/kg i.p.), blood ethanol concentration (BEC) 60 min after injection [mg/ml] x x 1.93 2.249 1.859 1.861 1.848 1.654 2.113 2.228 1.907 1.447 2.002 2.01 1.927 2.089 1.767 1.749 x 1.833 1.861 1.969 x 2.337 1.794 1.996 1.935 1.864 1.627 1.56 1.615 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10178 Original post publication description: Ethanol response (3 g/kg ip), blood ethanol concentration (BEC) 60 minutes after injection [mg/ml] None Pharmacology: Ethanol response (3 g/kg i.p.), blood ethanol concentration (BEC) 60 min after injection [mg/ml] x x 3.145 3.464 2.434 2.847 2.951 2.895 3.284 3.562 2.894 2.606 3.57 3.076 2.951 3.326 2.903 3.185 x 3.084 2.702 2.975 x 3.652 3.826 3.544 3.198 2.956 2.828 2.395 2.325 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10179 Original post publication description: Cancer biology: Metastasis of implanted breast tumor in lymph node [number of mice with tumor metastasis] None Cancer biology: Metastasis of implanted breast tumor in lymph node [number of mice with tumor metastasis] x x 0.0 0.0 0.0 x 0.0 x x 0.0 0.0 0.0 x x x 0.0 x x x 0.0 x x x 5.0 3.0 0.0 4.0 x 5.0 3.0 0.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10180 Original post publication description: Cancer biology: Metastasis of implanted breast tumor in pancreas [number of mice with tumor metastasis] None Cancer biology: Metastasis of implanted breast tumor in pancreas [number of mice with tumor metastasis] x x 0.0 0.0 0.0 x 0.0 x x 0.0 0.0 0.0 x x x 0.0 x x x 0.0 x x x 3.0 2.0 0.0 3.0 x 2.0 3.0 0.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10181 Original post publication description: Cancer biology: Necrosis of implanted breast tumor [number of mice with tumor metastasis] None Cancer biology: Necrosis of implanted breast tumor [number of mice with tumor metastasis] x x 0.0 1.0 0.0 x 0.0 x x 0.0 0.0 0.0 x x x 0.0 x x x 0.0 x x x 5.0 5.0 0.0 5.0 x 5.0 5.0 0.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10182 Original post publication description: Cancer biology: Syngeneic breast tumor growth, number of mice with tumor metastasis [n] None Cancer biology: Syngeneic breast tumor growth, number of mice with tumor metastasis [n] x x 4.0 2.0 4.0 x 4.0 x x 3.0 2.0 3.0 x x x 2.0 x x x 4.0 x x x 1.0 1.0 3.0 1.0 x 1.0 1.0 2.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10183 Original post publication description: Cancer biology: Syngeneic breast cancer tumor growth, day 5 [mm^3] None Cancer biology: Syngeneic breast cancer tumor growth, day 5 [mm^3] x x 20.6 33.3 18.9 x 14.7 x x 40.2 27.5 38.7 x x x 33.7 x x x 22.7 x x x 52.6 32.0 37.4 58.7 x 47.1 57.2 25.8 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10184 Original post publication description: Cancer biology: Growth of syngeneic breast cancer tumors day 10 [mm3] None Cancer biology: Growth of syngeneic breast cancer tumors day 10 [mm3] x x 42.5 35.0 34.1 x 41.3 x x 54.3 45.3 73.1 x x x 44.7 x x x 40.7 x x x 119.6 84.2 53.2 106.0 x 87.3 131.1 50.4 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10185 Original post publication description: Cancer biology: Growth of syngeneic breast cancer tumors day 15 [mm3] None Cancer biology: Growth of syngeneic breast cancer tumors day 15 [mm3] x x 89.3 70.8 72.2 x 81.4 x x 73.4 67.0 96.3 x x x 76.2 x x x 83.0 x x x 157.5 164.7 78.1 187.9 x 185.0 201.3 75.2 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10186 Original post publication description: Cancer biology: Syngeneic breast cancer tumor growth, day 20 [mm^3] None Cancer biology: Syngeneic breast cancer tumor growth, day 20 [mm^3] x x 41.4 106.3 52.8 x 43.2 x x 139.3 112.5 149.7 x x x 119.6 x x x 52.2 x x x 279.2 263.1 170.0 198.3 x 266.7 279.2 127.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10187 Original post publication description: Cancer biology: Growth of syngeneic breast cancer tumors day 25 [mm3] None Cancer biology: Growth of syngeneic breast cancer tumors day 25 [mm3] x x 17.2 187.0 35.1 x 37.3 x x 177.9 162.6 189.3 x x x 179.2 x x x 15.8 x x x 283.3 279.0 214.7 326.0 x 355.0 328.1 182.5 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10188 Original post publication description: Cancer biology: Syngeneic breast cancer tumor growth at day 30 [mm^3] None Cancer biology: Syngeneic breast cancer tumor growth at day 30 [mm^3] x x x 212.9 14.4 x 19.2 x x 224.9 188.3 252.3 x x x 173.0 x x x x x x x 358.4 369.6 231.3 388.5 x 504.3 460.5 222.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10189 Original post publication description: Cancer biology: Syngeneic breast cancer tumor growth, day 35 [mm^3] None Cancer biology: Syngeneic breast cancer tumor growth, day 35 [mm^3] x x x 254.2 x x x x x 185.1 275.8 301.7 x x x 279.2 x x x x x x x 502.6 468.3 190.8 500.5 x 662.1 724.6 262.5 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10190 Original post publication description: Cancer biology: Growth of syngeneic breast cancer tumors day 40 [mm3] None Cancer biology: Growth of syngeneic breast cancer tumors day 40 [mm3] x x x 315.6 x x x x x 70.2 335.5 135.3 x x x 303.6 x x x x x x x x x 112.6 x x x x 329.1 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10191 Original post publication description: Cancer biology: Growth of syngeneic breast cancer tumors day 45 [mm3] None Cancer biology: Growth of syngeneic breast cancer tumors day 45 [mm3] x x x 530.0 x x x x x 31.9 457.0 42.8 x x x 417.2 x x x x x x x x x 49.6 x x x x 448.6 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10192 Original post publication description: Cancer biology: Growth of syngeneic breast cancer tumors day 50 [mm3] None Cancer biology: Growth of syngeneic breast cancer tumors day 50 [mm3] x x x 672.5 x x x x x 1.3 537.1 14.3 x x x 504.3 x x x x x x x x x 20.9 x x x x 623.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10193 Original post publication description: Cancer biology: Leukocyte infiltration in metastatic breast tumor, day 5 [measured on scale of 0=no leukocyte infiltration and no destruction of implanted tumor cell to 4=most severe] None Cancer biology: Leukocyte infiltration in metastatic breast tumor, day 5 [measured on scale of 0=no leukocyte infiltration and no destruction of implanted tumor cell to 4=most severe] x x 2.07 0.91 2.52 x 2.64 x x 0.49 0.25 x x x x 1.51 x x x 1.92 x x x x x x x x x x 0.99 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10194 Original post publication description: Cancer biology: Leukocyte infiltration in metastatic breast tumor, day 12 [ordinal scale: 0=no leukocyte infiltration and no destruction of implanted tumor cell to 4=most severe] None Cancer biology: Leukocyte infiltration in metastatic breast tumor, day 12 [ordinal scale: 0=no leukocyte infiltration and no destruction of implanted tumor cell to 4=most severe] x x 3.63 0.81 3.34 x 3.28 x x 2.73 1.0 1.97 x x x 0.78 x x x 3.32 x x x 0.3 x 1.82 x x x 0.62 1.07 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10195 Original post publication description: Cancer biology: Leukocyte infiltration in metastatic breast tumor, day 30 [measured on scale of 0=no leukocyte infiltration and no destruction of implanted tumor cell to 4=most severe] None Cancer biology: Leukocyte infiltration in metastatic breast tumor, day 30 [measured on scale of 0=no leukocyte infiltration and no destruction of implanted tumor cell to 4=most severe] x x 2.12 x 2.37 x 2.71 x x 3.55 x 3.34 x x x x x x x 2.84 x x x x x 3.39 x x x x 0.5 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10196 Original post publication description: Cancer biology: T cell infiltration at tumor site in breast cancer cells, day 5 [measured on scale of 0=no T-cell infiltration and no destruction of implanted tumor cell to 4=most severe] None Cancer biology, immune system: T cell infiltration at tumor site in breast cancer cells, day 5 [measured on scale of 0=no T-cell infiltration and no destruction of implanted tumor cell to 4=most severe] x x 0.86 x 2.02 x 1.93 x x x x x x x x x x x x 1.66 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10197 Original post publication description: Cancer biology: T cell infiltration at tumor site in breast cancer cells, day 1 [measured on scale of 0=no T-cell infiltration and no destruction of implanted tumor cell to 4=most severe] None Cancer biology, immune system: T cell infiltration at tumor site in breast cancer cells, day 1 [measured on scale of 0=no T-cell infiltration and no destruction of implanted tumor cell to 4=most severe] x x 3.64 1.13 3.33 x 3.28 x x 1.72 1.52 1.46 x x x 1.27 x x x 3.85 x x x x x 1.82 x x x 0.47 1.07 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10198 Original post publication description: Cancer biology: T cell infiltration at tumor site in breast cancer cells, day 30 [measured on scale of 0=no T-cell infiltration and no destruction of implanted tumor cell to 4=most severe] None Cancer biology, immune system: T cell infiltration at tumor site in breast cancer cells, day 30 [measured on scale of 0=no T-cell infiltration and no destruction of implanted tumor cell to 4=most severe] x x 1.62 x 2.37 x 2.73 x x 3.52 0.18 3.69 x x x 0.29 x x x 2.34 x x x x x 3.38 x x x x 0.24 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10199 Original post publication description: Cancer biology: Apoptosis of breast tumor cells at day 12 [measured on scale of 0=no apoptosis infiltration and no destruction of implanted tumor cell to 4=most severe] None Cancer biology: Apoptosis of breast tumor cells at day 12 [measured on scale of 0=no apoptosis infiltration and no destruction of implanted tumor cell to 4=most severe] x x 3.5 0.3 3.31 x 3.26 x x 0.1 0.82 0.83 x x x 0.61 x x x 3.37 x x x x x 1.09 x x x x 0.7 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10200 Original post publication description: Cancer biology: Apoptosis of breast tumor cells, day 30 [measured on scale of 0=no apoptosis infiltration and no destruction of implanted tumor cell to 4=most severe] None Cancer biology: Apoptosis of breast tumor cells, day 30 [measured on scale of 0=no apoptosis infiltration and no destruction of implanted tumor cell to 4=most severe] x x 1.11 x 2.35 x 2.21 x x 2.85 0.46 2.4 x x x x x x x 1.81 x x x x x 3.09 x x x x 0.3 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10201 Original post publication description: Cancer biology: Mixed lymphocyte reaction (MLR) with BALB/c spleen cells [cpm stimulated/cpm unstimulated] None Cancer biology: Mixed lymphocyte reaction (MLR) with BALB/c spleen cells [cpm stimulated/cpm unstimulated] x x x x 1.59 x 1.79 x 55.0 1.33 1.4 1.67 x x x x x 43.62 x 2.44 x x x x x 2.25 x x 7.72 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10202 Original post publication description: Cocaine response (variable, iv), dosage required to induce tonic seizure infused via tail vein [mg/kg] None Central nervous system, pharmacology, behavior: Cocaine response (variable, iv), dosage required to induce tonic seizure infused via tail vein [mg/kg] x x 36.5093 45.8624 42.9704 46.3609 43.496 48.0771 44.6149 38.973 48.6678 39.5212 39.4037 39.9768 37.3012 43.33 39.4038 45.4332 x 35.9428 49.5509 x x 38.7928 46.6209 38.7701 38.7467 44.3891 42.0057 34.0522 44.0018 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10203 Original post publication description: Cocaine response (variable mg/kg, i.v. via tail vein), dose required to induce clonic seizure to induce clonic seizure [mg/kg] None Central nervous system, pharmacology, behavior: Cocaine response (variable mg/kg, i.v. via tail vein), dose required to induce clonic seizure to induce clonic seizure [mg/kg] x x 21.1276 21.9037 24.3794 21.8333 21.6786 20.1582 23.9731 21.8606 24.8676 17.5034 21.769 21.8179 17.4457 20.1132 24.3516 23.4872 x 20.3501 23.5815 x x 20.7145 22.1648 22.8863 19.643 20.8624 22.8057 20.1509 20.737 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10204 Original post publication description: Immune function: TRBV4+ T cell levels among CD8+ T cells in spleen [%] None Immune system, hematology: TRBV4+ T cell levels among CD8+ T cells in spleen [%] x x 36.6 11.5 24.5 37.1 28.3 18.4 13.2 30.8 20.6 11.7 12.9 27.4 36.6 7.6 11.6 28.0 x 37.8 17.5 20.2 x 27.0 18.4 17.0 14.1 40.0 10.0 24.3 34.9 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10205 Original post publication description: Immune function: TRBV4+ T cell levels among CD8+ T cells in peripheral blood [%] None Immune system, hematology: TRBV4+ T cell levels among CD8+ T cells in peripheral blood [%] x x 44.5 11.4 29.3 27.8 32.4 27.9 18.4 24.7 18.9 15.5 10.9 15.6 33.4 34.3 11.2 32.5 x 17.6 21.5 23.0 x 32.0 21.6 19.6 8.5 30.2 12.2 26.3 39.4 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10206 Original post publication description: Immune function: Granulocyte colony stimulating factor (G-CSF) induced progenitor cell mobilization from bone marrow to blood [PB-CFC/ul] None Immune system: Granulocyte colony stimulating factor (G-CSF) induced progenitor cell mobilization from bone marrow to blood [PB-CFC/ul] x x x x 0.6 0.5 0.5 1.0 0.6 6.8 0.7 0.6 0.9 3.6 2.1 4.0 2.0 1.4 3.1 1.2 1.0 6.7 x 5.2 1.4 2.5 1.6 2.8 1.0 2.2 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10207 Original post publication description: Proliferative capacity in vitro of bone marrow stem and progenitor cells from young mice - proliferation of lin-Sca1++ cells from 8-week-old mice in response to KL, flt3L and TPO (# of cells per 50 input cells after 5 days of culture) [cell number] None Immune system, hematopoesis, aging: Hematopoietic stem cell and progenitor cell proliferative capacity (Lin-Sca1++ cells from femur bone marrow), in vitro assay of cells from 2-3 month old females in response to KL, flt3L, and TPO (Figure 3A of paper) [n cells] x x x x 168.0 970.0 4368.0 124.0 543.0 276.0 795.0 738.0 2329.0 1234.0 2500.0 3046.0 2628.0 1469.0 x 400.0 3180.0 870.0 x 207.0 800.0 450.0 4337.0 1757.0 x 1107.0 334.0 1751.0 x 2197.0 217.0 x 1635.0 x 312.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10208 Original post publication description: Immune function: Hematopoietic stem cells and progenitor cells, numbers of lin-Sca1++ cells at 8 weeks [n] Immune system, hematopoesis, aging: Hematopoietic stem cells and progenitor cells, numbers of Lin-Sca1++ cells at 2 months of age in females (Figure 3B of paper) [n] x x x x 3872.0 1399.0 5475.0 721.0 2647.0 2566.0 1260.0 3130.0 3833.0 5058.0 3500.0 3562.0 6694.0 1750.0 x 1355.0 3558.0 1510.0 x 830.0 783.0 2611.0 6472.0 1150.0 x 1917.0 3927.0 3067.0 x 2195.0 1491.0 x 4633.0 x 2469.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10209 Original post publication description: Relative fraction of lin-Sca1++ cells [%] None Immune system, hematopoesis, aging: Relative fraction of hematopoietic stem cells and progenitor cells (Lin-Sca1++) from bone marrow in 2-3 month old females (Figure 3C of paper) [%] x x x x 0.376 0.149 0.747 0.128 0.438 0.277 0.201 0.352 0.579 0.46 0.316 0.495 0.6 0.201 x 0.189 0.606 0.297 x 0.165 0.201 0.27 0.652 0.18 x 0.379 0.738 0.579 x 0.264 0.229 x x x 0.338 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10210 Original post publication description: C-kit+ cells among lin-Sca1++ cells [%] None Immune system, hematopoesis, aging: Hematopoietic stem cells and progenitor cells in femur bone marrow, percentage of c-kit-postiive cells to c-kit-ngative cells among Lin-Sca1++ cells in 2-month old femaies (Figure 3d of paper) [%] x x x x x x 22.1 x x 25.0 0.6 19.9 20.8 x 17.0 x x 16.0 x 24.2 11.5 29.0 x 20.4 29.6 x 30.5 x x 37.6 27.3 19.7 x 1.74 10.6 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10211 Original post publication description: Immune system and blood, hematopoietic stem cells and progenitor cells (lin-Sca1++ c-kit+ cells, LSK) from femur [n] None Immune system, aging: Hematopoietic stem cells and progenitor cells (lin-Sca1++ c-kit+ cells) at 18 months of age taken from femur bone marrow (Fig 2A of paper) [n per well] x x x x 287.0 321.0 x 314.0 x 40.0 274.0 120.0 x 731.0 254.0 x 760.0 33.0 102.0 48.0 230.0 296.0 x 96.0 295.0 99.0 292.0 81.0 183.0 285.0 124.0 170.0 231.0 70.0 63.0 x 196.0 x 183.0 x 540.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10212 Original post publication description: Hematopoietic stem and progenitor cells in the bone marrow (lin-Sca1++ c-kit+) [%] None Immune system, aging: Percentage of hematopoietic stem cells and progenitor cells in femur bone marrow (lin-Sca1++ c-kit+) at 18 months of age (Figure 2B of paper) [%] x x x x 0.029 x 0.2 0.053 x 0.007 0.057 0.035 x 0.062 0.031 x 0.1 0.006 0.025 0.01 0.061 0.019 x 0.04 0.032 0.026 0.041 0.013 0.043 0.071 0.016 0.008 0.011 0.017 0.014 x 0.027 x 0.016 x 0.13 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10213 Original post publication description: Proliferative capacity in vitro of bone marrow stem and progenitor cells (lin-Sca1++ c-kit+ cells) in response to KL, flt3L and TPO [number of cells] None Immune system, aging: Proliferative capacity in vitro of bone marrow stem and progenitor cells (lin-Sca1++ c-kit+ cells) at 18 months of age in response to KL, flt3L and TPO (figure 2C of paper) [n cells] x x x x 494.0 x x 2153.0 x 1928.0 363.0 1141.0 x 3105.0 697.0 x 2400.0 843.0 552.0 1867.0 x 1062.0 x 1742.0 1008.0 434.0 4372.0 1268.0 3667.0 2000.0 2845.0 667.0 265.0 1176.0 6569.0 x 805.0 x 2633.0 x 4400.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10214 Original post publication description: Bone marrow stem and progenitor cells (lin-Sca1++ cells, data not included in paper) [number of cells] None Immune system, aging: Hematopoietic stem cells and progenitor cells (lin-Sca1++ c-kit+ cells) at 18 months of age taken from femur bone marrow (additional data not included in paper) [n cells total] x x x x 15970.0 11397.0 x 8793.0 x 5067.0 16367.0 9284.0 x 19682.0 4545.0 x 18476.0 5007.0 4585.0 3754.0 9201.0 7480.0 x 5323.0 7628.0 3535.0 22082.0 10551.0 24834.0 9964.0 10964.0 10017.0 7655.0 7796.0 7440.0 x 11347.0 x x x 10113.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10215 Original post publication description: Lin-Sca1++ c-kit+ cells in the bone marrow [number of cells]- unpublished Hematopoietic stem cells and progenitor cells (lin-Sca1++ c-kit+ cells) at 18 months of age taken from femur bone marrow Immune system, aging: Hematopoietic stem cell and progenitor cell number (lin-Sca1++ c-kit+ cells) from femur bone marrow of females a 18 months (confirm) (unpublished additional data) [n cells] x x x x 15693.0 11075.0 22000.0 7662.0 7000.0 5027.0 15723.0 9154.0 x 20333.0 5897.0 x 17716.0 4212.0 3710.0 3706.0 8436.0 7223.0 x 5217.0 7333.0 3435.0 22511.0 10471.0 24650.0 9145.0 10874.0 9963.0 7616.0 7726.0 6141.0 x 11151.0 x x x 9573.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10216 Original post publication description: Effect of TGF-beta2 (0.01 ng/ml) on the proliferation of lin-Sca1++ c-kit+ cells [%]-unpublished None Immune system, aging: Proliferative capacity, number of hematopoietic stem cells and progenitor cells (lin-Sca1++ c-kit+ cells) after treatment with transforming growth factor beta 2 (TGFB2, 0.01 ng/ml) at 18 months of age (confirm) (unpublished additional data) [% increase] x x x x 43.0 x x 69.0 x x 101.0 128.0 x 38.0 195.0 x 94.0 80.0 90.0 71.0 x 149.0 x 94.0 118.0 112.0 100.0 x 57.0 87.0 151.0 x x 72.0 57.0 x 62.0 x 94.0 x 81.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10217 Original post publication description: Effect of TGF-beta2 (0.1 ng/ml) on the proliferation of lin-Sca1++kit+ cells [%]-unpublished None Immune system, aging: Proliferative capacity, effect of TGF-beta2 stimulation (0.1 ng/ml) on numbers of lin-Sca1++ c-kit+ cells (unpublished additional data) [% increase] x x x x 46.0 x x 68.0 x x 95.0 x x 21.0 116.0 x 58.0 68.0 83.0 51.0 x 92.0 x 43.0 47.0 78.0 88.0 x 31.0 53.0 84.0 x x 47.0 23.0 x 71.0 x 83.0 x 47.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10218 Original post publication description: Difference between old and young mice on the effect of TGF-beta2 (0.1 nl/ml) on the proliferation of lin-Sca1++c-kit+ cells-unpublished None Immune system, aging: Proliferative capacity change, difference between old (18 months) and young (2 months) on number of hematopoietic stem cells and progenitor cells (lin-Sca1++ c-kit+ cells) after treatment with transforming growth factor beta 2 (TGFB2, 0.1 nl/ml) (unpublished additional data) [cells per well] x x x x 5.0 x x -55.0 x x -63.0 x x 35.0 -68.0 x -1.0 -53.0 x 7.0 x -43.0 x -8.0 -11.0 -47.0 -47.0 x x 2.0 -57.0 x x 8.0 16.0 x -45.0 x -38.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10219 Original post publication description: Lin-Sca1++c-kit- cells in the bone marrow [%]-unpublished None Immune system, aging: Percentage of hematopoietic stem cells and progenitor cells (lin-Sca1++ c-kit+ cells) at 18 months of age taken from femur bone marrow [%] x x x x 1.138 x 0.91 0.688 x 0.598 1.75 0.95 x 1.88 0.39 x 1.35 0.247 0.395 0.397 0.7 0.44 x 0.97 0.75 0.436 1.946 0.67 1.39 1.145 1.03 0.73 0.89 0.72 0.708 x 0.647 x 0.93 x 1.17 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10220 Original post publication description: Central nervous system, neuropharmacology: Caudate putamen Drd2/Drd3 receptor density binding of (125I) epidepride [fmol/mg] None Central nervous system, neuropharmacology: Striatum (caudate putamen) Drd2/Drd3 receptor density binding of (125I) epidepride [fmol/mg] x x 311.0 304.0 x x x 278.0 295.0 253.0 250.0 x 263.0 261.0 240.0 213.0 267.0 268.0 235.0 175.0 235.0 263.0 x 238.0 167.0 269.0 264.0 218.0 295.0 281.0 199.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10221 Original post publication description: Nucleus accumbens core Drd2/3 receptor density binding of [125I] epidepride [fmol/mg] None Central nervous system, neuropharmacology: Nucleus accumbens core Drd2/Drd3 receptor density binding of (125I) epidepride [fmol/mg] x x 238.0 228.0 x x x 253.0 214.0 184.0 196.0 x 213.0 228.0 222.0 174.0 212.0 202.0 210.0 143.0 208.0 237.0 x 190.0 127.0 197.0 198.0 168.0 193.0 194.0 163.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10222 Original post publication description: Central nervous system, neuropharmacology: Nucleus accumbens shell Drd2/Drd3 receptor density binding of (125I) epidepride [fmol/mg] None Central nervous system, neuropharmacology: Nucleus accumbens shell Drd2/Drd3 receptor density binding of (125I) epidepride [fmol/mg] x x 268.0 242.0 x x x 264.0 223.0 181.0 195.0 x 206.0 213.0 216.0 171.0 203.0 196.0 212.0 144.0 210.0 239.0 x 179.0 128.0 189.0 181.0 173.0 186.0 187.0 161.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10223 Original post publication description: Central nervous system, morphology, mesocortiolimbic system: Tyrosine hydroxylase dopaminergic neurons in ventral tegmental area [mean cells/section] None Central nervous system, morphology, mesocortiolimbic system: Tyrosine hydroxylase dopaminergic neurons in ventral tegmental area [mean cells/section] x x 94.0 110.0 78.0 93.0 93.0 94.0 95.0 81.0 91.0 89.0 98.0 92.0 92.0 102.0 105.0 101.0 89.0 86.0 91.0 93.0 x 100.0 99.0 74.0 85.0 86.0 78.0 82.0 78.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10224 Original post publication description: Central nervous system, morphology, extrapyramidal motor system: Tyrosine hydroxylase dopaminergic neurons in substantia nigra compacta [mean cells/section] None Central nervous system, morphology, mesocortiolimbic system: Tyrosine hydroxylase dopaminergic neurons in substantia nigra compacta [mean cells/section] x x 142.0 173.0 125.0 132.0 117.0 135.0 124.0 129.0 136.0 127.0 140.0 148.0 141.0 142.0 147.0 142.0 135.0 136.0 142.0 136.0 x 136.0 130.0 129.0 132.0 127.0 118.0 129.0 118.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10225 Original post publication description: T-cell proliferative response (age-related decline), concavalin-A induced thymic T-cell response at 22-month-old in females (average of days 2 and 4) None Immune system, aging: T-cell proliferative response (age-related decline), concavalin-A induced thymic T-cell response at 22-month-old in females (average of days 2 and 4)[unit] x x 9933.0 5404.0 x x x x x 2782.0 218.0 0.0 x x 9115.0 x 6777.0 911.0 x x 1298.0 175.0 x 5033.0 8719.0 11363.0 47862.0 24487.0 x x 135191.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10226 Original post publication description: Immune function, aging: Age-related T-cell decline, percentage of CD4-negative CD8-negative DN cells [%] None Immune system, aging: Age-related T-cell decline, percentage of CD4-negative CD8-negative DN cells in thymus [%] x x 3.8 11.4 x x x x x 3.7 16.0 44.4 x x 8.7 x 5.8 11.5 x x 8.8 5.9 x 33.5 5.4 5.3 8.0 6.1 x x 2.2 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10227 Original post publication description: Immune function, age-related T-cell decline, percent of CD4-CD8 double positive cells [%] None Immune system, aging: Age-related T-cell decline, percent of CD4-CD8 double positive cells in thymus [%] x x 84.6 68.4 x x x x x 86.9 64.2 43.7 x x 80.5 x 64.7 70.1 x x 73.0 76.4 x 43.6 87.3 82.1 77.1 81.5 x x 90.1 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10228 Original post publication description: Immune function and thymus, T-cell decline during aging, percentage of CD25-negative/CD44-positive double negative (CD4(-)CD8(-)) cells at 22 months [%] None Immune system, aging: T-cell decline during aging, percentage of CD25-negative/CD44-positive double negative (CD4(-)CD8(-)) cells in thymus at 22 months [%] x x 41.2 20.0 x x x x x 21.5 45.2 55.5 x x 40.0 x 22.0 37.3 x x 41.8 17.1 x 15.0 16.8 32.4 43.9 39.4 x x 20.5 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10229 Original post publication description: Immune function, aging: Age-related T-cell decline, percentage of CD25-positive CD44-negative DN cells [%] None Immune system, aging: Age-related T-cell decline, percentage of CD25-positive CD44-negative DN cells in thymus [%] x x 13.2 2.1 x x x x x 32.9 12.0 2.4 x x 28.2 x 6.3 20.4 x x 19.8 25.8 x 1.5 12.9 18.6 16.6 15.3 x x 22.8 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10230 Original post publication description: Immune and thymus function, age-related T-cell decline, percentage of CD25-CD44 double negative thymocytes at 22 months in females [%] None Immune system, aging: Age-related T-cell decline, percentage of CD25-CD44 double negative thymocytes at 22 months in females [%] x x 43.6 78.2 x x x x x 44.5 40.5 42.7 x x 28.9 x 71.9 37.6 x x 36.8 66.7 x 82.3 71.8 46.0 36.6 44.2 x x 56.4 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10231 Original post publication description: Thymus involution, age-related rate of decline measured as involution slope (-beta 1x10^4) None Immune system, aging: Thymus involution, age-related rate of decline measured as involution slope (-beta 1x10^4) x 39.0 41.0 49.0 37.0 x x 35.0 132.0 30.0 45.0 50.0 x 59.0 37.0 52.0 62.0 26.0 x x 52.0 x x 65.0 x 36.0 52.0 34.0 x 66.0 56.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10232 Original post publication description: Immune system, morphology, aging: Thymocyte count in young adult mice, initial [Beta 0] None Immune system, morphology, aging: Thymocyte count in young adult mice, initial [Beta 0] x 25.5 23.3 10.4 28.4 x x 26.5 32.6 17.3 24.6 15.2 x 37.2 36.4 21.5 26.7 22.0 x x 33.2 x x 30.0 x 39.7 16.4 35.2 x 33.3 14.1 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10233 Original post publication description: Thymocyte count, projected at 60 days [units] None immune system, aging: Thymocyte count, projected at 60 days [units] x 24.9 23.1 10.8 29.2 x x 24.9 39.1 16.4 25.1 20.4 x 37.3 37.5 25.0 27.9 22.2 x x 29.8 x x 32.6 x 40.8 18.9 40.4 x 34.9 16.7 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10234 Original post publication description: Dopamine transporter (DAT, SLC6A3) protein density in the dorsal striatum (caudate putamen) [Bmax, pmol/mg] None Central nervous system, pharmacology, protein expression: Dopamine transporter (DAT, SLC6A3) protein density in the dorsal striatum (caudate putamen) [Bmax, pmol/mg] x x 2.28 3.37 2.15 1.96 x 3.95 5.26 3.22 3.86 2.52 x 1.68 3.33 5.29 2.32 1.65 x 3.22 x x x 4.85 2.91 4.2 2.45 3.11 3.38 2.83 1.93 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10235 Original post publication description: Immune system: Proliferation of JTL-G12 (Tcell clone) without 50 ug/ml GAT (Glu60, Ala30, Tyr10) [cpm] None Cancer biology, immune system: Proliferation of JTL-G12 (Tcell clone) without 50 ug/ml GAT (Glu60, Ala30, Tyr10) [cpm] x x 410.0 10040.0 190.0 980.0 14010.0 120.0 10360.0 6050.0 7460.0 140.0 180.0 270.0 290.0 170.0 240.0 180.0 x 220.0 2260.0 140.0 x 6200.0 6750.0 8240.0 9110.0 6330.0 9920.0 290.0 6400.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10236 Original post publication description: Proliferation of JTL-G12 cells (T cell clone) with 50 ug/ml GAT (Glu60, Ala30, Tyr10) [cpm] None Immune system: Proliferation of JTL-G12 cells (T cell clone) with 50 ug/ml GAT (Glu60, Ala30, Tyr10) [cpm] x x 270.0 11340.0 9420.0 2380.0 15850.0 12450.0 10080.0 10210.0 10480.0 14080.0 250.0 330.0 370.0 14690.0 17530.0 170.0 x 6330.0 6120.0 280.0 x 9820.0 11460.0 11810.0 13760.0 5480.0 14000.0 8150.0 7970.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10237 Original post publication description: Immune system: Proliferation of JTL-G12.8 (T cell clone) without 50 ug/ml GAT (Glu60, Ala30, Tyr10) [cpm] None Cancer biology, immune system: Proliferation of JTL-G12.8 (T cell clone) without 50 ug/ml GAT (Glu60, Ala30, Tyr10) [cpm] x x 160.0 4940.0 170.0 980.0 7470.0 160.0 7080.0 7000.0 5220.0 140.0 230.0 350.0 320.0 340.0 570.0 120.0 x 190.0 3290.0 140.0 x 4100.0 4240.0 5770.0 5310.0 2920.0 5590.0 590.0 4920.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10238 Original post publication description: Proliferation of JTL-G12.8 (Tcell clone) with 50 ug/ml GAT (Glu60, Ala30, Tyr10) [cpm] None Immune system: Proliferation of JTL-G12.8 (T cell clone) with 50 ug/ml GAT (Glu60, Ala30, Tyr10) [cpm] x x 210.0 7310.0 6580.0 1020.0 9040.0 9870.0 7000.0 9170.0 7120.0 8000.0 300.0 280.0 430.0 9150.0 9690.0 210.0 x 2600.0 4640.0 180.0 x 6240.0 7680.0 9580.0 7290.0 2560.0 8260.0 6410.0 5760.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10239 Original post publication description: Iron level in medial prefrontal cortex of males [ug/g] None Central nervous system, pharmacology, metabolism: Iron level in medial prefrontal cortex of males [ug/g] x x x x x 22.9 x 33.2 12.7 x 19.8 18.0 24.6 18.7 x 19.3 x x x x 19.8 x x 24.3 x 21.3 19.9 14.9 x 20.2 15.4 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10240 Original post publication description: Iron level in medial prefrontal cortex of females [ug/g] None Central nervous system, pharmacology, metabolism: Iron level in medial prefrontal cortex of females [ug/g] x x x x x 25.8 x 15.4 27.4 x 19.9 17.9 15.3 22.0 x 21.3 x x x x 19.8 x x 23.7 x 21.2 24.8 19.3 x 20.3 13.9 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10241 Original post publication description: Iron level in dorsal striatum (caudate putamen) of males [ug/g] None Central nervous system, pharmacology, metabolism: Iron level in dorsal striatum (caudate putamen) of males [ug/g] x x x x x 13.9 x 16.5 15.7 x 21.9 13.7 16.5 12.1 x 18.5 x x x x 22.6 x x 19.8 x 20.9 26.2 18.7 x 18.7 17.1 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10242 Original post publication description: Iron level in dorsal striatum (caudate putamen) of females [ug/g] None Central nervous system, pharmacology, metabolism: Iron level in dorsal striatum (caudate putamen) of females [ug/g] x x x x x 15.9 x 19.2 15.3 x 21.6 14.8 13.7 23.7 x 18.7 x x x x 19.8 x x 21.0 x 17.0 21.9 17.6 x 18.2 14.1 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10243 Original post publication description: Iron level in nucleus accumbens of males [ug/g] None Central nervous system, pharmacology, metabolism: Iron level in nucleus accumbens of males [ug/g] x x x x x 20.1 x 24.8 15.5 x 26.8 19.8 25.6 19.6 x 26.0 x x x x 25.9 x x 22.8 x 22.9 22.0 22.0 x 19.9 20.6 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10244 Original post publication description: Iron level in nucleus accumbens of females [ug/g] None Central nervous system, pharmacology, metabolism: Iron level in nucleus accumbens of females [ug/g] x x x x x 18.8 x 26.1 19.1 x 32.4 22.2 14.7 27.1 x 24.3 x x x x 23.4 x x 24.6 x 20.7 30.1 24.0 x 22.8 20.1 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10245 Original post publication description: Iron level in ventral midbrain of males [ug/g] None Central nervous system, metabolism, nutrition: Iron level in ventral midbrain of males [ug/g] x x x x x 15.1 x 17.2 19.1 x 29.4 15.6 20.7 17.5 x 29.3 x x x x 35.1 x x 36.8 x 33.6 29.9 15.5 x 17.9 16.6 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10246 Original post publication description: Iron level in ventral midbrain of females [ug/g] None Central nervous system, metabolism, nutrition: Iron level in ventral midbrain of females [ug/g] x x x x x 14.2 x 18.3 17.1 x 38.4 14.4 15.7 16.4 x 29.3 x x x x 33.2 x x 35.9 x 29.6 36.0 17.5 x 20.7 17.2 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10247 Original post publication description: Iron level in liver of males [ug/g] None Metabolism, liver, nutrition: Iron level in liver of males [ug/g] x x x x x 94.7 x 105.2 116.6 x 145.2 121.8 126.9 92.8 x 99.3 x x x x 114.4 x x 112.2 x 103.0 105.0 172.3 x 132.7 205.7 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10248 Original post publication description: Iron level in liver of females [ug/g] None Metabolism, liver, nutrition: Iron level in liver of females [ug/g] x x x x x 142.1 x 187.4 135.0 x 138.7 204.9 201.5 154.9 x 181.8 x x x x 116.4 x x 154.4 x 159.0 134.2 143.0 x 214.7 233.8 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10249 Original post publication description: Dopamine receptor 1 (DRD1) protein density in nucleus accumbens of males and females [units] None Central nervous system, pharmacology, protein expression: Dopamine receptor 1 (DRD1) binding maximum (Bmax) in membrane fragments in nucleus accumbens of males and females (Schering compound 3H-23390 ligand) [fmol/mg wet weight] x x x x 1146.09 1218.17 1551.25 1431.13 1660.89 1385.05 724.54 1428.62 1437.34 x x 807.0 x x x x 1334.39 x x 1747.8 858.06 1234.18 x 788.02 x 1345.13 1258.18 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10250 Original post publication description: Dopamine receptor 1 (DRD1) protein density in nucleus accumbens of males [units] None Central nervous system, pharmacology, protein expression: Dopamine receptor 1 (DRD1) binding maximum (Bmax) in membrane fragments in nucleus accumbens of males (Schering compound 3H-23390 ligand) [fmol/mg wet weight] x x x x 1165.17 898.7 1236.23 1319.21 1548.25 1407.51 693.2 1662.47 1112.43 x x 1069.25 x x x x 1415.07 x x 1527.46 850.74 1108.99 x 559.63 x 1133.14 944.71 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10251 Original post publication description: Dopamine receptor 1 (DRD1) protein density in the nucleus accumbens of females [units] None Central nervous system, pharmacology, protein expression: Dopamine receptor 1 (DRD1) binding maximum (Bmax) in membrane fragments in the nucleus accumbens of females (Schering compound 3H-23390 ligand) [fmol/mg wet weight] x x x x 1127.0 1537.64 1866.27 1543.04 1773.52 1362.6 755.89 1194.78 1762.26 x x 544.75 x x x x 1253.71 x x 1968.13 865.37 1359.38 x 1016.41 x 1557.12 1571.65 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10252 Original post publication description: Dopamine receptor 1 (DRD1) density in dorsal striatum (caudate putamen) of males [fM Schering Compound 3H-23390] None Central nervous system, pharmacology, protein expression: Dopamine receptor 1 (DRD1) binding maximum (Bmax) in membrane fragments in the dorsal striatum (caudate putamen) of males (Schering compound 3H-23390 ligand) [fmol/mg wet weight] x x x x 1042.12 1502.01 1181.74 1238.93 2496.82 1913.99 637.83 2071.32 2041.24 x x 1124.94 x x x x 2497.22 x x 844.1 1433.32 1718.09 x 947.62 x 2229.84 1091.13 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10253 Original post publication description: Dopamine receptor 1 (DRD1) protein density in the dorsal striatum (caudate putamen) of females [units] None Central nervous system, pharmacology, protein expression: Dopamine receptor 1 (DRD1) binding maximum (Bmax) in membrane fragments in the dorsal striatum (caudate putamen) of females (Schering compound 3H-23390 ligand) [fmol/mg wet weight] x x x x 678.67 1267.17 500.06 1001.61 2038.68 1812.29 892.36 1420.57 2169.59 x x 579.79 x x x x 1941.54 x x 1983.04 1704.15 1780.39 x 1282.96 x 2015.38 1582.85 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10254 Original post publication description: Dopamine receptor 1 (DRD1) protein density in the dorsal striatum (caudate putamen) of males and females [units] None Central nervous system, pharmacology, protein expression: Dopamine receptor 1 (DRD1) binding maximum (Bmax) in membrane fragments in the dorsal striatum (caudate putamen) of males and females (Schering compound 3H-23390 ligand) [fmol/mg wet weight] x x x x 860.395 1384.59 840.9 1120.27 2267.75 1863.14 765.095 1745.94 2105.42 x x 852.365 x x x x 2219.38 x x 1413.57 1568.73 1749.24 x 1115.29 x 2122.61 1336.99 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10255 Original post publication description: Dopamine receptor 1 (DRD1) protein density in the prefrontal cortex of males [units] None Central nervous system, pharmacology, protein expression: Dopamine receptor 1 (DRD1) binding maximum (Bmax) in membrane fragments in the prefrontal cortex of males (Schering compound 3H-23390 ligand) [fmol/mg wet weight] x x x x 356.0 500.52 417.91 652.6 484.91 745.82 368.18 427.94 499.4 x x 327.51 x x x x 614.29 x x 633.2 390.88 347.02 x 330.04 x 501.81 321.84 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10256 Original post publication description: Dopamine receptor 1 (DRD1) protein density in the prefrontal cortex of females [units] None Central nervous system, pharmacology, protein expression: Dopamine receptor 1 (DRD1) binding maximum (Bmax) in membrane fragments in the prefrontal cortex of females (Schering compound 3H-23390 ligand) [fmol/mg wet weight] x x x x 222.5 673.62 1786.29 305.52 472.75 588.41 482.63 487.41 751.59 x x 112.91 x x x x 520.06 x x 548.29 347.19 463.85 x 228.38 x 757.84 383.92 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10257 Original post publication description: Dopamine receptor 1 (DRD1) protein density in the prefrontal cortex of males and females [units] None Central nervous system, pharmacology, protein expression: Dopamine receptor 1 (DRD1) binding maximum (Bmax) in membrane fragments in the prefrontal cortex of males and females (Schering compound 3H-23390 ligand) [fmol/mg wet weight] x x x x 289.25 587.07 1102.1 479.06 478.83 667.115 425.405 457.675 625.495 x x 220.21 x x x x 567.175 x x 590.745 369.035 405.435 x 279.21 x 629.825 352.88 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10258 Original post publication description: Dopamine receptor 1 (DRD1) protein density in the ventral midbrain (including the ventral tegmental area and substantia nigra) of males [units] None Central nervous system, pharmacology, protein expression: Dopamine receptor 1 (DRD1) binding maximum (Bmax) in membrane fragments in the ventral midbrain (including the ventral tegmental area and substantia nigra) of males (Schering compound 3H-23390 ligand) [fmol/mg wet weight] x x x x 112.98 182.53 143.66 302.51 249.05 403.05 317.52 319.56 330.16 x x 190.04 x x x x 301.39 x x 354.6 218.67 184.15 x 229.03 x 221.24 167.52 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10259 Original post publication description: Dopamine receptor 1 (DRD1) protein density in the ventral midbrain (including the ventral tegmental area and substantia nigra) of females [units] None Central nervous system, pharmacology, protein expression: Dopamine receptor 1 (DRD1) binding maximum (Bmax) in membrane fragments in the ventral midbrain of females (Schering compound 3H-23390 ligand) [fmol/mg wet weight] x x x x 227.5 345.06 271.11 180.47 255.11 404.21 325.62 312.17 515.21 x x 250.44 x x x x 358.99 x x 128.85 144.63 128.43 x 128.72 x 267.44 215.57 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10260 Original post publication description: Dopamine receptor 1 (DRD1) protein density in the ventral midbrain (including the ventral tegmental area and substantia nigra) of males and females [units] None Central nervous system, pharmacology, protein expression: Dopamine receptor 1 (DRD1) binding maximum (Bmax) in membrane fragments in the ventral midbrain (including the ventral tegmental area and substantia nigra) of males and females (Schering compound 3H-23390 ligand) [fmol/mg wet weight] x x x x 170.24 263.795 207.385 241.49 252.08 403.63 321.57 315.865 422.685 x x 220.24 x x x x 330.19 x x 241.725 181.65 156.29 x 178.875 x 244.34 191.545 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10261 Original post publication description: Dopamine receptor 2 (DRD2) protein density in the nucleus accumbens of males [units] None Central nervous system, pharmacology, protein expression: Dopamine receptor 2 (DRD2) binding maximum (Bmax) in membrane fragments in the nucleus accumbens of males (125I-epidepride ligand) [fmol/mg wet weight] x x x x 115.64 231.23 224.3 87.03 215.2 228.65 111.9 203.2 254.42 x x 136.06 x x x x 227.81 x x 195.84 141.91 252.69 161.82 82.15 x 244.89 151.57 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10262 Original post publication description: Dopamine receptor 2 (DRD2) protein density in the nucleus accumbens of females [units] None Central nervous system, pharmacology, protein expression: Dopamine receptor 2 (DRD2) binding maximum (Bmax) in membrane fragments in the nucleus accumbens of females (125I-epidepride ligand) [fmol/mg wet weight] x x x x x 308.7 321.67 101.75 200.61 212.38 81.26 222.68 210.88 x x 130.91 x x x x 171.23 x x 151.59 x 159.22 186.64 72.13 x 228.88 175.66 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10263 Original post publication description: Dopamine receptor 2 (DRD2) protein density in the nucleus accumbens of males and females [units] None Central nervous system, pharmacology, protein expression: Dopamine receptor 2 (DRD2) binding maximum (Bmax) in membrane fragments in the nucleus accumbens of males and females (125I-epidepride ligand) [fmol/mg wet weight] x x x x 115.64 269.965 272.985 94.39 207.905 220.515 96.58 212.94 232.65 x x 133.485 x x x x 199.52 x x 173.715 141.91 205.955 174.23 77.14 x 236.885 163.615 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10264 Original post publication description: Dopamine receptor 2 (DRD2) protein density in the dorsal striatum (caudate putamen) of males [units] None Central nervous system, pharmacology, protein expression: Dopamine receptor 2 (DRD2) binding maximum (Bmax) in membrane fragments in the dorsal striatum (caudate putamen) of males (125I-epidepride ligand) [fmol/mg wet weight] x x x x 67.47 286.9 256.8 128.17 353.21 343.32 129.5 263.71 268.08 x x 97.49 x x x x 331.8 x x 58.35 49.42 340.32 390.09 132.43 x 322.32 136.6 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10265 Original post publication description: Dopamine receptor 2 (DRD2) protein density in the dorsal striatum (caudate putamen) of females [units] None Central nervous system, pharmacology, protein expression: Dopamine receptor 2 (DRD2) binding maximum (Bmax) in membrane fragments in the dorsal striatum (caudate putamen) of females (125I-epidepride ligand) [fmol/mg wet weight] x x x x x 362.04 68.75 146.81 378.43 270.03 92.48 167.0 245.4 x x 129.03 x x x x 320.61 x x 175.18 x 288.78 298.0 163.73 x 400.11 271.82 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10266 Original post publication description: Dopamine receptor 2 (DRD2) protein density in the dorsal striatum (caudate putamen) of males and females [units] None Central nervous system, pharmacology, protein expression: Dopamine receptor 2 (DRD2) binding maximum (Bmax) in membrane fragments in the dorsal striatum (caudate putamen) of males and females (125I-epidepride ligand) [fmol/mg wet weight] x x x x 67.47 324.47 162.775 137.49 365.82 306.675 110.99 215.355 256.74 x x 113.26 x x x x 326.205 x x 116.765 49.42 314.55 344.045 148.08 x 361.215 204.21 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10267 Original post publication description: Dopamine receptor 2 (DRD2) protein density in the prefrontal cortex of males [units] None Central nervous system, pharmacology, protein expression: Dopamine receptor 2 (DRD2) binding maximum (Bmax) in membrane fragments in the prefrontal cortex of males (125I-epidepride ligand) [fmol/mg wet weight] x x x x 50.59 36.56 38.41 59.81 50.9 64.47 44.77 47.49 62.96 x x 28.51 x x x x 57.87 x x 42.6 25.91 63.01 66.75 44.71 x 83.44 23.54 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10268 Original post publication description: Dopamine receptor 2 (DRD2) protein density level in frontal cortex of females [units] None Central nervous system, pharmacology, protein expression: Dopamine receptor 2 (DRD2) binding maximum (Bmax) in membrane fragments in prefrontal cortex of females (125I-epidepride ligand) [fmol/mg wet weight] x x x x x 58.3 377.59 57.29 32.58 68.1 28.45 47.08 59.79 x x 10.81 x x x x 55.94 x x 39.29 x 49.15 76.42 62.11 x 72.48 32.93 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10269 Original post publication description: Dopamine receptor 2 (DRD2) protein density in the prefrontal cortex of males and females [units] None Central nervous system, pharmacology, protein expression: Dopamine receptor 2 (DRD2) binding maximum (Bmax) in membrane fragments in the prefrontal cortex of males and females (125I-epidepride ligand) [fmol/mg wet weight] x x x x 50.59 47.43 208.0 58.55 41.74 66.285 36.61 47.285 61.375 x x 19.66 x x x x 56.905 x x 40.945 25.91 56.08 71.585 53.41 x 77.96 28.235 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10270 Original post publication description: Dopamine receptor 2 (DRD2) protein density in the ventral midbrain (including the ventral tegmental area and substantia nigra) of males [units] None Central nervous system, pharmacology, protein expression: Dopamine receptor 2 (DRD2) binding maximum (Bmax) in membrane fragments in the ventral midbrain (including the ventral tegmental area and substantia nigra) of males (125I-epidepride ligand) [fmol/mg wet weight] x x x x 49.61 0.95 53.95 24.64 58.46 62.65 48.91 41.17 58.22 x x 32.54 x x x x 61.37 x x 47.44 42.6 46.8 74.43 39.58 x 44.64 45.91 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10271 Original post publication description: Dopamine receptor 2 (DRD2) protein density in the ventral midbrain (including the ventral tegmental area and substantia nigra) of females [units] None Central nervous system, pharmacology, protein expression: Dopamine receptor 2 (DRD2) binding maximum (Bmax) in membrane fragments in the ventral midbrain (including the ventral tegmental area and substantia nigra) of females (125I-epidepride ligand) [fmol/mg wet weight] x x x x x 60.23 60.42 27.86 49.09 59.08 49.41 35.56 68.84 x x 15.55 x x x x 54.8 x x 43.12 x 43.83 62.18 34.95 x 78.16 52.76 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10272 Original post publication description: Dopamine receptor 2 (DRD2) protein density in the ventral midbrain (including the ventral tegmental area and substantia nigra) of males and females [units] None Central nervous system, pharmacology, protein expression: Dopamine receptor 2 (DRD2) binding maximum (Bmax) in membrane fragments in the ventral midbrain (including the ventral tegmental area and substantia nigra) of males and females (125I-epidepride ligand) [fmol/mg wet weight] x x x x 49.61 30.59 57.185 26.25 53.775 60.865 49.16 38.365 63.53 x x 24.045 x x x x 58.085 x x 45.28 42.6 45.315 68.305 37.265 x 61.4 49.335 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10273 Original post publication description: Dopamine transporter (SLC6A3) protein density in the nucleus accumbens of males [units] None Central nervous system, pharmacology, protein expression: Dopamine transporter (SLC6A3) binding maximum (Bmax) in membrane fragments in nucleus accumbens of males (3H GBR-12935 ligand) [fmol/mg wet weight] x x x x 496.35 4820.0 2936.87 2956.52 3350.8 3311.0 1382.24 3887.1 3787.66 x x 3367.63 x x x x 4630.0 x x 2679.06 4503.83 4407.5 5570.0 1485.2 x 4348.0 2008.5 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10274 Original post publication description: Dopamine transporter (SLC6A3) protein density in the nucleus accumbens of females [units] None Central nervous system, pharmacology, protein expression: Dopamine transporter (SLC6A3) binding maximum (Bmax) in membrane fragments in nucleus accumbens of females (3H GBR-12935 ligand) [fmol/mg wet weight] x x x x x 4930.0 3283.0 4445.33 2548.0 2776.44 2480.13 2734.35 4749.0 x x 1286.33 x x x x 3560.0 x x 4371.0 3269.0 3660.97 5320.0 278.63 x 6356.38 2748.93 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10275 Original post publication description: Dopamine transporter (SLC6A3) protein density in the nucleus accumbens of males and females [units] None Central nervous system, pharmacology, protein expression: Dopamine transporter (SLC6A3) binding maximum (Bmax) in membrane fragments in nucleus accumbens of males and females (3H GBR-12935 ligand) [fmol/mg wet weight] x x x x 496.35 4875.0 3109.94 3700.93 2949.4 3043.72 1931.19 3310.73 4268.33 x x 2326.98 x x x x 4095.0 x x 3525.03 3886.42 4034.24 5445.0 881.915 x 5352.19 2378.72 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10276 Original post publication description: Dopamine transporter (SLC6A3) protein density in dorsal striatum (caudate putamen) of males [units] None Central nervous system, pharmacology, protein expression: Dopamine transporter (SLC6A3) binding maximum (Bmax) in membrane fragments in dorsal striatum (caudate putamen) of males (3H GBR-12935 ligand) [fmol/mg wet weight] x x x x 709.36 90.0 2787.62 2666.34 4228.58 7985.0 4698.77 3294.14 4768.66 x x 1495.5 x x x x 6940.0 x x 6453.62 6741.93 6109.09 8323.33 1967.76 x 8400.96 4286.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10277 Original post publication description: Dopamine transporter (SLC6A3) protein density in the dorsal striatum (caudate putamen) of females [units] None Central nervous system, pharmacology, protein expression: Dopamine transporter (SLC6A3) binding maximum (Bmax) in membrane fragments in dorsal striatum (caudate putamen) of females (3H GBR-12935 ligand) [fmol/mg wet weight] x x x x x 6540.0 7311.0 3667.55 6359.0 5249.45 4108.66 2649.03 7018.0 x x 937.83 x x x x 7050.0 x x 5979.0 7065.5 5028.35 7356.67 2541.46 x 7281.01 4465.53 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10278 Original post publication description: Dopamine transporter (SLC6A3) protein density in the dorsal striatum (caudate putamen) of males and females [units] None Central nervous system, pharmacology, protein expression: Dopamine transporter (SLC6A3) binding maximum (Bmax) in membrane fragments in dorsal striatum (caudate putamen) of males and females (3H GBR-12935 ligand) [fmol/mg wet weight] x x x x 709.36 3315.0 5049.31 3166.95 5293.79 6617.23 4403.71 2971.58 5893.33 x x 1216.67 x x x x 6995.0 x x 6216.31 6903.71 5568.72 7840.0 2254.61 x 7840.98 4375.77 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10279 Original post publication description: Dopamine transporter (SLC6A3) protein density in prefrontal cortex of males [units] None Central nervous system, pharmacology, protein expression: Dopamine transporter (SLC6A3) binding maximum (Bmax) in membrane fragments in prefrontal cortex of males (3H GBR-12935 ligand) [fmol/mg wet weight] x x x x 659.89 380.72 395.51 629.01 549.63 1093.0 721.69 730.29 1400.65 x x 226.96 x x x x 658.0 x x 1639.37 1084.06 981.23 640.5 121.98 x 1351.14 793.1 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10280 Original post publication description: Dopamine transporter (SLC6A3) protein density in prefrontal cortex of females [units] None Central nervous system, pharmacology, protein expression: Dopamine transporter (SLC6A3) binding maximum (Bmax) in membrane fragments in prefrontal cortex of females (3H GBR-12935 ligand) [fmol/mg wet weight] x x x x x 533.09 954.9 403.68 97.31 1232.51 472.13 1348.58 606.1 x x 399.67 x x x x 264.0 x x 117.0 1211.12 659.24 440.0 400.29 x 1332.19 343.12 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10281 Original post publication description: Dopamine transporter (SLC6A3) protein density in prefrontal cortex of males and females [units] None Central nervous system, pharmacology, protein expression: Dopamine transporter (SLC6A3) binding maximum (Bmax) in membrane fragments in prefrontal cortex of males and females (3H GBR-12935 ligand) [fmol/mg wet weight] x x x x 659.89 456.905 675.205 516.345 323.47 1162.76 596.91 1039.44 1003.38 x x 313.315 x x x x 461.0 x x 878.185 1147.59 820.235 540.25 261.135 x 1341.67 568.11 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10282 Original post publication description: Dopamine transporter (SLC6A3) protein density in the ventral midbrain (including the ventral tegmental area and substantia nigra) of males [units] None Central nervous system, pharmacology, protein expression: Dopamine transporter (SLC6A3) binding maximum (Bmax) in membrane fragments in the ventral midbrain (including the ventral tegmental area and substantia nigra) of males (3H GBR-12935 ligand) [fmol/mg wet weight] x x x x 47.51 376.11 250.61 422.72 346.32 172.3 198.34 124.21 1024.01 x x 834.55 x x x x 852.0 x x 390.0 1083.4 900.86 304.0 185.13 x 824.58 324.7 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10283 Original post publication description: Dopamine transporter (SLC6A3) protein density in the ventral midbrain (including the ventral tegmenal area and substantia nigra) of females [units] None Central nervous system, pharmacology, protein expression: Dopamine transporter (SLC6A3) binding maximum (Bmax) in membrane fragments in the ventral midbrain (including the ventral tegmental area and substantia nigra) of females (3H GBR-12935 ligand) [fmol/mg wet weight] x x x x x 290.49 411.3 737.98 231.1 674.25 492.02 674.14 625.7 x x 419.03 x x x x 811.0 x x 84.49 1745.31 350.21 645.33 113.77 x 942.05 466.97 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10284 Original post publication description: Dopamine transporter (SLC6A3) protein density in the ventral midbrain (including the ventral tegmental area and substantia nigra) of males and females [units] None Central nervous system, pharmacology, protein expression: Dopamine transporter (SLC6A3) binding maximum (Bmax) in membrane fragments in the ventral midbrain (including the ventral tegmental area and substantia nigra) of males and females (3H GBR-12935 ligand) [fmol/mg wet weight] x x x x 47.51 333.3 330.955 580.35 288.71 423.275 345.18 399.175 824.855 x x 626.79 x x x x 831.5 x x 237.245 1414.35 625.535 474.665 149.45 x 883.315 395.835 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10285 Original post publication description: Novel open fled behavior, habituation measured as the difference in locomotion between 0-5 min and 26-30 min periods for males and females [cm] None Central nervous system, behavior: Novel open fled behavior, habituation measured as the difference in locomotion between 0-5 min and 26-30 min periods for males and females [cm] x x x x 3602.0 7970.0 2689.0 9260.0 7485.0 5825.0 7816.0 4720.0 7377.0 6725.0 x 4464.0 6348.0 5098.0 x 5746.0 5518.0 x x 5811.0 3865.0 9888.0 10600.0 4914.0 5392.0 7645.0 9783.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10286 Original post publication description: Cocaine stereotypy-number of repeated movements 5 mg/kg cocaine ip (difference from saline)-males None Central nervous system, pharmacology, behavior: Cocaine response (5 mg/kg ip), stereotypy, repeated movements measured as difference from saline control in males [n difference] x x x x 23.9 -12.0909 -0.4545 -3.6364 28.4 25.0 19.8182 -5.5455 32.1 8.4 x 5.3333 8.625 16.0 x 27.8 20.1 x x 18.2222 28.0 29.3333 31.3 10.8 35.5 12.1818 16.2727 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10287 Original post publication description: Cocaine stereotypy-number of repeated movements 5 mg/kg cocaine ip (difference from saline)-females None Central nervous system, pharmacology, behavior: Cocaine response (5 mg/kg ip), stereotypy, repeated movements measured as difference from saline control in females [n difference] x x x x -6.8 -11.9 12.3 18.0 15.3636 34.75 22.4545 0.7 8.5 12.5 x 13.5 x 37.5 x 21.8333 18.6 x x 15.0 34.0 52.3 30.0 17.8 x -1.5 19.333 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10288 Original post publication description: Cocaine stereotypy - number of repeated movements 5 mg/kg cocaine ip (difference from saline) - male and female mean None Central nervous system, pharmacology, behavior: Cocaine response (5 mg/kg ip), stereotypy, repeated movements measured as difference from saline control in males and females [n difference] x x x x 13.6667 -12.0 5.619 7.6522 21.5714 30.5714 21.1364 -2.5714 20.3 10.45 x 9.4167 8.625 26.75 x 25.5625 19.35 x x 16.45 30.6667 39.7727 30.6842 14.3 35.5 5.6667 17.65 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10289 Original post publication description: Cocaine open field activity-total distance 5 mg/kg cocaine (difference from saline)-males None Central nervous system, pharmacology, behavior: Cocaine response (5 mg/kg ip), locomotion activity measured as difference from saline control in males [cm difference] x x x x 2194.6 1093.73 653.27 255.13 2711.7 3715.22 1177.6 759.91 1904.4 2046.7 x 179.83 1372.88 2233.75 x 1512.5 1201.3 x x 2041.89 1101.89 2742.33 2597.11 1795.0 2155.0 1690.27 1310.91 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10290 Original post publication description: Cocaine open field locomotor response, difference in distance between cocaine injection (5 mg/kg) and saline control injection for females [cm/test] None Central nervous system, pharmacology, behavior: Cocaine response (5 mg/kg ip), locomotion measured as difference from saline control in females [cm difference] x x x x 1835.8 2194.5 588.7 1351.08 1839.36 4055.36 2005.82 1197.0 1000.4 1543.22 x 1182.33 x 3846.25 x 2829.67 2100.9 x x 2051.18 2692.25 3533.5 3915.33 2787.8 x 1762.7 1210.7 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10291 Original post publication description: Cocaine response, open field activity, difference in locomotion between cocaine (5 mg/kg ip) and saline in males and females None Central nervous system, pharmacology, behavior: Cocaine response (5 mg/kg ip), locomotion activity measured as difference from saline control in males and females [cm difference] x x x x 2075.0 1617.9 622.52 912.7 2254.76 3902.3 1611.43 968.05 1452.4 1808.21 x 681.08 1372.88 3040.0 x 2006.44 1651.1 x x 2047.0 1850.29 3101.95 3256.22 2291.4 2155.0 1724.76 1263.19 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10292 Original post publication description: Cocaine exploratory activity-nose pokes in holeboard 5 mg/kg cocaine ip (difference from saline)-males None Central nervous system, pharmacology, behavior: Cocaine response (5 mg/kg ip), exploratory activity, nose pokes in holeboard measured as difference from saline control in males [n] x x x x -2.0 1.4545 1.6 2.0 -0.3333 -2.375 5.0 -5.7273 -7.5 -8.4 x -1.0 -14.0 -7.5 x -0.4 -4.4 x x 0.4444 -3.1 -1.1667 0.5 -6.6 11.3333 -5.0909 10.5455 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10293 Original post publication description: Cocaine exploratory activity-nose pokes in holeboard 5 mg/kg cocaine ip (difference from saline)-females None Central nervous system, pharmacology, behavior: Cocaine response (5 mg/kg ip), exploratory activity, nose pokes in holeboard measured as difference from saline control in females [n difference x x x x 10.0 7.4 -14.1 6.0 11.0 1.5455 0.8182 -4.0 -5.7 -1.0 x -2.8333 x -14.0 x -8.0 7.1 x x -3.2727 -7.2857 -1.4 1.5 -8.6 x -7.2 4.5 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10294 Original post publication description: Cocaine response (5 mg/kg ip), exploratory activity, nose pokes in holeboard measured as difference from saline level (mean of males and females) [n difference/test] None Central nervous system, pharmacology, behavior: Cocaine response (5 mg/kg ip), exploratory activity, nose pokes in holeboard measured as difference from saline control in males and females [n difference] x x x x 2.2857 4.2857 -6.25 4.087 5.9 -0.1053 2.901 -4.9048 -6.6 -4.7 x -1.9167 -14.0 -10.75 x -3.5294 1.35 x x -1.6 -4.8235 -1.2727 1.0 -7.6 11.3333 -6.0952 7.6667 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10295 Original post publication description: Cocaine response (15 mg/kg ip), cocaine stereotypy, number of movements as difference from saline control injection in males [n] None Central nervous system, pharmacology, behavior: Cocaine response (15 mg/kg ip), cocaine stereotypy, number of movements as difference from saline control injection in males [n] x x x x 19.4545 3.6667 14.7 -0.7273 42.6 61.7 45.6364 7.3636 47.6154 16.9 x 10.5 19.0 25.5 x 70.7 62.9 x x 68.4545 50.0 41.3 33.6364 2.0 77.333 86.8182 44.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10296 Original post publication description: Cocaine stereotypy-number of movements 15 mg/kg cocaine ip (difference from saline)-females None Cocaine stereotypy-number of movements 15 mg/kg cocaine ip (difference from saline)-females x x x x x -7.44 26.545 40.917 1000.42 86.1 79.5 -1.909 46.3 38.2 x 25.0 x 60.25 x 53.4 80.7 x x 35.545 39.333 52.273 74.364 18.0 x 39.182 61.6 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10297 Original post publication description: Cocaine response (15 mg/kg ip), stereotypy, number of movements relative to saline control injection, male and female average [n] None Cocaine response (15 mg/kg ip), stereotypy, number of movements relative to saline control injection, male and female average [n] x x x x 19.4545 -1.8889 20.9048 21.0 74.1364 73.9 61.7619 2.7273 47.0435 27.55 x 17.0909 19.0 42.875 x 64.9333 71.8 x x 52.0 44.6667 47.0476 54.0 8.4 77.333 63.0 52.381 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10298 Original post publication description: Cocaine open field activity-total distance 15 mg/kg cocaine (difference from saline)-males None Central nervous system, pharmacology, behavior: Cocaine response (15 mg/kg ip), locomotion in an open field, total distance measured as difference from saline control in males [cm] x x x x 3579.18 6650.91 1774.6 3500.6 5088.82 7017.6 4368.64 5007.0 6213.31 4561.3 x 3574.83 5452.83 5496.25 x 6155.3 4326.5 x x 5827.64 4063.4 11211.0 4230.36 4538.0 4457.0 5598.09 4223.64 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10299 Original post publication description: Cocaine response (15 mg/kg ip), open field activity, total distance, difference from saline control in females [cm] None Central nervous system, pharmacology, behavior: Cocaine response (15 mg/kg ip), open field activity, total distance, difference from saline control in females [cm] x x x x x 3512.2 3032.18 7606.27 8513.17 9589.56 6710.8 5271.17 4328.0 5476.0 x 3917.2 x 6116.5 x 3859.0 4828.8 x x 5737.82 6150.22 9452.0 7746.27 1128.25 x 4944.0 4797.7 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10300 Original post publication description: Cocaine open field locomotor response, difference in total distance after 15 mg/kg injection compared to saline, males and females [cm] None Cocaine open field locomotor response, difference in total distance after 15 mg/kg injection compared to saline, males and females [cm] x x x x 3579.18 5156.29 2433.33 5651.19 6875.43 8235.89 5483.95 5144.83 5393.61 5018.65 x 3730.45 5452.83 5806.38 x 5389.87 4577.65 x x 5782.73 5051.89 10285.2 5988.32 3174.1 4457.0 5271.05 4497.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10301 Original post publication description: Cocaine response (15 mg/kg ip), exploratory activation, nose pokes in hole board (difference from saline) for males [n] None Central nervous system, pharmacology, behavior: Cocaine response (15 mg/kg ip), exploratory activity (nose pokes in holeboard) difference relative to saline control, adult males [n difference] x x x x -3.3 -6.5455 -11.3333 -0.3636 -3.5455 -19.125 -7.3636 -4.6364 -11.1538 -4.1 x 1.5 -2.5714 -6.75 x -5.0 -7.0 x x -6.0909 -8.4 -3.7 -0.4 -8.3333 -18.8 -6.3636 -2.1 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10302 Original post publication description: Cocaine response (15 mg/kg ip), exploratory activation, nose pokes in hole board (difference from saline) for females [n] None Central nervous system, pharmacology, behavior: Cocaine response (15 mg/kg ip), exploratory activity (nose pokes in holeboard) difference relative to saline control, adult females [n difference] x x x x x -1.4444 -9.2 -7.0909 -7.0833 -11.4 -7.9 -3.0833 -15.875 -4.5 x -3.4 x -7.0 x -7.0 -14.1111 x x -5.5455 -8.6667 -1.2727 -9.0 -0.5 x -9.6364 -8.4444 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10303 Original post publication description: Cocaine exploratory activity-nose pokes in holeboard 15 mg/kg cocaine ip (difference from saline)-mean males and females None Central nervous system, pharmacology, behavior: Cocaine response (15 mg/kg ip), exploratory activity (nose pokes in holeboard) difference relative to saline control, adult males and females [n difference] x x x x 2.2857 -4.25 -10.2105 -3.7273 -5.3913 -14.8333 -7.619 -3.8261 -12.9524 -4.3 x -0.7273 -2.5714 -6.875 x -5.6667 -10.3684 x x -5.8182 -8.5263 -2.4286 -4.9048 -5.2 -18.8 -8.0 -5.1053 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10304 Original post publication description: Cocaine response (30 mg/kg ip), stereotypy, number of movements relative to saline control injection for males [n] None Central nervous system, pharmacology, behavior: Cocaine response (30 mg/kg ip), stereotypy, number of movements relative to saline control injection for males [n] x x x x 15.5566 3.8 20.0 39.6 54.818 71.667 47.5 36.909 81.75 33.778 x 3.25 41.333 32.25 x 37.571 59.818 x x 51.385 69.0 68.727 68.222 18.833 82.2 50.5 109.091 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10305 Original post publication description: Cocaine stereotypy-number of movements 30 mg/kg cocaine ip (difference from saline)-females None Cocaine stereotypy-number of movements 30 mg/kg cocaine ip (difference from saline)-females x x x x 32.75 14.0 22.545 24.0 63.545 93.364 76.083 9.636 70.0 0.556 x 21.667 x 70.25 x 97.4 101.364 x x 77.222 31.2 73.444 120.091 x x 40.455 63.182 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10306 Original post publication description: Cocaine response (30 mg/kg ip), stereotypy, number of movements relative to from saline control injection, male and female mean [n] None Central nervous system, pharmacology, behavior: Cocaine response (30 mg/kg ip), stereotypy, number of movements relative to saline control injection, male and female combined [n] x x x x 20.8462 8.9 21.333 31.8 59.1818 83.6 63.0909 23.2727 76.4091 17.1667 x 11.1429 41.3333 51.25 x 80.0 80.5909 x x 61.9545 51.0 70.85 96.75 18.8333 82.2 45.2381 86.1364 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10307 Original post publication description: Cocaine response (30 mg/kg ip), open field activity, total distance (difference from saline control) in males [units] None Cocaine response (30 mg/kg ip), open field activity, total distance (difference from saline control) in males [units] x x x x 5138.78 7692.3 2523.3 9445.14 8038.09 6483.44 8598.8 4809.09 7829.0 6242.56 x 3394.13 6141.17 6317.75 x 5389.86 5089.25 x x 6155.62 5855.36 11323.9 9137.43 6353.67 6395.2 7609.4 7896.2 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10308 Original post publication description: Cocaine open field activity-total distance 30 mg/kg cocaine (difference from saline)- females None Cocaine open field activity-total distance 30 mg/kg cocaine (difference from saline)- females x x x x 4406.25 8029.9 2724.55 6993.56 7777.18 9570.0 6825.09 3844.36 3277.8 8067.14 x 4819.0 x 7586.5 x 7748.2 6778.27 x x 6744.3 3145.89 9256.78 13633.0 x x 7764.27 10213.1 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10309 Original post publication description: Cocaine open field activity-total distance 30 mg/kg cocaine (difference from saline)-male and female mean None Cocaine open field activity-total distance 30 mg/kg cocaine (difference from saline)-male and female mean x x x x 4913.38 7861.1 2628.71 8066.13 7907.64 8181.05 7669.71 4326.73 7123.91 7040.81 x 4004.79 6141.17 6952.13 x 6372.5 5897.04 x x 6411.57 4636.1 10393.7 11884.7 6353.67 6395.2 7690.52 9109.81 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10310 Original post publication description: Cocaine exploratory activity-nose pokes in holeboard 30 mg/kg cocaine ip (difference from saline)-males None Central nervous system, pharmacology, behavior: Cocaine response (30 mg/kg ip), exploratory activity (nose pokes in holeboard) difference relative to saline control, adult males [n difference] x x x x -9.25 -7.1111 -22.375 -4.4 1.4 -11.4444 -7.8 -3.4545 -15.1667 -10.6667 x -1.875 -6.8333 -10.0 x -4.8571 -15.4545 x x -1.6923 -11.8182 -3.2727 -3.1 -9.1667 -7.25 -8.1 -8.8182 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10311 Original post publication description: Cocaine response, exploratory activity, difference holeboard nose pokes between cocaine (30 mg/kg ip) and saline in females [n] None Central nervous system, pharmacology, behavior: Cocaine response (30 mg/kg ip), exploratory activity (nose pokes in holeboard) difference relative to saline control, adult females [n difference] x x x x -11.75 -10.1111 -10.8182 -12.0 1.81818 -13.5455 -9.16667 -0.72727 -10.6 -5.125 x -2.66667 -8.0 -10.25 x -2.0 -14.0 x x -6.3 -10.3 -12.2222 -11.7273 -12.3333 -27.0 -5.72727 -14.4 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10312 Original post publication description: Cocaine exploratory activity-nose pokes in holeboard 30 mg/kg cocaine ip (difference from saline)-male and female mean None Central nervous system, pharmacology, behavior: Cocaine response (30 mg/kg ip), exploratory activity (nose pokes in holeboard) difference relative to saline control, adult males and females [n difference] x x x x -10.0833 -8.6111 -15.6842 -8.0 1.619 -12.6 -8.5455 -2.0909 -13.0909 -13.2222 x -2.2143 -6.8333 -10.125 x -3.6667 -15.0952 x x -3.6957 -11.5 -7.3 -7.619 -9.1667 -7.25 -6.8571 -11.4762 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10313 Original post publication description: Cocaine response, stereotypy, difference in number of movements after cocaine (45 mg/kg ip) compared to saline control in males None Cocaine response, stereotypy, difference in number of movements after cocaine (45 mg/kg ip) compared to saline control in males x x x x 31.125 40.2727 12.0833 14.3636 83.2727 47.2727 30.9 14.7273 89.0833 16.9 x 1.5 28.375 45.25 x 36.5714 39.5455 x x 18.2 51.3 79.0 55.6 16.8333 76.5 5.4 51.1111 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10314 Original post publication description: Cocaine response (45 mg/kg cocaine ip), stereotypy, number of movements relative to saline control injection in females [n] None Cocaine response (45 mg/kg cocaine ip), stereotypy, number of movements relative to saline control injection in females [n] x x x x 51.6 5.8 0.8182 31.2 50.75 58.5556 53.0 0.2222 74.7273 38.4 x 10.8 x 20.75 x 43.2 66.2 x x 19.333 41.2 57.8 77.4 15.333 x 33.1818 46.4167 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10315 Original post publication description: Cocaine response, stereotypy, difference in number of movements between cocaine (45 mg/kg ip) and saline in males and females None Cocaine response, stereotypy, difference in number of movements between cocaine (45 mg/kg ip) and saline in males and females x x x x 39.0 23.8571 6.6957 22.381 69.5789 52.35 42.4762 8.2 82.2174 27.65 x 5.7273 28.375 33.0 x 39.3333 52.2381 x x 18.8182 46.25 68.4 66.5 16.3333 76.5 19.9524 48.4286 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10316 Original post publication description: Cocaine open field activity-total distance 45 mg/kg cocaine (difference from saline)-males None Cocaine open field activity-total distance 45 mg/kg cocaine (difference from saline)-males x x x x 5167.88 8081.18 3118.17 7006.45 7651.0 9608.18 5561.9 5277.55 7793.67 5834.1 x 5273.83 4397.75 6007.75 x 4820.57 4210.73 x x 4037.9 4716.67 9595.73 5946.67 5099.67 5787.0 6691.9 7125.5 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10317 Original post publication description: Cocaine open field activity-total distance 45 mg/kg cocaine (difference from saline)-females None Cocaine open field activity-total distance 45 mg/kg cocaine (difference from saline)-females x x x x 6258.8 6524.8 3339.09 7076.55 7885.44 7719.89 7430.18 3791.22 7100.36 7641.1 x 4305.6 x 5703.0 x 5240.0 5918.6 x x 5297.77 4288.89 7085.9 9051.2 5508.67 x 7988.18 5792.83 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10318 Original post publication description: Cocaine open field activity-total distance 45 mg/kg cocaine (difference from saline)-males and females None Cocaine open field activity-total distance 45 mg/kg cocaine (difference from saline)-males and females x x x x 5587.46 7340.05 3223.83 7041.5 7756.5 8758.45 6540.52 4608.7 7462.09 6737.6 x 4833.73 4397.75 5855.38 x 4995.33 5024.0 x x 4750.0 4502.78 8400.57 7580.63 5236.0 5787.0 7370.9 6325.9 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10319 Original post publication description: Cocaine exploratory activity-nose pokes in holeboard 45 mg/kg cocaine ip (difference from saline)-males None Central nervous system, pharmacology, behavior: Cocaine response (45 mg/kg ip), exploratory activity (nose pokes in holeboard) difference relative to saline control, adult males [n difference] x x x x -4.0 -10.2727 -12.6 -11.7273 -6.1818 -7.7273 -10.5 -4.0 -8.1667 -10.25 x -4.6667 -13.5 -7.75 x 0.5714 -5.9 x x -2.7778 -11.5 -0.6364 -6.4 -3.0 -19.0 -8.1818 -9.5 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10320 Original post publication description: Cocaine response (45 mg/kg ip), exploratory activity assayed by nose pokes in holeboard minus saline control in females [n] None Central nervous system, pharmacology, behavior: Cocaine response (45 mg/kg ip), exploratory activity (nose pokes in holeboard) difference relative to saline control, adult females [n difference] x x x x -5.5 -12.3 -27.0 -12.1667 0.375 -22.625 -7.4545 -12.2222 -19.6364 -11.3333 x -4.0 x -7.75 x -0.4 -7.0 x x -8.0 -16.2 -10.3 -16.4 -11.3333 x -16.9 -12.9167 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10321 Original post publication description: Cocaine response (45 mg/kg ip), exploratory activation, nose pokes in hole board (difference from saline) for males and females [n] None Central nervous system, pharmacology, behavior: Cocaine response (45 mg/kg ip), exploratory activity (nose pokes in holeboard) difference relative to saline control, adult males and females [n difference] x x x x -4.5455 -11.2381 -19.8 -11.9565 -3.4211 -14.0 -8.9048 -7.7 -13.6522 -10.8235 x -4.3636 -13.5 -7.75 x 0.1667 -6.45 x x -5.8636 -13.85 -5.2381 -11.4 -5.7778 -19.0 -11.8571 -11.55 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10322 Original post publication description: Cocaine open field behavior-total distance area under curve, 5 mg/kg cocaine, saline covariate None Central nervous system, behavior, pharmacology: Cocaine open field behavior-total distance area under curve, 5 mg/kg cocaine, saline covariate x x x x 6344.1 5600.6 3904.9 5340.5 5714.2 7861.3 5091.8 4983.1 4877.1 5963.5 x 4240.7 6514.6 7005.2 x 5962.8 4785.9 x x 5435.1 5873.0 6522.6 6735.3 6477.4 6479.8 5332.6 5263.8 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10323 Original post publication description: Cocaine response, open field behavior, total distance area under curve, 15 mg/kg ip, with saline covariate [cm] None Cocaine response, open field behavior, total distance area under curve, 15 mg/kg ip, with saline covariate [cm] x x x x 8070.2 8952.4 6378.8 9327.2 10735.2 12173.5 9471.2 8978.4 9227.5 8828.8 x 7701.2 9170.7 9655.7 x 8873.1 8577.0 x x 9751.9 8952.6 14268.4 9888.3 6628.1 8682.7 9204.5 8352.3 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10324 Original post publication description: Cocaine open field behavior-total distance area under curve, 30 mg/kg cocaine, saline covariate None Central nervous system, behavior: Cocaine open field behavior-total distance area under curve, 30 mg/kg cocaine, saline covariate x x x x 8966.9 11803.8 6140.4 12347.2 11570.5 11909.3 11419.9 8272.3 10733.8 11381.1 x 7682.1 9567.0 11022.5 x 10457.0 9480.2 x x 10020.9 8494.0 13953.4 15114.6 10095.9 9632.3 11379.2 13001.7 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10325 Original post publication description: Cocaine response, open field behavior, total distance area under curve (45 mg/kg ip) with saline covariate [cm] None Central nervous system, behavior, pharmacology: Cocaine response, open field behavior, total distance area under curve (45 mg/kg ip) with saline covariate [cm] x x x x 10619.6 11321.9 6331.1 11605.6 11243.0 12728.1 9879.0 8835.7 10837.6 11773.3 x 8156.1 10098.4 10310.8 x 8823.8 8130.9 x x 7990.5 8542.5 11679.6 11098.3 9591.9 10106.3 10914.4 10489.1 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10326 Original post publication description: Cocaine response (15 mg/kg ip), open field behavior, difference in time spent in the field center relative saline injection for females [sec] None Central nervous system, pharmacology, behavior: Cocaine response (15 mg/kg ip), open field behavior, difference in time spent in the field center relative saline injection for females [sec] x x x x -52.3333 -69.2 67.1 -30.0833 -8.66667 -45.3333 -20.4 -37.8182 -12.4 -6.0 x 53.75 -42.0 -29.0 x -42.2 38.9 x x -43.1111 -49.5556 4.9 -47.1818 12.75 26.3333 -80.2 -12.5 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10327 Original post publication description: Cocaine response (30 mg/kg), open field behavior, center time (difference from saline) in males [sec] None Central nervous system, pharmacology, behavior: Cocaine response (30 mg/kg), open field behavior, center time (difference from saline) in males [sec] x x x x -11.1111 -64.1 1.11111 -7.5 1.09091 -41.4444 1.7 19.0909 6.75 -44.8889 x 25.7143 -4.16667 -37.0 x -9.42857 11.5455 x x -26.9231 -47.9091 -1.0 -71.7778 -17.5 -15.6 -18.5 -45.3636 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10328 Original post publication description: Cocaine open field behavior-center time (difference from saline) 30 mg/kg cocaine-females None Central nervous system, pharmacology, behavior: Cocaine response (30 mg/kg ip), open field behavior, center time difference from saline control in females [sec] x x x x -58.25 -55.3 21.4444 -23.8889 32.6364 -92.4546 37.4167 -44.0909 -3.0 -37.8889 x 2.16667 8.0 -14.75 x 25.4 30.1818 x x -39.7 -73.6 -40.375 -74.5 0.0 44.0 -43.9 -63.2727 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10329 Original post publication description: Cocaine open field behavior-center time (difference from saline) 45 mg/kg cocaine-males None Cocaine open field behavior-center time (difference from saline) 45 mg/kg cocaine-males x x x x -17.2857 -67.8182 63.4 -20.0 -5.0 -69.4546 -10.3 -30.6364 -4.08333 -31.7 x -9.5 -16.75 -17.5 x 6.71429 55.1818 x x -53.5 -12.6 41.6 -32.9 20.3333 -8.5 0.09091 -61.5556 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10330 Original post publication description: Cocaine open field behavior-center time (difference from saline) 45 mg/kg cocaine-females None Cocaine open field behavior-center time (difference from saline) 45 mg/kg cocaine-females x x x x -33.6 11.3 17.1 1.5 67.8889 -38.3333 36.6364 -26.4444 -10.0 -55.4 x -12.0 -62.5 92.5 x 22.0 62.1 x x 3.33333 -38.2222 -6.5 -47.7 -12.0 9.0 -2.2 -49.6667 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10331 Original post publication description: Central nervous system, behavior: Novel open fled behavior, habituation measured as the difference in locomotion between 0-5 min and 26-30 min periods for males [cm] None Central nervous system, behavior: Novel open fled behavior, habituation measured as the difference in locomotion between 0-5 min and 26-30 min periods for males [cm] x x x x 3703.0 8768.0 2398.0 11354.0 6675.0 3863.0 9278.0 5540.0 7742.0 5381.0 x 4402.0 6348.0 5393.0 x 5415.0 5138.0 x x 5527.0 6118.0 11639.0 7952.0 5848.0 5392.0 7660.0 8248.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10332 Original post publication description: Novel open fled behavior, habituation measured as the difference in locomotion between 0-5 min and 26-30 min periods for females [cm] None Novel open fled behavior, habituation measured as the difference in locomotion between 0-5 min and 26-30 min periods for females [cm] x x x x 3303.0 7068.0 2961.0 7784.0 8209.0 7369.0 6527.0 3869.0 6799.0 8371.0 x 4770.0 x 4781.0 x 5942.0 5984.0 x x 7237.0 1189.0 7814.0 12083.0 -3478.0 x 7618.0 11201.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10333 Original post publication description: Cocaine open field behavior-center time (difference from saline) 5 mg/kg cocaine-males None Cocaine open field behavior-center time (difference from saline) 5 mg/kg cocaine-males x x x x -53.5 -64.1818 -75.6 -35.9091 -26.2222 -39.1111 -36.2727 -58.2727 -45.6 -30.0 x -65.6667 -54.75 -91.6667 x -30.5 0.2 x x -33.0 -12.5 -2.25 -0.14286 -12.8 26.4 -55.5454 -31.0909 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10334 Original post publication description: Cocaine open field behavior-center time (difference from saline) 5 mg/kg cocaine-females None Central nervous system, pharmacology, behavior: Cocaine response (5 mg/kg), anxiety assay, center time in an open field test, difference from saline control in females [sec] x x x x -33.4 -56.5 -32.875 -16.4167 -60.0 -43.5833 -17.6364 -15.0 -33.9 -34.5556 x 10.3333 -17.3333 -25.0 x -22.3333 44.375 x x -53.6 -50.5 -10.3 -1.8 -41.6 -30.5 -60.0 -44.9 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10335 Original post publication description: Cocaine response (15 mg/kg ip), open field behavior, time in the field center (difference from saline control) in males [sec] None Central nervous system, pharmacology, behavior: Cocaine response (15 mg/kg ip), open field behavior, time in the field center (difference from saline control) in males [sec] x x x x -37.7273 -35.1818 -36.2222 -37.1818 -6.0 -22.2 -11.0 -24.5455 -23.7692 -25.8 x -53.8333 -17.8571 -18.0 x -20.6 39.8 x x -1.8 -48.2222 -13.6667 -66.6364 3.33333 19.5 -42.5 -57.0909 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10336 Original post publication description: Haloperidol response, induced catalepsy at ED50 [mg/kg] None Central nervous system, pharmacology: Haloperidol response, induced catalepsy at ED50 [mg/kg] x x 3.8 0.4 1.17 7.9 1.23 3.25 1.48 1.73 2.47 2.94 1.53 2.31 1.17 4.18 4.43 2.39 2.8 0.98 0.61 5.89 x 0.93 3.62 1.35 2.73 6.67 0.55 0.96 3.81 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10337 Original post publication description: Central nervous system, morphology: Hippocampus granule cell number [n total per side] None Central nervous system, morphology: Hippocampus granule cell number [n total per side] x x 344252.0 298849.0 x 281933.0 386307.0 435866.0 343767.0 x x 303769.0 x x x x 308851.0 335002.0 x x x x x x 292057.0 x 309037.0 348995.0 284144.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10338 Original post publication description: Central nervous system, adult neurogenesis: Proliferation of BrdU-labeled cells in subgranular zone, day 1 after last BrdU injection [n cells] None Central nervous system, adult neurogenesis: Proliferation of BrdU-labeled cells in subgranular zone, day 1 after last BrdU injection [n cells] x x 5416.0 2014.0 x 2961.0 x 5389.0 7001.0 x x x x x x x 4047.0 2968.0 x x x x x x 6131.0 x 3515.0 2254.0 4227.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10339 Original post publication description: Central nervous system, adult neurogenesis: Survival of BrdU-labelled cells in the hippocampal dentate gyrus subgranular zone 4 weeks after last injection [n cells] None Central nervous system, adult neurogenesis: Survival of BrdU-labelled cells in the hippocampal dentate gyrus subgranular zone 4 weeks after last injection [n cells] x x 2184.0 864.0 x 403.0 1157.0 2709.0 3745.0 x x 1052.0 x x x x 1085.0 1072.0 x x x x x x 1283.0 x 1215.0 679.0 883.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10340 Original post publication description: Central nervous system, adult neurogenesis: fraction of new neurons in hippocampal dendate gyrus 4 weeks after last BrdU injection [%] None Central nervous system, adult neurogenesis: fraction of new neurons in hippocampal dentate gyrus 4 weeks after last BrdU injection [%] x x 78.3 51.8 x 27.9 63.7 67.6 78.6 x x 44.4 x x x x 57.7 68.7 x x x x x x 79.2 x 68.8 50.5 56.9 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10341 Original post publication description: Central nervous system, learning and memory, adult neurogenesis: Astrocyte cell number percentage, 4 weeks after last BrdU injection [%] None Central nervous system, learning and memory, adult neurogenesis: Astrocyte cell number percentage, 4 weeks after last BrdU injection [%] x x 85.3 80.4 x 64.9 81.8 81.1 87.7 x x 69.3 x x x x 80.0 91.8 x x x x x x 93.8 x 85.6 77.1 89.5 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10342 Original post publication description: Central nervous systems, adult neurogenesis: Newly generated neurons in the dentate gyrus 4 weeks after last BrdU injection [n BrdU cells X ratio of NeuN / BrdU labeled cells] None Central nervous systems, adult neurogenesis: Newly generated neurons in the dentate gyrus 4 weeks after last BrdU injection [n BrdU cells X ratio of NeuN / BrdU labeled cells] x x 1695.0 433.0 x 110.0 732.0 1816.0 2891.0 x x 462.0 x x x x 621.0 731.0 x x x x x x 1007.0 x 872.0 365.0 493.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10343 Original post publication description: Central nervous system, adult neurogenesis: New astrocytes, 4 weeks after last BrdU injection [n BrdU cells X ratio of S100 beta / BrdU labelled cells] None Central nervous system, adult neurogenesis: New astrocytes, 4 weeks after last BrdU injection [n BrdU cells X ratio of S100 beta / BrdU labelled cells] x x 136.0 245.0 x 142.0 243.0 404.0 326.0 x x 255.0 x x x x 235.0 245.0 x x x x x x 179.0 x 165.0 183.0 290.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10344 Original post publication description: Central nervous system, behavior, learning and memory: Learning measured by the time spent in target quadrant on day 5 (probe trial) using the Morris water maze [%] None Central nervous system, behavior, learning and memory: Learning measured by the time spent in target quadrant on day 5 (probe trial) using the Morris water maze [%] x x 31.7 23.1 x 34.2 x 37.7 28.6 x x 34.4 x x x x 28.1 31.4 x x x x x x 35.1 x 30.5 24.9 32.2 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10345 Original post publication description: Central nervous system, behavior: Learning and memory function, probe trial water maze time spent in swim path, day 5 [%] None Central nervous system, behavior: Learning and memory function, probe trial water maze time spent in swim path, day 5 [%] x x 33.6 20.7 x 33.9 x 38.5 30.6 x x 35.7 x x x x 28.4 37.9 x x x x x x 33.6 x 28.0 24.8 31.7 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10819 Original post publication description: Central nervous system, behavior: Open field behavior, locomotion from 0-45 min [n beam breaks] None Central nervous system, behavior: Open field behavior, locomotion from 0-45 min [n beam breaks] x x 212.6 207.4 x 211.25 x 216.2 220.0 x x 180.0 x x x x 154.6 228.2 x x x x x x 212.0 x x 296.6 206.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10347 Original post publication description: Ethanol response (1.75 g/kg ip), initial sensitivity measured by blood ethanol concentration (BEC, retrobulbar bleed) at loss of balance using a dowel test (BEC time 0) [mg % ethanol] None Central nervous system, pharmacology, behavior: Ethanol response (1.75 g/kg ip), initial sensitivity measured by blood ethanol concentration (BEC, retrobulbar bleed) at loss of balance using a dowel test (BEC time 0) [mg % ethanol] x x 195.33 205.91 197.28 128.9 201.4 152.49 169.13 190.51 207.85 209.95 202.57 221.38 153.89 152.64 192.77 201.79 176.98 169.36 231.42 x x 231.88 169.98 x 168.04 186.86 195.65 190.36 160.71 160.26 x 185.8 x x 215.79 213.37 194.48 x 188.26 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10348 Original post publication description: Ethanol response (1.75 g/kg ip then 2 g/kg ip), acute functional tolerance (AFT) measured as the difference in blood alcohol concentration (BEC, retrobulbar bleed) following the second recovery of balance and the first recovery of balance using a dowel test (BEC2 minus BEC1) [mg %] None Central nervous system, pharmacology, behavior: Ethanol response (1.75 g/kg ip then 2 g/kg ip), acute functional tolerance (AFT) measured as the difference in blood alcohol concentration (BEC, retrobulbar bleed) following the second recovery of balance and the first recovery of balance using a dowel test (BEC2 minus BEC1) [mg %] x x 65.2 94.1 96.8 71.0 112.9 96.5 81.1 103.7 107.0 119.3 116.0 110.6 58.4 65.7 56.2 91.3 76.7 79.1 109.5 x x 81.2 128.3 x 79.2 85.0 92.3 49.3 64.4 98.3 x 63.5 x x 47.2 87.0 96.9 x 106.9 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10349 Original post publication description: Ethanol response (1.75 mg/kg ip), time to ataxia measured as loss of balance using a dowel test (Loss corresponds to BEC time 0) [min] None Central nervous system, pharmacology, behavior: Ethanol response (1.75 mg/kg ip), time to ataxia measured as loss of balance using a dowel test (Loss corresponds to BEC time 0) [min] x x 2.09 2.33 1.75 1.03 2.3 1.47 2.11 1.55 1.82 2.19 2.2 1.81 1.83 1.2 1.38 2.47 2.32 1.41 3.47 x x 3.22 1.64 x 1.56 2.25 1.71 2.28 1.44 1.6 x 1.44 x x 1.57 1.56 2.02 x 1.63 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10350 Original post publication description: Ethanol response (1.75 mg/kg ip), duration of ataxia following the first ethanol injection using a dowel test (Regain Test 1 corresponds to BEC1) [min] None Central nervous system, pharmacology, behavior: Ethanol response (1.75 mg/kg ip), duration of ataxia following the first ethanol injection using a dowel test (Regain Test 1 corresponds to BEC1) [min] x x 10.53 9.61 16.36 27.99 14.12 10.75 14.07 9.7 11.98 14.21 24.58 17.73 10.7 34.74 32.7 15.12 11.38 32.69 15.11 x x 13.39 14.39 x 16.12 9.24 7.99 18.67 56.55 24.92 x 26.7 x x 24.18 20.31 9.39 x 9.36 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10351 Original post publication description: Ethanol response (1.75 g/kg ip then 2 g/kg ip), duration of ataxia following the second ethanol injection using a dowel test (Regain Test 2 corresponds to BEC2) [min] None Central nervous system, pharmacology, behavior: Ethanol response (1.75 g/kg ip then 2 g/kg ip), duration of ataxia following the second ethanol injection using a dowel test (Regain Test 2 corresponds to BEC2) [min] x x 162.53 133.15 139.07 181.94 128.1 141.62 144.5 126.94 131.42 140.1 142.0 129.97 164.01 175.99 183.48 132.35 127.23 175.02 149.64 x x 141.95 133.14 x 144.59 125.47 118.8 173.19 220.28 152.77 x 189.91 x x 198.64 162.91 137.19 x 109.16 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10352 Original post publication description: cyclic AMP accumulation in cerebellum, basal level measured by liquid scintillation counting [% conversion [3H]ATP to [3H]cAMP] None Central nervous system, pharmacology: cyclic AMP accumulation in cerebellum, basal level measured by liquid scintillation counting [% conversion [3H]ATP to [3H]cAMP] x x 0.608 1.48 1.23 1.1 1.15 1.26 1.14 1.04 1.04 1.26 0.688 0.994 1.87 1.15 0.972 1.38 0.85 1.31 0.885 x x 0.819 1.34 x 1.18 1.04 1.37 0.866 0.866 1.43 x 1.11 x x 0.85 1.06 0.868 x 1.21 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10353 Original post publication description: cyclic AMP accumulation in cerebellum, stimuated with forskolin (10 uM) measured by liquid scintillation counting [% conversion [3H]ATP to [3H]cAMP] None Central nervous system, pharmacology: cyclic AMP accumulation in cerebellum, stimuated with forskolin (10 uM) measured by liquid scintillation counting [% conversion [3H]ATP to [3H]cAMP] x x 18.5 22.8 18.6 22.3 18.9 18.3 18.6 24.5 21.7 26.2 17.4 29.0 25.2 20.9 18.4 27.7 17.1 18.9 19.4 x x 18.7 20.9 x 21.6 21.7 20.1 18.5 17.0 18.6 x 21.3 x x 19.2 22.8 18.8 x 22.5 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10354 Original post publication description: cyclic AMP accumulation in cerebellum, stimuated with isoproterenol (1 um) measured by liquid scintillation counting [% conversion [3H]ATP to [3H]cAMP] None Central nervous system, pharmacology: cyclic AMP accumulation in cerebellum, stimulated with isoproterenol (1 um) measured by liquid scintillation counting [% conversion [3H]ATP to [3H]cAMP] x x 3.37 6.0 4.77 3.68 4.23 4.24 4.31 6.37 5.05 5.17 4.29 5.15 9.38 5.19 4.27 5.14 4.83 5.63 4.81 x x 5.88 5.41 x 4.34 4.62 5.51 3.81 4.1 4.85 x 4.8 x x 5.15 5.23 4.27 x 5.24 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10355 Original post publication description: Immune system, environmental toxicology: Airway inflammatory response to ozone (2 ppm for 3 h) measured as lavageable bronchoalveolar polymorphonuclear leukocytes 6 h after acute exposure [number of PMNs x10^3] None Immune system, environmental toxicology: Airway inflammatory response to ozone (2 ppm for 3 h) measured as lavageable bronchoalveolar polymorphonuclear leukocytes 6 h after acute exposure [number of PMNs x10^3] x x 10.0 2.0 2.0 4.0 x x 2.0 1.0 13.0 2.0 x x x 1.0 x x x 15.0 x x x 3.0 2.0 23.0 1.0 1.0 2.0 1.0 1.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10356 Original post publication description: Immune function, environmental toxicology: Airway inflammatory response to ozon (0.30 ppm for 48 h) measured as lavageable bronchoalveolar polymorphonuclear leukocytes 6 h after exposure [n PMNs x10^3] None Immune system, pulmonary system, environmental toxicology: Airway inflammatory response to ozone (0.30 ppm for 48 h) measured as lavageable bronchoalveolar polymorphonuclear leukocytes 6 h after exposure [n PMNs x10^3] x x 10.0 2.0 14.0 16.0 x x 14.0 1.0 23.0 1.0 x x x 4.0 x x x 2.0 x x x 2.0 2.0 14.0 1.0 2.0 2.0 1.0 1.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10357 Original post publication description: Musculoskeletal system, morphology, metabolism: Bone mineral density (BMD) measured by DXA in 12-week-old females for whole body [mg/cm2] None Musculoskeletal system, morphology, metabolism: Bone mineral density (BMD) measured by DXA in 12-week-old females for whole body [mg/cm2] x x 63.5 55.5 55.3 60.6 57.4 57.8 59.4 64.2 57.7 55.4 59.2 65.0 67.8 57.2 62.7 58.3 x 57.8 65.0 x x 59.3 56.1 54.0 57.5 57.2 53.3 63.9 57.8 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10358 Original post publication description: Musculoskeletal system, morphology: Body weight [g] None Musculoskeletal system, morphology: Body weight [g] x x 19.6 20.3 15.8 20.5 19.1 18.0 17.6 24.9 17.3 16.9 20.4 22.2 20.7 22.0 21.0 17.6 x 19.1 17.5 x x 19.4 16.1 17.0 19.1 18.9 14.2 18.0 19.6 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10359 Original post publication description: Musculoskeletal system, morphology: Femur bone cross-sectional area, weight corrected, in males [mm^2] None Musculoskeletal system, morphology: Femur bone cross-sectional area, weight corrected, in males [mm^2] x x 1.906 1.273 2.26 1.64 x 1.69 1.89 x 1.91 2.18 x 1.89 x 1.95 2.08 1.78 x 1.76 x 1.62 x 1.38 x 1.82 2.12 1.85 x 1.85 1.52 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10360 Original post publication description: Musculoskeletal system, morphology: Femur bone cross-sectional area, weight corrected, in females [mm^2] None Musculoskeletal system, morphology: Femur bone cross-sectional area, weight corrected, in females [mm^2] x x 1.663 1.14 1.82 1.5 x 1.54 1.7 x 1.44 1.55 x 1.62 x 1.62 1.61 1.64 x 1.49 x 1.55 x 1.15 x 1.5 1.49 1.7 x 1.52 1.35 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10361 Original post publication description: Progenitor cell proliferation in young mice-effect of TGF-beta2 (0.1 ng/ml) on the proliferation of lin-Sca1++kit+ cells [% of ctrl without TGF-beta2] None Immune system, aging: Progenitor cell proliferation in young mice (2 months of age), effect of TGFB2 (0.1 ng/ml) on the proliferation of lin-Sca1++kit+ cells relative to control without TGFB2 [%] x x x x 51.0 24.0 42.0 13.0 42.0 27.0 32.0 42.0 32.0 56.0 48.0 68.0 57.0 15.0 x 58.0 24.0 49.0 x 35.0 36.0 31.0 41.0 43.0 x 55.0 27.0 57.0 28.0 55.0 39.0 x 26.0 x 45.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10362 Original post publication description: Central nervous system, morphology: Hippocampus mossy fiber pathway volume, total [units] None Central nervous system, morphology: Hippocampus mossy fiber pathway volume, total [units] x x 201035.0 170534.0 235457.0 183237.0 176552.0 204155.0 241324.0 183084.0 167761.0 168565.0 182073.0 208777.0 181884.0 166098.0 166098.0 195597.0 183097.0 195597.0 167891.0 169252.0 x 159822.0 169252.0 159888.0 195822.0 183649.0 172789.0 206713.0 159736.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10363 Original post publication description: Central nervous system, morphology: Hippocampus mossy fiber pathway volume, CA4 (dentate gyrus) component [volume units] None Central nervous system, morphology: Hippocampus mossy fiber pathway volume, CA4 (dentate gyrus) component [volume units] x x 95604.0 73495.0 108113.0 79558.0 69461.0 98145.0 102257.0 82676.0 76052.0 71343.0 80200.0 85196.0 91529.0 84975.0 72329.0 78205.0 80195.0 82715.0 77941.0 79350.0 x 69893.0 72158.0 67393.0 86697.0 81027.0 73771.0 89044.0 70752.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10364 Original post publication description: Central nervous system, morphology: Hippocampus mossy fiber pathway volume, suprapyramidal component (SPMF) [units] None Central nervous system, morphology: Hippocampus mossy fiber pathway volume, suprapyramidal component (SPMF) [units] x x 78388.0 93765.0 101833.0 83695.0 82143.0 92057.0 105625.0 84840.0 76814.0 75664.0 84697.0 98555.0 118355.0 77463.0 72642.0 93293.0 77409.0 92860.0 90151.0 79737.0 x 77537.0 75635.0 74170.0 85185.0 83292.0 83211.0 98742.0 74437.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10365 Original post publication description: Central nervous system, morphology: Hippocampus mossy fiber pathway volume, intra- and infrapyramidal component (IIPMF) [units] None Central nervous system, morphology: Hippocampus mossy fiber pathway volume, intra- and infrapyramidal component (IIPMF) [units] x x 27042.0 12275.0 25512.0 19984.0 24948.0 13953.0 33443.0 15568.0 14895.0 21558.0 17176.0 25025.0 14859.0 19446.0 21127.0 12645.0 7688.0 20021.0 15005.0 26597.0 x 20462.0 21460.0 18326.0 24939.0 19329.0 15807.0 18926.0 14546.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10366 Original post publication description: Central nervous system, morphology: Hippocampus mossy fiber pathway, ratio of volume of CA4 to total MF [%] None Central nervous system, morphology: Hippocampus mossy fiber pathway, ratio of volume of CA4 to total MF [%] x x 47.56 40.88 45.42 43.33 39.48 48.17 42.3 45.26 45.36 42.32 44.08 40.6 40.6 46.77 43.53 42.64 48.55 42.21 42.57 42.66 x 41.82 42.65 42.2 43.74 44.11 42.72 42.64 44.29 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10367 Original post publication description: Central nervous system, morphology: Hippocampus mossy fiber pathway volume, fraction of suprapyramidal component relative to total volume [%] None Central nervous system, morphology: Hippocampus mossy fiber pathway volume, fraction of suprapyramidal component relative to total volume [%] x x 39.03 52.37 43.77 45.94 46.47 45.06 43.77 46.39 45.85 44.97 46.61 47.62 52.8 42.62 43.77 50.57 46.88 47.69 49.27 43.05 x 46.2 44.73 46.5 43.68 45.41 48.17 48.16 46.67 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10368 Original post publication description: Central nervous system, morphology: Hippocampus mossy fiber pathway volume, fraction of IIPMT relative to total volume [%] None Central nervous system, morphology: Hippocampus mossy fiber pathway volume, fraction of IIPMT relative to total volume [%] x x 13.41 6.76 10.81 10.73 14.05 6.77 13.93 8.34 8.79 12.71 9.31 11.78 6.6 10.61 12.7 6.78 4.57 10.1 8.16 14.29 x 11.97 12.62 11.31 12.58 10.48 9.11 9.0 9.04 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10369 Original post publication description: Genetics, epigenetics, imprinting: egg modifier phenotype [% androgenetic blastocyts] None Genetics, epigenetics, imprinting: egg modifier phenotype [% androgenetic blastocyts] x x 50.0 6.0 41.0 56.0 23.0 52.0 41.0 50.0 57.0 8.0 x 46.0 39.0 62.0 71.0 32.0 27.0 10.0 61.0 51.0 x 46.0 64.0 61.0 44.0 20.0 64.0 49.0 63.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10370 Original post publication description: Cancer: Hepatocellular carcinoma tumor multiplicities induced by N,N-diethylnitrosamine (DEN 0.01 ml/g, ip at postnatal day 12), mean tumor multiplicity in liver at 32 weeks in male [n] None Cancer: Hepatocellular carcinoma tumor multiplicities induced by N,N-diethylnitrosamine (DEN 0.01 ml/g, ip at postnatal day 12), mean tumor multiplicity in liver at 32 weeks in male [n] x x 1.6 31.0 2.7 14.0 22.0 1.3 18.0 x 63.0 1.7 8.2 x 0.06 22.0 16.0 43.0 x 14.0 x 5.8 x 15.0 12.0 14.0 5.6 2.3 3.5 8.6 8.1 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10371 Original post publication description: Cytosolic aryl-hydrocarbon receptor (AHR) protein levels in liver (fmol/mg cytosolic protein) None Cytosolic aryl-hydrocarbon receptor (AHR) protein levels in liver (fmol/mg cytosolic protein) x x 38.0 0.5 57.0 0.5 9.0 50.0 46.0 1.0 39.0 1.0 43.0 66.0 1.0 12.0 65.0 1.0 2.0 0.5 1.0 1.0 x 0.5 60.0 1.0 2.0 42.0 41.0 0.5 0.5 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10372 Original post publication description: Immune function: tumor necrosis factor (TNF)-induced hypothermia [degree C] None Immune system: Tumor necrosis factor (TNF)-induced hypothermia [degree C] x 35.7 26.3 35.1 30.1 26.2 x 35.4 35.5 31.9 35.6 x x 31.3 33.3 34.5 x x 23.6 31.6 30.4 30.2 x 35.6 35.4 31.2 31.6 x 27.2 26.0 34.2 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10373 Original post publication description: Tumor necrosis factor (TNF) lethal shock, induction of serum interleukin 6 (IL-6) cytokine after injection [ng/ml] None Tumor necrosis factor (TNF) lethal shock, induction of serum interleukin 6 (IL-6) cytokine after injection [ng/ml] x 2.2 5.0 2.45 4.0 5.3 x 2.5 3.0 2.9 2.5 x x 5.5 2.95 2.55 x x 4.4 4.25 4.8 5.0 x 1.8 2.5 2.8 3.0 x 4.3 4.9 1.7 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10374 Original post publication description: Immune function: Lethality due to tumor necrosis factor (TNF) injection [%] None Immune system: Lethality due to tumor necrosis factor (TNF) injection [%] x x 100.0 0.0 79.0 100.0 66.0 0.0 0.0 12.0 0.0 x 0.0 89.0 0.0 20.0 56.0 75.0 100.0 100.0 89.0 100.0 x 10.0 0.0 10.0 20.0 x 100.0 83.0 10.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10375 Original post publication description: Central nervous system, morphology: Hippocampus weight, bilateral, fixed and hand-dissected tissue, unadjusted for differences in age, sex, or body weight [mg] None Central nervous system, morphology: Hippocampus weight, bilateral, fixed and hand-dissected tissue, unadjusted for differences in age, sex, or body weight [mg] x x x x 27.1 25.3 26.8 26.3 26.2 25.4 25.5 26.4 24.7 26.0 27.9 28.3 26.2 28.3 24.3 26.5 25.3 24.3 x 23.9 24.5 23.3 23.1 22.1 21.1 23.6 25.3 26.3 23.8 26.1 25.7 24.5 27.3 24.7 30.5 x 27.4 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10376 Original post publication description: Central nervous system, morphology: Hippocampus bilateral weight [mg] with adjustment only for age and sex (no adjustment for brain weight). None Central nervous system, morphology: Hippocampus bilateral weight [mg] with adjustment only for age and sex (no adjustment for brain weight). x x 28.4 23.0 27.6 24.9 29.9 26.7 28.7 25.7 25.2 26.7 23.5 26.4 26.2 28.1 26.0 28.0 24.3 25.6 24.5 24.5 x 21.6 23.7 22.9 24.1 23.3 21.3 23.7 24.1 26.7 24.4 26.4 26.4 23.6 28.3 25.3 30.8 x 27.5 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10377 Original post publication description: Central nervous system, morphology: Hippocampus granule cell density [n x10^3] None Central nervous system, morphology: Hippocampus granule cell density [n x10^3] x x 857.0 871.0 1040.0 849.0 859.0 x 974.0 936.0 756.0 985.0 850.0 880.0 907.0 892.0 1010.0 954.0 921.0 x 928.0 828.0 x 1053.0 782.0 837.0 932.0 900.0 905.0 860.0 970.0 822.0 850.0 897.0 837.0 x 793.0 793.0 853.0 x 748.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10378 Original post publication description: Central nervous system, morphology: Hippocampus granule cell number, unilateral [n x10^3] None Central nervous system, morphology: Hippocampus granule cell number, unilateral [n x10^3] x x 886.0 697.0 1067.0 639.0 835.0 x 1155.0 708.0 793.0 887.0 864.0 1019.0 766.0 x 800.0 1002.0 709.0 x 960.0 725.0 x 766.0 966.0 684.0 742.0 645.0 734.0 700.0 809.0 760.0 533.0 772.0 664.0 x 718.0 776.0 995.0 x 794.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10379 Original post publication description: Central nervous system, morphology: Brain weight [mg] None Central nervous system, morphology: Brain weight [mg] x x 496.0 415.0 433.0 417.0 544.0 386.0 477.0 448.0 415.0 453.0 384.0 412.0 447.0 455.0 435.0 436.0 399.0 429.0 441.0 435.0 x 388.0 412.0 373.0 415.0 403.0 367.0 409.0 444.0 427.0 420.0 413.0 405.0 411.0 418.0 405.0 438.0 x 443.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10380 Original post publication description: B-mannosidase activity in liver of female [mg p-nitrophenl liberated/g tissue wet weight/hr at 37 degrees C] None Biochemistry, protein activity, liver: B-mannosidase activity in liver of female [mg p-nitrophenl liberated/g tissue wet weight/hr at 37 degrees C] x x 2.187 1.734 1.676 1.536 2.741 1.633 1.051 1.813 1.439 1.466 x 1.956 2.548 2.717 1.524 1.46 x 1.608 1.829 x x 1.658 1.732 2.529 1.636 2.567 x 2.275 1.304 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10381 Original post publication description: B-mannosidase activity in kidney of female [mg p-nitrophenl liberated/g tissue wet weight/hr at 37 degrees C] None Biochemistry, protein activity, kidney: B-mannosidase activity in kidney of female [mg p-nitrophenl liberated/g tissue wet weight/hr at 37 degrees C] x x 2.71 1.505 3.341 2.011 3.473 3.29 0.03 3.558 1.68 2.027 x 2.643 3.093 1.42 2.097 0.299 x 2.062 3.789 x x 2.808 1.679 4.234 2.001 3.614 x 3.252 1.479 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10382 Original post publication description: Raffinose bitter taste response (raffinose undecaacetate 0.4 mM in water), consumption [%] None Raffinose bitter taste response (raffinose undecaacetate 0.4 mM in water), consumption [%] x x x x x 42.0 x 40.0 x 7.0 x 44.0 x x x 43.0 43.0 5.0 x x 49.0 x x x x 48.0 49.0 16.0 44.0 37.0 6.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10383 Original post publication description: Lactose sweet taste response (0.3 mM beta-lactose acetate in water), consumption [%] None Central nervous system, behavior, gustation: Lactose sweet taste response (0.3 mM beta-lactose acetate in water), consumption [%] x x x x x 6.0 x 18.0 x 30.0 x 7.0 x x x 11.0 3.0 34.0 x x 16.0 x x x x 19.0 17.0 36.0 6.0 15.0 34.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10384 Original post publication description: Saccharin sweet taste response (3.2 mM in water), consumption [%] None Central nervous system, behavior, gustation: Saccharin sweet taste response (3.2 mM in water), consumption [%] x x x x 62.0 66.0 95.0 88.0 57.0 x 92.0 65.0 x x 80.0 68.0 64.0 86.0 x x 64.0 x x 84.0 81.0 62.0 55.0 93.0 55.0 84.0 55.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10385 Original post publication description: Acesulfame sweet taste response (3.2 mM in water), consumption [%] None Central nervous system, behavior, gustation: Acesulfame sweet taste response (3.2 mM in water), consumption [%] x x x x 53.0 57.0 93.0 82.0 58.0 x 89.0 57.0 x x 81.0 57.0 60.0 77.0 x x 56.0 x x 79.0 77.0 54.0 51.0 85.0 53.0 88.0 52.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10386 Original post publication description: Glycine (sweet) taste response (10 mM in water), consumption [%] None Glycine (sweet) taste response (10 mM in water), consumption [%] x x x x 6.0 32.0 8.0 34.0 13.0 x 7.0 31.0 x x 4.0 33.0 45.0 7.0 x x 42.0 x x 4.0 9.0 35.0 36.0 4.0 35.0 39.0 6.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10387 Original post publication description: Seizure threshold pressure at compression rate of 100 atm hr-1 (100iPc) (also see McCall, 2011, 21384758) [atm] None Central nervous system, behavior: Seizure threshold pressure at compression rate of 100 atm hr-1 (100iPc) (also see McCall, 2011, 21384758) [atm] x x 89.1 69.9 89.7 89.0 71.5 x 81.8 82.9 74.5 77.0 x 83.0 81.7 72.0 88.9 85.8 84.9 89.0 x 82.0 x 72.9 76.7 74.5 84.3 89.9 73.1 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10388 Original post publication description: Seizure threshold pressure at compression rate of 1000 atm hr-1 (1000iPc) (also see McCall, 2011, 21384758) [atm] None Central nervous system, behavior: Seizure threshold pressure at compression rate of 1000 atm hr-1 (1000iPc) (also see McCall, 2011, 21384758) [atm] x x 79.8 62.6 65.9 80.6 67.6 x 77.4 66.7 66.1 67.3 x 68.8 79.9 67.6 71.4 80.0 77.9 77.2 x 80.5 x 65.3 63.4 67.4 71.1 78.7 64.3 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10389 Original post publication description: Central nervous system, auditory system, behavior: High frequency hearing loss, acoustic startle response to 5 kHz white-noise bursts at 100 dB SPL [g] None Central nervous system, auditory system, behavior: High frequency hearing loss, acoustic startle response to 5 kHz white-noise bursts at 100 dB SPL [g] x x 0.3 1.1 0.4 x 0.4 5.3 2.8 0.1 1.5 2.7 0.8 -0.1 1.8 4.9 0.1 6.4 x -0.5 0.8 0.8 x 1.7 -0.4 8.8 -1.0 0.6 0.1 0.5 1.7 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10390 Original post publication description: High frequency hearing loss and cochlear pathology, acoustic startle response to 10 kHz white noise bursts at 100 dB [g] None Central nervous system, auditory system, behavior: High frequency hearing loss and cochlear pathology, acoustic startle response to 10 kHz white noise bursts at 100 dB [g] x x 14.7 10.2 6.7 x 5.2 19.4 6.2 2.1 6.0 11.5 6.4 4.9 11.0 13.9 2.5 9.4 x 1.8 3.4 1.3 x 10.8 3.8 42.2 10.0 4.0 11.7 7.6 4.7 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10391 Original post publication description: High frequency hearing loss and cochlear pathology; acoustic startle response to 15 kHz white-noise bursts at 100 dB SPL [g] None Central nervous system, auditory system, behavior: High frequency hearing loss and cochlear pathology; acoustic startle response to 15 kHz white-noise bursts at 100 dB SPL [g] x x 21.4 7.3 9.9 x 5.1 14.8 2.0 2.4 8.8 10.0 5.2 10.4 7.6 18.1 4.6 7.8 x 3.6 5.0 1.0 x 15.4 5.2 39.5 7.4 3.4 24.9 9.9 3.6 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10392 Original post publication description: High frequency hearing loss and cochlear pathology; acoustic startle response to 20 kHz white-noise bursts at 100 dB [g] None Central nervous system, auditory system, behavior: High frequency hearing loss and cochlear pathology; acoustic startle response to 20 kHz white-noise bursts at 100 dB [g] x x 9.1 6.3 6.4 x 3.4 13.0 2.1 2.2 6.4 10.6 5.2 8.5 8.6 14.7 2.0 4.7 x 5.5 4.1 1.2 x 11.0 3.6 31.6 7.4 3.6 17.4 7.8 2.1 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10393 Original post publication description: Audition and hearing, high frequency hearing loss and cochlear pathology, acoustic startle response to 25 kHz white-noise bursts at 100 dB SPL [g] None Central nervous system, auditory system, behavior: High frequency hearing loss and cochlear pathology, acoustic startle response to 25 kHz white noise bursts at 100 dB SPL [g] x x 2.9 1.8 2.4 x 2.0 3.4 -0.4 1.4 2.1 4.1 2.2 1.0 4.6 10.4 0.9 1.4 x -0.2 0.6 -0.5 x -0.2 1.2 16.0 0.2 1.4 4.4 2.5 -0.8 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10394 Original post publication description: Acoustic startle response to a 110 dB SPL, 10 kHz tone without prepulse stimulus[g] None Central nervous system, behavior: Acoustic startle response to a 110 dB SPL, 10 kHz tone without prepulse stimulus[g] x x 23.6 14.1 23.5 x 10.7 30.7 10.3 5.6 17.2 14.2 16.3 18.3 14.4 26.2 6.7 18.9 x 7.9 7.9 2.1 x 26.4 14.2 57.3 10.6 24.7 15.1 20.7 18.1 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10395 Original post publication description: Central nervous system, auditory system: High frequency hearing loss and cochlear pathology, acoustic startle response to white-noise bursts at 110 dB SPL [force] None Central nervous system, auditory system: High frequency hearing loss and cochlear pathology, acoustic startle response to white-noise bursts at 110 dB SPL [force] x x 24.3 7.4 14.5 x 11.7 23.5 12.1 7.5 15.9 x 10.9 12.4 13.2 21.1 2.6 17.1 x 2.1 5.5 3.6 x 20.2 11.3 47.1 12.1 10.1 21.3 16.4 20.9 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10396 Original post publication description: Central nervous system, behavior: Prepulse inhibition of the acoustic startle response to 110 dB SPL white-noise bursts, 5 kHz, 80 dB prepulse stimulus [%] None Central nervous system, behavior: Prepulse inhibition of the acoustic startle response to 110 dB SPL white-noise bursts, 5 kHz, 80 dB prepulse stimulus [%] x x 50.8 24.4 31.6 x 34.8 17.5 36.3 40.7 9.9 x 35.3 -6.7 14.2 12.3 x 34.1 x x 16.0 39.5 x -14.6 19.0 11.6 19.0 31.5 -9.9 14.9 -10.4 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10397 Original post publication description: Central nervous system, behavior: Prepulse inhibition of the acoustic startle response to 110 dB SPL white-noise bursts, 10 kHz, 80 dB prepulse stimulus [%] None Central nervous system, behavior: Prepulse inhibition of the acoustic startle response to 110 dB SPL white-noise bursts, 10 kHz, 80 dB prepulse stimulus [%] x x 62.9 42.2 46.6 x 40.2 15.8 45.9 49.3 38.0 x 37.8 12.5 17.4 6.2 x 43.1 x x 16.7 24.8 x -2.7 27.4 20.6 39.1 37.5 -1.0 19.8 4.2 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10398 Original post publication description: Central nervous system, behavior: Prepulse inhibiition of the acoustic startle response to 110 dB SPL white-noise bursts, 15 kHz, 80 dB prepulse stimulus [%] None Central nervous system, behavior: Prepulse inhibiition of the acoustic startle response to 110 dB SPL white-noise bursts, 15 kHz, 80 dB prepulse stimulus [%] x x 46.0 45.9 40.8 x 54.7 25.5 27.0 37.5 33.3 x 25.6 -1.9 -10.6 6.6 x 22.4 x x 15.6 59.4 x 17.1 41.0 4.5 29.8 46.2 14.8 18.8 -6.6 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10399 Original post publication description: Central nervous system, behavior: Prepulse inhibition of the acoustic startle response to 110 dB SPL white-noise bursts, 20 kHz, 80 dB prepulse stimulus [%] None Central nervous system, behavior: Prepulse inhibition of the acoustic startle response to 110 dB SPL white-noise bursts, 20 kHz, 80 dB prepulse stimulus [%] x x 40.6 9.2 31.6 x 23.0 15.3 13.6 21.7 25.7 x 11.8 -9.7 8.8 -7.3 x 7.1 x x 9.6 31.9 x -6.3 0.2 2.7 13.2 32.2 -2.6 13.1 -3.4 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10400 Original post publication description: Central nervous system, behavior: Prepulse inhibition of the acoustic startle response to a 110 db SPL, 10 kHz tone, 56 db SPL white-noise prepulse stimulus [%] None Central nervous system, behavior: Prepulse inhibition of the acoustic startle response to a 110 db SPL, 10 kHz tone, 56 db SPL white-noise prepulse stimulus [%] x x 26.8 2.1 44.0 x 25.9 13.4 60.1 35.7 13.3 35.4 30.4 27.9 13.7 9.8 59.5 8.4 x 44.7 36.2 x x 15.1 39.1 4.9 25.1 3.4 35.8 15.2 17.8 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10401 Original post publication description: Central nervous system, behavior: Prepulse inhibition of the acoustic startle response to a 110 db SPL 10 kHz tone, following a 68 db SPL white noise prepulse stimulus [%] None Central nervous system, behavior: Prepulse inhibition of the acoustic startle response to a 110 db SPL 10 kHz tone, following a 68 db SPL white noise prepulse stimulus [%] x x 32.8 15.5 53.0 x 30.5 15.2 65.3 31.5 14.2 21.4 35.2 33.8 18.1 12.9 57.9 28.4 x 40.6 51.0 x x 24.2 39.8 13.0 38.0 18.3 38.6 28.5 25.8 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10402 Original post publication description: Central nervous system, behavior: Prepulse inhibition of the acoustic startle response to a 110 db SPL, 10 kHz tone, 80 db SPL white-noise prepulse stimulus [%] None Central nervous system, behavior: Prepulse inhibition of the acoustic startle response to a 110 db SPL, 10 kHz tone, 80 db SPL white-noise prepulse stimulus [%] x x 42.9 22.6 62.4 x 29.4 30.1 75.1 33.4 35.9 32.8 46.2 37.5 25.6 21.8 58.5 34.4 x 7.9 48.7 x x 36.4 50.6 21.7 55.6 14.2 37.5 42.3 42.9 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10403 Original post publication description: Infectious disease, immune function: Theiler's murine encephalomyelitis virus (TMEV) susceptibility [% affected] None Infectious disease, immune system: Theiler's murine encephalomyelitis virus (TMEV) susceptibility [% affected] x x x x 56.0 11.0 73.0 x 11.0 63.0 84.0 100.0 0.0 0.0 0.0 x 53.0 10.0 x 0.0 10.0 0.0 x 93.0 10.0 88.0 0.0 0.0 67.0 89.0 20.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10404 Original post publication description: Infectious disease, immune function: Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease correlating with TMEV-specific DTH responsiveness [change in ear swelling (x10-4 in.)] None Infectious disease, immune system: Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease correlating with TMEV-specific DTH responsiveness [change in ear swelling (x10-4 in.)] x x 4.2 16.9 12.4 4.3 16.1 x 10.0 19.2 x x x 4.9 7.7 x 22.1 0.2 x x x 0.9 x 32.8 3.5 x 2.4 6.5 x 17.4 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10405 Original post publication description: Immune function: Antigenic activity of irradiated spleen cells for Thy-1+CD3+CD4+CD8- T-cell clone (11.1B/c) [thymidine uptake cpm] None Immune system: Antigenic activity of irradiated spleen cells for Thy-1+CD3+CD4+CD8- T-cell clone (11.1B/c) [thymidine uptake cpm] x x x x 412.0 x x 17161.0 795.0 38026.0 x 281.0 x 337.0 x x 292.0 x x x 765.0 x x x 22049.0 29821.0 29808.0 x 15452.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10406 Original post publication description: Immune function: Antigenic activity of irradiated spleen cells for Thy-1+CD3+CD4+CD8- T-cell clone D9 [thymidine uptake cpm] None Immune system: Antigenic activity of irradiated spleen cells for Thy-1+CD3+CD4+CD8- T-cell clone D9 [thymidine uptake cpm] x x x x 260.0 x x 11245.0 205.0 4758.0 x 194.0 x 220.0 x x 156.0 x x x 432.0 x x x 11748.0 4883.0 15283.0 x 8478.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10407 Original post publication description: Antigenic activity of irradiated BXD spleen cells for Thy-1+CD3+CD4+CD8- T-cell clone E4.3 [Thymidine uptake cpm] None Immune system: Antigenic activity of irradiated BXD spleen cells for Thy-1+CD3+CD4+CD8- T-cell clone E4.3 [thymidine uptake cpm] x x x x 318.0 x x 7345.0 336.0 12950.0 x 328.0 x 251.0 x x 139.0 x x x 299.0 x x x 6293.0 4343.0 4662.0 x 5170.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10408 Original post publication description: Immune function, graft-vs-host reaction, antigenic activity of irradiated spleen cells for Thy-1+CD3+CD4+CD8- T-cell clone 11.4 B/c [thymidine uptake, cpm] None Immune system: Graft-vs-host reaction, antigenic activity of irradiated spleen cells for Thy-1+CD3+CD4+CD8- T-cell clone 11.4 B/c [thymidine uptake, cpm] x x x x 221.0 x x 145.0 161.0 173.0 x 25194.0 x x x x 17405.0 x x x 457.0 x x x 304.0 6760.0 8570.0 x 8299.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10409 Original post publication description: Antigenic activity of irradiated BXD spleen cells for Thy-1+CD3+CD4+CD8- T-cell clone TGVH 9 [Thymidine uptake cpm] None Immune system: Antigenic activity of irradiated BXD spleen cells for Thy-1+CD3+CD4+CD8- T-cell clone TGVH 9 [thymidine uptake cpm] x x x x 13801.0 x x 463.0 235.0 407.0 x 387.0 x 359.0 x x 424.0 x x x 38485.0 x x x 12698.0 134.0 158.0 x 47300.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10410 Original post publication description: Immune function: Antigenic activity of irradiated BXD spleen cells for Thy1+CD3+CD4+CD8- T-cell clone TGVH32 [thymidine uptake in cpm] None Immune system: Antigenic activity of irradiated BXD spleen cells for Thy1+CD3+CD4+CD8- T-cell clone TGVH32 [thymidine uptake in cpm] x x x x 21536.0 x x 656.0 575.0 201.0 x 249.0 x 335.0 x x 465.0 x x x 32232.0 x x x 20878.0 425.0 169.0 x 18342.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10411 Original post publication description: Antigenic activity of irradiated spleen cells for Thy-1+CD3+CD4-CD8+ H-2(d) specific T-cell clone F10 ECK [thymidine uptake cpm] None Immune system: Antigenic activity of irradiated spleen cells for Thy-1+CD3+CD4-CD8+ H-2(d) specific T-cell clone F10 ECK [thymidine uptake cpm] x x x x 5234.0 x x 3138.0 340.0 3766.0 x 5407.0 x 289.0 x x 2580.0 x x x 5023.0 x x x 4804.0 2413.0 2244.0 x 4130.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10412 Original post publication description: Immune function: Antigenic activity of irradiated spleen cells for Thy-1+CD3+CD4+CD8- Mls(a) specific T-cell clone F5J10 [thymidine uptake cpm] None Immune system: Antigenic activity of irradiated spleen cells for Thy-1+CD3+CD4+CD8- Mls(a) specific T-cell clone F5J10 [thymidine uptake cpm] x x x x 266.0 x x 259.0 12535.0 7934.0 x 109.0 x x x x 261.0 x x x 6819.0 x x x 14339.0 9057.0 18358.0 x 18635.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10413 Original post publication description: Central nervous system, behavior, learning and memory: Spatial navigation, latency to reach platform using Morris water maze (test 1) [log sec] None Central nervous system, behavior, learning and memory: Spatial navigation, latency to reach hidden platform using Morris water maze (test 1, Trait Llat1 Table 1), males and females combined [log sec] x x 1.466 1.273 1.814 1.432 1.254 1.646 1.463 1.277 1.357 1.674 1.636 1.43 1.854 1.571 1.64 1.578 1.746 1.803 1.352 1.365 x 1.51 1.346 1.657 1.67 1.795 1.59 1.597 1.371 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10414 Original post publication description: Central nervous system, behavior, learning and memory: Spatial navigation, latency to reach platform using Morris water maze (test 2) [log sec] None Central nervous system, behavior, learning and memory: Spatial navigation, latency to reach hidden platform using Morris water maze (test 2, Trait Llat2 Table 1), males and females combined [log sec] x x 1.169 1.179 1.483 1.244 1.094 1.405 1.444 1.257 1.176 1.427 1.505 1.395 1.603 1.414 1.463 1.565 1.51 1.551 1.176 1.341 x 1.204 1.169 1.337 1.392 1.587 1.26 1.513 1.219 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10415 Original post publication description: Central nervous system, behavior, learning and memory: Spatial navigation, latency to reach platform using Morris water maze (test 3) [log sec] None Central nervous system, behavior, learning and memory: Spatial navigation, latency to reach hidden platform using Morris water maze (test 3, Trait Llat3 Table 1), males and females combined [log sec] x x 1.147 1.198 1.425 1.195 1.051 1.134 1.282 1.002 1.037 1.249 1.33 1.141 1.422 1.344 1.336 1.401 1.298 1.325 1.079 1.314 x 1.397 1.041 1.137 1.264 1.393 1.202 1.505 1.009 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10416 Original post publication description: Locomotion, distance traveled in 30 min in open field, baseline [cm] None Locomotion, distance traveled in 30 min in open field, baseline [cm] x x 7281.6 8898.1 11964.4 x 8103.6 14430.4 x 6556.6 4687.7 8899.7 x x 8686.1 5096.9 10100.3 x x x x x x x x 6022.7 x x x 6449.8 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10417 Original post publication description: Cocaine response (dose), locomotion after injection, distance in 30 min [cm] None Central nervous system, pharmacology, behavior: Cocaine response (dose), locomotion after injection, distance in 30 min [cm] x x 7767.0 10920.7 13071.2 x 7896.4 14561.5 x 10946.6 8200.6 14453.1 x x 12119.7 3038.8 10679.6 x x x x x x x x 4284.8 x x x 5728.2 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10418 Original post publication description: Pain response, thermal nociception, 54 degree C hot plate latency baseline test (before 3 min forced swim in 15 degree C water) for males and females [sec] None Central nervous system, peripheral nervous system, behavior, nociception: Pain response, thermal nociception, 54 degree C hot plate latency baseline test (before 3 min forced swim in 15 degree C water) for males and females [sec] x x 19.1 24.3 22.6 19.4 18.3 19.8 28.6 19.8 18.1 24.5 23.9 24.6 18.3 15.1 25.9 16.1 x 20.9 24.6 15.9 x x 24.2 20.4 18.3 17.9 18.9 13.0 13.6 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10419 Original post publication description: Pain response, thermal nociception, 54 degree C hot plate latency baseline test (before 3 min forced swim in 15 degree C water) for females [sec] None Central nervous system, peripheral nervous system, behavior, nociception: Pain response, thermal nociception, 54 degree C hot plate latency baseline test (before 3 min forced swim in 15 degree C water) for females [sec] x x 20.5 22.2 21.4 20.0 17.1 19.9 27.3 16.3 14.9 26.0 21.3 18.7 16.5 15.9 23.6 15.2 x 20.7 17.3 13.5 x x 19.5 21.3 17.4 16.9 18.0 12.6 12.4 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10420 Original post publication description: Pain response, 54 degree C hot plate latencies baseline (before 3 min forced swim in 15 degree C water), male [seconds] None Central nervous system, peripheral nervous system, behavior, nociception: Pain response, 54 degree C hot plate latencies baseline (before 3 min forced swim in 15 degree C water), male [seconds] x x 17.5 26.1 23.7 18.9 19.8 19.7 30.5 26.6 22.1 23.0 26.6 29.7 20.3 14.1 27.4 17.0 x 21.0 28.2 18.2 x x 27.9 19.5 19.2 18.8 19.9 13.3 14.7 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10421 Original post publication description: Pain response, thermal nociception, 54 degree C hot plate latencies post-swim, male and female average [sec] None Central nervous system, peripheral nervous system, behavior: Pain response, thermal nociception, 54 degree C hot plate latencies post-swim, male and female average [sec] x x 46.5 42.5 58.2 32.5 48.2 50.6 52.1 55.5 52.5 55.1 60.0 35.8 43.9 49.6 51.5 33.1 x 56.4 44.2 37.0 x x 54.9 54.5 50.7 33.4 34.2 24.6 41.4 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10422 Original post publication description: Pain response, 54 degree C hot plate latencies post-swim in female [seconds] None Central nervous system, peripheral nervous system, behavior: Pain response, 54 degree C hot plate latencies post-swim in female [seconds] x x 46.7 39.1 58.1 29.6 51.6 51.3 54.2 53.2 54.5 55.4 60.0 30.0 39.4 50.2 47.7 34.0 x 60.0 31.7 31.5 x x 57.1 60.0 47.1 33.4 28.0 14.7 44.4 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10423 Original post publication description: Pain response, 54 degree C hot plate latencies post-swim in male [sec] None Central nervous system, peripheral nervous system, behavior, nociception: Pain response, 54 degree C hot plate latencies post-swim in male [sec] x x 46.2 45.6 58.3 35.1 44.2 49.9 49.1 60.0 49.8 54.7 60.0 40.9 48.8 48.8 53.9 32.1 x 52.7 50.5 42.6 x x 53.2 48.9 54.3 33.5 40.1 32.3 38.6 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10424 Original post publication description: Pain response, thermal nociception, 54 degree C hot plate latency baseline and post swim in maximum possible effect for males and females [%MPE=(postswim-baseline)/(cut-off-baseline)*100)] None Central nervous system, peripheral nervous system, behavior, nociception: Pain response, thermal nociception, 54 degree C hot plate latency baseline and post swim in maximum possible effect for males and females [%MPE=(postswim-baseline)/(cut-off-baseline)*100)] x x 68.7 52.2 95.0 34.3 74.3 78.6 79.5 90.4 83.6 82.9 100.0 41.6 64.3 77.0 77.2 40.1 x x 6.28 50.3 x x 86.5 87.2 79.2 39.8 41.9 25.5 59.5 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10425 Original post publication description: Pain response, thermal nociception, 54 degree C hot plate latency baseline and post swim in maximum possible effect for females [%MPE=(postswim-baseline)/(cut-off-baseline)*100)] None Central nervous system, peripheral nervous system, behavior, nociception: Pain response, thermal nociception, 54 degree C hot plate latency baseline and post swim in maximum possible effect for females [%MPE=(postswim-baseline)/(cut-off-baseline)*100)] x x 67.8 47.2 95.3 26.2 81.5 80.0 83.8 86.2 88.2 82.3 99.7 33.8 55.2 77.7 68.7 43.9 x x 40.3 41.2 x x 94.0 99.7 71.4 38.5 28.3 5.6 65.9 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10426 Original post publication description: Pain response, thermal nociception, 54 degree C hot plate latency baseline and post swim in maximum possible effect for males [%MPE=(postswim-baseline)/(cut-off-baseline)*100)] None Central nervous system, peripheral nervous system, behavior: Pain response, thermal nociception, 54 degree C hot plate latency baseline and post swim in maximum possible effect for males [%MPE=(postswim-baseline)/(cut-off-baseline)*100)] x x 71.0 58.3 96.5 43.2 66.9 77.6 76.4 60.1 79.3 84.6 102.0 50.0 74.6 78.7 84.3 37.7 x x 75.5 60.4 x x 81.8 76.5 88.4 41.5 57.8 45.0 54.5 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10427 Original post publication description: Infectious disease, immune function: xenotropic MuLV envelope-related cell-surface antigens (XenCSA) levels on thymus cells [mean flourescence value=sum of products of each channel number times n cells in that channel divided by n cells counted] None Infectious disease, immune system: xenotropic MuLV envelope-related cell-surface antigens (XenCSA) levels on thymus cells [mean flourescence value=sum of products of each channel number times n cells in that channel divided by n cells counted] x x 80.0 160.0 111.0 67.0 96.0 118.0 95.0 74.0 62.0 114.0 216.0 328.0 109.0 227.0 131.0 80.0 71.0 101.0 63.0 70.0 x 62.0 133.0 126.0 160.0 65.0 146.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10428 Original post publication description: Immune system: lymphocyte major glycoprotein (gp70) xenotropic leukemia virus envelope-related cell-surface antigen (XenCSA) level [mean fluorescence value=sum of products of each channel number times the number of spleen cells in that channel divided by the number of cells counted] None Immune system: lymphocyte major glycoprotein (gp70) xenotropic leukemia virus envelope-related cell-surface antigen (XenCSA) level [mean fluorescence value=sum of products of each channel number times the number of spleen cells in that channel divided by the number of cells counted] x x 120.0 464.0 261.0 104.0 156.0 189.0 180.0 151.0 126.0 291.0 430.0 493.0 250.0 345.0 340.0 107.0 143.0 215.0 110.0 194.0 x 120.0 308.0 208.0 405.0 110.0 451.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10429 Original post publication description: Metabolism, genetics, blood chemistry: Serum amyloid P component (APCS protein, endogenous SAP) level [ug/ml] None Metabolism, genetics, blood chemistry: Serum amyloid P component (APCS protein, endogenous SAP) level [ug/ml] x x 38.8 230.8 31.5 137.1 195.2 39.8 204.7 176.0 106.6 19.0 47.2 76.2 30.9 36.3 43.6 37.1 x 63.5 249.0 65.7 x 188.1 144.3 135.9 137.7 41.3 244.3 26.6 233.5 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10430 Original post publication description: Cancer biology: Tumor growth and size, 2 weeks post-implantation [mm^3] None Cancer biology: Tumor growth and size, 2 weeks post-implantation [mm^3] x x x x x x 15.2 x x 32.3 17.6 100.1 x x x x x x x x x x x 52.4 29.9 x 41.1 x x 145.8 33.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10431 Original post publication description: Cancer biology: Tumor growth 3 weeks post-implantation [mm3] None Cancer biology: Tumor growth 3 weeks post-implantation [mm3] x x x x x x 11.6 x x 11.7 2.7 62.7 x x x x x x x x x x x 37.7 18.2 x 30.6 x x 175.5 0.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10432 Original post publication description: Cancer biology: Tumor growth 7 weeks post-implantation [mm3] None Cancer biology: Tumor growth 7 weeks post-implantation [mm3] x x x x x x 92.3 x x 0.0 3.3 62.1 x x x x x x x x x x x 26.9 0.0 x 26.9 x x 856.7 0.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10433 Original post publication description: Immune function: Immune complex deposits in kidney immunized with the 16/6 Id [0=no immune complexes; 1=1-5 immune complex deposits; 2=5-20 immune complex deposits; 3=20-50 immune complex deposits; 4=50 immune complex deposits] None Immune system, urogenital system: Immune complex deposits in kidney immunized with the 16/6 Id [0=no immune complexes; 1=1-5 immune complex deposits; 2=5-20 immune complex deposits; 3=20-50 immune complex deposits; 4=50 immune complex deposits] x x 0.0 3.0 0.0 3.0 2.0 0.0 x 2.0 3.0 0.0 0.0 4.0 0.0 0.0 0.0 x x 0.0 1.0 x x 0.0 2.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10434 Original post publication description: Audiogenic seizure [% occurrence] None Audiogenic seizure [% occurrence] x x 2.0 91.0 0.0 92.0 68.0 0.0 23.0 93.0 21.0 0.0 0.0 8.0 94.0 0.0 0.0 35.0 x 92.0 x 40.0 x 22.0 0.0 29.0 22.0 0.0 0.0 x 90.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10435 Original post publication description: Audiogenic seizure severity, mean [ordinal scale] None Audiogenic seizure severity, mean [ordinal scale] x x 0.07 1.88 0.2 1.92 1.64 0.14 0.57 1.85 1.04 0.3 0.1 0.33 1.94 0.21 0.07 0.73 x 1.92 x 1.16 x 1.09 0.36 1.29 1.0 0.09 0.0 x 1.9 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10436 Original post publication description: Central nervous system, morphology: Cerebellum fissure number (vermis, midsagittal section, intraculminate fissure variation) [n] None Central nervous system, morphology: Cerebellum fissure number (vermis, midsagittal section, intraculminate fissure variation) [n] x x 10.0 9.0 9.95 6.19 8.41 10.27 9.1 9.89 8.83 7.33 9.5 9.1 9.13 8.57 10.25 8.4 9.2 8.83 9.0 10.13 x 9.4 8.06 8.96 10.07 9.0 9.0 7.25 8.85 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10437 Original post publication description: Audiogenic seizure-mean severity score in response to pure tone [severity of seizure] None Audiogenic seizure-mean severity score in response to pure tone [severity of seizure] x x 0.07 1.88 0.2 1.92 1.64 0.14 0.57 1.85 1.04 0.3 0.1 0.33 1.94 0.21 0.07 0.73 x 1.92 x 1.16 x 1.09 0.36 1.29 1.0 0.09 0.0 x 1.89 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10438 Original post publication description: Audiogeneic seizure-relative frequency of seizures [%] None Audiogeneic seizure-relative frequency of seizures [%] x x 2.0 91.0 0.0 92.0 68.0 0.0 23.0 93.0 21.0 0.0 0.0 8.0 94.0 0.0 0.0 35.0 x 92.0 x 40.0 x 22.0 0.0 29.0 22.0 0.0 0.0 x 94.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10439 Original post publication description: Lung, pulmonary function, immune function: Airway bronchial constrictor response after exposure to atracurium [airway pressure time index, cmH2O/s] None Pulmonary system, immune system: Airway bronchial constrictor response after exposure to atracurium, airway pressure time index [cmH2O/s] x x 86.0 404.0 109.0 142.0 65.0 169.0 247.0 273.0 107.0 408.0 281.0 53.0 462.0 521.0 164.0 84.0 x 317.0 54.0 x x 83.0 984.0 570.0 291.0 102.0 346.0 304.0 142.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10440 Original post publication description: Cardiovascular system, blood chemistry: Red blood cell osmotic fragility [% lysis of red cells at 0.425% NaCl] None Cardiovascular system, blood chemistry: Red blood cell osmotic fragility [% lysis of red cells at 0.425% NaCl] x x 59.8 16.1 51.8 43.7 30.8 40.0 35.9 23.9 42.9 17.9 x 34.1 16.0 50.8 32.9 48.0 x 27.0 40.0 22.1 x 30.7 33.1 57.6 37.0 36.0 30.0 8.0 32.1 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10441 Original post publication description: Anti-F antigen (liver protein) titer, experiment 1 [log10 of the reciprocal of the dilution of serum required to bind 50% of the labeled antigen] None Anti-F antigen (liver protein) titer, experiment 1 [log10 of the reciprocal of the dilution of serum required to bind 50% of the labeled antigen] x x x x x 0.83 2.4 x 1.27 x x 3.25 x x x 3.49 2.96 x x x 3.4 x x 3.39 3.21 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10442 Original post publication description: Anti-F antigen (liver protein) titer, experiment 2 [log10 of the reciprocal of the dilution of serum required to bind 50% of the labeled antigen] None Anti-F antigen (liver protein) titer, experiment 2 [log10 of the reciprocal of the dilution of serum required to bind 50% of the labeled antigen] x x x x x 1.07 x x 1.03 x 2.36 1.76 1.65 x x 1.81 1.92 0.76 x x 2.41 x x 2.11 2.31 x x x 2.39 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10443 Original post publication description: Musculoskeletal system, morphology, metabolism: Bone mineral density (WC-BMD) in males corrected for whole body weight [mg/cm2] None Musculoskeletal system, morphology, metabolism: Bone mineral density (WC-BMD) in males corrected for whole body weight [mg/cm2] x x 65.8 65.6 62.2 59.5 x 66.8 x x 56.9 63.5 x 58.2 x 60.4 57.4 57.2 x 59.1 x x x 59.7 60.5 56.6 59.9 57.2 56.7 60.6 65.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10444 Original post publication description: Musculoskeletal system, morphology, metabolism: Bone mineral density (WC-BMD) in females corrected for whole body weight [mg/cm2] None Musculoskeletal system, morphology, metabolism: Bone mineral density (WC-BMD) in females corrected for whole body weight [mg/cm2] x x 65.5 67.8 59.7 61.3 x 60.1 x x 60.4 58.8 x 64.0 x 56.4 61.8 61.2 x 59.7 x x x 60.2 60.0 56.7 58.5 58.8 58.5 66.2 58.7 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10445 Original post publication description: Central nervous system, behavior: Fear response control (unconditioned auditory stimulus stimulus, US) in a contextualized fear conditioning paradigm [% freezing] None Central nervous system, behavior: Fear response control (unconditioned auditory stimulus stimulus, US) in a contextualized fear conditioning paradigm [% freezing] x x 70.0 60.0 62.0 45.0 x 20.0 51.0 60.0 100.0 40.0 64.0 32.0 x 18.0 x 20.0 x 67.0 61.0 64.0 x 41.0 50.0 53.0 61.0 64.0 62.0 x 65.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10446 Original post publication description: Central nervous system, behavior: Fear response to context [% freezing] None Central nervous system, behavior: Fear response to context [% freezing] x x 38.0 15.0 23.0 23.0 x 10.0 29.0 10.0 38.0 10.0 38.0 10.0 x 23.0 x 11.0 x 23.0 35.0 50.0 x 20.0 15.0 40.0 38.0 5.0 23.0 x 45.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10447 Original post publication description: Central nervous system, behavior: Fear response to preconditioned (altered) context stimulus [% freezing] None Central nervous system, behavior: Fear response to preconditioned (altered) context stimulus [% freezing] x x 32.0 10.0 5.0 11.0 x 5.0 30.0 15.0 22.0 7.0 20.0 6.0 x 17.0 x 6.0 x 27.0 35.0 35.0 x 15.0 10.0 32.0 32.0 0.0 5.0 x 40.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10448 Original post publication description: ATPase activity (total activity) for whole brain homogenate [umol Pi/h/mg protein] None ATPase activity (total activity) for whole brain homogenate [umol Pi/h/mg protein] x x 7.94 6.71 7.29 6.52 7.07 7.1 x 7.69 7.45 6.42 6.32 x 6.81 9.03 x x x x x 7.31 x x x x 8.61 6.76 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10449 Original post publication description: ATPase activity (Mg2+ ATPase, magnesium ATPase, Mg-ATPase) for whole brain homogenate [umol Pi/h/mg protein] None Central nervous system, biochemistry: ATPase activity (Mg2+ ATPase, magnesium ATPase, Mg-ATPase) for whole brain homogenate [umol Pi/h/mg protein] x x 4.66 3.34 3.78 3.72 4.01 3.9 x 3.58 4.31 3.64 3.66 x 3.71 5.02 x x x x x 4.16 x x x x 4.6 4.45 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10450 Original post publication description: ATPase activity (Na+/K+-ATPase, sodium-potassium ATPase, sodium-potassium pump) for whole brain homogenate [umol Pi/h/mg protein] None ATPase activity (Na+/K+-ATPase, sodium-potassium ATPase, sodium-potassium pump) for whole brain homogenate [umol Pi/h/mg protein] x x 3.28 3.37 3.51 2.92 3.06 3.2 x 4.11 3.14 2.79 2.66 x 3.1 4.01 x x x x x 3.15 x x x x 4.01 2.31 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10451 Original post publication description: Seizure susceptibility, audiogenic seizure severity [scale] None Seizure susceptibility, audiogenic seizure severity [scale] x x 0.07 1.89 0.2 1.92 1.64 0.14 x 1.85 1.04 0.3 0.09 x 1.78 0.21 x x x x x 1.16 x x x x 1.0 0.09 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10452 Original post publication description: Seizure susceptibility, Clonic-tonic audiogenic seizure [%] None Seizure susceptibility, Clonic-tonic audiogenic seizure [%] x x 1.8 91.4 0.0 92.0 68.0 0.0 x 93.0 21.0 0.0 0.0 x 82.2 0.0 x x x x x 40.0 x x x x 22.0 0.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10453 Original post publication description: Control vehicle response ( 20% 2-hydroxypropyl-beta-cyclodextrin ip), difference in locomotion using Accuscan activity monitors between day 3 (third vehicle injection) and day 2 (vehicle baseline) [cm/30 min test] None Control vehicle response ( 20% 2-hydroxypropyl-beta-cyclodextrin ip), difference in locomotion using Accuscan activity monitors between day 3 (third vehicle injection) and day 2 (vehicle baseline) [cm/30 min test] x x -88.0476 -640.6 -321.125 -1170.3 -1008.17 -1589.12 -174.154 -816.0 -483.929 -923.833 -25.8182 -1479.08 -1180.15 -207.917 -535.615 276.067 x -408.769 -408.692 x x -204.5 -1464.23 285.214 -521.462 -1958.2 -312.615 -524.462 -620.227 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10454 Original post publication description: Allopregnanolone response (10 mg/kg 3a-hydroxy-5a-pregnan-20-one, THP, in 20% 2-hydroxypropyl-beta-cyclodextrin vehicle, ip), difference in locomotion using Accuscan activity monitors between day 3 (first allopregnanolone injection) and day 2 (vehicle baseline) [cm/30 min test] None Central nervous system, behavior, pharmacology: Allopregnanolone response (10 mg/kg 3a-hydroxy-5a-pregnan-20-one, THP, in 20% 2-hydroxypropyl-beta-cyclodextrin vehicle, ip), difference in locomotion using Accuscan activity monitors between day 3 (first allopregnanolone injection) and day 2 (vehicle baseline) [cm/30 min test] x x 3477.6 3019.9 598.467 2017.67 846.308 1093.14 1020.0 1203.59 674.0 1166.06 1419.27 1484.75 1831.77 3109.76 1081.69 2940.64 x 994.917 1652.58 x x 337.091 523.692 801.714 1036.23 1559.0 11.0 393.667 694.458 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10455 Original post publication description: Allopregnanolone response (17 mg/kg 3a-hydroxy-5a-pregnan-20-one in 20% 2-hydroxypropyl-beta-cyclodextrin vehicle, ip), difference in locomotion using Accuscan activity monitor between day 3 (first allopregnanolone injection) and day 2 (vehicle baseline) [cm/30 min test] None Allopregnanolone response (17 mg/kg 3a-hydroxy-5a-pregnan-20-one in 20% 2-hydroxypropyl-beta-cyclodextrin vehicle, ip), difference in locomotion using Accuscan activity monitor between day 3 (first allopregnanolone injection) and day 2 (vehicle baseline) [cm/30 min test] x x 2414.73 5722.41 2639.67 4524.91 2317.92 3171.17 3867.77 3759.94 4051.0 3099.88 2904.92 2294.17 3454.23 4645.22 5758.31 5285.5 x 4636.69 3529.08 x x 3781.0 4282.14 6489.57 428.167 5010.5 6124.31 2913.08 4020.41 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10456 Original post publication description: Central nervous system, morphology: Hippocampus volume, total [mm^3] None Central nervous system, morphology: Hippocampus volume, total [mm^3] x x 28.0 24.3 28.4 22.4 26.7 x 28.0 22.5 25.7 25.3 23.7 24.6 27.0 22.7 24.5 27.4 21.7 x 26.8 23.6 x 23.6 22.5 20.4 21.3 20.4 18.9 23.7 26.6 21.6 20.5 23.0 23.6 x 24.1 22.2 27.4 x 25.4 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10457 Original post publication description: Central nervous system, morphology: Hippocampus proper volume [mm^3] None Central nervous system, morphology: Hippocampus proper volume [mm^3] x x 22.4 19.7 23.0 18.7 21.4 x 22.3 18.1 21.3 20.5 19.2 19.7 21.9 18.9 19.6 22.2 17.6 x 21.3 19.2 x 19.3 18.2 16.7 17.1 16.3 15.2 19.3 21.6 17.5 16.8 18.5 19.3 x 19.8 17.9 22.2 x 20.2 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10458 Original post publication description: Central nervous system, morphology: Hippocampus pyramidal cell layer volume, unilateral [mm^3] None Central nervous system, morphology: Hippocampus pyramidal cell layer volume, unilateral [mm^3] x x 1.41 1.18 1.68 1.42 1.6 x 1.69 1.38 1.6 1.58 1.46 1.61 1.58 1.37 1.55 1.74 1.16 x 1.49 1.44 x 1.47 1.43 1.336 1.33 1.15 1.24 1.43 1.48 1.39 1.38 1.38 1.46 x 1.64 1.23 1.65 x 1.48 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10459 Original post publication description: Central nervous system, morphology: Hippocampus dentate gyrus granule cell layer volume, unilateral [mm^3] None Central nervous system, morphology: Hippocampus dentate gyrus granule cell layer volume, unilateral [mm^3] x x 1.09 0.75 1.06 0.75 0.99 x 1.13 0.85 1.0 0.87 0.95 1.1 0.85 0.5 0.87 0.97 0.75 x 1.01 0.8 x 0.84 0.94 0.75 0.84 0.69 0.79 0.78 0.91 0.74 0.66 0.85 0.76 x 0.84 0.96 1.04 x 1.05 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10460 Original post publication description: Central nervous system, morphology: Hippocampus dentate gyrus volume [mm^3] None Central nervous system, morphology: Hippocampus dentate gyrus volume [mm^3] x x 5.63 4.55 5.44 3.74 5.31 x 5.71 4.39 4.45 4.72 4.52 4.95 5.17 3.86 4.86 5.25 4.05 x 5.47 4.35 x 4.39 4.3 3.7 4.21 4.07 3.74 4.37 4.94 4.13 3.69 4.55 4.3 x 4.38 4.23 5.19 x 5.2 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10461 Original post publication description: Metabolism, morphology: Body weight, average males and females [g] None Metabolism, morphology: Body weight, average males and females [g] x x 28.6 25.9 20.7 21.9 28.3 x 24.3 23.9 19.1 23.2 23.1 23.2 28.7 23.5 22.0 21.2 21.7 x 25.5 18.3 x 25.8 15.7 23.5 21.3 16.9 18.2 22.0 25.3 20.5 23.5 19.9 19.7 x 20.2 18.5 18.5 x 21.2 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10462 Original post publication description: Central nervous system, morphology: Brain weight [mg] None Central nervous system, morphology: Brain weight [mg] x x 477.4 401.4 458.0 426.6 544.9 x 424.8 434.9 429.0 438.4 417.7 444.4 453.1 435.6 418.0 425.4 392.2 x 458.2 414.1 x 408.1 391.9 358.0 395.4 371.7 361.2 402.2 446.0 429.2 413.5 410.0 409.3 x 415.6 396.6 429.7 x 454.5 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10463 Original post publication description: Morphology, immune system: Thymus to body size ratio [x10^3] None Morphology, immune system: Thymus to body size ratio [x10^3] x x x x 1.8 0.82 1.1 1.72 0.91 1.7 1.14 1.11 1.72 0.95 x 1.1 0.9 2.17 x 1.05 1.2 x x 1.12 x x x 1.25 1.16 1.82 1.22 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10464 Original post publication description: Immune function: T cell receptor expression, V-gamma-1 positive, V-gamma-4 positive, percentage of total gamma-delta intestinal intraepithelial lymphocytes [%] None Immune system, gastrointestinal system: Intestinal intraepithelial gamma-delta type T lymphocytes (i-IELs) in 2-6 month old adults based on receptor expression (V-gamma-1 positive, Vgamma-4 positive T cells) [%] x 8.0 3.0 6.0 14.75 1.5 3.25 4.75 4.25 6.25 2.25 10.75 8.75 7.5 2.25 2.75 8.75 1.5 x 2.75 3.75 10.75 x 3.25 19.25 1.5 2.25 8.75 9.0 4.25 4.25 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10465 Original post publication description: Immune function: T cell receptor expression, V-gamma-7 positive and V-gamma-4] positive percentage of total gamma-delta intestinal intraepithelial lymphocytes [%] None Immune system, gastrointestinal system: Intestinal intraepithelial gamma-delta type T lymphocytes (i-IELs) in 2-6 month old adults based on receptor expression (V-gamma-7 positive, Vgamma-4 positive T cells) [%] x 6.5 21.5 8.5 26.5 6.0 13.0 5.0 7.5 9.0 9.0 8.5 13.0 3.5 8.5 9.5 7.5 9.0 x 12.0 22.5 20.5 x 19.5 15.0 16.5 30.5 6.0 21.5 7.5 8.5 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10466 Original post publication description: Immune function: T cell receptor expression, V-gamma-7 positive, Vgamma-4 negative, percentage of total gamma-delta intestinal intraepithelial lymphocytes [%] None Immune system, gastrointestinal system: Intestinal intraepithelial gamma-delta type T lymphocytes (i-IELs) in 2-6 month old adults based on receptor expression (V-gamma-7 positive, Vgamma-4 negative T cells) from Fig 4 y-axis [%] x 31.0 40.5 31.0 24.0 49.5 21.0 17.5 57.0 27.5 36.5 27.5 43.0 38.0 52.5 34.0 26.0 58.5 x 22.0 26.0 41.0 x 34.0 24.0 29.5 31.5 43.0 27.5 31.5 22.5 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10467 Original post publication description: Immune function: T cell receptor expression, V-gamma-1 positive, V-gamma-4 negative, percentage of total gamma-delta intestinal intraepithelial lymphocytes [%] None Immune system, gastrointestinal system: Intestinal intraepithelial gamma-delta type T lymphocytes (i-IELs) in 2-6 month old adults based on receptor expression (V-gamma-1 positive, Vgamma-4 negative T cells) from Fig 4 x-axis [%] x 47.0 26.0 45.0 36.5 34.5 55.5 67.5 39.0 55.5 49.0 49.0 31.0 41.5 33.5 61.5 51.0 33.5 x 57.5 41.5 35.5 x 34.0 35.5 44.0 40.0 32.0 36.5 51.0 54.5 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10469 Original post publication description: Morphine response (0.3 to 0.7 mg/ml p.o.), consumption using two-bottle choice test [ml/test period] None Central nervous system, pharmacology, behavior: Morphine response (0.3 to 0.7 mg/ml p.o.), consumption using two-bottle choice test [ml/test period] x x 157.0 16.0 16.0 42.0 84.0 50.0 27.0 27.0 x 97.0 29.0 23.0 148.0 16.0 17.0 x x 19.0 96.0 19.0 x 99.0 52.0 71.0 49.0 97.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10470 Original post publication description: Quinine response, consumption using two-bottle choice test (quinine at 0.1 to 0.4 mg/ml) [ml/test period] None Central nervous system, gustatory system, behavior: Quinine response, consumption using two-bottle choice test (quinine at 0.1 to 0.4 mg/ml) [ml/test period] x x 36.0 24.0 32.0 12.0 135.0 20.0 13.0 10.0 x 11.0 17.0 17.0 62.0 5.0 27.0 x x 11.0 9.0 19.0 x 58.0 85.0 25.0 39.0 88.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10471 Original post publication description: Saccharin response, consumption using two-bottle choice test (concentration) [ml/test period] None Saccharin response, consumption using two-bottle choice test (concentration) [ml/test period] x x 806.5 383.0 352.0 459.5 1178.5 544.5 342.0 343.0 x 410.5 258.5 528.0 484.0 353.5 410.0 x x 332.5 261.5 417.5 x 442.5 453.5 365.0 472.0 536.5 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10472 Original post publication description: Saccharin response, preference using two-bottle choice test [ratio relative tap water] None Saccharin response, preference using two-bottle choice test [ratio relative tap water] x x 0.95 0.715 0.79 0.765 0.915 0.9 0.715 0.695 x 0.765 0.6675 0.805 0.86 0.77 0.765 x x 0.615 0.641 0.84 x 0.8965 0.717 0.7255 0.873 0.79 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10473 Original post publication description: Saccharin response, consumption using a two-bottle choice test (0.2%, mg/kg) vs. tap water, mean of day 2 and day 4 over a 4-day 24-hr access period [g/kg/day] None Central nervous system, gustatory system, behavior: Saccharin response, consumption using a two-bottle choice test (0.2%, mg/kg) vs. tap water, mean of day 2 and day 4 over a 4-day 24-hr access period [g/kg/day] x x 853.935 471.707 x 250.743 748.408 787.394 x 330.42 x 343.077 420.033 537.171 652.835 415.414 412.785 639.584 x 533.912 x 438.621 x 674.217 807.822 534.837 x 1071.04 x 591.661 572.167 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10474 Original post publication description: Ethanol response (3%, g/kg in tap water), consumption using a two-bottle choice test vs. tap water, mean of day 2 and day 4 of a 4-day 24-hr access period [g/kg/day] None Central nervous system, pharmacology, behavior: Ethanol response (3%, g/kg in tap water), consumption using a two-bottle choice test vs. tap water, mean of day 2 and day 4 of a 4-day 24-hr access period [g/kg/day] x x 3.538 0.279 x 2.052 1.669 2.086 x 0.981 x 2.765 0.438 0.906 3.578 2.218 0.951 2.975 x 0.967 x 1.64 x 0.614 1.741 2.159 x 2.795 x 2.658 0.819 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10475 Original post publication description: Ethanol response (3%, g/kg in 0.2% saccharin and tap water), consumption using a two-bottle choice test vs. tap water, mean of day 2 and day 4 of a 4-day 24-hr access period [g/kg/day] None Ethanol response (3%, g/kg in 0.2% saccharin and tap water), consumption using a two-bottle choice test vs. tap water, mean of day 2 and day 4 of a 4-day 24-hr access period [g/kg/day] x x 10.965 2.0 x 6.135 11.207 7.023 x 2.924 x 4.828 6.245 6.159 7.236 5.58 3.274 5.534 x 5.473 x 11.658 x 6.992 8.083 6.646 x 10.266 x 7.308 4.638 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10476 Original post publication description: Ethanol response (10%, g/kg in tap water), consumption using a two-bottle choice test offered vs. tap water, mean of day 2 and day 4 of a 4-day 24-hr access period [g/kg/day] None Central nervous system, pharmacology, behavior: Ethanol response (10%, g/kg in tap water), consumption using a two-bottle choice test offered vs. tap water, mean of day 2 and day 4 of a 4-day 24-hr access period [g/kg/day] x x 10.562 1.306 x 6.084 5.506 4.425 x 0.601 x 2.759 0.687 1.741 5.836 4.849 0.364 2.477 x 2.589 x 2.203 x 2.417 2.024 6.658 x 2.466 x 8.096 1.28 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10477 Original post publication description: Ethanol response (10%, g/kg in 0.2% saccharin and tap water), consumption using a two-bottle choice test offered vs. tap water, mean of day 2 and day 4 of a 4-day 24-hr access period [g/kg/day] None Central nervous system, pharmacology, behavior: Ethanol response (10%, g/kg in 0.2% saccharin and tap water), consumption using a two-bottle choice test offered vs. tap water, mean of day 2 and day 4 of a 4-day 24-hr access period [g/kg/day] x x 18.194 1.05 x 11.378 13.58 12.161 x 1.98 x 6.256 6.588 5.727 14.376 11.1 3.678 6.692 x 8.083 x 15.58 x 10.256 10.05 12.975 x 13.02 x 12.737 4.135 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10478 Original post publication description: Ethanol response, withdrawal severity, handling-induced convulsion (HIC) score [corrected area under the HIC curve after voluntary ethanol consumption] None Central nervous system, pharmacology, behavior: Ethanol response, withdrawal severity, handling-induced convulsion (HIC) score [corrected area under the HIC curve after voluntary ethanol consumption] x x 5.66 2.61 x 0.52 2.18 5.69 x 0.6 x 1.64 1.05 1.17 3.21 4.68 0.48 0.0 x 4.82 x 1.26 x 1.75 2.33 3.3 x 3.42 x 0.31 1.5 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10479 Original post publication description: Ethanol response (10%, g/kg in tap water), preference using a two-bottle choice test offered vs. tap water, mean of day 2 and day 4 of a 4-day 24-hr access period [ratio of consumption] None Central nervous system, pharmacology, behavior: Ethanol response (10%, g/kg in tap water), preference using a two-bottle choice test offered vs. tap water, mean of day 2 and day 4 of a 4-day 24-hr access period [ratio of consumption] x x 0.554 0.086 x 0.32 0.35 0.251 x 0.051 x 0.168 0.045 0.061 0.356 0.302 0.024 0.167 x 0.146 x 0.127 x 0.265 0.171 0.428 x 0.14 x 0.488 0.112 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10480 Original post publication description: Water response, consumption using a two-bottle choice test offered vs. 10% ethanol [ml] None Water response, consumption using a two-bottle choice test offered vs. 10% ethanol [ml] x x 4.82 2.25 x 4.65 3.54 3.75 x 4.23 x 3.06 4.64 6.82 3.55 4.13 4.95 4.65 x 4.45 x 4.54 x 2.35 3.63 3.05 x 5.55 x 2.36 5.25 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10481 Original post publication description: Water response, consumption using a two-bottle choice test offered vs. 0.2% saccharin [ml] None Water response, consumption using a two-bottle choice test offered vs. 0.2% saccharin [ml] x x 1.4 0.38 x 4.75 1.86 0.11 x 0.73 x 1.1 0.49 1.79 0.79 1.51 0.7 1.08 x 0.39 x 2.6 x 0.09 0.2 0.6 x 0.49 x 1.41 0.7 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10482 Original post publication description: Ethanol response (2 g/kg ip), difference in locomotion in saline control group between day 11 (first and only ethanol injection) and day 3 (saline treatment) 1- 5 min after injection [cm] None Central nervous system, pharmacology, behavior: Ethanol response (2 g/kg ip), acute locomotor activity response (horizontal distance), 1-5 min after injections, difference between day 2 saline control and day 11 ethanol injection (first and only ethanol injection) in young adult control saline (CS) females (ACCS) [cm] x x 546.0 973.0 -241.0 725.0 -208.0 -493.0 1185.0 358.0 921.0 387.0 662.0 813.0 -266.0 38.0 726.0 x x 1074.0 454.0 996.0 x 194.0 1242.0 837.0 529.0 309.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10483 Original post publication description: Ethanol response (2 g/kg ip), locomotor sensitization measured as difference between groups treated over 10 days with ip ethanol or saline to final acute ethanol test on day 11, 1-5 min after injection [cm] None Central nervous system, pharmacology, behavior: Ethanol response (2 g/kg ip), sensitization to ethanol, difference in locomotor activity between saline control group (CS) and ethanol treated group (CD) to final acute ethanol test on day 11 (deltaBG) [cm] x x -694.0 -134.0 -468.0 507.0 435.0 395.0 -558.0 663.0 456.0 -372.0 1226.0 275.0 176.0 1026.0 1065.0 x x 696.0 -62.0 758.0 x 935.0 430.0 388.0 677.0 356.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10484 Original post publication description: Ethanol response (2 g/kg ip), difference in locomotion (sensitization or habituation) in chronic ethanol group between day 11 (fifth treatment) and day 3 (saline treatment), 1 to 5 min after injection [cm] None Central nervous system, pharmacology, behavior: Ethanol response (2 g/kg ip), sensitization to ethanol (CD group), difference in locomotor activity between fifth ethanol treatment (day 11) and first ethanol treatment (day 3), 1- 5 min after injections in young adult females (Figure 2 of paper, deltaCD) [cm] x x -318.0 -725.0 -866.0 260.0 279.0 -51.0 -1013.0 1060.0 726.0 -297.0 644.0 -46.0 365.0 433.0 1119.0 x x 682.0 39.0 1125.0 x 899.0 252.0 402.0 586.0 192.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10485 Original post publication description: Ethanol response (2 g/kg ip), difference in acute locomotion, 1-5 min after injection in chronic ethanol-sensitized group [cm/test period] None Central nervous system, pharmacology, behavior: Ethanol response (2 g/kg ip), acute locomotor activity response (horizontal distance), 1-5 min after injection, difference between day 2 saline injection response and day 3 ethanol injection in young adult females (Figure 1 of paper, ACCD) [cm] x x 84.0 1521.0 268.0 843.0 -174.0 -36.0 1587.0 -162.0 924.0 504.0 976.0 1157.0 -204.0 649.0 675.0 x x 1026.0 163.0 644.0 x 45.0 1445.0 891.0 747.0 382.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10486 Original post publication description: Saline response (baseline), locomotor activity on day 2, 1 to 5 min after injection [cm] None Central nervous system, behavior: Acute locomotor baseline activity response (horizontal distance), 1-5 min after saline injection on day 2 in young adult females (BASACT in the CD group) [cm] x x 1447.0 1362.0 1661.0 1528.0 1086.0 1162.0 886.0 1845.0 573.0 1643.0 1175.0 1729.0 1171.0 1035.0 2014.0 x x 1411.0 949.0 1264.0 x 823.0 1360.0 1074.0 899.0 2146.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10487 Original post publication description: Saline response (vehicle ip), locomotion (baseline) on day 2 using Accuscan activity monitors, mean of all mice regardless of subsequent treatment [cm/15 min test] None Central nervous system, behavior: Saline control response (vehicle ip), locomotion (baseline) on day 2 using Accuscan activity monitors, mean all cases [cm/15 min test] x x 2826.82 2799.72 3664.41 2743.58 2678.95 2617.88 2099.21 4694.2 1362.02 3449.32 2847.36 3622.44 3085.52 1983.13 4519.18 3043.59 x 2886.95 2093.05 2820.62 x 1630.07 2906.81 2545.33 1674.5 5521.39 3115.33 2654.05 3486.72 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10488 Original post publication description: Cocaine response (10 mg/kg ip), difference in locomotion using Accuscan activity monitor between day 3 (first cocaine treatment) and day 2 (saline ip baseline) [cm/15 min] None Cocaine response (10 mg/kg ip), difference in locomotion using Accuscan activity monitor between day 3 (first cocaine treatment) and day 2 (saline ip baseline) [cm/15 min] x x 2961.25 3386.93 8506.82 4132.17 3241.0 3306.25 3463.42 5637.17 1755.69 7339.0 3957.9 3418.67 3078.09 99.667 5716.33 7159.5 x 5805.08 5342.25 5091.12 x 1101.55 4192.42 4569.42 2988.67 3540.61 5187.23 4367.27 5093.09 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10489 Original post publication description: Cocaine response (40 mg/kg ip), difference in locomotion using Accuscan activity monitor between day 3 (first cocaine treatment) and day 2 (saline ip baseline) [cm/15 min] None Cocaine response (40 mg/kg ip), difference in locomotion using Accuscan activity monitor between day 3 (first cocaine treatment) and day 2 (saline ip baseline) [cm/15 min] x x 12932.8 12608.9 15426.9 14007.7 4837.0 12578.4 8107.42 13238.8 7105.69 10082.5 7614.1 8616.09 6817.5 5307.42 12385.7 14297.8 x 10363.3 12060.9 13099.3 x 2832.9 7053.0 14651.7 10958.5 11884.2 8294.15 15252.9 10339.9 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10490 Original post publication description: Cocaine response (10 mg/kg ip), sensitization of locomotion following 5 daily injections, difference between day 11 (fifth treatment) and day 3 (first treatment) [cm/15 min] None Cocaine response (10 mg/kg ip), sensitization of locomotion following 5 daily injections, difference between day 11 (fifth treatment) and day 3 (first treatment) [cm/15 min] x x 3823.0 4570.71 6091.36 2503.73 3704.73 6180.0 2812.92 4479.33 1517.23 1760.83 4708.0 3883.5 3864.5 893.083 3789.0 8423.75 x 5866.08 4600.0 2285.5 x 2925.82 4008.58 5286.58 4198.75 -1518.92 2158.0 3725.27 4234.82 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10491 Original post publication description: Cocaine response (40 mg/kg ip), sensitization of locomotion following 5 daily injections, difference between day 11 (fifth treatment) and day 3 (first treatment) [cm/15 min] None Cocaine response (40 mg/kg ip), sensitization of locomotion following 5 daily injections, difference between day 11 (fifth treatment) and day 3 (first treatment) [cm/15 min] x x -1069.33 1470.4 5966.54 -2287.75 4268.08 1017.15 3505.17 2721.33 872.615 -4245.61 7010.8 993.364 471.5 3670.33 3281.25 5300.33 x 3580.83 -2874.44 2053.14 x 4624.7 -2123.3 -3130.7 2830.69 -283.833 4110.54 2393.42 3420.25 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10492 Original post publication description: Cocaine response (5 mg/kg ip), sensitization of locomotion following 5 daily injections, difference between day 11 (fifth treatment) and day 3 (first treatment) [cm/15 min] None Cocaine response (5 mg/kg ip), sensitization of locomotion following 5 daily injections, difference between day 11 (fifth treatment) and day 3 (first treatment) [cm/15 min] x x 3395.42 3456.86 3015.25 1590.0 1287.44 1901.92 1616.5 3988.67 1729.25 1232.5 2971.5 1963.64 644.25 1597.23 630.455 3115.23 x 1851.83 1931.12 3096.71 x 1753.18 2246.25 4200.31 3825.54 1217.45 3591.33 1692.82 4256.78 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10493 Original post publication description: Cocaine response (5 mg/kg ip), difference in locomotion using Accuscan activity monitor between day 3 (first cocaine treatment) and day 2 (saline ip baseline) [cm/15 min] None Cocaine response (5 mg/kg ip), difference in locomotion using Accuscan activity monitor between day 3 (first cocaine treatment) and day 2 (saline ip baseline) [cm/15 min] x x 1297.67 2004.0 2726.25 2301.0 412.6 4.692 1229.42 3147.42 -468.417 1689.25 1944.4 2009.08 916.25 52.385 3776.46 2880.23 x 2212.25 745.5 1521.43 x -139.818 1853.67 141.385 1411.23 571.364 1223.25 1440.36 317.6 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10494 Original post publication description: Ethanol response (2 g/kg ip), difference in locomotion using grid test (Accuscan activity monitor) following ethanol injection, day 3 (first treatment) minus day 2 (saline baseline) in the chronic ethanol group [beam breaks/10 min test] None Central nervous system, pharmacology, behavior: Ethanol response (2 g/kg ip), difference in locomotion using grid test (Accuscan activity monitor) following ethanol injection, day 3 (first treatment) minus day 2 (saline baseline) in the chronic ethanol group [beam breaks/10 min test] x x -18.0 151.0 96.0 350.0 -227.0 -401.0 88.0 x 188.0 -128.0 353.0 79.0 78.0 -67.0 269.0 541.0 x 562.0 -117.0 -37.0 x -44.0 241.0 608.0 -23.0 58.0 947.0 -142.0 -345.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10495 Original post publication description: Ethanol response (2 g/kg ip), difference in locomotion between day 11 (first and only ethanol treatment) and day 2 (saline baseline) in the chronic saline group [n beam breaks/10 min test] None Ethanol response (2 g/kg ip), difference in locomotion between day 11 (first and only ethanol treatment) and day 2 (saline baseline) in the chronic saline group [n beam breaks/10 min test] x x -105.0 272.0 68.0 304.0 -426.0 -443.0 170.0 x 262.0 33.0 524.0 -68.0 3.0 -214.0 213.0 780.0 x 428.0 8.0 -23.0 x 79.0 247.0 687.0 -30.0 538.0 979.0 -13.0 -379.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10496 Original post publication description: Ethanol response (2 g/kg ip), difference in locomotion using grid test (Accuscan activity monitor) after repeated treatment, day 11 (fifth treatment) minus day 3 (first treatment) in the chronic ethanol group [beam breaks/10 min test] None Central nervous system, pharmacology, behavior: Ethanol response (2 g/kg ip), difference in locomotion using grid test (Accuscan activity monitor) after repeated treatment, day 11 (fifth treatment) minus day 3 (first treatment) in the chronic ethanol group [beam breaks/10 min test] x x 20.0 265.0 164.0 -238.0 254.0 214.0 121.0 x 395.0 201.0 516.0 119.0 210.0 386.0 482.0 234.0 x 136.0 234.0 360.0 x 98.0 548.0 -140.0 428.0 982.0 261.0 205.0 466.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10497 Original post publication description: Ethanol response (2 g/kg ip), acute ataxia, difference between day 3 (first ethanol treatment) and day 2 (saline baseline) in the chronic drug group [n grid test errors/10 min test] None Central nervous system, pharmacology, behavior: Ethanol response (2 g/kg ip), acute ataxia, difference between day 3 (first ethanol treatment) and day 2 (saline baseline) in the chronic drug group [n grid test errors/10 min test] x x 114.0 123.0 135.0 187.0 86.0 103.0 143.0 x 129.0 154.0 191.0 165.0 138.0 227.0 320.0 289.0 x 186.0 108.0 165.0 x 132.0 151.0 185.0 152.0 298.0 159.0 164.0 109.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10498 Original post publication description: Ethanol response (2 g/kg ip), acute ataxia measured using using grid test (Accuscan activity monitor), difference between day 11 (first and only ethanol treatment) and day 2 (saline baseline) in the chronic saline group [n errors/activity counts/10 min test] None Ethanol response (2 g/kg ip), acute ataxia measured using using grid test (Accuscan activity monitor), difference between day 11 (first and only ethanol treatment) and day 2 (saline baseline) in the chronic saline group [n errors/activity counts/10 min test] x x 116.0 168.0 150.0 199.0 91.0 111.0 201.0 x 153.0 140.0 230.0 210.0 129.0 195.0 287.0 351.0 x 175.0 110.0 185.0 x 106.0 172.0 256.0 130.0 337.0 212.0 171.0 107.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10499 Original post publication description: Ethanol response (2 g/kg ip), difference in missteps using grid test (Accuscan activity monitor) after repeated treatment, day 11 (fifth treatment) minus day 3 (first treatment) in the chronic ethanol group [n/10 min test] None Central nervous system, pharmacology, behavior: Ethanol response (2 g/kg ip), intoxication and adaptation measured as difference in missteps using grid test (Accuscan activity monitor) after repeated treatment, day 11 (fifth treatment) minus day 3 (first treatment) in the chronic ethanol group [n/10 min test] x x -33.0 -40.0 33.0 -83.0 -13.0 -14.0 -18.0 x -43.0 -40.0 64.0 -5.0 -13.0 -30.0 83.0 -34.0 x -33.0 -10.0 -8.0 x -69.0 -7.0 4.0 66.0 -63.0 -57.0 -24.0 47.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10500 Original post publication description: Ethanol response (2 g/kg ip), difference in ataxia using grid test (Accuscan activity monitor) between acute ethanol on day 3 (first ethanol treatment) and day 2 (saline baseline) in the chronic ethanol group [n errors/activity counts/10 min test] None Ethanol response (2 g/kg ip), difference in ataxia using grid test (Accuscan activity monitor) between acute ethanol on day 3 (first ethanol treatment) and day 2 (saline baseline) in the chronic ethanol group [n errors/activity counts/10 min test] x x 17.6 11.4 14.8 20.8 18.1 25.2 18.5 x 14.9 17.6 18.0 19.7 17.7 47.6 26.4 22.9 x 14.5 19.8 26.3 x 33.7 14.0 14.3 24.4 16.9 9.0 29.9 24.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10501 Original post publication description: Ethanol response (2 g/kg ip), difference in ataxia using grid test (Accuscan activity monitor) between injection on day 11 (first and only ethanol treatment) and day 2 (saline baseline) in the chronic saline group [errors/activity counts/10 min test] None Ethanol response (2 g/kg ip), difference in ataxia using grid test (Accuscan activity monitor) between injection on day 11 (first and only ethanol treatment) and day 2 (saline baseline) in the chronic saline group [errors/activity counts/10 min test] x x 15.9 14.7 14.3 19.9 26.0 27.5 22.7 x 18.2 15.1 18.1 26.0 17.5 47.5 24.5 24.5 x 16.1 17.4 27.3 x 27.1 17.9 18.5 22.1 17.6 11.1 32.7 22.9 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10502 Original post publication description: Ethanol response, change in ataxic effects of 2 g/kg (ip) after repeated treatment, difference between day 11 (fifth treatment) minus day 3 (first treatment) in the chronic drug (CD) group, 10 min test [grid test inside accuscan activity monitors] None Ethanol response, change in ataxic effects of 2 g/kg (ip) after repeated treatment, difference between day 11 (fifth treatment) minus day 3 (first treatment) in the chronic drug (CD) group, 10 min test [grid test inside accuscan activity monitors] x x -6.9 -5.1 0.3 -8.0 -6.8 -11.2 -2.8 x -8.0 -8.2 -1.3 -5.4 -5.3 -23.5 -0.6 -5.3 x -3.8 -8.4 -10.2 x -22.3 -5.8 0.8 -2.7 -8.6 -4.6 -12.4 -7.5 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10503 Original post publication description: Saline response (vehicle ip control), baseline locomotor activity using grid test on day 2 after injection [n beam breaks/10 min test] None Saline response (vehicle ip control), baseline locomotor activity using grid test on day 2 after injection [n beam breaks/10 min test] x x 825.0 877.0 975.0 795.0 756.0 873.0 705.0 x 641.0 1040.0 725.0 971.0 766.0 621.0 967.0 762.0 x 721.0 700.0 790.0 x 510.0 813.0 762.0 645.0 1596.0 814.0 693.0 887.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10504 Original post publication description: Audiogenic seizure susceptibility at 21 days [severity of seizure] None Audiogenic seizure susceptibility at 21 days [severity of seizure] x x 0.25 2.75 0.25 2.25 2.25 0.25 1.75 2.75 1.25 0.25 0.25 0.25 2.75 0.25 x 1.25 x 2.75 x 1.25 x 1.25 0.25 1.75 1.25 0.25 0.25 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10505 Original post publication description: Open-field activity following saline injection [number of crossings during 3 min] None Central nervous system, behavior: Open-field activity following saline injection [number of crossings during 3 min] x x 160.0 140.0 180.0 180.0 190.0 160.0 120.0 x 80.0 140.0 120.0 160.0 100.0 160.0 140.0 160.0 x 180.0 x 160.0 x 120.0 x 140.0 80.0 180.0 100.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10506 Original post publication description: Seizure susceptibility to high atmospheric pressure at 100 atmospheres [measured at atm which seizure occurred] None Central nervous system, behavior: Seizure susceptibility to high atmospheric pressure at 100 atmospheres [atm of seizure initiation] x x 89.0 71.0 89.0 89.0 71.0 x 83.0 83.0 74.0 77.0 x 83.0 83.0 71.0 89.0 86.0 83.0 89.0 x 83.0 x 74.0 77.0 74.0 83.0 89.0 74.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10507 Original post publication description: Seizure susceptibility to high atmospheric pressure at 1000 atmospheres [measured at atm which seizure occurred] None Central nervous system, behavior: Seizure susceptibility to high atmospheric pressure at 1000 atmospheres [measured at atm which seizure occurred] x x 78.0 63.0 66.0 81.0 66.0 x 78.0 66.0 66.0 66.0 x 69.0 78.0 66.0 72.0 78.0 78.0 78.0 x 81.0 x 66.0 63.0 66.0 72.0 78.0 66.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10508 Original post publication description: Immune function: V beta 3+ T cells in lymph nodes [%] None Immune system: V beta 3+ T cells in lymph nodes [%] x x 3.3 0.1 1.5 2.7 1.9 4.9 1.0 1.8 0.1 0.6 4.0 2.7 1.3 0.3 1.3 1.4 x 1.4 1.4 1.0 x 0.1 0.2 0.1 1.6 0.7 0.2 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10509 Original post publication description: Antinociceptive responsive, nitrous oxide antinociception in the acetic acid writhing (abdominal constriction) test [%] None Central and peripheral nervous system, behavior: Antinociceptive responsive (pain analgesia), nitrous oxide antinociception in the acetic acid writhing (abdominal constriction) test [%] x x 77.0 27.0 87.0 70.0 94.0 x 37.0 80.0 40.0 85.0 60.0 100.0 80.0 74.0 x 30.0 x 31.0 96.0 x x 89.0 100.0 10.0 90.0 70.0 24.0 90.0 70.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10510 Original post publication description: Body temperature postinjection (120 min) with 4 g/kg of ethanol in males [degrees C] None Central nervous system, pharmacology, metabolism: Ethanol response (4 g/kg ip), body temperature 120 min after injection in males [degrees C] x x 34.7 33.5 x 33.8 x 33.9 34.8 34.8 35.4 33.6 34.2 33.2 34.2 34.8 34.4 34.1 x 34.4 x 34.0 x x x x x 35.1 x 34.5 34.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10511 Original post publication description: Blood glucose levels preinjection with 4g/kg of ethanol in females [mg/dl] None Central nervous system, pharmacology, metabolism: Blood glucose levels before 4 g/kg ip ethanol injection in females [mg/dl] x x 103.8 88.3 x 88.0 x 99.0 100.3 x 102.0 80.0 100.0 95.3 85.8 77.9 86.1 85.3 x 104.2 x x x x x 100.6 x 100.1 87.2 x 89.4 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10512 Original post publication description: Blood glucose levels preinjection with 4g/kg of ethanol in males [mg/dl] None Central nervous system, pharmacology, metabolism: Blood glucose levels before 4 g/kg ip ethanol injection in males [mg/dl] x x 122.7 98.3 x 87.8 x 112.1 108.5 113.2 109.5 86.0 106.2 111.6 81.3 89.7 84.3 89.6 x 121.5 x 95.0 x x x x x 105.2 x 112.7 87.8 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10513 Original post publication description: Blood glucose levels postinjection (120 min) with 4g/kg of ethanol in females [mg/dl] None Central nervous system, pharmacology, metabolism: Ethanol response (4 g/kg ip), blood glucose levels 120 min after injection in females [mg/dl] x x 163.0 117.8 x 127.7 x 137.0 138.6 x 105.2 125.9 113.0 120.3 76.2 109.3 106.7 111.3 x 127.7 x x x x x 113.0 x 132.0 95.2 x 110.1 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10514 Original post publication description: Blood glucose levels postinjection (120 min) with 4g/kg of ethanol in males [mg/dl] None Central nervous system, pharmacology, metabolism: Ethanol response (4 g/kg ip), blood glucose levels 120 min after injection in males [mg/dl] x x 234.2 152.5 x 166.6 x 155.0 187.0 184.7 138.2 118.4 130.2 138.3 119.0 137.0 111.1 151.4 x 231.9 x 149.0 x x x x x 188.6 x 182.2 140.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10515 Original post publication description: Blood glucose levels preinjection with saline in females [mg/dl] None Central nervous system, pharmacology, metabolism: Blood glucose levels before saline ip control injection in females [mg/dl] x x 105.4 90.0 x 93.4 x 94.2 102.7 x 100.0 87.1 87.7 70.3 81.6 77.8 83.5 82.2 x 98.4 x x x x x 95.8 x 102.1 x x 86.5 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10516 Original post publication description: Blood glucose levels preinjection with saline in males [mg/dl] None Central nervous system, pharmacology, metabolism: Blood glucose levels before saline ip control injection in males [mg/dl] x x 117.8 104.0 x 95.6 x 113.2 120.0 107.5 102.2 87.5 114.0 109.6 77.7 92.6 86.0 90.2 x 125.6 x 101.7 x x x x x 105.5 x x 86.1 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10517 Original post publication description: Blood glucose levels postinjection (120 min) with saline in females [mg/dl] None Central nervous system, pharmacology, metabolism: Saline control response (saline ip), blood glucose levels 120 min after injection in females [mg/dl] x x 119.6 99.3 x 102.4 x 103.9 114.7 x 109.3 101.8 109.3 106.3 71.6 82.1 92.6 99.2 x 112.6 x x x x x 114.6 x 104.0 x x 93.9 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10518 Original post publication description: Blood glucose levels postinjection (120 min) with saline in males [mg/dl] None Central nervous system, pharmacology, metabolism: Saline control response (saline ip), blood glucose levels 120 min after injection in males [mg/dl] x x 140.8 117.2 x 121.6 x 130.4 145.0 120.7 130.0 103.4 118.0 104.3 86.1 90.3 90.0 108.5 x 154.0 x 143.0 x x x x x 111.2 x x 101.6 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10519 Original post publication description: Body temperature, baseline level before injection with 4 g/kg of ethanol in females [degrees C] None Central nervous system, pharmacology, metabolism: Body temperature baseline control before injection with ethanol (4 g/kg ip) in females [degrees C] x x 37.4 37.7 x 37.7 x 37.4 37.4 x 37.5 37.8 37.4 37.4 37.1 36.9 37.3 37.2 x 37.8 x x x x x 37.9 x 37.7 37.2 37.3 37.1 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10520 Original post publication description: Metabolism: Body temperature, control baseline before injection with 4 g/kg of ethanol in males [degrees C] None Central nervous system, pharmacology, metabolism: Body temperature baseline control before injection with ethanol (4 g/kg ip) in males [degrees C] x x 37.3 37.4 x 37.4 x 36.9 36.9 37.6 37.7 37.1 37.0 37.0 36.0 36.9 36.7 37.0 x 37.5 x 36.9 x x x x x 37.8 x 37.5 37.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10521 Original post publication description: Ethanol response (4 g/kg), body temperature 120 min after injection in females [degrees C] None Central nervous system, pharmacology, metabolism: Ethanol response (4 g/kg ip), body temperature 120 min after injection in females [degrees C] x x 34.4 33.8 x 34.1 x 34.1 35.1 x 36.1 33.1 35.4 34.1 34.1 35.2 34.7 34.2 x 34.9 x x x x x 35.6 x 34.9 35.4 34.9 33.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10522 Original post publication description: Body temperature preinjection with saline in females [degrees C] None Central nervous system, pharmacology, metabolism: Body temperature baseline control before saline injection in females [degrees C] x x 37.4 37.7 x 37.7 x 37.1 37.3 x 37.9 37.9 37.5 37.4 37.0 36.9 37.3 37.1 x 37.4 x x x x x 37.8 x 37.5 37.0 37.5 37.5 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10563 Original post publication description: Locomotor activity after 0.25 mg/kg of paraoxon from 16-20 min [activity counts/min] None Central nervous system, pharmacology, behavior: Paraoxon organophosphate (OP) acetylcholinesterase inhibitor response (0.25 mg/kg ip), locomotor activity 16-20 min after injection [activity counts/min] x x 17.6 3.8 10.7 29.7 4.9 25.7 18.6 x 10.6 15.6 2.5 21.1 7.6 6.8 20.9 8.4 x 10.9 x x x 0.8 17.2 16.5 6.4 15.0 21.1 3.7 2.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10564 Original post publication description: Locomotor activity after 10 ml/kg of oil from 16-20 min [activity counts/min] None Central nervous system, pharmacology, behavior: Control response (10 mg/kg oil vehicle), locomotor activity 16-20 min after injection [activity counts/min] x x 42.7 42.8 53.2 22.4 19.4 36.4 31.7 x 29.6 33.6 29.3 37.6 26.7 18.9 29.3 33.8 x 36.4 x x x 17.5 32.5 29.4 20.9 42.5 23.3 30.9 36.2 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10565 Original post publication description: Locomotor activity after 0.25 mg/kg of paraoxon from 21-25 min [activity counts/min] None Central nervous system, pharmacology, behavior: Paraoxon organophosphate (OP) acetylcholinesterase inhibitor response (0.25 mg/kg ip), locomotor activity 21-25 min after injection [activity counts/min] x x 12.9 3.8 4.2 37.6 6.2 25.3 15.2 x 8.1 13.1 2.5 15.2 4.3 10.1 13.0 9.8 x 8.7 x x x 1.7 12.2 16.3 4.4 16.3 13.3 2.9 1.9 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10566 Original post publication description: Locomotor activity after 10 ml/kg of oil from 21-25 min [activity counts/min] None Central nervous system, pharmacology, behavior: Control response (10 mg/kg oil vehicle), locomotor activity 21-25 min after injection [activity counts/min] x x 36.7 41.4 37.6 26.2 19.0 37.5 31.2 x 31.8 30.4 20.8 38.7 19.1 27.6 24.0 32.6 x 33.8 x x x 26.0 35.1 24.8 15.7 38.7 25.4 31.0 35.5 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10567 Original post publication description: Locomotor activity after 0.25 mg/kg of paraoxon from 26-30 min [activity counts/min] None Central nervous system, pharmacology, behavior: Paraoxon organophosphate (OP) acetylcholinesterase inhibitor response (0.25 mg/kg ip), locomotor activity 26-30 min after injection [activity counts/min] x x 16.2 3.2 2.6 30.6 5.3 27.0 16.4 x 8.4 5.6 0.7 17.2 5.0 7.7 24.0 6.6 x 6.9 x x x 3.5 13.1 19.1 6.9 17.9 12.1 3.6 2.3 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10568 Original post publication description: Locomotor activity after 10 ml/kg of oil from 26-30 min [activity counts/min] None Central nervous system, pharmacology, behavior: Control response (10 mg/kg oil vehicle), locomotor activity 26-30 min after injection [activity counts/min] x x 38.3 34.8 38.2 30.6 29.8 36.6 32.1 x 27.6 29.1 17.0 41.2 25.6 17.7 23.6 40.4 x 27.2 x x x 11.0 28.4 21.2 17.4 33.8 23.5 25.8 33.2 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10569 Original post publication description: Locomotor activity after 0.25 mg/kg of paraoxon in first 15 min of 30 min activity test [activity counts/min] None Central nervous system, pharmacology, behavior: Paraoxon organophosphate (OP) acetylcholinesterase inhibitor response (0.25 mg/kg ip), locomotor activity from 0-15 min after injection [activity counts/min] x x 43.1 25.3 48.1 52.8 23.6 53.0 32.6 x 21.8 29.3 21.7 50.8 28.6 22.4 43.7 37.6 x 25.1 x x x 18.2 35.7 36.8 19.5 57.9 34.7 27.3 22.6 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10570 Original post publication description: Locomotor activity after 10 ml/kg of oil in first 15 min of 30 min activity test [activity counts/min] None Central nervous system, pharmacology, behavior: Control response (10 mg/kg oil vehicle), locomotor activity from 0-15 min after injection [activity counts/min] x x 54.1 53.8 26.3 40.4 31.4 68.7 41.6 x 32.2 49.9 41.8 60.0 39.6 42.5 52.7 53.9 x 49.8 x x x 32.2 50.6 41.5 30.4 73.7 38.6 44.3 48.8 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10571 Original post publication description: Locomotor activity after 0.25 mg/kg of paraoxon in last 15 min of 30 min activity test [activity counts/min] None Central nervous system, pharmacology, behavior: Paraoxon organophosphate (OP) acetylcholinesterase inhibitor response (0.25 mg/kg ip), locomotor activity from 15-30 min after injection [activity counts/min] x x 16.3 4.3 6.3 33.5 5.7 26.0 17.6 x 9.5 11.4 2.5 18.9 6.3 8.5 19.5 8.4 x 9.4 x x x 2.5 14.5 17.3 6.2 16.4 15.5 3.7 2.26 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10572 Original post publication description: Locomotor activity after after 10 ml/kg of oil in last 15 min of 30 min activity test [activity counts/min] None Central nervous system, pharmacology, behavior: Control response (10 mg/kg oil vehicle), locomotor activity from 15-30 min after injection [activity counts/min] x x 40.0 40.8 43.6 26.0 23.7 37.4 32.4 x 30.4 31.0 22.3 39.5 24.7 21.4 26.4 26.1 x 32.9 x x x 18.2 32.7 25.3 18.3 38.4 24.6 29.7 35.7 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10573 Original post publication description: Ethanol response (4/g/kg ip), plasma corticosterone concentration 1 hr after injection [ug/dl] None Ethanol response (4/g/kg ip), plasma corticosterone concentration 1 hr after injection [ug/dl] x x 16.21 20.29 17.42 16.89 22.63 12.53 13.97 28.12 x 24.68 17.17 23.09 16.11 27.64 20.39 x x 16.41 20.13 x x 22.82 15.07 24.24 24.03 16.34 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10574 Original post publication description: Corticosterone plasma concentration 1 hr after saline injection [ug/dl] None Corticosterone plasma concentration 1 hr after saline injection [ug/dl] x x 4.36 4.07 4.35 8.28 3.99 8.59 15.19 5.07 x 5.64 2.47 6.14 6.04 7.54 1.09 x x 5.66 4.22 x x 6.95 11.34 11.86 7.77 2.88 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10575 Original post publication description: Ethanol response (4 g/kg ip), plasma corticosterone concentration 6 hr after injection [ug/dl] None Endocrinology, hematology, pharmacology: Ethanol response (4 g/kg ip), plasma corticosterone concentration 6 hr after injection [ug/dl] x x 7.0 10.5 7.5 x 10.0 10.0 6.0 12.0 3.5 10.5 x 7.5 8.0 7.5 7.5 5.0 x 6.0 x x x 10.5 3.0 4.5 7.5 10.0 7.5 4.0 4.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10576 Original post publication description: Saline response (vehicle ip), plasma corticosterone concentration 6 hr after injection [ug/dl] None Endocrinology, pharmacology: Plasma corticosterone concentration 6 hr after saline control injection (ip) [ug/dl] x x 1.0 7.5 1.0 x 6.0 2.5 2.0 3.5 3.0 2.0 x 5.5 4.5 3.5 6.0 2.0 x 2.5 x x x 3.5 2.5 4.0 3.0 1.5 5.0 4.0 4.5 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10577 Original post publication description: Ethanol response (4 g/kg ip), corticosterone plasma level 7 hr after injection [ug/dl] None Central nervous system, pharmacology, endocrinology: Ethanol response (4 g/kg ip), corticosterone plasma level 7 hr after injection [ug/dl] x x 7.0 12.0 4.0 10.0 12.0 12.5 5.0 13.0 10.0 9.5 6.0 6.0 9.0 7.0 5.5 4.0 x 8.0 9.5 x x 15.0 x 24.5 8.0 15.5 16.0 8.5 13.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10578 Original post publication description: Ethanol response (4 g/kg ip), handling-induced convulsion (HIC) score 7 hr after injection None Central nervous system, pharmacology, behavior: Ethanol response (4 g/kg ip), handling-induced convulsion (HIC) score 7 hr after injection x x 0.2 3.0 0.8 2.4 0.9 0.0 0.9 2.0 0.7 0.4 1.8 1.4 0.9 0.4 0.3 0.0 x 0.9 0.8 x x 0.0 x 1.2 0.8 0.1 2.3 0.0 1.8 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10579 Original post publication description: Ethanol response (4 g/kg ip), corticosterone plasma level 6 hr after injection in females (unpublished means from Roberts et al. 1995, Behav Neurosci 109:1199) [ug/dl] None Ethanol response (4 g/kg ip), corticosterone plasma level 6 hr after injection in females (unpublished means from Roberts et al. 1995, Behav Neurosci 109:1199) [ug/dl] x x 5.0 9.0 4.0 9.0 14.0 8.0 4.0 10.0 5.0 22.0 18.0 12.0 17.0 7.0 20.0 13.0 x 13.0 9.0 16.0 x 12.0 8.0 21.0 16.0 12.0 18.0 10.0 16.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10580 Original post publication description: Ethanol response [4/g/kg ip], plasma corticosterone concentration 6 hr after injection in males (unpublished data from Roberts, Phillips, Belknap, Finn, Keith 1995, Behavioral Neurosci 109:1199-1208) [ug/dl] None Central nervous system, pharmacology, endocrinology: Ethanol response [4/g/kg ip], plasma corticosterone concentration 6 hr after injection in males (unpublished data from Roberts, Phillips, Belknap, Finn, Keith 1995, Behavioral Neurosci 109:1199-1208) [ug/dl] x x x x x 16.4 15.3 13.9 4.5 x 4.7 21.9 17.7 16.5 17.7 15.3 20.0 x x 13.3 12.8 16.1 x 14.8 8.6 21.5 16.3 11.8 18.1 9.5 15.7 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10581 Original post publication description: Ethanol response (10% in water po), acceptance, total consumption over 24 hr for females [g/kg] None Central nervous system, pharmacology, behavior: Ethanol response (10% in water po), acceptance, total consumption over 24 hr for females [g/kg] x x 20.21 9.18 15.99 15.76 19.37 17.07 12.32 11.03 18.78 16.25 14.88 18.6 x 21.47 13.51 x x 21.97 15.52 x x 10.85 12.45 10.88 9.63 15.71 x 18.19 10.39 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10582 Original post publication description: Ethanol response (10% in water po), acceptance, total consumption over 24 hr for males [g/kg] None Central nervous system, pharmacology, behavior: Ethanol response (10% in water po), acceptance, total consumption over 24 hr for males [g/kg] x x 16.84 10.22 16.1 14.96 15.26 13.48 11.46 7.73 16.78 14.43 10.03 10.35 x 14.77 7.08 x x 16.47 14.66 x x 5.12 11.71 12.06 11.73 15.57 x 15.58 12.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10583 Original post publication description: Ethanol response (10% in water po), preference for alcohol for females [g/kg] None Central nervous system, pharmacology, behavior: Ethanol response (10% in water po), preference for alcohol for females [g/kg] x x 16.92 2.64 5.56 6.51 4.59 8.03 4.28 3.33 4.98 4.81 2.4 3.2 x 9.61 4.06 x x 4.7 4.29 x x 3.15 7.95 8.39 6.63 3.91 x 10.49 2.19 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10584 Original post publication description: Ethanol response (10% v/v in water), preference of females using 2-bottle choice [g/kg] None Central nervous system, pharmacology, behavior: Ethanol response (10% v/v in water), preference of females using 2-bottle choice [g/kg] x x 12.84 2.07 3.32 3.65 3.68 4.69 4.98 2.64 5.05 5.2 2.03 2.15 x 4.08 2.18 x x 4.57 3.73 x x 2.34 7.25 6.37 6.84 5.06 x 8.04 2.32 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10585 Original post publication description: Ethanol response (dose ip), hypnotic dose sensitivity (HDS), sleep time for females [min] None Ethanol response (dose ip), hypnotic dose sensitivity (HDS), sleep time for females [min] x x 103.83 116.46 109.89 121.93 17.96 112.66 125.27 97.84 107.41 159.76 91.98 119.62 x 104.52 x x x 100.89 132.81 x x 110.6 115.38 111.68 116.27 119.97 x 146.8 141.16 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10586 Original post publication description: Ethanol response (4.1 g/kg ip), high dose sensitivity, duration of loss of righting reflex of males [min] None Central nervous system, pharmacology, behavior: Ethanol response (4.1 g/kg ip), high dose sensitivity, duration of loss of righting reflex of males [min] x x 118.43 108.61 116.96 142.79 150.8 136.34 126.14 109.79 109.32 157.56 125.0 105.96 x 140.48 x x x 103.54 153.76 x x 129.67 145.67 128.02 109.74 128.2 x 141.96 154.62 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10587 Original post publication description: Ethanol response (10% in water po), acceptance and consumption of 10% ethanol in 24 hours after 24 hours of water deprivation [g/kg] None Central nervous system, pharmacology, behavior: Ethanol response (10% v/v in water), acceptance of ethanol under thirst motivation in a single-bottle (no choice) test following 24 hr water deprivation, total 24 hr ethanol intake [g/kg] x x 18.48 9.71 16.05 15.41 17.43 15.37 11.86 9.38 17.67 15.34 12.45 14.48 x 18.12 10.3 x x 19.08 15.11 x x 7.98 12.1 11.47 10.68 15.64 x 16.88 11.24 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10588 Original post publication description: Ethanol response (10% in water po), preference and consumption of 10% ethanol vs. water over 15 days [g/kg] None Central nervous system, pharmacology, behavior: Ethanol response (10% in water po), preference and consumption of 10% ethanol vs. water over 15 days [g/kg] x x 14.83 2.35 4.44 5.08 4.13 6.36 4.67 2.98 5.02 5.0 2.22 2.7 x 6.54 3.07 x x 4.64 4.01 x x 2.72 7.6 7.83 6.73 4.49 x 9.27 2.25 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10589 Original post publication description: Ethanol response (4.1 g/kg ip), high dose sensitivity, duration of loss of righting reflex [min] None Ethanol response (4.1 g/kg ip), high dose sensitivity, duration of loss of righting reflex [min] x x 112.1 112.41 113.21 132.36 139.98 124.5 125.7 103.5 108.37 158.71 110.55 112.39 x 118.9 x x x 102.21 144.6 x x 120.13 127.85 119.85 113.0 124.08 x 144.54 148.24 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10590 Original post publication description: Vascular endothelial growth factor (VEGF)-induced angiogenesis None Cardiovascular system: Vascular endothelial growth factor (VEGF)-induced angiogenesis measured using corneal micropocket neovascularization assay [mm2] x 1.1 0.8 1.4 0.87 x 0.92 0.94 0.62 0.86 1.29 0.71 1.04 0.91 0.96 2.22 x 1.04 0.77 1.35 0.65 x x 1.34 0.96 x 1.35 1.07 1.06 0.67 0.98 0.32 1.28 0.82 x 1.48 1.01 1.07 0.85 x 1.3 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10591 Original post publication description: Infectious disease, immune function: Murine cytomegalovirus (MCMV) titer in spleen 4 days after infection with 5X10^4 PFU [log10] None Infectious disease, immune system: Murine cytomegalovirus (MCMV) titer in spleen 4 days after infection with 5X10^4 PFU (KLRA complex) [log10] x x 2.1 4.6 4.25 x 4.64 1.3 5.2 4.72 4.91 1.66 5.42 x 5.2 1.3 1.31 5.48 1.31 1.66 1.3 1.29 x 4.65 x 2.23 1.3 5.26 1.49 1.74 4.62 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10592 Original post publication description: Infectious disease, immune function: Anergy measured by footpad thickness resulting from BCG injection [mm] None Infectious disease, immune system: Anergy measured by footpad thickness resulting from BCG injection [mm] x x x x 0.68 0.22 0.25 0.67 0.14 0.63 0.64 0.79 x 0.15 0.48 0.92 0.92 0.15 0.86 1.0 0.31 0.3 x 0.6 x 0.74 0.8 x 0.99 0.46 0.64 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10593 Original post publication description: Amphetamine response (20 mg/kg ip d amphetamine), core temperature change after injection [degrees C] None Central nervous system, pharmacology, metabolism: Amphetamine response (20 mg/kg ip d amphetamine), core body temperature change after injection [degree C] x x 0.42 1.66 x x x x x 1.26 x 0.52 x x 0.42 x x 1.77 0.41 0.21 x 1.56 x x x 1.78 1.46 x 1.36 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10594 Original post publication description: Central nervous system, morphology: Brain weight [mg] None Central nervous system, morphology: Brain weight [mg] x x 478.0 393.0 441.0 424.0 540.0 x 428.0 431.0 434.0 438.0 415.0 444.0 453.0 431.0 419.0 432.0 392.0 x 446.0 414.0 x 407.0 401.0 352.0 394.0 376.0 369.0 414.0 443.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10595 Original post publication description: Central nervous system, morphology, visual system: Dorsal lateral geniculate nucleus (dLGN) volume, unilateral [mm^3] None Central nervous system, morphology, visual system: Dorsal lateral geniculate nucleus (dLGN) volume, unilateral, corrected for shrinkage [mm^3] x 0.32 0.3 0.26 0.3 0.25 0.36 x 0.23 0.29 0.32 0.23 0.26 0.26 0.29 0.26 0.25 0.31 0.25 x 0.33 0.35 x 0.25 0.26 0.25 0.23 0.24 0.23 0.28 0.27 0.25 0.28 0.28 0.27 x 0.27 0.32 0.35 x 0.31 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10596 Original post publication description: Central nervous system, morphology, visual system: Dorsal lateral geniculate nucleus (dLGN) total cell number, unilateral [n x10^3] None Central nervous system, morphology, visual system: Dorsal lateral geniculate nucleus (dLGN) total cell number, unilateral [n x10^3] x 43.1 46.7 37.0 36.9 34.6 45.6 x 32.9 39.4 46.1 36.3 39.7 37.3 41.4 48.2 38.7 35.7 41.0 x 50.4 40.7 x 38.6 35.0 31.5 35.5 40.7 37.3 43.8 34.2 38.4 40.6 39.3 40.0 x 36.0 36.3 43.0 x 39.8 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10597 Original post publication description: Central nervous system, morphology, visual system: Dorsal lateral geniculate nucleus (dLGN) neuron number, unilateral [n x10^3] None Central nervous system, morphology, visual system: Dorsal lateral geniculate nucleus (dLGN) neuron number, unilateral [n x10^3] x 18.8 19.9 16.2 14.9 13.7 18.1 x 15.1 15.5 18.5 15.5 17.7 14.7 18.2 20.0 15.8 14.5 14.8 x 18.4 17.6 x 15.3 16.1 14.8 15.7 17.4 15.7 18.3 13.2 18.4 19.4 16.5 17.4 x 15.1 15.1 16.1 x 16.7 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10598 Original post publication description: Central nervous system, morphology, visual system: Dorsal lateral geniculate nucleus (dLGN) glial cell number, unilateral [n x10^3] None Central nervous system, morphology, visual system: Dorsal lateral geniculate nucleus (dLGN) glial cell number, unilateral [n x10^3] x 14.7 15.1 13.2 10.8 11.2 15.9 x 10.2 12.4 12.5 12.4 12.9 13.1 11.5 16.3 13.3 12.6 13.8 x 17.1 15.2 x 11.0 10.9 9.6 11.7 13.6 12.4 14.0 12.3 11.2 12.3 13.2 13.0 x 11.4 13.1 13.0 x 12.5 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10599 Original post publication description: Central nervous system, morphology, visual system: Dorsal lateral geniculate nucleus (dLGN) endothelial cell number, unilateral [n x10^3] None Central nervous system, morphology, visual system: Dorsal lateral geniculate nucleus (dLGN) endothelial cell number, unilateral [n x10^3] x 9.6 11.7 7.5 11.3 9.6 11.6 x 7.6 11.5 15.0 8.4 9.2 9.6 11.7 11.9 9.6 8.7 12.3 x 14.8 7.9 x 12.3 8.1 7.1 8.1 9.6 9.2 11.5 8.7 8.7 8.9 9.7 9.6 x 9.5 8.1 13.9 x 10.6 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10600 Original post publication description: Central nervous system, morphology, eye, visual system: Retinal ganglion cell number, unilateral [x 1000] None Central nervous system, morphology, eye, visual system: Retinal ganglion cell number, unilateral [x 1000] x x 54.6 63.4 59.5 65.9 73.4 62.7 57.1 64.0 60.9 53.3 54.3 63.6 62.5 64.3 53.7 63.8 61.6 60.0 63.1 52.6 x 61.4 52.6 50.9 55.2 61.2 67.4 64.2 74.5 57.4 58.6 60.7 63.3 x 59.7 67.5 67.4 x 63.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10601 Original post publication description: Central nervous system, morphology, eye, visual system: Retinal ganglion cells (RGC) to lateral geniculate nucleus (LGN) principal neuron number ratio [ratio] None Central nervous system, morphology, eye, visual system: Retinal ganglion cells (RGC) to lateral geniculate nucleus (LGN) principal neuron number ratio [ratio] x x 2.74 3.91 3.99 4.81 4.06 x 3.78 4.13 3.29 3.44 3.07 4.33 3.43 3.22 3.4 4.4 4.16 x 3.43 2.99 x 4.01 3.27 3.44 3.52 3.52 4.29 3.51 5.64 3.12 3.02 3.68 3.64 x 3.95 4.47 4.19 x 3.77 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10602 Original post publication description: Endocrinology: Serum thyroxine (T4), total serum T4 content [ug/100ml] None Endocrinology: Serum thyroxine (T4), total serum T4 content [ug/100ml] x x 6.7 10.3 x 10.2 x 6.0 x 6.2 x 8.6 x x x 8.7 x 7.3 x x x x x x x x x 9.9 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10603 Original post publication description: Serum thyroxine (T4) content (free) [ug/100ml] None Endocrinology, metabolism: Serum thyroxine (T4) content (free) [ug/100ml] x x 2.2 3.2 x 2.4 x 2.1 x 1.6 x 3.0 x x x 2.5 x 2.6 x x x x x x x x x 3.4 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10604 Original post publication description: Central nervous system, behavior: Seizure susceptibility (audiogenic), severity [score] None Central nervous system, behavior: Seizure susceptibility (audiogenic), severity [score] x x 0.07 1.89 x 1.92 x 0.14 x 1.85 x 0.3 x x x 0.21 x 0.73 x x x x x x x x x 0.09 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10605 Original post publication description: Central nervous system, behavior: Seizure susceptibility (audiogenic), clonic tonic percentage [%] None Central nervous system, behavior: Seizure susceptibility (audiogenic), clonic tonic percentage [%] x x 1.8 91.4 x 92.0 x 0.0 x 93.0 x 0.0 x x x 0.0 x 35.0 x x x x x x x x x 0.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10606 Original post publication description: High affinity choline uptake (concentration of 0.5*10^-6M) in frontal cortex [pmole/4min/mg protein] None Central nervous system, pharmacology: High affinity choline uptake (concentration of 0.5 10xE-6 M) in frontal cortex [pmole/4min/mg protein] x x 17.2 13.1 18.5 17.3 13.7 15.4 25.0 22.1 12.8 17.8 25.5 19.0 24.4 17.3 18.2 24.9 x 23.4 16.4 26.8 x 19.3 23.7 17.3 21.2 20.5 18.7 12.5 25.9 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10607 Original post publication description: High affinity choline uptake (concentration of 0.5*10^-6M) in hippocampus [pmole/4min/mg protein] None High affinity choline uptake (concentration of 0.5*10^-6M) in hippocampus [pmole/4min/mg protein] x x 17.5 14.2 17.6 18.9 22.4 18.9 20.8 25.9 21.2 19.9 27.7 22.2 23.3 17.4 19.1 28.5 x 25.2 21.6 26.2 x 17.9 36.0 21.0 22.4 30.3 22.8 17.7 23.6 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10608 Original post publication description: High affinity choline uptake (concentration of 0.5*10^-6M) in striatum [pmole/4min/mg protein] None Central nervous system, pharmacology: High affinity choline uptake (concentration of 0.5*10^-6M) in striatum [pmole/4min/mg protein] x x 80.1 64.8 52.4 62.8 43.5 55.5 112.1 94.2 59.4 54.7 92.3 90.4 112.8 62.7 55.2 107.1 x 89.3 59.5 107.9 x 51.7 128.9 76.2 78.1 79.2 51.6 52.5 87.2 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10609 Original post publication description: Cocaine response (32 mg/kg ip), locomotion from 0-60 min after injections in an activity chamber [n beam breaks] None Cocaine response (32 mg/kg ip), locomotion from 0-60 min after injections in an activity chamber [n beam breaks] x x 1481.0 2470.0 x x 1814.0 x 2574.0 x 1557.0 x 1622.0 1333.0 1995.0 1787.0 x x x 2345.0 1702.0 1383.0 x x 2158.0 1539.0 1494.0 x 1771.0 1597.0 1909.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10610 Original post publication description: Cocaine response (32 mg/kg ip), sensitization of locomotor response [% initial response] None Cocaine response (32 mg/kg ip), sensitization of locomotor response [% initial response] x x 81.4 28.2 x x 92.5 x 71.7 x 111.4 x 128.7 97.1 53.1 115.0 x x x 59.0 81.3 100.0 x x 87.4 86.4 102.0 x 102.0 88.6 90.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10611 Original post publication description: Cocaine response (32 mg/kg ip, daily), stereotypical behavior frequency after consecutive daily injections on day 8 [units] None Central nervous system, pharmacology, behavior: Cocaine response (32 mg/kg ip, daily), stereotypical behavior frequency after consecutive daily injections on day 8 [units] x x 0.75 17.21 x x 3.67 x 1.33 x 0.33 x 0.67 1.33 4.0 0.0 x x x 4.68 3.33 1.0 x x 0.0 5.0 0.0 x 0.0 0.0 0.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10612 Original post publication description: Cancer, genetics: endogenous mouse mammary tumor virus (MMTV)-specific RNA in mammary glands, dot blot assay, primiparous lactating female [% total RNA] None Cancer, genetics: endogenous mouse mammary tumor virus (MMTV)-specific RNA in mammary glands, dot blot assay, primiparous lactating female [% total RNA] x x 0.0265 0.016 0.0216 0.0062 0.023 0.0192 0.0138 0.0064 0.0141 0.012 0.0149 0.0 0.0134 0.0067 0.0118 0.0198 x 0.0062 0.003 0.016 x 0.0107 0.0268 x 0.0077 0.0198 0.019 0.0267 0.024 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10613 Original post publication description: Cancer, genetics: endogenous mouse mammary tumor virus (MMTV)-specific RNA in mammary glands, dot blot assay, multiparous lactating female [% total RNA] None Cancer, genetics: endogenous mouse mammary tumor virus (MMTV)-specific RNA in mammary glands, dot blot assay, multiparous lactating female [% total RNA] x x 0.024 x 0.032 0.0077 0.028 0.0212 0.0161 x 0.0213 0.0213 0.024 0.0034 x 0.0252 0.0161 0.0214 x 0.0064 0.016 0.0133 x 0.024 x x 0.0184 0.023 0.016 0.016 0.031 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10614 Original post publication description: Pentylenetetrazol (PTZ) induced seizure thresholds [mg/kg] None Central nervous system, pharmacology, behavior: Pentylenetetrazol (PTZ, a GABA antagonists) response, dosage level (threshold) required to induce seizure [mg/kg] x x 35.0 23.0 30.0 41.0 28.0 40.0 x 25.0 37.0 32.0 28.0 27.0 x 33.0 31.0 30.0 x 29.0 29.0 29.0 x 28.0 29.0 x 32.0 34.0 38.0 33.0 27.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10615 Original post publication description: Proliferation of A9.4 (subclone) without 50 ug/ml KLH experiment 1 [cpm] None Immune system: Proliferation of A9.4 (subclone) without 50 ug/ml KLH experiment 1 [cpm] x x 1107.0 925.0 2021.0 158.0 x 2267.0 108.0 x x 1757.0 x x x x x x x x x x x 127.0 x x x 158.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10616 Original post publication description: Proliferation of A9.4 (subclone) with 50 ug/ml KLH experiment 1, 5X105 stimulator cells [cpm] None Immune system: Proliferation of A9.4 (subclone) with 50 ug/ml KLH experiment 1, 5X105 stimulator cells [cpm] x x 3457.0 3736.0 4568.0 209.0 x 5070.0 148.0 x x 3990.0 x x x x x x x x x x x 381.0 x x x 86.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10617 Original post publication description: Proliferation of A9.4 (subclone) without 50 ug/ml KLH experiment 2 [cpm] None Immune system: Proliferation of A9.4 (subclone) without 50 ug/ml KLH experiment 2 [cpm] x x 3765.0 x 4902.0 511.0 x 4413.0 593.0 x x 2941.0 x x x x x x x x x x x 158.0 x x x 248.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10618 Original post publication description: Proliferation of A9.4 (subclone) with 50 ug/ml KLH experiment 2, 1X106 stimulator cells [cpm] None Immune system: Proliferation of A9.4 (subclone) with 50 ug/ml KLH experiment 2, 1X106 stimulator cells [cpm] x x 10955.0 x 11742.0 781.0 x 7541.0 378.0 x x 10521.0 x x x x x x x x x x x 150.0 x x x 421.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10619 Original post publication description: Learning and memory performance, site preference, number of crosses over the trained site minus the mean of crosses over alternative sites, using Morris water maze [n] None Learning and memory performance, site preference, number of crosses over the trained site minus the mean of crosses over alternative sites, using Morris water maze [n] x x x x 1.12 5.85 x x x 1.89 x x x x 2.06 2.74 x x x 2.21 x 2.0 x 3.0 3.82 2.34 3.29 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10620 Original post publication description: Morris water maze search-time preference, amount of time spent in the trained quadrant of the pool minus mean time in the alternative quadrants [seconds] None Central nervous system, behavior, learning and memory: Morris water maze search-time preference, amount of time spent in the trained quadrant of the pool minus mean time in the alternative quadrants [seconds] x x x x 8.43 19.45 x x x 6.11 x x x x 11.61 10.47 x x x 7.59 x 12.37 x 10.84 13.35 6.23 11.92 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10621 Original post publication description: Protein kinase C (PKC) activity in hippocampus [pmol/min/mg protein total hippocampus] None Central nervous system, learning and memory, protein expression: Protein kinase C (PKC) activity in hippocampus [pmol/min/mg protein total hippocampus] x x x x 416.0 1347.0 x x x 568.0 x x x x 398.0 901.0 x x x 856.0 x 844.0 x 1122.0 931.0 843.0 902.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10622 Original post publication description: Protein kinase C (PKC) activity for particulate hippocampus [pmol/min/mg protein] None Central nervous system, learning and memory, protein expression: Protein kinase C (PKC) activity for particulate hippocampus [pmol/min/mg protein] x x x x 95.0 349.0 x x x 195.0 x x x x 140.0 353.0 x x x 142.0 x 296.0 x 213.0 375.0 209.0 437.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10623 Original post publication description: Protein kinase C (PKC) activity for cytosolic hippocampus [pmol/min/mg protein] None Central nervous system, protein expression, behavior, learning and memory: Protein kinase C (PKC) activity for cytosolic hippocampus [pmol/min/mg protein] x x x x 438.0 992.0 x x x 374.0 x x x x 257.0 544.0 x x x 715.0 x 57.4 x 906.0 449.0 636.0 457.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10624 Original post publication description: Central nervous system, learning and memory: Protein kinase C (PKC) activity for neocortex (total sample) [pmol/min/mg protein] None Central nervous system, learning and memory: Protein kinase C (PKC) activity for neocortex (total sample) [pmol/min/mg protein] x x x x 391.0 619.0 x x x 279.0 x x x x 494.0 419.0 x x x 1018.0 x 273.0 x 503.0 356.0 495.0 540.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10625 Original post publication description: Central nervous system, learning and memory: Protein kinase C (PKC) activity for neocortex sample (particulate fraction) [pmol/min/mg protein] None Central nervous system, learning and memory, protein expression: Protein kinase C (PKC) activity for neocortex sample (particulate fraction) [pmol/min/mg protein] x x x x 184.0 177.0 x x x 113.0 x x x x 295.0 142.0 x x x 560.0 x 154.0 x 137.0 67.0 259.0 194.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10626 Original post publication description: Protein kinase C (PKC) activity for cytosolic cortex [pmol/min/mg protein] None Protein kinase C (PKC) activity for cytosolic cortex [pmol/min/mg protein] x x x x 302.0 512.0 x x x 169.0 x x x x 261.0 276.0 x x x 461.0 x 229.0 x 361.0 285.0 345.0 451.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10627 Original post publication description: Mean 51Cr release at 20:1 E:T after spleen cells primed and boosted in MLC in pool of 5 responders [mean] None Immune system: Mean 51Cr release at 20:1 E:T after spleen cells primed and boosted in MLC in pool of 5 responders [mean] x x x 45.0 x x x 59.0 x x 55.0 55.0 x x x 38.0 x x x 51.0 x x x 51.0 x 46.0 78.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10628 Original post publication description: Mean 51Cr release at 10:1 E:T after spleen cells primed and boosted in MLC in pool of 5 responders [mean] None Immune system: Mean 51Cr release at 10:1 E:T after spleen cells primed and boosted in MLC in pool of 5 responders [mean] x x x 39.0 x x x 42.0 x x 40.0 45.0 x x x 29.0 x x x 37.0 x x x 33.0 x 29.0 42.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10629 Original post publication description: Mean 51Cr release at 5:1 E:T after spleen cells primed and boosted in MLC in pool of 5 responders [mean] None Immune system: T-cell response, antibody-dependent cell-mediated cytotoxicity, 51Cr release at 5:1 E:T after spleen cells primed and boosted in mixed lymphocyte culture (MLC) in pool of five responders [mean] x x x 30.0 x x x 29.0 x x 37.0 32.0 x x x 17.0 x x x 28.0 x x x 26.0 x 17.0 34.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10630 Original post publication description: Immune system: 51Cr release at 20:1 E:T after spleen cells primed and boosted in MLC in responder 1 [units] None Immune system: 51Cr release at 20:1 E:T after spleen cells primed and boosted in MLC in responder 1 [units] x x x x x x x 63.0 x x 3.0 0.0 x x x 14.0 x x x 32.0 x x x 2.0 x 27.0 33.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10631 Original post publication description: Immune sytstem: T-cell response, cytotoxic T lymphocytes, 51Cr release at 10:1 E:T after spleen cells primed and boosted in MLC in responder 1 [units] None Immune sytstem: T-cell response, cytotoxic T lymphocytes, 51Cr release at 10:1 E:T after spleen cells primed and boosted in MLC in responder 1 [units] x x x x x x x 40.0 x x 2.0 0.0 x x x 10.0 x x x 16.0 x x x 0.0 x 18.0 17.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10632 Original post publication description: Mean 51Cr release at 5:1 E:T after spleen cells primed and boosted in MLC in responder 1 [mean] None Immune sytstem: 51Cr release at 5:1 E:T after spleen cells primed and boosted in MLC in responder 1 [mean] x x x x x x x 16.0 x x 1.0 0.0 x x x 3.0 x x x 8.0 x x x 0.0 x 12.0 16.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10633 Original post publication description: 51Cr release at 20:1 E:T after spleen cells primed and boosted in MLC in responder 2 None Immune sytstem: 51Cr release at 20:1 E:T after spleen cells primed and boosted in MLC in responder 2 x x x x x x x 100.0 x x 6.0 0.0 x x x 48.0 x x x 66.0 x x x 11.0 x 72.0 68.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10634 Original post publication description: Immune function: 51Cr release at 10:1 E:T after spleen cells primed and boosted with mixed lymphocyte culture in responder 2 [units] None Immune sytstem: 51Cr release at 10:1 E:T after spleen cells primed and boosted with mixed lymphocyte culture in responder 2 [units] x x x x x x x 100.0 x x 5.0 0.0 x x x 36.0 x x x 47.0 x x x 7.0 x 46.0 72.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10635 Original post publication description: 51Cr release at 5:1 E:T after spleen cells primed and boosted in MLC in responder 2 None Immune sytstem: 51Cr release at 5:1 E:T after spleen cells primed and boosted in MLC in responder 2 x x x x x x x 67.0 x x 3.0 0.0 x x x 23.0 x x x 32.0 x x x 6.0 x 40.0 29.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10636 Original post publication description: 51Cr release at 20:1 E:T after spleen cells primed and boosted in MLC in responder 3 None Immune sytstem: 51Cr release at 20:1 E:T after spleen cells primed and boosted in MLC in responder 3 x x x x x x x 47.0 x x 4.0 0.0 x x x 15.0 x x x 32.0 x x x 0.0 x 27.0 49.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10637 Original post publication description: 51Cr release at 10:1 E:T after spleen cells primed and boosted in MLC in responder 3 None Immune sytstem: 51Cr release at 10:1 E:T after spleen cells primed and boosted in MLC in responder 3 x x x x x x x 32.0 x x 2.0 0.0 x x x 10.0 x x x 22.0 x x x 3.0 x 18.0 35.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10638 Original post publication description: Mean 51Cr release at 5:1 E:T after spleen cells primed and boosted in MLC in responder 3 [mean] None Immune sytstem: 51Cr release at 5:1 E:T after spleen cells primed and boosted in MLC in responder 3 [mean] x x x x x x x 22.0 x x 2.0 0.0 x x x 7.0 x x x 12.0 x x x 0.0 x 7.0 29.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10639 Original post publication description: Hindbrain medulla weight (unadjusted) [mg] None Hindbrain medulla weight (unadjusted) [mg] x x x x x x x 5.5 8.2 8.6 x x x x 6.8 x x 5.7 x 7.3 x x x x x x x x x x x 6.3 6.3 5.9 5.7 x 6.4 6.4 7.2 x 7.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10640 Original post publication description: Hindbrain weight, unadjusted [mg] None Central nervous system, morphology: Hindbrain weight, unadjusted [mg] x x x x x x x x x x 42.5 46.5 42.0 43.4 39.1 44.1 44.7 43.1 34.3 36.2 42.6 41.8 x 46.3 39.2 30.8 44.4 41.5 38.6 43.6 50.1 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10642 Original post publication description: Olfactory bulb weight, bilateral and unadjusted for age, sex, or body weight [mg] None Central nervous system, morphology: Olfactory bulb weight, bilateral, without any statistical corrections (raw) [mg] x x x x 20.9 23.1 22.3 21.2 20.2 22.0 17.7 20.3 18.0 18.7 18.8 21.5 21.1 18.7 18.2 18.9 21.0 x x 16.9 17.6 17.9 19.1 19.1 17.8 20.4 21.7 20.3 23.0 24.0 17.5 23.0 22.4 19.5 22.0 x 20.9 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10643 Original post publication description: Central nervous system, morphology: Olfactory bulb weight, adjusted [mg] by age, sex, body weight, and brain minus olfactory bulb weight. None Central nervous system, morphology: Olfactory bulb weight, adjusted by age, sex, body weight, and brain minus olfactory bulb weight (Hager et al. 2012) [mg] x x 21.9 21.6 20.7 21.1 18.3 22.0 19.3 20.0 18.7 20.0 19.4 19.9 18.0 19.7 21.0 18.6 20.9 17.3 19.8 18.7 x 18.6 18.3 20.3 19.7 20.1 20.7 21.4 20.1 20.3 23.2 23.6 18.1 21.2 22.5 20.4 20.3 x 19.3 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10645 Original post publication description: Olfactory bulb weight, bilateral, fixed tissue, hand-dissected, unadjusted [mg] None Central nervous system, morphology, olfaction: Olfactory bulb weight, bilateral, fixed tissue, hand-dissected, unadjusted [mg] x x 22.7 19.8 21.6 21.2 21.2 20.3 22.6 21.7 18.6 20.4 18.5 20.9 19.0 21.7 22.2 18.6 18.8 17.9 20.8 18.1 x 17.3 17.4 17.7 19.2 19.1 18.6 21.0 19.8 21.0 23.8 24.4 18.2 19.9 23.1 20.4 21.7 x 21.4 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10646 Original post publication description: Central nervous system, morphology: Brain weight [mg] None Central nervous system, morphology: Brain weight [mg] x x 495.0 415.0 456.0 440.0 502.0 391.0 498.0 469.0 420.0 447.0 402.0 439.0 449.0 467.0 445.0 432.0 382.0 442.0 444.0 420.0 x 394.0 410.0 375.0 413.0 403.0 382.0 415.0 432.0 445.0 439.0 449.0 427.0 428.0 437.0 423.0 464.0 x 469.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10647 Original post publication description: Body weight [g] None Metabolism, morphology: Body weight, adult sex average [g] x x 24.7 19.3 18.8 28.9 22.2 19.9 22.9 23.6 18.8 21.2 19.5 21.7 24.3 23.9 21.3 21.2 19.0 21.8 20.3 20.0 x 20.7 19.2 20.2 23.1 22.3 18.2 20.8 26.0 17.7 21.1 25.8 17.2 22.5 19.4 20.2 20.2 x 21.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10648 Original post publication description: Central nervous system, morphology: Brain weight [mg] None Central nervous system, morphology: Brain weight [mg] x x 475.0 412.0 465.0 432.0 526.0 388.0 412.0 422.0 437.0 434.0 427.0 442.0 443.0 469.0 427.0 431.0 398.0 443.0 457.0 434.0 x 391.0 431.0 393.0 407.0 413.0 399.0 426.0 434.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10649 Original post publication description: Central nervous system, morphology, eye, visual system: Retinal ganglion cell number, unilateral [n x10^3] None Central nervous system, morphology, eye, visual system: Retinal ganglion cell number, unilateral [n x10^3] x x 55.4 63.4 60.3 65.9 75.5 62.7 62.8 65.6 61.0 56.8 54.7 64.0 63.8 64.0 55.1 67.1 59.9 60.0 64.5 53.0 x 62.4 53.8 50.8 52.4 63.6 66.0 66.6 75.8 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10650 Original post publication description: Central nervous system, morphology, eye, visual system: Retinal ganglion cell number residuals, unilateral, corrected for variation in brain and body size, sex, and age [residual n x10^3] None Central nervous system, morphology, eye, visual system: Retinal ganglion cell number residuals, unilateral, corrected for variation in brain and body size, sex, and age [residual n x10^3] x x -4.5 4.5 -4.67 3.88 5.09 4.6 2.56 4.47 -1.47 -5.4 -6.88 1.08 0.79 -1.33 -6.48 5.16 0.91 -3.0 0.25 -9.2 x 4.03 -8.14 -7.75 -7.4 3.27 6.92 5.11 13.6 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10651 Original post publication description: Central nervous system, morphology, auditory system: Spiral ganglion cell density hook [cells per 10000 um2] None Central nervous system, morphology, auditory system: Spiral ganglion cell density hook [cells per 10000 um2] x x 17.0 8.0 17.0 4.0 9.0 8.0 4.0 8.0 8.0 7.0 x 10.0 7.0 3.0 8.0 x 5.0 6.0 7.0 9.0 x 6.0 18.0 3.0 12.0 12.0 9.0 12.0 6.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10652 Original post publication description: Central nervous system, morphology, auditory system, stereology: Spiral ganglion cell density mid base [cells per 10000 um2] None Central nervous system, morphology, auditory system, stereology: Spiral ganglion cell density mid base [cells per 10000 um2] x x 43.0 11.0 15.0 5.0 17.0 22.0 6.0 12.0 13.0 8.0 x 25.0 17.0 3.0 21.0 x 9.0 23.0 13.0 22.0 x 5.0 23.0 11.0 19.0 17.0 25.0 31.0 19.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10653 Original post publication description: Central nervous system, morphology, auditory system, stereology: Spiral ganglion cell density mid-apical [cells per 10000 um2] None Central nervous system, morphology, auditory system, stereology: Spiral ganglion cell density mid-apical [cells per 10000 um2] x x 46.0 25.0 40.0 15.0 16.0 25.0 11.0 33.0 28.0 12.0 x 26.0 21.0 4.0 22.0 x 26.0 23.0 21.0 25.0 x 20.0 27.0 10.0 29.0 23.0 24.0 35.0 32.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10654 Original post publication description: Central nervous system, morphology, auditory system: Spiral ganglion cell density apical [cells per 10000 um2] None Central nervous system, morphology, auditory system: Spiral ganglion cell density apical [cells per 10000 um2] x x 47.0 24.0 27.0 25.0 20.0 30.0 35.0 26.0 18.0 21.0 x 20.0 19.0 12.0 16.0 x 16.0 32.0 18.0 22.0 x 32.0 30.0 11.0 14.0 10.0 4.0 19.0 33.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10655 Original post publication description: Central nervous system, morphology, auditory system, stereology: Spiral ganglion cell density total [cells per 10000 um2] None Central nervous system, morphology, auditory system, stereology: Spiral ganglion cell density total [cells per 10000 um2] x x 168.0 68.0 100.0 49.0 62.0 85.0 56.0 79.0 67.0 48.0 x 81.0 64.0 22.0 67.0 x 56.0 84.0 59.0 78.0 x 53.0 98.0 35.0 74.0 62.0 62.0 97.0 90.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10656 Original post publication description: Infectious disease, immune function: LacZ expression 7 days post 5x109 PFU i.v injection of AdLacZ [counts/mg protein/minx10-4] None Infectious disease, immune system: LacZ expression 7 days post 5x109 PFU i.v injection of AdLacZ [counts/mg protein/minx10-4] x x 1.82 1.92 2.08 2.19 2.23 1.84 1.96 1.77 2.29 1.93 x x 1.81 2.0 2.0 1.78 x x 2.15 2.31 x 1.89 x 2.03 2.04 x 2.09 2.0 2.26 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10657 Original post publication description: Infectious disease, immune function: LacZ expression 21 days post 5x109 PFU i.v injection of AdLacZ [counts/mg protein/minx10-4] None Infectious disease, immune system: LacZ expression 21 days post 5x109 PFU i.v injection of AdLacZ [counts/mg protein/minx10-4] x x 0.295 0.392 0.474 1.75 0.18 0.104 0.451 0.107 1.12 0.105 x x 0.234 0.861 0.128 0.113 x x 0.127 1.45 x 0.172 x 0.121 0.18 x 0.187 0.242 0.305 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10658 Original post publication description: Infectious disease, immune function: LacZ expression 30 days post 5x109 PFU i.v injection of AdLacZ [counts/mg protein/minx10-4] None Infectious disease, immune system: LacZ expression 30 days post 5x109 PFU i.v injection of AdLacZ [counts/mg protein/minx10-4] x x 0.195 0.359 0.112 1.45 0.082 0.086 0.201 0.098 0.78 0.082 x x 0.15 0.565 0.115 0.083 x x 0.103 1.51 x 0.097 x 0.102 0.148 x 0.112 0.14 0.205 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10659 Original post publication description: Infectious disease, immune function: LacZ expression 50 days post 5x109 PFU i.v injection of AdLacZ [counts/mg protein/minx10-4] None Infectious disease, immune system: LacZ expression 50 days post 5x109 PFU i.v injection of AdLacZ [counts/mg protein/minx10-4] x x 0.029 0.084 0.053 1.15 0.057 0.022 0.109 0.054 0.39 0.037 x x 0.066 0.199 0.049 0.042 x x 0.057 0.956 x 0.076 x 0.037 0.091 x 0.043 0.043 0.031 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10660 Original post publication description: Infectious disease, immune function: Cytotoxicity in spleen T cells 7 days after 5x109 PFU AdLacZ i.v injection [%] None Infectious disease, immune system: Cytotoxicity in spleen T cells 7 days after 5x109 PFU AdLacZ i.v injection [%] x x 18.5 18.5 18.1 7.7 15.4 11.7 19.1 11.5 11.7 18.7 x x 18.1 7.13 18.4 18.1 x x 18.6 5.4 x 18.5 x 18.4 18.5 x 18.5 15.1 17.9 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10661 Original post publication description: Infectious disease, immune function: Cytotoxicity in spleen T cells 21 days post 5x109 PFU AdLacZ i.v injection [%] None Infectious disease, immune system: Cytotoxicity in spleen T cells 21 days post 5x109 PFU AdLacZ i.v injection [%] x x 72.7 73.6 73.1 47.3 72.4 72.6 64.5 73.2 62.3 73.4 x x 70.0 25.9 73.4 73.1 x x 72.5 11.0 x 73.0 x 73.3 64.0 x 70.7 73.3 73.5 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10662 Original post publication description: Infectious disease, immune function: Cytotoxicity in spleen T cells 30 days post 5x109 PFU AdLacZ i.v injection [%] None Infectious disease, immune system: Cytotoxicity in spleen T cells 30 days post 5x109 PFU AdLacZ i.v injection [%] x x 101.0 103.0 102.0 64.5 102.0 102.0 80.3 103.0 76.0 73.1 x x 101.0 76.6 96.0 95.1 x x 101.0 24.1 x 85.4 x 95.0 67.3 x 92.2 91.3 103.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10663 Original post publication description: Infectious disease, immune function: Cytotoxicity in spleen T cells 50 days post 5x109 PFU AdLacZ i.v injection [%] None Infectious disease, immune system: Cytotoxicity in spleen T cells 50 days post 5x109 PFU AdLacZ i.v injection [%] x x 99.2 102.0 103.0 58.3 101.0 101.0 71.0 102.0 43.1 104.0 x x 96.6 59.9 88.7 89.0 x x 92.6 8.9 x 76.1 x 88.4 36.6 x 85.5 84.2 90.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10664 Original post publication description: Infectious disease, immune function: Cytotoxic T-cell (CTL) response (5 x 10^9 PFU AdLacZ iv), measured as interferon gamma (IFNG) cytokine expression [ng/ml/] None Infectious disease, immune system: Cytotoxic T-cell (CTL) response (5 x 10^9 PFU AdLacZ iv), measured as interferon gamma (IFNG) cytokine expression [ng/ml/] x x 80.8 7.71 0.943 0.812 6.5 3.83 x 12.1 18.9 16.0 x 13.0 13.0 20.9 x 16.5 x 42.4 27.3 36.5 x 43.2 58.4 65.4 51.9 47.8 x 74.1 52.6 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10665 Original post publication description: Infectious disease, immune function: Cytotoxic T-cell (CTL) response (5 x 10^9 PFU AdLacZ iv), measured as tumor necrosis factor alpha (TNFa) cytokine expression [pg/ml] None Infectious disease, immune system: Cytotoxic T-cell (CTL) response (5 x 10^9 PFU AdLacZ iv), measured as tumor necrosis factor alpha (TNFa) cytokine expression [pg/ml] x x 49.5 3.07 2.77 49.9 2.49 17.3 x 6.96 13.3 12.1 x 25.9 27.5 11.6 x 30.8 x 14.0 15.9 39.9 x 26.5 28.0 23.1 29.9 27.8 x 56.3 35.8 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10666 Original post publication description: Infectious disease, immune function: Cytotoxic T-cell (CTL) response (5 x 10^9 PFU AdLacZ iv), measured as interleukin 6 (IL-6) cytokine expression [pg/ml] None Infectious disease, immune system: Cytotoxic T-cell (CTL) response (5 x 10^9 PFU AdLacZ iv), measured as interleukin 6 (IL-6) cytokine expression [pg/ml] x x 38.9 4.16 0.279 41.5 1.81 18.8 x 3.5 5.68 16.5 x 18.6 18.0 8.29 x 24.0 x 11.3 11.2 31.0 x 14.6 18.0 23.3 27.6 16.5 x 32.0 23.7 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10667 Original post publication description: Eye, morphology, visual system: Eye weight corrected for age, sex, body and brain weight (BXD38 added) [mg] None Eye, morphology, visual system: Eye weight corrected for age, sex, body and brain weight (BXD38 added) [mg] x x 18.9 20.2 20.1 20.1 19.6 19.7 18.7 19.4 20.3 18.9 18.2 18.3 19.1 19.3 17.3 20.1 19.4 15.6 19.3 18.4 x 16.3 16.8 19.2 17.5 19.4 17.8 20.0 20.0 x x x x x 19.5 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10668 Original post publication description: Eye, morphology, visual system: Lens weight [mg] None Eye, morphology, visual system: Lens weight [mg] x x 5.9 6.7 6.2 6.1 5.7 5.9 5.8 6.0 6.0 5.3 5.3 5.7 5.7 6.1 5.2 6.5 5.5 4.8 6.0 5.5 x 5.3 5.3 5.6 5.0 5.9 5.5 6.0 6.2 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10669 Original post publication description: Central nervous system, morphology, eye, visual system: Retinal area, adults of both sexes [mm2] None Central nervous system, morphology, eye, visual system: Retinal area, adults of both sexes [mm2] x x 18.5 20.1 19.8 20.2 19.1 19.8 18.6 19.3 20.2 18.9 19.3 18.7 19.3 19.0 18.1 19.7 18.8 16.2 19.5 18.2 x 17.0 17.6 18.9 17.8 19.3 18.4 19.2 19.3 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10670 Original post publication description: Central nervous system, morphology, eye, visual system: Retinal ganglion cell number, unilateral [x1000] None Central nervous system, morphology, eye, visual system: Retinal ganglion cell number, unilateral [x1000] x x 55.4 63.4 60.3 65.9 75.5 62.7 62.8 65.6 61.0 56.8 54.7 64.0 63.8 64.0 55.1 67.1 59.9 60.0 64.5 53.0 x 62.4 53.8 50.8 52.4 63.6 66.0 66.6 75.8 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10671 Original post publication description: Eye, morphology, visual system: Eye weight, regression corrected for age, sex, body and brain weight [mg] None Eye, morphology, visual system: Eye weight, regression corrected for age, sex, body and brain weight [mg] x x 18.9 20.2 20.1 20.1 19.6 19.7 18.7 19.4 20.3 18.9 18.2 18.3 19.1 19.3 17.3 20.1 19.4 15.6 19.3 18.4 x 16.3 16.8 19.2 17.5 19.4 17.8 20.0 20.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10672 Original post publication description: Central nervous system, morphology: Brain weight [mg] None Central nervous system, morphology: Brain weight [mg] x x 475.0 412.0 465.0 432.0 526.0 388.0 412.0 422.0 437.0 434.0 427.0 442.0 443.0 469.0 427.0 431.0 398.0 443.0 457.0 434.0 x 391.0 431.0 393.0 407.0 413.0 399.0 426.0 434.0 427.3 417.3 415.4 406.6 410.6 418.1 401.8 431.7 x 448.6 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10673 Original post publication description: Testis weight [g] None Morphology, urogenital system: Testis weight [g] x x 0.16 0.22 0.16 0.22 0.22 0.23 0.17 x 0.21 0.16 0.13 0.16 0.24 0.24 0.15 0.14 x 0.2 0.25 0.14 x 0.24 0.16 0.16 0.21 0.17 0.16 0.16 0.2 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10674 Original post publication description: Amygdala, basolateral complex volume (LaDL, LaVL, LaVM, BLP, and BLA), unilateral, shrinkage corrected from serial histological sections [mm^3] None Central nervous system, morphology, stereology: Amygdala, basolateral complex volume (LaDL, LaVL, LaVM, BLP, and BLA), unilateral, shrinkage corrected from serial histological sections [mm^3] x 1.87 1.628 1.55 1.566 1.434 1.596 1.221 1.51 1.515 1.478 1.469 1.387 1.489 1.424 1.55 1.481 1.797 1.517 1.455 1.573 1.476 x 1.517 1.402 1.429 1.374 1.067 1.145 1.522 1.61 1.324 1.536 1.467 1.44 1.4 1.426 1.34 1.497 x 1.442 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10675 Original post publication description: Central nervous system, morphology: Amygdala, basolateral complex volume (LaDL, LaVL, LaVM, BLP, and BLA), unilateral shrinkage corrected and adjusted for variation in body weight and plane of section from serial histological sections [mm^3] None Central nervous system, morphology: Amygdala, basolateral complex volume (LaDL, LaVL, LaVM, BLP, and BLA), unilateral shrinkage corrected and adjusted for variation in body weight and plane of section from serial histological sections [mm^3] x 1.77 1.62 1.549 1.565 1.37 1.59 1.255 1.49 1.55 1.55 1.457 1.371 1.435 1.38 1.529 1.466 1.793 1.52 1.439 1.569 1.44 x 1.494 1.46 1.432 1.393 1.096 1.2 1.51 1.73 1.337 1.51 1.469 1.488 1.32 1.446 1.37 1.53 x 1.46 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10676 Original post publication description: Amygdala, basolateral complex (LaDL, LaVL, LaVM, BLP, and BLA), neuron number, unilateral [n/mm^3] None Central nervous system, morphology, stereology: Amygdala, basolateral complex (LaDL, LaVL, LaVM, BLP, and BLA), neuron number, unilateral [n/mm^3] x x 118630.0 122192.0 145976.0 131359.0 128675.0 88555.0 134500.0 144911.0 158513.0 169263.0 145143.0 134307.0 152039.0 129656.0 134624.0 150659.0 140469.0 128420.0 113606.0 102254.0 x 139895.0 111356.0 127519.0 117092.0 115391.0 120955.0 169290.0 131745.0 140445.0 147905.0 113316.0 150588.0 x 111140.0 97207.0 117230.0 x 105948.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10677 Original post publication description: Amygdala, basolateral complex (LaDL, LaVL, LaVM, BLP, and BLA), glial cell number, unilateral without adjustment [n] None Central nervous system, morphology, stereology: Amygdala, basolateral complex (LaDL, LaVL, LaVM, BLP, and BLA), glial cell number, unilateral without adjustment [n] x 49515.0 17346.0 13806.0 25188.0 16368.0 15903.0 7126.0 10085.0 6991.0 26372.0 18533.0 19532.0 17495.0 3740.0 13739.0 9159.0 14141.0 8861.0 10742.0 15322.0 15338.0 x 9074.0 10652.0 10636.0 16779.0 7337.0 8966.0 14446.0 15896.0 15057.0 16763.0 16137.0 17002.0 25434.0 9028.0 12216.0 19195.0 x 7626.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10678 Original post publication description: Coat color (version 1, ordinal test case, black=4, brown=3, grey=2, dba dilute=1) None Skin, pigmentation: Hair coat color, ordinal scale version 1 black=4, brown=3, grey=2, dba dilute=1 [color intensity] 4.0 4.0 4.0 1.0 1.0 4.0 2.0 2.0 2.0 1.0 4.0 2.0 3.0 4.0 3.0 2.0 2.0 2.0 4.0 1.0 2.0 4.0 3.0 3.0 3.0 3.0 3.0 2.0 1.0 4.0 4.0 2.0 4.0 4.0 3.0 x 2.0 2.0 2.0 x 4.0 4.0 1.0 1.0 x x 4.0 2.0 4.0 4.0 3.0 3.0 x 3.0 4.0 x x 3.0 3.0 1.0 3.0 1.0 1.0 3.0 3.0 1.0 3.0 1.0 1.0 1.0 3.0 1.0 3.0 1.0 2.0 1.0 3.0 2.0 1.0 1.0 x 1.0 1.0 1.0 4.0 4.0 3.0 1.0 1.0 1.0 1.0 1.0 2.0 1.0 4.0 3.0 1.0 1.0 4.0 2.0 3.0 1.0 +10679 Original post publication description: Central nervous system, adult neurogenesis: New neurons in dentate gyrus [density index] None Central nervous system, adult neurogenesis: New neurons in dentate gyrus [density index] x x 648.5 135.9 177.2 63.2 363.9 511.3 x 248.9 40.9 143.2 x 462.2 236.3 166.6 225.0 307.8 x 519.2 180.3 x x 312.0 396.4 322.1 158.2 133.0 200.4 244.0 52.8 281.5 146.0 567.0 x x 626.4 145.6 374.9 x 395.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10680 Original post publication description: Amygdala, basolateral complex (LaDL, LaVL, LaVM, BLP, and BLA), glial cell number, unilateral, adjusted for data-collector as a predictor [n] None Central nervous system, morphology, stereology: Amygdala, basolateral complex (LaDL, LaVL, LaVM, BLP, and BLA), glial cell number, unilateral, adjusted for data-collector as a predictor [n] x 27284.0 17084.0 19532.0 24926.0 16106.0 21133.0 12357.0 9823.0 12222.0 17872.0 18271.0 15609.0 17233.0 8971.0 13478.0 8897.0 13880.0 14092.0 10481.0 15060.0 15076.0 x 14305.0 10390.0 15866.0 22010.0 12567.0 14197.0 19676.0 11973.0 14795.0 12840.0 15876.0 15368.0 x 14259.0 11954.0 18934.0 x 12857.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10681 Original post publication description: Amygdala, basolateral complex (LaDL, LaVL, LaVM, BLP, and BLA), total cell number (neurons, glia, and endothelial cells), unilateral without adjustment [n] None Central nervous system, morphology, stereology: Amygdala, basolateral complex (LaDL, LaVL, LaVM, BLP, and BLA), total cell number (neurons, glia, and endothelial cells), unilateral without adjustment [n] x 221979.0 155155.0 160320.0 193887.0 161465.0 162937.0 110008.0 154854.0 166398.0 191778.0 202550.0 173271.0 165921.0 168307.0 154853.0 157273.0 179804.0 168306.0 154443.0 158289.0 130278.0 x 161921.0 142848.0 163329.0 157318.0 147945.0 146161.0 207417.0 169074.0 177990.0 186523.0 153340.0 178442.0 x 135235.0 127721.0 158536.0 x 136131.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10682 Original post publication description: Amygdala, basolateral complex (LaDL, LaVL, LaVM, BLP, and BLA), total cell number (neurons, glia, and endothelial cells), unilateral and adjusted for data-collector as a predictor [n] None Central nervous system, morphology, stereology: Amygdala, basolateral complex (LaDL, LaVL, LaVM, BLP, and BLA), total cell number (neurons, glia, and endothelial cells), unilateral and adjusted for data-collector as a predictor [n] x 204790.0 154952.0 157287.0 193684.0 161263.0 166982.0 114052.0 154652.0 170442.0 185206.0 202348.0 170237.0 165719.0 172352.0 154650.0 157070.0 179602.0 172351.0 154241.0 158087.0 130075.0 x 165966.0 142646.0 167374.0 161363.0 151989.0 150205.0 211461.0 166041.0 177788.0 183490.0 153138.0 177179.0 x 139279.0 127518.0 158334.0 x 140176.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10683 Original post publication description: Amygdala, basolateral complex (LaDL, LaVL, LaVM, BLP, and BLA), non-neuronal cell number (glial and endothelial cells), unilateral [n] None Central nervous system, morphology, stereology: Amygdala, basolateral complex (LaDL, LaVL, LaVM, BLP, and BLA), non-neuronal cell number (glial and endothelial cells), unilateral [n] x 79883.0 36379.0 38193.0 47982.0 30304.0 34269.0 21890.0 20676.0 21600.0 33449.0 33386.0 28294.0 31755.0 16245.0 25181.0 22502.0 29198.0 27772.0 26036.0 31855.0 28051.0 x 22118.0 31578.0 35878.0 40513.0 32483.0 25261.0 38420.0 37409.0 37578.0 38704.0 39941.0 28237.0 x 24280.0 30583.0 41119.0 x 30189.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10684 Original post publication description: Amygdala, basolateral complex (LaDL, LaVL, LaVM, BLP, and BLA), non-neuronal cell number (glial and endothelial cells), unilateral and adjusted for data-collector as a predictor [n] None Central nervous system, morphology, stereology: Amygdala, basolateral complex (LaDL, LaVL, LaVM, BLP, and BLA), non-neuronal cell number (glial and endothelial cells), unilateral and adjusted for data-collector as a predictor [n] x 58250.0 36124.0 34376.0 47727.0 30049.0 39359.0 26980.0 20422.0 26690.0 25177.0 33132.0 24476.0 31500.0 21335.0 24926.0 22247.0 28944.0 32862.0 25782.0 31600.0 27796.0 x 27209.0 31323.0 40969.0 45603.0 37573.0 30351.0 43510.0 33592.0 37324.0 34887.0 39687.0 26647.0 x 29370.0 30328.0 40865.0 x 35279.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10685 Original post publication description: Central nervous system, morphology, aging: Polyglucosan bodies in the hippocampus of 18-month-old females [density] None Central nervous system, morphology, aging: Polyglucosan bodies in the hippocampus of 18-month-old females [density] x x 406.8 5.8 18.9 45.4 9.5 4.2 x 34.4 160.8 9.8 x 22.5 17.8 8.0 133.0 22.6 646.0 43.2 150.0 11.8 x 4.1 2.6 28.4 4.6 5.2 25.4 19.9 1.5 x 194.5 x 40.5 x 68.0 3.25 75.7 x 8.25 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10686 Original post publication description: Central nervous system, morphology, aging: Polyglucosan bodies in 18-month-old females (also see AXB/BXA data) [log number] None Central nervous system, morphology, aging: Polyglucosan bodies in 18-month-old females (also see AXB/BXA data) [log number] x x 2.609 0.763 1.276 1.657 0.978 0.623 x 1.537 2.206 0.991 x 1.352 1.25 0.903 2.124 1.354 2.81 1.635 2.176 1.072 x 0.613 0.415 1.453 0.663 0.716 1.405 1.299 0.176 1.602 2.289 2.301 1.607 x 1.833 0.512 1.879 x 0.916 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10687 Original post publication description: Infectious disease, immune function: Mycoplasmosis susceptibility (M. pulmonis, intranasal 10^4 CFU) 21 days after infection [ratio, death incidence] None Infectious disease, immune function: Mycoplasmosis susceptibility (M. pulmonis, intranasal 10^4 CFU) 21 days after infection [ratio, death incidence] x 0.0 0.0 0.2 0.17 0.2 0.13 0.0 0.11 0.0 0.0 0.1 0.2 0.2 0.0 0.22 0.2 0.0 x 0.13 0.4 0.3 x 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.1 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10688 Original post publication description: Myoplasmosis susceptibility (M. pulmonis, intranasal 10^4 CFU) 21 days post-infection gross pulmonary lesions None Immune system, infectious disease: Myoplasmosis susceptibility (M. pulmonis, intranasal 10^4 CFU) 21 days post-infection gross pulmonary lesions [burden] x 0.1 0.11 0.55 0.83 0.6 0.5 0.5 0.56 0.4 0.11 0.2 0.8 0.6 0.11 0.33 0.6 0.56 x 0.13 0.88 0.6 x 0.44 0.3 0.6 0.86 0.5 0.5 0.3 0.5 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10689 Original post publication description: Mycoplasmosis susceptibility (M. pulmonis, intranasal 10^4 CFU) 21 days post-infection, airway exudate None Mycoplasmosis susceptibility (M. pulmonis, intranasal 10^4 CFU) 21 days post-infection, airway exudate x x 0.07 0.36 0.57 0.44 0.37 0.38 0.45 0.3 0.08 0.13 0.71 0.43 0.11 0.24 0.37 0.44 x 0.14 0.78 0.45 x 0.31 0.29 0.56 0.79 0.36 0.35 0.28 0.34 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10690 Original post publication description: Mycoplasmosis susceptibility (M. pulmonis, intranasal 10^4 CFU) 21 days post-infection, airway epithelial hyperplasia None Infectious disease, immune system: Mycoplasmosis susceptibility (M. pulmonis, intranasal 10^4 CFU) 21 days post-infection, airway epithelial hyperplasia x x 0.05 0.21 0.43 0.25 0.06 0.24 0.25 0.23 0.07 0.05 0.45 0.24 0.12 0.11 0.2 0.34 x 0.0 0.12 0.2 x 0.32 0.22 0.16 0.7 0.25 0.33 0.16 0.27 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10691 Original post publication description: Mycoplasmosis susceptibility (M. pulmonis, intranasal 10^4 CFU) 21 days post-infection, airway lymphoid hyperplasia None Infectious disease, immune function: Mycoplasmosis susceptibility (M. pulmonis, intranasal 10^4 CFU) 21 days post-infection, airway lymphoid hyperplasia x x 0.08 0.32 0.49 0.39 0.24 0.31 0.4 0.31 0.15 0.09 0.63 0.51 0.15 0.14 0.04 0.46 x 0.08 0.46 0.23 x 0.39 0.43 0.24 0.75 0.41 0.4 0.24 0.32 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10692 Original post publication description: Infectious disease, immune function: Mycoplasmosis susceptibility (M. pulmonis, intranasal 10^4 CFU) 21 days post-infection, alveolar exudate [units] None Infectious disease, immune function: Mycoplasmosis susceptibility (M. pulmonis, intranasal 10^4 CFU) 21 days post-infection, alveolar exudate [units] x x 0.05 0.28 0.23 0.33 0.18 0.2 0.25 0.29 0.05 0.12 0.41 0.38 0.06 0.19 0.28 0.36 x 0.03 0.48 0.4 x 0.2 0.16 0.32 0.59 0.25 0.35 0.19 0.21 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10693 Original post publication description: Morphine metabolism, morphine UDP-glucuronyltransferase activity [units] None Morphine metabolism, morphine UDP-glucuronyltransferase activity [units] x x x x x x x x x x 6.391 3.591 x 3.807 1.013 x 4.576 0.899 x 3.31 0.36 x x 3.037 1.653 x x x x x x x 3.591 0.244 x x x x x x 3.591 x x x x x x x x x x x x x x x x x x x x x x x x 1.393 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10694 Original post publication description: Morphine UDP-glucouronytransferease activity [units] None Central nervous system, protein expression: Morphine UDP-glucouronytransferease activity (B3GAT genes) [units] x x x x 6.391 3.807 4.576 3.31 3.037 x x 3.591 x 2.268 2.009 x 5.6 x x 4.246 x x x 3.525 x x x 4.263 x x 3.991 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10695 Original post publication description: Infectious disease, immune function: Lung inflammatory response, pulmonary granulomatous inflammation induced by BCG [units] None Infectious disease, immune system, pulmonary system: Lung inflammatory response, pulmonary granulomatous inflammation induced by BCG [units] x x 22.64 9.099 14.695 16.536 14.607 10.647 12.069 9.949 10.0 14.353 14.099 14.797 11.701 7.718 x 12.259 x x 18.541 7.779 x 9.67 16.624 11.865 7.652 18.579 22.348 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10696 Original post publication description: Spleen weight, splenomegaly induced by BCG [units] None Spleen weight, splenomegaly induced by BCG [units] x x 33.745 5.443 33.284 23.358 14.483 5.304 15.277 8.284 9.133 11.882 17.989 21.679 4.096 6.476 x 9.723 x x 35.627 5.055 x 4.557 13.911 11.624 6.642 14.852 19.502 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10697 Original post publication description: Infectious disease, immune function: Autoimmune disease, spontaneous development of immune response, anti-DNA antibodies sera titers, 13 month females (Fig 7 from Mountz et al., 2005) [natural log of the average sum of IgG1, IgG2a, IgG2b, IgM x10^4, ln of 0 set to 0] None Infectious disease, immune system: Autoimmune disease, spontaneous development of immune response, anti-DNA antibodies sera titers, 13 month females (Fig 7 from Mountz et al., 2005) [natural log of the average sum of IgG1, IgG2a, IgG2b, IgM x10^4, ln of 0 set to 0] x x 3.912 3.689 6.174 8.856 x 7.405 x 5.628 4.19 5.67 x 0.0 3.689 0.0 5.659 0.0 6.328 x 0.0 x x 3.912 5.687 2.996 0.0 4.094 5.521 x 5.606 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10698 Original post publication description: Infectious disease, immune function: Autoimmune disease, rheumatoid factor sera titers, 13 month females (natural log of the average sum of IgG1, IgG2a, IgG2b, IgM x10^4) None Infectious disease, immune system: Autoimmune disease, rheumatoid factor sera titers, 13 month females (natural log of the average sum of IgG1, IgG2a, IgG2b, IgM x10^4) x x 8.745 6.771 6.917 9.13 x 7.243 x 7.095 7.941 6.924 x 6.399 7.175 6.223 6.672 6.033 6.565 x 6.586 x x 7.466 6.599 6.702 5.595 7.17 6.601 x 7.037 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10702 Original post publication description: Cocaine and amphetamine-regulated transcript (CART) expression in hypothalamus [cycles] None Central nervous system, gene expression: Cocaine and amphetamine-regulated transcript (CART) expression in hypothalamus [rtPCR cycles] x x 27.143 27.862 x x 25.832 26.54 26.923 x 26.607 26.79 x 25.388 x 25.795 25.515 26.998 x 24.702 24.515 23.168 x 24.782 27.948 27.396 25.89 25.555 x 25.538 25.075 24.713 28.695 x 24.193 x 25.962 25.655 24.0 x 24.625 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10817 Original post publication description: Iron level in plasma of males [ug/dL] None Blood chemistry: Iron level in plasma of males [ug/dL] x x 133.99 185.47 204.86 150.66 x 170.13 231.86 202.81 183.33 139.13 170.15 180.51 198.0 175.42 180.97 186.07 145.2 174.44 x 180.55 x 190.1 x 201.64 173.95 190.06 x 162.19 172.04 165.4 165.3 x 176.21 x 145.66 197.27 185.21 x 174.99 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10818 Original post publication description: Iron level in spleen of males [ug/g] None Metabolism, physiology, nutrition: Iron level in spleen of males [ug/g] x x 385.82 811.1 423.06 318.64 x 311.34 683.85 783.24 1030.55 671.97 565.97 444.43 1033.67 377.62 715.0 289.37 1595.53 567.83 x 874.93 x 573.01 x 415.31 767.53 1165.92 x 615.58 584.82 793.1 539.07 x 443.64 x 609.76 758.64 530.73 x 226.63 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10815 Original post publication description: Central nervous system, learning and memory: Learning performance measured as the difference in swim path to reach the platform between days 1 and 4 of training using Morris water maze [cm] None Central nervous system, learning and memory: Learning performance measured as the difference in swim path to reach the platform between days 1 and 4 of training using Morris water maze [cm] x x 310.68 45.72 x 277.14 x 346.78 247.07 x x -63.8 x x x x -104.11 -55.06 x x x x x x 353.97 x 407.09 135.78 32.44 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10816 Original post publication description: Central nervous system, learning and memory: Learning measured by the difference in time (latency) to reach the platform between day 1 and day 4 of training using Morris water maze [s] None Central nervous system, learning and memory: Learning measured by the difference in time (latency) to reach the platform between day 1 and day 4 of training using Morris water maze [s] x x 16.49 7.12 x 18.86 x 19.6 17.12 x x -0.16 x x x x 2.43 8.74 x x x x x x 21.73 x 21.19 11.78 13.02 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10812 Original post publication description: Iron level in liver of males [ug/g] None Metabolism, biochemistry: Iron level in liver of males [ug/g] x x 69.82 111.22 77.53 74.37 x 96.36 83.95 75.04 93.44 117.78 71.52 88.16 72.39 79.52 63.21 70.95 147.81 68.94 x 90.22 x 74.16 x 90.39 73.15 85.93 x 102.04 99.63 122.39 113.22 x 95.57 x 61.37 68.06 72.12 x 60.14 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10813 Original post publication description: Iron level in spleen of females [ug/g] None Metabolism, physiology, nutrition: Iron level in spleen of females [ug/g] x x 860.54 995.27 542.28 494.1 x 784.22 1181.4 1311.17 1426.57 759.04 1088.49 774.11 1220.66 711.74 1205.27 574.18 x 754.29 x 1848.53 x 1120.68 x 846.75 921.91 1189.27 x 1162.38 836.93 927.8 747.57 x 773.9 x 1095.0 1282.41 973.58 x 296.73 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10810 Original post publication description: Central nervous system, behavior, learning and memory: Average path length to reach the platform during acquisition of task using Morris water maze [cm] None Central nervous system, behavior, learning and memory: Average path length to reach the platform during acquisition of task using Morris water maze [cm] x x 511.9 667.87 x 448.8 x 545.87 431.97 x x 523.36 x x x x 702.46 649.13 x x x x x x 514.95 x 606.24 642.95 626.08 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10808 Original post publication description: Central nervous system, behavior, learning and memory: Learning performance measured as the latency to reach the platform during acquisition of Morris water maze task [s] None Central nervous system, behavior, learning and memory: Learning performance measured as the latency to reach the platform during acquisition of Morris water maze task [s] x x 21.39 25.42 x 19.4 x 29.27 22.51 x x 27.53 x x x x 37.81 29.27 x x x x x x 20.93 x 25.25 29.27 30.66 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10709 Original post publication description: Central nervous system, adult neurogenesis: New astrocytes in the dentate gyrus [n per gyrus] None Central nervous system, adult neurogenesis: New astrocytes in the dentate gyrus [n per gyrus] x x 33.0 79.0 39.0 53.0 21.0 86.0 x 72.0 51.0 33.0 x 65.0 36.0 30.0 29.0 86.0 x 36.0 46.0 x x 32.0 86.0 36.0 61.0 54.0 53.0 51.0 33.0 34.0 59.0 32.0 x x 41.0 108.0 19.0 x 73.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10710 Original post publication description: Striatum volume, dorsal striatum, bilateral and shrinkage corrected [mm^3] None Central nervous system, morphology: Striatum volume, dorsal striatum of young adults, bilateral and shrinkage corrected [mm^3] x x 23.0 21.39 25.505 20.197 27.27 18.768 21.44 23.974 24.309 20.669 18.857 21.035 21.35 20.869 20.812 22.859 19.768 23.424 25.43 18.924 x 22.433 19.59 19.938 20.123 18.741 19.16 20.33 25.748 23.531 22.67 20.276 21.417 x 19.805 21.827 23.241 x 24.039 21.778 26.3 22.73 x x x x x 24.827 x x x x x x x x 24.055 x 25.336 22.865 x x x x x 22.643 x x x 23.606 x 22.097 x 24.02 x x x x x 23.811 x 22.137 26.518 21.136 x 20.182 22.48 x 21.836 x x x x 21.949 x x x x x x +10711 Original post publication description: Phenyloxazolone hapten-induced Igh-Ox antibody marker level (public idiotype) None Immune system: Phenyloxazolone hapten-induced Igh-Ox antibody marker level (public idiotype)[units] x x 1364.69 57.701 27.576 1335.46 x 682.708 1983.83 58.501 95.828 149.365 494.757 1424.11 135.619 55.259 34.918 1056.04 67.055 747.63 1972.85 942.434 x 47.254 1993.3 2339.99 65.649 1462.76 154.432 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10712 Original post publication description: Cancer susceptibility, skin tumors after initiation with N-methyl-N'-nitro-N-nitrosoguanidine and promotion with phorbol ester, 12-o-tetradecanoylphorbol-13-acetate [n/animal] None Toxicology, cancer biology: Skin tumors after initiation with N-methyl-N'-nitro-N-nitrosoguanidine and promotion with phorbol ester, 12-o-tetradecanoylphorbol-13-acetate [n per case] x x 0.2 1.7 1.89 x 0.0 2.88 4.0 0.0 0.09 0.5 x 0.0 0.0 0.86 1.5 3.56 x 0.1 1.2 0.22 x 0.13 0.17 0.88 0.0 1.38 0.1 x 0.63 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10713 Original post publication description: Development, urogenital system, environmental toxicology: Hydronephrosis induced by gestational tetrachlorodibenzofuran exposure, AHR-dependent (TCDBF, 0.6 mg/kg ip at E12) [%] None Development, urogenital system, environmental toxicology: Hydronephrosis induced by gestational tetrachlorodibenzofuran exposure, AHR-dependent (TCDBF, 0.6 mg/kg ip at E12) [%] x x x x x 17.0 68.0 39.0 31.0 x 53.0 22.0 x 39.0 0.0 47.0 x 0.0 x 4.0 6.0 x x 0.0 x x x 50.0 x 0.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10714 Original post publication description: Musculoskeletal system, development, environmental toxicology: Cleft palate frequency induced by gestational tetrachlorodibenzofuran exposure, AHR-dependent (TCDBF, 0.6 mg/kg ip at E12) [%] None Musculoskeletal system, development, environmental toxicology: Cleft palate frequency induced by gestational tetrachlorodibenzofuran exposure, AHR-dependent (TCDBF, 0.6 mg/kg ip at E12) [%] x x x x x 0.0 100.0 89.0 91.0 x 88.0 71.0 x 100.0 0.0 88.0 x 0.0 x 0.0 0.0 x x 0.0 x x x 100.0 x 0.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10715 Original post publication description: Infectious disease, immune function: Sendai virus lethality with 1.0 TCID50 [% mortality] None Infectious disease, immune system: Sendai virus lethality with 1.0 TCID50 [% mortality] x 0.0 3.0 89.0 0.0 0.0 100.0 33.3 0.0 0.0 0.0 0.0 33.3 33.3 0.0 0.0 100.0 0.0 0.0 66.6 0.0 100.0 x 0.0 0.0 100.0 66.6 100.0 33.3 0.0 33.3 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10716 Original post publication description: Immune function, cancer: Resistance to lymphoma tumors induced by ESb DBA/2 (H-2d) cell transplant [%] None Immune system, cancer: Resistance to lymphoma tumors induced by ESb DBA/2 (H-2d) cell transplant [%] x x 100.0 0.0 65.0 x 21.0 100.0 x 79.0 78.0 x x x x 87.0 71.0 x x 79.0 61.0 x x 70.0 54.0 61.0 35.0 x 76.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10717 Original post publication description: Epidermal ornithine decarboxylase (ODC) activity induced by topical TPA administration None Epidermal ornithine decarboxylase (ODC) activity induced by topical TPA administration x x 36.065 18.652 x x 23.087 x 20.739 x x 20.739 x x 48.261 32.641 x 51.489 x 24.033 11.087 24.978 x x x x x x 34.5 x 28.141 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10718 Original post publication description: Infectious disease, immune function: Leishmania L. mexicana lesion diameter in males None Infectious disease, immune system: Leishmania L. mexicana lesion diameter after subcutaneous injection in males (this entry is missing data) [mm] x x 4.139 0.0 x x 1.39 4.284 0.95 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10719 Original post publication description: Infectious disease, immune function: Leishmania L. mexicana skin lesion diameter in females [mm] None Infectious disease, immune system: Leishmania L. mexicana skin lesion diameter in females [mm] x x 3.892 0.0 x 9.438 1.97 4.332 1.447 x 1.988 4.161 x x x x x x x x x x x 0.418 0.765 3.307 5.929 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10720 Original post publication description: Zinc level in ventral midbrain of males [ug/g] None Central nervous system, metabolism, nutrition: Zinc level in ventral midbrain of males [ug/g] x x x x x 149.52 x 133.91 177.94 x 172.94 150.62 161.37 156.81 x 195.85 x x x x 182.55 x x 180.42 x 190.9 166.7 186.46 x 164.04 186.84 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10721 Original post publication description: Zinc level in ventral midbrain of females [ug/g] None Central nervous system, metabolism, nutrition: Zinc level in ventral midbrain of females [ug/g] x x x x x 170.59 x 144.32 154.43 x 202.17 147.75 184.7 152.93 x 160.81 x x x x 177.96 x x 168.37 x 162.66 192.69 165.58 x 152.53 164.94 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10722 Original post publication description: Zinc levels in nucleus accumbens of males [ug/g] None Central nervous system, metabolism, nutrition: Zinc levels in nucleus accumbens of males [ug/g] x x x x x 153.68 x 170.7 150.03 x 208.74 173.65 180.31 145.47 x 226.41 x x x x 204.03 x x 204.73 x 239.0 206.68 177.51 x 168.61 193.68 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10723 Original post publication description: Zinc level in nucleus accumbens of females [ug/g] None Central nervous system, metabolism, nutrition: Zinc level in nucleus accumbens of females [ug/g] x x x x x 147.18 x 178.7 135.98 x 240.55 167.41 238.01 127.37 x 199.38 x x x x 212.23 x x 212.73 x 182.21 179.17 150.38 x 184.77 205.74 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10724 Original post publication description: Zinc level in medial prefrontal cortex of males [ug/g] None Central nervous system, metabolism, nutrition: Zinc level in medial prefrontal cortex of males [ug/g] x x x x x 199.68 x 244.13 205.22 x 249.67 201.61 216.4 212.34 x 241.08 x x x x 253.03 x x 245.68 x 247.56 217.94 201.92 x 222.9 223.78 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10725 Original post publication description: Zinc level in medial prefrontal cortex of females [ug/g] None Central nervous system, metabolism, nutrition: Zinc level in medial prefrontal cortex of females [ug/g] x x x x x 179.96 x 198.21 211.45 x 238.6 202.93 276.27 189.87 x 186.31 x x x x 244.43 x x 260.38 x 277.28 234.49 256.44 x 216.3 201.08 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10726 Original post publication description: Zinc level in dorsal striatum (caudate putamen) of males [ug/g] None Central nervous system, metabolism, nutrition: Zinc level in dorsal striatum (caudate putamen) of males [ug/g] x x x x x 182.98 x 202.7 217.13 x 243.42 182.11 196.95 173.83 x 221.24 x x x x 223.38 x x 193.24 x 203.63 219.95 320.0 x 196.99 255.18 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10727 Original post publication description: Zinc level in dorsal striatum (caudate putamen) of females [ug/g] None Central nervous system, metabolism, nutrition: Zinc level in dorsal striatum (caudate putamen) of females [ug/g] x x x x x 212.84 x 231.07 183.34 x 233.53 209.86 291.67 162.54 x 199.81 x x x x 217.49 x x 185.85 x 212.26 191.16 223.03 x 197.97 245.29 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10728 Original post publication description: Copper level in ventral midbrain of males [ug/g] None Central nervous system, metabolism, nutrition: Copper level in ventral midbrain of males [ug/g] x x x x x 61.2 x 70.79 76.38 x 58.5 61.36 71.8 58.51 x 69.64 x x x x 70.9 x x 71.75 x 58.91 49.5 64.74 x 63.46 60.08 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10729 Original post publication description: Copper level in ventral midbrain of females [ug/g] None Central nervous system, metabolism, nutrition: Copper level in ventral midbrain of females [ug/g] x x x x x 57.73 x 74.25 63.01 x 78.55 46.63 72.34 58.24 x 68.71 x x x x 74.13 x x 75.22 x 53.1 63.44 84.25 x 70.42 56.39 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10730 Original post publication description: Copper level in nucleus accumbens of males [ug/g] None Central nervous system, metabolism, nutrition: Copper level in nucleus accumbens of males [ug/g] x x x x x 29.88 x 74.49 40.044 x 35.56 24.45 46.61 40.37 x 47.98 x x x x 50.63 x x 28.05 x 103.61 57.09 81.26 x 89.34 51.25 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10731 Original post publication description: Copper level in nucleus accumbens of females [ug/g] None Central nervous system, metabolism, nutrition: Copper level in nucleus accumbens of females [ug/g] x x x x x 34.7 x 86.77 45.14 x 58.89 35.4 62.1 33.52 x 45.26 x x x x 50.67 x x 41.84 x 35.86 44.25 75.93 x 42.02 42.86 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10732 Original post publication description: Copper level in medial prefrontal cortex of males [ug/g] None Central nervous system, metabolism, nutrition: Copper level in medial prefrontal cortex of males [ug/g] x x x x x 45.62 x 73.08 35.43 x 84.01 43.51 65.37 49.51 x 83.37 x x x x 72.03 x x 82.4 x 48.89 69.58 31.48 x 67.82 60.49 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10733 Original post publication description: Copper level in medial prefrontal cortex of females [ug/g] None Central nervous system, metabolism, nutrition: Copper level in medial prefrontal cortex of females [ug/g] x x x x x 38.55 x 45.03 49.33 x 93.36 46.13 62.34 93.94 x 79.53 x x x x 71.04 x x 64.64 x 74.37 61.39 85.1 x 53.04 46.39 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10734 Original post publication description: Copper level in dorsal striatum (caudate putamen) of males [ug/g] None Central nervous system, metabolism, nutrition: Copper level in dorsal striatum (caudate putamen) of males [ug/g] x x x x x 41.1 x 54.34 70.97 x 55.04 52.73 50.95 36.14 x 61.24 x x x x 51.67 x x 62.49 x 49.71 45.91 71.26 x 48.42 66.58 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10735 Original post publication description: Copper level in dorsal striatum (caudate putamen) of females [ug/mg] None Central nervous system, metabolism, nutrition: Copper level in dorsal striatum (caudate putamen) of females [ug/mg] x x x x x 43.04 x 57.17 50.24 x 57.15 51.49 77.19 37.75 x 62.28 x x x x 49.54 x x 57.52 x 44.98 71.22 72.06 x 40.31 38.58 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10736 Original post publication description: Skin tumor incidence following initiation with N-Methyl-N'-nitro-N-nitrosoguanidine and promotion with phorbol ester, 12-o-tetradecanoylphorbol-13-acetate [% mice] None Toxicology, cancer biology: Skin tumor incidence following initiation with N-Methyl-N'-nitro-N-nitrosoguanidine and promotion with phorbol ester, 12-o-tetradecanoylphorbol-13-acetate [% mice] x x 20.0 95.0 78.0 x 0.0 75.0 100.0 0.0 9.0 50.0 x 0.0 0.0 57.0 100.0 100.0 x 10.0 90.0 22.0 x 13.0 8.0 75.0 0.0 88.0 10.0 x 63.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10738 Original post publication description: Dorsal thalamus volume, shrinkage corrected [mm^3] None Central nervous system, morphology: Dorsal thalamus volume of young adults, shrinkage corrected [mm^3] x x 19.194 16.097 20.507 14.104 22.032 14.353 17.757 20.111 18.285 18.78 16.781 19.045 18.192 17.993 15.932 17.498 15.826 16.783 19.291 20.157 x 16.229 16.804 16.723 16.401 15.967 14.11 16.832 18.686 16.419 15.61 17.648 16.733 x 16.157 16.111 19.959 x 19.137 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10737 Original post publication description: Cerebral cortex grey matter volume residuals after adjustment for age [mm^3 residuals] None Central nervous system, morphology: Cerebral cortex grey matter volume residuals after adjustment for age [mm^3 residuals] x x x x 2.619 -0.538 21.425 -15.268 -7.566 25.875 -4.135 1.498 -2.068 9.026 24.222 13.021 3.022 -1.797 -4.767 x 12.923 3.102 x -4.391 -1.041 -16.278 -6.036 -12.216 -24.019 -4.962 -8.868 -7.719 0.553 -6.175 2.427 x -6.443 -2.833 -0.18 x -7.763 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10739 Original post publication description: Musculoskeletal system, morphology: Soleus muscle weight of ~ 200-day-old males [mg] None Musculoskeletal system, morphology: Soleus muscle weight of ~ 200-day-old males [mg] x x x x x 9.48 x 10.0 10.52 x 9.213 7.147 9.213 9.747 x 8.44 x 9.467 x x 6.067 x x 8.427 x 9.373 8.987 11.227 8.0 8.12 6.667 12.653 8.0 x x x 10.04 10.507 6.733 x 8.72 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10740 Original post publication description: Musculoskeletal system, morphology: Soleus weight in 200-day-old females [mg] None Musculoskeletal system, morphology: Soleus weight in 200-day-old females [mg] x x x x x 7.133 x 8.8 8.867 x 7.467 6.853 7.64 7.48 x 6.933 x 7.267 x x 4.507 x x 6.267 x 7.88 8.147 7.813 6.8 6.667 5.733 9.947 6.133 x x x 7.227 7.8 5.76 x 6.907 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10741 Original post publication description: Musculoskeletal system, morphology: Extensor digitorum longus (EDL) muscle weight in 200-day-old males [mg] None Musculoskeletal system, morphology: Extensor digitorum longus (EDL) muscle weight in 200-day-old males [mg] x x x x x 9.707 x 10.787 11.133 x 12.067 8.987 9.48 9.4 x 8.893 x 9.813 x x 8.4 x x 10.213 x 11.0 9.013 12.773 8.547 10.347 8.747 13.467 9.44 x x x 11.627 11.707 8.0 x 9.253 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10742 Original post publication description: Musculoskeletal system, morphology: Extensor digitorum longus (EDL) weight in 200-day-old females [mg] None Musculoskeletal system, morphology: Extensor digitorum longus (EDL) weight in 200-day-old females [mg] x x x x x 8.133 x 9.707 9.267 x 8.947 7.92 8.053 7.6 x 8.267 x 8.133 x x 7.067 x x 8.133 x 8.8 7.387 9.773 7.387 8.427 7.733 10.333 7.6 x x x 9.267 9.093 6.413 x 7.427 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10743 Original post publication description: Musculoskeletal system, morphology: Tibialis anterior (TA) muscle mass in 200-day-old males [mg] None Musculoskeletal system, morphology: Tibialis anterior (TA) muscle mass in 200-day-old males [mg] x x x x x 49.152 x 49.03 55.394 x 52.485 53.333 51.333 52.182 x 52.485 x 49.273 x x 38.727 x x 44.545 x 48.121 48.606 52.424 39.636 44.424 37.758 56.121 48.061 x x x 51.091 51.091 41.333 x 44.848 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10744 Original post publication description: Musculoskeletal system, morphology: Tibialis anterior (TA) weight in 200-day-old females [mg] None Musculoskeletal system, morphology: Tibialis anterior (TA) weight in 200-day-old females [mg] x x x x x 37.212 x 44.485 50.303 x 42.636 46.667 42.424 40.909 x 46.909 x 40.242 x x 32.061 x x 33.394 x 40.667 38.545 42.909 33.939 38.606 37.758 45.576 39.515 x x x 42.667 41.212 34.061 x 40.727 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10745 Original post publication description: Musculoskeletal system, morphology: Gastrocnemius muscle mass of 200-day-old males [mg] None Musculoskeletal system, morphology: Gastrocnemius muscle mass of 200-day-old males [mg] x x x x x 137.444 x 133.333 142.667 x 131.0 131.0 128.333 138.111 x 142.111 x 142.111 x x 110.0 x x 122.222 x 110.0 123.889 135.111 120.111 128.0 102.889 156.667 129.889 x x x 141.0 150.444 114.222 x 120.667 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10746 Original post publication description: Musculoskeletal system, morphology: Gastrocnemius weight in 200-day-old females [mg] None Musculoskeletal system, morphology: Gastrocnemius muscle weight in 200-day-old females [mg] x x x x x 105.333 x 113.333 125.0 x 101.778 115.556 105.333 106.667 x 126.667 x 112.444 x x 92.889 x x 91.444 x 91.778 105.556 111.333 96.333 110.556 94.333 120.444 105.556 x x x 109.0 123.889 90.0 x 107.556 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10747 Original post publication description: Polydipsia, drinking slope (contact G Mittleman, g.mittleman@mail.psyc.memphis.edu) None Polydipsia, drinking slope (contact G Mittleman, g.mittleman@mail.psyc.memphis.edu) x x 0.161 0.041 x x 0.8 0.663 x 0.738 0.8 0.714 1.7 1.667 x x x x x 0.6 x x x 0.657 x 1.018 x 0.873 x 0.967 0.722 0.9 1.122 x 1.683 x 0.714 0.933 1.0 x 1.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10748 Original post publication description: Aortic atherosclerotic lesions following 16-week atherogenic diet in 16-month females [average lesions/strain] None Aortic atherosclerotic lesions following 16-week atherogenic diet in 16-month females [average lesions/strain] x x x x 11.364 x x 38.848 2.242 4.909 55.212 2.121 x 3.939 x 2.242 2.121 8.485 x x 3.182 26.818 x 39.394 6.424 21.939 7.939 0.758 30.515 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10749 Original post publication description: Blood chemistry, metabolism: High-density lipoprotein (HDL) cholesterol level following 16-week high-fat diet [mg/dL] None Blood chemistry, metabolism: High-density lipoprotein (HDL) cholesterol level following 16-week high-fat diet [mg/dL] x x x x 53.908 x x 55.692 40.862 33.169 42.154 38.892 x 98.462 x 54.215 52.308 32.615 x x 43.815 26.092 x 54.462 78.585 100.308 39.938 38.892 47.631 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10750 Original post publication description: HDL cholesterol levels following 16-week chow diet (control group) [mg/dL] None Blood chemistry, metabolism: HDL cholesterol levels following 16-week chow diet (control group) [mg/dL] x x x x 53.347 x x 70.248 54.628 74.339 67.479 51.446 x 73.223 x 45.537 42.769 53.347 x x 56.24 62.479 x 68.182 54.711 76.281 48.43 62.644 43.471 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10751 Original post publication description: LDL cholesterol levels following 16-week chow diet (control group) [mg/dL] None LDL cholesterol levels following 16-week chow diet (control group) [mg/dL] x x x x 6.098 x x 20.031 18.14 9.085 15.163 16.124 x 17.096 x 5.096 8.217 11.214 x x 6.15 16.155 x 16.155 4.041 18.129 15.09 8.145 15.101 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10752 Original post publication description: Metabolism, cardiovascular system: Cholesterol levels following 16-week high-fat diet [natural log of cholesterol levels] None Metabolism, cardiovascular system: Cholesterol levels following 16-week high-fat diet [natural log of cholesterol levels] x x x x 5.0 x x 5.687 5.305 5.432 5.926 7.358 x 5.63 x 5.424 5.309 5.156 x x 5.848 5.778 x 5.737 5.556 6.053 6.136 7.086 5.185 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10753 Original post publication description: Metabolism, cardiovascular system: LDL cholesterol levels following 16-week high-fat diet [natural log of cholesterol levels] None Metabolism, cardiovascular system: LDL cholesterol levels following 16-week high-fat diet [natural log of cholesterol levels] x x x x 4.558 x x 5.479 5.062 5.281 5.835 7.393 x 5.248 x 5.149 5.041 4.959 x x 5.723 5.686 x 5.521 5.281 5.814 6.07 7.124 4.847 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10754 Original post publication description: Cortical grey matter volume (residual mm3 after adjusting for volume of thalamus, coronal plane, from MBL images) None Central nervous system, morphology: Cortical grey matter volume (residual mm3 after adjusting for volume of thalamus, coronal plane, from MBL images) x x 14.714 -11.664 -8.595 13.231 4.261 -2.471 -8.05 16.206 -6.68 -2.978 1.256 3.516 22.04 11.616 9.659 -1.27 2.283 x 6.454 -6.746 x 1.087 2.193 -12.728 -1.229 -5.712 -10.281 -1.837 -12.973 -2.983 8.446 -6.234 5.938 x -0.684 3.105 -9.26 x -13.631 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10755 Original post publication description: Central nervous system, morphology: Hippocampus, dorsal hippocampus volume, age-adjusted residuals [mm^3] None Central nervous system, morphology: Hippocampus, dorsal hippocampus volume, age-adjusted residuals [mm^3] x x 2.05 -0.006 1.666 -1.157 1.292 0.315 -1.458 0.862 2.679 -1.457 -1.097 -0.344 2.303 0.542 -4.256 2.744 -0.282 x 1.256 0.174 x -0.775 -0.927 -1.738 0.299 -2.522 -1.782 -0.816 0.611 0.722 -0.005 -0.514 -0.537 x -0.416 -0.379 2.876 x 1.108 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10756 Original post publication description: Central nervous system, morphology: Hippocampus, ventral hippocampus volume, age-adjusted residuals (V2 Table 2A) [mm^3] None Central nervous system, morphology: Hippocampus, ventral hippocampus volume, age-adjusted residuals (V2 Table 2A) [mm^3] x x 0.8 0.3 4.8 -0.5 1.0 -2.5 0.4 -0.1 0.5 -1.6 -0.8 -0.9 1.5 -0.4 -1.2 3.6 -0.6 x 3.6 0.1 x 0.1 -1.0 -3.4 -1.7 -0.8 -1.0 -0.6 3.3 -2.0 -0.6 -1.3 -0.1 x 0.6 -0.9 2.0 x 0.5 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10757 Original post publication description: Central nervous system, morphology: Hippocampus, ventral hippocampus volume residuals, adjusted for differences in age and brain weight (from V3 Table 2A) [mm^3] None Central nervous system, morphology: Hippocampus, ventral hippocampus volume residuals, adjusted for differences in age and brain weight (from V3 Table 2A) [mm^3] x x 0.9 0.3 4.8 -2.4 1.1 -2.6 0.4 0.1 0.6 -1.5 -0.8 -0.9 1.6 -0.4 -1.2 3.5 -0.6 x 3.6 0.1 x 0.1 -1.1 -3.5 -1.7 -0.9 -1.1 -0.6 3.3 -1.9 -0.7 -1.3 -0.1 x 0.5 -1.0 2.0 x 0.5 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10758 Original post publication description: Musculoskeletal system, morphology: Soleus muscle weight in males at 500 days [mg] None Musculoskeletal system, morphology: Soleus muscle weight in males at 500 days [mg] x x 10.725 8.626 x 9.791 x 11.033 11.835 x 9.022 6.989 x 12.121 x 8.67 x 9.593 x x 5.352 x x 8.022 x 11.352 9.44 12.121 9.374 6.824 7.143 11.407 9.308 x x x 8.769 11.011 8.418 x 9.374 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10759 Original post publication description: Musculoskeletal system, morphology: Soleus muscle weight at ~ 500-days-of-age for females [mg] None Musculoskeletal system, morphology: Soleus muscle weight at ~ 500-days-of-age for females [mg] x x 8.626 7.407 x 6.758 x 9.374 9.418 x 8.89 6.857 x 8.813 x 7.176 x 9.297 x x 4.176 x x 6.352 x 9.791 8.253 8.769 8.121 6.824 5.088 8.725 7.879 x x x 8.945 8.264 6.44 x 8.319 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10760 Original post publication description: Musculoskeletal system, morphology: Extensor digitorum longus (EDL) weight in 500-day-old males [mg] None Musculoskeletal system, morphology: Extensor digitorum longus (EDL) weight in 500-day-old males [mg] x x 12.286 10.703 x 11.022 x 11.978 12.813 x 12.033 10.341 x 11.374 x 9.451 x 12.44 x x 9.451 x x 10.209 x 14.637 9.297 14.088 10.593 12.165 9.451 13.088 11.352 x x x 10.934 12.11 9.264 x 11.374 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10761 Original post publication description: Musculoskeletal system, morphology: Extensor digitorum longus (EDL) muscle weight of 500-day-old females [mg] None Musculoskeletal system, morphology: Extensor digitorum longus (EDL) muscle weight of 500-day-old females [mg] x x 9.187 8.495 x 7.791 x 10.593 11.758 x 11.176 8.176 x 8.736 x 8.714 x 10.659 x x 7.89 x x 8.714 x 11.396 8.011 10.165 9.143 9.363 8.374 11.011 9.824 x x x 9.253 11.033 7.868 x 8.242 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10762 Original post publication description: Musculoskeletal system, morphology: Tibialis anterior muscle weight in 500-day-old males [mg] None Musculoskeletal system, morphology: Tibialis anterior muscle weight in 500-day-old males [mg] x x 56.063 44.528 x 47.953 x 50.433 55.472 x 50.669 50.669 x 56.614 x 51.102 x 50.669 x x 38.398 x x 45.0 x 51.102 43.031 53.858 39.291 49.567 40.354 49.173 51.52 x x x 45.118 51.26 43.819 x 48.622 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10763 Original post publication description: Musculoskeletal system, morphology: Tibialis anterior muscle weight in 500-day-old females [mg] None Musculoskeletal system, morphology: Tibialis anterior muscle weight in 500-day-old females [mg] x x 46.299 40.157 x 35.315 x 41.732 49.685 x 47.835 42.913 x 45.63 x 44.567 x 46.378 x x 31.299 x x 34.685 x 44.016 37.323 41.22 35.63 41.181 34.094 42.874 43.228 x x x 40.472 45.984 34.606 x 40.276 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10764 Original post publication description: Musculoskeletal system, morphology: Gastrocnemius muscle mass of 500-day-old males [mg] None Musculoskeletal system, morphology: Gastrocnemius muscle mass of 500-day-old males [mg] x x 141.604 112.736 x 123.868 x 123.868 141.132 x 116.509 117.358 x 143.113 x 128.491 x 142.453 x x 112.736 x x 114.528 x 112.736 104.623 143.113 110.755 128.491 111.509 126.887 138.679 x x x 118.208 136.321 105.566 x 118.774 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10765 Original post publication description: Musculoskeletal system, morphology: Gastrocnemius muscle mass in 500-day-old females (mg) None Musculoskeletal system, morphology: Gastrocnemius muscle mass in 500-day-old females [mg] x x 120.755 96.321 x 92.547 x 100.283 122.075 x 108.019 105.66 x 122.83 x 118.113 x 124.906 x x 89.245 x x 88.491 x 104.057 96.887 112.547 98.585 112.925 91.038 120.377 114.623 x x x 101.321 125.943 91.792 x 105.566 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10766 Original post publication description: Infectious disease, immune function: Autoimmune disease, spontaneous development of immune response, IgG1-specific anti-DNA serum levels in 13-month-old mice [ELISA OD 450 (x 10^4)] None Infectious disease, immune system: Autoimmune disease, spontaneous development of immune response, IgG1-specific anti-DNA serum levels in 13-month-old mice [ELISA OD 450 (x 10^4)] x x x x 30.968 983.226 x 0.0 x 0.0 19.355 38.71 x 0.0 0.0 0.0 0.0 0.0 34.839 x 0.0 x x 34.839 0.0 34.839 0.0 27.097 0.0 x 46.452 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10767 Original post publication description: Infectious disease, immune function: Autoimmune disease, spontaneous development of immune response, IgG2a-specific anti-DNA serum levels in 13-month-old mice [ELISA OD 450 (x 10^4)] None Infectious disease, immune system: Autoimmune disease, spontaneous development of immune response, IgG2a-specific anti-DNA serum levels in 13-month-old mice [ELISA OD 450 (x 10^4)] x x 13.333 41.111 44.444 861.111 x 288.889 x 288.889 30.0 30.0 x 0.0 52.222 0.0 295.556 0.0 32.222 x 0.0 x x 0.0 0.0 0.0 13.333 13.333 38.889 x 20.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10768 Original post publication description: Infectious disease, immune function: Autoimmune disease, spontaneous development of immune response, IgG2b-specific anti-DNA serum levels in 13-month-old mice [ELISA OD 450 (x 10^4)] None Infectious disease, immune system: Autoimmune disease, spontaneous development of immune response, IgG2b-specific anti-DNA serum levels in 13-month-old mice [ELISA OD 450 (x 10^4)] x x 62.326 0.0 416.744 3823.26 x 0.0 x 0.0 19.535 27.907 x 0.0 0.0 0.0 0.0 0.0 84.651 x 0.0 x x 46.512 50.233 0.0 0.0 50.233 55.814 x 23.256 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10769 Original post publication description: Infectious disease, immune function: Autoimmune disease, spontaneous development of IgM-specific anti-DNA serum levels in 13-month-old mice [ELISA OD 450 (x 10^4)] None Infectious disease, immune system: Autoimmune disease, spontaneous development of IgM-specific anti-DNA serum levels in 13-month-old mice [ELISA OD 450 (x 10^4)] x x 0.0 0.0 28.0 691.0 x 675.0 x 12.0 34.0 111.0 x 0.0 0.0 44.0 0.0 0.0 226.0 x 50.0 x x 0.0 136.0 0.0 44.0 22.0 101.0 x 116.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10770 Original post publication description: Infectious disease, immune function: Autoimmune disease, spontaneous development of immune response, IgG1-specific rheumatoid factor (RF) serum levels in 13-month-old mice [ELISA OD 450 (x 10^4)] None Infectious disease, immune system: Autoimmune disease, spontaneous development of immune response, IgG1-specific rheumatoid factor (RF) serum levels in 13-month-old mice [ELISA OD 450 (x 10^4)] x x 204.706 465.882 308.824 1235.29 x 451.765 x 494.118 425.294 245.294 x 317.647 532.941 335.294 432.353 285.882 114.706 x 337.059 x x 287.647 51.177 377.647 102.353 266.471 460.588 x 536.471 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10771 Original post publication description: Infectious disease, immune function: Autoimmune disease, spontaneous development of immune response, IgG2a-specific rheumatoid factor (RF) serum levels in 13-month-old mice [ELISA OD 450 (x 10^4)] None Infectious disease, immune system: Autoimmune disease, spontaneous development of immune response, IgG2a-specific rheumatoid factor (RF) serum levels in 13-month-old mice [ELISA OD 450 (x 10^4)] x x 126.667 114.0 26.667 231.333 x 160.667 x 115.333 120.0 310.667 x 104.0 426.667 30.0 106.667 62.667 108.667 x 36.0 x x 412.0 16.667 106.667 96.667 15.333 33.333 x 186.667 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10772 Original post publication description: Infectious disease, immune function: Autoimmune disease, spontaneous development of immune response, IgG2b-specific rheumatoid factor (RF) serum levels in 13-month-old mice [ELISA OD 450 (x 10^4)] None Infectious disease, immune system: Autoimmune disease, spontaneous development of immune response, IgG2b-specific rheumatoid factor (RF) serum levels in 13-month-old mice [ELISA OD 450 (x 10^4)] x x 1586.67 366.67 593.333 5386.67 x 253.333 x 200.0 580.0 360.0 x 220.0 360.0 160.0 206.667 120.0 306.667 x 240.0 x x 433.333 700.0 266.667 120.0 700.0 213.333 x 366.67 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10773 Original post publication description: Infectious disease, immune function: Autoimmune disease, spontaneous development of immune response, IgM-specific rheumatoid factor (RF) serum levels in 13-month-old mice [ELISA OD 450 (x 10^4)] None Infectious disease, immune system: Autoimmune disease, spontaneous development of immune response, IgM-specific rheumatoid factor (RF) serum levels in 13-month-old mice [ELISA OD 450 (x 10^4)] x x 2523.08 92.308 134.615 2211.54 x 553.846 x 500.0 1676.92 157.692 x 0.0 80.769 123.077 123.077 107.692 250.0 x 207.692 x x 657.692 138.462 211.538 119.231 430.769 169.231 x 200.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10774 Original post publication description: Infectious disease, immune function: IgG2b anti-AAV2 (adeno-associated virus type 2) response following injection of 3e11 vg/mouse AAV2-(ApoE)4/hAAT-cF.IX, day 0 baseline [ELISA OD 450] None Infectious disease, immune system: IgG2b anti-AAV2 (adeno-associated virus type 2) response following injection of 3e11 vg/mouse AAV2-(ApoE)4/hAAT-cF.IX, day 0 baseline [ELISA OD 450] x x 0.073 0.055 x 0.046 x 0.051 0.49 0.049 0.096 0.063 x x x x x 0.058 x 0.17 0.053 0.054 x x 0.064 x 0.031 x x 0.048 0.041 0.04 x x x x 0.06 x 0.037 x 0.038 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10775 Original post publication description: IgG2b anti-AAV2 (adeno-associated virus type 2) response following injection of 3e11 vg/mouse AAV2-(ApoE)4/hAAT-cF.IX - Day 14 [ELISA OD 450] None Immune system: IgG2b anti-AAV2 (adeno-associated virus type 2) response following injection of 3e11 vg/mouse AAV2-(ApoE)4/hAAT-cF.IX - Day 14 [ELISA OD 450] x x 0.235 0.192 x 0.154 x 0.192 0.231 0.204 0.144 0.129 x x x x x 0.187 x 0.438 0.272 0.225 x x 0.305 x 0.108 x x 0.133 0.077 0.11 x x x x 0.085 x 0.045 x 0.175 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10776 Original post publication description: Infectious disease, immune function: IgG2b anti-AAV2 (adeno-associated virus type 2) immune response following injection of 3xE11 vector genomes vg/mouse AAV2-(ApoE)4/hAAT-cF.IX, on day 42 [ELISA OD 450] None Infectious disease, immune system: IgG2b anti-AAV2 (adeno-associated virus type 2) immune response following injection of 3xE11 vector genomes vg/mouse AAV2-(ApoE)4/hAAT-cF.IX, on day 42 [ELISA OD 450] x x 0.348 0.213 x 0.145 x 0.278 0.214 0.191 0.185 0.106 x x x x x 0.248 x 0.538 0.346 0.251 x x 0.369 x 0.147 x x 0.258 0.129 0.166 x x x x 0.219 x 0.069 x 0.275 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10777 Original post publication description: IgG2b anti-AAV2 (adeno-associated virus type 2) response following injection of 3e11 vg/mouse AAV2-(ApoE)4/hAAT-cF.IX - Day 120 [ELISA OD 450] None IgG2b anti-AAV2 (adeno-associated virus type 2) response following injection of 3e11 vg/mouse AAV2-(ApoE)4/hAAT-cF.IX - Day 120 [ELISA OD 450] x x 0.369 0.166 x 0.139 x 0.25 0.243 0.201 0.154 0.078 x x x x x 0.25 x 0.381 0.253 0.151 x x 0.321 x 0.13 x x 0.258 0.113 0.147 x x x x 0.18 x 0.057 x 0.187 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10778 Original post publication description: IgG2b anti-AAV2 (adeno-associated virus type 2) response following injection of 3xE11 vector genomes (vg) /mouse AAV2-(ApoE)4/hAAT-cF.IX on day 180 [ELISA OD 450] None IgG2b anti-AAV2 (adeno-associated virus type 2) response following injection of 3xE11 vector genomes (vg) /mouse AAV2-(ApoE)4/hAAT-cF.IX on day 180 [ELISA OD 450] x x 0.339 0.166 x 0.231 x 0.229 0.136 0.163 0.115 0.058 x x x x x 0.202 x 0.325 0.244 0.12 x x 0.288 x 0.121 x x 0.216 0.125 0.14 x x x x 0.18 x 0.081 x 0.154 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10779 Original post publication description: Infectious disease, immune function: IgG1 isotype-specific anti-cF.IX (coagulation Factor IX) response following injection of 3e11 vg/mouse AAV2-cF.IX [ELISA OD 450 (x 10^4)] None Infectious disease, immune system: IgG1 isotype-specific anti-cF.IX (coagulation Factor IX) response following injection of 3e11 vg/mouse AAV2-cF.IX [ELISA OD 450 (x 10^4)] x x x x x 173.326 x 482.721 156.048 192.765 133.909 363.931 x x x x x 105.832 x 126.89 65.335 452.484 x x 74.514 x 362.851 x x 105.292 400.108 516.739 x x x x 184.125 x 36.177 x 272.678 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10780 Original post publication description: Coagulation Factor IX (cF.IX) levels following injection of 3e11 vg/mouse AAV2-cF.IX [ng/ml] None Immune function: Antibody IgG1 response following iv injection of canine coagulation factor IX (cF.IX, 3E11 vg/mouse) [ng/ml] x x x x x 48.596 x 471.382 176.026 271.058 207.883 677.106 x x x x x 123.11 x 115.551 160.367 166.847 x x 141.469 x 381.749 x x 77.214 136.069 118.79 x x x x 118.79 x 63.175 x 126.89 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10781 Original post publication description: Central nervous system, behavior: Preference for cinnamon-flavored food with pre-exposure to only plain-flavored food [percentage of total diet] None Central nervous system, behavior, gustation: Preference for cinnamon-flavored food with pre-exposure to only plain-flavored food [percentage of total diet] x x 41.769 25.462 36.769 30.769 18.231 37.538 40.462 27.308 17.077 46.538 x 35.846 x 62.692 24.769 38.077 x 39.231 38.077 x x 28.769 26.538 49.231 18.231 x 18.769 x 5.846 53.692 22.077 49.231 x x 56.154 29.231 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10782 Original post publication description: Preference for cinnamon-flavored food with pre-exposure to cinnamon-flavored food [percentage of total diet] None Central nervous system, behavior, gustation: Preference for cinnamon-flavored food with pre-exposure to cinnamon-flavored food [percentage of total diet] x x 19.522 45.578 38.566 49.562 28.526 22.869 25.976 15.936 40.876 40.717 x 65.976 x 28.446 30.677 35.06 x 37.052 25.657 x x 14.661 16.733 22.47 54.024 x 27.41 x 23.586 67.57 18.167 35.857 x x 51.793 20.319 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10783 Original post publication description: Novel food preference for cinnamon-flavored food [difference score, percentage total diet without pre-exposure minus percentage total diet with pre-exposure to cinnamon] None Novel food preference for cinnamon-flavored food [difference score, percentage total diet without pre-exposure minus percentage total diet with pre-exposure to cinnamon] x x 21.059 -20.249 -2.118 -19.252 -10.779 14.891 14.704 11.34 -23.863 5.421 x -30.218 x x -6.231 3.115 x 5.358 12.71 x x 14.081 10.031 26.231 -36.76 x -8.411 x -17.695 -14.704 4.237 12.648 x x 4.486 9.221 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10784 Original post publication description: Infectious disease, immune function: Autoimmune disease, spontaneous development of generalized Ig to anti-DNA in 13-month-old mice [natural log of total Ig to anti-DNA (ELISA OD 450 x 10^4)] None Infectious disease, immune system: Autoimmune disease, spontaneous development of generalized Ig to anti-DNA in 13-month-old mice [natural log of total Ig to anti-DNA (ELISA OD 450 x 10^4)] x x 3.9 3.733 6.175 14.167 x 7.433 x x 4.2 5.708 x 0.0 3.733 0.0 5.708 0.0 6.375 x 0.0 x x 3.9 5.708 3.05 0.0 4.125 5.55 x 5.658 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10785 Original post publication description: Infectious disease, immune function: Autoimmune disease, spontaneous development of generalized autoimmunity measured as ratio of Ig to rheumatoid factor (RF) in 13-month-old mice [ratio, natural log of total Ig to RF (ELISA OD 450 x 10^4)] None Infectious disease, immune system: Autoimmune disease, spontaneous development of generalized autoimmunity measured as ratio of Ig to rheumatoid factor (RF) in 13-month-old mice [ratio, natural log of total Ig to RF (ELISA OD 450 x 10^4)] x x 8.377 6.785 6.919 9.13 x 7.247 x 7.103 7.955 6.919 x 6.408 7.179 6.238 6.682 6.04 6.57 x 6.605 x x 7.471 6.605 6.695 5.601 7.179 6.605 x 7.031 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10786 Original post publication description: Corticotropin-releasing factor (CRF) transcript abundance in total hypothalamic RNA [detection threshold cycle (higher values correspond to lower abundance)] None Central nervous system, gene expression: Corticotropin-releasing factor (CRF) transcript abundance in total hypothalamic RNA [detection threshold cycle (higher values correspond to lower abundance)] x x 31.032 30.143 31.841 x 30.81 30.94 31.107 x 30.687 30.361 x 31.187 30.194 30.611 30.274 30.81 x 30.778 30.115 31.143 x 30.31 29.817 29.23 30.496 29.437 29.02 28.639 29.325 29.941 30.48 30.345 x x x 29.905 30.044 x 30.56 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10787 Original post publication description: Crf-R1 transcript abundance in total hypothalamic RNA [detection threshold cycle (higher values correspond to lower abundance)] None Central nervous system, pharmacology, genetics: Corticotropin releasing factor receptor 1 (Crf-R1, CRF1, CRHR1) mRNA transcript abundance in total hypothalamic RNA [detection threshold cycle (higher values correspond to lower abundance)] x x 35.373 34.468 x x 34.969 34.468 35.46 x 34.468 34.579 x 33.881 x 35.778 33.365 36.476 x 32.96 33.873 31.595 x 34.095 36.198 34.135 34.969 31.056 x 34.714 31.389 32.079 38.571 x 32.27 x 33.246 34.302 31.794 x 33.27 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10788 Original post publication description: Corticotropin-releasing factor binding protein (Crf-BP) transcript abundance in total hypothalamic RNA [detection threshold cycle (higher values correspond to lower abundance)] None Central nervous system, gene expression: Corticotropin-releasing factor binding protein (CRFBP, CRHBP) mRNA expression level in total hypothalamic RNA [detection threshold cycle (higher values correspond to lower abundance)] x x 32.293 22.973 x x 36.147 31.467 32.813 x 33.347 33.52 x 35.453 x 35.053 35.6 36.6 x 32.973 36.6 35.827 x 35.88 27.693 32.973 19.613 28.8 x 21.867 30.587 29.64 33.907 x 25.44 x 32.253 30.587 28.973 x 26.427 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10789 Original post publication description: Arginine vasopressin (AVP) transcript abundance in total hypothalamic RNA [detection threshold cycle (higher values correspond to lower abundance)] None Central nervous system, gene expression: Arginine vasopressin (AVP) transcript abundance in total hypothalamic RNA [detection threshold cycle (higher values correspond to lower abundance)] x x 24.046 23.377 x x 22.766 24.023 22.766 x 23.914 23.183 x 23.114 x 21.983 22.08 24.709 x 22.28 21.463 21.326 x 23.28 25.543 23.846 22.926 23.034 x 20.943 21.406 21.903 24.686 x 21.743 x 24.017 22.029 21.983 x 22.526 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10790 Original post publication description: Ethanol response, locomotion during 0 to 5 min interval (updated data PMID 9880575) [cm] None Central nervous system, pharmacology, behavior: Ethanol response (1.5 g/kg ip), locomotion during 0 to 5 min interval (updated data PMID 9880575) [cm] x 2220.13 229.56 2286.16 1069.18 x 273.585 220.126 1160.38 301.887 323.899 704.403 864.78 279.874 820.755 1411.95 2251.57 1805.03 1477.99 1358.49 405.66 528.302 x 172.956 452.83 588.05 544.025 261.006 996.855 471.698 1207.55 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10791 Original post publication description: Ethanol response, locomotion during 5 to 10 min interval (updated data PMID 9880575) [cm] None Ethanol response, locomotion during 5 to 10 min interval (updated data PMID 9880575) [cm] x 754.63 560.185 1703.7 458.333 x -342.593 -518.519 1384.26 -2018.52 453.704 1310.19 324.074 356.481 -273.148 1652.78 2129.63 458.333 2245.37 1851.85 -1134.26 185.185 x -435.185 -435.185 1810.19 495.37 689.815 888.889 634.259 680.556 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10792 Original post publication description: Ethanol response, locomotion during 10 to 15 min interval (updated data PMID 9880575) [cm] None Ethanol response, locomotion during 10 to 15 min interval (updated data PMID 9880575) [cm] x 310.185 365.741 1115.74 231.481 x -879.63 -1111.11 1324.07 -2425.93 578.704 578.704 305.556 -134.259 -462.963 1356.48 2254.63 -134.259 1625.0 1675.93 -657.407 -125.0 x -435.185 -680.556 972.222 935.185 490.741 717.593 912.037 912.037 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10793 Original post publication description: Ethanol response, locomotion during 15 to 20 min interval (updated data PMID 9880575) [cm] None Ethanol response, locomotion during 15 to 20 min interval (updated data PMID 9880575) [cm] x 138.889 240.741 763.889 601.852 x -847.222 -1365.74 1120.37 -2078.7 583.333 694.444 -250.0 -625.0 -490.741 1189.81 1828.7 -347.222 1050.93 1578.7 -555.556 -69.444 x -416.667 -671.296 435.185 717.593 69.444 875.0 1152.78 1046.3 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10794 Original post publication description: Ethanol response, adaptation to ethanol defined as 15-20 min interval locomotion minus 0-5 min interval locomotion [cm] None Central nervous system, pharmacology, behavior: Ethanol response, adaptation to ethanol defined as 15-20 min interval locomotion minus 0-5 min interval locomotion [cm] x 2133.84 30.303 1560.61 482.323 x 1156.57 11811.8 55.556 2401.51 -287.879 -37.879 1146.46 931.818 1338.38 232.323 535.354 2212.12 449.495 -232.323 957.071 560.606 x 593.434 1136.36 159.091 -222.222 -333.333 133.838 -719.697 191.919 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10795 Original post publication description: Central nervous system, adult neurogenesis: Cell proliferation in the adult dentate gyrus, Ki67-positive cells [residuals] None Central nervous system, adult neurogenesis: Cell proliferation in the adult dentate gyrus, Ki67-positive cells [residuals] x x x x -1.6 -6.24 -3.37 2.61 x 2.25 -6.45 -3.21 x 5.78 -1.78 0.37 0.54 -0.33 x -1.07 0.59 x x -2.67 6.11 1.96 0.7 2.6 -1.6 -2.47 -2.49 1.72 -4.37 3.46 x x 5.12 -0.82 -1.35 x 2.43 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10796 Original post publication description: Central nervous system, adult neurogenesis: Survival of new cells in the adult dentate gyrus, BrdU-positive cells [residual n] None Central nervous system, adult neurogenesis: Survival of new cells in the adult dentate gyrus, BrdU-positive cells [residual n] x x 0.62 -0.34 -0.66 -0.83 -0.13 0.75 x 0.05 -1.15 -0.36 x 0.83 -0.26 -0.4 -0.25 0.13 x -0.01 -0.14 x x -0.38 0.03 0.05 -0.33 -0.39 -0.25 -0.18 -0.4 0.0 -0.41 0.39 x x 0.63 -0.23 0.35 x 0.36 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10797 Original post publication description: Central nervous system, adult neurogenesis: New neurons in the adult dentate gyrus [BrdU/NeuN; residuals] None Central nervous system, adult neurogenesis: New neurons in the adult dentate gyrus [BrdU/NeuN; residuals] x x 1.03 -0.51 -0.81 -1.57 0.24 0.8 x 0.08 -1.97 -0.46 x 0.69 -0.17 -0.53 -0.27 0.05 x 0.05 -0.43 x x -0.28 0.2 0.23 -0.4 -0.54 -0.4 -0.23 -0.85 0.04 -0.64 0.62 x x 0.91 -0.76 0.5 x 0.21 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10798 Original post publication description: Central nervous system, adult neurogenesis: New astrocyte production level based on ratio of total BrdU cells to S100b+BrdU labeled cells [residuals of the ratio] None Central nervous system, adult neurogenesis: New astrocyte production level based on ratio of total BrdU cells to S100b+BrdU labeled cells [residuals of the ratio] x x -0.32 0.52 0.0 0.16 -0.28 0.64 x 0.29 0.17 -0.3 x 0.31 -0.2 -0.64 -0.43 0.41 x -0.25 -0.09 x x -0.52 0.64 -0.47 0.13 0.0 0.16 0.43 -0.02 -0.71 0.28 -0.25 x x -0.11 0.91 -0.88 x 0.36 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10799 Original post publication description: Eye weight, fresh unfixed, corrected for age [mg] None Eye, visual system: Eye weight, fresh unfixed, corrected for age [mg] x 22.438 20.723 21.891 22.96 22.575 20.14 24.059 22.161 19.647 23.296 21.767 18.47 21.509 23.06 x 21.97 21.2 22.563 18.201 20.862 21.266 x 18.683 19.753 22.421 17.692 22.383 18.64 21.702 22.052 21.076 18.87 20.29 23.709 18.28 22.832 24.534 21.32 x x 23.004 20.975 21.847 x x 23.844 20.75 21.377 21.073 21.64 19.32 26.408 23.082 17.51 x x x 21.868 22.109 21.954 22.842 22.026 22.454 22.271 21.324 23.686 21.929 15.583 23.27 19.32 22.824 19.311 22.243 23.439 24.864 21.936 23.22 23.686 21.06 x 21.477 22.774 22.795 21.603 21.854 24.232 18.572 23.357 23.303 22.798 23.761 x 21.39 21.925 22.878 22.188 23.473 x x x x +10801 Original post publication description: Infectious disease, immune function: Streptococcus pyogenes disease severity, residuals after correction for multiple cofactors [severity scale] None Infectious disease, immune system: Streptococcus pyogenes disease severity, corrected relative survival index (Fig 1A, residuals after correction for age, sex, body weight and log inoculum, with added strains BXD76 and BXD80) [-1 = high susceptible, +1 is resistant] x x -0.047 -0.5 x x x x x -0.35 x x x x x x x x x x x x x x x x x x x x x x 0.39 x x x x x x x x x -0.32 -0.065 x x 0.91 x x 0.22 x x x x x x x x -0.36 -0.39 0.26 x -0.19 x -0.29 x 0.24 0.57 -0.01 0.46 x 0.62 -0.3 -0.42 -0.49 -0.55 x -0.15 -0.355 x x x x 0.47 x 1.08 x 0.44 -0.5 x 1.09 x -0.64 x x -0.49 -0.02 x -0.47 x x x +10803 Original post publication description: Cardiovascular system, morphology: Heart weight without statistical adjustment [mg] None Cardiovascular system, morphology: Heart weight without statistical adjustment (C57BL/6J data looks anomalous) [mg] 118.9 x 122.3 192.4 149.7 165.7 x 131.4 151.5 130.2 156.7 x x 126.3 x x x 101.4 x 169.2 142.5 141.8 x 150.4 x 132.3 x 124.6 x 125.8 122.1 156.5 x x 142.5 x 157.2 150.1 x x x 126.5 122.7 119.1 x x 134.6 x 160.2 140.2 x 181.9 168.4 155.6 x x x x 145.4 129.5 128.6 146.7 147.0 151.1 156.3 125.7 140.8 145.7 148.0 176.7 x 149.3 124.0 132.1 138.4 184.9 125.3 161.3 144.4 x x 135.4 141.0 132.8 180.0 162.3 x 142.9 164.6 142.9 154.6 x x 148.9 137.1 151.2 150.7 148.7 x x x x +12487 Original post publication description: Iron level in ventral midbrain of 120-day-old in females fed 3 ppm Fe diet [µg/g] None Central nervous system, nutrition: Iron level in ventral midbrain of 120-day-old in females fed 3 ppm Fe diet [µg/g] x x 14.1 12.3 16.3 10.7 x 17.0 10.8 16.4 13.4 12.2 13.8 14.2 x 12.0 13.2 13.2 x 12.0 x x x x x x 15.2 13.3 x 18.4 12.5 12.3 15.5 x x x 10.1 13.0 10.3 x 13.2 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12488 Original post publication description: Spleen weight of 120-day-old females fed 3 ppm Fe diet [g] None Spleen weight of 120-day-old females fed 3 ppm Fe diet [g] x x 0.115 0.183 0.068 0.562 x 0.114 0.158 0.241 0.088 0.16 0.209 0.244 x 0.216 0.156 0.352 x 0.466 x x x x x x 0.149 0.144 x 0.041 0.227 0.198 0.071 x x x 0.135 0.113 0.096 x 0.235 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12489 Original post publication description: Iron level in spleen of 120-day-old females fed 3 ppm Fe diet [µg/g] None Iron level in spleen of 120-day-old females fed 3 ppm Fe diet [µg/g] x x 111.3 61.0 195.9 77.6 x 77.8 51.3 86.2 76.5 141.5 57.4 54.8 x 59.2 167.6 28.7 x 37.2 x x x x x x 79.6 64.3 x 268.2 84.9 76.2 164.5 x x x 68.0 99.5 105.9 x 44.3 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12490 Original post publication description: Iron level of liver of 120-day-old females fed 3 ppm Fe diet [µg/g] None Iron level of liver of 120-day-old females fed 3 ppm Fe diet [µg/g] x x 29.1 31.5 31.2 47.4 x 28.7 29.1 27.7 27.5 28.8 27.0 20.5 x 29.8 57.5 23.0 x 29.3 x x x x x x 29.1 26.2 x 42.4 35.3 26.7 113.3 x x x 28.7 24.0 25.5 x 20.4 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10805 Original post publication description: Central nervous system, adult neurogenesis: Rostral migratory stream (RMS) BrdU-labeled cells in adults [number per mm] None Central nervous system, adult neurogenesis: Rostral migratory stream (RMS) BrdU-labeled cells in adults [number per mm] x x 76.0 131.0 x 101.0 x x x 96.0 x x x x x x 83.0 x x x x x x x x x x x x x 91.0 x x x 89.0 x x 114.0 x x x 108.0 88.0 94.0 x x 78.0 x 83.0 54.0 x x x x x x x x 85.0 99.0 97.0 x x 94.0 x 129.0 96.0 126.0 90.0 x x 96.0 104.0 126.0 x 78.0 x x 100.0 x x x x 96.0 92.0 115.0 x 92.0 74.0 94.0 119.0 141.0 x x 103.0 98.0 x x x x x x +10806 Original post publication description: Infectious disease, immune function: Chlamydia psittaci (6BC) infection response (10^4 IFU ip), survival index at 11 days in 2-4 month males [mean score, 0=resistant, 1=weight loss and all survive, 2=weight loss some survive, 3=no survival] None Infectious disease, immune system: Chlamydia psittaci (6BC) infection response (10^4 IFU ip), survival index at 11 days in 2-4 month males [mean score, 0=resistant, 1=weight loss and all survive, 2=weight loss some survive, 3=no survival] x x 0.0 3.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 2.0 x x x 0.0 3.0 0.0 x x x x 0.0 3.0 x x x x 3.0 x x x 0.0 3.0 0.5 x 1.0 x 3.0 x x 0.0 x x x 3.0 x 3.0 x 3.0 x x 3.0 x x 3.0 3.0 3.0 0.0 x x 3.0 x x 3.0 x 3.0 x 3.0 x x x x x x x +10811 Original post publication description: Iron level in spleen of males and females [ug/g] None Metabolism, physiology, nutrition: Iron level in spleen of males and females [ug/g] x x 607.35 899.77 474.15 403.54 x 591.56 958.36 1066.06 1228.56 713.76 922.23 583.91 1108.47 566.96 943.79 426.87 x 657.33 x 1445.66 x 864.32 x 617.55 844.72 1179.65 x 878.05 706.53 860.45 639.46 x 621.47 x 828.9 1028.97 752.16 x 256.29 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10814 Original post publication description: Central nervous system, behavior: average swim speed during acquisition of task using Morris water maze [cm/s] None Central nervous system, behavior: Swimming speed during acquisition of task using Morris water maze [cm/s] x x 24.69 26.03 x 23.96 x 19.36 19.91 x x 18.13 x x x x 18.32 18.55 x x x x x x 26.43 x 25.13 20.27 21.9 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10809 Original post publication description: Iron binding capacity (total iron-binding capacity, TIBC, transferrin level) of males and females [ug/dL] None Blood chemistry: Iron binding capacity (total iron-binding capacity, TIBC, transferrin level) of males and females [ug/dL] x x 405.86 499.9 494.61 571.99 x 447.98 535.23 430.96 384.65 451.14 485.46 530.98 588.62 476.69 509.86 392.74 x 516.44 x 511.89 x 526.13 x 520.23 440.44 477.62 x 523.38 383.28 500.41 443.78 x 379.25 x 433.27 441.1 442.84 x 441.77 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10807 Original post publication description: Central nervous system, learning and memory, adult neurogenesis: percentage of swim path spent in target quadrant [%] None Central nervous system, learning and memory, adult neurogenesis: percentage of swim path spent in target quadrant [%] x x 31.68 23.14 x 34.18 x 37.46 28.65 x x 34.2 x x x x 28.08 37.46 x x x x x x 35.05 x 30.48 37.46 32.23 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10820 Original post publication description: Hematocrit (packed cell volume, erythrocyte volume fraction) in males and females [%] None Blood chemistry: Hematocrit (packed cell volume, erythrocyte volume fraction) in males and females [%] x x 41.53 39.3 46.86 40.94 x 37.02 39.61 42.24 39.52 39.04 46.19 40.72 41.0 43.06 40.0 38.87 x 40.04 x 45.68 x 45.11 x 40.45 44.24 41.59 x 38.46 38.72 40.5 40.14 x 40.66 x 36.03 42.58 34.93 x 41.72 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10821 Original post publication description: Iron level in liver of males and females [ug/g] None Iron level in liver of males and females [ug/g] x x 82.28 136.53 85.89 89.34 x 117.26 117.25 84.85 108.4 131.24 97.3 97.59 79.97 132.04 80.28 92.54 x 88.83 x 95.41 x 100.97 x 107.66 93.55 94.2 x 116.85 134.11 134.32 139.9 x 107.34 x 77.34 86.54 88.94 x 65.93 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10822 Original post publication description: Transferrin saturation of males [%] None Blood chemistry, metabolism: Transferrin saturation of males [%] x x 31.91 42.59 42.41 28.61 x 39.4 41.16 46.55 45.48 27.95 26.45 34.77 30.1 37.9 37.93 51.23 31.8 32.03 x 37.72 x 36.48 x 43.13 39.72 41.77 x 34.31 43.29 36.95 38.0 x 46.87 x 32.32 41.63 43.83 x 39.8 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10823 Original post publication description: Transferrin saturation of males and females [%] None Blood chemistry, metabolism: Transferrin saturation of males and females [%] x x 34.87 39.8 42.47 27.9 x 38.0 40.29 46.88 48.46 30.01 35.17 32.76 28.22 36.87 38.27 42.46 x 31.69 x 36.28 x 33.94 x 42.46 39.16 38.99 x 31.77 44.51 33.19 41.19 x 44.26 x 32.19 41.85 40.24 x 39.98 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10824 Original post publication description: Central nervous system, behavior: Locomotor performance, duration on an accelerating rotarod, mean of three trials [s] None Central nervous system, behavior: Locomotor performance, duration on an accelerating rotarod, mean of three trials [s] x x 77.8 32.4 x 48.94 x 45.15 52.75 x x 70.75 x x x x 45.45 50.2 x x x x x x 91.56 x 36.31 66.0 69.42 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10825 Original post publication description: Hemoglobin in males [g/dL] None Blood chemistry: Hemoglobin in males [g/dL] x x 13.63 14.34 13.7 14.15 x 13.62 14.02 13.47 13.0 13.69 10.75 14.04 14.57 15.11 13.46 13.72 14.1 13.47 x 14.79 x 14.91 x 13.66 14.81 15.16 x 14.89 12.21 13.28 14.59 x 13.33 x 12.97 13.43 12.49 x 13.28 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10826 Original post publication description: Blood chemistry, cardiovascular system: Hemoglobin in males and females [g/dL] None Blood chemistry, cardiovascular system: Hemoglobin in males and females [g/dL] x x 13.28 13.5 13.91 13.84 x 13.21 13.46 13.83 12.64 13.38 15.76 14.62 14.94 14.78 13.48 12.91 x 13.41 x 14.79 x 14.53 x 13.76 15.33 14.65 x 14.64 12.59 13.71 14.69 x 13.31 x 12.3 13.26 11.6 x 13.22 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10827 Original post publication description: Blood chemistry, metabolism: Iron binding capacity (systemic, total iron-binding capacity, TIBC, transferrin level) of males [ug/dL] None Blood chemistry, metabolism: Iron binding capacity (systemic, total iron-binding capacity, TIBC, transferrin level) of males [ug/dL] x x 427.91 418.69 507.52 540.17 x 452.83 568.56 412.65 424.63 512.82 655.2 545.96 649.53 467.31 482.24 373.37 460.93 537.41 x 506.46 x 517.26 x 481.24 437.83 475.98 x 501.26 381.27 472.93 421.39 x 377.46 x 458.63 464.6 428.13 x 462.24 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10828 Original post publication description: Iron level in plasma of females [g/dL] None Blood chemistry: Iron level in plasma of females [g/dL] x x 133.96 213.66 191.86 163.39 x 142.49 195.61 183.71 181.07 127.25 163.88 138.06 127.8 178.12 190.96 141.17 x 145.98 x 180.83 x 161.31 x 207.75 177.56 164.6 x 147.04 166.63 153.13 190.61 x 159.51 x 134.29 163.68 152.65 x 166.23 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10829 Original post publication description: Iron level in plasma of males and females [ug/dL] None Blood chemistry: Iron level in plasma of males and females [ug/dL] x x 133.97 198.0 199.77 157.24 x 154.77 212.53 192.62 181.07 133.43 165.55 165.08 169.92 176.95 186.13 163.62 x 160.83 x 180.72 x 175.37 x 204.42 175.76 175.4 x 155.52 169.62 159.26 177.11 x 167.57 x 140.16 179.93 170.09 x 171.23 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10830 Original post publication description: Transferrin saturation of females [%] None Blood chemistry, metabolism: Transferrin saturation of females [%] x x 38.03 36.71 42.58 27.19 x 36.89 39.73 47.15 51.71 32.45 38.7 29.24 25.4 36.09 38.62 33.07 x 31.34 x 35.16 x 31.64 x 41.65 38.63 37.19 x 28.55 45.83 29.43 44.59 x 41.66 x 32.04 42.04 36.08 x 40.23 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10831 Original post publication description: Iron binding capacity (total iron-binding capacity, TIBC, transferrin level) of females [ug/dL] None Blood chemistry: Iron binding capacity (total iron-binding capacity, TIBC, transferrin level) of females [ug/dL] x x 380.87 587.28 474.53 605.93 x 444.1 512.32 446.05 336.68 372.64 417.56 507.68 497.25 483.99 537.48 413.51 x 495.48 x 515.89 x 534.23 x 561.66 442.92 478.83 x 551.52 385.6 527.9 469.37 x 380.81 x 404.29 418.97 459.81 x 413.85 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10832 Original post publication description: Hemoglobin in females [g/dL] None Blood chemistry, hematology: Hemoglobin in females [g/dL] x x 12.91 12.63 14.22 13.51 x 13.09 13.0 14.18 12.28 13.0 16.26 15.46 15.5 14.54 13.5 12.04 x 13.34 x 14.93 x 14.15 x 13.88 15.81 14.29 x 14.32 13.02 13.71 14.79 x 13.3 x 11.55 13.11 10.59 x 13.13 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10833 Original post publication description: Hematocrit (packed cell volume, erythrocyte volume fraction) in males [%] None Blood chemistry: Hematocrit (packed cell volume, erythrocyte volume fraction) in males [%] x x 40.93 36.43 47.69 43.06 x 38.91 41.64 42.2 38.92 40.21 32.0 39.64 39.67 42.79 39.06 42.75 40.0 39.31 x 45.53 x 47.96 x 38.94 42.76 45.29 x 38.86 39.47 44.25 38.6 x 41.29 x 36.94 42.0 37.44 x 42.06 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10834 Original post publication description: Hematocrit (packed cell volume, erythrocyte volume fraction) in females [%] None Blood chemistry, cardiovascular system: Hematocrit (packed cell volume, erythrocyte volume fraction) in females [%] x x 42.13 42.58 42.22 38.67 x 36.56 37.94 42.29 40.18 37.67 47.5 42.09 41.0 43.26 40.94 34.73 x 40.91 x 45.79 x 42.14 x 42.06 45.74 39.0 x 38.0 37.93 36.75 41.79 x 40.07 x 35.0 43.13 32.07 x 41.25 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10835 Original post publication description: Iron level in liver of females [ug/g] None Iron level in liver of females [ug/g] x x 96.4 169.68 98.89 104.32 x 133.98 144.67 94.02 124.73 146.94 116.92 113.58 91.35 167.98 98.49 112.69 x 112.35 x 99.73 x 124.43 x 127.24 110.89 100.29 x 134.13 171.05 146.25 170.13 x 118.33 x 94.38 105.02 108.35 x 74.36 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10836 Original post publication description: Infectious disease susceptibility: Streptococcus pyogenes disease index [ordinal scale] None Infectious disease, immune system: Streptococcus pyogenes disease severity, corrected relative survival index (differs from Fig 1A slightly, residuals after correction for age, sex, body weight and log inoculum, with added strain BXD80) [-1 = high susceptible, +1 is resistant] x x 1.779 1.415 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 2.093 1.078 1.815 x x 2.027 x x 1.386 x x x x x x x x 1.224 1.298 1.751 x 1.306 x 0.957 x 2.017 2.5 1.427 2.142 x 2.411 1.481 1.289 x x x 2.076 1.714 x x x x 2.144 x 2.818 x 2.297 1.276 x 2.58 x 1.454 x x 0.997 2.5 x x x x x +12492 Original post publication description: Blood chemistry, cardiovascular system: Hematocrit of 120-day-old females fed 3 parts per million iron (ppm Fe) diet [% packed red blood cells] None Blood chemistry, cardiovascular system: Hematocrit of 120-day-old females fed 3 parts per million iron (ppm Fe) diet [% packed red blood cells] x x 38.4 37.0 38.0 34.2 x 36.6 22.8 33.2 38.6 32.1 35.8 41.5 x 32.8 42.3 24.0 x 22.5 x x x x x x 36.7 34.5 x 39.3 38.2 37.0 44.0 x x x 35.6 32.1 34.7 x 25.4 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12493 Original post publication description: Body weight of 120-day-old females fed 3 ppm Fe diet [g] None Morphology, nutrition: Body weight of 120-day-old females fed 3 ppm Fe diet [g] x x 21.1 23.6 19.8 24.9 x 24.8 20.8 25.1 22.5 19.5 24.5 24.9 x 28.6 33.5 24.0 x 20.2 x x x x x x 22.9 22.2 x 23.6 24.9 19.5 25.3 x x x 22.1 23.1 22.1 x 22.7 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12491 Original post publication description: Blood chemistry, cardiovascular system, nutrition: Hemoglobin of 120-day-old females fed 3 ppm iron (Fe) diet [ug/dl] None Blood chemistry, cardiovascular system, nutrition: Hemoglobin of 120-day-old females fed 3 ppm iron (Fe) diet [ug/dl] x x 8.9 8.9 9.2 8.2 x 8.3 4.5 8.3 9.5 7.0 12.0 9.5 x 7.1 12.6 4.8 x 4.5 x x x x x x 8.5 7.2 x 13.6 9.1 8.6 10.8 x x x 8.5 8.9 8.7 x 5.8 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12640 Original post publication description: Anxiety assay (S5_PTR), restraint stress (15 min) + saline treated (0.018 mL/g i.p.), percent time spent (sec) without locomotion in the light side of light-dark box in 8-12 week-old males during 5 min session [n %]. None Central nervous system, behavior, pharmacology: Anxiety assay (S5_PTR), restraint stress (15 min) + saline treated (0.018 mL/g i.p.), percent time spent (sec) without locomotion in the light side of light-dark box in 8-12 week-old males during 5 min session [n %]. x x 9.08 11.848 7.496 8.1 1.041 4.996 12.762 11.181 0.639 15.7 x 5.194 8.213 23.29 3.348 6.389 7.424 19.824 10.448 6.257 x x x 1.7 0.944 x x 8.496 8.025 7.354 7.244 x 4.815 x 7.586 0.958 x x 10.559 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10984 Original post publication description: Anxiety assay (E10_TLA), restraint stress (15 min) + ethanol treated (1.8 g/kg i.p.), total distance traveled in light-dark box, using 8-12 week-old males during 10 min session [n cm]. None Central nervous system, pharmacology, behavior: Anxiety assay (E10_TLA), restraint stress (15 min) + ethanol treated (1.8 g/kg i.p.), total distance traveled in light-dark box, using 8-12 week-old males during 10 min session [cm] x x 2538.23 3539.62 4208.19 3025.98 1114.16 3942.18 2829.21 2799.54 2457.24 3444.01 x 3353.31 3119.24 3055.16 4828.09 3165.43 3371.16 2966.15 1845.94 2921.62 x x x 2447.56 1943.92 x x 2981.95 3794.69 2435.22 2972.78 x 3479.25 x 3333.48 1668.42 x x 4491.54 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10982 Original post publication description: Anxiety assay (E10_PDT), restraint stress (15 min) + ethanol treated (1.8 g/kg i.p.), percent distance traveled in light side (cm) using a light-dark box in 8-12 week-old males during 10 min session [n %]. None Central nervous system, behavior, pharmacology: Anxiety assay (E10_PDT), restraint stress (15 min) + ethanol treated (1.8 g/kg i.p.), percent distance traveled in light side (cm) using a light-dark box in 8-12 week-old males during 10 min session [%] x x 41.393 32.543 51.612 54.307 42.156 47.588 37.965 29.171 30.413 60.671 x 41.866 43.132 51.213 54.276 34.034 41.365 44.076 26.278 44.246 x x x 27.206 24.952 x x 34.305 31.229 54.844 43.86 x 21.746 x 33.285 30.388 x x 47.312 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12623 Original post publication description: Ethanol response (10% EtOH in tap water) average daily consumption, two bottle choice [g/kg], males None Central nervous system, pharmacology, behavior: Ethanol response (10% EtOH in tap water) average daily consumption, two bottle choice [g/kg], males x x x x 3.76 x x 5.1 x x 2.62 x 1.15 4.71 x 4.67 x 2.28 x x 0.4 x 3.28 3.99 x 4.79 x x x 4.88 x x 2.16 x 2.37 x 3.42 x 3.23 x 3.06 8.38 7.42 x x x x x x 4.5 x x x 3.86 4.91 x x x 7.11 x x x x x 1.93 x 3.7 4.52 6.34 1.66 x 2.8 x 2.82 x 2.73 x 8.17 6.24 x x 1.31 5.96 3.67 1.97 3.75 x 3.82 4.81 x 3.16 x x x x x x x 5.97 x x x +10979 Original post publication description: Anxiety assay (S10_NR), restraint stress (15 min) + saline treated (0.018 mL/g i.p.), number of rears in the light side using a light-dark box in 8-12 week-old males during 10 min session [n beam breaks]. None Central nervous system, behavior, pharmacology: Anxiety assay (S10_NR), restraint stress (15 min) + saline treated (0.018 mL/g i.p.), number of rears in the light side using a light-dark box in 8-12 week-old males during 10 min session [n beam breaks]. x x 23.933 34.875 11.333 10.714 2.0 21.75 36.143 30.0 1.0 35.5 x 9.0 20.125 28.571 11.286 19.556 12.429 39.429 4.0 11.286 x x x 3.714 x x x 12.875 21.125 11.375 17.667 x 6.111 x 14.714 2.0 x x 40.111 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12634 Original post publication description: Anxiety assay (E5_TS), restraint stress (15 min) + ethanol treated (1.8 g/kg i.p.), time spent in light side using a light-dark box in 8-12 week-old males during 5 min [n sec]. None Central nervous system, pharmacology, behavior: Anxiety assay (E5_TS), restraint stress (15 min) + ethanol treated (1.8 g/kg i.p.), time spent in light side using a light-dark box in 8-12 week-old males during 5 min [sec] x x 144.8 116.331 187.325 212.325 140.1 172.45 133.662 87.717 113.117 194.157 x 155.914 143.988 200.55 219.875 122.05 163.986 182.757 115.65 143.767 x x x 89.55 89.25 x x 136.629 84.263 180.475 158.7 x 84.583 x 127.338 96.633 x x 174.988 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10978 Original post publication description: Anxiety assay (S10_NT), restraint stress (15 min) + saline treated (0.018 mL/g i.p.), number of entries into light side of light-dark box, using 8-12 week-old males during 10 min session [n entries]. None Central nervous system, pharmacology, behavior: Anxiety assay (S10_NT), entries into light side of light-dark box after restraint stress (15 min) and saline control injection (0.018 ml/g ip) in 8-12 week-old males during a 10 min test [n] x x 20.733 33.063 24.556 24.286 8.889 20.625 22.286 30.714 3.333 21.375 11.75 22.167 28.375 21.0 x 34.111 13.0 37.0 18.0 14.143 x x x 7.429 3.667 x x 17.625 17.875 12.125 20.333 x 16.333 x 19.714 5.75 x x 37.333 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12643 Original post publication description: Anxiety assay (S5_TS), restraint stress (15 min) + saline treated (0.018 mL/g i.p.), time spent in light side using a light-dark box in 8-12 week-old males during 5 min [n sec]. None Central nervous system, behavior, pharmacology: Anxiety assay (S5_TS), restraint stress (15 min) + saline treated (0.018 mL/g i.p.), time spent in light side using a light-dark box in 8-12 week-old males during 5 min [n sec]. x x 75.173 78.369 68.222 79.357 8.433 39.538 81.986 68.757 5.867 110.0 x 46.117 50.487 127.243 34.371 46.678 49.843 116.814 60.871 41.529 x x x 12.443 7.011 x x 54.025 50.438 52.788 55.1 x 39.356 x 53.886 7.862 x x 100.033 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10975 Original post publication description: Anxiety assay (S10_TLA), restraint stress (15 min) + saline treated (0.018 mL/g i.p.), total distance traveled in light-dark box, using 8-12 week-old males during 10 min session [n cm]. None Central nervous system, pharmacology, behavior: Anxiety assay (S10_TLA), restraint stress (15 min) and saline treated (0.018 ml/g ip), distance traveled in light-dark box, 8-12 week-old males during a 10 min session [cm] x x 2257.13 2248.7 2499.44 2141.28 879.617 2348.46 1462.39 1806.77 583.32 2661.98 x 1893.22 2169.0 1620.3 2080.8 2006.74 1149.83 2277.4 1371.43 1332.59 x x x 676.619 661.988 x x 1550.01 1900.54 1263.98 1885.71 x 2095.34 x 1833.82 794.588 x x 3148.48 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10973 Original post publication description: Anxiety assay (S10_PDT), restraint stress (15 min) + saline treated (0.018 mL/g i.p.), percent distance traveled in light side (cm) using a light-dark box in 8-12 week-old males during 10 min session [n %]. None Central nervous system, behavior, pharmacology: Anxiety assay (S10_PDT), restraint stress (15 min) + saline treated (0.018 mL/g i.p.), percent distance traveled in light side (cm) using a light-dark box in 8-12 week-old males during 10 min session [n %]. x x 27.759 27.025 19.83 30.325 6.859 23.304 34.103 28.758 7.199 35.379 x 16.975 25.969 35.477 18.288 24.102 22.176 37.981 21.512 20.338 x x x 12.369 4.405 x x 24.061 19.774 27.251 24.165 x 13.984 x 24.446 7.098 x x 32.963 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12712 Original post publication description: Infectious disease, immune function: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) interleukin-5 from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control] None Infectious disease, immune function: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) interleukin-5 from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control] x 5.922 100.0 11.175 x x x x x x 7.87 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 8.584 1.245 4.312 69.422 x x x 32.543 65.329 x x x x 5.91 6.172 x x x 8.861 38.63 216.377 x x x x x x 96.705 1.081 x x x 23.349 x x 4.084 x x 32.295 x x 6.431 x x x x x 3.24 x x x x x x 49.312 x x x x x x x +12631 Original post publication description: Anxiety assay (E5_PTR), restraint stress (15 min) + ethanol treated (1.8 g/kg i.p), percent time spent (sec) without locomotion in the light side of light-dark box in 8-12 week-old males during 5 min session [n %]. None Central nervous system, behavior, pharmacology: Anxiety assay (E5_PTR), restraint stress (15 min) + ethanol treated (1.8 g/kg i.p), percent time spent (sec) without locomotion in the light side of light-dark box in 8-12 week-old males during 5 min session [n %]. x x 19.219 15.192 16.721 31.371 30.138 21.104 15.625 11.556 16.728 25.252 x 16.914 19.158 27.183 23.25 17.062 20.757 26.362 19.129 19.639 x x x 12.7 12.996 x x 19.552 10.046 24.825 23.021 x 8.5 x 15.433 14.283 x x 17.579 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12632 Original post publication description: Anxiety assay (E5_PTS), restraint stress (15 min) + ethanol treated (1.8 g/kg i.p.), percent time spent in light side (sec) using a light-dark box in 8-12 week-old males during 5 min session [n %]. None Central nervous system, pharmacology, behavior: Anxiety assay (E5_PTS), restraint stress (15 min) + ethanol treated (1.8 g/kg i.p.), percent time spent in light side (sec) using a light-dark box in 8-12 week-old males during 5 min session [%] x x 48.267 38.777 62.442 70.775 46.7 57.483 44.554 29.239 37.706 64.719 x 51.971 47.996 66.85 73.292 40.683 54.662 60.919 38.55 47.922 x x x 29.85 29.75 x x 45.543 28.087 60.158 52.9 x 28.194 x 42.446 32.211 x x 58.329 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10970 Original post publication description: Anxiety assay (E5_NR), restraint stress (15 min) + ethanol treated (1.8 g/kg i.p.), number of rears in the light side using a light-dark box in 8-12 week-old males during 5 min session [n beam breaks] None Anxiety assay (E5_NR), restraint stress (15 min) + ethanol treated (1.8 g/kg i.p.), number of rears in the light side using a light-dark box in 8-12 week-old males during 5 min session [n beam breaks] x x 9.75 18.769 14.625 11.125 3.143 12.25 13.375 11.333 6.833 35.143 x 18.429 7.625 13.0 15.0 8.625 19.857 15.0 6.75 7.5 x x x 6.5 2.375 x x 6.0 10.25 14.75 13.25 x 8.833 x 1.75 8.667 x x 33.25 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12638 Original post publication description: Anxiety assay (E10_TR), restraint stress (15 min) + ethanol treated (1.8 g/kg i.p.), time spent without locomotion in the light side of light-dark box in 8-12 week-old males during 10 min session [n sec]. Central nervous system, pharmacology, behavior: Anxiety assay (E10_TR), restraint stress (15 min) + ethanol treated (1.8 g/kg i.p.), time spent without locomotion in the light side of light-dark box in 8-12 week-old males during 10 min session [n sec] Central nervous system, pharmacology, behavior: Anxiety assay (E10_TR), restraint stress (15 min) + ethanol treated (1.8 g/kg i.p.), time spent without locomotion in the light side of light-dark box in 8-12 week-old males during 10 min session [n sec] x x 99.987 73.246 73.975 163.05 171.686 98.412 61.575 64.317 75.4 22.629 x 84.8 100.35 152.113 105.775 88.237 58.014 108.357 81.912 90.15 x x x 59.612 44.112 x x 100.614 62.337 161.512 122.025 x 34.65 x 61.55 69.567 x x 91.6 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12639 Original post publication description: Anxiety assay (E10_PTR), restraint stress (15 min) + ethanol treated (1.8 g/kg i.p.), percent time spent (sec) without locomotion in the light side of light-dark box in 8-12 week-old males during 10 min session [n %]. Central nervous system, pharmacology, behavior: Anxiety assay (E10_PTR), restraint stress (15 min) + ethanol treated (1.8 g/kg i.p.), percent time spent (sec) without locomotion in the light side of light-dark box in 8-12 week-old males during 10 min session [n %] Central nervous system, pharmacology, behavior: Anxiety assay (E10_PTR), restraint stress (15 min) + ethanol treated (1.8 g/kg i.p.), percent time spent (sec) without locomotion in the light side of light-dark box in 8-12 week-old males during 10 min session [n %] x x 33.329 24.415 24.658 54.35 57.229 32.804 20.525 21.439 25.133 7.543 x 28.267 33.45 50.704 35.258 29.413 19.338 36.119 27.304 30.05 x x x 19.871 14.704 x x 33.538 20.779 53.837 40.675 x 11.55 x 20.517 23.189 x x 30.533 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10969 Original post publication description: Anxiety assay (E5_NT) , restraint stress (15 min) + ethanol treated (1.8 g/kg i.p.), number of entries into light side of light-dark box, using 8-12 week-old males during 5 min session [n entries]. None Central nervous system, pharmacology, behavior: Anxiety level following restraint stress (15 min) and ethanol treatment (1.8 g/kg i.p., E5 NT group) measured as the number of entries into light side of light-dark box in 8-12 week-old males (5 min session) [n] x x 15.5 19.077 21.125 12.5 7.429 22.0 21.125 14.0 11.167 9.857 x 17.429 15.125 12.125 12.0 12.0 14.0 14.143 11.375 14.667 x x x 12.375 13.375 x x 9.286 18.125 13.625 11.25 x 12.667 x 16.25 11.5 x x 21.25 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10966 Original post publication description: Anxiety assay (E5_TLA), restraint stress (15 min) + ethanol treated (1.8 g/kg i.p.), total distance traveled in light-dark box, using 8-12 week-old males during 5 min session [n cm]. None Anxiety assay (E5_TLA), restraint stress (15 min) + ethanol treated (1.8 g/kg i.p.), total distance traveled in light-dark box, using 8-12 week-old males during 5 min session [n cm]. x x 1562.29 1894.02 2293.85 1610.76 864.433 2005.05 1796.43 1404.06 1370.9 1764.78 x 1952.68 1609.46 1542.4 2519.68 1618.42 1836.63 1575.04 959.035 1685.44 x x x 1383.49 1284.67 x x 1576.17 1906.79 1483.2 1594.09 x 1985.53 x 1769.5 1101.41 x x 2438.62 x x x x x 2346.97 x 2287.76 x x x x x x x x x x x x 964.198 x x 1564.71 1214.91 x x 1495.34 x x x x 1382.2 x x x x x x x x x x x x x x 2631.01 x x x x x x x 2511.43 x x x x x +10964 Original post publication description: Anxiety assay (E5_PDT), restraint stress (15 min) + ethanol treated (1.8 g/kg i.p.), percent distance traveled in light side (cm) using a light-dark box in 8-12 week-old males during 5 min session [n %]. Central nervous system, pharmacology, behavior: Anxiety assay (E5_PDT), after restraint stress (15 min) with ethanol treatment (1.8 g/kg i.p.), percent distance traveled in light side (cm) using a light-dark box in 8-12 week-old males during 5 min session [%] Central nervous system, pharmacology, behavior: Anxiety assay (E5_PDT), after restraint stress (15 min) with ethanol treatment (1.8 g/kg i.p.), percent distance traveled in light side (cm) using a light-dark box in 8-12 week-old males during 5 min session [%] x x 45.784 37.126 63.005 64.8 49.976 56.924 45.156 30.137 36.471 64.762 x 48.449 46.517 58.562 68.62 37.274 48.779 56.771 33.143 48.495 x x x 29.73 32.681 x x 42.209 29.919 57.416 50.539 x 29.627 x 43.82 33.13 x x 55.564 x x x x x 38.536 x 36.1 x x x x x x x x x x x x 27.962 x x 35.01 18.174 x x 48.489 x x x x 26.263 x x x x x x x x x x x x x x 49.749 x x x x x x x 42.78 x x x x x +12641 Original post publication description: Anxiety assay (S5_PTS), restraint stress (15 min) + saline treated (0.018 mL/g i.p.), percent time spent in light side (sec) using a light-dark box in 8-12 week-old males during 5 min session [n %]. None Central nervous system, behavior, pharmacology: Anxiety assay (S5_PTS), restraint stress (15 min) + saline treated (0.018 mL/g i.p.), percent time spent in light side (sec) using a light-dark box in 8-12 week-old males during 5 min session [n %]. x x 25.058 26.123 22.741 26.452 2.811 13.179 27.329 22.919 1.956 36.667 x 15.372 16.829 42.414 11.457 15.559 16.614 38.938 20.29 13.843 x x x 4.148 2.337 x x 18.008 16.812 17.596 18.367 x 13.119 x 17.962 2.621 x x 33.344 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10960 Original post publication description: Anxiety assay (S5_NT), restraint stress (15 min) + saline treated (0.018 mL/g i.p.), number of entries into light side of light-dark box, using 8-12 week-old males during 5 min session [n entries] None Anxiety assay (S5_NT), restraint stress (15 min) + saline treated (0.018 mL/g i.p.), number of entries into light side of light-dark box, using 8-12 week-old males during 5 min session [n entries] x x 11.6 17.875 16.222 14.571 3.889 8.25 11.429 11.571 2.667 11.5 x 14.667 12.75 10.286 9.714 15.0 11.143 18.857 10.429 8.286 x x x 4.714 3.0 x x 7.5 9.125 6.125 11.222 x 11.333 x 9.571 3.125 x x 19.333 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10961 Original post publication description: Anxiety assay (S5_NR), restraint stress (15 min) + saline treated (0.018 mL/g i.p.), number of rears in the light side using a light-dark box in 8-12 week-old males during 5 min session [n beam breaks]. None Anxiety assay (S5_NR), restraint stress (15 min) + saline treated (0.018 mL/g i.p.), number of rears in the light side using a light-dark box in 8-12 week-old males during 5 min session [n beam breaks]. x x 13.8 14.25 8.444 7.429 0.556 7.875 15.571 12.571 0.833 17.875 x 6.333 3.375 12.429 6.0 5.222 10.143 15.857 2.286 4.714 x x x x x x x 4.75 9.75 5.625 8.778 x 5.0 x 5.143 1.0 x x 22.444 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12633 Original post publication description: Anxiety assay (E5_TR), restraint stress (15 min) + ethanol treated (1.8 g/kg i.p.), time spent without locomotion in the light side of light-dark box in 8-12 week-old males during 5 min session [n sec]. None Central nervous system, behavior, pharmacology: Anxiety assay (E5_TR), restraint stress (15 min) + ethanol treated (1.8 g/kg i.p.), time spent without locomotion in the light side of light-dark box in 8-12 week-old males during 5 min session [n sec]. x x 57.656 45.577 50.163 94.112 90.414 63.312 46.875 34.667 50.183 75.757 x 50.743 57.475 81.55 69.75 51.188 62.271 79.086 57.388 58.917 x x x 38.1 38.987 x x 58.657 30.137 74.475 69.062 x 25.5 x 46.3 42.85 x x 52.737 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10855 Original post publication description: Infectious disease, immune function: Chlamydia psittaci (6BC) infection response (10^4 IFU ip), weight loss ratio at 11 days compared to baseline in 2-4 month males [ratio] None Infectious disease, immune system: Chlamydia psittaci (6BC) infection response (10^4 IFU ip), weight loss ratio at 11 days compared to baseline in 2-4 month males [ratio] x x 1.0 0.8 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 1.065 0.768 1.078 x x x x x 0.792 x x x x x x x x 0.998 0.826 0.866 x 1.01 x x x x 1.061 x x x 0.799 x 0.92 x 0.791 x x 0.826 x x 0.789 0.867 0.771 x x x 0.8 x x 0.949 x 0.866 x x x x x x x x x +10856 Original post publication description: Kidney weight, males and females (unilateral, uncorrected, 2006) [mg] None Urogenital system, kidney, morphology: Kidney weight, males and females (unilateral, uncorrected, 2006) [mg] x x 145.606 270.55 187.45 216.55 x 143.088 221.625 164.025 172.275 126.35 x 149.985 x x x 151.267 x 253.633 167.2 145.277 x 199.235 x 142.462 x 174.5 x 153.713 171.961 144.0 x x 173.982 x 199.013 141.056 x x x 144.399 151.833 172.024 x x 157.463 x 171.458 209.064 x 274.35 211.35 209.722 x x x x 185.52 179.969 179.91 141.2 183.463 183.585 219.989 172.281 190.638 221.318 206.082 231.39 x 165.882 169.575 200.732 155.82 292.702 191.014 226.09 162.03 x x 176.2 216.021 145.465 166.538 162.842 300.35 196.438 203.683 183.683 196.775 x x 199.694 175.005 182.109 220.757 170.811 x x x x +10858 Original post publication description: Kidney weight (unilateral, regressed to eliminate variance due to age, body weight, and sex in 2006) [mg] None Urogenital system, kidney, morphology: Kidney weight (unilateral, regressed to eliminate variance due to age, body weight, and sex in 2006) [mg] x x 160.302 248.716 195.054 216.096 x 173.805 205.424 160.032 170.277 179.388 x 165.871 x x x 127.126 x 225.016 156.464 162.615 x 176.723 x 162.575 x 162.222 x 161.436 193.208 163.863 x x 176.489 x 212.577 169.393 x x x 155.03 159.074 204.2 x x 155.162 x 171.14 206.747 x 206.42 184.106 202.612 x x x x 158.987 186.115 183.108 161.031 152.0 170.446 218.927 173.647 184.101 218.163 204.682 183.115 x 180.648 183.043 204.719 168.835 254.595 195.797 182.673 161.99 x x 173.937 203.098 146.312 161.186 157.216 115.01 200.015 202.309 208.604 180.893 x x 161.39 167.595 179.197 207.365 170.742 x x x x +10859 Original post publication description: Urogenital system, morphology: Kidney weight of adult females, unilateral, without any adjustments [mg] None Urogenital system, kidney, morphology: Kidney weight of adult females, unilateral, without any adjustments [mg] x x 146.607 214.31 160.95 231.55 x 136.592 222.375 145.56 154.4 126.35 x 133.84 x x x 131.675 x x 201.1 112.12 x 168.671 x 122.036 x x x 135.264 145.403 131.817 x x 128.06 x 185.038 136.15 x x x 131.994 130.447 148.027 x x 148.373 x 173.67 191.003 x 274.35 211.35 201.867 x x x x 154.714 144.4 139.315 130.95 183.367 177.967 170.78 173.438 174.513 181.503 166.713 153.375 x 138.956 151.575 181.6 153.6 290.395 170.79 211.683 165.6 x x 155.5 195.667 134.111 138.155 149.541 x 173.531 190.289 160.95 167.797 x x 186.557 161.911 173.15 201.56 162.442 x x x x +10861 Original post publication description: Kidney weight of females (unilateral, corrected for age and body weight)[mg] None Urogenital system, kidney, morphology: Kidney weight of females (unilateral, corrected for age and body weight)[mg] x x 149.614 203.459 173.53 233.396 x 153.291 205.087 147.163 148.028 152.649 x 146.156 x x x 115.627 x x 185.232 141.853 x 157.42 x 131.798 x x x 148.291 159.66 137.435 x x 143.219 x 196.898 159.379 x x x 136.423 136.623 172.44 x x 149.131 x 156.345 193.801 x 201.819 163.679 193.083 x x x x 138.794 153.511 146.038 140.338 129.688 151.809 170.837 159.757 168.833 180.444 164.677 123.317 x 155.365 163.358 176.808 157.689 249.396 176.063 158.13 146.601 x x 152.475 184.854 133.447 133.099 140.349 x 171.187 183.591 178.114 156.081 x x 145.403 149.806 170.285 180.041 152.242 x x x x +10862 Original post publication description: Kidney weight of males (unilateral) [mg] None Urogenital system, kidney, morphology: Kidney weight of males (unilateral) [mg] x x 144.203 364.283 213.95 201.55 x 162.575 220.875 182.49 225.9 x x 170.167 x x x 190.45 x 253.633 133.3 166.0 x 270.55 x 179.908 x 174.5 x 166.397 217.11 150.092 x x 199.494 x 212.988 145.963 x x x 165.331 188.495 231.096 x x 165.673 x 160.4 222.61 x x x 213.65 x x x x 205.864 219.095 220.505 164.262 183.75 196.225 281.5 171.125 206.763 254.496 228.579 283.4 x 185.465 178.575 219.864 159.15 295.01 241.575 247.7 161.138 x x 196.9 231.287 163.128 207.086 183.743 300.35 219.344 222.435 229.15 228.972 x x 245.675 184.825 193.629 268.75 187.55 x x x x +10863 Original post publication description: Urogenital system, renal system, morphology: Kidney weight of males (unilateral, adjusted for age and body size) [mg] None Urogenital system, kidney, morphology: Kidney weight of males (unilateral, adjusted for age and body size) [mg] x x 172.0 327.439 217.683 200.212 x 185.718 208.151 174.213 194.833 x x 187.654 x x x 130.047 x 249.599 131.801 186.345 x 188.575 x 202.577 x 189.365 x 180.41 234.066 196.828 x x 208.001 x 230.947 182.928 x x x 172.941 181.847 244.243 x x 164.911 x 167.489 224.027 x x x 223.003 x x x x 181.56 220.421 221.701 180.807 184.799 189.836 274.082 192.622 201.25 255.718 241.609 228.725 x 208.063 209.506 236.947 177.814 263.663 206.952 214.419 190.784 x x 197.541 225.396 155.507 192.297 172.478 109.885 232.413 222.378 246.043 207.672 x x 177.982 190.784 181.574 244.909 191.05 x x x x +13408 Original post publication description: Musculoskeletal system, morphology: Femur cortical material bone mineral density (F.Ct.BMDmat) of 12-week-old males measured at midshaft by microcomputed tomography (µCT) [mm] Original pre publication description: Musculoskeletal system, morphology: VDavid122. Musculoskeletal system, morphology: VDavid122. Musculoskeletal system, morphology: Femur cortical material bone mineral density (F.Ct.BMDmat) of 12-week-old males measured at midshaft by microcomputed tomography (µCT) [mm] x 1125.18 x x 1126.86 x x x x x x 1109.47 x 1095.64 x x x x x x x x x 1148.74 x 1105.37 x 1091.85 x 1146.07 x x 1151.72 x x x x 1135.98 x x x x 1148.68 x x x 1086.46 1117.78 x x x x x x 1162.25 x x x 1081.2 x 1172.09 x x 1152.19 x x 1146.35 1141.01 x 1149.01 x 1140.99 x x x x x x x x x x x x x x x x x x x x x x x x x x x 1131.98 x 1116.59 +13419 Original post publication description: Musculoskeletal system, morphology: Femur moment of inertia around the longer axis divided by the maximum radius perpendicular to Imin direction (F.Imin/Cmin) of 12-week-old males measured at midshaft by microcomputed tomography (µCT) [mm3] Original pre publication description: Musculoskeletal system, morphology: VDavid133. Musculoskeletal system, morphology: VDavid133. Musculoskeletal system, morphology: Femur moment of inertia around the longer axis divided by the maximum radius perpendicular to Imin direction (F.Imin/Cmin) of 12-week-old males measured at midshaft by microcomputed tomography (µCT) [mm3] x 0.191 x x 0.238 x x x x x x 0.202 x 0.179 x x x x x x x x x 0.186 x 0.145 x 0.18 x 0.171 x x 0.182 x x x x 0.177 x x x x 0.166 x x x 0.21 0.311 x x x x x x 0.151 x x x 0.157 x 0.208 x x 0.157 x x 0.152 0.149 x 0.139 x 0.167 x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.13 x 0.148 +13410 Original post publication description: Musculoskeletal system, morphology: Femur cortical volume (F.Ct.V) of 12-week-old males measured at midshaft by microcomputed tomography (µCT) [mm3] Original pre publication description: Musculoskeletal system, morphology: VDavid124 Musculoskeletal system, morphology: VDavid124 Musculoskeletal system, morphology: Femur cortical volume (F.Ct.V) of 12-week-old males measured at midshaft by microcomputed tomography (µCT) [mm3] x 0.738 x x 0.774 x x x x x x 0.7 x 0.611 x x x x x x x x x 0.765 x 0.567 x 0.696 x 0.697 x x 0.662 x x x x 0.635 x x x x 0.661 x x x 0.744 0.922 x x x x x x 0.614 x x x 0.61 x 0.791 x x 0.607 x x 0.66 0.615 x 0.603 x 0.677 x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.508 x 0.579 +13417 Original post publication description: Musculoskeletal system, morphology: Femur moment of inertia around the longer axis (F.Imin) of 12-week-old males measured at midshaft by microcomputed tomography (µCT) [g*mm2] Original pre publication description: Musculoskeletal system, morphology: VDavid131 Musculoskeletal system, morphology: VDavid131 Musculoskeletal system, morphology: Femur moment of inertia around the longer axis (F.Imin) of 12-week-old males measured at midshaft by microcomputed tomography (µCT) [g*mm2] x 0.113 x x 0.155 x x x x x x 0.131 x 0.11 x x x x x x x x x 0.123 x 0.08 x 0.11 x 0.1 x x 0.107 x x x x 0.108 0.107 x 0.127 x 0.093 x x x 0.132 0.232 x x x x x x 0.086 x x x 0.093 x 0.127 x x 0.095 x x 0.092 0.082 x 0.076 x 0.096 x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.072 x 0.086 +13409 Original post publication description: Musculoskeletal system, morphology: Femur cortical cross-sectional volume (F.Ct.CSV) of 12-week-old males measured at midshaft by microcomputed tomography (µCT) [mm3] Original pre publication description: Musculoskeletal system, morphology: VDavid123 Musculoskeletal system, morphology: VDavid123 Musculoskeletal system, morphology: Femur cross-sectional volume (F.CSV) of 12-week-old males measured at midshaft by microcomputed tomography (µCT) [mm3] x 1.944 x x 2.186 x x x x x x 2.246 x 1.987 x x x x x x x x x 2.377 x 1.735 x 1.921 x 2.178 1.73 x 1.94 x x x x 2.128 x x x x 1.924 x x x 2.221 2.946 x x x x x x 2.151 x x x 2.123 x 2.338 x x 1.722 x x 2.145 1.976 x 1.89 x 2.462 x x x x x x x x x x x x x x x x x x x x x x x x x x x 1.74 x 1.629 +13411 Original post publication description: Musculoskeletal system, morphology: Femur cortical marrow volume (F.Ct.MaV) of 12-week-old males measured at midshaft by microcomputed tomography (µCT) [mm3] Original pre publication description: Musculoskeletal system, morphology: VDavid125. Musculoskeletal system, morphology: VDavid125. Musculoskeletal system, morphology: Femur cortical marrow volume (F.MaV) of 12-week-old males measured at midshaft by microcomputed tomography (µCT) [mm3] x 1.206 x x 1.412 x x x x x x 1.546 x 1.376 x x x x x x x x x 1.612 x 1.168 x 1.224 x 1.48 x x 1.278 x x x x 1.493 x x x x 1.263 x x x 1.477 2.024 x x x x x x 1.537 x x x 1.513 x 1.547 x x 1.114 x x 1.485 1.361 x 1.287 x 1.785 x x x x x x x x x x x x x x x x x x x x x x x x x x x 1.232 x 1.05 +13407 Original post publication description: Musculoskeletal system, morphology: Femur cortical apparent bone mineral density (F.Ct.BMDapp) of 12-week-old males measured at midshaft by microcomputed tomography (µCT) [mm] Original pre publication description: Musculoskeletal system, morphology: VDavid121. Musculoskeletal system, morphology: VDavid121. Musculoskeletal system, morphology: Femur cortical apparent bone mineral density (F.Ct.BMDapp) of 12-week-old males measured at midshaft by microcomputed tomography (µCT) [mm] x 1058.55 x x 1060.0 x x x x x x 1037.49 x 1017.67 x x x x x x x x x 1064.42 x 1026.68 x 1015.17 x 1074.17 x x 1075.48 x x x x 1057.4 x x x x 1079.21 x x x 1022.05 1044.05 x x x x x x 1081.96 x x x 1004.64 x 1101.34 x x 1079.85 x x 1073.67 1066.19 x 1071.53 x 1068.21 x x x x x x x x x x x x x x x x x x x x x x x x x x x 1044.59 x 1043.12 +13418 Original post publication description: Musculoskeletal system, morphology: Femur moment of inertia around the shorter axis divided by the maximum radius perpendicular to Imax direction (F.Imax/Cmax) of 12-week-old males measured at midshaft by microcomputed tomography (µCT) [mm3] Original pre publication description: Musculoskeletal system, morphology: VDavid132 Musculoskeletal system, morphology: VDavid132 Musculoskeletal system, morphology: Femur moment of inertia around the shorter axis divided by the maximum radius perpendicular to Imax direction (F.Imax/Cmax) of 12-week-old males measured at midshaft by microcomputed tomography (µCT) [mm3] x 0.28 x x 0.303 x x x x x x 0.277 x 0.237 x x x x x x x x x 0.244 x 0.21 x 0.283 x 0.253 x x 0.258 x x x x 0.246 x x x x 0.223 x x x 0.297 0.426 x x x x x x 0.22 x x x 0.23 x 0.32 x x 0.19 x x 0.219 0.215 x 0.207 x 0.256 x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.178 x 0.192 +13416 Original post publication description: Musculoskeletal system, morphology: Femur moment of inertia around the shorter axis (F.Imax) of 12-week-old males measured at midshaft by microcomputed tomography (µCT) [g*mm2] Original pre publication description: Musculoskeletal system, morphology: VDavid130 Musculoskeletal system, morphology: VDavid130 Musculoskeletal system, morphology: Femur moment of inertia around the shorter axis (F.Imax) of 12-week-old males measured at midshaft by microcomputed tomography (µCT) [g*mm2] x 0.263 x x 0.299 x x x x x x 0.25 x 0.216 x x x x x x x x x 0.252 x 0.189 x 0.268 x 0.263 x x 0.239 x x x x 0.234 x x x x 0.199 x x x 0.298 0.47 x x x x x x 0.197 x x x 0.212 x 0.347 x x 0.147 x x 0.219 0.19 x 0.184 x 0.247 x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.148 x 0.164 +13395 Original post publication description: Musculoskeletal system, morphology:Femur material bone mineral density (FBMDmat) of 12-week-old males measured by microcomputed tomography (µCT) [mg/cm3] Original pre publication description: Musculoskeletal system, morphology: VDavid101. Musculoskeletal system, morphology: VDavid101. Musculoskeletal system, morphology:Femur material bone mineral density (FBMDmat) of 12-week-old males measured by microcomputed tomography (µCT) [mg/cm3] 1051.24 1049.39 1041.72 1072.6 1032.56 x x x x x 1033.94 1027.9 x 1029.09 x x x x x x x x x x x x x 1014.41 x 1044.11 1045.3 x 1065.49 x x x 1058.73 1069.4 x x x x 1061.51 x x x 1023.37 1025.36 x x x x x x 1069.03 x x x 1012.59 x 1077.46 x x 1063.73 x x 1046.13 1047.05 1016.6 1048.7 x 1044.6 x 1061.88 x x x 1080.76 1023.48 x x 1062.04 x x x 1057.84 x 1043.8 1064.68 x x x x x x x 1037.83 x 1030.75 x 1029.29 x +13412 Original post publication description: Musculoskeletal system, morphology: Femur cross-sectional area (F.CSAr) of 12-week-old males measured at midshaft by microcomputed tomography (µCT) [mm2] Original pre publication description: Musculoskeletal system, morphology: VDavid126 Musculoskeletal system, morphology: VDavid126 Musculoskeletal system, morphology: Femur cross-sectional area (F.CSAr) of 12-week-old males measured at midshaft by microcomputed tomography (µCT) [mm2] x 2.479 x x 2.788 x x x x x x 2.865 x 2.534 x x x x x x x x x 3.031 x 2.213 x 2.45 x 2.777 x x 2.475 x x x x 2.714 x x x x 2.454 x x x 2.833 3.758 x x x x x x 2.744 x x x 2.707 x 2.982 x x 2.196 x x 2.736 2.521 x 2.41 x 3.14 x x x x x x x x x x x x x x x x x x x x x x x x x x x 2.219 x 2.078 +13414 Original post publication description: Musculoskeletal system, morphology: Femur marrow area (F.Ma.Ar) of 12-week-old males measured at midshaft by microcomputed tomography (µCT) [mm2] Original pre publication description: Musculoskeletal system, morphology: VDavid128 Musculoskeletal system, morphology: VDavid128 Musculoskeletal system, morphology: Femur marrow area (F.Ma.Ar) of 12-week-old males measured at midshaft by microcomputed tomography (µCT) [mm2] x 1.538 x x 1.801 x x x x x x 1.972 x 1.755 x x x x x x x x x 2.056 x 1.49 x 1.562 x 1.888 x x 1.63 x x x x 1.904 x x x x 1.611 x x x 1.884 2.581 x x x x x x 1.961 x x x 1.929 x 1.973 x x 1.421 x x 1.894 1.736 x 1.642 x 2.277 x x x x x x x x x x x x x x x x x x x x x x x x x x x 1.572 x 1.34 +13965 Original post publication description: Central nervous system, protein: Soluble (2B7/2B7) FRET in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, R62 only [ratio] Original pre publication description: Central nervous system, protein: Soluble (2B7/2B7) FRET in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, R62 only [ratio] Central nervous system, protein: Soluble (2B7/2B7) FRET in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, R62 only [ratio] Central nervous system, protein: Soluble (2B7/2B7) FRET in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, R62 only [ratio] x 1493.0 1365.0 x x 1760.0 1462.0 1433.0 x 1361.0 1347.0 1501.0 x 1467.0 x x 1421.0 x 1536.0 x 1461.0 x x x x x 1497.0 x x 1369.0 x x 1456.0 x x x x 1529.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13415 Original post publication description: Musculoskeletal system, morphology: Femur polar moment of inertia (F.pMOI) of 12-week-old males measured at midshaft by microcomputed tomography (µCT) [g*mm2] Original pre publication description: Musculoskeletal system, morphology: VDavid129 Musculoskeletal system, morphology: VDavid129 Musculoskeletal system, morphology: Femur polar moment of inertia (F.pMOI) of 12-week-old males measured at midshaft by microcomputed tomography (µCT) [g*mm2] x 0.376 x x 0.454 x x x x x x 0.382 x 0.325 x x x x x x x x x 0.375 x 0.269 x 0.377 x 0.363 x x 0.346 x x x x 0.342 x x x x 0.292 x x x 0.429 0.703 x x x x x x 0.283 x x x 0.305 x 0.474 x x 0.242 x x 0.31 0.271 x 0.259 x 0.343 x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.22 x 0.25 +13420 Original post publication description: Central nervous system, morphology; Neocortical Neuron Number, corrected for age, sex, plane of section, and epoch. Original pre publication description: Central nervous system, morphology; CX Neur Resid Epoch Central nervous system, morphology: CX neur resid epoch Central nervous system, morphology: Neocortex total neuron number in adults (bilateral) corrected for age, sex, plane of section, brain weight, and epoch [n million] x x 11830800.0 11157100.0 10601600.0 11163400.0 13334600.0 11109200.0 11990700.0 11132200.0 12209600.0 11521900.0 11265000.0 11495800.0 12114200.0 11177800.0 12085700.0 11620500.0 11263900.0 10483900.0 12840200.0 10715500.0 x 11331800.0 11303000.0 11028200.0 11331300.0 10437800.0 10095300.0 12014600.0 11759000.0 10762400.0 11859700.0 12469000.0 11108400.0 x 10347300.0 11323000.0 10732600.0 x 10218500.0 11152900.0 x 10307600.0 x x 12237000.0 x 12149400.0 10632700.0 x x x 11260100.0 11501900.0 x x x x 11141100.0 x 11049800.0 10282500.0 11083500.0 11665400.0 10327700.0 10396700.0 11758800.0 11135800.0 10761600.0 x 11565100.0 11159500.0 10463700.0 11687700.0 10196000.0 x 11794400.0 12256400.0 x x 11226000.0 12464100.0 10303100.0 11803200.0 11738200.0 x 10119300.0 12368900.0 x 10835800.0 12668900.0 x x 11098400.0 11870500.0 x x x x x x +13421 Original post publication description: Central nervous system, morphology; Neocortical non-neuron number, corrected for age, sex, plane of section, brain weight, and epoch. Original pre publication description: Central nervous system, morphology; NN Resid Epoch Central nervous system, morphology: NN Resid Epoch Central nervous system, morphology: Neocortex total non-neuron number (bilateral) corrected for age, sex, plane of section, brain weight, and epoch [n million] x x 8190010.0 6923150.0 6652630.0 7052070.0 8048980.0 7476330.0 7163880.0 7100610.0 8002900.0 8035020.0 7530320.0 7538210.0 8094700.0 7242550.0 7126570.0 7136640.0 7288940.0 7044620.0 7999740.0 7279960.0 x 6785060.0 6967760.0 6941780.0 7888920.0 6362900.0 6667770.0 8256570.0 6965960.0 6796330.0 7059900.0 7838800.0 6529180.0 x 6340740.0 6899080.0 7034380.0 x 6664930.0 8148550.0 x 7085650.0 x x 6470000.0 x 5906590.0 7234430.0 x x x 8142930.0 7697750.0 x x x x 7247230.0 x 7263900.0 6951120.0 7260540.0 7355060.0 6760940.0 7668470.0 7356350.0 7338400.0 8079740.0 x 7992770.0 6408160.0 7275730.0 5803020.0 7332970.0 x 6212290.0 7795820.0 x x 7114380.0 6938030.0 7011400.0 6977880.0 7983970.0 x 6532480.0 7256050.0 x 7024570.0 6503720.0 x x 4922660.0 7944690.0 x x x x x x +13413 Original post publication description: Musculoskeletal system, morphology: Femur cortical area (F.Ct.Ar) of 12-week-old males measured at midshaft by microcomputed tomography (µCT) [mm2] Original pre publication description: Musculoskeletal system, morphology: VDavid127 Musculoskeletal system, morphology: VDavid127 Musculoskeletal system, morphology: Femur cortical area (F.Ct.Ar) of 12-week-old males measured at midshaft by microcomputed tomography (µCT) [mm2] x 0.941 x x 0.987 x x x x x x 0.893 x 0.78 x x x x x x x x x 0.976 x 0.723 x 0.888 x 0.889 x x 0.845 x x x x 0.81 x x x x 0.843 x x x 0.949 1.176 x x x x x x 0.783 x x x 0.778 x 1.009 x x 0.775 x x 0.841 0.784 x 0.769 x 0.863 x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.648 x 0.739 +10865 Original post publication description: Infectious disease, immune function: H5N1 influenza A virus mortality rate 30 days after infection (Boon-Webby Trait 1) [% death] None Infectious disease, immune system: H5N1 influenza A virus mortality rate 30 days after infection (10^4 EID-50 of HK213 virus in 30 microliters saline) [% death] x 0.0 0.0 100.0 66.7 0.0 100.0 50.0 0.0 100.0 0.0 28.6 100.0 100.0 66.7 33.3 100.0 100.0 100.0 100.0 100.0 66.7 x x x 83.3 100.0 0.0 x 0.0 100.0 100.0 100.0 x 100.0 x 62.5 0.0 75.0 x 100.0 0.0 83.3 50.0 x x 28.6 x 100.0 50.0 x x x 100.0 100.0 x x x 22.2 71.4 66.7 0.0 x 100.0 75.0 100.0 0.0 83.3 57.1 0.0 x 90.0 x 81.8 x 88.9 x x 75.0 x x 100.0 100.0 0.0 85.7 66.7 x 85.7 80.0 x 100.0 x x x 0.0 100.0 12.5 100.0 11.1 x x x +10866 Original post publication description: Infectious disease, immune function: H5N1 influenza A virus survival time (Trait 2) [days, max to 30] None Infectious disease, immune system: H5N1 influenza A virus survival time (10^4 EID-50 of HK213 virus in 30 microliters saline) [days, max to 30] x 30.0 30.0 8.0 16.0 30.0 11.0 22.0 30.0 11.0 30.0 24.0 8.0 12.0 19.0 23.0 10.0 12.0 12.0 11.0 8.0 20.0 x x x 16.0 9.0 30.0 x 30.0 9.0 11.0 8.0 x 9.0 x 19.0 30.0 18.0 x 9.0 30.0 15.0 21.0 x x 26.0 x 11.0 20.0 x x x 12.0 11.0 x x x 27.0 18.0 17.0 30.0 x 11.0 19.0 10.0 30.0 15.0 21.0 30.0 x 12.0 x 15.0 x 15.0 x x 15.0 x x 11.0 10.0 30.0 15.0 19.0 x 13.0 14.0 x 11.0 x x x 30.0 9.0 28.0 11.0 29.0 x x x +10867 Original post publication description: Infection disease, immune function: Cox-Hasty trait 1 None Infection disease, immune function: Cox-Hasty trait 1 x 15474.0 4345.0 24993.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 14177.0 x x x x x x x 16427.0 9416.0 x x x x 8735.0 11947.0 17931.0 x x x x x 20306.0 x x x 21675.0 x 26393.0 x x x x x x x x x x x x x x +10870 Original post publication description: Corticosterone in plasma, level after a 10 min forced swim test (blood taken 30 min after stressor) [ng/ml] None Endocrinology, metabolism, pharmacology, central nervous system: Corticosterone in plasma, level after a 10 min forced Porsolt swim test (blood taken 30 min after stressor) [ng/ml] x x 180.282 167.389 x x x x 280.992 x 302.05 108.79 x x x 150.224 x x x 294.586 210.1 256.259 x x x x x x x x x x x x x x 323.41 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12985 Original post publication description: Liver distress test fold change in females (serum alanine aminotransferase activity fold change at 24hr post-gavage relative to averaged saline control activity) [ratio] None Liver, metabolism, toxicology: Liver distress test, serum alanine aminotransferase activity fold change at 24 hr post-gavage in adult females relative to averaged saline control activity) [ratio] x x 1.65 1.56 x x x x x x x x x x x 1.49 x 0.97 x x x x 1.32 x x x x x x x 1.25 x 1.33 x x x 0.95 1.04 1.0 x 1.5 1.06 1.35 1.1 x x 1.13 x 1.26 1.0 x x x 0.92 1.31 x x x 1.01 1.42 1.05 x x x 1.04 x 0.77 1.61 0.88 0.87 x 0.89 x 1.04 x 0.88 x x x x x 1.21 0.97 x 0.85 1.35 x 1.01 0.97 x x x x x 1.17 x 0.97 x 1.67 0.78 1.38 1.62 +13010 Original post publication description: Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), median body weight loss day 6 after infection in 9-14 week-old females [%], file: mm2_weight_median_variantII_hko_180311 Original pre publication description: Infectious disease, immune function: Schughart (kls@helmholtz-hzi.de) WP12, median BWL day 6 [%], file hko_180311_vII Infectious disease, immune function: Schughart (kls@helmholtz-hzi.de) WP12, median BWL day 6 [%] Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), median body weight loss day 6 after infection in 9-14 week-old females [%] x 83.6 85.9 75.0 87.4 82.8 86.25 x 87.85 100.0 87.7 76.4 92.65 76.5 75.0 81.2 75.0 81.5 87.7 84.95 x 91.2 x x x x 75.0 x x 77.5 82.0 x 75.2 x 75.0 x 75.0 89.5 77.7 x 86.2 95.7 77.19 x x x x x x 75.0 x x x 83.6 77.03 x x x 81.33 84.25 75.0 x x 86.26 x 84.62 x 83.88 75.02 84.55 x 78.1 79.71 86.16 x x x 90.78 75.22 x x x 83.04 x x 86.67 x 77.89 x x 89.61 x x x 87.3 99.0 95.35 x 79.57 x 78.94 75.0 +10957 Original post publication description: Central nervous system, behavior: Anxiety assay (S5_TLA), restraint stress (15 min) + saline treated (0.018 mL/g i.p.), total distance traveled in light-dark box, using 8-12 week-old males during 5 min session [n cm]. None Central nervous system, behavior: Anxiety assay (S5_TLA), restraint stress (15 min) + saline treated (0.018 mL/g i.p.), total distance traveled in light-dark box, using 8-12 week-old males during 5 min session [n cm]. x x 1350.63 1168.65 1583.18 1344.02 501.837 1264.05 844.097 841.759 358.64 1442.16 x 1170.17 1013.29 974.677 1299.97 1063.92 809.81 1162.45 778.19 808.136 x x x 361.024 469.222 x x 767.665 1072.95 857.003 1098.72 x 1374.07 x 939.474 437.724 x x 1754.67 x x x x x 1496.21 x 1347.73 x x x x x x x x x x x x 430.348 x x 835.454 494.76 x x 1091.98 x x x x 842.195 x x x x x x x x x x x x x x 1529.77 x x x x x x x 1216.5 x x x x x +10873 Original post publication description: Corticosterone in plasma, baseline control level [ng/ml] None Endocrinology, metabolism, pharmacology: Corticosterone in plasma, baseline control level [ng/ml] x x 19.572 63.643 x x x x 48.046 x 16.76 9.61 x x x 42.994 x x x 33.048 x 45.808 x x x x x x x x x x x x x x 66.803 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12716 Original post publication description: Infectious disease, immune function: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) interleukin-17 from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control] None Infectious disease, immune function: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) interleukin-17 from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control] x 17.598 100.0 102.367 x x x x x x 1333.47 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 3906.73 2286.04 1108.91 199.614 x x x 296.821 69.278 x x x x 504.909 17.634 x x x 126.807 1772.56 357.497 x x x x x x 8.794 84.718 x x x 9.822 x x 220.352 x x 248.021 x x 1912.9 x x x x x 836.166 x x x x x x 1680.49 x x x x x x x +10955 Original post publication description: Central nervous system, behavior: Anxiety assay (S5_PDT), restraint stress (15 min) + saline treated (0.018 mL/g i.p.), percent distance traveled in light side (cm) using a light-dark box in 8-12 week-old males during 5 min session [n %]. None Central nervous system, behavior: Anxiety assay (S5_PDT), restraint stress (15 min) + saline treated (0.018 mL/g i.p.), percent distance traveled in light side (cm) using a light-dark box in 8-12 week-old males during 5 min session [n %]. x x 27.477 25.55 24.462 36.169 6.198 15.932 34.124 21.273 7.226 35.495 x 19.588 15.663 34.683 15.39 17.709 25.045 37.856 23.462 18.899 x x x 6.982 4.88 x x 21.75 17.493 23.355 22.891 x 15.207 x 22.688 5.087 x x 36.745 x x x x x 13.927 x 16.425 x x x x x x x x x x x x 16.298 x x 21.808 12.588 x x 34.589 x x x x 17.812 x x x x x x x x x x x x x x 18.526 x x x x x x x 17.197 x x x x x +10877 Original post publication description: Amygdala, basolateral complex (LaDL, LaVL, LaVM, BLP, and BLA), neuron number, unilateral without adjustment (revised) [n] None Central nervous system, morphology, stereology: Amygdala, basolateral complex (LaDL, LaVL, LaVM, BLP, and BLA), neuron number, unilateral without adjustment (revised) [n] x 142096.0 118776.0 115640.0 145905.0 131162.0 128669.0 88118.3 134178.0 144798.0 158329.0 169164.0 144977.0 134166.0 152062.0 129672.0 134771.0 150606.0 140534.0 128407.0 126434.0 102227.0 x 139803.0 111270.0 127451.0 116805.0 115461.0 120899.0 168997.0 131665.0 140412.0 147819.0 113399.0 150205.0 117114.0 110955.0 97137.7 117417.0 x 105942.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10878 Original post publication description: Central nervous system, morphology, stereology: Amygdala, basolateral complex (LaDL, LaVL, LaVM, BLP, and BLA), neuron cell density [n/mm^3] None Central nervous system, morphology, stereology: Amygdala, basolateral complex (LaDL, LaVL, LaVM, BLP, and BLA), neuron cell density [n/mm^3] x 195332.0 194029.0 191757.0 224537.0 233111.0 216619.0 193513.0 211763.0 236667.0 268387.0 277313.0 262789.0 228693.0 247519.0 226246.0 240694.0 226049.0 252630.0 246571.0 186919.0 205137.0 x 221443.0 207733.0 222699.0 208493.0 249199.0 249590.0 259808.0 216680.0 256055.0 263028.0 214974.0 257486.0 260372.0 216735.0 192564.0 211243.0 x 202496.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10879 Original post publication description: Amygdala, basolateral complex (LaDL, LaVL, LaVM, BLP, and BLA), glial cell density [n/mm^3] None Central nervous system, morphology, stereology: Amygdala, basolateral complex (LaDL, LaVL, LaVM, BLP, and BLA), glial cell density [n/mm^3] x 67549.0 28476.0 21240.0 38917.0 31885.0 27324.0 14627.0 16736.0 11461.0 44827.0 33476.0 39408.0 29326.0 5881.0 23344.0 15903.0 21626.0 17393.0 17351.0 12012.0 29319.0 x 14468.0 18041.0 18387.0 29748.0 15832.0 18953.0 22418.0 26687.0 26513.0 29121.0 31479.0 27871.0 47965.0 17975.0 23602.0 33304.0 x 14832.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10919 Original post publication description: Primary somatosensory cortex, posterior medial barrel subfield, statistically adjusted for variation in brain weight [mm2] None Central nervous system, morphology: Primary somatosensory cortex, posterior medial barrel subfield, statistically adjusted for variation in brain weight [mm2] x 2.45 1.96 2.14 1.68 1.822 x x x 1.928 x 1.866 x x x x x x x x x x x 2.031 2.0 x x x x 1.78 1.825 1.942 x x x x x 1.771 1.955 x x 2.353 1.761 x x x x x x 2.095 x x x 2.163 1.914 x x x 1.929 1.942 1.577 1.876 1.86 x 1.979 x 1.871 1.942 1.903 2.014 2.041 1.693 x 1.692 x 1.982 x x 1.95 x x 1.746 2.079 x 1.885 x 2.065 2.093 2.093 x 1.954 2.246 x x 1.564 2.105 1.724 x x x x x +10887 Original post publication description: Primary somatosensory cortex, posterior medial barrel subfield area [mm2, no adjustments] None Central nervous system, morphology: Primary somatosensory cortex, posterior medial barrel subfield area [mm2, no adjustments] x 2.5 2.0 2.08 1.7 1.81 x x x 1.96 x 1.89 x x x x x x x x x x x 2.0 1.97 x x x x 1.76 1.82 1.9 x x x x x 1.73 2.02 x x 2.38 1.82 x x x x x x 2.15 x x x 2.25 1.92 x x x 1.96 2.0 x 1.87 1.8 x 1.88 x 1.9 1.99 1.86 2.11 2.05 1.76 x 1.71 x 2.03 x x 1.95 x x 1.8 2.06 x 1.97 x 2.07 2.05 2.09 x 2.05 2.25 x x 1.69 2.15 1.71 x x x x x +10888 Original post publication description: Central nervous system, morphology: Brain weight, fixed tissue without corrections [mg] None Central nervous system, morphology: Brain weight, fixed tissue without corrections [mg] x 423.62 415.57 345.83 394.0 375.45 x x x 403.9 x 397.5 x x x x x x x x x x x 357.5 361.0 x x x x 363.21 380.48 350.9 x x x x x 352.3 428.4 x x 399.55 422.85 x x x x x x 420.6 x x x 445.85 388.6 x x x 405.85 421.35 388.2 375.9 336.17 x 311.73 x 400.65 415.3 349.65 455.9 385.8 432.7 x 394.6 x 413.97 x x 380.38 x x 421.55 370.4 x 446.45 x 389.03 346.35 382.03 x 450.55 388.4 x x 474.55 417.05 368.45 x x x x x +10890 Original post publication description: Hematopoietic stem cell number (cobblestone-area-forming cells per femur at 35 days of age from 3 females, also previously published) None Hematopoietic stem cell number (cobblestone-area-forming cells per femur at 35 days of age from 3 females, also previously published) x x 346.5 553.0 260.0 831.0 618.0 292.0 373.0 724.0 921.0 555.0 195.0 510.0 359.0 545.0 461.0 449.0 371.0 515.0 515.0 287.0 x 335.0 249.0 320.0 597.0 144.0 478.0 554.0 468.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10891 Original post publication description: Central nervous system, morphology, visual system: Photoreceptor density (rods and cones) [cells/mm^3] None Central nervous system, morphology, eye, visual system: Photoreceptor density (rods and cones) in young adults of both sexes (BXD32 excluded due to retinal degeneration, 201980+/-30851) [cells/mm^3] 532285.0 496127.0 454220.0 476438.0 457599.0 x 430738.0 446377.0 495641.0 420529.0 430495.0 450736.0 466350.0 414452.0 446296.0 x x x x x x 433777.0 x x x 440170.0 x x x 412741.0 x 417369.0 459468.0 x 453167.0 x 483159.0 444788.0 425391.0 x x 447714.0 391359.0 476600.0 x x 429863.0 x 464332.0 463797.0 x x x 424639.0 481688.0 x x x 430323.0 438309.0 487072.0 435697.0 465094.0 484666.0 470057.0 417661.0 x 438878.0 439927.0 514277.0 x 454852.0 483608.0 472325.0 x 507147.0 x x 475595.0 489766.0 x x 426039.0 466512.0 465377.0 409347.0 x 471576.0 447365.0 x 506701.0 x x x 421453.0 459746.0 451449.0 x x x x x +12719 Original post publication description: Infectious disease, immune function: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) KC from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control] None Infectious disease, immune function: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks), chemokine (C-X-C motif) ligand 1 level (CXCL1, KC, Chr 5 at 91 Mb) from draining lymph node 3 weeks post infection in females [% of C57BL/6 control] x 43.682 100.0 84.903 x x x x x x 196.495 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 412.083 211.6 416.608 146.014 x x x 74.957 211.98 x x x x 703.704 16.132 x x x 44.87 240.669 92.471 x x x x x x 89.935 52.013 x x x 69.647 x x 47.703 x x 81.268 x x 145.258 x x x x x 120.342 x x x x x x 237.246 x x x x x x x +10893 Original post publication description: Septal nuclei volume, in situ postmortem from high field MRI [bilateral, mm^3] None Central nervous system, morphology: Septal nuclei volume, bilateral, in situ postmortem from high field MRI [mm^3] x x 2.764 2.186 2.834 x x 3.254 x x x x x x 2.557 2.564 x x x x x x x 2.805 x 2.136 2.506 2.665 x x x x 2.437 x x x x x 2.397 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10894 Original post publication description: Striatum (caudate-putamen), bilateral, in situ postmortem from high field MRI [mm^3] None Central nervous system, morphology: Striatum (caudate-putamen), bilateral, in situ postmortem from high field MRI [mm^3] x x 22.228 17.108 20.532 x x 17.816 x x x x x x 24.143 20.484 x x x x x x x 20.261 x 20.086 20.311 18.547 x x x x 22.331 x x x x x 21.044 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10895 Original post publication description: Hippocampus volume, bilateral, in situ postmortem from high field MRI [mm^3] None Central nervous system, morphology: Hippocampus volume, bilateral, in situ postmortem from high field MRI [mm^3] x x 29.905 21.497 23.571 x x 20.215 x x x x x x 26.703 23.468 x x x x x x x 21.193 x 21.532 21.124 23.303 x x x x 21.921 x x x x x 26.575 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10896 Original post publication description: Anxiety assay, closed arm entries in an elevated plus maze test [n] None Central nervous system, behavior: Anxiety assay, closed arm entries in an elevated plus maze test [n] x x 16.33 24.58 x x x x 12.42 x 6.38 16.18 16.33 x x 17.42 x 18.17 x 18.8 20.69 16.17 x x x x 11.2 x x 11.89 23.83 x 19.58 x x x 17.33 17.182 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10897 Original post publication description: Pain response, thermal nociception, latency to paw withdrawal and licking response using a hot plate test [sec] None Central nervous system, behavior: Pain response, thermal nociception, latency to paw withdrawal and licking response using a hot plate test [sec] x x 7.136 6.709 x x x x 11.95 x 7.829 7.355 8.0 x x 7.225 x 5.433 x 5.533 8.07 6.027 x x x x 8.36 x x 3.3 2.955 x 6.842 x x x 6.518 6.012 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10898 Original post publication description: Anxiety assay, open arm entries in an elevated plus maze test [n] None Central nervous system, behavior: Anxiety assay, open arm entries in an elevated plus maze test [n] x x 3.25 4.5 x x x x 4.92 x 1.69 5.91 4.83 x x 3.5 x 2.75 x 3.1 4.31 5.33 x x x x 5.4 x x 8.44 6.5 x 4.0 x x x 2.83 2.182 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10899 Original post publication description: Fear conditioning, baseline preconditioning freezing during a 2 min acclimation period prior to first pairing of conditioned stimulus (CS) and unconditioned stimulus (US) [%] None Central nervous system, behavior, learning and memory: Fear conditioning, baseline preconditioning freezing during a 2 min acclimation period prior to first pairing of conditioned stimulus (CS) and unconditioned stimulus (US) [%] x x 5.556 4.041 x x x x 6.061 x x 1.768 4.17 x x 4.63 x 3.935 x 0.347 3.536 3.472 x x x x 13.332 x x 1.19 5.324 x 7.871 x x x 7.717 10.353 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10900 Original post publication description: Fear conditioning, freezing during consolidation period after final pairing of conditioned stimulus (CS) and unconditioned stimulus (US) [%] None Central nervous system, behavior, learning and memory: Fear conditioning, freezing during consolidation period after final pairing of conditioned stimulus (CS) and unconditioned stimulus (US) [%] x x 70.075 73.485 x x x x 69.419 x 80.952 65.405 87.502 x x 84.027 x 52.777 x 57.812 87.247 66.436 x x x x 27.778 x x 55.16 59.029 x 82.638 x x x 81.635 78.031 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10901 Original post publication description: Fear conditioning, freezing in response to context exposure 48 hr after conditioning [%] None Central nervous system, behavior, learning and memory: Fear conditioning, freezing in response to context exposure 48 hr after conditioning [%] x x 41.97 28.166 x x x x 32.273 x 41.429 47.879 51.67 x x 41.946 x 37.223 x 50.625 23.167 33.889 x x x x 22.0 x x 17.143 40.973 x 40.555 x x x 40.557 66.515 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10902 Original post publication description: Fear conditioning, freezing during conditioned stimulus exposure, 24 hr after conditioning [%] None Central nervous system, behavior, learning and memory: Fear conditioning, freezing during conditioned stimulus exposure, 24 hr after conditioning [%] x x 72.474 49.242 x x x x 41.161 x 81.482 82.501 97.22 x x 63.889 x 65.046 x 61.806 44.723 50.463 x x x x 72.776 x x 48.015 60.649 x 79.398 x x x 79.012 88.131 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10903 Original post publication description: Depression assay, immobility from 2-10 min in a 10 min Porsolt forced swim test [%] None Central nervous system, behavior: Depression assay, immobility from 2-10 min in a 10 min Porsolt forced swim test [%] x x 70.694 41.806 x x x x 61.333 x 49.667 61.296 71.667 x x 19.0 x 64.097 x 59.722 20.0 54.722 x x x x 64.0 x x 60.741 57.197 x 71.809 x x x 74.0 38.106 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10904 Original post publication description: Anxiety assay, locomotion in the light compartment relative to total in a light-dark test [%] None Central nervous system, behavior: Anxiety assay, locomotion in the light compartment relative to total in a light-dark test [%] x x 29.99 34.14 x x x x 36.82 x 18.76 33.93 35.33 x x 34.89 x 28.86 x 34.63 36.09 28.67 x x x x 35.21 x x 41.47 29.09 x 30.43 x x x 30.89 23.145 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10905 Original post publication description: Anxiety assay, time in the center of an elevated plus maze [sec] None Central nervous system, behavior: Anxiety assay, time in the center of an elevated plus maze [sec] x x 30.27 31.27 x x x x 24.64 x 13.63 26.85 28.63 x x 29.2 x 36.85 x 32.57 35.16 31.39 x x x x 19.25 x x 28.9 31.68 x 35.19 x x x 21.73 24.217 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10906 Original post publication description: Novel open field behavior, time in the field center [sec] None Central nervous system, behavior: Novel open field behavior, time in the field center [sec] x x 10.86 7.2 x x x x 10.44 x 7.8 6.87 6.48 x x 9.5 x 10.85 x 12.76 4.82 7.93 x x x x 3.53 x x 6.11 6.39 x 10.05 x x x 9.76 4.608 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10907 Original post publication description: Anxiety assay, percentage of time in light compartment of a light-dark test [%] None Central nervous system, behavior: Anxiety assay, percentage of time in light compartment of a light-dark test [%] x x 34.08 36.25 x x x x 33.99 x 10.0 34.95 34.87 x x 38.09 x 31.9 x 33.86 38.45 29.45 x x x x 28.72 x x 41.54 32.18 x 28.84 x x x 32.09 21.9 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10908 Original post publication description: Anxiety assay, percentage of time in open arms of an elevated plus maze [%] None Central nervous system, behavior: Anxiety assay, percentage of time in open arms of an elevated plus maze [%] x x 7.51 6.99 x x x x 11.56 x 1.95 8.37 17.21 x x 9.32 x 7.12 x 6.96 7.97 11.23 x x x x 24.28 x x 19.89 9.1 x 9.63 x x x 4.08 4.086 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10909 Original post publication description: Anxiety assay, arm entries (total) in an elevated plus maze [n] None Central nervous system, behavior: Anxiety assay, arm entries (total) in an elevated plus maze [n] x x 19.58 29.08 x x x x 17.33 x 8.08 22.09 21.17 x x 20.92 x 20.92 x 21.9 25.0 21.5 x x x x 16.6 x x 20.33 30.33 x 23.58 x x x 20.17 19.364 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10910 Original post publication description: Novel open field behavior, locomotion from 0-30 min [cm] None Central nervous system, behavior: Novel open field behavior, locomotion from 0-30 min [cm] x x 11211.0 9755.0 x x x x 9116.0 x 7605.0 10608.0 7778.0 x x 10351.0 x 10140.0 x 10047.0 8595.0 10773.0 x x x x 5882.0 x x 8850.0 10270.0 x 9116.0 x x x 9832.0 7260.45 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10911 Original post publication description: Novel open field behavior, locomotion from 0-5 min [cm] None Central nervous system, behavior: Novel open field behavior, locomotion from 0-5 min [cm] x x 2355.0 1725.0 x x x x 1395.0 x 1228.0 1865.0 1889.0 x x 2221.0 x 1434.0 x 1762.0 1408.0 1628.0 x x x x 985.0 x x 1740.0 1947.0 x 1268.0 x x x 1806.0 1179.66 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10912 Original post publication description: Novel open field behavior, locomotion from 10-15 min [cm] None Central nervous system, behavior: Novel open field behavior, locomotion from 10-15 min [cm] x x 1712.7 1682.7 x x x x 1563.9 x 1370.9 1807.2 1348.2 x x 1774.4 x 1939.7 x 1777.2 1452.7 1770.1 x x x x 1090.4 x x 1522.7 1766.8 x 1630.2 x x x 1665.0 1328.42 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10913 Original post publication description: Novel open field behavior, locomotion from 15-20 min [cm] None Central nervous system, behavior: Novel open field behavior, locomotion from 15-20 min [cm] x x 1873.4 1610.6 x x x x 1548.7 x 1200.4 1784.8 1128.6 x x 1598.4 x 1762.1 x 1562.4 1471.2 1843.6 x x x x 874.8 x x 1318.2 1609.0 x 1689.2 x x x 1640.7 1206.87 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10914 Original post publication description: Novel open field behavior, locomotion from 20-25 min [cm] None Central nervous system, behavior: Novel open field behavior, locomotion from 20-25 min [cm] x x 1658.0 1443.0 x x x x 1522.0 x 1135.0 1704.0 980.0 x x 1452.0 x 1599.0 x 1660.0 1435.0 1739.0 x x x x 936.0 x x 1345.0 1508.0 x 1497.0 x x x 1444.0 1148.44 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10915 Original post publication description: Novel open field behavior, locomotion from 25-30 min [cm] None Central nervous system, behavior: Novel open field behavior, locomotion from 25-30 min [cm] x x 1600.0 1305.0 x x x x 1531.0 x 1333.0 1412.0 930.0 x x 1389.0 x 1520.0 x 1543.0 1270.0 1930.0 x x x x 801.0 x x 1262.0 1423.0 x 1381.0 x x x 1407.0 1137.86 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10916 Original post publication description: Novel open field behavior, locomotion from 5-10 min [cm] None Central nervous system, behavior: Novel open field behavior, locomotion from 5-10 min [cm] x x 2012.0 1989.0 x x x x 1556.0 x 1337.0 2036.0 1502.0 x x 1917.0 x 1885.0 x 1742.0 1557.0 1862.0 x x x x 1196.0 x x 1662.0 2015.0 x 1651.0 x x x 1870.0 1259.2 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10917 Original post publication description: Anxiety assay, transitions between light and dark compartments in light/dark test [n] None Central nervous system, behavior: Anxiety assay, transitions between light and dark compartments in light/dark test [n] x x 31.91 39.17 x x x x 32.17 x 11.33 41.73 74.5 x x 67.25 x 33.58 x 27.0 52.83 36.08 x x x x 23.8 x x 38.33 44.75 x 29.83 x x x 32.8 22.818 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10918 Original post publication description: Pain response, chemical nociception, acetic acid writhing test [writhes] None Central nervous system, peripheral nervous system, behavior: Pain response, chemical nociception, acetic acid writhing test [writhes] x x x x 5.4 3.2 10.0 x 10.4 9.8 10.5 8.8 4.2 2.1 10.6 5.6 x 3.4 x 3.6 5.0 x x 5.2 5.5 6.6 6.2 7.4 6.1 3.8 4.1 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10921 Original post publication description: Cerebellum volume, in situ postmortem from high field MRI [bilateral mm^3] None Central nervous system, morphology: Cerebellum volume, in situ postmortem from high field MRI [bilateral mm^3] x x 55.932 49.206 60.504 x x 52.416 x x x x x x 53.59 55.511 x x x x x x x 53.948 x 48.535 56.904 51.988 x x x x 57.433 x x x x x 52.078 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10922 Original post publication description: Cerebral cortex volume, bilateral, in situ postmortem from high field MRI [mm^3] None Central nervous system, morphology: Cerebral cortex volume, bilateral, in situ postmortem from high field MRI [mm^3] x x 169.46 137.31 158.04 x x 135.0 x x x x x x 162.71 151.62 x x x x x x x 132.5 x 131.85 137.52 137.69 x x x x 150.8 x x x x x 163.34 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10923 Original post publication description: Olfactory bulb volume, bilateral, in situ postmortem from high field MRI [mm^3] None Central nervous system, morphology: Olfactory bulb volume, bilateral, in situ postmortem from high field MRI [mm^3] x x 29.593 24.825 27.679 x x 25.692 x x x x x x 26.91 28.273 x x x x x x x 23.255 x 24.114 28.882 24.234 x x x x 30.472 x x x x x 29.007 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10924 Original post publication description: Amygdala volume, bilateral, in situ postmortem from high field MRI [mm^3] None Central nervous system, morphology: Amygdala volume, bilateral, in situ postmortem from high field MRI [mm^3] x x 13.608 10.193 9.8351 x x 11.072 x x x x x x 13.368 12.25 x x x x x x x 10.489 x 8.7893 10.426 10.813 x x x x 9.8895 x x x x x 11.579 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10925 Original post publication description: Hypothalamus volume, bliateral, in situ postmortem from high field MRI [mm^3] None Central nervous system, morphology: Hypothalamus volume, bliateral, in situ postmortem from high field MRI [mm^3] x x 11.555 9.0017 10.099 x x 8.4256 x x x x x x 8.0882 8.7409 x x x x x x x 9.2559 x 8.2462 8.8628 9.0166 x x x x 9.3621 x x x x x 11.005 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10926 Original post publication description: Superior colliculus volume (bilateral, in situ postmortem from high field MRI) [mm^3] None Central nervous system, morphology: Superior colliculus volume, bilateral, from in situ postmortem high field MRI) [mm^3] x x 10.774 9.6975 9.8349 x x 8.5317 x x x x x x 9.7906 9.5366 x x x x x x x 7.7724 x 7.7987 8.903 8.9374 x x x x 9.1159 x x x x x 11.099 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10927 Original post publication description: Inferior colliculus volume, bilateral, in situ postmortem from high field MRI [mm^3] None Central nervous system, morphology: Inferior colliculus volume, bilateral, in situ postmortem from high field MRI [mm^3] x x 7.1723 7.169 6.5132 x x 4.1923 x x x x x x 5.5034 5.7329 x x x x x x x 4.3586 x 4.992 5.7999 7.0282 x x x x 5.0296 x x x x x 7.4207 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10928 Original post publication description: Brain volume, in situ postmortem from high field MRI [mm^3] None Central nervous system, morphology: Brain volume, in situ postmortem from high field MRI [mm^3] x x 511.52 417.02 470.42 x x 406.01 x x x x x x 477.8 469.44 x x x x x x x 416.77 x 408.42 436.15 425.63 x x x x 457.15 x x x x x 488.32 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10929 Original post publication description: Central nervous system, morphology: Brain ventricle volume (bilateral, all ventricles, in situ postmortem from high field MRI [mm^3] None Central nervous system, morphology: Brain ventricle volume (bilateral, all ventricles, in situ postmortem from high field MRI [mm^3] x x 3.7047 2.8433 3.894 x x 1.383 x x x x x x 4.7483 3.7351 x x x x x x x 3.481 x 2.9628 3.2284 3.157 x x x x 3.1359 x x x x x 3.4616 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10930 Original post publication description: Corpus callosum volume, bilateral, in situ postmortem from high field MRI [mm^3] None Central nervous system, morphology: Corpus callosum volume, bilateral, in situ postmortem from high field MRI [mm^3] x x 17.695 10.552 13.771 x x 8.5138 x x x x x x 17.093 16.573 x x x x x x x 15.106 x 14.091 13.486 12.828 x x x x 15.978 x x x x x 15.758 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10931 Original post publication description: Trigeminal tract volume, bilateral, in situ postmortem from high field MRI [mm^3] None Central nervous system, morphology: Trigeminal tract volume, bilateral, in situ postmortem from high field MRI [mm^3] x x 0.88817 0.6365 0.69115 x x 0.46133 x x x x x x 0.68897 0.65331 x x x x x x x 0.68245 x 0.65593 0.61025 0.64763 x x x x 0.55575 x x x x x 0.76971 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10932 Original post publication description: Central nervous system, morphology, visual system: Optic tract volume, bilateral, in situ postmortem from high field MRI [mm^3] None Central nervous system, morphology, visual system: Optic tract volume, bilateral, in situ postmortem from high field MRI [mm^3] x x 0.94459 0.98109 0.94789 x x 0.73174 x x x x x x 1.0707 0.93661 x x x x x x x 0.80663 x 0.7715 0.81479 0.88221 x x x x 0.85537 x x x x x 0.99481 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10933 Original post publication description: Anterior pretectal nucleus volume (mm^3, bilateral, in situ postmortem from high field MRI) None Central nervous system, morphology, visual system: Anterior pretectal nucleus volume, bilateral, from in situ postmortem high field MRI [mm^3] x x 0.43291 0.43137 0.49657 x x 0.57245 x x x x x x 0.51919 0.48662 x x x x x x x 0.42544 x 0.38366 0.47032 0.45375 x x x x 0.45056 x x x x x 0.4702 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10934 Original post publication description: Central nervous system, morphology, visual system: Geniculate nuclei volume of thalamus (MGN and LGN combined, bilateral, in situ postmortem from high field MRI) [mm^3] None Central nervous system, morphology, visual system: Geniculate nuclei volume of thalamus (MGN and LGN combined, bilateral, in situ postmortem from high field MRI) [mm^3] x x 0.86027 0.82465 0.86523 x x 0.70881 x x x x x x 0.79404 0.7827 x x x x x x x 0.67259 x 0.73023 0.74228 0.7482 x x x x 0.72674 x x x x x 0.86543 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10935 Original post publication description: Laterodorsal nucleus of thalamus volume, bilateral, in situ postmortem from high field MRI [mm^3] None Central nervous system, morphology: Laterodorsal nucleus of thalamus volume, bilateral, in situ postmortem from high field MRI [mm^3] x x 0.49179 0.29095 0.39077 x x 0.22377 x x x x x x 0.32876 0.28492 x x x x x x x 0.27616 x 0.32741 0.31123 0.38831 x x x x 0.25955 x x x x x 0.42306 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10936 Original post publication description: Central nervous system, morphology: Deep mesencephalic nuclei (MRN, RN, right and left combined) volume in situ from high field MRI [mm3] None Central nervous system, morphology: Deep mesencephalic nuclei (MRN, RN, right and left combined) volume in situ from high field MRI [mm3] x x 1.673 2.2957 2.4213 x x 2.5477 x x x x x x 2.8222 3.212 x x x x x x x 2.1445 x 2.0063 2.4112 2.2786 x x x x 2.395 x x x x x 2.0998 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10937 Original post publication description: Central nervous system, morphology: Globus pallidus volume, in situ postmortem from high field MRI [bilateral mm^3] None Central nervous system, morphology: Globus pallidus volume, in situ postmortem from high field MRI [bilateral mm^3] x x 1.9809 2.0181 2.2347 x x 3.3573 x x x x x x 2.4806 2.9966 x x x x x x x 2.7641 x 1.6496 1.9099 1.9249 x x x x 2.8704 x x x x x 2.5875 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10938 Original post publication description: Central nervous system, morphology, auditory system: Cochlear nuclei volume (right and left combined), in situ postmortem from high field MRI [mm3] None Central nervous system, morphology, auditory system: Cochlear nuclei volume (right and left combined), in situ postmortem from high field MRI [mm3] x x 1.1315 0.95081 1.0622 x x 1.1166 x x x x x x 1.0104 0.88682 x x x x x x x 0.88893 x 0.9288 0.89346 0.86857 x x x x 0.8225 x x x x x 0.85235 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10939 Original post publication description: Central nervous system, morphology: Interpeduncular nucleus volume, bilateral, in situ postmortem from high field MRI [mm^3] None Central nervous system, morphology: Interpeduncular nucleus volume, bilateral, in situ postmortem from high field MRI [mm^3] x x 0.49974 0.46607 0.33802 x x 0.26313 x x x x x x 0.27776 0.29767 x x x x x x x 0.31107 x 0.26428 0.34566 0.27009 x x x x 0.31477 x x x x x 0.30431 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10940 Original post publication description: Cerebral peduncle [mm^3, bilateral, in situ postmortem from high field MRI] None Central nervous system, morphology: Cerebral peduncle volume, bilateral, from in situ postmortem high field MRI [mm^3] x x 1.3838 1.3645 1.451 x x 1.2481 x x x x x x 1.8868 1.9148 x x x x x x x 1.4964 x 1.2776 1.3409 1.2222 x x x x 1.4708 x x x x x 1.3318 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10941 Original post publication description: Substantia nigra, bilateral, in situ postmortem from high field MRI [mm^3] None Central nervous system, morphology: Substantia nigra, bilateral, in situ postmortem from high field MRI [mm^3] x x 2.1758 1.912 1.8285 x x 1.4542 x x x x x x 2.1749 1.9676 x x x x x x x 1.6528 x 2.0067 1.7809 1.6619 x x x x 1.6621 x x x x x 1.9314 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10942 Original post publication description: Pontine nuclei (right and left combined, mm3, in situ postmortem from high field MRI) None Central nervous system, morphology: Pontine nuclei volume, bilateral, in situ postmortem from high field MRI [mm^3] x x 1.3106 1.1556 1.4789 x x 1.3895 x x x x x x 1.0291 1.223 x x x x x x x 1.0631 x 1.044 1.4227 1.1487 x x x x 1.1814 x x x x x 1.3357 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10943 Original post publication description: Central nervous system, morphology: Nucleus accumbens volume, bilateral, in situ postmortem from high field MRI [mm^3] None Central nervous system, morphology: Nucleus accumbens volume, bilateral, in situ postmortem from high field MRI [mm^3] x x 5.332 3.872 4.73 x x 2.012 x x x x x x 5.042 5.03 x x x x x x x 4.178 x 3.754 4.145 4.457 x x x x 4.402 x x x x x 4.854 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10944 Original post publication description: Anterior commissure volume (mm^3, bilateral, in situ postmortem from high field MRI) None Central nervous system, morphology: Anterior commissure volume, bilateral, from in situ postmortem high field MRI [mm^3] x x 1.1293 0.84488 0.93965 x x 0.58283 x x x x x x 0.95953 0.99522 x x x x x x x 0.9742 x 1.0384 0.94673 0.75862 x x x x 1.0667 x x x x x 0.81662 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10945 Original post publication description: Ventral thalamic nuclei volume, bilateral in situ postmortem from high field MRI (includes the VPL, VPM, VP, and VA) [mm^3] None Central nervous system, morphology: Ventral thalamic nuclei volume, bilateral from in situ postmortem from high field MRI (includes the VPL, VPM, VP, and VA) [mm^3] x x 7.3049 5.9318 7.2004 x x 5.743 x x x x x x 6.4884 6.7828 x x x x x x x 5.9832 x 6.0655 6.3021 6.5992 x x x x 6.3731 x x x x x 7.3819 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10946 Original post publication description: Central nervous system, morphology: Fimbria volume, bilateral, in situ postmortem from high field MRI [mm^3] None Central nervous system, morphology: Fimbria volume, bilateral, in situ postmortem from high field MRI [mm^3] x x 3.798 3.0328 3.5032 x x 2.3604 x x x x x x 3.3433 3.1391 x x x x x x x 2.92 x 2.8428 3.0176 3.2634 x x x x 2.9108 x x x x x 3.5745 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10948 Original post publication description: Periaqueductal gray volume, bilateral, in situ postmortem from high field MRI [mm^3] None Central nervous system, morphology: Periaqueductal gray volume, bilateral, in situ postmortem from high field MRI [mm^3] x x 3.3285 2.448 2.9656 x x 2.3007 x x x x x x 2.8502 2.9693 x x x x x x x 2.8233 x 2.1587 2.692 2.5896 x x x x 2.7973 x x x x x 3.3016 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10949 Original post publication description: Central nervous system, morphology: Lateral lemniscus (right and left combined), in situ postmortem from high field MRI [mm3] None Central nervous system, morphology: Lateral lemniscus (right and left combined), in situ postmortem from high field MRI [mm3] x x 0.75496 0.69287 0.89787 x x 0.48535 x x x x x x 0.84182 0.87076 x x x x x x x 0.70196 x 0.70487 0.76359 0.78525 x x x x 0.73377 x x x x x 0.77269 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10950 Original post publication description: Thalamus volume, bilateral, in situ postmortem from high field MRI [mm^3] None Central nervous system, morphology: Thalamus volume, bilateral, in situ postmortem from high field MRI [mm^3] x x 30.287 24.2364 27.9764 x x 23.0626 x x x x x x 27.0562 29.3124 x x x x x x x 24.6 x 24.7371 25.5856 25.4117 x x x x 25.7364 x x x x x 29.8854 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10951 Original post publication description: Midbrain partial volume, bilateral (excludes individually segmented nuclei) in situ postmortem from high field MRI [mm^3] None Central nervous system, morphology: Midbrain partial volume, bilateral (excludes individually segmented nuclei) in situ postmortem from high field MRI [mm^3] x x 78.105 66.058 67.047 x x 63.562 x x x x x x 66.036 70.574 x x x x x x x 61.228 x 65.248 67.036 64.875 x x x x 66.091 x x x x x 75.189 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10952 Original post publication description: Brainstem partial volume, bilateral including DpMe, APT, pons, but excluding other individually segmented nuclei, in situ postmortem from high field MRI [mm^3] None Central nervous system, morphology: Brainstem partial volume, bilateral including DpMe, APT, pons, but excluding other individually segmented nuclei, in situ postmortem from high field MRI [mm^3] x x 81.5215 69.9407 71.4438 x x 68.0716 x x x x x x 70.4065 75.4956 x x x x x x x 64.861 x 68.682 71.3402 68.7561 x x x x 70.118 x x x x x 79.0947 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10953 Original post publication description: Brain volume minus cerebellum volume, in situ postmortem value from high field MRI [mm^3] None Central nervous system, morphology: Brain volume minus cerebellum volume, in situ postmortem value from high field MRI [mm^3] x x 455.589 367.815 409.921 x x 353.597 x x x x x x 424.205 413.929 x x x x x x x 362.819 x 359.885 379.241 373.645 x x x x 399.712 x x x x x 436.246 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10954 Original post publication description: Cancer: Hepatocellular carcinoma tumor multiplicity in liver of males after infection with 0.01 ml/g body wt N,N-diethylnitrosamine [n] None Cancer: Hepatocellular carcinoma tumor multiplicity in liver of males after infection with 0.01 ml/g body wt N,N-diethylnitrosamine [n] x x 0.204 1.491 0.431 1.146 1.342 0.114 1.255 x 1.799 0.23 0.914 x 0.1 1.342 1.204 1.633 x 1.146 x 0.763 x 1.176 1.079 1.146 0.748 0.362 0.544 0.934 0.909 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10987 Original post publication description: Anxiety assay (E10_NT), restraint stress (15 min) + ethanol treated (1.8 g/kg i.p.), number of entries into light side of light-dark box, using 8-12 week-old males during 10 min session [n entries]. None Central nervous system, pharmacology, behavior: Anxiety assay (E10_NT), restraint stress (15 min) + ethanol treated (1.8 g/kg i.p.), number of entries into light side of light-dark box, using 8-12 week-old males during a 10 min session [n] x x 23.938 37.0 42.625 32.0 11.0 47.375 35.25 27.0 21.143 17.571 x 30.429 30.25 34.125 27.875 28.375 27.286 27.429 24.875 27.333 x x x 24.25 16.125 x x 18.714 41.875 24.875 25.375 x 21.167 x 27.75 17.5 x x 49.5 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10988 Original post publication description: Anxiety assay (E10_NR), restraint stress (15 min) + ethanol treated (1.8 g/kg i.p.), number of rears in the light side using a light-dark box in 8-12 week-old males during 10 min session [n beam breaks]. None Anxiety assay (E10_NR), restraint stress (15 min) + ethanol treated (1.8 g/kg i.p.), number of rears in the light side using a light-dark box in 8-12 week-old males during 10 min session [n beam breaks]. x x 13.625 30.846 21.125 15.625 3.857 18.5 17.625 20.667 12.0 61.429 x 24.857 16.375 22.75 23.625 17.375 25.857 21.429 10.75 14.5 x x x 10.125 2.375 x x 9.857 23.125 19.75 20.25 x 11.167 x 2.75 11.333 x x 50.5 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12642 Original post publication description: Anxiety assay (S5_TR), restraint stress (15 min) + saline treated (0.018 mL/g i.p.), time spent without locomotion in the light side of light-dark box in 8-12 week-old males during 5 min session [n sec]. None Central nervous system, behavior, pharmacology: Anxiety assay (S5_TR), restraint stress (15 min) + saline treated (0.018 mL/g i.p.), time spent without locomotion in the light side of light-dark box in 8-12 week-old males during 5 min session [n sec]. x x 27.24 35.544 22.489 24.3 3.122 14.988 38.286 33.543 1.917 47.1 x 15.583 24.637 69.871 10.043 19.167 22.271 59.471 31.343 18.771 x x x 5.1 2.833 x x 25.488 24.075 22.062 21.733 x 14.444 x 22.757 2.875 x x 31.678 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10991 Original post publication description: Morphology, urogenital system: Kidney weight, adult, males and females combined, without statistical adjustments [mg, unilateral None Urogenital system, kidney, morphology: Kidney weight, adult, males and females combined, without statistical adjustments [mg, unilateral 206.036 208.343 154.796 242.522 215.584 231.699 x 153.21 259.422 172.926 187.124 207.174 x 174.994 x x x x x x x 158.439 x x 137.233 167.318 x x x 159.482 198.233 154.039 255.015 x 168.08 x 205.354 174.533 178.691 x x 159.89 157.841 198.561 x x 170.394 x 195.803 220.951 x x x 243.686 x x x x 196.208 195.099 193.092 149.055 x 185.471 178.309 x 205.272 218.602 200.456 183.994 x 174.756 x 215.45 x 330.417 x x 185.967 x x 176.052 208.7 150.448 185.637 162.539 x 200.247 217.565 x 206.734 x x x 195.211 227.181 230.637 x 201.049 x x x +10992 Original post publication description: Central nervous system, morphology: Cerebral cortex volume, shrinkage corrected [mm^3] None Central nervous system, morphology: Cerebral cortex volume, shrinkage corrected [mm^3] x x 115.59 91.92 118.47 99.58 125.11 90.41 101.54 107.47 108.96 105.06 103.77 103.47 119.99 115.06 103.33 90.66 97.1 111.76 108.19 100.65 x 99.81 99.65 93.83 89.0 84.53 77.29 95.4 99.07 102.47 101.59 105.73 102.7 x 98.36 101.14 100.47 x 101.05 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10993 Original post publication description: Central nervous system, morphology: Cerebral cortex volume, regression adjusted for age and body weight, shrinkage corrected [mm^3] None Central nervous system, morphology: Cerebral cortex volume, regression adjusted for age and body weight, shrinkage corrected [mm^3] x x 123.27 104.63 126.78 106.36 136.07 103.1 111.48 117.53 121.34 114.15 110.28 111.53 128.03 121.32 112.84 101.64 107.85 122.58 116.05 112.47 x 108.36 113.57 105.01 97.9 96.48 90.87 103.1 106.77 110.98 106.29 115.86 113.49 x 108.29 108.94 111.04 x 108.89 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +10994 Original post publication description: Kidney weight (unilateral, corrected for age, sex, and body weight) [mg] None Urogenital system, kidney, morphology: Kidney weight (unilateral, corrected for age, sex, and body weight) [mg] 197.12 205.47 169.6 248.94 210.54 219.19 x 181.55 210.14 169.25 176.27 193.75 x 183.23 x x x x x x x 167.2 x x 146.58 183.05 x x x 156.82 209.91 168.4 240.8 x 179.6 x 224.36 164.63 188.03 x x 163.02 169.03 220.83 x x 166.09 x 169.67 217.19 x x x 233.38 x x x x 173.7 201.7 197.34 166.88 x 180.45 186.0 x 190.81 224.54 198.81 183.32 x 188.48 x 218.59 x 301.44 x x 181.25 x x 187.51 215.94 156.19 172.32 164.25 x 198.37 210.33 x 198.54 x x x 185.04 203.14 218.73 x 184.47 x x x +10995 Original post publication description: Central nervous system, morphology: Cerebral cortex volume, bilateral, shrinkage corrected [mm^3] None Central nervous system, morphology: Cerebral cortex volume, bilateral, shrinkage corrected [mm^3] x x 123.563 93.862 113.139 95.57 126.88 81.562 110.893 114.859 111.874 99.199 104.929 101.035 113.142 103.924 98.437 106.412 98.6 105.3 109.703 112.605 x 103.229 103.204 94.034 100.526 91.096 73.369 90.36 111.133 102.823 106.734 100.681 103.46 x 100.524 109.516 111.505 x 104.596 98.165 106.542 102.34 x x 83.274 x x 109.854 x x x x x x x x 95.695 x 106.982 101.595 x x x x x 95.922 x x x 102.449 x 95.231 x 99.144 x x x x x 108.515 x 98.494 114.585 90.128 x 110.516 101.768 x 89.329 x x x x 96.0 x x x x x x +10997 Original post publication description: Central nervous system, morphology: Cerebral cortex volume, adjusted for shrinkage, age, sex, plane of section, and BXD group/epoch) [mm^3] None Central nervous system, morphology: Cerebral cortex volume, adjusted for shrinkage, age, sex, plane of section, and BXD group/epoch) [mm^3] x x 121.04 97.136 110.459 91.536 118.767 83.153 112.074 113.193 110.146 95.825 104.765 100.252 110.164 100.834 97.469 104.747 99.759 100.109 106.489 111.304 x 103.274 105.887 99.129 101.904 92.584 76.449 90.07 109.221 101.749 105.698 100.219 103.054 x 99.699 110.878 110.318 x 100.201 102.686 109.326 102.919 x x 85.193 x x 111.005 x x x x x x x x 94.973 x 109.502 106.294 x x x x x 96.21 x x x 105.911 x 101.145 x 101.082 x x x x x 112.395 x 100.124 111.287 93.809 x 113.985 104.414 x 91.931 x x x x 98.883 x x x x x x +10998 Original post publication description: Central nervous system, morphology: Striatum volume, dorsal striatum, bilateral and adjusted for shrinkage, age, sex, plane of section, and BXD group/epoch (mm^3) None Central nervous system, morphology: Striatum volume, dorsal striatum, bilateral and adjusted for shrinkage, age, sex, plane of section, and BXD group/epoch (mm^3) x x 20.52 22.63 24.769 19.942 23.64 20.931 22.367 23.869 24.345 20.062 19.567 20.996 20.435 19.761 21.732 23.454 21.391 22.656 24.507 19.015 x 23.566 21.565 23.475 21.512 21.496 22.203 21.455 25.35 23.918 23.216 21.135 22.314 x 20.622 23.005 23.339 x 23.025 21.439 25.427 21.545 x x x x x 23.451 x x x x x x x x 21.816 x 24.288 22.725 x x x x x 21.01 x x x 22.655 x 22.659 x 22.669 x x x x x 23.067 x 20.905 23.337 20.927 x 18.925 21.361 x 21.347 x x x x 20.785 x x x x x x +11001 Original post publication description: Infectious disease, immune function: Immune response to bacterial LPS, polymorphonuclear macrophage after 4 hr acute, bronchial lavage [1000/ml] None Infectious disease, immune system: Immune response to bacterial LPS, polymorphonuclear macrophage after 4 hr acute, bronchial lavage [1000/ml] x x 136.47 411.05 255.52 396.35 67.36 402.06 301.65 204.94 218.88 188.94 293.77 192.72 285.4 745.33 199.56 53.76 878.4 265.66 389.71 x x 116.58 235.39 139.4 251.05 0.51 294.21 240.49 193.41 249.21 135.26 x 291.83 x 271.8 289.51 212.65 x 308.6 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +11002 Original post publication description: Ethanol response (3 g/kg ip), hypothermia (supplementary data to Brigman et al.) [deg C] None Central nervous system, pharmacology, metabolism: Ethanol response (3 g/kg ip), hypothermia (supplementary data to Brigman et al.) [deg C] x 1.615 2.225 -5.99 x x x x -9.206 -8.235 x x x 1.994 x x x x x x x x x x x x x x x x 1.744 x x x x x x x x x x x x -5.742 x x x x x 1.788 x x x 2.844 x x x x 2.145 3.138 x x x 1.875 -8.119 x x -5.338 -8.539 x x x x 2.078 x x x x x -6.256 x x x x -6.81 1.094 x x 1.312 x x x x -7.166 2.292 -4.474 x -6.407 -6.964 x x x +11003 Original post publication description: Ethanol response (3 g/kg ip), loss of righting reflex (LORR) sleep time (supplementary data to Brigman et al.) [min] None Central nervous system, pharmacology, behavior: Ethanol response (3 g/kg ip), loss of righting reflex (LORR) sleep time (supplementary data to Brigman et al.) [min] x 40.5 58.333 43.6 x x x x 53.0 x x x x 50.5 x x x x x x x x x x x x x x x x 75.375 x x x x x x x x x x x x 44.333 x x x x x 96.167 x x x 76.0 x x x x 66.2 89.0 x x x 68.75 31.0 x x 43.75 48.75 x x x x 100.0 x x x x x x x x x x 69.667 x x x 71.0 x x x x x 76.0 x x 48.5 x x x x +11004 Original post publication description: Rotarod performance, baseline control (supplementary data to Brigman et al.) [sec] None Central nervous system, behavior: Rotarod performance, baseline control (supplementary data to Brigman et al.) [sec] x 15.8 27.0 21.75 x x x x 10.75 11.0 x x x 17.75 x x x x x x x x x x x x x x x x 33.0 x x x x x x x x x x x x 20.25 x x x x x 25.0 x x x 55.875 x x x x 57.8 35.0 x x x 49.0 24.75 x x 11.0 20.25 x x x x 20.364 x x x x x 11.25 x x x x 9.333 15.25 x x 31.0 x x x x 15.333 37.833 29.333 x 19.25 15.75 x x x +11005 Original post publication description: Motor performance, improvement in rotarod training measured as change in time on rod [sec] None Central nervous system, behavior: Motor performance, improvement in rotarod training measured as change in time on rod [sec] x 86.4 63.667 52.5 x x x x 80.75 34.0 x x x 44.5 x x x x x x x x x x x x x x x x 57.222 x x x x x x x x x x x x 34.0 x x x x x 26.833 x x x 18.125 x x x x 29.2 9.4 x x x 60.0 58.0 x x 73.0 28.75 x x x x 13.364 x x x x x 46.75 x x x x 71.0 52.75 x x 54.25 x x x x 25.0 34.667 31.667 x 30.5 64.5 x x x +11006 Original post publication description: Ethanol response (1.75 g/kg ip), ataxia measured by rotarod performance, difference from saline baseline (supplementary data to Brigman et al.) None Central nervous system, pharmacology, behavior: Ethanol response (1.75 g/kg ip), ataxia measured by rotarod performance, difference from saline baseline (supplementary data to Brigman et al.) x 26.8 58.167 42.125 x x x x 58.0 32.667 x x x 33.625 x x x x x x x x x x x x x x x x 33.278 x x x x x x x x x x x x 30.125 x x x x x 19.333 x x x 21.75 x x x x 17.4 12.8 x x x 45.375 21.5 x x 49.0 53.625 x x x x 18.455 x x x x x 21.125 x x x x 21.167 43.0 x x 41.125 x x x x 28.0 37.5 37.333 x 39.625 48.0 x x x +11007 Original post publication description: Central nervous system, behavior: Startle response to loud acoustic stimulus [amplitude] None Central nervous system, behavior: Startle response to loud acoustic stimulus [amplitude] x 46.48 223.733 55.34 x x x x 81.35 46.65 x x x 46.475 x x x x x x x x x x x x x x x x 156.037 x x x x x x x x x x x x 119.5 x x x x x 213.617 x x x 47.9 x x x x 404.067 140.12 x x x 157.375 97.1 x x 56.875 126.175 x x x x 100.427 x x x x x 90.3 x x x x 52.567 294.425 x x 42.2 x x x x x 140.117 179.3 x 125.525 141.9 x x x +11008 Original post publication description: Prepulse inhibition of the acoustic startle response [%] None Central nervous system, behavior: Prepulse inhibition of the acoustic startle response [%] x 10.92 65.567 26.64 x x x x 45.925 11.925 x x x 33.3 x x x x x x x x x x x x x x x x 79.062 x x x x x x x x x x x x 34.7 x x x x x 15.367 x x x 12.0 x x x x 65.067 34.66 x x x 26.525 14.625 x x 21.875 53.325 x x x x 33.418 x x x x x 32.525 x x x x 14.4 18.575 x x 12.175 x x x x x 66.2 22.367 x 49.425 45.15 x x x +11009 Original post publication description: Fear conditioning, freezing response to conditioned cue after 48 hours (%) None Central nervous system, behavior, learning and memory: Fear conditioning, freezing response time to conditioned cue after 48 hours [%] x 84.0 93.333 45.0 x x x x 60.0 40.0 x x x 90.0 x x x x x x x x x x x x x x x x 45.0 x x x x x x x x x x x x 25.0 x x x x x 70.0 x x x 40.0 x x x x 80.0 60.0 x x x 90.0 80.0 x x 65.0 10.0 x x x x 47.273 x x x x x 85.0 x x x x 73.333 60.0 x x 50.0 x x x x x 70.0 26.667 x 65.0 60.0 x x x +11010 Original post publication description: Fear conditioning, freezing response to conditioned cue after 24 hours (%) None Central nervous system, behavior, learning and memory: Fear conditioning, freezing response time to conditioned cue after 24 hours [%] x 90.56 69.433 24.3 x x x x 38.9 23.167 x x x 50.025 x x x x x x x x x x x x x x x x 22.212 x x x x x x x x x x x x 49.3 x x x x x 49.533 x x x 17.7 x x x x 51.867 49.98 x x x 36.125 73.625 x x 50.0 40.275 x x x x 19.691 x x x x x 65.3 x x x x 91.633 68.05 x x 45.85 x x x x x 64.35 68.5 x 55.55 25.675 x x x +11011 Original post publication description: Fear conditioning, freezing response to context after 48 hours (%) None Central nervous system, behavior, learning and memory: Fear conditioning, freezing response to context after 48 hours (%) x 27.68 40.567 9.175 x x x x 26.25 5.0 x x x 2.075 x x x x x x x x x x x x x x x x 18.962 x x x x x x x x x x x x 7.9 x x x x x 7.217 x x x 0.625 x x x x 2.233 0.0 x x x 2.925 10.825 x x 15.825 5.85 x x x x 1.355 x x x x x 20.825 x x x x 28.867 17.9 x x 1.25 x x x x x 19.15 6.1 x 6.65 23.35 x x x +11012 Original post publication description: Anxiety assay, time in open arm of elevated plus maze [sec] None Central nervous system, behavior: Anxiety assay, time in open arm of elevated plus maze [sec] x 20.036 35.503 5.9 x x x x 20.625 15.46 x x x 36.165 x x x x x x x x x x x x x x x x 43.63 x x x x x x x x x x x x 31.29 x x x x x 74.0 x x x 34.521 x x x x 82.0 68.4 x x x 48.75 29.707 x x 25.585 78.832 x x x x 79.015 x x x x x 41.292 x x x x 8.943 30.625 x x 24.497 x x x x 22.223 48.252 17.723 x 19.168 19.207 x x x +11013 Original post publication description: Anxiety assay, number of closed arm entries using elevated plus maze [n] None Central nervous system, behavior: Anxiety assay, number of closed arm entries using elevated plus maze [n] x 16.4 18.667 7.8 x x x x 11.5 20.0 x x x 26.0 x x x x x x x x x x x x x x x x 22.111 x x x x x x x x x x x x 30.0 x x x x x 19.167 x x x 20.0 x x x x 24.0 30.0 x x x 20.75 13.75 x x 25.0 13.25 x x x x 21.364 x x x x x 17.5 x x x x 13.667 9.5 x x 16.25 x x x x 15.333 15.833 17.333 x 15.5 11.25 x x x +11014 Original post publication description: Open field behavior, locomotion [cm] None Central nervous system, behavior: Locomotor activity, distance, open field behavior [cm] x 10601.8 10821.3 10518.1 x x x x 9499.72 10368.3 x x x 10583.3 x x x x x x x x x x x x x x x x 11049.2 x x x x x x x x x x x x 12942.8 x x x x x 11472.2 x x x 12825.3 x x x x 9435.16 9833.92 x x x 11667.4 9093.5 x x 11010.6 12170.7 x x x x 9654.04 x x x x x 8137.39 x x x x 10352.2 7851.91 x x 9467.93 x x x x 10164.0 9560.43 10063.2 x 11573.5 8946.62 x x x +11015 Original post publication description: Anxiety assay, open field behavior, duration in center of field [sec] None Central nervous system, behavior: Anxiety assay, open field behavior, duration in center of field [sec] x 180.1 296.223 214.708 x x x x 174.125 256.045 x x x 142.5 x x x x x x x x x x x x x x x x 289.408 x x x x x x x x x x x x 299.915 x x x x x 192.167 x x x 136.396 x x x x 262.868 157.166 x x x 292.5 191.625 x x 243.0 216.667 x x x x 224.123 x x x x x 150.915 x x x x 219.333 90.457 x x 218.04 x x x x 126.0 232.805 112.223 x 120.665 171.25 x x x +11016 Original post publication description: Central nervous system, morphology: Brain weight, statistically adjusted for variation in sex, age, body weight, litter size, and parity [mg] None Central nervous system, morphology: Brain weight, statistically adjusted for variation in sex, age, body weight, litter size, and parity [mg] x x 487.0 424.7 465.7 424.3 527.6 419.7 460.7 432.2 442.2 436.2 406.1 442.5 436.0 462.5 421.6 434.1 407.4 457.6 450.4 439.8 x 399.7 433.9 382.6 408.9 398.7 392.8 417.4 432.7 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +11018 Original post publication description: Central nervous system, morphology: Forebrain weight, adjusted by age, sex, body weight and BXD epoch [mg] None Central nervous system, morphology: Forebrain weight, adjusted by age, sex, body weight and BXD epoch [mg] 325.587 326.8 334.116 291.154 313.532 290.277 349.953 273.138 330.311 319.497 302.973 322.222 286.387 308.654 320.855 320.94 316.608 309.071 281.454 311.144 326.695 306.994 x 291.113 301.926 271.017 288.777 283.585 268.43 295.677 296.499 311.882 293.02 294.723 306.222 298.413 309.376 284.5 326.097 x 312.554 306.31 315.326 303.153 x x 291.201 313.382 282.75 306.125 x x x 342.428 295.637 x x x 316.175 335.036 308.256 311.741 299.177 295.429 294.365 296.548 315.903 312.96 304.496 304.495 x 311.459 289.053 294.282 300.713 301.672 313.807 x 321.572 295.2 x 313.099 321.888 302.895 325.998 296.464 x 308.345 302.208 357.403 290.207 301.46 x x 276.676 299.298 317.23 305.397 293.22 x x x +12558 Original post publication description: Musculoskeletal system, morphology: diaphysis bone density of females at 4 months [mg/cc] None Musculoskeletal system, morphology: Diaphysis bone density of tibia of females at 4 months measured by micro computed tomography (microCT) (ImTek MicroCAT II, 2005) [mg/cc] x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 2706.0 x 3091.0 x x x x 3780.0 x x x x 3916.0 x x x x x 3440.0 x 4174.0 x x 3248.0 3087.0 3953.0 x x 4003.0 x x 3367.0 x 3947.0 x 3664.0 4220.0 3622.0 x x 3459.0 3475.0 3765.0 3630.0 3386.0 x 3542.0 3120.0 x x 3433.0 x x x x 3346.0 x x x x x +11020 Original post publication description: Kidney morphology, Wilms tumor 1 homolog negative cells per glomerular cross section in males (8 - 20 weeks of age) [n/section] None Urogenital system, kidney, morphology: Wilms tumor 1 negative (WT1-neg) cells per glomerular cross section in males (8 - 20 weeks of age) [n/section] x x 28.939 35.643 x x x x x 33.741 x x x 54.781 x x x x x x x x x x x x x x x 46.631 39.633 x 33.7 x x x x x x x 34.06 27.6 39.722 30.083 x x x x x 27.694 x x x x x x x x 41.073 x 27.379 x x 38.667 x x 27.929 35.367 37.594 x x 28.6 x 29.65 x 36.263 x x 32.95 x x 27.955 37.689 32.984 39.031 34.117 x 28.994 33.586 x 40.35 x 29.065 x x x x x x x x x +11021 Original post publication description: Group A Streptococcal sepsis, bacterial dissemination to spleens None Infectious disease, immune system: Streptococcus pyogenes (Group A streptococcal infection) dissemination to spleens, 24 h post-infection (Fig 1C) [CFU/ml] x x -1.123 1.445 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.52 -0.003 -0.209 x x -0.617 x x -0.615 x x x x x x x x 0.92 0.43 -0.402 x 0.053 x 0.828 x -0.254 -0.053 0.332 -1.112 x -0.933 0.483 0.579 x x x 0.81 x x x x x 0.389 x -2.186 x -1.087 1.215 x -1.491 x 0.311 x x 0.658 1.112 x x x x x +11022 Original post publication description: Infectious disease, immune function: Streptococcus pyogenes (Group A streptococcal infection) sepsis bacteremia 24 h post-infection [units] None Infectious disease, immune system: Streptococcus pyogenes (Group A streptococcal infection) sepsis bacteremia 24 h post-infection corrected for age, sex, body weight, log inoculum (Fig 1B) [corrected log CFU/ml] x x 0.166 0.054 x x x x x x x x x x x x x x x x x x x x x x x x x x x x -1.646 x x x x x x x x -0.544 0.032 -0.099 x x 0.291 x x -0.284 x x x x x x x x 0.847 0.632 -0.006 x 0.158 x 1.073 x -0.306 -1.277 0.036 -1.048 x -0.42 0.973 0.725 x 0.404 x 0.683 x x x x x -0.139 x -0.359 x -0.379 0.389 x -0.214 x 0.561 x x 0.741 -1.045 x x x x x +11023 Original post publication description: CxEct_Rosen_Mar2011 CxEct_Rosen_Mar2011 Central nervous system, morphology, development: ectopias in neocortex (cerebral cortex) of adults (celloidin material from the Mouse Brain Library) [2x arcsine % affected animals] x x 1.231 0.522 0.0 0.881 0.0 0.982 1.047 1.159 0.0 0.0 0.0 0.613 0.0 0.562 0.586 0.0 1.682 0.0 1.318 1.571 x 0.0 0.0 1.662 1.571 0.0 1.128 1.318 0.0 0.0 1.047 0.68 0.0 x 0.881 1.176 0.644 x 0.586 0.0 0.841 0.586 x x 0.927 x 0.0 0.0 x x x 0.841 1.128 x x x 0.0 0.586 0.0 1.099 1.159 0.0 1.338 1.047 1.459 1.231 0.541 1.7 x 0.0 0.0 0.841 1.231 1.403 1.7 0.0 0.0 x x 1.002 0.0 0.0 0.0 0.0 x 0.0 1.176 0.0 0.841 0.0 x x 1.427 0.0 0.0 1.369 x x x x +11024 Original post publication description: Central nervous system, morphology, eye, visual system: Photoreceptor number (rods and cones), unilateral per retina [n x10^6] None Central nervous system, morphology, eye, visual system: Photoreceptor number (rods and cones), unilateral per retina in young adults of both sexes (BXD32 excluded due to retinal degeneration (3.46+/-0.096 million) [n x10^6] 8.2 8.2 7.85 9.0 8.17 x 7.03 7.54 7.84 6.14 7.92 7.14 x 6.29 8.18 x x x x x x 7.9 x x x 6.97 x x x 7.07 x 6.07 7.38 x 8.76 x 7.78 7.5 6.64 x x 7.87 5.78 7.21 x x 6.53 x x 7.22 x x x 6.77 8.71 x x x 7.3 8.19 7.43 7.28 7.69 7.8 7.07 6.99 x 6.98 5.95 8.23 x 7.24 7.04 6.98 x 8.05 x x 7.74 7.7 x x 6.64 7.23 6.95 6.25 x 7.38 7.2 x 8.14 x x x 6.66 7.49 6.56 x x x x x +11025 Original post publication description: Infectious disease, immune function: Chlamydia psittaci (6BC) infection response (10^4 IFU ip), pathogen load in peritoneal cavity at 30 days among surviving 3-5 month males [log nanogram Cp DNA, -1.301 is technical minimum] (subset of animals described in Miyiari et al.) None Infectious disease, immune system: Chlamydia psittaci (6BC) infection response (10^4 IFU ip), pathogen load in peritoneal cavity at 30 days among surviving 3-5 month males [log nanogram Cp DNA, -1.301 is technical minimum] (subset of animals described in Miyiari et al.) x x -0.91 x x x x x x -1.301 x x x x x x -1.301 x x x -1.301 x x x -1.301 x x x x -1.301 x x x x x x x x -1.301 x x 0.969 x -0.081 x x x x x x x x x 0.074 x x x x 1.238 0.162 -1.301 x x 0.691 x x x -1.301 x x x x x x x x x x x x x x x x 0.202 x x x x x x x x 1.13 x -0.268 x x 0.387 x x x +11026 Original post publication description: Infectious disease, immune function: Chlamydia psittaci (6BC) infection response (10^4 IFU ip), spleen weight at 30 days among surviving animals, 2-4 months males (subset of cases from Miyiari 2007) [gm] None Infectious disease, immune system: Chlamydia psittaci (6BC) infection response (10^4 IFU ip), spleen weight at 30 days among surviving animals, 2-4 months males (subset of cases from Miyiari 2007) [gm] x x 0.143 x x x x x x 0.09 x x x x x x 0.105 x x x 0.09 x x x 0.09 x x x x x x x x x x x x x 0.08 x x 0.21 x 0.175 x x x x x x x x x 0.245 x x x x 0.27 0.25 0.08 x x 0.155 x x x 0.077 x x x x x x x x x x x x x x x x 0.187 x x x x x x x x 0.41 x 0.185 x x 0.3 x x x +11027 Original post publication description: Iron level in hippocampus of males [ug/g] None Central nervous system, metabolism, nutrition: Iron level in hippocampus of males [ug/g] x x 13.2 15.3 19.3 14.9 x 11.5 14.4 13.4 14.1 13.9 19.3 13.8 15.6 15.6 11.0 12.0 x 13.6 x 16.0 x 15.4 x 14.4 15.2 16.4 x 14.7 11.1 16.0 14.5 x 13.5 x 11.2 15.3 11.4 x 12.4 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +11028 Original post publication description: Iron level in hippocampus of females [ug/g] None Central nervous system, metabolism, nutrition: Iron level in hippocampus of females [ug/g] x x 13.0 16.4 15.9 14.6 x 14.4 12.1 11.3 12.6 14.8 18.5 15.2 16.7 16.3 12.8 12.8 x 13.8 x 15.8 x 17.8 x 13.4 16.9 15.5 x 14.5 11.4 16.4 13.9 x 13.4 x 12.3 13.0 13.1 x 11.9 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +11029 Original post publication description: Copper level in hippocampus of males [ug/g wet tissue] None Central nervous system, metabolism, nutrition: Copper level in hippocampus of males [ug/g wet tissue] x x 4.0 4.5 8.3 3.6 x 3.3 4.8 3.5 4.0 3.5 10.3 3.9 9.4 5.5 3.1 4.4 x 4.4 x 6.7 x 5.6 x 4.5 6.1 6.2 x 6.5 2.8 9.4 3.5 x 4.7 x 4.0 4.3 3.0 x 3.1 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +11030 Original post publication description: Copper level in hippocampus of females [ug/g wet weight] None Central nervous system, metabolism, nutrition: Copper level in hippocampus of females [ug/g wet weight] x x 4.3 7.3 6.5 4.0 x 3.9 3.5 3.1 4.0 4.6 8.8 4.7 7.4 6.3 4.7 4.5 x 4.3 x 7.7 x 6.4 x 5.3 6.2 4.1 x 5.5 3.8 6.9 3.5 x 5.2 x 4.5 3.5 3.8 x 3.9 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +11031 Original post publication description: Zinc level in hippocampus of males [ug/g] None Central nervous system, metabolism, nutrition: Zinc level in hippocampus of males [ug/g] x x 20.4 19.0 24.6 19.0 x 16.4 18.8 19.6 17.7 17.6 23.9 18.1 21.3 19.5 15.1 18.4 x 16.7 x 20.0 x 18.0 x 20.0 21.2 20.9 x 22.1 15.4 24.9 15.3 x 17.2 x 16.5 19.2 16.8 x 17.8 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +11032 Original post publication description: Zinc level in hippocampus of females [ug/g] None Central nervous system, metabolism, nutrition: Zinc level in hippocampus of females [ug/g] x x 15.6 21.8 19.2 18.9 x 19.2 16.2 16.1 15.8 19.4 23.2 21.0 21.6 20.0 18.0 19.0 x 17.0 x 20.8 x 22.9 x 18.0 21.4 21.1 x 24.6 15.7 23.8 17.3 x 16.5 x 18.4 16.0 20.3 x 18.4 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +11033 Original post publication description: Muscloskeletal system, morphology: Soleus-femoral muscle attachment anomaly [frequency] None Musculoskeletal system, morphology: Soleus-femoral muscle attachment anomaly [frequency] x x 0.038 0.018 0.889 0.057 x 0.0 0.0 0.0 0.102 0.5 0.174 0.015 x 0.239 0.05 0.022 x 0.0 0.018 0.037 x 0.0 x 0.01 0.154 0.08 0.053 0.044 0.215 0.031 0.095 x 0.0 x 0.596 0.0 0.039 x 0.0 0.586 0.043 0.0 x x 0.474 x x 0.29 x x 0.643 x 0.708 x x x 0.04 0.091 0.0 0.0 x x 0.0 x x 0.15 0.0 x x 0.0 x 0.0 x 0.0 x x x x x x 0.059 0.0 0.0 0.0 x 0.0 0.0 x x x x x 0.25 0.0 x 0.0 x x x x +11348 Original post publication description: Novel open field behavior, locomotion in the periphery from 45-60 min for males in the morphine test battery [cm] None Novel open field behavior, locomotion in the periphery from 45-60 min for males in the morphine test battery [cm] x x x x 2121.41 602.646 x 2799.09 3240.75 2360.0 1285.65 1926.51 596.408 2017.6 1176.77 1610.98 1769.79 1775.29 1514.65 1879.29 x x x 1511.53 x 1058.02 1045.45 4236.82 x 811.324 1401.65 2420.32 1216.22 x 308.978 x 2368.24 1268.56 3170.28 x 2091.71 1991.72 699.052 2774.02 x x 3245.98 x 3551.25 1785.52 x x x 899.964 375.223 x x x 1209.5 2900.82 194.827 2142.52 x 2006.05 1993.68 993.315 2529.45 2099.72 2328.67 3514.14 x 1118.88 x 1738.32 x x x x 920.815 x x 1781.65 2060.6 440.964 2032.4 2046.94 x 2975.1 847.468 x 2517.47 x x x 1062.08 1005.89 3091.89 3790.18 1797.6 x x x +11347 Original post publication description: Central nervous system, behavior: Novel open field behavior, locomotion in the periphery from 30-45 min for males in the morphine test battery [cm] None Central nervous system, behavior: Novel open field behavior, locomotion in the periphery from 30-45 min for males in the morphine test battery [cm] x x x x 3219.92 1226.13 x 3197.81 3771.38 3383.74 1681.62 2224.0 1232.43 2177.07 1674.51 2396.22 2355.45 2243.17 1362.84 2685.57 x x x 2168.92 x 2159.34 1621.6 5207.74 x 1668.84 2015.48 3564.41 1836.11 x 269.855 x 2707.18 1319.7 3881.05 x 2460.13 2331.39 1245.07 3870.8 x x 3953.36 x 4050.12 2457.68 x x x 1439.83 334.627 x x x 2613.81 3261.2 227.466 2780.77 x 2990.32 2191.82 1532.55 3064.85 2120.79 2495.99 3081.19 x 1524.15 x 1945.75 x x x x 1283.45 x x 2170.1 2872.95 1273.11 3415.08 2437.34 x 3009.97 1760.11 x 3057.65 x x x 1361.55 2911.42 3203.04 4249.46 2130.7 x x x +11346 Original post publication description: Novel open field behavior, locomotion locomotion in the periphery from 15-30 min for males in the morphine test battery [cm] None Novel open field behavior, locomotion locomotion in the periphery from 15-30 min for males in the morphine test battery [cm] x x x x 3483.77 1969.1 x 4560.43 3115.58 4196.29 2346.33 3769.99 2391.5 2415.9 2091.57 2651.26 3725.4 2732.79 2740.77 2790.24 x x x 2312.39 x 3616.5 2542.89 6893.53 x 2762.83 2583.98 3412.49 2700.01 x 471.79 x 2964.66 2030.45 3940.42 x 3671.13 2871.21 1803.23 3789.61 x x 4008.11 x 3979.21 2691.58 x x x 2222.48 679.956 x x x 3553.55 4005.44 936.0 2830.38 x 3357.29 2399.99 1750.06 3736.74 2222.54 2783.0 3343.06 x 2188.23 x 2258.36 x x x x 1780.5 x x 2002.2 3180.55 2587.2 3585.09 2623.25 x 3309.14 2389.92 x 3219.23 x x x 1690.26 3357.64 3901.66 4214.82 2025.3 x x x +11345 Original post publication description: Central nervous system, behavior: Novel open field behavior, locomotion in the periphery from 0-15 min for males in the morphine test battery [cm] None Central nervous system, behavior: Novel open field behavior, locomotion in the periphery from 0-15 min for males in the morphine test battery [cm] x x x x 3701.48 3277.99 x 5929.09 2528.98 4609.18 1934.72 5025.12 3057.36 3427.83 2030.74 3010.38 6244.45 2440.83 3455.8 3074.54 x x x 2439.5 x 3028.59 2703.75 6755.32 x 3666.51 3640.67 2953.67 3510.76 x 2448.3 x 4566.45 2261.2 4961.05 x 5173.58 2798.85 2892.69 4139.66 x x 4553.54 x 3957.96 3222.05 x x x 3287.71 1600.45 x x x 4816.91 4519.15 1504.22 2256.73 x 3564.85 3092.41 2035.92 3947.63 3188.63 3548.57 3861.37 x 2484.01 x 2826.58 x x x x 2250.33 x x 2618.6 3717.48 3463.43 4142.86 2971.97 x 3761.78 3689.12 x 4181.3 x x x 3221.2 4756.29 5087.2 4627.59 2164.0 x x x +11344 Original post publication description: Novel open field behavior, locomotion in the periphery from 45-60 min for males in the morphine test battery [n beam breaks] None Novel open field behavior, locomotion in the periphery from 45-60 min for males in the morphine test battery [n beam breaks] x x x x 542.5 145.0 x 775.5 998.667 714.4 283.0 507.0 130.0 464.0 275.667 452.75 540.5 459.75 434.5 534.0 x x x 329.8 x 288.0 220.0 1306.4 x 198.333 342.0 665.375 287.667 x 64.5 x 573.5 274.333 886.833 x 574.667 525.167 178.6 787.0 x x 887.0 x 1116.0 448.571 x x x 234.333 80.4 x x x 385.0 833.25 40.1667 561.333 x 590.833 474.667 251.5 633.0 586.0 524.333 815.0 x 293.8 x 396.833 x x x x 231.4 x x 398.0 523.5 97.5 584.25 635.8 x 820.333 155.667 x 616.333 x x x 216.833 201.0 941.5 1180.0 454.5 x x x +11343 Original post publication description: Novel open field behavior, locomotion in the periphery from 30-45 min for males in the morphine test battery [n beam breaks] None Novel open field behavior, locomotion in the periphery from 30-45 min for males in the morphine test battery [n beam breaks] x x x x 875.667 315.5 x 906.167 1164.33 1103.8 365.0 583.5 295.75 526.25 379.0 695.0 693.0 575.25 403.5 745.667 x x x 467.8 x 632.714 361.167 1667.6 x 400.167 497.0 1020.62 468.333 x 63.75 x 682.333 285.167 1088.5 x 693.833 600.667 314.8 1128.0 x x 1227.0 x 1300.83 631.714 x x x 344.167 66.2 x x x 790.571 976.5 44.8333 769.333 x 867.0 509.0 372.667 761.0 572.333 596.833 805.0 x 379.8 x 446.5 x x x x 304.0 x x 474.167 780.0 293.5 995.5 784.2 x 832.0 336.667 x 785.0 x x x 296.0 712.0 967.5 1342.4 524.833 x x x +11342 Original post publication description: Novel open field behavior, locomotion in the periphery from 15-30 min for males in the morphine test battery [n beam breaks] None Central nervous system, pharmacology, behavior: Novel open field behavior, locomotion in the periphery from 15-30 min for males in the morphine test battery [n beam breaks] x x x x 999.833 529.167 x 1413.17 874.0 1309.2 584.0 1138.5 629.75 589.25 473.0 756.25 1212.0 706.5 759.5 763.667 x x x 493.8 x 1108.57 629.0 2357.2 x 711.167 690.0 936.5 720.833 x 121.25 x 716.833 447.5 1102.5 x 1070.67 773.0 457.4 1062.25 x x 1257.0 x 1268.67 694.429 x x x 536.0 109.6 x x x 1055.57 1165.25 222.333 717.667 x 948.833 581.833 407.167 1056.0 623.333 709.333 889.0 x 552.5 x 536.667 x x x x 435.4 x x 431.5 867.167 645.167 1001.25 800.4 x 927.667 537.333 x 851.667 x x x 389.833 862.5 1190.0 1312.0 472.333 x x x +11341 Original post publication description: Novel open field behavior, locomotion in the periphery from 0-15 min for males in the morphine test battery [n beam breaks] None Novel open field behavior, locomotion in the periphery from 0-15 min for males in the morphine test battery [n beam breaks] x x x x 1106.17 974.5 x 1921.5 622.333 1417.4 442.0 1637.5 829.0 944.25 408.5 880.5 2111.5 612.5 1003.5 850.833 x x x 482.2 x 790.571 652.833 2207.4 x 958.0 1053.25 767.375 973.167 x 626.25 x 1362.0 498.0 1517.67 x 1652.83 747.0 747.4 1101.5 x x 1399.0 x 1243.5 907.714 x x x 836.0 317.8 x x x 1441.29 1386.75 357.5 490.333 x 961.833 827.333 471.167 1107.4 996.0 992.333 935.0 x 608.6 x 725.0 x x x x 602.2 x x 573.833 1039.17 909.5 1173.0 794.8 x 1086.67 977.0 x 1191.0 x x x 926.333 1431.5 1661.0 1461.2 479.167 x x x +11340 Original post publication description: Morphine response (50 mg/kg ip), vertical activity (rears) from 0-180 min after injection (total vertical activity over 3 hour test) for males [n beam breaks] None Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), vertical activity (rears) from 0-180 min after injection (total vertical activity over 3 hour test) for males [n beam breaks] x x x x 6367.33 3621.83 x 6149.0 1444.0 5888.2 1338.0 4580.5 2125.25 9106.75 500.333 7446.75 3061.25 659.5 6843.5 3365.0 x x x 3192.0 x 5477.29 1148.83 4255.4 x 3934.67 131.5 1902.25 765.167 x 3174.75 x 4016.0 3870.83 8673.83 x 991.833 684.833 1316.4 4764.75 x x 1237.0 x 2300.33 6505.0 x x x 35.3333 723.8 x x x 96.5714 1550.0 1392.67 4229.33 x 1773.5 1651.17 1327.5 3862.4 631.0 7762.33 8024.0 x 4034.3 x 2090.5 x x x x 3841.0 x x 931.167 424.333 6025.67 4442.25 61.4 x 451.167 3845.33 x 972.0 x x x 3947.33 868.5 4330.75 156.6 5138.0 x x x +11339 Original post publication description: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), change in locomotion for males (last 15 min of morphine test (165-180 min) minus first 15 min after naloxone) [cm difference] None Central nervous system, pharmacology, behavior: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), change in locomotion for males (last 15 min of morphine test (165-180 min) minus first 15 min after naloxone) [cm difference] x x x x 2858.52 5108.5 x 4090.99 -558.311 1748.44 108.3 1562.34 593.559 4314.78 -330.011 440.465 -817.29 -28.2453 0.511655 1599.49 x x x -69.7091 x 3073.71 253.908 58.3685 x 1150.46 -646.261 1532.3 -679.56 x 272.892 x 1920.77 2247.3 2594.33 x 2309.58 -1557.85 -767.58 3894.03 x x 22.4665 x -307.208 4932.6 x x x -110.669 -865.643 x x x -670.085 238.863 154.365 6176.85 x -307.477 1019.76 430.233 492.038 338.439 7061.51 5094.06 x 4506.33 x -47.6348 x x x x 2884.11 x x 36.1002 1890.64 2611.44 9028.44 -841.978 x -633.193 2228.88 x -316.514 x x x -552.735 50.6484 -1135.16 -1499.08 1644.65 x x x +11338 Original post publication description: Morphine response (50 mg/kg ip), locomotion from 0-180 min (total activity over 3 hour test) after injection in an activity chamber for males [cm] None Morphine response (50 mg/kg ip), locomotion from 0-180 min (total activity over 3 hour test) after injection in an activity chamber for males [cm] x x x x 106890.0 55191.8 x 104096.0 34085.4 107510.0 62022.9 140106.0 52545.9 105990.0 28199.6 110832.0 41161.0 15655.1 138678.0 75400.3 x x x 73582.9 x 102086.0 25236.9 87067.5 x 120264.0 3521.49 36081.4 25753.0 x 76096.7 x 65290.6 92380.8 161647.0 x 17164.2 9521.27 24839.2 74815.4 x x 54982.7 x 56932.0 171021.0 x x x 4841.61 21625.6 x x x 2103.62 19740.3 43234.4 94614.0 x 32315.7 33293.1 35266.1 67879.2 15423.8 105450.0 128651.0 x 46551.5 x 43330.4 x x x x 90755.1 x x 13026.5 10387.6 110243.0 111015.0 1426.82 x 5413.09 75976.0 x 35314.9 x x x 20191.4 14997.8 74538.7 3595.24 56186.5 x x x +11337 Original post publication description: Morphine response (50 mg/kg ip), locomotion from 0-180 min after injection (total open field activity over 3 hour test) for males [n beam breaks] None Morphine response (50 mg/kg ip), locomotion from 0-180 min after injection (total open field activity over 3 hour test) for males [n beam breaks] x x x x 35796.7 18362.2 x 33446.2 10491.0 34967.8 19751.0 51288.0 14241.8 37651.5 6785.33 41466.5 12435.0 4206.25 48140.5 24349.5 x x x 23112.8 x 33555.7 7226.67 28767.8 x 43895.8 974.5 10135.4 6740.5 x 26988.0 x 18438.8 28921.0 61351.5 x 4672.83 2719.17 7615.2 22506.5 x x 16431.0 x 19188.2 61234.6 x x x 1131.0 3211.2 x x x 605.571 5964.5 13660.7 24674.3 x 9254.67 10466.5 8548.83 21805.0 4523.83 30201.7 42840.0 x 13304.0 x 13715.5 x x x x 31638.8 x x 3730.0 2547.5 36532.0 40198.5 380.8 x 1501.33 21542.7 x 10487.7 x x x 5993.5 3883.0 26143.8 1074.6 16903.3 x x x +11336 Original post publication description: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), number of jumps for males [n/15 min test] None Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), number of jumps for males [n/15 min test] x x x x 0.0 0.0 x 1.66667 0.0 0.4 0.0 0.5 6.5 0.0 0.0 0.0 6.0 0.0 5.25 7.33333 x x x 0.0 x 3.42857 6.33333 0.0 x 0.0 0.0 0.0 3.33333 x 0.0 x 0.666667 3.0 0.833333 x 4.5 3.83333 0.0 4.5 x x 1.5 x 0.0 3.0 x x x 0.0 7.2 x x x 0.142857 0.0 0.0 0.0 x 0.0 0.0 0.0 0.0 0.0 0.5 0.0 x 0.3 x 0.0 x x x x 3.6 x x 0.0 2.66667 1.33333 1.0 0.0 x 0.0 0.0 x 1.66667 x x x 1.5 0.0 6.75 0.0 6.33333 x x x +11335 Original post publication description: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), defecation in an activity chamber for males [n fecal boli] None Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), defecation in an activity chamber for males [n fecal boli] x x x x 2.0 3.33333 x 3.0 1.0 0.6 2.0 4.0 0.75 1.75 1.83333 0.25 1.25 3.0 2.0 1.5 x x x 1.0 x 1.14286 0.0 2.4 x 1.83333 1.75 0.625 2.83333 x 2.75 x 0.0 1.5 1.33333 x 2.66667 3.33333 2.8 2.75 x x 0.5 x 1.66667 2.85714 x x x 2.0 1.2 x x x 3.85714 4.0 1.66667 0.666667 x 2.83333 1.66667 4.16667 1.2 1.66667 0.5 3.0 x 2.0 x 3.66667 x x x x 3.0 x x 2.0 2.83333 0.5 2.75 1.8 x 1.33333 2.0 x 1.33333 x x x 2.0 3.5 2.0 2.2 0.666667 x x x +11334 Original post publication description: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), severity of abdominal contraction for males [ordinal scale, 0=no effect, 3=max] None Central nervous system, pharmacology, behavior: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), severity of abdominal contraction for males [ordinal scale, 0=no effect, 3=max] x x x x 0.0 0.333333 x 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 x x x 0.0 x 0.142857 0.0 0.2 x 0.0 0.0 0.0 0.166667 x 0.0 x 0.0 0.0 0.0 x 0.0 0.0 0.0 0.25 x x 0.0 x 0.0 0.0 x x x 0.0 0.0 x x x 0.0 0.0 0.0 0.0 x 0.0 0.0 0.0 0.0 0.0 0.0 0.0 x 0.0 x 0.0 x x x x 0.0 x x 0.0 0.0 0.0 0.25 0.0 x 0.0 0.0 x 0.0 x x x 0.0 0.0 0.0 0.0 0.0 x x x +11333 Original post publication description: Morphine response (50 mg/kg ip), locomotion (open field) from 75-90 min after injection in an activity chamber for males [cm] None Morphine response (50 mg/kg ip), locomotion (open field) from 75-90 min after injection in an activity chamber for males [cm] x x x x 12298.8 4579.62 x 12542.8 8243.59 14680.2 11290.1 17666.2 7009.53 12641.7 3687.13 17045.5 4684.07 455.723 17217.6 10804.1 x x x 10221.2 x 13925.4 2157.55 11098.9 x 10927.4 267.956 3002.51 3903.8 x 10194.4 x 7407.62 11763.1 21464.2 x 497.94 1264.92 4004.96 9665.69 x x 6895.36 x 7407.69 19634.0 x x x 144.874 2487.82 x x x 25.7629 1406.09 5751.83 9412.8 x 6103.21 5136.6 6027.54 9982.21 1700.5 9949.54 6525.46 x 4250.73 x 4791.84 x x x x 13266.3 x x 1758.06 116.522 12302.8 12234.9 39.2653 x 17.3776 8336.78 x 4510.36 x x x 3122.08 1643.21 9958.22 342.95 5999.12 x x x +11332 Original post publication description: Morphine response (50 mg/kg ip), locomotion (open field) from 60-75 min after injection in an activity chamber for males [cm] None Morphine response (50 mg/kg ip), locomotion (open field) from 60-75 min after injection in an activity chamber for males [cm] x x x x 11333.2 3604.59 x 12835.8 5396.71 15328.1 10915.7 17941.3 6400.25 11230.3 3583.35 17684.8 5617.39 158.578 16448.6 10095.7 x x x 9510.55 x 12961.8 1598.82 10395.2 x 16451.2 235.985 2785.13 3193.75 x 13772.9 x 7586.75 11643.9 20527.6 x 273.546 957.739 4505.8 8491.82 x x 6742.33 x 10118.7 18368.1 x x x 70.3153 1997.65 x x x 112.304 904.603 6054.29 9087.17 x 5749.14 4005.67 4005.48 11547.5 1348.43 9182.32 10540.8 x 3314.01 x 3735.26 x x x x 11772.2 x x 1630.15 20.1998 13551.9 8596.89 95.8489 x 0.0 7132.8 x 5415.76 x x x 2524.57 1422.24 10621.6 255.075 4976.95 x x x +11331 Original post publication description: Morphine response (50 mg/kg ip), locomotion (open field) from 45-60 min after injection in an activity chamber for males [cm] None Morphine response (50 mg/kg ip), locomotion (open field) from 45-60 min after injection in an activity chamber for males [cm] x x x x 9653.85 2160.45 x 11531.9 2024.51 12496.3 8785.21 16972.9 4954.4 8056.44 2790.86 17121.3 5235.33 27.3364 15220.3 7909.12 x x x 8868.73 x 10767.9 1192.79 8937.76 x 19825.2 67.1376 2562.71 2278.48 x 14764.9 x 6289.32 8929.75 17134.2 x 177.83 726.556 3703.7 6248.65 x x 5822.06 x 11987.2 16991.9 x x x 37.0836 1819.62 x x x 9.17922 328.053 6042.11 7927.91 x 4150.54 2569.76 2111.91 11766.2 879.605 8050.25 17669.4 x 2130.4 x 2580.1 x x x x 9143.26 x x 1104.0 6.35 12944.0 7616.05 127.983 x 13.4203 5650.03 x 4870.99 x x x 1833.57 1217.75 11181.9 109.27 3977.23 x x x +11330 Original post publication description: Morphine response (50 mg/kg ip), locomotion (open field) from 30-45 min after injection in an activity chamber for males [cm] None Morphine response (50 mg/kg ip), locomotion (open field) from 30-45 min after injection in an activity chamber for males [cm] x x x x 7296.9 1577.45 x 9924.63 796.667 8077.75 6309.71 15981.4 3594.25 5847.4 2433.82 14323.9 4473.3 40.0034 12902.5 5431.33 x x x 7031.66 x 7593.73 517.033 6155.81 x 20621.7 48.3042 2124.79 1477.29 x 11708.4 x 5174.99 7192.77 13420.3 x 176.072 451.236 3379.42 4466.76 x x 5407.34 x 9978.39 13691.9 x x x 12.7419 1323.37 x x x 114.788 284.696 5356.25 6432.72 x 2914.15 1372.16 866.106 9499.62 706.794 6152.44 25510.3 x 1244.33 x 1670.23 x x x x 4892.38 x x 604.893 9.525 10545.0 4363.51 100.833 x 22.079 4464.8 x 3432.84 x x x 1071.26 173.499 9712.89 20.32 3252.17 x x x +11329 Original post publication description: Morphine response (50 mg/kg ip), locomotion (open field) from 15-30 min after injection in an activity chamber for males [cm] None Morphine response (50 mg/kg ip), locomotion (open field) from 15-30 min after injection in an activity chamber for males [cm] x x x x 5902.69 978.639 x 7288.48 145.304 5127.8 2273.06 13870.5 1689.58 4467.96 1905.09 9376.68 4059.25 8.255 11126.4 2589.27 x x x 4147.98 x 5188.22 456.184 5852.66 x 15830.6 61.2789 2145.22 1296.94 x 4471.54 x 3204.43 6228.33 9899.72 x 174.612 473.335 1925.83 3705.12 x x 3806.47 x 5037.28 12009.0 x x x 61.2174 933.445 x x x 159.749 294.461 2884.97 5898.97 x 1859.1 1518.61 382.164 5665.6 354.214 5614.81 27903.4 x 1349.92 x 1207.19 x x x x 2765.85 x x 207.673 25.1377 7648.04 1883.95 33.5857 x 52.4089 4598.61 x 1856.11 x x x 508.398 97.5167 9305.91 16.51 2682.68 x x x +11328 Original post publication description: Morphine response (50 mg/kg ip), locomotion (open field) from 165-180 min after injection in an activity chamber for males [cm] None Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion (open field) from 165-180 min after injection in an activity chamber for males [cm] x x x x 3877.12 6491.5 x 4825.85 687.474 2653.6 889.155 2670.07 1675.58 4999.2 359.685 1249.38 922.18 1284.57 1777.9 3475.57 x x x 900.548 x 4490.5 1870.61 1194.85 x 2262.29 570.576 3088.16 732.083 x 950.666 x 3296.51 3306.69 3908.74 x 4393.71 216.093 319.399 5285.23 x x 1293.34 x 676.626 6115.71 x x x 1046.98 1121.54 x x x 539.041 1385.18 923.776 6685.86 x 261.989 1629.48 913.455 1548.29 1554.74 7944.1 5716.18 x 5210.47 x 814.721 x x x x 3936.73 x x 839.43 2960.28 3743.28 10864.5 232.477 x 1067.66 2877.97 x 737.117 x x x 808.058 1294.02 434.736 578.471 3427.75 x x x +11327 Original post publication description: Morphine response (50 mg/kg ip), locomotion (open field) from 150-165 min after injection in an activity chamber for males [cm] None Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion (open field) from 150-165 min after injection in an activity chamber for males [cm] x x x x 5484.31 7382.02 x 5638.55 603.367 4406.49 984.389 4057.5 2437.82 8909.02 437.839 2453.17 612.901 3510.13 3763.35 3797.04 x x x 1512.5 x 4763.6 3280.08 2736.45 x 4016.82 622.395 3079.71 697.885 x 715.231 x 4236.08 4317.17 6194.03 x 4054.82 31.9992 575.645 4916.32 x x 2092.9 x 843.122 10053.6 x x x 472.121 1780.24 x x x 172.389 2356.22 1013.64 7858.5 x 122.663 2353.07 1747.19 520.141 1412.23 9086.62 5301.81 x 5224.16 x 2201.25 x x x x 5531.12 x x 889.204 2291.1 5416.44 12363.0 83.8599 x 919.353 5713.19 x 1463.14 x x x 1323.87 1692.35 226.498 290.506 4023.41 x x x +11326 Original post publication description: Morphine response (50 mg/kg ip), locomotion (open field) from 0-15 min after injection in an activity chamber for males [cm] None Morphine response (50 mg/kg ip), locomotion (open field) from 0-15 min after injection in an activity chamber for males [cm] x x x x 5531.1 1679.31 x 3711.77 798.939 4682.05 1064.29 5523.89 760.109 2722.34 1968.46 4956.09 4039.4 351.563 6708.64 1548.3 x x x 2409.23 x 2739.43 683.537 5460.99 x 5616.66 428.127 2689.98 1398.59 x 1992.33 x 3271.05 3735.41 8408.84 x 907.922 1123.11 1853.35 2729.71 x x 3143.9 x 1829.07 6672.25 x x x 847.238 979.74 x x x 540.575 750.773 1462.57 3363.47 x 1114.34 2755.96 778.209 2890.09 1048.98 8312.93 10202.0 x 2141.57 x 1437.28 x x x x 1860.99 x x 469.456 611.606 2895.68 623.537 314.22 x 1788.4 4073.89 x 965.344 x x x 568.889 783.451 6080.76 696.505 2452.71 x x x +11325 Original post publication description: Morphine response (50 mg/kg ip), locomotion (open field) from 120-135 min after injection in an activity chamber for males [cm] None Morphine response (50 mg/kg ip), locomotion (open field) from 120-135 min after injection in an activity chamber for males [cm] x x x x 10567.0 7142.52 x 7456.86 1795.04 9044.45 3538.33 9077.16 5516.6 11509.6 1941.83 3833.05 2421.97 3692.31 12020.8 6750.9 x x x 6423.33 x 8412.58 3618.58 8955.91 x 5704.36 274.611 3780.12 2318.16 x 2640.7 x 5968.67 7336.61 13559.2 x 1775.32 1350.37 720.18 6437.58 x x 4664.02 x 1538.29 15861.5 x x x 695.513 2252.64 x x x 181.968 3690.58 2811.95 9591.27 x 1258.81 2552.99 4197.78 1341.13 1351.41 10322.5 4534.55 x 5645.41 x 6330.1 x x x x 8563.54 x x 1212.31 1348.25 10121.9 13130.8 130.98 x 686.281 8217.86 x 2726.17 x x x 1732.76 1635.51 4283.34 263.598 6511.41 x x x +11324 Original post publication description: Morphine response (50 mg/kg ip), locomotion (open field) from 105-120 min after injection in an activity chamber for males None Morphine response (50 mg/kg ip), locomotion (open field) from 105-120 min after injection in an activity chamber for males x x x x 13121.5 6624.62 x 10243.5 5246.08 11530.5 5668.87 13225.8 7081.87 12487.7 3621.08 7437.69 3191.87 2429.94 15546.1 8102.43 x x x 9421.57 x 11869.7 3332.87 10401.8 x 6177.15 278.674 3560.26 3393.78 x 4261.92 x 6700.42 10292.6 16929.6 x 1266.4 1355.33 1134.2 8029.88 x x 5650.4 x 2496.65 18894.7 x x x 535.187 2392.06 x x x 43.91 2913.32 4637.68 9589.29 x 3400.27 3116.71 5262.94 4201.93 2101.29 10244.9 4446.06 x 5032.15 x 6825.0 x x x x 9487.22 x x 1398.7 822.332 11122.0 13508.9 28.2443 x 168.495 8979.7 x 2971.06 x x x 2564.57 1436.44 5185.56 379.73 7008.81 x x x +11323 Original post publication description: Morphine response (50 mg/kg ip), locomotion (open field) from 90-105 min after injection in an activity chamber for males [cm] None Morphine response (50 mg/kg ip), locomotion (open field) from 90-105 min after injection in an activity chamber for males [cm] x x x x 13319.8 5660.21 x 12297.0 7889.28 13647.6 8358.18 16791.0 7474.66 13429.0 4334.51 12817.9 3582.17 654.305 17295.2 10180.3 x x x 10419.5 x 13541.5 2768.06 11010.7 x 7880.29 267.315 3616.86 3664.3 x 8425.49 x 7202.13 11548.5 20438.0 x 815.083 1313.5 2230.91 8991.11 x x 6628.82 x 3808.96 20089.5 x x x 372.333 2462.74 x x x 36.1343 2658.36 4575.47 9624.99 x 5027.26 4695.63 6131.91 8530.58 1713.1 10777.7 5281.6 x 4792.44 x 6659.99 x x x x 11953.3 x x 1800.22 364.467 12018.9 12217.1 47.2227 x 31.7829 8754.49 x 3797.97 x x x 2996.69 1668.97 6602.65 330.893 6414.85 x x x +11322 Original post publication description: Morphine response (50 mg/kg ip), locomotion from 75-90 min after injection in an activity chamber for males [n beam breaks] None Morphine response (50 mg/kg ip), locomotion from 75-90 min after injection in an activity chamber for males [n beam breaks] x x x x 4177.5 1374.33 x 4196.67 2696.33 5249.2 3763.67 6696.0 1999.5 4455.25 961.167 6777.5 1417.0 52.25 6379.25 3689.5 x x x 3396.6 x 4794.14 553.0 3740.0 x 3906.33 65.0 812.5 1127.83 x 3623.25 x 2126.17 3872.0 8902.83 x 67.3333 373.667 1266.4 3365.5 x x 2110.0 x 2520.83 7254.29 x x x 11.0 273.4 x x x 7.85714 364.75 1807.83 2498.67 x 1974.5 1700.0 1485.5 3421.8 507.833 3003.33 1283.0 x 1155.6 x 1523.5 x x x x 4957.4 x x 513.333 9.33333 4187.0 4602.0 10.8 x 1.66667 2361.67 x 1383.67 x x x 935.5 454.5 3450.75 103.0 1846.17 x x x +11321 Original post publication description: Morphine response (50 mg/kg ip), locomotion from 60-75 min after injection in an activity chamber for males [n beam breaks] None Morphine response (50 mg/kg ip), locomotion from 60-75 min after injection in an activity chamber for males [n beam breaks] x x x x 3811.0 988.833 x 4326.83 1453.33 5599.4 3561.67 6914.0 1710.5 3844.75 987.5 7137.25 1766.5 12.25 5983.0 3439.0 x x x 3126.6 x 4378.86 413.667 3454.6 x 6320.0 47.75 732.875 839.667 x 5026.25 x 2288.83 3795.67 8454.5 x 28.3333 267.167 1382.2 2752.25 x x 1983.0 x 3493.17 6805.14 x x x 3.66667 160.4 x x x 28.8571 176.75 1970.5 2354.33 x 1747.33 1304.33 834.0 3953.4 389.167 2633.0 3312.0 x 812.5 x 1109.5 x x x x 4309.8 x x 454.0 2.33333 4744.33 2995.25 20.6 x 0.0 1895.0 x 1652.67 x x x 729.333 325.5 3764.5 67.6 1476.5 x x x +11320 Original post publication description: Morphine response (50 mg/kg ip), locomotion from 45-60 min after injection in an activity chamber for males [n beam breaks] None Morphine response (50 mg/kg ip), locomotion from 45-60 min after injection in an activity chamber for males [n beam breaks] x x x x 3125.33 540.167 x 3773.0 495.0 4147.4 2702.0 6586.5 1178.25 2780.25 551.667 6767.25 1642.75 2.25 5355.5 2646.33 x x x 2899.8 x 3512.57 248.5 2853.6 x 8016.33 9.0 685.5 526.167 x 5289.5 x 1832.17 2614.0 6657.5 x 15.5 195.0 1119.8 1812.75 x x 1731.0 x 4245.17 6346.86 x x x 1.83333 132.4 x x x 0.142857 48.75 2056.83 1857.67 x 1029.17 768.833 275.667 3941.8 243.167 2126.83 6476.0 x 447.2 x 703.167 x x x x 3250.2 x x 293.167 0.333333 4554.0 2495.5 24.0 x 1.5 1351.0 x 1434.0 x x x 526.5 303.0 3977.25 21.4 1074.67 x x x +11319 Original post publication description: Morphine response (50 mg/kg ip), locomotion from 30-45 min after injection in an activity chamber for males [n beam breaks] None Morphine response (50 mg/kg ip), locomotion from 30-45 min after injection in an activity chamber for males [n beam breaks] x x x x 2338.67 365.833 x 3178.0 188.333 2313.8 1868.67 5844.5 680.25 2093.0 404.0 5236.25 1407.0 2.75 4297.5 1604.33 x x x 2097.4 x 2314.71 63.6667 1851.8 x 8400.5 4.5 571.0 266.833 x 4140.5 x 1413.0 2045.67 4813.33 x 15.5 105.0 1022.2 1073.25 x x 1600.0 x 3429.33 4953.29 x x x 0.666667 99.8 x x x 27.4286 40.0 1853.0 1343.0 x 628.5 326.167 78.8333 2990.6 201.833 1278.33 10782.0 x 203.7 x 424.333 x x x x 1552.2 x x 157.5 0.5 3625.33 1270.5 18.4 x 2.0 975.0 x 961.0 x x x 305.333 40.0 3400.0 2.6 852.667 x x x +11318 Original post publication description: Morphine response (50 mg/kg ip), locomotion from 15-30 min after injection in an activity chamber for males [n beam breaks] None Morphine response (50 mg/kg ip), locomotion from 15-30 min after injection in an activity chamber for males [n beam breaks] x x x x 1826.67 199.0 x 2275.33 25.3333 1296.0 651.667 4914.5 263.75 1565.0 222.667 2989.0 1278.5 1.0 3572.25 657.0 x x x 989.2 x 1514.14 48.0 1860.4 x 6081.17 7.5 634.5 206.0 x 1612.25 x 905.667 1829.5 3523.67 x 31.1667 101.0 581.2 802.25 x x 1106.5 x 1542.67 4201.0 x x x 6.66667 79.6 x x x 41.5714 55.75 820.667 1275.0 x 368.333 365.333 30.1667 1529.4 103.333 1159.83 12059.0 x 289.7 x 333.0 x x x x 819.2 x x 50.8333 4.16667 2449.33 459.75 3.0 x 9.5 1111.0 x 476.333 x x x 149.167 17.0 3277.0 1.0 722.333 x x x +11317 Original post publication description: Morphine response (50 mg/kg ip), locomotion from 165-180 min after injection in an activity chamber for males [n beam breaks] None Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion from 165-180 min after injection in an activity chamber for males [n beam breaks] x x x x 1208.5 2241.83 x 1517.0 190.333 703.6 285.333 835.0 462.25 1740.75 81.5 357.25 249.5 362.75 538.5 1082.83 x x x 257.8 x 1521.57 584.833 364.4 x 681.5 159.5 852.125 209.5 x 323.75 x 945.833 980.333 1178.17 x 1403.17 51.1667 96.6 1516.0 x x 373.0 x 225.0 1940.43 x x x 287.833 279.2 x x x 163.571 448.75 247.0 1741.67 x 78.3333 560.0 258.0 426.8 460.5 2155.83 1381.0 x 1603.1 x 243.5 x x x x 1321.0 x x 228.0 824.0 1117.33 3909.25 59.4 x 309.833 840.667 x 191.0 x x x 225.0 333.5 135.75 182.6 1009.83 x x x +11316 Original post publication description: Morphine response (50 mg/kg ip), locomotion from 150-165 min after injection in an activity chamber for males [n beam breaks] None Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion from 150-165 min after injection in an activity chamber for males [n beam breaks] x x x x 1772.67 2612.17 x 1713.17 161.667 1216.2 325.667 1300.0 669.0 3177.25 65.8333 740.5 126.75 1037.0 1205.25 1147.17 x x x 421.0 x 1448.43 1074.5 883.8 x 1204.17 190.0 852.75 207.333 x 224.75 x 1214.33 1260.33 1917.17 x 1255.67 1.5 159.0 1410.0 x x 605.5 x 278.5 3401.0 x x x 125.5 426.4 x x x 49.4286 750.0 246.5 2131.0 x 34.1667 811.167 483.667 151.8 380.333 2588.33 1094.0 x 1629.5 x 703.5 x x x x 1868.2 x x 258.0 592.333 1688.5 4582.75 27.4 x 267.0 1755.67 x 416.667 x x x 376.167 451.0 72.5 89.0 1190.83 x x x +11307 Original post publication description: Pain response, thermal nociception using Hargreaves' test for males [units] None Central nervous system, peripheral nervous system, behavior: Pain response, thermal nociception using Hargreaves' test for males [units] x x x x x x x 10.5148 13.8 x 8.56691 16.5295 14.3669 10.2102 13.7917 9.74463 13.7313 9.50583 10.3367 16.7707 x x x 15.12 x 11.3156 11.5027 13.236 x 9.93312 10.9415 15.0217 13.407 x 14.5357 x 15.3733 10.7323 12.2503 x 9.9575 17.6442 11.6169 9.893 x x 10.969 x 10.2867 10.8322 x x x 12.0997 12.3933 x x x 10.8968 15.1283 10.9194 16.4203 x 14.608 16.475 19.9303 14.4356 11.9458 23.7783 14.7875 x 14.407 x 15.6732 x 13.441 x x 10.7275 x x 17.484 12.7757 20.18 8.48271 11.0256 x 16.1733 x x 16.3293 x x x 12.707 13.2608 15.5398 19.0475 20.2953 x x x +11304 Original post publication description: Ethanol response (2 mg/kg ip), motor coordination, time on dowel over a 5 min test period starting 30 min after injection for males [sec] None Central nervous system, pharmacology, behavior: Ethanol response (2 g/kg ip), motor coordination, time on dowel over a 5 min test period starting 30 min after injection for males [sec] x x x x 159.0 x x 9.5 x x 118.571 18.5 3.75 4.66667 x 4.5 2.85714 45.6 x 2.2 x x x x x 25.2 0.0 17.0 x 3.42857 10.3636 12.3333 6.2 x 13.8 x 0.0 33.0 13.8 x 14.8 34.0 74.3333 6.4 x x 60.0 x 13.4 10.6 x x x 4.2 6.0 x x x 9.5 4.33333 223.2 42.0 x 5.6 14.75 4.8 11.6 8.6 3.5 5.0 x 14.1667 x 27.8 x x x x 3.625 x x x 19.0 x 10.0 6.0 x 5.33333 x x x x x x 6.5 7.0 9.0 x 14.0 x x x +11262 Original post publication description: Endocrinology, neuroendocrine system, morphology: Adrenal medulla width for females [um] None Endocrinology, neuroendocrine system, morphology: Adrenal medulla width for females [um] x x 402.226 523.907 450.785 490.49 x 601.115 449.645 581.748 414.77 404.61 445.335 412.065 568.498 428.64 461.643 435.34 622.83 528.365 x x x 521.165 x 541.238 461.57 x x 489.12 516.865 458.63 500.303 x 564.64 x 534.47 441.085 431.635 x 348.738 602.81 416.12 633.32 x x 615.518 x 634.253 582.92 x x x 548.745 516.257 x x x 538.163 536.015 338.857 646.415 x 453.62 509.543 413.488 471.13 475.643 522.077 500.737 x 527.333 x 483.71 x 390.2 x x 530.51 x x 501.56 517.29 517.88 534.32 486.16 x 457.99 551.22 x 485.913 x x x 556.897 429.613 605.425 533.785 601.36 x x x +11263 Original post publication description: Endocrinology, neuroendocrine system, morphology: Adrenal medulla width for males [um] None Endocrinology, neuroendocrine system, morphology: Adrenal medulla width for males [um] x x 426.34 434.136 579.675 497.753 x 511.878 526.28 580.493 x 471.985 529.285 457.245 657.665 514.583 593.267 443.765 509.843 x x x x 587.04 x 599.963 633.815 483.573 x 597.365 565.12 650.39 596.103 x 552.727 x 542.623 485.41 488.157 x 462.205 554.213 458.587 383.755 x x 664.306 x 605.425 576.775 x x x 560.378 490.595 x x x 570.082 567.2 531.377 712.67 x 476.243 534.083 516.67 547.203 469.353 518.645 592.017 x 593.765 x 482.713 x 510.183 x x 538.105 x x 565.905 533.747 539.44 548.805 599.59 x 667.32 632.015 x 528.195 x x x 518.855 490.337 634.35 640.205 580.97 x x x +11266 Original post publication description: Endocrinology, neuroendocrine system, morphology: Adrenal width (total) for males [um] None Endocrinology, neuroendocrine system, morphology: Adrenal width (total) for males [um] x x 1065.04 906.118 1131.54 1029.55 x 1210.67 1064.63 1131.33 x 962.84 1019.47 960.715 1130.33 1249.22 1122.56 996.24 1204.9 x x x x 1170.92 x 1157.2 1157.93 964.037 x 1074.44 1060.65 1210.14 1194.71 x 1084.26 x 1156.26 1037.65 958.603 x 1101.15 1059.56 981.133 1026.11 x x 1262.81 x 1063.93 1271.21 x x x 1084.97 1057.65 x x x 1150.09 1091.13 1128.02 1249.06 x 1038.56 1101.78 1104.05 1102.79 1111.58 969.45 1149.26 x 1083.49 x 1022.65 x 1020.94 x x 1022.99 x x 1002.44 1111.89 1112.88 1041.82 1175.94 x 1115.32 1165.52 x 1061.99 x x x 1093.56 1033.61 1169.91 1162.54 1330.42 x x x +11267 Original post publication description: Endocrinology, neuroendocrine system, morphology: Adrenal width (total) for females [um] None Endocrinology, neuroendocrine system, morphology: Adrenal width (total) for females [um] x x 1178.02 1185.5 1135.51 1253.38 x 1461.82 1064.81 1271.12 1306.77 1067.68 1279.95 1037.69 1214.73 1409.33 1325.71 1076.3 1395.26 1245.78 x x x 1247.53 x 1271.53 1449.89 x x 1235.49 1411.22 1217.19 1203.64 x 1289.41 x 1330.0 1303.38 1137.89 x 1116.28 1287.82 1037.93 1396.88 x x 1344.69 x 1406.93 1514.21 x x x 1193.36 1348.0 x x x 1337.82 1262.56 1436.28 1408.98 x 1209.61 1305.66 1118.29 1236.96 1286.81 1230.03 1067.72 x 1233.93 x 1185.86 x 1024.55 x x 1130.1 x x 1199.17 1272.53 1215.21 1078.08 1248.08 x 1177.55 1285.69 x 1264.53 x x x 1269.19 1189.6 1286.06 1239.37 1350.56 x x x +11268 Original post publication description: Endocrinology, neuroendocrine system, morphology: Adrenal zona glomerulosa width for males [um] None Endocrinology, neuroendocrine system, morphology: Adrenal zona glomerulosa width for males [um] x x 46.556 45.552 39.74 40.657 x 53.423 42.765 43.795 x 32.108 36.988 33.0 43.31 44.66 46.826 39.255 48.108 x x x x 50.044 x 39.44 35.48 41.165 x 36.59 36.11 49.865 45.065 x 42.637 x 40.91 43.295 39.113 x 51.123 39.254 43.188 45.325 x x 47.328 x 41.395 61.518 x x x 42.569 50.258 x x x 49.17 41.382 39.29 50.803 x 42.542 38.973 47.998 39.66 42.613 35.783 46.085 x 46.94 x 44.035 x 43.315 x x 41.263 x x 37.215 39.393 43.474 40.223 39.913 x 38.53 43.711 x 41.838 x x x 38.513 42.297 42.423 38.808 45.568 x x x +11269 Original post publication description: Endocrinology, neuroendocrine system, morphology: Adrenal zona glomerulosa width for females [um] None Endocrinology, neuroendocrine system, morphology: Adrenal zona glomerulosa width for females [um] x x 41.181 38.095 44.028 46.978 x 46.555 38.608 41.95 38.55 31.413 45.888 32.013 45.048 49.253 42.849 41.127 38.743 45.475 x x x 41.043 x 47.889 39.273 x x 50.775 33.42 33.585 46.018 x 40.327 x 44.51 50.293 39.312 x 46.389 40.286 46.438 51.898 x x 41.491 x 46.912 55.374 x x x 43.653 49.995 x x x 48.664 43.032 54.27 47.183 x 42.036 39.36 49.168 49.75 40.317 46.153 43.77 x 47.219 x 44.699 x 48.383 x x 35.532 x x 42.102 45.355 44.42 42.495 39.863 x 38.4 50.189 x 42.041 x x x 46.277 42.865 39.565 41.816 34.317 x x x +11270 Original post publication description: Endocrinology, neuroendocrine system, morphology: Adrenal zona fasciculata width in young adult males [um] None Endocrinology, neuroendocrine system, morphology: Adrenal zona fasciculata width in young adult males [um] x x 143.661 110.983 144.29 137.802 x 168.833 143.043 113.957 x 117.235 116.838 125.473 99.86 189.717 107.054 150.653 178.804 x x x x 142.653 x 140.071 132.65 109.183 x 113.015 129.925 123.068 143.8 x 115.698 x 131.993 121.932 108.823 x 136.706 122.646 120.145 143.783 x x 135.825 x 97.393 154.478 x x x 121.086 128.77 x x x 128.304 117.66 134.057 134.858 x 125.613 128.033 137.158 132.928 164.698 108.38 109.328 x 109.578 x 119.445 x 107.222 x x 107.76 x x 100.418 124.467 127.223 114.48 135.8 x 109.478 116.346 x 115.568 x x x 134.49 127.74 121.407 116.573 148.21 x x x +11271 Original post publication description: Endocrinology, neuroendocrine system, morphology: Adrenal zona fasciculata width for females [um] None Endocrinology, neuroendocrine system, morphology: Adrenal zona fasciculata width for females [um] x x 190.799 114.783 136.563 182.118 x 228.625 142.955 153.214 192.095 150.615 201.718 142.485 164.184 221.848 122.774 154.223 147.14 153.648 x x x 184.065 x 143.865 133.215 x x 173.49 102.86 195.993 179.93 x 127.681 x 171.698 224.443 202.105 x 155.734 163.203 155.08 189.82 x x 184.469 x 156.525 232.236 x x x 145.49 214.718 x x x 181.467 174.325 259.647 212.683 x 175.089 195.732 185.485 178.443 172.478 138.397 149.028 x 162.344 x 148.823 x 136.4 x x 132.493 x x 164.467 184.065 156.943 130.532 157.143 x 120.338 141.634 x 173.931 x x x 166.875 165.24 179.257 156.44 203.055 x x x +11272 Original post publication description: Endocrinology, neuroendocrine system, morphology: Adrenal X-zone width for males [um] None Endocrinology, neuroendocrine system, morphology: Adrenal X-zone width for males [um] x x 0.0 0.0 0.0 0.0 x 0.0 0.0 0.0 x 0.0 0.0 0.0 19.25 38.52 11.223 0.0 0.0 x x x x 0.0 x 0.0 0.0 0.0 x 0.0 0.0 7.3 0.0 x 27.892 x 36.83 0.0 0.0 x 0.0 0.0 0.0 0.0 x x 0.0 x 0.0 14.148 x x x 0.0 20.99 x x x 0.0 0.0 0.0 0.0 x 0.0 0.0 0.0 0.0 0.0 0.0 0.0 x 0.0 x 0.0 x 0.0 x x 0.0 x x 0.0 0.0 0.0 0.0 0.0 x 0.0 0.0 x 0.0 x x x 0.0 0.0 0.0 0.0 0.0 x x x +11273 Original post publication description: Endocrinology, neuroendocrine system, morphology: Adrenal X-zone width for females [um] None Endocrinology, neuroendocrine system, morphology: Adrenal X-zone width for females [um] x x 36.523 47.136 37.885 66.465 x 52.876 50.103 42.921 109.35 58.865 74.81 51.448 40.746 66.28 78.404 43.97 65.747 47.285 x x x 54.343 x 61.791 39.665 x x 57.715 40.903 57.445 58.905 x 63.556 x 57.615 64.723 47.01 x 57.071 48.404 36.67 57.945 x x 44.26 x 60.232 66.824 x x x 53.933 51.742 x x x 49.251 47.962 74.492 43.605 x 71.183 69.267 27.418 53.578 86.36 74.662 28.355 x 37.744 x 65.528 x 56.488 x x 51.843 x x 57.118 54.343 70.81 36.315 80.77 x 34.318 53.14 x 70.659 x x x 58.248 78.33 40.185 64.744 51.243 x x x +11280 Original post publication description: Coat color (version 2, ordinal test case, black=4, grey=3, brown=2, dba dilute=1) None Skin, pigmentation: Hair coat color, ordinal scale version 2 where black=4, grey=3, brown=2, dba dilute=1 [color intensity] 4.0 4.0 4.0 1.0 1.0 4.0 3.0 3.0 3.0 1.0 4.0 3.0 2.0 4.0 2.0 3.0 3.0 3.0 4.0 1.0 3.0 4.0 2.0 2.0 2.0 2.0 2.0 3.0 1.0 4.0 4.0 3.0 4.0 4.0 2.0 x 3.0 3.0 3.0 x 4.0 4.0 1.0 1.0 x x 4.0 3.0 4.0 4.0 2.0 2.0 x 2.0 4.0 x x 2.0 2.0 1.0 2.0 1.0 1.0 2.0 2.0 1.0 2.0 1.0 1.0 1.0 2.0 1.0 2.0 1.0 3.0 1.0 2.0 3.0 1.0 1.0 x 1.0 1.0 1.0 4.0 4.0 2.0 1.0 1.0 1.0 1.0 1.0 3.0 1.0 4.0 2.0 1.0 1.0 4.0 3.0 2.0 1.0 +11281 Original post publication description: Central nervous system, visual system: Ocular dominance index (imaged ocular dominance index of undeprived mice at P35 given by (control_OD_contra - control_OD_ipsi) / (control_OD_contra+control_OD_ipsi) [ratio] None Central nervous system, visual system: Ocular dominance index (imaged ocular dominance index of undeprived mice at P35 given by (control_OD_contra - control_OD_ipsi) / (control_OD_contra+control_OD_ipsi) [ratio] x x 0.409 0.474 0.368 0.571 x 0.384 x 0.74 0.408 x x 0.48 x 0.645 x 0.404 x 0.518 x x x x x 0.43 0.347 0.374 x 0.365 0.405 0.373 0.426 x 0.43 x x 0.473 0.422 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +11282 Original post publication description: Central nervous system, visual system: Visual cortex (V1) optical signal strength to stimulation of contralateral eye [intensity] None Central nervous system, visual system: Visual cortex (V1) optical signal strength to stimulation of contralateral eye [intensity] x x 0.325 0.146 0.26 0.301 x 0.273 x 0.131 0.265 x x 0.303 x 0.295 x 0.518 x 0.197 x x x x x 0.189 0.257 0.409 x 0.328 0.317 0.211 0.275 x 0.286 x x 0.295 0.235 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +11283 Original post publication description: Central nervous system, visual system: Visual cortex (V1) optical signal strength to stimulation of ipsilateral eye [intensity] None Central nervous system, visual system: Visual cortex (V1) optical signal strength to stimulation of ipsilateral eye [intensity] x x 0.14 0.059 0.119 0.085 x 0.128 x 0.021 0.124 x x 0.111 x 0.076 x 0.217 x 0.062 x x x x x 0.078 0.12 0.18 x 0.157 0.137 0.095 0.114 x 0.11 x x 0.104 0.096 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +11284 Original post publication description: Central nervous system, visual system: Ocular dominance index shift after monocular deprivation of the contralateral eye from P28 to P35 None Central nervous system, visual system: Ocular dominance index shift after monocular deprivation of the contralateral eye from P28 to P35 x x -0.408 -0.304 -0.322 0.133 x -0.349 x x x x x -0.257 x -0.606 x x x -0.337 x x x x x x 0.057 -0.23 x -0.276 x -0.364 -0.242 x x x x -0.336 -0.195 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +11285 Original post publication description: Central nervous system, visual system: Contralateral visual cortex (V1) shift in intrinsic response to contralateral eye stimulation after monocular deprivation of the contralateral eye from P28 to P35 None Central nervous system, visual system: Contralateral visual cortex (V1) shift in intrinsic response to contralateral eye stimulation after monocular deprivation of the contralateral eye from P28 to P35 x x -0.073 -0.023 -0.092 0.047 x -0.072 x x x x x -0.013 x x x x x -0.069 x x x x x x -0.056 x x -0.088 x -0.041 0.006 x x x x -0.06 0.015 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +11286 Original post publication description: Central nervous system, visual system: Visual cortex (V1) activity, ipsilateral shift in intrinsic response to ipsilateral eye stimulation after monocular deprivation of the contralateral eye from P28 to P35 None Central nervous system, visual system: Visual cortex (V1) activity, ipsilateral shift in intrinsic response to ipsilateral eye stimulation after monocular deprivation of the contralateral eye from P28 to P35 x x 0.104 0.033 0.045 -0.015 x 0.055 x x x x x 0.083 x x x x x 0.036 x x x x x x -0.037 x x 0.048 x 0.064 0.079 x x x x 0.068 0.062 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +11308 Original post publication description: Pain response, thermal nociception, hot plate test, average of two trials for males [sec] None Central nervous system, behavior: Pain response, thermal nociception, hot plate test, average of two trials for males [sec] x x x x x x x 8.429 12.175 x 7.69429 8.35286 4.795 6.459 9.7925 5.11444 9.879 5.583 6.2875 5.455 x x x 12.24 x 10.0006 7.53909 7.48938 x 5.81563 5.79833 8.914 7.282 x 6.572 x 9.14 7.2185 9.819 x 5.70563 12.475 8.09444 14.265 x x 16.526 x 10.866 7.75778 x x x 11.0225 6.12 x x x 8.99542 8.65667 8.4975 15.683 x 8.46875 7.23214 8.49071 6.72083 6.71417 8.675 11.87 x 12.191 x 10.32 x 6.41222 x x 8.254 x x 7.72214 12.0783 9.29 10.1344 4.6575 x 9.331 x x 10.1412 x x x 13.026 9.7 7.78889 5.6775 9.62 x x x +11309 Original post publication description: Pain response, mechanical nociception, tail clip latency for males [sec] None Central nervous system, behavior: Pain response, mechanical nociception, tail clip latency for males [sec] x x x x x x x 10.073 27.525 x 19.5257 8.97571 18.3988 11.23 30.025 17.9378 14.444 8.665 31.96 6.134 x x x 15.484 x 21.3687 47.7682 37.4412 x 29.1775 29.045 19.754 47.54 x 16.204 x 8.364 29.006 25.027 x 9.32 16.14 17.8989 27.289 x x 39.695 x 28.453 18.25 x x x 12.315 60.0 x x x 16.5742 23.5067 37.462 25.188 x 16.584 9.56714 22.6329 41.7108 21.8008 3.77 29.565 x 20.554 x 32.251 x 38.572 x x 23.046 x x 14.7571 5.907 12.18 11.7963 10.02 x 15.988 x x 14.834 x x x 46.598 36.015 24.27 16.555 8.3 x x x +11310 Original post publication description: Pain response, thermal nociception, tail withdrawal latency for males [sec] None Pain response, thermal nociception, tail withdrawal latency for males [sec] x x x x x x x 8.756 10.845 x 14.1876 11.7452 9.29917 6.84933 19.0733 9.95111 11.8793 14.5993 8.48667 7.21267 x x x 18.0547 x 12.7392 14.9267 21.0554 x 10.0842 12.015 11.68 13.7673 x 13.9807 x 12.7407 12.5237 21.616 x 13.7592 9.66333 12.597 22.7887 x x 13.082 x 18.0887 12.167 x x x 9.988 28.13 x x x 11.9231 12.8433 13.1127 10.8133 x 8.88933 11.5671 21.0171 10.7622 13.6206 14.235 10.7933 x 18.9863 x 14.2343 x 17.9141 x x 12.701 x x 10.3314 13.745 5.64667 20.5637 11.4021 x 15.3253 x x 7.93933 x x x 12.8227 13.9633 9.157 9.56833 15.436 x x x +11311 Original post publication description: Somatosensory response, mechanical sensitivity using Von Frey test, threshold for males [Force in mg] None Somatosensory response, mechanical sensitivity using Von Frey test, threshold for males [Force in mg] x x x x x x x 4.07095 3.96175 x 4.33079 4.30861 4.475 4.41765 4.37725 4.16708 4.37985 4.1105 4.23112 4.2374 x x x 4.23845 x 4.15503 4.35966 4.21844 x 4.27931 4.07069 4.0338 4.1918 x 3.9919 x 4.10945 4.03083 4.13415 x 4.37741 3.69375 4.42419 4.26197 x x 4.1711 x 4.1815 4.37061 x x x 4.40882 4.22 x x x 4.19504 4.15158 4.19117 4.24515 x 4.01775 4.19268 4.11783 4.30873 3.98298 4.246 3.95263 x 4.15525 x 4.03135 x 4.15495 x x 4.39307 x x 4.17318 3.78443 4.11475 4.23116 4.07288 x 3.94595 x x 4.06385 x x x 4.1174 3.99612 4.1125 4.07363 4.17915 x x x +11312 Original post publication description: Morphine response (50 mg/kg ip), locomotion from 90-105 min after injection in an activity chamber for males [n beam breaks] None Morphine response (50 mg/kg ip), locomotion from 90-105 min after injection in an activity chamber for males [n beam breaks] x x x x 4631.5 1888.67 x 4062.33 2638.67 4797.6 2744.0 6312.5 2173.5 4901.5 1312.83 4929.0 1039.25 78.25 6324.75 3434.67 x x x 3479.0 x 4678.86 793.333 3745.2 x 2541.0 81.5 1020.5 1046.0 x 3026.0 x 1985.83 3784.5 8330.83 x 136.0 411.5 711.6 3018.75 x x 2039.5 x 1192.83 7378.86 x x x 54.3333 353.4 x x x 11.4286 807.0 1438.0 2625.33 x 1607.33 1540.0 1598.5 2882.2 527.833 3364.67 628.0 x 1389.8 x 2175.67 x x x x 4335.8 x x 537.0 60.0 3970.17 4603.25 12.4 x 4.33333 2591.67 x 1195.33 x x x 929.833 460.5 2290.75 96.6 2037.17 x x x +11313 Original post publication description: Morphine response (50 mg/kg ip), locomotion from 105-120 min after injection in an activity chamber for males [n beam breaks] None Morphine response (50 mg/kg ip), locomotion from 105-120 min after injection in an activity chamber for males [n beam breaks] x x x x 4541.67 2355.5 x 3266.0 1710.67 3854.4 1818.67 4935.0 2092.0 4604.75 1051.83 2815.0 921.25 608.0 5484.5 2637.83 x x x 3112.0 x 4089.14 984.0 3557.8 x 1801.83 85.25 1021.62 955.333 x 1482.5 x 1824.17 3384.67 6521.83 x 269.667 439.833 358.6 2502.0 x x 1760.5 x 786.667 6778.43 x x x 131.5 374.6 x x x 11.7143 928.0 1492.83 2715.33 x 1047.83 974.167 1482.33 1367.0 653.667 3114.17 507.0 x 1482.2 x 2246.0 x x x x 3210.6 x x 422.333 144.167 3618.67 5092.25 6.6 x 18.6667 2773.0 x 914.667 x x x 794.833 361.5 1807.75 115.2 2282.67 x x x +11314 Original post publication description: Morphine response (50 mg/kg ip), locomotion from 120-135 min after injection in an activity chamber for males [n beam breaks] None Morphine response (50 mg/kg ip), locomotion from 120-135 min after injection in an activity chamber for males [n beam breaks] x x x x 3691.0 2605.17 x 2249.17 537.333 2832.4 1137.0 3087.5 1675.0 4207.25 480.0 1338.0 616.25 1051.5 4037.75 2169.5 x x x 2028.2 x 2764.43 1091.0 3041.0 x 1641.67 87.5 1066.75 635.0 x 887.0 x 1566.5 2348.5 4821.17 x 431.5 412.333 217.2 1872.0 x x 1398.0 x 491.167 5601.14 x x x 169.333 408.6 x x x 53.2857 1200.75 873.333 2703.33 x 363.167 778.833 1148.83 373.6 402.167 3185.67 627.0 x 1716.1 x 2151.83 x x x x 2904.0 x x 353.0 293.167 3292.0 4879.0 40.2 x 177.833 2578.33 x 818.0 x x x 524.5 398.5 1496.5 77.8 2000.5 x x x +11315 Original post publication description: Morphine response (50 mg/kg ip), locomotion from 0-15 min after injection in an activity chamber for males [n beam breaks] None Morphine response (50 mg/kg ip), locomotion from 0-15 min after injection in an activity chamber for males [n beam breaks] x x x x 1820.5 514.333 x 1194.0 279.0 1342.0 297.333 1836.0 178.5 818.5 405.5 1589.75 1354.0 113.5 2086.25 393.333 x x x 514.4 x 778.286 189.0 1811.6 x 1813.0 113.25 837.0 340.5 x 629.5 x 994.0 1152.17 3003.17 x 270.833 307.667 562.6 731.5 x x 908.5 x 579.833 2226.29 x x x 201.833 178.4 x x x 159.857 219.5 371.167 870.333 x 279.833 864.333 123.667 664.8 321.5 2657.0 3822.0 x 636.0 x 419.667 x x x x 595.2 x x 128.333 180.0 726.0 184.0 90.0 x 531.0 1130.33 x 305.0 x x x 155.833 243.5 2143.5 224.6 748.667 x x x +11305 Original post publication description: Motor coordination, time on dowel over a 2 min baseline test period for males [sec] None Motor coordination, time on dowel over a 2 min baseline test period for males [sec] x x x x 75.5 x x 85.5 x x 120.0 120.0 95.0 120.0 x 82.0 59.1429 120.0 x 108.4 x x x x x 117.0 104.0 120.0 x 105.714 117.818 120.0 120.0 x 102.2 x 120.0 116.0 120.0 x 120.0 120.0 120.0 101.6 x x 120.0 x 120.0 120.0 x x x 120.0 60.0 x x x 109.0 120.0 120.0 120.0 x 102.2 120.0 120.0 105.0 120.0 120.0 75.0 x 120.0 x 120.0 x x x x 91.375 x x x 120.0 x 51.8 100.0 x 120.0 x x x x x x 120.0 69.0 85.0 x 120.0 x x x +11306 Original post publication description: Depression assay, Porsolt behavioral despair test, time immobile for males [sec] None Depression assay, Porsolt behavioral despair test, time immobile for males [sec] x x x x 7.5 x x 96.3333 x x 52.9286 86.75 98.75 102.0 x 0.0 98.8571 137.4 x 41.5 x x x x x 36.3 125.6 168.8 x 84.3571 57.7273 74.3333 174.75 x 30.0 x 188.667 28.8 166.0 x 99.2 100.333 61.7778 172.8 x x 121.75 x 84.7 26.7 x x x 187.4 223.5 x x x 119.75 134.333 59.8 70.5 x 78.8 165.5 183.2 105.2 81.5 129.0 17.75 x 46.5 x 122.6 x x x x 7.25 x x x 179.5 x 80.4 84.375 x 78.3333 x x x x x x 131.0 12.0 68.0 x 136.0 x x x +11302 Original post publication description: Pain sensitivity, vocalization threshold to mild foot shock for males [mA] None Central nervous system, behavior, somatosensory system: Pain sensitivity, vocalization threshold to mild foot shock for males [mA] x x x x 0.21 0.54 0.34 0.25 0.3 0.25 0.34 0.24 0.31 0.24 0.4125 0.375 0.45 0.3 x 0.29 x 0.508333 x 0.42 x 0.32 0.23 0.34 x 0.34 0.35 0.26 0.43 x 0.341667 x 0.3 0.31 0.36 x 0.3 0.31875 0.33 0.375 x x 0.3 0.3625 0.33 0.37 x x x x x x x x 0.3625 0.37 0.4 0.45 0.31 0.32 0.2 0.3 0.283333 0.36 0.4 0.266667 x 0.29 0.36 0.33 x 0.328571 0.36 0.45 0.27 0.27 x 0.392857 0.29 0.355556 0.34 0.35 x 0.24 0.31 0.35 0.29 0.35 x x 0.27 x x x x x x x +11303 Original post publication description: Ethanol response (2 mg/kg ip), motor coordination, time on dowel over a 5 min test period immediately after injection for males [sec] None Central nervous system, pharmacology, behavior: Ethanol response (2 g/kg ip), motor coordination, time on dowel over a 5 min test period immediately after injection for males [sec] x x x x 210.0 x x 45.0 x x 142.143 9.0 73.25 103.0 x 42.5 19.4286 111.2 x 13.2 x x x x x 95.2 46.4 88.6 x 72.7143 62.7273 68.6667 72.6 x 139.0 x 63.6667 138.4 115.2 x 118.0 119.0 90.5556 110.4 x x 72.0 x 89.2 69.0 x x x 86.6 39.5 x x x 50.75 133.667 88.4 114.5 x 56.2 118.75 75.8 61.6 90.2 52.5 78.1667 x 88.8333 x 82.0 x x x x 87.375 x x x 90.2 x 29.4 81.25 x 48.3333 x x x x x x 57.5 5.0 94.0 x 185.5 x x x +11288 Original post publication description: Endocrinology, neuroendocrine system, morphology: Adrenal zona intermedia width for females [um] None Endocrinology, neuroendocrine system, morphology: Adrenal zona intermedia width for females [um] x x 17.922 13.538 14.27 15.91 x 14.934 15.66 14.271 14.625 10.515 14.968 11.938 13.818 17.498 15.369 13.675 15.338 16.813 x x x 12.508 x 14.999 12.158 x x 12.37 8.778 11.295 16.592 x 14.339 x 14.18 20.188 12.553 x 16.867 15.571 14.318 11.14 x x 14.741 x 14.215 14.981 x x x 12.555 14.373 x x x 18.562 13.865 15.702 14.165 x 14.478 14.137 13.939 15.583 14.21 13.048 15.298 x 16.041 x 15.644 x 13.063 x x 12.02 x x 13.583 16.412 15.005 13.102 14.88 x 11.045 14.766 x 14.919 x x x 15.232 14.62 13.018 16.051 13.905 x x x +11291 Original post publication description: Endocrinology, neuroendocrine system, morphology: Adrenal zona reticularis width for females [um] None Endocrinology, neuroendocrine system, morphology: Adrenal zona reticularis width for females [um] x x 52.486 70.501 68.45 76.213 x 53.148 46.853 54.23 69.125 68.4 66.92 67.89 42.958 86.39 92.872 53.863 73.843 64.73 x x x 63.84 x 63.858 75.79 x x 54.475 62.708 71.29 61.757 x 81.446 x 80.073 72.338 48.38 x 71.764 45.598 46.248 58.128 x x 48.044 x 76.015 71.63 x x x 54.16 68.625 x x x 64.057 64.642 96.248 47.735 x 71.495 74.408 44.241 51.09 86.117 69.703 38.432 x 43.229 x 67.219 x 54.758 x x 51.587 x x 58.165 59.087 59.193 36.69 72.735 x 51.99 61.533 x 75.918 x x x 55.372 66.603 54.367 66.481 61.518 x x x +11293 Original post publication description: Endocrinology, neuroendocrine system, morphology: Adrenal zona intermedia width for males [um] None Endocrinology, neuroendocrine system, morphology: Adrenal zona intermedia width for males [um] x x 19.583 14.612 14.463 12.303 x 20.754 13.25 15.413 x 10.478 11.535 13.17 12.878 14.505 16.773 10.973 19.379 x x x x 15.388 x 19.481 14.375 13.355 x 12.605 12.583 16.86 14.668 x 12.043 x 13.719 13.103 11.848 x 14.626 12.006 14.853 17.253 x x 13.993 x 12.734 12.978 x x x 12.513 11.153 x x x 17.706 12.875 13.232 14.685 x 13.183 14.827 16.996 13.685 13.695 12.909 14.208 x 18.089 x 14.67 x 14.302 x x 15.295 x x 10.05 12.69 14.573 14.668 14.408 x 15.293 14.061 x 14.21 x x x 13.655 14.372 13.733 14.135 13.865 x x x +11295 Original post publication description: Endocrinology, neuroendocrine system, morphology: Adrenal zona reticularis width for males [um] None Endocrinology, neuroendocrine system, morphology: Adrenal zona reticularis width for males [um] x x 65.385 44.882 70.66 61.038 x 67.733 59.855 69.408 x 70.323 66.98 70.288 44.54 69.567 49.492 49.845 60.133 x x x x 60.298 x 55.286 47.605 64.715 x 51.198 64.68 59.298 85.428 x 54.647 x 57.87 75.217 64.257 x 74.423 60.99 72.888 66.94 x x 76.554 x 59.435 48.075 x x x 57.435 49.483 x x x 65.479 78.823 101.203 45.67 x 82.208 83.257 55.975 81.123 83.477 58.024 72.81 x 46.761 x 85.392 x 78.947 x x 71.19 x x 59.845 98.782 79.995 67.235 90.003 x 38.128 60.433 x 81.588 x x x 81.168 76.52 72.792 69.6 108.243 x x x +11296 Original post publication description: Mechanical sensitivity, Von Frey threshold [units] None Central and peripheral nervous system, integumentary system: mechanical sensitivity, Von Frey hair test threshold [units] x x x x 0.71 0.746 0.888 0.72 1.088 0.959 0.863 0.636 1.169 1.19 1.692 0.864 1.354 0.695 1.313 1.282 1.051 1.133 x 1.348 1.146 1.12 1.256 0.716 1.423 1.234 0.989 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +11297 Original post publication description: Ethanol response (10% w/v in water), consumption using a two-bottle choice for males and females, average between days 5-11, new BXD strains only [g/kg consumed in 24 h] (loaded by M Miles 2009) None Central nervous system, pharmacology, behavior: Ethanol response (10% w/v in water), consumption using a two-bottle choice for males and females, average between days 5-11, new BXD strains only [g/kg/24h] x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 1.44 1.44 x x x 5.21 x x 2.7 x x x x x x x x 9.84 x 13.32 x x x x x x 2.67 1.79 x x 3.78 x 1.38 x x x x x x x x x x x x x x x x x x x x x x x x x x x x +11298 Original post publication description: Endocrinology, neuroendocrine system, morphology: Adrenal total weight for females [mg] None Endocrinology, neuroendocrine system, morphology: Adrenal total weight for females [mg] x x 2.18 2.3 2.013 2.5 x 2.788 2.3 2.388 3.1 2.263 2.563 2.213 2.438 3.063 2.843 1.863 2.525 2.238 x x x 2.2 x 2.3 3.433 2.15 x 2.3 3.525 2.65 2.8 x 2.325 x 2.9 2.575 2.0 x 2.456 2.3 1.563 2.388 x x 2.663 x 2.55 2.75 x x x 1.95 2.738 x x x 2.433 2.25 3.113 2.538 x 2.488 2.7 2.35 2.763 3.1 2.338 1.688 x 2.108 x 2.263 x 2.025 x x 1.825 x x 2.4 2.638 2.5 1.9 2.688 x 2.238 2.125 x 2.863 x x x 2.313 2.563 2.55 2.4 2.488 x x x +11299 Original post publication description: Endocrinology, neuroendocrine system, morphology: Adrenal total weight for males [mg] None Endocrinology, neuroendocrine system, morphology: Adrenal total weight for males [mg] x x 1.388 1.91 1.725 1.475 x 2.125 1.788 1.5 1.95 2.113 1.613 1.913 1.85 2.363 1.814 1.525 1.875 1.975 x x x 1.725 x 1.771 2.317 1.625 x 1.95 1.788 1.688 2.163 x 1.713 x 1.775 2.063 1.575 x 1.519 1.663 1.45 1.513 x x 1.869 x 1.5 1.8 x x x 1.2 1.588 x x x 1.78 1.617 1.983 1.625 x 1.575 1.575 1.488 1.813 1.717 1.463 1.4 x 1.55 x 1.55 x 1.59 x x 1.538 x x 1.675 1.713 1.663 1.463 1.688 x 1.75 1.538 x 1.513 x x x 2.038 1.55 1.663 1.738 1.95 x x x +11300 Original post publication description: Genetics: Mitochondrial strain origin (-1 = C57BL/6J and 1 = DBA/2J) [strain] None Metabolism, genetics: Mitochondrial strain origin (-1 = C57BL/6J and 1 = DBA/2J) [genotype] 1.0 -1.0 -1.0 1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 x x -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 x x -1.0 -1.0 1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 1.0 -1.0 1.0 -1.0 -1.0 -1.0 -1.0 -1.0 x -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 1.0 1.0 1.0 -1.0 -1.0 -1.0 1.0 -1.0 -1.0 -1.0 1.0 -1.0 x x x +11349 Original post publication description: Novel open field behavior, vertical activity (rears) from 0-15 min for males [n beam breaks] None Novel open field behavior, vertical activity (rears) from 0-15 min for males [n beam breaks] x x x x 205.167 215.167 x 315.333 197.0 328.4 136.667 310.5 166.0 276.75 145.0 274.5 342.25 298.25 273.75 244.833 x x x 68.4 x 114.429 146.667 358.8 x 269.333 207.5 302.625 281.5 x 196.5 x 279.333 137.333 345.167 x 327.333 428.0 220.0 220.5 x x 461.5 x 326.667 279.571 x x x 181.667 120.6 x x x 366.857 373.25 153.667 158.333 x 166.833 243.5 181.333 387.2 220.333 291.333 289.0 x 300.2 x 274.833 x x x x 259.0 x x 161.667 305.167 315.667 263.0 190.2 x 322.333 177.333 x 228.333 x x x 395.5 255.5 315.0 420.4 230.5 x x x +11350 Original post publication description: Novel open field behavior, vertical activity (rears) from 15-30 min for males [n beam breaks] None Central nervous system, behavior: Novel open field behavior, vertical activity (rears) from 15-30 min for males [n beam breaks] x x x x 248.167 191.5 x 365.5 350.0 413.0 156.333 314.5 195.5 264.25 184.167 299.5 319.5 309.75 312.5 264.0 x x x 115.8 x 204.857 238.833 475.6 x 315.167 232.25 426.625 254.5 x 75.25 x 337.667 173.833 422.833 x 381.5 505.0 198.6 297.5 x x 462.0 x 375.0 293.857 x x x 174.167 90.4 x x x 336.429 405.25 137.333 258.0 x 248.833 255.0 253.5 387.0 242.833 331.0 361.0 x 347.6 x 292.5 x x x x 291.0 x x 224.833 389.0 363.667 286.75 211.8 x 348.667 192.0 x 219.667 x x x 424.333 260.5 343.0 428.6 288.333 x x x +11351 Original post publication description: Novel open field behavior, vertical activity (rears) from 30-45 min for males [n beam breaks] None Central nervous system, behavior: Novel open field behavior, vertical activity (rears) from 30-45 min for males [n beam breaks] x x x x 225.167 151.667 x 351.667 462.0 368.0 154.667 210.5 121.5 252.0 170.167 318.0 283.5 287.0 214.25 241.5 x x x 165.4 x 172.286 181.833 484.0 x 302.833 223.25 435.5 190.167 x 57.75 x 327.333 158.0 478.5 x 291.167 418.167 157.0 250.25 x x 521.5 x 412.667 286.571 x x x 152.5 47.4 x x x 284.857 457.75 51.3333 221.333 x 229.5 203.667 262.667 285.6 221.333 362.5 291.0 x 316.6 x 283.333 x x x x 256.4 x x 237.667 400.333 222.0 243.25 208.0 x 357.5 146.333 x 266.0 x x x 376.167 261.5 238.25 409.8 304.5 x x x +11352 Original post publication description: Novel open field behavior, vertical activity (rears) from 45-60 min for males [n beam breaks] None Central nervous system, behavior: Novel open field behavior, vertical activity (rears) from 45-60 min for males [n beam breaks] x x x x 188.0 77.3333 x 306.833 407.667 350.4 118.333 179.0 75.25 260.75 154.667 323.0 266.0 198.5 212.5 205.0 x x x 131.0 x 105.0 138.5 451.0 x 232.167 197.5 327.875 148.5 x 79.0 x 345.333 110.5 469.5 x 254.333 384.5 99.2 226.0 x x 454.0 x 414.833 217.143 x x x 97.8333 51.6 x x x 150.143 473.25 33.3333 203.333 x 173.833 196.0 223.0 287.6 268.833 322.833 463.0 x 235.5 x 260.0 x x x x 210.8 x x 227.5 323.5 127.667 144.25 208.4 x 383.833 108.333 x 204.0 x x x 303.0 218.5 330.0 403.8 275.333 x x x +11353 Original post publication description: Central nervous system, behavior: Novel open field behavior, locomotion in the center from 0-60 min for males [n beam breaks] None Central nervous system, behavior: Novel open field behavior, locomotion in the center from 0-60 min for males [n beam breaks] x x x x 3524.17 1964.17 x 5016.33 3659.33 4544.8 1674.0 3866.5 1884.5 2523.75 1536.17 2784.5 4557.0 2354.0 2601.0 2894.17 x x x 1773.6 x 2819.86 1863.0 7538.6 x 2267.67 2582.25 3389.88 2450.0 x 875.75 x 3334.67 1505.0 4595.5 x 3992.0 2645.83 1698.2 4078.75 x x 4770.0 x 4929.0 2682.43 x x x 1950.5 574.0 x x x 3672.43 4361.75 664.833 2538.67 x 3368.5 2392.83 1502.5 3557.4 2777.67 2822.83 3444.0 x 1834.7 x 2105.0 x x x x 1573.0 x x 1877.5 3209.83 1945.67 3754.0 3015.2 x 3666.67 2006.67 x 3444.0 x x x 1829.0 3207.0 4760.0 5295.6 1930.83 x x x +11354 Original post publication description: Central nervous system, behavior: Novel open field behavior, locomotion in the center from 0-60 min for males [cm] None Central nervous system, behavior: Novel open field behavior, locomotion in the center from 0-60 min for males [cm] x x x x 12526.6 7075.87 x 16486.4 12656.7 14549.2 7248.32 12945.6 7277.7 10038.4 6973.6 9668.84 14095.1 9192.09 9074.06 10429.6 x x x 8432.33 x 9862.43 7913.69 23093.4 x 8909.5 9641.77 12350.9 9263.1 x 3498.92 x 12606.5 6879.91 15952.8 x 13396.5 9993.17 6640.04 14574.1 x x 15761.0 x 15538.5 10156.8 x x x 7849.98 2990.26 x x x 12193.8 14686.6 2862.51 10010.4 x 11918.5 9677.89 6311.84 13278.7 9631.68 11156.2 13799.8 x 7315.26 x 8769.0 x x x x 6235.1 x x 8572.56 11831.6 7764.69 13175.4 10079.5 x 13056.0 8686.63 x 12975.7 x x x 7335.1 12031.2 15283.8 16882.0 8117.59 x x x +11355 Original post publication description: Novel open field behavior, vertical activity (rears) in the center from 0-60 min for males [n beam breaks] None Central nervous system, behavior: Novel open field behavior, vertical activity (rears) in the center from 0-60 min for males [n beam breaks] x x x x 866.5 635.667 x 1339.33 1416.67 1459.8 566.0 1014.5 558.25 1053.75 654.0 1215.0 1211.25 1093.5 1013.0 955.333 x x x 480.6 x 596.571 705.833 1769.4 x 1119.5 860.5 1492.62 874.667 x 408.5 x 1289.67 579.667 1716.0 x 1254.33 1735.67 674.8 994.25 x x 1899.0 x 1529.17 1077.14 x x x 606.167 310.0 x x x 1138.29 1709.5 375.667 841.0 x 819.0 898.167 920.5 1347.4 953.333 1307.67 1404.0 x 1199.9 x 1110.67 x x x x 1017.2 x x 851.667 1418.0 1029.0 937.25 818.4 x 1412.33 624.0 x 918.0 x x x 1499.0 996.0 1226.25 1662.6 1098.67 x x x +11356 Original post publication description: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), locomotion from 0-15 min after naloxone injection for males [n beam breaks] None Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), locomotion from 0-15 min after naloxone injection for males [n beam breaks] x x x x 292.667 435.333 x 207.667 365.333 275.8 214.0 366.5 318.0 178.0 160.333 250.25 624.0 412.25 575.5 613.667 x x x 209.4 x 452.286 531.167 380.4 x 301.333 394.75 487.25 446.333 x 207.0 x 435.5 331.667 395.5 x 588.333 572.833 345.2 425.25 x x 425.5 x 320.667 405.571 x x x 311.667 615.6 x x x 389.857 386.5 226.167 129.333 x 150.0 195.333 122.0 311.0 384.833 252.5 187.0 x 202.0 x 235.167 x x x x 341.0 x x 189.333 356.667 310.0 643.0 345.4 x 531.5 179.0 x 290.333 x x x 452.667 286.5 476.5 710.2 572.667 x x x +11357 Original post publication description: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), horizontal activity (distance traveled) from 0-15 min after naloxone injection for males [cm] None Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), horizontal activity (distance traveled) from 0-15 min after naloxone injection for males [cm] x x x x 1018.6 1383.0 x 734.861 1245.78 905.154 780.855 1107.73 1082.02 684.42 689.696 808.914 1739.47 1312.81 1777.39 1876.08 x x x 970.258 x 1416.79 1616.7 1136.48 x 1111.83 1216.84 1555.85 1411.64 x 677.775 x 1375.74 1059.38 1314.41 x 2084.13 1773.95 1086.98 1391.2 x x 1270.88 x 983.834 1183.11 x x x 1157.65 1987.18 x x x 1209.13 1146.32 769.411 509.013 x 569.466 609.715 483.222 1056.26 1216.3 882.597 622.12 x 704.141 x 862.356 x x x x 1052.62 x x 803.33 1069.64 1131.84 1836.04 1074.46 x 1700.86 649.093 x 1053.63 x x x 1360.79 1243.37 1569.89 2077.55 1783.1 x x x +11358 Original post publication description: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), vertical activity (rears) from 0-15 min for males [n beam breaks] None Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip) and naloxone response (30 mg/kg ip), naloxone-induced withdrawal after morphine, vertical activity (rears) from 0-15 min for males [n beam breaks] x x x x 75.3333 138.667 x 97.1667 61.0 55.2 30.6667 51.5 109.25 95.0 50.0 71.5 87.5 115.25 160.5 151.167 x x x 92.4 x 74.4286 60.0 61.8 x 119.0 76.25 31.25 95.5 x 53.25 x 191.0 75.5 110.333 x 206.667 147.167 110.4 119.75 x x 44.5 x 83.8333 143.571 x x x 126.333 210.8 x x x 59.7143 135.75 56.6667 34.6667 x 32.6667 98.5 125.667 68.4 48.8333 106.5 43.0 x 126.1 x 136.833 x x x x 75.2 x x 120.0 75.0 140.167 37.0 75.6 x 157.667 62.6667 x 115.0 x x x 159.167 57.0 140.5 80.8 208.0 x x x +11359 Original post publication description: Central nervous system, pharmacology, behavior: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), postural changes for males [ordinal scale, 0=no effect, 3=max] None Central nervous system, pharmacology, behavior: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), postural changes for males [ordinal scale, 0=no effect, 3=max] x x x x 0.166667 0.333333 x 0.0 0.0 0.4 0.333333 0.5 0.25 1.25 0.166667 0.0 0.25 0.25 0.0 0.166667 x x x 0.2 x 0.428571 0.0 0.0 x 0.0 0.0 0.0 0.0 x 0.0 x 0.166667 0.333333 0.0 x 0.166667 0.333333 0.0 0.5 x x 0.5 x 0.0 0.285714 x x x 0.166667 0.0 x x x 0.285714 0.0 0.166667 0.0 x 0.166667 0.166667 0.666667 0.2 0.166667 0.5 0.0 x 0.1 x 0.166667 x x x x 0.2 x x 0.0 0.166667 0.333333 0.5 0.2 x 0.0 0.333333 x 0.666667 x x x 0.333333 0.5 0.0 0.0 0.333333 x x x +11360 Original post publication description: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), ptosis for males [ordinal scale, 0=no effect, 3=max] None Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), ptosis for males [ordinal scale, 0=no effect, 3=max] x x x x 1.5 0.0 x 0.333333 1.33333 0.0 0.0 0.5 0.0 0.0 2.66667 1.5 0.0 0.0 0.0 0.0 x x x 0.4 x 0.285714 1.16667 0.8 x 0.0 0.75 0.125 0.5 x 0.25 x 0.0 1.33333 0.0 x 0.0 0.166667 0.0 0.0 x x 0.0 x 0.166667 0.142857 x x x 0.5 0.0 x x x 0.857143 0.5 0.833333 0.0 x 1.5 0.666667 0.5 0.0 0.333333 1.5 0.0 x 0.0 x 0.333333 x x x x 0.2 x x 0.166667 0.0 0.333333 0.0 0.2 x 0.0 0.666667 x 1.66667 x x x 0.833333 0.0 0.25 0.0 0.0 x x x +11361 Original post publication description: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), salivation for males [ordinal scale, 0=control level, 3=max] None Central nervous system, pharmacology, behavior: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), salivation for males [ordinal scale, 0=control level, 3=max] x x x x 0.166667 0.5 x 0.333333 0.333333 0.0 0.0 0.0 0.25 0.75 0.0 0.5 0.0 0.0 0.0 0.5 x x x 0.0 x 0.0 0.0 0.6 x 0.666667 0.0 0.0 0.0 x 0.75 x 1.83333 0.166667 0.0 x 0.0 0.166667 0.2 0.5 x x 0.0 x 0.0 0.285714 x x x 0.666667 0.4 x x x 0.428571 0.5 0.333333 0.666667 x 0.333333 0.5 0.0 0.4 0.0 0.0 0.0 x 0.8 x 0.5 x x x x 0.8 x x 0.0 0.0 0.333333 0.0 0.4 x 0.333333 0.333333 x 0.333333 x x x 0.833333 0.0 0.25 0.0 0.0 x x x +11362 Original post publication description: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), wet dog shakes for males [ordinal scale, 0=no effect, 3=max] None Central nervous system, pharmacology, behavior: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), wet dog shakes for males [ordinal scale, 0=no effect, 3=max] x x x x 0.0 1.33333 x 1.16667 0.0 0.0 0.0 0.0 2.0 1.25 0.5 0.25 0.5 0.25 0.25 0.666667 x x x 0.6 x 0.571429 0.166667 0.6 x 0.5 0.0 0.625 0.333333 x 0.0 x 3.0 1.16667 0.166667 x 1.33333 1.83333 0.6 0.25 x x 0.5 x 0.5 1.57143 x x x 1.0 3.0 x x x 0.142857 2.5 0.5 0.0 x 0.5 0.833333 0.833333 0.2 1.16667 0.166667 0.0 x 1.8 x 1.16667 x x x x 0.0 x x 1.66667 0.333333 0.666667 0.0 1.2 x 1.83333 0.666667 x 1.33333 x x x 1.0 1.5 1.5 0.2 0.666667 x x x +11363 Original post publication description: Novel open field behavior, urinations for males [n/test period] None Novel open field behavior, urinations for males [n/test period] x x x x 1.66667 2.83333 x 2.33333 1.33333 1.0 1.33333 1.5 2.75 1.5 1.83333 1.5 2.0 2.0 1.5 2.16667 x x x 0.6 x 1.57143 1.33333 1.8 x 1.0 0.5 1.375 2.0 x 1.25 x 1.83333 2.16667 1.5 x 1.66667 0.833333 0.2 2.0 x x 0.5 x 0.666667 1.71429 x x x 2.5 1.4 x x x 0.857143 2.0 2.0 2.33333 x 1.66667 1.66667 3.0 0.8 0.5 2.83333 0.0 x 1.4 x 1.83333 x x x x 0.8 x x 1.33333 1.5 1.66667 2.0 1.6 x 1.83333 1.0 x 1.66667 x x x 1.33333 1.5 1.0 1.6 1.66667 x x x +11364 Original post publication description: Morphine response (50 mg/kg ip), vertical activity (rears) from 90-105 min after injection in an activity chamber for males [n beam breaks] None Morphine response (50 mg/kg ip), vertical activity (rears) from 90-105 min after injection in an activity chamber for males [n beam breaks] x x x x 784.5 384.667 x 683.167 258.667 850.4 133.667 516.0 291.5 1124.0 51.3333 808.0 278.5 58.0 772.0 403.333 x x x 369.6 x 674.857 137.0 448.2 x 300.0 5.75 184.375 91.8333 x 352.5 x 512.833 473.667 1003.17 x 76.1667 71.0 100.2 506.25 x x 64.0 x 154.333 714.857 x x x 5.16667 59.2 x x x 1.0 150.0 153.333 420.0 x 218.833 167.167 216.333 492.4 54.3333 741.0 660.0 x 419.6 x 291.0 x x x x 471.6 x x 131.167 36.0 616.167 539.0 0.0 x 13.6667 372.0 x 94.6667 x x x 564.667 70.5 434.75 5.2 457.833 x x x +11365 Original post publication description: Morphine response (50 mg/kg ip), vertical activity (rears) from 105-120 min after injection in an activity chamber for males [n beam breaks] None Morphine response (50 mg/kg ip), vertical activity (rears) from 105-120 min after injection in an activity chamber for males [n beam breaks] x x x x 748.833 435.333 x 627.5 179.0 725.4 94.0 419.5 219.75 1057.25 32.8333 580.0 293.75 119.0 677.5 338.833 x x x 338.6 x 606.429 150.167 405.0 x 292.5 6.5 178.125 81.1667 x 220.25 x 490.5 379.833 859.333 x 102.167 61.0 44.8 478.75 x x 102.5 x 95.3333 671.0 x x x 2.33333 56.4 x x x 3.14286 137.25 158.833 410.0 x 115.833 139.0 142.0 225.6 57.5 718.0 492.0 x 449.8 x 310.0 x x x x 463.2 x x 92.3333 61.0 552.167 565.5 0.0 x 34.0 369.333 x 69.0 x x x 479.0 96.0 393.75 5.2 540.833 x x x +11366 Original post publication description: Morphine response (50 mg/kg ip), vertical activity (rears) from 120-135 min after injection in an activity chamber for males [n beam breaks] None Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), vertical activity (rears) from 120-135 min after injection in an activity chamber for males [n beam breaks] x x x x 634.667 453.167 x 587.833 74.3333 503.0 73.6667 364.5 160.0 916.5 5.33333 358.75 231.5 147.25 579.25 279.333 x x x 210.8 x 453.143 148.667 354.6 x 266.333 2.5 175.0 45.6667 x 159.5 x 408.5 268.167 677.0 x 126.5 56.0 48.4 387.5 x x 166.5 x 84.0 584.0 x x x 5.33333 48.4 x x x 2.85714 236.75 128.5 397.667 x 36.0 157.833 102.0 78.8 46.6667 711.833 395.0 x 494.5 x 249.333 x x x x 397.0 x x 77.6667 73.1667 488.167 544.5 1.8 x 46.1667 340.333 x 81.3333 x x x 374.833 150.5 335.0 7.4 576.0 x x x +11367 Original post publication description: Morphine response (50 mg/kg ip), vertical activity (rears) from 0-15 min after injection in an activity chamber for males [n beam breaks] None Morphine response (50 mg/kg ip), vertical activity (rears) from 0-15 min after injection in an activity chamber for males [n beam breaks] x x x x 259.333 66.1667 x 169.833 11.3333 184.0 27.0 86.5 7.75 114.5 41.8333 237.25 134.75 11.75 292.0 40.1667 x x x 98.4 x 124.0 21.6667 249.2 x 166.833 14.0 83.0 29.0 x 54.75 x 107.833 136.333 335.167 x 24.1667 70.0 65.6 103.0 x x 62.5 x 80.3333 208.286 x x x 9.66667 36.0 x x x 22.7143 50.75 42.1667 92.0 x 48.1667 129.833 19.6667 91.4 9.5 474.667 484.0 x 111.0 x 46.0 x x x x 65.0 x x 20.6667 14.6667 214.333 10.25 4.6 x 69.6667 240.0 x 4.66667 x x x 51.0 7.5 224.25 13.8 133.667 x x x +11368 Original post publication description: Morphine response (50 mg/kg ip), vertical activity (rears) from 150-165 min after injection in an activity chamber for males [n beam breaks] None Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), vertical activity (rears) from 150-165 min after injection in an activity chamber for males [n beam breaks] x x x x 358.167 466.5 x 415.0 45.3333 153.8 18.0 155.5 86.25 758.5 10.0 404.0 199.5 117.0 207.75 215.0 x x x 76.6 x 347.286 107.5 162.2 x 240.333 30.25 150.875 18.8333 x 56.5 x 264.667 134.5 371.667 x 166.333 14.8333 50.0 308.75 x x 236.0 x 74.3333 400.0 x x x 1.5 32.6 x x x 17.8571 245.75 83.8333 300.0 x 11.3333 109.667 36.0 63.8 95.0 594.833 428.0 x 451.6 x 107.667 x x x x 224.2 x x 36.3333 70.5 302.833 398.25 2.4 x 65.1667 244.333 x 37.0 x x x 261.333 119.5 124.5 25.8 458.5 x x x +11369 Original post publication description: Morphine response (50 mg/kg ip), vertical activity (rears) from 165-180 min after injection in an activity chamber for males [n beam breaks] None Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), vertical activity (rears) from 165-180 min after injection in an activity chamber for males [n beam breaks] x x x x 272.5 401.0 x 281.667 58.0 76.4 37.0 155.5 58.5 448.5 3.5 218.25 226.75 42.0 113.5 204.167 x x x 72.0 x 282.286 53.8333 94.4 x 150.5 29.75 136.875 26.0 x 50.75 x 198.667 87.6667 217.0 x 191.0 25.1667 27.4 294.75 x x 178.0 x 51.6667 263.143 x x x 6.0 39.0 x x x 32.8571 176.25 78.6667 227.333 x 13.1667 88.6667 43.1667 89.6 91.3333 596.833 475.0 x 423.7 x 118.5 x x x x 142.6 x x 38.3333 84.8333 200.833 353.0 16.0 x 118.667 98.3333 x 26.6667 x x x 224.0 73.5 91.0 52.8 277.833 x x x +11370 Original post publication description: Morphine response (50 mg/kg ip), vertical activity (rears) from 15-30 min after injection in an activity chamber for males [n beam breaks] None Morphine response (50 mg/kg ip), vertical activity (rears) from 15-30 min after injection in an activity chamber for males [n beam breaks] x x x x 368.167 86.1667 x 403.5 12.0 291.2 63.6667 311.5 102.5 260.25 75.3333 610.5 182.75 1.0 579.75 122.167 x x x 253.2 x 366.571 43.1667 386.0 x 441.333 4.25 123.375 62.6667 x 158.5 x 179.333 313.5 585.333 x 22.1667 96.3333 106.2 287.75 x x 28.0 x 243.833 493.429 x x x 0.166667 70.4 x x x 0.857143 45.25 97.1667 308.0 x 133.667 134.833 42.1667 376.6 9.16667 587.833 919.0 x 150.3 x 74.5 x x x x 164.6 x x 16.0 0.166667 466.5 31.75 4.6 x 6.33333 297.333 x 117.667 x x x 56.3333 0.0 431.75 0.0 300.667 x x x +11371 Original post publication description: Morphine response (50 mg/kg ip), vertical activity (rears) from 30-45 min after injection in an activity chamber for males [n beam breaks] None Morphine response (50 mg/kg ip), vertical activity (rears) from 30-45 min after injection in an activity chamber for males [n beam breaks] x x x x 412.833 124.167 x 549.167 84.0 458.6 179.0 544.0 235.75 490.75 71.6667 838.5 256.25 4.25 691.5 241.333 x x x 376.8 x 409.714 50.6667 435.8 x 564.167 2.0 153.5 74.6667 x 452.5 x 292.833 376.833 877.333 x 27.1667 45.1667 192.0 392.5 x x 38.0 x 383.167 567.571 x x x 1.33333 72.4 x x x 2.57143 51.75 120.667 424.667 x 217.833 124.167 74.6667 563.4 31.8333 605.167 961.0 x 136.6 x 100.5 x x x x 232.0 x x 49.8333 0.0 586.333 163.5 11.0 x 31.3333 311.0 x 137.0 x x x 170.833 4.5 543.25 25.2 377.833 x x x +11372 Original post publication description: Morphine response (50 mg/kg ip), vertical activity (rears) from 45-60 min after injection in an activity chamber for males [n beam breaks] None Morphine response (50 mg/kg ip), vertical activity (rears) from 45-60 min after injection in an activity chamber for males [n beam breaks] x x x x 603.833 163.833 x 623.0 132.667 719.4 236.333 647.5 263.0 758.0 64.8333 1009.25 296.75 2.5 812.75 356.333 x x x 442.4 x 516.286 81.8333 519.4 x 522.833 13.0 166.75 89.0 x 562.75 x 391.333 465.5 1012.67 x 25.5 69.8333 222.4 465.25 x x 22.0 x 454.0 658.714 x x x 0.166667 98.8 x x x 0.0 41.0 121.5 401.667 x 307.0 134.0 146.0 625.2 38.8333 653.5 925.0 x 233.5 x 160.333 x x x x 355.0 x x 101.333 0.166667 755.333 337.25 7.8 x 7.33333 411.333 x 114.667 x x x 355.333 65.0 570.25 1.6 465.167 x x x +11373 Original post publication description: Morphine response (50 mg/kg ip), vertical activity (rears) from 60-75 min after injection in an activity chamber for males [n beam breaks] None Morphine response (50 mg/kg ip), vertical activity (rears) from 60-75 min after injection in an activity chamber for males [n beam breaks] x x x x 683.333 250.167 x 659.333 256.667 834.2 226.667 584.5 281.5 1149.5 65.1667 1026.75 343.75 27.75 846.0 430.5 x x x 409.4 x 632.571 88.6667 501.0 x 415.333 8.25 189.75 108.833 x 530.25 x 424.5 522.333 1092.83 x 43.3333 77.5 240.6 578.25 x x 47.0 x 342.667 746.429 x x x 0.5 82.8 x x x 2.28571 91.25 138.833 420.333 x 330.833 154.0 202.667 617.2 56.6667 712.0 906.0 x 285.4 x 203.333 x x x x 487.2 x x 146.667 0.666667 784.0 443.75 5.8 x 0.666667 444.667 x 127.0 x x x 548.333 70.5 571.0 2.4 490.667 x x x +11374 Original post publication description: Morphine response (50 mg/kg ip), vertical activity (rears) from 75-90 min after injection in an activity chamber for males [n beam breaks] None Morphine response (50 mg/kg ip), vertical activity (rears) from 75-90 min after injection in an activity chamber for males [n beam breaks] x x x x 759.5 319.0 x 673.167 303.333 826.2 204.0 576.5 286.0 1177.75 76.0 992.0 335.75 46.0 845.25 464.5 x x x 419.2 x 681.286 122.167 486.0 x 322.667 6.5 178.875 113.333 x 490.75 x 458.833 488.5 1102.17 x 51.6667 86.3333 163.0 564.25 x x 77.5 x 262.667 739.0 x x x 1.5 85.2 x x x 0.857143 101.25 161.5 434.0 x 327.167 198.0 234.833 580.6 66.1667 722.0 947.0 x 362.4 x 226.333 x x x x 493.6 x x 160.833 10.3333 669.833 540.25 3.0 x 10.5 414.667 x 95.0 x x x 605.667 86.5 491.75 3.4 549.667 x x x +11375 Original post publication description: 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) response (10 mg/kg subcutaneous), locomotion on day 2 for males [cm/90 min test] None Central nervous system, pharmacology, behavior: 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) response (10 mg/kg subcutaneous), locomotion on day 2 for males [cm/90 min test] x x x x x x x 812.5 x x x 4105.0 x x x x x x x x x x x x x x 1384.0 x x x x x x x 490.333 x x 1235.0 5446.25 x 12099.0 x 364.5 x x x x x x x x x x 530.5 x x x x x 1584.5 x x x 16648.0 3004.75 x x x x x x x x x x 2974.5 x x x x x x 5317.5 x x x x x x x 1622.0 x x x 2365.33 x 765.5 x x x x x +11376 Original post publication description: Locomotor activity after first saline injection (day 1) for males (MDMA control) [cm/ test period] None Central nervous system, behavior: Locomotor activity after first saline injection (day 1) for males (MDMA control) [cm/ test period] x x x x x x x 6961.0 x x 2111.0 5727.0 x x x x x x x x x x x x x x 4800.0 x x x x x x x 1492.0 x x 818.0 10970.0 x 5158.0 x 4096.5 x x x x x x x x x x 7717.5 x x x x x 5058.0 x x x 3744.0 7132.0 x x x x x x x x x x 2867.5 x x x x x x 5534.0 x x x x x x x 4383.5 x x x 6561.33 x 6559.5 x x x x x +11377 Original post publication description: Saline control response, locomotor activity after second injection for males (control for MDMA response experiment) [cm/test period] None Central nervous system, behavior: Saline control response, locomotor activity after second injection for males (control for MDMA response experiment) [cm/test period] x x x x x x x 832.5 x x 3311.0 780.0 x x x x x x x x x x x x x x 888.0 x x x x x x x 352.667 x x 638.5 2590.75 x 802.75 x 2013.5 x x x x x x x x x x 2260.5 x x x x x 166.0 x x x 1258.5 967.0 x x x x x x x x x x 814.0 x x x x x x 527.0 x x x x x x x 965.0 x x x 2219.67 x 580.0 x x x x x +11378 Original post publication description: Ethanol response (4.0 g/kg ip), handling-induced convulsion (HIC) 4 hrs after injection for males [explain the score] None Central nervous system, pharmacology, behavior: Ethanol response (4.0 g/kg ip), handling-induced convulsion (HIC) 4 hrs after injection for males [explain the score] x x x x x x 1.33333 x x x x x 0.0 0.0 0.0 x x x x 0.5 x x x x x x x x x x x x x x 0.1 x 0.0 x x x x 0.222222 0.909091 x x x 0.0 x x 0.0 x x x x x x x x 0.25 x 0.8 x x 0.0 x x x 0.0 0.0 0.0 x 0.0 0.0 0.0 x 0.1 0.0 x 0.0 0.0 x 0.0 0.0 0.0 0.0 0.0 x 0.142857 x x 0.0 x x x x x x x x x x x +11379 Original post publication description: Ethanol response (4.0 g/kg ip), Handling-induced convulsions (HIC) 6 hrs after injections for males [units] None Ethanol response (4.0 g/kg ip), Handling-induced convulsions (HIC) 6 hrs after injections for males [units] x x x x x x 0.0 x x x x x 1.0 4.0 0.0 x x x x 2.0 x x x x x x x x x x x x x x 0.8 x 0.0 x x x x 1.11111 1.63636 x x x 0.5 x x 0.0 x x x x x x x x 1.125 x 2.2 x x 2.5 x x x 1.7 0.0 1.44444 x 0.6 0.0 1.6 x 0.2 0.0 x 1.0 0.5 x 5.0 0.142857 0.0 3.0 0.272727 x 0.142857 x x 0.2 x x x x x x x x x x x +11380 Original post publication description: Ethanol response (4.0 g/kg ip), handling-induced convulsion (HIC) score 7 hrs after ethanol injection for males [units] None Central nervous system, pharmacology, behavior: Ethanol response (4.0 g/kg ip), handling-induced convulsion (HIC) score 7 hrs after ethanol injection for males [units] x x x x x x 1.0 x x x x x 4.0 4.0 0.0 x x x x 3.0 x x x x x x x x x x x x x x 0.9 x 0.0 x x x x 0.777778 1.18182 x x x 0.1 x x 0.888889 x x x x x x x x 0.375 x 2.6 x x 2.0 x x x 2.5 0.0 0.777778 x 0.2 0.333333 0.2 x 0.7 0.0 x 0.2 0.0 x 4.5 0.285714 0.2 2.5 0.090909 x 0.857143 x x 0.1 x x x x x x x x x x x +11381 Original post publication description: Seizure susceptibility, handling-induced convulsion (HIC) baseline for males [score] None Central nervous system, behavior: Seizure susceptibility, handling-induced convulsion (HIC) baseline for males [score] x x x x x x 0.333333 x x x x x 0.0 1.0 0.0 x x x x 0.5 x x x x x x x x x x x x x x 0.2 x 0.0 x x x x 0.222222 0.727273 x x x 0.0 x x 0.0 x x x x x x x x 0.125 x 1.0 x x 0.0 x x x 0.3 0.0 0.0 x 0.0 0.0 0.0 x 0.0 0.0 x 0.1 0.0 x 0.75 0.0 0.0 0.5 0.090909 x 0.142857 x x 0.2 x x x x x x x x x x x +11382 Original post publication description: Ethanol response (4.0 g/kg ip), handling-induced convulsion (HIC) after injection for males [explain the score] None Ethanol response (4.0 g/kg ip), handling-induced convulsion (HIC) after injection for males [explain the score] x x x x x x 1.33333 x x x x x 5.0 6.0 0.0 x x x x 4.25 x x x x x x x x x x x x x x 1.7 x 0.0 x x x x x 2.0 x x x x x x x x x x x x x x x x x x x x 4.5 x x x 3.6 0.0 0.777778 x 0.7 0.333333 1.8 x 0.9 0.0 x 1.1 0.5 x 8.0 0.428571 0.2 5.0 0.181818 x 1.0 x x 0.3 x x x x x x x x x x x +11383 Original post publication description: Pain response, thermal nociception, hot plate latency for males [sec] None Pain response, thermal nociception, hot plate latency for males [sec] x x x x 8.115 6.81714 x 6.175 10.3617 x 7.47667 12.332 7.81111 7.425 7.15286 8.76571 8.83143 8.772 x 10.0192 x x x 8.83818 x 8.68222 7.24917 5.75833 x 7.3175 6.67167 9.08111 8.85875 x 8.315 x 9.39769 6.73667 9.26333 x 6.544 6.59 10.8494 9.12714 x x 10.15 x 7.53667 7.23417 x x x 9.05 7.35833 x x x 6.56667 11.59 8.14929 x x 7.875 11.4433 8.18222 9.42 8.97905 10.1367 8.69 x 8.661 x 9.58667 x 10.7433 x x 5.71625 x x 12.5267 7.7325 8.183 10.8975 8.21286 x 8.044 x x 12.3 x x x 9.76917 6.472 6.535 4.715 5.9625 x x x +11384 Original post publication description: Locomotion in dark compartment of a light-dark box for males [cm] None Central nervous system, behavior: Locomotion in dark compartment of a light-dark box for males [cm] x x x x 1713.5 757.143 x 970.083 489.167 x 225.667 688.2 413.444 828.875 408.429 616.429 836.857 471.1 x 765.5 x x x 351.091 x 333.111 269.5 894.875 x 693.375 948.833 521.222 571.75 x 727.0 x 486.0 471.444 832.333 x 843.6 666.714 652.941 752.429 x x 827.875 x 663.833 507.667 x x x 1013.29 245.167 x x x 631.0 606.4 409.286 x x 535.458 526.667 512.333 659.75 784.048 647.167 943.0 x 658.4 x 692.0 x 595.667 x x 699.125 x x 506.667 769.0 676.8 626.375 606.0 x 542.444 x x 435.8 x x x 736.5 409.0 910.5 1107.0 514.833 x x x +11385 Original post publication description: Anxiety assay, time in dark side of a light-dark box for males [sec] None Central nervous system, behavior: Anxiety assay, time in dark side of a light-dark box for males [sec] x x x x 486.65 520.829 x 371.25 406.233 x 305.267 404.42 392.122 393.062 405.357 335.614 291.029 348.26 x 374.258 x x x 161.545 x 343.044 291.192 373.531 x 358.875 471.05 335.233 328.575 x 409.467 x 347.908 440.744 345.95 x 398.95 412.929 378.159 418.214 x x 422.225 x 376.017 413.2 x x x 412.271 377.883 x x x 394.467 421.94 390.593 x x 469.346 311.6 460.667 388.756 370.59 328.7 418.75 x 402.5 x 396.65 x 396.878 x x 448.0 x x 446.9 404.9 383.37 433.15 446.5 x 342.689 x x 316.22 x x x 447.183 398.58 475.45 434.5 396.45 x x x +11386 Original post publication description: Locomotion in both compartments of a light-dark box for males [cm] None Central nervous system, behavior: Locomotion in both compartments of a light-dark box for males [cm] x x x x 2285.5 956.714 x 1504.83 823.5 x 394.556 1043.8 631.444 1296.25 616.714 1009.57 1468.57 726.9 x 1244.83 x x x 840.818 x 436.0 413.667 1381.81 x 1153.0 1253.83 883.556 964.375 x 1069.0 x 755.077 645.889 1352.67 x 1371.2 1015.57 1022.59 1121.0 x x 1199.75 x 1000.5 768.583 x x x 1502.71 397.333 x x x 930.5 917.4 556.429 x x 694.458 840.444 664.111 969.5 1306.48 1159.17 1276.0 x 1009.3 x 1053.5 x 840.111 x x 1016.38 x x 681.333 1150.29 1002.7 867.375 877.714 x 969.889 x x 674.8 x x x 1008.0 654.4 1139.33 1502.5 793.5 x x x +11387 Original post publication description: Anxiety assay, locomotion in the light compartment of a light-dark box for males [cm] None Central nervous system, behavior: Anxiety assay, locomotion in the light compartment of a light-dark box for males [cm] x x x x 572.0 199.571 x 534.75 334.333 x 168.889 355.6 218.0 467.375 208.286 393.143 631.714 255.8 x 479.333 x x x 489.727 x 102.889 144.167 486.938 x 459.625 305.0 362.333 392.625 x 342.0 x 269.077 174.444 520.333 x 527.6 348.857 369.647 368.571 x x 371.875 x 336.667 260.917 x x x 489.429 152.167 x x x 299.5 311.0 147.143 x x 159.0 313.778 151.778 309.75 522.429 512.0 333.0 x 350.9 x 361.5 x 244.444 x x 317.25 x x 174.667 381.286 325.9 241.0 271.714 x 427.444 x x 239.0 x x x 271.5 245.4 228.833 395.5 278.667 x x x +11388 Original post publication description: Anxiety assay, time in light side of a light-dark box for males [sec] None Central nervous system, behavior: Anxiety assay, time in light side of a light-dark box for males [sec] x x x x 113.35 79.1714 x 228.75 193.767 x 294.733 195.58 207.878 206.938 194.643 264.386 308.971 251.74 x 225.742 x x x 438.455 x 256.956 308.808 226.469 x 241.125 128.95 264.767 271.425 x 190.533 x 252.092 159.256 254.05 x 201.05 187.071 221.841 181.786 x x 177.775 x 223.983 186.8 x x x 187.729 222.117 x x x 205.533 178.06 209.407 x x 130.654 288.4 139.333 211.244 229.41 271.3 181.25 x 197.5 x 203.35 x 203.122 x x 152.0 x x 153.1 195.1 216.63 166.85 153.5 x 257.311 x x 283.78 x x x 152.817 201.42 124.55 165.5 203.55 x x x +11389 Original post publication description: Anxiety assay, percentage of locomotion in light side of a light-dark box for males [%] None Central nervous system, behavior: Anxiety assay, percentage of locomotion in light side of a light-dark box for males [%] x x x x 22.8574 19.7366 x 34.4899 39.7584 x 43.546 33.4199 36.5076 36.0706 28.5682 37.641 47.3982 35.7052 x 38.458 x x x 58.4355 x 32.9443 39.3891 33.172 x 39.5441 24.0786 40.7766 40.3427 x 31.9881 x 38.4997 27.0011 39.0076 x 37.9187 33.536 35.9875 31.7741 x x 30.9179 x 33.6973 33.9002 x x x 32.2701 36.7659 x x x 35.5928 32.7514 29.5102 x x 24.1288 42.6192 22.904 29.5736 39.7661 44.3447 26.312 x 32.9553 x 34.1568 x 29.3749 x x 31.9719 x x 26.0803 31.9611 31.5351 25.2644 29.6179 x 42.2581 x x 36.7648 x x x 26.0058 35.6119 20.0612 26.3724 34.7742 x x x +11390 Original post publication description: Anxiety assay, percentage of time in light side of a light-dark box for males [%] None Central nervous system, behavior: Anxiety assay, percentage of time in light side of a light-dark box for males [%] x x x x 18.8917 13.1214 x 38.6944 31.7861 x 50.3259 31.9733 34.6463 34.1583 32.4405 44.2405 51.4952 42.615 x 37.6236 x x x 73.0758 x 42.8259 51.4681 38.1188 x 39.6688 21.2861 44.1278 44.0 x 31.7556 x 40.9859 26.5426 42.3472 x 32.7933 32.0 36.9804 30.2976 x x 29.6292 x 37.3306 32.4653 x x x 31.2881 37.0194 x x x 33.7389 29.6767 34.3333 x x 21.5417 48.0667 23.1907 35.8125 37.7635 44.1417 29.9167 x 32.9617 x 33.8917 x 33.8537 x x 25.3333 x x 26.3667 32.5167 37.2183 28.1979 25.5524 x 42.8852 x x 47.2967 x x x 25.3681 33.57 20.7583 27.5833 33.8056 x x x +11391 Original post publication description: Anxiety assay, transitions between light and dark sides of a light-dark box for males [n] None Central nervous system, behavior: Anxiety assay, transitions between light and dark sides of a light-dark box for males [n] x x x x 64.5 26.7143 x 46.4167 25.5 x 11.0 24.4 22.3333 47.125 17.0 35.8571 47.8571 21.9 x 40.4167 x x x 24.1818 x 8.77778 11.1667 41.875 x 41.375 35.6667 34.1111 31.25 x 32.8333 x 22.4615 17.5556 62.3333 x 50.2 32.1429 34.1176 46.2857 x x 40.5 x 29.3333 23.0 x x x 44.8571 10.0 x x x 21.8333 40.2 17.5 x x 13.7083 24.4444 16.2222 40.3125 61.8095 49.5 38.0 x 35.1 x 50.1667 x 25.8889 x x 39.875 x x 19.5 42.5714 30.8 27.875 29.4286 x 32.6667 x x 17.2 x x x 32.0 14.4 26.0 59.5 32.6667 x x x +11392 Original post publication description: Fear conditioning response, activity in altered context for males [units] None Central nervous system, behavior: Fear conditioning response, activity in altered context for males [units] x x x x 52.0 34.8095 x 39.4861 32.5278 x 23.8889 24.6 32.1111 44.3542 30.7857 22.8333 37.4048 35.6 x 38.6111 x x x 30.2424 x 26.6852 26.0694 53.3021 x 28.4167 36.6667 25.8519 26.5 x 41.3056 x 42.7821 24.1852 45.3889 x 36.4667 34.8333 34.8333 48.7857 x x 39.6042 x 29.6667 34.5417 x x x 54.0 18.6389 x x x 36.25 34.0333 16.5952 x x 37.8194 36.3889 37.4444 28.5104 33.127 38.0833 34.1667 x 35.2833 x 30.4444 x 39.9259 x x 38.9167 x x 44.1667 46.0714 33.6 31.5 36.0238 x 39.6667 x x 39.7333 x x x 34.4861 40.5667 39.0278 39.5833 35.4167 x x x +11393 Original post publication description: Fear conditioning behavior, baseline activity in apparatus for males [units] None Central nervous system, behavior: Fear conditioning behavior, baseline activity in apparatus for males [units] x x x x 65.125 23.0357 x 35.625 38.6667 x 16.0278 33.5 26.4167 36.625 23.4643 30.5714 41.1786 20.85 x 34.7292 x x x 28.3864 x 18.5556 17.5833 42.0938 x 30.7188 34.7917 31.6944 28.5 x 37.125 x 30.1538 22.6389 39.9583 x 39.725 34.5357 29.1471 43.6786 x x 33.0938 x 27.8333 26.1042 x x x 35.3214 17.3333 x x x 25.8333 39.45 14.5357 x x 25.1771 37.5556 22.3611 20.4062 40.0357 35.25 45.25 x 28.2 x 35.7917 x 34.1389 x x 33.9375 x x 28.75 27.25 25.65 24.0625 32.6429 x 32.3333 x x 29.9 x x x 28.6875 25.0 34.1667 17.125 31.2083 x x x +11394 Original post publication description: Fear conditioning response, contextual activity for males [units] None Central nervous system, behavior: Fear conditioning response, contextual activity for males [units] x x x x 39.55 14.4429 x 7.31667 14.0167 x 8.53333 16.68 21.8444 16.3125 25.6357 9.77143 19.0071 15.77 x 20.7583 x x x 13.4364 x 9.26667 10.0167 27.3531 x 9.4625 24.825 13.4444 14.4875 x 10.6333 x 17.0231 7.98889 31.975 x 26.48 18.2143 26.9559 27.7571 x x 13.175 x 14.75 17.0542 x x x 29.4071 4.40833 x x x 16.4833 32.7 4.96786 x x 14.4333 11.0556 21.3167 11.4969 9.85238 23.9 35.4 x 11.73 x 17.0333 x 23.4722 x x 10.0875 x x 23.7833 15.6714 15.5 10.375 11.7857 x 24.7111 x x 13.88 x x x 10.3667 5.08 27.1917 23.95 15.2708 x x x +11395 Original post publication description: Fear conditioning response, activity in altered context during presentation of cue for males [n beam breaks] None Central nervous system, behavior: Fear conditioning response, activity in altered context during presentation of cue for males [n beam breaks] x x x x 9.33333 17.8333 x 18.1944 6.58333 x 3.31482 5.33333 5.75926 9.9375 3.19048 11.5 9.28571 10.25 x 6.625 x x x 6.57576 x 5.87037 4.05556 23.6146 x 5.04167 7.97222 3.77778 2.10417 x 9.08333 x 7.41026 4.01852 12.2778 x 18.95 11.2857 12.402 27.2143 x x 19.1667 x 6.63889 3.75 x x x 24.9286 1.69444 x x x 7.75 12.5 5.15476 x x 5.57639 4.05556 11.3148 7.05208 6.4127 7.63889 25.25 x 8.51667 x 8.69444 x 9.68519 x x 9.91667 x x 13.7778 15.2381 12.6667 4.97917 3.83333 x 12.1481 x x 5.26667 x x x 8.97222 6.8 10.7778 11.0 6.56944 x x x +11396 Original post publication description: Fear conditioning response, suppression of activity in altered context for males [units] None Central nervous system, behavior, learning and memory: Fear conditioning response, suppression of activity in altered context for males [units] x x x x x 0.414803 x 0.463535 0.199834 x 0.109772 0.301065 0.184636 0.226953 0.129261 0.515883 0.298875 0.368716 x 0.154434 x x x 0.220592 x 0.087649 0.142541 0.420912 x 0.174951 0.221084 0.189514 0.079494 x 0.215163 x 0.175516 0.157428 0.218831 x 0.526718 0.313888 0.371388 0.556997 x x 0.486757 x 0.220518 0.119127 x x x 0.467703 0.083163 x x x 0.214411 0.363145 0.377714 x x 0.141914 0.124455 0.25937 0.300014 0.181168 0.225024 0.778944 x 0.251601 x 0.309739 x 0.213147 x x 0.254054 x x 0.289408 0.322909 0.387818 0.172283 0.105362 x 0.318321 x x 0.136962 x x x 0.2529 0.157916 0.281453 0.291383 0.176164 x x x +11397 Original post publication description: Fear conditioning response, activity during first tone-shock pairing for males [units] None Central nervous system, behavior: Fear conditioning response, activity during first tone-shock pairing for males [units] x x x x 73.0 27.5714 x 36.3333 35.0 x 19.1111 22.6 17.0 26.75 21.0 26.2857 27.2857 24.9 x 38.5 x x x 33.8182 x 21.7778 22.5 41.125 x 33.25 39.5 22.1111 23.0 x 34.0 x 30.0 22.6667 37.8333 x 35.2 37.8571 32.1765 42.4286 x x 34.0 x 32.1667 29.1667 x x x 46.1429 16.5 x x x 35.0 28.4 22.1429 x x 27.5 22.3333 24.0 23.6875 45.1429 31.3333 53.0 x 20.6 x 28.1667 x 42.3333 x x 28.375 x x 22.8333 25.2857 20.1 24.5 33.7143 x 30.2222 x x 33.8 x x x 27.9167 33.2 36.3333 19.5 29.9167 x x x +11398 Original post publication description: Fear conditioning response, activity during second tone-shock pairing for males [units] None Central nervous system, behavior: Fear conditioning response, activity during second tone-shock pairing for males [units] x x x x 38.0 20.1429 x 20.4167 25.3333 x 15.4444 19.0 12.8889 21.375 16.2857 13.2857 21.5714 19.9 x 28.4167 x x x 28.8182 x 23.1111 19.0833 28.5 x 28.125 31.3333 24.2222 20.625 x 23.3333 x 18.3846 15.2222 34.3333 x 24.1 25.7143 27.7647 26.8571 x x 33.125 x 24.0 20.0 x x x 37.1429 10.3333 x x x 31.8333 27.6 14.0714 x x 21.3333 18.1111 22.3333 21.1875 28.6667 26.1667 48.0 x 22.1 x 25.6667 x 27.6667 x x 21.5 x x 29.3333 24.1429 19.6 23.375 22.2857 x 20.8889 x x 18.4 x x x 20.9167 19.6 26.3333 25.5 23.75 x x x +11399 Original post publication description: Fear conditioning response, activity during third tone-shock pairing for males [units] None Central nervous system, behavior: Fear conditioning response, activity during third tone-shock pairing for males [units] x x x x 29.0 16.4286 x 18.5833 17.5 x 11.2222 31.6 10.8889 17.0 9.85714 8.85714 17.0 18.3 x 15.1667 x x x 17.7273 x 20.1111 24.3333 21.9375 x 20.875 21.6667 27.1111 14.625 x 18.1667 x 15.7692 14.5556 25.3333 x 28.9 25.5714 22.2353 26.8571 x x 19.625 x 18.1667 14.25 x x x 26.0 8.5 x x x 37.6667 23.2 14.3571 x x 20.0 16.1111 18.0 14.75 25.5238 19.3333 28.0 x 13.9 x 21.5 x 29.8889 x x 27.125 x x 24.5 26.7143 18.8 26.625 11.5714 x 16.2222 x x 17.8 x x x 17.6667 19.4 24.1667 35.0 18.8333 x x x +11400 Original post publication description: Fear conditioning response, activity after first tone shock pairing for males [n beam breaks/30 sec test] None Central nervous system, behavior: Fear conditioning response, activity after first tone shock pairing for males [n beam breaks/30 sec test] x x x x 27.125 23.6786 x 6.1875 13.125 x 2.83333 10.5 9.44444 15.2188 8.17857 6.89286 19.7143 10.125 x 12.9167 x x x 20.7045 x 13.0556 9.77083 19.3594 x 17.625 14.4167 7.72222 13.8438 x 12.875 x 6.86539 4.55556 23.0 x 19.475 17.75 17.9559 29.1429 x x 16.2812 x 18.625 12.6458 x x x 28.2143 7.41667 x x x 23.0417 22.25 5.28571 x x 9.70833 13.0833 10.1389 11.4688 17.0119 11.5417 31.5 x 15.625 x 18.5 x 14.8333 x x 14.8438 x x 22.9167 15.75 25.725 8.1875 6.75 x 16.1389 x x 9.6 x x x 16.5208 8.85 18.0833 4.375 18.125 x x x +11401 Original post publication description: Fear conditioning response, activity after second tone-shock pairing for males [n beam breaks/30 sec test] None Central nervous system, behavior: Fear conditioning response, activity after second tone-shock pairing for males [n beam breaks/30 sec test] x x x x 19.25 18.9286 x 6.22917 6.16667 x 1.77778 15.05 4.47222 9.78125 7.78571 3.28571 14.6786 8.575 x 11.875 x x x 14.6364 x 11.8333 11.875 21.2656 x 12.375 12.5417 5.05556 3.8125 x 7.66667 x 7.44231 2.86111 16.4583 x 21.65 11.8214 12.7206 31.1429 x x 11.5625 x 12.0833 8.04167 x x x 26.0714 5.04167 x x x 12.2083 18.8 5.35714 x x 8.70833 8.5 9.77778 7.26562 12.7976 15.25 25.5 x 11.45 x 12.4167 x 16.0278 x x 16.7812 x x 13.6667 12.3929 24.45 5.71875 4.89286 x 16.3611 x x 7.65 x x x 12.1458 4.3 16.8333 5.0 15.2083 x x x +11402 Original post publication description: Fear conditioning response, activity after third tone-shock pairing for males [n beam breaks/30 sec test] None Central nervous system, behavior: Fear conditioning response, activity after third tone-shock pairing for males [n beam breaks/30 sec test] x x x x 28.0 14.0 x 3.66667 11.3333 x 3.88889 9.8 6.0 13.5 16.1429 3.14286 15.4286 8.5 x 10.25 x x x 8.72727 x 6.88889 12.5833 18.0625 x 9.0 6.0 4.88889 5.625 x 12.6667 x 12.8462 6.66667 11.1667 x 17.1 19.1429 10.9412 28.0 x x 11.875 x 8.33333 7.66667 x x x 11.7143 8.66667 x x x 8.5 14.4 6.42857 x x 6.45833 4.11111 8.77778 12.6875 8.7619 17.0 32.5 x 20.2 x 9.33333 x 17.1111 x x 10.75 x x 8.0 15.7143 12.5 4.0 7.14286 x 14.1111 x x 3.6 x x x 11.25 10.8 16.6667 13.5 14.0833 x x x +11403 Original post publication description: Fear conditioning response, cue conditioning, activity suppression after third tone-shock pairing for males [units] None Central nervous system, behavior, learning and memory: Fear conditioning response, cue conditioning, activity suppression after third tone-shock pairing for males [units] x x x x 0.419859 0.665349 x 0.122732 0.328108 x 0.46698 0.284072 0.234885 0.344792 0.743 0.129462 0.374429 0.421149 x 0.304483 x x x 0.318892 x 0.968435 0.947446 0.457793 x 0.307081 0.166029 0.234521 0.231704 x 0.343743 x 0.437798 0.350382 0.290283 x 0.425398 0.527256 0.447024 0.640386 x x 0.362502 x 0.276434 0.329456 x x x 0.331328 0.516575 x x x 0.33114 0.361762 0.683253 x x 0.265066 0.106937 0.446903 0.669669 0.222403 0.537659 0.718025 x 0.759078 x 0.26084 x 0.399955 x x 0.419724 x x 0.274695 0.602081 0.581566 0.157413 0.225362 x 0.45933 x x 0.144092 x x x 0.414964 0.70695 0.535839 0.907018 0.427185 x x x +11404 Original post publication description: Open field behavior, percentage of distance in the center for males [%] None Central nervous system, behavior: Open field behavior, percentage of distance in the center for males [%] x x x x 47.5922 22.2511 x 33.7074 33.8505 x 26.9011 27.3044 30.0451 32.7967 26.4645 39.5517 38.1148 23.8 x 33.4322 x x x 47.2721 x 12.389 17.7159 19.5317 x 34.3412 26.5988 35.5744 25.7129 x 24.6892 x 29.5805 26.4911 37.4642 x 33.6939 32.4145 23.6561 30.6265 x x 25.0747 x 26.5675 21.0835 x x x 28.614 22.6917 x x x 19.9243 23.834 22.3253 x x 22.2828 30.7544 28.4501 28.5905 35.9184 39.0805 28.4942 x 24.7029 x 23.8406 x 33.9456 x x 26.4213 x x 35.3407 14.3226 21.5318 32.0908 20.065 x 33.9087 x x 22.6105 x x x 32.1542 26.3169 19.1432 28.5559 38.1785 x x x +11405 Original post publication description: Open field behavior, percentage of time in center for males [%] None Open field behavior, percentage of time in center for males [%] x x x x 43.8875 11.9893 x 24.5 18.6653 x 15.1769 12.2983 17.0778 22.925 18.8393 32.9548 23.7321 13.4775 x 18.6125 x x x 28.6455 x 4.975 11.9868 10.9661 x 28.2479 12.9625 25.6602 17.2313 x 9.96111 x 15.9833 14.1657 21.8069 x 20.8975 16.006 13.1779 16.2536 x x 13.7969 x 12.6208 10.2451 x x x 17.7202 17.4347 x x x 10.8194 9.90333 12.2411 x x 11.591 19.7463 20.5074 20.8078 23.069 24.4625 16.1875 x 12.9183 x 12.2889 x 31.7657 x x 14.2615 x x 20.0986 7.15625 12.0992 22.1365 9.53929 x 19.9565 x x 10.7817 x x x 24.2146 16.6117 6.70694 16.875 21.1556 x x x +11406 Original post publication description: Open field behavior, time in corners for males [min] None Central nervous system, behavior: Open field behavior, time in corners for males [min] x x x x 41.7125 33.9583 x 42.3264 42.2667 x 28.9333 43.5 45.2389 43.6937 39.5655 41.0381 49.3179 45.5158 x 38.9799 x x x 40.9258 x 28.0574 36.3063 45.3089 x 47.0844 43.6444 43.8204 44.8854 x 35.9278 x 43.2545 42.963 43.025 x 43.0108 38.3976 43.5382 47.4976 x x 46.6813 x 40.2778 44.2757 x x x 45.6667 51.4375 x x x 37.0306 42.575 37.703 x x 39.4559 40.2574 47.2907 42.8714 46.3317 45.9861 47.2625 x 37.8625 x 40.4736 x 47.1222 x x 39.5469 x x 45.225 54.0354 43.5192 47.7031 41.3595 x 45.4861 x x 39.2 x x x 44.9833 48.525 34.5153 41.8208 43.75 x x x +11407 Original post publication description: Open field behavior, locomotion from 0-5 min for males [cm] None Open field behavior, locomotion from 0-5 min for males [cm] x x x x 1337.5 418.571 x 859.25 359.167 x 223.444 525.6 346.222 703.125 229.143 641.0 834.857 310.0 x 648.083 x x x 475.364 x 162.778 114.083 743.5 x 403.25 389.833 562.889 417.75 x 556.667 x 379.538 287.444 848.5 x 677.7 426.143 467.0 675.143 x x 560.625 x 478.167 470.083 x x x 812.286 195.333 x x x 360.167 530.8 152.357 x x 262.0 470.889 308.889 479.125 543.429 588.167 635.5 x 541.9 x 528.167 x 382.556 x x 471.125 x x 407.667 406.0 366.3 503.625 404.143 x 506.0 x x 344.6 x x x 543.333 390.4 418.333 706.0 430.0 x x x +11408 Original post publication description: Open field behavior, locomotion from 10-15 min for males [cm] None Open field behavior, locomotion from 10-15 min for males [cm] x x x x 1304.5 256.571 x 865.25 392.833 x 257.111 413.0 270.222 440.125 386.429 492.0 679.714 402.7 x 429.667 x x x 525.545 x 193.111 253.917 794.938 x 554.25 467.667 429.111 415.25 x 380.5 x 347.0 269.0 709.167 x 493.7 334.143 437.647 563.571 x x 457.875 x 490.0 336.667 x x x 773.0 289.833 x x x 406.833 574.4 267.429 x x 410.917 403.889 489.222 471.0 582.238 578.667 668.5 x 490.2 x 425.5 x 655.556 x x 482.0 x x 411.167 454.0 502.3 494.5 326.0 x 496.778 x x 524.4 x x x 364.167 464.6 465.167 650.0 342.917 x x x +11409 Original post publication description: Open field behavior, locomotion from 15-20 min for males [cm] None Open field behavior, locomotion from 15-20 min for males [cm] x x x x 1002.0 258.143 x 829.833 363.333 x 219.333 314.8 247.778 409.125 319.143 455.286 615.0 388.5 x 400.917 x x x 465.636 x 205.111 240.417 677.062 x 505.25 406.667 436.556 407.25 x 275.833 x 318.692 241.444 625.333 x 450.8 340.714 367.824 524.714 x x 462.0 x 524.167 348.0 x x x 680.286 329.167 x x x 384.0 551.6 232.429 x x 397.167 400.889 480.333 524.188 535.619 600.833 504.0 x 492.2 x 398.5 x 834.556 x x 479.75 x x 377.167 415.0 527.9 473.875 314.0 x 481.667 x x 454.4 x x x 344.083 485.4 423.5 636.0 283.833 x x x +11410 Original post publication description: Open field behavior, locomotion from 5-10 min for males [cm] None Central nervous system, behavior: Open field behavior, locomotion from 5-10 min for males [cm] x x x x 1392.5 395.714 x 896.167 356.5 x 220.222 411.8 315.111 528.875 411.714 570.286 809.286 415.1 x 515.917 x x x 637.909 x 204.556 252.25 849.375 x 540.5 589.0 498.667 472.125 x 476.667 x 424.0 262.889 753.5 x 599.4 360.286 504.588 649.143 x x 506.75 x 562.0 399.75 x x x 851.286 291.833 x x x 543.167 627.6 201.286 x x 422.417 417.222 440.778 503.75 594.19 566.833 645.0 x 510.3 x 496.833 x 560.222 x x 510.25 x x 490.833 459.25 563.6 547.0 358.857 x 485.0 x x 504.6 x x x 477.5 424.2 455.667 633.0 353.5 x x x +11411 Original post publication description: Central nervous system, behavior: Open field activity, habituation ratio for males (ratio of activity during last 5 min interval and first 5 min interval) [ratio n beam breaks] None Central nervous system, behavior: Open field activity, habituation ratio for males (ratio of activity during last 5 min interval and first 5 min interval) [ratio n beam breaks] x x x x 0.412021 0.386808 x 0.499355 0.584485 x 0.533762 0.379177 0.416883 0.361718 0.596545 0.415634 0.436824 0.59747 x 0.374387 x x x 0.497585 x 0.519478 0.70453 0.504739 x 0.57488 0.536579 0.450558 0.495266 x 0.318976 x 0.48649 0.428878 0.416796 x 0.40512 0.408928 0.452213 0.447193 x x 0.453089 x 0.516075 0.42822 x x x 0.460135 0.653781 x x x 0.536256 0.504888 0.545367 x x 0.619402 0.478405 0.609318 0.545735 0.504068 0.504275 0.442927 x 0.475019 x 0.418838 x 0.629927 x x 0.533803 x x 0.510124 0.543208 0.612408 0.497692 0.434068 x 0.507922 x x 0.55968 x x x 0.413164 0.566834 0.541323 0.476828 0.405243 x x x +11412 Original post publication description: Open field behavior, percentage time in perimeter minus time in corners for males [%] None Open field behavior, percentage time in perimeter minus time in corners for males [%] x x x x 14.4 54.0524 x 33.1736 39.0681 x 55.8898 44.2017 37.6833 33.3812 41.5952 26.0071 26.95 41.0067 x 42.4076 x x x 30.4288 x 66.9676 51.7069 43.725 x 24.6677 43.3931 30.5194 37.8833 x 54.1111 x 40.7622 42.8713 35.1681 x 36.0917 45.5964 43.2838 36.2488 x x 39.5219 x 47.1014 45.4792 x x x 36.6131 31.1278 x x x 52.15 47.5217 50.056 x x 48.9531 39.9963 32.2019 36.3208 30.5992 29.5514 36.55 x 49.2192 x 47.2375 x 21.112 x x 46.1917 x x 34.6764 38.8083 44.3817 30.1604 49.1012 x 34.5574 x x 50.0183 x x x 30.8021 34.8633 58.7778 41.3042 35.0944 x x x +11413 Original post publication description: Open field behavior, vertical activity (rears) from 0-20 min for males [n beam breaks] None Open field behavior, vertical activity (rears) from 0-20 min for males [n beam breaks] x x x x 88.5 52.7143 x 148.833 90.3333 x 51.0 135.4 65.5556 127.5 79.4286 98.7143 162.0 99.4 x 180.667 x x x 96.5455 x 38.4444 35.3333 101.0 x 156.0 81.8333 125.889 103.5 x 101.333 x 60.0769 51.8889 162.667 x 125.2 136.857 99.5294 149.857 x x 145.0 x 162.333 135.5 x x x 125.143 32.6667 x x x 103.167 135.8 39.6429 x x 85.9167 140.667 128.778 129.625 141.571 146.0 132.0 x 199.5 x 186.833 x 34.0 x x 103.0 x x 69.1667 91.25 120.0 163.0 90.8571 x 164.222 x x 102.0 x x x 127.167 149.8 78.0 168.5 126.417 x x x +11414 Original post publication description: Open field behavior, vertical activity (rears) from 0-5 min for males [n beam breaks] None Open field behavior, vertical activity (rears) from 0-5 min for males [n beam breaks] x x x x 8.5 13.7143 x 26.0833 10.8333 x 10.4444 23.0 12.0 26.75 5.0 18.2857 32.4286 12.8 x 41.5833 x x x 9.81818 x 1.77778 2.5 14.25 x 17.875 11.1667 29.4444 18.5 x 28.1667 x 7.15385 9.11111 36.0 x 24.9 21.5714 18.4706 36.7143 x x 29.25 x 31.6667 35.9167 x x x 25.8571 4.66667 x x x 17.6667 23.6 2.85714 x x 7.83333 28.1111 6.88889 16.875 20.4286 26.5 26.0 x 41.1 x 41.0 x 2.88889 x x 12.25 x x 8.0 9.25 17.7 27.25 22.1429 x 15.3333 x x 11.2 x x x 25.1667 16.2 13.6667 36.5 22.1667 x x x +11415 Original post publication description: Open field behavior, vertical activity (rears) 10-15 min for males [n beam breaks] None Open field behavior, vertical activity (rears) 10-15 min for males [n beam breaks] x x x x 27.5 10.2857 x 41.75 29.1667 x 15.5556 42.0 17.7778 31.375 29.2857 25.8571 42.4286 29.6 x 45.25 x x x 30.2727 x 13.2222 11.5 29.6875 x 47.375 23.1667 28.5556 29.375 x 22.6667 x 16.3077 14.7778 45.8333 x 31.5 41.0 26.5294 33.1429 x x 42.125 x 43.0 28.75 x x x 31.5714 8.0 x x x 27.8333 35.4 14.9286 x x 26.75 37.8889 44.5556 35.5 39.8095 42.1667 39.0 x 51.3 x 49.3333 x 11.5556 x x 33.125 x x 20.5 28.0 32.3 45.875 23.8571 x 53.0 x x 30.8 x x x 34.1667 46.0 22.1667 52.5 39.1667 x x x +11416 Original post publication description: Open field behavior, vertical activity (rears) from 15-20 min for males [n beam breaks] None Open field behavior, vertical activity (rears) from 15-20 min for males [n beam breaks] x x x x 22.0 12.0 x 43.0 29.8333 x 13.2222 35.8 17.5556 33.75 23.1429 28.4286 43.4286 28.3 x 41.25 x x x 27.5455 x 14.4444 14.9167 29.375 x 50.5 20.0 35.5556 26.125 x 15.6667 x 20.5385 15.2222 33.5 x 31.2 36.5714 27.1765 35.2857 x x 34.75 x 44.8333 34.4167 x x x 29.4286 10.5 x x x 25.1667 36.6 12.9286 x x 28.4167 33.8889 44.7778 44.75 44.3333 41.5 31.5 x 54.4 x 47.3333 x 9.33333 x x 30.75 x x 26.0 35.75 36.9 40.25 23.0 x 59.2222 x x 34.6 x x x 29.5 50.0 20.8333 42.0 30.75 x x x +11417 Original post publication description: Open field behavior, vertical activity (rears) from 5-10 min for males [n beam breaks] None Open field behavior, vertical activity (rears) from 5-10 min for males [n beam breaks] x x x x 30.5 16.7143 x 38.0 20.5 x 11.7778 34.6 18.2222 35.625 22.0 26.1429 43.7143 28.7 x 52.5833 x x x 28.9091 x 9.0 6.41667 27.6875 x 40.25 27.5 32.3333 29.5 x 34.8333 x 16.0769 12.7778 47.3333 x 37.6 37.7143 27.3529 44.7143 x x 38.875 x 42.8333 36.4167 x x x 38.2857 9.5 x x x 32.5 40.2 8.92857 x x 22.9167 40.7778 32.5556 32.5 37.0 35.8333 35.5 x 52.7 x 49.1667 x 10.2222 x x 26.875 x x 14.6667 18.25 33.1 49.625 21.8571 x 36.6667 x x 25.4 x x x 38.3333 37.6 21.3333 37.5 34.3333 x x x +11418 Original post publication description: Open field behavior, locomotion for entire test period for males [cm] None Open field behavior, locomotion for entire test period for males [cm] x x x x 5036.5 1329.0 x 3450.5 1471.83 x 920.111 1665.2 1179.33 2081.25 1346.43 2158.57 2938.86 1516.3 x 1994.58 x x x 2104.45 x 765.556 860.667 3064.88 x 2003.25 1853.17 1927.22 1712.38 x 1689.67 x 1469.23 1060.78 2936.5 x 2221.6 1461.29 1777.06 2412.57 x x 1987.25 x 2054.33 1554.5 x x x 3116.86 1106.17 x x x 1694.17 2284.4 853.5 x x 1492.5 1692.89 1719.22 1978.06 2255.48 2334.5 2453.0 x 2034.6 x 1849.0 x 2432.89 x x 1943.12 x x 1686.83 1734.25 1960.1 2019.0 1403.0 x 1969.44 x x 1828.0 x x x 1729.08 1764.6 1762.67 2625.0 1410.25 x x x +11419 Original post publication description: Open field behavior, percentage of distance in the perimeter for males [%] None Central nervous system, behavior: Open field behavior, percentage of distance in the perimeter for males [%] x x x x 52.4078 77.7489 x 66.2926 66.1495 x 73.0989 72.6956 69.9549 67.2033 73.5355 60.4483 61.8852 76.2 x 66.5678 x x x 52.7279 x 87.611 82.2841 80.4683 x 65.6588 73.4012 64.4256 74.2871 x 75.3108 x 70.4195 73.5089 62.5358 x 66.3061 67.5854 76.3439 69.3735 x x 74.9253 x 73.4325 78.9165 x x x 71.386 77.3083 x x x 80.0757 76.166 77.6747 x x 77.7172 69.2456 71.5499 71.4095 64.0816 60.9195 71.5058 x 75.2971 x 76.1594 x 66.0544 x x 73.5787 x x 64.6593 85.6774 78.4682 67.9092 79.935 x 66.0913 x x 77.3895 x x x 67.8458 73.6831 80.8568 71.4441 61.8215 x x x +11420 Original post publication description: Open field behavior, percentage of time in perimeter for males [%] None Open field behavior, percentage of time in perimeter for males [%] x x x x 56.1125 88.0107 x 75.5 81.3347 x 84.8232 87.7017 82.9222 77.075 81.1607 67.0452 76.2679 86.5225 x 81.3875 x x x 71.3545 x 95.025 88.0132 89.0339 x 71.7521 87.0375 74.3398 82.7688 x 90.0389 x 84.0167 85.8343 78.1931 x 79.1025 83.994 86.8221 83.7464 x x 86.2031 x 87.3792 89.7549 x x x 82.2798 82.5653 x x x 89.1806 90.0967 87.7589 x x 88.409 80.2537 79.4926 79.1922 76.931 75.5375 83.8125 x 87.0817 x 87.7111 x 68.2343 x x 85.7385 x x 79.9014 92.8438 87.9008 77.8635 90.4607 x 80.0435 x x 89.2183 x x x 75.7854 83.3883 93.2931 83.125 78.8444 x x x +11421 Original post publication description: Startle response, baseline level for males [units] None Startle response, baseline level for males [units] x x x x 0.076 0.115987 x 0.143808 0.09897 x 0.079076 0.064236 0.070584 0.122803 0.12074 0.154312 0.103532 0.094691 x 0.109371 x x x 0.127636 x 0.159375 0.123644 0.195176 x 0.108011 0.096197 0.061779 0.074227 x 0.079409 x 0.119669 0.071828 0.078727 x 0.147784 0.119922 0.078898 0.081221 x x 0.080318 x 0.127636 0.118227 x x x 0.045758 0.148424 x x x x 0.0538 0.096344 x x 0.104794 0.063515 0.101475 0.123517 0.093036 0.086652 0.269864 x 0.090736 x 0.047432 x 0.129055 x x 0.119102 x x 0.089606 0.111922 0.121545 0.08625 0.071247 x 0.141195 x x 0.740636 x x x 0.154955 0.090855 0.140545 0.077273 0.1225 x x x +11422 Original post publication description: Central nervous system, behavior: Acoustic startle response, maximum response at 120 db for males (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, prepulse PPI control data by M Cook, UMemphis) [force] None Central nervous system, behavior: Acoustic startle response, maximum response at 120 db for males (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, prepulse PPI control data by M Cook, UMemphis) [force] x x x x 3.53121 0.814163 x 1.63367 0.713345 x 1.93318 1.12877 1.99244 2.10435 1.31396 1.06357 1.24712 0.728007 x 0.130107 x x x 0.968325 x 4.33644 1.39854 1.47392 x 3.38005 0.644536 1.26275 0.330518 x 0.551607 x 0.735623 1.37984 0.35919 x 0.357286 2.11628 1.97644 1.29952 x x 2.54731 x 1.84281 1.38295 x x x 0.582905 1.66363 x x x x 0.780786 0.778969 x x 1.5648 1.61298 0.408056 0.865509 0.483886 3.14271 1.19079 x 0.270664 x 0.267714 x 0.981457 x x 1.33399 x x 2.16787 1.45764 0.260829 0.369455 0.4215 x 0.760184 x x 1.33662 x x x 1.60635 4.78576 0.88056 1.73575 1.8588 x x x +11423 Original post publication description: Central nervous system, behavior: Acoustic startle response, maximum response at 70 db for males (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, prepulse PPI control data by M Cook, UMemphis) [force] None Central nervous system, behavior: Acoustic startle response, maximum response at 70 db for males (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, prepulse PPI control data by M Cook, UMemphis) [force] x x x x 2.3465 0.883171 x 1.20969 0.478517 x 0.9686 0.87046 1.43746 2.26213 0.953614 1.24443 0.786229 0.54933 x 0.1175 x x x 0.9436 x 3.94691 1.50698 1.24832 x 2.77924 0.5803 0.875514 0.380625 x 0.42675 x 0.538127 1.02516 0.237217 x 0.285863 1.62179 1.20051 0.975871 x x 2.53536 x 1.0816 0.88667 x x x 0.3013 1.5086 x x x x 0.58342 0.661343 x x 1.00751 1.28526 0.268167 0.479125 0.48608 2.75788 0.70165 x 0.26389 x 0.1836 x 0.73984 x x 1.20673 x x 1.48017 1.52229 0.24436 0.345212 0.272243 x 0.666357 x x 0.766133 x x x 1.33795 3.74856 0.707583 1.27735 1.46641 x x x +11424 Original post publication description: Central nervous system, behavior: Acoustic startle response, maximum response at 80 db for males (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, prepulse PPI control data by M Cook, UMemphis) [force] None Central nervous system, behavior: Acoustic startle response, maximum response at 80 db for males (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, prepulse PPI control data by M Cook, UMemphis) [force] x x x x 0.8255 0.534357 x 0.935467 0.291067 x 0.8181 0.75868 1.03677 1.7023 0.6986 0.9971 0.287614 0.31577 x 0.102483 x x x 0.589218 x 2.78904 0.901267 0.702493 x 2.47108 0.357717 0.558214 0.285762 x 0.472325 x 0.398864 0.585744 0.22745 x 0.190475 1.10197 0.629753 0.600529 x x 1.98193 x 0.296283 0.48387 x x x 0.173567 1.22143 x x x x 0.41534 0.461443 x x 0.470667 1.056 0.209956 0.224131 0.26068 2.25518 0.27915 x 0.1789 x 0.133075 x 0.41274 x x 0.63155 x x 1.35165 0.921357 0.20077 0.180787 0.206614 x 0.475414 x x 0.496467 x x x 0.62255 2.5629 0.417717 0.8686 0.766075 x x x +11425 Original post publication description: Central nervous system, behavior: Acoustic startle response, maximum response at 85 db for males (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, prepulse PPI control data by M Cook, UMemphis) [force] None Central nervous system, behavior: Acoustic startle response, maximum response at 85 db for males (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, prepulse PPI control data by M Cook, UMemphis) [force] x x x x 0.5462 0.381714 x 0.782889 0.200783 x 0.753567 0.75316 0.8357 1.42097 0.621014 0.964714 0.318343 0.34496 x 0.099725 x x x 0.507136 x 1.8589 0.8293 0.63078 x 2.08421 0.35445 0.509257 0.241487 x 0.3552 x 0.370736 0.472556 0.21545 x 0.21235 0.7155 0.601241 0.516114 x x 1.79414 x 0.327467 0.56776 x x x 0.114033 0.973067 x x x x 0.35896 0.303393 x x 0.444267 0.889178 0.200689 0.215475 0.21418 2.15558 0.25345 x 0.15422 x 0.09635 x 0.3927 x x 0.5411 x x 1.36758 0.863671 0.21761 0.190238 0.228157 x 0.448443 x x 0.767533 x x x 0.445583 2.72254 0.4179 0.73045 0.751917 x x x +11426 Original post publication description: Central nervous system, behavior: Acoustic startle response, prepulse inhibition (PPI) at 70 dB for males (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, data by M Cook, UMemphis) [% inhibition] None Central nervous system, behavior: Acoustic startle response, prepulse inhibition (PPI) at 70 dB for males (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, data by M Cook, UMemphis) [% inhibition] x x x x 31.8625 -14.3781 x 24.9191 29.4952 x 55.4663 23.0248 23.1485 -10.1356 29.2715 -8.26697 34.6269 25.1284 x 11.9009 x x x -1.07855 x 8.99673 -9.74715 13.4676 x 16.9234 11.0487 29.5496 -25.0252 x 18.5433 x 24.1566 19.6035 25.7913 x 23.7481 24.2318 35.5166 22.5302 x x 2.42607 x 40.4802 27.4653 x x x 45.0653 6.40973 x x x x 27.2168 17.1704 x x 33.8511 19.002 27.0098 43.8189 3.27372 13.2832 47.7629 x 0.047551 x 29.6153 x 24.9174 x x 9.11357 x x 28.2087 -4.39566 -0.653405 -1.46868 31.8903 x 12.4346 x x 39.347 x x x 15.1432 20.071 17.3323 22.712 22.5925 x x x +11427 Original post publication description: Central nervous system, behavior: Acoustic startle response, prepulse inhibition (PPI) at 80 dB for males (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, data by M Cook, UMemphis) [% inhibition] None Central nervous system, behavior: Acoustic startle response, prepulse inhibition (PPI) at 80 dB for males (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, data by M Cook, UMemphis) [% inhibition] x x x x 76.2695 34.109 x 41.6348 54.8681 x 62.8654 33.0929 42.4165 17.7501 43.9674 14.5913 74.5509 57.4607 x 19.371 x x x 38.4973 x 36.3844 33.2503 52.2326 x 27.4109 41.2723 51.875 4.66378 x 19.3895 x 43.8726 48.9323 20.6776 x 44.0033 46.849 65.7721 52.1974 x x 24.56 x 82.9681 60.9206 x x x 68.4616 25.8014 x x x x 48.5845 44.4443 x x 68.8393 33.0552 42.4598 69.1468 40.2674 28.4318 78.3847 x 28.3099 x 48.3603 x 55.9221 x x 49.9424 x x 43.1714 42.1036 17.3611 45.4302 48.4745 x 33.9249 x x 58.7508 x x x 59.5097 43.9016 51.0839 49.1563 61.0722 x x x +11428 Original post publication description: Central nervous system, behavior: Acoustic startle response, prepulse inhibition (PPI) at 85 dB for males (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, data by M Cook, UMemphis) [% inhibition] None Central nervous system, behavior: Acoustic startle response, prepulse inhibition (PPI) at 85 dB for males (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, data by M Cook, UMemphis) [% inhibition] x x x x 84.3712 52.977 x 52.3002 69.0214 x 65.6511 33.9538 54.4029 31.3187 48.8105 15.2388 71.8177 57.1195 x 23.8991 x x x 45.6469 x 57.4984 38.719 57.432 x 40.0873 40.4909 60.0198 22.2605 x 31.458 x 46.6422 59.9091 23.3277 x 40.0314 65.0361 68.1653 57.2601 x x 31.2547 x 81.685 56.0712 x x x 79.4247 37.9335 x x x x 55.6974 62.4519 x x 69.2557 42.3827 42.2874 73.1479 46.3172 31.578 78.208 x 36.0629 x 55.0784 x 56.3105 x x 57.3531 x x 46.0892 46.1734 11.7799 40.7199 48.2078 x 39.5847 x x 40.5684 x x x 71.7857 40.8072 51.4907 49.939 60.7701 x x x +13035 Original post publication description: Reproductive system, toxicology: Cadmium response (0.03 mM/kg CdCl2 subcutaneous in 0.1 ml), susceptibility to cadmium-induced testicular necrosis at 48 hrs, recessive cadmium resistance locus cdm [-1= resistant, 1 = susceptible] None Reproductive system, toxicology: Cadmium response (0.03 mM/kg CdCl2 subcutaneous in 0.1 ml), susceptibility to cadmium-induced testicular necrosis at 48 hrs, recessive cadmium resistance locus Cdm (Slc39a8) [-1= resistant, 1 = susceptible] x 1.0 -1.0 1.0 x 1.0 -1.0 -1.0 1.0 x 1.0 1.0 1.0 1.0 x -1.0 0.5 -0.5 1.0 1.0 0.0 0.0 x -0.5 x -1.0 1.0 -1.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13036 Original post publication description: Reproductive system, toxicology: Cadmium response (0.03 mM/kg CdCl2 subcutaneous in 0.1 ml), susceptibility to cadmium-induced testicular necrosis at 48 hrs, recessive cadmium resistance locus cdm [-1= resistant, 1 = susceptible] None Reproductive system, toxicology: Cadmium response (0.03 mM/kg CdCl2 subcutaneous in 0.1 ml), susceptibility to cadmium-induced testicular necrosis at 48 hrs, recessive cadmium resistance locus cdm [-1= resistant, 1 = susceptible] x x -1.0 1.0 -1.0 1.0 -1.0 -1.0 1.0 -1.0 1.0 1.0 1.0 1.0 -1.0 -1.0 1.0 1.0 1.0 1.0 -1.0 1.0 x -1.0 1.0 -1.0 1.0 -1.0 -1.0 -1.0 1.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +11432 Original post publication description: Time below threshold for males None Central nervous system, behavior: Depression assay, immobility using a tail suspension test (TST) for males [sec below threshold movement level] x x x x x x x x x x x 47.25 205.0 x x x 94.5 x x 192.0 x x x x x x 217.0 x x x 141.5 196.0 238.75 x 103.5 x 180.0 280.0 119.25 x x x 206.333 x x x x x x 116.0 x x x x x x x x x 168.5 182.5 x x 73.0 x x 29.0 x 78.0 x x x x x x x x x x x x x x x x 210.0 x x x x x x x x x x x x x x x x +11433 Original post publication description: Locomotion in zero maze for males [n beam breaks] None Central nervous system, behavior: Locomotion in zero maze for males [n beam breaks] x x x x 885.5 575.429 x 710.9 460.667 x 327.0 634.0 444.6 637.5 556.0 526.857 573.857 513.429 x 556.7 x x x 505.444 x 490.5 336.111 711.267 x 507.0 575.167 510.286 557.667 x 656.333 x 513.231 408.667 616.5 x 612.8 302.857 538.059 730.286 x x 538.75 x 380.167 485.0 x x x 583.429 582.333 x x x 533.333 602.6 364.714 x x 613.417 406.889 479.357 536.312 653.286 563.5 564.0 x 605.8 x 525.75 x 412.889 x x 581.375 x x 514.5 524.714 637.1 564.5 506.571 x 444.0 x x 549.2 x x x 574.833 799.6 618.5 383.5 426.857 x x x +11434 Original post publication description: Anxiety assay, entries in closed quadrants of a zero maze for males [n] None Central nervous system, behavior: Anxiety assay, entries in closed quadrants of a zero maze for males [n] x x x x 128.5 61.5714 x 139.7 37.1667 x 38.625 104.25 16.4 69.1667 46.7143 48.2857 60.7143 42.4286 x 74.7 x x x 57.2222 x 55.0 30.5556 93.4 x 69.625 98.5 52.0 69.5 x 70.6667 x 28.6154 40.5556 62.0 x 100.7 92.4286 59.5294 72.5714 x x 104.25 x 113.5 69.75 x x x 71.5714 67.5 x x x 102.833 111.4 55.0 x x 74.5 69.7778 36.7857 103.375 116.143 67.6667 87.5 x 95.2 x 66.0 x 41.7778 x x 102.875 x x 66.5 87.4286 92.3 70.875 112.429 x 85.8889 x x 78.0 x x x 120.667 94.4 94.1667 131.0 57.0 x x x +11435 Original post publication description: Anxiety assay, entries in open quadrants of a zero maze for males [n] None Central nervous system, behavior: Anxiety assay, entries in open quadrants of a zero maze for males [n] x x x x 128.0 61.7143 x 138.9 37.1667 x 38.875 104.5 16.6 69.1667 46.8571 48.4286 61.1429 42.7143 x 74.8 x x x 57.3333 x 54.8333 30.6667 93.0667 x 69.875 98.6667 52.0 69.5 x 70.6667 x 28.6154 40.5556 62.3333 x 100.5 92.7143 59.5294 72.7143 x x 103.875 x 113.333 69.5833 x x x 71.4286 67.3333 x x x 102.5 110.6 55.0 x x 74.4583 69.8889 36.7143 102.562 116.19 68.0 86.5 x 95.0 x 65.75 x 41.6667 x x 102.5 x x 66.5 87.4286 91.8 71.0 112.571 x 86.5556 x x 77.6 x x x 120.833 94.4 94.0 132.0 57.1429 x x x +11436 Original post publication description: Zero maze, latency to enter an open quadrant for males [sec] None Zero maze, latency to enter an open quadrant for males [sec] x x x x 0.45 14.8286 x 12.47 84.3167 x 30.4625 1.975 48.88 14.3667 58.7571 23.6714 47.5333 64.9167 x 35.7 x x x 8.8 x 46.34 35.6667 21.56 x 14.1875 15.4 40.8857 23.1167 x 19.7333 x 76.6333 82.3375 42.05 x 18.23 17.8286 21.8824 21.6714 x x 23.75 x 11.15 20.9583 x x x 20.1571 23.5833 x x x 10.6833 13.66 31.8154 x x 31.2333 18.4 49.0167 15.8 14.72 24.4833 36.7 x 15.82 x 24.875 x 91.125 x x 9.8875 x x 37.0 25.2714 11.15 41.3375 12.3286 x 30.3556 x x 23.3 x x x 9.425 12.08 26.9167 16.1 24.9143 x x x +11437 Original post publication description: Anxiety assay, percentage of time in open quadrants of a zero maze for males [%] None Central nervous system, behavior: Anxiety assay, percentage of time in open quadrants of a zero maze for males [%] x x x x 16.4833 8.70952 x 23.54 9.62778 x 6.0375 17.2417 1.98 8.76111 11.8143 5.30476 12.9952 9.48571 x 11.2067 x x x 18.7407 x 10.9556 22.2815 26.06 x 14.1667 21.1 7.58571 19.3722 x 11.1056 x 2.23077 11.1926 21.45 x 24.92 43.8238 13.4549 10.9429 x x 22.7042 x 44.4667 21.5639 x x x 14.2476 8.68333 x x x 29.5611 31.0 23.0214 x x 11.4431 20.6519 9.22857 32.8417 18.7746 15.6111 23.8 x 13.8733 x 24.1167 x 22.5 x x 20.7542 x x 10.5 15.6762 17.7 16.8625 27.6619 x 21.1815 x x 13.1267 x x x 17.425 8.38667 20.3 43.7 12.1571 x x x +11438 Original post publication description: Anxiety assay, time in closed quadrants of a zero maze for males [sec] None Central nervous system, behavior: Anxiety assay, time in closed quadrants of a zero maze for males [sec] x x x x 250.55 273.871 x 221.38 271.117 x 281.888 248.275 294.06 273.717 264.557 284.086 261.014 266.014 x 262.16 x x x 243.778 x 267.133 257.078 233.527 x 257.5 236.7 277.243 241.883 x 266.683 x 293.308 266.422 235.65 x 225.24 168.529 259.635 267.171 x x 207.988 x 166.6 235.308 x x x 257.257 273.95 x x x 211.317 207.0 230.936 x x 265.671 238.044 272.314 201.475 243.676 253.167 228.6 x 258.38 x 227.65 x 232.5 x x 237.738 x x 268.5 241.243 246.9 249.413 217.014 x 218.3 x x 260.62 x x x 235.067 274.84 239.1 168.9 252.086 x x x +11439 Original post publication description: Anxiety assay, time in open quadrants of a zero maze for males [sec] None Central nervous system, behavior: Anxiety assay, time in open quadrants of a zero maze for males [sec] x x x x 49.45 26.1286 x 78.62 28.8833 x 18.1125 51.725 5.94 26.2833 35.4429 15.9143 38.9857 33.9857 x 37.84 x x x 56.2222 x 32.8667 42.9222 66.4733 x 42.5 63.3 22.7571 58.1167 x 33.3167 x 6.69231 33.5778 64.35 x 74.76 131.471 40.3647 32.8286 x x 92.0125 x 133.4 64.6917 x x x 42.7429 26.05 x x x 88.6833 93.0 69.0643 x x 34.3292 61.9556 27.6857 98.525 56.3238 46.8333 71.4 x 41.62 x 72.35 x 67.5 x x 62.2625 x x 31.5 58.7571 53.1 50.5875 82.9857 x 81.7 x x 39.38 x x x 64.9333 25.16 60.9 131.1 47.9143 x x x +11440 Original post publication description: Ethanol response (2.25 g/kg ip), locomotor activity after injection from 0-5 min for males [cm] None Central nervous system, pharmacology, behavior: Ethanol response (2.25 g/kg ip), locomotor activity after injection from 0-5 min for males [cm] x x x x 1089.36 1194.46 x 509.389 x 280.75 893.872 1602.59 751.134 554.335 242.882 935.877 1768.28 1165.3 x 1325.21 x x x 190.395 x 1117.21 354.432 1356.16 x 1345.51 868.182 880.992 1151.55 x 1233.95 x 415.818 833.95 1127.67 x 1384.34 583.177 728.755 1827.55 x x 1093.69 x 1372.14 1355.83 x x x 358.945 306.5 x x x 1021.57 849.047 376.438 406.07 x 846.483 1599.09 838.47 1013.58 245.562 1612.04 674.003 x 1012.5 x 216.34 x x x x 445.253 x x 1008.47 630.272 267.925 406.778 437.578 x 368.643 639.35 x 941.27 x x x 396.473 603.73 561.43 1532.58 343.25 x x x +11441 Original post publication description: Saline control response (10 ml/kg ip), locomotor activity after injection from 0-5 min for males [cm] None Saline control response (10 ml/kg ip), locomotor activity after injection from 0-5 min for males [cm] x x x x 722.237 376.0 x 777.314 x 583.535 657.202 1055.82 443.454 731.032 202.682 622.262 1173.07 785.747 x 945.685 x x x 436.597 x 772.753 269.565 1183.16 x 717.953 570.972 531.93 553.505 x 507.212 x 575.443 522.768 833.353 x 1041.7 648.69 1056.32 1162.76 x x 878.742 x 761.02 463.682 x x x 701.615 282.0 x x x 1179.09 625.465 300.53 220.075 x 707.477 471.125 548.578 611.723 685.023 1263.15 534.123 x 667.296 x 455.828 x x x x 690.945 x x 669.103 964.06 446.923 582.368 549.002 x 877.685 714.27 x 949.92 x x x 762.425 868.585 747.32 1253.52 622.07 x x x +11442 Original post publication description: Ethanol response (2.25 g/kg ip), locomotor activity after injection from 5-10 min for males [cm] None Central nervous system, pharmacology, behavior: Ethanol response (2.25 g/kg ip), locomotor activity after injection from 5-10 min for males [cm] x x x x 675.84 1388.19 x 364.508 x 333.53 787.73 1365.86 552.992 217.13 175.937 934.86 1567.04 785.8 x 912.605 x x x 176.312 x 961.797 440.825 1278.51 x 1178.89 858.093 534.963 1004.94 x 822.07 x 312.12 177.148 1054.41 x 1346.55 212.492 610.503 1608.82 x x 904.32 x 1341.14 973.162 x x x 0.9925 112.495 x x x 848.305 969.805 231.758 121.24 x 716.078 1060.02 897.185 681.013 245.523 1390.45 730.727 x 907.286 x 167.492 x x x x 348.902 x x 1053.74 631.59 255.708 250.417 392.683 x 256.127 677.992 x 686.128 x x x 320.938 345.15 133.395 754.125 296.478 x x x +11443 Original post publication description: Saline control response (10 ml/kg ip), locomotor activity after injection from 5-10 min after injection for males [cm] None Central nervous system, pharmacology, behavior: Saline control response (10 ml/kg ip), locomotor activity after injection from 5-10 min after injection for males [cm] x x x x 372.858 205.965 x 438.27 x 381.522 622.225 665.943 278.684 372.138 127.742 255.777 603.46 518.068 x 624.575 x x x 187.637 x 568.575 101.082 952.24 x 397.957 289.393 433.358 483.545 x 75.56 x 418.328 330.592 571.218 x 516.278 263.03 562.458 582.35 x x 626.095 x 449.395 353.185 x x x 635.43 87.73 x x x 693.715 377.508 140.77 55.535 x 491.155 164.977 397.172 441.65 367.908 1265.02 321.83 x 325.334 x 216.065 x x x x 379.337 x x 400.72 366.478 360.287 378.248 361.328 x 545.675 241.02 x 444.693 x x x 483.062 505.505 371.978 1030.55 364.12 x x x +11444 Original post publication description: Ethanol response (2.25 g/kg ip), locomotor activity after injection from 10-15 min for males [cm] None Ethanol response (2.25 g/kg ip), locomotor activity after injection from 10-15 min for males [cm] x x x x 528.835 775.265 x 254.164 x 400.59 659.277 909.055 459.586 213.097 163.713 898.477 1326.74 772.615 x 636.18 x x x 297.853 x 703.775 286.98 1137.71 x 1024.93 892.422 334.405 838.81 x 696.828 x 385.378 212.395 1007.45 x 1246.02 124.085 505.205 1397.1 x x 989.333 x 1069.73 893.545 x x x 157.2 420.79 x x x 615.88 798.648 148.435 296.285 x 637.492 849.513 1094.09 828.66 138.117 1392.57 826.11 x 723.022 x 771.42 x x x x 637.855 x x 1246.34 740.322 294.942 173.288 357.742 x 461.175 1057.49 x 991.633 x x x 314.685 453.47 377.617 870.595 284.02 x x x +11445 Original post publication description: Saline control response (10 ml/kg ip), locomotor activity after injection from 10-15 min for males [cm] None Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotor activity after injection from 10-15 min for males [cm] x x x x 245.363 174.69 x 414.807 x 436.332 578.503 483.61 239.862 300.483 62.1333 194.492 421.908 300.185 x 431.925 x x x 124.333 x 589.182 168.54 767.635 x 324.365 300.515 432.335 313.56 x 206.28 x 378.555 369.925 445.522 x 485.58 445.578 392.883 632.76 x x 533.013 x 512.89 461.783 x x x 498.33 89.625 x x x 669.095 335.087 211.965 43.345 x 324.615 159.712 515.345 479.08 381.203 1364.19 306.607 x 256.376 x 151.497 x x x x 373.26 x x 241.125 259.91 277.023 352.513 319.298 x 453.792 149.042 x 380.672 x x x 270.985 639.655 367.33 924.115 321.08 x x x +11446 Original post publication description: Ethanol response (2.25 g/kg ip), locomotor activity after injection from 15-20 min for males [cm] None Central nervous system, pharmacology, behavior: Ethanol response (2.25 g/kg ip), locomotor activity after injection from 15-20 min for males [cm] x x x x 269.975 682.56 x 226.792 x 303.275 761.02 719.3 497.494 308.502 147.387 692.128 886.665 698.42 x 661.347 x x x 277.888 x 542.188 190.97 802.948 x 736.177 745.652 366.195 895.177 x 573.122 x 348.39 181.137 983.723 x 975.292 527.395 556.19 1197.58 x x 894.165 x 917.53 688.965 x x x 17.3875 236.395 x x x 555.025 820.523 132.122 254.58 x 635.325 786.708 894.917 634.907 273.212 1002.78 761.753 x 567.664 x 1124.87 x x x x 674.713 x x 1201.28 514.348 274.89 282.245 271.012 x 649.71 1163.92 x 835.335 x x x 628.45 621.53 477.622 878.75 281.475 x x x +11447 Original post publication description: Saline control response (10 ml/kg ip), locomotion from 15-20 min after injection for males [cm] None Saline control response (10 ml/kg ip), locomotion from 15-20 min after injection for males [cm] x x x x 410.943 169.355 x 322.239 x 558.747 419.408 431.817 278.642 267.432 61.1183 143.485 412.652 245.215 x 345.48 x x x 119.52 x 427.802 127.72 802.432 x 276.515 246.743 413.83 263.848 x 162.482 x 284.948 268.69 616.975 x 448.095 222.678 130.122 198.835 x x 517.838 x 363.177 484.633 x x x 237.5 87.15 x x x 580.295 283.52 126.455 72.855 x 307.14 141.765 496.017 605.563 406.698 1231.46 488.423 x 323.592 x 152.265 x x x x 272.905 x x 236.51 164.645 278.3 279.523 350.228 x 552.73 97.7775 x 314.495 x x x 208.387 535.525 395.64 1000.72 467.71 x x x +11448 Original post publication description: Ethanol response (2.25 g/kg ip), locomotor activity, difference in distance traveled (saline minus ethanol) from 0-20 min for males [cm] None Ethanol response (2.25 g/kg ip), locomotor activity, difference in distance traveled (saline minus ethanol) from 0-20 min for males [cm] x x x x 812.607 3114.47 x -597.778 x -641.992 824.56 2618.91 1020.56 -1103.52 276.243 2245.33 2937.64 1572.92 x 1187.68 x x x 74.3617 x 966.662 606.3 869.86 x 2568.71 1956.72 305.103 2276.02 x 2374.44 x -195.568 -87.345 1706.19 x 2460.55 -132.825 258.872 3454.36 x x 1325.82 x 2614.06 2148.22 x x x -1538.35 529.675 x x x -81.42 1816.44 109.033 686.365 x 1004.99 3357.75 1767.55 1020.14 -938.415 -4732.0 1341.61 x 1364.9 x 1304.46 x x x x 390.275 x x 2962.37 761.438 -269.068 -479.925 -120.842 x -694.226 2336.64 x 1364.58 x x x -64.315 -525.39 -332.203 -172.845 -569.758 x x x +11449 Original post publication description: Ethanol response (2.25 g/kg ip), locomotor activity after injection from 0-20 min for males [cm] None Ethanol response (2.25 g/kg ip), locomotor activity after injection from 0-20 min for males [cm] x x x x 2564.01 4040.48 x 1354.85 x 1318.15 3101.9 4596.81 2261.21 1293.06 729.918 3461.34 5548.72 3422.13 x 3535.35 x x x 942.448 x 3324.98 1273.21 4575.33 x 4285.5 3364.35 2116.55 3890.48 x 3325.97 x 1461.7 1404.63 4173.26 x 4952.2 1447.15 2400.65 6031.06 x x 3881.51 x 4700.54 3911.5 x x x 534.525 1076.18 x x x 3040.78 3438.02 888.753 1078.18 x 2835.38 4295.33 3724.66 3158.16 902.415 391.81 2992.59 x 2675.4 x 2280.12 x x x x 2106.72 x x 4509.83 2516.53 1093.46 1112.73 1459.02 x 1735.66 3538.75 x 3454.36 x x x 1660.55 2023.88 1550.06 4036.05 1205.22 x x x +11450 Original post publication description: Saline control response (10 ml/kg ip), locomotion 0-20 min after injection for males [cm] None Saline control response (10 ml/kg ip), locomotion 0-20 min after injection for males [cm] x x x x 1751.4 926.01 x 1952.63 x 1960.14 2277.34 2637.19 1240.64 2396.58 453.675 1216.02 2611.09 1849.21 x 2347.67 x x x 868.087 x 2358.31 666.907 3705.47 x 1716.79 1407.62 1811.45 1614.46 x 951.535 x 1657.27 1491.97 2467.07 x 2491.65 1579.97 2141.78 2576.7 x x 2555.69 x 2086.48 1763.28 x x x 2072.88 546.505 x x x 3122.2 1621.58 779.72 391.81 x 1830.39 937.58 1957.11 2138.02 1840.83 5123.81 1650.98 x 1310.5 x 975.655 x x x x 1716.45 x x 1547.46 1755.09 1362.53 1592.65 1579.86 x 2429.88 1202.11 x 2089.78 x x x 1724.86 2549.27 1882.27 4208.9 1774.98 x x x +11451 Original post publication description: Ethanol response (2.25 g/kg ip), locomotor activity, difference in distance traveled (saline minus ethanol) from 0-5 min for males [cm] None Central nervous system, pharmacology, behavior: Ethanol response (2.25 g/kg ip), locomotor activity, difference in distance traveled (saline minus ethanol) from 0-5 min for males [cm] x x x x 367.12 818.465 x -267.925 x -302.785 236.67 810.72 307.68 -176.697 40.2 313.615 595.215 379.547 x 379.53 x x x -246.202 x 344.462 84.8675 173.0 x 627.555 297.21 349.062 598.047 x 726.737 x -159.625 311.182 294.32 x 342.645 -65.5125 -327.562 664.795 x x 214.947 x 611.117 892.148 x x x -342.67 24.5 x x x -157.525 223.583 75.9075 185.995 x 139.007 1127.97 289.892 401.857 -439.46 348.885 139.88 x 287.672 x -239.488 x x x x -245.693 x x 339.362 -333.788 -178.998 -175.59 -111.423 x -509.041 -74.92 x -8.65 x x x -365.953 -264.855 -185.89 279.065 -278.82 x x x +11452 Original post publication description: Ethanol response (2.25 g/kg ip), locomotor activity, difference in distance traveled (saline minus ethanol) between the first 5 min and last 5 min for males [cm] None Ethanol response (2.25 g/kg ip), locomotor activity, difference in distance traveled (saline minus ethanol) between the first 5 min and last 5 min for males [cm] x x x x -140.967 513.205 x -95.4463 x -255.473 341.612 395.438 218.852 41.07 86.2683 548.643 474.013 453.205 x 315.867 x x x 158.368 x 114.385 63.25 0.515 x 459.663 498.908 -47.635 631.33 x 410.64 x 63.4425 -87.5525 366.748 x 527.198 304.717 426.068 998.745 x x 376.328 x 554.352 204.333 x x x -220.113 149.245 x x x -25.27 537.003 5.6675 181.725 x 328.185 644.943 398.9 29.3433 -133.485 -228.685 273.33 x 203.393 x 972.602 x x x x 401.807 x x 964.773 349.703 -3.41 2.72167 -79.2167 x 96.98 1066.14 x 520.84 x x x 420.062 86.005 81.9825 -121.97 -186.235 x x x +11453 Original post publication description: Ethanol response (2.25 g/kg ip), blood ethanol concentration (BEC) for males [mg/dl XX min after injection] None Central nervous system, pharmacology, behavior: Ethanol response (2.25 g/kg ip), blood ethanol concentration (BEC) for males [mg/dl XX min after injection] x x x x 268.8 221.9 x 296.717 x 311.1 209.133 217.525 276.167 263.483 248.3 250.9 216.96 202.575 x 233.8 x x x 243.92 x 206.1 223.5 249.45 x 231.75 229.633 248.1 212.3 x 244.4 x 279.2 220.9 245.7 x 238.95 231.65 301.375 259.3 x x 198.55 x 231.15 223.85 x x x 213.85 291.0 x x x 313.9 283.85 257.75 191.35 x 313.32 239.95 259.45 248.6 326.85 171.85 280.267 x 281.5 x 282.25 x x x x 297.0 x x 219.0 263.967 291.933 217.15 284.433 x 251.867 265.55 x 237.45 x x x 273.5 265.8 238.475 145.15 202.1 x x x +11454 Original post publication description: Anxiety assay, untreated baseline, entries into closed arms of a plus maze for males [n] None Central nervous system, behavior: Anxiety assay, untreated baseline, entries into closed arms of a plus maze for males [n] x x x x 54.75 51.5 x 90.6667 x 42.25 45.25 40.0 47.5 49.5 41.1667 37.3333 76.5 49.0 x 55.5 x x x 45.5 x 65.0 56.0 46.0 x 55.25 29.3333 50.75 49.5 x 41.75 x 42.25 37.75 57.1667 x 37.325 39.0 69.25 58.0 x x 56.5 x 59.5 57.0 x x x 53.5 38.0 x x x 44.0 50.75 79.5 37.0 x 51.0 19.5 51.0 82.3333 53.5 25.0 44.3333 x 67.0 x 90.0 x x x x 60.25 x x 34.5 57.1667 56.3333 37.6667 46.0 x 31.6667 60.0 x 58.25 x x x 40.0 55.5 39.0 31.0 37.25 x x x +11455 Original post publication description: Anxiety assay, untreated baseline, entries into open arms of a plus maze for males [n] None Central nervous system, behavior: Anxiety assay, untreated baseline, entries into open arms of a plus maze for males [n] x x x x 39.25 32.5 x 77.0 x 65.25 71.25 78.5 30.5 65.5 12.5 37.0 48.5 49.0 x 55.75 x x x 25.25 x 47.5 41.25 73.75 x 67.5 18.6667 48.0 79.5 x 74.25 x 49.25 38.25 38.8333 x 68.25 27.5 43.75 18.0 x x 61.5 x 57.0 59.5 x x x 26.75 17.5 x x x 47.0 25.75 45.5 25.0 x 39.8333 35.75 41.0 41.6667 24.5 51.0 26.6667 x 40.2 x 91.3333 x x x x 48.75 x x 26.6667 54.6667 24.8333 31.0 47.3333 x 53.8333 49.5 x 51.5 x x x 23.5 22.5 19.75 57.5 30.5 x x x +11456 Original post publication description: Anxiety assay, untreated baseline, percentage of entries into closed arms of a plus maze for males [%] None Central nervous system, behavior: Anxiety assay, untreated baseline, percentage of entries into closed arms of a plus maze for males [%] x x x x 33.0073 44.11 x 66.3 x 27.0902 41.385 34.3279 69.3321 41.7664 68.4564 53.1287 60.292 48.7675 x 45.255 x x x 38.1542 x 55.93 54.2975 29.6825 x 37.3525 36.1288 45.94 33.445 x 35.75 x 44.015 38.475 47.1784 x 31.8797 62.3684 65.4551 86.045 x x 33.65 x 49.6728 46.8315 x x x 41.2825 40.45 x x x 45.3 57.8558 64.1947 62.2 x 46.8314 22.15 40.3052 68.5667 60.3541 41.075 63.8519 x 57.1204 x 20.1248 x x x x 60.1758 x x 45.3477 49.2395 50.9287 48.588 41.6159 x 36.826 53.9889 x 49.8003 x x x 75.95 54.1032 57.3739 33.565 46.6112 x x x +11457 Original post publication description: Anxiety assay, untreated baseline, percent entries into open arms of an elevated plus maze for males [%] None Central nervous system, behavior: Anxiety assay, untreated baseline, percent entries into open arms of an elevated plus maze for males [%] x x x x 66.9927 55.89 x 33.7 x 47.9098 58.615 65.6721 30.6679 58.2336 14.8769 46.8713 39.708 51.2325 x 54.745 x x x 61.8458 x 44.07 45.7025 70.3175 x 62.6475 30.5379 54.085 66.555 x 64.25 x 55.985 61.525 36.155 x 68.1203 37.6316 34.5449 13.955 x x 66.35 x 50.3272 53.1685 x x x 50.9725 59.55 x x x 54.7 42.1442 35.8053 37.8 x 53.1686 77.85 59.6948 31.4333 39.6459 58.925 36.1481 x 42.8796 x 46.5418 x x x x 39.8242 x x 54.6523 50.7605 32.4046 51.412 58.3841 x 63.174 46.0111 x 50.1997 x x x 24.075 45.8968 42.6261 66.435 53.3888 x x x +11458 Original post publication description: Anxiety assay, untreated baseline, percent time in closed arms of a plus maze for males [%] None Central nervous system, behavior: Anxiety assay, untreated baseline, percent time in closed arms of a plus maze for males [%] x x x x 37.1033 37.605 x 45.3678 x 28.5717 26.8525 29.5842 79.4267 32.525 74.835 62.2233 65.72 39.43 x 35.6625 x x x 25.235 x 43.98 60.8025 32.5225 x 42.92 28.7894 46.8325 31.965 x 40.6083 x 61.5775 32.5375 39.8572 x 45.2892 68.6467 68.9133 85.695 x x 36.55 x 42.4083 46.7417 x x x 59.95 49.3383 x x x 58.885 60.0442 54.395 41.2583 x 52.4406 10.75 37.7867 51.2211 44.8358 26.085 65.9289 x 52.752 x 26.0344 x x x x 61.7175 x x 36.7656 42.6583 51.3456 58.6033 34.0594 x 36.0194 45.1858 x 53.665 x x x 58.1217 60.7233 59.3167 26.77 50.9417 x x x +11459 Original post publication description: Anxiety assay, untreated baseline, percentage of time in open arms of a plus maze for males [%] None Central nervous system, behavior: Anxiety assay, untreated baseline, percentage of time in open arms of a plus maze for males [%] x x x x 57.1125 57.055 x 49.5033 x 36.8533 64.5325 58.8925 17.63 53.1025 4.18556 31.4928 21.1192 46.3225 x 51.6225 x x x 55.3075 x 39.675 33.62 59.24 x 51.2575 26.3483 42.175 53.56 x 54.6083 x 33.795 61.51 31.5789 x 47.175 26.1467 23.4092 5.225 x x 60.855 x 45.1642 45.1083 x x x 31.4525 50.4133 x x x 33.325 19.45 23.3433 25.6117 x 42.7317 37.175 39.3825 14.2333 46.1833 45.31 17.2944 x 37.41 x 37.3622 x x x x 34.9033 x x 41.4556 49.2956 16.0672 37.4406 56.5356 x 58.4117 41.9508 x 41.2525 x x x 35.3833 34.005 25.6383 57.835 45.0083 x x x +11460 Original post publication description: Ethanol response (2.25 g/kg ip), motor coordination effects, difference in time on rotarod between training session and ethanol for males and females [sec] None Central nervous system, pharmacology, behavior: Ethanol response (2.25 g/kg ip), motor coordination effects, difference in time on rotarod between training session and ethanol for males and females [sec] x x x x 21.7917 5.3 x 15.3938 x 19.55 11.4217 -15.6083 1.57333 12.0722 8.21111 10.8278 12.7833 -2.86667 x -0.9 x x x 9.33889 x 1.825 15.425 22.8417 x 8.43333 12.4 -1.71667 21.85 x -4.44167 x 13.975 27.9 8.60556 x -1.85 -1.15833 10.0833 -12.7667 x x 7.475 x -9.825 11.7075 x x x 12.85 4.48333 x x x 25.7667 -1.49167 15.1083 4.66667 x 0.838889 1.66667 -2.15 -0.355556 16.35 4.68333 6.06667 x 24.8333 x -0.35 x x x x 28.7583 x x -16.7833 8.55 7.51667 3.17222 17.4111 x 18.55 28.6 x 0.483333 x x x -8.125 -9.61667 1.9 5.18333 12.3633 x x x +11461 Original post publication description: Ethanol response (2.25 g/kg ip), duration on rotarod following injection for males [sec] None Central nervous system, pharmacology, behavior: Ethanol response (2.25 g/kg ip), duration on rotarod following injection for males [sec] x x x x 21.7817 41.35 x 44.3222 x 21.9167 56.7117 49.3417 17.9778 27.1556 14.9717 35.3989 19.1889 43.135 x 31.24 x x x 16.7172 x 25.2758 27.26 31.43 x 31.0975 33.6489 42.5425 44.235 x 47.2975 x 13.645 33.5075 30.11 x 33.1908 24.4083 28.2508 40.085 x x 32.44 x 68.7992 27.3608 x x x 15.235 11.55 x x x 25.065 31.5083 41.8092 28.25 x 27.2222 37.4917 16.8342 52.6222 24.5675 23.8833 26.8222 x 46.5993 x 25.7667 x x x x 25.5333 x x 43.4444 24.6556 19.0056 25.85 18.8278 x 18.1778 29.075 x 31.7167 x x x 34.2492 30.6833 30.8167 35.4167 38.595 x x x +11462 Original post publication description: Ethanol response (2.25 g/kg ip), motor coordination effects, tolerance assay, difference in time on rotarod between saline and ethanol for males [sec] None Central nervous system, pharmacology, behavior: Ethanol response (2.25 g/kg ip), motor coordination effects, tolerance assay, difference in time on rotarod between saline and ethanol for males [sec] x x x x -13.2083 -10.8333 x 13.3604 x -6.80833 5.95611 16.5917 5.71333 -7.82222 2.49444 -4.64444 -4.9 12.7167 x -4.08333 x x x -3.08889 x -1.20833 -14.6833 -17.0833 x -3.69167 -5.41667 1.375 0.375 x 4.48333 x -4.4 -24.375 -14.8944 x 3.86667 5.50833 -8.19167 7.95 x x -9.075 x 7.50917 4.69167 x x x 1.00833 -2.6 x x x -14.3 -0.758333 -20.8 -2.91667 x -2.28889 -13.725 -5.33333 -10.4889 -0.008333 -2.56667 11.8889 x -22.7267 x -1.625 x x x x -5.58333 x x 5.07222 5.31667 -2.3 -4.51111 9.2 x -7.36667 -13.5167 x 11.15 x x x 6.89167 24.15 -10.325 -0.7 -8.32267 x x x +11463 Original post publication description: Saline control response (10 ml/kg ip), motor coordination, rotarod performance following injection for males [sec] None Central nervous system, behavior: Saline control response (10 ml/kg ip), motor coordination, rotarod performance following injection for males [sec] x x x x 43.5825 46.65 x 55.5824 x 41.4667 68.1322 33.7317 15.45 39.2283 23.1833 46.23 31.9711 40.27 x 30.345 x x x 26.0556 x 27.0992 42.685 54.2725 x 39.5325 46.05 40.8225 58.6233 x 42.8575 x 27.6175 61.4075 38.7156 x 31.3417 23.25 38.3342 27.32 x x 39.9158 x 58.975 39.0683 x x x 28.085 16.035 x x x 50.835 30.0167 56.9175 32.9167 x 28.0617 39.1567 14.6825 52.2667 40.9175 28.5667 32.8889 x 71.4327 x 25.4167 x x x x 54.2917 x x 26.6611 33.2056 26.5222 29.0222 43.4867 x 36.7278 57.675 x 32.2 x x x 34.8333 21.0667 32.7167 40.6 50.9583 x x x +11464 Original post publication description: Saline response (dose ip), motor coordination effects, difference in time on rotarod between training session and saline for males [sec] None Central nervous system, behavior: Motor coordination effect of saline control injection (ip), difference in time on rotarod between training session and saline for males [sec] x x x x 8.58333 -5.53333 x 28.7542 x 12.7417 17.3778 0.983333 7.28667 4.25 10.7056 6.18333 7.88333 9.85 x -4.98333 x x x 6.25 x 0.616667 0.741667 5.75833 x 4.74167 6.98333 -0.341667 22.225 x 0.041667 x 9.575 3.525 -6.28889 x 2.01667 4.35 1.89167 -4.81667 x x -1.6 x -2.31583 16.3992 x x x 13.8583 1.88333 x x x 11.4667 -2.25 -5.69167 1.75 x -1.45 -12.0583 -7.48333 -10.8444 16.3417 2.11667 17.9556 x 2.10667 x -1.975 x x x x 23.175 x x -11.7111 13.8667 5.21667 -1.33889 26.6111 x 11.1833 15.0833 x 11.6333 x x x -1.23333 14.5333 -8.425 4.48333 4.04067 x x x +11465 Original post publication description: Motor coordination, rotarod performance, untreated training trial for males [sec] None Motor coordination, rotarod performance, untreated training trial for males [sec] x x x x 30.365 35.815 x 61.9958 x 34.6583 74.0883 50.3233 18.0733 31.4044 25.6783 41.5833 27.0717 52.985 x 26.2575 x x x 22.9661 x 25.8925 28.0 37.1925 x 35.8425 40.6333 42.2 44.34 x 47.34 x 23.2175 37.035 23.8211 x 35.2075 28.7583 30.1408 35.265 x x 30.8433 x 66.4842 43.7583 x x x 29.09 13.43 x x x 36.535 29.2575 36.1175 30.0 x 25.7728 25.4325 9.34833 41.7778 40.9083 26.0 44.7778 x 48.706 x 23.7917 x x x x 48.7083 x x 31.7333 38.5222 24.2222 24.5111 45.4389 x 29.3611 44.1583 x 43.35 x x x 33.0175 45.2167 22.3917 39.9 42.6357 x x x +11466 Original post publication description: Anxiety assay, time in closed arms of an elevated plus maze for males [sec] None Central nervous system, behavior: Anxiety assay, time in closed arms of an elevated plus maze for males [sec] x x x x 111.308 112.815 x 136.06 x 85.715 80.58 88.74 238.28 97.5925 224.498 186.672 197.163 118.283 x 106.945 x x x 75.705 x 131.93 182.405 97.565 x 128.765 86.3683 140.45 95.895 x 121.85 x 184.705 97.6175 119.572 x 135.867 205.94 206.735 257.085 x x 109.66 x 127.223 140.227 x x x 179.852 148.015 x x x 176.655 180.133 163.185 123.775 x 157.322 32.22 113.363 153.663 134.523 78.25 197.787 x 158.246 x 78.1033 x x x x 185.152 x x 110.295 127.975 154.037 175.807 102.198 x 108.058 135.557 x 160.995 x x x 174.4 182.17 177.95 80.3 152.827 x x x +11467 Original post publication description: Anxiety assay, time in middle of an elevated plus maze for males [sec] None Central nervous system, behavior: Anxiety assay, time in middle of an elevated plus maze for males [sec] x x x x 17.36 16.01 x 15.4733 x 103.725 25.8425 34.5675 8.83 43.1225 62.96 18.85 39.48 42.73 x 38.185 x x x 58.375 x 49.04 16.735 24.695 x 17.465 134.587 33.0 43.42 x 14.34 x 13.9625 17.8525 85.6917 x 22.6125 15.62 23.035 27.24 x x 7.78 x 37.28 24.4425 x x x 25.7875 0.745 x x x 23.37 61.5175 66.785 99.39 x 14.4833 156.295 68.4525 103.637 26.9575 85.825 50.33 x 29.538 x 109.81 x x x x 10.1375 x x 65.3367 24.1383 97.7617 11.87 28.1817 x 16.7067 38.59 x 15.2475 x x x 19.5 15.815 45.135 46.2 12.145 x x x +11468 Original post publication description: Anxiety assay, time in open arms of a plus maze for males [sec] None Central nervous system, behavior: Anxiety assay, time in open arms of a plus maze for males [sec] x x x x 171.333 171.175 x 148.467 x 110.56 193.598 176.69 52.89 159.295 12.5417 94.4783 63.3425 138.958 x 154.87 x x x 165.92 x 119.03 100.86 177.74 x 153.77 79.045 126.545 160.685 x 163.825 x 101.33 184.53 94.7367 x 141.52 78.44 70.23 15.675 x x 182.56 x 135.497 135.33 x x x 94.36 151.24 x x x 99.975 58.35 70.03 76.835 x 128.195 111.485 118.185 42.7 138.52 135.925 51.8833 x 112.216 x 112.087 x x x x 104.71 x x 124.368 147.887 48.2017 112.323 169.62 x 175.235 125.853 x 123.757 x x x 106.1 102.015 76.915 173.5 135.027 x x x +11469 Original post publication description: Cocaine response (10 mg/kg ip), locomotion from 0-15 min after first injection in an activity chamber for males [n beam breaks] None Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), locomotion from 0-15 min after first injection in an activity chamber for males [n beam breaks] x x x x 2391.71 1403.9 x 993.692 955.4 2715.6 1072.36 2018.8 1063.07 2567.73 1020.25 817.385 2905.53 1720.69 957.0 2637.55 x x x 2387.62 x 1772.5 1222.27 2050.08 x 1903.75 892.333 3703.23 1456.94 x 583.111 x 1888.92 1576.31 4417.88 x 2316.64 3037.87 1434.05 1712.89 x x 1771.92 x 1730.56 1156.12 x x x 1135.0 1004.56 x x x 1854.5 1297.86 870.438 1901.31 x 1733.86 617.692 1072.71 1974.92 3103.6 2375.68 3183.24 x 1290.06 x 1496.55 x 4048.42 x x 1383.35 x x 1256.8 2308.4 860.882 1820.42 1862.29 x 2346.27 x x 1621.5 x x x 2165.25 2914.8 2551.83 2567.29 2017.18 x x x +11470 Original post publication description: Cocaine response (10 mg/kg ip), locomotion from 15-30 min after first injection in an activity chamber for males [n beam breaks] None Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), locomotion from 15-30 min after first injection in an activity chamber for males [n beam breaks] x x x x 2314.79 815.9 x 869.923 634.6 2571.6 1135.55 1765.9 1097.0 2028.0 906.5 958.462 1873.35 1968.15 1227.0 2175.0 x x x 1818.88 x 1269.5 1002.0 1898.62 x 2137.88 1396.33 3062.38 1230.76 x 473.444 x 2033.75 1488.85 4278.69 x 2105.64 2785.8 1244.29 1222.89 x x 1483.75 x 1845.0 1348.12 x x x 1299.5 1074.61 x x x 1965.57 1389.77 895.0 1892.92 x 1717.07 764.846 1317.07 1917.31 3316.87 2494.58 3300.88 x 1139.41 x 1508.82 x 3181.92 x x 1190.59 x x 1131.6 2292.5 926.824 1896.08 1889.29 x 2217.36 x x 1822.36 x x x 1770.25 2330.6 2026.83 2897.41 1912.09 x x x +11471 Original post publication description: Cocaine response (10 mg/kg ip), locomotion from 30-45 min after first injection in an activity chamber for males [n beam breaks] None Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), locomotion from 30-45 min after first injection in an activity chamber for males [n beam breaks] x x x x 1558.43 686.7 x 666.231 702.6 2005.2 1257.09 1306.3 962.714 1614.4 696.25 874.385 1192.0 1470.69 1337.0 1749.82 x x x 1399.38 x 968.7 795.364 1474.23 x 1413.88 1410.0 2298.0 866.529 x 365.778 x 1579.75 1175.15 3198.25 x 1433.5 1821.2 935.286 962.889 x x 1589.17 x 1536.67 1197.65 x x x 1144.0 663.278 x x x 1728.71 1264.32 472.438 1205.31 x 1238.71 607.077 1177.43 1647.15 2827.8 2003.42 2421.47 x 892.824 x 1356.27 x 2183.08 x x 1028.82 x x 968.267 1954.7 521.353 1597.75 1554.06 x 1762.73 x x 1449.14 x x x 1157.75 1820.2 1100.75 2661.82 1468.36 x x x +11472 Original post publication description: Cocaine response (10 mg/kg ip), locomotion from 45-60 min after first injection in an activity chamber for males [n beam breaks] None Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), locomotion from 45-60 min after first injection in an activity chamber for males [n beam breaks] x x x x 1174.21 396.2 x 462.385 469.4 1711.4 853.909 1234.1 780.857 1077.33 477.0 836.846 1140.82 806.154 794.0 1401.36 x x x 1185.38 x 575.2 532.364 1110.54 x 1278.75 1240.33 1683.62 447.647 x 207.222 x 1159.83 950.154 2473.38 x 1021.71 1418.73 656.143 667.667 x x 1260.25 x 1132.89 1050.65 x x x 856.333 232.0 x x x 1307.71 922.273 322.188 705.462 x 1050.86 492.769 1010.93 1278.38 2327.4 1676.53 1930.29 x 690.824 x 1082.0 x 1532.17 x x 630.706 x x 798.467 1352.5 323.176 1162.0 1047.12 x 1580.55 x x 1044.43 x x x 1844.38 1447.0 908.833 2274.12 1072.09 x x x +11473 Original post publication description: Cocaine response (10 mg/kg ip), locomotion from 0-15 min after first injection in an activity chamber for males [cm] None Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), locomotion from 0-15 min after first injection in an activity chamber for males [cm] x x x x 6803.54 4170.04 x 2966.53 2997.62 7522.03 3062.7 5763.18 3326.14 7425.7 3051.77 2574.53 7993.21 5587.93 2933.3 7378.28 x x x 6788.72 x 5109.82 3648.73 6001.78 x 5756.39 2617.81 9993.69 4417.63 x 1908.84 x 5738.72 4515.74 11584.9 x 6895.67 8422.96 4412.16 5395.51 x x 5192.93 x 5329.35 3815.92 x x x 3753.56 3375.18 x x x 5389.7 3901.29 2683.48 5801.81 x 5188.4 2046.31 3572.57 6125.98 8829.99 6897.64 8911.82 x 3986.5 x 4697.63 x 10593.4 x x 4107.25 x x 4226.47 6867.35 2955.96 5315.73 5651.85 x 6992.84 x x 4914.25 x x x 6375.15 8159.97 6944.12 7519.05 5997.08 x x x +11474 Original post publication description: Cocaine response (10 mg/kg ip), locomotion from 15-30 min after first injection in an activity chamber for males [cm] None Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), locomotion from 15-30 min after first injection in an activity chamber for males [cm] x x x x 6492.58 2621.3 x 2666.18 2139.1 7025.14 3358.91 5310.67 3592.64 6021.15 2759.84 2955.02 5446.17 6479.86 3541.36 6310.98 x x x 5337.0 x 3849.83 3231.92 5679.19 x 6262.1 4037.63 8317.7 3788.06 x 1552.16 x 6062.3 4247.41 11056.7 x 6174.98 7887.0 3759.9 4105.16 x x 4552.86 x 5603.98 4351.81 x x x 4197.84 3639.58 x x x 5749.7 4191.79 2791.48 5665.06 x 5137.49 2582.83 4137.11 5987.15 9324.98 7144.64 9083.56 x 3592.49 x 4713.82 x 8670.18 x x 3664.71 x x 3805.13 6709.07 3082.5 5518.4 5586.59 x 6628.93 x x 5599.99 x x x 5401.41 6700.13 5642.13 8312.44 5770.9 x x x +11475 Original post publication description: Cocaine response (10 mg/kg ip), locomotion from 30-45 min after first injection in an activity chamber for males [cm] None Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), locomotion from 30-45 min after first injection in an activity chamber for males [cm] x x x x 4556.32 2257.54 x 2108.0 2451.51 5733.6 3731.9 4179.94 3204.39 4883.41 2321.13 2754.0 3517.55 4972.7 3934.44 5293.79 x x x 4349.03 x 3114.86 2620.16 4691.75 x 4247.65 4126.46 6630.44 2827.03 x 1263.31 x 4931.91 3509.85 8631.64 x 4362.01 5512.87 2924.96 3353.88 x x 4901.57 x 4737.19 3939.2 x x x 3732.71 2267.92 x x x 5123.4 3869.89 1608.61 3652.77 x 3841.13 2037.43 3729.7 5146.89 8174.96 5965.88 6803.18 x 2887.97 x 4314.86 x 6287.98 x x 3156.85 x x 3272.73 5964.73 1841.26 4768.39 4627.43 x 5344.69 x x 4555.9 x x x 3880.97 5200.0 3141.68 7630.34 4636.75 x x x +11476 Original post publication description: Cocaine response (10 mg/kg ip), locomotion from 45-60 min after first injection in an activity chamber for males [cm] None Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), locomotion from 45-60 min after first injection in an activity chamber for males [cm] x x x x 3579.86 1423.81 x 1557.87 1682.89 5028.89 2589.47 3993.26 2670.62 3366.78 1664.48 2593.68 3528.1 2852.32 2430.52 4389.21 x x x 3875.99 x 2033.36 1935.2 3654.29 x 3982.53 3670.71 5206.57 1527.72 x 736.09 x 3835.61 2902.21 7008.9 x 3231.94 4610.76 2098.67 2364.34 x x 3944.4 x 3624.35 3541.97 x x x 2856.11 802.259 x x x 3930.53 2952.88 1181.43 2164.62 x 3254.93 1720.02 3212.25 3998.09 6916.79 5146.18 5551.64 x 2195.02 x 3496.1 x 4671.85 x x 2008.16 x x 2698.29 4356.84 1146.43 3564.41 3212.09 x 4896.0 x x 3296.96 x x x 5230.67 4135.58 2689.71 6694.73 3565.08 x x x +11477 Original post publication description: Cocaine response (10 mg/kg ip), vertical activity (rears) in an open field 0-15 min after injection for males [n beam breaks] None Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), vertical activity (rears) in an open field 0-15 min after injection for males [n beam breaks] x x x x 283.714 314.9 x 277.923 156.4 303.6 118.909 248.5 227.929 560.533 143.75 299.077 255.765 418.077 156.5 355.0 x x x 236.75 x 278.1 182.818 448.385 x 301.25 190.583 267.077 305.0 x 142.778 x 327.833 135.462 514.312 x 601.929 568.8 356.476 323.556 x x 468.25 x 459.444 299.824 x x x 278.083 194.611 x x x 332.786 291.955 321.062 246.692 x 270.214 172.308 387.357 444.308 680.2 360.579 478.235 x 304.647 x 385.364 x 509.5 x x 360.176 x x 354.6 443.3 222.941 315.667 404.412 x 487.818 x x 277.714 x x x 510.375 292.6 332.917 478.294 430.182 x x x +11478 Original post publication description: Cocaine response (10 mg/kg ip), vertical activity (rears) in an open field 15-30 min after injection for males [n beam breaks] None Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), vertical activity (rears) in an open field 15-30 min after injection for males [n beam breaks] x x x x 375.857 282.8 x 301.231 212.8 376.4 175.636 369.5 319.786 587.2 202.625 375.462 269.824 548.769 185.0 436.182 x x x 249.125 x 276.5 251.182 444.385 x 382.875 340.75 379.231 306.412 x 173.556 x 420.333 196.231 623.875 x 522.071 688.2 344.619 338.889 x x 477.583 x 460.778 327.059 x x x 313.5 272.389 x x x 385.357 381.455 376.25 348.923 x 294.571 283.231 458.929 470.077 806.0 429.105 547.235 x 327.824 x 475.636 x 595.417 x x 422.294 x x 408.6 483.7 290.176 345.5 415.471 x 558.909 x x 375.786 x x x 596.5 322.8 390.75 528.353 512.909 x x x +11479 Original post publication description: Cocaine response (10 mg/kg ip), vertical activity (rears) in an open field 30-45 min after injection for males [n beam breaks] None Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), vertical activity (rears) in an open field 30-45 min after injection for males [n beam breaks] x x x x 332.429 268.9 x 241.231 289.8 389.8 224.0 339.7 316.786 504.8 181.0 335.769 260.588 460.154 189.5 424.636 x x x 278.0 x 252.0 185.455 402.769 x 318.375 336.25 418.538 246.059 x 132.444 x 396.0 197.462 605.75 x 433.5 571.333 315.381 332.0 x x 525.083 x 464.889 314.588 x x x 277.75 184.333 x x x 347.786 395.136 341.25 248.692 x 239.571 212.769 438.0 414.308 753.867 426.368 481.765 x 300.529 x 478.273 x 558.25 x x 348.294 x x 349.267 508.8 231.294 308.333 371.235 x 475.273 x x 332.786 x x x 499.5 263.4 269.167 522.118 497.727 x x x +11480 Original post publication description: Cocaine response (10 mg/kg ip), vertical activity (rears) in an open field 45-60 min after injection for males [n beam breaks] None Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), vertical activity (rears) in an open field 45-60 min after injection for males [n beam breaks] x x x x 344.071 220.6 x 177.385 251.0 428.2 191.727 368.4 276.214 392.467 146.375 326.462 255.294 315.154 160.0 389.727 x x x 274.375 x 205.2 208.0 383.923 x 331.0 314.583 396.385 163.235 x 99.8889 x 407.083 203.0 616.312 x 355.929 582.267 221.905 254.333 x x 477.583 x 405.0 278.529 x x x 219.917 67.8889 x x x 288.929 361.182 275.688 187.0 x 226.286 187.385 420.571 315.923 706.867 412.263 440.588 x 264.235 x 397.273 x 527.5 x x 264.529 x x 348.8 469.5 141.882 263.333 291.059 x 481.091 x x 259.071 x x x 488.75 287.8 268.25 526.882 446.273 x x x +11481 Original post publication description: Cocaine response (2 x 10 mg/kg ip), locomotion from 0-15 min after second injection in an activity chamber for males [n beam breaks] None Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), locomotion from 0-15 min after second injection in an activity chamber for males [n beam breaks] x x x x 4968.43 1944.4 x 1990.54 2265.0 5345.2 1234.27 3347.0 2227.14 3970.07 1307.0 1661.38 3952.59 3135.31 1628.0 4486.55 x x x 3071.5 x 3081.4 3022.36 2893.0 x 2805.0 1980.58 6078.85 2036.59 x 703.111 x 2838.33 2394.62 6471.44 x 3861.86 3610.67 2337.48 1820.78 x x 2539.42 x 2002.0 2269.65 x x x 1786.58 1688.94 x x x 3233.21 2033.05 1130.56 2815.0 x 2192.0 1391.0 1594.57 2982.54 4170.73 3711.89 4045.41 x 2152.59 x 2617.1 x 5222.5 x x 2390.06 x x 2332.33 3980.0 1485.94 4165.8 2742.94 x 3157.55 x x 2401.64 x x x 3084.62 4029.4 4383.42 3411.06 2427.64 x x x +11482 Original post publication description: Cocaine response (2 x 10 mg/kg ip), locomotion from 15-30 min after second injection in an activity chamber for males [n beam breaks] None Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), locomotion from 15-30 min after second injection in an activity chamber for males [n beam breaks] x x x x 3475.86 683.6 x 1347.92 845.8 4717.0 1375.55 2268.9 1914.93 2846.07 1429.0 1527.08 2974.12 2460.92 1780.0 2909.64 x x x 1760.75 x 2098.8 1978.73 2155.0 x 2750.75 1810.0 4624.0 1552.71 x 416.333 x 2432.33 1852.62 5368.06 x 3048.79 2699.93 1856.33 1298.11 x x 1903.25 x 1770.56 2027.65 x x x 2068.58 1509.44 x x x 2987.29 1705.27 841.312 2034.38 x 2070.21 1208.92 1588.14 2194.62 3667.33 3412.78 3684.0 x 1371.47 x 1855.1 x 3536.0 x x 1569.65 x x 1824.53 3289.3 1232.18 3591.6 2179.18 x 2443.82 x x 1958.07 x x x 1911.25 3342.0 2566.5 2951.56 1954.91 x x x +11483 Original post publication description: Cocaine response (2 x 10 mg/kg ip), locomotion from 30-45 min after second injection in an activity chamber for males [n beam breaks] None Central nervous system, behavior, pharmacology: Cocaine response (2 x 10 mg/kg ip), locomotion from 30-45 min after second injection in an activity chamber for males [n beam breaks] x x x x 2468.57 441.7 x 1109.31 875.0 3031.6 1204.09 1415.1 1156.71 1879.67 1175.62 1236.54 2011.41 1545.69 2121.5 2111.91 x x x 1429.12 x 1210.9 1269.09 1730.54 x 2014.75 1508.33 2847.31 1043.18 x 338.889 x 1804.75 1361.23 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +11484 Original post publication description: Cocaine response (2 x 10 mg/kg ip), locomotion from 45-60 min after second injection in an activity chamber for males [n beam breaks] None Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), locomotion from 45-60 min after second injection in an activity chamber for males [n beam breaks] x x x x 1720.86 345.6 x 709.385 691.0 2149.4 1023.0 1072.5 931.929 1315.2 633.75 957.769 1732.59 725.538 1659.5 1709.27 x x x 1006.38 x 768.0 898.636 1140.69 x 1562.38 1246.0 1946.46 548.412 x 121.333 x 1431.0 958.923 2782.12 x 1518.86 1276.0 837.19 556.222 x x 1216.08 x 1212.33 1053.82 x x x 1502.75 466.5 x x x 1680.21 1066.55 288.875 826.462 x 1287.93 692.385 1119.86 1142.38 2641.13 2030.11 1953.53 x 701.412 x 1010.3 x 1809.67 x x 851.471 x x 972.0 1704.3 489.059 1764.3 1248.65 x 1560.27 x x 1112.79 x x x 1181.5 1635.4 1025.75 2442.31 1150.09 x x x +11485 Original post publication description: Cocaine response (2 x 10 mg/kg ip), locomotion in an open field from 0-15 min after second injection in an activity chamber for males [cm] None Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), locomotion in an open field from 0-15 min after second injection in an activity chamber for males [cm] x x x x 12562.3 5479.07 x 5677.66 6293.29 13889.9 3531.52 8658.28 6482.38 10817.9 3640.22 4685.5 10292.2 9289.86 4615.12 11709.6 x x x 8325.97 x 8135.02 8277.83 8220.84 x 7868.79 5561.35 15202.7 5856.35 x 2114.4 x 8202.51 6670.79 15959.8 x 10752.5 9796.95 6736.89 5638.43 x x 7220.15 x 5925.78 6697.08 x x x 5601.17 5167.12 x x x 9009.37 5833.23 3217.16 8054.34 x 6323.28 4032.56 4967.24 8847.29 11564.9 10031.5 10830.3 x 6178.8 x 7902.37 x 13130.4 x x 6448.32 x x 6892.33 10460.0 4676.38 11076.7 7747.26 x 8737.48 x x 6867.45 x x x 8450.12 10666.5 11664.0 9374.63 7102.49 x x x +11486 Original post publication description: Cocaine response (2 x 10 mg/kg ip), locomotion in an open field from 15-30 min after second injection in an activity chamber for males [cm] None Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), locomotion in an open field from 15-30 min after second injection in an activity chamber for males [cm] x x x x 8874.27 2191.54 x 4000.53 2879.05 11898.2 4079.55 6341.59 5649.16 7985.99 4056.28 4471.69 7856.15 7573.91 5100.98 8182.21 x x x 5136.35 x 5880.64 6134.62 6278.68 x 7489.06 5102.89 11786.1 4574.18 x 1405.07 x 7113.89 5244.09 13187.3 x 8551.73 7568.28 5384.13 4251.88 x x 5733.48 x 5377.26 6123.37 x x x 6553.23 4908.25 x x x 8230.51 4937.91 2472.42 5845.12 x 5924.33 3649.87 4972.35 6634.43 10274.2 9365.51 9872.84 x 4076.65 x 5794.69 x 9583.41 x x 4602.61 x x 5529.31 8961.31 4070.8 9775.23 6210.6 x 7035.01 x x 5730.93 x x x 5611.92 8853.12 7098.01 8229.84 5905.41 x x x +11487 Original post publication description: Cocaine response (2 x 10 mg/kg ip), locomotion in an open field from 30-45 min after second injection in an activity chamber for males [cm] None Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), locomotion in an open field from 30-45 min after second injection in an activity chamber for males [cm] x x x x 6600.85 1532.71 x 3406.92 3048.58 7780.75 3650.4 4368.77 3750.33 5503.89 3611.9 3749.59 5588.23 4962.57 6157.44 6258.18 x x x 4445.44 x 3759.98 4274.04 5234.54 x 5575.72 4390.01 7812.64 3345.7 x 1116.24 x 5592.88 4084.49 10133.7 x 6470.16 5708.47 3986.99 4449.02 x x 5041.06 x 4184.9 4841.53 x x x 5644.63 2814.96 x x x 6793.55 4165.04 1497.95 4033.3 x 4478.93 3537.86 4250.43 5252.65 8893.29 7663.03 7687.5 x 3112.88 x 4741.01 x 7099.6 x x 3315.13 x x 4013.49 7515.72 2641.16 6925.35 4642.22 x 5925.29 x x 4508.03 x x x 4112.31 6898.26 4523.08 7633.9 4731.85 x x x +11488 Original post publication description: Cocaine response (2 x 10 mg/kg ip), locomotion in an open field from 45-60 min after second injection in an activity chamber for males [cm] None Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), locomotion in an open field from 45-60 min after second injection in an activity chamber for males [cm] x x x x 4921.85 1240.0 x 2187.32 2269.95 5925.85 3165.64 3390.76 3149.13 4021.32 2200.4 2927.76 4839.67 2463.73 4461.73 5378.12 x x x 3448.56 x 2594.86 3203.34 3611.69 x 4538.74 3771.37 5770.14 1854.38 x 424.242 x 4608.55 3109.84 7706.21 x 4499.09 4137.59 2651.38 1895.78 x x 3928.34 x 3880.91 3636.56 x x x 4824.66 1658.06 x x x 4803.02 3340.94 1001.39 2493.5 x 3883.91 2264.5 3589.42 3693.62 7637.64 6000.1 5423.29 x 2217.81 x 3404.52 x 5455.41 x x 2579.15 x x 3255.51 5272.92 1691.64 5184.15 3629.88 x 4768.83 x x 3563.62 x x x 3861.99 4857.69 3070.12 7049.01 3873.11 x x x +11489 Original post publication description: Cocaine response (2 x 10 mg/kg ip), vertical activity (rears) from 15-30 min after second injection in an activity chamber for males [n beam breaks] None Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), vertical activity (rears) from 15-30 min after second injection in an activity chamber for males [n beam breaks] x x x x 309.857 353.2 x 425.615 183.6 443.6 146.545 259.7 333.143 695.667 143.875 327.231 379.0 607.462 222.5 529.818 x x x 281.375 x 365.3 343.818 580.769 x 400.375 356.25 324.692 394.235 x 145.0 x 441.833 223.615 645.625 x 757.786 592.467 462.333 339.0 x x 522.333 x 397.556 418.353 x x x 331.25 238.611 x x x 529.571 374.318 304.625 278.154 x 258.643 244.846 486.714 546.462 829.2 461.667 522.647 x 300.412 x 644.8 x 612.833 x x 384.471 x x 426.6 484.9 300.882 482.4 449.588 x 511.364 x x 341.786 x x x 602.375 356.4 554.333 483.938 558.636 x x x +11490 Original post publication description: Cocaine response (2 x 10 mg/kg ip), vertical activity (rears) from 15-30 min after second injection in an activity chamber for males [n beam breaks] None Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), vertical activity (rears) from 15-30 min after second injection in an activity chamber for males [n beam breaks] x x x x 414.571 225.7 x 436.923 256.8 527.2 229.364 317.2 412.571 696.4 219.125 396.462 415.294 600.385 238.0 574.364 x x x 252.25 x 383.4 467.182 515.462 x 460.125 418.583 408.923 351.765 x 180.333 x 459.917 261.308 668.75 x 656.643 628.533 434.095 335.556 x x 565.5 x 458.333 416.118 x x x 458.083 320.222 x x x 537.286 436.136 378.875 297.0 x 303.286 332.308 584.357 497.769 902.8 555.333 557.588 x 295.471 x 590.1 x 689.333 x x 431.882 x x 477.133 587.1 350.765 525.2 467.118 x 528.0 x x 355.929 x x x 616.125 380.8 432.917 524.875 639.364 x x x +11491 Original post publication description: Cocaine response (2 x 10 mg/kg ip), vertical activity (rears) from 30-45 min after second injection in an activity chamber for males [n beam breaks] None Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), vertical activity (rears) from 30-45 min after second injection in an activity chamber for males [n beam breaks] x x x x 400.214 193.5 x 375.615 320.6 470.4 225.273 284.3 319.786 559.2 234.75 334.308 342.647 434.846 302.0 527.545 x x x 301.125 x 318.2 422.273 473.0 x 397.625 387.167 385.077 305.706 x 147.333 x 455.167 280.538 710.5 x 548.429 639.4 354.381 323.889 x x 505.167 x 407.556 361.471 x x x 415.667 215.667 x x x 452.214 459.591 346.062 243.0 x 248.429 310.462 544.857 412.308 834.6 509.167 514.706 x 292.412 x 584.9 x 642.75 x x 349.176 x x 424.4 548.5 269.529 450.7 408.118 x 526.273 x x 318.429 x x x 543.75 355.4 355.25 564.125 579.909 x x x +11492 Original post publication description: Cocaine response (2 x 10 mg/kg ip), vertical activity (rears) from 45-60 min after second injection in an activity chamber for males [n beam breaks] None Cocaine response (2 x 10 mg/kg ip), vertical activity (rears) from 45-60 min after second injection in an activity chamber for males [n beam breaks] x x x x 362.143 161.3 x 286.385 306.8 483.6 221.818 269.8 315.857 470.2 192.875 338.538 316.353 247.385 241.0 485.909 x x x 265.125 x 260.7 332.636 360.538 x 364.375 362.583 375.0 203.941 x 91.6667 x 436.25 245.692 668.875 x 430.929 548.8 263.667 182.222 x x 484.167 x 417.0 314.882 x x x 374.417 151.833 x x x 352.571 413.864 250.062 189.462 x 234.571 257.154 511.357 351.846 753.6 479.778 405.824 x 259.941 x 470.9 x 570.333 x x 296.765 x x 371.933 493.9 211.529 410.0 326.647 x 457.909 x x 291.929 x x x 570.25 270.6 325.583 573.188 531.818 x x x +11493 Original post publication description: Conditioned place preference (CPP) baseline control for cocaine CPP test, time in drug-paired compartment for males [sec] None Conditioned place preference (CPP) baseline control for cocaine CPP test, time in drug-paired compartment for males [sec] x x x x 395.143 387.358 x 326.72 374.16 x 380.867 373.067 318.833 405.836 276.062 418.621 395.87 388.869 492.45 408.117 x x x 501.71 x 391.664 406.64 408.288 x 513.138 449.943 384.519 430.683 x 301.5 x 325.47 384.756 299.636 x 345.456 384.05 370.475 301.967 x x 442.615 x 325.0 367.527 x x x 348.05 350.05 x x x 397.718 421.571 394.868 319.48 x 399.156 317.669 364.017 389.038 385.506 420.468 351.117 x 368.327 x 444.079 x 427.557 x x 403.292 x x 448.495 335.05 382.818 414.95 463.346 x 444.567 x x 418.63 x x x 412.967 496.45 356.336 368.441 499.35 x x x +11494 Original post publication description: Conditioned place preference (CPP) baseline control for cocaine CPP test, time spent in saline-paired unconditioned side before conditioning for males [sec] None Central nervous system, behavior, learning and memory: Conditioned place preference (CPP) baseline control for cocaine CPP test, time spent in saline-paired unconditioned side before conditioning for males [sec] x x x x 428.614 569.35 x 557.67 425.32 x 570.058 538.467 376.583 452.668 504.875 404.464 496.68 426.175 394.4 470.167 x x x 385.5 x 459.407 448.96 476.1 x 379.575 454.529 505.169 451.358 x 461.725 x 450.36 442.306 502.268 x 569.844 458.369 460.969 406.939 x x 484.16 x 501.55 518.659 x x x 461.693 465.777 x x x 518.445 504.918 415.936 452.805 x 495.556 473.612 515.844 419.619 479.811 457.032 423.206 x 443.795 x 532.35 x 434.564 x x 440.413 x x 448.075 535.88 466.832 375.658 441.154 x 439.642 x x 436.245 x x x 490.108 459.95 501.414 519.359 419.264 x x x +11495 Original post publication description: Cocaine response (3 x 3.2 mg/kg ip, Days 2, 3, 4), conditioned place preference (CPP), time in drug-paired compartment on Day 5 for males [sec] None Cocaine response (3 x 3.2 mg/kg ip, Days 2, 3, 4), conditioned place preference (CPP), time in drug-paired compartment on Day 5 for males [sec] x x x x 407.929 513.45 x 562.68 478.83 x 363.025 573.983 349.872 547.941 465.025 467.536 456.58 453.294 647.7 448.808 x x x 529.0 x 416.783 514.39 388.337 x 639.25 251.807 373.25 541.432 x 223.613 x 427.99 395.65 433.495 x 452.017 537.606 456.153 548.761 x x 447.37 x 198.4 497.232 x x x 500.814 437.096 x x x 394.432 471.9 363.941 406.61 x 497.5 425.419 459.328 413.644 447.244 420.836 436.667 x 402.377 x 425.907 x 492.036 x x 449.246 x x 461.995 443.44 433.191 334.4 496.071 x 462.108 x x 490.21 x x x 490.242 427.4 423.064 452.641 470.7 x x x +11496 Original post publication description: Cocaine response (3 x 3.2 mg/kg ip, Days 2, 3, 4), conditioned place preference (CPP), time in unconditioned saline-paired compartment on Day 5 for males [sec] None Cocaine response (3 x 3.2 mg/kg ip, Days 2, 3, 4), conditioned place preference (CPP), time in unconditioned saline-paired compartment on Day 5 for males [sec] x x x x 378.736 454.03 x 393.65 438.9 x 499.317 334.833 521.667 383.845 372.712 280.764 448.883 382.312 206.75 417.117 x x x 396.41 x 420.942 382.24 423.388 x 329.25 503.121 412.95 359.205 x 597.2 x 442.035 477.825 344.336 x 381.667 372.394 421.831 286.839 x x 423.735 x 263.15 435.414 x x x 455.893 354.562 x x x 539.182 461.986 479.195 411.85 x 358.961 371.25 458.478 403.375 454.294 420.596 375.989 x 323.236 x 516.657 x 366.914 x x 434.871 x x 439.805 393.47 402.755 310.82 390.317 x 401.775 x x 435.115 x x x 410.942 614.65 498.8 464.555 439.5 x x x +11497 Original post publication description: Conditioned place preference (CPP) baseline control for cocaine CPP test, percentage of time spent in conditioned side before conditioning for males [%] None Central nervous system, behavior: Conditioned place preference (CPP) baseline control for cocaine CPP test, percentage of time spent in conditioned side before conditioning for males [%] x x x x 48.0201 40.6905 x 37.2979 45.9591 x 40.8245 40.9748 45.6397 47.5682 35.7702 51.1679 44.5186 47.0787 55.53 46.3339 x x x 56.444 x 45.8195 47.435 46.1859 x 57.0022 49.7091 43.1618 48.8683 x 39.0825 x 41.9992 46.861 37.3041 x 38.0661 45.961 44.3834 42.8554 x x 47.6412 x 40.3954 41.5969 x x x 43.2473 43.0294 x x x 43.4548 45.4694 47.462 41.3834 x 44.7692 40.3299 41.141 47.6404 44.6826 47.9584 45.2392 x 45.4835 x 45.4544 x 49.2207 x x 47.8909 x x 50.1474 37.5538 44.9649 52.0053 51.2096 x 50.0377 x x 48.5662 x x x 45.4994 51.9082 41.8 41.4163 54.0023 x x x +11498 Original post publication description: Cocaine response (3 x 3.2 mg/kg ip, Days 2, 3, and 4), conditioned place preference (CPP), change in time in cocaine-paired compartment relative to baseline (Day 5 minus Day 1) for males [sec] None Central nervous system, pharmacology, behavior: Cocaine response (3 x 3.2 mg/kg ip, Days 2, 3, and 4), conditioned place preference (CPP), change in time in cocaine-paired compartment relative to baseline (Day 5 minus Day 1) for males [sec] x x x x 12.7857 122.33 x 235.96 104.67 x -17.8417 200.917 31.0389 142.105 188.962 48.9143 60.71 64.425 155.25 40.6917 x x x 27.29 x 31.475 107.75 -19.95 x 126.113 -198.136 -11.2688 108.55 x -77.8875 x 102.52 10.8938 133.859 x 106.561 153.556 85.6781 246.794 x x 4.755 x -24.55 129.705 x x x 152.764 87.0462 x x x -3.28636 50.3286 -30.9273 87.13 x 98.3444 107.75 95.3111 24.6063 53.3312 0.367857 85.55 x 34.05 x -18.1714 x 64.4786 x x 45.9542 x x 13.5 108.39 50.3727 -91.24 32.725 x 17.5417 x x 71.58 x x x 77.275 -69.05 66.7286 84.2 -28.65 x x x +11499 Original post publication description: Cocaine response (3 x 3.2 mg/kg ip, Days 2, 3, and 4), conditioned place preference (CPP), change in percentage of time in cocaine-paired compartment relative to baseline (Day 5 minus Day 1) for males [% change] None Cocaine response (3 x 3.2 mg/kg ip, Days 2, 3, and 4), conditioned place preference (CPP), change in percentage of time in cocaine-paired compartment relative to baseline (Day 5 minus Day 1) for males [% change] x x x x 4.23632 12.0691 x 21.2289 6.19673 x 2.63913 22.5418 -4.92952 11.0764 19.823 10.7777 6.00674 7.65657 20.28 5.61447 x x x 0.560599 x 5.36613 9.81094 2.23497 x 8.82496 -15.2886 3.97439 11.2671 x -12.135 x 7.78289 -1.70634 18.0516 x 13.8899 13.0031 8.33092 22.0361 x x 3.64808 x 19.51 11.7157 x x x 9.16607 11.7 x x x -1.28769 4.9747 -2.17557 9.16594 x 13.3941 13.0059 8.98967 3.37691 4.0679 2.07174 8.28169 x 7.80626 x -0.086746 x 8.26846 x x 3.21906 x x 1.25471 15.1553 6.41567 0.701178 4.65644 x 3.59936 x x 4.22577 x x x 9.08239 -10.8929 3.87671 8.51196 -2.45831 x x x +11500 Original post publication description: Novel open field behavior, locomotion in the center from 0-60 min for males [n beam breaks] None Novel open field behavior, locomotion in the center from 0-60 min for males [n beam breaks] x x x x 1887.0 1919.82 x 3204.92 2566.2 3768.2 2139.73 3719.4 1247.29 2698.73 694.125 1734.15 2601.71 1187.08 1478.0 2228.73 x x x 1851.5 x 506.533 712.636 2932.23 x 1196.62 2689.92 2592.23 1358.0 x 394.333 x 2158.08 1022.23 3025.06 x 2064.07 1568.31 900.571 1488.22 x x 2465.92 x 2421.77 1581.59 x x x 2393.58 324.389 x x x 2531.0 1824.36 520.062 1171.77 x 2352.57 1480.62 1487.21 1776.31 3039.07 3134.2 2399.0 x 952.706 x 2430.58 x 2707.42 x x 2083.12 x x 1049.0 1394.0 579.176 2192.42 1945.59 x 2824.91 x x 2404.14 x x x 1309.12 2084.6 3491.25 3626.18 1453.91 x x x +11501 Original post publication description: Novel open field behavior, locomotion in the center from 0-60 min for males [cm] None Novel open field behavior, locomotion in the center from 0-60 min for males [cm] x x x x 6067.31 5577.63 x 8515.68 7339.61 10234.1 5983.62 9733.47 4158.64 7853.81 2393.62 5171.64 6994.83 4038.3 4297.36 6303.63 x x x 6262.12 x 1626.86 2660.96 7529.19 x 4035.47 7468.52 7912.39 4150.92 x 1337.15 x 6410.6 3273.29 8570.74 x 6068.23 4816.85 2647.3 4786.0 x x 7552.74 x 6576.38 5037.34 x x x 6860.24 1231.41 x x x 7147.63 5496.47 1983.27 3742.9 x 6778.17 4664.75 4832.93 5787.55 8411.19 9354.54 6909.45 x 2952.47 x 6885.36 x 7275.32 x x 6017.77 x x 3487.54 4380.35 1981.92 6289.71 5269.18 x 8414.48 x x 7184.04 x x x 4300.89 6194.98 9016.19 9654.83 4615.94 x x x +11502 Original post publication description: Novel open field behavior, vertical activity (rears) from 0-60 min in the center for males [n beam breaks] None Novel open field behavior, vertical activity (rears) from 0-60 min in the center for males [n beam breaks] x x x x 330.643 424.909 x 495.308 396.0 536.4 270.091 597.2 271.571 710.0 94.5 323.154 262.0 255.769 167.5 220.455 x x x 271.5 x 71.0667 137.182 266.615 x 173.0 369.083 632.538 224.765 x 60.6667 x 365.083 126.615 658.5 x 376.071 492.5 112.81 181.778 x x 626.167 x 384.846 240.824 x x x 216.25 36.7222 x x x 433.571 321.5 280.438 179.923 x 303.571 227.154 333.786 402.0 772.133 741.0 444.294 x 211.941 x 436.167 x 251.833 x x 502.824 x x 182.933 368.5 159.059 318.583 301.176 x 586.273 x x 334.286 x x x 666.125 277.4 329.833 532.294 465.455 x x x +11503 Original post publication description: Cocaine response (10 mg/kg ip), locomotion from 0-60 min after first cocaine injection in an activity chamber for males [n beam breaks] None Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), locomotion from 0-60 min after first cocaine injection in an activity chamber for males [n beam breaks] x x x x 7439.14 3302.7 x 2992.23 2762.0 9003.8 4318.91 6325.1 3903.64 7287.47 3100.0 3487.08 7111.71 5965.69 4315.0 7963.73 x x x 6791.25 x 4585.9 3552.0 6533.46 x 6734.25 4939.0 10747.2 4001.88 x 1629.56 x 6662.25 5190.46 14368.2 x 6877.5 9063.6 4269.76 4566.33 x x 6105.08 x 6245.11 4752.53 x x x 4434.83 2974.44 x x x 6856.5 4874.23 2560.06 5705.0 x 5740.5 2482.38 4578.14 6817.77 11575.7 8550.21 10835.9 x 4013.12 x 5443.64 x 10945.6 x x 4233.47 x x 4155.13 7908.1 2632.24 6476.25 6352.76 x 7906.91 x x 5937.43 x x x 6937.62 8512.6 6588.25 10400.6 6469.73 x x x +11504 Original post publication description: Cocaine response (10 mg/kg ip), locomotion in an open field from 0-60 min after first cocaine injection for males [cm] None Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), locomotion in an open field from 0-60 min after first cocaine injection for males [cm] x x x x 21432.3 10472.7 x 9298.57 9271.12 25309.7 12743.0 19247.1 12793.8 21697.0 9797.23 10877.2 20485.0 19892.8 12839.6 23372.3 x x x 20350.7 x 14107.9 11436.0 20027.0 x 20248.7 14452.6 30148.4 12560.4 x 5460.4 x 20568.5 15175.2 38282.2 x 20664.6 26433.6 13195.7 15218.9 x x 18591.8 x 19294.9 15648.9 x x x 14540.2 10084.9 x x x 20193.3 14915.9 8264.99 17284.3 x 17422.0 8386.6 14651.6 21258.1 33246.7 25154.3 30350.2 x 12662.0 x 17222.4 x 30223.4 x x 12937.0 x x 14002.6 23898.0 9026.15 19166.9 19078.0 x 23862.5 x x 18367.1 x x x 20888.2 24195.7 18417.6 30156.6 19969.8 x x x +11505 Original post publication description: Cocaine response (10 mg/kg ip), vertical activity (rears) in open field from 0-60 min after first cocaine injection for males [n beam breaks] None Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), vertical activity (rears) in open field from 0-60 min after first cocaine injection for males [n beam breaks] x x x x 1336.07 1087.2 x 997.769 910.0 1498.0 710.273 1326.1 1140.71 2045.0 673.75 1336.77 1041.47 1742.15 691.0 1605.55 x x x 1038.25 x 1011.8 827.455 1679.46 x 1333.5 1182.17 1461.23 1020.71 x 548.667 x 1551.25 732.154 2360.25 x 1913.43 2410.6 1238.38 1248.78 x x 1948.5 x 1790.11 1220.0 x x x 1089.25 719.222 x x x 1354.86 1429.73 1314.25 1031.31 x 1030.64 855.692 1704.86 1644.62 2946.93 1628.32 1947.82 x 1197.24 x 1736.55 x 2190.67 x x 1395.29 x x 1461.27 1905.3 886.294 1232.83 1482.18 x 2003.09 x x 1245.36 x x x 2095.12 1166.6 1261.08 2055.65 1887.09 x x x +11506 Original post publication description: Novel open field behavior, locomotion in the center from 0-15 min for males [n beam breaks] None Central nervous system, behavior: Novel open field behavior, locomotion in the center from 0-15 min for males [n beam breaks] x x x x 562.357 708.909 x 1131.92 473.8 1127.6 278.364 874.2 360.357 973.667 219.875 361.231 1035.12 271.846 471.0 681.273 x x x 478.625 x 233.2 131.545 802.538 x 392.625 805.417 601.0 548.647 x 275.444 x 636.667 279.308 853.625 x 912.357 430.5 418.857 385.889 x x 771.083 x 542.385 418.706 x x x 639.917 148.111 x x x 862.5 584.455 201.438 171.154 x 655.429 491.538 365.571 326.846 840.067 795.2 623.353 x 315.647 x 647.583 x 1017.92 x x 552.0 x x 319.2 441.8 195.529 763.917 515.235 x 826.182 x x 714.0 x x x 520.375 723.4 1041.58 894.235 368.455 x x x +11507 Original post publication description: Novel open field behavior, locomotion in the center from 15-30 min for males [n beam breaks] None Novel open field behavior, locomotion in the center from 15-30 min for males [n beam breaks] x x x x 505.214 523.273 x 1004.31 618.6 1069.8 660.909 1103.0 398.857 766.667 214.25 430.154 727.706 426.385 497.0 646.182 x x x 607.125 x 174.2 215.0 842.923 x 307.375 768.083 711.0 444.882 x 90.1111 x 581.833 304.538 752.25 x 550.571 381.938 278.857 488.333 x x 686.5 x 614.692 393.882 x x x 821.25 114.278 x x x 776.5 506.273 142.75 386.0 x 752.857 435.538 492.786 511.154 860.2 767.3 658.588 x 283.059 x 678.25 x 793.167 x x 606.824 x x 308.6 409.5 182.412 674.25 540.647 x 816.455 x x 733.0 x x x 330.125 697.0 1005.17 985.941 474.182 x x x +11508 Original post publication description: Novel open field behavior, locomotion in the center from 30-45 min for males [n beam breaks] None Novel open field behavior, locomotion in the center from 30-45 min for males [n beam breaks] x x x x 483.357 409.364 x 654.692 693.2 1005.0 607.818 898.5 305.643 530.8 164.375 480.769 522.941 266.538 391.0 522.364 x x x 442.25 x 81.4 257.0 710.846 x 278.625 674.5 708.462 260.941 x 15.8889 x 512.083 272.538 695.625 x 374.571 415.062 136.81 346.444 x x 552.25 x 641.923 413.647 x x x 568.75 48.0556 x x x 618.429 419.5 112.188 346.538 x 637.143 353.154 400.214 535.231 723.533 834.95 568.824 x 240.235 x 619.5 x 536.25 x x 476.882 x x 247.267 309.9 133.588 449.333 468.824 x 644.273 x x 622.714 x x x 237.125 341.6 821.583 910.0 367.545 x x x +11509 Original post publication description: Novel open field behavior, locomotion in the center from 45-60 min for males [n beam breaks] None Central nervous system, behavior: Novel open field behavior, locomotion in the center from 45-60 min for males [n beam breaks] x x x x 336.071 278.273 x 414.0 780.6 565.8 592.636 843.7 182.429 427.6 95.625 462.0 315.941 222.308 119.0 378.909 x x x 323.5 x 17.7333 109.091 575.923 x 218.0 441.917 571.769 103.529 x 12.8889 x 427.5 165.846 723.562 x 226.571 340.812 66.0476 267.556 x x 456.083 x 622.769 355.353 x x x 363.667 13.9444 x x x 273.571 314.136 63.6875 268.077 x 307.143 200.385 228.643 403.077 615.267 736.75 548.235 x 113.765 x 485.25 x 360.083 x x 447.412 x x 173.933 232.8 67.6471 304.917 420.882 x 538.0 x x 334.429 x x x 221.5 322.6 622.917 836.0 243.727 x x x +11510 Original post publication description: Novel open field behavior, locomotion in the center from 0-15 min for males [cm] None Central nervous system, behavior: Novel open field behavior, locomotion in the center from 0-15 min for males [cm] x x x x 1732.73 2000.23 x 2903.28 1387.73 3081.89 835.364 2291.14 1242.22 2714.79 714.343 1141.93 2702.82 943.662 1340.02 1903.38 x x x 1582.26 x 741.65 520.076 2042.27 x 1468.62 2196.6 1925.84 1621.14 x 908.036 x 1849.33 947.112 2428.55 x 2532.21 1305.97 1185.33 1268.49 x x 2259.37 x 1482.15 1330.08 x x x 1911.38 550.435 x x x 2415.77 1744.46 728.361 657.172 x 1921.03 1538.76 1306.71 1056.99 2262.9 2349.09 1865.45 x 994.189 x 1817.83 x 2647.61 x x 1566.61 x x 1094.67 1353.16 676.896 2237.77 1427.08 x 2451.77 x x 2110.88 x x x 1556.17 2140.38 2664.5 2422.25 1181.81 x x x +11511 Original post publication description: Novel open field behavior, locomotion in the center from 15-30 min for males [cm] None Novel open field behavior, locomotion in the center from 15-30 min for males [cm] x x x x 1622.3 1517.33 x 2621.68 1822.58 2904.87 1828.91 2862.95 1304.66 2188.38 739.551 1265.07 1966.39 1386.57 1452.35 1812.1 x x x 1930.57 x 554.914 832.95 2121.2 x 1028.34 2088.91 2138.95 1380.81 x 313.111 x 1725.57 965.402 2189.43 x 1675.28 1179.66 823.812 1523.48 x x 2103.88 x 1655.07 1239.66 x x x 2332.19 444.399 x x x 2233.59 1511.63 560.636 1239.58 x 2138.33 1402.45 1532.03 1664.43 2310.85 2294.33 1868.0 x 875.36 x 1906.32 x 2141.52 x x 1697.94 x x 1040.45 1280.18 612.636 1930.64 1453.81 x 2369.66 x x 2188.68 x x x 1119.78 1988.41 2563.73 2606.42 1444.72 x x x +11512 Original post publication description: Novel open field behavior, locomotion in the center from 30-45 min for males [cm] None Novel open field behavior, locomotion in the center from 30-45 min for males [cm] x x x x 1587.9 1216.12 x 1801.2 1997.94 2718.95 1661.8 2338.38 1006.75 1629.49 603.443 1396.88 1423.82 937.408 1193.92 1456.68 x x x 1538.33 x 264.061 893.175 1818.42 x 862.594 1919.21 2135.11 825.151 x 58.6671 x 1529.19 833.668 1968.49 x 1136.01 1276.71 429.993 1130.71 x x 1707.86 x 1747.24 1322.83 x x x 1598.64 182.425 x x x 1708.1 1286.35 416.877 1020.47 x 1824.79 1095.81 1249.99 1727.36 2081.71 2469.13 1622.24 x 728.971 x 1778.9 x 1446.27 x x 1398.8 x x 785.872 969.276 440.901 1268.56 1273.92 x 1974.57 x x 1875.04 x x x 840.877 1071.91 2139.72 2404.84 1178.78 x x x +11513 Original post publication description: Novel open field behavior, locomotion in the center from 45-60 min for males [cm] None Central nervous system, behavior: Novel open field behavior, locomotion in the center from 45-60 min for males [cm] x x x x 1124.38 843.955 x 1189.53 2131.37 1528.39 1657.55 2241.0 605.006 1321.15 336.285 1367.77 901.806 770.662 311.062 1131.47 x x x 1210.97 x 66.2312 414.758 1547.3 x 675.929 1263.8 1712.49 323.814 x 57.3372 x 1306.51 527.106 1984.27 x 724.731 1054.5 208.164 863.317 x x 1481.63 x 1691.92 1144.77 x x x 1018.03 54.1519 x x x 790.171 954.031 277.392 825.677 x 894.02 627.734 744.206 1338.77 1755.73 2241.99 1553.76 x 353.945 x 1382.31 x 1039.92 x x 1354.42 x x 566.549 777.732 251.489 852.739 1114.37 x 1618.49 x x 1009.44 x x x 784.061 994.281 1648.24 2221.32 810.641 x x x +11514 Original post publication description: Novel open field behavior, vertical activity (rears) from 0-15 min in the center for males [n beam breaks] None Novel open field behavior, vertical activity (rears) from 0-15 min in the center for males [n beam breaks] x x x x 66.7857 134.182 x 127.231 45.6 130.4 28.0 91.4 52.7143 188.267 18.0 36.7692 78.1176 45.6154 45.0 53.0 x x x 51.5 x 28.8667 23.4545 39.6923 x 54.25 77.0833 140.308 83.4706 x 39.4444 x 58.9167 32.0 136.125 x 108.357 101.125 40.381 28.3333 x x 147.917 x 57.4615 62.6471 x x x 55.5833 12.4444 x x x 140.071 91.0909 67.6875 23.3846 x 84.3571 74.0 73.0714 54.0 133.933 121.65 93.2353 x 49.5294 x 71.25 x 67.6667 x x 74.5294 x x 44.9333 60.6 36.4706 120.0 59.4706 x 118.273 x x 77.2857 x x x 151.125 78.2 100.167 136.353 85.3636 x x x +11515 Original post publication description: Novel open field behavior, vertical activity (rears) from 15-30 min in the center for males [n beam breaks] None Novel open field behavior, vertical activity (rears) from 15-30 min in the center for males [n beam breaks] x x x x 97.0714 127.364 x 159.462 100.2 156.0 87.5455 183.9 82.3571 211.333 34.25 89.0 80.1765 76.4615 60.0 64.5455 x x x 83.75 x 25.6 33.5455 73.4615 x 59.625 100.667 184.0 81.5882 x 14.4444 x 98.3333 40.6154 173.125 x 115.214 122.5 41.5238 73.7778 x x 181.417 x 100.769 68.7059 x x x 74.5 14.9444 x x x 145.286 99.1818 80.625 59.4615 x 97.6429 65.0769 94.7143 114.538 220.933 178.2 115.824 x 63.5882 x 116.833 x 72.9167 x x 132.765 x x 58.8 109.8 50.5294 96.4167 83.9412 x 164.182 x x 95.0 x x x 197.75 65.6 87.3333 136.176 141.273 x x x +11516 Original post publication description: Novel open field behavior, vertical activity (rears) from 30-45 min in the center for males [n beam breaks] None Novel open field behavior, vertical activity (rears) from 30-45 min in the center for males [n beam breaks] x x x x 96.7857 95.1818 x 116.308 113.2 164.0 76.9091 163.0 69.5714 163.867 23.0 91.4615 56.6471 78.8462 58.0 58.2727 x x x 74.375 x 13.7333 54.1818 75.9231 x 38.25 104.083 166.923 43.1765 x 1.33333 x 88.5833 33.0 168.375 x 83.4286 149.625 22.4762 46.8889 x x 159.25 x 108.385 58.0588 x x x 55.25 7.72222 x x x 98.2857 79.0 82.375 50.0 x 83.7143 57.0 98.2143 118.538 232.733 223.65 117.0 x 62.7647 x 138.833 x 56.0 x x 141.529 x x 42.8667 104.8 45.6471 61.0 80.3529 x 157.909 x x 104.286 x x x 183.375 68.6 81.5 141.765 129.909 x x x +11517 Original post publication description: Novel open field behavior, vertical activity (rears) from 45-60 min in the center for males [n beam breaks] None Central nervous system, behavior: Novel open field behavior, vertical activity (rears) from 45-60 min in the center for males [n beam breaks] x x x x 70.0 68.1818 x 92.3077 137.0 86.0 77.6364 158.9 41.9286 146.533 19.25 105.923 47.0588 54.8462 4.5 44.6364 x x x 61.875 x 2.86667 26.0 77.5385 x 20.875 87.25 141.308 16.5294 x 5.44444 x 119.25 21.0 180.875 x 69.0714 119.25 8.42857 32.7778 x x 137.583 x 118.231 51.4118 x x x 30.9167 1.61111 x x x 49.9286 52.2273 49.75 47.0769 x 37.8571 31.0769 67.7857 114.923 184.533 217.5 118.235 x 36.0588 x 109.25 x 55.25 x x 154.0 x x 36.3333 93.3 26.4118 41.1667 77.4118 x 145.909 x x 57.7143 x x x 133.875 65.0 60.8333 118.0 108.909 x x x +11518 Original post publication description: Novel open field behavior, locomotion in the periphery from 0-15 min for males in the cocaine test battery [n beam breaks] None Central nervous system, pharmacology, behavior: Novel open field behavior, locomotion in the periphery from 0-15 min for males in the cocaine test battery [n beam breaks] x x x x 482.643 398.0 x 1118.38 622.6 698.8 360.455 848.0 462.571 528.4 328.0 464.0 825.941 561.0 617.0 575.545 x x x 297.5 x 434.133 329.636 1405.92 x 426.5 677.333 460.538 414.235 x 382.0 x 510.25 398.538 765.688 x 765.071 362.312 688.524 639.556 x x 436.667 x 630.923 455.529 x x x 783.333 291.556 x x x 938.714 603.545 331.625 345.154 x 495.286 414.615 377.5 512.077 748.0 471.1 536.647 x 445.882 x 526.25 x 679.0 x x 559.353 x x 309.8 593.1 433.529 626.5 535.588 x 543.455 x x 482.0 x x x 285.75 552.6 846.833 830.647 258.182 x x x +11519 Original post publication description: Novel open field behavior, locomotion in the periphery from 15-30 min for males in the cocaine test battery [n beam breaks] None Central nervous system, behavior: Novel open field behavior, locomotion in the periphery from 15-30 min for males in the cocaine test battery [n beam breaks] x x x x 342.143 266.636 x 637.846 397.8 699.6 328.273 690.1 316.071 324.067 332.5 317.538 494.706 537.923 365.5 444.636 x x x 214.75 x 281.333 353.273 1089.62 x 380.375 471.083 426.615 271.647 x 170.0 x 381.167 292.308 537.312 x 511.857 308.375 391.714 551.889 x x 295.167 x 585.0 385.824 x x x 698.333 138.389 x x x 540.143 432.182 217.875 336.615 x 390.714 309.385 381.286 460.769 627.333 403.65 516.824 x 296.882 x 345.5 x 547.75 x x 377.765 x x 216.6 385.4 309.941 554.5 403.235 x 547.455 x x 388.5 x x x 214.75 380.8 646.75 808.294 199.182 x x x +11520 Original post publication description: Novel open field behavior, locomotion in the periphery from 30-45 min for males in the cocaine test battery [n beam breaks] None Novel open field behavior, locomotion in the periphery from 30-45 min for males in the cocaine test battery [n beam breaks] x x x x 282.929 231.273 x 460.462 362.6 613.0 316.364 614.0 235.0 231.267 240.875 321.462 361.765 421.077 203.5 402.909 x x x 186.75 x 144.2 258.455 847.846 x 204.625 386.75 363.769 197.0 x 50.0 x 297.083 245.385 493.188 x 343.929 278.125 221.619 424.0 x x 271.0 x 650.538 350.235 x x x 483.917 40.3889 x x x 483.429 357.5 144.812 219.615 x 376.143 264.154 304.0 437.231 505.533 383.95 438.824 x 202.353 x 266.417 x 368.083 x x 305.235 x x 176.467 321.6 220.0 426.083 304.471 x 387.182 x x 310.714 x x x 167.625 170.2 519.917 697.765 155.273 x x x +11521 Original post publication description: Novel open field behavior, locomotion in the periphery from 45-60 min for males in the cocaine test battery [n beam breaks] None Novel open field behavior, locomotion in the periphery from 45-60 min for males in the cocaine test battery [n beam breaks] x x x x 210.357 178.364 x 277.846 292.4 382.8 292.364 538.2 156.357 203.0 99.375 239.769 247.529 300.538 114.5 323.364 x x x 169.375 x 44.9333 141.182 619.385 x 138.875 288.417 294.154 100.118 x 10.6667 x 255.167 143.077 456.062 x 199.571 256.5 111.238 341.0 x x 220.583 x 584.308 295.706 x x x 307.167 17.2222 x x x 265.143 264.727 70.9375 151.462 x 220.214 165.0 175.429 322.077 413.667 350.65 363.176 x 90.1176 x 224.917 x 266.917 x x 242.765 x x 130.4 184.7 95.3529 307.75 262.118 x 342.636 x x 172.929 x x x 117.375 206.8 332.417 622.353 126.182 x x x +11522 Original post publication description: Novel open field behavior, locomotion from 0-15 min in the periphery for males in the cocaine test battery [cm] None Central nervous system, pharmacology, behavior: Novel open field behavior, locomotion from 0-15 min in the periphery for males in the cocaine test battery [cm] x x x x 1881.73 1675.07 x 3727.68 2389.72 2576.67 1483.43 3030.68 1893.43 2021.88 1441.02 1820.83 2962.63 2243.89 2295.9 2186.84 x x x 1488.4 x 1754.99 1620.78 4674.17 x 1893.82 2505.81 1990.21 1730.26 x 1651.24 x 2080.6 1820.83 2882.71 x 2747.84 1616.67 2676.59 2522.4 x x 1884.31 x 2465.99 1837.84 x x x 2902.77 1388.64 x x x 3394.05 2401.29 1450.42 1600.18 x 2046.9 1744.32 1626.18 2059.02 2789.76 1965.03 2182.66 x 1873.5 x 2152.44 x 2436.38 x x 2154.91 x x 1460.67 2485.38 1897.78 2495.46 2151.17 x 2180.96 x x 1997.6 x x x 1296.62 2255.49 2960.29 3095.35 1341.76 x x x +11523 Original post publication description: Novel open field behavior, locomotion from 15-30 min in the periphery for males in the cocaine test battery [cm] None Novel open field behavior, locomotion from 15-30 min in the periphery for males in the cocaine test battery [cm] x x x x 1431.2 1129.64 x 2273.53 1637.7 2548.46 1419.57 2476.25 1419.09 1346.67 1378.7 1306.03 1916.53 2171.01 1526.27 1787.41 x x x 1158.99 x 1112.39 1499.54 3705.13 x 1537.61 1815.89 1768.23 1188.73 x 771.356 x 1615.89 1260.91 2197.77 x 1959.09 1425.56 1542.52 2151.8 x x 1356.51 x 2279.76 1586.59 x x x 2560.01 674.225 x x x 2031.73 1786.42 982.717 1351.31 x 1630.74 1391.66 1576.14 1847.98 2436.48 1749.15 1935.34 x 1317.23 x 1484.31 x 1913.77 x x 1531.23 x x 1095.7 1813.71 1395.51 2154.82 1620.72 x 2147.06 x x 1613.46 x x x 998.131 1653.93 2303.15 2971.52 1082.54 x x x +11524 Original post publication description: Novel open field behavior, locomotion from 30-45 min in the periphery for males in the cocaine test battery [cm] None Novel open field behavior, locomotion from 30-45 min in the periphery for males in the cocaine test battery [cm] x x x x 1245.29 1014.41 x 1672.45 1586.23 2261.0 1293.63 2232.18 1079.51 1025.07 1066.14 1297.37 1452.46 1719.99 821.121 1642.78 x x x 1052.81 x 549.112 1198.42 3008.45 x 822.041 1499.3 1565.52 881.711 x 218.73 x 1327.98 1045.82 2035.65 x 1323.8 1342.43 895.472 1726.88 x x 1262.27 x 2526.63 1509.0 x x x 1786.35 211.166 x x x 1785.18 1480.34 686.841 858.359 x 1505.59 1169.3 1283.4 1748.97 2005.23 1707.23 1606.1 x 876.902 x 1189.56 x 1413.42 x x 1271.51 x x 880.816 1515.11 987.45 1561.01 1212.94 x 1680.45 x x 1264.08 x x x 838.159 780.886 1862.83 2627.65 853.45 x x x +11525 Original post publication description: Novel open field behavior, locomotion from 45-60 min in the periphery for males in the cocaine test battery [cm] None Novel open field behavior, locomotion from 45-60 min in the periphery for males in the cocaine test battery [cm] x x x x 958.664 787.706 x 1088.49 1252.15 1487.81 1227.48 1996.42 716.636 878.287 441.643 982.0 1012.71 1243.69 379.745 1297.23 x x x 886.147 x 175.224 649.405 2301.13 x 527.445 1152.57 1264.92 437.205 x 56.4759 x 1173.43 615.311 1886.56 x 759.251 1226.81 447.755 1407.61 x x 1008.43 x 2262.67 1277.39 x x x 1132.75 82.4967 x x x 977.655 1083.04 365.019 582.37 x 888.122 694.568 755.789 1298.93 1690.59 1562.17 1370.4 x 444.697 x 1025.6 x 1036.46 x x 1019.32 x x 654.736 923.195 441.126 1190.47 1011.05 x 1463.45 x x 707.224 x x x 659.944 866.017 1255.28 2378.41 701.525 x x x +11526 Original post publication description: Novel open field behavior, vertical activity (rears) in the periphery from 0-15 min for males [n beam breaks] None Central nervous system, behavior: Novel open field behavior, vertical activity (rears) in the periphery from 0-15 min for males [n beam breaks] x x x x 155.071 213.455 x 263.308 235.4 242.0 120.909 285.0 152.714 228.267 142.625 164.615 207.471 222.077 249.5 211.182 x x x 109.75 x 176.533 118.455 238.308 x 196.375 226.583 238.0 204.941 x 184.444 x 242.167 163.308 267.188 x 264.643 273.688 247.714 178.556 x x 257.417 x 283.538 224.059 x x x 242.417 123.667 x x x 307.286 276.455 219.25 118.231 x 203.429 211.615 184.214 262.538 332.6 244.15 218.765 x 278.706 x 243.333 x 184.417 x x 246.882 x x 185.4 298.9 236.118 276.083 257.471 x 254.273 x x 171.5 x x x 267.0 177.6 232.25 339.529 190.636 x x x +11527 Original post publication description: Novel open field behavior, vertical activity (rears) in the periphery from 15-30 min for males [n beam breaks] None Novel open field behavior, vertical activity (rears) in the periphery from 15-30 min for males [n beam breaks] x x x x 177.714 185.182 x 258.231 225.8 260.6 135.909 352.9 213.5 212.6 156.875 174.385 189.706 263.692 213.5 219.727 x x x 115.125 x 168.067 139.0 323.077 x 208.375 223.0 256.462 169.647 x 122.444 x 265.333 185.923 318.75 x 259.571 297.188 194.048 209.889 x x 243.583 x 331.615 214.882 x x x 246.5 90.1667 x x x 211.214 293.5 234.0 139.231 x 191.071 215.077 230.714 258.231 382.867 264.45 241.235 x 282.882 x 258.167 x 278.333 x x 281.353 x x 210.667 286.3 269.353 277.167 239.765 x 291.364 x x 168.357 x x x 261.375 158.8 249.417 366.765 219.636 x x x +11528 Original post publication description: Novel open field behavior, vertical activity (rears) in the periphery from 30-45 min for males [n beam breaks] None Central nervous system, behavior: Novel open field behavior, vertical activity (rears) in the periphery from 30-45 min for males [n beam breaks] x x x x 174.5 169.455 x 255.846 264.2 279.6 130.545 322.6 194.786 185.2 207.875 217.0 190.059 235.308 226.0 218.273 x x x 110.625 x 81.6667 143.0 326.769 x 192.625 211.667 243.846 143.824 x 52.4444 x 250.5 172.077 347.25 x 208.786 316.0 130.714 185.778 x x 236.5 x 356.0 199.941 x x x 215.333 37.5556 x x x 188.929 280.273 187.625 103.385 x 160.643 194.615 234.0 226.385 328.533 262.95 237.294 x 226.176 x 261.583 x 322.0 x x 289.647 x x 169.0 307.5 214.118 219.833 189.588 x 289.364 x x 157.0 x x x 235.5 135.2 234.917 331.412 216.182 x x x +11529 Original post publication description: Novel open field behavior, vertical activity (rears) in the periphery from 45-60 min for males [n beam breaks] None Central nervous system, behavior: Novel open field behavior, vertical activity (rears) in the periphery from 45-60 min for males [n beam breaks] x x x x 171.143 148.0 x 228.846 202.8 267.8 134.091 319.3 153.071 183.2 121.0 187.923 140.706 180.615 96.5 166.182 x x x 84.25 x 36.1333 108.091 284.231 x 141.25 194.75 238.308 82.5294 x 17.2222 x 217.75 161.846 338.438 x 159.929 308.5 71.8571 153.444 x x 229.5 x 349.0 175.706 x x x 161.333 14.3889 x x x 136.429 278.364 140.75 85.9231 x 157.714 119.615 203.929 207.154 277.8 259.0 216.588 x 182.706 x 249.667 x 277.083 x x 274.059 x x 159.533 212.2 107.471 204.5 179.882 x 256.727 x x 132.429 x x x 260.625 123.0 224.25 287.235 162.182 x x x +11530 Original post publication description: Novel open field behavior, percentage of locomotion in the periphery for males [%] None Central nervous system, behavior: Novel open field behavior, percentage of locomotion in the periphery for males [%] x x x x 49.1384 45.8614 x 51.2534 49.3777 46.9238 49.1581 51.118 56.2152 40.5034 74.5913 52.7356 52.7583 65.8704 56.0976 53.0332 x x x 42.9603 x 73.6323 66.663 64.8537 x 62.9237 48.9316 45.6892 51.5184 x 69.1825 x 50.6749 59.6384 52.0169 x 52.9091 54.1653 69.4147 63.7567 x x 42.9271 x 60.8577 55.9267 x x x 56.0033 71.0932 x x x 54.1916 55.8427 65.2336 61.4206 x 51.1564 54.4535 56.0035 57.5834 51.8573 43.8237 55.8662 x 63.3591 x 48.0646 x 49.886 x x 51.6778 x x 55.2163 62.0839 73.0474 55.2489 57.7165 x 46.5019 x x 46.5025 x x x 46.6379 49.8812 51.3999 53.5997 47.0433 x x x +11531 Original post publication description: Novel open field behavior, locomotion in the periphery from 0-60 min for males [n beam breaks] None Novel open field behavior, locomotion in the periphery from 0-60 min for males [n beam breaks] x x x x 1318.07 1074.27 x 2494.54 1675.4 2394.2 1297.45 2690.3 1170.0 1286.73 1000.75 1342.77 1929.94 1820.54 1300.5 1746.45 x x x 868.375 x 904.6 1082.55 3962.77 x 1150.38 1823.58 1545.08 983.0 x 612.667 x 1443.67 1079.31 2252.25 x 1820.43 1205.31 1413.1 1956.44 x x 1223.42 x 2450.77 1487.29 x x x 2272.75 487.556 x x x 2227.43 1657.95 765.25 1052.85 x 1482.36 1153.15 1238.21 1732.15 2294.53 1609.35 1855.47 x 1035.24 x 1363.08 x 1861.75 x x 1485.12 x x 833.267 1484.8 1058.82 1914.83 1505.41 x 1820.73 x x 1354.14 x x x 785.5 1310.4 2345.92 2959.06 738.818 x x x +11532 Original post publication description: Novel open field behavior, locomotion in the periphery from 0-60 min for males [cm] None Novel open field behavior, locomotion in the periphery from 0-60 min for males [cm] x x x x 5516.89 4606.83 x 8762.15 6865.8 8873.95 5424.11 9735.53 5108.67 5271.91 4327.49 5406.23 7344.33 7378.58 5023.04 6914.25 x x x 4586.35 x 3591.72 4968.15 13688.9 x 4780.92 6973.58 6588.88 4237.9 x 2697.8 x 6197.9 4742.88 9002.68 x 6789.98 5611.47 5562.34 7808.68 x x 5511.53 x 9535.05 6210.83 x x x 8381.88 2356.53 x x x 8188.61 6751.1 3485.0 4392.22 x 6071.35 4999.85 5241.51 6954.89 8922.06 6983.59 7094.5 x 4512.33 x 5851.91 x 6800.03 x x 5976.97 x x 4091.92 6737.4 4721.86 7401.77 5995.88 x 7471.93 x x 5582.37 x x x 3792.86 5556.32 8381.55 11072.9 3979.28 x x x +11533 Original post publication description: Novel open field behavior, vertical activity (rears) in the periphery from 0-60 min for males [n beam breaks] None Central nervous system, behavior: Novel open field behavior, vertical activity (rears) in the periphery from 0-60 min for males [n beam breaks] x x x x 678.429 716.091 x 1006.23 928.2 1050.0 521.455 1279.8 666.929 809.267 628.375 743.923 727.941 901.692 785.5 815.364 x x x 419.75 x 462.4 508.545 1172.38 x 738.625 856.0 976.615 600.941 x 376.556 x 975.75 683.154 1271.62 x 892.929 1195.38 644.333 727.667 x x 967.0 x 1320.15 814.588 x x x 865.583 265.778 x x x 843.857 1128.59 781.625 446.769 x 712.857 740.923 852.857 954.308 1321.8 1030.55 913.882 x 970.471 x 1012.75 x 1061.83 x x 1091.94 x x 724.6 1104.9 827.059 977.583 866.706 x 1091.73 x x 629.286 x x x 1024.5 594.6 940.833 1324.94 788.636 x x x +11534 Original post publication description: Saline control response (10 ml/kg ip), locomotion in an open field from 0-60 min after injection for males [n beam breaks] None Saline control response (10 ml/kg ip), locomotion in an open field from 0-60 min after injection for males [n beam breaks] x x x x 1484.43 1063.64 x 2589.0 2057.6 4393.6 2793.64 3067.8 1803.57 2407.53 1205.0 2220.38 2061.0 1728.31 1148.5 2978.82 x x x 2150.62 x 620.571 889.455 4668.85 x 2120.38 2570.58 3363.62 1583.76 x 344.778 x 2680.75 1934.85 4243.44 x 2495.43 2235.94 1240.9 1528.56 x x 2341.33 x 2414.0 2178.88 x x x 3162.08 728.333 x x x 4327.36 2134.36 740.25 1187.46 x 2110.57 855.615 2021.86 2650.31 4863.53 2915.3 3119.24 x 611.059 x 1749.25 x 2989.67 x x 2775.24 x x 1560.33 2099.1 917.176 3050.92 1659.53 x 4230.64 x x 2254.5 x x x 1865.62 1400.6 2776.08 3736.29 1608.55 x x x +11535 Original post publication description: Saline control response (10 ml/kg ip), locomotion in an open field from 0-60 min after injection for males [cm] None Saline control response (10 ml/kg ip), locomotion in an open field from 0-60 min after injection for males [cm] x x x x 5710.92 3822.87 x 8206.88 7602.84 13827.0 9015.84 10501.4 6841.0 8245.4 4515.61 7450.6 6986.87 6491.06 3953.66 10063.7 x x x 8283.64 x 2476.17 3588.25 15397.9 x 7234.47 8331.64 11763.1 5642.41 x 1306.99 x 9845.61 6617.08 14179.3 x 8236.67 8266.23 4385.73 5805.77 x x 8332.14 x 8307.88 8427.33 x x x 10442.2 2884.64 x x x 13587.7 7390.72 2938.13 4137.07 x 7157.33 3210.99 7430.97 9456.49 15887.0 10304.0 10255.2 x 2405.85 x 6197.68 x 10033.3 x x 9207.92 x x 6094.86 8276.5 3790.79 10233.8 5784.3 x 14290.4 x x 8004.53 x x x 7098.29 5317.69 8361.1 11965.8 6008.98 x x x +11536 Original post publication description: Saline control response (10 ml/kg), open field behavior, vertical activity (rears) 0-60 min after injection for males [n beam breaks/60 min] None Saline control response (10 ml/kg), open field behavior, vertical activity (rears) 0-60 min after injection for males [n beam breaks/60 min] x x x x 710.714 460.273 x 1095.38 959.8 1257.8 701.182 1196.8 859.643 1187.27 478.875 1178.46 706.706 838.769 390.5 942.818 x x x 602.625 x 285.643 472.909 1382.31 x 842.75 834.583 1236.08 662.529 x 157.556 x 1380.75 685.308 1634.94 x 1013.21 1309.5 519.238 625.778 x x 1406.08 x 1046.5 938.353 x x x 882.417 265.667 x x x 1101.29 1369.0 856.562 316.077 x 659.929 498.154 1199.93 1193.08 2005.47 1106.15 1181.94 x 535.706 x 901.417 x 1318.92 x x 1394.06 x x 915.333 1223.8 686.824 1063.0 760.118 x 1675.09 x x 665.857 x x x 1595.12 535.0 767.0 1090.71 836.909 x x x +11537 Original post publication description: Cocaine response (2 x 10 mg/kg, ip), sensitization, locomotion after the second injection minus locomotion after the first injection for males [difference in cm/1 hr test, positive values indicate sensitization] None Cocaine response (2 x 10 mg/kg, ip), sensitization, locomotion after the second injection minus locomotion after the first injection for males [difference in cm/1 hr test, positive values indicate sensitization] x x x x 11526.9 -29.3762 x 5973.82 5219.75 14185.0 1684.13 3512.42 6237.2 6632.06 3711.58 4957.3 8091.25 4397.21 7495.78 8155.8 x x x 1005.61 x 5693.29 10453.8 3318.69 x 5223.58 4373.0 10423.1 3070.14 x -400.361 x 4949.31 3933.95 8704.88 x 9608.91 777.753 5563.7 1016.21 x x 3331.23 x 74.0201 5649.64 x x x 8083.48 4463.45 x x x 8643.12 3361.27 -76.1015 3141.93 x 3188.43 5098.23 3127.81 3169.8 5123.27 6573.86 3463.7 x 2924.21 x 2918.64 x 5045.43 x x 4008.25 x x 5688.01 8311.99 4053.82 12698.9 3151.97 x 2604.15 x x 2302.95 x x x 1148.16 7079.87 7937.6 3253.31 1643.06 x x x +11538 Original post publication description: Cocaine response (2 x 10 mg/kg, ip), locomotion from 0-60 min after the second injection in sensitization test for males [n beam breaks, positive values indicate sensitization] None Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg, ip), locomotion from 0-60 min after the second injection in sensitization test for males [n beam breaks, positive values indicate sensitization] x x x x 12633.7 3415.3 x 5157.15 4676.8 15243.2 4836.91 8103.5 6230.71 10011.0 4545.38 5382.77 10670.7 7867.46 7189.0 11217.4 x x x 7267.75 x 6508.27 7168.82 7919.23 x 9132.88 6544.92 15496.6 5180.88 x 1579.67 x 8506.42 6567.38 18519.4 x 10675.6 9442.53 6346.05 5027.33 x x 7291.0 x 6324.11 6845.65 x x x 7151.08 4499.22 x x x 10337.8 6169.77 2710.31 7029.92 x 7048.93 4499.46 5632.71 8017.15 13601.9 11879.4 12490.2 x 5237.29 x 6935.5 x 12987.8 x x 5918.35 x x 6375.67 11610.4 3979.82 11950.0 7731.59 x 9124.55 x x 6910.43 x x x 7497.0 11464.4 9514.5 11477.3 7032.27 x x x +11539 Original post publication description: Cocaine response (2 x 10 mg/kg, ip), locomotion from 0-60 min after the second injection in sensitization test for males [cm, positive values indicate sensitization] None Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg, ip), locomotion from 0-60 min after the second injection in sensitization test for males [cm, positive values indicate sensitization] x x x x 32959.2 10443.3 x 15272.4 14490.9 39494.7 14427.1 22759.4 19031.0 28329.1 13508.8 15834.5 28576.3 24290.1 20335.3 31528.1 x x x 21356.3 x 18518.6 21889.8 23345.8 x 25472.3 18825.6 40571.5 15630.6 x 5059.96 x 25517.8 19109.2 46987.1 x 30273.5 27211.3 18759.4 16235.1 x x 21923.0 x 19368.9 21298.5 x x x 22623.7 14548.4 x x x 28836.4 18277.1 8188.92 20426.3 x 20610.5 13484.8 17779.4 24428.0 38370.0 33060.1 33813.9 x 15586.1 x 21842.6 x 35268.8 x x 16945.2 x x 19690.6 32210.0 13080.0 32961.4 22230.0 x 26466.6 x x 20670.0 x x x 22036.3 31275.5 26355.3 32287.4 21612.9 x x x +11540 Original post publication description: Cocaine response (2 x 10 mg/kg ip), sensitization, change in vertical activity (rears) for males between first and second injections [difference in n/1 hr test, positive values indicate sensitization] None Cocaine response (2 x 10 mg/kg ip), sensitization, change in vertical activity (rears) for males between first and second injections [difference in n/1 hr test, positive values indicate sensitization] x x x x 1486.79 933.7 x 1524.54 1067.8 1924.8 823.0 1131.0 1381.36 2421.47 790.625 1396.54 1453.29 1890.08 1003.5 2117.64 x x x 1099.88 x 1206.91 1565.91 1929.77 x 1622.5 1524.58 1493.69 1255.65 x 564.333 x 1793.17 1011.15 2693.75 x 2393.79 2409.2 1514.48 1180.67 x x 2077.17 x 1680.44 1510.82 x x x 1579.42 926.333 x x x 1871.64 1683.91 1279.62 1007.62 x 1044.93 1144.77 2127.29 1808.38 3320.2 2005.94 2000.76 x 1148.24 x 2290.7 x 2515.25 x x 1462.29 x x 1700.07 2114.4 1132.71 1868.3 1651.47 x 2023.55 x x 1308.07 x x x 2332.5 1363.2 1668.08 2146.12 2309.73 x x x +11541 Original post publication description: Saline control response (10 ml/kg ip), locomotion in an open field from 0-15 min after injection for males [n beam breaks/15 min] None Saline control response (10 ml/kg ip), locomotion in an open field from 0-15 min after injection for males [n beam breaks/15 min] x x x x 581.857 453.909 x 661.923 582.4 1272.0 492.818 798.5 612.929 895.467 331.625 433.923 896.176 511.462 462.0 779.273 x x x 732.625 x 249.929 298.455 1509.0 x 516.875 603.0 815.538 575.647 x 261.556 x 664.833 515.231 1051.75 x 975.929 557.75 718.381 597.889 x x 596.5 x 504.0 453.412 x x x 955.0 388.778 x x x 1356.57 641.091 243.688 395.077 x 754.143 389.538 527.357 660.923 1362.0 815.4 954.706 x 322.118 x 721.333 x 1073.08 x x 758.0 x x 537.867 752.4 302.588 1061.83 521.294 x 1219.64 x x 692.357 x x x 649.875 589.0 1089.25 875.647 416.182 x x x +11542 Original post publication description: Saline control response (10 ml/kg ip), locomotion in an open field from 15-30 min after injection for males [n beam breaks/15 min] None Saline control response (10 ml/kg ip), locomotion in an open field from 15-30 min after injection for males [n beam breaks/15 min] x x x x 439.643 202.0 x 613.077 422.0 1238.6 678.909 695.7 489.571 567.267 416.0 454.769 535.353 474.0 403.5 699.0 x x x 614.5 x 166.429 266.636 1180.69 x 592.125 608.167 738.154 444.176 x 59.8889 x 619.083 547.231 1050.75 x 615.857 548.125 291.524 483.667 x x 565.417 x 632.8 544.824 x x x 1067.83 186.278 x x x 1143.64 617.136 174.812 294.538 x 692.571 243.385 569.5 742.615 1272.67 681.15 787.765 x 187.882 x 402.167 x 790.833 x x 730.647 x x 435.267 502.7 253.0 763.583 494.412 x 1168.73 x x 762.214 x x x 409.75 236.6 693.5 949.588 435.818 x x x +11543 Original post publication description: Saline control response (10 ml/kg ip), locomotion in an open field from 30-45 min after injection for males [n beam breaks/15 min] None Saline control response (10 ml/kg ip), locomotion in an open field from 30-45 min after injection for males [n beam breaks/15 min] x x x x 277.0 176.455 x 710.308 555.0 939.0 783.182 670.1 406.286 505.2 279.125 578.231 353.0 392.615 182.5 784.364 x x x 400.375 x 131.857 124.727 992.385 x 511.875 715.5 894.231 323.059 x 20.0 x 690.583 422.769 1020.81 x 495.214 584.125 125.143 270.556 x x 592.333 x 637.1 570.353 x x x 746.917 111.222 x x x 993.643 503.818 190.0 241.308 x 414.571 151.769 508.786 672.769 1224.07 682.6 782.588 x 57.0 x 330.25 x 623.0 x x 629.412 x x 330.333 405.2 203.941 686.583 391.588 x 978.636 x x 453.643 x x x 415.0 296.4 506.333 966.235 389.364 x x x +11544 Original post publication description: Saline control response (10 ml/kg ip), locomotion in an open field from 45-60 min after injection for males [n beam breaks/15 min] None Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotion in an open field from 45-60 min after injection for males [n beam breaks/15 min] x x x x 185.929 231.273 x 603.692 498.2 944.0 838.727 903.5 294.786 439.6 178.25 753.462 276.471 350.231 100.5 716.182 x x x 403.125 x 72.3571 199.636 986.769 x 499.5 643.917 915.692 240.882 x 3.33333 x 706.25 449.615 1120.12 x 408.429 545.938 105.857 176.444 x x 587.083 x 640.1 610.294 x x x 392.333 42.0556 x x x 833.5 372.318 131.75 256.538 x 249.286 70.9231 416.214 574.0 1004.8 736.15 594.176 x 44.0588 x 295.5 x 502.75 x x 657.176 x x 256.867 438.8 157.647 538.917 252.235 x 863.636 x x 346.286 x x x 391.0 278.6 487.0 944.824 367.182 x x x +11545 Original post publication description: Saline control response (10 ml/kg ip), locomotion in an open field from 0-15 min after injection for males [cm] None Saline control response (10 ml/kg ip), locomotion in an open field from 0-15 min after injection for males [cm] x x x x 2231.95 1551.31 x 2092.7 2161.96 3958.65 1668.23 2781.25 2254.26 2916.85 1280.93 1593.72 2955.45 1970.93 1601.23 2792.85 x x x 2787.42 x 949.768 1236.0 4774.6 x 1978.59 1974.63 2934.95 2028.92 x 963.437 x 2495.78 1813.58 3612.47 x 3212.74 2026.31 2471.05 2247.26 x x 2061.01 x 1779.8 1807.32 x x x 3339.92 1601.76 x x x 4204.39 2232.47 958.391 1507.04 x 2551.07 1442.45 2032.99 2393.21 4402.46 2785.45 3176.84 x 1262.89 x 2378.26 x 3491.85 x x 2528.93 x x 2104.11 2800.84 1278.73 3495.23 1884.5 x 4010.82 x x 2485.81 x x x 2368.04 2134.4 3252.16 2815.02 1574.97 x x x +11546 Original post publication description: Saline control response (10 ml/kg ip), locomotion in an open field from 15-30 min after injection for males [cm] None Saline control response (10 ml/kg ip), locomotion in an open field from 15-30 min after injection for males [cm] x x x x 1709.54 762.187 x 1986.17 1649.75 3787.72 2230.54 2455.53 1905.53 1985.68 1547.22 1586.59 1854.76 1809.74 1413.64 2495.96 x x x 2368.64 x 683.334 1063.0 3903.04 x 2023.81 2039.43 2647.9 1590.62 x 243.222 x 2289.45 1844.43 3539.16 x 2038.82 2030.76 1081.59 1855.11 x x 2029.24 x 2178.41 2155.48 x x x 3507.05 726.858 x x x 3599.77 2126.77 720.752 1037.65 x 2374.29 930.325 2119.72 2692.59 4099.84 2401.16 2604.17 x 750.939 x 1416.65 x 2668.65 x x 2462.88 x x 1692.78 2067.27 1060.31 2547.0 1681.48 x 3907.92 x x 2677.36 x x x 1615.06 992.026 2119.2 3082.5 1629.67 x x x +11547 Original post publication description: Saline control response (10 ml/kg ip), locomotion in an open field from 30-45 min after injection for males [cm] None Saline control response (10 ml/kg ip), locomotion in an open field from 30-45 min after injection for males [cm] x x x x 1054.65 691.296 x 2219.78 2029.41 3079.09 2481.71 2269.39 1584.05 1784.25 1022.99 1903.72 1238.33 1430.59 620.282 2556.74 x x x 1588.94 x 554.001 511.402 3344.28 x 1624.03 2303.91 3098.14 1162.56 x 82.9381 x 2503.91 1420.7 3361.76 x 1660.71 2181.26 470.248 1053.77 x x 2115.75 x 2184.35 2221.94 x x x 2357.31 405.728 x x x 3137.65 1726.92 729.606 770.31 x 1403.42 559.536 1787.84 2360.11 4058.43 2446.15 2564.79 x 220.127 x 1260.85 x 2110.17 x x 2063.6 x x 1290.09 1696.35 818.444 2373.45 1361.78 x 3366.44 x x 1635.31 x x x 1557.06 1173.68 1487.2 3058.77 1440.4 x x x +11548 Original post publication description: Saline control response (10 ml/kg ip), locomotion in an open field from 45-60 min after injection for males [cm] None Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotion in an open field from 45-60 min after injection for males [cm] x x x x 714.777 818.075 x 1908.23 1761.72 3001.5 2635.36 2995.22 1097.16 1558.61 664.468 2366.56 938.328 1279.8 318.51 2218.14 x x x 1538.64 x 289.068 777.854 3375.98 x 1608.05 2013.68 3082.05 860.322 x 17.3864 x 2556.47 1538.37 3665.87 x 1324.41 2027.9 362.841 649.633 x x 2126.14 x 2165.32 2242.59 x x x 1237.9 150.3 x x x 2645.86 1304.56 529.379 822.067 x 828.555 278.683 1490.43 2010.57 3326.29 2671.22 1909.35 x 171.898 x 1141.93 x 1762.67 x x 2152.51 x x 1007.87 1712.05 633.301 1818.16 856.544 x 3005.23 x x 1206.06 x x x 1558.12 1017.58 1502.54 3009.55 1363.95 x x x +11549 Original post publication description: Saline control response (10 mg/kg ip), open field behavior, vertical activity (rears) 0-15 min after injection for males [n beam breaks/15 min] None Central nervous system, pharmacology, behavior: Saline control response (10 mg/kg ip), open field behavior, vertical activity (rears) 0-15 min after injection for males [n beam breaks/15 min] x x x x 176.0 138.818 x 251.462 181.8 307.6 116.727 225.8 192.929 301.333 109.75 225.231 188.529 215.462 121.0 199.455 x x x 167.0 x 91.4286 90.5455 317.385 x 188.125 165.583 253.154 210.824 x 88.5556 x 289.75 141.077 331.062 x 321.286 242.188 229.095 192.667 x x 271.333 x 199.1 211.235 x x x 271.417 119.5 x x x 317.0 333.682 204.625 79.3846 x 192.286 194.462 278.786 321.385 469.733 226.8 273.765 x 230.353 x 231.0 x 313.0 x x 302.706 x x 228.867 297.8 203.824 289.083 194.118 x 358.455 x x 177.5 x x x 387.625 130.2 213.75 244.412 166.636 x x x +11550 Original post publication description: Saline control response (10 mg/kg ip), open field behavior, vertical activity (rears) 15-30 min after injection for males [n beam breaks/15 min] None Central nervous system, behavior: Saline control response (10 mg/kg ip), open field behavior, vertical activity (rears) 15-30 min after injection for males [n beam breaks/15 min] x x x x 232.0 104.455 x 305.769 267.2 343.0 181.273 290.1 254.786 309.467 141.125 306.385 204.118 247.462 166.5 263.273 x x x 187.75 x 83.9286 143.182 369.846 x 247.375 227.333 322.846 201.235 x 41.2222 x 367.667 202.077 427.375 x 262.714 354.875 146.667 214.222 x x 384.5 x 282.3 248.471 x x x 287.0 81.5556 x x x 298.357 382.409 247.0 86.4615 x 214.857 157.308 343.357 339.923 512.133 274.65 315.471 x 175.765 x 261.417 x 364.5 x x 386.235 x x 258.2 322.2 216.706 276.083 230.059 x 459.182 x x 228.071 x x x 418.25 133.8 210.667 279.588 230.182 x x x +11551 Original post publication description: Saline control response (10 mg/kg ip), open field behavior, vertical activity (rears) 30-45 min after injection for males [n beam breaks/15 min] None Central nervous system, behavior: Saline control response (10 mg/kg ip), open field behavior, vertical activity (rears) 30-45 min after injection for males [n beam breaks/15 min] x x x x 161.786 92.6364 x 299.462 261.2 296.6 184.0 304.9 239.786 310.133 119.375 317.923 175.706 194.462 93.5 245.0 x x x 129.375 x 68.6429 121.545 350.308 x 213.25 232.167 339.846 137.882 x 17.3333 x 359.917 183.231 407.625 x 242.714 376.812 86.8095 136.222 x x 382.667 x 289.3 238.824 x x x 217.917 43.5556 x x x 253.857 356.409 222.25 75.6923 x 141.786 92.4615 309.357 286.923 556.6 287.35 333.412 x 81.0 x 206.5 x 321.0 x x 351.353 x x 245.133 309.9 160.0 258.833 196.647 x 438.091 x x 142.857 x x x 420.5 156.4 193.083 283.118 216.0 x x x +11552 Original post publication description: Saline control response (10 mg/kg ip), open field behavior, vertical activity (rears) 45-60 min after injection for males [n beam breaks/15 min] None Central nervous system, behavior: Saline control response (10 mg/kg ip), open field behavior, vertical activity (rears) 45-60 min after injection for males [n beam breaks/15 min] x x x x 140.929 124.364 x 238.692 249.6 310.6 219.182 376.0 172.143 266.333 108.625 328.923 138.353 181.385 9.5 235.091 x x x 118.5 x 41.6429 117.636 344.769 x 194.0 209.5 320.231 112.588 x 10.4444 x 363.417 158.923 468.875 x 186.5 335.625 56.6667 82.6667 x x 367.583 x 275.8 239.824 x x x 106.083 21.0556 x x x 232.071 296.5 182.688 74.5385 x 111.0 53.9231 268.429 244.846 467.0 317.35 259.294 x 48.5882 x 202.5 x 320.417 x x 353.765 x x 183.133 293.9 106.294 239.0 139.294 x 419.364 x x 117.429 x x x 368.75 114.6 149.5 283.588 224.091 x x x +11553 Original post publication description: Novel open field behavior, locomotion in the center and periphery from 0-60 min for males in the cocaine test battery [n beam breaks] None Novel open field behavior, locomotion in the center and periphery from 0-60 min for males in the cocaine test battery [n beam breaks] x x x x 3205.07 2994.09 x 5699.46 4241.6 6162.4 3437.18 6409.7 2417.29 3985.47 1694.88 3076.92 4531.65 3007.62 2778.5 3975.18 x x x 2719.88 x 1411.13 1795.18 6895.0 x 2347.0 4513.5 4137.31 2341.0 x 1007.0 x 3601.75 2101.54 5277.31 x 3884.5 2773.62 2313.67 3444.67 x x 3689.33 x 4872.54 3068.88 x x x 4666.33 811.944 x x x 4758.43 3482.32 1285.31 2224.62 x 3834.93 2633.77 2725.43 3508.46 5333.6 4743.55 4254.47 x 1987.94 x 3793.67 x 4569.17 x x 3568.24 x x 1882.27 2878.8 1638.0 4107.25 3451.0 x 4645.64 x x 3758.29 x x x 2094.62 3395.0 5837.17 6585.24 2192.73 x x x +11554 Original post publication description: Novel open field behavior, locomotion in the center and periphery from 0-60 min for males in the cocaine test battery [cm] None Novel open field behavior, locomotion in the center and periphery from 0-60 min for males in the cocaine test battery [cm] x x x x 11584.2 10184.5 x 17277.9 14205.4 19108.1 11407.7 19468.9 9267.31 13125.7 6721.12 10577.9 14339.2 11416.9 9320.55 13217.9 x x x 10848.5 x 5218.6 7629.08 21218.2 x 8816.4 14442.0 14501.3 8388.82 x 4034.94 x 12608.5 8016.2 17573.4 x 12858.2 10428.4 8209.71 12594.7 x x 13064.2 x 16111.4 11248.1 x x x 15242.1 3587.94 x x x 15336.2 12247.5 5468.24 8135.13 x 12849.5 9664.6 10074.4 12742.4 17333.2 16338.1 14004.0 x 7464.77 x 12737.2 x 14075.4 x x 11994.7 x x 7579.45 11117.7 6703.78 13691.5 11265.1 x 15886.4 x x 12766.5 x x x 8093.75 11751.3 17397.7 20727.8 8595.21 x x x +11555 Original post publication description: Novel open field behavior, vertical activity (rears) in the center and periphery from 0-60 min for males in the cocaine test battery [n beam breaks] None Novel open field behavior, vertical activity (rears) in the center and periphery from 0-60 min for males in the cocaine test battery [n beam breaks] x x x x 1009.07 1141.0 x 1501.54 1324.2 1586.4 791.545 1877.0 938.5 1519.27 722.875 1067.08 989.941 1157.46 953.0 1035.82 x x x 691.25 x 533.467 645.727 1439.0 x 911.625 1225.08 1609.15 825.706 x 437.222 x 1340.83 809.769 1930.12 x 1269.0 1687.88 757.143 909.444 x x 1593.17 x 1705.0 1055.41 x x x 1081.83 302.5 x x x 1277.43 1450.09 1062.06 626.692 x 1016.43 968.077 1186.64 1356.31 2093.93 1771.55 1358.18 x 1182.41 x 1448.92 x 1313.67 x x 1594.76 x x 907.533 1473.4 986.118 1296.17 1167.88 x 1678.0 x x 963.571 x x x 1690.62 872.0 1270.67 1857.24 1254.09 x x x +11556 Original post publication description: Central nervous system, adult neurogenesis: BrdU-labeled cells in the rostral migratory stream 1 hr after BrdU injection for adult males [density] None Central nervous system, adult neurogenesis: BrdU-labeled cells in the rostral migratory stream 1 hr after BrdU injection for adult males [density] x x x x x 100.0 x 76.0 x 98.5 x x x 69.0 108.0 x 77.5 x x x x x x x x 63.0 x x x x 87.0 x x x 85.8 x x 132.5 x x x 108.75 79.0 84.6667 x x x x 82.75 x x x x x x x x x 67.0 100.333 83.25 x 79.5 101.5 72.5 142.0 122.0 128.0 95.5 x x 81.0 100.333 97.0 x 76.0 x x 102.0 x x x x 79.0 94.5 104.0 x 97.5 74.25 90.6667 121.5 98.6667 x x 87.5 85.0 74.0 x x x x x +11557 Original post publication description: Adrenal weight (left) of males [mg] None Endocrinology, morphology: Adrenal weight (left) of males [mg] x x x x 1.75 1.6 x 2.1125 1.775 1.5 2.1 2.025 1.675 2.1 1.9 2.475 1.95 1.525 1.825 1.975 x x x 1.8 x 1.8 2.325 1.7 x 2.0 1.9 1.7 2.125 x 1.675 x 1.775 2.025 1.5 x 1.6375 1.65 1.4 1.65 x x 1.875 x 1.45 1.9 x x x 1.275 1.675 x x x 1.775 1.65 2.175 1.675 x 1.725 1.6 1.575 1.875 1.75 1.55 1.43333 x 1.55 x 1.65 x 1.58333 x x 1.625 x x 1.675 1.7 1.7 1.475 1.75 x 1.575 1.6 x 1.725 x x x 2.05 1.65 1.8 1.625 2.05 x x x +11558 Original post publication description: Adrenal weight (right) of males [mg] None Endocrinology, morphology: Adrenal weight (right) of males [mg] x x x x 1.7 1.35 x 2.1375 1.8 1.5 1.925 2.2 1.55 1.725 1.8 2.25 1.46667 1.525 1.925 2.0 x x x 1.65 x 1.8625 2.25 1.55 x 1.9 1.675 1.675 2.2 x 1.75 x 1.775 2.1 1.65 x 1.4 1.675 1.5 1.375 x x 1.8625 x 1.55 1.7 x x x 1.125 1.5 x x x 1.6375 1.65 1.75 1.575 x 1.425 1.55 1.4 1.75 1.725 1.375 1.23333 x 1.4875 x 1.45 x 1.53333 x x 1.45 x x 1.675 1.725 1.625 1.45 1.625 x 1.575 1.475 x 1.3 x x x 2.025 1.45 1.525 1.85 1.85 x x x +11559 Original post publication description: Pain sensitivity, vocalization threshold to mild foot shock for females [mA] None Central nervous system, behavior: Pain sensitivity, vocalization threshold to mild foot shock for females [mA] x x x x 0.27 0.316667 0.37 0.26 0.3 0.28 0.34 0.23 0.2875 0.22 0.26 0.3125 0.34 0.35 x 0.26 x 0.35 x 0.39 x 0.38 0.23 0.32 x 0.32 0.43 0.25 0.29 x 0.3 x 0.26 0.3 0.32 x 0.24 0.3875 0.32 0.1625 x x 0.33125 0.25 0.29 0.33 x x x x x x x x 0.36 0.39 0.37 0.38 0.3625 0.36 0.27 x 0.33 0.31875 0.33 0.25 x 0.32 0.34 0.43 x 0.32 0.39 0.5 0.41 0.283333 x 0.28 0.32 0.31 0.3 0.35 0.65 0.26 0.24 x 0.29 0.2 x x 0.31 x x x x x x x +11560 Original post publication description: Ethanol response (2 mg/kg ip), motor coordination, time on dowel over a 5 min test period immediately after injection for females [sec] None Central nervous system, pharmacology, behavior: Ethanol response (2 g/kg ip), motor coordination, time on dowel over a 5 min test period immediately after injection for females [sec] x x x x 120.5 39.6667 x x x x 89.0 143.333 112.0 x x 84.3333 31.0 101.5 x 163.0 x x x x x 142.286 77.3333 80.6 x 112.0 87.8 122.333 64.2 x 89.5 x 54.0 114.167 74.1667 x 103.4 95.0 85.0 67.6667 x x 123.0 x 100.0 73.8 x x x 97.8 x x x x 51.5 54.6 84.4 x x 123.667 113.4 x 157.0 87.4 76.75 x x 116.167 x 122.75 x x x x x x x 75.6667 163.333 x x 83.0 x x x x 71.3333 x x x x x 74.0 x x x x x +11561 Original post publication description: Ethanol response (2 mg/kg ip), motor coordination, time on dowel over a 5 min test period starting 30 min after injection for females [sec] None Central nervous system, pharmacology, behavior: Ethanol response (2 g/kg ip), motor coordination, time on dowel over a 5 min test period starting 30 min after injection for females [sec] x x x x 23.5 9.0 x x x x 14.5 11.3333 5.0 x x 10.3333 7.5 98.0 x 75.0 x x x x x 122.429 4.16667 8.6 x 16.0 20.8 6.66667 1.8 x 6.0 x 1.6 93.8333 106.5 x 140.6 188.5 45.0 19.3333 x x 46.5 x 62.4 30.6 x x x 79.2 x x x x 12.5 4.6 185.2 x x 24.3333 30.6 x 11.0 24.6 11.25 x x 59.8333 x 41.0 x x x x x x x 111.667 176.0 x x 10.3333 x x x x 12.6667 x x x x x 6.66667 x x x x x +11562 Original post publication description: Motor coordination, time on dowel over a 2 min baseline test period for females [sec] None Central nervous system, behavior: Motor coordination, time on dowel over a 2 min baseline test period for females [sec] x x x x 120.0 120.0 x x x x 120.0 120.0 120.0 x x 120.0 120.0 120.0 x 120.0 x x x x x 120.0 103.667 120.0 x 120.0 120.0 120.0 107.0 x 120.0 x 114.4 120.0 120.0 x 120.0 120.0 86.5 83.0 x x 120.0 x 120.0 120.0 x x x 120.0 x x x x 120.0 113.0 120.0 x x 120.0 120.0 x 120.0 120.0 120.0 x x 120.0 x 120.0 x x x x x x x 83.3333 120.0 x x 120.0 x x x x 89.6667 x x x x x 87.3333 x x x x x +11563 Original post publication description: Depression assay, Porsolt behavioral despair test, time immobile for females [sec] None Central nervous system, behavior: Depression assay, Porsolt behavioral despair test, time immobile for females [sec] x x x x 0.25 41.8333 x x x x 98.5 18.6667 20.0 x x 16.3333 138.0 89.0 x 161.75 x x x x x 25.4286 150.333 108.4 x 49.0 31.9 48.0 149.0 x 27.5 x 148.3 31.6 98.0833 x 53.9 75.25 61.1667 152.0 x x 98.5 x 85.4 15.5 x x x 123.7 x x x x 159.0 166.8 65.6 x x 109.0 174.8 x 8.0 95.9 139.5 x x 30.9167 x 105.875 x x x x x x x 102.5 93.0 x x 150.5 x x x x 59.6667 x x x x x 85.3333 x x x x x +11564 Original post publication description: Pain response, thermal nociception, Hargreaves' test for females [units] None Central nervous system, peripheral nervous system, behavior: Pain response, thermal nociception, Hargreaves' test for females [units] x x x x 20.9517 x x 8.602 10.1283 x 7.39 19.9239 13.807 9.03611 x 6.39167 13.364 10.1483 x 14.2025 x x x 10.1675 x 11.0133 10.4803 13.8645 x 15.1867 10.579 8.70813 10.0198 x 12.1297 x 14.157 16.0387 8.94014 x 11.5657 9.55375 8.72074 12.3953 x x 10.1448 x 10.8205 6.84111 x x x 9.19352 x x x x 13.6783 8.92648 13.0527 12.7197 x 13.8387 13.4446 11.1142 11.3353 14.0602 12.6843 x x 14.3312 x 11.3888 x 10.6592 x x 7.81667 x x 10.4375 14.9417 x 9.071 8.6925 x 14.0667 x x 15.5675 x x x 11.0558 x 13.6533 x 12.5727 x x x +11565 Original post publication description: Pain response, thermal nociception, hot plate test, average of two trials for females [sec] None Central nervous system, peripheral nervous system, behavior, nociception: Pain response, thermal nociception, hot plate test, average of two trials for females [sec] x x x x 8.5075 x x 6.8005 11.485 x 9.22 10.0562 5.073 6.78889 x 4.89 9.239 4.3075 x 7.0885 x x x 9.605 x 9.51357 10.966 7.04857 x 5.637 6.798 10.0233 9.52429 x 6.07 x 10.9389 13.309 14.0985 x 6.914 9.745 8.985 14.355 x x 16.825 x 18.0537 7.05167 x x x 5.40357 x x x x 9.245 6.73556 11.923 16.472 x 5.586 7.679 5.935 7.07 5.29714 11.1625 x x 8.94714 x 17.9007 x 9.745 x x 6.525 x x 9.51429 7.8125 x 9.202 8.27571 x 7.827 x x 5.19583 x x x 10.7605 x 8.45063 x 11.2987 x x x +11566 Original post publication description: Pain response, mechanical nociception, tail clip latency for females [sec] None Central nervous system, peripheral nervous system, behavior: Pain response, mechanical nociception, tail clip latency for females [sec] x x x x 33.835 x x 23.807 24.74 x 34.185 9.23667 33.24 12.9567 x 17.74 21.59 4.95 x 8.167 x x x 59.125 x 19.3729 39.592 22.0557 x 47.518 43.52 19.9167 41.8114 x 21.87 x 5.46778 25.57 20.335 x 23.178 23.942 22.5367 36.962 x x 30.8778 x 21.334 9.555 x x x 10.6711 x x x x 5.276 17.3778 51.464 28.708 x 28.266 22.71 21.91 41.0583 12.9357 20.11 x x 28.8743 x 40.4987 x 23.014 x x 17.19 x x 25.1786 7.835 x 22.038 10.4657 x 12.966 x x 18.5917 x x x 23.798 x 29.868 x 11.56 x x x +11567 Original post publication description: Pain response, thermal nociception, tail withdrawal latency for females [sec] None Central nervous system, peripheral nervous system, behavior: Pain response, thermal nociception, tail withdrawal latency for females [sec] x x x x 8.28333 x x 12.1093 13.5867 x 18.1683 8.6425 7.70867 9.71667 x 10.3267 8.87133 10.825 x 9.34133 x x x 13.4517 x 10.9748 9.83933 13.7867 x 10.6333 12.004 13.3696 11.1086 x 13.708 x 10.7637 11.424 21.7508 x 9.40933 10.7347 10.603 16.8787 x x 9.74963 x 9.944 11.0467 x x x 11.3048 x x x x 7.64267 9.91667 8.83267 9.572 x 7.95533 12.3587 10.4233 10.005 13.6105 9.50458 x x 12.479 x 12.4329 x 10.9933 x x 9.56444 x x 12.5295 18.3633 x 13.9277 8.45905 x 8.28067 x x 7.74056 x x x 9.89767 x 8.89433 x 11.276 x x x +11568 Original post publication description: Somatosensory response, mechanical sensitivity using Von Frey test, threshold for females [Force in mg] None Central nervous system, peripheral nervous system, somatosensory system: Mechanical sensitivity using Von Frey test, threshold for females [force in mg] x x x x 4.38912 x x 3.96575 3.97475 x 4.2685 3.97069 4.3442 4.35722 x 4.44767 4.2621 4.14525 x 4.11555 x x x 4.18925 x 4.17504 4.2432 4.06868 x 4.063 4.03625 4.15914 4.37232 x 4.0235 x 4.14119 4.08505 4.0025 x 4.10835 4.1567 4.335 4.027 x x 3.96939 x 3.99605 4.25925 x x x 4.37758 x x x x 3.9029 4.22761 4.3283 4.06905 x 4.1605 4.15625 4.19425 4.16129 3.98496 4.24087 x x 3.88375 x 3.97894 x 4.1465 x x 4.34458 x x 4.20311 3.77325 x 4.17462 4.06539 x 4.2096 x x 4.016 x x x 4.09027 x 4.17847 x 3.9719 x x x +11569 Original post publication description: Morphine response (50 mg/kg ip), locomotion from 90-105 min after injection in an activity chamber for females [n beam breaks] None Morphine response (50 mg/kg ip), locomotion from 90-105 min after injection in an activity chamber for females [n beam breaks] x x x x 3364.29 322.6 x 3241.83 0.0 2658.83 3617.5 6188.0 2081.0 2613.75 1333.33 4054.25 5083.17 543.25 3468.8 4297.33 x x x 3612.5 x 6389.83 601.875 2468.0 x 3104.38 310.0 1727.0 541.143 x 2776.33 x 2396.67 3386.22 4475.36 x 511.091 191.0 1704.62 4220.5 x x 2082.25 x 652.143 4947.73 x x x 337.286 671.0 x x x 1.33333 44.5 2563.0 3298.0 x 2501.0 1089.67 2740.17 162.25 937.125 4880.0 2678.67 x 3677.17 x 1825.33 x 37.25 x x 2429.8 x x 1027.83 202.6 2729.5 5512.5 118.5 x 331.6 1725.17 x 2803.33 x x x 768.167 2569.0 1816.83 61.5 3152.0 x x x +11570 Original post publication description: Morphine response (50 mg/kg ip), locomotion from 105-120 min after injection in an activity chamber for females [n beam breaks] None Morphine response (50 mg/kg ip), locomotion from 105-120 min after injection in an activity chamber for females [n beam breaks] x x x x 3122.43 439.8 x 3214.33 0.0 2181.17 2579.75 4887.4 1963.4 2326.0 1299.67 2676.75 4711.0 1290.0 2668.0 3370.5 x x x 2668.5 x 5245.5 738.25 1722.33 x 1957.75 313.25 1853.2 502.143 x 2114.0 x 2320.33 3487.89 3413.27 x 728.182 385.0 1577.38 4254.0 x x 1799.25 x 606.857 3943.91 x x x 578.0 567.8 x x x 2.83333 46.5 2040.17 2681.5 x 2344.0 1304.67 2272.33 43.25 692.625 4011.0 2211.67 x 3277.83 x 1352.33 x 16.0 x x 1666.4 x x 923.167 396.8 3162.5 5022.67 124.333 x 512.4 1824.83 x 2342.0 x x x 583.5 3527.5 1466.83 262.333 2777.62 x x x +11571 Original post publication description: Morphine response (50 mg/kg ip), locomotion from 120-135 min after injection in an activity chamber for females [n beam breaks] None Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion from 120-135 min after injection in an activity chamber for females [n beam breaks] x x x x 2742.57 573.8 x 2760.33 6.0 1754.0 1429.25 2830.4 2039.4 1268.5 1002.83 2128.25 3857.0 1094.25 2116.8 2433.67 x x x 1652.0 x 3716.33 898.375 765.833 x 1587.0 336.0 1481.6 331.0 x 1844.67 x 2148.0 3402.22 2666.73 x 1171.18 510.5 1324.0 4229.25 x x 1045.25 x 522.429 3339.36 x x x 815.143 395.8 x x x 64.3333 75.75 1688.67 1797.5 x 2036.62 901.167 1750.83 49.5 616.125 3636.12 2213.0 x 2850.83 x 682.833 x 70.25 x x 1172.0 x x 857.667 550.8 3368.0 4612.5 118.0 x 1175.6 1752.67 x 1653.67 x x x 429.5 4430.5 1088.17 353.667 2108.25 x x x +11572 Original post publication description: Morphine response (50 mg/kg ip), locomotion from 0-15 min after injection in an activity chamber for females [n beam breaks] None Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion from 0-15 min after injection in an activity chamber for females [n beam breaks] x x x x 2734.14 404.6 x 517.0 134.0 1167.33 2768.0 2196.8 230.2 1611.75 334.667 2443.75 1486.17 158.25 1121.0 1112.33 x x x 989.25 x 1370.83 217.375 1041.5 x 2239.25 165.0 801.2 216.429 x 1764.0 x 1200.5 766.889 2686.55 x 736.818 298.833 1121.62 897.75 x x 868.0 x 265.857 693.545 x x x 409.571 568.4 x x x 95.1667 216.75 309.5 946.25 x 471.125 487.0 448.667 321.5 413.75 2811.12 4925.33 x 529.833 x 951.667 x 494.0 x x 1126.4 x x 287.167 258.2 1013.67 1377.17 156.667 x 713.8 1222.33 x 784.333 x x x 412.5 562.0 2155.17 375.667 933.875 x x x +11573 Original post publication description: Morphine response (50 mg/kg ip), locomotion from 150-165 min after injection in an activity chamber for females [n beam breaks] None Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion from 150-165 min after injection in an activity chamber for females [n beam breaks] x x x x 1372.71 615.8 x 1430.17 62.0 1257.17 401.5 1039.4 1511.6 686.25 620.667 485.0 1945.67 415.75 573.0 1238.17 x x x 456.5 x 1719.83 859.75 24.5 x 865.375 186.5 1383.6 59.5714 x 1761.67 x 1505.83 2156.78 1531.55 x 1988.18 248.833 497.0 3199.5 x x 349.0 x 217.0 1919.91 x x x 533.714 163.2 x x x 54.1667 230.75 781.667 1427.25 x 1086.88 243.0 1007.67 5.25 256.0 2787.5 2109.17 x 2374.0 x 398.333 x 182.75 x x 532.0 x x 442.0 887.0 3094.0 2703.0 65.5 x 1257.6 992.5 x 838.333 x x x 217.5 3370.5 280.333 262.5 1409.62 x x x +11574 Original post publication description: Morphine response (50 mg/kg ip), locomotion from 165-180 min after injection in an activity chamber for females [n beam breaks] None Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion from 165-180 min after injection in an activity chamber for females [n beam breaks] x x x x 1003.86 659.2 x 808.333 21.0 1028.17 250.25 675.0 622.2 577.0 623.833 432.25 1348.33 371.25 406.8 815.5 x x x 420.5 x 758.833 818.5 58.1667 x 356.5 129.75 1387.6 156.0 x 718.0 x 1340.17 1665.33 1098.18 x 2038.73 93.6667 250.0 1938.75 x x 563.5 x 95.2857 1452.64 x x x 302.857 150.4 x x x 28.3333 301.25 489.5 1143.5 x 751.375 180.0 419.667 26.25 260.0 2563.88 1595.0 x 1425.17 x 379.167 x 283.5 x x 446.0 x x 307.333 1188.0 2526.0 2085.33 42.5 x 939.2 516.667 x 646.667 x x x 144.667 2109.0 118.667 168.0 1427.12 x x x +11575 Original post publication description: Morphine response (50 mg/kg ip), locomotion from 15-30 min after injection in an activity chamber for females [n beam breaks] None Morphine response (50 mg/kg ip), locomotion from 15-30 min after injection in an activity chamber for females [n beam breaks] x x x x 3040.14 85.4 x 530.5 0.0 1290.17 4455.25 5287.6 230.6 905.0 331.333 3906.25 1655.67 35.5 2113.2 1961.33 x x x 1192.25 x 2581.33 24.125 2115.33 x 5518.5 4.25 704.6 85.4286 x 3671.0 x 1477.0 934.222 3951.0 x 193.091 100.333 1222.25 1176.75 x x 988.75 x 505.0 974.364 x x x 41.2857 356.2 x x x 1.5 43.75 780.0 1300.5 x 442.375 197.333 296.0 1545.5 173.875 1874.62 9722.5 x 853.5 x 1014.83 x 137.25 x x 1835.2 x x 136.667 0.2 2220.33 2113.17 6.66667 x 103.0 1010.33 x 782.667 x x x 347.0 351.5 3334.33 9.66667 1123.0 x x x +11576 Original post publication description: Morphine response (50 mg/kg ip), locomotion from 30-45 min after injection in an activity chamber for females [n beam breaks] None Morphine response (50 mg/kg ip), locomotion from 30-45 min after injection in an activity chamber for females [n beam breaks] x x x x 3497.57 105.4 x 1029.17 3.0 3132.83 6202.5 6581.6 631.4 1225.5 488.0 5278.0 2690.83 139.0 2808.0 3312.0 x x x 2458.5 x 3588.83 65.625 3234.33 x 8352.25 9.0 616.6 126.429 x 4844.33 x 1890.67 1225.11 4115.55 x 112.0 30.6667 981.75 1365.75 x x 1217.75 x 1023.29 1566.45 x x x 16.8571 554.6 x x x 1.0 12.0 1444.0 1667.25 x 681.125 271.167 794.333 2848.75 217.875 2260.0 8441.17 x 1537.67 x 1449.0 x 27.75 x x 2266.4 x x 306.5 0.6 2926.5 2527.33 22.1667 x 40.2 962.333 x 1251.67 x x x 409.167 288.0 4096.67 4.5 1535.62 x x x +11577 Original post publication description: Morphine response (50 mg/kg ip), locomotion from 45-60 min after injection in an activity chamber for females [n beam breaks] None Morphine response (50 mg/kg ip), locomotion from 45-60 min after injection in an activity chamber for females [n beam breaks] x x x x 4121.71 135.2 x 2244.67 0.0 3678.67 6916.5 6892.8 1186.4 1675.75 609.833 6174.0 3155.67 297.5 3307.4 3773.67 x x x 3137.0 x 5006.5 145.125 3899.0 x 8703.5 31.75 820.6 207.714 x 4711.33 x 2114.5 1978.44 4751.36 x 173.0 37.5 1379.75 1890.5 x x 1912.5 x 1100.29 2711.18 x x x 23.0 1025.8 x x x 0.833333 27.25 2163.0 2317.0 x 1063.38 394.5 1289.5 3099.0 398.25 3354.0 6591.83 x 1974.67 x 2279.33 x 7.5 x x 3059.2 x x 569.667 3.4 2996.0 3755.67 48.6667 x 24.8 1282.5 x 2003.33 x x x 548.5 395.5 4365.0 47.1667 2090.12 x x x +11578 Original post publication description: Morphine response (50 mg/kg ip), locomotion from 60-75 min after injection in an activity chamber for females [n beam breaks] None Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion from 60-75 min after injection in an activity chamber for females [n beam breaks] x x x x 4406.57 179.2 x 3072.5 0.0 3186.0 6298.75 7363.0 1581.8 2028.75 705.0 6364.0 4396.33 173.5 3744.6 4463.5 x x x 3898.0 x 6027.33 276.625 4040.17 x 7421.38 122.0 1112.6 364.286 x 3840.67 x 2421.33 2609.89 4792.0 x 307.818 77.8333 1843.88 2626.5 x x 2192.75 x 950.0 3827.45 x x x 54.0 1059.6 x x x 0.666667 36.5 2227.83 3232.75 x 1567.5 660.5 1671.5 2283.5 654.25 3909.0 4918.67 x 2570.67 x 2656.5 x 24.25 x x 3729.0 x x 827.333 41.8 2921.17 4897.33 75.0 x 46.8 1688.5 x 2261.0 x x x 675.667 806.0 3832.83 175.167 2546.88 x x x +11579 Original post publication description: Morphine response (50 mg/kg ip), locomotion from 75-90 min after injection in an activity chamber for females [n beam breaks] None Morphine response (50 mg/kg ip), locomotion from 75-90 min after injection in an activity chamber for females [n beam breaks] x x x x 3783.71 250.0 x 3355.0 0.0 2807.83 4414.0 6976.6 1897.2 2349.25 951.667 5486.0 5069.5 263.0 3506.4 4781.67 x x x 4167.25 x 6632.5 454.0 3373.33 x 5396.0 234.25 1545.6 464.429 x 3531.0 x 2440.5 3028.78 4835.09 x 409.273 143.0 1928.12 3341.5 x x 2337.5 x 654.571 4716.18 x x x 184.571 744.0 x x x 1.33333 58.0 2498.17 3400.25 x 2141.0 878.5 2535.17 833.75 1060.12 4618.12 3647.17 x 3275.83 x 2611.0 x 51.25 x x 3552.0 x x 916.0 167.8 2823.83 5538.5 107.0 x 156.0 2011.0 x 2648.33 x x x 775.667 1599.5 2450.33 143.833 3104.88 x x x +11580 Original post publication description: Morphine response (50 mg/kg ip), locomotion (open field) from 90-105 min after injection in an activity chamber for females [cm] None Morphine response (50 mg/kg ip), locomotion (open field) from 90-105 min after injection in an activity chamber for females [cm] x x x x 10990.1 1583.24 x 10144.8 0.0 8794.66 11004.6 16057.9 6787.78 8770.84 5338.25 11285.6 13853.3 2147.59 10851.3 11895.8 x x x 10856.4 x 17620.0 2516.43 7177.84 x 9371.44 970.655 5643.35 1995.27 x 8323.78 x 8609.84 10454.7 12924.5 x 1946.83 776.32 5131.9 11888.4 x x 6619.84 x 1910.1 13964.7 x x x 1379.72 2159.31 x x x 21.1667 201.93 7133.43 10368.1 x 8929.46 3805.6 8714.57 654.226 3035.42 13945.9 9122.61 x 11252.5 x 5459.82 x 301.657 x x 7514.69 x x 3264.29 1387.01 9013.92 14104.3 389.566 x 1493.79 6434.7 x 9618.27 x x x 2421.18 9375.98 5587.52 286.57 9841.19 x x x +11581 Original post publication description: Morphine response (50 mg/kg ip), locomotion (open field) from 105-120 min after injection in an activity chamber for females [cm] None Morphine response (50 mg/kg ip), locomotion (open field) from 105-120 min after injection in an activity chamber for females [cm] x x x x 10367.4 1982.87 x 10051.9 0.0 7429.45 8112.42 12949.1 6584.52 7834.62 4952.79 7683.29 12902.4 4215.74 8525.27 9731.66 x x x 8006.48 x 15125.3 2921.52 5024.49 x 6812.19 968.735 5990.13 1794.88 x 6480.52 x 8385.76 10594.2 10661.4 x 2608.32 1375.47 4563.34 12324.1 x x 5688.48 x 1877.97 11348.7 x x x 2180.91 1806.06 x x x 12.9117 197.803 5761.59 8988.65 x 8338.1 4424.34 7148.16 170.488 2206.43 12073.2 8259.5 x 9833.49 x 4132.14 x 175.259 x x 5608.11 x x 2967.67 2217.69 10031.2 13164.9 399.518 x 2257.93 6651.0 x 8492.49 x x x 1869.26 11580.5 4570.3 1002.53 8986.93 x x x +11582 Original post publication description: Morphine response (50 mg/kg ip), locomotion (open field) from 120-135 min after injection in an activity chamber for females [cm] None Morphine response (50 mg/kg ip), locomotion (open field) from 120-135 min after injection in an activity chamber for females [cm] x x x x 9161.34 2246.01 x 8651.85 25.4 6148.35 4677.48 8065.81 6702.81 5067.92 4087.61 6428.17 10823.4 3469.28 6959.6 7404.54 x x x 5302.35 x 11268.4 3311.2 2356.8 x 5611.4 1026.37 4920.64 1281.96 x 5642.6 x 7995.85 10169.4 8845.87 x 3778.18 1711.5 3256.09 12329.0 x x 3387.07 x 1631.29 9832.09 x x x 2799.43 1227.95 x x x 198.357 278.464 4941.48 6803.47 x 7332.8 3007.62 5464.93 214.813 1982.21 11063.3 8334.33 x 8467.92 x 2104.43 x 412.085 x x 4073.26 x x 2719.68 2858.02 10589.6 12282.6 370.184 x 4271.2 6132.1 x 6525.11 x x x 1400.75 13139.7 3471.23 1202.41 7179.61 x x x +11583 Original post publication description: Morphine response (50 mg/kg ip), locomotion (open field) from 0-15 min after injection in an activity chamber for females [cm] None Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion (open field) from 0-15 min after injection in an activity chamber for females [cm] x x x x 7978.38 1417.43 x 1676.99 470.626 3971.86 7549.68 6263.29 1038.24 4857.87 1831.26 7171.8 4661.19 560.811 3816.95 3843.24 x x x 3662.31 x 4457.54 828.748 3285.77 x 6257.07 541.2 2649.11 974.193 x 5697.42 x 3880.0 2566.04 7827.27 x 2329.61 977.534 3509.92 3097.61 x x 2862.74 x 944.525 2734.62 x x x 1540.03 2052.73 x x x 331.315 801.113 1258.97 3608.93 x 1794.65 1713.69 1887.33 1238.83 1437.95 8535.84 12905.2 x 1651.14 x 3005.39 x 1684.44 x x 3393.57 x x 988.388 738.64 3692.99 4467.85 458.032 x 2911.57 4419.01 x 3236.84 x x x 1510.24 1885.94 6344.16 1158.49 3285.97 x x x +11584 Original post publication description: Morphine response (50 mg/kg ip), locomotion (open field) from 150-165 min after injection in an activity chamber for females [cm] None Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion (open field) from 150-165 min after injection in an activity chamber for females [cm] x x x x 4773.9 2414.98 x 4637.04 212.178 4117.37 1191.82 3297.2 5003.65 3050.28 2636.3 1761.99 5976.51 1400.94 2065.15 4178.54 x x x 1576.75 x 5611.23 3016.83 100.877 x 2647.88 595.198 4694.92 270.124 x 5303.99 x 6367.5 6949.24 5202.65 x 5870.2 961.407 1174.11 9319.43 x x 1162.08 x 739.497 6090.24 x x x 1906.63 520.257 x x x 164.911 719.964 2450.61 5760.27 x 4247.73 877.721 3204.97 16.8275 901.811 8919.33 7727.14 x 7489.11 x 1278.33 x 829.62 x x 1933.93 x x 1424.01 3432.81 9832.4 7753.43 205.895 x 4489.45 3412.87 x 4181.88 x x x 790.144 10525.1 889.813 869.665 5013.17 x x x +11585 Original post publication description: Morphine response (50 mg/kg ip), locomotion (open field) from 165-180 min after injection in an activity chamber for females [cm] None Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion (open field) from 165-180 min after injection in an activity chamber for females [cm] x x x x 3428.39 2476.51 x 2563.53 86.0564 3205.75 805.078 2120.11 2396.26 2610.25 2559.72 1687.86 4003.8 1302.61 1495.61 2832.27 x x x 1466.85 x 2610.13 2793.34 213.094 x 1205.7 408.981 4486.88 556.772 x 2174.74 x 5755.71 5643.55 3686.09 x 5960.67 379.952 659.513 6344.52 x x 1859.01 x 315.283 4965.51 x x x 1152.74 549.452 x x x 88.447 923.301 1533.32 4577.64 x 3017.45 648.57 1310.29 97.8364 888.807 8411.83 6047.09 x 4659.98 x 1197.65 x 1064.1 x x 1692.04 x x 1073.82 3987.72 8132.76 6163.7 139.917 x 3461.52 1804.36 x 3514.02 x x x 602.423 7259.9 374.175 589.732 4963.2 x x x +11586 Original post publication description: Morphine response (50 mg/kg ip), locomotion (open field) from 15-30 min after injection in an activity chamber for females [cm] None Morphine response (50 mg/kg ip), locomotion (open field) from 15-30 min after injection in an activity chamber for females [cm] x x x x 9498.16 577.499 x 2148.57 0.0 4755.71 11774.8 13786.4 1220.27 3382.54 1902.2 12050.2 5497.8 251.492 6820.35 6594.49 x x x 4784.58 x 8068.89 226.626 6478.3 x 14396.5 24.258 2663.44 639.847 x 11581.5 x 5257.01 3680.46 11292.7 x 917.866 491.303 4552.79 3923.6 x x 3589.62 x 1808.18 3898.06 x x x 353.035 1701.49 x x x 26.3434 248.413 2833.52 5971.56 x 2556.7 895.924 1957.35 5197.36 927.362 7341.41 23696.8 x 2856.1 x 3304.16 x 757.578 x x 5337.15 x x 556.858 1.29515 7942.03 6704.66 65.7439 x 932.267 4536.06 x 3981.93 x x x 1347.21 1549.19 9727.54 51.3296 4370.05 x x x +11587 Original post publication description: Morphine response (50 mg/kg ip), locomotion (open field) from 30-45 min after injection in an activity chamber for females [cm] None Morphine response (50 mg/kg ip), locomotion (open field) from 30-45 min after injection in an activity chamber for females [cm] x x x x 11134.2 663.505 x 3945.56 26.67 8978.56 15778.0 16881.9 2905.79 4371.05 2806.02 14780.4 8026.99 654.196 8486.65 9699.08 x x x 8339.68 x 10822.0 690.039 9384.43 x 20707.3 94.6164 2506.34 886.393 x 14121.4 x 6680.26 5146.33 12176.7 x 731.258 228.215 3989.62 4244.23 x x 4390.85 x 3384.92 5704.0 x x x 210.109 2378.63 x x x 26.5608 84.1375 4659.42 7506.9 x 4030.91 1355.62 3669.74 8583.62 1049.17 8541.38 21221.5 x 5347.44 x 4739.33 x 221.912 x x 6632.16 x x 1149.52 8.89 9736.57 7782.08 156.765 x 505.329 4470.37 x 5878.62 x x x 1622.08 2036.58 11644.5 47.2512 5768.57 x x x +11588 Original post publication description: Morphine response (50 mg/kg ip), locomotion (open field) from 45-60 min after injection in an activity chamber for females [cm] None Morphine response (50 mg/kg ip), locomotion (open field) from 45-60 min after injection in an activity chamber for females [cm] x x x x 12679.6 907.419 x 7449.59 0.0 10548.2 17393.2 17759.5 5035.0 5751.53 3705.6 16412.3 9431.09 1381.04 10162.4 10690.5 x x x 10169.9 x 14302.0 1148.04 10963.9 x 21348.4 157.29 3169.99 1195.2 x 13736.5 x 7490.47 7301.84 13691.6 x 960.739 254.989 4947.9 5462.22 x x 6444.78 x 3493.8 8741.28 x x x 235.263 3439.56 x x x 18.0732 182.449 6564.34 9120.37 x 5428.74 1859.6 5391.09 9287.42 1793.77 11019.6 17825.0 x 7193.62 x 7039.26 x 73.9509 x x 8597.46 x x 2079.27 42.033 9468.66 10471.6 278.407 x 304.196 5493.71 x 7981.31 x x x 1978.08 2862.1 12445.5 288.449 7362.81 x x x +11589 Original post publication description: Morphine response (50 mg/kg ip), locomotion (open field) from 60-75 min after injection in an activity chamber for females [cm] None Morphine response (50 mg/kg ip), locomotion (open field) from 60-75 min after injection in an activity chamber for females [cm] x x x x 13322.8 1046.88 x 9609.08 0.0 9718.23 16583.6 18683.8 6049.03 6872.41 4144.57 16879.9 12134.7 995.369 11363.6 12165.6 x x x 11919.4 x 16868.2 1522.75 11226.1 x 18935.8 460.226 4005.41 1673.84 x 11420.2 x 8416.28 8944.93 13714.8 x 1346.87 443.431 6176.04 7764.76 x x 7119.37 x 2911.19 11535.6 x x x 411.752 3404.48 x x x 20.1083 193.962 6655.99 10564.1 x 6807.8 2719.36 6612.37 7248.88 2590.69 12122.6 14357.3 x 8811.02 x 7951.71 x 204.98 x x 10328.4 x x 2861.06 339.162 9492.21 12799.4 367.161 x 524.606 6521.81 x 8735.46 x x x 2263.59 4606.02 11003.1 727.852 8571.85 x x x +11590 Original post publication description: Morphine response (50 mg/kg ip), locomotion (open field) from 75-90 min after injection in an activity chamber for females [cm] None Morphine response (50 mg/kg ip), locomotion (open field) from 75-90 min after injection in an activity chamber for females [cm] x x x x 12026.9 1303.54 x 10320.3 0.0 9189.87 12993.2 17846.3 6533.18 8129.21 4531.33 14967.2 13610.3 1384.29 10577.9 12899.0 x x x 12425.5 x 18174.2 2074.94 9451.71 x 14314.9 796.344 5147.75 1926.0 x 10518.7 x 8486.53 9829.37 13758.6 x 1663.49 599.331 5979.84 9600.81 x x 7453.85 x 1982.16 13607.2 x x x 1020.16 2339.84 x x x 33.8667 299.207 7152.64 10747.3 x 8207.36 3169.46 8550.39 2991.71 3561.08 13485.6 11368.3 x 10491.4 x 7757.22 x 405.169 x x 9919.35 x x 3009.01 1184.76 9054.62 14101.1 421.975 x 939.853 7271.67 x 9513.55 x x x 2492.95 7189.92 7251.44 570.093 9880.12 x x x +11591 Original post publication description: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), severity of abdominal contraction for females [ordinal scale, 0=no effect, 3=max] None Central nervous system, pharmacology, behavior: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), severity of abdominal contraction for females [ordinal scale, 0=no effect, 3=max] x x x x 0.0 0.0 x 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.166667 0.0 0.0 0.166667 x x x 0.0 x 0.0 0.0 0.0 x 0.0 0.0 0.0 0.0 x 0.0 x 0.0 0.0 0.0 x 0.0 0.0 0.0 0.0 x x 0.0 x 0.0 0.181818 x x x 0.0 0.0 x x x 0.0 0.0 0.0 0.0 x 0.0 0.0 0.0 0.0 0.0 0.0 0.0 x 0.0 x 0.0 x 0.0 x x 0.0 x x 0.0 0.0 0.0 0.0 0.333333 x 0.0 0.333333 x 0.0 x x x 0.0 0.0 0.0 0.0 0.0 x x x +11592 Original post publication description: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), defecation in an activity chamber for females [n fecal boli] None Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), defecation in an activity chamber for females [n fecal boli] x x x x 1.71429 3.0 x 3.16667 6.0 0.833333 1.0 2.0 1.0 2.25 2.0 0.75 1.83333 4.25 1.8 1.5 x x x 2.75 x 1.5 0.875 1.0 x 1.375 3.0 0.0 2.85714 x 1.0 x 0.166667 1.44444 1.45455 x 1.36364 2.0 1.125 1.75 x x 2.5 x 3.28571 2.0 x x x 3.14286 4.6 x x x 4.0 2.5 3.16667 1.5 x 1.0 1.5 2.66667 2.75 1.375 1.125 4.5 x 0.833333 x 3.0 x 2.33333 x x 3.0 x x 3.66667 2.0 0.166667 2.5 1.83333 x 1.4 1.83333 x 0.833333 x x x 1.66667 1.0 3.0 1.66667 0.25 x x x +11593 Original post publication description: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), number of jumps for females [n/15 min test] None Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), number of jumps for females [n/15 min test] x x x x 0.0 0.0 x 0.0 0.0 3.16667 0.0 0.0 3.4 0.0 0.0 0.0 5.83333 0.0 2.2 0.0 x x x 0.0 x 3.33333 2.0 0.0 x 0.0 0.0 0.0 3.14286 x 0.0 x 0.166667 1.77778 0.0 x 4.72727 0.0 0.25 5.25 x x 2.75 x 1.0 1.72727 x x x 0.0 0.0 x x x 4.0 0.0 1.83333 0.0 x 4.75 0.0 0.0 0.0 0.0 2.25 0.0 x 0.333333 x 0.0 x 0.0 x x 0.4 x x 0.0 2.6 0.0 1.33333 0.0 x 0.0 5.5 x 1.16667 x x x 14.1667 7.5 0.0 29.0 2.625 x x x +11594 Original post publication description: Morphine response (50 mg/kg ip), locomotion from 0-180 min (total activity over 3 hour test) after injection in an activity chamber for females [n beam breaks] None Morphine response (50 mg/kg ip), locomotion from 0-180 min (total activity over 3 hour test) after injection in an activity chamber for females [n beam breaks] x x x x 35226.0 4324.8 x 23897.5 277.0 25523.5 39929.0 52637.4 15618.8 18436.2 9100.33 40522.8 38608.3 5348.0 26875.8 33282.0 x x x 25500.0 x 45569.2 6095.25 22860.7 x 46711.8 2103.25 14855.0 3214.29 x 33271.0 x 23065.0 27490.1 40442.1 x 9969.45 2754.17 14699.4 33390.8 x x 16031.0 x 7053.57 32707.1 x x x 4052.71 6534.6 x x x 314.5 1178.0 18041.7 24965.8 x 16697.1 7178.5 16722.8 11259.8 6065.5 39929.2 51408.3 x 27324.3 x 16112.8 x 1483.25 x x 22536.4 x x 7330.33 4396.8 33097.2 43870.0 952.333 x 6824.6 16449.3 x 19091.5 x x x 5691.33 24758.0 25545.3 2203.5 23880.5 x x x +11595 Original post publication description: Morphine response (50 mg/kg ip), locomotion from 0-180 min (total activity over 3 hour test) after injection in an activity chamber for females [cm] None Morphine response (50 mg/kg ip), locomotion from 0-180 min (total activity over 3 hour test) after injection in an activity chamber for females [cm] x x x x 112361.0 18800.9 x 76738.3 1033.67 81555.5 109847.0 138907.0 55605.1 65327.0 41925.2 114564.0 110098.0 19641.4 84562.1 97570.3 x x x 81354.8 x 133034.0 24561.4 66084.2 x 125456.0 6859.04 50697.0 13854.9 x 100256.0 x 84625.0 90000.7 121144.0 x 33076.4 10219.6 45955.3 98128.1 x x 52801.7 x 22495.3 100393.0 x x x 15790.7 22519.8 x x x 1140.56 4431.0 54265.9 90744.4 x 66656.4 26390.0 58450.5 35858.8 21662.3 125391.0 149418.0 x 86770.3 x 49575.1 x 6854.36 x x 67630.3 x x 24374.9 19289.2 107403.0 120190.0 3461.98 x 27369.0 62211.4 x 76484.4 x x x 19653.9 85547.4 75016.0 7897.98 81048.4 x x x +11596 Original post publication description: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), change in locomotion for females (last 15 min of morphine test (165-180 min) minus first 15 min after naloxone) [cm difference] None Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), change in locomotion for females (last 15 min of morphine test (165-180 min) minus first 15 min after naloxone) [cm difference] x x x x 2387.97 1284.13 x 1788.86 -780.056 2094.71 -71.4445 693.94 1460.92 2041.37 1875.24 761.829 2318.57 381.424 -65.6929 1949.95 x x x 272.73 x 636.661 474.457 -847.413 x 416.711 -1585.04 3259.62 -1139.42 x 1635.04 x 5061.62 4793.9 2630.84 x 4302.47 -1436.5 -51.3446 4451.72 x x 535.394 x -844.552 3955.01 x x x -75.3665 -387.7 x x x -1163.57 204.566 394.132 3793.42 x 2118.45 -89.0678 693.25 -555.598 -318.608 7186.49 5239.1 x 3767.58 x 287.104 x 333.953 x x 788.712 x x 148.014 2453.78 7183.01 4137.8 -845.303 x 2054.06 914.574 x 2627.34 x x x -820.319 6441.29 -1316.12 -2763.77 3674.15 x x x +11597 Original post publication description: Morphine response (50 mg/kg ip), vertical activity (rears) from 0-180 min (total activity over 3 hour test) after injection in an activity chamber for females [n beam breaks] None Morphine response (50 mg/kg ip), vertical activity (rears) from 0-180 min (total activity over 3 hour test) after injection in an activity chamber for females [n beam breaks] x x x x 4977.14 1023.8 x 6453.33 123.0 3693.0 2767.25 4718.4 2910.2 5001.25 348.5 8838.25 5945.67 676.5 3675.6 3920.17 x x x 2955.25 x 5896.5 1149.0 2601.17 x 4050.62 228.0 1606.8 341.714 x 3229.0 x 4974.83 4083.78 6819.36 x 1646.64 399.667 1718.38 2306.75 x x 2516.0 x 833.714 4389.91 x x x 284.0 490.0 x x x 161.0 300.5 1688.83 3713.75 x 2107.5 2431.83 2614.17 933.0 1130.75 4576.25 7217.5 x 5083.5 x 3511.83 x 438.75 x x 3581.0 x x 977.0 670.6 5104.33 6101.5 154.833 x 1891.6 5259.5 x 4559.17 x x x 3005.17 6597.5 3786.83 401.333 5508.25 x x x +11598 Original post publication description: Novel open field behavior, locomotion in the periphery from 0-15 min for females in the morphine test battery [n beam breaks] None Novel open field behavior, locomotion in the periphery from 0-15 min for females in the morphine test battery [n beam breaks] x x x x 1533.86 902.8 x 1433.5 639.0 845.167 991.0 1529.6 651.2 1167.5 162.0 771.25 2158.33 1097.75 857.2 1143.67 x x x 589.5 x 670.333 338.0 2029.33 x 945.0 865.25 1131.0 980.143 x 686.333 x 536.0 516.333 1493.55 x 1391.36 775.667 713.25 1542.75 x x 795.75 x 1394.29 1175.18 x x x 1619.71 505.8 x x x 1650.0 1026.0 580.667 307.25 x 776.625 548.167 391.333 741.75 1199.5 1233.25 1297.83 x 881.5 x 842.5 x 1397.5 x x 1029.8 x x 503.333 677.2 755.667 1275.67 1072.17 x 1059.6 1033.17 x 1233.0 x x x 1010.67 1252.5 1306.0 1860.67 471.25 x x x +11599 Original post publication description: Novel open field behavior, locomotion in the periphery from 15-30 min for females in the morphine test battery [n beam breaks] None Central nervous system, behavior: Novel open field behavior, locomotion in the periphery from 15-30 min for females in the morphine test battery [n beam breaks] x x x x 1082.57 666.8 x 1038.67 989.0 949.833 802.0 1206.2 635.4 805.25 168.667 493.75 1520.0 1092.25 554.2 755.5 x x x 582.75 x 314.167 416.625 1785.67 x 641.375 620.75 1118.4 592.143 x 267.0 x 596.667 605.778 1320.82 x 944.545 689.5 370.625 1360.5 x x 711.75 x 1319.57 916.0 x x x 1250.57 249.8 x x x 991.167 931.25 436.167 607.25 x 814.5 397.167 523.5 830.0 1140.12 1252.25 1363.0 x 748.333 x 725.833 x 1364.5 x x 570.6 x x 449.5 726.4 653.0 1039.67 769.667 x 1288.8 491.333 x 1000.33 x x x 528.833 661.0 1409.83 1581.0 450.875 x x x +11600 Original post publication description: Novel open field behavior, locomotion in the periphery from 30-45 min for females in the morphine test battery [n beam breaks] None Novel open field behavior, locomotion in the periphery from 30-45 min for females in the morphine test battery [n beam breaks] x x x x 928.0 329.8 x 840.667 1149.0 756.5 996.75 1103.0 469.0 564.75 316.167 324.0 1159.67 973.5 282.0 579.667 x x x 436.0 x 109.0 296.75 1197.0 x 434.375 577.75 1128.6 411.429 x 109.667 x 551.167 458.889 1185.09 x 734.727 717.667 260.25 779.25 x x 571.5 x 1353.29 869.091 x x x 983.429 179.0 x x x 661.0 837.5 417.667 687.75 x 610.5 381.833 526.5 718.5 1200.5 1214.75 1370.83 x 612.333 x 569.0 x 1081.0 x x 488.6 x x 402.167 705.2 564.833 746.833 623.167 x 1303.4 448.667 x 868.333 x x x 364.5 549.5 1400.33 1215.17 432.375 x x x +11601 Original post publication description: Novel open field behavior, locomotion in the periphery from 45-60 min for females in the morphine test battery [n beam breaks] None Novel open field behavior, locomotion in the periphery from 45-60 min for females in the morphine test battery [n beam breaks] x x x x 814.286 278.2 x 767.0 993.0 536.5 669.5 907.8 225.8 434.25 219.5 438.0 978.0 618.5 172.6 439.167 x x x 308.75 x 28.5 208.5 1050.5 x 205.0 310.25 965.8 291.286 x 69.0 x 454.167 351.667 909.182 x 617.727 616.0 154.875 268.0 x x 552.5 x 1175.14 566.818 x x x 684.714 41.4 x x x 527.0 814.0 232.333 586.75 x 516.875 291.5 458.333 495.75 964.0 1046.75 1037.83 x 549.833 x 562.5 x 1007.0 x x 263.8 x x 343.833 586.4 379.5 489.667 418.833 x 1122.2 294.833 x 760.833 x x x 275.833 389.0 1291.33 1051.5 370.375 x x x +11602 Original post publication description: Novel open field behavior, locomotion in the periphery from 0-15 min for females in the morphine test battery [cm] None Novel open field behavior, locomotion in the periphery from 0-15 min for females in the morphine test battery [cm] x x x x 4837.79 3227.47 x 4596.56 2491.75 2904.89 3278.89 4770.0 2569.63 4047.58 986.159 2737.7 6404.02 3654.42 3062.19 3754.7 x x x 2559.49 x 2655.7 1615.82 6320.83 x 3486.55 3065.0 3883.22 3483.53 x 2723.26 x 2353.98 2156.95 4827.42 x 4577.67 2702.97 2617.77 5001.44 x x 2803.29 x 4397.01 3872.31 x x x 5349.2 2030.04 x x x 5136.08 3667.0 1994.64 1580.28 x 3050.59 2162.78 1883.22 2847.86 4083.4 4151.92 4449.81 x 3208.97 x 3020.5 x 4367.48 x x 3656.91 x x 2073.61 2727.66 2883.99 4203.35 3466.27 x 3781.48 3769.16 x 4271.84 x x x 3407.98 3966.97 4231.38 5748.61 2037.6 x x x +11603 Original post publication description: Novel open field behavior, locomotion in the periphery from 15-30 min for females in the morphine test battery [cm] None Novel open field behavior, locomotion in the periphery from 15-30 min for females in the morphine test battery [cm] x x x x 3776.94 2296.65 x 3421.78 3516.0 3153.53 2685.87 3980.13 2677.89 2878.27 1021.1 1897.67 4713.03 3950.22 2053.25 2652.73 x x x 2474.7 x 1250.32 1911.39 5452.64 x 2506.79 2290.22 3961.97 2334.19 x 1158.95 x 2588.13 2329.17 4379.19 x 3353.5 2558.17 1377.51 4368.28 x x 2427.9 x 4169.91 3300.48 x x x 4122.67 1275.36 x x x 3290.51 3342.88 1780.98 2553.73 x 2993.51 1679.01 2214.16 3204.22 3831.19 4136.24 4465.81 x 2719.07 x 2697.56 x 4247.02 x x 2310.71 x x 1920.8 2869.36 2486.22 3441.52 2587.32 x 4294.59 2239.86 x 3635.67 x x x 1970.84 2505.43 4428.46 4981.89 1894.47 x x x +11604 Original post publication description: Novel open field behavior, locomotion in the periphery from 30-45 min for females in the morphine test battery [cm] None Novel open field behavior, locomotion in the periphery from 30-45 min for females in the morphine test battery [cm] x x x x 3159.82 1226.38 x 2855.83 3500.01 2668.91 3108.21 3683.35 2063.84 2036.4 1618.72 1369.0 3679.01 3498.39 1091.33 1908.81 x x x 1989.13 x 412.642 1448.3 3764.05 x 1716.48 2033.89 3867.09 1591.62 x 475.633 x 2322.48 1870.17 3936.7 x 2629.74 2677.74 970.682 2716.09 x x 2132.84 x 4270.95 3137.46 x x x 3426.34 861.135 x x x 2239.64 3084.71 1608.93 2788.35 x 2189.54 1485.06 2188.67 2951.68 4081.04 4080.72 4410.47 x 2315.72 x 2225.27 x 3494.36 x x 1895.83 x x 1672.62 2705.45 2063.04 2476.86 2119.28 x 4285.03 2015.1 x 3149.9 x x x 1454.32 1986.18 4462.45 3993.77 1687.39 x x x +11605 Original post publication description: Novel open field behavior, locomotion in the periphery from 45-60 min for females in the morphine test battery [cm] None Novel open field behavior, locomotion in the periphery from 45-60 min for females in the morphine test battery [cm] x x x x 2769.91 976.646 x 2671.16 3299.83 1821.36 2280.32 3127.07 1128.71 1723.43 1148.85 1654.91 3113.26 2203.18 617.629 1384.07 x x x 1412.72 x 114.537 992.6 3348.52 x 781.016 1065.86 3324.2 1094.37 x 291.152 x 2028.39 1507.52 3114.38 x 2191.66 2351.07 560.053 1055.43 x x 2047.71 x 3695.3 2130.65 x x x 2415.29 229.685 x x x 1668.45 2967.01 1035.05 2331.56 x 1853.43 1160.43 1933.5 2105.35 3377.42 3580.18 3419.65 x 2098.55 x 2107.11 x 3242.21 x x 1102.94 x x 1427.72 2345.33 1408.6 1649.14 1414.11 x 3779.39 1510.14 x 2634.58 x x x 1083.4 1410.4 4117.85 3456.0 1481.58 x x x +11606 Original post publication description: Novel open field behavior, vertical activity (rears) from 0-15 for females [n beam breaks] None Central nervous system, behavior: Novel open field behavior, vertical activity (rears) from 0-15 for females [n beam breaks] x x x x 211.0 210.0 x 269.167 234.0 227.0 165.75 208.4 74.8 276.5 29.0 219.5 284.5 284.5 259.4 266.5 x x x 82.25 x 178.5 78.125 287.5 x 228.0 144.25 273.6 299.857 x 129.0 x 196.667 110.111 357.636 x 291.909 354.833 108.875 312.5 x x 216.5 x 355.143 265.364 x x x 287.143 46.4 x x x 347.0 261.0 142.167 56.75 x 160.875 219.5 166.167 274.0 284.75 251.875 279.167 x 320.167 x 243.0 x 239.0 x x 317.4 x x 106.0 258.6 306.667 305.0 233.833 x 341.2 253.667 x 185.333 x x x 378.333 260.5 192.0 404.333 123.5 x x x +11607 Original post publication description: Novel open field behavior, vertical activity (rears) from 15-30 min for females [n beam breaks] None Central nervous system, behavior: Novel open field behavior, vertical activity (rears) from 15-30 min for females [n beam breaks] x x x x 268.0 210.4 x 315.167 331.0 283.167 173.25 242.0 170.8 281.25 51.6667 302.0 347.667 396.5 211.2 245.333 x x x 91.5 x 116.833 142.5 409.833 x 263.5 178.5 364.0 236.0 x 117.667 x 316.167 177.556 422.909 x 310.0 461.333 100.75 292.0 x x 289.0 x 408.429 265.909 x x x 309.429 47.0 x x x 276.5 326.25 219.667 141.5 x 260.125 260.167 306.5 340.75 400.375 348.0 362.333 x 420.0 x 276.833 x 337.25 x x 332.4 x x 172.833 354.4 330.667 314.0 224.333 x 455.4 252.0 x 243.5 x x x 417.833 239.0 237.0 386.5 208.875 x x x +11608 Original post publication description: Novel open field behavior, vertical activity (rears) from 30-45 min for females [n beam breaks] None Central nervous system, behavior: Novel open field behavior, vertical activity (rears) from 30-45 min for females [n beam breaks] x x x x 210.857 204.6 x 299.667 393.0 299.833 158.0 280.6 166.8 249.75 47.3333 314.0 313.667 421.0 156.8 203.0 x x x 70.75 x 65.1667 127.625 382.667 x 234.875 158.25 391.8 170.429 x 61.0 x 370.833 152.778 392.909 x 286.636 477.167 79.625 164.75 x x 256.5 x 454.714 242.636 x x x 301.571 42.4 x x x 239.0 369.0 221.167 191.75 x 186.75 201.333 323.5 299.75 415.375 401.5 384.833 x 384.0 x 248.167 x 363.75 x x 355.2 x x 160.5 386.2 327.167 227.0 201.667 x 461.0 219.0 x 238.0 x x x 367.0 278.5 283.0 302.5 207.0 x x x +11609 Original post publication description: Novel open field behavior, vertical activity (rears) from 45-60 min for females [n beam breaks] None Central nervous system, behavior: Novel open field behavior, vertical activity (rears) from 45-60 min for females [n beam breaks] x x x x 231.286 121.6 x 332.333 338.0 268.667 111.75 240.6 102.0 232.0 55.0 306.25 290.333 311.0 84.6 136.5 x x x 46.25 x 45.0 108.125 409.0 x 160.25 122.75 405.2 123.286 x 41.6667 x 386.333 195.444 358.091 x 279.727 474.333 54.25 81.75 x x 285.0 x 405.286 199.545 x x x 224.857 18.4 x x x 150.5 314.0 185.167 170.25 x 202.375 198.167 309.833 257.5 410.625 384.75 348.333 x 365.0 x 267.667 x 336.25 x x 265.2 x x 169.833 357.2 260.0 177.333 176.667 x 458.2 195.167 x 171.5 x x x 349.167 181.0 289.5 316.667 203.375 x x x +11610 Original post publication description: Novel open field behavior, locomotion in the center from 0-60 min for females [n beam breaks] None Novel open field behavior, locomotion in the center from 0-60 min for females [n beam breaks] x x x x 4358.71 2177.6 x 4079.83 3770.0 3088.0 3459.25 4746.6 1981.4 2971.75 866.333 2027.0 5816.0 3782.0 1866.0 2918.0 x x x 1917.0 x 1122.0 1259.88 6062.5 x 2225.75 2374.0 4343.8 2275.0 x 1132.0 x 2138.0 1932.67 4908.64 x 3688.36 2798.83 1499.0 3950.5 x x 2631.5 x 5242.29 3527.09 x x x 4538.43 976.0 x x x 3829.17 3608.75 1666.83 2189.0 x 2718.5 1618.67 1899.67 2786.0 4504.12 4747.0 5069.5 x 2792.0 x 2699.83 x 4850.0 x x 2352.8 x x 1698.83 2695.2 2353.0 3551.83 2883.83 x 4774.0 2268.0 x 3862.5 x x x 2179.83 2852.0 5407.5 5708.33 1724.88 x x x +11611 Original post publication description: Novel open field behavior, locomotion in the center from 0-60 min for females [cm] None Novel open field behavior, locomotion in the center from 0-60 min for females [cm] x x x x 14544.5 7727.15 x 13545.3 12807.6 10548.7 11353.3 15560.5 8440.08 10685.7 4774.83 7659.28 17909.3 13306.2 6824.4 9700.3 x x x 8436.05 x 4433.2 5968.11 18886.0 x 8490.84 8454.98 15036.5 8503.71 x 4648.99 x 9292.98 7863.81 16257.7 x 12752.6 10290.0 5526.02 13141.2 x x 9411.74 x 16533.2 12440.9 x x x 15313.5 4396.22 x x x 12334.7 13061.6 6419.6 9253.93 x 10087.1 6487.29 8219.56 11109.1 15373.1 15949.0 16745.7 x 10342.3 x 10050.4 x 15351.1 x x 8966.4 x x 7094.75 10647.8 8841.86 11770.9 9586.98 x 16140.5 9534.26 x 13692.0 x x x 7916.54 9868.99 17240.1 18180.3 7101.04 x x x +11612 Original post publication description: Novel open field behavior, vertical activity (rears) in the center from 0-60 min for females [n beam breaks] None Central nervous system, behavior: Novel open field behavior, vertical activity (rears) in the center from 0-60 min for females [n beam breaks] x x x x 921.143 746.6 x 1216.33 1296.0 1078.67 608.75 971.6 514.4 1039.5 183.0 1141.75 1236.17 1413.0 712.0 851.333 x x x 290.75 x 405.5 456.375 1489.0 x 886.625 603.75 1434.6 829.571 x 349.333 x 1270.0 635.889 1531.55 x 1168.27 1767.67 343.5 851.0 x x 1047.0 x 1623.57 973.455 x x x 1123.0 154.2 x x x 1013.0 1270.25 768.167 560.25 x 810.125 879.167 1106.0 1172.0 1511.12 1386.12 1374.67 x 1489.17 x 1035.67 x 1276.25 x x 1270.2 x x 609.167 1356.4 1224.5 1023.33 836.5 x 1715.8 919.833 x 838.333 x x x 1512.33 959.0 1001.5 1410.0 742.75 x x x +11613 Original post publication description: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), locomotion from 0-15 min after naloxone injection for females [n beam breaks] None Central nervous system, pharmacology, behavior: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), locomotion from 0-15 min after naloxone injection for females [n beam breaks] x x x x 283.571 351.2 x 224.333 272.0 315.0 241.5 414.4 259.6 148.0 154.833 271.75 554.5 260.5 424.2 229.333 x x x 304.5 x 578.0 685.125 342.167 x 213.5 673.5 397.6 570.571 x 142.333 x 184.0 243.556 317.727 x 482.545 594.333 205.75 605.5 x x 455.5 x 329.571 338.636 x x x 353.143 228.2 x x x 394.5 218.0 384.333 202.75 x 250.125 233.0 172.5 168.75 367.5 384.125 229.333 x 270.333 x 271.667 x 278.667 x x 266.0 x x 241.5 505.4 259.5 659.5 305.167 x 413.2 255.333 x 231.5 x x x 448.333 236.5 485.833 1136.83 407.125 x x x +11614 Original post publication description: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), horizontal activity (distance traveled) from 0-15 min after naloxone injection for females [cm] None Central nervous system, pharmacology, behavior: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), horizontal activity (distance traveled) from 0-15 min after naloxone injection for females [cm] x x x x 1040.41 1192.38 x 774.669 866.112 1111.03 876.523 1426.17 935.343 568.881 684.475 926.03 1685.23 921.181 1561.3 882.322 x x x 1194.13 x 1973.47 2318.88 1060.51 x 788.99 1994.02 1227.26 1696.19 x 539.691 x 694.091 849.65 1055.25 x 1658.2 1816.45 710.858 1892.8 x x 1323.61 x 1159.83 1010.5 x x x 1228.1 937.153 x x x 1252.02 718.735 1139.19 784.218 x 899.002 737.637 617.037 653.434 1207.42 1225.34 807.984 x 892.401 x 910.542 x 1084.85 x x 903.33 x x 925.804 1533.95 949.745 2025.9 985.22 x 1407.46 889.788 x 886.683 x x x 1422.74 818.619 1690.29 3353.51 1289.05 x x x +11615 Original post publication description: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), vertical activity (rears) from 0-15 min after naloxone injection for females [n beam breaks] None Central nervous system, pharmacology, behavior: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), vertical activity (rears) from 0-15 min after naloxone injection for females [n beam breaks] x x x x 82.2857 72.2 x 98.8333 42.0 73.5 47.5 80.2 88.8 52.75 41.6667 72.75 111.5 95.25 161.4 116.833 x x x 56.75 x 166.833 91.25 88.8333 x 62.5 94.25 25.4 101.714 x 32.3333 x 118.333 73.2222 53.1818 x 145.727 153.333 57.25 151.0 x x 130.25 x 135.429 101.091 x x x 118.571 24.0 x x x 103.667 74.0 44.8333 64.0 x 92.5 121.5 117.833 46.25 46.25 133.75 64.8333 x 108.333 x 136.667 x 68.3333 x x 111.2 x x 101.5 70.4 148.833 63.5 37.6667 x 151.2 65.6667 x 98.5 x x x 201.0 109.5 92.3333 196.5 81.75 x x x +11616 Original post publication description: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), postural changes for females [ordinal scale, 0=no effect, 3=max] None Central nervous system, pharmacology, behavior: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), postural changes for females [ordinal scale, 0=no effect, 3=max] x x x x 0.0 0.0 x 0.0 0.0 0.0 0.75 0.2 0.6 0.25 0.333333 0.0 1.16667 0.0 0.0 0.166667 x x x 0.0 x 0.166667 0.125 0.666667 x 0.125 0.0 0.0 0.142857 x 0.0 x 0.5 0.222222 0.090909 x 0.0 0.0 0.125 0.75 x x 0.0 x 0.857143 0.636364 x x x 0.285714 0.0 x x x 0.333333 0.5 0.0 0.0 x 0.125 0.166667 0.166667 0.0 0.125 0.125 0.333333 x 0.166667 x 0.166667 x 0.333333 x x 0.2 x x 0.0 0.0 0.0 0.666667 0.0 x 0.0 0.166667 x 0.333333 x x x 0.166667 0.0 0.333333 0.0 0.0 x x x +11617 Original post publication description: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), ptosis for females [ordinal scale, 0=no effect, 3=max] None Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), ptosis for females [ordinal scale, 0=no effect, 3=max] x x x x 1.57143 0.0 x 0.166667 2.0 0.0 0.0 0.0 0.0 0.25 1.66667 1.25 0.666667 0.25 0.0 0.0 x x x 0.25 x 0.333333 0.125 0.833333 x 0.0 0.25 0.4 0.0 x 0.333333 x 0.0 0.0 0.272727 x 0.090909 0.0 0.0 0.0 x x 0.5 x 0.285714 0.454545 x x x 0.714286 0.0 x x x 0.666667 0.0 0.833333 0.0 x 0.0 0.833333 0.166667 0.0 0.0 1.5 0.333333 x 0.333333 x 0.0 x 1.0 x x 0.6 x x 0.166667 0.0 0.0 0.166667 0.0 x 0.0 0.0 x 0.333333 x x x 0.333333 0.0 0.0 0.0 0.0 x x x +11618 Original post publication description: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), salivation for females [ordinal scale, 0=control level, 3=max] None Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), salivation for females [ordinal scale, 0=control level, 3=max] x x x x 0.285714 0.0 x 0.166667 0.0 0.0 0.25 0.2 0.2 0.25 0.0 0.25 0.333333 0.0 0.0 0.333333 x x x 0.5 x 0.166667 0.0 0.666667 x 0.375 0.25 0.0 0.0 x 0.333333 x 2.16667 0.222222 0.090909 x 0.545455 0.166667 0.0 0.75 x x 0.25 x 0.0 0.181818 x x x 0.857143 0.2 x x x 0.0 0.25 0.166667 0.0 x 0.125 0.0 0.0 0.5 0.5 0.125 0.166667 x 0.5 x 0.5 x 0.0 x x 0.0 x x 0.0 0.6 0.5 0.0 0.166667 x 0.0 0.0 x 0.0 x x x 1.16667 0.0 0.0 0.166667 0.0 x x x +11619 Original post publication description: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), wet dog shakes for females [ordinal scale, 0=no effect, 3=max] None Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), wet dog shakes for females [ordinal scale, 0=no effect, 3=max] x x x x 0.285714 2.2 x 0.5 0.0 0.0 0.5 0.0 2.4 0.5 0.0 0.5 0.833333 0.75 1.2 1.0 x x x 0.25 x 2.5 1.0 0.666667 x 0.25 0.0 0.4 0.142857 x 0.0 x 2.66667 0.777778 0.181818 x 1.45455 1.83333 0.375 1.5 x x 1.5 x 0.285714 1.36364 x x x 1.28571 1.6 x x x 0.166667 1.5 0.0 0.0 x 1.5 1.33333 0.5 0.0 1.375 0.5 0.166667 x 1.0 x 1.5 x 2.33333 x x 0.0 x x 0.666667 0.6 0.666667 0.166667 0.166667 x 0.6 0.666667 x 1.5 x x x 1.5 0.5 2.16667 1.5 0.5 x x x +11620 Original post publication description: Novel open field behavior, urinations for females [n/test period] None Central nervous system, behavior: Novel open field behavior, urinations for females [n/test period] x x x x 1.0 1.4 x 1.16667 1.0 1.33333 1.75 1.2 1.8 1.5 0.833333 1.0 1.16667 1.5 1.8 1.5 x x x 1.5 x 1.83333 0.875 1.5 x 1.0 1.0 1.0 1.0 x 0.333333 x 1.5 1.0 0.454545 x 1.45455 0.833333 0.75 0.75 x x 1.5 x 1.28571 1.36364 x x x 1.14286 1.2 x x x 1.66667 1.5 1.16667 1.0 x 1.375 1.83333 1.5 0.75 0.875 2.125 1.0 x 0.833333 x 0.833333 x 1.0 x x 1.0 x x 0.5 1.0 1.0 1.66667 0.5 x 1.2 1.16667 x 1.0 x x x 1.5 2.0 1.5 1.33333 1.0 x x x +11621 Original post publication description: Morphine response (50 mg/kg ip), vertical activity (rears) from 90-105 min after injection in an activity chamber for females [n beam breaks] None Morphine response (50 mg/kg ip), vertical activity (rears) from 90-105 min after injection in an activity chamber for females [n beam breaks] x x x x 438.429 92.2 x 792.0 1.0 385.0 246.25 530.2 298.8 454.75 41.3333 835.75 687.0 46.75 415.2 417.167 x x x 342.5 x 742.0 129.75 254.5 x 479.625 40.75 159.8 36.7143 x 268.333 x 551.0 457.111 728.545 x 133.455 33.3333 170.0 256.75 x x 237.5 x 61.5714 610.0 x x x 30.2857 32.0 x x x 1.16667 18.5 223.667 372.75 x 291.875 440.167 309.5 52.0 124.75 377.0 525.5 x 627.833 x 408.0 x 30.25 x x 431.6 x x 122.333 55.8 389.0 765.167 19.3333 x 119.2 509.0 x 443.0 x x x 325.333 730.0 221.167 17.6667 617.625 x x x +11622 Original post publication description: Morphine response (50 mg/kg ip), vertical activity (rears) from 105-120 min after injection in an activity chamber for females [n beam breaks] None Morphine response (50 mg/kg ip), vertical activity (rears) from 105-120 min after injection in an activity chamber for females [n beam breaks] x x x x 422.286 98.8 x 763.5 1.0 304.0 173.5 463.8 311.6 497.75 31.1667 683.25 700.833 101.75 314.8 373.667 x x x 246.25 x 642.5 134.5 197.5 x 359.5 32.0 145.2 26.1429 x 209.0 x 497.667 461.0 703.818 x 150.091 45.0 154.0 180.0 x x 196.5 x 150.571 515.0 x x x 34.1429 15.4 x x x 6.66667 23.0 172.667 364.0 x 285.25 447.5 254.167 48.25 85.125 334.0 471.5 x 601.833 x 280.0 x 28.0 x x 301.4 x x 116.833 102.2 439.5 681.333 12.6667 x 169.2 486.333 x 427.167 x x x 247.5 917.0 141.167 36.6667 580.625 x x x +11623 Original post publication description: Morphine response (50 mg/kg ip), vertical activity (rears) from 120-135 min after injection in an activity chamber for females [n beam breaks] None Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), vertical activity (rears) from 120-135 min after injection in an activity chamber for females [n beam breaks] x x x x 451.857 118.8 x 686.833 9.0 259.667 93.75 237.2 341.6 465.25 23.0 704.75 648.833 131.0 253.2 290.667 x x x 151.75 x 523.5 137.625 109.167 x 223.875 25.25 150.0 18.4286 x 206.333 x 409.667 436.0 660.091 x 200.545 56.3333 91.75 133.25 x x 118.5 x 162.857 396.091 x x x 20.2857 6.4 x x x 12.0 16.25 132.5 300.75 x 254.75 224.167 223.0 52.0 66.375 286.0 452.167 x 489.333 x 124.333 x 26.0 x x 175.0 x x 114.167 109.8 448.667 513.5 11.5 x 241.4 442.333 x 352.167 x x x 181.5 1173.0 109.833 34.5 491.875 x x x +11624 Original post publication description: Morphine response (50 mg/kg ip), vertical activity (rears) from 0-15 min after injection in an activity chamber for females [n beam breaks] None Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), vertical activity (rears) from 0-15 min after injection in an activity chamber for females [n beam breaks] x x x x 408.143 52.4 x 121.5 7.0 160.0 169.75 155.2 35.2 272.0 41.6667 341.0 116.667 17.75 133.6 103.5 x x x 62.0 x 199.5 38.125 134.333 x 137.875 10.0 63.0 31.8571 x 111.0 x 153.833 103.556 336.091 x 61.6364 40.6667 112.125 86.5 x x 74.75 x 36.1429 87.0 x x x 30.8571 34.6 x x x 15.1667 45.25 9.83333 73.0 x 67.125 80.1667 85.1667 21.25 37.5 462.0 535.167 x 32.3333 x 119.5 x 69.25 x x 109.4 x x 38.5 22.4 203.333 114.0 6.5 x 188.6 308.167 x 206.833 x x x 135.0 20.5 295.5 38.3333 127.375 x x x +11625 Original post publication description: Morphine response (50 mg/kg ip), vertical activity (rears) 150-165 min after injection in an activity chamber for females [n beam breaks] None Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), vertical activity (rears) 150-165 min after injection in an activity chamber for females [n beam breaks] x x x x 298.429 109.2 x 491.5 22.0 179.167 27.5 129.4 248.0 390.25 11.0 335.5 370.167 46.25 75.0 236.5 x x x 45.25 x 285.0 102.0 48.3333 x 96.125 7.75 153.6 10.4286 x 175.333 x 296.5 381.778 332.636 x 219.727 17.3333 33.375 321.0 x x 66.75 x 89.8571 270.909 x x x 15.5714 3.6 x x x 17.3333 37.25 64.3333 268.25 x 80.25 41.3333 99.0 57.25 88.125 317.125 415.0 x 438.333 x 85.6667 x 8.75 x x 93.2 x x 43.6667 93.2 510.333 329.167 6.5 x 266.8 235.833 x 262.5 x x x 139.333 765.5 75.1667 16.1667 324.25 x x x +11626 Original post publication description: Morphine response (50 mg/kg ip), vertical activity (rears) from 165-180 min after injection in an activity chamber for females [n beam breaks] None Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), vertical activity (rears) from 165-180 min after injection in an activity chamber for females [n beam breaks] x x x x 258.714 116.8 x 222.167 28.0 144.833 38.75 129.8 106.8 326.0 6.66667 325.25 236.167 60.75 99.2 181.5 x x x 47.25 x 174.0 78.125 54.6667 x 67.125 10.0 140.6 30.4286 x 69.6667 x 302.0 294.667 185.636 x 203.818 15.0 15.875 297.25 x x 110.75 x 32.4286 204.455 x x x 27.2857 3.6 x x x 4.66667 28.25 49.8333 248.5 x 38.625 33.1667 85.6667 33.25 68.5 291.75 323.667 x 267.0 x 117.333 x 3.25 x x 92.8 x x 37.3333 126.2 356.833 290.667 3.16667 x 185.0 86.3333 x 201.667 x x x 127.167 500.0 53.0 13.0 296.625 x x x +11627 Original post publication description: Morphine response (50 mg/kg ip), vertical activity (rears) from 15-30 min after injection in an activity chamber for females [n beam breaks] None Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), vertical activity (rears) from 15-30 min after injection in an activity chamber for females [n beam breaks] x x x x 556.429 50.2 x 264.333 0.0 228.333 349.75 411.0 103.8 384.75 47.1667 915.5 319.667 24.25 347.4 259.0 x x x 199.75 x 358.5 24.75 252.833 x 367.5 4.5 106.4 24.2857 x 362.333 x 385.667 205.556 613.091 x 68.2727 51.3333 229.625 162.5 x x 328.75 x 12.1429 192.727 x x x 43.1429 66.2 x x x 3.5 33.25 40.1667 254.75 x 91.875 55.1667 213.5 50.5 67.5 543.0 1168.67 x 128.167 x 248.0 x 79.75 x x 285.2 x x 26.5 0.0 404.0 360.167 3.33333 x 139.0 524.167 x 400.667 x x x 230.333 42.5 576.667 101.5 288.75 x x x +11628 Original post publication description: Morphine response (50 mg/kg ip), vertical activity (rears) from 30-45 min after injection in an activity chamber for females [n beam breaks] None Morphine response (50 mg/kg ip), vertical activity (rears) from 30-45 min after injection in an activity chamber for females [n beam breaks] x x x x 383.714 50.6 x 402.667 18.0 392.833 427.75 626.6 217.8 410.0 34.5 1065.0 446.667 39.25 438.0 398.0 x x x 404.25 x 505.5 56.0 375.5 x 510.0 8.5 115.4 32.1429 x 451.333 x 485.833 261.111 612.364 x 61.0909 21.6667 205.125 60.0 x x 339.25 x 36.0 283.0 x x x 19.4286 89.6 x x x 9.0 14.0 174.0 375.75 x 142.25 112.5 239.0 165.25 71.625 415.75 854.667 x 322.167 x 366.333 x 33.0 x x 391.0 x x 51.1667 0.8 446.0 455.0 12.8333 x 77.0 502.667 x 473.667 x x x 286.833 139.5 645.5 11.1667 466.75 x x x +11629 Original post publication description: Morphine response (50 mg/kg ip), vertical activity (rears) from 45-60 min after injection in an activity chamber for females [n beam breaks] None Morphine response (50 mg/kg ip), vertical activity (rears) from 45-60 min after injection in an activity chamber for females [n beam breaks] x x x x 433.571 66.4 x 546.5 0.0 470.167 433.5 659.8 294.6 405.25 33.5 1115.25 516.833 59.75 531.4 469.167 x x x 440.75 x 616.667 87.5 428.167 x 533.125 11.75 130.4 41.0 x 433.0 x 493.667 291.111 699.818 x 84.1818 16.1667 199.75 121.5 x x 327.0 x 25.5714 420.818 x x x 12.8571 109.0 x x x 31.5 21.25 256.0 391.75 x 196.5 197.0 263.833 226.0 116.125 441.75 702.0 x 474.5 x 515.333 x 16.75 x x 481.8 x x 98.6667 15.8 481.5 614.0 19.0 x 53.0 568.167 x 502.333 x x x 363.0 222.0 688.667 29.8333 577.0 x x x +11630 Original post publication description: Morphine response (50 mg/kg ip), vertical activity (rears) from 60-75 min after injection in an activity chamber for females [n beam breaks] None Morphine response (50 mg/kg ip), vertical activity (rears) from 60-75 min after injection in an activity chamber for females [n beam breaks] x x x x 500.571 64.6 x 705.167 0.0 500.0 412.0 610.8 352.2 431.75 29.0 1101.25 647.5 29.75 525.8 498.333 x x x 533.0 x 719.5 111.75 406.5 x 520.0 23.0 143.0 39.5714 x 411.667 x 548.167 365.0 693.182 x 108.727 33.3333 236.625 221.5 x x 314.5 x 31.1429 493.091 x x x 13.4286 80.8 x x x 41.6667 17.5 247.0 401.75 x 245.25 296.0 310.0 116.75 156.5 403.375 686.0 x 569.333 x 577.833 x 47.0 x x 591.8 x x 114.0 21.4 470.667 773.833 28.0 x 80.4 609.167 x 499.167 x x x 381.167 393.0 603.0 46.0 681.125 x x x +11631 Original post publication description: Morphine response (50 mg/kg ip), vertical activity (rears) from 75-90 min after injection in an activity chamber for females [n beam breaks] None Morphine response (50 mg/kg ip), vertical activity (rears) from 75-90 min after injection in an activity chamber for females [n beam breaks] x x x x 485.571 89.4 x 818.167 3.0 477.333 349.0 574.6 324.6 480.0 37.1667 965.75 681.0 41.5 434.4 457.833 x x x 429.5 x 708.667 129.25 302.5 x 598.75 32.0 154.6 43.2857 x 333.667 x 538.833 440.222 721.545 x 110.818 23.8333 214.625 220.5 x x 306.75 x 40.2857 566.091 x x x 28.0 40.8 x x x 3.33333 27.25 246.333 386.25 x 238.625 382.5 389.833 40.0 176.125 388.875 634.0 x 640.333 x 566.0 x 68.0 x x 508.0 x x 120.333 45.8 475.167 801.667 24.1667 x 92.2 635.167 x 493.5 x x x 395.667 554.5 331.167 28.8333 651.875 x x x +11632 Original post publication description: 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) response (10 mg/kg subcutaneous), locomotion on day 2 for females [cm/90 min test] None Central nervous system, pharmacology, behavior: 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) response (10 mg/kg subcutaneous), locomotion on day 2 for females [cm/90 min test] x x x x x x x x x x x 2392.0 x x x 735.5 x x x x x x x x x x 1219.0 x x x x x x x 217.5 x x 2288.5 x x x 1463.5 538.5 x x x x x x x x x x x x x x x 4339.0 x 27235.0 x x x x x x 19276.0 x x x 22764.0 x 2664.0 x x x x x x x x x x 36001.5 x x x x x x x x x x x x x x x x x +11633 Original post publication description: Locomotor activity after first saline injection (day 1) for females (MDMA control) [cm/ test period] None Locomotor activity after first saline injection (day 1) for females (MDMA control) [cm/ test period] x x x x x x x x x x 2766.0 7316.5 x x x 5692.0 x x x x x x x x x x 3966.0 x x x x x x x 1678.0 x x 5494.5 x x x 3902.0 1717.5 x x x x x x x x x x x x x x x 4637.0 x 5353.5 x x x x x x 16310.0 x x x 3506.5 x 5529.0 x x x x x x x x x x 5212.0 x x x x x x x x x x x x x x x x x +11634 Original post publication description: Saline control response, locomotor activity after second injection for females (control for MDMA response experiment) [cm/test period] None Saline control response, locomotor activity after second injection for females (control for MDMA response experiment) [cm/test period] x x x x x x x x x x 2147.0 875.0 x x x 1220.0 x x x x x x x x x x x x x x x x x x 208.0 x x 1156.5 x x x 1544.0 592.5 x x x x x x x x x x x x x x x 137.5 x 544.5 x x x x x x 7598.5 x x x 1611.0 x 1072.0 x x x x x x x x x x 635.5 x x x x x x x x x x x x x x x x x +11635 Original post publication description: Ethanol response (4.0 g/kg ip), handling-induced convulsion (HIC) 4 hrs after injection for females [explain the score] None Central nervous system, pharmacology, behavior: Ethanol response (4.0 g/kg ip), handling-induced convulsion (HIC) 4 hrs after injection for females [explain the score] x x x x x x x x x x x x 0.0 0.0 x x x x x x x x x x x x x x x x x x x x 0.142857 x 0.0 x x x x 0.333333 1.125 x x x 0.0 x x 0.0 x x x x x x x x 0.125 x 0.4 x x 0.0 x x x 0.125 0.0 0.0 x 0.1 0.0 0.0 x 0.071429 0.0 x 0.0 x x 0.0 0.0 0.1 0.0 0.0 x 0.0 x x 0.0 x x x x x x x x x x x +11636 Original post publication description: Ethanol response (4.0 g/kg ip), Handling-induced convulsions (HIC) 6 hrs after injections for females [units] None Ethanol response (4.0 g/kg ip), Handling-induced convulsions (HIC) 6 hrs after injections for females [units] x x x x x x x x x x x x 0.0 0.75 x x x x x x x x x x x x x x x x x x x x 1.14286 x 0.0 x x x x 0.666667 3.375 x x x 0.0 x x 1.33333 x x x x x x x x 1.375 x 1.6 x x 0.333333 x x x 1.375 0.0 0.5 x 0.9 0.2 0.2 x 1.07143 2.0 x 1.0 x x 1.66667 0.0 0.8 0.6 0.833333 x 1.25 x x 0.4 x x x x x x x x x x x +11637 Original post publication description: Ethanol response (4.0 g/kg ip), handling-induced convulsion (HIC) score 7 hrs after ethanol injection for females [units] None Central nervous system, pharmacology, behavior: Ethanol response (4.0 g/kg ip), handling-induced convulsion (HIC) score 7 hrs after ethanol injection for females [units] x x x x x x x x x x x x 0.6 1.75 x x x x x x x x x x x x x x x x x x x x 1.85714 x 0.0 x x x x 0.666667 1.75 x x x 0.0 x x 0.0 x x x x x x x x 0.25 x 1.3 x x 0.333333 x x x 1.625 0.0 0.5 x 0.7 0.0 0.0 x 1.0 0.0 x 0.0 x x 1.0 0.5 0.0 1.3 0.5 x 0.625 x x 0.2 x x x x x x x x x x x +11638 Original post publication description: Seizure susceptibility, handling-induced convulsion (HIC) baseline for females [score] None Seizure susceptibility, handling-induced convulsion (HIC) baseline for females [score] x x x x x x x x x x x x 0.0 1.5 x x x x x x x x x x x x x x x x x x x x 0.142857 x 0.0 x x x x 1.0 0.375 x x x 0.0 x x 0.0 x x x x x x x x 0.5 x 0.6 x x 0.0 x x x 0.375 0.0 0.5 x 0.0 0.0 0.0 x 0.0 1.66667 x 0.0 x x 0.0 0.0 0.0 0.2 0.166667 x 0.375 x x 0.0 x x x x x x x x x x x +11639 Original post publication description: Ethanol response (4.0 g/kg ip), handling-induced convulsion (HIC) after injection for females [explain the score] None Ethanol response (4.0 g/kg ip), handling-induced convulsion (HIC) after injection for females [explain the score] x x x x x x x x x x x x 0.6 1.0 x x x x x x x x x x x x x x x x x x x x 2.71429 x 0.0 x x x x x 5.125 x x x x x x x x x x x x x x x x x x x x 0.666667 x x x 2.25 0.0 0.5 x 1.6 0.2 0.2 x 2.14286 0.333333 x 1.0 x x 2.66667 0.5 0.9 1.6 1.16667 x 1.25 x x 0.6 x x x x x x x x x x x +11640 Original post publication description: Pain response, thermal nociception, hot plate latency for females [sec] None Central nervous system, peripheral nervous system, behavior: Pain response, thermal nociception, hot plate latency for females [sec] x x x x x 6.19889 x 7.795 11.23 x 7.68333 10.7457 7.088 7.61 6.07667 9.76333 8.66714 7.42454 x 9.77231 x x x 7.46875 x 8.72429 10.13 7.12308 x 5.73714 6.467 11.0837 11.6175 x 6.97857 x 8.20111 6.99091 5.84273 x 8.58286 7.386 9.4625 10.894 x x 9.5425 x 5.6975 8.28625 x x x 7.94889 7.122 x x x 8.00636 8.88208 6.53833 x x 9.46 9.38 6.87625 6.87909 8.40481 10.275 8.715 x 8.72143 x 11.056 x 7.26 x x 6.001 x x 12.0983 7.2625 x 12.8183 8.268 x 9.3725 x x 6.70167 x x x 10.43 8.3475 5.978 x 7.41286 x x x +11641 Original post publication description: Locomotion in dark compartment of a light-dark box for females [cm] None Central nervous system, behavior: Locomotion in dark compartment of a light-dark box for females [cm] x x x x x 777.222 x 966.375 564.0 x 270.667 1013.14 422.556 831.0 260.0 668.5 924.714 422.636 x 775.692 x x x 338.875 x 469.714 362.286 813.308 x 765.556 911.1 439.625 664.143 x 590.857 x 579.444 329.636 782.0 x 745.143 738.2 506.5 748.4 x x 724.75 x 640.25 507.125 x x x 914.556 334.2 x x x 800.727 598.958 402.833 x x 756.375 696.25 537.25 679.182 757.37 705.375 524.5 x 733.222 x 437.8 x 622.75 x x 583.25 x x 561.5 640.125 x 645.5 531.8 x 745.75 x x 634.5 x x x 808.833 652.25 903.6 x 535.857 x x x +11642 Original post publication description: Anxiety assay, time in dark side of a light-dark box for females [sec] None Central nervous system, behavior: Anxiety assay, time in dark side of a light-dark box for females [sec] x x x x x 462.822 x 413.212 477.5 x 356.35 472.871 395.789 445.4 304.9 328.45 354.129 350.882 x 368.108 x x x 219.637 x 446.471 415.014 392.515 x 433.433 438.07 403.625 405.786 x 461.829 x 501.211 441.2 350.427 x 356.686 394.22 402.942 390.14 x x 412.962 x 372.275 452.237 x x x 411.833 490.14 x x x 396.5 388.617 462.15 x x 396.587 437.525 415.65 386.036 367.467 350.55 385.85 x 463.567 x 315.76 x 447.325 x x 480.938 x x 466.95 366.837 x 461.967 455.88 x 370.575 x x 473.1 x x x 469.05 459.425 495.04 x 440.243 x x x +11643 Original post publication description: Locomotion in both compartments of a light-dark box for females [cm] None Locomotion in both compartments of a light-dark box for females [cm] x x x x x 1048.67 x 1447.12 810.5 x 396.0 1319.14 665.222 1169.5 427.0 1062.5 1538.0 613.455 x 1231.54 x x x 715.375 x 604.429 478.143 1181.77 x 1059.78 1210.3 713.125 985.571 x 832.143 x 734.222 445.0 1318.0 x 1246.86 1123.4 772.25 1155.1 x x 1076.0 x 956.25 730.625 x x x 1366.78 451.8 x x x 1130.09 941.125 535.167 x x 1151.0 991.75 723.75 996.455 1263.48 1188.5 765.833 x 1014.44 x 738.8 x 919.25 x x 810.375 x x 750.833 982.875 x 863.667 756.4 x 1205.0 x x 830.167 x x x 1096.33 863.25 1135.4 x 778.714 x x x +11644 Original post publication description: Anxiety assay, locomotion in the light compartment of a light-dark box for females [cm] None Central nervous system, behavior: Anxiety assay, locomotion in the light compartment of a light-dark box for females [cm] x x x x x 271.444 x 480.75 246.5 x 125.333 306.0 242.667 338.5 167.0 394.0 613.286 190.818 x 455.846 x x x 376.5 x 134.714 115.857 368.462 x 294.222 299.2 273.5 321.429 x 241.286 x 154.778 115.364 536.0 x 501.714 385.2 265.75 406.7 x x 351.25 x 316.0 223.5 x x x 452.222 117.6 x x x 329.364 342.167 132.333 x x 394.625 295.5 186.5 317.273 506.111 483.125 241.333 x 281.222 x 301.0 x 296.5 x x 227.125 x x 189.333 342.75 x 218.167 224.6 x 459.25 x x 195.667 x x x 287.5 211.0 231.8 x 242.857 x x x +11645 Original post publication description: Anxiety assay, time in light side of a light-dark box for females [sec] None Central nervous system, behavior: Anxiety assay, time in light side of a light-dark box for females [sec] x x x x x 137.178 x 186.788 122.5 x 243.65 127.129 204.211 154.6 295.1 271.55 245.871 249.118 x 231.892 x x x 380.362 x 153.529 184.986 207.485 x 166.567 161.93 196.375 194.214 x 138.171 x 98.7889 158.8 249.573 x 243.314 205.78 197.058 209.86 x x 187.038 x 227.725 147.762 x x x 188.167 109.86 x x x 203.5 211.383 137.85 x x 203.413 162.475 184.35 213.964 232.533 249.45 214.15 x 136.433 x 284.24 x 152.675 x x 119.062 x x 133.05 233.163 x 138.033 144.12 x 229.425 x x 126.9 x x x 130.95 140.575 104.96 x 159.757 x x x +11646 Original post publication description: Anxiety assay, percentage of locomotion in light side of a light-dark box for females [%] None Central nervous system, behavior: Anxiety assay, percentage of locomotion in light side of a light-dark box for females [%] x x x x x 24.7038 x 32.6783 30.1223 x 32.7031 23.8904 36.5268 28.6394 39.9012 42.8887 39.6247 33.6851 x 36.6407 x x x 52.5716 x 21.2905 25.7806 28.106 x 26.6908 24.3065 38.1161 32.5301 x 28.3624 x 20.2575 26.6187 39.9989 x 40.1834 34.4316 34.7788 35.327 x x 31.8272 x 32.9554 29.6804 x x x 33.6636 25.3322 x x x 28.4731 35.6058 24.1541 x x 32.908 29.6984 27.3512 31.0239 39.4541 40.1693 28.0115 x 26.9657 x 45.4204 x 30.308 x x 27.0662 x x 22.6999 34.1281 x 22.7131 28.3803 x 37.5026 x x 22.9114 x x x 25.718 20.4027 17.7425 x 30.2221 x x x +11647 Original post publication description: Anxiety assay, percentage of time in the light side of a light-dark box for females [%] None Central nervous system, behavior: Anxiety assay, percentage of time in the light side of a light-dark box for females [%] x x x x x 22.863 x 31.1313 20.4167 x 40.6083 21.1881 34.5611 25.7667 50.4056 45.2083 40.9786 41.3227 x 37.8192 x x x 63.3937 x 25.7857 30.831 34.6192 x 27.537 26.6467 32.9313 32.181 x 23.0286 x 17.2444 25.4591 41.2121 x 40.5524 34.9533 32.6833 34.9767 x x 31.1729 x 37.9542 25.4958 x x x 31.6722 18.31 x x x 33.7727 35.6799 23.5139 x x 33.8729 28.8208 30.725 35.6606 38.4562 41.4896 35.6917 x 22.1463 x 47.3733 x 25.4458 x x 20.0167 x x 22.2 40.3583 x 23.0056 24.02 x 38.8583 x x 21.15 x x x 21.825 23.4292 17.4933 x 26.6262 x x x +11648 Original post publication description: Anxiety assay, transitions between light and dark sides of a light-dark box for females [n] None Central nervous system, behavior: Anxiety assay, transitions between light and dark sides of a light-dark box for females [n] x x x x x 30.5556 x 49.625 28.5 x 8.5 35.0 25.8889 41.0 11.6667 38.3333 60.4286 21.2727 x 38.5385 x x x 27.375 x 16.1429 9.42857 36.6154 x 34.5556 38.3 25.5 34.0 x 24.5714 x 17.4444 12.1818 53.5455 x 50.4286 42.8 26.5833 47.1 x x 42.375 x 27.25 25.0 x x x 45.4444 15.0 x x x 36.0 40.7083 14.1667 x x 37.0 34.5 16.375 39.0 61.6667 49.875 31.1667 x 35.1111 x 31.2 x 31.75 x x 27.875 x x 21.8333 36.75 x 26.0 23.0 x 42.0 x x 19.6667 x x x 35.6667 16.75 33.4 x 29.1429 x x x +11649 Original post publication description: Fear conditioning response, activity in altered context for females [units] None Central nervous system, behavior: Fear conditioning response, activity in altered context for females [units] x x x x x 31.7222 x 40.625 43.8333 x 23.6667 36.619 35.4259 41.4167 15.0556 34.8333 41.119 36.3333 x 40.7821 x x x 26.75 x 30.9048 33.3095 51.8333 x 39.537 30.1167 27.3958 29.4524 x 38.7381 x 36.6296 23.7424 42.9545 x 36.7143 32.7667 33.5556 44.0 x x 39.7083 x 29.2917 42.7708 x x x 41.7222 36.0333 x x x 36.7121 40.5 11.4444 x x 42.7708 37.3333 37.2708 29.6667 34.8025 40.5833 38.0556 x 37.8889 x 32.0333 x 41.0 x x 37.2292 x x 49.6944 39.5 x 29.6111 32.5667 x 41.0417 x x 42.0556 x x x 36.7222 42.4583 39.6667 x 32.5952 x x x +11650 Original post publication description: Fear conditioning response, baseline activity in apparatus for females [units] None Central nervous system, behavior: Fear conditioning response, baseline activity in apparatus for females [units] x x x x x 35.9722 x 38.5 41.0 x 13.375 39.9643 26.75 34.125 18.0833 36.875 42.1429 20.4773 x 34.3846 x x x 31.125 x 18.2143 24.2857 40.6154 x 23.9722 25.45 21.4375 23.7143 x 38.3214 x 25.0556 13.6591 36.2045 x 42.1429 33.05 29.875 44.325 x x 37.4375 x 23.4375 27.625 x x x 34.8889 15.3 x x x 28.9545 38.0312 21.0 x x 35.3438 34.9375 29.75 22.2727 37.2315 36.8438 29.2917 x 35.9444 x 32.9 x 26.8125 x x 24.25 x x 36.75 33.875 x 27.5 29.35 x 40.375 x x 29.5833 x x x 28.625 27.0 36.25 x 35.3571 x x x +11651 Original post publication description: Fear conditioning response, contextual activity for females [units] None Central nervous system, behavior: Fear conditioning response, contextual activity for females [units] x x x x x 26.0222 x 11.9625 32.0 x 15.5833 16.4143 9.66667 16.25 5.93333 15.7917 35.9857 11.3727 x 19.3846 x x x 12.1625 x 14.9214 20.8571 24.1769 x 11.5 10.24 9.85625 16.3286 x 11.6 x 10.3444 5.15454 25.2545 x 25.3286 19.46 23.2458 29.34 x x 16.3375 x 18.225 13.825 x x x 32.3889 5.56 x x x 22.4091 18.1187 2.86667 x x 19.275 17.25 18.2625 10.2773 11.2648 28.6688 16.65 x 19.6167 x 15.06 x 19.275 x x 19.65 x x 28.3167 30.075 x 7.88333 11.06 x 25.425 x x 6.7 x x x 13.95 6.4 20.06 x 15.2286 x x x +11652 Original post publication description: Fear conditioning response, activity in altered context during presentation of cue for females [units] None Central nervous system, behavior: Fear conditioning response, activity in altered context during presentation of cue for females [units] x x x x x 12.8333 x 17.5625 3.08333 x 2.5 8.61905 4.16667 6.75 1.33333 8.30556 2.52381 8.34848 x 9.33333 x x x 1.72917 x 4.54762 6.73809 16.5897 x 8.40741 6.0 5.02083 5.02381 x 6.92857 x 9.62963 3.0303 10.1061 x 16.5952 9.23333 10.25 11.7 x x 14.3333 x 7.125 12.7292 x x x 16.9815 1.9 x x x 7.4697 8.15278 4.55556 x x 5.1875 3.125 10.2083 5.77273 5.05556 5.77083 12.9722 x 10.4815 x 7.53333 x 13.75 x x 8.41667 x x 16.1944 14.8958 x 4.27778 4.83333 x 8.91667 x x 3.94444 x x x 10.8611 5.29167 9.96667 x 7.19048 x x x +11653 Original post publication description: Fear conditioning response, suppression of activity in altered context for females [units] None Central nervous system, behavior: Fear conditioning response, suppression of activity in altered context for females [units] x x x x x 0.264403 x 0.303767 0.070847 x 0.064849 0.326699 0.117863 0.157382 0.091292 0.131842 0.013102 0.21245 x 0.211793 x x x 0.040411 x 0.156877 0.210121 0.331952 x 0.235225 0.312653 0.096904 0.159818 x 0.170742 x 0.256616 0.141369 0.248604 x 0.47071 0.305785 0.311311 0.272351 x x 0.374913 x 0.271834 0.298039 x x x 0.405976 0.053272 x x x 0.201244 0.212319 0.464686 x x 0.116615 0.081265 0.228567 0.227731 0.139697 0.1401 0.304711 x 0.281419 x 0.255427 x 0.331464 x x 0.197971 x x 0.323489 0.523537 x 0.135619 0.142611 x 0.202627 x x 0.093116 x x x 0.303276 0.123186 0.266635 x 0.219737 x x x +11654 Original post publication description: Fear conditioning response, activity during first tone-shock pairing for females [units] None Central nervous system, behavior: Fear conditioning response, activity during first tone-shock pairing for females [units] x x x x x 31.7778 x 42.875 42.0 x 30.3333 35.8571 15.8889 19.5 21.0 31.3333 26.4286 22.0 x 34.2308 x x x 31.875 x 20.5714 29.5714 43.3846 x 25.7778 26.7 28.625 22.2857 x 27.5714 x 27.5556 24.2727 29.8182 x 30.1429 37.6 34.3333 30.4 x x 42.0 x 25.25 34.375 x x x 38.7778 13.2 x x x 33.5455 25.625 21.0 x x 36.25 26.75 33.0 29.2727 46.6667 32.875 43.5 x 27.6667 x 24.2 x 30.25 x x 26.625 x x 31.5 28.75 x 31.1667 21.4 x 34.25 x x 30.3333 x x x 32.1667 35.25 40.2 x 24.7143 x x x +11655 Original post publication description: Fear conditioning response, activity during second tone-shock pairing for females [units] None Central nervous system, behavior: Fear conditioning response, activity during second tone-shock pairing for females [units] x x x x x 31.3333 x 20.0 23.5 x 17.0 26.4286 10.8889 23.5 12.3333 14.6667 26.7143 22.8182 x 26.9231 x x x 21.625 x 19.2857 26.5714 30.5385 x 24.8889 24.0 25.75 15.2857 x 16.2857 x 17.1111 17.6364 25.0909 x 26.0 30.2 31.4167 30.0 x x 26.5 x 28.25 23.75 x x x 28.4444 10.4 x x x 22.8182 19.5833 16.6667 x x 20.25 17.75 22.125 20.4545 29.9259 23.5 26.3333 x 23.4444 x 22.4 x 20.0 x x 23.625 x x 24.5 25.75 x 28.3333 16.6 x 14.25 x x 23.0 x x x 24.6667 19.25 33.8 x 17.2857 x x x +11656 Original post publication description: Fear conditioning response, activity during third tone-shock pairing for females [units] None Central nervous system, behavior: Fear conditioning response, activity during third tone-shock pairing for females [units] x x x x x 14.8889 x 17.125 13.0 x 14.5 21.8571 7.77778 12.5 9.0 10.1667 27.0 15.0909 x 15.0 x x x 13.75 x 15.0 25.5714 23.3077 x 15.2222 18.9 24.25 13.7143 x 11.0 x 17.6667 20.0 20.2727 x 25.8571 30.6 18.9167 27.4 x x 18.375 x 20.0 14.25 x x x 21.7778 6.2 x x x 22.6364 16.3333 16.0 x x 17.125 12.5 15.25 16.6364 27.9259 22.25 24.3333 x 16.7778 x 22.4 x 23.25 x x 18.5 x x 21.6667 27.125 x 21.6667 12.2 x 18.25 x x 24.5 x x x 19.8333 15.5 23.6 x 18.0 x x x +11657 Original post publication description: Fear conditioning response, activity after first tone-shock pairing for females [n beam breaks/30 sec test] None Central nervous system, behavior: Fear conditioning response, activity after first tone-shock pairing for females [n beam breaks/30 sec test] x x x x x 19.5556 x 4.40625 8.5 x 2.66667 17.25 5.55556 6.125 7.91667 7.66667 19.4286 16.0682 x 17.4038 x x x 12.6562 x 7.14286 11.3571 19.5385 x 14.0278 6.075 8.875 13.0714 x 9.10714 x 5.61111 1.90909 13.5455 x 14.9286 24.25 14.6458 23.1 x x 19.125 x 13.4375 15.375 x x x 21.9167 3.6 x x x 16.0 17.2188 0.583333 x x 9.53125 14.0625 11.1562 12.8636 10.9815 10.5938 19.5 x 14.3611 x 15.85 x 13.3125 x x 12.0 x x 21.4583 10.6875 x 7.70833 8.5 x 20.4375 x x 10.1667 x x x 14.4583 11.3125 21.5 x 13.9643 x x x +11658 Original post publication description: Fear conditioning response, activity after second tone-shock pairing for females [n beam breaks/30 sec test] None Central nervous system, behavior: Fear conditioning response, activity after second tone-shock pairing for females [n beam breaks/30 sec test] x x x x x 12.7222 x 5.5625 4.875 x 2.875 13.3214 2.30556 4.25 4.58333 2.875 12.7857 8.84091 x 8.53846 x x x 4.34375 x 3.64286 12.8929 21.4231 x 7.41667 6.45 5.75 4.5 x 3.92857 x 5.16667 2.61364 7.84091 x 17.0 16.2 6.4375 20.75 x x 7.625 x 14.125 5.875 x x x 18.4722 2.25 x x x 8.72727 13.4688 1.33333 x x 5.625 9.1875 11.0 6.52273 8.65741 9.65625 16.4167 x 14.6944 x 11.2 x 12.3125 x x 9.96875 x x 12.75 8.90625 x 5.75 3.65 x 20.0 x x 2.625 x x x 6.58333 4.8125 13.95 x 8.57143 x x x +11659 Original post publication description: Fear conditioning response, activity after third tone-shock pairing for females [n beam breaks/30 sec test] None Central nervous system, behavior: Fear conditioning response, activity after third tone-shock pairing for females [n beam breaks/30 sec test] x x x x x 8.44444 x 7.25 6.5 x 1.33333 19.5714 4.33333 10.5 14.0 4.5 8.57143 9.0 x 6.84615 x x x 9.0 x 6.57143 12.7143 14.8462 x 10.1111 8.7 7.125 4.71429 x 12.1429 x 6.0 1.81818 9.63636 x 14.8571 7.0 5.66667 21.9 x x 6.5 x 3.5 6.5 x x x 10.6667 5.6 x x x 9.54545 7.95833 7.16667 x x 10.875 4.0 7.5 9.09091 8.37037 13.0 18.8333 x 9.88889 x 13.0 x 7.75 x x 5.625 x x 7.16667 12.125 x 5.33333 2.8 x 12.5 x x 3.66667 x x x 11.1667 6.0 9.6 x 8.42857 x x x +11660 Original post publication description: Fear conditioning response, cue conditioning, activity suppression after third tone-shock pairing for females [units] None Central nervous system, behavior, learning and memory: Fear conditioning response, cue conditioning, activity suppression after third tone-shock pairing for females [units] x x x x x 0.263736 x 0.181384 0.167742 x 0.099437 0.483816 0.160755 0.306116 0.820547 0.118258 0.192899 0.450263 x 0.196751 x x x 0.317297 x 0.533989 0.632072 0.358838 x 0.43865 0.426535 0.302025 0.222676 x 0.315176 x 0.248715 0.143086 0.248572 x 0.35656 0.225752 0.19039 0.496873 x x 0.219516 x 0.146025 0.251705 x x x 0.333014 0.630337 x x x 0.414747 0.216205 0.364532 x x 0.295333 0.113991 0.286884 0.425944 0.22916 0.408989 0.743509 x 0.302854 x 0.453191 x 0.314854 x x 0.23172 x x 0.189251 0.378583 x 0.272224 0.089136 x 0.325465 x x 0.123532 x x x 0.396497 0.188587 0.276833 x 0.228242 x x x +11661 Original post publication description: Open field behavior, percentage of distance in the center for females [%] None Open field behavior, percentage of distance in the center for females [%] x x x x x 21.5691 x 29.1432 31.7203 x 25.1966 27.4659 17.4721 30.9176 18.4053 31.9107 28.7318 20.3419 x 33.368 x x x 40.9781 x 10.7646 15.6218 18.2967 x 23.3482 20.181 35.2807 27.5504 x 19.8347 x 31.4954 16.482 32.6517 x 31.2346 29.8493 24.807 23.463 x x 30.4582 x 17.6804 17.8149 x x x 24.4075 14.5337 x x x 25.9094 25.9028 18.9444 x x 26.8235 23.1917 24.4348 24.9442 35.5874 39.85 23.5273 x 19.7433 x 13.5595 x 34.9244 x x 28.228 x x 28.7228 17.9572 x 29.0621 21.1673 x 32.8822 x x 29.6979 x x x 21.8183 21.5721 20.0511 x 35.0575 x x x +11662 Original post publication description: Open field behavior, percentage of time in center for females [%] None Open field behavior, percentage of time in center for females [%] x x x x x 8.94167 x 19.3771 15.1667 x 5.45556 12.9821 6.54537 16.7667 8.13333 20.2903 17.4988 12.0417 x 17.3019 x x x 22.5917 x 7.04405 7.42143 9.63333 x 15.5954 9.37083 20.5802 16.6167 x 6.48333 x 14.6389 6.92348 18.4462 x 16.944 12.6683 13.0097 11.6833 x x 16.7052 x 11.9438 7.46667 x x x 12.9583 7.13 x x x 16.0205 11.4017 10.9389 x x 14.3188 10.5208 16.1656 18.0129 21.4667 24.8083 12.1056 x 9.31296 x 4.95833 x 22.6187 x x 15.4083 x x 13.525 9.44479 x 18.6111 10.7417 x 17.025 x x 19.6125 x x x 9.22917 13.9667 7.76667 x 20.0036 x x x +11663 Original post publication description: Open field behavior, time in corners for females [min] None Open field behavior, time in corners for females [min] x x x x x 39.1935 x 43.024 43.0062 x 25.0861 40.0643 38.975 38.4875 41.9917 46.1958 40.25 45.7212 x 40.7346 x x x 42.8417 x 24.0071 47.2726 44.4013 x 44.3639 35.87 44.3688 43.0226 x 28.75 x 44.163 36.3652 39.0689 x 39.6833 39.2117 43.6326 45.8625 x x 45.124 x 34.9938 43.6698 x x x 42.4713 43.2967 x x x 40.8545 35.8247 34.6514 x x 41.8063 43.8417 47.2938 45.4447 45.1769 45.0198 46.1889 x 34.6667 x 36.5617 x 51.2458 x x 44.8258 x x 40.6653 46.2042 x 45.2347 42.0133 x 41.6708 x x 43.3014 x x x 39.0931 41.4625 37.6317 x 50.8119 x x x +11664 Original post publication description: Open field behavior, locomotion from 0-5 min for females [cm] None Open field behavior, locomotion from 0-5 min for females [cm] x x x x x 451.556 x 804.625 496.75 x 108.333 815.286 227.333 795.0 360.333 594.5 766.0 300.727 x 632.077 x x x 458.5 x 136.143 213.714 819.846 x 402.889 440.6 406.875 329.143 x 436.286 x 334.667 118.091 750.182 x 832.571 527.2 385.0 601.4 x x 554.125 x 586.75 400.625 x x x 717.778 170.6 x x x 503.909 490.042 298.0 x x 543.875 702.25 368.375 475.182 597.963 768.875 262.167 x 365.667 x 366.0 x 511.25 x x 595.9 x x 385.0 393.5 x 490.667 361.6 x 765.0 x x 599.667 x x x 404.833 460.5 478.8 x 451.429 x x x +11665 Original post publication description: Open field behavior, locomotion from 10-15 min for females [cm] None Open field behavior, locomotion from 10-15 min for females [cm] x x x x x 272.444 x 731.125 302.25 x 228.667 496.429 308.556 677.5 175.0 401.167 524.857 366.0 x 441.923 x x x 428.5 x 284.143 286.571 820.769 x 351.444 412.3 388.25 292.429 x 176.286 x 281.667 205.091 613.455 x 460.714 318.6 422.667 477.5 x x 382.375 x 560.25 389.875 x x x 636.0 175.8 x x x 514.182 381.333 231.0 x x 630.75 349.75 468.875 550.273 599.926 677.125 488.167 x 427.0 x 437.2 x 576.5 x x 510.7 x x 365.0 342.25 x 495.833 377.8 x 520.5 x x 503.667 x x x 413.333 572.25 607.8 x 396.143 x x x +11666 Original post publication description: Open field behavior, locomotion from 15-20 min for females [cm] None Open field behavior, locomotion from 15-20 min for females [cm] x x x x x 277.222 x 686.125 322.5 x 238.667 519.571 256.0 673.5 271.667 438.5 612.714 380.545 x 431.615 x x x 430.875 x 203.286 270.857 713.231 x 378.111 360.7 327.0 307.143 x 169.429 x 293.444 163.818 573.455 x 400.429 356.8 367.0 454.8 x x 359.75 x 565.0 380.5 x x x 652.222 166.4 x x x 490.091 358.042 215.167 x x 592.75 322.5 488.0 570.0 598.667 613.375 589.667 x 394.444 x 340.2 x 517.5 x x 537.8 x x 370.333 314.375 x 492.333 373.2 x 573.0 x x 498.667 x x x 272.167 534.0 607.8 x 321.429 x x x +11667 Original post publication description: Open field behavior locomotion from 5-10 min for females [cm] None Open field behavior locomotion from 5-10 min for females [cm] x x x x x 348.556 x 747.75 517.0 x 227.167 578.429 292.667 569.5 331.333 468.0 600.429 376.364 x 521.615 x x x 453.125 x 255.0 254.429 951.0 x 408.778 502.4 377.375 297.143 x 301.286 x 350.889 125.818 625.818 x 574.286 344.0 454.417 590.3 x x 430.625 x 591.0 428.75 x x x 647.222 211.2 x x x 582.455 409.25 239.333 x x 641.375 412.25 459.625 520.182 604.593 683.875 414.833 x 395.556 x 453.8 x 650.75 x x 534.6 x x 378.5 381.0 x 484.5 344.4 x 556.75 x x 474.167 x x x 398.167 524.5 560.8 x 430.143 x x x +11668 Original post publication description: Central nervous system, behavior: Open field activity, habituation ratio for females (ratio of activity during last 5 min interval and first 5 min interval) [ratio n beam breaks] None Central nervous system, behavior: Open field activity, habituation ratio for females (ratio of activity during last 5 min interval and first 5 min interval) [ratio n beam breaks] x x x x x 0.386532 x 0.469993 0.389388 x 0.739229 0.381068 0.555799 0.438077 0.430148 0.41748 0.491322 0.587473 x 0.401464 x x x 0.493233 x 0.582527 0.580669 0.471252 x 0.498233 0.476317 0.44661 0.480782 x 0.237611 x 0.489065 0.561503 0.429596 x 0.316014 0.393092 0.483296 0.408015 x x 0.402197 x 0.488186 0.491483 x x x 0.478306 0.49765 x x x 0.49027 0.420176 0.416883 x x 0.541481 0.317282 0.561927 0.555268 0.505668 0.443641 0.724383 x 0.535821 x 0.49765 x 0.530742 x x 0.477231 x x 0.536112 0.450469 x 0.4899 0.488498 x 0.428443 x x 0.453708 x x x 0.387096 0.539348 0.551586 x 0.4194 x x x +11669 Original post publication description: Open field behavior, percentage time in perimeter minus time in corners for females [%] None Open field behavior, percentage time in perimeter minus time in corners for females [%] x x x x x 51.8648 x 37.599 41.8271 x 69.4583 46.9536 54.4796 44.7458 49.875 33.5139 42.2512 42.2371 x 41.9635 x x x 34.5667 x 68.9488 45.306 45.9654 x 40.0407 54.7592 35.051 40.3607 x 64.7667 x 41.1981 56.7114 42.4848 x 43.3726 48.12 43.3576 42.4542 x x 38.1708 x 53.0625 48.8635 x x x 44.5704 49.5733 x x x 43.125 52.7736 54.4097 x x 43.875 45.6375 36.5406 36.5424 33.3565 30.1719 41.7056 x 56.0204 x 58.48 x 26.1354 x x 39.7658 x x 45.8097 44.351 x 36.1542 47.245 x 41.3042 x x 37.0861 x x x 51.6778 44.5708 54.6017 x 29.1845 x x x +11670 Original post publication description: Open field behavior, vertical activity (rears) from 0-20 min for females [n beam breaks] None Open field behavior, vertical activity (rears) from 0-20 min for females [n beam breaks] x x x x x 76.5556 x 99.0 95.0 x 33.6667 190.286 72.1111 88.5 39.3333 68.3333 138.429 70.7273 x 171.692 x x x 111.375 x 46.2857 59.4286 91.2308 x 95.1111 67.9 110.625 78.8571 x 59.4286 x 69.0 23.4545 151.0 x 131.429 139.6 110.833 128.4 x x 118.0 x 171.75 143.125 x x x 129.667 22.2 x x x 126.455 97.9583 71.5 x x 160.0 133.5 128.75 163.364 167.481 179.125 67.1667 x 138.889 x 126.2 x 114.75 x x 124.9 x x 57.6667 112.625 x 145.167 84.6 x 198.5 x x 136.333 x x x 144.833 151.5 93.4 x 133.857 x x x +11671 Original post publication description: Open field behavior, vertical activity (rears) from 0-5 min for females [n beam breaks] None Open field behavior, vertical activity (rears) from 0-5 min for females [n beam breaks] x x x x x 17.8889 x 22.375 20.75 x 3.16667 50.4286 5.88889 32.0 7.0 13.3333 28.2857 5.27273 x 40.4615 x x x 12.25 x 4.14286 5.57143 14.8462 x 15.5556 11.2 17.375 15.0 x 25.4286 x 12.4444 2.54545 37.1818 x 34.0 23.4 22.4167 32.7 x x 29.5 x 36.25 32.125 x x x 32.3333 0.6 x x x 27.7273 21.2083 14.5 x x 25.5 36.5 11.125 25.7273 29.8148 37.5 6.16667 x 28.1111 x 24.2 x 17.0 x x 25.7 x x 8.33333 17.5 x 26.0 18.2 x 37.75 x x 25.1667 x x x 25.3333 15.75 10.0 x 18.4286 x x x +11672 Original post publication description: Open field behavior, vertical activity (rears) from 10-15 min for females [n beam breaks] None Open field behavior, vertical activity (rears) from 10-15 min for females [n beam breaks] x x x x x 18.0 x 23.75 20.0 x 10.6667 46.0 23.3333 16.5 9.33333 16.3333 35.2857 21.0909 x 41.2308 x x x 32.5 x 15.1429 17.5714 25.9231 x 25.6667 19.0 33.75 21.4286 x 7.57143 x 17.5556 9.72727 38.0 x 29.7143 44.0 30.5833 29.3 x x 28.375 x 44.5 35.25 x x x 32.1111 9.6 x x x 31.5455 24.8333 18.6667 x x 46.75 30.75 39.625 45.5455 45.3704 48.0 21.0 x 36.8889 x 33.8 x 30.75 x x 30.6 x x 13.8333 32.25 x 35.5 24.6 x 52.75 x x 37.0 x x x 44.0 44.5 29.8 x 41.1429 x x x +11673 Original post publication description: Open field behavior, vertical activity (rears) from 15-20 min for females [n beam breaks] None Open field behavior, vertical activity (rears) from 15-20 min for females [n beam breaks] x x x x x 17.8889 x 26.625 22.25 x 9.16667 44.1429 23.8889 18.0 13.0 22.8333 40.0 26.0 x 44.9231 x x x 37.25 x 13.5714 20.5714 24.6154 x 26.0 17.8 30.25 25.1429 x 9.0 x 18.6667 7.63636 35.9091 x 31.4286 36.8 31.5833 30.8 x x 25.0 x 48.5 36.75 x x x 31.6667 9.4 x x x 29.1818 28.6667 18.0 x x 46.0 27.75 47.0 53.4545 52.963 45.5 26.1667 x 38.6667 x 31.6 x 30.75 x x 34.6 x x 21.3333 31.375 x 42.1667 25.2 x 56.5 x x 40.1667 x x x 35.0 50.5 32.0 x 35.7143 x x x +11674 Original post publication description: Open field behavior, vertical activity (rears) from 5-10 min for females [n beam breaks] None Open field behavior, vertical activity (rears) from 5-10 min for females [n beam breaks] x x x x x 22.7778 x 26.25 32.0 x 10.6667 49.7143 19.0 22.0 10.0 15.8333 34.8571 18.3636 x 45.0769 x x x 29.375 x 13.4286 15.7143 25.8462 x 27.8889 19.9 29.25 17.2857 x 17.4286 x 20.3333 3.54545 39.9091 x 36.2857 35.4 26.25 35.6 x x 35.125 x 42.5 39.0 x x x 33.5556 2.6 x x x 38.0 23.25 20.3333 x x 41.75 38.5 31.0 38.6364 39.3333 48.125 13.8333 x 35.2222 x 36.6 x 36.25 x x 34.0 x x 14.1667 31.5 x 41.5 16.6 x 51.5 x x 34.0 x x x 40.5 40.75 21.6 x 38.5714 x x x +11675 Original post publication description: Open field behavior, locomotion for entire test period for females [cm] None Open field behavior, locomotion for entire test period for females [cm] x x x x x 1349.78 x 2969.62 1638.5 x 802.833 2409.71 1084.56 2715.5 1138.33 1902.17 2504.0 1423.64 x 2027.23 x x x 1771.0 x 878.571 1025.57 3304.85 x 1541.22 1716.0 1499.5 1225.86 x 1083.29 x 1260.67 612.818 2562.91 x 2268.0 1546.6 1629.08 2124.0 x x 1726.88 x 2303.0 1599.75 x x x 2653.22 724.0 x x x 2090.64 1638.67 983.5 x x 2408.75 1786.75 1784.88 2115.64 2401.15 2743.25 1754.83 x 1582.67 x 1597.2 x 2256.0 x x 2179.0 x x 1498.83 1431.12 x 1963.33 1457.0 x 2415.25 x x 2076.17 x x x 1488.5 2091.25 2255.2 x 1599.14 x x x +11676 Original post publication description: Open field behavior, percentage distance in the perimeter for females [%] None Open field behavior, percentage distance in the perimeter for females [%] x x x x x 78.4309 x 70.8568 68.2797 x 74.8034 72.5341 82.5279 69.0824 81.5947 68.0893 71.2682 79.6581 x 66.632 x x x 59.0219 x 89.2354 84.3782 81.7033 x 76.6517 79.819 64.7193 72.4496 x 80.1653 x 68.5046 83.518 67.3483 x 68.7654 70.1507 75.193 76.537 x x 69.5418 x 82.3196 82.1851 x x x 75.5925 85.4663 x x x 74.0906 74.0972 81.0556 x x 73.1765 76.8083 75.5652 75.0558 64.4126 60.15 76.4727 x 80.2567 x 86.4405 x 65.0756 x x 71.772 x x 71.2772 82.0428 x 70.9379 78.8327 x 67.1178 x x 70.3021 x x x 78.1817 78.4279 79.9489 x 64.9425 x x x +11677 Original post publication description: Open field behavior, percentage of time in perimeter for females [%] None Open field behavior, percentage of time in perimeter for females [%] x x x x x 91.0583 x 80.6229 84.8333 x 94.5444 87.0179 93.4546 83.2333 91.8667 79.7097 82.5012 87.9583 x 82.6981 x x x 77.4083 x 92.956 92.5786 90.3667 x 84.4046 90.6292 79.4198 83.3833 x 93.5167 x 85.3611 93.0765 81.5538 x 83.056 87.3317 86.9903 88.3167 x x 83.2948 x 88.0563 92.5333 x x x 87.0417 92.87 x x x 83.9795 88.5983 89.0611 x x 85.6813 89.4792 83.8344 81.9871 78.5333 75.1917 87.8944 x 90.687 x 95.0417 x 77.3812 x x 84.5917 x x 86.475 90.5552 x 81.3889 89.2583 x 82.975 x x 80.3875 x x x 90.7708 86.0333 92.2333 x 79.9964 x x x +11678 Original post publication description: Startle response, baseline level for females [units] None Central nervous system, behavior: Startle response, baseline level for females [amplitude] x x x x x 0.124323 x 0.136205 0.102045 x 0.064636 0.173 0.054325 0.086409 x 0.094591 0.055675 0.131773 x 0.112322 x x x 0.112216 x 0.142532 0.084 0.130661 x 0.10003 0.081055 0.065455 0.062662 x 0.069709 x 0.12102 0.071331 0.09619 x 0.076442 0.099636 0.095985 0.102709 x x 0.115291 x 0.113477 0.115803 x x x 0.137291 0.098218 x x x 0.108657 0.091273 0.054273 x x 0.066623 0.025545 0.133784 0.103831 0.121512 0.115398 0.114545 x 0.079899 x 0.02197 x 0.114636 x x 0.086682 x x 0.085455 0.141159 x 0.086955 0.077455 x 0.069273 x x 0.089477 x x x 0.028545 0.121 0.221291 x 0.108974 x x x +11679 Original post publication description: Central nervous system, behavior: Acoustic startle response, maximum response at 120 db for females (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, prepulse PPI control data by M Cook, UMemphis) [force] None Central nervous system, behavior: Acoustic startle response, maximum response at 120 db for females (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, prepulse PPI control data by M Cook, UMemphis) [force] x x x x x 0.719746 x 1.02988 0.81925 x 0.948357 0.590459 1.5707 1.92696 x 0.490357 1.27387 0.737518 x 0.119291 x x x 1.01301 x 3.27919 0.657571 1.06245 x 2.62263 0.522357 0.75108 0.757439 x 0.756843 x 0.534397 0.829058 0.485922 x 0.139745 1.31336 1.44901 1.68587 x x 3.47681 x 0.895536 0.634214 x x x 1.41053 1.22033 x x x 1.22902 0.781807 0.376071 x x 0.821898 0.614143 0.247723 0.619102 0.847737 2.01863 1.29191 x 0.409905 x 0.623024 x 0.775786 x x 0.666125 x x 1.88755 0.677955 x 0.426393 0.875667 x 0.297214 x x 1.59095 x x x 0.615536 3.6765 0.764329 x 1.00142 x x x +11680 Original post publication description: Central nervous system, behavior: Acoustic startle response, maximum response at 70 db for females (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, prepulse PPI control data by M Cook, UMemphis) [force] None Central nervous system, behavior: Acoustic startle response, maximum response at 70 db for females (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, prepulse PPI control data by M Cook, UMemphis) [force] x x x x x 0.770622 x 1.24983 0.5135 x 0.543833 0.479086 1.28033 1.9151 x 0.449833 0.496329 0.536637 x 0.105338 x x x 0.909325 x 3.01327 0.7769 0.887509 x 2.2065 0.48441 0.644038 0.645571 x 0.4715 x 0.524967 0.619245 0.360645 x 0.093086 0.8699 1.06858 1.24572 x x 3.28074 x 0.6521 0.5315 x x x 1.00498 1.22906 x x x 1.16174 0.530112 0.3913 x x 0.477129 0.53295 0.229587 0.361186 0.7909 1.5532 1.14833 x 0.443022 x 0.438033 x 0.85455 x x 0.503463 x x 1.22685 0.600612 x 0.3768 0.3559 x 0.2426 x x 1.07973 x x x 0.537 2.6009 0.78366 x 0.694857 x x x +11681 Original post publication description: Central nervous system, behavior: Acoustic startle response, maximum response at 80 db for females (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, prepulse PPI control data by M Cook, UMemphis) [force] None Central nervous system, behavior: Acoustic startle response, maximum response at 80 db for females (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, prepulse PPI control data by M Cook, UMemphis) [force] x x x x x 0.542133 x 0.711712 0.32615 x 0.427617 0.358486 1.0839 1.4623 x 0.280617 0.198729 0.370588 x 0.094954 x x x 0.671612 x 1.94926 0.53014 0.568391 x 1.59179 0.28895 0.446937 0.499257 x 0.36174 x 0.426344 0.417182 0.286482 x 0.100443 0.39426 0.5018 0.9682 x x 2.73232 x 0.30255 0.2667 x x x 0.56612 1.00876 x x x 1.07818 0.339471 0.27735 x x 0.295629 0.41425 0.158675 0.172171 0.481386 1.12269 0.654567 x 0.297078 x 0.345867 x 0.50495 x x 0.387587 x x 1.07275 0.319487 x 0.205925 0.320533 x 0.3373 x x 0.6159 x x x 0.384 1.92265 0.41982 x 0.277886 x x x +11682 Original post publication description: Central nervous system, behavior: Acoustic startle response, maximum response at 85 db for females (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, prepulse PPI control data by M Cook, UMemphis) [force] None Central nervous system, behavior: Acoustic startle response, maximum response at 85 db for females (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, prepulse PPI control data by M Cook, UMemphis) [force] x x x x x 0.375022 x 0.489488 0.23175 x 0.390217 0.374114 1.04821 1.43695 x 0.270033 0.175014 0.289637 x 0.097692 x x x 0.6346 x 1.57317 0.53262 0.476064 x 1.53428 0.28609 0.4276 0.369929 x 0.31276 x 0.440767 0.334518 0.295773 x 0.103457 0.3987 0.461183 0.59858 x x 2.3735 x 0.21865 0.229017 x x x 0.47344 0.9048 x x x 0.976722 0.296025 0.22665 x x 0.1962 0.3652 0.17575 0.188286 0.378336 0.963187 0.556067 x 0.241756 x 0.292733 x 0.46745 x x 0.351388 x x 1.03628 0.264288 x 0.19625 0.358667 x 0.2498 x x 0.534575 x x x 0.29255 1.74185 0.36166 x 0.259 x x x +11683 Original post publication description: Central nervous system, behavior: Acoustic startle response, prepulse inhibition (PPI) at 70 dB for females (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, data by M Cook, UMemphis) [% inhibition] None Central nervous system, behavior: Acoustic startle response, prepulse inhibition (PPI) at 70 dB for females (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, data by M Cook, UMemphis) [% inhibition] x x x x x -8.13248 x -13.2447 37.9026 x 36.6549 16.8212 21.337 -0.949543 x 11.0234 62.3644 26.302 x 6.9075 x x x 16.8608 x 7.74532 -26.1948 15.9232 x 16.689 10.4971 8.37587 20.9267 x 36.6992 x 3.29247 19.3839 24.1118 x 31.6543 32.0111 25.3548 28.0579 x x 6.89739 x 24.4176 15.5423 x x x 30.4637 1.16016 x x x 3.71022 32.9654 -8.15699 x x 38.529 11.8917 6.46058 40.0655 5.28535 23.9094 13.1757 x -7.94903 x 29.7377 x -11.6459 x x 27.1552 x x 32.9707 6.33238 x 9.8158 59.4721 x -4.90555 x x 38.7742 x x x 11.0716 28.9691 -0.633259 x 34.7869 x x x +11684 Original post publication description: Central nervous system, behavior: Acoustic startle response, prepulse inhibition (PPI) at 80 dB for females (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, data by M Cook, UMemphis) [% inhibition] None Central nervous system, behavior: Acoustic startle response, prepulse inhibition (PPI) at 80 dB for females (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, data by M Cook, UMemphis) [% inhibition] x x x x x 28.4922 x 33.4127 61.3543 x 57.1939 35.0656 33.1596 23.1737 x 41.4743 83.4132 49.6382 x 16.136 x x x 37.2079 x 41.7908 13.5818 42.3663 x 38.9885 45.9525 31.5367 42.2912 x 50.1825 x 20.9774 44.69 35.3982 x 26.4771 69.0956 67.2802 44.0292 x x 23.3257 x 65.1737 58.8972 x x x 60.54 20.6991 x x x 19.7518 56.0682 23.5079 x x 61.7838 30.1002 34.0477 68.9413 44.4875 43.3394 50.593 x 25.8722 x 48.219 x 34.7349 x x 42.6033 x x 43.5956 50.9835 x 31.6007 64.2471 x -16.2871 x x 65.3809 x x x 38.4715 47.9003 43.5226 x 70.9693 x x x +11685 Original post publication description: Central nervous system, behavior: Acoustic startle response, prepulse inhibition (PPI) at 85 dB for females (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, data by M Cook, UMemphis) [% inhibition] None Central nervous system, behavior: Acoustic startle response, prepulse inhibition (PPI) at 85 dB for females (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, data by M Cook, UMemphis) [% inhibition] x x x x x 50.6708 x 51.1225 72.2281 x 61.8176 35.4641 35.5502 24.7378 x 36.9222 85.1805 61.2886 x 14.7205 x x x 45.3885 x 54.3546 16.2628 51.6874 x 42.4509 47.7412 35.3039 56.2488 x 59.264 x 19.0205 54.3475 34.3259 x 27.7858 70.3468 67.7301 64.8971 x x 33.7379 x 75.2925 63.5255 x x x 66.4764 28.4193 x x x 29.0539 61.618 38.3069 x x 69.1859 36.4804 24.2115 65.6362 52.4535 52.9066 57.6334 x 40.3651 x 59.296 x 39.9124 x x 48.3482 x x 45.9483 57.7309 x 35.8101 60.5934 x 9.53289 x x 67.4968 x x x 51.578 52.5113 51.22 x 73.2082 x x x +11689 Original post publication description: Depression assay, immobility using a tail suspension test for females [sec below threshold movement level] None Central nervous system, behavior: Depression assay, immobility using a tail suspension test (TST) for females [sec below threshold movement level] x x x x x x x x x x x 143.2 196.0 x x 60.5 144.0 x x 204.0 x x x x x x 83.0 x x x 147.6 x 165.5 x 112.0 x x x 16.0 x 128.5 x x x x x x x x x x x x x x x x x x 51.0 161.0 x x 170.4 x x x x x x x 178.5 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +11690 Original post publication description: Activity level, locomotion in zero maze for females [n beam breaks] None Central nervous system, behavior: Activity level, locomotion in zero maze for females [n beam breaks] x x x x x 538.857 x 698.5 478.0 x 425.0 662.4 453.286 705.5 538.0 499.667 576.571 457.0 x 624.182 x x x 462.25 x 497.429 407.333 718.875 x 507.625 602.1 412.375 516.2 x 655.0 x 445.889 393.909 560.909 x 629.143 417.4 449.091 603.75 x x 470.0 x 350.75 494.875 x x x 588.556 495.2 x x x 519.091 586.208 462.25 x x 672.6 516.0 590.375 476.222 553.0 560.5 601.833 x 649.857 x 375.667 x 485.75 x x 547.8 x x 472.5 521.875 x 544.333 511.0 x 571.25 x x 625.333 x x x 552.5 834.0 592.2 x 467.286 x x x +11691 Original post publication description: Anxiety assay, entries in closed quadrants of a zero maze for females [n] None Central nervous system, behavior: Anxiety assay, entries in closed quadrants of a zero maze for females [n] x x x x x 92.4286 x 133.25 82.25 x 35.75 137.0 24.8571 33.5 50.3333 35.6667 42.2857 74.8889 x 51.0909 x x x 66.625 x 46.2857 53.3333 90.0 x 87.5 114.2 67.75 108.8 x 71.4286 x 29.1111 42.9091 89.8182 x 100.714 90.8 67.5455 62.625 x x 130.375 x 109.5 78.125 x x x 61.5556 57.2 x x x 109.818 99.2917 86.25 x x 51.2 85.0 45.125 100.444 88.3333 85.0 90.1667 x 79.8571 x 40.3333 x 31.5 x x 110.7 x x 100.5 71.375 x 62.1667 107.6 x 118.5 x x 117.167 x x x 125.5 92.75 102.8 x 90.0 x x x +11692 Original post publication description: Anxiety assay, entries into open quadrants of a zero maze for females [n] None Central nervous system, behavior: Anxiety assay, entries into open quadrants of a zero maze for females [n] x x x x x 92.1429 x 132.5 82.5 x 35.75 136.8 25.0 33.5 50.3333 35.5 42.4286 74.8889 x 51.3636 x x x 67.0 x 46.4286 53.3333 89.875 x 87.625 113.8 68.125 108.4 x 71.4286 x 29.1111 42.9091 89.6364 x 100.714 91.0 67.5455 62.75 x x 130.625 x 109.75 78.0 x x x 61.5556 57.2 x x x 109.727 98.9167 86.0 x x 51.2 85.25 45.125 100.111 88.2963 85.375 90.3333 x 80.1429 x 40.3333 x 31.25 x x 110.3 x x 100.0 71.5 x 62.1667 107.4 x 118.75 x x 117.333 x x x 125.167 93.0 103.0 x 90.0 x x x +11693 Original post publication description: Zero maze, latency to enter an open quadrant for females [sec] None Zero maze, latency to enter an open quadrant for females [sec] x x x x x 22.7429 x 25.9125 36.025 x 13.15 4.02 12.9429 24.6 67.7667 17.1833 10.1286 40.2889 x 52.0273 x x x 18.2125 x 126.3 63.7833 11.2714 x 22.1625 10.86 74.275 23.62 x 21.2429 x 48.4 20.36 19.1909 x 11.6571 30.02 11.2 26.325 x x 6.8375 x 24.175 19.475 x x x 13.1778 54.02 x x x 14.0 21.125 27.8 x x 38.1 22.75 34.3875 21.4778 26.4852 35.4 45.4167 x 16.4429 x 66.3667 x 108.25 x x 8.73 x x 22.55 42.4625 x 62.2 37.8 x 30.475 x x 16.3333 x x x 17.2833 39.75 16.94 x 16.3286 x x x +11694 Original post publication description: Anxiety assay, percentage time in open quadrants of a zero maze for females [%] None Central nervous system, behavior: Anxiety assay, percentage time in open quadrants of a zero maze for females [%] x x x x x 13.5524 x 24.3625 18.2167 x 5.15 20.14 7.37143 2.86667 10.2222 3.66667 9.75238 11.6556 x 5.25151 x x x 19.2083 x 6.87619 16.7333 14.6667 x 12.4667 22.0933 17.4125 25.2667 x 10.2905 x 5.4037 7.57879 32.6879 x 18.6095 35.6 19.3485 15.3542 x x 35.375 x 33.125 17.1458 x x x 9.94815 5.6 x x x 36.1303 22.1431 21.4917 x x 5.72667 28.15 9.8625 29.0259 21.1556 16.4917 24.7056 x 11.781 x 8.54444 x 7.475 x x 22.9567 x x 25.0167 18.3375 x 15.5833 19.7733 x 24.1333 x x 15.1778 x x x 28.3167 11.875 24.72 x 26.2048 x x x +11695 Original post publication description: Anxiety assay, time in closed quadrants of a zero maze for females [sec] None Central nervous system, behavior: Anxiety assay, time in closed quadrants of a zero maze for females [sec] x x x x x 259.343 x 226.913 245.35 x 284.55 239.58 278.771 291.4 269.333 289.0 270.743 251.178 x 284.245 x x x 242.375 x 279.371 249.8 256.0 x 251.65 233.72 247.762 217.84 x 269.129 x 283.789 277.264 201.936 x 244.171 193.2 241.955 271.663 x x 193.875 x 176.15 248.562 x x x 270.156 283.2 x x x 191.609 233.571 235.525 x x 282.82 215.55 270.413 212.922 236.533 250.525 225.883 x 264.657 x 274.367 x 277.575 x x 231.13 x x 224.95 244.988 x 253.25 240.68 x 227.6 x x 254.467 x x x 215.05 264.375 225.84 x 221.386 x x x +11696 Original post publication description: Anxiety assay, time in open quadrants of a zero maze for females [sec] None Central nervous system, behavior: Anxiety assay, time in open quadrants of a zero maze for females [sec] x x x x x 40.6571 x 73.0875 54.65 x 15.45 60.42 21.2286 8.6 30.6667 11.0 29.2571 48.8222 x 15.7545 x x x 57.625 x 20.6286 50.2 44.0 x 48.35 66.28 52.2375 82.16 x 30.8714 x 16.2111 22.7364 98.0636 x 55.8286 106.8 58.0455 28.3375 x x 106.125 x 123.85 51.4375 x x x 29.8444 16.8 x x x 108.391 66.4292 64.475 x x 17.18 84.45 29.5875 87.0778 63.4667 49.475 74.1167 x 35.3429 x 25.6333 x 22.425 x x 68.87 x x 75.05 55.0125 x 46.75 59.32 x 72.4 x x 45.5333 x x x 84.95 35.625 74.16 x 78.6143 x x x +11697 Original post publication description: Ethanol response (2.25 g/kg ip), locomotor activity after injection from 0-5 min for females [cm] None Ethanol response (2.25 g/kg ip), locomotor activity after injection from 0-5 min for females [cm] x x x x 1488.92 795.097 x 892.64 x 1047.02 1004.0 2256.69 826.64 597.89 724.77 1338.81 1700.62 908.006 341.965 1904.56 x x x 16.92 x 491.775 240.615 1693.09 x 1687.33 1197.03 1341.23 1151.42 x x x 216.995 1371.01 882.955 x 1943.99 400.653 488.478 1780.76 x x 859.605 x 1431.69 1800.52 x x x 1456.8 1795.94 x x x 333.238 823.662 289.205 453.958 x 1893.02 1434.44 393.812 936.62 670.463 1087.06 1899.48 x 1947.83 x 942.505 x x x x 1123.33 x x 836.475 322.58 394.32 688.307 490.702 x 636.275 1036.06 x 1124.14 x x x 808.472 x 1053.44 1198.48 1361.54 x x x +11698 Original post publication description: Saline control response (10 ml/kg ip), locomotor activity after injection from 0-5 min for females [cm] None Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotor activity after injection from 0-5 min for females [cm] x x x x 818.265 758.173 x 891.8 x 829.242 677.933 914.05 428.703 767.198 194.048 461.41 865.725 362.376 795.815 859.11 x x x 59.56 x 375.35 365.935 987.64 x 1080.93 626.86 589.604 695.612 x x x 449.335 450.677 806.885 x 915.302 506.568 516.227 1215.42 x x 668.72 x 666.835 690.133 x x x 1124.3 919.935 x x x 692.2 549.875 348.305 204.545 x 1233.99 474.812 269.415 800.16 1024.65 682.156 767.45 x 532.82 x 670.667 x x x x 593.278 x x 399.085 801.18 779.552 606.148 503.428 x 833.343 555.475 x 894.703 x x x 826.975 x 1060.88 694.272 524.905 x x x +11699 Original post publication description: Ethanol response (2.25 g/kg ip), locomotor activity after injection from 5-10 min for females [cm] None Central nervous system, pharmacology, behavior: Ethanol response (2.25 g/kg ip), locomotor activity after injection from 5-10 min for females [cm] x x x x 1017.22 656.217 x 689.995 x 453.135 724.477 2143.48 336.4 394.772 512.278 1478.57 1454.1 783.756 281.2 1685.88 x x x 118.18 x 870.095 245.223 1639.06 x 1054.26 788.43 1125.76 1123.34 x x x 236.17 1339.54 730.545 x 1745.91 106.767 509.293 1814.48 x x 762.245 x 1119.15 1351.69 x x x 787.345 994.407 x x x 351.482 884.612 286.997 245.363 x 1692.03 959.19 354.538 726.52 216.297 1097.81 1643.75 x 1764.99 x 1078.07 x x x x 926.927 x x 926.04 306.957 842.6 588.662 554.237 x 948.42 972.725 x 903.373 x x x 692.315 x 636.812 1091.71 767.765 x x x +11700 Original post publication description: Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotor activity after injection from 5-10 min after injection for females [cm] None Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotor activity after injection from 5-10 min after injection for females [cm] x x x x 271.948 316.332 x 528.568 x 468.707 331.04 692.73 359.357 587.7 85.0225 312.685 342.388 298.232 241.975 540.196 x x x 186.63 x 307.677 111.54 544.707 x 951.037 322.12 366.7 268.798 x x x 277.83 232.4 529.958 x 384.64 234.615 225.895 756.72 x x 635.63 x 455.155 477.807 x x x 721.715 684.175 x x x 389.562 203.852 104.308 174.005 x 944.795 179.87 406.065 538.245 755.663 442.238 481.733 x 296.413 x 464.163 x x x x 310.698 x x 324.28 279.44 491.302 518.828 254.185 x 485.897 335.335 x 380.59 x x x 335.188 x 410.47 599.855 193.685 x x x +11701 Original post publication description: Ethanol response (2.25 g/kg ip), locomotor activity after injection from 10-15 min for females [cm] None Central nervous system, pharmacology, behavior: Ethanol response (2.25 g/kg ip), locomotor activity after injection from 10-15 min for females [cm] x x x x 1465.15 640.078 x 534.438 x 643.795 464.77 1540.44 493.763 281.508 360.065 1489.96 1318.63 651.04 441.77 1388.55 x x x 27.08 x 496.122 338.885 1844.69 x 1240.71 986.98 946.026 851.818 x x x 417.8 1106.03 941.622 x 1527.42 591.393 583.508 1310.02 x x 913.505 x 863.41 1215.89 x x x 682.79 572.7 x x x 342.412 889.715 269.155 267.638 x 1766.11 902.992 623.403 704.94 225.51 1517.39 1442.27 x 1353.01 x 1344.68 x x x x 1108.1 x x 1069.29 280.17 849.208 460.592 694.455 x 1016.98 1133.39 x 1079.33 x x x 556.487 x 748.872 1194.94 660.39 x x x +11702 Original post publication description: Saline control response (10 ml/kg ip), locomotor activity after injection from 10-15 min for females [cm] None Saline control response (10 ml/kg ip), locomotor activity after injection from 10-15 min for females [cm] x x x x 333.908 191.868 x 456.77 x 356.98 219.543 470.74 384.103 523.115 80.735 137.24 246.423 202.88 288.75 438.674 x x x 152.98 x 330.9 134.055 503.095 x 731.438 141.71 395.712 378.915 x x x 299.64 264.22 337.783 x 289.665 273.823 145.617 387.57 x x 382.485 x 360.147 544.073 x x x 565.795 500.138 x x x 201.208 224.163 203.745 178.877 x 705.97 121.72 329.323 433.758 660.607 341.394 384.193 x 254.035 x 232.19 x x x x 306.188 x x 217.755 192.688 371.615 531.148 190.672 x 464.43 175.72 x 365.937 x x x 228.225 x 313.457 539.685 157.97 x x x +11703 Original post publication description: Ethanol response (2.25 g/kg ip), locomotor activity after injection from 15-20 min for females [cm] None Central nervous system, pharmacology, behavior: Ethanol response (2.25 g/kg ip), locomotor activity after injection from 15-20 min for females [cm] x x x x 967.182 529.783 x 440.638 x 558.833 289.51 1540.78 242.197 239.923 341.025 1192.86 1268.19 478.558 306.24 1072.85 x x x 0.0 x 365.255 346.122 1584.52 x 1049.93 924.245 731.646 835.568 x x x 377.925 908.18 1354.2 x 1029.37 237.443 694.475 1332.85 x x 762.905 x 416.743 1012.51 x x x 457.075 515.017 x x x 325.103 935.422 196.34 384.003 x 1319.94 572.275 753.263 537.157 278.737 1210.88 1243.04 x 1097.67 x 1132.71 x x x x 1003.5 x x 1049.9 268.108 602.105 495.772 744.615 x 622.932 960.23 x 958.667 x x x 483.55 x 868.91 1153.69 515.98 x x x +11704 Original post publication description: Saline control response (10 ml/kg ip), locomotion from 15-20 min after injection for females [cm] None Saline control response (10 ml/kg ip), locomotion from 15-20 min after injection for females [cm] x x x x 338.592 172.565 x 300.0 x 368.13 421.227 522.565 194.333 391.165 158.135 155.645 301.342 230.466 327.345 458.128 x x x 40.0 x 216.863 146.55 479.025 x 611.073 114.54 407.65 457.455 x x x 224.64 264.927 460.408 x 267.802 356.79 84.035 559.35 x x 262.025 x 213.857 569.057 x x x 714.835 206.315 x x x 342.007 306.43 106.387 136.92 x 633.515 105.577 367.922 693.155 711.397 334.328 231.113 x 252.828 x 216.852 x x x x 247.653 x x 213.185 215.935 362.823 423.312 230.81 x 426.655 138.29 x 447.81 x x x 244.88 x 244.727 674.563 289.42 x x x +11705 Original post publication description: Ethanol response (2.25 g/kg ip), locomotor activity, difference in distance traveled (saline minus ethanol) from 0-20 min for females [cm] None Central nervous system, pharmacology, behavior: Ethanol response (2.25 g/kg ip), locomotor activity, difference in distance traveled (saline minus ethanol) from 0-20 min for females [cm] x x x x 3175.75 1182.24 x 380.573 x 679.725 833.017 4881.29 -1522.22 -755.085 1420.2 4433.23 3985.67 1727.41 -282.71 3755.72 x x x -276.99 x 992.458 412.765 4246.9 x 1657.75 2691.46 2385.0 2161.37 x x x -2.555 3512.53 1774.3 x 4389.29 -369.603 1303.98 3319.05 x x 1349.4 x 1177.26 1754.38 x x x 257.36 597.987 x x x -279.892 2249.09 278.953 656.617 x 3152.81 2986.92 752.29 439.92 -1761.31 3113.02 4364.06 x 2223.32 x 2567.28 x x x x 2481.17 x x 2727.39 -311.427 682.94 153.9 1304.91 x 1014.28 2897.59 x 1976.47 x x x 905.557 x 1278.5 2130.45 2139.69 x x x +11706 Original post publication description: Ethanol response (2.25 g/kg ip), locomotor activity after injection from 0-20 min for females [cm] None Central nervous system, pharmacology, behavior: Ethanol response (2.25 g/kg ip), locomotor activity after injection from 0-20 min for females [cm] x x x x 4938.46 2621.18 x 2557.71 x 2702.78 2482.76 7481.38 1899.0 1514.09 1938.14 5500.21 5741.55 2821.36 1371.18 6051.83 x x x 162.18 x 2223.25 1170.84 6761.37 x 5032.23 3896.69 4144.67 3962.15 x x x 1248.89 4724.76 3909.33 x 6246.69 1002.19 2275.75 6238.1 x x 3298.26 x 2873.25 4035.45 x x x 3384.0 2908.55 x x x 1345.08 3533.41 1041.7 1350.96 x 6671.09 3868.9 2125.01 2905.24 1391.01 4913.14 6228.55 x 3559.42 x 4151.16 x x x x 3938.99 x x 3881.7 1177.81 2688.23 2233.33 2484.01 x 3224.61 4102.41 x 4065.51 x x x 2540.82 x 3308.03 4638.83 3305.67 x x x +11707 Original post publication description: Saline control response (10 ml/kg ip), locomotion 0-20 min after injection for females [cm] None Saline control response (10 ml/kg ip), locomotion 0-20 min after injection for females [cm] x x x x 1762.71 1438.94 x 2177.14 x 2023.06 1649.74 2600.08 3421.22 2269.18 517.94 1066.98 1755.88 1093.95 1653.89 2296.11 x x x 439.17 x 1230.79 758.08 2514.47 x 3374.48 1205.23 1759.67 1800.78 x x x 1251.44 1212.22 2135.03 x 1857.41 1371.8 971.775 2919.05 x x 1948.86 x 1695.99 2281.07 x x x 3126.65 2310.56 x x x 1624.98 1284.32 762.745 694.347 x 3518.27 881.98 1372.72 2465.32 3152.31 1800.12 1864.49 x 1336.1 x 1583.87 x x x x 1457.82 x x 1154.31 1489.24 2005.29 2079.44 1179.09 x 2210.32 1204.82 x 2089.04 x x x 1635.27 x 2029.53 2508.38 1165.98 x x x +11708 Original post publication description: Ethanol response (2.25 g/kg ip), locomotor activity, difference in distance traveled (saline minus ethanol) from 0-5 min for females [cm] None Ethanol response (2.25 g/kg ip), locomotor activity, difference in distance traveled (saline minus ethanol) from 0-5 min for females [cm] x x x x 670.653 36.9233 x 0.84 x 217.78 326.07 1342.64 397.937 -169.307 530.722 877.395 834.9 545.63 -453.85 1045.45 x x x -42.64 x 116.425 -125.32 705.453 x 606.4 570.17 751.628 455.81 x x x -232.34 920.333 76.07 x 1028.69 -206.077 -27.75 565.34 x x 190.885 x 406.935 660.255 x x x 332.495 427.022 x x x -358.962 273.788 -59.1 249.413 x 659.02 959.633 124.397 136.46 -354.183 404.9 1132.03 x 1090.37 x 271.837 x x x x 530.052 x x 437.39 -478.6 -385.233 82.16 -12.7267 x -197.068 480.59 x 229.437 x x x -18.5025 x -7.4375 504.21 836.63 x x x +11709 Original post publication description: Ethanol response (2.25 g/kg ip), locomotor activity, difference in distance traveled (saline minus ethanol) between the first 5 min and last 5 min for females [cm] None Central nervous system, pharmacology, behavior: Ethanol response (2.25 g/kg ip), locomotor activity, difference in distance traveled (saline minus ethanol) between the first 5 min and last 5 min for females [cm] x x x x 628.59 357.218 x 140.637 x 190.702 -131.717 1018.21 47.8633 -151.242 182.89 1037.21 966.85 248.092 -21.105 614.72 x x x -40.0 x 148.393 199.572 1105.5 x 438.858 809.705 323.996 378.113 x x x 153.285 643.253 893.797 x 761.568 -178.708 610.44 773.505 x x 500.88 x 98.7 190.322 x x x -257.76 179.947 x x x -16.9033 628.992 89.9525 247.083 x 686.425 466.698 385.34 -155.997 -432.66 876.554 1011.93 x 661.898 x 915.862 x x x x 755.85 x x 836.71 52.1725 239.283 72.46 513.805 x 196.277 821.94 x 510.857 x x x 238.67 x 624.182 479.13 226.56 x x x +11710 Original post publication description: Ethanol response (2.25 g/kg ip), blood ethanol concentration (BEC) for females [mg/dl XX min after injection] None Pharmacology, metabolism: Ethanol response (2.25 g/kg ip), blood ethanol concentration (BEC) for females [mg/dl XX min after injection] x x x x 288.625 258.4 x 172.05 x 263.425 223.933 249.1 251.167 255.9 272.65 x 293.1 142.58 330.5 232.08 x x x x x 268.75 271.9 216.6 x 274.2 260.1 259.2 236.867 x x x 276.4 227.8 236.467 x 212.7 282.1 367.3 208.7 x x 237.4 x 219.6 246.35 x x x 297.1 259.75 x x x 319.5 254.55 259.7 284.267 x 299.6 271.05 297.5 282.25 269.3 281.48 269.933 x 190.52 x 194.0 x x x x 254.883 x x 246.2 307.3 300.1 274.45 188.55 x 291.2 212.8 x 342.067 x x x 178.425 x 281.6 270.75 229.9 x x x +11711 Original post publication description: Anxiety assay, untreated baseline, entries into closed arms of a plus maze for females [n] None Central nervous system, behavior: Anxiety assay, untreated baseline, entries into closed arms of a plus maze for females [n] x x x x 67.75 56.6 x 65.5 x 47.0 72.0 78.0 27.0 54.5 72.25 x 36.5 x 56.0 51.0 x x x x x 37.6667 40.5 124.0 x 45.5 72.0 80.75 46.1667 x x x 32.5 69.3333 x x 43.5 65.0 94.25 122.0 x x 83.0 x 44.6667 58.75 x x x 150.5 65.75 x x x 66.8333 52.75 43.5 48.6667 x 97.0 54.0 44.75 70.0 53.3333 53.0 59.0 x 78.5 x 93.3333 x x x x 74.4 x x 72.5 47.25 52.0 41.0 39.1667 x 42.25 68.0 x 36.3333 x x x 39.75 x 70.5 47.4 65.5 x x x +11712 Original post publication description: Anxiety assay, untreated baseline, entries into open arms of a plus maze for females [n] None Central nervous system, behavior: Anxiety assay, untreated baseline, entries into open arms of a plus maze for females [n] x x x x 66.0 27.2 x 87.5 x 49.0 52.0 94.0 21.0 41.5 43.75 x 48.75 x 48.5 67.5 x x x x x 34.0 9.75 44.3333 x 22.0 47.0 67.75 56.1667 x x x 26.0 47.6667 x x 41.0 36.5 9.25 52.0 x x 103.0 x 46.6667 87.25 x x x 76.5 63.25 x x x 34.6667 36.75 43.75 4.66667 x 34.0 42.0 41.25 15.75 44.6667 46.2 43.6667 x 91.0 x 18.0 x x x x 54.4 x x 29.75 20.0 34.25 28.0 22.1667 x 28.75 51.0 x 13.0 x x x 69.75 x 47.25 52.4 78.0 x x x +11713 Original post publication description: Anxiety assay, untreated baseline, percentage of entries into closed arms of a plus maze for females [%] None Central nervous system, behavior: Anxiety assay, untreated baseline, percentage of entries into closed arms of a plus maze for females [%] x x x x 43.1448 59.4847 x 43.94 x 42.9938 63.0687 43.85 56.25 49.9185 61.7221 x 24.6827 x 38.0952 37.6284 x x x x x 38.5518 66.4775 73.6705 x 69.4 60.0082 37.3007 43.0348 x x x 27.7778 61.7177 x x 45.9399 48.075 91.3726 70.11 x x 46.23 x 47.3567 42.475 x x x 66.3 64.5 x x x 71.55 43.388 50.0896 94.6667 x 74.25 55.3413 44.0608 37.2768 53.1 51.2655 39.3649 x 52.6613 x 84.525 x x x x 59.237 x x 66.466 64.769 66.5944 32.0 50.3466 x 55.4658 58.7779 x 88.9667 x x x 30.3809 x 57.4239 50.51 45.9438 x x x +11714 Original post publication description: Anxiety assay, untreated baseline, percent entries into open arms of an elevated plus maze for females [%] None Central nervous system, behavior: Anxiety assay, untreated baseline, percent entries into open arms of an elevated plus maze for females [%] x x x x 56.8552 40.5153 x 56.06 x 57.0062 36.9313 56.15 43.75 50.0815 38.2779 x 50.3173 x 61.9048 62.3716 x x x x x 61.4482 33.5225 26.3295 x 30.6 39.9918 62.6993 56.9652 x x x 22.2222 38.2823 x x 54.0601 51.925 8.62738 29.89 x x 53.77 x 52.6433 57.525 x x x 33.7 35.5 x x x 28.45 56.612 49.9104 5.33325 x 25.75 44.6587 55.9392 37.7232 46.9 48.7345 27.3018 x 47.3387 x 15.475 x x x x 40.763 x x 33.534 35.231 33.4056 68.0 49.6534 x 44.5342 41.2221 x 11.0333 x x x 69.6191 x 42.5761 49.49 54.0562 x x x +11715 Original post publication description: Anxiety assay, untreated baseline, percent time in closed arms of a plus maze for females [%] None Central nervous system, behavior: Anxiety assay, untreated baseline, percent time in closed arms of a plus maze for females [%] x x x x 28.6033 47.9953 x 10.735 x 37.9608 46.9311 44.27 23.135 33.1842 66.7125 x 20.82 x 33.5467 31.8733 x x x x x 34.1044 52.3675 68.3011 x 52.6575 48.1183 35.7142 33.7494 x x x 25.7317 62.2708 36.86 x 37.0817 40.4492 90.9608 68.305 x x 44.22 x 49.755 40.0642 x x x 71.6 65.235 x x x 73.5694 45.3108 56.4317 96.9367 x 68.9 43.465 44.0458 36.5292 46.92 39.9147 28.79 x 46.3917 x 78.1556 x x x x 58.686 x x 64.6325 32.7292 56.2975 29.5975 40.7867 x 55.7758 73.5617 x 85.7956 x x x 31.0842 x 40.3392 43.414 51.63 x x x +11716 Original post publication description: Anxiety assay, untreated baseline, percentage of time in open arms of a plus maze for females [%] None Central nervous system, behavior: Anxiety assay, untreated baseline, percentage of time in open arms of a plus maze for females [%] x x x x 53.1958 39.566 x 78.235 x 52.0783 44.1811 50.1283 17.325 43.31 26.8325 x 30.9242 x 60.7967 44.7767 x x x x x 47.0744 29.8375 25.0044 x 33.9875 42.5783 58.92 41.415 x x x 16.4933 31.4783 12.405 x 40.1267 24.2517 4.30167 28.01 x x 46.09 x 46.5958 48.6017 x x x 24.8 25.1333 x x x 16.5894 29.21 35.115 1.87889 x 19.2 24.9292 51.675 31.1475 16.2789 45.5087 28.6211 x 44.1617 x 7.08222 x x x x 31.1193 x x 22.7125 24.0442 34.1983 57.0542 42.0389 x 39.4583 21.33 x 7.86667 x x x 58.895 x 30.4917 42.9773 40.215 x x x +11717 Original post publication description: Ethanol response (2.25 g/kg ip), motor coordination effects, difference in time on rotarod between training session and ethanol for females [sec] None Central nervous system, pharmacology, behavior: Ethanol response (2.25 g/kg ip), motor coordination effects, difference in time on rotarod between training session and ethanol for females [sec] x x x x 16.95 5.57778 x 17.5833 x 16.6667 11.1667 3.05 -1.3 26.9583 3.68333 29.4333 23.675 -2.84667 15.4 -7.43333 x x x 7.7 x -16.3333 -6.1 10.8056 x 9.95 20.2667 7.78667 55.9833 x x x -1.76667 21.7667 -15.4333 x 9.76667 2.26667 11.7583 -2.15 x x 3.46667 x 7.85 11.4667 x x x -0.6 -4.7 x x x 19.5778 6.21667 3.03333 -1.37778 x 0.633333 -0.25 1.18333 12.35 15.5556 8.32667 2.81111 x 24.8389 x -13.5583 x x x x 16.1111 x x -11.2417 -0.466667 1.64167 0.955833 23.6222 x 10.6075 -0.55 x -19.8778 x x x 2.05833 x -16.575 0.677778 -9.93333 x x x +11718 Original post publication description: Ethanol response (2.25 g/kg ip), duration on rotarod following injection for females [sec] None Ethanol response (2.25 g/kg ip), duration on rotarod following injection for females [sec] x x x x 27.1258 37.2994 x 37.5 x 28.9167 39.3311 26.3167 23.9678 21.2675 26.7167 x 30.4325 40.16 12.4667 42.0933 x x x 17.3667 x 40.3417 57.8925 27.1672 x 32.89 36.5167 42.4267 35.1267 x x x 10.0667 43.275 34.5842 x 21.8917 24.115 20.525 37.35 x x 22.965 x 49.2075 34.9 x x x 33.6 21.38 x x x 25.8156 33.7167 39.875 27.9544 x 40.53 35.3767 14.0333 45.8667 46.6222 25.0267 33.7667 x 53.38 x 54.05 x x x x 35.7556 x x 31.625 30.9758 42.9833 42.9617 19.6111 x 10.7258 56.0167 x 40.5756 x x x 29.4333 x 35.7758 43.2222 43.6 x x x +11719 Original post publication description: Ethanol response (2.25 g/kg ip), motor coordination effects, tolerance assay, difference in time on rotarod between saline and ethanol for females [sec] None Central nervous system, pharmacology, behavior: Ethanol response (2.25 g/kg ip), motor coordination effects, tolerance assay, difference in time on rotarod between saline and ethanol for females [sec] x x x x -2.7 -6.96667 x 0.016667 x -13.15 10.5667 9.35 -3.43333 -17.4417 -5.30833 21.55 -23.7917 -2.06667 -11.25 0.026667 x x x 5.83333 x 2.575 -18.775 -0.088889 x 4.525 -3.21667 -3.57333 -46.0978 x x x 14.5667 -17.1333 2.18333 x 9.225 1.43333 -6.825 -13.0 x x 1.81667 x -16.925 -20.9083 x x x 5.75 -0.658333 x x x -2.98889 -4.45 -8.51667 0.45 x -4.85 -0.875 -3.575 -19.4917 -6.66667 -7.16667 3.28889 x -21.2167 x -3.16667 x x x x -3.98889 x x 0.991667 3.29167 -5.925 -3.25 -9.83333 x 2.1 -7.51667 x 11.5667 x x x -4.75 x 10.7583 -0.211111 -11.3 x x x +11720 Original post publication description: Saline control response (10 ml/kg ip), motor coordination, rotarod performance following injection for females [sec] None Central nervous system, pharmacology, behavior: Saline control response (10 ml/kg ip), motor coordination, rotarod performance following injection for females [sec] x x x x 44.075 42.8789 x 55.0825 x 45.5833 50.4989 29.3667 22.6667 48.225 30.4008 58.8667 54.1067 37.3133 27.8667 34.66 x x x 25.0667 x 24.0075 51.79 37.9722 x 42.84 56.7833 50.2133 91.1117 x x x 8.3 65.0417 19.1508 x 31.6583 26.3825 32.2833 35.2 x x 26.435 x 57.0575 46.3675 x x x 33.0 16.685 x x x 45.3939 39.9333 42.9075 26.5833 x 41.17 35.1233 15.2158 58.2167 62.1778 33.3533 36.5778 x 69.3222 x 40.4917 x x x x 51.8667 x x 20.3833 30.5092 44.625 43.9167 43.2333 x 21.3333 55.4667 x 31.0483 x x x 31.4917 x 25.6 43.8933 33.6667 x x x +11721 Original post publication description: Saline control response (dose ip), motor coordination effects, difference in time on rotarod between training session and saline for females [sec] None Saline control response (dose ip), motor coordination effects, difference in time on rotarod between training session and saline for females [sec] x x x x 14.25 -1.38889 x 17.6 x 3.51667 21.7333 12.4 -4.73333 9.51667 -1.625 50.9833 -0.116667 -4.91333 4.15 -7.40667 x x x 13.5333 x -13.7583 -24.875 10.7167 x 14.475 17.05 4.21333 9.88556 x x x 12.8 4.63333 -13.25 x 18.9917 3.7 4.93333 -15.15 x x 5.28333 x -9.075 -9.44167 x x x 5.15 -5.35833 x x x 16.5889 1.76667 -5.48333 -0.927778 x -4.21667 -1.125 -2.39167 -7.14167 8.88889 1.16 6.1 x 3.62222 x -16.725 x x x x 12.1222 x x -10.25 2.825 -4.28333 -2.29417 13.7889 x 12.7075 -8.06667 x -8.31111 x x x -2.69167 x -5.81667 0.466667 -21.2333 x x x +11722 Original post publication description: Motor coordination, rotarod performance, untreated training trial for females [sec] None Central nervous system, behavior: Motor coordination, rotarod performance, untreated training trial for females [sec] x x x x 41.3733 35.9117 x 55.1 x 32.4333 61.0667 38.7167 19.2333 30.7842 25.09 50.9833 30.3175 35.2467 16.6167 34.6867 x x x 30.9 x 26.585 33.0175 37.8833 x 47.3675 53.5667 46.64 45.0122 x x x 22.8667 47.91 21.3333 x 40.8833 27.8175 25.4583 22.2 x x 28.25 x 40.1325 25.4575 x x x 38.75 16.025 x x x 42.4056 35.4833 34.3908 27.0278 x 36.315 34.2492 11.6408 38.725 55.5111 26.1867 39.8667 x 48.1056 x 37.325 x x x x 47.8778 x x 21.375 33.8 38.7008 40.6675 33.4 x 23.4333 47.95 x 32.2689 x x x 26.7417 x 29.9583 43.6883 22.3667 x x x +11723 Original post publication description: Anxiety assay, time in closed arms of an elevated plus maze for females [sec] None Central nervous system, behavior: Central nervous system, behavior: Anxiety assay, time in closed arms of an elevated plus maze for females [sec] x x x x 85.8125 143.982 x 32.2 x 113.882 140.8 132.81 69.4 99.55 200.122 x 62.4375 x 100.64 95.62 x x x x x 102.313 157.092 204.9 x 157.913 144.355 107.143 101.25 x x x 77.195 186.807 110.57 x 111.245 121.348 272.883 204.92 x x 132.66 x 149.262 120.192 x x x 214.77 195.705 x x x 220.708 135.932 169.295 290.81 x 206.7 130.395 132.143 109.588 140.76 119.744 86.37 x 139.172 x 234.47 x x x x 176.058 x x 193.898 98.1925 168.893 88.7725 122.358 x 167.327 220.685 x 257.357 x x x 93.255 x 121.022 130.238 154.89 x x x +11724 Original post publication description: Anxiety assay, time in middle of an elevated plus maze for females [sec] None Central nervous system, behavior: Anxiety assay, time in middle of an elevated plus maze for females [sec] x x x x 54.5975 37.324 x 33.09 x 29.8825 26.6633 16.805 178.62 70.52 19.4075 x 144.785 x 16.97 70.05 x x x x x 56.4633 53.425 20.0883 x 40.0975 27.91 16.0975 74.5083 x x x 173.325 18.7525 56.345 x 68.375 105.897 14.2125 11.05 x x 29.07 x 10.9525 34.0025 x x x 10.825 28.895 x x x 29.5217 76.4375 25.36 3.55 x 35.695 94.8175 12.82 96.97 110.403 43.73 127.767 x 28.3467 x 44.2867 x x x x 30.582 x x 37.965 129.673 28.515 40.06 51.5267 x 14.2975 15.325 x 19.0133 x x x 30.0575 x 87.505 40.83 24.465 x x x +11725 Original post publication description: Anxiety assay, time in open arms of an elevated plus maze for females [sec] None Central nervous system, behavior: Anxiety assay, time in open arms of an elevated plus maze for females [sec] x x x x 159.59 118.694 x 234.7 x 156.235 132.563 150.385 52.0 129.93 80.47 x 92.7775 x 182.39 134.33 x x x x x 141.223 89.4825 75.0117 x 101.99 127.735 176.76 124.242 x x x 49.48 94.44 133.085 x 120.38 72.755 12.905 84.03 x x 138.27 x 139.785 145.805 x x x 74.405 75.4 x x x 49.77 87.63 105.345 5.64 x 57.65 74.7875 155.038 93.4425 48.8367 136.526 85.8633 x 132.482 x 21.2433 x x x x 93.36 x x 68.1375 72.135 102.592 171.167 126.115 x 118.375 63.99 x 23.63 x x x 176.688 x 91.4725 128.932 120.645 x x x +11726 Original post publication description: Cocaine response (10 mg/kg ip), locomotion from 0-15 min after first injection in an activity chamber for females [n beam breaks] None Cocaine response (10 mg/kg ip), locomotion from 0-15 min after first injection in an activity chamber for females [n beam breaks] x x x x 1409.0 1360.1 x 868.455 1060.86 3039.8 530.9 1698.09 1062.5 2995.0 659.5 979.5 2923.86 1853.6 934.5 3013.55 x x x 2374.88 x 1324.57 1440.0 3010.11 x 2021.9 1423.09 3022.17 1105.71 x 578.625 x 2506.36 1423.29 3805.43 x 2376.67 2427.56 1032.44 1905.0 x x 1636.11 x 1524.0 1110.47 x x x 1767.2 592.316 x x x 2907.67 1316.5 949.4 1939.18 x 2537.08 907.375 1297.38 1828.36 3257.71 2012.93 3791.5 x 1307.18 x 1685.09 x 3293.57 x x 1734.0 x x 1396.27 3716.88 1227.47 1948.92 1463.0 x 3112.0 778.0 x 1818.18 x x x 2222.67 2983.17 2876.81 2868.18 848.321 x x x +11727 Original post publication description: Cocaine response (10 mg/kg ip), locomotion from 15-30 min after first injection in an activity chamber for females [n beam breaks] None Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), locomotion from 15-30 min after first injection in an activity chamber for females [n beam breaks] x x x x 1267.33 723.6 x 783.455 524.571 2521.4 838.6 1150.09 829.0 1794.14 306.167 890.625 2374.14 1398.0 1420.5 2772.09 x x x 1525.88 x 894.429 718.5 2113.89 x 1976.5 1479.64 2525.58 1007.57 x 271.25 x 2137.64 937.643 3292.07 x 2002.07 1888.44 740.188 1545.38 x x 1637.89 x 1648.43 1013.2 x x x 1542.5 373.947 x x x 2721.87 1251.78 840.8 1565.36 x 2105.42 875.5 1303.08 1942.64 3101.24 2147.47 3562.58 x 1086.94 x 1240.45 x 2194.86 x x 1332.56 x x 1060.2 2289.19 1560.0 1392.69 1137.1 x 2251.75 380.2 x 1743.55 x x x 1780.93 2270.83 1323.52 3182.91 786.179 x x x +11728 Original post publication description: Cocaine response (10 mg/kg ip), locomotion from 30-45 min after first injection in an activity chamber for females [n beam breaks] None Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), locomotion from 30-45 min after first injection in an activity chamber for females [n beam breaks] x x x x 1110.67 477.2 x 928.364 513.286 2078.0 902.3 979.727 774.167 1248.29 313.667 739.375 1522.29 454.6 1803.25 1997.82 x x x 1301.25 x 626.214 670.5 1336.33 x 1390.3 1383.36 1475.25 816.857 x 91.125 x 1605.73 782.357 2242.64 x 1206.67 1545.0 576.938 1852.25 x x 1539.78 x 1271.29 769.333 x x x 1436.7 220.316 x x x 1926.0 983.722 670.933 1226.73 x 1468.0 798.875 1007.92 1481.86 2501.05 1478.87 2785.75 x 836.882 x 734.727 x 1467.0 x x 938.444 x x 822.667 1199.12 1122.4 1055.31 678.4 x 1791.5 222.2 x 1287.18 x x x 1226.67 1421.67 660.524 2675.27 647.964 x x x +11729 Original post publication description: Cocaine response (10 mg/kg ip), locomotion from 45-60 min after first injection in an activity chamber for females [n beam breaks] None Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), locomotion from 45-60 min after first injection in an activity chamber for females [n beam breaks] x x x x 793.333 251.5 x 536.0 503.286 1425.8 783.4 809.182 490.583 1009.57 144.0 898.125 780.857 178.8 1109.0 1617.27 x x x 1009.5 x 400.857 741.75 785.444 x 928.8 1008.27 1289.0 545.357 x 32.25 x 1190.36 710.643 1829.57 x 1022.2 1087.44 450.375 1500.38 x x 1310.22 x 1250.57 610.267 x x x 1117.6 92.7368 x x x 1481.93 837.556 379.333 855.0 x 1132.42 613.0 925.0 1049.21 2036.62 1195.2 2053.92 x 552.0 x 497.636 x 1169.57 x x 728.889 x x 781.733 939.438 680.533 829.0 581.9 x 1511.0 189.0 x 1069.82 x x x 1106.53 1132.83 432.19 2208.91 592.0 x x x +11730 Original post publication description: Cocaine response (10 mg/kg ip), locomotion from 0-15 min after first injection in an activity chamber for females [cm] None Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), locomotion from 0-15 min after first injection in an activity chamber for females [cm] x x x x 4230.6 3880.27 x 2499.61 3129.13 7971.05 1677.26 4910.78 3294.76 8545.92 2165.83 2944.77 7835.97 5359.83 2859.37 8285.53 x x x 6846.67 x 4030.69 4188.85 8656.43 x 6047.12 4113.59 8213.68 3370.96 x 1836.12 x 7378.2 4084.12 9900.45 x 7075.52 7501.34 3226.44 5733.33 x x 4736.57 x 4614.37 3599.0 x x x 5372.53 1982.58 x x x 8229.71 3924.21 2838.12 5773.52 x 7151.38 2724.92 4075.17 5681.67 8806.02 5986.97 10547.5 x 4093.9 x 5097.92 x 9198.41 x x 5200.68 x x 4458.84 10079.6 4096.85 5672.63 4432.53 x 8866.25 2850.69 x 5557.08 x x x 6283.3 8045.93 7588.26 8326.11 2685.01 x x x +11731 Original post publication description: Cocaine response (10 mg/kg ip), locomotion from 15-30 min after first injection in an activity chamber for females [cm] None Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), locomotion from 15-30 min after first injection in an activity chamber for females [cm] x x x x 3847.64 2138.81 x 2343.12 1786.85 6607.77 2655.28 3615.0 2666.83 5334.81 1190.19 2785.73 6388.96 4266.01 4381.6 7658.9 x x x 4566.34 x 2964.01 2225.46 6161.4 x 5996.48 4309.65 7065.5 3173.82 x 952.578 x 6450.89 2791.75 8789.17 x 6109.2 6349.56 2389.77 4663.5 x x 4878.6 x 4890.48 3404.4 x x x 4698.1 1344.05 x x x 7613.5 3807.91 2590.36 4600.96 x 6114.99 2651.21 4059.44 5877.66 8440.45 6299.76 9823.25 x 3521.12 x 3962.8 x 6516.93 x x 4036.14 x x 3406.68 6553.78 5051.97 4079.95 3520.95 x 6637.42 1539.9 x 5317.39 x x x 5203.49 6292.42 3626.54 8862.52 2609.74 x x x +11732 Original post publication description: Cocaine response (10 mg/kg ip), locomotion from 30-45 min after first injection in an activity chamber for females [cm] None Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), locomotion from 30-45 min after first injection in an activity chamber for females [cm] x x x x 3544.59 1531.03 x 2797.3 1951.93 5387.31 2893.81 3166.58 2677.47 3866.66 1196.1 2341.68 4269.98 1550.33 5562.46 5622.17 x x x 4115.45 x 2095.23 2284.8 4063.94 x 4431.44 4134.73 4500.31 2687.4 x 340.694 x 5025.51 2453.9 6403.7 x 3937.17 5230.34 1926.88 5509.04 x x 4662.84 x 3895.29 2761.68 x x x 4553.74 786.603 x x x 5510.64 3115.6 2200.11 3763.67 x 4497.07 2515.85 3198.75 4695.52 6971.5 4660.86 7873.86 x 2761.1 x 2558.2 x 4745.46 x x 2988.76 x x 2814.35 3900.01 3708.05 3326.33 2143.37 x 5457.19 948.936 x 4193.43 x x x 3826.08 4081.13 2002.22 7658.37 2170.65 x x x +11733 Original post publication description: Cocaine response (10 mg/kg ip), locomotion from 45-60 min after first injection in an activity chamber for females [cm] None Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), locomotion from 45-60 min after first injection in an activity chamber for females [cm] x x x x 2632.07 896.436 x 1690.94 1968.1 4012.88 2573.5 2673.66 1737.93 3192.59 585.927 2802.55 2281.67 665.749 3487.11 4711.07 x x x 3214.3 x 1379.0 2455.35 2587.76 x 3142.35 3089.61 4042.58 1801.67 x 107.51 x 3895.06 2290.77 5481.12 x 3296.58 3690.93 1548.02 4438.86 x x 4021.64 x 3826.03 2259.72 x x x 3634.63 334.395 x x x 4351.75 2750.54 1314.84 2729.37 x 3638.86 1974.56 2999.73 3524.15 5922.04 3907.72 5983.88 x 1866.53 x 1770.34 x 3881.44 x x 2364.06 x x 2659.89 3250.66 2326.26 2672.68 1863.51 x 4779.58 701.345 x 3473.34 x x x 3508.65 3298.06 1376.34 6455.46 2009.79 x x x +11734 Original post publication description: Cocaine response (10 mg/kg ip), vertical activity (rears) in an open field 0-15 min after injection for females [n beam breaks] None Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), vertical activity (rears) in an open field 0-15 min after injection for females [n beam breaks] x x x x 77.3333 206.9 x 133.273 174.0 275.8 87.6 233.273 125.0 406.5 73.6667 199.0 308.714 212.8 157.75 374.091 x x x 246.375 x 331.286 148.0 479.111 x 369.5 298.455 303.833 211.143 x 79.625 x 373.0 157.643 391.143 x 493.867 709.111 222.625 324.875 x x 457.333 x 279.286 331.133 x x x 228.1 53.5263 x x x 403.133 329.889 231.667 191.273 x 369.167 186.5 365.462 406.429 463.095 401.2 487.667 x 431.176 x 359.364 x 554.143 x x 407.444 x x 364.4 293.188 255.733 295.077 325.5 x 396.25 173.0 x 296.727 x x x 533.333 288.333 258.095 416.091 170.714 x x x +11735 Original post publication description: Cocaine response (10 mg/kg ip), vertical activity (rears) in an open field 15-30 min after injection for females [n beam breaks] None Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), vertical activity (rears) in an open field 15-30 min after injection for females [n beam breaks] x x x x 130.333 144.4 x 173.091 206.286 294.4 165.5 289.455 144.333 423.357 99.3333 276.75 336.286 253.8 269.0 473.545 x x x 240.25 x 307.286 136.0 435.111 x 437.8 363.0 388.833 240.929 x 74.625 x 408.909 144.429 567.643 x 508.933 794.778 194.875 349.625 x x 581.667 x 325.429 312.8 x x x 268.0 67.0 x x x 438.2 401.611 341.8 206.273 x 398.583 262.0 397.154 463.571 577.667 473.133 535.417 x 467.294 x 426.091 x 557.857 x x 398.778 x x 394.467 326.625 369.667 263.923 272.9 x 417.0 133.6 x 320.182 x x x 568.533 334.667 181.048 484.091 246.25 x x x +11736 Original post publication description: Cocaine response (10 mg/kg ip), vertical activity (rears) in an open field 30-45 min after injection for females [n beam breaks] None Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), vertical activity (rears) in an open field 30-45 min after injection for females [n beam breaks] x x x x 197.667 125.3 x 188.273 253.143 283.6 205.0 279.636 216.583 387.786 124.167 225.125 312.714 142.0 386.5 393.364 x x x 250.375 x 214.857 175.5 326.0 x 397.9 348.091 350.5 233.0 x 28.75 x 425.0 157.857 500.571 x 372.933 636.889 176.375 402.75 x x 527.889 x 316.857 286.8 x x x 334.2 55.0526 x x x 382.067 405.056 334.533 169.364 x 326.5 250.875 378.077 390.5 543.429 404.6 544.667 x 374.353 x 355.909 x 545.0 x x 361.111 x x 346.533 379.938 310.333 224.462 209.5 x 430.5 86.4 x 281.727 x x x 532.6 286.667 171.143 510.909 233.536 x x x +11737 Original post publication description: Cocaine response (10 mg/kg ip), vertical activity (rears) in an open field 45-60 min after injection for females [n beam breaks] None Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), vertical activity (rears) in an open field 45-60 min after injection for females [n beam breaks] x x x x 160.0 85.6 x 163.0 262.286 303.6 202.8 230.091 153.75 325.5 74.0 288.125 204.143 83.2 278.25 348.091 x x x 224.625 x 154.714 263.5 220.111 x 333.4 278.273 338.25 196.857 x 6.875 x 427.364 187.714 518.571 x 323.6 508.444 163.688 353.375 x x 507.778 x 322.429 227.8 x x x 293.6 24.2632 x x x 349.2 410.389 237.4 158.364 x 319.75 277.875 370.385 336.643 563.81 395.933 502.583 x 305.059 x 276.182 x 512.286 x x 336.667 x x 325.467 362.562 242.867 238.0 189.0 x 436.75 73.2 x 229.0 x x x 505.533 232.5 121.952 515.0 254.643 x x x +11738 Original post publication description: Cocaine response (2 x 10 mg/kg ip), locomotion from 0-15 min after second injection in an activity chamber for females [n beam breaks] None Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), locomotion from 0-15 min after second injection in an activity chamber for females [n beam breaks] x x x x 3535.0 2876.0 x 1240.09 1327.86 4549.2 830.3 2715.36 2391.75 3816.5 889.167 1885.71 4435.29 4025.2 2861.75 4920.18 x x x 2910.62 x 2940.38 3664.5 3602.44 x 2558.1 2296.45 4552.5 1471.71 x 953.5 x 3805.0 2439.64 5736.36 x 3004.67 3185.11 1914.25 2703.88 x x 2292.56 x 1650.17 2128.4 x x x 2669.6 884.684 x x x 4290.27 1731.94 1265.4 2942.73 x 3007.45 1959.62 1824.15 2551.07 4942.38 3174.6 5382.25 x 2329.53 x 2853.27 x 4188.57 x x 2260.83 x x 2456.33 5058.69 2703.13 3655.46 2652.0 x 3828.25 939.2 x 2790.45 x x x 3227.73 5425.4 3167.38 3743.55 1410.5 x x x +11739 Original post publication description: Cocaine response (2 x 10 mg/kg ip), locomotion from 15-30 min after second injection in an activity chamber for females [n beam breaks] None Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), locomotion from 15-30 min after second injection in an activity chamber for females [n beam breaks] x x x x 2713.33 1178.3 x 797.636 748.0 3926.0 1072.0 1528.73 1587.67 2199.0 735.167 1749.0 2741.71 2792.4 2622.5 2924.82 x x x 1941.25 x 1720.54 1858.75 2257.89 x 1994.2 1680.73 3049.75 767.5 x 377.5 x 2554.45 1928.43 3797.5 x 1978.33 2488.67 1385.56 2062.88 x x 1609.56 x 1407.17 1647.53 x x x 2219.6 487.263 x x x 3644.47 1221.72 859.067 2492.91 x 2048.18 1453.38 1726.23 2062.57 4189.14 2753.47 4758.58 x 1606.06 x 1664.0 x 2511.71 x x 1468.06 x x 1583.8 2921.69 2338.27 2410.54 1828.0 x 2190.25 544.6 x 2252.64 x x x 1981.33 2773.2 1607.19 3151.91 909.036 x x x +11740 Original post publication description: Cocaine response (2 x 10 mg/kg ip), locomotion from 30-45 min after second injection in an activity chamber for females [n beam breaks] None Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), locomotion from 30-45 min after second injection in an activity chamber for females [n beam breaks] x x x x 1600.67 687.7 x 845.455 579.714 2751.0 920.1 1008.45 838.0 1281.36 549.0 1283.14 1497.14 1128.4 1866.5 2094.82 x x x 1412.88 x 1063.23 1309.0 1749.33 x 1654.1 1348.45 2130.75 641.929 x 230.75 x 1362.55 1119.93 2394.93 x 1383.13 1525.22 895.5 1897.5 x x 1214.78 x 1231.5 1117.13 x x x 1787.0 319.474 x x x 2552.53 968.667 678.6 1718.45 x 1325.27 1208.38 1227.23 1455.64 2966.62 2018.2 3725.58 x 969.647 x 904.909 x 1646.57 x x 1015.0 x x 1122.2 1669.5 1388.07 1383.69 1237.5 x 1776.75 322.2 x 1650.45 x x x 1314.73 2022.0 815.905 2672.45 775.786 x x x +11741 Original post publication description: Cocaine response (2 x 10 mg/kg ip), locomotion from 45-60 min after second injection in an activity chamber for females [n beam breaks] None Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), locomotion from 45-60 min after second injection in an activity chamber for females [n beam breaks] x x x x 661.333 514.1 x 799.0 487.286 1831.4 975.6 790.545 701.75 1096.64 470.167 1075.29 857.714 320.8 1210.75 1643.82 x x x 857.375 x 761.462 743.0 1266.22 x 1125.7 986.364 1544.83 574.929 x 27.375 x 1054.82 909.214 1838.64 x 1136.73 1232.11 601.875 1250.25 x x 1191.67 x 1149.33 846.067 x x x 1460.7 185.421 x x x 1797.73 828.778 357.2 1047.55 x 676.636 927.375 1026.08 1042.0 2313.81 1511.4 2823.08 x 641.235 x 647.273 x 1225.86 x x 693.056 x x 864.067 1032.5 1085.2 1074.77 874.4 x 1587.75 144.4 x 1043.55 x x x 970.867 1234.0 460.286 2129.18 617.036 x x x +11742 Original post publication description: Cocaine response (2 x 10 mg/kg ip), locomotion in an open field from 0-15 min after second injection in an activity chamber for females [cm] None Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), locomotion in an open field from 0-15 min after second injection in an activity chamber for females [cm] x x x x 9524.15 7599.11 x 3494.01 3656.02 11493.9 2393.81 7493.6 6742.47 10439.3 2713.42 5284.43 11352.3 11094.2 8419.04 12833.2 x x x 8046.3 x 8425.87 9787.7 9803.84 x 7394.73 6310.7 11771.3 4418.41 x 2777.14 x 10611.7 6524.19 14368.7 x 8839.97 9608.01 5579.16 7820.48 x x 6454.29 x 4975.27 6234.04 x x x 7917.85 2780.06 x x x 11464.4 5006.97 3715.25 8030.78 x 8139.33 5357.53 5513.75 7315.2 12810.4 8823.13 14147.8 x 6592.98 x 8254.81 x 11064.4 x x 6530.52 x x 7052.38 13013.1 8106.57 10093.1 7438.16 x 10539.8 3073.48 x 7822.25 x x x 8846.96 14075.4 8306.78 10293.6 4169.36 x x x +11743 Original post publication description: Cocaine response (2 x 10 mg/kg ip), locomotion in an open field from 15-30 min after second injection in an activity chamber for females [cm] None Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), locomotion in an open field from 15-30 min after second injection in an activity chamber for females [cm] x x x x 7200.01 3237.57 x 2445.65 2353.06 10046.6 3212.21 4567.87 4718.66 6287.63 2391.69 4805.75 7283.9 8330.69 7933.58 8181.87 x x x 5665.02 x 5331.53 5318.87 6472.11 x 5839.64 4855.65 8258.7 2497.33 x 1296.61 x 7389.62 5335.72 9778.14 x 6042.26 7695.64 4216.99 6059.87 x x 4819.44 x 4202.09 4914.37 x x x 6534.23 1712.67 x x x 9840.64 3722.5 2615.24 7005.63 x 6023.86 4113.97 5134.96 6162.58 10841.8 7737.16 12473.3 x 4748.33 x 5254.57 x 6974.07 x x 4391.12 x x 4775.61 7950.31 7035.53 6911.03 5140.7 x 6468.23 1999.1 x 6500.8 x x x 5680.93 7599.26 4417.77 8617.31 2957.26 x x x +11744 Original post publication description: Cocaine response (2 x 10 mg/kg ip), locomotion in an open field from 30-45 min after second injection in an activity chamber for females [cm] None Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), locomotion in an open field from 30-45 min after second injection in an activity chamber for females [cm] x x x x 4628.31 2073.51 x 2625.72 2060.65 7358.3 2905.37 3299.36 2718.04 3930.2 2043.27 3767.69 4285.74 3953.34 5765.79 6168.37 x x x 4426.48 x 3603.26 4204.66 5302.73 x 4944.13 3984.07 6235.47 2129.26 x 794.163 x 4435.32 3329.51 6763.34 x 4435.14 5198.77 2873.71 5581.4 x x 3755.97 x 3827.32 3639.01 x x x 5339.45 1173.19 x x x 7106.67 3063.62 2254.02 5045.73 x 4216.91 3580.65 3822.39 4584.42 8031.46 5994.75 10009.3 x 3023.18 x 3156.1 x 5091.71 x x 3163.87 x x 3640.83 5004.1 4461.65 4308.18 3640.36 x 5438.41 1275.69 x 5045.95 x x x 3964.73 5852.9 2539.79 7613.65 2589.4 x x x +11745 Original post publication description: Cocaine response (2 x 10 mg/kg ip), locomotion in an open field from 45-60 min after second injection in an activity chamber for females [cm] None Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), locomotion in an open field from 45-60 min after second injection in an activity chamber for females [cm] x x x x 2105.64 1629.19 x 2526.38 1832.14 5218.03 3050.59 2629.32 2471.64 3435.91 1738.01 3273.38 2462.39 1172.29 3703.43 4914.52 x x x 2875.28 x 2690.14 2489.52 3905.14 x 3583.35 3090.7 4715.9 1984.84 x 84.1075 x 3560.47 2897.09 5374.12 x 3716.21 4272.17 2026.55 3876.97 x x 3711.01 x 3602.32 2911.03 x x x 4585.72 664.119 x x x 5132.04 2663.01 1242.65 3341.56 x 2328.5 2855.85 3310.81 3473.22 6549.12 4755.22 7869.97 x 2124.36 x 2459.73 x 4174.72 x x 2239.76 x x 2911.49 3373.36 3586.15 3540.16 2611.34 x 4865.18 520.602 x 3397.59 x x x 3145.28 3714.28 1512.61 6277.72 2133.0 x x x +11746 Original post publication description: Cocaine response (2 x 10 mg/kg ip), vertical activity (rears) from 15-30 min after second injection in an activity chamber for females [n beam breaks] None Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), vertical activity (rears) from 15-30 min after second injection in an activity chamber for females [n beam breaks] x x x x 133.333 330.5 x 184.091 189.0 319.6 98.8 367.636 195.333 524.214 124.667 310.0 461.571 447.0 546.75 492.636 x x x 289.625 x 568.0 311.25 558.333 x 439.0 366.455 369.917 284.929 x 98.375 x 490.818 178.857 550.214 x 669.0 882.889 339.375 445.75 x x 554.889 x 355.5 467.4 x x x 424.7 65.4211 x x x 572.867 375.278 311.467 234.182 x 311.545 276.25 439.462 425.571 645.762 549.667 617.5 x 449.471 x 493.727 x 579.429 x x 459.611 x x 453.6 382.562 441.067 491.846 458.8 x 465.5 185.2 x 332.727 x x x 645.933 317.2 337.238 513.455 252.857 x x x +11747 Original post publication description: Cocaine response (2 x 10 mg/kg ip), vertical activity (rears) from 15-30 min after second injection in an activity chamber for females [n beam breaks] None Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), vertical activity (rears) from 15-30 min after second injection in an activity chamber for females [n beam breaks] x x x x 158.0 199.5 x 200.455 212.571 391.0 192.6 318.182 217.75 482.286 169.667 387.857 418.0 469.8 526.0 503.818 x x x 278.375 x 485.692 309.5 471.778 x 409.1 379.273 415.917 193.071 x 110.125 x 461.364 217.357 533.786 x 549.933 850.444 315.688 471.125 x x 553.556 x 304.667 387.2 x x x 398.8 85.4737 x x x 599.733 444.722 381.267 272.182 x 386.818 376.625 456.923 482.5 671.905 630.8 606.75 x 416.824 x 574.364 x 503.143 x x 431.611 x x 458.733 373.625 491.133 409.077 353.1 x 405.75 145.8 x 348.818 x x x 574.267 313.6 237.381 507.0 294.929 x x x +11748 Original post publication description: Cocaine response (2 x 10 mg/kg ip), vertical activity (rears) from 30-45 min after second injection in an activity chamber for females [n beam breaks] None Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), vertical activity (rears) from 30-45 min after second injection in an activity chamber for females [n beam breaks] x x x x 151.667 155.5 x 201.364 261.857 391.0 199.8 278.364 194.5 381.071 202.167 296.714 325.714 385.2 412.75 472.818 x x x 258.5 x 388.154 329.75 391.111 x 410.6 333.727 389.833 219.429 x 66.0 x 452.273 190.571 516.643 x 456.867 687.0 230.438 420.625 x x 462.222 x 355.833 308.467 x x x 341.0 72.4211 x x x 499.467 371.556 380.733 250.818 x 330.455 350.625 404.769 382.643 637.095 566.667 543.583 x 358.0 x 454.727 x 538.0 x x 355.5 x x 395.8 379.375 382.267 310.615 296.1 x 390.0 98.2 x 320.636 x x x 511.733 375.6 191.143 517.727 318.5 x x x +11749 Original post publication description: Cocaine response (2 x 10 mg/kg ip), vertical activity (rears) from 45-60 min after second injection in an activity chamber for females [n beam breaks] None Cocaine response (2 x 10 mg/kg ip), vertical activity (rears) from 45-60 min after second injection in an activity chamber for females [n beam breaks] x x x x 103.333 190.3 x 192.455 211.571 396.4 218.3 213.909 237.417 391.286 159.667 285.0 218.143 173.6 277.5 420.818 x x x 196.125 x 298.0 240.0 348.556 x 406.2 306.0 332.417 232.857 x 14.0 x 430.636 220.857 478.857 x 393.267 570.333 184.188 341.5 x x 466.111 x 342.667 274.267 x x x 352.0 39.6842 x x x 419.267 389.111 261.867 205.636 x 224.091 319.625 401.462 350.071 588.429 524.067 496.083 x 301.941 x 376.727 x 529.857 x x 314.556 x x 357.067 350.75 400.467 324.615 219.0 x 342.0 45.4 x 239.636 x x x 509.533 315.2 128.048 500.182 282.929 x x x +11750 Original post publication description: Conditioned place preference (CPP) baseline control for cocaine CPP test, time in drug-paired compartment for females [sec] None Conditioned place preference (CPP) baseline control for cocaine CPP test, time in drug-paired compartment for females [sec] x x x x 416.1 392.87 x 446.536 458.043 x 365.112 503.8 332.263 446.378 314.45 379.675 390.55 x 435.65 420.433 x x x 448.867 x 389.644 598.525 409.225 x 381.175 391.771 340.731 400.206 x 197.367 x 365.567 395.583 369.444 x 339.73 406.538 455.973 326.087 x x 403.444 x 419.812 342.106 x x x 358.55 300.635 x x x 308.944 452.019 386.631 297.194 x 424.064 285.383 351.231 343.744 419.761 443.315 422.386 x 361.438 x 403.425 x 393.1 x x 335.604 x x 469.81 399.682 388.906 345.288 389.17 x 362.3 514.567 x 372.493 x x x 457.604 413.138 383.743 413.206 452.463 x x x +11751 Original post publication description: Conditioned place preference (CPP) baseline control for cocaine CPP test, time spent in saline-paired unconditioned side before conditioning for females [sec] None Conditioned place preference (CPP) baseline control for cocaine CPP test, time spent in saline-paired unconditioned side before conditioning for females [sec] x x x x 471.5 556.94 x 497.75 459.471 x 370.712 445.469 486.888 477.822 528.2 508.35 462.775 x 491.05 403.342 x x x 444.217 x 418.494 369.8 499.9 x 537.8 533.25 494.069 497.028 x 689.983 x 449.122 432.328 434.767 x 537.54 464.275 445.136 344.788 x x 485.756 x 479.025 456.522 x x x 474.63 415.946 x x x 550.194 419.388 471.45 434.744 x 451.314 376.433 505.65 395.417 427.168 458.795 443.707 x 480.438 x 460.267 x 379.95 x x 465.381 x x 478.0 492.368 502.933 502.85 440.35 x 375.95 476.933 x 515.85 x x x 475.079 457.525 466.764 484.017 444.661 x x x +11752 Original post publication description: Cocaine response (3 x 3.2 mg/kg ip, Days 2, 3, 4), conditioned place preference (CPP), time in drug-paired compartment on Day 5 for females [sec] None Cocaine response (3 x 3.2 mg/kg ip, Days 2, 3, 4), conditioned place preference (CPP), time in drug-paired compartment on Day 5 for females [sec] x x x x 523.05 430.48 x 438.679 459.321 x 403.45 693.581 416.306 539.783 321.9 423.45 557.075 x 431.95 452.225 x x x 558.742 x 508.494 530.925 344.55 x 538.35 343.514 384.419 600.75 x 237.575 x 486.283 500.378 358.494 x 379.025 459.817 540.15 516.869 x x 381.044 x 409.217 368.611 x x x 432.96 278.7 x x x 322.131 441.977 479.531 406.688 x 428.371 564.567 419.45 477.006 498.504 398.96 422.329 x 392.275 x 519.292 x 542.987 x x 375.369 x x 454.465 506.635 439.756 461.406 335.03 x 324.15 326.75 x 392.664 x x x 389.237 499.85 413.964 379.044 482.365 x x x +11753 Original post publication description: Cocaine response (3 x 3.2 mg/kg ip, Days 2, 3, 4), conditioned place preference (CPP), time in unconditioned saline-paired compartment on Day 5 for females [sec] None Cocaine response (3 x 3.2 mg/kg ip, Days 2, 3, 4), conditioned place preference (CPP), time in unconditioned saline-paired compartment on Day 5 for females [sec] x x x x 174.75 550.78 x 390.579 397.943 x 552.312 235.438 485.45 425.722 157.6 429.587 335.8 x 417.1 396.417 x x x 433.642 x 330.562 421.3 456.475 x 460.75 543.343 347.712 289.961 x 673.767 x 321.45 350.222 561.439 x 465.235 409.617 355.395 265.975 x x 395.163 x 547.117 443.089 x x x 434.69 353.181 x x x 549.05 486.815 542.744 369.056 x 503.521 337.2 495.9 255.844 341.964 437.605 505.107 x 436.969 x 363.558 x 362.013 x x 469.404 x x 387.485 364.105 425.3 384.85 478.72 x 367.95 405.6 x 528.836 x x x 527.704 367.35 359.561 489.65 469.287 x x x +11754 Original post publication description: Conditioned place preference (CPP) baseline control for cocaine CPP test, percentage of time spent in conditioned side before conditioning for females [%] None Conditioned place preference (CPP) baseline control for cocaine CPP test, percentage of time spent in conditioned side before conditioning for females [%] x x x x 46.8792 41.4642 x 47.4779 49.6171 x 47.9623 52.9764 40.6174 48.487 37.3168 42.777 45.5089 x 47.01 50.5744 x x x 50.0102 x 48.0337 61.805 45.125 x 41.4839 42.2944 40.5973 44.5103 x 23.2035 x 44.5284 47.8228 46.095 x 39.0468 46.5359 50.701 48.5228 x x 45.2516 x 46.4625 43.1293 x x x 43.0788 41.8508 x x x 35.5631 52.3091 44.7718 40.702 x 48.1398 45.0249 41.0208 46.1789 49.2875 49.0858 48.8028 x 42.9267 x 46.4217 x 51.6334 x x 41.5006 x x 49.6608 44.8981 43.591 40.117 47.0254 x 49.0755 52.19 x 42.2461 x x x 48.9635 47.4177 45.2486 45.8164 50.3107 x x x +11755 Original post publication description: Cocaine response (3 x 3.2 mg/kg ip, Days 2, 3, and 4), conditioned place preference (CPP), change in time in cocaine-paired compartment relative to baseline (Day 5 minus Day 1) for females [sec] None Cocaine response (3 x 3.2 mg/kg ip, Days 2, 3, and 4), conditioned place preference (CPP), change in time in cocaine-paired compartment relative to baseline (Day 5 minus Day 1) for females [sec] x x x x 106.95 37.61 x -7.85714 1.27857 x 38.3375 189.781 84.0437 93.4056 7.45 43.775 166.525 x -3.7 31.7917 x x x 109.875 x 107.637 -67.6 -64.675 x 157.175 -48.2571 43.6875 200.544 x 40.2083 x 120.717 104.794 -10.95 x 39.295 -61.675 84.1773 190.781 x x -22.4 x 50.25 26.5056 x x x 74.41 -21.9346 x x x 13.1875 -10.0423 92.9 109.494 x 4.30714 279.183 68.2188 133.261 78.7429 -44.355 -0.057143 x 30.8375 x 115.867 x 149.887 x x 39.7654 x x -15.345 96.78 50.85 116.119 -54.14 x -38.15 -187.817 x 20.1714 x x x -68.3667 86.7125 30.2214 -34.1611 29.9022 x x x +11756 Original post publication description: Cocaine response (3 x 3.2 mg/kg ip, Days 2, 3, and 4), conditioned place preference (CPP), change in percentage time in cocaine-paired compartment relative to baseline (Day 5 minus Day 1) for females [% change] None Central nervous system, pharmacology, behavior: Cocaine response (3 x 3.2 mg/kg ip, Days 2, 3, and 4), conditioned place preference (CPP), change in percentage time in cocaine-paired compartment relative to baseline (Day 5 minus Day 1) for females [% change] x x x x 28.0778 1.80665 x 4.4017 3.96045 x -5.96558 20.9859 5.42069 7.08287 29.8156 7.37825 17.0043 x 3.86 2.6049 x x x 6.3378 x 12.0171 -6.085 -2.005 x 12.1334 -2.30311 11.2862 22.9774 x 4.59814 x 14.6315 11.6819 -6.7949 x 5.96568 5.32642 9.44486 17.4434 x x 3.54304 x 1.15 3.29076 x x x 7.06459 3.09155 x x x 1.61384 -4.30311 1.80924 10.8895 x -2.11217 17.2795 5.94599 18.5984 10.2449 -1.29891 -2.86138 x 5.49672 x 12.8228 x 8.14131 x x 2.92834 x x 5.45814 12.1983 7.16915 14.3607 -4.99415 x -2.2398 -7.7 x 0.308785 x x x -5.88903 10.5909 7.91986 -2.44206 0.207328 x x x +11757 Original post publication description: Novel open field behavior, locomotion in the center from 0-60 min for females [n beam breaks] None Novel open field behavior, locomotion in the center from 0-60 min for females [n beam breaks] x x x x 950.0 1998.7 x 2312.82 1446.71 3249.4 1381.6 3116.91 836.75 2650.5 785.667 2045.12 4115.57 954.0 2068.75 2520.82 x x x 2592.38 x 714.467 1185.75 2990.56 x 966.9 2506.82 2677.25 1452.93 x 414.375 x 2363.0 2051.86 3000.43 x 2245.13 1867.56 997.75 2616.12 x x 3329.44 x 2471.33 1704.27 x x x 2470.9 168.211 x x x 2490.33 1829.17 492.2 1052.45 x 2310.67 2239.88 1988.92 1383.86 3215.9 3445.67 3134.17 x 1493.88 x 1722.18 x 2692.14 x x 2327.11 x x 1359.33 1473.44 669.8 1777.54 1479.08 x 2693.25 906.8 x 1604.27 x x x 2307.6 2708.17 2510.52 3025.27 1378.36 x x x +11758 Original post publication description: Novel open field behavior, locomotion in the center from 0-60 min for females [cm] None Novel open field behavior, locomotion in the center from 0-60 min for females [cm] x x x x 3175.3 5379.71 x 6370.67 4409.6 8875.52 4207.56 8089.85 2851.47 7742.45 2579.01 6066.76 10412.1 3468.43 5151.83 6771.92 x x x 7445.92 x 2223.38 3676.85 7774.18 x 2989.19 6922.18 8048.95 4377.0 x 1408.39 x 6723.66 5758.26 8636.59 x 6617.55 5660.48 2986.98 7355.4 x x 9529.27 x 6681.43 5157.94 x x x 7032.16 617.923 x x x 7353.17 5319.27 1688.89 3401.28 x 6633.34 6463.86 6260.05 4446.06 9021.29 10001.5 8824.45 x 4515.61 x 5098.12 x 8286.63 x x 6620.67 x x 4379.47 4642.9 2097.64 5139.08 4213.61 x 7898.24 3178.4 x 4725.78 x x x 6406.52 7751.73 6327.84 8382.01 4060.77 x x x +11759 Original post publication description: Novel open field behavior, vertical activity (rears) from 0-60 min in the center for females [n beam breaks] None Central nervous system, behavior: Novel open field behavior, vertical activity (rears) from 0-60 min in the center for females [n beam breaks] x x x x 129.667 155.1 x 226.636 280.571 490.8 182.6 356.364 138.917 609.286 103.833 428.375 431.857 199.6 95.0 264.818 x x x 247.75 x 145.733 247.0 255.778 x 141.2 342.636 583.083 240.143 x 46.375 x 410.364 214.5 539.429 x 327.133 512.889 141.625 424.0 x x 627.889 x 270.778 229.0 x x x 203.1 6.42105 x x x 470.667 341.389 176.6 139.545 x 360.583 326.625 401.692 274.286 647.476 645.6 547.583 x 424.529 x 237.545 x 668.429 x x 549.222 x x 295.6 416.938 179.667 291.769 209.917 x 583.75 206.0 x 174.909 x x x 559.267 313.5 169.762 466.727 260.143 x x x +11760 Original post publication description: Cocaine response (10 mg/kg ip), locomotion from 0-60 min after first cocaine injection in an activity chamber for females [n beam breaks] None Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), locomotion from 0-60 min after first cocaine injection in an activity chamber for females [n beam breaks] x x x x 4580.33 2812.4 x 3116.27 2602.0 9065.0 3055.2 4637.09 3156.25 7047.0 1423.33 3507.62 7601.14 3885.0 5267.25 9400.73 x x x 6211.5 x 3246.07 3570.75 7245.78 x 6317.5 5294.36 8312.0 3475.5 x 973.25 x 7440.09 3853.93 11169.7 x 6607.6 6948.44 2799.94 6803.0 x x 6124.0 x 5694.29 3503.27 x x x 5864.0 1279.32 x x x 9037.47 4389.56 2840.47 5586.27 x 7242.92 3194.75 4533.38 6302.07 10896.6 6834.47 12193.8 x 3783.0 x 4157.91 x 8125.0 x x 4733.89 x x 4060.87 8144.62 4590.4 5225.92 3860.4 x 8666.25 1569.4 x 5918.73 x x x 6336.8 7808.5 5293.05 10935.3 2874.46 x x x +11761 Original post publication description: Cocaine response (10 mg/kg ip), locomotion in an open field from 0-60 min after first cocaine injection for females [cm] None Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), locomotion in an open field from 0-60 min after first cocaine injection for females [cm] x x x x 14254.9 8446.55 x 9330.97 8836.01 23979.0 9799.84 14366.0 10377.0 20940.0 5138.06 10874.7 20776.6 11841.9 16290.5 26277.7 x x x 18742.8 x 10468.9 11154.5 21469.5 x 19617.4 15647.6 23822.1 11033.9 x 3236.91 x 22749.7 11620.5 30574.4 x 20418.5 22772.2 9091.11 20344.7 x x 18299.6 x 17226.2 12024.8 x x x 18259.0 4447.62 x x x 25705.6 13598.3 8943.43 16867.5 x 21402.3 9866.54 14333.1 19779.0 30140.0 20855.3 34228.5 x 12242.7 x 13389.3 x 24342.2 x x 14589.6 x x 13339.8 23784.0 15183.1 15751.6 11960.4 x 25740.4 6040.87 x 18541.2 x x x 18821.5 21717.5 14593.4 31302.5 9475.19 x x x +11762 Original post publication description: Cocaine response (10 mg/kg ip), vertical activity (rears) in open field from 0-60 min after first cocaine injection for females [n beam breaks] None Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), vertical activity (rears) in open field from 0-60 min after first cocaine injection for females [n beam breaks] x x x x 565.333 562.2 x 657.636 895.714 1157.4 660.9 1032.45 639.667 1543.14 371.167 989.0 1161.86 691.8 1091.5 1589.09 x x x 961.625 x 1008.14 723.0 1460.33 x 1538.6 1287.82 1381.42 881.929 x 189.875 x 1634.27 647.643 1977.93 x 1699.33 2649.22 757.562 1430.62 x x 2074.67 x 1244.0 1158.53 x x x 1123.9 199.842 x x x 1572.6 1546.94 1145.4 725.273 x 1414.0 977.25 1511.08 1597.14 2148.0 1674.87 2070.33 x 1577.88 x 1417.55 x 2169.29 x x 1504.0 x x 1430.87 1362.31 1178.6 1021.46 996.9 x 1680.5 466.2 x 1127.64 x x x 2140.0 1142.17 732.238 1926.09 905.143 x x x +11763 Original post publication description: Novel open field behavior, locomotion in the center from 0-15 min for females [n beam breaks] None Novel open field behavior, locomotion in the center from 0-15 min for females [n beam breaks] x x x x 319.333 992.4 x 680.0 281.857 732.4 213.0 869.909 255.917 878.0 235.0 517.375 1480.0 237.8 593.5 652.818 x x x 694.875 x 246.467 265.5 770.222 x 473.0 657.455 629.0 499.214 x 271.875 x 717.818 403.071 905.929 x 836.533 597.333 383.0 676.25 x x 1005.44 x 398.556 477.8 x x x 672.5 142.947 x x x 804.667 538.389 220.667 117.455 x 886.417 601.0 431.154 299.0 948.333 869.333 761.917 x 358.294 x 488.727 x 783.857 x x 610.056 x x 339.133 375.125 189.4 610.154 399.667 x 755.5 331.6 x 663.273 x x x 916.333 651.167 778.333 705.636 398.643 x x x +11764 Original post publication description: Novel open field behavior, locomotion in the center from 15-30 min for females [n beam breaks] None Novel open field behavior, locomotion in the center from 15-30 min for females [n beam breaks] x x x x 223.333 504.5 x 727.636 343.143 907.4 461.3 814.364 276.333 673.071 261.0 373.625 1202.57 352.6 599.5 650.636 x x x 839.0 x 208.467 437.75 869.556 x 263.2 767.0 694.25 441.0 x 118.25 x 630.182 614.714 753.0 x 580.467 454.778 331.5 766.875 x x 894.667 x 708.667 543.067 x x x 716.0 23.2105 x x x 785.6 485.944 134.733 330.182 x 680.0 621.625 634.231 390.857 887.286 858.667 874.25 x 443.176 x 542.273 x 738.143 x x 639.611 x x 391.733 399.062 211.067 523.077 428.75 x 748.75 187.0 x 515.636 x x x 610.8 766.5 721.667 744.909 442.714 x x x +11765 Original post publication description: Novel open field behavior, locomotion in the center from 30-45 min for females [n beam breaks] None Central nervous system, behavior: Novel open field behavior, locomotion in the center from 30-45 min for females [n beam breaks] x x x x 263.333 291.4 x 483.545 465.429 926.6 427.5 762.0 180.583 574.929 167.0 512.0 823.286 263.6 473.25 670.364 x x x 656.75 x 161.733 301.25 694.556 x 147.2 602.818 746.417 289.857 x 21.875 x 577.182 586.571 682.714 x 454.867 458.778 175.75 685.875 x x 793.889 x 670.222 397.2 x x x 698.3 0.0 x x x 548.867 432.111 78.0667 320.727 x 430.0 561.625 522.0 412.5 779.095 882.467 838.583 x 395.765 x 390.364 x 640.857 x x 621.0 x x 318.4 366.312 152.733 377.385 370.5 x 753.0 207.2 x 266.636 x x x 423.467 793.333 572.905 798.818 315.857 x x x +11766 Original post publication description: Novel open field behavior, locomotion in the center from 45-60 min for females [n beam breaks] None Central nervous system, behavior: Novel open field behavior, locomotion in the center from 45-60 min for females [n beam breaks] x x x x 144.0 210.4 x 421.636 356.286 683.0 279.8 670.636 123.917 524.5 122.667 642.125 609.714 100.0 402.5 547.0 x x x 401.75 x 97.8 181.25 656.222 x 83.5 479.545 607.583 222.857 x 2.375 x 437.818 447.5 658.786 x 373.267 356.667 107.5 487.125 x x 635.444 x 693.889 286.2 x x x 384.1 2.05263 x x x 351.2 372.722 58.7333 284.091 x 314.25 455.625 401.538 281.5 601.19 835.2 659.417 x 296.647 x 300.818 x 529.286 x x 456.444 x x 310.067 332.938 116.6 266.923 280.167 x 436.0 181.0 x 158.727 x x x 357.0 497.167 437.619 775.909 221.143 x x x +11767 Original post publication description: Novel open field behavior, locomotion in the center from 0-15 min for females [cm] None Central nervous system, behavior: Novel open field behavior, locomotion in the center from 0-15 min for females [cm] x x x x 1006.87 2554.06 x 1799.63 913.39 2021.0 643.637 2194.37 928.47 2465.38 757.71 1471.11 3678.38 832.905 1573.94 1833.99 x x x 2131.03 x 777.604 846.059 2025.51 x 1466.23 1795.87 1939.72 1484.51 x 933.852 x 2080.67 1182.66 2569.56 x 2346.37 1753.09 1144.89 1918.33 x x 2744.15 x 1109.89 1433.09 x x x 1991.29 515.944 x x x 2359.66 1535.24 737.555 485.639 x 2496.25 1736.57 1443.85 948.442 2600.82 2543.46 2253.75 x 1112.2 x 1446.26 x 2251.02 x x 1714.66 x x 1164.03 1172.65 631.906 1856.27 1178.07 x 2175.58 1196.58 x 1919.84 x x x 2403.66 1902.14 1910.31 2005.06 1175.32 x x x +11768 Original post publication description: Novel open field behavior, locomotion in the center from 15-30 min for females [cm] None Central nervous system, behavior: Novel open field behavior, locomotion in the center from 15-30 min for females [cm] x x x x 729.837 1388.46 x 1983.91 1033.56 2414.81 1322.52 2103.87 918.564 1976.55 801.804 1208.04 3019.4 1201.58 1476.82 1710.33 x x x 2332.31 x 647.942 1349.05 2227.54 x 834.417 2067.9 2095.6 1317.87 x 395.923 x 1780.14 1658.08 2130.85 x 1760.89 1397.34 964.447 2119.24 x x 2576.5 x 1888.1 1605.37 x x x 1999.44 93.884 x x x 2308.85 1392.35 461.035 1074.02 x 1991.52 1785.52 1935.14 1293.27 2455.59 2467.96 2419.97 x 1310.07 x 1549.59 x 2353.88 x x 1815.92 x x 1245.25 1231.69 656.974 1476.42 1229.24 x 2136.88 667.522 x 1529.74 x x x 1714.06 2191.5 1824.21 2094.79 1287.29 x x x +11769 Original post publication description: Novel open field behavior, locomotion in the center from 30-45 min for females [cm] None Central nervous system, behavior: Novel open field behavior, locomotion in the center from 30-45 min for females [cm] x x x x 940.88 811.122 x 1370.62 1382.71 2522.98 1307.56 2008.9 584.535 1737.1 583.299 1523.63 2097.55 1014.21 1127.63 1767.44 x x x 1783.69 x 495.506 912.081 1805.81 x 440.101 1686.4 2187.45 881.987 x 73.433 x 1609.84 1606.49 1990.27 x 1388.86 1407.42 544.602 1930.18 x x 2276.6 x 1798.09 1232.52 x x x 1944.28 0.0 x x x 1625.96 1294.98 277.391 971.866 x 1235.8 1647.51 1607.56 1312.5 2206.62 2541.07 2291.86 x 1182.9 x 1170.22 x 2032.69 x x 1746.95 x x 994.974 1168.22 470.609 1070.39 1034.23 x 2230.81 690.609 x 802.631 x x x 1242.43 2233.38 1468.0 2160.41 917.501 x x x +11770 Original post publication description: Novel open field behavior, locomotion in the center from 45-60 min for females [cm] None Central nervous system, behavior: Novel open field behavior, locomotion in the center from 45-60 min for females [cm] x x x x 497.716 626.067 x 1216.51 1079.93 1916.73 933.843 1782.71 419.899 1563.42 436.198 1863.97 1616.8 419.731 973.45 1460.16 x x x 1198.89 x 302.323 569.665 1715.33 x 248.441 1372.01 1826.17 692.632 x 5.17803 x 1253.02 1311.03 1945.91 x 1121.42 1102.63 333.044 1387.65 x x 1932.02 x 1885.35 886.966 x x x 1097.15 8.09501 x x x 1058.69 1096.71 212.909 869.761 x 909.774 1294.26 1273.51 891.842 1758.26 2449.01 1858.88 x 910.439 x 932.042 x 1649.04 x x 1343.13 x x 975.222 1070.33 338.15 736.008 772.082 x 1354.96 623.687 x 473.571 x x x 1046.36 1424.71 1125.31 2121.74 680.663 x x x +11771 Original post publication description: Novel open field behavior, vertical activity (rears) from 0-15 min in the center for females [n beam breaks] None Novel open field behavior, vertical activity (rears) from 0-15 min in the center for females [n beam breaks] x x x x 18.3333 58.4 x 33.9091 29.8571 87.4 14.5 47.1818 16.9167 124.429 23.8333 39.875 142.429 28.6 33.0 66.1818 x x x 54.25 x 44.5333 31.75 40.3333 x 52.9 55.3636 98.0833 75.2857 x 30.25 x 56.2727 32.6429 105.857 x 82.1333 125.111 36.75 60.25 x x 135.0 x 33.2222 59.9333 x x x 51.4 5.68421 x x x 141.867 72.4444 52.4 12.3636 x 106.417 62.875 72.3077 53.5 117.095 113.733 120.25 x 68.1765 x 43.2727 x 101.286 x x 88.0556 x x 48.3333 63.3125 34.0 110.385 47.25 x 99.25 37.4 x 64.8182 x x x 156.667 57.6667 30.619 107.273 59.2857 x x x +11772 Original post publication description: Novel open field behavior, vertical activity (rears) from15-30 min in the center for females [n beam breaks] None Central nervous system, behavior: Novel open field behavior, vertical activity (rears) from15-30 min in the center for females [n beam breaks] x x x x 40.0 46.4 x 72.0 58.0 163.0 55.7 90.5455 37.3333 173.429 25.3333 97.625 144.429 52.6 26.25 66.8182 x x x 74.0 x 40.9333 105.5 76.7778 x 53.6 87.0 176.917 70.9286 x 13.875 x 103.091 63.7857 131.214 x 91.7333 121.111 50.75 145.375 x x 172.333 x 73.7778 73.0 x x x 58.2 0.736842 x x x 144.6 97.2778 45.9333 32.7273 x 125.5 82.875 115.846 63.2857 178.333 149.467 149.083 x 123.647 x 65.0 x 191.571 x x 151.389 x x 92.7333 115.75 60.2 79.5385 66.1667 x 153.0 48.8 x 65.5455 x x x 156.333 98.5 55.7619 118.909 86.9286 x x x +11773 Original post publication description: Novel open field behavior, vertical activity (rears) from 30-45 min in the center for females [n beam breaks] None Central nervous system, behavior: Novel open field behavior, vertical activity (rears) from 30-45 min in the center for females [n beam breaks] x x x x 50.6667 28.8 x 60.5455 98.8571 133.6 63.6 108.273 41.9167 156.357 28.3333 133.5 78.2857 77.4 20.25 72.3636 x x x 59.0 x 36.0667 75.5 70.7778 x 18.0 100.818 163.333 52.6429 x 2.25 x 125.273 63.3571 155.286 x 87.5333 149.0 31.8125 115.375 x x 177.667 x 77.4444 54.4 x x x 57.5 0.0 x x x 105.267 95.5556 46.4 46.2727 x 67.75 94.875 112.538 89.9286 194.048 184.533 136.667 x 124.647 x 65.4545 x 205.0 x x 162.5 x x 75.5333 118.125 48.8667 53.6923 55.4167 x 190.75 61.0 x 31.2727 x x x 132.8 103.5 40.1905 118.727 66.1071 x x x +11774 Original post publication description: Novel open field behavior, vertical activity (rears) from 45-60 min in the center for females [n beam breaks] None Novel open field behavior, vertical activity (rears) from 45-60 min in the center for females [n beam breaks] x x x x 20.6667 21.5 x 60.1818 93.8571 106.8 48.8 110.364 26.75 155.071 26.3333 157.375 66.7143 41.0 15.5 59.4545 x x x 60.5 x 24.2 34.25 67.8889 x 16.7 99.4545 144.75 41.2857 x 0.0 x 125.727 54.7143 147.071 x 65.7333 117.667 22.3125 103.0 x x 142.889 x 86.3333 41.6667 x x x 36.0 0.0 x x x 78.9333 76.1111 31.8667 48.1818 x 60.9167 86.0 101.0 67.5714 158.0 197.867 141.583 x 108.059 x 63.8182 x 170.571 x x 147.278 x x 79.0 119.75 36.6 48.1538 41.0833 x 140.75 58.8 x 13.2727 x x x 113.467 53.8333 43.1905 121.818 47.8214 x x x +11775 Original post publication description: Novel open field behavior, locomotion in the periphery from 0-15 min for females in the cocaine test battery [n beam breaks] None Novel open field behavior, locomotion in the periphery from 0-15 min for females in the cocaine test battery [n beam breaks] x x x x 634.0 495.8 x 1089.36 434.714 666.4 396.9 1052.55 414.667 614.286 444.167 503.25 1127.0 379.4 856.5 491.455 x x x 498.0 x 411.733 518.5 1695.44 x 642.9 735.0 514.167 462.143 x 402.875 x 647.364 554.929 709.071 x 824.4 437.556 597.0 833.625 x x 538.111 x 658.778 644.133 x x x 814.1 399.421 x x x 834.667 626.667 372.267 368.091 x 532.75 739.875 441.769 534.714 647.571 503.2 737.0 x 585.294 x 585.364 x 497.143 x x 660.556 x x 365.4 573.5 451.8 585.0 613.75 x 592.5 474.2 x 571.0 x x x 586.267 800.167 1101.29 812.273 310.393 x x x +11776 Original post publication description: Novel open field behavior, locomotion in the periphery from 15-30 min for females in the cocaine test battery [n beam breaks] None Central nervous system, pharmacology, behavior: Novel open field behavior, locomotion in the periphery from 15-30 min for females in the cocaine test battery [n beam breaks] x x x x 407.0 341.4 x 722.273 302.143 688.0 348.5 725.364 329.417 353.571 397.833 305.875 826.0 406.6 808.0 417.818 x x x 385.375 x 268.667 412.5 1185.78 x 420.7 532.0 440.083 331.0 x 160.5 x 508.636 413.071 500.5 x 560.467 399.889 343.438 712.875 x x 340.0 x 621.222 604.333 x x x 854.3 61.1579 x x x 582.8 438.222 202.267 426.091 x 398.167 625.375 445.923 490.929 501.333 459.133 791.167 x 450.294 x 362.182 x 324.571 x x 482.5 x x 266.133 473.125 381.933 522.0 470.583 x 537.0 185.0 x 439.091 x x x 359.933 570.833 736.238 842.0 246.786 x x x +11777 Original post publication description: Novel open field behavior, locomotion in the periphery from 30-45 min for females in the cocaine test battery [n beam breaks] None Central nervous system, pharmacology, behavior: Novel open field behavior, locomotion in the periphery from 30-45 min for females in the cocaine test battery [n beam breaks] x x x x 261.333 226.3 x 463.545 240.0 645.4 299.1 622.091 220.25 280.786 208.333 266.75 600.0 223.8 517.0 375.091 x x x 309.25 x 167.267 351.25 905.333 x 223.8 367.091 408.5 254.786 x 39.0 x 425.909 362.714 404.857 x 397.8 393.222 218.625 536.375 x x 297.667 x 633.667 463.6 x x x 635.4 6.8421 x x x 399.333 354.778 98.7333 232.727 x 262.5 496.25 374.462 439.214 455.238 431.133 605.5 x 381.588 x 265.727 x 289.714 x x 411.5 x x 223.267 390.875 235.667 366.692 383.917 x 389.5 147.6 x 227.818 x x x 267.733 436.333 490.095 874.909 197.357 x x x +11778 Original post publication description: Novel open field behavior, locomotion in the periphery from 45-60 min for females in the cocaine test battery [n beam breaks] None Central nervous system, behavior: Novel open field behavior, locomotion in the periphery from 45-60 min for females in the cocaine test battery [n beam breaks] x x x x 150.667 206.3 x 336.091 227.143 590.0 253.5 511.273 113.333 236.857 167.5 279.375 383.429 132.6 506.25 346.091 x x x 213.125 x 81.4 218.75 630.778 x 130.0 314.818 323.417 198.786 x 3.75 x 318.455 309.714 422.571 x 281.867 319.444 126.562 351.875 x x 257.0 x 567.333 378.0 x x x 378.1 11.8421 x x x 280.133 264.889 75.2 203.455 x 223.417 410.5 268.077 273.786 348.524 450.467 514.333 x 295.118 x 228.091 x 231.0 x x 325.778 x x 195.133 340.25 158.6 273.769 245.667 x 307.0 113.6 x 135.182 x x x 214.133 275.333 338.476 784.545 152.286 x x x +11779 Original post publication description: Novel open field behavior, locomotion from 0-15 min in the periphery for females in the cocaine test battery [cm] None Novel open field behavior, locomotion from 0-15 min in the periphery for females in the cocaine test battery [cm] x x x x 2319.93 1907.68 x 3730.99 1817.42 2390.48 1564.67 3545.53 1697.72 2301.26 1940.76 1847.66 3831.63 1629.58 3205.17 1934.81 x x x 2053.17 x 1751.48 2279.91 5414.32 x 2535.7 2664.71 2090.22 1886.38 x 1698.95 x 2432.81 2132.19 2687.89 x 2917.58 1919.53 2362.92 3022.28 x x 2078.55 x 2518.57 2427.61 x x x 3098.33 1680.84 x x x 3038.94 2472.75 1514.88 1665.19 x 2111.71 2662.72 1801.59 2148.3 2396.77 2026.68 2751.21 x 2255.64 x 2378.92 x 2028.09 x x 2491.37 x x 1605.92 2492.23 1923.96 2335.33 2332.84 x 2315.2 2006.81 x 2318.89 x x x 2184.52 2880.23 3645.43 3023.05 1460.76 x x x +11780 Original post publication description: Novel open field behavior, locomotion from 15-30 min in the periphery for females in the cocaine test battery [cm] None Central nervous system, pharmacology, behavior: Novel open field behavior, locomotion from 15-30 min in the periphery for females in the cocaine test battery [cm] x x x x 1588.31 1346.55 x 2592.89 1317.85 2320.89 1483.17 2558.97 1367.73 1421.14 1557.94 1211.55 2920.19 1757.06 2969.02 1642.4 x x x 1599.23 x 1095.47 1794.75 3995.27 x 1668.71 1953.2 1811.82 1433.88 x 706.774 x 1988.68 1608.55 2017.86 x 2084.13 1743.92 1392.16 2536.63 x x 1416.53 x 2365.07 2283.75 x x x 3111.76 269.89 x x x 2119.33 1747.61 867.814 1668.02 x 1611.64 2247.06 1796.48 1956.94 1944.45 1839.78 2807.49 x 1752.19 x 1551.11 x 1331.72 x x 1874.67 x x 1202.97 2061.78 1535.37 2053.11 1779.2 x 2086.72 849.094 x 1760.98 x x x 1422.35 2081.62 2415.5 3124.49 1211.14 x x x +11781 Original post publication description: Novel open field behavior, locomotion from 30-45 min in the periphery for females in the cocaine test battery [cm] None Central nervous system, pharmacology, behavior: Novel open field behavior, locomotion from 30-45 min in the periphery for females in the cocaine test battery [cm] x x x x 1110.87 926.252 x 1711.37 1058.54 2240.85 1273.66 2255.58 907.737 1145.64 917.8 1111.36 2164.75 943.883 1897.22 1437.81 x x x 1310.33 x 679.48 1514.39 3137.98 x 871.169 1449.06 1654.17 1118.23 x 165.361 x 1761.52 1441.52 1687.84 x 1511.23 1789.4 881.586 1953.83 x x 1248.73 x 2376.82 1813.79 x x x 2377.0 25.4112 x x x 1462.51 1437.26 438.583 929.19 x 1031.21 1885.07 1527.52 1726.36 1790.64 1742.27 2135.87 x 1519.68 x 1172.34 x 1145.01 x x 1631.25 x x 1048.7 1761.08 951.977 1429.33 1405.21 x 1559.21 716.598 x 926.687 x x x 1089.28 1716.4 1702.83 3217.99 971.179 x x x +11782 Original post publication description: Novel open field behavior, locomotion from 45-60 min in the periphery for females in the cocaine test battery [cm] None Novel open field behavior, locomotion from 45-60 min in the periphery for females in the cocaine test battery [cm] x x x x 633.643 860.276 x 1262.9 952.934 2126.5 1051.18 1895.84 506.635 1000.25 726.929 1131.3 1434.84 658.46 1826.9 1288.05 x x x 929.323 x 342.933 998.967 2250.78 x 496.702 1221.36 1287.89 817.829 x 18.4587 x 1361.2 1250.84 1792.36 x 1097.17 1449.44 507.883 1319.45 x x 1149.36 x 2189.4 1471.28 x x x 1472.66 51.0453 x x x 1039.36 1051.33 311.951 856.802 x 870.948 1525.89 1107.38 1115.76 1446.11 1851.93 1864.49 x 1204.47 x 1036.09 x 931.329 x x 1322.7 x x 896.355 1564.27 647.824 1042.08 926.396 x 1219.87 638.617 x 558.212 x x x 899.879 1106.08 1187.38 2915.28 749.153 x x x +11783 Original post publication description: Novel open field behavior, vertical activity (rears) in the periphery from 0-15 min for females [n beam breaks] None Novel open field behavior, vertical activity (rears) in the periphery from 0-15 min for females [n beam breaks] x x x x 116.667 188.7 x 224.636 181.714 184.2 132.9 278.364 130.75 180.286 146.833 166.5 294.0 185.6 324.0 216.364 x x x 125.75 x 196.333 220.5 254.444 x 213.3 234.182 202.417 210.857 x 153.0 x 241.727 160.143 248.571 x 267.2 307.333 190.0 228.875 x x 238.333 x 264.111 265.0 x x x 257.6 100.737 x x x 284.6 284.778 218.067 89.8182 x 206.667 247.375 186.231 244.214 239.238 239.067 227.667 x 279.529 x 211.545 x 182.857 x x 270.0 x x 163.267 266.875 242.4 236.923 200.5 x 225.25 163.8 x 176.818 x x x 296.4 175.5 180.952 337.545 199.25 x x x +11784 Original post publication description: Novel open field behavior, vertical activity (rears) in the periphery from 15-30 min for females [n beam breaks] None Central nervous system, behavior: Novel open field behavior, vertical activity (rears) in the periphery from 15-30 min for females [n beam breaks] x x x x 128.667 184.2 x 212.818 235.714 207.2 149.9 286.636 151.167 191.5 180.167 140.625 286.286 266.4 298.5 229.909 x x x 144.625 x 180.933 268.0 301.333 x 224.3 225.909 228.833 186.071 x 99.25 x 290.545 182.357 265.429 x 247.6 306.889 161.25 223.0 x x 245.111 x 319.889 241.467 x x x 279.3 28.3684 x x x 212.4 316.944 187.6 137.818 x 193.75 260.25 219.077 228.0 267.19 264.133 256.333 x 299.647 x 245.455 x 171.571 x x 295.5 x x 211.067 293.562 242.8 237.692 211.75 x 235.5 145.0 x 165.091 x x x 312.067 186.0 175.333 371.0 222.964 x x x +11785 Original post publication description: Novel open field behavior, vertical activity (rears) in the periphery from 30-45 min for females [n beam breaks] None Novel open field behavior, vertical activity (rears) in the periphery from 30-45 min for females [n beam breaks] x x x x 128.0 133.3 x 193.727 244.286 209.2 144.6 279.091 139.0 180.714 125.667 130.75 256.286 148.6 203.0 220.818 x x x 132.25 x 102.667 202.5 273.0 x 150.4 201.0 229.25 153.929 x 40.625 x 294.636 190.286 283.214 x 213.2 323.778 106.312 187.875 x x 252.111 x 333.0 192.0 x x x 231.5 2.0 x x x 175.333 282.722 138.867 119.727 x 166.667 252.375 215.308 209.571 269.667 258.733 235.0 x 292.588 x 234.727 x 187.0 x x 301.889 x x 191.733 318.188 196.933 179.462 157.417 x 208.25 117.0 x 115.182 x x x 294.533 182.833 143.857 406.455 197.643 x x x +11786 Original post publication description: Novel open field behavior, vertical activity (rears) in the periphery from 45-60 min for females [n beam breaks] None Central nervous system, behavior: Novel open field behavior, vertical activity (rears) in the periphery from 45-60 min for females [n beam breaks] x x x x 86.3333 117.7 x 147.273 219.429 208.2 109.4 247.182 79.0833 165.714 103.667 158.875 235.0 140.6 170.75 162.364 x x x 111.5 x 53.9333 165.0 247.889 x 85.0 188.727 194.667 126.357 x 5.5 x 271.182 183.5 281.929 x 184.733 301.778 66.5625 159.75 x x 222.222 x 339.667 179.067 x x x 192.4 2.8421 x x x 142.667 251.167 89.6 124.364 x 131.25 226.75 192.154 231.571 256.048 303.533 237.5 x 266.824 x 189.727 x 218.571 x x 276.778 x x 193.333 291.938 158.867 128.923 127.833 x 206.5 128.4 x 83.8182 x x x 286.133 179.167 154.81 361.909 167.25 x x x +11787 Original post publication description: Novel open field behavior, percentage of locomotion in the periphery for females [%] None Central nervous system, behavior: Novel open field behavior, percentage of locomotion in the periphery for females [%] x x x x 65.6958 48.5248 x 61.2095 56.904 54.1042 56.2651 56.7484 62.7276 43.9076 73.9903 47.216 50.5299 63.2896 72.8388 47.2282 x x x 44.3504 x 72.5886 64.126 65.7464 x 68.9551 54.4811 46.6021 56.21 x 67.5658 x 54.2546 54.9714 49.6197 x 53.1022 55.0293 65.0997 57.5273 x x 38.1267 x 58.5992 61.8665 x x x 60.4929 79.1555 x x x 52.6249 57.7911 69.6574 67.6576 x 47.6663 56.3496 52.332 63.0567 45.7551 42.1898 53.553 x 61.55 x 57.6221 x 41.0388 x x 54.0779 x x 52.8176 63.9722 73.4484 58.6756 63.4772 x 48.2442 60.435 x 56.0406 x x x 47.3772 52.0334 63.1972 60.0461 53.9837 x x x +11788 Original post publication description: Novel open field behavior, locomotion in the periphery from 0-60 min for females [n beam breaks] None Central nervous system, behavior: Novel open field behavior, locomotion in the periphery from 0-60 min for females [n beam breaks] x x x x 1453.0 1269.8 x 2611.27 1204.0 2589.8 1298.0 2911.27 1077.67 1485.5 1217.83 1355.25 2936.43 1142.4 2687.75 1630.45 x x x 1405.75 x 929.067 1501.0 4417.33 x 1417.4 1948.91 1686.17 1246.71 x 606.125 x 1900.36 1640.43 2037.0 x 2064.53 1550.11 1285.62 2434.75 x x 1432.78 x 2481.0 2090.07 x x x 2681.9 479.263 x x x 2096.93 1684.56 748.467 1230.36 x 1416.83 2272.0 1530.23 1738.64 1952.67 1843.93 2648.0 x 1712.29 x 1441.36 x 1342.43 x x 1880.33 x x 1049.93 1777.75 1228.0 1747.46 1713.92 x 1826.0 920.4 x 1373.09 x x x 1428.07 2082.67 2666.1 3313.73 906.821 x x x +11789 Original post publication description: Novel open field behavior, locomotion in the periphery from 0-60 min for females [cm] None Central nervous system, behavior: Novel open field behavior, locomotion in the periphery from 0-60 min for females [cm] x x x x 5652.75 5040.76 x 9298.15 5146.75 9078.71 5372.67 10255.9 4479.82 5868.29 5143.43 5301.86 10351.4 4988.98 9898.31 6303.07 x x x 5892.05 x 3869.37 6588.01 14798.4 x 5572.28 7288.32 6844.1 5256.32 x 2589.55 x 7544.21 6433.11 8185.95 x 7610.13 6902.29 5144.54 8832.18 x x 5893.18 x 9449.85 7996.43 x x x 10059.8 2027.18 x x x 7660.14 6708.95 3133.23 5119.2 x 5625.51 8320.75 6232.97 6947.36 7577.97 7460.65 9559.06 x 6731.99 x 6138.45 x 5436.15 x x 7319.99 x x 4753.94 7879.37 5059.13 6859.84 6443.65 x 7181.0 4211.12 x 5564.77 x x x 5596.02 7784.32 8951.13 12280.8 4392.23 x x x +11790 Original post publication description: Novel open field behavior, vertical activity (rears) in the periphery from 0-60 min for females [n beam breaks] None Central nervous system, behavior: Novel open field behavior, vertical activity (rears) in the periphery from 0-60 min for females [n beam breaks] x x x x 459.667 623.9 x 778.455 881.143 808.8 536.8 1091.27 462.667 718.214 556.333 596.75 1071.57 741.2 996.25 829.455 x x x 514.125 x 533.867 856.0 1076.67 x 673.0 849.818 855.167 677.214 x 298.375 x 1098.09 716.286 1079.14 x 912.733 1239.78 524.125 799.5 x x 957.778 x 1256.67 877.533 x x x 960.8 133.947 x x x 815.0 1135.61 634.133 471.727 x 698.333 986.75 812.769 913.357 1032.14 1065.47 956.5 x 1138.59 x 881.455 x 760.0 x x 1144.17 x x 759.4 1170.56 841.0 783.0 697.5 x 875.5 554.2 x 540.909 x x x 1189.13 723.5 654.952 1476.91 787.107 x x x +11791 Original post publication description: Saline control response (10 ml/kg ip), locomotion in an open field from 0-60 min after injection for females [n beam breaks] None Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotion in an open field from 0-60 min after injection for females [n beam breaks] x x x x 1613.67 1232.7 x 3212.27 2012.57 6147.8 2070.7 2834.82 1387.42 3355.93 1189.33 2111.88 2999.86 1642.0 2974.25 3975.91 x x x 3350.12 x 722.667 1847.25 4526.44 x 1879.9 2568.0 3706.58 1693.5 x 362.25 x 2985.09 2126.57 4190.5 x 2466.27 2954.22 1367.5 3863.0 x x 3940.89 x 2915.44 2213.4 x x x 3928.1 387.737 x x x 4888.27 2965.39 655.8 1315.09 x 3136.25 2251.75 2523.31 2583.36 4701.43 4512.0 3700.08 x 1531.94 x 1859.18 x 3246.14 x x 2292.22 x x 1665.13 2519.56 1310.8 2552.62 1880.33 x 5307.5 1021.2 x 2323.09 x x x 2745.73 3422.67 2307.95 4863.36 1919.5 x x x +11792 Original post publication description: Saline control response (10 ml/kg ip), locomotion in an open field from 0-60 min after injection for females [cm] None Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotion in an open field from 0-60 min after injection for females [cm] x x x x 5815.59 4248.44 x 9732.8 7283.04 18284.1 7123.17 9259.24 4968.42 10994.8 4932.98 6951.58 9514.06 6510.45 9661.7 12148.6 x x x 11321.6 x 2789.58 6576.73 14292.1 x 6629.03 8203.8 12307.3 5888.72 x 1475.56 x 10487.0 7224.61 13670.1 x 8307.66 10709.6 4824.78 12528.2 x x 12597.9 x 9358.61 8121.53 x x x 12873.3 1481.13 x x x 15081.8 9838.84 2421.73 4895.96 x 10487.7 7435.72 8955.37 9128.07 14945.7 15127.6 12009.5 x 5486.42 x 6796.37 x 11490.9 x x 7682.79 x x 6291.39 9475.09 5062.0 8523.48 6059.67 x 16910.7 3977.23 x 8319.99 x x x 9060.38 10743.8 7306.17 15868.0 6858.06 x x x +11793 Original post publication description: Saline control response (10 ml/kg), open field behavior, vertical activity (rears) 0-60 min after injection for females [n beam breaks/60 min] None Central nervous system, behavior: Saline control response (10 ml/kg), open field behavior, vertical activity (rears) 0-60 min after injection for females [n beam breaks/60 min] x x x x 505.0 441.3 x 743.545 1118.0 1587.6 600.1 910.364 471.583 1260.5 383.833 895.375 827.0 831.6 1013.25 938.455 x x x 851.5 x 352.533 669.5 1150.0 x 785.7 883.273 1433.92 660.286 x 148.0 x 1402.36 682.786 1487.64 x 964.867 1588.11 478.562 1107.62 x x 1704.89 x 966.333 937.6 x x x 1004.3 82.1053 x x x 1216.2 1527.94 609.8 378.273 x 1007.58 1085.5 1294.0 1185.64 1596.76 1690.6 1267.58 x 1038.88 x 997.091 x 1645.43 x x 1256.72 x x 1047.87 1402.19 886.467 844.923 622.0 x 1786.5 354.6 x 622.0 x x x 1662.4 832.167 590.048 1585.55 939.893 x x x +11794 Original post publication description: Cocaine response (2 x 10 mg/kg, ip), sensitization, locomotion after the second injection minus locomotion after the first injection for females [difference in cm/1 hr test, positive values indicate sensitization] None Cocaine response (2 x 10 mg/kg, ip), sensitization, locomotion after the second injection minus locomotion after the first injection for females [difference in cm/1 hr test, positive values indicate sensitization] x x x x 9203.21 6092.84 x 1760.79 1065.86 10137.8 1762.14 3624.15 6273.82 3153.0 3748.33 4805.1 4607.85 12708.6 9531.42 5820.29 x x x 2270.26 x 8785.53 10646.4 4014.22 x 2144.5 2593.5 7159.25 -4.01234 x 1715.16 x 3247.45 6465.89 5709.84 x 2615.15 4002.41 5605.31 2994.0 x x 440.907 x -3370.71 5673.66 x x x 6118.26 1882.42 x x x 7838.17 857.855 883.712 6556.18 x 465.333 6041.5 3448.82 1756.41 8092.79 6454.91 10271.8 x 4246.17 x 5735.92 x 2962.65 x x 1735.64 x x 5040.55 5556.91 8006.78 9100.84 6870.2 x 1571.2 827.885 x 4225.35 x x x 2816.35 5972.99 2183.59 1499.79 2373.82 x x x +11795 Original post publication description: Cocaine response (2 x 10 mg/kg, ip), locomotion from 0-60 min after the second injection in sensitization test for females [n beam breaks, positive values indicate sensitization] None Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg, ip), locomotion from 0-60 min after the second injection in sensitization test for females [n beam breaks, positive values indicate sensitization] x x x x 8510.33 5256.1 x 3682.18 3142.86 13057.6 3798.0 6043.09 5519.17 8393.5 2643.5 5993.14 9531.86 8266.8 8561.5 11583.6 x x x 7122.12 x 6485.62 7575.25 8875.89 x 7332.1 6312.0 11277.8 3456.07 x 1589.12 x 8776.82 6397.21 13767.4 x 7502.87 8431.11 4797.19 7914.5 x x 6308.56 x 5438.17 5739.13 x x x 8136.9 1876.84 x x x 12285.0 4751.11 3160.27 8201.64 x 7057.55 5548.75 5803.69 7111.29 14412.0 9457.67 16689.5 x 5546.47 x 6069.45 x 9572.71 x x 5436.94 x x 6026.4 10682.4 7514.67 8524.46 6591.9 x 9383.0 1950.4 x 7737.09 x x x 7494.67 11454.6 6050.76 11697.1 3712.36 x x x +11796 Original post publication description: Cocaine response (2 x 10 mg/kg, ip), locomotion from 0-60 min after the second injection in sensitization test for females [cm, positive values indicate sensitization] None Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg, ip), locomotion from 0-60 min after the second injection in sensitization test for females [cm, positive values indicate sensitization] x x x x 23458.1 14539.4 x 11091.8 9901.87 34116.9 11562.0 17990.2 16650.8 24093.0 8886.39 17131.2 25384.4 24550.5 25821.8 32098.0 x x x 21013.1 x 20050.8 21800.7 25483.8 x 21761.9 18241.1 30981.3 11029.8 x 4952.02 x 25997.1 18086.5 36284.3 x 23033.6 26774.6 14696.4 23338.7 x x 18740.7 x 16607.0 17698.5 x x x 24377.3 6330.04 x x x 33543.8 14456.1 9827.16 23423.7 x 20708.6 15908.0 17781.9 21535.4 38232.8 27310.3 44500.4 x 16488.9 x 19125.2 x 27304.9 x x 16325.3 x x 18380.3 29340.9 23189.9 24852.4 18830.6 x 27311.6 6868.88 x 22766.6 x x x 21637.9 31241.8 16776.9 32802.2 11849.0 x x x +11797 Original post publication description: Cocaine response (2 x 10 mg/kg ip), sensitization, change in vertical activity (rears) for females between first and second injections [difference in n/1 hr test, positive values indicate sensitization] None Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), sensitization, change in vertical activity (rears) for females between first and second injections [difference in n/1 hr test, positive values indicate sensitization] x x x x 546.333 875.8 x 778.364 875.0 1498.0 709.5 1178.09 845.0 1778.86 656.167 1279.57 1423.43 1475.6 1763.0 1890.09 x x x 1022.62 x 1739.85 1190.5 1769.78 x 1664.9 1385.45 1508.08 930.286 x 288.5 x 1835.09 807.643 2079.5 x 2069.07 2990.67 1069.69 1679.0 x x 2036.78 x 1358.67 1437.33 x x x 1516.5 263.0 x x x 2091.33 1580.67 1335.33 962.818 x 1252.91 1323.12 1702.62 1640.79 2543.19 2271.2 2263.92 x 1526.24 x 1899.55 x 2150.43 x x 1561.28 x x 1665.2 1486.31 1714.93 1536.15 1327.0 x 1603.25 474.6 x 1241.82 x x x 2241.47 1321.6 893.81 2038.36 1149.21 x x x +11798 Original post publication description: Saline control response (10 ml/kg ip), locomotion in an open field from 0-15 min after injection for females [n beam breaks/15 min] None Saline control response (10 ml/kg ip), locomotion in an open field from 0-15 min after injection for females [n beam breaks/15 min] x x x x 647.0 450.9 x 784.818 504.143 1668.2 325.6 883.0 551.5 1219.86 450.167 505.5 1431.29 493.8 694.25 898.091 x x x 950.625 x 271.6 478.5 1545.78 x 710.5 620.091 903.083 563.214 x 249.25 x 899.909 460.357 1077.93 x 816.4 778.444 633.312 1070.75 x x 910.111 x 576.556 553.333 x x x 1089.9 289.158 x x x 1474.67 764.333 262.267 416.091 x 1034.17 466.875 671.385 729.071 1173.71 1099.4 1040.92 x 481.824 x 718.636 x 1077.43 x x 660.889 x x 582.267 752.0 400.4 783.538 604.25 x 1247.5 373.0 x 834.182 x x x 907.333 1098.33 945.143 1310.64 443.036 x x x +11799 Original post publication description: Saline control response (10 ml/kg ip), locomotion in an open field from 15-30 min after injection for females [n beam breaks/15 min] None Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotion in an open field from 15-30 min after injection for females [n beam breaks/15 min] x x x x 528.667 238.3 x 860.091 472.143 1532.2 519.9 631.091 260.667 788.214 229.667 509.875 653.429 449.2 748.75 1059.0 x x x 858.625 x 178.0 474.25 1254.67 x 512.6 696.0 820.25 425.286 x 98.125 x 805.455 566.286 1004.71 x 589.533 622.111 295.562 947.25 x x 942.222 x 749.333 587.267 x x x 1019.5 70.6842 x x x 1344.2 687.444 189.8 357.818 x 709.833 633.5 637.231 747.5 1243.71 1031.87 880.333 x 398.824 x 492.818 x 751.143 x x 566.833 x x 396.4 580.562 303.4 652.308 465.5 x 1353.75 307.4 x 739.545 x x x 683.067 1057.67 528.762 1101.0 459.143 x x x +11800 Original post publication description: Saline control response (10 ml/kg ip), locomotion in an open field from 30-45 min after injection for females [n beam breaks/15 min] None Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotion in an open field from 30-45 min after injection for females [n beam breaks/15 min] x x x x 337.333 244.1 x 785.818 552.286 1642.4 598.9 699.0 335.417 728.714 322.5 508.5 515.571 332.0 798.75 1080.82 x x x 898.5 x 145.333 402.25 859.778 x 363.2 621.909 1038.5 344.071 x 4.875 x 721.909 515.643 1115.64 x 611.733 768.0 228.75 901.875 x x 960.889 x 785.556 577.8 x x x 873.2 19.5789 x x x 1088.6 746.667 114.8 289.545 x 845.667 513.5 603.692 602.071 1214.05 1255.8 916.083 x 373.588 x 333.455 x 707.571 x x 531.111 x x 366.667 553.125 339.0 495.615 424.583 x 1462.0 226.8 x 482.182 x x x 625.933 757.333 486.333 1135.45 507.25 x x x +11801 Original post publication description: Saline control response (10 ml/kg ip), locomotion in an open field from 45-60 min after injection for females [n beam breaks/15 min] None Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotion in an open field from 45-60 min after injection for females [n beam breaks/15 min] x x x x 100.667 299.4 x 781.545 484.0 1305.0 626.3 621.727 239.833 619.143 187.0 588.0 399.571 367.0 732.5 938.0 x x x 642.375 x 127.733 492.25 866.222 x 293.6 630.0 944.75 360.929 x 10.0 x 557.818 584.286 992.214 x 448.6 785.667 209.875 943.125 x x 1127.67 x 804.0 495.0 x x x 945.5 8.31579 x x x 980.8 766.944 88.9333 251.636 x 546.583 637.875 611.0 504.714 1069.95 1124.93 862.75 x 277.706 x 314.273 x 710.0 x x 533.389 x x 319.8 633.875 268.0 621.154 386.0 x 1244.25 114.0 x 267.182 x x x 529.4 509.333 347.714 1316.27 510.071 x x x +11802 Original post publication description: Saline control response (10 ml/kg ip), locomotion in an open field from 0-15 min after injection for females [cm] None Saline control response (10 ml/kg ip), locomotion in an open field from 0-15 min after injection for females [cm] x x x x 2258.12 1496.01 x 2412.21 1881.36 4926.43 1174.03 2825.31 1977.51 3881.46 1839.48 1669.57 4424.53 1990.28 2291.71 3090.05 x x x 3266.6 x 1033.57 1659.31 4877.23 x 2438.53 2045.52 2996.45 1921.58 x 1006.78 x 3164.91 1595.23 3604.66 x 2771.04 2683.16 2229.01 3553.84 x x 2885.86 x 1932.74 2089.64 x x x 3618.14 1106.35 x x x 4584.88 2569.45 951.108 1656.46 x 3487.78 1614.1 2415.94 2607.07 3704.14 3666.82 3418.17 x 1751.51 x 2601.96 x 3631.34 x x 2203.26 x x 2151.66 2766.22 1517.57 2664.06 2034.4 x 4042.16 1454.68 x 2996.57 x x x 2907.42 3494.86 2897.29 4306.08 1662.24 x x x +11803 Original post publication description: Saline control response (10 ml/kg ip), locomotion in an open field from 15-30 min after injection for females [cm] None Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotion in an open field from 15-30 min after injection for females [cm] x x x x 1945.13 868.606 x 2573.44 1692.37 4604.82 1816.99 2083.43 962.484 2582.4 1110.33 1758.85 2093.97 1810.05 2454.68 3209.69 x x x 2928.15 x 709.215 1718.45 3875.88 x 1901.52 2224.29 2767.33 1522.19 x 405.914 x 2783.92 1987.96 3310.43 x 2012.71 2316.47 1019.72 3123.49 x x 3114.46 x 2354.1 2197.99 x x x 3333.2 271.631 x x x 4153.75 2300.27 700.45 1288.02 x 2415.96 2083.83 2310.83 2639.96 3936.86 3514.32 2859.99 x 1438.67 x 1772.86 x 2731.46 x x 1900.27 x x 1521.61 2202.72 1188.03 2181.89 1468.48 x 4314.65 1236.69 x 2598.19 x x x 2271.2 3194.62 1687.81 3621.7 1659.15 x x x +11804 Original post publication description: Saline control response (10 ml/kg ip), locomotion in an open field from 30-45 min after injection for females [cm] None Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotion in an open field from 30-45 min after injection for females [cm] x x x x 1215.27 877.301 x 2391.69 1966.64 4897.33 2042.26 2277.84 1189.49 2433.64 1290.43 1634.76 1716.76 1311.11 2532.71 3155.2 x x x 2997.23 x 564.307 1486.79 2787.82 x 1255.25 1955.69 3381.16 1215.44 x 23.333 x 2519.57 1722.55 3599.77 x 2046.57 2837.35 823.79 2825.48 x x 3082.25 x 2493.29 2113.07 x x x 2853.2 66.2703 x x x 3346.59 2465.05 437.396 1052.08 x 2793.28 1722.73 2145.89 2063.72 3841.9 4152.08 2953.58 x 1302.23 x 1249.22 x 2544.95 x x 1780.97 x x 1382.82 2103.0 1317.77 1650.86 1359.52 x 4476.77 833.648 x 1767.37 x x x 2096.27 2417.92 1571.53 3678.19 1766.55 x x x +11805 Original post publication description: Saline control response (10 ml/kg ip), locomotion in an open field from 45-60 min after injection for females [cm] None Central nervous system, pharmacology, behavior: Saline control response (10 ml/kg ip), locomotion in an open field from 45-60 min after injection for females [cm] x x x x 397.073 1006.52 x 2355.46 1742.67 3855.54 2089.88 2072.65 838.928 2097.3 692.745 1888.4 1278.8 1399.01 2382.61 2693.66 x x x 2129.6 x 482.487 1712.17 2751.12 x 1033.74 1978.31 3162.34 1229.51 x 39.5273 x 2018.57 1918.87 3155.19 x 1477.34 2872.65 752.26 3025.41 x x 3515.35 x 2578.48 1720.82 x x x 3068.78 36.8821 x x x 2996.58 2504.07 332.778 899.389 x 1790.73 2015.06 2082.71 1817.31 3462.78 3794.4 2777.72 x 994.012 x 1172.33 x 2583.18 x x 1798.28 x x 1235.29 2403.16 1038.63 2026.67 1197.28 x 4077.07 452.211 x 957.857 x x x 1785.49 1636.38 1149.54 4262.05 1770.12 x x x +11806 Original post publication description: Saline control response (10 mg/kg ip), open field behavior, vertical activity (rears) 0-15 min after injection for females [n beam breaks/15 min] None Central nervous system, behavior: Saline control response (10 mg/kg ip), open field behavior, vertical activity (rears) 0-15 min after injection for females [n beam breaks/15 min] x x x x 147.333 120.8 x 184.182 208.571 386.8 89.6 200.273 139.833 297.214 123.833 169.375 284.571 229.8 233.75 261.182 x x x 207.5 x 106.333 124.75 312.667 x 222.9 163.273 289.917 206.286 x 87.375 x 322.818 131.786 278.643 x 276.067 318.778 189.375 260.25 x x 388.778 x 166.222 256.333 x x x 266.0 52.1579 x x x 342.933 360.278 178.933 87.0 x 260.333 232.625 284.923 315.429 321.571 348.4 276.167 x 285.765 x 279.273 x 403.0 x x 289.389 x x 237.333 292.188 207.667 242.846 185.417 x 369.75 96.0 x 204.636 x x x 408.667 207.667 149.857 388.182 170.714 x x x +11807 Original post publication description: Saline control response (10 mg/kg ip), open field behavior, vertical activity (rears) 15-30 min after injection for females [n beam breaks/15 min] None Central nervous system, behavior: Saline control response (10 mg/kg ip), open field behavior, vertical activity (rears) 15-30 min after injection for females [n beam breaks/15 min] x x x x 153.0 113.1 x 188.0 264.857 427.4 154.2 221.545 107.917 325.357 105.333 261.75 197.714 265.4 285.25 260.273 x x x 242.75 x 97.4667 185.0 292.889 x 245.2 254.545 364.25 180.429 x 49.625 x 354.727 192.429 404.429 x 259.267 375.333 113.5 302.875 x x 463.889 x 237.222 248.667 x x x 266.9 22.7368 x x x 330.733 405.222 182.133 108.0 x 274.833 292.5 352.846 365.929 433.0 410.467 312.917 x 301.647 x 269.182 x 433.286 x x 332.0 x x 287.133 349.688 230.267 228.846 165.083 x 493.25 129.4 x 203.364 x x x 424.0 244.667 155.19 376.455 245.607 x x x +11808 Original post publication description: Saline control response (10 mg/kg ip), open field behavior, vertical activity (rears) 30-45 min after injection for females [n beam breaks/15 min] None Central nervous system, behavior: Saline control response (10 mg/kg ip), open field behavior, vertical activity (rears) 30-45 min after injection for females [n beam breaks/15 min] x x x x 138.667 105.8 x 195.182 331.714 429.2 171.8 249.0 127.75 327.857 92.0 236.875 190.857 178.0 239.25 231.0 x x x 226.25 x 85.8 191.75 266.556 x 162.3 219.818 409.167 141.714 x 6.25 x 365.0 181.071 415.214 x 242.533 436.667 94.0 253.875 x x 418.444 x 274.444 240.667 x x x 234.9 4.8421 x x x 279.467 397.333 135.8 95.4545 x 280.083 271.0 334.462 269.786 433.952 454.8 360.167 x 257.824 x 214.091 x 398.857 x x 301.833 x x 290.333 339.562 253.933 171.692 147.583 x 482.0 73.8 x 149.182 x x x 425.667 197.833 146.81 383.091 255.286 x x x +11809 Original post publication description: Saline control response (10 mg/kg ip), open field behavior, vertical activity (rears) 45-60 min after injection for females [n beam breaks/15 min] None Central nervous system, behavior: Saline control response (10 mg/kg ip), open field behavior, vertical activity (rears) 45-60 min after injection for females [n beam breaks/15 min] x x x x 66.0 101.6 x 176.182 312.857 344.2 184.5 239.545 96.0833 310.071 62.6667 227.375 153.857 158.4 255.0 186.0 x x x 175.0 x 62.9333 168.0 277.889 x 155.3 245.636 370.583 131.857 x 4.75 x 359.818 177.5 389.357 x 187.0 457.333 81.6875 290.625 x x 433.778 x 288.444 191.933 x x x 236.5 2.36842 x x x 263.067 365.111 112.933 87.8182 x 192.333 289.375 321.769 234.5 408.238 476.933 318.333 x 193.647 x 234.545 x 410.286 x x 333.5 x x 233.067 420.75 194.6 201.538 123.917 x 441.5 55.4 x 64.8182 x x x 404.067 182.0 138.19 437.818 268.286 x x x +11810 Original post publication description: Novel open field behavior, locomotion in the center and periphery from 0-60 min for females in the cocaine test battery [n beam breaks] None Central nervous system, pharmacology, behavior: Novel open field behavior, locomotion in the center and periphery from 0-60 min for females in the cocaine test battery [n beam breaks] x x x x 2403.0 3268.5 x 4924.09 2650.71 5839.2 2679.6 6028.18 1914.42 4136.0 2003.5 3400.38 7052.0 2096.4 4756.5 4151.27 x x x 3998.12 x 1643.53 2686.75 7407.89 x 2384.3 4455.73 4363.42 2699.64 x 1020.5 x 4263.36 3692.29 5037.43 x 4309.67 3417.67 2283.38 5050.88 x x 4762.22 x 4952.33 3794.33 x x x 5152.8 647.474 x x x 4587.27 3513.72 1240.67 2282.82 x 3727.5 4511.88 3519.15 3122.5 5168.57 5289.6 5782.17 x 3206.18 x 3163.55 x 4034.57 x x 4207.44 x x 2409.27 3251.19 1897.8 3525.0 3193.0 x 4519.25 1827.2 x 2977.36 x x x 3735.67 4790.83 5176.62 6339.0 2285.18 x x x +11811 Original post publication description: Novel open field behavior, locomotion in the center and periphery from 0-60 min for females in the cocaine test battery [cm] None Central nervous system, pharmacology, behavior: Novel open field behavior, locomotion in the center and periphery from 0-60 min for females in the cocaine test battery [cm] x x x x 8828.05 10420.5 x 15668.8 9556.35 17954.2 9580.23 18345.8 7331.29 13610.7 7722.44 11368.6 20763.6 8457.4 15050.1 13074.9 x x x 13338.0 x 6092.66 10265.0 22572.5 x 8561.52 14210.5 14893.1 9633.35 x 3997.9 x 14267.9 12191.3 16822.6 x 14227.7 12562.8 8131.41 16187.6 x x 15422.4 x 16131.3 13154.4 x x x 17091.9 2645.11 x x x 15013.3 12028.2 4822.11 8520.49 x 12258.9 14784.6 12493.0 11393.4 16599.4 17462.1 18383.5 x 11247.5 x 11236.5 x 13722.8 x x 13940.7 x x 9133.41 12522.3 7156.77 11998.9 10657.3 x 15079.2 7389.51 x 10290.5 x x x 12002.5 15536.0 15279.0 20662.8 8453.0 x x x +11812 Original post publication description: Novel open field behavior, vertical activity (rears) in the center and periphery from 0-60 min for females in the cocaine test battery [n beam breaks] None Central nervous system, pharmacology, behavior: Novel open field behavior, vertical activity (rears) in the center and periphery from 0-60 min for females in the cocaine test battery [n beam breaks] x x x x 589.333 779.0 x 1005.09 1161.71 1299.6 719.4 1447.64 601.583 1327.5 660.167 1025.12 1503.43 940.8 1091.25 1094.27 x x x 761.875 x 679.6 1103.0 1332.44 x 814.2 1192.45 1438.25 917.357 x 344.75 x 1508.45 930.786 1618.57 x 1239.87 1752.67 665.75 1223.5 x x 1585.67 x 1527.44 1106.53 x x x 1163.9 140.368 x x x 1285.67 1477.0 810.733 611.273 x 1058.92 1313.38 1214.46 1187.64 1679.62 1711.07 1504.08 x 1563.12 x 1119.0 x 1428.43 x x 1693.39 x x 1055.0 1587.5 1020.67 1074.77 907.417 x 1459.25 760.2 x 715.818 x x x 1748.4 1037.0 824.714 1943.64 1047.25 x x x +11813 Original post publication description: Central nervous systems, adult neurogenesis: BrdU-labeled cells in the rostral migratory stream 1 hr after BrdU injection for adult females [density] None Central nervous systems, adult neurogenesis: BrdU-labeled cells in the rostral migratory stream 1 hr after BrdU injection for adult females [density] x x x x x 72.5 x 75.0 x 78.75 x x x x 85.0 x 87.5 x x x x x x x x 59.0 x x x 71.0 93.0 x x x 93.0 x x 97.6667 x x x 107.25 67.0 118.0 x x 83.3333 x x x x x x x x x x x 94.0 97.0 115.333 x x 85.6667 x 115.0 80.2 131.0 86.3333 x x 98.0 109.0 143.0 x 79.5 x x 92.6 x x x x 104.5 89.0 125.25 x 92.0 x 100.0 113.0 157.333 x x 110.75 95.6667 x x x x x x +11814 Original post publication description: Adrenal weight (left) of females [mg] None Endocrinology: Adrenal weight (left) of females [mg] x x x x 2.125 2.475 x 2.7625 2.45 2.525 3.025 2.375 2.5 2.35 2.575 3.45 3.1 1.925 2.625 2.35 x x x 2.25 x 2.3375 3.475 2.05 x 2.225 3.4 2.75 2.875 x 2.55 x 2.9 2.625 2.225 x 2.6 2.35 1.6 2.475 x x 2.6875 x 2.75 2.95 x x x 2.125 2.925 x x x 2.3625 2.225 3.325 2.75 x 2.65 2.85 2.45 2.8 3.275 2.4 1.75 x 2.1 x 2.45 x 2.05 x x 1.95 x x 2.6 2.775 2.6 1.95 2.65 x 2.325 2.075 x 3.05 x x x 2.425 2.7 2.625 2.425 2.675 x x x +11815 Original post publication description: Adrenal weight (right) of females [mg] None Endocrinology, morphology: Adrenal weight (right) of females [mg] x x x x 1.9 2.525 x 2.3375 2.0 2.25 3.025 2.15 2.625 2.075 2.3 2.675 2.4875 1.8 2.425 2.125 x x x 2.15 x 2.2625 3.525 2.125 x 1.85 3.65 2.55 2.725 x 2.375 x 2.9 2.525 2.1 x 2.3125 2.25 1.525 2.3 x x 2.6375 x 2.35 2.55 x x x 1.775 2.55 x x x 2.1125 2.1 2.9 2.325 x 2.325 2.55 2.25 2.725 2.925 2.275 1.625 x 1.9125 x 2.075 x 2.0 x x 1.7 x x 2.2 2.5 2.4 1.85 2.725 x 2.15 2.175 x 2.675 x x x 2.2 2.425 2.175 2.375 2.3 x x x +11816 Original post publication description: Central nervous system, behavior: Pain sensitivity, vocalization threshold to mild foot shock for males and females [mA] None Central nervous system, behavior: Pain sensitivity, vocalization threshold to mild foot shock for males and females [mA] x x x x 0.24 0.418182 0.355 0.255 0.3 0.265 0.34 0.235 0.3 0.23 0.327778 0.34375 0.38125 0.327778 x 0.275 x 0.485714 x 0.405 x 0.35 0.23 0.33 x 0.33 0.39 0.255 0.36 x 0.320833 x 0.28 0.305 0.34 x 0.27 0.353125 0.325 0.233333 x x 0.319231 0.295 0.31 0.35 x x x x x x x x 0.361538 0.38 0.385 0.391667 0.333333 0.34 0.235 0.3 0.3125 0.334615 0.365 0.25625 x 0.305 0.35 0.38 x 0.325 0.375 0.475 0.34 0.275 x 0.345833 0.305 0.339286 0.32 0.35 0.65 0.25 0.275 0.35 0.29 0.2375 x x 0.29 x x x x x x x +11817 Original post publication description: Ethanol response (2 mg/kg ip), motor coordination, time on dowel over a 5 min test period immediately after injection for males and females [sec] None Central nervous system, pharmacology, behavior: Ethanol response (2 g/kg ip), motor coordination, time on dowel over a 5 min test period immediately after injection for males and females [sec] x x x x 165.25 39.6667 x 45.0 x x 122.818 89.6 81.0 103.0 x 67.6 22.0 108.429 x 56.0 x x x x x 122.667 63.2727 84.6 x 87.0 70.5625 95.5 68.4 x 124.857 x 57.625 125.182 92.8182 x 110.7 111.0 88.3333 94.375 x x 89.0 x 94.6 71.4 x x x 92.2 39.5 x x x 51.125 84.25 86.4 114.5 x 81.5 115.778 75.8 97.375 88.8 68.6667 78.1667 x 102.5 x 100.111 x x x x 87.375 x x 75.6667 117.625 x 29.4 82.0 x 48.3333 x x 71.3333 x x x 57.5 5.0 82.0 x 185.5 x x x +11818 Original post publication description: Ethanol response (2 mg/kg ip), motor coordination, time on dowel over a 5 min test period starting 30 min after injection for males and females [sec] None Central nervous system, pharmacology, behavior: Ethanol response (2 g/kg ip), motor coordination, time on dowel over a 5 min test period starting 30 min after injection for males and females [sec] x x x x 91.25 9.0 x 9.5 x x 80.7273 14.2 4.0 4.66667 x 8.0 3.88889 60.5714 x 23.0 x x x x x 81.9167 2.27273 12.8 x 8.0 13.625 9.5 4.0 x 11.5714 x 1.0 66.1818 64.3636 x 77.7 85.5 62.6 11.25 x x 55.5 x 37.9 20.6 x x x 41.7 6.0 x x x 11.0 4.5 204.2 42.0 x 12.625 23.5556 4.8 11.375 16.6 8.66667 5.0 x 37.0 x 33.6667 x x x x 3.625 x x 111.667 77.875 x 10.0 7.85714 x 5.33333 x x 12.6667 x x x 6.5 7.0 7.6 x 14.0 x x x +11819 Original post publication description: Motor coordination, time on dowel over a 2 min baseline test period for males and females [sec] None Motor coordination, time on dowel over a 2 min baseline test period for males and females [sec] x x x x 97.75 120.0 x 85.5 x x 120.0 120.0 100.0 120.0 x 104.8 72.6667 120.0 x 111.714 x x x x x 118.75 103.818 120.0 x 110.909 118.5 120.0 113.5 x 107.286 x 116.5 118.182 120.0 x 120.0 120.0 106.6 94.625 x x 120.0 x 120.0 120.0 x x x 120.0 60.0 x x x 114.5 115.625 120.0 120.0 x 108.875 120.0 120.0 110.625 120.0 120.0 75.0 x 120.0 x 120.0 x x x x 91.375 x x 83.3333 120.0 x 51.8 108.571 x 120.0 x x 89.6667 x x x 120.0 69.0 86.4 x 120.0 x x x +11820 Original post publication description: Depression assay, Porsolt behavioral despair test, time immobile for males and females [sec] None Depression assay, Porsolt behavioral despair test, time immobile for males and females [sec] x x x x 3.875 41.8333 x 96.3333 x x 69.5 45.9 83.0 102.0 x 9.8 107.556 129.333 x 75.8571 x x x x x 29.9583 139.091 138.6 x 71.5 49.6562 61.1667 169.6 x 29.2857 x 163.438 30.2 128.955 x 76.55 90.3 61.5333 165.0 x x 114.0 x 85.05 21.1 x x x 155.55 223.5 x x x 139.375 154.625 62.7 70.5 x 90.125 170.667 183.2 68.75 88.7 136.0 17.75 x 38.7083 x 115.167 x x x x 7.25 x x 102.5 147.062 x 80.4 112.714 x 78.3333 x x 59.6667 x x x 131.0 12.0 78.4 x 136.0 x x x +11821 Original post publication description: Pain response, thermal nociception, Hargreaves' test for males and females None Pain response, thermal nociception, Hargreaves' test for males and females x x x x 20.9517 x x 9.55842 11.9642 x 8.30537 17.5478 14.1515 9.65403 13.7917 8.90639 13.5477 9.61292 10.3367 15.0586 x x x 13.4692 x 11.1746 11.1832 13.5293 x 11.9537 10.8349 11.1364 11.4311 x 13.3327 x 14.5914 12.5011 10.4448 x 10.576 12.2506 10.1688 10.7271 x x 10.5569 x 10.4646 9.23578 x x x 10.7231 12.3933 x x x 11.7149 10.4769 11.6813 14.57 x 14.2233 15.2628 17.7262 13.4021 12.7248 14.071 14.7875 x 14.3758 x 13.769 x 12.6462 x x 10.0558 x x 14.2318 13.1367 20.18 8.80954 10.0257 x 15.12 x x 15.9138 x x x 11.6062 13.2608 14.5966 19.0475 16.434 x x x +11822 Original post publication description: Pain response, thermal nociception, hot plate test, average of two trials for males and females [sec] None Pain response, thermal nociception, hot plate test, average of two trials for males and females [sec] x x x x 8.5075 x x 7.61475 11.83 x 8.03333 8.97227 4.90192 6.61526 9.7925 5.05833 9.559 5.37042 6.2875 6.62179 x x x 11.4871 x 9.77333 8.61 7.28367 x 5.74692 6.09235 9.62714 8.59 x 6.321 x 10.2964 9.24867 12.1532 x 6.17038 10.525 8.53972 14.295 x x 16.6676 x 12.9196 7.47533 x x x 8.40033 6.12 x x x 9.05781 7.21583 9.63933 16.0775 x 6.86722 7.41833 7.92278 6.83722 6.1921 10.665 11.87 x 10.8553 x 13.8577 x 7.6025 x x 7.855 x x 8.61821 11.3027 9.29 9.61639 6.346 x 8.579 x x 7.174 x x x 11.5157 9.7 8.10029 5.6775 10.4594 x x x +11823 Original post publication description: Pain response, mechanical nociception, tail clip latency for males and females [sec] None Central nervous system, behavior: Pain response, mechanical nociception, tail clip latency for males and females [sec] x x x x 33.835 x x 16.94 26.1325 x 22.7833 9.054 24.1069 12.0479 30.025 17.8883 18.017 8.04583 31.96 7.48933 x x x 27.9529 x 20.4373 45.2131 30.2613 x 36.2315 33.3024 19.8586 44.1983 x 19.037 x 6.50214 27.8607 22.4677 x 14.65 21.7129 20.2178 30.5133 x x 35.5184 x 26.08 14.772 x x x 11.5363 60.0 x x x 13.2512 18.91 42.1293 26.948 x 22.425 15.0433 22.4722 41.4933 18.5347 16.842 29.565 x 23.98 x 35.9167 x 33.386 x x 21.6946 x x 19.9679 6.22833 12.18 17.4861 10.228 x 14.477 x x 16.8836 x x x 31.398 36.015 27.069 16.555 9.93 x x x +11824 Original post publication description: Pain response, thermal nociception, tail withdrawal latency for males and females [sec] None Pain response, thermal nociception, tail withdrawal latency for males and females [sec] x x x x 8.28333 x x 10.4327 12.2158 x 15.0722 10.617 8.68744 8.20754 19.0733 10.045 10.3753 13.9703 8.48667 8.63178 x x x 16.7395 x 11.9158 13.3369 17.6633 x 10.2954 12.0118 12.7662 12.2164 x 13.8443 x 11.4698 12.1571 21.6895 x 12.0862 10.4286 11.6 20.8187 x x 11.5035 x 15.3738 11.7189 x x x 10.6118 28.13 x x x 10.6641 10.6483 11.686 10.1927 x 8.42233 11.8969 18.663 10.5098 13.6168 10.4507 10.7933 x 16.3069 x 13.4337 x 15.6072 x x 11.9772 x x 11.4305 14.5147 5.64667 16.877 10.0287 x 11.803 x x 7.83091 x x x 10.8727 13.9633 9.02567 9.56833 13.356 x x x +11825 Original post publication description: Somatosensory response, mechanical sensitivity using Von Frey test, threshold for males and females [Force in mg] None Central nervous system, peripheral nervous system, skin, behavior: Somatosensory response, mechanical sensitivity using Von Frey test, threshold for males and females [force in mg] x x x x 4.38912 x x 4.01835 3.96825 x 4.31694 4.18573 4.42469 4.38903 4.37725 4.23723 4.32097 4.11629 4.23112 4.15617 x x x 4.22439 x 4.16437 4.32327 4.14855 x 4.19612 4.06056 4.11438 4.2971 x 4.0077 x 4.12986 4.0489 4.06234 x 4.27392 4.02443 4.3796 4.18365 x x 4.07555 x 4.11968 4.32607 x x x 4.39403 4.22 x x x 4.10912 4.2086 4.23688 4.1571 x 4.08913 4.1775 4.13694 4.25669 3.98371 4.2419 3.95263 x 4.02855 x 4.00806 x 4.15213 x x 4.38189 x x 4.18814 3.78256 4.11475 4.19975 4.06938 x 4.07778 x x 4.03775 x x x 4.09932 3.99612 4.14549 4.07363 4.07552 x x x +11826 Original post publication description: Morphine response (50 mg/kg ip), locomotion from 90-105 min after injection in an activity chamber for males and females [n beam breaks] None Morphine response (50 mg/kg ip), locomotion from 90-105 min after injection in an activity chamber for males and females [n beam breaks] x x x x 3949.15 1176.82 x 3652.08 1979.0 3631.0 3243.14 6223.57 2122.11 3757.62 1323.08 4491.62 3465.6 310.75 4738.11 3866.0 x x x 3538.33 x 5468.54 683.929 3048.55 x 2862.93 195.75 1292.23 774.154 x 2919.0 x 2191.25 3545.53 5836.12 x 378.706 301.25 1322.69 3619.62 x x 2068.0 x 901.692 5893.17 x x x 206.692 512.2 x x x 6.76923 425.75 2000.5 3009.71 x 2118.0 1314.83 2169.33 1673.33 761.714 4230.57 2385.71 x 2247.56 x 2000.5 x 37.25 x x 3382.8 x x 782.417 124.818 3349.83 5148.8 70.2727 x 153.091 2014.0 x 2267.33 x x x 849.0 1514.75 2006.4 77.4545 2674.21 x x x +11827 Original post publication description: Morphine response (50 mg/kg ip), locomotion from 105-120 min after injection in an activity chamber for males and females [n beam breaks] None Morphine response (50 mg/kg ip), locomotion from 105-120 min after injection in an activity chamber for males and females [n beam breaks] x x x x 3777.46 1484.73 x 3240.17 1283.0 2941.73 2253.57 4901.0 2020.56 3465.38 1175.75 2745.88 3195.1 949.0 3919.78 3004.17 x x x 2914.89 x 4622.85 843.571 2556.64 x 1890.93 199.25 1341.46 711.308 x 1753.14 x 2072.25 3446.6 4510.41 x 566.353 412.417 1108.62 3378.0 x x 1786.33 x 689.846 5046.22 x x x 371.923 471.2 x x x 7.61539 487.25 1766.5 2696.0 x 1788.5 1139.42 1877.33 778.667 675.929 3626.64 1968.14 x 2155.56 x 1799.17 x 16.0 x x 2438.5 x x 672.75 259.0 3390.58 5050.5 70.8182 x 243.091 2140.89 x 1866.22 x x x 689.167 1944.5 1603.2 195.455 2565.5 x x x +11828 Original post publication description: Morphine response (50 mg/kg ip), locomotion from 120-135 min after injection in an activity chamber for males and females [n beam breaks] None Morphine response (50 mg/kg ip), locomotion from 120-135 min after injection in an activity chamber for males and females [n beam breaks] x x x x 3180.31 1681.82 x 2504.75 404.5 2244.18 1304.0 2903.86 1877.44 2737.88 741.417 1733.12 2560.7 1072.88 2970.56 2301.58 x x x 1861.0 x 3203.77 980.929 1800.0 x 1610.43 211.75 1226.31 471.308 x 1297.43 x 1857.25 2980.73 3427.12 x 910.118 461.417 898.308 3050.62 x x 1162.83 x 508.0 4218.94 x x x 517.077 402.2 x x x 58.3846 638.25 1281.0 2185.71 x 1319.43 840.0 1449.83 229.556 524.429 3443.07 1986.43 x 2141.62 x 1417.33 x 70.25 x x 2038.0 x x 605.333 410.273 3330.0 4719.1 82.6364 x 631.364 2027.89 x 1375.11 x x x 477.0 2414.5 1251.5 228.273 2062.07 x x x +11829 Original post publication description: Morphine response (50 mg/kg ip), locomotion from 0-15 min after injection in an activity chamber for males and females [n beam breaks] None Morphine response (50 mg/kg ip), locomotion from 0-15 min after injection in an activity chamber for males and females [n beam breaks] x x x x 2312.46 464.455 x 855.5 242.75 1246.73 1709.14 2093.71 207.222 1215.12 370.083 2016.75 1433.3 135.875 1550.0 752.833 x x x 725.444 x 1051.77 205.214 1391.55 x 2056.57 139.125 823.231 273.692 x 1115.71 x 1097.25 921.0 2798.29 x 572.353 303.25 906.615 814.625 x x 881.5 x 410.769 1289.61 x x x 313.692 373.4 x x x 130.0 218.125 340.333 913.714 x 389.143 675.667 286.167 512.222 374.214 2745.07 4767.71 x 596.188 x 685.667 x 494.0 x x 860.8 x x 207.75 215.545 869.833 899.9 126.364 x 614.091 1191.67 x 624.556 x x x 284.167 402.75 2150.5 307.0 854.5 x x x +11830 Original post publication description: Morphine response (50 mg/kg ip), locomotion from 150-165 min after injection in an activity chamber for males and females [n beam breaks] None Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion from 150-165 min after injection in an activity chamber for males and females [n beam breaks] x x x x 1557.31 1704.73 x 1571.67 136.75 1238.55 369.0 1113.86 1137.11 1931.75 343.25 612.75 1218.1 726.375 854.0 1192.67 x x x 436.778 x 1573.69 951.786 415.091 x 1010.57 188.25 1056.92 127.769 x 883.429 x 1360.08 1798.2 1667.65 x 1729.65 125.167 367.0 2304.75 x x 434.5 x 245.385 2495.89 x x x 345.308 294.8 x x x 51.6154 490.375 514.083 1728.86 x 635.714 527.083 745.667 86.6667 309.286 2702.14 1964.14 x 1908.69 x 550.917 x 182.75 x x 1200.1 x x 350.0 726.273 2391.25 3454.9 48.1818 x 717.273 1246.89 x 697.778 x x x 296.833 1910.75 197.2 183.636 1315.86 x x x +11831 Original post publication description: Morphine response (50 mg/kg ip), locomotion from 165-180 min after injection in an activity chamber for males and females [n beam breaks] None Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion from 165-180 min after injection in an activity chamber for males and females [n beam breaks] x x x x 1098.31 1522.45 x 1162.67 148.0 880.636 265.286 720.714 551.111 1158.88 352.667 394.75 908.8 367.0 465.333 949.167 x x x 330.111 x 1169.54 718.357 197.364 x 495.786 144.625 1058.08 180.692 x 492.714 x 1143.0 1391.33 1126.41 x 1814.41 72.4167 191.0 1727.38 x x 500.0 x 155.154 1642.33 x x x 295.923 214.8 x x x 101.154 375.0 368.25 1399.86 x 462.929 370.0 338.833 248.778 345.929 2389.0 1564.43 x 1536.38 x 311.333 x 283.5 x x 883.5 x x 267.667 989.455 1821.67 2814.9 50.1818 x 595.909 624.667 x 494.778 x x x 184.833 1221.25 125.5 174.636 1248.29 x x x +11832 Original post publication description: Morphine response (50 mg/kg ip), locomotion from 15-30 min after injection in an activity chamber for males and females [n beam breaks] None Morphine response (50 mg/kg ip), locomotion from 15-30 min after injection in an activity chamber for males and females [n beam breaks] x x x x 2480.08 147.364 x 1402.92 19.0 1292.82 2825.14 5181.0 245.333 1235.0 277.0 3447.62 1504.8 18.25 2761.67 1309.17 x x x 1079.44 x 2006.69 34.3571 1999.45 x 5759.64 5.875 661.462 141.077 x 2494.57 x 1191.33 1292.33 3800.18 x 135.941 100.667 975.692 989.5 x x 1028.0 x 983.923 2229.17 x x x 25.3077 217.9 x x x 23.0769 49.75 800.333 1289.57 x 410.643 281.333 163.083 1536.56 143.643 1568.29 10056.3 x 501.125 x 673.917 x 137.25 x x 1327.2 x x 93.75 2.36364 2334.83 1451.8 5.0 x 52.0 1043.89 x 680.556 x x x 248.083 184.25 3311.4 5.72727 951.286 x x x +11833 Original post publication description: Morphine response (50 mg/kg ip), locomotion from 30-45 min after injection in an activity chamber for males and females [n beam breaks] None Morphine response (50 mg/kg ip), locomotion from 30-45 min after injection in an activity chamber for males and females [n beam breaks] x x x x 2962.69 247.455 x 2103.58 142.0 2760.55 4345.14 6371.0 653.111 1659.25 446.0 5257.12 2177.3 70.875 3470.0 2458.17 x x x 2257.89 x 2902.77 64.7857 2605.91 x 8372.93 6.75 588.538 191.231 x 4442.14 x 1651.83 1553.33 4361.82 x 77.9412 67.8333 997.308 1219.5 x x 1345.17 x 2133.77 2883.56 x x x 9.38461 327.2 x x x 15.2308 26.0 1648.5 1528.29 x 658.571 298.667 436.583 2927.56 211.0 1839.29 8775.57 x 703.938 x 936.667 x 27.75 x x 1909.3 x x 232.0 0.545455 3275.92 2024.6 20.4545 x 19.3636 966.556 x 1154.78 x x x 357.25 164.0 3818.0 3.63636 1242.93 x x x +11834 Original post publication description: Morphine response (50 mg/kg ip), locomotion from 45-60 min after injection in an activity chamber for males and females [n beam breaks] None Morphine response (50 mg/kg ip), locomotion from 45-60 min after injection in an activity chamber for males and females [n beam breaks] x x x x 3661.85 356.091 x 3008.83 371.25 3891.73 5110.29 6805.29 1182.78 2228.0 580.75 6470.62 2550.5 149.875 4217.67 3210.0 x x x 3005.22 x 4202.08 189.429 3423.82 x 8409.0 20.375 737.462 354.692 x 5041.71 x 1973.33 2232.67 5424.12 x 117.412 116.25 1279.77 1851.62 x x 1852.0 x 2551.77 4125.06 x x x 13.2308 579.1 x x x 0.461538 38.0 2109.92 2120.14 x 1048.71 581.667 782.583 3567.22 331.786 2828.07 6575.29 x 1020.0 x 1491.25 x 7.5 x x 3154.7 x x 431.417 1.72727 3775.0 3251.6 37.4545 x 12.0909 1305.33 x 1813.56 x x x 537.5 349.25 4209.9 35.4545 1654.93 x x x +11835 Original post publication description: Morphine response (50 mg/kg ip), locomotion from 60-75 min after injection in an activity chamber for males and females [n beam breaks] None Morphine response (50 mg/kg ip), locomotion from 60-75 min after injection in an activity chamber for males and females [n beam breaks] x x x x 4131.69 620.818 x 3699.67 1090.0 4283.0 5125.71 7234.71 1639.0 2936.75 846.25 6750.62 3344.4 92.875 4739.44 3951.25 x x x 3469.44 x 5139.69 335.357 3774.0 x 6949.36 84.875 878.923 583.692 x 4518.14 x 2355.08 3084.2 6084.65 x 209.176 172.5 1666.31 2689.38 x x 2122.83 x 2123.77 4985.44 x x x 30.7692 610.0 x x x 15.8462 106.625 2099.17 2856.29 x 1644.57 982.417 1252.75 3211.22 540.643 3362.14 4689.14 x 1471.81 x 1883.0 x 24.25 x x 4019.4 x x 640.667 20.2727 3832.75 4136.5 50.2727 x 21.2727 1757.33 x 2058.22 x x x 702.5 565.75 3805.5 126.273 2088.14 x x x +11836 Original post publication description: Morphine response (50 mg/kg ip), locomotion from 75-90 min after injection in an activity chamber for males and females [n beam breaks] None Morphine response (50 mg/kg ip), locomotion from 75-90 min after injection in an activity chamber for males and females [n beam breaks] x x x x 3965.46 863.273 x 3775.83 2022.25 3917.55 4135.29 6896.43 1942.67 3402.25 956.417 6131.75 3608.5 157.625 4783.22 4235.58 x x x 3739.11 x 5642.62 496.429 3540.0 x 4757.57 149.625 1094.46 770.615 x 3583.71 x 2283.33 3366.07 6270.76 x 288.588 258.333 1673.62 3353.5 x x 2261.67 x 1515.92 5703.22 x x x 104.462 508.7 x x x 4.84615 211.375 2153.0 3013.86 x 2069.64 1289.25 2010.33 2271.56 823.429 3926.07 3309.43 x 1950.69 x 2067.25 x 51.25 x x 4254.7 x x 714.667 81.3636 3505.42 5163.9 63.2727 x 71.8182 2127.89 x 2226.78 x x x 855.583 1027.0 2850.5 125.273 2565.43 x x x +11837 Original post publication description: Morphine response (50 mg/kg ip), locomotion (open field) from 90-105 min after injection in an activity chamber for males and females [cm] None Morphine response (50 mg/kg ip), locomotion (open field) from 90-105 min after injection in an activity chamber for males and females [cm] x x x x 12065.3 3807.04 x 11220.9 5916.96 11000.5 9870.44 16267.3 7093.06 11099.9 4836.38 12051.8 9744.87 1400.95 13715.3 11038.0 x x x 10613.7 x 15423.9 2624.27 8920.04 x 8732.37 618.985 4396.28 2765.59 x 8381.9 x 7905.98 10892.3 15576.3 x 1547.39 1044.91 4016.13 10439.8 x x 6622.84 x 2786.5 16346.6 x x x 914.775 2311.03 x x x 29.2262 1430.15 5854.45 10049.6 x 7257.09 4250.62 7423.24 5029.98 2468.71 12588.1 8573.89 x 7214.97 x 6059.9 x 301.657 x x 9733.97 x x 2532.25 829.259 10516.4 13349.5 233.955 x 696.334 7207.96 x 7678.17 x x x 2708.93 5522.48 5993.57 306.717 8372.75 x x x +11838 Original post publication description: Morphine response (50 mg/kg ip), locomotion (open field) from 105-120 min after injection in an activity chamber for males and females [cm] None Morphine response (50 mg/kg ip), locomotion (open field) from 105-120 min after injection in an activity chamber for males and females [cm] x x x x 11638.5 4514.73 x 10147.7 3934.56 9293.54 7065.19 13028.2 6805.56 10161.1 4286.93 7560.49 9018.19 3322.84 11645.6 8917.04 x x x 8792.64 x 13372.3 3097.81 7468.73 x 6540.03 623.704 4494.82 2532.83 x 5212.75 x 7543.09 10473.6 12873.7 x 2134.7 1365.4 3244.44 10177.0 x x 5675.79 x 2163.52 14283.2 x x x 1421.35 2099.06 x x x 29.6031 1555.56 5199.63 9246.07 x 6221.89 3770.53 6205.55 2410.18 2161.37 11289.6 7714.72 x 6832.65 x 5478.57 x 175.259 x x 7547.67 x x 2183.19 1456.59 10576.6 13302.5 230.757 x 1118.24 7427.24 x 6652.02 x x x 2216.92 6508.46 4816.4 719.439 8139.17 x x x +11839 Original post publication description: Morphine response (50 mg/kg ip), locomotion (open field) from 120-135 min after injection in an activity chamber for males and females [cm] None Morphine response (50 mg/kg ip), locomotion (open field) from 120-135 min after injection in an activity chamber for males and females [cm] x x x x 9810.1 4916.83 x 8054.35 1352.63 7464.76 4189.27 8354.76 6175.61 8288.75 3014.72 5130.61 7462.82 3580.79 9209.01 7077.72 x x x 5925.11 x 9730.65 3442.93 5356.39 x 5651.24 650.489 4218.79 1760.21 x 3927.23 x 6982.26 9036.28 10509.4 x 3071.29 1530.93 2280.74 9383.31 x x 3812.72 x 1588.37 12176.9 x x x 1828.39 1740.29 x x x 189.532 1984.52 3876.71 7998.24 x 4729.66 2780.31 4831.36 840.545 1711.87 10745.8 7791.51 x 6703.85 x 4217.26 x 412.085 x x 6318.4 x x 1965.99 2034.51 10355.8 12621.9 261.455 x 2315.79 6827.35 x 5258.79 x x x 1566.76 7387.58 3796.07 775.677 6893.24 x x x +11840 Original post publication description: Morphine response (50 mg/kg ip), locomotion (open field) from 0-15 min after injection in an activity chamber for males and females [cm] None Morphine response (50 mg/kg ip), locomotion (open field) from 0-15 min after injection in an activity chamber for males and females [cm] x x x x 6848.87 1560.27 x 2694.38 716.861 4294.67 4770.23 6052.03 914.625 3790.1 1899.86 6063.94 4412.47 456.187 5102.15 2695.77 x x x 2966.16 x 3532.4 766.514 4274.51 x 5982.61 484.664 2674.26 1170.07 x 3580.22 x 3575.53 3033.79 8032.53 x 1827.84 1050.32 2872.78 2913.66 x x 2956.46 x 1352.78 4265.92 x x x 1220.28 1516.23 x x x 443.994 775.943 1360.77 3503.74 x 1503.09 2234.82 1332.77 2156.2 1271.25 8440.31 12519.0 x 1957.66 x 2221.33 x 1684.44 x x 2627.28 x x 728.922 669.349 3294.34 2930.12 392.663 x 2298.93 4303.97 x 2479.67 x x x 1039.57 1334.7 6238.8 948.5 2928.86 x x x +11841 Original post publication description: Morphine response (50 mg/kg ip), locomotion (open field) from 150-165 min after injections in an activity chamber for males and females [cm] None Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), locomotion (open field) from 150-165 min after injections in an activity chamber for males and females [cm] x x x x 5101.78 5124.28 x 5137.79 505.57 4248.79 1102.92 3514.43 3863.28 5979.65 1537.07 2107.58 3831.07 2455.53 2819.9 3987.79 x x x 1541.06 x 5154.82 3129.65 1298.87 x 3234.57 608.797 3700.94 467.552 x 2681.84 x 5301.79 5896.41 5552.55 x 5229.48 496.703 943.93 7117.88 x x 1472.36 x 787.324 7631.54 x x x 1244.55 1150.25 x x x 168.938 1538.09 1732.13 6659.51 x 2479.84 1615.39 2476.08 296.446 1120.56 8991.03 7380.67 x 6073.51 x 1739.79 x 829.62 x x 3732.52 x x 1156.61 2810.06 7624.42 9597.26 150.425 x 2542.13 4179.65 x 3275.64 x x x 1057.01 6108.74 624.487 606.411 4588.99 x x x +11842 Original post publication description: Morphine response (50 mg/kg ip), locomotion (open field) from 165-180 min after injection in an activity chamber for males and females [cm] None Morphine response (50 mg/kg ip), locomotion (open field) from 165-180 min after injection in an activity chamber for males and females [cm] x x x x 3635.49 4666.5 x 3694.69 537.119 2954.77 841.111 2277.24 2075.96 3804.72 1459.7 1468.62 2771.15 1293.59 1621.07 3153.92 x x x 1152.24 x 3622.64 2397.88 659.348 x 1658.52 489.778 3626.13 637.685 x 1475.27 x 4526.11 4708.81 3764.68 x 5407.63 298.022 528.7 5814.87 x x 1670.45 x 482.056 5412.81 x x x 1103.93 835.496 x x x 331.075 1154.24 1228.55 5481.16 x 1836.54 1139.02 1111.87 903.646 1174.21 8211.38 5999.82 x 5004.04 x 1006.18 x 1064.1 x x 2814.39 x x 956.624 3427.3 5938.02 8044.01 181.99 x 2155.78 2162.23 x 2588.39 x x x 705.241 4276.96 398.4 584.614 4305.15 x x x +11843 Original post publication description: Morphine response (50 mg/kg ip), locomotion (open field) from 15-30 min after injection in an activity chamber for males and females [cm] None Morphine response (50 mg/kg ip), locomotion (open field) from 15-30 min after injection in an activity chamber for males and females [cm] x x x x 7838.71 796.303 x 4718.53 108.978 4924.84 7702.61 13810.4 1428.85 3925.25 1903.65 10713.4 4922.38 129.873 8734.16 4591.88 x x x 4430.91 x 6517.76 325.008 6193.92 x 15011.1 42.7684 2344.54 943.12 x 7518.69 x 4230.72 4699.61 10801.0 x 655.541 482.319 3542.42 3814.36 x x 3661.9 x 3298.53 7052.33 x x x 218.35 1317.47 x x x 98.1774 271.437 2859.24 5940.45 x 2257.73 1207.27 1169.76 5457.49 681.727 6601.43 24297.8 x 1914.74 x 2255.67 x 757.578 x x 4051.5 x x 382.266 14.3002 7795.03 4776.38 51.1265 x 452.344 4556.91 x 3273.32 x x x 927.806 823.354 9558.89 35.5025 3646.89 x x x +11844 Original post publication description: Morphine response (50 mg/kg ip), locomotion (open field) from 30-45 min after injection in an activity chamber for males and females [cm] None Morphine response (50 mg/kg ip), locomotion (open field) from 30-45 min after injection in an activity chamber for males and females [cm] x x x x 9363.14 1162.02 x 6935.09 604.168 8569.1 11720.2 16624.6 3211.77 5109.23 2619.92 14552.1 6605.52 347.1 10449.3 7565.21 x x x 7613.01 x 9083.72 615.894 7916.88 x 20670.6 71.4603 2271.54 1159.11 x 12742.5 x 5927.63 5964.9 12615.6 x 535.31 339.725 3754.93 4355.5 x x 4729.68 x 6428.06 8810.42 x x x 119.017 1851.0 x x x 74.0679 184.417 5007.84 7046.53 x 3552.3 1363.89 2267.92 9092.51 902.436 7517.55 21834.2 x 2783.0 x 3204.78 x 221.912 x x 5762.27 x x 877.207 9.23636 10140.8 6414.65 131.342 x 241.738 4468.51 x 5063.36 x x x 1346.67 1105.04 10871.8 35.0098 4690.11 x x x +11845 Original post publication description: Morphine response (50 mg/kg ip), locomotion (open field) from 45-60 min after injection in an activity chamber for males and females [cm] None Morphine response (50 mg/kg ip), locomotion (open field) from 45-60 min after injection in an activity chamber for males and females [cm] x x x x 11283.1 1590.89 x 9490.75 1518.38 11433.7 13704.1 17534.7 4999.17 6903.99 3248.23 16766.8 7752.79 704.189 12410.4 9299.82 x x x 9447.03 x 12399.0 1167.22 10042.9 x 20695.6 112.214 2796.28 1695.17 x 14324.2 x 6889.89 7953.0 14906.7 x 684.419 490.773 4469.36 5855.44 x x 6237.21 x 7413.83 11949.8 x x x 143.796 2629.59 x x x 13.2841 255.251 6303.22 8609.31 x 4880.94 2214.68 3751.5 10664.5 1401.99 9747.03 17802.7 x 4029.1 x 4809.68 x 73.9509 x x 8870.36 x x 1591.63 22.5695 11206.3 9329.36 210.032 x 145.591 5545.82 x 6944.53 x x x 1905.83 2039.93 11940.0 207.004 5911.85 x x x +11846 Original post publication description: Morphine response (50 mg/kg ip), locomotion (open field) from 60-75 min after injection in an activity chamber for males and females [cm] None Morphine response (50 mg/kg ip), locomotion (open field) from 60-75 min after injection in an activity chamber for males and females [cm] x x x x 12404.5 2441.99 x 11222.5 4047.53 12268.2 14154.5 18471.7 6205.13 9051.34 3863.96 17282.3 9527.78 576.974 13623.6 11130.6 x x x 10581.2 x 14764.8 1555.35 10848.4 x 17871.0 348.105 3254.47 2375.34 x 12764.6 x 8001.51 10024.5 16119.3 x 968.047 700.585 5533.64 8128.29 x x 6993.69 x 6237.73 14192.7 x x x 254.166 2701.06 x x x 69.7519 549.283 6355.14 9931.14 x 6354.09 3362.52 5308.92 9637.01 2058.29 10862.5 13812.1 x 5375.38 x 5843.49 x 204.98 x x 11050.3 x x 2245.61 165.183 11522.0 11118.4 243.837 x 238.457 6725.48 x 7628.89 x x x 2394.08 3014.13 10850.5 512.954 7031.18 x x x +11847 Original post publication description: Morphine response (50 mg/kg ip), locomotion (open field) from 75-90 min after injection in an activity chamber for males and females [cm] None Morphine response (50 mg/kg ip), locomotion (open field) from 75-90 min after injection in an activity chamber for males and females [cm] x x x x 12152.4 3090.49 x 11431.5 6182.69 11685.5 12263.3 17794.9 6744.89 10385.5 4109.23 16006.3 10039.8 920.005 13528.8 11851.6 x x x 11200.9 x 15886.4 2110.35 10200.4 x 12863.1 532.15 3827.6 2838.83 x 10333.4 x 7947.08 10602.9 16478.2 x 1252.12 932.124 5220.27 9633.25 x x 7267.69 x 4486.25 15951.0 x x x 616.183 2413.83 x x x 29.5031 852.65 6452.24 10175.4 x 7305.58 4153.03 7288.96 6875.32 2763.69 11970.2 10676.4 x 6590.99 x 6274.53 x 405.169 x x 11592.8 x x 2383.54 602.084 10678.7 13354.6 248.016 x 436.685 7626.71 x 7845.82 x x x 2807.51 4416.56 8334.15 466.846 8216.83 x x x +11848 Original post publication description: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), severity of abdominal contraction for males and females [ordinal scale, 0=no effect, 3=max] None Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), severity of abdominal contraction for males and females [ordinal scale, 0=no effect, 3=max] x x x x 0.0 0.181818 x 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.083333 x x x 0.0 x 0.076923 0.0 0.090909 x 0.0 0.0 0.0 0.076923 x 0.0 x 0.0 0.0 0.0 x 0.0 0.0 0.0 0.125 x x 0.0 x 0.0 0.111111 x x x 0.0 0.0 x x x 0.0 0.0 0.0 0.0 x 0.0 0.0 0.0 0.0 0.0 0.0 0.0 x 0.0 x 0.0 x 0.0 x x 0.0 x x 0.0 0.0 0.0 0.1 0.181818 x 0.0 0.222222 x 0.0 x x x 0.0 0.0 0.0 0.0 0.0 x x x +11849 Original post publication description: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), defecation in an activity chamber for males and females [n fecal boli] None Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), defecation in an activity chamber for males and females [n fecal boli] x x x x 1.84615 3.18182 x 3.08333 2.25 0.727273 1.42857 2.57143 0.888889 2.0 1.91667 0.5 1.6 3.625 1.88889 1.5 x x x 1.77778 x 1.30769 0.5 1.63636 x 1.57143 2.375 0.384615 2.84615 x 2.0 x 0.083333 1.46667 1.41176 x 1.82353 2.66667 1.76923 2.25 x x 1.83333 x 2.53846 2.33333 x x x 2.61539 2.9 x x x 3.92308 3.25 2.41667 1.14286 x 1.78571 1.58333 3.41667 1.88889 1.5 0.857143 4.28571 x 1.5625 x 3.33333 x 2.33333 x x 3.0 x x 2.83333 2.45455 0.333333 2.6 1.81818 x 1.36364 1.88889 x 1.0 x x x 1.83333 2.25 2.6 1.90909 0.428571 x x x +11850 Original post publication description: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), number of jumps for males and females [n/15 min test] None Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), number of jumps for males and females [n/15 min test] x x x x 0.0 0.0 x 0.833333 0.0 1.90909 0.0 0.142857 4.77778 0.0 0.0 0.0 5.9 0.0 3.55556 3.66667 x x x 0.0 x 3.38461 3.85714 0.0 x 0.0 0.0 0.0 3.23077 x 0.0 x 0.416667 2.26667 0.294118 x 4.64706 1.91667 0.153846 4.875 x x 2.33333 x 0.538462 2.22222 x x x 0.0 3.6 x x x 1.92308 0.0 0.916667 0.0 x 2.71429 0.0 0.0 0.0 0.0 1.5 0.0 x 0.3125 x 0.0 x 0.0 x x 2.0 x x 0.0 2.63636 0.666667 1.2 0.0 x 0.0 3.66667 x 1.33333 x x x 7.83333 3.75 2.7 15.8182 4.21429 x x x +11851 Original post publication description: Morphine response (50 mg/kg ip), locomotion from 0-180 min (total activity over 3 hour test) after injection in an activity chamber for males and females [n beam breaks] None Morphine response (50 mg/kg ip), locomotion from 0-180 min (total activity over 3 hour test) after injection in an activity chamber for males and females [n beam breaks] x x x x 35489.4 11981.5 x 28671.8 7937.5 29816.4 31281.3 52251.9 15006.8 28043.9 7942.83 40994.6 28139.0 4777.12 36326.8 28815.8 x x x 24173.8 x 39100.4 6580.14 25545.7 x 45504.9 1538.88 11950.6 4841.77 x 29680.7 x 20751.9 28062.5 47821.9 x 8100.06 2736.67 11974.7 27948.6 x x 16164.3 x 12654.2 43801.1 x x x 2704.23 4872.9 x x x 471.231 3571.25 15851.2 24840.9 x 13507.5 8822.5 12635.8 17118.2 5404.79 35760.3 50184.3 x 18561.6 x 14914.2 x 1483.25 x x 27087.6 x x 5530.17 3388.09 34814.6 42401.4 692.545 x 3921.0 18147.1 x 16223.6 x x x 5842.42 14320.5 25784.7 1690.36 20890.3 x x x +11852 Original post publication description: Morphine response (50 mg/kg ip), locomotion from 0-180 min (total activity over 3 hour test) after injection in an activity chamber for males and females [cm] None Morphine response (50 mg/kg ip), locomotion from 0-180 min (total activity over 3 hour test) after injection in an activity chamber for males and females [cm] x x x x 109836.0 38650.5 x 90417.1 25822.4 93353.1 89351.2 139250.0 54245.5 85658.7 35062.4 112698.0 82523.3 17648.2 108613.0 86485.3 x x x 77037.1 x 116370.0 24850.9 75622.1 x 123231.0 5190.27 41702.8 19346.3 x 86450.7 x 74957.8 90952.8 135439.0 x 27460.3 9870.44 37833.7 86471.7 x x 53528.7 x 38389.2 127859.0 x x x 10737.3 22072.7 x x x 1659.13 12085.7 48750.2 92402.8 x 51938.9 29841.5 46858.3 53647.9 18988.7 116845.0 146452.0 x 61633.6 x 46452.8 x 6854.36 x x 79192.7 x x 18700.7 14433.8 108823.0 116520.0 2536.91 x 15393.0 66799.6 x 62761.3 x x x 19922.7 50272.6 74825.1 5942.18 70393.3 x x x +11853 Original post publication description: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), change in locomotion for males and females (last 15 min of morphine test (165-180 min) minus first 15 min after naloxone) [cm difference] None Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), change in locomotion for males and females (last 15 min of morphine test (165-180 min) minus first 15 min after naloxone) [cm difference] x x x x 2605.15 3370.15 x 2939.93 -613.747 1937.32 5.58881 942.053 1075.43 3178.07 772.615 601.147 1064.23 176.59 -36.2687 1774.72 x x x 82.4859 x 1948.92 379.936 -435.694 x 731.174 -1115.65 2196.65 -927.178 x 856.671 x 3491.2 3775.26 2617.96 x 3599.09 -1497.18 -326.82 4172.87 x x 364.418 x -596.547 4335.19 x x x -91.6599 -626.672 x x x -897.848 221.714 274.248 4814.89 x 1078.77 465.349 561.742 26.4219 -37.0167 7132.92 5218.38 x 4229.3 x 119.735 x 333.953 x x 1836.41 x x 92.0569 2146.61 4897.23 6094.06 -843.791 x 588.285 1352.68 x 1646.06 x x x -686.527 3245.97 -1243.73 -2188.91 2804.36 x x x +11854 Original post publication description: Morphine response (50 mg/kg ip), vertical activity (rears) from 0-180 min (total activity over 3 hour test) after injection in an activity chamber for males and females [n beam breaks] None Morphine response (50 mg/kg ip), vertical activity (rears) from 0-180 min (total activity over 3 hour test) after injection in an activity chamber for males and females [n beam breaks] x x x x 5618.77 2440.91 x 6301.17 1113.75 4690.82 2154.71 4679.0 2561.33 7054.0 424.417 8142.5 4791.9 668.0 5083.56 3642.58 x x x 3086.78 x 5670.77 1148.93 3353.09 x 4000.93 179.75 1788.62 537.154 x 3198.0 x 4495.42 3998.6 7473.88 x 1415.53 542.25 1563.77 3535.75 x x 2089.67 x 1510.62 5212.44 x x x 169.231 606.9 x x x 126.308 925.25 1540.75 3934.71 x 1964.36 2041.5 1970.83 2560.44 916.571 5941.71 7332.71 x 4427.75 x 2801.17 x 438.75 x x 3711.0 x x 954.083 536.273 5565.0 5437.8 112.364 x 1105.91 4788.11 x 3363.44 x x x 3476.25 3733.0 4004.4 290.091 5349.57 x x x +11855 Original post publication description: Novel open field behavior, locomotion in the periphery from 0-15 min for males and females in the morphine test battery [n beam breaks] None Novel open field behavior, locomotion in the periphery from 0-15 min for males and females in the morphine test battery [n beam breaks] x x x x 1336.46 941.909 x 1677.5 626.5 1105.27 755.714 1560.43 730.222 1055.88 285.25 825.875 2139.6 855.125 922.222 997.25 x x x 529.889 x 735.077 472.929 2110.27 x 950.571 959.25 907.231 976.923 x 652.0 x 949.0 509.0 1502.06 x 1483.65 761.333 726.385 1322.12 x x 996.833 x 1324.69 1071.17 x x x 1258.0 411.8 x x x 1537.62 1206.38 469.083 385.714 x 856.0 687.75 431.25 944.889 1112.29 1130.0 1246.0 x 710.938 x 783.75 x 1397.5 x x 816.0 x x 538.583 874.636 832.583 1234.6 946.091 x 1074.36 1014.44 x 1219.0 x x x 968.5 1342.0 1448.0 1679.09 474.643 x x x +11856 Original post publication description: Novel open field behavior, locomotion in the periphery from 15-30 min for males and females in the morphine test battery [n beam breaks] None Central nervous system, pharmacology, behavior: Novel open field behavior, locomotion in the periphery from 15-30 min for males and females in the morphine test battery [n beam breaks] x x x x 1044.38 591.727 x 1225.92 902.75 1113.18 708.571 1186.86 632.889 697.25 320.833 625.0 1396.8 899.375 645.444 759.583 x x x 533.333 x 741.923 507.643 2045.45 x 671.286 655.375 1006.46 651.538 x 183.714 x 656.75 542.467 1243.76 x 989.059 731.25 404.0 1211.38 x x 893.5 x 1296.08 829.833 x x x 920.769 179.7 x x x 1025.85 1048.25 329.25 654.571 x 872.071 489.5 465.333 955.556 918.643 1019.57 1295.29 x 625.938 x 631.25 x 1364.5 x x 503.0 x x 440.5 803.182 649.083 1024.3 783.636 x 1091.82 506.667 x 950.778 x x x 459.333 761.75 1321.9 1458.73 460.071 x x x +11857 Original post publication description: Novel open field behavior, locomotion in the periphery from 30-45 min for males and females in the morphine test battery [n beam breaks] None Central nervous system, behavior, neuropharmacology: Novel open field behavior, locomotion in the periphery from 30-45 min for males and females in the morphine test battery [n beam breaks] x x x x 903.846 322.0 x 873.417 1160.5 914.364 726.0 954.571 392.0 545.5 347.583 509.5 973.0 774.375 336.0 662.667 x x x 453.667 x 391.0 324.357 1410.91 x 419.714 537.375 1062.15 437.692 x 83.4286 x 616.75 389.4 1151.0 x 720.294 659.167 281.231 953.625 x x 790.0 x 1329.08 776.778 x x x 688.385 122.6 x x x 730.769 907.0 231.25 722.714 x 720.429 445.417 449.583 742.111 931.286 949.929 1290.0 x 467.0 x 507.75 x 1081.0 x x 396.3 x x 438.167 746.0 429.167 846.3 696.364 x 1046.27 411.333 x 840.556 x x x 330.25 630.75 1227.2 1273.0 472.0 x x x +11858 Original post publication description: Novel open field behavior, locomotion in the periphery from 45-60 min for males and females in the morphine test battery [n beam breaks] None Novel open field behavior, locomotion in the periphery from 45-60 min for males and females in the morphine test battery [n beam breaks] x x x x 688.846 205.545 x 771.25 997.25 617.364 503.857 793.286 183.222 449.125 247.583 445.375 803.0 539.125 289.0 486.583 x x x 320.444 x 168.231 213.429 1166.82 x 202.143 326.125 780.923 289.615 x 66.4286 x 513.833 320.733 901.294 x 602.529 570.583 164.0 527.5 x x 664.0 x 1147.85 520.833 x x x 476.846 60.9 x x x 450.538 823.625 136.25 575.857 x 548.571 383.083 354.917 572.0 802.0 822.857 1006.0 x 389.812 x 479.667 x 1007.0 x x 247.6 x x 370.917 552.091 238.5 527.5 517.455 x 957.545 248.444 x 712.667 x x x 246.333 295.0 1151.4 1109.91 406.429 x x x +11859 Original post publication description: Novel open field behavior, locomotion in the periphery from 0-15 min for males and females in the morphine test battery [cm] None Central nervous system, pharmacology, behavior: Novel open field behavior, locomotion in the periphery from 0-15 min for males and females in the morphine test battery [cm] x x x x 4313.34 3255.03 x 5262.83 2519.68 3679.57 2702.82 4842.89 2786.4 3737.7 1508.45 2874.04 6340.19 3047.63 3237.13 3414.62 x x x 2492.83 x 2856.49 2082.07 6518.33 x 3563.68 3352.83 3311.19 3496.09 x 2566.14 x 3460.22 2198.65 4874.58 x 4787.99 2750.91 2723.51 4570.55 x x 3386.71 x 4194.37 3619.44 x x x 4397.74 1815.25 x x x 4964.22 4093.08 1749.43 1870.19 x 3270.99 2627.6 1959.57 3458.84 3699.93 3893.34 4365.75 x 2755.87 x 2923.54 x 4367.48 x x 2953.62 x x 2346.1 3267.56 3173.71 4179.15 3241.59 x 3770.73 3742.48 x 4241.66 x x x 3314.59 4361.63 4573.7 5239.06 2091.77 x x x +11860 Original post publication description: Novel open field behavior, locomotion locomotion in the periphery from 15-30 for males and females in the morphine test battery [cm] None Novel open field behavior, locomotion locomotion in the periphery from 15-30 for males and females in the morphine test battery [cm] x x x x 3641.63 2117.99 x 3991.1 3215.68 3627.51 2540.35 3920.09 2550.6 2647.09 1556.34 2274.47 4317.98 3341.51 2358.81 2721.49 x x x 2384.53 x 2524.42 2182.03 6107.59 x 2616.52 2437.1 3623.83 2503.03 x 766.286 x 2776.4 2209.68 4224.33 x 3465.6 2714.69 1541.25 4078.95 x x 2954.64 x 4081.9 3063.68 x x x 3245.66 977.658 x x x 3432.15 3674.16 1358.49 2672.3 x 3149.42 2039.5 1982.11 3500.06 3141.77 3556.28 4305.41 x 2387.3 x 2477.96 x 4247.02 x x 2045.61 x x 1961.5 3039.1 2536.71 3498.94 2603.65 x 3757.07 2289.88 x 3496.85 x x x 1830.55 2931.54 4217.74 4633.22 1950.54 x x x +11861 Original post publication description: Novel open field behavior, locomotion in the periphery from 30-45 min for males and females in the morphine test battery [cm] None Central nervous system, behavior, neuropharmacology: Novel open field behavior, locomotion in the periphery from 30-45 min for males and females in the morphine test battery [cm] x x x x 3187.56 1226.24 x 3026.82 3703.54 2993.83 2496.81 3266.39 1694.32 2106.73 1646.62 1882.61 3149.59 2870.78 1212.0 2297.19 x x x 2089.01 x 1353.17 1522.57 4420.27 x 1696.06 2024.69 3680.82 1704.46 x 358.046 x 2514.83 1649.98 3917.06 x 2569.88 2504.57 1076.21 3293.45 x x 2739.68 x 4169.03 2873.1 x x x 2509.49 597.881 x x x 2441.12 3172.95 918.196 2785.1 x 2532.73 1838.44 1860.61 3014.56 3240.93 3401.55 4220.57 x 1820.99 x 2085.51 x 3494.36 x x 1589.64 x x 1921.36 2796.81 1668.07 2852.15 2263.85 x 3589.54 1930.1 x 3119.15 x x x 1407.93 2448.8 3958.69 4109.99 1877.38 x x x +11862 Original post publication description: Novel open field behavior, locomotion in the periphery from 45-60 min for males and females in the morphine test battery [cm] None Novel open field behavior, locomotion in the periphery from 45-60 min for males and females in the morphine test battery [cm] x x x x 2470.61 772.646 x 2735.12 3255.52 2066.19 1854.03 2784.05 892.132 1870.51 1162.81 1632.95 2575.87 1989.23 1016.3 1631.68 x x x 1467.61 x 622.564 1015.25 3752.29 x 794.005 1233.75 2767.97 1150.61 x 301.338 x 2198.31 1411.94 3134.11 x 2156.38 2171.4 613.514 1914.72 x x 2447.13 x 3628.82 1996.44 x x x 1715.91 302.454 x x x 1421.33 2933.91 614.939 2250.54 x 1918.84 1577.05 1463.41 2340.96 2829.83 3043.82 3433.15 x 1486.25 x 1922.71 x 3242.21 x x 1011.88 x x 1604.69 2190.02 924.781 1802.45 1701.76 x 3340.69 1289.25 x 2595.54 x x x 1072.74 1208.15 3707.47 3607.9 1617.01 x x x +11863 Original post publication description: Novel open field behavior,vertical activity (rears) from 0-15 min for males and females [n beam breaks] None Central nervous system, behavior: Novel open field behavior,vertical activity (rears) from 0-15 min for males and females [n beam breaks] x x x x 208.308 212.818 x 292.25 206.25 273.091 153.286 237.571 115.333 276.625 87.0 247.0 307.6 291.375 265.778 255.667 x x x 74.5556 x 144.0 107.5 319.909 x 245.714 175.875 291.462 291.385 x 167.571 x 238.0 121.0 353.235 x 304.412 391.417 151.615 266.5 x x 298.167 x 342.0 270.889 x x x 238.462 83.5 x x x 357.692 317.125 147.917 100.286 x 163.429 231.5 173.75 336.889 257.143 268.786 280.571 x 307.688 x 258.917 x 239.0 x x 288.2 x x 133.833 284.0 311.167 288.2 214.0 x 330.909 228.222 x 199.667 x x x 386.917 258.0 241.2 411.636 169.357 x x x +11864 Original post publication description: Novel open field behavior, vertical activity (rears) from 15-30 min for males and females [n beam breaks] None Central nervous system, behavior: Novel open field behavior, vertical activity (rears) from 15-30 min for males and females [n beam breaks] x x x x 258.846 200.091 x 340.333 345.25 342.182 166.0 262.714 181.778 272.75 117.917 300.75 336.4 353.125 256.222 254.667 x x x 105.0 x 164.231 183.786 439.727 x 285.643 205.375 402.538 244.538 x 93.4286 x 326.917 176.067 422.882 x 335.235 483.167 138.385 294.75 x x 346.667 x 393.0 276.778 x x x 247.0 68.7 x x x 308.769 365.75 178.5 191.429 x 255.286 257.583 280.0 366.444 332.857 340.714 362.143 x 374.75 x 284.667 x 337.25 x x 311.7 x x 198.833 373.273 347.167 303.1 218.636 x 397.182 232.0 x 235.556 x x x 421.083 249.75 279.4 405.636 242.929 x x x +11865 Original post publication description: Novel open field behavior, vertical activity (rears) from min 30-45 for males and females [n beam breaks] None Central nervous system, behavior: Novel open field behavior, vertical activity (rears) from min 30-45 for males and females [n beam breaks] x x x x 217.462 175.727 x 325.667 444.75 330.818 156.571 260.571 146.667 250.875 108.75 316.0 301.6 354.0 182.333 222.25 x x x 123.333 x 122.846 150.857 428.727 x 264.0 190.75 418.692 179.538 x 59.1429 x 349.083 154.867 423.118 x 288.235 447.667 109.385 207.5 x x 344.833 x 435.308 259.722 x x x 232.769 44.9 x x x 263.692 413.375 136.25 204.429 x 205.071 202.5 293.083 291.889 332.214 384.786 371.429 x 341.875 x 265.75 x 363.75 x x 305.8 x x 199.083 393.909 274.583 233.5 204.545 x 404.545 194.778 x 247.333 x x x 371.583 270.0 265.1 351.273 248.786 x x x +11866 Original post publication description: Novel open field behavior, vertical activity (rears) from 45-60 min for males and females [n beam breaks] None Central nervous system, behavior: Novel open field behavior, vertical activity (rears) from 45-60 min for males and females [n beam breaks] x x x x 211.308 97.4545 x 319.583 390.25 305.818 114.571 223.0 90.1111 246.375 104.833 314.625 280.6 254.75 141.444 170.75 x x x 93.3333 x 77.3077 121.143 428.091 x 191.071 160.125 357.615 134.923 x 63.0 x 365.833 161.467 397.412 x 270.765 429.417 71.5385 153.875 x x 341.333 x 409.692 206.389 x x x 166.231 35.0 x x x 150.308 393.625 109.25 184.429 x 190.143 197.083 266.417 274.222 349.857 358.214 364.714 x 284.062 x 263.833 x 336.25 x x 238.0 x x 198.667 338.818 193.833 164.1 191.091 x 417.636 166.222 x 182.333 x x x 326.083 199.75 305.7 356.273 234.214 x x x +11867 Original post publication description: Novel open field behavior, locomotion in the center from 0-60 min for males and females [n beam breaks] None Central nervous system, behavior: Novel open field behavior, locomotion in the center from 0-60 min for males and females [n beam breaks] x x x x 3973.54 2061.18 x 4548.08 3687.0 3750.18 2694.14 4495.14 1938.33 2747.75 1201.25 2405.75 5312.4 3068.0 2192.67 2906.08 x x x 1837.33 x 2036.23 1518.36 6733.45 x 2243.71 2478.12 3756.77 2355.77 x 985.571 x 2736.33 1761.6 4798.12 x 3795.53 2722.33 1575.62 4014.62 x x 3344.33 x 5097.69 3198.61 x x x 3344.0 775.0 x x x 3744.77 3985.25 1165.83 2338.86 x 2997.07 2005.75 1701.08 3214.56 3764.21 3922.36 4837.29 x 2193.69 x 2402.42 x 4850.0 x x 1962.9 x x 1788.17 2975.91 2149.33 3632.7 2943.55 x 4170.0 2180.89 x 3723.0 x x x 2004.42 3029.5 5148.5 5520.73 1813.14 x x x +11868 Original post publication description: Novel open field behavior, locomotion in the center from 0-60 min for males and females [cm] None Novel open field behavior, locomotion in the center from 0-60 min for males and females [cm] x x x x 13613.1 7371.9 x 15015.9 12694.4 12367.1 9594.02 14813.4 7923.46 10362.0 5874.21 8664.06 16383.6 11249.1 7824.25 10065.0 x x x 8433.98 x 7356.64 6801.93 20798.5 x 8670.27 9048.37 13383.8 8854.2 x 3991.81 x 10949.8 7470.25 16150.1 x 12979.9 10141.6 5954.49 13857.7 x x 11528.2 x 16074.1 11552.7 x x x 11868.8 3693.24 x x x 12258.8 13874.1 4641.05 9578.13 x 10872.0 8082.59 7265.7 12314.4 12912.5 13895.0 16324.9 x 8450.4 x 9409.72 x 15351.1 x x 7600.75 x x 7833.66 11293.5 8303.27 12332.7 9810.85 x 14458.0 9251.72 x 13453.2 x x x 7625.82 10950.1 16457.6 17590.2 7536.71 x x x +11869 Original post publication description: Novel open field behavior, vertical activity (rears) in the center from 0-60 min for males and females [n beam breaks] None Central nervous system, behavior: Novel open field behavior, vertical activity (rears) in the center from 0-60 min for males and females [n beam breaks] x x x x 895.923 686.091 x 1277.83 1386.5 1251.91 590.429 983.857 533.889 1046.62 418.5 1178.38 1226.2 1253.25 845.778 903.333 x x x 396.222 x 508.385 563.286 1616.45 x 986.429 732.125 1470.31 850.385 x 383.143 x 1279.83 613.4 1596.65 x 1198.65 1751.67 470.923 922.625 x x 1331.0 x 1580.0 1013.78 x x x 884.462 232.1 x x x 1080.46 1489.88 571.917 680.571 x 813.929 888.667 1013.25 1269.44 1272.07 1352.5 1378.86 x 1308.38 x 1073.17 x 1276.25 x x 1143.7 x x 730.417 1390.0 1126.75 988.9 828.273 x 1550.27 821.222 x 864.889 x x x 1505.67 977.5 1091.4 1524.82 895.286 x x x +11870 Original post publication description: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), locomotion from 0-15 min after naloxone injection for males and females [n beam breaks] None Central nervous system, pharmacology, behavior: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), locomotion from 0-15 min after naloxone injection for males and females [n beam breaks] x x x x 287.769 397.091 x 216.0 342.0 297.182 229.714 400.714 285.556 163.0 157.583 261.0 582.3 336.375 491.444 421.5 x x x 251.667 x 510.308 619.143 359.545 x 251.143 534.125 452.769 513.231 x 179.286 x 309.75 278.8 345.176 x 519.882 583.583 259.385 515.375 x x 445.5 x 325.462 364.667 x x x 334.0 421.9 x x x 392.0 302.25 305.25 171.286 x 207.214 214.167 147.25 247.778 374.929 327.714 223.286 x 227.625 x 253.417 x 278.667 x x 303.5 x x 215.417 424.273 284.75 652.9 323.455 x 477.727 229.889 x 251.111 x x x 450.5 261.5 482.1 942.909 478.071 x x x +11871 Original post publication description: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), horizontal activity (distance traveled) from 0-15 min after naloxone injection for males and females [cm] None Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), horizontal activity (distance traveled) from 0-15 min after naloxone injection for males and females [cm] x x x x 1030.34 1296.36 x 754.765 1150.87 1017.45 835.522 1335.19 1000.53 626.651 687.085 867.472 1706.93 1117.0 1657.34 1379.2 x x x 1069.75 x 1673.72 2017.95 1095.04 x 927.35 1605.43 1429.47 1564.86 x 618.596 x 1034.91 933.544 1146.72 x 1808.53 1795.2 855.52 1642.0 x x 1306.04 x 1078.6 1077.62 x x x 1195.59 1462.17 x x x 1228.92 932.527 954.298 666.273 x 757.773 673.676 550.129 877.224 1211.22 1078.45 781.432 x 774.738 x 886.449 x 1084.85 x x 977.974 x x 864.567 1280.69 1040.79 1949.96 1025.78 x 1567.5 809.557 x 942.333 x x x 1391.77 1030.99 1642.13 2773.53 1500.79 x x x +11872 Original post publication description: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), vertical activity (rears) from 0-15 min after naloxone injection for males and females [n beam breaks] None Central nervous system, pharmacology, behavior: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), vertical activity (rears) from 0-15 min after naloxone injection for males and females [n beam breaks] x x x x 79.0769 108.455 x 98.0 56.25 65.1818 40.2857 72.0 97.8889 73.875 45.8333 72.125 101.9 105.25 161.0 134.0 x x x 76.5556 x 117.077 77.8571 76.5455 x 86.7143 85.25 29.0 98.8462 x 44.2857 x 154.667 74.1333 73.3529 x 167.235 150.25 77.6923 135.375 x x 101.667 x 111.615 117.611 x x x 122.154 117.4 x x x 80.0 104.875 50.75 51.4286 x 66.8571 110.0 121.75 58.5556 47.3571 122.071 61.7143 x 119.438 x 136.75 x 68.3333 x x 93.2 x x 110.75 72.9091 144.5 52.9 54.9091 x 154.727 64.6667 x 104.0 x x x 180.083 83.25 111.6 143.909 135.857 x x x +11873 Original post publication description: Central nervous system, pharmacology, behavior: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), postural changes for males and females [ordinal scale, 0=no effect, 3=max] None Central nervous system, pharmacology, behavior: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), postural changes for males and females [ordinal scale, 0=no effect, 3=max] x x x x 0.076923 0.181818 x 0.0 0.0 0.181818 0.571429 0.285714 0.444444 0.75 0.25 0.0 0.8 0.125 0.0 0.166667 x x x 0.111111 x 0.307692 0.071429 0.363636 x 0.071429 0.0 0.0 0.076923 x 0.0 x 0.333333 0.266667 0.058824 x 0.058824 0.166667 0.076923 0.625 x x 0.166667 x 0.461538 0.5 x x x 0.230769 0.0 x x x 0.307692 0.25 0.083333 0.0 x 0.142857 0.166667 0.416667 0.111111 0.142857 0.285714 0.285714 x 0.125 x 0.166667 x 0.333333 x x 0.2 x x 0.0 0.090909 0.166667 0.6 0.090909 x 0.0 0.222222 x 0.444444 x x x 0.25 0.25 0.2 0.0 0.142857 x x x +11874 Original post publication description: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), ptosis for males and females [ordinal scale, 0=no effect, 3=max] None Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), ptosis for males and females [ordinal scale, 0=no effect, 3=max] x x x x 1.53846 0.0 x 0.25 1.5 0.0 0.0 0.142857 0.0 0.125 2.16667 1.375 0.4 0.125 0.0 0.0 x x x 0.333333 x 0.307692 0.571429 0.818182 x 0.0 0.5 0.230769 0.230769 x 0.285714 x 0.0 0.533333 0.176471 x 0.058824 0.083333 0.0 0.0 x x 0.333333 x 0.230769 0.333333 x x x 0.615385 0.0 x x x 0.769231 0.25 0.833333 0.0 x 0.642857 0.75 0.333333 0.0 0.142857 1.5 0.285714 x 0.125 x 0.166667 x 1.0 x x 0.4 x x 0.166667 0.0 0.166667 0.1 0.090909 x 0.0 0.222222 x 0.777778 x x x 0.583333 0.0 0.1 0.0 0.0 x x x +11875 Original post publication description: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), salivation for males and females [ordinal scale, 0=control level, 3=max] None Central nervous system, pharmacology, behavior: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), salivation for males and females [ordinal scale, 0=control level, 3=max] x x x x 0.230769 0.272727 x 0.25 0.25 0.0 0.142857 0.142857 0.222222 0.5 0.0 0.375 0.2 0.0 0.0 0.416667 x x x 0.222222 x 0.076923 0.0 0.636364 x 0.5 0.125 0.0 0.0 x 0.571429 x 2.0 0.2 0.058824 x 0.352941 0.166667 0.076923 0.625 x x 0.166667 x 0.0 0.222222 x x x 0.769231 0.3 x x x 0.230769 0.375 0.25 0.285714 x 0.214286 0.25 0.0 0.444444 0.285714 0.071429 0.142857 x 0.6875 x 0.5 x 0.0 x x 0.4 x x 0.0 0.272727 0.416667 0.0 0.272727 x 0.181818 0.111111 x 0.111111 x x x 1.0 0.0 0.1 0.090909 0.0 x x x +11876 Original post publication description: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), wet dog shakes for males [ordinal scale, 0=no effect, 3=max] None Central nervous system, pharmacology, behavior: Naloxone-induced morphine withdrawal, naloxone (30 mg/kg ip) after morphine (50 mg/kg dose ip), wet dog shakes for males [ordinal scale, 0=no effect, 3=max] x x x x 0.153846 1.72727 x 0.833333 0.0 0.0 0.285714 0.0 2.22222 0.875 0.25 0.375 0.7 0.5 0.777778 0.833333 x x x 0.444444 x 1.46154 0.642857 0.636364 x 0.357143 0.0 0.538462 0.230769 x 0.0 x 2.83333 0.933333 0.176471 x 1.41176 1.83333 0.461538 0.875 x x 1.16667 x 0.384615 1.44444 x x x 1.15385 2.3 x x x 0.153846 2.0 0.25 0.0 x 1.07143 1.08333 0.666667 0.111111 1.28571 0.357143 0.142857 x 1.5 x 1.33333 x 2.33333 x x 0.0 x x 1.16667 0.454545 0.666667 0.1 0.636364 x 1.27273 0.666667 x 1.44444 x x x 1.25 1.0 1.9 0.909091 0.571429 x x x +11877 Original post publication description: Novel open field behavior, urinations for males and females [n/test period] None Central nervous system, behavior: Novel open field behavior, urinations for males and females [n/test period] x x x x 1.30769 2.18182 x 1.75 1.25 1.18182 1.57143 1.28571 2.22222 1.5 1.33333 1.25 1.5 1.75 1.66667 1.83333 x x x 1.0 x 1.69231 1.07143 1.63636 x 1.0 0.75 1.23077 1.46154 x 0.857143 x 1.66667 1.46667 0.823529 x 1.52941 0.833333 0.538462 1.375 x x 1.16667 x 1.0 1.5 x x x 1.76923 1.3 x x x 1.23077 1.75 1.58333 1.57143 x 1.5 1.75 2.25 0.777778 0.714286 2.42857 0.857143 x 1.1875 x 1.33333 x 1.0 x x 0.9 x x 0.916667 1.27273 1.33333 1.8 1.0 x 1.54545 1.11111 x 1.22222 x x x 1.41667 1.75 1.3 1.45455 1.28571 x x x +11878 Original post publication description: Morphine response (50 mg/kg ip), vertical activity (rears) from 90-105 min after injection in an activity chamber for males and females [n beam breaks] None Morphine response (50 mg/kg ip), vertical activity (rears) from 90-105 min after injection in an activity chamber for males and females [n beam breaks] x x x x 598.154 251.727 x 737.583 194.25 596.545 198.0 526.143 295.556 789.375 46.3333 821.875 523.6 52.375 573.778 410.25 x x x 357.556 x 705.846 132.857 342.545 x 402.643 23.25 174.923 62.1538 x 316.429 x 531.917 463.733 825.471 x 113.235 52.1667 143.154 381.5 x x 179.667 x 104.385 650.778 x x x 18.6923 45.6 x x x 1.07692 84.25 188.5 393.0 x 260.571 303.667 262.917 296.667 94.5714 533.0 544.714 x 497.688 x 349.5 x 30.25 x x 451.6 x x 126.75 45.0 502.583 674.7 10.5455 x 61.6364 463.333 x 326.889 x x x 445.0 400.25 306.6 12.0 549.143 x x x +11879 Original post publication description: Morphine response (50 mg/kg ip), vertical activity (rears) from 105-120 min after injection in an activity chamber for males and females [n beam breaks] None Morphine response (50 mg/kg ip), vertical activity (rears) from 105-120 min after injection in an activity chamber for males and females [n beam breaks] x x x x 573.0 282.364 x 695.5 134.5 495.545 139.429 451.143 270.778 777.5 32.0 631.625 538.0 110.375 476.0 356.25 x x x 297.556 x 623.077 141.214 291.818 x 330.786 19.25 165.462 51.5385 x 215.429 x 494.083 428.533 758.706 x 133.176 53.0 112.0 329.375 x x 165.167 x 125.077 575.667 x x x 19.4615 35.9 x x x 4.76923 80.125 165.75 383.714 x 212.643 293.25 198.083 146.778 73.2857 498.571 474.429 x 506.812 x 295.0 x 28.0 x x 382.3 x x 104.583 79.7273 495.833 635.0 6.90909 x 95.4545 447.333 x 307.778 x x x 363.25 506.5 242.2 22.3636 563.571 x x x +11880 Original post publication description: Morphine response (50 mg/kg ip), vertical activity (rears) from 120-135 min after injection in an activity chamber for males and females [n beam breaks] None Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), vertical activity (rears) from 120-135 min after injection in an activity chamber for males and females [n beam breaks] x x x x 536.231 301.182 x 637.333 58.0 370.273 85.1429 273.571 260.889 690.875 14.1667 531.75 481.9 139.125 398.111 285.0 x x x 184.556 x 485.615 142.357 220.727 x 242.071 13.875 165.385 31.0 x 179.571 x 409.083 368.867 666.059 x 174.412 56.1667 75.0769 260.375 x x 134.5 x 126.462 469.167 x x x 13.3846 27.4 x x x 7.07692 126.5 130.5 342.286 x 161.0 191.0 162.5 66.8889 57.9286 468.5 444.0 x 492.562 x 186.833 x 26.0 x x 286.0 x x 95.9167 89.8182 468.417 525.9 7.09091 x 134.909 408.333 x 261.889 x x x 278.167 661.75 199.9 22.1818 527.929 x x x +11881 Original post publication description: Morphine response (50 mg/kg ip), vertical activity (rears) from 0-15 min after injection in an activity chamber for males and females [n beam breaks] None Morphine response (50 mg/kg ip), vertical activity (rears) from 0-15 min after injection in an activity chamber for males and females [n beam breaks] x x x x 339.462 59.9091 x 145.667 10.25 170.909 108.571 135.571 23.0 193.25 41.75 289.125 123.9 14.75 204.0 71.8333 x x x 82.2222 x 158.846 31.0714 186.545 x 150.286 12.0 75.3077 30.5385 x 78.8571 x 130.833 116.667 335.765 x 48.4118 55.3333 94.2308 94.75 x x 70.6667 x 56.5385 134.167 x x x 21.0769 35.3 x x x 19.2308 48.0 26.0 81.1429 x 59.0 105.0 52.4167 60.2222 25.5 467.429 527.857 x 81.5 x 82.75 x 69.25 x x 87.2 x x 29.5833 18.1818 208.833 72.5 5.63636 x 123.727 285.444 x 139.444 x x x 93.0 14.0 267.0 27.1818 130.071 x x x +11882 Original post publication description: Morphine response (50 mg/kg ip), vertical activity (rears) from 150-165 min after injection in an activity chamber for males and females [n beam breaks] None Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), vertical activity (rears) from 150-165 min after injection in an activity chamber for males and females [n beam breaks] x x x x 326.0 304.091 x 453.25 39.5 167.636 23.4286 136.857 176.111 574.375 10.5 369.75 301.9 81.625 134.0 225.75 x x x 62.6667 x 318.538 104.357 100.091 x 157.929 19.0 151.923 14.3077 x 107.429 x 280.583 282.867 346.412 x 200.882 16.0833 39.7692 314.875 x x 123.167 x 82.6923 321.111 x x x 9.07692 18.1 x x x 17.6154 141.5 74.0833 281.857 x 50.7143 75.5 67.5 60.8889 91.0714 436.143 416.857 x 446.625 x 96.6667 x 8.75 x x 158.7 x x 40.0 80.8182 406.583 356.8 4.63636 x 156.818 238.667 x 187.333 x x x 200.333 442.5 94.9 20.5455 381.786 x x x +11883 Original post publication description: Morphine response (50 mg/kg ip), vertical activity (rears) from 165-180 min after injection in an activity chamber for males and females [n beam breaks] None Central nervous system, pharmacology, behavior: Morphine response (50 mg/kg ip), vertical activity (rears) from 165-180 min after injection in an activity chamber for males and females [n beam breaks] x x x x 265.077 271.818 x 251.917 50.5 113.727 38.0 137.143 85.3333 387.25 5.08333 271.75 232.4 51.375 105.556 192.833 x x x 61.0 x 232.308 67.7143 72.7273 x 102.857 19.875 138.308 28.3846 x 58.8571 x 250.333 211.867 196.706 x 199.294 20.0833 20.3077 296.0 x x 133.167 x 41.3077 227.278 x x x 17.4615 21.3 x x x 19.8462 102.25 64.25 239.429 x 27.7143 60.9167 64.4167 64.5556 78.2857 422.5 345.286 x 364.938 x 117.917 x 3.25 x x 117.7 x x 37.8333 103.636 278.833 315.6 9.0 x 148.818 90.3333 x 143.333 x x x 175.583 286.75 68.2 31.0909 288.571 x x x +11884 Original post publication description: Morphine response (50 mg/kg ip), vertical activity (rears) from 15-30 min after injection in an activity chamber for males and females [n beam breaks] None Morphine response (50 mg/kg ip), vertical activity (rears) from 15-30 min after injection in an activity chamber for males and females [n beam breaks] x x x x 469.538 69.8182 x 333.917 9.0 256.909 227.143 382.571 103.222 322.5 61.25 763.0 264.9 12.625 450.667 190.583 x x x 229.444 x 362.846 32.6429 313.364 x 399.143 4.375 116.846 42.0 x 245.857 x 282.5 248.733 603.294 x 52.0 73.8333 182.154 225.125 x x 228.5 x 119.077 309.667 x x x 23.3077 68.3 x x x 2.07692 39.25 68.6667 277.571 x 109.786 95.0 127.833 231.667 42.5 562.214 1133.0 x 142.0 x 161.25 x 79.75 x x 224.9 x x 21.25 0.090909 435.25 228.8 3.90909 x 66.6364 448.556 x 306.333 x x x 143.333 21.25 518.7 55.3636 293.857 x x x +11885 Original post publication description: Morphine response (50 mg/kg ip), vertical activity (rears) from 30-45 min after injection in an activity chamber for males and females [n beam breaks] None Morphine response (50 mg/kg ip), vertical activity (rears) from 30-45 min after injection in an activity chamber for males and females [n beam breaks] x x x x 397.154 90.7273 x 475.917 67.5 422.727 321.143 603.0 225.778 450.375 53.0833 951.75 370.5 21.75 550.667 319.667 x x x 389.0 x 453.923 53.7143 402.909 x 533.214 5.25 138.846 51.7692 x 452.0 x 389.333 307.4 705.882 x 49.1176 33.4167 200.077 226.25 x x 238.833 x 196.231 393.667 x x x 11.0769 81.0 x x x 5.53846 32.875 147.333 396.714 x 174.643 118.333 156.833 386.444 54.5714 496.929 869.857 x 206.188 x 233.417 x 33.0 x x 311.5 x x 50.5 0.363636 516.167 338.4 12.0 x 52.0909 438.778 x 361.444 x x x 228.833 72.0 604.6 17.5455 428.643 x x x +11886 Original post publication description: Morphine response (50 mg/kg ip), vertical activity (rears) from 45-60 min after injection in an activity chamber for males and females [n beam breaks] None Morphine response (50 mg/kg ip), vertical activity (rears) from 45-60 min after injection in an activity chamber for males and females [n beam breaks] x x x x 512.154 119.545 x 584.75 99.5 583.455 349.0 656.286 280.556 581.625 49.1667 1062.25 428.8 31.125 656.444 412.75 x x x 441.667 x 562.615 85.0714 469.636 x 528.714 12.375 152.769 63.1538 x 507.143 x 442.5 360.867 810.235 x 63.4706 43.0 208.462 293.375 x x 225.333 x 223.308 513.333 x x x 7.0 103.9 x x x 14.5385 31.125 188.75 396.0 x 243.857 165.5 204.917 447.778 83.0 532.5 733.857 x 323.875 x 337.833 x 16.75 x x 418.4 x x 100.0 7.27273 618.417 503.3 13.9091 x 28.0909 515.889 x 373.111 x x x 359.167 143.5 641.3 17.0 529.071 x x x +11887 Original post publication description: Morphine response (50 mg/kg ip), vertical activity (rears) from 60-75 min after injection in an activity chamber for males and females [n beam breaks] None Morphine response (50 mg/kg ip), vertical activity (rears) from 60-75 min after injection in an activity chamber for males and females [n beam breaks] x x x x 584.923 165.818 x 682.25 192.5 651.909 332.571 603.286 320.778 790.625 47.0833 1064.0 526.0 28.75 668.111 464.417 x x x 464.333 x 672.692 101.857 449.455 x 475.143 15.625 171.769 71.5385 x 479.429 x 486.333 427.933 834.235 x 85.6471 55.4167 238.154 399.875 x x 225.333 x 174.923 591.611 x x x 7.46154 81.8 x x x 20.4615 54.375 192.917 409.714 x 281.929 225.0 256.333 394.778 113.714 535.643 717.429 x 391.875 x 390.583 x 47.0 x x 539.5 x x 130.333 10.0909 627.333 641.8 17.9091 x 36.9091 554.333 x 375.111 x x x 464.75 231.75 590.2 26.1818 599.5 x x x +11888 Original post publication description: Morphine response (50 mg/kg ip), vertical activity (rears) from 75-90 min after injection in an activity chamber for males and females [n beam breaks] None Morphine response (50 mg/kg ip), vertical activity (rears) from 75-90 min after injection in an activity chamber for males and females [n beam breaks] x x x x 612.0 214.636 x 745.667 228.25 635.909 286.857 575.143 307.444 828.875 56.5833 978.875 542.9 43.75 617.0 461.167 x x x 423.778 x 693.923 126.214 385.909 x 480.429 19.25 169.538 75.6154 x 423.429 x 498.833 459.533 855.882 x 89.9412 55.0833 194.769 392.375 x x 230.333 x 142.923 633.333 x x x 15.7692 63.0 x x x 2.0 64.25 203.917 406.714 x 276.571 290.25 312.333 340.333 129.0 531.643 678.714 x 466.625 x 396.167 x 68.0 x x 500.8 x x 140.583 26.4545 572.5 697.1 14.5455 x 47.6364 561.667 x 360.667 x x x 500.667 320.5 395.4 17.2727 608.071 x x x +11889 Original post publication description: Central nervous system, neuropharmacology, behavior: 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) response (10 mg/kg subcutaneous), locomotion on day 2 for males and females [cm/90 min test] None Central nervous system, pharmacology, behavior: 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) response (10 mg/kg subcutaneous), locomotion on day 2 for males and females [cm/90 min test] x x x x x x x 812.5 x x x 3248.5 x x x 735.5 x x x x x x x x x x 1301.5 x x x x x x x 381.2 x x 1761.75 5446.25 x 12099.0 1463.5 451.5 x x x x x x x x x x 530.5 x x x x 4339.0 1584.5 27235.0 x x 16648.0 3004.75 x x 19276.0 x x x 22764.0 x 2664.0 x 2974.5 x x x x x x 5317.5 x 36001.5 x x x x x 1622.0 x x x 2365.33 x 765.5 x x x x x +11890 Original post publication description: Locomotor activity after first saline injection (day 1) for males and females (MDMA control) [cm/ test period] None Locomotor activity after first saline injection (day 1) for males and females (MDMA control) [cm/ test period] x x x x x x x 6961.0 x x 2547.67 6521.75 x x x 5692.0 x x x x x x x x x x 4383.0 x x x x x x x 1566.4 x x 3156.25 10970.0 x 5158.0 3902.0 2907.0 x x x x x x x x x x 7717.5 x x x x 4637.0 5058.0 5353.5 x x 3744.0 7132.0 x x 16310.0 x x x 3506.5 x 5529.0 x 2867.5 x x x x x x 5534.0 x 5212.0 x x x x x 4383.5 x x x 6561.33 x 6559.5 x x x x x +11891 Original post publication description: Saline control response, locomotor activity after second injection for males and females (control for MDMA response experiment) [cm/test period] None Saline control response, locomotor activity after second injection for males and females (control for MDMA response experiment) [cm/test period] x x x x x x x 832.5 x x 2535.0 827.5 x x x 1220.0 x x x x x x x x x x 888.0 x x x x x x x 294.8 x x 897.5 2590.75 x 802.75 1544.0 1303.0 x x x x x x x x x x 2260.5 x x x x 137.5 166.0 544.5 x x 1258.5 967.0 x x 7598.5 x x x 1611.0 x 1072.0 x 814.0 x x x x x x 527.0 x 635.5 x x x x x 965.0 x x x 2219.67 x 580.0 x x x x x +11892 Original post publication description: Ethanol response (4.0 g/kg ip), handling-induced convulsion (HIC) 4 hrs after injection for males and females [ordinal scale] None Central nervous system, pharmacology, behavior: Ethanol response (4.0 g/kg ip), handling-induced convulsion (HIC) 4 hrs after injection for males and females [ordinal scale] x x x x x x 1.33333 x x x x x 0.0 0.0 0.0 x x x x 0.5 x x x x x x x x x x x x x x 0.117647 x 0.0 x x x x 0.25 1.0 x x x 0.0 x x 0.0 x x x x x x x x 0.1875 x 0.533333 x x 0.0 x x x 0.055556 0.0 0.0 x 0.05 0.0 0.0 x 0.083333 0.0 x 0.0 0.0 x 0.0 0.0 0.05 0.0 0.0 x 0.066667 x x 0.0 x x x x x x x x x x x +11893 Original post publication description: Ethanol response (4.0 g/kg ip), Handling-induced convulsions (HIC) 6 hrs after injections for males and females [units] None Central nervous system, behavior, pharmacology: Ethanol response (4.0 g/kg i.p.), handling-induced convulsions (HIC) 6 hrs after injections for males and females [units] x x x x x x 0.0 x x x x x 0.166667 1.4 0.0 x x x x 2.0 x x x x x x x x x x x x x x 0.941176 x 0.0 x x x x 1.0 2.36842 x x x 0.238095 x x 0.333333 x x x x x x x x 1.25 x 1.8 x x 1.2 x x x 1.55556 0.0 1.27273 x 0.75 0.125 1.13333 x 0.708333 1.0 x 1.0 0.5 x 3.57143 0.090909 0.4 1.0 0.470588 x 0.733333 x x 0.266667 x x x x x x x x x x x +11894 Original post publication description: Ethanol response (4.0 g/kg ip), handling-induced convulsion (HIC) score 7 hrs after ethanol injection for males and females [units] None Central nervous system, pharmacology, behavior: Ethanol response (4.0 g/kg ip), handling-induced convulsion (HIC) score 7 hrs after ethanol injection for males and females [ordinal scale] x x x x x x 1.0 x x x x x 1.16667 2.2 0.0 x x x x 3.0 x x x x x x x x x x x x x x 1.29412 x 0.0 x x x x 0.75 1.42105 x x x 0.047619 x x 0.666667 x x x x x x x x 0.3125 x 1.73333 x x 1.0 x x x 2.11111 0.0 0.727273 x 0.45 0.125 0.133333 x 0.875 0.0 x 0.181818 0.0 x 3.0 0.363636 0.1 1.5 0.235294 x 0.733333 x x 0.133333 x x x x x x x x x x x +11895 Original post publication description: Seizure susceptibility, handling-induced convulsion (HIC) baseline for males and females [score] None Central nervous system, behavior: Seizure susceptibility, handling-induced convulsion (HIC) baseline for males and females [score] x x x x x x 0.333333 x x x x x 0.0 1.4 0.0 x x x x 0.5 x x x x x x x x x x x x x x 0.176471 x 0.0 x x x x 0.416667 0.578947 x x x 0.0 x x 0.0 x x x x x x x x 0.3125 x 0.733333 x x 0.0 x x x 0.333333 0.0 0.090909 x 0.0 0.0 0.0 x 0.0 0.833333 x 0.090909 0.0 x 0.428571 0.0 0.0 0.25 0.117647 x 0.266667 x x 0.133333 x x x x x x x x x x x +11896 Original post publication description: Ethanol response (4.0 g/kg ip), handling-induced convulsion (HIC) after injection for males and females [explain the score] None Central nervous system, pharmacology, behavior: Ethanol response (4.0 g/kg ip), handling-induced convulsion (HIC) after injection for males and females [ordinal scale] x x x x x x 1.33333 x x x x x 1.33333 2.0 0.0 x x x x 4.25 x x x x x x x x x x x x x x 2.11765 x 0.0 x x x x x 3.31579 x x x x x x x x x x x x x x x x x x x x 2.2 x x x 3.0 0.0 0.727273 x 1.15 0.25 1.26667 x 1.625 0.166667 x 1.09091 0.5 x 5.71429 0.454545 0.55 2.16667 0.529412 x 1.13333 x x 0.4 x x x x x x x x x x x +11897 Original post publication description: Pain response, thermal nociception, hot plate latency for males and females [sec] None Pain response, thermal nociception, hot plate latency for males and females [sec] x x x x 8.115 6.46938 x 6.823 10.709 x 7.55933 11.4067 7.55286 7.462 6.83 9.22615 8.74929 8.06619 x 9.8908 x x x 8.26158 x 8.70063 8.31053 6.468 x 6.58 6.54375 10.0235 9.77833 x 7.59539 x 8.90818 6.8765 7.05 x 7.38353 6.92167 10.2755 9.86333 x x 9.84625 x 6.801 7.655 x x x 8.43062 7.25091 x x x 7.49824 9.34897 7.666 x x 8.14828 10.8085 7.56765 8.38482 8.65604 10.2157 8.70875 x 8.68588 x 10.2545 x 9.67154 x x 5.87444 x x 12.3125 7.41917 8.183 11.7207 8.23583 x 8.63444 x x 9.24636 x x x 9.98944 7.30556 6.28182 4.715 6.63933 x x x +11898 Original post publication description: Locomotion in dark compartment of a light-dark box for males and females [cm] None Locomotion in dark compartment of a light-dark box for males and females [cm] x x x x 1713.5 768.438 x 968.6 507.875 x 243.667 877.75 418.0 829.3 363.9 640.462 880.786 445.714 x 770.8 x x x 345.947 x 392.875 303.684 858.31 x 731.588 925.25 482.824 614.867 x 653.692 x 524.227 393.45 799.765 x 803.059 696.5 592.345 750.059 x x 776.312 x 654.4 507.45 x x x 957.75 285.636 x x x 740.824 600.241 407.35 x x 590.688 578.846 524.059 667.667 769.042 680.429 629.125 x 693.842 x 576.455 x 604.0 x x 641.188 x x 534.083 700.267 676.8 634.571 575.083 x 605.0 x x 544.182 x x x 760.611 517.111 907.364 1107.0 522.579 x x x +11899 Original post publication description: Anxiety assay, time in dark side of a light-dark box for males and females [sec] None Central nervous system, behavior: Anxiety assay, time in dark side of a light-dark box for males and females [sec] x x x x 486.65 488.2 x 388.035 424.05 x 325.7 444.35 393.956 403.53 375.22 332.308 322.579 349.633 x 371.06 x x x 186.005 x 388.294 336.811 382.041 x 398.347 450.438 367.418 364.607 x 437.662 x 410.623 440.995 348.847 x 381.547 405.133 388.414 401.7 x x 417.594 x 374.52 428.815 x x x 412.025 428.909 x x x 395.782 394.362 412.06 x x 451.156 350.346 439.482 387.648 368.833 341.186 394.075 x 431.426 x 359.882 x 412.4 x x 464.469 x x 456.925 384.6 383.37 445.5 450.408 x 351.269 x x 401.791 x x x 454.472 425.622 484.355 434.5 412.584 x x x +11900 Original post publication description: Locomotion in both compartments of a light-dark box for males and females [cm] None Locomotion in both compartments of a light-dark box for males and females [cm] x x x x 2285.5 1008.44 x 1481.75 820.25 x 395.133 1204.42 648.333 1270.9 559.8 1034.0 1503.29 667.476 x 1237.92 x x x 788.0 x 509.688 437.421 1292.14 x 1103.65 1226.62 803.353 974.267 x 941.462 x 746.545 535.4 1330.24 x 1320.0 1060.5 919.0 1141.06 x x 1137.88 x 982.8 753.4 x x x 1426.25 422.091 x x x 1059.65 937.034 550.05 x x 808.594 887.0 692.176 980.482 1282.29 1175.93 893.375 x 1011.74 x 910.455 x 864.462 x x 913.375 x x 716.083 1061.0 1002.7 865.786 827.167 x 1042.23 x x 759.545 x x x 1037.44 747.222 1137.55 1502.5 788.053 x x x +11901 Original post publication description: Anxiety assay, locomotion in the light compartment of a light-dark box for males and females [cm] None Central nervous system, behavior: Anxiety assay, locomotion in the light compartment of a light-dark box for males and females [cm] x x x x 572.0 240.0 x 513.15 312.375 x 151.467 326.667 230.333 441.6 195.9 393.538 622.5 221.762 x 467.12 x x x 442.053 x 116.812 133.737 433.828 x 372.059 301.375 320.529 359.4 x 287.769 x 222.318 141.95 530.471 x 516.941 364.0 326.655 391.0 x x 361.562 x 328.4 245.95 x x x 468.5 136.455 x x x 318.824 336.793 142.7 x x 217.906 308.154 168.118 312.815 513.25 495.5 264.25 x 317.895 x 334.0 x 260.462 x x 272.188 x x 182.0 360.733 325.9 231.214 252.083 x 437.231 x x 215.364 x x x 276.833 230.111 230.182 395.5 265.474 x x x +11902 Original post publication description: Anxiety assay, time in light side of a light-dark box for males and females [sec] None Central nervous system, behavior: Anxiety assay, time in light side of a light-dark box for males and females [sec] x x x x 113.35 111.8 x 211.965 175.95 x 274.3 155.65 206.044 196.47 224.78 267.692 277.421 250.367 x 228.94 x x x 413.995 x 211.706 263.189 217.959 x 201.653 149.562 232.582 235.393 x 162.338 x 189.377 159.005 251.153 x 218.453 194.867 211.586 198.3 x x 182.406 x 225.48 171.185 x x x 187.975 171.091 x x x 204.218 205.638 187.94 x x 148.844 249.654 160.518 212.352 231.167 258.814 205.925 x 168.574 x 240.118 x 187.6 x x 135.531 x x 143.075 215.4 216.63 154.5 149.592 x 248.731 x x 198.209 x x x 145.528 174.378 115.645 165.5 187.416 x x x +11903 Original post publication description: Anxiety assay, percentage of locomotion in light side of a light-dark box for males and females [%] None Central nervous system, behavior: Anxiety assay, percentage of locomotion in light side of a light-dark box for males and females [%] x x x x 22.8574 22.5306 x 33.7652 37.3494 x 39.2088 27.861 36.5172 34.5844 31.9681 40.063 43.5114 34.6471 x 37.513 x x x 55.9665 x 27.8457 34.3755 30.9011 x 32.7394 24.2211 39.5246 36.6968 x 30.0358 x 31.037 26.7908 39.6491 x 38.8512 33.9092 35.4874 33.864 x x 31.3725 x 33.4006 32.2123 x x x 33.0539 31.5688 x x x 30.986 35.1137 27.9034 x x 26.3236 38.6436 24.9968 30.1645 39.5906 41.9588 27.5866 x 30.1181 x 39.2766 x 29.662 x x 29.5191 x x 24.3901 33.1169 31.5351 24.171 29.1023 x 40.7949 x x 29.2084 x x x 25.9099 28.8522 19.0073 26.3724 33.0971 x x x +11904 Original post publication description: Anxiety assay, percentage time in light side of a light-dark box for males and females [%] None Central nervous system, behavior: Anxiety assay, percentage time in light side of a light-dark box for males and females [%] x x x x 18.8917 18.601 x 35.6692 28.9438 x 46.4389 25.6819 34.6037 32.48 37.83 44.6872 46.2369 41.9381 x 37.7253 x x x 68.9991 x 35.3708 43.8649 36.55 x 33.2461 24.6365 38.8588 38.4844 x 27.0564 x 31.2735 25.9467 41.6127 x 35.9882 33.2306 35.2023 33.05 x x 30.401 x 37.58 29.6775 x x x 31.5042 28.5152 x x x 33.7608 34.6448 31.0875 x x 24.6245 42.1449 26.7363 35.7506 38.1531 42.6262 34.2479 x 27.8386 x 40.0197 x 31.2667 x x 22.675 x x 24.2833 36.6989 37.2183 25.9726 24.9139 x 41.6462 x x 33.0348 x x x 24.187 29.063 19.2742 27.5833 31.1605 x x x +11905 Original post publication description: Anxiety assay, transitions between light and dark sides of a light-dark box for males and females [n] None Central nervous system, behavior: Anxiety assay, transitions between light and dark sides of a light-dark box for males and females [n] x x x x 64.5 28.875 x 47.7 26.25 x 10.0 30.5833 24.1111 45.9 15.4 37.0 54.1429 21.5714 x 39.44 x x x 25.5263 x 12.0 10.5263 39.5172 x 37.7647 37.3125 30.0588 32.5333 x 28.3846 x 20.4091 14.6 56.6471 x 50.2941 36.5833 31.0 46.7647 x x 41.4375 x 28.5 23.8 x x x 45.1875 12.2727 x x x 31.0 40.6207 16.5 x x 19.5312 27.5385 16.2941 39.7778 61.7292 49.7143 32.875 x 35.1053 x 41.5455 x 27.6923 x x 33.875 x x 20.6667 39.4667 30.8 27.0714 26.75 x 35.5385 x x 18.5455 x x x 33.2222 15.4444 29.3636 59.5 31.3684 x x x +11906 Original post publication description: Fear conditioning response, activity in altered context for males and females [units] None Central nervous system, behavior, learning and memory: Fear conditioning response, activity in altered context for males and females [units] x x x x 52.0 33.0729 x 39.9417 35.3542 x 23.8 31.6111 33.7685 43.7667 26.0667 28.3718 39.2619 35.9841 x 39.74 x x x 28.7719 x 28.5312 28.7368 52.6437 x 34.3039 32.5729 26.5784 27.8778 x 39.9231 x 40.2652 23.9417 43.8137 x 36.5686 33.9722 34.3046 45.9706 x x 39.6562 x 29.5167 37.8333 x x x 47.0938 26.5455 x x x 36.549 39.3851 15.05 x x 39.0573 36.6795 37.3627 28.9815 34.0694 39.5119 37.0833 x 36.5175 x 31.1667 x 40.2564 x x 38.0729 x x 46.9306 42.5667 33.6 30.6905 34.5833 x 40.0897 x x 41.0 x x x 35.2315 41.4074 39.3182 39.5833 34.3772 x x x +11907 Original post publication description: Fear conditioning response, baseline activity in apparatus for males and females [units] None Central nervous system, behavior: Fear conditioning response, baseline activity in apparatus for males and females [units] x x x x 65.125 30.3125 x 36.775 39.25 x 14.9667 37.2708 26.5833 36.125 21.85 33.4808 41.6607 20.6548 x 34.55 x x x 29.5395 x 18.4062 20.0526 41.431 x 27.1471 28.9531 26.8676 26.2667 x 37.7692 x 28.0682 17.7 37.5294 x 40.7206 33.9167 29.4483 44.0588 x x 35.2656 x 26.075 26.7125 x x x 35.0781 16.4091 x x x 27.8529 38.2759 16.475 x x 27.7188 36.75 25.8382 21.1667 38.4583 36.1607 33.2812 x 31.8684 x 34.4773 x 31.8846 x x 29.0938 x x 32.75 30.7833 25.65 25.5357 31.2708 x 34.8077 x x 29.7273 x x x 28.6667 25.8889 35.1136 17.125 32.7368 x x x +11908 Original post publication description: Fear conditioning response, contextual activity for males and females [units] None Central nervous system, behavior: Fear conditioning response, contextual activity for males and females [units] x x x x 39.55 20.9562 x 9.175 18.5125 x 11.3533 16.525 15.7556 16.3 19.725 12.55 27.4964 13.4667 x 20.044 x x x 12.9 x 11.7406 14.0105 25.9293 x 10.5412 15.7094 11.7559 15.3467 x 11.1538 x 14.2909 6.43 27.6265 x 26.0059 18.7333 25.4207 28.6882 x x 14.7563 x 16.14 15.7625 x x x 31.0844 4.93182 x x x 20.3176 20.6328 4.3375 x x 15.6438 12.9615 19.8794 11.0 10.6469 26.625 21.3375 x 15.4658 x 16.1364 x 22.1808 x x 14.8687 x x 26.05 23.3533 15.5 9.30714 11.4833 x 24.9308 x x 9.96364 x x x 11.5611 5.66667 23.95 23.95 15.2553 x x x +11909 Original post publication description: Fear conditioning response, activity in altered context during presentation of cue for males and females [units] None Central nervous system, behavior, learning and memory: Fear conditioning response, activity in altered context during presentation of cue for males and females [units] x x x x 9.33333 15.0208 x 17.9417 5.70833 x 2.98889 7.25 4.96296 9.3 2.63333 10.0256 5.90476 9.25397 x 8.03333 x x x 4.53509 x 5.29167 5.04386 20.4655 x 6.82353 6.73958 4.36274 3.46667 x 7.92308 x 8.31818 3.475 10.8725 x 17.9804 10.4306 11.5115 18.0882 x x 16.75 x 6.83333 7.34167 x x x 20.4583 1.78788 x x x 7.56863 8.9023 4.975 x x 5.47917 3.76923 10.7941 6.53086 5.64931 6.57143 16.0417 x 9.44737 x 8.16667 x 10.9359 x x 9.16667 x x 14.9861 15.0556 12.6667 4.67857 4.25 x 11.1538 x x 4.54545 x x x 9.60185 6.12963 10.4091 11.0 6.79825 x x x +11910 Original post publication description: Fear conditioning response, suppression of activity in altered context for males and females [units] None Central nervous system, behavior, learning and memory: Fear conditioning response, suppression of activity in altered context for males and females [units] x x x x x 0.339603 x 0.410279 0.167587 x 0.091803 0.315306 0.151249 0.213039 0.11787 0.323863 0.155988 0.280816 x 0.181604 x x x 0.156241 x 0.136108 0.170368 0.393112 x 0.205088 0.262707 0.161019 0.116979 x 0.191244 x 0.208694 0.147208 0.236695 x 0.503656 0.310512 0.346528 0.389558 x x 0.430835 x 0.241045 0.190692 x x x 0.432982 0.069576 x x x 0.205891 0.238324 0.403806 x x 0.135589 0.111166 0.24568 0.274502 0.15995 0.182562 0.541828 x 0.265725 x 0.285052 x 0.242726 x x 0.23162 x x 0.309857 0.383098 0.387818 0.153951 0.120882 x 0.282723 x x 0.113046 x x x 0.269692 0.14248 0.274717 0.291383 0.192217 x x x +11911 Original post publication description: Fear conditioning response, activity during first tone-shock pairing for males and females [units] None Central nervous system, behavior: Fear conditioning response, activity during first tone-shock pairing for males and females [units] x x x x 73.0 29.9375 x 38.95 36.75 x 23.6 30.3333 16.4444 25.3 21.0 28.6154 26.8571 23.381 x 36.28 x x x 33.0 x 21.25 25.1053 42.1379 x 29.2941 31.5 25.1765 22.6667 x 30.5385 x 29.0 23.55 32.6471 x 33.1176 37.75 33.069 35.3529 x x 38.0 x 29.4 31.25 x x x 42.0 15.0 x x x 34.0588 26.1034 21.8 x x 29.6875 23.6923 28.2353 25.963 46.0 32.2143 45.875 x 23.9474 x 26.3636 x 38.6154 x x 27.5 x x 27.1667 27.1333 20.1 27.3571 28.5833 x 31.4615 x x 31.9091 x x x 29.3333 34.1111 38.0909 19.5 28.0 x x x +11912 Original post publication description: Fear conditioning response, activity during second tone-shock pairing for males and females [units] None Central nervous system, behavior: Fear conditioning response, activity during second tone-shock pairing for males and females [units] x x x x 38.0 26.4375 x 20.25 24.875 x 16.0667 23.3333 11.8889 21.8 15.1 13.9231 24.1429 21.4286 x 27.64 x x x 25.7895 x 21.4375 21.8421 29.4138 x 26.4118 26.75 24.9412 18.1333 x 19.5385 x 17.8636 16.55 28.3529 x 24.8824 27.5833 29.2759 28.7059 x x 29.8125 x 25.7 21.5 x x x 32.25 10.3636 x x x 26.0 20.9655 14.85 x x 21.0625 18.0 22.2353 20.8889 29.375 24.6429 31.75 x 22.7368 x 24.1818 x 25.3077 x x 22.5625 x x 26.9167 25.0 19.6 25.5 19.9167 x 18.8462 x x 20.9091 x x x 22.1667 19.4444 29.7273 25.5 21.3684 x x x +11913 Original post publication description: Fear conditioning response, activity during third tone-shock pairing for males and females [units] None Central nervous system, behavior: Fear conditioning response, activity during third tone-shock pairing for males and females [units] x x x x 29.0 15.5625 x 18.0 16.375 x 12.5333 25.9167 9.33333 16.1 9.6 9.46154 22.0 16.619 x 15.08 x x x 16.0526 x 17.875 24.7895 22.5517 x 17.8824 19.9375 25.7647 14.2 x 14.3077 x 16.5455 17.55 22.0588 x 27.6471 27.6667 20.8621 27.1765 x x 19.0 x 18.9 14.25 x x x 23.625 7.45455 x x x 27.9412 17.5172 14.85 x x 19.2812 15.0 16.7059 15.5185 26.875 21.0 25.25 x 15.2632 x 21.9091 x 27.8462 x x 22.8125 x x 23.0833 26.9333 18.8 24.5 11.8333 x 16.8462 x x 21.4545 x x x 18.3889 17.6667 23.9091 35.0 18.5263 x x x +11914 Original post publication description: Fear conditioning response, activity after first tone-shock pairing for males and females [n beam breaks/30 sec test] None Central nervous system, behavior, learning and memory: Fear conditioning response, activity after first tone-shock pairing for males and females [n beam breaks/30 sec test] x x x x 27.125 21.3594 x 5.475 11.9688 x 2.76667 14.4375 7.5 13.4 8.1 7.25 19.5714 13.2381 x 15.25 x x x 17.3158 x 10.4688 10.3553 19.4397 x 15.7206 9.20312 8.26471 13.4833 x 10.8462 x 6.35227 3.1 16.8824 x 17.6029 20.4583 16.5862 25.5882 x x 17.7031 x 16.55 13.7375 x x x 24.6719 5.68182 x x x 18.4853 18.0862 3.875 x x 9.66406 13.3846 10.6176 12.037 13.6198 11.0 22.5 x 15.0263 x 17.2955 x 14.3654 x x 13.4219 x x 22.1875 13.05 25.725 7.98214 7.47917 x 17.4615 x x 9.90909 x x x 15.8333 9.94444 19.6364 4.375 16.5921 x x x +11915 Original post publication description: Fear conditioning response, activity after second tone-shock pairing for males and females [n beam breaks/30 sec test] None Central nervous system, behavior: Fear conditioning response, activity after second tone-shock pairing for males and females [n beam breaks/30 sec test] x x x x 19.25 15.4375 x 5.9625 5.84375 x 2.21667 14.0417 3.38889 8.675 6.825 3.09615 13.7321 8.71429 x 10.14 x x x 10.3026 x 8.25 12.25 21.3362 x 9.75 8.73438 5.38235 4.13333 x 5.65385 x 6.51136 2.725 10.8824 x 19.7353 13.6458 10.1207 25.0294 x x 9.59375 x 12.9 7.175 x x x 21.7969 3.77273 x x x 9.95588 14.3879 4.15 x x 7.9375 8.71154 10.3529 6.96296 10.4688 12.0536 18.6875 x 12.9868 x 11.8636 x 14.8846 x x 13.375 x x 13.2083 10.5333 24.45 5.73214 4.375 x 17.4808 x x 4.90909 x x x 10.2917 4.52778 15.5227 5.0 12.7632 x x x +11916 Original post publication description: Fear conditioning response, activity after third tone-shock pairing for males and females [n beam breaks/30 sec test] None Central nervous system, behavior: Fear conditioning response, activity after third tone-shock pairing for males and females [n beam breaks/30 sec test] x x x x 28.0 10.875 x 5.1 10.125 x 2.86667 15.5 5.16667 12.9 15.5 3.76923 12.0 8.7619 x 8.48 x x x 8.8421 x 6.75 12.6316 16.6207 x 9.58823 7.6875 5.94118 5.2 x 12.3846 x 10.0455 4.0 10.1765 x 16.1765 14.0833 8.75862 24.4118 x x 9.1875 x 6.4 7.2 x x x 11.125 7.27273 x x x 9.17647 9.06897 6.65 x x 7.5625 4.07692 8.17647 11.2222 8.54167 14.7143 22.25 x 15.3158 x 11.0 x 14.2308 x x 8.1875 x x 7.58333 13.8 12.5 4.57143 5.33333 x 13.6154 x x 3.63636 x x x 11.2222 8.66667 13.4545 13.5 12.0 x x x +11917 Original post publication description: Fear conditioning response, cue conditioning, activity suppression after third tone-shock pairing for males and females [units] None Central nervous system, behavior, learning and memory: Fear conditioning response, cue conditioning, activity suppression after third tone-shock pairing for males and females [units] x x x x 0.419859 0.439442 x 0.146193 0.288017 x 0.319963 0.400589 0.19782 0.337057 0.766264 0.124291 0.283664 0.436399 x 0.248462 x x x 0.318221 x 0.778365 0.831256 0.413434 x 0.376735 0.328845 0.266288 0.227491 x 0.328361 x 0.360445 0.236369 0.263294 x 0.397053 0.401629 0.340831 0.555966 x x 0.295775 x 0.224271 0.298355 x x x 0.332277 0.568285 x x x 0.385239 0.241301 0.587637 x x 0.272633 0.109107 0.3716 0.570374 0.226203 0.464133 0.737138 x 0.542972 x 0.348272 x 0.37377 x x 0.325722 x x 0.231973 0.482882 0.581566 0.206618 0.168601 x 0.418141 x x 0.132878 x x x 0.408808 0.476566 0.418109 0.907018 0.35389 x x x +11918 Original post publication description: Open field behavior, percentage of distance in the center for males and females [%] None Open field behavior, percentage of distance in the center for males and females [%] x x x x 47.5922 21.8675 x 31.8817 32.9984 x 26.2193 27.3986 23.7586 32.4208 24.0468 36.0251 33.4233 21.9886 x 33.3988 x x x 44.622 x 11.6783 16.9444 18.978 x 28.5214 22.5877 35.4362 26.5704 x 22.0753 x 30.3639 20.9861 34.3503 x 32.6813 31.3457 24.1323 26.4127 x x 27.7664 x 23.0127 19.776 x x x 26.2479 18.9835 x x x 23.797 25.5461 21.3111 x x 23.418 28.4274 26.5605 27.105 35.7322 39.5202 24.769 x 22.3536 x 19.1674 x 34.2467 x x 27.425 x x 32.0317 16.7457 21.5318 30.7928 20.5243 x 33.5929 x x 26.4763 x x x 28.7089 24.2081 19.5559 28.5559 37.0287 x x x +11919 Original post publication description: Open field behavior, percentage of time in center for males and females [%] None Open field behavior, percentage of time in center for males and females [%] x x x x 43.8875 10.275 x 22.4508 17.2658 x 11.2883 12.6972 11.8116 21.6933 15.6275 27.1096 20.6155 12.7254 x 17.931 x x x 26.0965 x 5.88021 10.3048 10.3687 x 21.5495 10.7177 23.2696 16.9444 x 8.08846 x 15.4333 10.1825 19.6324 x 19.2696 14.6153 13.1083 13.5652 x x 15.251 x 12.35 9.13375 x x x 15.0417 12.7508 x x x 14.1848 11.1434 11.8504 x x 12.2729 16.9077 18.4642 19.6691 22.1677 24.6601 13.126 x 11.2105 x 8.95682 x 28.9513 x x 14.8986 x x 16.8118 8.68194 12.0992 20.6256 10.0403 x 19.0545 x x 15.5985 x x x 19.2194 15.4361 7.18864 16.875 20.7311 x x x +11920 Original post publication description: Open field behavior, time in corners for males and females [min] None Open field behavior, time in corners for males and females [min] x x x x 41.7125 36.9031 x 42.6054 42.5625 x 27.3944 41.4958 42.1069 42.6525 40.2933 43.4186 44.7839 45.6234 x 39.8923 x x x 41.7325 x 26.2854 40.3465 44.902 x 45.6441 38.7854 44.0784 44.0161 x 32.0628 x 43.6261 39.3342 40.4652 x 41.6407 38.7368 43.5773 46.5358 x x 45.9026 x 38.1642 44.0333 x x x 43.8693 47.7371 x x x 39.5049 36.9885 36.7875 x x 40.0435 41.3603 47.2922 43.9198 45.6821 45.4339 46.4573 x 36.3487 x 38.6955 x 48.391 x x 42.4796 x x 42.9451 48.8146 43.5192 46.6452 41.6319 x 44.3122 x x 41.4371 x x x 43.0199 45.3861 35.9318 41.8208 46.3518 x x x +11921 Original post publication description: Open field behavior, locomotion from 0-5 min for males and females [cm] None Open field behavior, locomotion from 0-5 min for males and females [cm] x x x x 1337.5 437.125 x 837.4 414.2 x 177.4 694.583 286.778 721.5 268.5 619.538 800.429 305.143 x 639.76 x x x 468.263 x 151.125 150.789 777.724 x 403.059 421.562 489.471 376.4 x 491.846 x 361.182 194.3 784.882 x 741.471 468.25 433.069 631.765 x x 557.375 x 521.6 442.3 x x x 759.125 184.091 x x x 453.176 497.069 196.05 x x 332.469 542.077 336.882 477.519 574.104 691.429 355.5 x 458.421 x 454.455 x 422.154 x x 540.444 x x 396.333 397.667 366.3 498.071 386.417 x 585.692 x x 483.727 x x x 497.167 421.556 445.818 706.0 437.895 x x x +11922 Original post publication description: Open field behavior, locomotion from 10-15 min for males and females [cm] None Open field behavior, locomotion from 10-15 min for males and females [cm] x x x x 1304.5 265.5 x 811.6 356.6 x 245.733 461.667 289.389 487.6 323.0 450.077 602.286 383.476 x 436.04 x x x 484.684 x 232.938 265.947 806.517 x 446.882 433.062 409.882 357.933 x 270.538 x 320.273 233.85 647.235 x 480.118 327.667 431.448 512.941 x x 420.125 x 518.1 357.95 x x x 695.938 238.0 x x x 476.294 414.621 256.5 x x 465.875 387.231 479.647 503.296 592.188 634.929 533.25 x 460.263 x 430.818 x 631.231 x x 497.944 x x 388.083 379.5 502.3 495.071 347.583 x 504.077 x x 513.091 x x x 380.556 512.444 530.0 650.0 362.526 x x x +11923 Original post publication description: Open field behavior, locomotion from 15-20 min for males and females [cm] None Open field behavior, locomotion from 15-20 min for males and females [cm] x x x x 1002.0 268.875 x 772.35 347.0 x 227.067 434.25 251.889 462.0 304.9 447.538 613.857 384.333 x 416.88 x x x 451.0 x 204.312 251.632 693.276 x 437.941 377.938 385.0 360.533 x 218.538 x 308.364 198.75 591.765 x 430.059 347.417 367.483 483.588 x x 410.875 x 540.5 361.0 x x x 664.5 255.182 x x x 452.647 391.414 227.25 x x 446.062 376.769 483.941 542.852 571.083 608.0 568.25 x 445.895 x 372.0 x 737.0 x x 512.0 x x 373.75 347.917 527.9 481.786 338.667 x 509.769 x x 478.545 x x x 320.111 507.0 507.273 636.0 297.684 x x x +11924 Original post publication description: Open field behavior, locomotion from 5-10 min for males and females [cm] None Open field behavior, locomotion from 5-10 min for males and females [cm] x x x x 1392.5 369.188 x 836.8 420.7 x 223.0 509.0 303.889 537.0 387.6 523.077 704.857 394.81 x 518.88 x x x 560.105 x 226.625 253.053 894.931 x 470.765 534.875 441.588 390.467 x 382.231 x 394.091 187.5 670.882 x 589.059 353.5 483.828 614.529 x x 468.688 x 573.6 411.35 x x x 736.5 255.182 x x x 568.588 446.897 212.7 x x 477.156 415.692 449.647 510.444 600.042 633.714 472.375 x 455.947 x 477.273 x 588.077 x x 523.778 x x 434.667 407.083 563.6 520.214 352.833 x 507.077 x x 488.0 x x x 451.056 468.778 503.455 633.0 381.737 x x x +11925 Original post publication description: Central nervous system, behavior: Open field activity, habituation ratio for males and females (ratio of activity during last 5 min interval and first 5 min interval) [ratio n beam breaks] None Central nervous system, behavior: Open field activity, habituation ratio for males and females (ratio of activity during last 5 min interval and first 5 min interval) [ratio n beam breaks] x x x x 0.412021 0.386653 x 0.48761 0.506446 x 0.615949 0.38028 0.486341 0.376989 0.546626 0.416486 0.464073 0.592234 x 0.388467 x x x 0.495752 x 0.547062 0.658897 0.489728 x 0.534302 0.498915 0.4487 0.488507 x 0.275164 x 0.487543 0.501822 0.425078 x 0.36843 0.40233 0.465075 0.424147 x x 0.427643 x 0.504919 0.453525 x x x 0.470356 0.582812 x x x 0.5065 0.434781 0.506821 x x 0.599922 0.428829 0.587016 0.549619 0.504968 0.469627 0.654019 x 0.50382 x 0.454662 x 0.599408 x x 0.502374 x x 0.523118 0.481382 0.612408 0.494353 0.456747 x 0.483467 x x 0.501877 x x x 0.404474 0.554618 0.545988 0.476828 0.410459 x x x +11926 Original post publication description: Open field behavior, percentage of time in perimeter minus time in corners for males and females [%] None Open field behavior, percentage of time in perimeter minus time in corners for males and females [%] x x x x 14.4 52.8219 x 34.9437 40.1717 x 61.3172 45.8069 46.0815 35.6542 44.0792 29.4718 34.6006 41.6512 x 42.1767 x x x 32.1711 x 67.8344 49.3487 44.7293 x 32.8064 50.4969 32.652 39.0394 x 59.8487 x 40.9405 50.4833 39.9025 x 39.0897 46.6479 43.3144 39.899 x x 38.8464 x 49.4858 46.8329 x x x 41.0891 39.5121 x x x 46.3103 51.8681 51.3621 x x 47.6836 41.7321 34.2436 36.4111 32.1502 29.906 40.4167 x 52.4408 x 52.3477 x 22.6577 x x 42.6218 x x 40.2431 42.5035 44.3817 32.7292 48.3278 x 36.6333 x x 42.9644 x x x 37.7606 39.1778 56.8795 41.3042 32.9171 x x x +11927 Original post publication description: Open field behavior, vertical activity (rears) from 0-20 min for males and females [n beam breaks] None Open field behavior, vertical activity (rears) from 0-20 min for males and females [n beam breaks] x x x x 88.5 66.125 x 128.9 92.2 x 44.0667 167.417 68.8333 119.7 67.4 84.6923 150.214 84.381 x 176.0 x x x 102.789 x 41.875 44.2105 96.6207 x 123.765 73.125 118.706 92.0 x 78.7692 x 63.7273 36.25 155.118 x 127.765 138.0 104.207 137.235 x x 131.5 x 166.1 138.55 x x x 127.688 27.9091 x x x 118.235 104.483 49.2 x x 104.438 138.462 128.765 143.37 156.146 164.929 83.375 x 170.789 x 159.273 x 58.8462 x x 115.167 x x 63.4167 105.5 120.0 155.357 88.25 x 174.769 x x 120.727 x x x 133.056 150.556 85.0 168.5 129.158 x x x +11928 Original post publication description: Open field behavior, vertical activity (rears) from 0-5 min for males and females [n beam breaks] None Open field behavior, vertical activity (rears) from 0-5 min for males and females [n beam breaks] x x x x 8.5 16.0625 x 24.6 14.8 x 7.53333 39.0 8.94444 27.8 5.6 16.0 30.3571 8.85714 x 41.0 x x x 10.8421 x 2.8125 3.63158 14.5172 x 16.6471 11.1875 23.7647 16.8667 x 26.6923 x 9.31818 5.5 36.7647 x 28.6471 22.3333 20.1034 34.3529 x x 29.375 x 33.5 34.4 x x x 29.5 2.81818 x x x 24.1765 21.6207 6.35 x x 12.25 30.6923 8.88235 20.4815 25.7083 32.7857 11.125 x 34.9474 x 33.3636 x 7.23077 x x 19.7222 x x 8.16667 14.75 17.7 26.7143 20.5 x 22.2308 x x 18.8182 x x x 25.2222 16.0 12.0 36.5 20.7895 x x x +11929 Original post publication description: Open field behavior, vertical activity (rears) from 10-15 min for males and females [n beam breaks] None Open field behavior, vertical activity (rears) from 10-15 min for males and females [n beam breaks] x x x x 27.5 14.625 x 34.55 25.5 x 13.6 44.3333 20.5556 28.4 23.3 21.4615 38.8571 25.1429 x 43.16 x x x 31.2105 x 14.0625 13.7368 28.0 x 35.8824 20.5625 31.0 25.6667 x 14.5385 x 16.8182 12.0 40.7647 x 30.7647 42.25 28.2069 30.8824 x x 35.25 x 43.6 31.35 x x x 31.875 8.72727 x x x 30.2353 26.6552 16.05 x x 31.75 35.6923 42.2353 39.5926 42.9375 45.5 25.5 x 44.4737 x 42.2727 x 17.4615 x x 31.7222 x x 17.1667 30.8333 32.3 41.4286 24.1667 x 52.9231 x x 34.1818 x x x 37.4444 45.3333 25.6364 52.5 39.8947 x x x +11930 Original post publication description: Open field behavior, vertical activity (rears) from 15-20 min for males and females [n beam breaks] None Open field behavior, vertical activity (rears) from 15-20 min for males and females [n beam breaks] x x x x 22.0 15.3125 x 36.45 26.8 x 11.6 40.6667 20.7222 30.6 20.1 25.8462 41.7143 27.0952 x 43.16 x x x 31.6316 x 14.0625 17.0 27.2414 x 37.5294 18.625 33.0588 25.6667 x 12.0769 x 19.7727 11.05 35.0588 x 31.2941 36.6667 29.0 32.6471 x x 29.875 x 46.3 35.35 x x x 30.6875 10.0 x x x 27.7647 30.0345 14.45 x x 32.8125 32.0 45.8235 48.2963 49.1875 43.7857 27.5 x 46.9474 x 40.1818 x 15.9231 x x 32.8889 x x 23.6667 32.8333 36.9 41.0714 23.9167 x 58.3846 x x 37.6364 x x x 31.3333 50.2222 25.9091 42.0 32.5789 x x x +11931 Original post publication description: Open field behavior, vertical activity (rears) from 5-10 min for males and females [n beam breaks] None Open field behavior, vertical activity (rears) from 5-10 min for males and females [n beam breaks] x x x x 30.5 20.125 x 33.3 25.1 x 11.3333 43.4167 18.6111 32.9 18.4 21.3846 39.2857 23.2857 x 48.68 x x x 29.1053 x 10.9375 9.8421 26.8621 x 33.7059 22.75 30.8824 23.8 x 25.4615 x 17.8182 7.7 42.5294 x 37.0588 36.75 26.8966 39.3529 x x 37.0 x 42.7 37.45 x x x 35.625 6.36364 x x x 36.0588 26.1724 12.35 x x 27.625 40.0769 31.8235 35.0 38.3125 42.8571 19.25 x 44.4211 x 43.4545 x 18.2308 x x 30.8333 x x 14.4167 27.0833 33.1 46.1429 19.6667 x 41.2308 x x 30.0909 x x x 39.0556 39.0 21.4545 37.5 35.8947 x x x +11932 Original post publication description: Open field behavior, locomotion for entire test period for males and females [cm] None Open field behavior, locomotion for entire test period for males and females [cm] x x x x 5036.5 1340.69 x 3258.15 1538.5 x 873.2 2099.5 1131.94 2208.1 1284.0 2040.23 2721.43 1467.76 x 2011.56 x x x 1964.05 x 815.0 921.421 3172.45 x 1758.65 1767.44 1725.94 1485.33 x 1363.15 x 1383.91 814.4 2694.76 x 2240.71 1496.83 1715.83 2242.82 x x 1857.06 x 2153.8 1572.6 x x x 2856.06 932.455 x x x 1950.71 1750.0 892.5 x x 1721.56 1721.77 1750.12 2034.11 2337.42 2568.07 1929.38 x 1820.53 x 1734.55 x 2378.46 x x 2074.17 x x 1592.83 1532.17 1960.1 1995.14 1425.5 x 2106.62 x x 1963.36 x x x 1648.89 1909.78 1986.55 2625.0 1479.84 x x x +11933 Original post publication description: Open field behavior, percentage of distance in the perimeter for males and females [%] None Open field behavior, percentage of distance in the perimeter for males and females [%] x x x x 52.4078 78.1325 x 68.1183 67.0016 x 73.7807 72.6014 76.2414 67.5792 75.9532 63.9749 66.5767 78.0114 x 66.6012 x x x 55.378 x 88.3217 83.0556 81.022 x 71.4786 77.4123 64.5638 73.4296 x 77.9247 x 69.6361 79.0139 65.6497 x 67.3187 68.6543 75.8677 73.5873 x x 72.2336 x 76.9873 80.224 x x x 73.7521 81.0165 x x x 76.203 74.4539 78.6889 x x 76.582 71.5726 73.4395 72.895 64.2678 60.4798 75.231 x 77.6464 x 80.8326 x 65.7533 x x 72.575 x x 67.9683 83.2543 78.4682 69.2072 79.4757 x 66.4071 x x 73.5237 x x x 71.2911 75.7919 80.4441 71.4441 62.9713 x x x +11934 Original post publication description: Open field behavior, percentage of time in perimeter for males and females [%] None Open field behavior, percentage of time in perimeter for males and females [%] x x x x 56.1125 89.725 x 77.5492 82.7342 x 88.7117 87.3028 88.1884 78.3067 84.3725 72.8904 79.3845 87.2746 x 82.069 x x x 73.9035 x 94.1198 89.6952 89.6313 x 78.4505 89.2823 76.7304 83.0556 x 91.9115 x 84.5667 89.8175 80.3676 x 80.7304 85.3847 86.8917 86.4348 x x 84.749 x 87.65 90.8662 x x x 84.9583 87.2492 x x x 85.8152 88.8566 88.1496 x x 87.7271 83.0923 81.5358 80.3309 77.8323 75.3399 86.874 x 88.7895 x 91.0432 x 71.0487 x x 85.1014 x x 83.1882 91.3181 87.9008 79.3744 89.9597 x 80.9455 x x 84.4015 x x x 80.7806 84.5639 92.8114 83.125 79.2689 x x x +11935 Original post publication description: Startle response, baseline level for males and females [units] None Central nervous system, behavior: Startle response, baseline level for males and females [amplitude] x x x x 0.076 0.120676 x 0.14023 0.099739 x 0.071856 0.127682 0.062455 0.113705 0.12074 0.126748 0.079604 0.111172 x 0.110905 x x x 0.121144 x 0.151515 0.111984 0.167881 x 0.103786 0.086733 0.063739 0.06883 x 0.07402 x 0.120277 0.071555 0.090027 x 0.114491 0.11147 0.083356 0.090174 x x 0.093769 x 0.121973 0.117318 x x x 0.102966 0.125603 x x x 0.108657 0.084812 0.091085 x x 0.092649 0.056612 0.116679 0.117526 0.116239 0.103078 0.153375 x 0.085603 x 0.036519 x 0.124935 x x 0.102892 x x 0.08753 0.127515 0.121545 0.086485 0.073109 x 0.125212 x x 0.368545 x x x 0.123352 0.099468 0.177248 0.077273 0.117517 x x x +11936 Original post publication description: Central nervous system, behavior: Acoustic startle response, maximum response at 120 db for males and females (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, prepulse PPI control data by M Cook, UMemphis) [force] None Central nervous system, behavior: Acoustic startle response, maximum response at 120 db for males and females (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, prepulse PPI control data by M Cook, UMemphis) [force] x x x x 3.53121 0.761054 x 1.34953 0.739821 x 1.44077 0.814756 1.78157 2.06 1.31396 0.799011 1.26049 0.732234 x 0.124483 x x x 0.987139 x 3.84306 1.18061 1.29984 x 2.97907 0.568174 0.989857 0.529748 x 0.665627 x 0.645071 1.07691 0.441193 x 0.255767 1.78173 1.83885 1.4605 x x 2.90481 x 1.4639 1.10217 x x x 1.10017 1.46213 x x x 1.22902 0.781631 0.728607 x x 1.32842 1.43137 0.332605 0.790516 0.780357 2.50038 1.26663 x 0.33662 x 0.41999 x 0.922694 x x 1.00006 x x 2.02771 1.04181 0.260829 0.388435 0.55775 x 0.657302 x x 1.48195 x x x 1.35864 4.46883 0.827727 1.73575 1.54292 x x x +11937 Original post publication description: Central nervous system, behavior: Acoustic startle response, maximum response at 70 db for males and females (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, prepulse PPI control data by M Cook, UMemphis) [force] None Central nervous system, behavior: Acoustic startle response, maximum response at 70 db for males and females (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, prepulse PPI control data by M Cook, UMemphis) [force] x x x x 2.3465 0.819863 x 1.22858 0.487262 x 0.756217 0.642158 1.35889 2.17537 0.953614 0.877692 0.641279 0.543689 x 0.111176 x x x 0.929168 x 3.51121 1.29225 1.09567 x 2.47602 0.520369 0.75206 0.504267 x 0.451611 x 0.532205 0.801905 0.317082 x 0.1959 1.3085 1.16609 1.08831 x x 2.82205 x 0.9098 0.753481 x x x 0.7411 1.38154 x x x 1.16174 0.539303 0.627587 x x 0.838755 1.14847 0.250012 0.44323 0.734452 2.06949 1.03666 x 0.348742 x 0.292643 x 0.772614 x x 0.855094 x x 1.35351 1.03073 0.24436 0.355742 0.29734 x 0.572189 x x 0.945329 x x x 1.13771 3.42066 0.742164 1.27735 1.18215 x x x +11938 Original post publication description: Central nervous system, behavior: Acoustic startle response, maximum response at 80 db for males and females (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, prepulse PPI control data by M Cook, UMemphis) [force] None Central nervous system, behavior: Acoustic startle response, maximum response at 80 db for males and females (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, prepulse PPI control data by M Cook, UMemphis) [force] x x x x 0.8255 0.538731 x 0.830171 0.299837 x 0.622858 0.525233 1.06034 1.6423 0.6986 0.666415 0.243171 0.340133 x 0.098568 x x x 0.623911 x 2.39714 0.792112 0.645758 x 2.00557 0.314738 0.498867 0.385393 x 0.410889 x 0.41123 0.493035 0.265647 x 0.14846 0.807092 0.596374 0.753725 x x 2.27054 x 0.29879 0.402431 x x x 0.418913 1.12476 x x x 1.07818 0.352552 0.438431 x x 0.414973 0.939318 0.185824 0.208317 0.440515 1.60804 0.560712 x 0.234879 x 0.224271 x 0.439086 x x 0.509569 x x 1.2122 0.60036 0.20077 0.189167 0.24079 x 0.444722 x x 0.564714 x x x 0.562913 2.37997 0.418673 0.8686 0.586216 x x x +11939 Original post publication description: Central nervous system, behavior: Acoustic startle response, maximum response at 85 db for males and females (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, prepulse PPI control data by M Cook, UMemphis) [force] None Central nervous system, behavior: Acoustic startle response, maximum response at 85 db for males and females (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, prepulse PPI control data by M Cook, UMemphis) [force] x x x x 0.5462 0.37795 x 0.644818 0.208525 x 0.571892 0.53205 0.941957 1.42496 0.621014 0.644092 0.246679 0.320372 x 0.098668 x x x 0.560805 x 1.72556 0.742041 0.565323 x 1.79307 0.311725 0.465707 0.301427 x 0.331622 x 0.40225 0.396635 0.267424 x 0.161533 0.5835 0.564704 0.550475 x x 2.01697 x 0.28394 0.440731 x x x 0.338662 0.942036 x x x 0.976722 0.306876 0.2938 x x 0.365336 0.793909 0.188953 0.2072 0.347937 1.47421 0.480413 x 0.195684 x 0.180514 x 0.414057 x x 0.446244 x x 1.20193 0.544 0.21761 0.192242 0.26731 x 0.4043 x x 0.634414 x x x 0.407325 2.44234 0.392336 0.73045 0.570316 x x x +11940 Original post publication description: Central nervous system, behavior: Acoustic startle response, prepulse inhibition (PPI) at 70 dB for males and females (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, data by M Cook, UMemphis) [% inhibition] None Central nervous system, behavior: Acoustic startle response, prepulse inhibition (PPI) at 70 dB for males and females (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, data by M Cook, UMemphis) [% inhibition] x x x x 31.8625 -10.8649 x 6.95964 31.597 x 46.0606 19.406 22.2427 -7.83911 29.2715 0.636287 48.4957 25.65 x 9.30433 x x x 6.47487 x 8.41274 -14.5847 14.5065 x 16.7993 10.704 18.257 -3.58099 x 28.6299 x 14.7677 19.4828 24.7046 x 27.4377 27.4732 32.8657 24.8334 x x 4.14581 x 34.0551 22.9941 x x x 35.9393 4.02356 x x x 3.71022 31.9743 14.0044 x x 35.3395 17.7092 17.3396 42.6765 4.91283 19.3553 21.8225 x -3.7403 x 29.6678 x 14.4707 x x 18.1344 x x 30.5897 1.32596 -0.653405 2.29281 40.1648 x 8.58126 x x 39.0196 x x x 14.1253 22.6134 9.16613 22.712 27.0852 x x x +11941 Original post publication description: Central nervous system, behavior: Acoustic startle response, prepulse inhibition (PPI) at 80 dB for males and females (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, data by M Cook, UMemphis) [% inhibition] None Central nervous system, behavior: Acoustic startle response, prepulse inhibition (PPI) at 80 dB for males and females (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, data by M Cook, UMemphis) [% inhibition] x x x x 76.2695 30.9496 x 37.7656 56.4897 x 60.0297 34.2436 37.7881 19.106 43.9674 26.9988 78.9821 53.984 x 17.6888 x x x 37.9544 x 38.9074 27.4655 48.0584 x 33.5402 44.1975 41.0279 22.2232 x 36.4967 x 33.5698 46.599 30.2027 x 35.8244 56.1184 66.1655 48.794 x x 24.0852 x 75.8504 60.1618 x x x 63.5106 23.4822 x x x 19.7518 54.7779 41.8273 x x 66.5944 32.5179 38.5011 69.0842 43.706 36.9505 57.5409 x 27.1552 x 48.2998 x 49.8686 x x 46.2729 x x 43.3835 46.8395 17.3611 40.8204 53.2063 x 22.7667 x x 62.5394 x x x 54.2501 45.0441 47.6469 49.1563 64.7185 x x x +11942 Original post publication description: Central nervous system, behavior: Acoustic startle response, prepulse inhibition (PPI) at 85 dB for males and females (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, data by M Cook, UMemphis) [% inhibition] None Central nervous system, behavior: Acoustic startle response, prepulse inhibition (PPI) at 85 dB for males and females (65 dB background noise, Hamilton-Kinder SM100 startle chamber, 10 msec interval, 120 dB startle stimulus, data by M Cook, UMemphis) [% inhibition] x x x x 84.3712 51.6797 x 51.746 69.8231 x 63.7344 34.8348 44.9766 29.6735 48.8105 25.2465 78.4991 58.9724 x 19.1262 x x x 45.5381 x 56.0313 32.1142 55.0016 x 41.3386 45.0223 46.8379 38.1217 x 46.9057 x 34.2124 56.8502 30.4442 x 34.3168 67.2489 68.0517 60.4422 x x 32.2098 x 79.128 58.8666 x x x 71.332 33.6089 x x x 29.0539 60.5972 59.4338 x x 69.2335 41.3096 33.7811 70.8617 51.3172 43.7657 62.777 x 38.1008 x 56.8859 x 51.6254 x x 52.8506 x x 46.0188 52.3374 11.7799 39.0833 51.9235 x 32.9065 x x 55.9561 x x x 66.7337 44.1512 51.3677 49.939 65.3525 x x x +11946 Original post publication description: Time below threshold for males and females None Central nervous system, behavior: Depression assay, immobility using a tail suspension test (TST) for males and females [sec below threshold movement level] x x x x x x x x x x x 100.556 199.6 x x 60.5 127.5 x x 198.0 x x x x x x 150.0 x x x 145.857 196.0 214.333 x 107.75 x 180.0 280.0 98.6 x 128.5 x 206.333 x x x x x x 116.0 x x x x x x x x x 129.333 171.75 x x 154.167 x x 29.0 x 78.0 x x 178.5 x x x x x x x x x x x x x 210.0 x x x x x x x x x x x x x x x x +11947 Original post publication description: Locomotion in zero maze for males and females [n beam breaks] None Central nervous system, behavior: Locomotion in zero maze for males and females [n beam breaks] x x x x 885.5 557.143 x 705.389 467.6 x 359.667 649.778 449.667 654.5 550.6 514.308 575.214 481.688 x 592.048 x x x 485.118 x 494.231 364.6 713.913 x 507.312 592.0 458.067 538.818 x 655.615 x 485.682 400.55 580.529 x 619.529 350.583 503.107 662.8 x x 504.375 x 368.4 488.95 x x x 586.312 542.727 x x x 524.118 589.034 386.389 x x 623.621 440.462 519.727 514.68 596.875 561.786 592.375 x 631.5 x 461.429 x 435.308 x x 562.722 x x 493.5 523.2 637.1 555.857 508.417 x 483.154 x x 590.727 x x x 567.389 814.889 606.545 383.5 447.071 x x x +11948 Original post publication description: Anxiety assay, entries in closed quadrants of a zero maze for males and females [n] None Central nervous system, behavior: Anxiety assay, entries in closed quadrants of a zero maze for males and females [n] x x x x 128.5 77.0 x 136.833 55.2 x 37.6667 122.444 21.3333 60.25 47.8 42.4615 51.5 60.6875 x 62.3333 x x x 61.6471 x 50.3077 39.6667 92.2174 x 78.5625 108.312 60.4 87.3636 x 71.0769 x 28.8182 41.85 80.0 x 100.706 91.75 62.6786 67.2667 x x 117.312 x 111.9 73.1 x x x 65.9375 62.8182 x x x 107.353 101.379 61.9444 x x 70.4828 74.4615 39.8182 102.32 100.5 77.5714 89.5 x 86.25 x 55.0 x 38.6154 x x 107.222 x x 83.5 78.8667 92.3 67.1429 110.417 x 95.9231 x x 99.3636 x x x 122.278 93.6667 98.0909 131.0 73.5 x x x +11949 Original post publication description: Anxiety assay, entries into open quadrants of a zero maze for males and females [n] None Central nervous system, behavior: Anxiety assay, entries into open quadrants of a zero maze for males and females [n] x x x x 128.0 76.9286 x 136.056 55.3 x 37.8333 122.444 21.5 60.25 47.9 42.4615 51.7857 60.8125 x 62.5238 x x x 61.8824 x 50.3077 39.7333 91.9565 x 78.75 108.125 60.6 87.1818 x 71.0769 x 28.8182 41.85 80.0 x 100.588 92.0 62.6786 67.4 x x 117.25 x 111.9 72.95 x x x 65.875 62.7273 x x x 107.176 100.931 61.8889 x x 70.4483 74.6154 39.7727 101.68 100.5 77.9286 89.375 x 86.3333 x 54.8571 x 38.4615 x x 106.833 x x 83.25 78.9333 91.8 67.2143 110.417 x 96.4615 x x 99.2727 x x x 122.278 93.7778 98.0909 132.0 73.5714 x x x +11950 Original post publication description: Zero maze, latency to enter an open quadrant for males and females [sec] None Central nervous system, behavior: Anxiety assay, latency to enter an open quadrant of a zero maze for males and females [sec] x x x x 0.45 18.7857 x 18.4444 65.0 x 24.6917 3.11111 27.9167 16.925 61.46 20.6769 27.3923 50.14 x 44.2524 x x x 13.2294 x 92.9833 46.9133 18.2864 x 18.175 12.5625 58.6933 23.3455 x 20.5462 x 64.5333 47.9056 27.2588 x 15.5235 22.9083 17.6857 24.1533 x x 15.2937 x 16.36 20.365 x x x 16.2313 37.4182 x x x 12.8294 19.8379 30.8706 x x 32.4172 19.85 43.165 17.844 21.4787 30.7214 43.2375 x 16.1833 x 42.6571 x 96.8333 x x 9.24444 x x 29.775 34.44 11.15 50.2786 22.9417 x 30.3923 x x 19.5 x x x 12.0444 24.3778 22.3818 16.1 20.6214 x x x +11951 Original post publication description: Anxiety assay, percentage time in open quadrants of a zero maze for males and females [%] None Central nervous system, behavior: Anxiety assay, percentage time in open quadrants of a zero maze for males and females [%] x x x x 16.4833 11.131 x 23.9056 13.0633 x 5.74167 18.8519 5.125 7.2875 11.3367 4.54872 11.3738 10.7063 x 8.0873 x x x 18.9608 x 8.75897 20.0622 22.0971 x 13.3167 21.7208 12.8267 22.0515 x 10.6667 x 3.52879 9.205 28.7216 x 22.3216 40.3972 15.7702 13.2956 x x 29.0396 x 39.93 19.7967 x x x 11.8292 7.28182 x x x 33.8118 23.6701 22.6815 x x 10.4575 22.959 9.45909 31.468 20.1139 16.1143 24.4792 x 12.6528 x 17.4429 x 17.8769 x x 21.9778 x x 17.7583 17.0956 17.7 16.3143 24.375 x 22.0897 x x 14.2455 x x x 21.0556 9.93704 22.3091 43.7 19.181 x x x +11952 Original post publication description: Anxiety assay, time in closed quadrants of a zero maze for males and females [sec] None Central nervous system, behavior: Anxiety assay, time in closed quadrants of a zero maze for males and females [sec] x x x x 250.55 266.607 x 223.839 260.81 x 282.775 243.444 285.142 278.138 265.99 286.354 265.879 257.669 x 273.729 x x x 243.118 x 273.723 254.167 241.343 x 254.575 234.837 261.52 230.955 x 268.0 x 289.414 272.385 213.835 x 233.035 178.808 252.689 269.567 x x 200.931 x 170.42 240.61 x x x 264.513 278.155 x x x 198.565 228.99 231.956 x x 268.628 231.123 271.623 205.596 239.658 251.657 226.562 x 262.042 x 247.671 x 246.369 x x 234.067 x x 246.725 243.24 246.9 251.057 226.875 x 221.162 x x 257.264 x x x 228.394 270.189 233.073 168.9 236.736 x x x +11953 Original post publication description: Anxiety assay, time in open quadrants of a zero maze for males and females [sec] None Central nervous system, behavior: Anxiety assay, time in open quadrants of a zero maze for males and females [sec] x x x x 49.45 33.3929 x 76.1611 39.19 x 17.225 56.5556 14.8583 21.8625 34.01 13.6462 34.1214 42.3312 x 26.2714 x x x 56.8824 x 26.2769 45.8333 58.6565 x 45.425 65.1625 38.48 69.0455 x 32.0 x 10.5864 27.615 86.1647 x 66.9647 121.192 47.3107 30.4333 x x 99.0687 x 129.58 59.39 x x x 35.4875 21.8455 x x x 101.435 71.0103 68.0444 x x 31.3724 68.8769 28.3773 94.404 60.3417 48.3429 73.4375 x 37.9583 x 52.3286 x 53.6308 x x 65.9333 x x 53.275 56.76 53.1 48.9429 73.125 x 78.8385 x x 42.7364 x x x 71.6056 29.8111 66.9273 131.1 63.2643 x x x +11954 Original post publication description: Ethanol response (2.25 g/kg ip), locomotor activity after injection from 0-5 min for males and females [cm] None Ethanol response (2.25 g/kg ip), locomotor activity after injection from 0-5 min for males and females [cm] x x x x 1289.14 894.939 x 637.139 x 663.886 930.582 1820.62 779.449 571.757 435.637 1036.61 1741.22 1022.36 341.965 1647.07 x x x 165.613 x 804.495 297.524 1558.32 x 1516.42 950.394 1136.68 1151.47 x 1233.95 x 349.543 1102.48 1029.79 x 1664.17 504.953 608.616 1804.15 x x 1015.66 x 1397.66 1546.41 x x x 724.895 1200.17 x x x 505.321 836.355 332.821 441.986 x 1108.12 1516.77 616.141 969.603 427.663 1237.05 1286.74 x 1480.16 x 579.422 x x x x 852.099 x x 939.669 507.195 318.483 519.39 464.14 x 475.696 771.588 x 1019.64 x x x 602.472 603.73 807.435 1282.01 682.678 x x x +11955 Original post publication description: Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotor activity after injection from 0-5 min for males and females [cm] None Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotor activity after injection from 0-5 min for males and females [cm] x x x x 770.251 662.63 x 815.476 x 706.389 664.112 999.114 437.922 745.498 199.228 582.049 1050.13 550.541 795.815 897.588 x x x 382.734 x 574.051 317.75 1065.85 x 899.443 584.944 563.971 638.769 x 507.212 x 533.407 486.723 822.766 x 978.5 577.629 786.273 1189.08 x x 808.735 x 713.927 576.907 x x x 842.51 707.29 x x x 813.924 587.67 324.418 208.428 x 839.106 472.969 408.996 719.401 830.576 848.154 650.787 x 593.945 x 563.247 x x x x 632.345 x x 561.096 898.908 579.975 591.88 526.215 x 859.948 661.338 x 926.256 x x x 794.7 868.585 904.099 834.084 589.682 x x x +11956 Original post publication description: Ethanol response (2.25 g/kg ip), locomotor activity after injection from 5-10 min for males and females [cm] None Ethanol response (2.25 g/kg ip), locomotor activity after injection from 5-10 min for males and females [cm] x x x x 846.53 839.209 x 473.003 x 393.332 766.646 1625.07 471.77 288.187 310.473 1070.79 1521.86 784.664 281.2 1342.2 x x x 168.007 x 915.946 343.024 1494.84 x 1116.57 840.677 863.186 1075.98 x 822.07 x 286.803 758.345 924.864 x 1546.23 167.181 559.898 1711.65 x x 856.962 x 1246.0 1135.39 x x x 263.11 641.642 x x x 475.688 927.209 259.378 214.333 x 960.065 1009.61 625.861 707.017 232.997 1181.42 1187.24 x 1288.49 x 622.782 x x x x 695.717 x x 1002.66 501.737 490.465 385.715 473.46 x 533.044 776.237 x 779.233 x x x 506.626 345.15 385.104 1007.32 453.573 x x x +11957 Original post publication description: Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotor activity after injection from 5-10 min after injection for males and females [cm] None Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotor activity after injection from 5-10 min after injection for males and females [cm] x x x x 322.402 288.74 x 468.369 x 425.115 525.163 676.658 308.936 458.363 110.654 270.004 499.031 395.937 241.975 577.698 x x x 187.493 x 438.126 106.311 707.72 x 674.497 297.575 396.326 354.697 x 75.56 x 371.495 281.496 554.714 x 450.459 248.822 394.176 669.535 x x 629.273 x 452.275 415.496 x x x 664.192 485.36 x x x 465.6 290.68 122.539 144.387 x 604.565 172.424 401.619 496.847 534.089 677.317 401.782 x 309.559 x 340.114 x x x x 338.154 x x 370.144 331.663 412.693 434.48 307.757 x 521.764 272.458 x 417.22 x x x 409.125 505.505 391.224 707.528 307.308 x x x +11958 Original post publication description: Ethanol response (2.25 g/kg ip), locomotor activity after injection from 10-15 min for males and females [cm] None Central nervous system, pharmacology, behavior: Ethanol response (2.25 g/kg ip), locomotor activity after injection from 10-15 min for males and females [cm] x x x x 996.99 673.875 x 347.588 x 522.193 594.441 1119.52 472.402 240.461 242.254 1046.35 1323.49 705.073 441.77 1054.16 x x x 259.171 x 599.949 312.932 1561.9 x 1132.82 916.061 674.194 846.615 x 696.828 x 396.185 659.211 981.12 x 1386.72 324.36 544.356 1353.56 x x 964.057 x 981.31 1031.69 x x x 332.397 511.936 x x x 410.779 844.181 208.795 274.8 x 919.646 876.253 858.745 757.963 175.571 1481.73 1134.19 x 1038.02 x 1058.05 x x x x 920.005 x x 1175.52 556.261 516.648 288.21 526.098 x 683.497 1082.79 x 1029.22 x x x 435.586 453.47 563.245 1113.85 409.477 x x x +11959 Original post publication description: Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotor activity after injection from 10-15 min for males and females [cm] None Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotor activity after injection from 10-15 min for males and females [cm] x x x x 289.635 187.574 x 428.795 x 396.656 458.85 478.462 293.953 389.536 69.574 180.179 351.714 246.127 288.75 435.674 x x x 128.426 x 460.041 151.298 608.911 x 527.901 260.814 411.989 352.773 x 206.28 x 352.25 317.073 402.426 x 387.622 359.7 269.25 510.165 x x 482.837 x 436.519 502.927 x x x 520.818 363.3 x x x 318.18 279.625 207.855 144.994 x 419.954 140.716 422.334 453.181 500.947 633.621 345.4 x 255.099 x 191.844 x x x x 333.017 x x 231.777 233.021 314.86 423.967 254.985 x 458.047 157.935 x 374.357 x x x 249.605 639.655 340.394 635.792 266.71 x x x +11960 Original post publication description: Ethanol response (2.25 g/kg ip), locomotor activity after injection from 15-20 min for males and females [cm] None Central nervous system, pharmacology, behavior: Ethanol response (2.25 g/kg ip), locomotor activity after injection from 15-20 min for males and females [cm] x x x x 618.579 567.977 x 298.074 x 431.054 603.85 993.125 401.758 281.07 224.842 817.311 1039.28 576.274 306.24 889.959 x x x 238.19 x 453.721 268.546 1271.89 x 893.054 790.3 569.223 859.412 x 573.122 x 358.235 544.659 1131.92 x 1002.33 403.13 625.333 1265.22 x x 850.412 x 702.907 827.626 x x x 163.95 403.568 x x x 382.584 877.972 164.231 351.647 x 806.479 679.491 824.09 579.05 275.58 1151.42 1002.4 x 832.668 x 1128.79 x x x x 871.987 x x 1140.73 415.852 405.776 367.656 507.813 x 638.999 1096.02 x 888.191 x x x 556.0 621.53 673.266 1084.96 359.643 x x x +11961 Original post publication description: Saline control response (10 ml/kg ip), locomotion from 15-20 min after injection for males and females [cm] None Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotion from 15-20 min after injection for males and females [cm] x x x x 374.767 171.762 x 314.826 x 463.439 420.014 468.116 247.026 316.925 99.925 146.525 368.128 237.021 327.345 408.062 x x x 108.16 x 322.332 137.135 608.388 x 443.794 213.693 410.397 380.012 x 162.482 x 264.845 266.809 554.348 x 357.949 289.734 107.079 379.092 x x 432.567 x 288.517 526.845 x x x 396.612 166.593 x x x 401.579 294.975 116.421 120.904 x 388.734 123.671 431.97 655.616 537.283 590.651 359.768 x 284.994 x 184.559 x x x x 257.754 x x 227.18 185.161 312.109 337.039 290.519 x 502.3 111.282 x 371.63 x x x 226.634 535.525 320.184 756.102 408.28 x x x +11962 Original post publication description: Ethanol response (2.25 g/kg ip), locomotor activity, difference in distance traveled (saline minus ethanol) from 0-20 min for males and females [cm] None Central nervous system, pharmacology, behavior: Ethanol response (2.25 g/kg ip), locomotor activity, difference in distance traveled (saline minus ethanol) from 0-20 min for males and females [cm] x x x x 1994.18 1665.29 x -271.661 x 18.8662 827.379 3373.04 67.0188 -964.146 733.825 2792.3 3356.85 1658.74 -282.71 2614.37 x x x 24.1686 x 979.56 509.533 2896.08 x 2113.23 2140.41 1460.6 2207.23 x 2374.44 x -131.23 1712.59 1733.43 x 3424.92 -251.214 781.425 3386.71 x x 1333.68 x 1895.66 1951.3 x x x -939.78 575.217 x x x -230.274 2032.77 193.992 664.054 x 1541.95 3172.34 1259.92 688.587 -1291.08 871.586 2852.83 x 1794.11 x 1935.88 x x x x 1644.81 x x 2868.38 332.292 111.735 -226.395 592.036 x -10.8227 2523.62 x 1626.82 x x x 420.621 -525.39 473.15 1554.63 333.392 x x x +11963 Original post publication description: Ethanol response (2.25 g/kg ip), locomotor activity after injection from 0-20 min for males and females [cm] None Central nervous system, pharmacology, behavior: Ethanol response (2.25 g/kg ip), locomotor activity after injection from 0-20 min for males and females [cm] x x x x 3751.24 2976.0 x 1755.81 x 2010.46 2895.52 5558.33 2125.38 1381.47 1213.21 3971.06 5625.85 3088.37 1371.18 4933.39 x x x 830.981 x 2774.11 1222.03 5886.95 x 4658.87 3497.43 3243.28 3933.48 x 3325.97 x 1390.77 3064.7 4067.69 x 5599.45 1224.67 2338.2 6134.58 x x 3687.09 x 3786.9 3973.48 x x x 1484.35 2297.76 x x x 1769.01 3485.72 965.225 1282.77 x 3794.31 4082.12 2924.84 3013.63 1111.81 3621.33 4610.57 x 3117.41 x 3215.64 x x x x 3206.08 x x 4258.58 1981.05 1731.37 1560.97 1971.51 x 2331.24 3726.64 x 3716.28 x x x 2100.69 2023.88 2429.05 4488.13 1905.37 x x x +11964 Original post publication description: Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotion 0-20 min after injection for males and females [cm] None Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotion 0-20 min after injection for males and females [cm] x x x x 1757.06 1310.71 x 2027.47 x 1991.6 2068.14 2622.35 2058.36 2345.62 479.381 1178.76 2269.0 1429.63 1653.89 2319.02 x x x 806.813 x 1794.55 712.494 2990.87 x 2545.64 1357.03 1782.68 1726.25 x 951.535 x 1522.0 1352.1 2334.25 x 2174.53 1475.89 1556.78 2747.88 x x 2353.41 x 1891.24 2022.18 x x x 2424.13 1722.54 x x x 1999.28 1452.95 771.232 618.713 x 2252.36 909.78 1664.92 2325.05 2402.89 2749.74 1757.74 x 1323.3 x 1279.76 x x x x 1561.27 x x 1390.2 1648.75 1619.64 1787.37 1379.48 x 2342.06 1203.01 x 2089.46 x x x 1680.06 2549.27 1955.9 2933.51 1571.98 x x x +11965 Original post publication description: Ethanol response (2.25 g/kg ip), locomotor activity, difference in distance traveled (saline minus ethanol) from 0-5 min for males and females [cm] None Central nervous system, pharmacology, behavior: Ethanol response (2.25 g/kg ip), locomotor activity, difference in distance traveled (saline minus ethanol) from 0-5 min for males and females [cm] x x x x 518.886 232.309 x -178.337 x -42.5025 266.47 988.027 341.526 -173.741 236.409 454.56 691.089 471.816 -453.85 749.483 x x x -217.121 x 230.444 -20.2262 492.472 x 616.977 365.45 572.71 512.705 x 726.737 x -183.863 615.758 207.02 x 685.669 -135.795 -177.656 615.068 x x 206.927 x 509.026 776.201 x x x -117.615 292.848 x x x -308.603 248.685 8.40375 233.559 x 269.01 1043.8 207.145 250.201 -402.913 388.896 635.957 x 689.02 x 16.175 x x x x 219.754 x x 378.573 -391.713 -261.492 -72.49 -62.075 x -384.252 110.25 x 93.3871 x x x -192.227 -264.855 -96.6637 447.924 92.9967 x x x +11966 Original post publication description: Ethanol response (2.25 g/kg ip), locomotor activity, difference in distance traveled (saline minus ethanol) between the first 5 min and last 5 min for males and females [cm] None Central nervous system, pharmacology, behavior: Ethanol response (2.25 g/kg ip), locomotor activity, difference in distance traveled (saline minus ethanol) between the first 5 min and last 5 min for males and females [cm] x x x x 243.811 396.215 x -16.7517 x -32.385 183.836 603.028 154.731 -35.855 124.917 670.786 671.148 339.253 -21.105 481.897 x x x 130.03 x 131.389 131.411 663.504 x 449.26 576.607 158.827 479.4 x 410.64 x 93.39 277.85 577.568 x 644.383 63.005 518.254 886.125 x x 417.845 x 326.526 197.327 x x x -232.662 169.713 x x x -18.995 582.997 47.81 230.744 x 417.745 555.82 392.12 -76.5657 -261.703 560.771 642.628 x 432.646 x 944.232 x x x x 614.233 x x 913.548 230.691 93.667 30.617 217.294 x 136.699 984.74 x 516.561 x x x 329.366 86.005 353.082 328.855 -48.6367 x x x +11967 Original post publication description: Ethanol response (2.25 g/kg ip), blood ethanol concentration (BEC) for males and females [mg/dl XX min after injection] None Central nervous system, pharmacology, behavior: Ethanol response (2.25 g/kg ip), blood ethanol concentration (BEC) for males and females [mg/dl XX min after injection] x x x x 278.712 247.971 x 246.85 x 287.263 214.067 228.05 263.667 260.45 258.04 250.9 250.8 169.244 330.5 232.725 x x x 243.92 x 237.425 247.7 229.74 x 252.975 237.25 253.65 230.725 x 244.4 x 278.267 224.35 242.622 x 225.825 256.875 334.337 234.0 x x 211.5 x 226.2 235.1 x x x 241.6 270.167 x x x 318.1 269.2 258.725 261.038 x 311.033 255.5 278.475 271.033 307.667 250.157 275.1 x 230.956 x 238.125 x x x x 271.73 x x 229.88 281.3 295.2 240.07 236.492 x 267.6 247.967 x 282.286 x x x 225.962 265.8 260.038 239.35 211.367 x x x +11968 Original post publication description: Anxiety assay, untreated baseline, entries into closed arms of a plus maze for males and females [n] None Central nervous system, behavior: Anxiety assay, untreated baseline, entries into closed arms of a plus maze for males and females [n] x x x x 61.25 55.1429 x 80.6 x 44.625 56.7143 52.6667 37.25 52.0 53.6 37.3333 56.5 49.0 56.0 54.0 x x x 45.5 x 48.6 48.25 92.8 x 50.375 40.0 65.75 47.0 x 41.75 x 39.0 51.2857 57.1667 x 39.3833 56.3333 81.75 79.3333 x x 69.75 x 53.1429 57.875 x x x 85.8333 56.5 x x x 61.125 51.75 61.5 45.75 x 62.5 36.75 47.875 75.2857 53.4286 45.0 51.6667 x 73.2727 x 91.6667 x x x x 68.1111 x x 49.7 53.2 54.6 39.0 42.5833 x 35.9 62.6667 x 48.8571 x x x 39.875 55.5 54.75 42.7143 46.6667 x x x +11969 Original post publication description: Anxiety assay, untreated baseline, entries into open arms of a plus maze for males and females [n] None Central nervous system, behavior: Anxiety assay, untreated baseline, entries into open arms of a plus maze for males and females [n] x x x x 52.625 28.7143 x 81.2 x 57.125 63.0 83.6667 25.75 53.5 25.0 37.0 48.625 49.0 48.5 59.6667 x x x 25.25 x 39.4 25.5 56.1 x 44.75 25.75 57.875 62.0 x 74.25 x 41.5 42.2857 38.8333 x 59.1667 33.5 26.5 29.3333 x x 82.25 x 52.5714 73.375 x x x 43.3333 48.0 x x x 37.75 31.25 44.625 9.75 x 38.375 38.875 41.125 26.8571 33.1429 47.5714 35.1667 x 67.9091 x 54.6667 x x x x 51.8889 x x 27.9 40.8 28.6 29.8 34.75 x 43.8 50.0 x 35.0 x x x 46.625 22.5 33.5 53.8571 46.3333 x x x +11970 Original post publication description: Anxiety assay, untreated baseline, percentage of entries into closed arms of a plus maze for males and females [%] None Central nervous system, behavior: Anxiety assay, untreated baseline, percentage of entries into closed arms of a plus maze for males and females [%] x x x x 38.076 55.0919 x 57.356 x 35.042 50.678 37.5019 64.9714 45.8424 65.7627 53.1287 42.4873 48.7675 38.0952 42.7128 x x x 38.1542 x 45.5031 60.3875 56.0753 x 53.3763 42.0986 41.6204 40.6374 x 35.75 x 38.6026 48.4362 47.1784 x 36.5664 52.8395 78.4139 80.7333 x x 39.94 x 48.6802 44.6533 x x x 49.6217 56.4833 x x x 64.9875 50.6219 57.1422 86.5501 x 53.686 44.2775 42.183 50.6867 57.9361 48.3539 51.6084 x 54.6881 x 52.3249 x x x x 59.6542 x x 54.7336 55.4513 57.195 41.9528 45.9812 x 44.2819 55.5853 x 66.5859 x x x 53.1655 54.1032 57.3989 45.6686 46.3888 x x x +11971 Original post publication description: Anxiety assay, untreated baseline, percent entries into open arms of an elevated plus maze for males and females [%] None Central nervous system, behavior: Anxiety assay, untreated baseline, percent entries into open arms of an elevated plus maze for males and females [%] x x x x 61.924 44.9081 x 42.644 x 52.458 49.322 62.4981 35.0286 54.1576 24.2373 46.8713 45.0127 51.2325 61.9048 57.2872 x x x 61.8458 x 54.4969 39.6125 43.9247 x 46.6237 32.9014 58.3921 59.3626 x 64.25 x 44.7307 51.5638 36.155 x 63.4336 47.1605 21.5861 19.2667 x x 60.06 x 51.3198 55.3467 x x x 45.215 43.5167 x x x 35.0125 49.3781 42.8578 13.4499 x 46.314 55.7225 57.817 35.0275 42.0639 51.6461 31.725 x 45.3119 x 31.0084 x x x x 40.3458 x x 45.2664 44.5487 32.805 58.0472 54.0188 x 55.7181 44.4147 x 33.4141 x x x 46.847 45.8968 42.6011 54.3314 53.6112 x x x +11972 Original post publication description: Anxiety assay, untreated baseline, percent time in closed arms of a plus maze for males and females [%] None Central nervous system, behavior: Anxiety assay, untreated baseline, percent time in closed arms of a plus maze for males and females [%] x x x x 32.8533 45.0267 x 31.5147 x 33.2663 35.4576 34.4794 51.2808 32.8546 71.586 62.2233 43.27 39.43 33.5467 34.3994 x x x 25.235 x 38.0547 56.585 53.9897 x 47.7887 33.6217 41.2733 33.3033 x 40.6083 x 49.6289 47.4042 39.1079 x 42.5533 49.8483 79.9371 77.0 x x 40.385 x 46.0817 43.4029 x x x 63.8333 59.9361 x x x 69.8983 52.6775 55.4133 83.0171 x 56.5554 27.1075 40.9162 42.8257 45.729 35.9633 47.3594 x 49.2827 x 52.095 x x x x 60.0333 x x 47.9123 38.6867 53.3263 47.001 37.4231 x 43.922 54.6444 x 67.4352 x x x 44.6029 60.7233 49.8279 38.6586 51.1711 x x x +11973 Original post publication description: Anxiety assay, untreated baseline, percentage of time in open arms of plus maze for males and females [%] None Central nervous system, behavior: Anxiety assay, untreated baseline, percentage of time in open arms of plus maze for males and females [%] x x x x 55.1542 44.5629 x 60.996 x 44.4658 55.8105 55.9711 17.4775 48.2062 13.2443 31.4928 26.0217 46.3225 60.7967 49.3406 x x x 55.3075 x 44.1147 31.7288 38.6987 x 42.6225 30.4058 50.5475 44.4512 x 54.6083 x 28.0278 46.4942 26.7854 x 44.8256 24.8833 13.8554 16.6175 x x 53.4725 x 45.88 46.855 x x x 29.235 33.56 x x x 20.7733 24.33 29.2292 7.81208 x 36.8488 31.0521 45.5288 23.8986 33.3671 45.4519 22.9578 x 41.0927 x 22.2222 x x x x 32.8011 x x 33.9583 39.195 23.3197 45.286 49.2872 x 50.8303 35.0772 x 26.9443 x x x 47.1392 34.005 28.065 47.2224 43.4106 x x x +11974 Original post publication description: Ethanol response (2.25 g/kg ip), motor coordination effects, difference in time on rotarod between training session and ethanol for males females [sec] None Central nervous system, pharmacology, behavior: Ethanol response (2.25 g/kg ip), motor coordination effects, difference in time on rotarod between training session and ethanol for males females [sec] x x x x 19.3708 5.50833 x 16.1236 x 18.1083 11.3367 -9.38889 0.495833 18.0267 6.4 15.4792 17.14 -2.85556 15.4 -4.52963 x x x 9.10476 x -7.25417 4.6625 15.62 x 9.19167 14.3667 3.56296 42.33 x -4.44167 x 8.72778 24.8333 -1.01 x 3.95833 0.554167 10.9208 -7.45833 x x 6.13889 x -0.9875 11.5871 x x x 8.36667 -1.63889 x x x 21.125 2.3625 9.07083 0.133333 x 0.7875 0.708333 -0.483333 6.90476 16.0095 7.28571 4.43889 x 24.8364 x -6.95417 x x x x 21.17 x x -14.5667 4.94333 5.16667 2.28567 20.5167 x 15.373 18.8833 x -8.24286 x x x -3.03333 -9.61667 -7.3375 1.80417 4.93111 x x x +11975 Original post publication description: Ethanol response (2.25 g/kg ip), duration on rotarod following injection for males and females [sec] None Central nervous system, pharmacology, behavior: Ethanol response (2.25 g/kg ip), duration on rotarod following injection for males and females [sec] x x x x 24.4538 38.3121 x 41.5933 x 25.4167 50.9181 41.6667 20.9728 24.8003 19.6697 35.3989 23.6863 41.4822 12.4667 37.2696 x x x 16.81 x 32.8088 42.5762 28.8723 x 31.9937 34.3658 42.4781 37.4038 x 47.2975 x 12.4522 38.3913 31.8997 x 27.5413 24.2617 24.3879 38.7175 x x 29.2817 x 59.0033 31.1304 x x x 21.3567 18.1033 x x x 25.6279 32.6125 40.8421 28.0283 x 30.5492 36.4342 15.4338 48.7619 34.0195 24.7 30.2944 x 49.9897 x 39.9083 x x x x 31.6667 x x 38.7167 27.1837 28.5967 32.6947 19.2194 x 15.197 38.0556 x 35.5133 x x x 31.8412 30.6833 33.2962 41.2708 40.2633 x x x +11976 Original post publication description: Ethanol response (2.25 g/kg ip), time on rotarod after saline minus time on rotarod after ethanol for males and females [sec] None Central nervous system, pharmacology, behavior: Ethanol response (2.25 g/kg ip), time on rotarod after saline minus time on rotarod after ethanol for males and females [sec] x x x x -7.95417 -7.93333 x 8.9125 x -9.97917 7.49296 14.1778 2.28333 -11.67 -0.626667 1.90417 -12.4567 4.5037 -11.25 -1.8 x x x -1.81429 x 0.683333 -16.7292 -6.88667 x 0.416667 -4.86667 -1.37407 -27.5087 x 4.48333 x 1.92222 -20.7542 -8.06333 x 6.54583 3.47083 -7.50833 -2.525 x x -5.44444 x -4.70792 -8.10833 x x x 2.58889 -1.30556 x x x -5.81667 -2.60417 -14.6583 -0.391667 x -2.92917 -7.3 -4.45417 -15.6333 -2.86191 -5.85238 7.58889 x -21.903 x -2.39583 x x x x -4.62667 x x 3.44 4.50667 -3.75 -4.00667 -0.316667 x -3.58 -11.5167 x 11.3286 x x x 1.07083 24.15 0.216667 -0.333333 -9.31511 x x x +11977 Original post publication description: Saline control response (10 ml/kg ip), motor coordination, rotarod performance following injection for males and females [sec] None Central nervous system, behavior: Saline control response (10 ml/kg ip), motor coordination, rotarod performance following injection for males and females [sec] x x x x 43.8288 43.8217 x 55.4006 x 43.525 62.2544 32.2767 18.5429 42.827 26.0703 48.0352 40.8253 38.6274 27.8667 32.7422 x x x 25.9143 x 25.5533 47.2375 44.4923 x 41.1862 48.7333 46.0396 80.2822 x 42.8575 x 21.1783 63.2246 30.8897 x 31.5 24.8162 35.3088 31.26 x x 35.4222 x 58.0163 42.7179 x x x 29.7233 16.4683 x x x 46.7542 34.975 49.9125 28.1667 x 31.3388 37.14 14.9492 55.6667 50.029 31.9857 34.7333 x 70.2815 x 32.9542 x x x x 52.8367 x x 24.15 32.127 33.7633 34.98 43.3485 x 30.57 56.9389 x 31.8161 x x x 32.9238 21.0667 29.6667 43.07 45.1944 x x x +11978 Original post publication description: Saline control response (dose ip), motor coordination effects, difference in time on rotarod between training session and saline for males and females [sec] None Central nervous system, behavior: Saline control response (dose ip), motor coordination effects, difference in time on rotarod between training session and saline for males and females [sec] x x x x 11.4167 -2.425 x 25.0361 x 8.12917 18.8296 4.78889 2.77917 6.35667 5.77333 17.3833 4.68333 1.64815 4.15 -6.32963 x x x 7.29048 x -6.57083 -12.0667 8.73333 x 9.60833 9.5 2.18889 14.8213 x 0.041667 x 10.65 4.07917 -9.07333 x 10.5042 4.025 3.4125 -9.98333 x x 0.694444 x -5.69542 3.47875 x x x 10.9556 -2.94444 x x x 15.3083 -0.241667 -5.5875 -0.258333 x -2.14167 -6.59167 -4.9375 -8.72857 13.1476 1.43333 12.0278 x 2.93333 x -9.35 x x x x 16.5433 x x -11.1267 9.45 1.41667 -1.721 20.2 x 11.793 7.36667 x 3.08571 x x x -1.9625 14.5333 -7.12083 1.47083 -4.384 x x x +11979 Original post publication description: Motor coordination, rotarod performance, untreated training trial for males and females [sec] None Central nervous system, behavior: Motor coordination, rotarod performance, untreated training trial for males and females [sec] x x x x 35.8692 35.8875 x 59.6972 x 33.5458 69.7478 46.4544 18.5083 31.1563 25.443 43.9333 28.37 43.1304 16.6167 30.9404 x x x 24.0995 x 26.2388 30.5088 37.607 x 41.605 43.8667 44.6667 44.7433 x 47.34 x 23.1006 42.4725 22.826 x 38.0454 28.2879 27.7996 28.7325 x x 29.9789 x 53.3083 34.6079 x x x 32.31 15.16 x x x 40.9379 32.3704 35.2542 27.7708 x 28.4083 29.8408 10.4946 40.0333 47.1667 26.1333 42.3222 x 48.3785 x 30.5583 x x x x 48.21 x x 27.59 36.6333 30.0137 30.9737 39.4194 x 26.99 45.4222 x 38.601 x x x 29.8796 45.2167 26.175 42.7412 35.8793 x x x +11980 Original post publication description: Anxiety assay, time in closed arms of an elevated plus maze for males and females [sec] None Central nervous system, behavior: Anxiety assay, time in closed arms of an elevated plus maze for males and females [sec] x x x x 98.56 135.077 x 94.516 x 99.7988 106.389 103.43 153.84 98.5713 214.748 186.672 129.8 118.283 100.64 103.17 x x x 75.705 x 114.16 169.749 161.966 x 143.339 100.865 123.796 99.9112 x 121.85 x 148.868 142.212 117.321 x 127.66 149.545 239.809 231.003 x x 121.16 x 138.242 130.21 x x x 191.492 179.808 x x x 209.695 158.033 166.24 249.051 x 169.666 81.3075 122.753 128.477 137.196 107.889 142.078 x 147.842 x 156.287 x x x x 180.1 x x 143.736 116.062 159.979 140.993 112.278 x 131.766 163.933 x 202.293 x x x 133.827 182.17 149.486 115.97 153.515 x x x +11981 Original post publication description: Anxiety assay, time in middle of an elevated plus maze for males and females [sec] None Central nervous system, behavior: Anxiety assay, time in middle of an elevated plus maze for males and females [sec] x x x x 35.9787 31.2343 x 22.52 x 66.8037 26.1943 28.6467 93.725 56.8213 45.539 18.85 92.1325 42.73 16.97 48.8067 x x x 58.375 x 53.494 35.08 21.931 x 28.7812 107.918 24.5487 66.7363 x 14.34 x 67.0833 18.3025 78.355 x 37.8667 75.805 18.6238 19.145 x x 18.425 x 24.1162 29.2225 x x x 20.8 19.5117 x x x 27.9837 68.9775 46.0725 27.51 x 19.7862 125.556 40.6362 99.8271 62.72 55.7571 89.0483 x 28.8882 x 77.0483 x x x x 21.4956 x x 54.388 66.352 70.063 23.146 39.8542 x 15.743 30.835 x 16.8614 x x x 24.7787 15.815 66.32 42.3643 16.2517 x x x +11982 Original post publication description: Anxiety assay, time in open arms of an elevated plus maze for males and females [sec] None Central nervous system, behavior: Anxiety assay, time in open arms of an elevated plus maze for males and females [sec] x x x x 165.461 133.689 x 182.96 x 133.398 167.44 167.922 52.445 144.613 39.713 94.4783 78.06 138.958 182.39 148.023 x x x 165.92 x 132.346 95.1712 116.103 x 127.88 91.2175 151.652 133.352 x 163.825 x 84.0467 139.485 104.324 x 134.473 74.65 41.5675 49.8525 x x 160.415 x 137.641 140.568 x x x 87.7083 100.68 x x x 62.3213 72.99 87.6875 23.4387 x 110.559 93.1363 136.611 71.6957 100.084 136.354 68.8733 x 123.27 x 66.665 x x x x 98.4044 x x 101.876 117.586 69.958 135.861 147.867 x 152.491 105.232 x 80.8457 x x x 141.394 102.015 84.1937 141.666 130.233 x x x +11983 Original post publication description: Cocaine response (10 mg/kg ip), locomotion from 0-15 min after first injection in an activity chamber for males and females [n beam breaks] None Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), locomotion from 0-15 min after first injection in an activity chamber for males and females [n beam breaks] x x x x 2218.29 1382.0 x 936.292 1016.92 2877.7 814.524 1850.81 1062.81 2774.0 865.643 879.143 2910.88 1757.61 942.0 2825.55 x x x 2381.25 x 1511.21 1280.33 2442.82 x 1969.39 1146.17 3376.32 1298.32 x 581.0 x 2184.22 1496.96 4132.07 x 2347.69 2809.0 1260.38 1803.29 x x 1713.71 x 1640.19 1134.72 x x x 1422.36 792.865 x x x 2399.24 1306.25 908.645 1918.67 x 2104.58 728.048 1180.89 1898.93 3193.5 2215.65 3434.93 x 1298.62 x 1590.82 x 3770.32 x x 1563.69 x x 1326.53 3175.15 1032.72 1887.24 1714.41 x 2550.47 778.0 x 1708.04 x x x 2202.7 2952.09 2758.64 2685.5 1178.0 x x x +11984 Original post publication description: Cocaine response (10 mg/kg ip), locomotion from 15-30 min after first injection in an activity chamber for males and females [n beam breaks] None Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), locomotion from 15-30 min after first injection in an activity chamber for males and females [n beam breaks] x x x x 2129.94 769.75 x 830.292 570.417 2546.5 994.143 1443.33 973.308 1915.1 649.214 932.619 2019.42 1809.78 1356.0 2473.55 x x x 1672.38 x 1050.71 926.4 1986.68 x 2048.22 1436.17 2804.72 1129.97 x 378.294 x 2083.43 1203.04 3818.27 x 2052.07 2449.29 1026.3 1374.65 x x 1549.81 x 1759.0 1191.12 x x x 1409.95 714.811 x x x 2356.76 1327.68 868.774 1742.79 x 1896.31 807.0 1310.33 1930.44 3191.08 2341.44 3409.17 x 1113.18 x 1374.64 x 2818.26 x x 1263.6 x x 1095.9 2290.46 1223.62 1634.32 1610.7 x 2226.53 380.2 x 1787.68 x x x 1777.22 2298.0 1579.27 3009.57 1103.74 x x x +11985 Original post publication description: Cocaine response (10 mg/kg ip), locomotion from 30-45 min after first injection in an activity chamber for males and females [n beam breaks] None Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), locomotion from 30-45 min after first injection in an activity chamber for males and females [n beam breaks] x x x x 1479.41 581.95 x 786.375 592.167 2041.6 1088.14 1135.24 875.692 1437.66 532.286 822.952 1288.33 1188.44 1647.83 1873.82 x x x 1350.31 x 768.917 762.067 1417.82 x 1400.78 1397.26 1903.08 844.097 x 236.529 x 1592.17 971.482 2752.3 x 1316.17 1717.62 780.324 1381.41 x x 1568.0 x 1420.56 996.875 x x x 1277.05 435.811 x x x 1830.76 1138.05 568.484 1215.12 x 1344.54 680.143 1095.81 1561.44 2637.19 1772.0 2572.21 x 864.853 x 1045.5 x 1919.26 x x 982.343 x x 895.467 1489.73 803.094 1315.68 1229.74 x 1770.4 222.2 x 1377.88 x x x 1202.7 1602.82 820.606 2667.11 879.359 x x x +11986 Original post publication description: Cocaine response (10 mg/kg ip), locomotion from 45-60 min after first injection in an activity chamber for males and females [n beam breaks] None Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), locomotion from 45-60 min after first injection in an activity chamber for males and females [n beam breaks] x x x x 1107.0 323.85 x 496.125 489.167 1568.6 820.333 1011.52 646.885 1044.62 334.286 860.19 1035.83 631.889 1004.0 1509.32 x x x 1097.44 x 473.5 588.2 977.545 x 1084.33 1129.35 1494.2 491.774 x 124.882 x 1174.43 825.963 2172.93 x 1021.97 1294.5 567.162 1059.53 x x 1281.67 x 1184.38 844.219 x x x 975.091 160.486 x x x 1397.83 884.15 349.839 774.0 x 1088.5 538.571 969.556 1159.56 2157.78 1464.18 1981.45 x 621.412 x 789.818 x 1398.58 x x 681.2 x x 790.1 1098.31 490.688 988.84 874.815 x 1562.0 189.0 x 1055.6 x x x 1363.17 1275.64 605.515 2248.5 727.41 x x x +11987 Original post publication description: Cocaine response (10 mg/kg ip), locomotion from 0-15 min after first injection in an activity chamber for males and females [cm] None Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), locomotion from 0-15 min after first injection in an activity chamber for males and females [cm] x x x x 6349.49 4025.16 x 2752.53 3074.33 7746.54 2402.97 5316.68 3311.65 7966.5 2672.08 2715.58 7947.35 5524.57 2884.02 7831.91 x x x 6817.69 x 4480.33 3792.76 7087.78 x 5917.91 3333.18 9139.29 3944.94 x 1874.62 x 6522.82 4291.93 10798.8 x 6988.7 8077.35 3899.42 5554.49 x x 4997.35 x 5016.55 3714.24 x x x 4489.45 2660.06 x x x 6858.67 3911.6 2758.3 5788.84 x 6094.39 2304.83 3814.56 5895.6 8816.01 6495.88 9588.67 x 4040.2 x 4897.77 x 10079.5 x x 4669.58 x x 4342.66 8844.09 3490.75 5501.32 5200.25 x 7492.42 2850.69 x 5197.09 x x x 6315.25 8097.77 7354.02 7836.11 3619.18 x x x +11988 Original post publication description: Cocaine response (10 mg/kg ip), locomotion from 15-30 min after first injection in an activity chamber for males and females [cm] None Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), locomotion from 15-30 min after first injection in an activity chamber for males and females [cm] x x x x 6025.83 2380.06 x 2518.11 1933.62 6816.46 3023.85 4422.46 3165.35 5689.82 2087.14 2890.53 5721.15 5864.9 4101.52 6984.94 x x x 4951.67 x 3333.1 2963.53 5876.45 x 6114.54 4167.73 7716.64 3510.66 x 1270.0 x 6248.15 3492.62 9998.54 x 6140.96 7310.46 3167.42 4367.91 x x 4692.46 x 5291.82 3907.71 x x x 4425.23 2460.79 x x x 6713.74 4019.04 2694.16 5177.35 x 5588.65 2608.88 4099.71 5930.38 8809.0 6771.9 9389.64 x 3556.81 x 4338.31 x 7876.88 x x 3855.73 x x 3605.9 6613.51 4005.69 4770.4 4821.53 x 6631.2 1539.9 x 5475.65 x x x 5272.33 6477.74 4359.48 8528.54 3501.35 x x x +11989 Original post publication description: Cocaine response (10 mg/kg ip), locomotion from 30-45 min after first injection in an activity chamber for males and females [cm] None Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), locomotion from 30-45 min after first injection in an activity chamber for males and females [cm] x x x x 4377.78 1894.28 x 2423.93 2160.09 5560.45 3332.81 3649.14 2961.2 4392.56 1838.98 2596.93 3737.01 4022.04 5019.79 5457.98 x x x 4232.24 x 2520.07 2530.73 4434.92 x 4349.76 4130.41 5607.98 2763.98 x 829.138 x 4976.68 2962.32 7591.93 x 4142.27 5406.92 2493.36 4368.08 x x 4799.25 x 4368.86 3387.23 x x x 4105.91 1507.24 x x x 5323.7 3530.46 1894.82 3703.6 x 4143.87 2219.68 3474.06 4912.85 7472.94 5390.14 7246.22 x 2824.54 x 3436.53 x 5719.68 x x 3070.4 x x 3043.54 4694.13 2716.32 4018.52 3707.41 x 5374.69 948.936 x 4396.41 x x x 3845.17 4589.7 2416.57 7641.35 2866.21 x x x +11990 Original post publication description: Cocaine response (10 mg/kg ip), locomotion from 45-60 min after first injection in an activity chamber for males and females [cm] None Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), locomotion from 45-60 min after first injection in an activity chamber for males and females [cm] x x x x 3412.61 1160.12 x 1618.86 1849.26 4520.89 2581.86 3302.04 2240.15 3282.69 1202.24 2673.25 3164.56 2244.94 3134.91 4550.14 x x x 3545.15 x 1651.65 2073.91 3217.98 x 3515.76 3392.79 4647.85 1651.44 x 440.288 x 3864.04 2585.17 6295.94 x 3265.38 4265.82 1860.55 3340.58 x x 3977.51 x 3712.58 2940.91 x x x 3209.98 562.005 x x x 4148.4 2861.83 1245.98 2423.47 x 3432.13 1816.99 3109.92 3752.34 6336.52 4599.8 5730.5 x 2030.78 x 2633.22 x 4380.64 x x 2191.2 x x 2679.09 3676.11 1699.48 3100.71 2712.61 x 4864.95 701.345 x 3374.57 x x x 4107.62 3678.75 1853.93 6600.73 2448.46 x x x +11991 Original post publication description: Cocaine response (10 mg/kg ip), vertical activity (rears) in an open field 0-15 min after injection for males and females [n beam breaks] None Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), vertical activity (rears) in an open field 0-15 min after injection for males and females [n beam breaks] x x x x 247.294 260.9 x 211.625 166.667 289.7 104.0 240.524 180.423 486.172 113.714 260.952 271.208 361.056 157.333 364.545 x x x 241.562 x 309.125 173.533 460.955 x 339.167 242.174 284.72 262.613 x 113.059 x 349.435 146.963 456.833 x 546.034 621.417 298.595 324.176 x x 463.571 x 380.625 314.5 x x x 255.364 122.162 x x x 369.172 309.025 277.806 221.292 x 315.885 177.714 376.815 424.667 553.556 378.5 482.138 x 367.912 x 372.364 x 525.947 x x 384.486 x x 359.5 350.923 238.312 304.96 375.185 x 463.4 173.0 x 286.08 x x x 525.348 290.273 285.303 453.857 243.897 x x x +11992 Original post publication description: Cocaine response (10 mg/kg ip), vertical activity (rears) in an open field 15-30 min after injection for males and females [n beam breaks] None Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), vertical activity (rears) in an open field 15-30 min after injection for males and females [n beam breaks] x x x x 332.529 213.6 x 242.5 209.0 335.4 170.81 327.571 238.808 508.103 158.357 337.857 289.208 466.833 241.0 454.864 x x x 244.688 x 294.458 220.467 440.591 x 413.389 351.391 383.84 276.839 x 127.0 x 414.87 169.37 597.633 x 515.276 728.167 279.865 343.941 x x 522.19 x 401.562 320.375 x x x 292.818 166.919 x x x 412.69 390.525 359.581 283.542 x 342.577 275.143 429.185 466.704 672.806 448.529 542.345 x 397.559 x 450.864 x 581.579 x x 410.2 x x 401.533 387.038 327.438 303.08 362.667 x 521.067 133.6 x 351.32 x x x 578.261 329.273 257.303 510.964 321.462 x x x +11993 Original post publication description: Cocaine response (10 mg/kg ip), vertical activity (rears) in an open field 30-45 min after injection for males and females [n beam breaks] None Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), vertical activity (rears) in an open field 30-45 min after injection for males and females [n beam breaks] x x x x 308.647 197.1 x 216.958 268.417 336.7 214.952 308.238 270.538 448.31 156.643 293.619 275.792 371.778 320.833 409.0 x x x 264.188 x 230.333 182.8 371.364 x 362.556 341.913 385.88 240.161 x 83.6471 x 409.87 176.926 556.667 x 402.172 595.917 255.27 365.294 x x 526.286 x 400.125 301.562 x x x 303.409 117.946 x x x 365.517 399.6 338.0 212.333 x 279.692 227.286 409.148 401.963 631.111 416.765 507.793 x 337.441 x 417.091 x 553.368 x x 354.886 x x 347.9 429.5 268.344 264.72 311.333 x 463.333 86.4 x 310.32 x x x 521.087 276.091 206.788 517.714 308.051 x x x +11994 Original post publication description: Cocaine response (10 mg/kg ip), vertical activity (rears) in an open field 45-60 min after injection for males and females [n beam breaks] None Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), vertical activity (rears) in an open field 45-60 min after injection for males and females [n beam breaks] x x x x 311.588 153.1 x 170.792 257.583 365.9 197.0 295.952 219.692 360.138 115.357 311.857 240.375 250.722 238.833 368.909 x x x 249.5 x 175.75 222.8 316.909 x 332.333 297.217 368.48 178.419 x 56.1176 x 416.783 195.074 570.7 x 339.207 554.583 196.73 300.941 x x 490.524 x 368.875 254.75 x x x 253.409 45.4865 x x x 320.103 383.325 257.161 173.875 x 269.423 221.857 396.407 326.667 623.417 405.059 466.241 x 284.647 x 336.727 x 521.895 x x 301.629 x x 337.133 403.692 189.219 250.16 253.259 x 469.267 73.2 x 245.84 x x x 499.696 257.636 175.152 522.214 308.692 x x x +11995 Original post publication description: Cocaine response (2 x 10 mg/kg ip), locomotion from 0-15 min after second injection in an activity chamber for males and females [n beam breaks] None Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), locomotion from 0-15 min after second injection in an activity chamber for males and females [n beam breaks] x x x x 4715.47 2410.2 x 1646.58 1718.33 4947.2 1041.9 3016.14 2303.12 3895.93 1127.93 1739.9 4093.38 3382.5 2450.5 4703.36 x x x 2991.06 x 3001.7 3193.6 3183.23 x 2667.83 2131.65 5346.2 1781.48 x 820.941 x 3300.65 2417.96 6128.4 x 3418.48 3451.08 2154.46 2236.35 x x 2433.62 x 1861.27 2203.44 x x x 2187.95 1275.95 x x x 3779.97 1897.55 1195.81 2873.54 x 2550.8 1607.62 1705.11 2758.81 4620.86 3467.67 4598.59 x 2241.06 x 2740.81 x 4841.58 x x 2323.6 x x 2394.33 4643.81 2056.5 3877.35 2709.26 x 3336.4 939.2 x 2572.72 x x x 3177.96 4727.4 3609.58 3546.52 1697.38 x x x +11996 Original post publication description: Cocaine response (2 x 10 mg/kg ip), locomotion from 15-30 min after second injection in an activity chamber for males and females [n beam breaks] None Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), locomotion from 15-30 min after second injection in an activity chamber for males and females [n beam breaks] x x x x 3341.29 930.95 x 1095.71 788.75 4321.5 1231.0 1881.19 1763.88 2533.69 1131.64 1604.75 2906.33 2553.0 2341.67 2917.23 x x x 1851.0 x 1885.0 1946.73 2197.09 x 2330.44 1748.17 3868.36 1198.1 x 398.059 x 2490.74 1891.93 4635.13 x 2495.1 2620.71 1652.76 1658.0 x x 1777.38 x 1625.2 1849.47 x x x 2137.23 984.541 x x x 3327.21 1487.68 849.903 2244.54 x 2060.52 1302.05 1654.63 2126.15 3971.72 3113.09 4128.66 x 1488.76 x 1755.0 x 3158.63 x x 1517.4 x x 1704.17 3063.08 1750.66 2924.04 2049.11 x 2376.2 544.6 x 2087.68 x x x 1956.96 3057.6 1956.03 3033.19 1204.03 x x x +11997 Original post publication description: Cocaine response (2 x 10 mg/kg ip), locomotion from 30-45 min after second injection in an activity chamber for males and females [n beam breaks] None Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), locomotion from 30-45 min after second injection in an activity chamber for males and females [n beam breaks] x x x x 2315.41 564.7 x 988.375 702.75 2891.3 1068.86 1202.1 1009.62 1590.83 907.071 1252.85 1861.42 1429.78 1951.5 2103.36 x x x 1421.0 x 1127.43 1279.73 1738.23 x 1814.39 1431.87 2503.36 861.968 x 288.0 x 1593.26 1236.11 3196.43 x 1799.76 1731.92 1133.62 1608.82 x x 1453.33 x 1296.13 1317.62 x x x 1790.36 569.946 x x x 2496.79 1186.6 560.387 1521.08 x 1422.44 1207.62 1280.59 1572.15 3031.67 2403.52 3187.24 x 990.735 x 1165.9 x 2134.79 x x 1059.77 x x 1184.5 2041.54 1061.12 1837.87 1441.07 x 1913.27 322.2 x 1531.44 x x x 1316.43 2239.8 1078.79 2672.41 979.949 x x x +11998 Original post publication description: Cocaine response (2 x 10 mg/kg ip), locomotion from 45-60 min after second injection in an activity chamber for males and females [n beam breaks] None Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), locomotion from 45-60 min after second injection in an activity chamber for males and females [n beam breaks] x x x x 1533.88 429.85 x 750.458 572.167 1990.4 1000.43 924.81 825.692 1209.69 563.643 998.9 1477.42 613.111 1360.33 1676.55 x x x 931.875 x 764.304 857.133 1192.05 x 1319.78 1121.83 1753.68 560.387 x 77.1176 x 1251.09 933.148 2341.83 x 1321.21 1259.54 735.432 882.824 x x 1205.62 x 1187.13 956.438 x x x 1483.64 322.162 x x x 1741.0 959.55 321.935 927.792 x 1018.96 781.905 1074.7 1090.33 2450.19 1794.33 2313.34 x 671.324 x 820.143 x 1594.58 x x 770.0 x x 918.033 1290.88 768.5 1374.57 1110.04 x 1567.6 144.4 x 1082.32 x x x 1044.13 1434.7 665.909 2314.74 767.385 x x x +11999 Original post publication description: Cocaine response (2 x 10 mg/kg ip), locomotion in an open field from 0-15 min after second injection in an activity chamber for males and females [cm] None Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), locomotion in an open field from 0-15 min after second injection in an activity chamber for males and females [cm] x x x x 12026.1 6539.09 x 4676.82 4754.89 12691.9 2989.75 8048.21 6602.42 10635.1 3243.02 4895.12 10601.4 9791.07 7151.07 12271.4 x x x 8186.14 x 8299.42 8680.46 8868.43 x 7605.42 5919.73 13555.6 5206.96 x 2426.28 x 9354.75 6594.77 15217.3 x 9763.28 9726.1 6236.25 6665.27 x x 6891.92 x 5545.57 6480.03 x x x 6654.21 3941.34 x x x 10279.2 5461.41 3458.17 8043.54 x 7122.34 4537.31 5230.37 8052.87 12291.4 9482.22 12203.1 x 6385.89 x 8086.98 x 12369.2 x x 6490.59 x x 6972.35 12031.2 6284.28 10520.7 7632.78 x 9218.11 3073.48 x 7287.56 x x x 8708.93 12370.9 9527.6 9749.02 4996.65 x x x +12000 Original post publication description: Cocaine response (2 x 10 mg/kg ip), locomotion in an open field from 15-30 min after second injection in an activity chamber for males and females [cm] None Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), locomotion in an open field from 15-30 min after second injection in an activity chamber for males and females [cm] x x x x 8578.81 2714.56 x 3287.88 2572.22 10972.4 3666.53 5412.5 5219.7 7166.09 3342.88 4588.61 7689.25 7784.13 6989.38 8182.04 x x x 5400.69 x 5570.27 5917.09 6357.81 x 6572.72 4984.65 10092.9 3636.25 x 1354.03 x 7245.76 5291.6 11596.4 x 7253.73 7616.04 4879.42 5102.7 x x 5341.75 x 4907.19 5556.65 x x x 6544.6 3267.27 x x x 9063.33 4390.98 2541.53 6377.02 x 5968.12 3826.67 5050.64 6389.76 10605.3 8625.35 10948.9 x 4412.49 x 5511.77 x 8622.07 x x 4493.85 x x 5152.46 8339.15 5460.52 8156.33 5814.34 x 6883.87 1999.1 x 6069.67 x x x 5656.93 8226.19 5392.41 8387.7 3788.79 x x x +12001 Original post publication description: Cocaine response (2 x 10 mg/kg ip), locomotion in an open field from 30-45 min after second injection in an activity chamber for males and females [cm] None Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), locomotion in an open field from 30-45 min after second injection in an activity chamber for males and females [cm] x x x x 6252.76 1803.11 x 3048.87 2472.29 7569.52 3295.62 3808.6 3273.89 4744.18 2939.63 3755.93 5208.34 4682.23 5896.34 6213.28 x x x 4435.96 x 3671.4 4255.54 5262.44 x 5224.84 4195.86 7055.59 2796.34 x 964.677 x 5039.27 3693.02 8560.88 x 5417.56 5517.33 3505.57 4981.9 x x 4490.31 x 4041.87 4277.85 x x x 5505.91 1971.89 x x x 6955.5 3669.4 1863.79 4497.33 x 4363.64 3554.16 4044.34 4906.16 8390.56 6904.72 8648.24 x 3068.03 x 3910.82 x 6359.85 x x 3237.34 x x 3827.16 5970.11 3494.51 5446.08 4271.16 x 5795.45 1275.69 x 4744.72 x x x 4016.06 6375.58 3260.98 7625.65 3193.68 x x x +12002 Original post publication description: Cocaine response (2 x 10 mg/kg ip), locomotion in an open field from 45-60 min after second injection in an activity chamber for males and females [cm] None Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), locomotion in an open field from 45-60 min after second injection in an activity chamber for males and females [cm] x x x x 4424.87 1434.59 x 2342.72 2014.56 5571.94 3110.85 2991.91 2836.44 3738.71 2002.23 3048.73 4146.3 2105.0 3956.2 5146.32 x x x 3161.92 x 2648.72 3012.99 3731.74 x 4007.97 3445.83 5264.1 1913.3 x 264.179 x 4107.29 2999.52 6617.9 x 4094.15 4188.06 2381.18 2828.1 x x 3835.2 x 3769.48 3296.47 x x x 4716.05 1147.66 x x x 4973.2 3035.87 1118.13 2882.19 x 3199.53 2489.78 3455.27 3579.34 7002.67 5434.24 6435.71 x 2171.09 x 2909.63 x 4983.58 x x 2404.61 x x 3083.5 4103.96 2579.69 4254.94 3252.64 x 4794.52 520.602 x 3490.57 x x x 3394.57 4285.98 2078.98 6734.78 2623.8 x x x +12003 Original post publication description: Cocaine response (2 x 10 mg/kg ip), vertical activity (rears) from 15-30 min after second injection in an activity chamber for males and females [n beam breaks] None Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), vertical activity (rears) from 15-30 min after second injection in an activity chamber for males and females [n beam breaks] x x x x 278.706 341.85 x 314.917 186.75 381.6 123.81 316.238 269.538 612.897 135.643 321.2 403.083 562.889 438.667 511.227 x x x 285.5 x 479.87 335.133 571.591 x 421.833 361.13 346.4 344.871 x 123.059 x 465.261 200.407 601.1 x 711.862 701.375 409.162 389.235 x x 536.286 x 380.733 441.344 x x x 373.727 149.676 x x x 551.966 374.75 307.935 258.0 x 281.92 256.81 463.963 483.778 722.194 501.667 561.897 x 374.941 x 565.667 x 600.526 x x 423.114 x x 440.1 421.923 366.594 487.739 453.0 x 499.133 185.2 x 337.8 x x x 630.783 336.8 416.182 495.963 339.103 x x x +12004 Original post publication description: Cocaine response (2 x 10 mg/kg ip), vertical activity (rears) from 15-30 min after second injection in an activity chamber for males and females [n beam breaks] None Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), vertical activity (rears) from 15-30 min after second injection in an activity chamber for males and females [n beam breaks] x x x x 369.294 212.6 x 328.542 231.0 459.1 211.857 317.714 322.654 593.034 197.929 393.45 416.083 564.111 430.0 539.091 x x x 265.312 x 441.217 425.133 497.591 x 431.778 399.783 412.28 280.097 x 147.294 x 460.609 238.519 605.767 x 601.448 711.75 382.892 399.353 x x 560.381 x 396.867 402.562 x x x 431.136 199.676 x x x 569.586 440.0 380.032 285.625 x 340.04 349.19 523.0 489.852 768.111 589.636 577.931 x 356.147 x 581.857 x 620.737 x x 431.743 x x 467.933 455.731 416.562 459.565 424.889 x 495.4 145.8 x 352.8 x x x 588.826 347.2 308.485 517.593 392.077 x x x +12005 Original post publication description: Cocaine response (2 x 10 mg/kg ip), vertical activity (rears) from 30-45 min after second injection in an activity chamber for males and females [n beam breaks] None Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), vertical activity (rears) from 30-45 min after second injection in an activity chamber for males and females [n beam breaks] x x x x 356.353 174.5 x 295.75 286.333 430.7 213.143 281.19 261.962 473.207 220.786 321.15 337.708 421.056 375.833 500.182 x x x 279.812 x 357.739 397.6 439.5 x 404.833 361.609 387.36 266.742 x 109.059 x 453.783 233.889 620.033 x 501.069 657.25 300.784 369.412 x x 486.762 x 386.867 336.625 x x x 381.727 142.108 x x x 476.655 419.975 362.839 246.583 x 284.52 325.762 477.407 396.926 719.389 535.303 526.655 x 325.206 x 516.714 x 604.158 x x 352.429 x x 410.1 444.423 322.375 371.522 366.63 x 489.933 98.2 x 319.4 x x x 522.87 365.5 250.818 545.222 392.231 x x x +12006 Original post publication description: Cocaine response (2 x 10 mg/kg ip), vertical activity (rears) from 45-60 min after second injection in an activity chamber for males and females [n beam breaks] None Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), vertical activity (rears) from 45-60 min after second injection in an activity chamber for males and females [n beam breaks] x x x x 316.471 175.8 x 243.333 251.25 440.0 220.143 240.524 279.654 432.103 178.643 319.8 287.708 226.889 265.333 453.364 x x x 230.625 x 281.783 307.933 355.636 x 387.611 335.522 354.56 217.0 x 55.1176 x 433.565 232.815 580.2 x 411.448 556.875 229.297 257.176 x x 476.429 x 387.267 295.844 x x x 364.227 94.2432 x x x 387.069 402.725 255.774 196.875 x 229.96 280.952 458.444 350.926 657.25 499.909 443.172 x 280.941 x 421.571 x 555.421 x x 305.914 x x 364.5 405.808 300.094 361.739 286.778 x 427.0 45.4 x 268.92 x x x 530.652 292.9 199.879 543.444 353.128 x x x +12007 Original post publication description: Conditioned place preference (CPP) baseline control for cocaine CPP test, time in drug-paired compartment for males and females [sec] None Central nervous system, pharmacology, behavior, learning and memory: Conditioned place preference (CPP) baseline control for cocaine CPP test, time in drug-paired compartment for males and females [sec] x x x x 397.763 389.864 x 396.612 423.092 x 374.565 468.145 325.153 424.08 283.74 404.459 394.75 388.869 464.05 414.275 x x x 472.886 x 390.528 461.464 408.6 x 469.15 420.857 362.625 417.621 x 239.02 x 344.463 390.488 331.05 x 342.442 391.546 405.307 313.318 x x 425.206 x 372.406 356.087 x x x 352.425 325.342 x x x 360.339 436.231 391.4 309.575 x 410.053 308.864 358.0 365.059 406.357 429.987 382.297 x 365.426 x 425.315 x 415.027 x x 368.094 x x 459.152 379.484 385.557 375.143 441.529 x 432.814 514.567 x 399.632 x x x 442.725 429.8 374.607 388.585 463.403 x x x +12008 Original post publication description: Conditioned place preference (CPP) baseline control for cocaine CPP test, time spent in saline-paired unconditioned side before conditioning for males and females [sec] None Central nervous system, pharmacology, behavior, learning and memory: Conditioned place preference (CPP) baseline control for cocaine CPP test, time spent in saline-paired unconditioned side before conditioning for males and females [sec] x x x x 433.975 563.709 x 522.717 445.242 x 490.32 470.832 428.491 463.987 509.54 442.241 489.542 426.175 442.725 436.754 x x x 417.527 x 436.394 426.343 484.033 x 432.317 493.889 499.619 470.931 x 598.68 x 449.774 437.024 471.892 x 552.842 460.337 454.519 377.691 x x 484.869 x 490.288 490.698 x x x 467.083 440.862 x x x 531.813 463.737 439.311 444.778 x 476.2 447.109 511.047 406.806 447.767 457.767 432.175 x 459.224 x 499.081 x 414.705 x x 453.396 x x 463.038 505.966 483.078 448.339 440.918 x 430.543 476.933 x 469.024 x x x 480.089 458.01 478.314 503.455 438.735 x x x +12009 Original post publication description: Cocaine response (3 x 3.2 mg/kg ip, Days 2, 3, 4), conditioned place preference (CPP), time in drug-paired compartment on Day 5 for males and females [sec] None Central nervous system, pharmacology, behavior, learning and memory: Cocaine response (3 x 3.2 mg/kg ip, days 2, 3, 4), conditioned place preference (CPP), time in drug-paired compartment on day 5 for males and females [sec] x x x x 422.319 471.965 x 490.346 467.45 x 379.195 660.964 381.135 544.27 436.4 451.505 477.737 453.294 539.825 450.517 x x x 545.223 x 469.189 519.114 373.742 x 605.617 297.661 378.834 568.125 x 231.99 x 455.603 451.094 399.745 x 413.6 516.391 490.374 533.753 x x 417.892 x 356.513 439.353 x x x 472.542 357.898 x x x 363.989 457.493 412.611 406.644 x 467.256 463.368 440.562 447.188 479.864 411.721 430.394 x 398.124 x 469.008 x 510.564 x x 410.83 x x 458.23 485.57 436.145 412.558 448.706 x 442.4 326.75 x 450.044 x x x 422.906 485.36 416.998 419.522 479.643 x x x +12010 Original post publication description: Cocaine response (3 x 3.2 mg/kg ip, Days 2, 3, 4), conditioned place preference (CPP), time in unconditioned saline-paired compartment on Day 5 for males and females [sec] None Central nervous system, pharmacology, behavior, learning and memory: Cocaine response (3 x 3.2 mg/kg ip, days 2, 3, 4), conditioned place preference (CPP), time in unconditioned saline-paired compartment on day 5 for males and females [sec] x x x x 353.237 502.405 x 391.858 415.008 x 520.515 262.545 504.624 402.69 329.69 334.882 425.076 382.312 311.925 406.767 x x x 416.718 x 369.296 393.4 434.417 x 373.083 523.232 380.331 328.045 x 643.14 x 384.916 410.271 442.033 x 425.65 382.545 394.765 277.021 x x 411.036 x 476.125 438.867 x x x 447.058 353.871 x x x 543.337 473.941 505.953 392.831 x 422.206 361.964 476.088 325.271 382.811 427.683 432.478 x 371.124 x 445.996 x 365.132 x x 452.828 x x 413.645 373.893 412.9 356.377 416.318 x 396.943 405.6 x 473.706 x x x 488.783 416.81 405.974 475.848 462.337 x x x +12011 Original post publication description: Conditioned place preference (CPP) baseline control for cocaine CPP test, percentage of time spent in conditioned side before conditioning for males and females [%] None Central nervous system, pharmacology, behavior, learning and memory: Conditioned place preference (CPP) baseline control for cocaine CPP test, percentage of time spent in conditioned side before conditioning for males and females [%] x x x x 47.8774 41.0773 x 43.2362 48.0929 x 43.6796 49.7033 43.2763 47.9817 36.0795 48.1167 44.7271 47.0787 51.27 48.4541 x x x 52.9346 x 47.065 51.5407 45.8322 x 51.8294 46.0017 41.8795 46.9072 x 29.5551 x 43.1972 47.3701 41.26 x 38.5823 46.1526 46.9573 45.5224 x x 46.5792 x 43.4289 42.2865 x x x 43.1771 42.4401 x x x 40.132 48.7626 46.3293 41.0806 x 46.2438 41.6103 41.0844 46.8667 47.4856 48.4281 46.7983 x 44.4069 x 45.9008 x 50.098 x x 44.5679 x x 49.9041 42.45 44.3466 45.212 49.979 x 49.9002 52.19 x 45.9638 x x x 47.8088 48.3158 44.0991 43.3964 51.1721 x x x +12012 Original post publication description: Cocaine response (3 x 3.2 mg/kg ip, Days 2, 3, and 4), conditioned place preference (CPP), change in time in cocaine-paired compartment relative to baseline (Day 5 minus Day 1) for males and females [sec] None Central nervous system, pharmacology, behavior, learning and memory: Cocaine response (3 x 3.2 mg/kg ip, days 2, 3, and 4), conditioned place preference (CPP), change in time in cocaine-paired compartment relative to baseline (day 5 minus day 1) for males and females [sec] x x x x 24.5562 79.97 x 93.7333 44.3583 x 4.63 192.818 55.9824 120.19 152.66 47.0455 82.9868 64.425 75.775 36.2417 x x x 72.3364 x 74.9964 57.65 -34.8583 x 136.467 -123.196 16.2094 149.947 x -7.03 x 111.139 60.6059 68.695 x 71.1579 81.8125 85.0667 220.435 x x -7.31389 x 31.55 83.265 x x x 120.117 32.5558 x x x 3.65 21.2611 21.2105 97.0694 x 57.2031 154.505 82.5618 82.1294 69.5023 -18.2667 48.0969 x 32.6974 x 43.6923 x 95.5364 x x 42.736 x x -0.9225 100.65 50.5875 36.3654 7.17647 x 9.58571 -187.817 x 50.4118 x x x -19.8194 55.56 42.3905 30.9375 16.24 x x x +12013 Original post publication description: Cocaine response (3 x 3.2 mg/kg ip, Days 2, 3, and 4), conditioned place preference (CPP), change in percentage time in cocaine-paired compartment relative to baseline (Day 5 minus Day 1) for males and females [% change] None Central nervous system, pharmacology, behavior, learning and memory: Cocaine response (3 x 3.2 mg/kg ip, days 2, 3, and 4), conditioned place preference (CPP), change in percentage time in cocaine-paired compartment relative to baseline (day 5 minus day 1) for males and females [% change] x x x x 7.2165 6.93789 x 11.413 4.89223 x -0.802755 21.4102 -0.058834 9.2793 21.8215 9.54156 8.32202 7.65657 12.07 4.10968 x x x 3.7118 x 9.16671 5.26925 0.821648 x 9.92777 -8.79587 7.63028 16.5368 x -2.09512 x 11.0269 5.38153 6.87069 x 9.71925 10.9094 8.78475 19.8748 x x 3.6014 x 5.74 7.92445 x x x 8.29045 7.39579 x x x -0.065991 0.507609 -0.497756 9.93197 x 6.61011 14.1714 7.55735 11.4353 7.99871 0.667304 3.4066 x 6.83382 x 5.8715 x 8.22222 x x 3.06789 x x 3.35643 13.184 6.75474 9.10703 1.81803 x 2.76519 -7.7 x 2.6129 x x x -0.898556 6.29417 6.57214 3.58265 -0.414655 x x x +12014 Original post publication description: Novel open field behavior, locomotion in the center from 0-60 min for males and females [n beam breaks] None Central nervous system, behavior: Novel open field behavior, locomotion in the center from 0-60 min for males and females [n beam breaks] x x x x 1721.65 1957.38 x 2796.04 1913.17 3508.8 1778.71 3403.81 1057.81 2675.45 733.357 1852.62 3043.25 1122.33 1871.83 2374.77 x x x 2221.94 x 610.5 838.8 2956.09 x 1069.0 2602.35 2633.04 1400.87 x 403.765 x 2256.09 1556.11 3013.57 x 2157.72 1676.04 942.595 2019.0 x x 2836.0 x 2442.05 1639.09 x x x 2428.73 244.189 x x x 2509.97 1826.53 506.581 1117.08 x 2333.23 1769.86 1728.78 1572.81 3142.22 3267.69 2703.21 x 1223.29 x 2091.78 x 2701.79 x x 2208.6 x x 1204.17 1442.88 621.656 1976.68 1752.55 x 2789.8 906.8 x 2052.2 x x x 1960.3 2424.73 2867.15 3390.11 1399.67 x x x +12015 Original post publication description: Novel open field behavior, locomotion in the center from 0-60 min for males and females [cm] None Central nervous system, behavior: Novel open field behavior, locomotion in the center from 0-60 min for males and females [cm] x x x x 5556.95 5483.38 x 7532.55 5630.44 9554.82 5137.88 8872.53 3555.33 7800.05 2473.07 5512.64 7991.54 3880.0 4867.01 6537.77 x x x 6854.02 x 1925.12 2931.86 7629.41 x 3454.2 7207.22 7977.94 4253.02 x 1370.67 x 6560.33 4561.79 8601.47 x 6352.36 5120.55 2794.19 5995.13 x x 8399.83 x 6619.36 5093.87 x x x 6938.38 916.377 x x x 7253.94 5416.73 1840.83 3586.32 x 6711.33 5350.13 5520.07 5091.96 8767.08 9631.81 7701.87 x 3734.04 x 6030.59 x 7647.91 x x 6327.83 x x 3933.5 4541.92 2036.16 5691.39 4832.39 x 8276.81 3178.4 x 6102.41 x x x 5674.13 7044.12 7305.42 9154.79 4217.36 x x x +12016 Original post publication description: Novel open field behavior, vertical activity (rears) from 0-60 min in the center for males and females [n beam breaks] None Central nervous system, behavior: Novel open field behavior, vertical activity (rears) from 0-60 min in the center for males and females [n beam breaks] x x x x 295.176 296.429 x 372.167 328.667 513.6 228.429 471.048 210.346 661.379 98.5 363.238 311.542 240.167 119.167 242.636 x x x 259.625 x 108.4 166.467 262.182 x 155.333 356.435 608.8 231.71 x 53.9412 x 386.739 172.185 602.933 x 350.759 499.84 125.27 295.765 x x 626.905 x 338.182 235.281 x x x 210.273 21.1622 x x x 452.759 330.45 230.194 161.417 x 329.885 265.048 366.481 335.778 699.417 700.114 487.034 x 318.235 x 341.174 x 405.316 x x 526.686 x x 239.267 398.308 168.719 304.64 263.414 x 585.6 206.0 x 264.16 x x x 596.435 297.091 227.97 506.536 318.051 x x x +12017 Original post publication description: Cocaine response (10 mg/kg ip), locomotion from 0-60 min after first cocaine injection in an activity chamber for males and females [n beam breaks] None Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), locomotion from 0-60 min after first cocaine injection in an activity chamber for males and females [n beam breaks] x x x x 6934.65 3057.55 x 3049.08 2668.67 9034.4 3717.14 5440.9 3558.69 7171.38 2381.43 3494.9 7254.46 5387.72 4949.83 8682.23 x x x 6501.38 x 3804.33 3557.0 6824.86 x 6502.72 5108.96 9578.32 3764.16 x 1320.71 x 7034.26 4497.44 12875.6 x 6737.9 8270.42 3634.16 5618.88 x x 6113.19 x 6004.12 4166.94 x x x 5084.45 2103.97 x x x 7984.59 4656.12 2695.74 5650.58 x 6433.92 2753.76 4556.59 6550.37 11179.6 7793.26 11397.8 x 3898.06 x 4800.77 x 9906.42 x x 4490.83 x x 4108.0 8053.65 3550.12 5826.08 5429.67 x 8109.4 1569.4 x 5929.2 x x x 6545.78 8128.55 5764.03 10610.7 3888.51 x x x +12018 Original post publication description: Cocaine response (10 mg/kg ip), locomotion in an open field from 0-60 min after first cocaine injection for males and females [cm] None Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), locomotion in an open field from 0-60 min after first cocaine injection for males and females [cm] x x x x 20165.7 9459.62 x 9313.42 9017.3 24644.3 11341.5 16690.3 11678.3 21331.6 7800.44 10876.3 20570.1 17656.5 15140.2 24825.0 x x x 19546.8 x 11985.2 11360.9 20617.1 x 19898.0 15024.1 27111.8 11871.0 x 4414.05 x 21611.7 13332.0 34685.2 x 20537.3 25060.6 11420.7 17631.1 x x 18466.6 x 18389.8 13950.1 x x x 16230.6 7190.1 x x x 23044.5 14322.9 8593.27 17093.3 x 19259.0 8950.38 14498.3 20491.2 31434.5 23257.7 31955.0 x 12452.3 x 15305.8 x 28056.7 x x 13786.9 x x 13671.2 23827.8 11912.2 17391.0 16441.8 x 24363.3 6040.87 x 18443.7 x x x 19540.4 22844.0 15984.0 30606.7 12435.2 x x x +12019 Original post publication description: Cocaine response (10 mg/kg ip), vertical activity (rears) in the open field from 0-60 min after first cocaine injection for males and females [n beam breaks] None Central nervous system, pharmacology, behavior: Cocaine response (10 mg/kg ip), vertical activity (rears) in the open field from 0-60 min after first cocaine injection for males and females [n beam breaks] x x x x 1200.06 824.7 x 841.875 901.667 1327.7 686.762 1172.29 909.462 1802.72 544.071 1204.29 1076.58 1450.39 958.0 1597.32 x x x 999.938 x 1009.67 799.6 1589.82 x 1447.44 1232.7 1422.92 958.032 x 379.824 x 1590.96 688.333 2181.83 x 1802.69 2500.08 1030.46 1334.35 x x 2002.57 x 1551.19 1191.19 x x x 1105.0 452.514 x x x 1467.48 1482.47 1232.55 891.042 x 1207.58 902.0 1611.56 1620.0 2480.89 1648.85 1998.52 x 1387.56 x 1577.05 x 2182.79 x x x x x x x x x x x x x x x x x x x x x x x x x x +12020 Original post publication description: Novel open field behavior, locomotion in the center from 0-15 min for males and females [n beam breaks] None Central nervous system, behavior: Novel open field behavior, locomotion in the center from 0-15 min for males and females [n beam breaks] x x x x 519.471 843.905 x 924.792 361.833 930.0 247.238 871.952 312.154 927.483 226.357 420.714 1164.88 262.389 552.667 667.045 x x x 586.75 x 239.833 167.267 789.318 x 437.278 734.652 614.44 526.323 x 273.765 x 675.478 343.481 878.033 x 873.138 490.56 403.351 522.529 x x 871.524 x 483.545 446.406 x x x 654.727 145.459 x x x 832.586 563.725 210.742 146.542 x 762.038 533.238 397.148 312.407 903.222 826.971 680.69 x 336.971 x 571.609 x 931.684 x x 581.857 x x 329.167 400.769 192.656 683.96 467.414 x 807.333 331.6 x 691.68 x x x 778.609 684.0 874.061 820.143 390.128 x x x +12021 Original post publication description: Novel open field behavior, locomotion in the center from 15-30 min for males and females [n beam breaks] None Central nervous system, behavior: Novel open field behavior, locomotion in the center from 15-30 min for males and females [n beam breaks] x x x x 455.471 514.333 x 877.5 457.917 988.6 565.857 951.81 342.308 721.483 234.286 408.619 866.208 405.889 565.333 648.409 x x x 723.062 x 191.333 274.4 853.818 x 282.833 767.565 702.96 443.129 x 103.353 x 604.957 465.37 752.6 x 566.034 408.16 301.622 619.412 x x 775.714 x 653.136 463.812 x x x 773.409 67.5135 x x x 781.207 497.125 138.871 360.417 x 719.231 506.429 560.889 448.778 876.0 806.457 747.828 x 363.118 x 613.217 x 772.895 x x 623.686 x x 350.167 403.077 195.844 595.64 494.345 x 798.4 187.0 x 637.36 x x x 513.174 734.909 824.758 891.25 451.59 x x x +12022 Original post publication description: Novel open field behavior, locomotion in the center from 30-45 min for males and females [n beam breaks] None Central nervous system, behavior: Novel open field behavior, locomotion in the center from 30-45 min for males and females [n beam breaks] x x x x 444.529 353.19 x 576.25 560.333 965.8 521.952 827.0 247.923 552.103 165.5 492.667 610.542 265.722 445.833 596.364 x x x 549.5 x 121.567 268.8 704.182 x 205.611 640.217 726.68 274.0 x 18.7059 x 543.217 435.37 689.6 x 416.103 430.8 153.649 506.176 x x 655.81 x 653.5 405.938 x x x 627.636 23.3784 x x x 582.448 425.175 95.6774 334.708 x 541.538 432.571 458.852 471.593 755.944 855.314 680.448 x 318.0 x 509.913 x 574.789 x x 551.0 x x 282.833 344.615 142.562 411.92 428.138 x 673.267 207.2 x 466.04 x x x 358.652 588.0 663.333 866.321 330.436 x x x +12023 Original post publication description: Novel open field behavior, locomotion in the center from 45-60 min for males and females [n beam breaks] None Central nervous system, behavior: Novel open field behavior, locomotion in the center from 45-60 min for males and females [n beam breaks] x x x x 302.176 245.952 x 417.5 533.083 624.4 443.667 753.048 155.423 474.379 107.214 530.619 401.625 188.333 308.0 462.955 x x x 362.625 x 57.7667 128.333 608.773 x 143.278 459.913 588.96 157.419 x 7.94118 x 432.435 311.889 693.333 x 302.448 346.52 83.973 370.882 x x 532.952 x 651.864 322.938 x x x 372.955 7.83784 x x x 313.724 340.5 61.2903 275.417 x 310.423 297.619 311.889 340.037 607.056 778.943 594.241 x 205.206 x 397.043 x 422.421 x x 452.057 x x 242.0 294.423 90.5938 285.16 362.655 x 510.8 181.0 x 257.12 x x x 309.87 417.818 505.0 812.393 227.513 x x x +12024 Original post publication description: Novel open field behavior, locomotion in the center from 0-15 min for males and females [cm] None Central nervous system, behavior: Novel open field behavior, locomotion in the center from 0-15 min for males and females [cm] x x x x 1604.64 2263.96 x 2397.44 1111.03 2551.44 744.066 2240.45 1097.41 2594.38 732.929 1267.33 2987.36 912.897 1495.97 1868.69 x x x 1856.65 x 759.627 607.005 2035.41 x 1467.29 2004.95 1932.51 1559.44 x 920.184 x 1959.97 1069.25 2494.35 x 2436.08 1466.93 1167.84 1574.3 x x 2467.13 x 1329.86 1378.37 x x x 1947.7 532.723 x x x 2386.75 1650.31 732.81 578.552 x 2186.52 1614.11 1372.74 1000.71 2460.02 2432.39 2026.13 x 1053.2 x 1640.12 x 2501.5 x x 1642.75 x x 1129.35 1242.08 655.807 2039.39 1324.04 x 2378.11 1196.58 x 2026.82 x x x 2108.88 2010.43 2184.56 2258.36 1177.15 x x x +12025 Original post publication description: Novel open field behavior, locomotion in the center from 15-30 min for males and females [cm] None Central nervous system, behavior: Novel open field behavior, locomotion in the center from 15-30 min for males and females [cm] x x x x 1464.8 1455.96 x 2329.37 1362.32 2659.84 1587.77 2465.34 1126.46 2086.12 766.231 1243.35 2273.52 1335.18 1468.66 1761.21 x x x 2131.44 x 601.428 970.576 2164.7 x 920.603 2078.86 2118.14 1352.39 x 352.082 x 1751.67 1324.57 2162.09 x 1719.56 1258.03 884.627 1803.84 x x 2306.43 x 1750.4 1411.09 x x x 2180.94 264.405 x x x 2272.52 1457.95 512.442 1163.7 x 2070.57 1548.39 1726.12 1471.98 2395.28 2368.74 2096.4 x 1092.71 x 1735.71 x 2219.76 x x 1758.62 x x 1142.85 1250.34 633.419 1694.44 1360.88 x 2307.58 667.522 x 1898.75 x x x 1507.36 2099.19 2093.12 2405.42 1331.69 x x x +12026 Original post publication description: Novel open field behavior, locomotion in the center from 30-45 min for males and females [cm] None Central nervous system, behavior: Novel open field behavior, locomotion in the center from 30-45 min for males and females [cm] x x x x 1473.72 1023.26 x 1603.85 1639.06 2620.97 1493.11 2165.79 811.881 1681.44 594.81 1445.16 1620.32 958.743 1149.73 1612.06 x x x 1661.01 x 379.784 898.216 1813.26 x 627.876 1807.86 2160.23 850.819 x 65.6158 x 1567.76 1234.39 1978.66 x 1266.79 1323.77 479.554 1506.93 x x 1951.6 x 1768.04 1280.49 x x x 1755.75 88.7473 x x x 1665.61 1290.23 349.384 998.194 x 1552.95 1305.98 1422.16 1512.25 2154.57 2499.96 1899.32 x 955.938 x 1487.79 x 1662.32 x x 1577.85 x x 890.423 1091.7 454.826 1165.51 1174.74 x 2042.9 690.609 x 1403.18 x x x 1102.76 1705.44 1712.27 2308.81 991.194 x x x +12027 Original post publication description: Novel open field behavior, locomotion in the center from 45-60 min for males and females [cm] None Central nervous system, behavior: Novel open field behavior, locomotion in the center from 45-60 min for males and females [cm] x x x x 1013.79 740.199 x 1201.9 1518.03 1722.56 1312.93 2000.94 519.572 1438.11 379.105 1556.8 1110.35 673.181 752.654 1295.82 x x x 1204.93 x 184.277 456.067 1616.04 x 438.436 1315.55 1767.06 490.377 x 32.7917 x 1280.93 933.586 1966.37 x 929.916 1071.82 262.167 1110.06 x x 1674.66 x 1771.05 1023.93 x x x 1053.99 30.5011 x x x 929.062 1018.24 246.191 845.882 x 901.291 881.648 999.054 1107.03 1757.21 2330.72 1680.02 x 632.192 x 1166.96 x 1264.33 x x 1348.61 x x 770.885 957.794 292.111 792.039 972.736 x 1548.22 623.687 x 773.659 x x x 955.127 1229.06 1315.47 2182.2 717.323 x x x +12028 Original post publication description: Novel open field behavior, vertical activity (rears) from 0-15 min in the center for males and females [n beam breaks] None Central nervous system, behavior: Novel open field behavior, vertical activity (rears) from 0-15 min in the center for males and females [n beam breaks] x x x x 58.2353 98.0952 x 84.4583 36.4167 108.9 21.5714 68.2381 36.1923 157.448 20.5 37.9524 96.875 40.8889 37.0 59.5909 x x x 52.875 x 36.7 25.6667 39.9545 x 53.5 66.6956 120.04 79.7742 x 35.1176 x 57.6522 32.3333 122.0 x 94.7931 109.76 38.8108 43.3529 x x 142.381 x 47.5455 61.375 x x x 53.6818 8.97297 x x x 141.0 82.7 60.2903 18.3333 x 94.5385 69.7619 72.7037 53.7407 124.111 118.257 104.414 x 58.8529 x 57.8696 x 80.0526 x x 81.4857 x x 46.6333 62.2692 35.3125 115.0 54.4138 x 113.2 37.4 x 71.8 x x x 154.739 67.0 55.9091 124.929 66.641 x x x +12029 Original post publication description: Novel open field behavior, vertical activity (rears) from 15-30 min in the center for males and females [n beam breaks] None Central nervous system, behavior: Novel open field behavior, vertical activity (rears) from 15-30 min in the center for males and females [n beam breaks] x x x x 87.0 88.8095 x 119.375 75.5833 159.5 72.381 135.0 61.5769 193.034 30.4286 92.2857 98.9167 69.8333 37.5 65.6818 x x x 78.875 x 33.2667 52.7333 74.8182 x 56.2778 94.1304 180.6 76.7742 x 14.1765 x 100.609 52.6296 153.567 x 103.069 122.0 45.5135 107.471 x x 177.524 x 89.7273 70.7188 x x x 67.0909 7.64865 x x x 144.931 98.325 63.8387 47.2083 x 110.5 71.8571 104.889 87.963 196.083 165.886 129.586 x 93.6176 x 92.0435 x 116.632 x x 142.343 x x 75.7667 113.462 55.0625 87.64 76.5862 x 161.2 48.8 x 82.04 x x x 170.739 83.5455 67.2424 129.393 102.256 x x x +12030 Original post publication description: Novel open field behavior, vertical activity (rears) from 30-45 min in the center for males and females [n beam breaks] None Central nervous system, behavior: Novel open field behavior, vertical activity (rears) from 30-45 min in the center for males and females [n beam breaks] x x x x 88.6471 63.5714 x 90.75 104.833 148.8 70.5714 134.333 56.8077 160.241 25.2857 107.476 62.9583 78.4444 32.8333 65.3182 x x x 66.6875 x 24.9 59.8667 73.8182 x 27.0 102.522 165.2 47.4516 x 1.76471 x 106.13 48.7407 162.267 x 85.5517 149.4 26.5135 79.1176 x x 167.143 x 95.7273 56.3438 x x x 56.2727 3.75676 x x x 101.897 86.45 64.9677 48.2917 x 76.3462 71.4286 105.111 103.704 210.167 206.886 125.138 x 93.7059 x 103.739 x 110.895 x x 152.314 x x 59.2 113.0 47.1562 57.2 70.0345 x 166.667 61.0 x 72.16 x x x 150.391 87.6364 55.2121 132.714 84.1026 x x x +12031 Original post publication description: Novel open field behavior, vertical activity (rears) from 45-60 min in the center for males and females [n beam breaks] None Central nervous system, behavior: Novel open field behavior, vertical activity (rears) from 45-60 min in the center for males and females [n beam breaks] x x x x 61.2941 45.9524 x 77.5833 111.833 96.4 63.9048 133.476 34.9231 150.655 22.2857 125.524 52.7917 51.0 11.8333 52.0455 x x x 61.1875 x 13.5333 28.2 73.5909 x 18.5556 93.087 142.96 27.7097 x 2.88235 x 122.348 38.4815 165.1 x 67.3448 118.68 14.4324 65.8235 x x 139.857 x 105.182 46.8438 x x x 33.2273 0.783784 x x x 64.931 62.975 41.0968 47.5833 x 48.5 52.0 83.7778 90.3704 169.056 209.086 127.897 x 72.0588 x 87.5217 x 97.7368 x x 150.543 x x 57.6667 109.577 31.1875 44.8 62.3793 x 144.533 58.8 x 38.16 x x x 120.565 58.9091 49.6061 119.5 65.0513 x x x +12032 Original post publication description: Novel open field behavior, locomotion in the periphery from 0-15 min for males and females in the cocaine test battery [n beam breaks] None Central nervous system, pharmacology, behavior: Novel open field behavior, locomotion in the periphery from 0-15 min for males and females in the cocaine test battery [n beam breaks] x x x x 509.353 444.571 x 1105.08 513.0 682.6 377.81 955.143 440.462 569.862 377.786 478.952 913.75 510.556 776.667 533.5 x x x 397.75 x 422.933 380.0 1524.36 x 546.722 704.913 486.28 435.871 x 391.824 x 575.826 479.63 739.267 x 795.759 389.4 648.946 730.882 x x 480.143 x 642.318 543.938 x x x 797.318 346.946 x x x 884.897 613.95 351.29 355.667 x 512.577 538.524 408.444 523.815 689.417 484.857 619.552 x 515.588 x 554.522 x 612.0 x x 611.4 x x 337.6 581.038 442.094 604.92 567.931 x 556.533 474.2 x 521.16 x x x 481.739 687.636 1008.76 823.429 295.667 x x x +12033 Original post publication description: Novel open field behavior, locomotion in the periphery from 15-30 min for males and females in the cocaine test battery [n beam breaks] None Central nervous system, pharmacology, behavior: Novel open field behavior, locomotion in the periphery from 15-30 min for males and females in the cocaine test battery [n beam breaks] x x x x 353.588 302.238 x 676.542 342.0 693.8 337.905 708.571 322.231 338.31 360.5 313.095 591.333 501.444 660.5 431.227 x x x 300.062 x 275.0 369.067 1128.95 x 402.778 500.217 433.08 298.452 x 165.529 x 442.13 354.926 520.133 x 537.0 341.32 370.838 627.647 x x 314.381 x 599.818 488.25 x x x 769.227 98.7297 x x x 562.207 434.9 210.323 377.625 x 394.154 429.762 412.407 476.407 553.833 427.429 630.345 x 373.588 x 353.478 x 465.526 x x 431.629 x x 241.367 439.385 343.688 537.6 431.103 x 544.667 185.0 x 410.76 x x x 309.435 484.455 703.697 821.536 233.359 x x x +12034 Original post publication description: Novel open field behavior, locomotion in the periphery from 30-45 min for males and females in the cocaine test battery [n beam breaks] None Central nervous system, pharmacology, behavior: Novel open field behavior, locomotion in the periphery from 30-45 min for males and females in the cocaine test battery [n beam breaks] x x x x 279.118 228.905 x 461.875 291.083 629.2 308.143 618.238 228.192 255.172 226.929 300.619 431.25 366.278 412.5 389.0 x x x 248.0 x 155.733 283.2 871.364 x 215.278 377.348 385.24 223.097 x 44.8235 x 358.696 306.222 451.967 x 371.793 319.56 220.324 476.882 x x 282.429 x 643.636 403.375 x x x 552.773 23.1622 x x x 439.931 356.275 122.516 225.625 x 323.692 352.571 337.926 438.259 476.194 404.171 507.793 x 291.971 x 266.087 x 339.211 x x 359.886 x x 199.867 364.231 227.344 395.2 337.345 x 387.8 147.6 x 274.24 x x x 232.913 315.364 500.939 767.357 185.487 x x x +12035 Original post publication description: Novel open field behavior, locomotion in the periphery from 45-60 min for males and females in the cocaine test battery [n beam breaks] None Central nervous system, pharmacology, behavior: Novel open field behavior, locomotion in the periphery from 45-60 min for males and females in the cocaine test battery [n beam breaks] x x x x 199.824 191.667 x 304.542 254.333 486.4 273.857 524.095 136.5 219.345 128.571 254.857 287.167 253.889 375.667 334.727 x x x 191.25 x 63.1667 161.867 624.045 x 133.944 301.043 308.2 144.677 x 7.41177 x 285.435 229.481 440.433 x 242.138 279.16 117.865 346.118 x x 236.19 x 577.364 334.281 x x x 339.409 14.4595 x x x 272.897 264.8 73.0 175.292 x 221.692 258.524 220.037 297.037 375.667 393.429 425.724 x 192.618 x 226.435 x 253.684 x x 285.457 x x 162.767 280.423 125.0 290.08 255.31 x 333.133 113.6 x 156.32 x x x 180.478 244.182 336.273 686.071 144.923 x x x +12036 Original post publication description: Novel open field behavior, locomotion from 0-15 min in the periphery for males and females in the cocaine test battery [cm] None Central nervous system, pharmacology, behavior: Novel open field behavior, locomotion from 0-15 min in the periphery for males and females in the cocaine test battery [cm] x x x x 1959.06 1785.84 x 3729.19 2055.88 2483.57 1522.12 3300.37 1803.1 2156.75 1655.19 1831.05 3216.08 2073.25 2902.08 2060.82 x x x 1770.78 x 1753.24 1796.55 4976.96 x 2250.42 2581.81 2038.22 1800.76 x 1673.69 x 2249.05 1982.28 2791.79 x 2835.64 1725.7 2540.95 2757.64 x x 1967.56 x 2487.5 2114.29 x x x 2991.66 1538.69 x x x 3210.37 2433.45 1481.61 1629.98 x 2076.81 2094.19 1710.64 2105.31 2560.52 1991.45 2417.92 x 2064.57 x 2260.76 x 2285.95 x x 2327.94 x x 1533.29 2489.6 1910.05 2412.19 2226.34 x 2216.76 2006.81 x 2138.97 x x x 1875.69 2596.26 3396.29 3066.95 1427.19 x x x +12037 Original post publication description: Novel open field behavior, locomotion from 15-30 min in the periphery for males and females in the cocaine test battery [cm] None Central nervous system, pharmacology, behavior: Novel open field behavior, locomotion from 15-30 min in the periphery for males and females in the cocaine test battery [cm] x x x x 1458.93 1232.93 x 2419.91 1451.12 2434.67 1449.86 2519.58 1395.39 1382.62 1455.52 1270.03 2209.27 2056.02 2488.1 1714.9 x x x 1379.11 x 1103.93 1578.26 3823.82 x 1610.44 1881.56 1789.15 1299.44 x 740.964 x 1794.18 1441.17 2113.81 x 2023.77 1540.17 1477.5 2332.89 x x 1382.23 x 2314.66 1913.38 x x x 2810.81 466.594 x x x 2077.04 1768.96 927.119 1496.47 x 1621.92 1717.53 1682.23 1904.48 2149.46 1787.99 2296.23 x 1534.71 x 1516.26 x 1699.33 x x 1707.86 x x 1149.34 1966.37 1461.07 2101.93 1686.3 x 2130.97 849.094 x 1678.37 x x x 1274.79 1887.22 2374.65 3031.61 1174.87 x x x +12038 Original post publication description: Novel open field behavior, locomotion from 30-45 min in the periphery for males and females in the cocaine test battery [cm] None Central nervous system, pharmacology, behavior: Novel open field behavior, locomotion from 30-45 min in the periphery for males and females in the cocaine test battery [cm] x x x x 1221.57 972.432 x 1690.29 1278.41 2250.93 1284.12 2244.44 1000.23 1083.27 1002.56 1226.51 1660.21 1504.41 1538.52 1540.29 x x x 1181.57 x 614.296 1282.68 3061.44 x 849.334 1475.27 1608.07 988.528 x 193.615 x 1535.33 1251.0 1873.34 x 1420.75 1503.34 889.467 1833.68 x x 1256.47 x 2465.34 1651.87 x x x 2054.83 115.778 x x x 1618.28 1460.96 566.716 890.823 x 1286.65 1441.97 1400.94 1737.24 1880.05 1722.25 1825.32 x 1198.29 x 1181.33 x 1314.53 x x 1456.52 x x 964.756 1666.48 970.822 1492.54 1292.5 x 1648.12 716.598 x 1115.63 x x x 1001.93 1291.17 1761.01 2859.57 937.974 x x x +12039 Original post publication description: Novel open field behavior, locomotion from 45-60 min in the periphery for males and females in the cocaine test battery [cm] None Central nervous system, pharmacology, behavior: Novel open field behavior, locomotion from 45-60 min in the periphery for males and females in the cocaine test battery [cm] x x x x 901.307 822.263 x 1168.43 1077.61 1807.15 1143.52 1943.73 619.713 937.167 563.909 1038.88 1135.83 1081.12 1344.51 1292.64 x x x 907.735 x 259.078 742.621 2280.53 x 510.366 1185.47 1275.95 609.1 x 38.5854 x 1263.24 944.846 1842.6 x 934.038 1306.96 473.756 1366.12 x x 1068.83 x 2232.69 1368.28 x x x 1287.26 66.346 x x x 1009.57 1068.77 339.341 708.151 x 880.196 1011.26 925.075 1203.95 1547.97 1686.35 1574.85 x 824.585 x 1030.62 x 997.729 x x 1175.34 x x 775.546 1317.7 538.016 1113.31 976.022 x 1398.5 638.617 x 641.659 x x x 816.423 996.96 1212.07 2589.32 735.719 x x x +12040 Original post publication description: Novel open field behavior, vertical activity (rears) in the periphery from 0-15 min for males and females [n beam breaks] None Central nervous system, behavior: Novel open field behavior, vertical activity (rears) in the periphery from 0-15 min for males and females [n beam breaks] x x x x 148.294 201.667 x 245.583 204.083 213.1 126.619 281.524 142.577 205.103 144.429 165.333 232.708 211.944 299.167 213.773 x x x 117.75 x 186.433 145.667 244.909 x 205.778 230.217 220.92 207.613 x 169.647 x 241.957 161.667 258.5 x 265.966 285.8 222.757 202.235 x x 249.238 x 275.591 243.25 x x x 249.318 111.892 x x x 295.552 280.2 218.677 105.208 x 204.923 225.238 185.185 253.037 278.139 241.971 222.448 x 279.118 x 228.13 x 183.842 x x 258.771 x x 174.333 279.192 239.062 255.72 233.897 x 246.533 163.8 x 173.84 x x x 286.174 176.455 199.606 338.75 196.821 x x x +12041 Original post publication description: Novel open field behavior, vertical activity (rears) in the periphery from 15-30 min for males and females [n beam breaks] None Central nervous system, behavior: Novel open field behavior, vertical activity (rears) in the periphery from 15-30 min for males and females [n beam breaks] x x x x 169.059 184.714 x 237.417 231.583 233.9 142.571 318.19 184.731 202.414 166.857 161.524 217.875 264.444 270.167 224.818 x x x 129.875 x 174.5 173.4 314.182 x 217.222 224.391 243.2 177.065 x 111.529 x 277.391 184.074 293.867 x 253.379 300.68 179.865 216.059 x x 244.238 x 326.818 227.344 x x x 261.409 58.4324 x x x 211.828 304.05 211.548 138.583 x 192.308 232.286 225.111 242.556 315.389 264.314 247.483 x 291.265 x 252.087 x 239.0 x x 288.629 x x 210.867 290.769 256.906 256.64 228.172 x 276.467 145.0 x 166.92 x x x 294.435 173.636 202.273 368.429 222.026 x x x +12042 Original post publication description: Novel open field behavior, vertical activity (rears) in the periphery from 30-45 min for males and females [n beam breaks] None Central nervous system, behavior: Novel open field behavior, vertical activity (rears) in the periphery from 30-45 min for males and females [n beam breaks] x x x x 166.294 152.238 x 227.375 252.583 244.4 137.238 299.81 169.038 183.034 172.643 184.143 209.375 211.222 210.667 219.545 x x x 121.438 x 92.1667 158.867 304.773 x 169.167 206.565 236.84 148.387 x 46.8824 x 271.609 181.519 317.367 x 211.069 318.8 120.162 186.765 x x 243.19 x 346.591 196.219 x x x 222.682 19.2973 x x x 181.897 281.375 164.032 110.875 x 163.423 216.619 225.0 217.667 294.194 261.143 236.345 x 259.382 x 248.739 x 272.263 x x 295.943 x x 180.367 314.077 206.062 198.84 176.276 x 267.733 117.0 x 138.6 x x x 274.0 161.182 176.97 360.893 202.872 x x x +12043 Original post publication description: Novel open field behavior, vertical activity (rears) in the periphery from 45-60 min for males and females [n beam breaks] None Central nervous system, behavior: Novel open field behavior, vertical activity (rears) in the periphery from 45-60 min for males and females [n beam breaks] x x x x 156.176 133.571 x 191.458 212.5 238.0 122.333 281.524 118.923 174.759 113.571 176.857 168.208 169.5 146.0 164.273 x x x 97.875 x 45.0333 123.267 269.364 x 110.0 191.87 217.36 102.323 x 11.7059 x 243.304 173.074 312.067 x 172.759 306.08 69.5676 156.412 x x 226.381 x 345.182 177.281 x x x 175.455 8.45946 x x x 139.655 266.125 116.0 103.542 x 145.5 160.429 198.259 219.815 265.111 278.086 225.241 x 224.765 x 221.0 x 255.526 x x 275.457 x x 176.433 261.269 131.562 165.2 158.345 x 243.333 128.4 x 111.04 x x x 277.261 153.636 180.061 316.571 165.821 x x x +12044 Original post publication description: Novel open field behavior, percentage of locomotion in the periphery for males and females [%] None Central nervous system, behavior: Novel open field behavior, percentage of locomotion in the periphery for males and females [%] x x x x 52.0603 47.1297 x 55.8166 53.768 50.514 52.5424 54.0672 59.2209 42.1468 74.3337 50.6329 52.1083 65.1535 67.2584 50.1307 x x x 43.6554 x 73.1105 65.9865 65.2189 x 66.2745 51.5857 46.1274 53.6372 x 68.4217 x 52.3869 57.2184 50.8982 x 53.009 54.4764 67.5487 60.8253 x x 40.8698 x 59.9337 58.711 x x x 58.044 75.2333 x x x 53.3812 56.7195 67.3742 64.2792 x 49.5456 55.1758 54.2357 60.4214 48.2977 43.1234 54.909 x 62.4545 x 52.6355 x 46.6265 x x 52.9122 x x 54.0169 63.2459 73.2354 57.0308 60.1002 x 46.9665 60.435 x 50.6993 x x x 47.12 51.0551 58.9073 56.1322 52.0261 x x x +12045 Original post publication description: Novel open field behavior, locomotion in the periphery from 0-60 min for males and females [n beam breaks] None Central nervous system, behavior: Novel open field behavior, locomotion in the periphery from 0-60 min for males and females [n beam breaks] x x x x 1341.88 1167.38 x 2548.04 1400.42 2492.0 1297.71 2806.05 1127.38 1382.69 1093.79 1347.52 2223.5 1632.17 2225.33 1688.45 x x x 1137.06 x 916.833 1194.13 4148.73 x 1298.72 1883.52 1612.8 1102.1 x 609.588 x 1662.09 1370.26 2151.8 x 1946.69 1329.44 1357.97 2181.53 x x 1313.14 x 2463.14 1769.84 x x x 2458.73 483.297 x x x 2159.93 1669.93 757.129 1134.21 x 1452.12 1579.38 1378.81 1735.52 2095.11 1709.89 2183.41 x 1373.76 x 1400.52 x 1670.42 x x 1688.37 x x 941.6 1665.08 1138.12 1827.8 1591.69 x 1822.13 920.4 x 1362.48 x x x 1204.57 1731.64 2549.67 3098.39 859.436 x x x +12046 Original post publication description: Novel open field behavior, locomotion in the periphery from 0-60 min for males and females [cm] None Central nervous system, behavior: Novel open field behavior, locomotion in the periphery from 0-60 min for males and females [cm] x x x x 5540.87 4813.46 x 9007.82 5863.02 8976.33 5399.62 10008.1 4818.43 5559.82 4677.18 5366.47 8221.39 6714.8 8273.22 6608.66 x x x 5239.2 x 3730.54 5400.11 14142.7 x 5220.57 7124.11 6711.38 4697.83 x 2646.86 x 6841.79 5619.29 8621.54 x 7214.19 6076.17 5381.67 8290.33 x x 5675.09 x 9500.2 7047.83 x x x 9144.55 2187.4 x x x 7915.27 6732.13 3314.79 4725.42 x 5865.58 6264.95 5718.88 6950.98 8138.01 7188.04 8114.32 x 5622.16 x 5988.95 x 6297.55 x x 6667.66 x x 4422.93 7440.15 4879.96 7119.97 6181.16 x 7394.35 4211.12 x 5574.62 x x x 4968.83 6771.6 8744.01 11547.5 4275.75 x x x +12047 Original post publication description: Novel open field behavior, vertical activity (rears) in the periphery from 0-60 min for males and females [n beam breaks] None Central nervous system, behavior: Novel open field behavior, vertical activity (rears) in the periphery from 0-60 min for males and females [n beam breaks] x x x x 639.824 672.19 x 901.833 900.75 929.4 528.762 1181.05 572.654 765.31 597.5 687.857 828.167 857.111 926.0 822.409 x x x 466.938 x 498.133 601.2 1133.23 x 702.167 853.043 918.32 635.387 x 339.765 x 1034.26 700.333 1181.8 x 903.172 1211.36 592.351 761.471 x x 963.048 x 1294.18 844.094 x x x 908.864 198.081 x x x 828.931 1131.75 710.258 458.208 x 706.154 834.571 833.556 933.074 1152.83 1045.51 931.517 x 1054.53 x 949.957 x 950.632 x x 1118.8 x x 742.0 1145.31 833.594 876.4 796.69 x 1034.07 554.2 x 590.4 x x x 1131.87 664.909 758.909 1384.64 787.538 x x x +12048 Original post publication description: Saline control response (10 ml/kg ip), locomotion in an open field from 0-60 min after injection for males and females [n beam breaks] None Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotion in an open field from 0-60 min after injection for males and females [n beam breaks] x x x x 1507.24 1144.14 x 2874.67 2031.33 5270.7 2449.38 2945.76 1611.5 2865.38 1198.29 2179.05 2334.83 1704.33 2365.67 3477.36 x x x 2750.38 x 673.379 1144.87 4610.59 x 1986.78 2569.35 3528.24 1633.32 x 353.0 x 2826.3 2034.26 4218.73 x 2480.34 2494.52 1295.65 2627.12 x x 3026.86 x 2651.53 2195.06 x x x 3510.27 553.432 x x x 4617.48 2508.32 699.387 1245.96 x 2583.96 1387.48 2263.3 2615.59 4768.97 3599.6 3359.59 x 1071.5 x 1801.83 x 3084.16 x x 2526.83 x x 1612.73 2357.85 1101.69 2791.8 1750.9 x 4517.8 1021.2 x 2284.68 x x x 2439.61 2503.55 2478.18 4179.07 1831.79 x x x +12049 Original post publication description: Saline control response (10 ml/kg ip), locomotion in an open field from 0-60 min after injection for males and females [cm] None Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotion in an open field from 0-60 min after injection for males and females [cm] x x x x 5729.39 4025.52 x 8906.26 7416.29 16055.5 8114.57 9850.75 5976.73 9572.69 4694.48 7260.5 7723.97 6496.44 7759.02 11106.1 x x x 9802.61 x 2638.28 4385.18 14945.5 x 6898.12 8270.5 12024.3 5753.65 x 1386.31 x 10152.4 6932.1 13941.6 x 8273.39 9145.85 4575.59 8969.28 x x 10160.3 x 8805.59 8283.99 x x x 11547.2 2163.92 x x x 14360.5 8492.37 2688.26 4484.89 x 8694.45 4820.41 8164.94 9286.19 15337.9 12371.3 10981.1 x 3946.14 x 6484.01 x 10570.4 x x 8423.57 x x 6193.12 9014.09 4386.67 9344.45 5898.25 x 14989.1 3977.23 x 8143.33 x x x 8377.91 8277.37 7689.78 13498.8 6618.58 x x x +12050 Original post publication description: Saline control response (10 ml/kg), open field behavior, vertical activity (rears) 0-60 min after injection for males and females [n beam breaks/60 min] None Central nervous system, behavior: Saline control response (10 ml/kg), open field behavior, vertical activity (rears) 0-60 min after injection for males and females [n beam breaks/60 min] x x x x 674.412 451.238 x 934.125 1052.08 1422.7 653.048 1046.76 680.538 1222.62 438.143 1070.62 741.792 836.778 805.667 940.636 x x x 727.062 x 320.241 525.333 1287.27 x 811.056 857.87 1331.04 661.516 x 153.059 x 1391.09 684.0 1566.2 x 988.207 1409.8 501.649 852.529 x x 1534.14 x 1008.53 938.0 x x x 937.818 171.405 x x x 1160.72 1440.53 737.161 344.583 x 820.385 721.905 1245.22 1189.22 1767.06 1356.63 1217.38 x 787.294 x 947.174 x 1439.21 x x 1323.43 x x 981.6 1333.58 780.406 949.6 702.966 x 1704.8 354.6 x 646.56 x x x 1639.0 697.091 654.394 1285.11 910.846 x x x +12051 Original post publication description: Cocaine response (2 x 10 mg/kg ip), sensitization, locomotion after the second injection minus locomotion after the first injection for males and females [difference in cm/1 hr test, positive values indicate sensitization] None Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), sensitization, locomotion after the second injection minus locomotion after the first injection for males and females [difference in cm/1 hr test, positive values indicate sensitization] x x x x 11116.9 3031.73 x 4042.85 2796.65 12161.4 1721.28 3570.94 6254.1 4952.51 3727.33 4904.03 7075.26 6705.93 8852.87 6988.05 x x x 1637.94 x 7368.25 10505.1 3603.23 x 3512.98 3521.93 8856.46 1681.81 x 595.177 x 4135.38 5246.81 7307.2 x 5991.45 1987.0 5581.7 1946.93 x x 2092.52 x -1303.87 5660.9 x x x 7190.19 3138.06 x x x 8226.77 2234.74 388.324 4706.79 x 1990.27 5457.57 3282.37 2436.93 6855.49 6519.79 6280.87 x 3585.19 x 4394.36 x 4278.09 x x 2839.48 x x 5364.28 6616.55 5906.77 10665.2 4529.09 x 2328.7 827.885 x 3148.81 x x x 2236.11 6526.43 4275.96 2538.92 2167.71 x x x +12052 Original post publication description: Cocaine response (2 x 10 mg/kg, ip), locomotion from 0-60 min after the second injection in sensitization test for males and females [n beam breaks, positive values indicate sensitization] None Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg, ip), locomotion from 0-60 min after the second injection in sensitization test for males and females [n beam breaks, positive values indicate sensitization] x x x x 11906.1 4335.7 x 4481.12 3782.0 14150.4 4342.19 7024.24 5902.31 9230.14 3730.29 5596.4 10338.5 7978.39 8104.0 11400.5 x x x 7194.94 x 6496.0 7277.2 8310.59 x 8132.44 6433.52 13471.6 4401.94 x 1584.12 x 8635.74 6479.15 16301.8 x 9034.55 9063.25 5676.27 6386.0 x x 6869.95 x 5969.73 6326.97 x x x 7599.18 3152.59 x x x 11345.0 5531.38 2928.03 7566.96 x 7052.72 4899.19 5715.04 7547.44 14074.4 10778.6 14227.8 x 5391.88 x 6481.86 x 11729.6 x x 5670.77 x x 6201.03 11039.3 5636.78 10013.8 7309.48 x 9193.47 1950.4 x 7274.16 x x x 7495.48 11459.5 7310.3 11566.9 4648.74 x x x +12053 Original post publication description: Cocaine response (2 x 10 mg/kg, ip), locomotion from 0-60 min after the second injection in sensitization test for males and females [cm, positive values indicate sensitization] None Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg, ip), locomotion from 0-60 min after the second injection in sensitization test for males and females [cm, positive values indicate sensitization] x x x x 31282.6 12491.4 x 13356.3 11814.0 36805.8 13062.8 20261.2 17932.5 26284.1 11527.8 16288.4 27645.3 24362.4 23993.0 31813.0 x x x 21184.7 x 19348.6 21866.1 24220.4 x 23410.9 18546.1 35968.2 13552.8 x 5009.16 x 25747.1 18578.9 41992.5 x 26528.7 27047.5 17002.4 19578.0 x x 20559.2 x 18264.1 19611.0 x x x 23420.8 10328.2 x x x 31271.3 16557.7 8981.61 21800.1 x 20653.6 14407.9 17780.6 22928.1 38290.0 30446.5 38235.9 x 16037.5 x 20419.2 x 32334.7 x x 16626.4 x x 19035.5 30444.4 17819.0 28378.1 20970.9 x 26692.0 6868.88 x 21592.5 x x x 21776.5 31258.7 20260.0 32497.1 14602.9 x x x +12054 Original post publication description: Cocaine response (2 x 10 mg/kg ip), sensitization, change in vertical activity (rears) for males and females between first and second injections [difference in n/1 hr test, positive values indicate sensitization] None Central nervous system, pharmacology, behavior: Cocaine response (2 x 10 mg/kg ip), sensitization, change in vertical activity (rears) for males and females between first and second injections [difference in n/1 hr test, positive values indicate sensitization] x x x x 1320.82 904.75 x 1182.54 955.333 1711.4 768.952 1155.67 1133.81 2111.24 733.0 1355.6 1444.58 1774.94 1509.83 2003.86 x x x 1061.25 x 1495.58 1465.8 1864.32 x 1646.06 1458.04 1500.6 1108.71 x 434.529 x 1813.22 905.63 2407.1 x 2225.83 2627.25 1322.14 1415.18 x x 2059.86 x 1551.73 1476.38 x x x 1550.82 585.703 x x x 1985.28 1637.45 1306.58 987.083 x 1136.44 1212.71 1922.81 1721.48 2866.94 2126.52 2109.66 x 1337.24 x 2085.81 x 2380.84 x x 1513.2 x x 1682.63 1727.88 1405.62 1680.57 1531.3 x 1911.47 474.6 x 1278.92 x x x 2273.13 1342.4 1175.36 2102.22 1476.54 x x x +12055 Original post publication description: Saline control response (10 ml/kg ip), locomotion in an open field from 0-15 min after injection for males and females [n beam breaks/15 min] None Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotion in an open field from 0-15 min after injection for males and females [n beam breaks/15 min] x x x x 593.353 452.476 x 718.25 536.75 1470.1 413.19 842.762 584.577 1052.07 382.429 461.19 1052.25 506.556 616.833 838.682 x x x 841.625 x 261.138 346.467 1524.05 x 624.444 611.174 857.56 570.032 x 255.765 x 777.261 486.778 1063.97 x 893.414 637.2 681.595 820.412 x x 730.905 x 538.368 500.25 x x x 1016.32 337.622 x x x 1417.66 696.55 252.677 404.708 x 883.385 419.0 596.704 696.259 1252.17 937.114 990.379 x 401.971 x 720.043 x 1074.68 x x 708.057 x x 560.067 752.154 348.438 917.12 555.621 x 1227.07 373.0 x 754.76 x x x 817.783 866.818 997.545 1046.54 435.462 x x x +12056 Original post publication description: Saline control response (10 ml/kg ip), locomotion in an open field from 15-30 min after injection for males and females [n beam breaks/15 min] None Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotion in an open field from 15-30 min after injection for males and females [n beam breaks/15 min] x x x x 455.353 219.286 x 726.292 451.25 1385.4 603.19 661.857 383.923 673.931 336.143 475.762 569.792 467.111 633.667 879.0 x x x 736.562 x 172.414 322.0 1210.95 x 547.944 650.174 777.56 435.645 x 77.8824 x 708.217 557.111 1029.27 x 602.241 574.76 293.27 701.824 x x 726.905 x 688.0 564.719 x x x 1045.86 126.919 x x x 1247.38 648.775 182.065 323.542 x 700.538 392.0 602.111 745.148 1255.78 831.457 826.069 x 293.353 x 445.522 x 776.211 x x 646.4 x x 415.833 550.615 276.625 705.72 482.448 x 1218.07 307.4 x 752.24 x x x 588.0 684.455 588.667 1009.07 452.564 x x x +12057 Original post publication description: Saline control response (10 ml/kg ip), locomotion in an open field from 30-45 min after injection for males and females [n beam breaks/15 min] None Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotion in an open field from 30-45 min after injection for males and females [n beam breaks/15 min] x x x x 287.647 208.667 x 744.917 553.417 1290.7 695.429 685.238 373.577 613.103 297.714 551.667 400.417 375.778 593.333 932.591 x x x 649.438 x 138.828 198.733 938.136 x 429.278 670.739 963.48 332.548 x 12.8824 x 705.565 470.926 1065.07 x 555.483 650.32 169.946 567.647 x x 750.286 x 707.421 573.844 x x x 804.318 64.1622 x x x 1042.76 613.1 153.613 263.417 x 613.538 289.571 554.482 636.111 1218.22 928.257 837.828 x 215.294 x 331.783 x 654.158 x x 578.857 x x 348.5 496.231 267.25 587.28 405.241 x 1107.53 226.8 x 466.2 x x x 552.565 547.818 493.606 1032.71 474.0 x x x +12058 Original post publication description: Saline control response (10 ml/kg ip), locomotion in an open field from 45-60 min after injection for males and females [n beam breaks/15 min] None Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotion in an open field from 45-60 min after injection for males and females [n beam breaks/15 min] x x x x 170.882 263.714 x 685.208 489.917 1124.5 737.571 755.905 269.423 526.276 182.0 690.429 312.375 354.889 521.833 827.091 x x x 522.75 x 101.0 277.667 937.455 x 385.111 637.261 929.64 295.097 x 6.47059 x 635.261 519.444 1060.43 x 429.207 632.24 150.838 537.235 x x 818.762 x 717.737 556.25 x x x 643.773 24.7297 x x x 909.69 549.9 111.032 254.292 x 386.5 286.905 510.0 538.074 1042.81 902.771 705.31 x 160.882 x 304.478 x 579.105 x x 593.514 x x 288.333 558.846 209.375 581.68 307.586 x 965.133 114.0 x 311.48 x x x 481.261 404.455 398.364 1090.75 469.769 x x x +12059 Original post publication description: Saline control response (10 ml/kg ip), locomotion in an open field from 0-15 min after injection for males and females [cm] None Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotion in an open field from 0-15 min after injection for males and females [cm] x x x x 2236.57 1524.98 x 2239.14 1998.28 4442.54 1432.9 2804.33 2126.53 3382.52 1520.31 1622.62 3383.93 1976.31 2061.55 2941.45 x x x 3027.01 x 993.116 1348.88 4816.58 x 2234.11 2008.53 2964.47 1980.44 x 983.836 x 2815.8 1700.36 3608.83 x 2984.27 2262.78 2366.38 2862.12 x x 2414.51 x 1852.25 1939.66 x x x 3466.38 1347.36 x x x 4401.19 2384.11 954.867 1575.53 x 2983.4 1507.84 2217.37 2504.1 3995.1 3163.18 3276.7 x 1507.2 x 2485.24 x 3543.24 x x 2361.44 x x 2127.89 2779.53 1390.69 3063.02 1946.53 x 4019.18 1454.68 x 2710.54 x x x 2719.81 2876.47 3026.34 3400.8 1637.62 x x x +12060 Original post publication description: Saline control response (10 ml/kg ip), locomotion in an open field from 15-30 min after injection for males and females [cm] None Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotion in an open field from 15-30 min after injection for males and females [cm] x x x x 1751.11 812.862 x 2255.34 1674.61 4196.27 2033.61 2260.62 1470.28 2273.76 1359.98 1652.22 1924.53 1809.82 2107.67 2852.83 x x x 2648.4 x 696.721 1237.79 3891.93 x 1955.87 2127.84 2705.23 1559.71 x 319.783 x 2525.94 1918.85 3432.42 x 2025.31 2133.62 1054.84 2452.0 x x 2494.33 x 2261.63 2175.41 x x x 3428.03 493.092 x x x 3886.31 2204.85 710.928 1152.4 x 2393.52 1369.76 2211.74 2665.3 4004.77 2878.23 2710.03 x 1094.8 x 1587.01 x 2691.79 x x 2173.54 x x 1607.2 2150.62 1120.18 2357.14 1593.34 x 4016.38 1236.69 x 2642.52 x x x 2042.98 2193.44 1844.68 3294.33 1650.83 x x x +12061 Original post publication description: Saline control response (10 ml/kg ip), locomotion in an open field from 30-45 min after injection for males and females [cm] None Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotion in an open field from 30-45 min after injection for males and females [cm] x x x x 1082.99 779.869 x 2298.57 1992.79 3988.21 2272.45 2273.82 1401.95 2097.75 1137.61 1801.26 1377.87 1397.4 1895.23 2855.97 x x x 2293.08 x 559.332 771.506 3116.64 x 1419.15 2137.37 3233.99 1186.44 x 54.8886 x 2511.4 1577.22 3472.83 x 1860.29 2417.45 623.131 1887.52 x x 2529.96 x 2330.69 2170.91 x x x 2582.72 231.412 x x x 3245.72 2059.08 588.214 899.455 x 2044.89 1002.66 1960.23 2206.43 3932.12 3177.27 2725.67 x 761.177 x 1255.29 x 2270.35 x x 1918.25 x x 1336.46 1946.59 1052.5 1997.7 1360.84 x 3662.53 833.648 x 1693.41 x x x 1908.72 1852.35 1540.87 3302.11 1674.56 x x x +12062 Original post publication description: Saline control response (10 ml/kg ip), locomotion in an open field from 45-60 min after injection for males and females [cm] None Central nervous system, behavior: Saline control response (10 ml/kg ip), locomotion in an open field from 45-60 min after injection for males and females [cm] x x x x 658.712 907.811 x 2113.21 1750.61 3428.52 2375.61 2511.97 977.978 1818.67 676.587 2184.4 1037.63 1312.92 1694.57 2455.9 x x x 1834.12 x 389.112 1027.01 3120.36 x 1288.99 1996.76 3120.59 1027.05 x 27.8056 x 2299.22 1735.67 3427.55 x 1403.51 2332.01 531.238 1767.65 x x 2721.52 x 2361.03 1998.01 x x x 2070.12 92.0585 x x x 2827.27 1844.34 434.25 857.506 x 1272.63 940.159 1775.6 1910.37 3405.91 3152.59 2268.68 x 582.955 x 1156.47 x 2064.96 x x 1970.34 x x 1121.58 2137.35 823.299 1926.59 997.536 x 3291.06 452.211 x 1096.85 x x x 1706.41 1355.11 1277.9 3501.61 1655.56 x x x +12063 Original post publication description: Saline control response (10 mg/kg ip), open field behavior, vertical activity (rears) 0-15 min after injection for males and females [n beam breaks/15 min] None Central nervous system, behavior: Saline control response (10 mg/kg ip), open field behavior, vertical activity (rears) 0-15 min after injection for males and females [n beam breaks/15 min] x x x x 170.941 130.238 x 220.625 197.417 347.2 103.81 212.429 168.423 299.345 115.786 203.952 216.542 219.444 196.167 230.318 x x x 187.25 x 99.1379 99.6667 315.455 x 207.444 164.478 270.8 208.774 x 88.0 x 305.565 136.259 306.6 x 297.897 269.76 211.919 224.471 x x 321.667 x 183.526 232.375 x x x 268.955 84.9189 x x x 330.414 345.65 192.194 82.875 x 223.692 209.0 281.741 318.296 383.306 278.914 274.759 x 258.059 x 254.087 x 346.158 x x 295.857 x x 233.1 294.346 205.625 265.04 190.517 x 361.467 96.0 x 189.44 x x x 401.348 172.455 173.091 300.893 169.564 x x x +12064 Original post publication description: Saline control response (10 mg/kg ip), open field behavior, vertical activity (rears) 15-30 min after injection for males and females [n beam breaks/15 min] None Central nervous system, behavior: Saline control response (10 mg/kg ip), open field behavior, vertical activity (rears) 15-30 min after injection for males and females [n beam breaks/15 min] x x x x 218.059 108.571 x 251.792 265.833 385.2 168.381 254.19 187.0 317.138 125.786 289.381 202.25 252.444 245.667 261.773 x x x 215.25 x 90.931 154.333 338.364 x 246.167 240.348 342.72 191.839 x 45.1765 x 361.478 197.074 416.667 x 260.931 362.24 132.324 255.941 x x 418.524 x 260.947 248.562 x x x 277.864 51.3514 x x x 315.103 392.675 215.613 96.3333 x 242.538 208.81 347.926 353.407 465.972 332.857 314.414 x 238.706 x 265.13 x 389.842 x x 358.343 x x 272.667 339.115 223.062 251.52 203.172 x 468.267 129.4 x 217.2 x x x 422.0 194.273 175.364 317.643 241.256 x x x +12065 Original post publication description: Saline control response (10 mg/kg ip), open field behavior, vertical activity (rears) 30-45 min after injection for males and females [n beam breaks/15 min] None Central nervous system, behavior: Saline control response (10 mg/kg ip), open field behavior, vertical activity (rears) 30-45 min after injection for males and females [n beam breaks/15 min] x x x x 157.706 98.9048 x 251.667 302.333 362.9 178.19 275.619 188.077 318.69 107.643 287.048 180.125 189.889 190.667 238.0 x x x 177.812 x 77.5172 140.267 316.045 x 184.944 226.261 373.12 139.613 x 12.1176 x 362.348 182.111 411.167 x 242.621 398.36 89.9189 191.588 x x 398.0 x 282.263 239.688 x x x 225.636 23.6757 x x x 267.103 374.825 180.419 84.75 x 205.615 160.476 321.444 278.037 485.056 359.114 344.483 x 169.412 x 210.13 x 349.684 x x 325.886 x x 267.733 328.154 204.031 213.52 176.345 x 449.8 73.8 x 145.64 x x x 423.87 179.0 163.636 322.393 244.205 x x x +12066 Original post publication description: Saline control response (10 mg/kg ip), open field behavior, vertical activity (rears) 45-60 min after injection for males and females [n beam breaks/15 min] None Central nervous system, behavior: Saline control response (10 mg/kg ip), open field behavior, vertical activity (rears) 45-60 min after injection for males and females [n beam breaks/15 min] x x x x 127.706 113.524 x 210.042 286.5 327.4 202.667 304.524 137.038 287.448 88.9286 290.238 142.875 175.0 173.167 210.545 x x x 146.75 x 52.6552 131.067 317.409 x 172.5 226.783 344.4 121.29 x 7.76471 x 361.696 168.556 431.767 x 186.759 379.44 67.4865 180.529 x x 395.952 x 281.789 217.375 x x x 165.364 11.4595 x x x 248.103 327.375 148.935 80.625 x 148.538 143.619 294.111 239.481 432.722 385.743 283.724 x 121.118 x 217.826 x 353.526 x x 343.343 x x 208.1 371.962 147.688 219.52 132.931 x 425.267 55.4 x 94.28 x x x 391.783 151.364 142.303 344.179 255.821 x x x +12067 Original post publication description: Novel open field behavior, locomotion in the center and periphery from 0-60 min for males and females in the cocaine test battery [n beam breaks] None Central nervous system, pharmacology, behavior: Novel open field behavior, locomotion in the center and periphery from 0-60 min for males and females in the cocaine test battery [n beam breaks] x x x x 3063.53 3124.76 x 5344.08 3313.58 6000.8 3076.43 6209.86 2185.19 4058.14 1827.14 3200.14 5266.75 2754.5 4097.17 4063.23 x x x 3359.0 x 1527.33 2032.93 7104.82 x 2367.72 4485.87 4245.84 2502.97 x 1013.35 x 3918.17 2926.37 5165.37 x 4104.41 3005.48 2300.57 4200.53 x x 4149.14 x 4905.18 3408.94 x x x 4887.45 727.487 x x x 4669.9 3496.45 1263.71 2251.29 x 3785.35 3349.24 3107.59 3308.33 5237.33 4977.57 4886.62 x 2597.06 x 3492.3 x 4372.21 x x 3896.97 x x 2145.77 3107.96 1759.78 3804.48 3344.24 x 4611.93 1827.2 x 3414.68 x x x 3164.87 4156.36 5416.82 6488.5 2259.1 x x x +12068 Original post publication description: Novel open field behavior, locomotion in the center and periphery from 0-60 min for males and females in the cocaine test battery [cm] None Central nervous system, pharmacology, behavior: Novel open field behavior, locomotion in the center and periphery from 0-60 min for males and females in the cocaine test battery [cm] x x x x 11097.8 10296.8 x 16540.4 11493.5 18531.1 10537.5 18880.6 8373.76 13359.9 7150.25 10879.1 16213.0 10594.8 13140.3 13146.4 x x x 12093.2 x 5655.63 8331.99 21772.2 x 8674.8 14331.3 14689.4 8950.86 x 4017.51 x 13402.1 10181.1 17223.0 x 13566.6 11196.8 8175.85 14285.5 x x 14074.9 x 16119.6 12141.7 x x x 16082.9 3103.78 x x x 15169.2 12148.9 5155.59 8311.75 x 12576.9 11615.1 11238.9 12042.9 16905.1 16819.8 15816.2 x 9356.16 x 12019.5 x 13945.5 x x 12995.5 x x 8356.43 11982.1 6916.12 12811.4 11013.6 x 15671.2 7389.51 x 11677.1 x x x 10642.9 13815.7 16049.4 20702.2 8493.11 x x x +12069 Original post publication description: Novel open field behavior, vertical activity (rears) in the center and periphery from 0-60 min for males and females in the cocaine test battery [n beam breaks] None Central nervous system, behavior: Novel open field behavior, vertical activity (rears) in the center and periphery from 0-60 min for males and females in the cocaine test battery [n beam breaks] x x x x 935.0 968.619 x 1274.0 1229.42 1443.0 757.19 1652.1 783.0 1426.69 696.0 1051.1 1139.71 1097.28 1045.17 1065.05 x x x 726.562 x 606.533 767.667 1395.41 x 857.5 1209.48 1527.12 867.097 x 393.706 x 1421.0 872.518 1784.73 x 1253.93 1711.2 717.622 1057.24 x x 1589.95 x 1632.36 1079.38 x x x 1119.14 219.243 x x x 1281.69 1462.2 940.452 619.625 x 1036.04 1099.62 1200.04 1268.85 1852.25 1745.63 1418.55 x 1372.76 x 1291.13 x 1355.95 x x 1645.49 x x 981.267 1543.62 1002.31 1181.04 1060.1 x 1619.67 760.2 x 854.56 x x x 1728.3 962.0 986.879 1891.18 1105.59 x x x +12070 Original post publication description: Central nervous system, adult neurogenesis: BrdU-labeled cells in the rostral migratory stream 1 hr after BrdU injection for adult males and females [density] None Central nervous system, adult neurogenesis: BrdU-labeled cells in the rostral migratory stream 1 hr after BrdU injection for adult males and females [density] x x x x x 86.25 x 75.5 x 88.625 x x x 69.0 96.5 x 82.5 x x x x x x x x 61.0 x x x 71.0 90.6 x x x 89.0 x x 111.6 x x x 108.0 76.0 98.0 x x 83.3333 x 82.75 x x x x x x x x x 85.0 99.0 97.0 x 79.5 94.7143 72.5 128.5 92.1429 130.0 90.0 x x 87.375 103.8 116.714 x 78.3333 x x 95.2857 x x x x 96.0 91.75 113.444 x 94.75 74.25 94.4 118.667 128.0 x x 103.0 91.4 74.0 x x x x x +12071 Original post publication description: Adrenal weight (left) of males and females [mg] None Endocrinology, morphology: Adrenal weight (left) of males and females [mg] x x x x 1.9375 2.0375 x 2.4375 2.1125 2.08571 2.5625 2.2 2.0875 2.225 2.2375 2.9625 2.60714 1.725 2.225 2.1625 x x x 2.025 x 2.06875 2.9 1.875 x 2.1125 2.65 2.225 2.5 x 2.1125 x 2.3375 2.325 1.8625 x 2.11875 2.0 1.5 2.0625 x x 2.28125 x 2.1 2.425 x x x 1.7 2.3 x x x 2.06875 1.9375 2.75 2.2125 x 2.1875 2.225 2.0125 2.3375 2.5125 1.975 1.61429 x 1.825 x 2.05 x 1.7 x x 1.7875 x x 2.1375 2.2375 2.15 1.7125 2.2 x 1.95 1.8375 x 2.3875 x x x 2.2375 2.175 2.2125 2.025 2.3625 x x x +12072 Original post publication description: Adrenal weight (right) of males and females [mg] None Endocrinology, morphology: Adrenal weight (right) of males and females [mg] x x x x 1.8 1.9375 x 2.2375 1.9 1.92857 2.475 2.175 2.0875 1.9 2.05 2.4625 2.05 1.6625 2.175 2.0625 x x x 1.9 x 2.0625 2.8875 1.8375 x 1.875 2.6625 2.1125 2.4625 x 2.0625 x 2.3375 2.3125 1.875 x 1.85625 1.9625 1.5125 1.8375 x x 2.25 x 1.95 2.125 x x x 1.45 2.025 x x x 1.875 1.875 2.325 1.95 x 1.875 2.05 1.825 2.2375 2.325 1.825 1.45714 x 1.7 x 1.7625 x 1.65 x x 1.575 x x 1.9375 2.1125 2.0125 1.65 2.175 x 1.8625 1.825 x 1.9875 x x x 2.1125 1.9375 1.85 2.1125 2.075 x x x +12556 Original post publication description: Endocrinology, neuroendocrine system, morphology: Adrenal zona fasciculata width [um] None Endocrinology, neuroendocrine system, morphology: Adrenal zona fasciculata width [um] x x 169.849 113.055 140.426 155.528 x 194.493 143.008 136.389 171.845 133.925 159.278 133.979 142.743 202.569 120.205 152.795 165.234 132.921 x x x 156.457 x 143.506 138.968 125.675 x 156.502 116.392 152.238 161.865 x 124.413 x 145.227 162.936 160.511 x 149.391 142.924 134.119 166.801 x x 152.04 x 122.735 206.317 x x x 129.221 180.339 x x x 156.341 149.779 190.531 173.77 x 153.885 161.882 161.321 151.134 164.188 121.244 129.178 x 125.497 x 136.232 x 118.893 x x 122.6 x x 138.847 154.266 137.129 124.111 146.471 x 114.907 128.99 x 154.477 x x x 153.921 146.49 147.913 136.506 181.117 x x x +12073 Original post publication description: Metabolism, blood chemistry: Albuminuria concentration [ACR at ug/mg] None Metabolism, blood chemistry: Albuminuria concentration [ACR at ug/mg] x x 28.484 81.904 162.387 92.737 x 64.187 x 42.508 60.282 81.417 166.265 69.422 x 52.48 56.37 82.731 62.527 90.893 x x x x x 100.987 67.346 80.005 x 37.647 258.376 26.578 82.287 x 71.905 x 28.089 x 47.559 x 101.808 67.218 85.44 x x x x x x 58.801 x x x 98.471 71.65 x x x 230.491 69.34 96.116 39.205 x 64.864 48.102 59.076 68.951 124.423 166.275 189.535 x 70.098 x 55.313 x 132.215 x x 101.154 x x 109.139 54.075 x 63.403 47.555 x 96.457 56.797 x x x x x 32.143 x 91.285 74.088 59.325 x x x +13014 Original post publication description: Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), median body weight loss day 10 after infection in 9-14 week-old females [%], file: mm2_weight_median_variantII_hko_180311 Original pre publication description: Infectious disease, immune function: Schughart (kls@helmholtz-hzi.de) WP12, median BWL day 10 [%], file hko_180311_vII Infectious disease, immune function: Schughart (kls@helmholtz-hzi.de) WP12, median BWL day 10 [%] Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), median body weight loss day 10 after infection in 9-14 week-old females [%] x 94.7 94.0 75.0 97.9 89.0 75.65 x 97.55 101.6 87.95 75.0 94.65 75.0 75.0 75.0 75.0 75.0 88.9 86.7 x 86.7 x x x x 75.0 x x 75.0 80.4 x 75.0 x 75.0 x 75.0 92.1 75.0 x 95.6 102.8 75.0 x x x x x x 75.0 x x x 75.0 75.0 x x x 86.05 88.25 75.0 x x 78.45 x 87.02 x 89.46 75.0 86.59 x 75.0 75.0 97.0 x x x 90.42 75.0 x x x 89.16 x x 80.17 x 75.0 x x 89.82 x x x 88.8 98.6 99.7 x 90.52 x 75.0 75.0 +13006 Original post publication description: Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), median body weight loss day 2 after infection in 9-14 week-old females [%], file: mm2_weight_median_variantII_hko_180311 Original pre publication description: Infectious disease, immune function: Schughart (kls@helmholtz-hzi.de) WP12, median BWL day 2 [%], file hko_180311_vII Infectious disease, immune function: Schughart (kls@helmholtz-hzi.de) WP12, median BWL day 2 [%] Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), median body weight loss day 2 after infection in 9-14 week-old females [%] x 92.9 98.2 93.15 95.0 95.0 99.35 x 99.15 98.9 98.0 96.7 97.9 97.2 94.2 97.1 94.9 99.4 97.7 94.7 x 99.4 x x x x 86.95 x x 96.8 94.9 x 91.8 x 94.7 x 95.3 93.7 98.9 x 100.75 100.0 95.66 x x x x x x 96.05 x x x 101.0 98.26 x x x 93.74 96.3 92.56 x x 98.83 x 98.47 x 93.5 100.34 99.44 x 97.6 99.71 96.35 x x x 99.49 92.61 x x x 98.42 x x 98.22 x 96.68 x x 99.03 x x x 97.75 100.2 100.0 x 95.86 x 98.02 97.85 +12401 Original post publication description: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during 10 min [n beam breaks] None Central nervous system, behavior: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during 10 min [n beam breaks] 887.33 871.43 897.5 902.6 923.33 808.8 756.67 1008.0 683.17 874.4 795.0 1112.33 799.83 x 1108.4 801.67 x 993.0 x 699.33 640.75 x x 834.0 790.67 707.83 626.33 x x 795.17 965.71 862.4 756.67 x x x x 554.0 1002.0 x 759.88 750.75 919.0 1024.0 x x 813.0 915.86 602.13 896.29 x 902.13 x 980.83 1016.67 x x x 912.33 695.8 726.75 x x 1088.14 577.33 929.57 823.5 847.57 799.5 865.75 x 838.0 x 821.5 x 720.8 x x 916.33 741.4 x 890.17 832.0 947.67 839.0 797.5 x 866.83 957.83 x 912.5 x x 979.22 941.5 1066.67 1238.5 883.67 832.17 789.0 882.83 906.86 +13004 Original post publication description: Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), percent survival day 10 after infection in 9-14 week-old females [%], file: mm2_survival_per4_per13_hko_180311 Original pre publication description: Infectious disease, immune function: Schughart (kls@helmholtz-hzi.de) WP12, perc sur day 10 [%], file: hko_180311 Infectious disease, immune function: Schughart (kls@helmholtz-hzi.de) WP12, perc sur day 10 [%] Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), percent survival day 10 after infection in 9-14 week-old females [%] x 82.8 100.0 3.3 100.0 60.0 50.0 x 100.0 100.0 100.0 0.0 100.0 0.0 0.0 0.0 0.0 20.0 100.0 100.0 x 88.8 x x x x 0.0 x x 0.0 57.1 x 0.0 x 0.0 x 0.0 100.0 25.0 x 100.0 100.0 0.0 x x x x x x 0.0 x x x 20.0 20.0 x x x 80.0 80.0 20.0 x x 50.0 x 80.0 x 80.0 0.0 80.0 x 20.0 0.0 100.0 x x x 100.0 0.0 x x x 80.0 x x 100.0 x 0.0 x x 80.0 x x x 100.0 100.0 100.0 x 100.0 x 40.0 0.0 +13002 Original post publication description: Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), percent survival day 8 after infection in 9-14 week-old females [%], file: mm2_survival_per4_per13_hko_180311 Original pre publication description: Infectious disease, immune function: Schughart (kls@helmholtz-hzi.de) WP12, perc sur day 8 [%], file: hko_180311 Infectious disease, immune function: Schughart (kls@helmholtz-hzi.de) WP12, perc sur day 8 [%] Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), percent survival day 8 after infection in 9-14 week-old females [%] x 82.8 100.0 5.0 100.0 60.0 50.0 x 100.0 100.0 100.0 0.0 100.0 20.0 0.0 20.0 0.0 80.0 100.0 100.0 x 88.8 x x x x 0.0 x x 14.0 71.4 x 0.0 x 0.0 x 0.0 100.0 33.3 x 100.0 100.0 0.0 x x x x x x 0.0 x x x 100.0 20.0 x x x 80.0 80.0 20.0 x x 75.0 x 80.0 x 80.0 0.0 80.0 x 20.0 0.0 100.0 x x x 100.0 0.0 x x x 80.0 x x 100.0 x 0.0 x x 100.0 x x x 100.0 100.0 100.0 x 100.0 x 40.0 0.0 +13003 Original post publication description: Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), percent survival day 9 after infection in 9-14 week-old females [%], file: mm2_survival_per4_per13_hko_180311 Original pre publication description: Infectious disease, immune function: Schughart (kls@helmholtz-hzi.de) WP12, perc sur day 9 [%], file: hko_180311 Infectious disease, immune function: Schughart (kls@helmholtz-hzi.de) WP12, perc sur day 9 [%] Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), percent survival day 9 after infection in 9-14 week-old females [%] x 82.8 100.0 3.3 100.0 60.0 50.0 x 100.0 100.0 100.0 0.0 100.0 0.0 0.0 0.0 0.0 60.0 100.0 100.0 x 88.8 x x x x 0.0 x x 0.0 57.1 x 0.0 x 0.0 x 0.0 100.0 25.0 x 100.0 100.0 0.0 x x x x x x 0.0 x x x 20.0 20.0 x x x 80.0 80.0 20.0 x x 62.5 x 80.0 x 80.0 0.0 80.0 x 20.0 0.0 100.0 x x x 100.0 0.0 x x x 80.0 x x 100.0 x 0.0 x x 80.0 x x x 100.0 100.0 100.0 x 100.0 x 40.0 0.0 +13001 Original post publication description: Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), percent survival day 7 after infection in 9-14 week-old females [%], file: mm2_survival_per4_per13_hko_180311 Original pre publication description: Infectious disease, immune function: Schughart (kls@helmholtz-hzi.de) WP12, perc sur day 7 [%], file: hko_180311 Infectious disease, immune function: Schughart (kls@helmholtz-hzi.de) WP12, perc sur day 7 [%] Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), percent survival day 7 after infection in 9-14 week-old females [%] x 86.2 100.0 8.3 100.0 60.0 75.0 x 100.0 100.0 100.0 0.0 100.0 100.0 0.0 60.0 0.0 100.0 100.0 100.0 x 100.0 x x x x 0.0 x x 85.7 100.0 x 0.0 x 0.0 x 0.0 100.0 50.0 x 100.0 100.0 20.0 x x x x x x 16.6 x x x 100.0 20.0 x x x 100.0 100.0 20.0 x x 100.0 x 100.0 x 100.0 0.0 100.0 x 40.0 80.0 100.0 x x x 100.0 0.0 x x x 100.0 x x 100.0 x 0.0 x x 100.0 x x x 100.0 100.0 100.0 x 100.0 x 60.0 0.0 +13005 Original post publication description: Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), median body weight loss day 1 after infection in 9-14 week-old females [%], file: mm2_weight_median_variantII_hko_180311 Original pre publication description: Infectious disease, immune function: Schughart (kls@helmholtz-hzi.de) WP12, median BWL day 1 [%], file hko_180311_vII Infectious disease, immune function: Schughart (kls@helmholtz-hzi.de) WP12, median BWL day 1 [%] Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), median body weight loss day 1 after infection in 9-14 week-old females [%] x 96.1 98.5 97.5 97.6 94.7 99.55 x 98.8 99.2 99.35 98.9 98.7 100.1 98.5 98.8 99.5 101.3 99.2 94.85 x 96.6 x x x x 92.35 x x 98.6 95.3 x 96.6 x 97.0 x 99.5 96.4 99.35 x 97.1 101.0 98.03 x x x x x x 98.65 x x x 102.1 97.63 x x x 96.78 95.8 96.85 x x 98.43 x 98.83 x 97.08 99.22 99.16 x 98.5 99.07 98.75 x x x 99.09 96.28 x x x 97.42 x x 99.37 x 97.28 x x 99.08 x x x 98.7 99.4 103.9 x 97.93 x 98.22 98.41 +13016 Original post publication description: Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), median body weight loss day 12 after infection in 9-14 week-old females [%], file: mm2_weight_median_variantII_hko_180311 Original pre publication description: Infectious disease, immune function: Schughart (kls@helmholtz-hzi.de) WP12, median BWL day 12 [%], file hko_180311_vII Infectious disease, immune function: Schughart (kls@helmholtz-hzi.de) WP12, median BWL day 12 [%] Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), median body weight loss day 12 after infection in 9-14 week-old females [%] x 96.2 96.1 75.0 97.8 91.3 77.5 x 99.0 102.2 91.4 75.0 96.15 75.0 75.0 75.0 75.0 75.0 91.6 92.9 x 91.8 x x x x 75.0 x x 75.0 87.4 x 75.0 x 75.0 x 75.0 92.85 75.0 x 96.85 104.1 75.0 x x x x x x 75.0 x x x 75.0 75.0 x x x 88.98 92.75 75.0 x x 81.02 x 91.35 x 93.67 75.0 93.9 x 75.0 75.0 102.06 x x x 97.12 75.0 x x x 95.25 x x 87.05 x 75.0 x x 93.36 x x x 92.45 99.6 99.45 x 95.91 x 75.0 75.0 +13017 Original post publication description: Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), median body weight loss day 13 after infection in 9-14 week-old females [%], file: mm2_weight_median_variantII_hko_180311 Original pre publication description: Infectious disease, immune function: Schughart (kls@helmholtz-hzi.de) WP12, median BWL day 13 [%], file hko_180311_vII Infectious disease, immune function: Schughart (kls@helmholtz-hzi.de) WP12, median BWL day 13 [%] Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), median body weight loss day 13 after infection in 9-14 week-old females [%] x 98.2 98.0 75.0 100.8 86.7 78.95 x 99.2 101.1 92.65 75.0 97.65 75.0 75.0 75.0 75.0 75.0 94.8 95.6 x 95.0 x x x x 75.0 x x 75.0 89.6 x 75.0 x 75.0 x 75.0 95.4 75.0 x 94.45 105.1 75.0 x x x x x x 75.0 x x x 75.0 75.0 x x x 90.58 94.6 75.0 x x 84.05 x 95.35 x 95.73 75.0 95.99 x 75.0 75.0 99.68 x x x 97.9 75.0 x x x 97.77 x x 92.14 x 75.0 x x 95.69 x x x 95.25 101.3 101.1 x 96.17 x 75.0 75.0 +12402 Original post publication description: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during first 5 min [beam breaks/sec] None Central nervous system, behavior: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during first 5 min [beam breaks/sec] 0.502 0.47 0.465 0.554 0.367 0.494 0.619 0.493 0.788 0.468 0.548 0.367 0.608 x 0.429 0.465 x 0.508 x 0.774 0.696 x x 0.556 0.436 0.78 0.797 x x 0.545 0.41 0.522 0.64 x x x x 0.878 0.49 x 0.458 0.544 0.428 0.423 x x 0.451 0.499 0.487 0.443 x 0.422 x 0.396 0.453 x x x 0.372 0.589 0.587 x x 0.387 0.759 0.504 0.541 0.458 0.495 0.487 x 0.63 x 0.384 x 0.538 x x 0.525 0.557 x 0.518 0.446 0.468 0.53 0.508 x 0.545 0.371 x 0.477 x x 0.387 0.434 0.395 0.38 0.424 0.526 0.498 0.429 0.515 +12996 Infectious disease, immune function: H1N1 (Pr8) influenza A virus (2x10E3 FFU), mean time to death after infection in 9-14 week-old females [days], file mm2_mean_time_death_hko_180311 Original pre publication description: Infectious disease, immune function: Schughart (kls@helmholtz-hzi.de) WP12, MTTD [days], file hko_180311 Infectious disease, immune function: Schughart (kls@helmholtz-hzi.de) WP12, MTTD [days], file hko_180311 Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), mean time to death after infection in 9-14 week-old females [days] x 11.07 12.0 6.47 12.0 10.0 9.75 x 12.0 12.0 12.0 7.0 12.0 8.2 7.0 7.8 6.4 9.8 11.8 12.0 x 11.56 x x x x 5.75 x x 8.0 10.43 x 6.67 x 6.8 x 6.8 12.0 8.33 x 12.0 12.0 7.2 x x x x x x 6.5 x x x 9.6 8.0 x x x 11.2 11.33 7.2 x x 10.38 x 11.2 x 11.2 6.6 11.2 x 8.2 7.8 12.0 x x x 12.0 6.5 x x x 11.2 x x 12.0 x 6.75 x x 11.4 x x x 12.0 12.0 12.0 x 12.0 x 9.2 6.4 +12995 Original post publication description: Infectious disease, immune function: Malaria lethality, Plasmodium yoelii (PY17XL subclone, 10^6 PRBC i.p.) in 7-10 week old females (1=resistant and 0= susceptible)[survival fraction] None Infectious disease, immune function: Malaria lethality, Plasmodium yoelii (PY17XL subclone, 10^6 PRBC i.p.) in 7-10 week old females (1=resistant and 0= susceptible)[survival fraction] x 0.5 1.0 0.6 x x 0.0 x x 0.0 0.0 1.0 0.0 x x x x x x x x x x 0.0 x 0.0 x x x 0.0 0.5 x 1.0 x x x 0.0 x 0.0 x 0.0 0.0 0.0 1.0 x x 0.0 1.0 0.0 0.5 x x x 1.0 0.5 x x x 1.0 x 1.0 x x x 0.0 1.0 0.53 x 1.0 x x 0.0 0.25 0.0 x 0.0 x x 0.0 x x x 0.0 1.0 0.0 x x x 0.9 x x x x 0.8 0.31 x x 0.0 x x 0.92 0.0 +12398 Original post publication description: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), time in open quadrants using an elevated zero maze in 60 to 120-day-old females only during 10 min [percentage of time] None Central nervous system, behavior: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), time in open quadrants using an elevated zero maze in 60 to 120-day-old females only during 10 min [percentage of time] 17.483 21.869 18.517 19.557 37.478 14.05 7.061 9.26 14.594 26.38 15.017 19.931 4.378 x 8.22 25.789 x 14.414 x 5.256 8.433 x x 20.35 25.172 22.017 8.839 x x 14.072 25.526 15.71 41.136 x x x x 2.7 24.944 x 35.919 26.562 25.906 16.175 x x 26.739 17.121 43.206 25.974 x 23.252 x 28.217 19.781 x x x 32.208 21.14 21.585 x x 23.045 21.95 9.407 32.106 28.662 26.575 32.163 x 14.229 x 35.719 x 27.957 x x 13.686 25.07 x 18.222 24.252 18.861 15.756 23.75 x 29.786 32.703 x 24.625 x x 26.424 21.336 17.058 9.369 36.608 18.514 19.85 26.397 13.033 +12400 Original post publication description: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during last 5 min [n beam breaks] None Central nervous system, behavior: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during last 5 min [n beam breaks] 375.33 393.71 379.5 424.4 409.33 327.4 314.67 434.0 297.67 402.8 314.0 452.33 316.83 x 462.8 340.67 x 475.67 x 285.33 239.0 x x 386.0 308.0 330.83 248.0 x x 326.33 434.43 383.4 360.5 x x x x 209.0 523.67 x 323.88 314.25 383.67 441.25 x x 353.0 411.0 245.75 412.29 x 348.63 x 447.17 474.83 x x x 366.67 319.4 318.75 x x 498.71 294.5 371.14 400.5 371.29 367.67 432.5 x 368.57 x 337.17 x 310.4 x x 439.17 330.2 x 425.0 335.86 411.5 348.67 332.67 x 397.0 438.83 x 446.33 x x 416.67 415.5 438.33 508.17 413.83 382.0 271.0 369.67 375.43 +12968 Original post publication description: Infectious disease, immunology: Malaria lethality, Plasmodium yoelii (PY17X subclone, 10^6 PRBC) in 7-12 week-old males (1 = 100% susceptible and 0 = 100% resistant) [fraction of cohort that survives] None Infectious disease, immune function: Malaria lethality, Plasmodium yoelii (PY17X subclone, 10^6 PRBC) in 7-12 week-old males (1 = 100% susceptible and 0 = 100% resistant) [fraction of cohort that survives] x x 0.13 1.0 x x 1.0 x x 1.0 1.0 x 0.33 x x 1.0 x 0.0 x x x x x 1.0 x 1.0 x x x 1.0 1.0 x x x 1.0 x 1.0 x 1.0 x x 1.0 x x x x 0.78 0.0 x x x 0.333 x 0.0 1.0 x x x 1.0 1.0 0.67 1.0 x 0.86 1.0 0.0 0.56 0.25 1.0 x x 1.0 0.6 1.0 x 1.0 x 1.0 x x x 1.0 1.0 0.75 1.0 1.0 1.0 1.0 0.38 1.0 x x x 0.0 0.5 1.0 x 1.0 1.0 0.5 0.0 1.0 +12966 Original post publication description: Ethanol Response, 2-bottle choice consumption, 2h access after cycle 2 of Ethanol exposure in vapor chambers. Average of 5 days ethanol intake [g/kg/2h]. CIE_T2_Etgkgave. None Central nervous system, behavior, pharmacology: Ethanol response, consumption of 15% ethanol (v/v) using two-bottle choice system (ethanol vs water), 2-hour access after cycle 2 of ethanol exposure in vapor chamber, average of 5 days ethanol intake [g/kg/2h] 2.109 x 3.184 1.498 x x 2.763 x x x x 1.8 x 1.296 x 1.053 x 1.847 x x x x x x x x x x x x 1.439 x 1.617 x x x x 1.268 x x x 1.494 x 0.986 x x x 1.891 2.724 2.106 x x x 3.106 x x x x x x 4.338 x 1.595 x 1.275 x x 4.065 x 1.61 x 1.925 1.764 1.525 x 1.077 x x 2.098 5.449 x 2.022 1.572 1.394 x x x 2.188 x x x x x x x x x 2.3 1.064 2.674 2.043 1.202 +12965 Original post publication description: Ethanol Response, 2-bottle choice consumption, 2h access after cycle 1 of Ethanol exposure in vapor chambers. Average of 5 days ethanol intake [g/kg/2h]. CIE_T1_Etgkgave. None Central nervous system, pharmacology, behavior: Ethanol response (ethanol vapor inhalation chronic intermittent ethanol (CIE) inhalation chamber), two-bottle choice consumption, 2 hr access after first cycle of exposure, intake over 5 days [g/kg/2h] 0.777 x 2.973 1.07 x x 1.712 x x x x 2.24 x 0.787 x 0.482 x 1.642 x x x x x x x x x x x x 1.257 x 2.151 x 1.157 x x 0.749 x x x 0.978 x 1.068 x x x 1.305 1.238 2.471 x x x 3.022 x x x x x x 3.957 x 1.136 x 1.541 x x 3.748 x 1.768 x 1.165 1.35 1.709 x 0.991 x x 1.751 5.878 x 1.748 0.994 1.4 x x x 1.073 x x x x x x x x x 2.434 0.817 1.114 1.232 1.151 +12962 Original post publication description: Ethanol response, consumption of 15% ethanol (v/v) using two-bottle choice system (ethanol vs water), 2-hour access after cycle 3 of air exposure (control group) in vapor chambers, average of 5 days ethanol intake [g/kg/2h] Central nervous system, behavior, pharmacology: Ethanol response, consumption of 15% ethanol (v/v) using two-bottle choice system (ethanol vs water), 2-hour access after cycle 3 of air exposure (control group) in vapor chambers, average of 5 days ethanol intake [g/kg/2h] Central nervous system, behavior, pharmacology: Ethanol response, consumption of 15% ethanol (v/v) using two-bottle choice system (ethanol vs water), 2-hour access after cycle 3 of air exposure (control group) in vapor chambers, average of 5 days ethanol intake [g/kg/2h] 3.644 x 2.744 1.797 x x 1.597 x x x x 1.918 x 1.507 x 2.311 x x x x x x x x x x x x x x 1.456 x 2.6 x x x x 1.043 x x x 1.448 x 1.513 x x x 2.357 3.516 1.604 x x x 4.875 x x x x x x 3.759 x 1.586 x 1.259 x x x x 2.38 x 2.463 1.06 2.381 x 1.284 x x 2.507 4.477 x 1.942 x 2.689 x x x 1.439 x x x x x x x x x x 1.263 3.098 1.029 1.423 +12963 Original post publication description: Ethanol Response, 2-bottle choice consumption, 2h access after cycle 2 of Air exposure in vapor chambers. Average of 5 days ethanol intake [g/kg/2h]. Air_T2_Etgkgave. Central nervous system, pharmacology: Ethanol response, ethanol intake using a 2-bottle choice test, 2 h access after the second cycle of air exposure (control for CIE) in vapor chamber (average of 5 days ethanol intake, young adult males or females [g/kg/2h] Central nervous system, pharmacology: Ethanol response, ethanol intake using a 2-bottle choice test, 2 h access after the second cycle of air exposure (control for CIE) in vapor chamber (average of 5 days ethanol intake, young adult males or females [g/kg/2h] 2.631 x 2.898 1.957 x x 1.13 x x x x 2.479 x 1.184 x 1.812 x 2.073 x x x x x x x x x x x x 1.719 x 1.424 x x x x 1.614 x x x 1.362 x 1.131 x x x 3.108 3.695 1.59 x x x 4.91 x x x x x x 3.48 x 0.595 x 1.499 x x 2.463 x 1.262 x 2.925 2.188 2.657 x 1.962 x x 1.134 4.225 x 1.316 2.59 2.191 x x x 1.51 x x x x x x x x x 1.932 1.56 2.374 1.424 1.775 +12961 Original post publication description: Ethanol Response, 2-bottle choice consumption, 2h access after cycle 4 of Air exposure in vapor chambers. Average of 5 days ethanol intake [g/kg/2h]. Air_T4_Etgkgave. None Central nervous system, pharmacology: Ethanol response, ethanol intake using a 2-bottle choice test, 2h access after cycle 4 of air exposure only (control for CIE) in vapor chambers (average of 5 days ethanol intake [g/kg/2h] 3.916 x 3.011 1.933 x x 1.007 x x x x 1.884 x 1.702 x 2.653 x x x x x x x x x x x x x x x x 1.521 x x x x 1.439 x x x 1.633 x 1.526 x x x 3.646 3.9 x x x x 4.19 x x x x x x 3.207 x x x 1.78 x x x x 0.982 x x 1.653 3.052 x 1.681 x x 1.476 6.114 x 1.424 x 2.281 x x x x x x x x x x x x x x 1.162 2.998 1.021 2.221 +13011 Original post publication description: Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), median body weight loss day 7 after infection in 9-14 week-old females [%], file: mm2_weight_median_variantII_hko_180311 Original pre publication description: Infectious disease, immune function: Schughart (kls@helmholtz-hzi.de) WP12, median BWL day 7 [%], file hko_180311_vII Infectious disease, immune function: Schughart (kls@helmholtz-hzi.de) WP12, median BWL day 7 [%], file hko_180311_vII Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), median body weight loss day 7 after infection in 9-14 week-old females [%] x 81.4 82.5 75.0 85.0 83.0 83.2 x 87.9 99.4 85.3 75.0 93.55 75.0 75.0 77.1 75.0 77.9 85.0 79.4 x 84.5 x x x x 75.0 x x 75.0 79.2 x 75.0 x 75.0 x 75.0 85.7 75.3 x 84.85 95.3 75.0 x x x x x x 75.0 x x x 79.2 75.0 x x x 79.51 82.7 75.0 x x 81.1 x 82.08 x 80.72 75.0 79.42 x 75.0 75.11 83.57 x x x 86.36 75.0 x x x 81.95 x x 81.76 x 75.0 x x 84.48 x x x 81.6 97.45 91.1 x 77.79 x 75.98 75.0 +12959 Original post publication description: Metabolism: Water intake of 13-week old males [ml/mouse/unit time] None Central nervous system, metabolism, behavior: Water intake of 13-week old males [ml/mouse/unit time] x x 2.558 x x x x 2.473 2.246 x x x x x x 1.113 2.727 x 2.708 x x x x x x x 2.744 x x 3.091 x x x x x x x x x x x x 2.997 3.096 x x 1.582 x x x x x x x 2.038 x x x x 2.008 x x x 1.831 1.336 x 3.01 2.765 x 1.994 x 1.702 x 2.499 x x x x x x x x 1.492 x 2.544 x x 1.797 x x 1.878 x x 2.166 2.301 x 2.93 x 1.293 1.793 x 1.131 +12957 Original post publication description: Morphology, metabolism: White adipose tissue mass of 20-week old males [g] None Morphology, metabolism: White adipose tissue mass of 20-week old males [g] x x 0.575 x 0.351 x x 0.299 0.465 x 0.406 x x x x 1.005 0.473 x 0.28 x x x x x x x 1.66 x x 0.515 x x 0.879 x x x x x x x 0.223 0.651 0.92 x x x 1.347 x x x x x x 0.281 0.346 x x x x 0.345 0.557 x x 0.217 0.502 x 0.683 0.939 x 0.532 x 0.3 x 0.265 x x x x 0.479 0.564 x 0.468 0.265 x 0.931 0.645 x 0.758 0.572 x x x x 0.501 0.525 1.35 0.477 x 0.372 0.484 x 0.416 +12955 Original post publication description: Metabolism: Volume of CO2 production of 13-week old males [ml/kg/h] None Respiratory system, metabolism: Volume of CO2 production of 13-week old males [ml/kg/h] x x 857.315 x x x x 930.783 1035.96 x x x x x x 821.693 1053.11 x 881.893 x x x x x x x 838.238 x x 770.988 x x x x x x x x x x x x 769.857 912.714 x x 763.357 x x x x x x x 826.75 x x x x 866.575 x x x 674.571 765.119 x 973.256 802.648 x 845.286 x 775.5 x 947.25 x x x x x x x x 590.143 x 909.5 x x 737.661 x x 800.071 x x 738.964 592.286 x 741.905 x 624.286 751.5 x 612.071 +12953 Original post publication description: Blood chemistry: Blood proteins (total) of 14-week old males [g/l] None Blood chemistry: Blood proteins (total) of 14-week old males [g/l] x x 46.76 x 43.667 x x 43.25 41.5 x 45.667 x x x x 43.0 46.0 x 45.25 x x x x x x x 47.333 x x 45.75 x x 50.0 x x x x x x x 51.75 48.0 50.0 52.5 x x 47.5 x x x x x x 54.5 48.5 x x x x x 45.667 x x 52.5 x x x x x 49.0 x x x 48.0 x x x x 52.0 53.0 x 54.0 51.0 x x 48.0 x 52.0 54.0 x 50.0 x x 52.75 50.5 49.0 52.333 x x 51.0 x 48.5 +12949 Original post publication description: Metabolism: Body temperature (rectal) of 13-week old males [deg C] None Metabolism: Body temperature (rectal) of 13-week old males [deg C] x x 37.392 x 38.225 x x 38.075 37.275 x 36.233 x x x x 36.375 38.05 x 38.15 x x x x x x x 37.033 x x 37.925 x x 35.8 x x x x x x x 37.225 36.1 37.971 37.4 x x 37.75 x x x x x x 37.65 38.3 x x x x 36.5 36.675 x x 36.45 36.25 x 37.163 37.283 x 37.85 x 37.05 x 36.45 x x x x 37.125 36.35 x 37.0 36.45 x 36.76 37.2 x 36.7 36.0 x 37.5 x x 38.875 38.15 38.175 38.567 x 37.35 36.0 x 36.4 +12950 Original post publication description: Cardiovascular system: Septum thickness by echocardiography of 17-week old males [mm] None Cardiovascular system: Septum thickness by echocardiography of 17-week old males [mm] x x 0.632 x 0.675 x x x x x 0.677 x x x x x x x x x x x x x x x 0.647 x x x x x 0.675 x x x x x x x 0.67 0.64 0.545 x x x 0.62 x x x x x x 0.65 0.595 x x x x 0.63 0.687 x x 0.63 0.59 x 0.633 0.54 x 0.7 x 0.61 x 0.6 x x x x 0.609 0.6 x 0.615 0.69 x 0.662 0.657 x 0.623 0.54 x 0.685 x x 0.653 0.625 0.675 0.635 x 0.595 0.745 x 0.735 +12951 Original post publication description: Blood chemistry, metabolism: Cholesterol (total) in serum of 14-week old males [mM] None Blood chemistry, metabolism: Cholesterol (total) in serum of 14-week old males [mM] x x 2.452 x 3.305 x x 2.095 1.908 x 2.343 x x x x 2.293 2.083 x 2.508 x x x x x x x 2.72 x x 3.158 x x 2.073 x x x x x x x 2.815 1.91 2.467 2.675 x x 3.115 x x x x x x 2.805 2.498 x x x x 2.45 3.59 x x 3.075 2.505 x 2.745 2.53 x 2.385 x 2.24 x 2.505 x x x x 2.788 3.305 x 2.88 2.29 x 2.75 2.843 x 2.23 3.41 x 2.245 x x 2.345 2.43 3.973 2.053 x 2.695 2.7 x 2.26 +12947 Original post publication description: Blood chemistry, cardiovascular system: Red blood cell count of 14-week old males [x10^6/ul] None Blood chemistry, cardiovascular system: Red blood cell count of 14-week old males [x10^6/ul] x x 9.086 x 9.71 x x 8.935 8.233 x 9.34 x x x x 9.268 11.16 x 10.468 x x x x x x x 10.03 x x 7.938 x x 9.715 x x x x x x x 11.178 9.7 9.457 8.955 x x 10.153 x x x x x x 9.035 9.873 x x x x 11.13 9.975 x x 9.1 12.095 x 10.47 10.015 x 8.44 x 9.405 x 9.96 x x x x 8.84 9.89 x 9.15 10.75 x 9.965 9.05 x 9.803 9.03 x 11.58 x x 9.385 10.33 10.525 8.59 x 9.91 10.275 x 10.78 +12945 Original post publication description: Blood chemistry, cardiovascular system: Platelet count of 14-week old males [x10^3/ul] None Blood chemistry, cardiovascular system: Platelet count of 14-week old males [x10^3/ul] x x 1093.92 x 1001.75 x x 1161.75 1409.25 x 1255.0 x x x x 1685.75 1107.0 x 1120.0 x x x x x x x 762.333 x x 1536.25 x x 1060.25 x x x x x x x 1182.75 1076.0 1049.0 1268.0 x x 922.0 x x x x x x 1089.5 800.25 x x x x 2261.0 938.5 x x 1302.5 1313.0 x 836.75 1280.5 x 620.5 x 1359.5 x 1276.0 x x x x 1514.67 1055.5 x 1276.0 1309.0 x 1172.0 1294.25 x 1202.25 1497.0 x 906.0 x x 970.0 916.5 1316.5 892.5 x 1473.0 1157.0 x 1207.0 +12942 Original post publication description: Blood chemistry, cardiovascular system: Mean cell volume of 14-week old males [fl] None Blood chemistry, cardiovascular system: Mean cell volume of 14-week old males [fl] x x 46.436 x 43.25 x x 45.0 45.325 x 43.6 x x x x 45.95 47.3 x 42.225 x x x x x x x 46.267 x x 43.85 x x 47.325 x x x x x x x 44.775 44.7 45.833 46.25 x x 42.225 x x x x x x 50.5 50.25 x x x x 48.6 47.775 x x 41.75 47.7 x 46.125 45.15 x 46.75 x 43.95 x 42.95 x x x x 45.833 47.3 x 46.25 47.25 x 49.0 49.3 x 47.825 44.2 x 45.25 x x 46.475 44.55 40.425 44.6 x 45.0 44.05 x 45.1 +12943 Original post publication description: Blood chemistry: Sodium of 14-week old males [mM] None Blood chemistry: Sodium of 14-week old males [mM] x x 147.84 x 146.25 x x 148.0 143.5 x 147.0 x x x x 144.25 148.5 x 149.0 x x x x x x x 148.0 x x 149.5 x x 149.0 x x x x x x x 159.75 149.0 148.667 150.0 x x 146.75 x x x x x x 148.0 149.0 x x x x x 145.75 x x 149.0 x x x x x 149.5 x x x 151.0 x x x x 149.25 149.5 x 150.0 150.5 x x 164.0 x 151.5 150.0 x 151.0 x x 150.75 151.5 145.25 149.333 x x 147.5 x 147.5 +12940 Original post publication description: Blood chemistry, cardiovascular system: Mean corpuscular hemoglobin of 14-week old males [pg] None Blood chemistry, cardiovascular system: Mean corpuscular hemoglobin of 14-week old males [pg] x x 15.908 x 14.675 x x 15.7 15.375 x 14.467 x x x x 15.15 15.575 x 14.6 x x x x x x x 14.967 x x 15.075 x x 15.2 x x x x x x x 14.175 15.3 15.367 15.55 x x 14.25 x x x x x x 16.4 16.45 x x x x 13.15 15.825 x x 13.75 13.45 x 15.05 14.9 x 16.5 x 14.45 x 14.2 x x x x 15.667 15.2 x 14.85 15.2 x 15.2 15.825 x 15.2 15.0 x 15.25 x x 15.925 15.5 13.65 15.833 x 14.2 15.15 x 15.2 +12941 Original post publication description: Blood chemistry, cardiovascular system: Mean cell hemoglobin concentration of 14-week old males [g/dl] None Blood chemistry, cardiovascular system: Mean cell hemoglobin concentration of 14-week old males [g/dl] x x 34.264 x 33.875 x x 34.95 33.825 x 33.133 x x x x 33.0 32.9 x 34.6 x x x x x x x 32.4 x x 34.4 x x 32.125 x x x x x x x 31.65 34.2 33.567 33.6 x x 33.75 x x x x x x 32.45 32.75 x x x x 27.1 33.1 x x 32.9 28.15 x 32.65 33.0 x 35.25 x 32.85 x 33.05 x x x x 34.233 32.1 x 32.05 32.15 x 31.0 32.075 x 31.775 33.9 x 33.7 x x 34.275 34.85 33.725 35.533 x 31.6 34.4 x 33.8 +12938 Original post publication description: Cardiovascular system: Left ventricular mass by echocardiography of 17-week old males [mg] None Cardiovascular system: Left ventricular mass by echocardiography of 17-week old males [mg] x x 95.216 x 109.589 x x x x x 104.059 x x x x x x x x x x x x x x x 103.493 x x x x x 119.427 x x x x x x x 113.22 77.383 61.001 x x x 87.447 x x x x x x 95.942 79.864 x x x x 86.189 100.651 x x 74.4 78.427 x 95.923 74.537 x 87.695 x 89.501 x 77.035 x x x x 79.604 96.555 x 100.319 106.12 x 99.262 107.419 x 84.131 61.087 x 128.117 x x 83.63 88.5 101.563 85.317 x 84.337 136.689 x 127.784 +12939 Original post publication description: Cardiovascular system: Left ventricular mass/body weight ratio by echocardiography of 17-week old males [ratio] None Cardiovascular system: Left ventricular mass/body weight ratio by echocardiography of 17-week old males [ratio] x x 3.457 x 3.519 x x x x x 4.04 x x x x x x x x x x x x x x x 3.353 x x x x x 3.937 x x x x x x x 4.456 2.954 2.432 x x x 3.097 x x x x x x 3.611 3.083 x x x x 3.511 3.767 x x 3.256 3.234 x 3.49 3.106 x 2.999 x 3.436 x 3.366 x x x x 3.334 3.627 x 3.477 4.405 x 3.511 4.488 x 3.301 2.368 x 3.534 x x 3.1 2.809 3.2 3.285 x 3.095 5.33 x 4.928 +12936 Original post publication description: Morphology, metabolism: Body lean mass percentage of 19-week old males [%] None Morphology, metabolism: Body lean mass percentage of 19-week old males [%] x x 77.628 x 78.055 x x 75.748 75.438 x 76.53 x x x x 68.848 75.793 x 79.023 x x x x x x x 71.38 x x 75.228 x x 72.915 x x x x x x x 78.578 70.44 76.345 x x x 76.29 x x x x x x 76.37 84.668 x x x x 84.835 75.023 x x 85.1 77.645 x 81.165 80.435 x 82.035 x 87.05 x 86.255 x x x x 72.923 70.05 x 75.76 86.835 x 82.115 73.977 x 82.265 72.67 x 73.825 x x 81.63 83.8 67.258 82.83 x 86.055 83.6 x 84.69 +12937 Original post publication description: Morphology, gastrointestinal system: Liver mass of 20-week old males [g] None Liver, morphology, gastrointestinal system: Liver mass of 20-week old males [g] x x 1.212 x 1.722 x x 1.066 1.384 x 1.266 x x x x 1.745 1.238 x 1.414 x x x x x x x 0.658 x x 1.519 x x 1.531 x x x x x x x 1.546 1.416 1.32 x x x 0.354 x x x x x x 1.528 1.488 x x x x 1.383 1.476 x x 1.501 1.247 x 1.574 1.33 x 1.409 x 1.414 x 1.389 x x x x 1.289 1.249 x 1.397 1.458 x 1.484 1.269 x 1.323 1.368 x x x x 1.384 1.568 1.813 1.398 x 1.655 1.37 x 1.209 +12934 Original post publication description: Blood chemistry: Potassium of 14-week old males [mM] None Blood chemistry: Potassium of 14-week old males [mM] x x 4.368 x 5.135 x x 5.32 4.865 x 3.983 x x x x 4.605 5.31 x 4.87 x x x x x x x 5.047 x x 4.528 x x 4.848 x x x x x x x 4.723 4.83 4.657 4.625 x x 4.738 x x x x x x 4.74 4.14 x x x x x 4.745 x x 4.54 x x x x x 4.485 x x x 5.27 x x x x 4.725 4.8 x 3.935 4.63 x x 4.878 x 4.775 4.78 x 5.365 x x 3.808 4.235 4.675 4.543 x x 3.95 x 4.325 +12935 Original post publication description: Morphology, metabolism: Body lean mass of 19-week old males [g] None Morphology, metabolism: Body lean mass of 19-week old males [g] x x 21.762 x 24.998 x x 20.15 20.987 x 20.786 x x x x 23.953 21.279 x 24.001 x x x x x x x 24.286 x x 22.809 x x 23.757 x x x x x x x 21.491 19.512 20.97 x x x 22.429 x x x x x x 22.719 22.627 x x x x 21.435 20.985 x x 19.351 19.574 x 23.198 21.445 x 22.235 x 22.448 x 19.992 x x x x 20.337 17.089 x 19.894 20.924 x 22.526 19.283 x 20.219 19.694 x 27.614 x x 21.345 25.418 22.455 21.791 x 24.473 21.066 x 21.267 +12932 Original post publication description: Blood chemistry, cardiovascular system: Hemoglobin of 14-week old males [g/dl] None Blood chemistry, cardiovascular system: Hemoglobin of 14-week old males [g/dl] x x 14.448 x 14.25 x x 14.05 12.625 x 13.5 x x x x 14.05 17.375 x 15.3 x x x x x x x 15.033 x x 11.975 x x 14.775 x x x x x x x 15.85 14.8 14.5 13.9 x x 14.45 x x x x x x 14.85 16.225 x x x x 14.45 15.75 x x 12.5 16.2 x 15.8 14.9 x 13.9 x 13.6 x 14.15 x x x x 13.833 15.05 x 13.6 16.3 x 15.1 14.325 x 14.875 13.5 x 17.65 x x 14.925 16.05 14.375 13.567 x 14.0 15.55 x 16.35 +12933 Original post publication description: Cardiovascular system: Heart rate during echocardiography of 17-week old males [beat/min] None Cardiovascular system: Heart rate during echocardiography of 17-week old males [beat/min] x x 557.891 x 541.622 x x 609.513 655.745 x 693.555 x x x x 464.456 499.576 x 538.847 x x x x x x x 610.617 x x 593.232 x x 645.632 x x x x x x x 589.989 653.624 632.445 645.73 x x 653.034 x x x x x x 634.764 652.541 x x x x 556.367 506.083 x x 534.4 592.858 x 692.363 579.39 x 701.017 x 627.14 x 614.076 x x x x 630.44 488.83 x 498.216 560.911 x 644.316 651.344 x 644.787 573.378 x 497.544 x x 534.761 614.136 550.284 592.827 x 757.377 553.169 x 622.021 +12929 Original post publication description: Metabolism: Blood glucose level (intraperitoneal glucose tolerance test) at time=30 min of 18-week old males [mg/dl] None Metabolism: Blood glucose level (intraperitoneal glucose tolerance test) at time=30 min of 18-week old males [mg/dl] x x 322.52 x 306.25 x x 260.5 191.5 x 277.333 x x x x 246.0 217.75 x 235.0 x x x x x x x 306.5 x x 287.0 x x 332.75 x x x x x x x 200.25 304.0 408.5 x x x 293.5 x x x x x x 160.5 290.75 x x x x 219.0 320.333 x x 229.0 230.0 x 348.75 345.0 x 257.0 x 265.0 x 251.5 x x x x 195.25 216.5 x 258.0 194.5 x 407.0 256.0 x 272.5 243.0 x 278.0 x x 343.5 246.5 337.75 315.667 x 267.0 205.5 x 220.5 +12930 Original post publication description: Metabolism: Blood glucose level (intraperitoneal glucose tolerance test) at time=60 min of 18-week old males [mg/dl] None Metabolism: Blood glucose level (intraperitoneal glucose tolerance test) at time=60 min of 18-week old males [mg/dl] x x 213.88 x 229.5 x x 205.25 142.75 x 246.0 x x x x 205.5 141.75 x 164.25 x x x x x x x 241.5 x x 206.75 x x 218.5 x x x x x x x 150.5 176.0 405.0 x x x 199.5 x x x x x x 115.5 202.0 x x x x 168.5 204.333 x x 164.0 214.5 x 292.5 272.0 x 209.5 x 209.5 x 185.0 x x x x 150.0 153.5 x 184.0 153.0 x 327.0 159.0 x 204.5 166.0 x 192.0 x x 274.75 188.0 251.5 226.333 x 199.5 167.0 x 160.0 +12927 Original post publication description: Metabolism: Blood glucose level (intraperitoneal glucose tolerance test) at time=120 min of 18-week old males [mg/dl] None Metabolism: Blood glucose level (intraperitoneal glucose tolerance test) at time=120 min of 18-week old males [mg/dl] x x 126.48 x 142.5 x x 130.75 86.5 x 146.0 x x x x 124.5 92.0 x 112.5 x x x x x x x 164.0 x x 148.75 x x 143.25 x x x x x x x 110.0 125.0 246.5 x x x 118.5 x x x x x x 83.5 112.5 x x x x 125.0 109.0 x x 131.5 108.5 x 142.25 176.0 x 120.5 x 128.0 x 128.0 x x x x 113.0 94.0 x 136.0 109.0 x 197.0 159.0 x 130.0 129.0 x 129.0 x x 155.0 129.5 168.5 138.333 x 115.0 106.5 x 131.0 +12928 Original post publication description: Metabolism: Blood glucose level (intraperitoneal glucose tolerance test) at time=15 min of 18-week old males [mg/dl] None Metabolism: Blood glucose level (intraperitoneal glucose tolerance test) at time=15 min of 18-week old males [mg/dl] x x 307.4 x 274.75 x x 272.0 233.0 x 239.0 x x x x 266.75 212.75 x 236.5 x x x x x x x 290.5 x x 270.5 x x 316.75 x x x x x x x 230.75 298.0 295.0 x x x 322.25 x x x x x x 195.0 255.25 x x x x 281.5 313.333 x x 276.0 242.0 x 281.25 315.0 x 249.0 x 317.0 x 271.5 x x x x 220.75 231.5 x 273.0 212.5 x 401.5 241.333 x 242.75 268.0 x 277.5 x x 273.0 247.0 312.25 246.667 x 278.5 190.0 x 246.0 +12925 Original post publication description: Blood chemistry, metabolism: Glucose after 4 hour fast of 14-week old males [mMl] None Blood chemistry, metabolism: Glucose after 4 hour fast of 14-week old males [mMl] x x 16.0 x 14.38 x x 16.058 14.685 x 15.227 x x x x 12.038 15.278 x 10.975 x x x x x x x 13.69 x x 14.198 x x 13.488 x x x x x x x 14.155 15.43 18.617 15.935 x x 16.508 x x x x x x 15.485 14.963 x x x x 16.195 14.755 x x 18.47 13.945 x 12.99 15.775 x 15.195 x 13.82 x 16.75 x x x x 15.345 18.48 x 16.165 13.395 x 19.715 14.607 x 13.383 19.67 x 12.79 x x 16.343 17.195 13.997 16.263 x 15.63 15.085 x 15.755 +12921 Original post publication description: Cardiovascular system: Ejection Fraction by echocardiography of 17-week old males [%] None Cardiovascular system: Ejection fraction by echocardiography of 17-week old males [%] x x 67.774 x 68.975 x x x x x 69.167 x x x x x x x x x x x x x x x 74.767 x x x x x 71.125 x x x x x x x 72.5 67.4 68.9 x x x 72.05 x x x x x x 64.25 62.975 x x x x 65.0 73.467 x x 74.4 67.25 x 66.125 61.0 x 70.6 x 62.0 x 57.5 x x x x 69.511 61.85 x 67.85 75.45 x 67.9 69.333 x 70.025 76.0 x 63.95 x x 66.425 71.95 75.8 71.8 x 73.5 73.15 x 66.55 +12922 Original post publication description: Metabolism: Food intake of 13-week old males [g/mouse] None Central nervous system, metabolism, behavior: Food intake of 13-week old males [g/mouse] x x 2.437 x x x x 1.871 2.45 x x x x x x 2.093 2.369 x 2.332 x x x x x x x 2.632 x x 2.707 x x x x x x x x x x x x 3.456 4.183 x x 2.269 x x x x x x x 1.335 x x x x 2.113 x x x 1.481 1.3 x 3.39 2.241 x 3.356 x 6.485 x 1.83 x x x x x x x x 1.534 x 2.613 x x 2.202 x x 1.032 x x 1.67 1.536 x 2.651 x 0.198 1.956 x 0.843 +12923 Original post publication description: Cardiovascular system: Shortening fraction by echocardiography of 17-week old males [%] None Cardiovascular system: Shortening fraction by echocardiography of 17-week old males [%] x x 32.852 x 33.875 x x x x x 33.833 x x x x x x x x x x x x x x x 38.3 x x x x x 34.375 x x x x x x x 36.6 32.1 33.4 x x x 35.825 x x x x x x 30.3 29.438 x x x x 30.75 37.033 x x 37.5 32.0 x 31.875 29.0 x 34.65 x 28.75 x 26.2 x x x x 33.921 28.7 x 33.0 39.3 x 33.0 34.0 x 34.25 38.9 x 30.35 x x 31.725 35.75 39.125 35.65 x 31.0 37.05 x 31.85 +12919 Original post publication description: Morphology, metabolism: Body fat mass percentage of 19-week old males [%] None Morphology, metabolism: Body fat mass percentage of 19-week old males [%] x x 13.801 x 11.205 x x 13.363 12.825 x 13.2 x x x x 19.693 13.035 x 9.645 x x x x x x x 19.02 x x 14.945 x x 17.893 x x x x x x x 10.683 19.74 23.655 x x x 14.138 x x x x x x 12.44 15.333 x x x x 15.165 14.337 x x 14.9 22.355 x 18.835 19.565 x 17.965 x 12.95 x 13.745 x x x x 16.873 20.23 x 14.41 13.165 x 17.885 16.053 x 17.735 16.2 x 26.175 x x 18.37 16.2 24.37 17.17 x 13.945 16.4 x 15.31 +12920 Original post publication description: Morphology, metabolism: Body fat mass of 19-week old males [g] None Morphology, metabolism: Body fat mass of 19-week old males [g] x x 3.844 x 3.587 x x 3.555 3.582 x 3.588 x x x x 6.841 3.659 x 2.964 x x x x x x x 6.808 x x 4.535 x x 5.85 x x x x x x x 2.924 5.468 6.595 x x x 4.16 x x x x x x 3.7 4.098 x x x x 3.835 4.007 x x 3.394 5.646 x 5.414 5.22 x 4.945 x 3.342 x 3.188 x x x x 4.737 4.998 x 3.778 3.176 x 4.974 4.185 x 4.369 4.39 x 9.811 x x 4.823 4.912 8.19 4.559 x 3.967 4.139 x 3.843 +12917 Original post publication description: Cardiovascular system: End-diastolic diameter by echocardiography of 17-week old males [mm] None Cardiovascular system: End-diastolic diameter by echocardiography of 17-week old males [mm] x x 4.27 x 4.503 x x x x x 4.4 x x x x x x x x x x x x x x x 4.303 x x x x x 4.693 x x x x x x x 4.645 3.76 3.505 x x x 4.008 x x x x x x 4.225 4.023 x x x x 4.115 4.207 x x 3.69 4.005 x 4.275 4.04 x 3.905 x 4.205 x 3.935 x x x x 3.921 4.47 x 4.4 4.15 x 4.286 4.48 x 3.988 3.83 x 4.715 x x 3.915 4.08 4.293 4.15 x 4.15 4.61 x 4.575 +12918 Original post publication description: Cardiovascular system: End-systolic diameter by echocardiography of 17-week old males [mm] None Cardiovascular system: End-systolic diameter by echocardiography of 17-week old males [mm] x x 2.877 x 2.975 x x x x x 12.06 x x x x x x x x x x x x x x x 2.65 x x x x x 3.073 x x x x x x x 2.945 2.56 2.34 x x x 2.575 x x x x x x 2.945 2.84 x x x x 2.875 2.647 x x 2.305 2.735 x 2.928 2.91 x 2.555 x 3.05 x 2.91 x x x x 2.592 3.195 x 2.945 2.52 x 2.88 2.933 x 2.628 2.34 x 3.3 x x 2.678 2.625 2.893 2.66 x 2.875 2.91 x 3.12 +12915 Original post publication description: Blood chemistry: Chloride of 14-week old males [mM] None Blood chemistry: Chloride of 14-week old males [mM] x x 111.84 x 109.0 x x 110.0 107.5 x 109.0 x x x x 106.0 112.5 x 110.25 x x x x x x x 110.667 x x 112.0 x x 113.0 x x x x x x x 118.0 113.0 110.0 109.5 x x 111.5 x x x x x x 111.0 111.5 x x x x x 107.75 x x 112.5 x x x x x 112.5 x x x 113.0 x x x x 111.5 109.5 x 109.5 114.5 x x 123.25 x 115.0 113.0 x 113.0 x x 111.25 113.0 109.5 109.333 x x 111.5 x 112.0 +12916 Original post publication description: Blood chemistry: Creatinine of 14-week old males [uM] None Blood chemistry: Creatinine of 14-week old males [uM] x x 7.954 x x x x 13.275 8.575 x 7.667 x x x x 9.3 7.85 x 9.225 x x x x x x x 5.68 x x 8.025 x x 10.313 x x x x x x x 9.153 7.2 7.667 6.6 x x 9.485 x x x x x x 7.35 7.725 x x x x x x x x 9.85 x x x x x 6.9 x x x 7.55 x x x x 7.95 5.8 x 7.85 8.7 x x 6.243 x 8.7 10.3 x 9.35 x x 7.65 8.9 x 8.7 x x 9.05 x 8.2 +12913 Original post publication description: Morphology: Body weight of 20-week old males at necropsy [g] None Musculoskeletal system, morphology: Body weight of 20-week old males at necropsy [g] x x 26.741 x 31.963 x x 24.681 26.608 x 26.049 x x x x 34.663 27.088 x 29.606 x x x x x x x 34.178 x x 28.223 x x 32.418 x x x x x x x 28.222 27.889 27.28 x x x 29.202 x x x x x x 28.623 26.276 x x x x 24.348 27.743 x x 24.404 24.473 x 29.095 26.583 x 28.815 x 24.597 x 24.304 x x x x 26.737 23.298 x 25.671 25.788 x 30.836 25.239 x 26.419 25.738 x x x x 27.349 29.863 33.575 26.822 x 28.088 27.243 x 27.829 +12910 Original post publication description: Morphology: Body weight of 19-week old males [g] None Musculoskeletal system, morphology: Body weight of 19-week old males [g] x x 28.12 x 32.375 x x 26.125 26.675 x 27.133 x x x x 33.525 27.5 x 29.45 x x x x x x x 34.7 x x 29.8 x x 32.65 x x x x x x x 27.2 28.6 27.95 x x x 29.075 x x x x x x 29.55 26.85 x x x x 24.45 28.0 x x 23.15 23.2 x 25.95 24.65 x 29.0 x 25.35 x 23.3 x x x x 27.4 24.75 x 26.25 23.5 x 26.0 25.933 x 25.325 26.7 x 37.1 x x 27.05 31.6 33.625 27.233 x 27.45 25.55 x 26.7 +12911 Original post publication description: Morphology, metabolism: Body weight at bone densitometry assay (peripheral dual energy X-ray absorptiometer (PDEXA)) of 19-week old males [g] None Morphology, metabolism: Body weight at bone densitometry assay (peripheral dual energy X-ray absorptiometer (PDEXA)) of 19-week old males [g] x x 28.304 x 32.025 x x 26.6 27.825 x 27.167 x x x x 34.8 28.075 x 30.4 x x x x x x x 34.35 x x 30.325 x x 32.6 x x x x x x x 27.35 27.7 28.8 x x x 29.4 x x x x x x 29.75 27.975 x x x x 26.2 27.967 x x 24.1 25.9 x 29.4 27.35 x 28.9 x 27.0 x 24.65 x x x x 27.925 24.45 x 26.25 25.65 x 28.6 26.067 x 26.075 27.1 x 38.95 x x 28.05 31.85 33.45 27.833 x 29.15 26.6 x 26.6 +12908 Original post publication description: Morphology: Body weight of 18-week old males [g] None Musculoskeletal system, morphology: Body weight of 18-week old males [g] x x 27.92 x 32.7 x x 25.775 25.25 x 25.633 x x x x 31.675 26.3 x 28.525 x x x x x x x 31.833 x x 29.05 x x 31.55 x x x x x x x 25.675 26.8 28.25 x x x 28.775 x x x x x x 28.95 25.45 x x x x 23.9 28.233 x x 23.5 22.8 x 25.625 25.2 x 28.45 x 24.9 x 24.2 x x x x 27.475 24.35 x 26.05 24.75 x 29.48 24.4 x 26.25 25.9 x 36.0 x x 26.5 30.85 32.275 26.633 x 27.4 25.9 x 26.4 +12909 Original post publication description: Metabolism: Body weight for glucose tolerance test (ip) test of 18-week old males [g] None Morphology, metabolism: Body weight for glucose tolerance test (ip) test of 18-week old males [g] x x 25.016 x 28.7 x x 23.8 21.3 x 22.7 x x x x 28.625 23.175 x 25.025 x x x x x x x 29.35 x x 25.575 x x 28.475 x x x x x x x 22.875 23.1 26.3 x x x 25.5 x x x x x x 25.9 23.75 x x x x 21.45 25.133 x x 21.35 22.25 x 25.3 23.95 x 25.9 x 23.2 x 20.5 x x x x 24.5 21.85 x 23.05 21.9 x 25.65 21.833 x 23.1 23.4 x 33.95 x x 24.875 27.55 29.6 23.767 x 24.35 23.05 x 23.95 +12906 Original post publication description: Morphology: Body weight of 17-week old males [g] None Musculoskeletal system, morphology: Body weight of 17-week old males [g] x x 27.324 x x x x 25.875 24.425 x 25.867 x x x x 30.675 26.4 x 29.475 x x x x x x x 31.467 x x 28.575 x x 30.325 x x x x x x x 25.45 25.8 27.533 24.1 x x 28.275 x x x x x x 28.85 26.5 x x x x 24.55 x x x 24.05 25.5 x 26.05 25.45 x 27.3 x 26.55 x 24.25 x x x x 25.75 24.15 x 26.6 25.05 x 28.34 23.7 x 25.675 26.2 x 36.45 x x 27.4 30.0 x 26.767 x 27.25 25.9 x 26.75 +12907 Original post publication description: Morphology, cardiovascular system: Body weight at echocardiography of 17-week old males [g] None Morphology, cardiovascular system: Body weight at echocardiography of 17-week old males [g] x x 27.608 x 31.125 x x x x x 25.867 x x x x x x x x x x x x x x x 31.167 x x x x x 30.325 x x x x x x x 25.45 26.2 25.15 22.7 x x 28.2 x x x x x x 26.6 x x x x x 24.55 26.6 x x 22.8 24.25 x 28.075 24.0 x 29.0 x 26.05 x 22.85 x x x x 24.105 26.55 x 28.85 24.1 x 28.48 23.7 x 25.55 25.8 x 36.25 x x x 31.0 31.85 x x 27.25 25.6 x 25.9 +12904 Original post publication description: Morphology: Body weight of 15-week old males [g] None Musculoskeletal system, morphology: Body weight of 15-week old males [g] x x 27.316 x 30.2 x x 25.775 23.4 x 25.167 x x x x 30.225 26.4 x 29.575 x x x x x x x 29.967 x x 27.925 x x 30.0 x x x x x x x 25.725 25.5 27.171 24.2 x x 27.125 x x x x x x 28.6 26.875 x x x x 24.45 26.425 x x 22.9 23.2 x 27.763 26.983 x 28.2 x 25.35 x 23.85 x x x x 26.85 23.7 x 26.05 23.15 x 27.9 24.375 x 24.8 26.0 x 32.9 x x 26.3 30.2 30.55 26.8 x 27.45 25.45 x 25.35 +12902 Original post publication description: Morphology: Body weight of 13-week old males [g] None Musculoskeletal system, morphology: Body weight of 13-week old males [g] x x 26.692 x 29.225 x x 24.85 21.775 x 25.1 x x x x 28.7 24.975 x 29.3 x x x x x x x 28.567 x x 27.375 x x 29.425 x x x x x x x 25.225 25.4 25.543 23.1 x x 26.1 x x x x x x 28.9 26.375 x x x x 23.6 25.775 x x 21.65 22.2 x 26.175 26.133 x 26.0 x 23.95 x 22.7 x x x x 26.35 23.9 x 25.45 20.95 x 27.02 24.15 x 23.825 25.6 x 28.15 x x 25.4 30.55 29.25 27.467 x 26.75 24.1 x 25.15 +12900 Original post publication description: Musculoskeletal system, metabolism: Bone surface area by peripheral dual energy X-ray absorptiometer (PDEXA) of 19-week old males [cm2] None Musculoskeletal system, metabolism: Bone surface area for whole body by peripheral dual energy X-ray absorptiometer (PDEXA) of 19-week old males [cm2] x x 8.063 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 7.045 x x x x x x x x x x x 7.225 x x x x 7.55 x x x 8.08 6.94 x 7.508 6.97 x 7.865 x 7.57 x 8.25 x x x x x x x x 8.055 x 6.975 x x 7.955 x x 8.195 x x 7.775 8.315 x 7.66 x 8.325 7.905 x 8.535 +12898 Original post publication description: Musculoskeletal system, metabolism: Bone mineral content by peripheral dual energy X-ray absorptiometer (PDEXA) of 19-week old males [g] None Musculoskeletal system, metabolism: Bone mineral content for whole body by peripheral dual energy X-ray absorptiometer (PDEXA) of 19-week old males [g] x x 0.403 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.38 x x x x x x x x x x x 0.368 x x x x 0.413 x x x 0.4 0.321 x 0.371 0.333 x 0.418 x 0.395 x 0.397 x x x x x x x x 0.362 x 0.356 x x 0.375 x x 0.412 x x 0.424 0.474 x 0.389 x 0.468 0.402 x 0.419 +12895 Original post publication description: Blood chemistry: Aspartate transaminase of 14-week old males [U/l] None Blood chemistry: Aspartate transaminase of 14-week old males [U/l] x x 64.72 x 72.0 x x 97.5 65.5 x 64.333 x x x x 75.75 92.25 x 146.0 x x x x x x x 134.667 x x 61.5 x x 172.25 x x x x x x x 104.5 40.0 68.0 47.5 x x 69.75 x x x x x x 47.5 64.5 x x x x 141.0 62.75 x x 69.5 74.0 x 146.25 121.5 x 42.5 x 125.0 x 76.5 x x x x 76.5 46.0 x 81.0 58.0 x 61.0 75.25 x 103.75 50.0 x 54.0 x x 55.75 72.5 39.5 99.667 x 105.0 41.5 x 70.0 +12896 Original post publication description: Metabolism: Blood glucose level (intraperitoneal glucose tolerance test), area under curve (AUC) of 18-week old males [mg/dl] None Metabolism: Blood glucose level (intraperitoneal glucose tolerance test), area under curve (AUC) of 18-week old males [mg/dl] x x 14275.2 x 13380.0 x x 8278.12 8947.5 x 14850.0 x x x x 13884.4 7891.88 x 8913.75 x x x x x x x 13653.8 x x 10753.1 x x 15511.9 x x x x x x x 4117.5 11617.5 26467.5 x x x 13338.8 x x x x x x 5463.75 12598.1 x x x x 9401.25 14622.5 x x 8298.75 11756.2 x 18470.6 15326.2 x 13278.8 x 10710.0 x 5133.75 x x x x 6031.88 9352.5 x 8141.25 8831.25 x 22755.0 11892.5 x 13228.1 6652.5 x 11227.5 x x 16659.4 11133.8 13243.1 14150.0 x 12937.5 9127.5 x 4931.25 +12893 Original post publication description: Blood chemistry: Albumin of 14-week old males [g/l] None Blood chemistry: Albumin of 14-week old males [g/l] x x 26.56 x 25.0 x x 24.5 22.75 x 25.0 x x x x 24.25 24.75 x 24.25 x x x x x x x 24.667 x x 22.75 x x 27.75 x x x x x x x 28.25 25.0 27.667 29.0 x x 25.75 x x x x x x 27.0 26.25 x x x x x 25.5 x x 27.5 x x x x x 26.5 x x x 24.5 x x x x 27.25 27.0 x 26.5 26.5 x x 26.667 x 27.0 28.0 x 25.0 x x 29.25 26.0 29.5 27.667 x x 26.5 x 25.5 +12894 Original post publication description: Blood chemistry: Alkaline phosphatase of 14-week old males (ALPL gene product) [U/l] None Blood chemistry: Alkaline phosphatase of 14-week old males (ALPL gene product) [U/l] x x 100.32 x 152.0 x x 91.75 232.0 x 78.0 x x x x 225.5 180.75 x 75.25 x x x x x x x 167.333 x x 44.0 x x 98.5 x x x x x x x 104.0 105.0 124.333 182.0 x x 147.5 x x x x x x 130.5 133.75 x x x x 160.5 75.25 x x 100.0 168.5 x 118.75 172.0 x 175.5 x 130.0 x 136.0 x x x x 118.0 195.0 x 140.0 171.0 x 136.5 152.75 x 187.5 245.0 x 120.0 x x 156.0 107.0 116.5 83.0 x 120.0 130.0 x 116.0 +12891 Original post publication description: Blood chemistry: Alpha-amylase of 14-week old males [U/l] None Blood chemistry: Alpha-amylase of 14-week old males [U/l] x x 575.56 x 692.5 x x 499.25 495.25 x 666.333 x x x x 554.75 735.25 x 879.0 x x x x x x x 496.333 x x 510.0 x x 672.0 x x x x x x x 845.75 615.0 643.0 487.5 x x 598.0 x x x x x x 673.0 504.0 x x x x x 595.25 x x 524.5 x x x x x 672.5 x x x 457.5 x x x x 756.25 619.0 x 645.0 504.5 x x 713.75 x 1688.25 529.0 x 620.5 x x 575.0 625.5 490.25 435.0 x x 501.5 x 635.5 +12892 Original post publication description: Blood chemistry: Alanine transaminase (ALT, ALAT, SGPT) level in serum of 14-week old males [U/L] None Blood chemistry: Alanine transaminase (ALT, ALAT, SGPT) level in serum of 14-week old males [U/L] x x 35.84 x 28.75 x x 51.0 24.25 x 56.667 x x x x 51.0 33.75 x 70.0 x x x x x x x 79.333 x x 29.25 x x 115.5 x x x x x x x 51.5 21.0 39.333 36.5 x x 43.25 x x x x x x 24.5 37.0 x x x x 47.0 32.0 x x 32.0 75.0 x 45.75 39.0 x 24.0 x 79.5 x 29.5 x x x x 32.75 25.5 x 44.5 23.5 x 59.5 67.5 x 30.5 26.0 x 36.0 x x 40.25 34.0 25.0 74.333 x 81.0 24.0 x 33.5 +12889 Original post publication description: Metabolism: Water intake of 13-week old females [ml/mouse/unit time] None Central nervous system, metabolism, behavior: Water intake of 13-week old females [ml/mouse/unit time] x x 2.173 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 1.819 x x x x x x x x x x x 3.012 x x x 1.779 1.904 x x x 1.592 1.679 x 3.681 2.106 x x x 1.585 x 1.435 x x x x x x x x 1.515 x 3.102 x x 1.455 x x x x x 3.001 x x 3.096 x 1.876 1.379 x 1.374 +12890 Original post publication description: Metabolism, behavior: Activity level of 13-week old females [total counts of fine movements and ambulatory activity/unit time] None Central nervous system, metabolism, behavior: Activity of 13-week old females, total counts of fine movements and ambulatory activity [counts/unit time] x x 1254.09 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 255.286 x x x x x x x x x x x 816.5 x x x 2714.57 1189.07 x x x 1317.64 651.286 x 1238.71 399.857 x x x 811.5 x 862.857 x x x x x x x x 1643.0 x 936.429 x x 715.214 x x x x x 707.929 x x 1481.93 x 577.571 1971.0 x 807.357 +12887 Original post publication description: Morphology, metabolism: White adipose tissue mass of 20-week old females [g] None Morphology, metabolism: White adipose tissue mass of 20-week old females [g] x x 0.271 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.518 0.421 x x x x x x x x x x 0.333 0.345 x x x 0.502 0.198 x x x 0.349 0.387 x 0.263 0.426 x x x 0.249 x 0.091 x x x x 0.496 0.269 x x 0.121 x 0.252 x x 0.393 0.627 x x x x 0.334 x x 0.25 x 0.347 0.293 x 0.256 +12888 Original post publication description: Blood chemistry, cardiovascular system: White blood cell count of 14-week old females [x10^3/ul] None Blood chemistry, cardiovascular system: White blood cell count of 14-week old females [x10^3/ul] x x 6.063 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 9.05 13.75 x x x x x x x x x x 9.6 7.6 x x x 9.2 8.9 x x x 6.35 6.7 x 6.25 5.95 x x x 7.85 x 8.6 x x x x 7.3 8.4 x x 7.3 x 9.7 x x 7.9 9.85 x x x x 9.4 x x 13.9 x 8.4 6.35 x 7.4 +12885 Original post publication description: Metabolism: Volume of CO2 production of 13-week old females [ml/kg/h] None Respiratory system, metabolism: Volume of CO2 production of 13-week old females [ml/kg/h] x x 783.048 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 669.929 x x x x x x x x x x x 1154.64 x x x 1102.64 903.583 x x x 953.0 803.143 x 1237.09 697.857 x x x 802.857 x 723.893 x x x x x x x x 845.857 x 1026.29 x x 609.357 x x x x x 779.571 x x 959.143 x 861.214 963.143 x 629.857 +12886 Original post publication description: Metabolism: Volume oxygen consumption of 13-week old females [ml/kg/h] None Respiratory system, metabolism: Volume oxygen consumption of 13-week old females [ml/kg/h] x x 928.667 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 741.286 x x x x x x x x x x x 1181.64 x x x 1121.25 882.083 x x x 941.643 909.0 x 1211.43 829.429 x x x 898.786 x 777.929 x x x x x x x x 954.071 x 1061.64 x x 706.071 x x x x x 900.714 x x 1033.71 x 869.214 1055.86 x 695.429 +12883 Original post publication description: Blood chemistry: Blood proteins (total) of 14-week old females [g/l] None Blood chemistry: Blood proteins (total) of 14-week old females [g/l] x x 53.333 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 52.5 48.0 x x x x x x x x x x 54.0 49.5 x x x 54.0 x x x x 53.0 x x x x x x x x x 48.5 x x x x 52.0 51.0 x x 49.0 x x x x 53.0 53.5 x x x x 51.5 x x 52.0 x x 46.5 x 49.5 +12884 Original post publication description: Blood chemistry: Urea of 14-week old females [mM] None Blood chemistry: Urea of 14-week old females [mM] x x 7.717 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 9.65 6.5 x x x x x x x x x x 8.8 6.0 x x x 6.7 x x x x 6.25 x x x x x x x x x 5.65 x x x x 7.6 8.0 x x 6.0 x x x x 7.25 8.95 x x x x 6.3 x x 6.2 x x 8.55 x 8.55 +12881 Original post publication description: Blood chemistry: Chlolesterol (total) of 14-week old females [mM] None Blood chemistry: Chlolesterol (total) of 14-week old females [mM] x x 1.878 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 1.805 2.165 x x x x x x x x x x 1.68 1.815 x x x 2.72 2.095 x x x 2.605 2.165 x 2.42 2.73 x x x 1.875 x 2.21 x x x x 2.28 2.63 x x 2.305 x 2.475 x x 2.175 2.915 x x x x 2.41 x x 1.79 x 1.935 2.45 x 1.935 +12882 Original post publication description: Blood chemistry: Triglyceride of 14-week old females [mM] None Blood chemistry: Triglyceride of 14-week old females [mM] x x 0.659 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.985 0.945 x x x x x x x x x x 0.935 0.94 x x x 1.1 1.01 x x x 1.28 0.89 x 0.645 0.66 x x x 0.875 x 0.66 x x x x 1.64 1.195 x x 1.43 x 1.365 x x 0.87 1.16 x x x x 0.735 x x 0.39 x 1.16 1.465 x 0.665 +12878 Original post publication description: Metabolism: Respiratory exchange ratio (RER) of 13-week old females [ratio] None Respiratory system, metabolism: Respiratory exchange ratio (RER) of 13-week old females [ratio] x x 0.835 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.892 x x x x x x x x x x x 0.971 x x x 0.978 1.005 x x x 1.008 0.879 x 1.017 0.841 x x x 0.881 x 0.909 x x x x x x x x 0.885 x 0.963 x x 0.856 x x x x x 0.855 x x 0.909 x 0.979 0.911 x 0.891 +12876 Original post publication description: Cardiovascular system: Posterior wall thickness by echocardiography of 17-week old females [mm] None Cardiovascular system: Posterior wall thickness by echocardiography of 17-week old females [mm] x x 0.586 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.62 0.58 x x x x x x x x x x 0.58 0.55 x x x 0.68 0.585 x x x 0.615 0.53 x 0.575 0.555 x x x 0.58 x 0.59 x x x x 0.66 0.605 x x 0.545 x 0.61 x x 0.62 0.57 x x x x 0.575 x x 0.54 x 0.565 0.635 x 0.595 +12874 Original post publication description: Blood chemistry: Phosphorus of 14-week old females [mM] None Blood chemistry: Phosphorus of 14-week old females [mM] x x 2.596 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 2.45 2.43 x x x x x x x x x x 2.805 2.25 x x x 2.075 x x x x 2.235 x x x x x x x x x 1.9 x x x x 2.56 2.965 x x 2.765 x x x x 2.765 2.665 x x x x 2.29 x x 2.5 x x 2.595 x 2.325 +12872 Original post publication description: Blood chemistry, cardiovascular system: Mean cell volume of 14-week old females [fl] None Blood chemistry, cardiovascular system: Mean cell volume of 14-week old females [fl] x x 46.85 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 44.25 46.0 x x x x x x x x x x 52.1 50.95 x x x 47.85 49.85 x x x 43.05 47.25 x 46.5 45.7 x x x 43.55 x 43.1 x x x x 45.9 48.5 x x 46.9 x 49.55 x x 47.75 44.2 x x x x 47.3 x x 44.8 x 42.75 43.95 x 44.75 +12870 Original post publication description: Blood chemistry, cardiovascular system: Mean corpuscular hemoglobin of 14-week old females [pg] None Blood chemistry, cardiovascular system: Mean corpuscular hemoglobin of 14-week old females [pg] x x 15.95 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 15.25 15.6 x x x x x x x x x x 16.8 16.6 x x x 15.65 15.2 x x x 14.5 14.55 x 15.5 15.15 x x x 14.15 x 14.45 x x x x 15.9 15.9 x x 14.8 x 15.25 x x 14.95 15.25 x x x x 15.95 x x 14.7 x 14.1 15.25 x 15.35 +12868 Original post publication description: Cardiovascular system: Left ventricular mass by echocardiography of 17-week old females [mg] None Cardiovascular system: Left ventricular mass by echocardiography of 17-week old females [mg] x x 72.325 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 82.914 69.548 x x x x x x x x x x 67.293 68.808 x x x 78.06 75.766 x x x 65.992 65.501 x 74.531 75.98 x x x 77.751 x 73.504 x x x x 80.675 74.093 x x 82.86 x 76.973 x x 78.162 62.324 x x x x 67.266 x x 67.28 x 70.184 75.891 x 84.837 +12866 Original post publication description: Morphology, metabolism: Body lean mass percentage of 19-week old females [%] None Morphology, metabolism: Body lean mass percentage of 19-week old females [%] x x 82.206 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 71.015 78.32 x x x x x x x x x x 76.07 86.395 x x x 83.355 84.115 x x x 83.65 80.79 x 82.905 82.485 x x x 83.96 x 86.56 x x x x 71.66 74.515 x x 87.91 x 83.325 x x 83.11 67.78 x x x x 85.66 x x 85.63 x 85.93 84.38 x 82.29 +12864 Original post publication description: Blood chemistry: Potassium of 14-week old females [mM] None Blood chemistry: Potassium of 14-week old females [mM] x x 4.326 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 4.17 3.835 x x x x x x x x x x 4.605 4.09 x x x 3.78 x x x x 4.85 x x x x x x x x x 4.85 x x x x 3.96 5.2 x x 4.52 x x x x 4.18 4.395 x x x x 4.055 x x 4.32 x x 4.39 x 4.325 +12862 Original post publication description: Blood chemistry, cardiovascular system: Hemoglobin of 14-week old females [g/dl] None Blood chemistry, cardiovascular system: Hemoglobin of 14-week old females [g/dl] x x 14.85 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 13.6 14.65 x x x x x x x x x x 15.15 10.95 x x x 16.85 14.4 x x x 14.55 14.9 x 15.0 16.55 x x x 16.05 x 13.25 x x x x 14.1 12.9 x x 15.45 x 17.25 x x 15.45 13.45 x x x x 14.4 x x 13.8 x 13.6 15.5 x 14.6 +12859 Original post publication description: Metabolism: Blood glucose level (intraperitoneal glucose tolerance test) at time=30 min of 18-week old females [mg/dl] None Metabolism: Blood glucose level (intraperitoneal glucose tolerance test) at time=30 min of 18-week old females [mg/dl] x x 240.857 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 247.0 295.5 x x x x x x x x x x 183.5 282.5 x x x 199.5 147.0 x x x 204.5 201.0 x 219.0 207.0 x x x 229.0 x 210.5 x x x x 205.0 176.5 x x 183.0 x 296.0 x x 191.5 195.5 x x x x 213.0 x x 211.0 x 197.0 170.0 x 180.0 +12860 Original post publication description: Metabolism: Blood glucose level (intraperitoneal glucose tolerance test) at time=60 min of 18-week old females [mg/dl] None Metabolism: Blood glucose level (intraperitoneal glucose tolerance test) at time=60 min of 18-week old females [mg/dl] x x 157.286 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 146.5 216.0 x x x x x x x x x x 124.0 202.0 x x x 152.5 99.0 x x x 167.0 116.0 x 130.5 142.0 x x x 147.0 x 160.5 x x x x 113.0 119.0 x x 124.5 x 158.5 x x 129.0 138.5 x x x x 153.5 x x 134.0 x 125.5 137.0 x 146.5 +12857 Original post publication description: Metabolism: Blood glucose level (intraperitoneal glucose tolerance test) at time=120 min of 18-week old females [mg/dl] None Metabolism: Blood glucose level (intraperitoneal glucose tolerance test) at time=120 min of 18-week old females [mg/dl] x x 102.571 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 87.5 109.0 x x x x x x x x x x 83.0 100.0 x x x 120.0 63.0 x x x 133.5 83.5 x 92.0 114.5 x x x 126.0 x 112.0 x x x x 66.0 59.0 x x 101.5 x 121.5 x x 90.0 102.0 x x x x 106.0 x x 103.0 x 109.0 96.5 x 101.0 +12858 Original post publication description: Metabolism: Blood glucose level (intraperitoneal glucose tolerance test) at time=15 min of 18-week old females [mg/dl] None Metabolism: Blood glucose level (intraperitoneal glucose tolerance test) at time=15 min of 18-week old females [mg/dl] x x 269.286 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 237.0 262.5 x x x x x x x x x x 207.5 246.0 x x x 211.5 196.0 x x x 258.0 236.5 x 234.0 268.5 x x x 260.0 x 257.5 x x x x 189.0 219.5 x x 202.0 x 351.5 x x 193.5 219.0 x x x x 261.5 x x 244.0 x 242.5 179.5 x 219.0 +12856 Original post publication description: Metabolism: Blood glucose level (intraperitoneal glucose tolerance test) at time=0 min of 18-week old females [mg/dl] None Metabolism: Blood glucose level (intraperitoneal glucose tolerance test) at time=0 min of 18-week old females [mg/dl] x x 101.75 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 84.0 93.0 x x x x x x x x x x 77.5 85.0 x x x 102.5 81.5 x x x 130.0 83.5 x 104.0 118.5 x x x 112.0 x 117.0 x x x x 76.0 78.0 x x 98.5 x 120.0 x x 85.0 104.0 x x x x 115.0 x x 88.0 x 109.0 72.0 x 100.5 +12854 Original post publication description: Morphology, musculoskeletal system: Gastrocnemius muscle mass of 20-week old females [g] None Muscloskeletal system, morphology: Gastrocnemius muscle mass of 20-week old females [g] x x 0.1 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.101 0.089 x x x x x x x x x x 0.096 0.108 x x x 0.088 0.096 x x x 0.095 0.105 x 0.122 0.117 x x x 0.087 x 0.095 x x x x 0.065 0.085 x x 0.108 x 0.089 x x 0.105 0.083 x x x x 0.114 x x 0.101 x 0.115 0.106 x 0.094 +12852 Original post publication description: Metabolism: Food intake of 13-week old females [g/mouse] None Central nervous system, metabolism, behavior: Food intake of 13-week old females [g/mouse] x x 2.817 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 1.116 x x x x x x x x x x x 3.0 x x x 2.106 1.244 x x x 1.544 0.689 x 4.994 0.887 x x x 2.107 x 1.457 x x x x x x x x 1.834 x 4.442 x x 1.42 x x x x x 2.382 x x 2.181 x 9.824 0.816 x 1.684 +12850 Original post publication description: Morphology, metabolism: Body fat mass of 19-week old females [g] None Morphology, metabolism: Body fat mass of 19-week old females [g] x x 2.967 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 3.726 4.3 x x x x x x x x x x 2.898 2.85 x x x 3.657 3.285 x x x 3.294 4.025 x 3.768 4.023 x x x 3.171 x 2.705 x x x x 4.223 2.945 x x 2.346 x 3.863 x x 3.654 5.332 x x x x 3.073 x x 3.19 x 3.363 3.113 x 3.408 +12848 Original post publication description: Cardiovascular system: End-systolic diameter by echocardiography of 17-week old females [mm] None Cardiovascular system: End-systolic diameter by echocardiography of 17-week old females [mm] x x 2.565 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 2.66 2.52 x x x x x x x x x x 2.52 2.66 x x x 2.2 2.63 x x x 2.235 2.7 x 2.82 2.785 x x x 2.765 x 2.16 x x x x 2.34 2.45 x x 2.805 x 2.665 x x 2.59 2.375 x x x x 2.34 x x 2.34 x 2.55 2.52 x 2.665 +12846 Original post publication description: Blood chemistry: Creatinine of 14-week old females [uM] None Blood chemistry: Creatinine of 14-week old females [uM] x x 8.9 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 9.4 7.9 x x x x x x x x x x 9.6 7.9 x x x 8.2 x x x x 9.2 x x x x x x x x x 9.4 x x x x 9.9 8.6 x x 7.9 x x x x 10.05 8.6 x x x x 8.05 x x 7.6 x x 11.0 x 10.4 +12844 Original post publication description: Blood chemistry: Calcium of 14-week old females [mM] None Blood chemistry: Calcium of 14-week old females [mM] x x 2.302 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 2.38 2.3 x x x x x x x x x x 2.585 2.445 x x x 2.42 x x x x 2.43 x x x x x x x x x 2.285 x x x x 2.7 2.51 x x 2.44 x x x x 2.27 2.59 x x x x 2.44 x x 2.21 x x 2.235 x 2.37 +12842 Original post publication description: Morphology: Body weight of 20-week old females [g] None Musculoskeletal system, morphology: Body weight of 20-week old females [g] x x 20.625 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 23.85 21.0 x x x x x x x x x x 22.85 23.35 x x x 24.05 20.15 x x x 22.6 19.45 x 21.95 21.9 x x x 19.05 x 22.95 x x x x 22.8 19.6 x x 20.45 x 22.05 x x 23.35 25.05 x x x x 22.95 x x 23.9 x 24.3 21.8 x 21.8 +12838 Original post publication description: Morphology: Body weight of 18-week old females [g] None Musculoskeletal system, morphology: Body weight of 18-week old females [g] x x 20.088 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 23.4 19.95 x x x x x x x x x x 22.35 21.2 x x x 23.05 19.25 x x x 21.85 19.5 x 21.35 23.0 x x x 18.2 x 20.95 x x x x 22.2 19.55 x x 20.1 x 21.15 x x 22.7 23.85 x x x x 22.35 x x 22.7 x 23.05 20.65 x 19.95 +12839 Original post publication description: Metabolism: Body weight for glucose tolerance test (ip) test of 18-week old females [g] None Morphology, metabolism: Body weight for glucose tolerance test (ip) test of 18-week old females [g] x x 17.85 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 20.35 18.5 x x x x x x x x x x 19.65 19.2 x x x 20.75 17.6 x x x 19.55 17.1 x 19.3 20.9 x x x 17.3 x 18.85 x x x x 18.6 16.85 x x 17.65 x 20.1 x x 20.45 21.1 x x x x 20.65 x x 20.1 x 21.6 18.5 x 18.3 +12840 Original post publication description: Morphology: Body weight of 19-week old females [g] None Musculoskeletal system, morphology: Body weight of 19-week old females [g] x x 20.613 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 23.0 20.9 x x x x x x x x x x 23.1 22.4 x x x 22.85 19.0 x x x 21.85 18.35 x 20.9 23.0 x x x 18.0 x 21.65 x x x x 24.9 20.0 x x 19.6 x 21.6 x x 21.85 24.3 x x x x 22.55 x x 24.5 x 23.75 20.1 x 19.9 +12836 Original post publication description: Morphology: Body weight of 17-week old females [g] None Musculoskeletal system, morphology: Body weight of 17-week old females [g] x x 20.413 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 23.2 20.6 x x x x x x x x x x 21.35 22.1 x x x 22.5 20.15 x x x 22.2 19.45 x 21.95 21.9 x x x 19.05 x 21.25 x x x x 21.6 19.25 x x 20.85 x 22.05 x x 23.1 23.4 x x x x 22.1 x x 24.0 x 24.3 22.0 x 20.75 +12837 Original post publication description: Morphology, cardiovascular system: Body weight at echocardiography of 17-week old females [g] None Morphology, cardiovascular system: Body weight at echocardiography of 17-week old females [g] x x 20.267 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 22.9 x x x x x x x x x x x 19.25 x x x x 23.05 19.3 x x x 21.6 18.95 x 21.3 21.3 x x x 18.65 x 21.2 x x x x 21.6 21.35 x x 19.8 x 21.8 x x 22.65 23.2 x x x x x x x x x 23.5 20.8 x 20.1 +12832 Original post publication description: Morphology: Body weight of 13-week old females [g] None Musculoskeletal system, morphology: Body weight of 13-week old females [g] x x 19.813 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 22.55 21.4 x x x x x x x x x x 21.8 21.65 x x x 21.15 19.25 x x x 20.7 18.35 x 20.45 22.8 x x x 17.45 x 19.8 x x x x 21.8 19.15 x x 19.15 x 21.25 x x 21.65 21.1 x x x x 21.75 x x 23.25 x 22.9 20.2 x 18.55 +12833 Original post publication description: Morphology: Body weight of 14-week old females [g] None Musculoskeletal system, morphology: Body weight of 14-week old females [g] x x 19.838 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 22.0 21.45 x x x x x x x x x x 21.3 22.15 x x x 21.4 19.25 x x x 21.2 19.5 x 21.35 23.0 x x x 18.2 x 21.3 x x x x 21.4 18.65 x x 20.55 x 21.15 x x 22.15 21.65 x x x x 21.8 x x 23.25 x 23.05 20.5 x 19.1 +12834 Original post publication description: Morphology: Body weight of 15-week old females [g] None Musculoskeletal system, morphology: Body weight of 15-week old females [g] x x 20.25 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 22.65 21.35 x x x x x x x x x x 21.2 22.25 x x x 21.8 19.0 x x x 21.35 18.35 x 20.9 23.0 x x x 18.0 x 20.5 x x x x 22.8 19.35 x x 20.9 x 21.6 x x 21.8 23.8 x x x x 22.05 x x 21.2 x 23.75 20.7 x 18.8 +12830 Original post publication description: Musculoskeletal system, metabolism: Bone surface area by peripheral dual energy X-ray absorptiometer (PDEXA) of 19-week old females [cm2] None Musculoskeletal system, metabolism: Bone surface area for whole body by peripheral dual energy X-ray absorptiometer (PDEXA) of 19-week old females [cm2] x x 7.995 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 7.085 x x x x x x x x x x x 7.715 x x x 8.29 7.89 x x x 8.185 6.91 x 7.885 7.435 x x x 7.105 x 8.33 x x x x x x x x 8.205 x 7.43 x x 8.205 x x x x x 8.435 x x 8.22 x 8.01 8.275 x 7.93 +12828 Original post publication description: Musculoskeletal system, metabolism: Bone mineral content by peripheral dual energy X-ray absorptiometer (PDEXA) of 19-week old females [g] None Musculoskeletal system, metabolism: Bone mineral content for whole body by peripheral dual energy X-ray absorptiometer (PDEXA) of 19-week old females [g] x x 0.403 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.384 x x x x x x x x x x x 0.416 x x x 0.451 0.416 x x x 0.407 0.328 x 0.387 0.388 x x x 0.343 x 0.445 x x x x x x x x 0.385 x 0.362 x x 0.397 x x x x x 0.465 x x 0.451 x 0.433 0.435 x 0.375 +12826 Original post publication description: Metabolism: Blood glucose level (intraperitoneal glucose tolerance test), area under curve (AUC) of 18-week old females [mg/dl] None Metabolism: Blood glucose level (intraperitoneal glucose tolerance test), area under curve (AUC) of 18-week old females [mg/dl] x x 8572.5 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 8880.0 13113.8 x x x x x x x x x x 6592.5 12573.8 x x x 6592.5 3930.0 x x x 5366.25 6401.25 x 5370.0 5178.75 x x x 6847.5 x 6018.75 x x x x 5962.5 5613.75 x x 4713.75 x 9210.0 x x 6153.75 5276.25 x x x x 5865.0 x x 7627.5 x 4725.0 7477.5 x 5651.25 +12824 Original post publication description: Blood chemistry: Alkaline phosphatase of 14-week old females, (ALPL gene product) [U/l] None Blood chemistry: Alkaline phosphatase of 14-week old females, (ALPL gene product) [U/l] x x 182.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 137.5 138.5 x x x x x x x x x x 195.5 153.0 x x x 139.5 226.0 x x x 161.0 160.0 x 124.5 204.0 x x x 164.5 x 135.5 x x x x 166.0 243.0 x x 205.5 x 175.5 x x 254.0 287.0 x x x x 209.5 x x 149.0 x 139.0 159.5 x 174.5 +12822 Original post publication description: Blood chemistry: Alanine transaminase (ALT, ALAT, SGPT) level in serum of 14-week old females [U/L] None Blood chemistry: Alanine transaminase (ALT, ALAT, SGPT) level in serum of 14-week old females [U/L] x x 34.5 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 24.0 33.0 x x x x x x x x x x 21.5 87.0 x x x 31.0 47.5 x x x 24.5 33.5 x 35.5 42.0 x x x 31.0 x 24.5 x x x x 44.0 68.0 x x 20.5 x 28.5 x x 18.0 38.0 x x x x 35.0 x x 26.0 x 27.5 23.5 x 30.0 +12399 Original post publication description: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during first 5 min [n beam breaks] None Central nervous system, behavior: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during first 5 min [n beam breaks] 512.0 477.71 518.0 478.2 514.0 481.4 442.0 574.0 385.5 471.6 481.0 660.0 483.0 x 645.6 461.0 x 517.33 x 414.0 401.75 x x 448.0 482.67 377.0 378.33 x x 468.83 531.29 479.0 396.17 x x x x 345.0 478.33 x 436.0 436.5 535.33 582.75 x x 460.0 504.86 356.38 484.0 x 553.5 x 533.67 541.83 x x x 545.67 376.4 408.0 x x 589.43 282.83 558.43 423.0 476.29 431.83 433.25 x 469.43 x 484.33 x 410.4 x x 477.17 411.2 x 465.17 496.14 536.17 490.33 464.83 x 469.83 519.0 x 466.17 x x 562.56 526.0 628.33 730.33 469.83 450.17 518.0 513.17 531.43 +12226 Original post publication description: Urogenital system, kidney, morphology: Wilms tumor 1 homolog positive cell density in glomerular sections in males (8-20 wks of age) [WT1-positive cell number per 1000 um2 glomerular area] None Urogenital system, kidney, morphology: Wilms tumor 1 homolog positive cell density in glomerular sections in males (8-20 wks of age) [WT1-positive cell number per 1000 um2 glomerular area] x x 5.121 5.009 x x x x x 4.92 x x x 3.636 x x x x x x x x x x x x x x x 3.885 3.758 x 4.393 x x x x x x x 4.244 4.119 2.924 4.037 x x x x x 2.941 x x x x x x x x 2.063 x 3.343 x x 3.263 x x 4.376 4.35 3.976 x x 3.715 x 4.752 x 3.514 x x 4.241 x x 3.755 3.612 4.016 3.229 4.264 x 4.464 3.17 x 3.611 x 3.411 x x x x x x x x x +12227 Original post publication description: Podocytes per glomerulus in males (8-20 wks) [number per glomerulus in cross sectioned material] None Urogenital system, kidney, morphology: Podocytes per glomerulus in males (8-20 wks) [number per glomerulus in cross sectioned material] x x 11.236 13.004 x x x x x 11.33 x x x 12.298 x x x x x x x x x x x x x x x 12.17 10.933 x 10.055 x x x x x x x 10.052 11.233 9.185 10.59 x x x x x 8.33 x x x x x x x x 7.794 x 9.477 x x 9.9 x x 11.821 12.597 10.969 x x 9.104 x 12.283 x 10.579 x x 11.505 x x 8.948 10.382 8.903 9.945 11.983 x 11.383 10.155 x 8.85 x 8.427 x x x x x x x x x +12228 Original post publication description: Urogenital system, kidney, morphology: Glomerular section area (GSA) in glomeruli of males (8-20 wks of age) [um^2] None Urogenital system, kidney, morphology: Glomerular section area (GSA) in glomeruli of males (8-20 wks of age) [um^2] x x 2457.0 2890.0 x x x x x 2320.67 x x x 3393.5 x x x x x x x x x x x x x x x 3138.31 2902.68 x 2309.06 x x x x x x x 2415.19 2727.0 3143.0 2661.05 x x x x x 2876.97 x x x x x x x x 3822.24 x 2845.99 x x 3034.0 x x 2741.72 2920.23 2831.0 x x 2468.5 x 2599.97 x 3010.0 x x 2743.85 x x 2429.34 2967.42 2224.02 3077.0 2810.2 x 2557.95 3203.09 x 2451.0 x 2470.0 x x x x x x x x x +12229 Original post publication description: Morphology, urogenital system: Kidney weight of males at 8-20 wk [mg] None Urogenital system, kidney, morphology: Kidney weight of males at 8-20 wk [mg] x x 158.395 186.55 x x x x x 131.867 x x x 95.175 x x x x x x x x x x x x x x x 121.475 132.9 x 100.4 x x x x x x x 64.45 137.45 203.95 174.875 x x x x x 216.2 x x x x x x x x 166.89 x 218.9 x x 230.475 x x 107.775 213.4 174.625 x x 201.525 x 193.6 x 265.05 x x 142.275 x x 201.475 182.0 176.825 298.05 114.275 x 157.233 238.025 x 150.925 x 207.3 x x x x x x x x x +12230 Original post publication description: Wilms tumor 1 homolog positive cells per glomerular section in males (8-20 wks of age) [WT1-positive cells/glomerular section] None Urogenital system, kidney, morphology: Wilms tumor 1 homolog positive cells per glomerular section in males (8-20 wks of age) [WT1-positive cells/glomerular section] x x 11.2362 13.0041 x x x x x 11.3295 x x x 12.2983 x x x x x x x x x x x x x x x 12.1704 10.9333 x 10.0548 x x x x x x x 10.0523 11.2333 9.185 10.5902 x x x x x 8.33295 x x x x x x x x 9.06667 x 9.47737 x x 9.9 x x 11.8214 12.5968 10.9688 x x 9.10417 x 12.2833 x 10.5789 x x 11.5054 x x 8.94786 10.3821 8.90322 9.94462 11.9833 x 11.3825 10.1552 x 8.85 x 8.42692 x x x x x x x x x +12231 Original post publication description: Kidney weight/body weight ratio in males (8 - 20 wks) [mg/g] None Urogenital system, kidney, morphology: Kidney weight/body weight ratio in males (8 - 20 wks) [mg/g] x x 6.2638 7.4259 x x x x x 4.5265 x x x 6.9969 x x x x x x x x x x x x x x x 5.5694 5.7439 x 5.9496 x x x x x x x 7.8068 5.0642 7.333 7.0809 x x x x x 8.0181 x x x x x x x x 7.6934 x 8.3075 x x 8.0936 x x 5.2566 8.6566 7.1774 x x 8.6172 x 7.8378 x 6.5632 x x 6.4762 x x 8.2429 8.5875 6.4985 7.2707 5.2297 x 5.7384 9.4999 x 4.5708 x 7.6631 x x x x x x x x x +12232 Original post publication description: Kidney morphology, glomerular cells per glomerular section in males (8 to 20 weeks of age) [cell density] None Urogenital system, kidney, morphology: Glomerular cells per glomerular section in males (8 to 20 weeks of age) [cell density] x x 42.95 50.476 x x x x x 45.07 x x x 67.079 x x x x x x x x x x x x x x x 58.801 50.567 x 43.755 x x x x x x x 44.112 38.833 48.907 40.673 x x x x x 36.027 x x x x x x x x 48.867 x 36.856 x x 48.567 x x 39.75 47.964 48.562 x x 37.704 x 41.933 x 46.842 x x 44.455 x x 36.943 48.071 41.887 48.976 46.1 x 40.377 43.741 x 49.2 x 37.492 x x x x x x x x x +12397 Original post publication description: Anxiety assay, saline treated (0.18 ml/kg ip, NOS group), time in open quadrants only during last 5 min of test using an elevated zero maze for 60- to 120-day-old females [%] None Central nervous system, behavior: Anxiety assay, saline treated (0.18 ml/kg ip, NOS group), time in open quadrants only during last 5 min of test using an elevated zero maze for 60- to 120-day-old females [%] 18.061 17.757 16.317 20.193 36.661 7.28 4.0 10.893 15.783 25.18 13.622 18.078 3.556 x 7.473 23.767 x 14.744 x 5.578 7.233 x x 23.8 18.267 27.283 12.056 x x 13.106 21.324 9.407 38.694 x x x x 1.242 22.689 x 34.158 29.3 25.456 13.783 x x 21.689 13.529 42.763 22.657 x 24.0 x 26.078 20.572 x x x 31.167 16.02 20.892 x x 20.714 14.661 9.71 30.939 25.871 23.206 32.667 x 11.81 x 33.661 x 23.74 x x 9.817 25.667 x 16.267 22.329 16.867 13.989 24.767 x 35.861 29.45 x 21.0 x x 24.781 17.989 16.572 7.539 38.356 15.633 17.956 25.911 9.467 +12396 Original post publication description: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), time in open quadrants using an elevated zero maze in 60 to 120-day-old females only during first 5 min [percentage of time] None Central nervous system, behavior: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), time in open quadrants using an elevated zero maze in 60 to 120-day-old females only during first 5 min [percentage of time] 16.906 25.981 20.717 18.92 38.294 20.82 10.122 7.627 13.406 27.58 16.411 21.783 5.2 x 8.967 27.811 x 14.083 x 4.933 9.633 x x 16.9 32.078 16.75 5.622 x x 15.039 29.729 22.013 43.578 x x x x 4.158 27.2 x 37.679 23.825 26.356 18.567 x x 31.789 20.714 43.65 29.29 x 22.504 x 30.356 18.989 x x x 33.25 26.26 22.279 x x 25.376 29.239 9.105 33.272 31.452 29.944 31.658 x 16.648 x 37.778 x 32.173 x x 17.556 24.473 x 20.178 26.176 20.856 17.522 22.733 x 23.711 35.956 x 28.25 x x 28.067 24.683 17.544 11.2 34.861 21.394 21.744 26.883 16.6 +12395 Original post publication description: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), latency to enter an open quadrant using an elevated zero maze in 60 to 120-day-old females only [sec] None Central nervous system, behavior: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), latency to enter an open quadrant using an elevated zero maze in 60 to 120-day-old females only [sec] 5.083 8.829 2.4 6.44 3.25 0.72 6.6 2.16 17.133 5.92 6.117 1.683 7.917 x 24.32 6.233 x 1.85 x 13.5 12.25 x x 4.5 3.5 4.917 19.933 x x 9.017 3.786 3.0 8.633 x x x x 5.7 22.0 x 2.425 2.3 5.033 6.225 x x 3.233 9.686 5.65 8.8 x 5.213 x 11.967 12.8 x x x 3.817 7.24 3.925 x x 6.4 3.983 10.771 2.333 5.257 5.333 6.7 x 4.186 x 7.467 x 7.06 x x 2.083 5.9 x 8.633 3.829 9.633 4.567 1.25 x 27.383 2.533 x 8.267 x x 4.533 4.533 5.9 10.633 3.133 2.433 0.267 3.6 7.486 +12392 Original post publication description: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during first 5 min [beam breaks/sec] None Central nervous system, behavior: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during first 5 min [beam breaks/sec] 0.374 0.449 0.645 0.69 0.317 0.32 0.768 0.308 0.4 2.33 0.493 0.218 0.577 x 0.514 0.317 x 0.48 0.385 0.356 x x x 2.821 0.415 0.378 0.651 x x 0.31 0.224 0.456 0.979 x 1.691 x 0.502 0.296 0.287 x 0.217 0.552 0.56 0.29 x x 0.496 0.318 0.267 0.363 x 0.39 x 0.516 1.043 x x x 0.569 0.383 0.869 x x 0.447 0.364 0.448 0.316 4.522 0.36 0.278 x 0.34 0.498 0.556 x 0.515 x x 0.297 0.602 x 0.278 0.459 1.336 0.723 0.431 x 4.095 0.247 x 0.886 x x 0.39 0.342 0.458 0.751 0.279 0.484 0.332 10.518 0.343 +12391 Original post publication description: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during 10 min [n beam breaks] None Central nervous system, behavior: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during 10 min [n beam breaks] 1157.64 1003.63 832.69 989.78 1460.0 1181.83 560.0 1307.17 1126.7 483.08 864.83 1359.0 950.17 x 1165.0 1261.33 x 1086.43 448.0 1408.57 x x x 227.5 978.0 1282.43 889.38 x x 1070.25 1327.17 1069.4 793.08 x 173.0 x 1069.0 1012.92 1047.31 x 1409.53 708.07 793.0 1302.08 x x 854.22 1221.36 999.2 992.0 x 602.0 x 854.73 1027.22 x x x 702.19 1040.23 680.14 x x 1211.33 1148.23 1094.78 1405.08 421.29 1002.5 1486.42 x 1244.33 1124.0 846.64 x 864.67 x x 1291.5 808.67 x 1339.31 1002.25 1098.42 780.82 783.62 x 535.0 1149.85 x 1147.83 x x 941.71 1226.5 969.17 779.07 1188.3 910.08 998.0 565.93 1077.0 +12390 Original post publication description: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during last 5 min [n beam breaks] None Central nervous system, behavior: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during last 5 min [n beam breaks] 520.73 457.06 357.54 521.56 768.3 608.83 228.0 678.25 521.6 250.23 414.08 654.75 424.67 x 580.33 704.33 x 581.14 82.0 746.57 x x x 173.5 451.0 645.29 384.38 x x 555.75 632.25 543.1 443.08 x 118.0 x 570.5 447.83 533.31 x 719.87 422.21 413.58 616.31 x x 424.33 575.55 461.8 454.11 x 157.0 x 397.0 542.11 x x x 358.88 581.38 379.5 x x 602.17 565.15 507.11 742.75 246.21 530.69 718.0 x 710.67 681.0 473.45 x 381.17 x x 670.33 447.11 x 646.08 468.25 554.5 432.82 382.46 x 303.3 579.08 x 551.42 x x 420.36 589.17 465.17 393.57 568.1 425.67 516.38 224.2 542.54 +12389 Original post publication description: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during first 5 min [n beam breaks] None Central nervous system, behavior: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during first 5 min [n beam breaks] 636.91 546.56 475.15 468.22 691.7 573.0 332.0 628.92 605.1 232.85 450.75 704.25 525.5 x 584.67 557.0 x 505.29 366.0 662.0 x x x 54.0 527.0 637.14 505.0 x x 514.5 694.92 526.3 350.0 x 55.0 x 498.5 565.08 514.0 x 689.67 285.86 379.42 685.77 x x 429.89 645.82 537.4 537.89 x 445.0 x 457.73 485.11 x x x 343.31 458.85 300.64 x x 609.17 583.08 587.67 662.33 175.07 471.81 768.42 x 533.67 443.0 373.18 x 483.5 x x 621.17 361.56 x 693.23 534.0 543.92 348.0 401.15 x 231.7 570.77 x 596.42 x x 521.36 637.33 504.0 385.5 620.2 484.42 481.62 341.73 534.46 +12388 Original post publication description: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males and females during 10 min [percentage of time] None Central nervous system, behavior: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males and females during 10 min [percentage of time] 24.886 27.213 17.322 35.707 31.168 29.917 7.65 34.494 28.388 15.937 24.506 43.392 9.078 x 17.828 40.419 x 21.862 57.85 20.817 x x x 36.508 25.825 30.819 14.267 x x 41.2 44.699 32.072 48.462 x 34.5 x 21.433 36.64 49.218 x 46.444 49.068 36.542 32.035 x x 47.561 35.85 52.572 34.419 x 21.117 x 36.47 12.498 x x x 31.408 32.101 33.556 x x 29.065 33.2 15.324 39.385 57.979 49.05 29.369 x 40.004 27.933 31.22 x 34.036 x x 38.526 30.613 x 32.936 24.026 18.574 33.395 43.551 x 40.942 47.255 x 29.031 x x 32.151 24.854 37.186 36.282 41.54 26.028 42.127 32.594 36.733 +12387 Original post publication description: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males and females during last 5 min [percentage of time] None Central nervous system, behavior: Anxiety assay, ethanol treated (1.8 g/kg i.p) (NOE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males and females during last 5 min [% time] 22.015 20.448 11.082 36.044 31.237 20.189 0.333 28.414 25.933 15.351 16.378 38.658 4.183 x 17.028 35.211 x 15.829 62.7 16.405 x x x 31.433 23.167 29.595 9.029 x x 31.971 39.528 27.143 48.144 x 0.0 x 19.65 25.081 44.05 x 40.676 35.914 27.597 27.049 x x 45.704 36.406 50.533 32.281 x 0.1 x 31.264 12.459 x x x 19.812 20.328 27.505 x x 27.206 30.205 14.222 33.475 54.571 48.858 27.656 x 31.831 29.333 22.891 x 30.433 x x 33.017 28.593 x 28.805 20.175 14.747 28.779 37.567 x 41.427 40.885 x 27.536 x x 24.905 17.711 31.506 30.217 37.27 17.736 37.615 20.129 30.669 +12386 Original post publication description: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males and females during first 5 min [percentage of time] None Central nervous system, behavior: Anxiety assay, ethanol treated (1.8 g/kg i.p) (NOE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males and females during first 5 min [percentage of time] 27.758 33.979 23.562 35.37 31.1 39.644 14.967 40.575 30.843 16.523 32.633 48.125 13.972 x 18.628 45.628 x 27.895 53.0 25.229 x x x 41.583 28.483 32.043 19.504 x x 50.429 49.869 37.0 48.781 x 69.0 x 23.217 48.2 54.385 x 52.213 62.221 45.486 37.021 x x 49.419 35.294 54.611 36.556 x 42.133 x 41.676 12.537 x x x 43.004 43.874 39.607 x x 30.925 36.195 16.426 45.294 61.386 49.242 31.083 x 48.178 26.533 39.548 x 37.639 x x 44.036 32.633 x 37.067 27.878 22.4 38.012 49.536 x 40.457 53.626 x 30.525 x x 39.398 31.997 42.867 42.348 45.81 34.319 46.638 45.06 42.797 +12385 Original post publication description: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), latency to enter an open quadrant using an elevated zero maze in 60 to 120-day-old males and females [sec] None Central nervous system, behavior: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), latency to enter an open quadrant using an elevated zero maze in 60 to 120-day-old males and females [sec] 15.918 15.194 2.454 27.433 4.3 2.683 0.3 7.875 21.06 55.545 8.325 2.725 36.433 x 30.6 8.167 x 36.067 5.6 9.257 x x x 17.7 4.85 11.043 4.763 x x 2.587 2.658 15.96 18.083 x 15.9 x 56.35 4.092 4.05 x 4.187 4.643 25.683 5.815 x x 7.122 13.609 1.733 10.056 x 4.2 x 11.709 20.967 x x x 7.963 8.477 12.464 x x 12.2 5.992 35.522 9.658 29.45 15.138 3.917 x 1.233 22.8 8.691 x 20.273 x x 3.1 1.967 x 0.523 9.383 12.764 2.291 13.254 x 42.95 4.177 x 9.242 x x 3.943 6.108 5.45 27.95 4.31 9.892 4.954 2.867 3.454 +12384 Original post publication description: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during 10 min [beam breaks/sec] None Central nervous system, behavior: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during 10 min [beam breaks/sec] 0.368 0.756 0.935 1.511 0.281 0.437 x 0.314 0.365 2.455 0.547 0.277 0.537 x 0.897 0.305 x 0.451 0.565 0.349 x x x 0.95 0.586 0.395 0.975 x x 0.426 0.251 0.494 0.429 x 2.272 x 0.476 0.407 0.25 x 0.23 0.922 0.469 0.392 x x 0.375 0.384 0.322 0.397 x 0.786 x 1.105 0.531 x x x 0.659 0.365 1.299 x x 0.48 0.351 0.413 0.269 1.498 0.311 0.369 x 0.266 0.385 0.617 x 0.564 x x 0.426 0.485 x 0.255 0.573 1.075 0.585 0.578 x 8.753 0.287 x 2.475 x x 0.66 0.393 0.622 0.832 0.349 0.462 0.353 61.34 0.412 +12383 Original post publication description: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during last 5 min [beam breaks/sec] None Central nervous system, behavior: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during last 5 min [beam breaks/sec] 0.442 0.862 1.167 12.746 0.254 0.438 x 0.368 0.457 2.051 0.579 0.309 0.607 x 1.099 0.274 x 0.451 1.365 0.341 x x x 0.851 0.624 0.372 1.657 x x 0.473 0.277 0.51 0.354 x 2.542 x 0.453 0.533 0.278 x 0.253 0.997 0.539 0.537 x x 0.348 0.435 0.388 0.444 x 1.909 x 3.312 0.454 x x x 0.719 0.36 2.022 x x 0.424 0.339 0.453 0.284 2.208 0.289 0.422 x 0.296 0.311 0.545 x 0.675 x x 0.488 0.394 x 0.28 0.814 0.775 0.599 0.861 x 53.09 0.308 x 25.293 x x 4.397 0.425 3.673 0.902 0.399 0.581 0.367 76.69 0.439 +12393 Original post publication description: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during last 5 min [beam breaks/sec] None Central nervous system, pharmacology, behavior: Ethanol response (1.8 g/kg ip), anxiety assay in ethanol-treated (NOE) group, activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during last 5 min [n beam breaks/sec] 0.544 0.693 0.95 6.517 0.287 0.43 1.311 0.396 0.527 1.819 0.89 0.279 1.123 x 0.565 0.281 x 0.498 1.365 0.339 x x x 1.126 0.516 0.345 1.424 x x 0.385 0.836 0.445 0.442 x 2.542 x 0.453 0.564 0.331 x 0.258 0.669 0.556 0.458 x x 0.517 0.38 0.358 0.457 x 1.909 x 2.233 0.534 x x x 0.749 0.445 1.267 x x 0.371 0.428 0.556 0.275 1.265 0.302 0.342 x 0.331 0.311 0.64 x 0.766 x x 0.355 0.49 x 0.341 0.692 0.673 0.568 0.68 x 31.945 0.446 x 12.854 x x 2.456 0.443 2.126 1.061 0.365 1.11 0.375 23.117 0.415 +12382 Original post publication description: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during first 5 min [beam breaks/sec] None Central nervous system, behavior: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during first 5 min [beam breaks/sec] 0.31 0.541 0.793 0.977 0.322 0.435 x 0.273 0.297 2.88 0.526 0.245 0.499 x 0.76 0.329 x 0.479 0.385 0.365 x x x 1.295 0.552 0.418 0.702 x x 0.393 0.229 0.518 0.701 x 1.691 x 0.502 0.306 0.225 x 0.209 0.806 0.429 0.313 x x 0.404 0.351 0.277 0.368 x 0.39 x 0.607 0.717 x x x 0.603 0.374 1.01 x x 0.633 0.397 0.38 0.255 1.267 0.384 0.336 x 0.215 0.498 0.787 x 0.494 x x 0.367 0.614 x 0.228 0.538 2.253 0.546 0.45 x 5.085 0.266 x 1.455 x x 0.447 0.357 0.517 0.986 0.298 0.382 0.34 30.677 0.391 +12381 Original post publication description: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during 10 min [n beam breaks] None Central nervous system, behavior: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during 10 min [n beam breaks] 1212.0 830.56 727.33 795.2 1536.5 1070.0 x 1185.5 1219.0 398.67 958.5 1750.0 1027.67 x 611.0 1184.8 x 1150.75 448.0 1417.5 x x x 175.0 927.0 1392.0 888.33 x x 942.75 1373.33 995.0 896.83 x 173.0 x 1069.0 967.17 1382.17 x 1516.0 447.71 794.17 1295.33 x x 848.6 1120.75 1018.25 979.0 x 602.0 x 718.86 1161.83 x x x 751.0 1098.83 724.17 x x 1146.0 1238.33 1182.25 1530.83 475.57 1089.8 1448.33 x 1418.25 1124.0 906.67 x 955.67 x x 1073.67 776.4 x 1395.33 882.67 1080.83 774.8 611.5 x 381.0 1226.0 x 1010.5 x x 752.43 1258.5 887.5 664.0 1196.83 1089.33 1181.0 395.8 1142.0 +12380 Original post publication description: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during last 5 min [n beam breaks] None Central nervous system, behavior: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during last 5 min [n beam breaks] 547.5 389.56 288.89 427.4 819.0 594.0 x 622.17 533.0 212.33 492.67 885.0 483.67 x 247.0 684.6 x 629.0 82.0 772.33 x x x 136.0 431.0 704.0 382.83 x x 492.5 660.5 506.86 462.17 x 118.0 x 570.5 446.17 672.83 x 748.25 264.0 399.67 597.0 x x 401.2 504.25 458.5 484.0 x 157.0 x 330.86 619.0 x x x 351.0 651.0 386.17 x x 606.83 671.33 534.25 813.0 280.43 611.1 681.5 x 789.0 681.0 502.0 x 450.0 x x 522.83 463.2 x 729.67 409.83 588.5 429.4 285.5 x 199.33 607.67 x 534.5 x x 325.29 611.83 402.33 360.63 584.67 523.5 624.5 150.6 617.17 +12379 Original post publication description: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during first 5 min [n beam breaks] None Central nervous system, behavior: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during first 5 min [n beam breaks] 664.5 441.0 438.44 367.8 717.5 476.0 x 563.33 686.0 186.33 465.83 865.0 544.0 x 364.0 500.2 x 521.75 366.0 645.17 x x x 39.0 496.0 688.0 505.5 x x 450.25 712.83 488.14 434.67 x 55.0 x 498.5 521.0 709.33 x 767.75 183.71 394.5 698.33 x x 447.4 616.5 559.75 495.0 x 445.0 x 388.0 542.83 x x x 400.0 447.83 338.0 x x 539.17 567.0 648.0 717.83 195.14 478.7 766.83 x 629.25 443.0 404.67 x 505.67 x x 550.83 313.2 x 665.67 472.83 492.33 345.4 326.0 x 181.67 618.33 x 476.0 x x 427.14 646.67 485.17 303.38 612.17 565.83 556.5 245.2 524.83 +12378 Original post publication description: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males only during 10 min [percentage of time] None Central nervous system, behavior: Anxiety assay, ethanol treated (1.8 g/kg i.p) (NOE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males only during 10 min [% time] 25.425 30.211 7.832 34.107 30.722 22.15 x 41.994 30.567 16.294 25.217 19.1 11.972 x 8.683 44.097 x 21.221 57.85 19.492 x x x 72.3 9.533 8.433 14.756 x x 35.638 44.869 29.412 49.319 x 34.5 x 21.433 37.606 42.622 x 43.302 53.821 40.6 26.819 x x 51.073 32.11 49.498 35.128 x 21.117 x 36.15 14.6 x x x 24.836 33.4 27.186 x x 19.164 31.897 20.1 31.994 49.876 45.015 18.836 x 41.321 27.933 15.403 x 30.719 x x 32.528 41.503 x 42.472 22.242 18.975 41.683 49.277 x 29.333 42.497 x 25.478 x x 35.536 22.322 38.672 43.006 39.061 25.092 31.185 25.153 31.1 +12377 Original post publication description: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males only during last 5 min [percentage of time] None Anxiety assay, ethanol treated (1.8 g/kg i.p.) (NOE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males only during last 5 min [% time] 20.583 21.007 1.574 33.793 31.767 13.267 x 33.917 25.856 21.694 22.078 8.967 8.144 x 9.533 39.247 x 13.45 62.7 13.35 x x x 61.433 10.3 12.733 9.061 x x 25.467 41.072 22.157 48.4 x 0.0 x 19.65 25.161 37.5 x 38.617 44.857 31.517 21.185 x x 54.02 33.408 47.283 30.667 x 0.1 x 25.705 13.906 x x x 18.856 22.433 16.344 x x 17.872 27.756 20.65 23.461 42.657 43.537 19.033 x 28.75 29.333 13.428 x 28.633 x x 25.378 40.993 x 34.0 17.367 16.333 30.673 40.354 x 25.244 39.517 x 23.922 x x 29.786 16.533 36.617 35.979 33.744 17.239 24.829 13.127 24.617 +12376 Original post publication description: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males only during first 5 min [percentage of time] None Central nervous system, behavior: Anxiety assay, ethanol treated (1.8 g/kg i.p.) (NOE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males only during first 5 min [% time] 30.267 39.415 14.089 34.42 29.678 31.033 x 50.072 35.278 10.894 28.356 29.233 15.8 x 7.833 48.947 x 28.992 53.0 25.633 x x x 83.167 8.767 4.133 20.45 x x 45.808 48.667 36.667 50.239 x 69.0 x 23.217 50.05 47.744 x 47.988 62.786 49.683 32.452 x x 48.127 30.813 51.713 39.589 x 42.133 x 46.595 15.294 x x x 30.817 44.367 38.028 x x 20.456 36.039 19.55 40.528 57.095 46.493 18.639 x 53.892 26.533 17.378 x 32.806 x x 39.678 42.013 x 50.944 27.117 21.617 52.693 58.2 x 33.422 45.478 x 27.033 x x 41.286 28.111 40.728 50.033 44.378 32.944 37.542 37.18 37.583 +12375 Original post publication description: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), latency to enter an open quadrant using an elevated zero maze in 60 to 120-day-old males only [sec] None Central nervous system, behavior: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), latency to enter an open quadrant using an elevated zero maze in 60 to 120-day-old males only [sec] 25.825 22.867 2.578 29.7 3.117 1.9 x 5.65 5.1 92.88 10.3 10.8 25.6 x 31.1 9.7 x 37.3 5.6 9.767 x x x 17.7 8.4 43.1 5.3 x x 1.725 3.583 19.871 10.817 x 15.9 x 56.35 6.4 8.517 x 5.588 4.657 4.217 8.022 x x 5.22 16.55 2.438 6.433 x 4.2 x 8.9 17.467 x x x 12.867 12.017 7.483 x x 17.633 7.283 10.275 9.533 14.871 9.93 6.233 x 2.2 22.8 14.25 x 32.24 x x 5.467 0.94 x 0.467 12.083 6.08 2.1 12.463 x 58.567 4.05 x 5.517 x x 3.357 7.367 2.95 39.075 5.65 8.183 6.025 3.12 3.0 +12374 Original post publication description: Anxiety assay, ethanol treated [1.8 g/kg ip] (NOE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during 10 min [beam breaks/sec] None Anxiety assay, ethanol treated (1.8 g/kg ip) (NOE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during 10 min [beam breaks/sec] 0.478 0.389 0.38 0.307 0.318 0.351 0.989 0.375 0.52 3.255 0.874 0.238 0.928 x 0.459 0.285 x 0.517 x 0.315 x x x 2.127 0.338 0.353 0.595 x x 0.262 0.647 0.301 0.737 x x x x 0.402 0.333 x 0.243 0.365 0.561 0.261 x x 0.672 0.231 0.279 0.404 x x x 0.35 0.81 x x x 0.623 0.45 0.625 x x 0.285 0.386 0.559 0.308 2.989 0.317 0.24 x 0.345 x 0.605 x 0.652 x x 0.221 0.591 x 0.323 0.445 0.475 0.663 0.387 x 0.363 0.321 x 0.362 x x 0.411 0.389 0.483 0.587 0.279 0.832 0.335 0.842 0.344 +12373 Original post publication description: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during last 5 min [beam breaks/sec] None Central nervous system, behavior: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during last 5 min [beam breaks/sec] 0.602 0.475 0.463 0.289 0.337 0.428 1.311 0.424 0.631 1.626 1.202 0.27 1.638 x 0.459 0.317 x 0.561 x 0.331 x x x 1.401 0.407 0.341 0.727 x x 0.297 1.396 0.293 0.529 x x x x 0.595 0.371 x 0.263 0.388 0.573 0.281 x x 0.73 0.236 0.322 0.463 x x x 0.345 0.696 x x x 0.769 0.519 0.621 x x 0.317 0.504 0.639 0.267 0.322 0.322 0.263 x 0.348 x 0.753 x 0.856 x x 0.222 0.61 x 0.36 0.57 0.57 0.542 0.392 x 0.228 0.564 x 0.415 x x 0.515 0.46 0.579 1.273 0.315 1.64 0.395 1.688 0.395 +12372 Original post publication description: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during first 5 min [beam breaks/sec] None Central nervous system, behavior: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during first 5 min [beam breaks/sec] 0.41 0.329 0.312 0.332 0.309 0.297 0.768 0.344 0.555 1.858 0.46 0.209 0.656 x 0.465 0.253 x 0.481 x 0.304 x x x 4.348 0.278 0.371 0.499 x x 0.228 0.22 0.312 1.258 x x x x 0.285 0.329 x 0.227 0.298 0.691 0.241 x x 0.613 0.227 0.257 0.36 x x x 0.355 1.696 x x x 0.546 0.39 0.764 x x 0.262 0.337 0.502 0.376 7.776 0.318 0.221 x 0.403 x 0.278 x 0.537 x x 0.226 0.587 x 0.293 0.381 0.419 0.871 0.4 x 2.611 0.23 x 0.316 x x 0.333 0.327 0.398 0.438 0.249 0.587 0.32 0.439 0.302 +12371 Original post publication description: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during 10 min [n beam breaks] None Central nervous system, pharmacology, behavior: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during 10 min [n beam breaks] 1126.57 1226.14 1069.75 1233.0 1345.25 1204.2 560.0 1428.83 988.25 555.43 771.17 1228.67 872.67 x 1275.8 1644.0 x 1000.67 x 1355.0 x x x 280.0 1029.0 1264.17 892.5 x x 1197.75 1281.0 1243.0 689.33 x x x x 1058.67 846.4 x 1287.86 968.43 791.83 1317.25 x x 861.25 1489.67 977.43 998.5 x x x 1092.5 758.0 x x x 672.9 990.0 647.13 x x 1276.67 1071.0 1024.8 1279.33 367.0 857.0 1524.5 x 1157.38 x 774.6 x 773.67 x x 1509.33 849.0 x 1322.5 1121.83 1116.0 785.83 1059.0 x 766.0 1084.57 x 1285.17 x x 1131.0 1194.5 1050.83 932.5 1175.5 730.83 705.2 651.0 1021.29 +12370 Original post publication description: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during last 5 min [n beam breaks] None Central nervous system, behavior: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during last 5 min [n beam breaks] 505.43 543.86 512.0 639.25 692.25 611.8 228.0 734.33 504.5 282.71 335.5 578.0 365.67 x 647.0 803.0 x 517.33 x 592.0 x x x 211.0 471.0 635.5 389.0 x x 619.0 604.0 627.67 424.0 x x x x 449.5 449.6 x 687.43 580.43 427.5 659.75 x x 453.25 765.67 465.57 439.17 x x x 512.75 388.33 x x x 363.6 521.71 374.5 x x 597.5 474.14 485.4 672.5 212.0 396.67 754.5 x 671.5 x 439.2 x 312.33 x x 817.83 427.0 x 621.0 526.67 520.5 435.67 537.6 x 459.25 554.57 x 568.33 x x 515.43 566.5 528.0 437.5 543.25 327.83 343.4 261.0 478.57 +12369 Original post publication description: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during first 5 min [n beam breaks] None Central nervous system, pharmacology, behavior: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during first 5 min [n beam breaks] 621.14 682.29 557.75 593.75 653.0 592.4 332.0 694.5 483.75 272.71 435.67 650.67 507.0 x 628.8 841.0 x 483.33 x 763.0 x x x 69.0 558.0 628.67 503.5 x x 578.75 677.0 615.33 265.33 x x x x 609.17 396.8 x 600.43 388.0 364.33 657.5 x x 408.0 724.0 511.86 559.33 x x x 579.75 369.67 x x x 309.3 468.29 272.63 x x 679.17 596.86 539.4 606.83 155.0 460.33 770.0 x 485.88 x 335.4 x 461.33 x x 691.5 422.0 x 701.5 595.17 595.5 350.17 521.4 x 306.75 530.0 x 716.83 x x 615.57 628.0 522.83 495.0 632.25 403.0 361.8 390.0 542.71 +12368 Original post publication description: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old females during whole 10 min test [% time] None Central nervous system, behavior: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old females during whole 10 min test [% time] 24.579 23.36 38.675 37.708 31.837 31.47 7.65 26.994 25.121 15.631 23.794 51.489 6.183 x 19.657 22.033 x 22.717 x 28.767 x x x 0.717 42.117 34.55 12.8 x x 46.763 44.528 38.278 47.606 x x x x 35.675 53.175 x 50.036 44.314 32.483 43.771 x x 43.171 45.822 56.086 34.064 x x x 37.029 8.294 x x x 35.352 30.988 38.333 x x 38.967 34.317 11.503 46.775 66.081 55.775 39.903 x 39.346 x 50.2 x 37.353 x x 44.525 17.0 x 30.075 25.811 18.172 26.489 34.39 x 58.354 51.333 x 32.583 x x 28.767 27.386 35.7 27.317 45.258 26.964 59.633 36.315 41.562 +12367 Original post publication description: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old females only during last 5 min [percentage of time] None Central nervous system, pharmacology, behavior: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old females only during last 5 min [percent time] 22.833 19.729 32.475 38.858 30.442 21.573 0.333 22.911 26.05 9.914 10.678 48.556 0.222 x 18.527 15.033 x 19.0 x 34.733 x x x 1.433 36.033 32.406 8.933 x x 38.475 37.983 38.778 47.889 x x x x 25.0 47.98 x 43.029 26.971 23.678 40.242 x x 35.308 44.4 54.248 33.089 x x x 40.992 9.567 x x x 20.387 18.524 35.875 x x 36.539 32.305 9.08 43.489 66.486 57.728 36.278 x 33.371 x 34.247 x 32.233 x x 40.656 13.092 x 27.247 22.983 13.161 27.2 33.107 x 65.7 42.057 x 31.15 x x 20.024 18.889 26.394 22.533 42.558 18.233 58.073 23.63 35.857 +12366 Original post publication description: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old females during first 5 min [% time] None Central nervous system, behavior: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old females during first 5 min [% time] 26.324 26.99 44.875 36.558 33.233 41.367 14.967 31.078 24.192 21.348 36.911 54.422 12.144 x 20.787 29.033 x 26.433 x 22.8 x x x 0.0 48.2 36.694 16.667 x x 55.05 51.072 37.778 47.322 x x x x 46.35 58.37 x 57.043 61.657 41.289 47.3 x x 51.033 47.244 57.924 35.039 x x x 33.067 7.022 x x x 50.317 43.452 40.792 x x 41.394 36.329 13.927 50.061 65.676 53.822 43.528 x 45.321 x 66.153 x 42.472 x x 48.394 20.908 x 32.903 28.639 23.183 25.778 35.673 x 51.008 60.61 x 34.017 x x 37.51 35.883 45.006 32.1 47.958 35.694 61.193 49.0 47.267 +12365 Original post publication description: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), latency to enter an open quadrant using an elevated zero maze in 60 to 120-day-old females only [sec] None Central nervous system, behavior: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), latency to enter an open quadrant using an elevated zero maze in 60 to 120-day-old females only [sec] 10.257 5.329 2.175 24.6 6.075 2.84 0.3 10.1 45.0 24.433 6.35 0.033 47.267 x 30.5 0.5 x 34.833 x 6.2 x x x x 1.3 5.7 3.15 x x 3.45 1.733 6.833 25.35 x x x x 1.783 1.37 x 2.586 4.629 47.15 0.85 x x 9.5 5.767 0.929 11.867 x x x 16.625 27.967 x x x 5.02 5.443 16.2 x x 6.767 4.886 55.72 9.783 44.029 23.817 1.6 x 0.75 x 2.02 x 10.3 x x 0.733 3.25 x 0.54 6.683 18.333 2.45 14.52 x 19.525 4.286 x 12.967 x x 4.529 4.85 7.95 13.117 2.3 11.6 3.24 2.74 3.843 +12364 Original post publication description: Anxiety assay, baseline untreated control (BASE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during 10 min [beam breaks/sec] None Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during 10 min [beam breaks/sec] 0.49 0.482 0.431 0.831 0.354 0.48 x 0.416 0.538 0.493 0.729 0.404 0.538 0.406 0.417 0.569 x 0.436 0.403 0.493 0.514 x x 0.477 0.509 0.597 0.698 x x 0.472 0.43 0.467 0.506 x x x 0.529 0.572 0.379 x 0.435 0.524 0.551 0.445 x x 0.431 0.612 0.513 0.517 x x x 0.428 0.542 x x x 0.408 0.496 0.544 x x 0.448 0.602 0.486 0.481 0.423 0.497 0.425 x 0.507 0.53 0.442 x 0.505 x 0.361 0.451 0.529 x 0.506 0.593 0.43 0.442 0.547 x 0.497 0.409 x 0.44 x x 0.421 0.476 0.413 0.385 0.426 0.588 0.487 0.541 0.457 +12363 Original post publication description: Anxiety assay, baseline untreated control (BASE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during last 5 min [beam breaks/sec] None Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during last 5 min [beam breaks/sec] 0.563 0.605 0.488 0.787 0.393 0.57 x 0.505 0.629 0.547 0.913 0.486 0.637 0.387 0.464 0.715 x 0.51 0.429 0.569 0.626 x x 0.492 0.719 0.644 0.754 x x 0.546 0.495 0.486 0.586 x x x 0.554 0.775 0.422 x 0.512 0.61 0.622 0.535 x x 0.497 0.719 0.563 0.56 x x x 0.451 0.667 x x x 0.463 0.607 0.543 x x 0.494 0.723 0.453 0.56 0.505 0.547 0.445 x 0.586 0.418 0.476 x 0.53 x 0.394 0.547 0.665 x 0.575 0.732 0.468 0.505 0.61 x 0.525 0.468 x 0.475 x x 0.477 0.59 0.474 0.406 0.448 0.625 0.53 0.773 0.574 +12362 Original post publication description: Anxiety assay, baseline untreated control (BASE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during first 5 min [beam breaks/sec] None Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during first 5 min [beam breaks/sec] 0.436 0.401 0.387 0.958 0.322 0.416 x 0.362 0.48 0.449 0.617 0.347 0.484 0.427 0.385 0.495 x 0.39 0.381 0.445 0.443 x x 0.465 0.367 0.565 0.663 x x 0.419 0.379 0.456 0.452 x x x 0.515 0.447 0.345 x 0.38 0.458 0.498 0.385 x x 0.377 0.549 0.484 0.481 x x x 0.418 0.461 x x x 0.366 0.421 0.649 x x 0.412 0.525 0.533 0.453 0.37 0.457 0.41 x 0.457 0.679 0.432 x 0.487 x 0.336 0.405 0.428 x 0.456 0.512 0.4 0.398 0.507 x 0.486 0.365 x 0.412 x x 0.382 0.405 0.367 0.375 0.412 0.591 0.455 0.433 0.389 +12356 Original post publication description: Anxiety assay, baseline untreated control (BASE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males and females during first 5 min [percentage of time] None Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males and females during first 5 min [percentage of time] 25.472 35.181 28.696 21.605 42.275 25.7 x 28.79 12.673 27.614 20.572 30.714 8.753 16.167 28.231 16.642 x 33.421 12.8 24.93 15.611 x x 27.342 26.467 17.981 9.029 x x 32.244 34.619 23.545 38.778 x x x 15.85 28.9 23.817 x 35.079 34.785 18.572 17.586 x x 33.904 17.85 42.178 32.205 x x x 32.949 11.558 x x x 44.758 32.717 33.636 x x 23.681 23.136 14.556 26.772 32.895 33.895 33.469 x 15.636 26.233 41.488 x 18.048 x 28.0 20.486 37.733 x 27.807 18.749 20.892 25.747 26.972 x 25.611 31.236 x 26.425 x x 30.626 26.25 18.854 29.06 32.469 21.283 22.986 29.56 26.414 +12357 Original post publication description: Anxiety assay, baseline untreated control (BASE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males and females during last 5 min [percentage of time] None Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males and females during last 5 min [percentage of time] 22.742 27.103 26.665 24.533 40.083 19.7 x 28.959 20.18 27.256 13.883 27.994 14.873 13.0 30.457 17.436 x 39.183 15.567 29.442 16.422 x x 36.242 2.033 25.443 9.233 x x 31.844 31.292 35.009 36.753 x x x 13.508 18.956 20.406 x 36.44 31.156 14.936 12.997 x x 22.779 22.722 49.914 30.81 x x x 32.682 10.607 x x x 47.219 26.278 33.856 x x 24.192 22.164 32.561 30.419 36.997 30.751 33.162 x 15.942 39.5 40.546 x 21.276 x 35.2 19.793 30.067 x 23.224 19.426 23.985 26.361 31.872 x 29.136 31.618 x 32.642 x x 34.041 17.986 17.029 32.871 38.697 18.797 27.229 26.802 25.086 +12358 Original post publication description: Anxiety assay, baseline untreated control (BASE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males and females during 10 min [percentage of time] None Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males and females during 10 min [percentage of time] 24.107 31.142 27.68 23.069 41.179 22.7 x 28.874 16.427 27.435 17.228 29.354 11.813 14.583 29.344 17.039 x 36.302 14.183 27.186 16.017 x x 31.792 14.25 21.712 9.131 x x 32.044 32.956 29.277 37.765 x x x 14.679 23.928 22.111 x 35.759 32.97 16.754 15.292 x x 28.342 20.286 46.046 31.507 x x x 32.815 11.082 x x x 45.989 29.497 33.746 x x 23.936 22.65 23.558 28.596 34.946 32.323 33.316 x 15.789 32.867 41.017 x 19.662 x 31.6 20.139 33.9 x 25.515 19.087 22.439 26.054 29.422 x 27.374 31.427 x 29.533 x x 32.333 22.118 17.942 30.965 35.583 20.04 25.107 28.181 25.75 +12359 Original post publication description: Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during first 5 min [n beam breaks] None Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during first 5 min [n beam breaks] 528.83 500.08 562.53 535.36 551.38 557.17 x 596.38 549.2 489.42 418.42 622.17 584.2 589.0 566.79 546.91 x 519.63 687.0 519.55 576.67 x x 473.13 601.0 448.44 430.29 x x 495.58 529.83 512.36 417.75 x x x 494.38 491.4 670.58 x 528.81 442.56 506.17 658.25 x x 531.88 467.0 365.67 442.93 x x x 545.92 587.4 x x x 444.17 482.92 386.67 x x 565.92 448.85 493.0 493.92 559.38 445.77 488.0 x 574.75 326.0 432.75 x 515.82 x 642.0 605.86 440.0 x 482.0 485.08 597.77 564.92 443.92 x 477.92 563.92 x 544.25 x x 545.89 556.5 673.0 596.0 491.62 422.3 520.29 499.93 577.53 +12360 Original post publication description: Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during last 5 min [n beam breaks] None Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during last 5 min [n beam breaks] 436.92 398.67 467.53 433.43 472.25 428.67 x 435.92 389.0 400.67 327.67 469.0 430.6 674.0 459.79 409.91 x 361.0 591.0 384.0 419.67 x x 389.5 409.0 356.5 378.71 x x 388.0 423.83 410.36 330.67 x x x 494.0 341.47 573.58 x 378.0 356.89 422.75 528.58 x x 484.38 344.17 284.67 394.93 x x x 465.77 424.27 x x x 345.25 382.33 370.75 x x 474.75 346.69 461.0 428.25 393.69 389.0 457.36 x 447.5 434.0 383.5 x 457.27 x 494.0 501.79 324.0 x 413.57 351.46 500.38 470.0 336.92 x 410.75 445.15 x 426.75 x x 420.22 455.17 547.0 514.29 423.92 405.5 423.0 355.0 439.06 +12361 Original post publication description: Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during 10 min [n beam breaks] None Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during 10 min [n beam breaks] 965.75 898.75 1030.06 968.79 1023.63 985.83 x 1032.31 938.2 890.08 746.08 1091.17 1014.8 1263.0 1026.57 956.82 x 880.63 1278.0 903.55 996.33 x x 862.63 1010.0 804.94 809.0 x x 883.58 953.67 922.73 748.42 x x x 988.38 832.87 1244.17 x 906.81 799.44 928.92 1186.83 x x 1016.25 811.17 650.33 837.86 x x x 1011.69 1011.67 x x x 789.42 865.25 757.42 x x 1040.67 795.54 954.0 922.17 953.08 834.77 945.36 x 1022.25 760.0 816.25 x 973.09 x 1136.0 1107.64 764.0 x 895.57 836.54 1098.15 1034.92 780.85 x 888.67 1009.08 x 971.0 x x 966.11 1011.67 1220.0 1110.29 915.54 827.8 943.29 854.93 1016.59 +12355 Original post publication description: Anxiety assay, baseline untreated control (BASE group), latency to enter an open quadrant using an elevated zero maze in 60 to 120-day-old males and females [sec] None Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), latency to enter an open quadrant using an elevated zero maze in 60 to 120-day-old males and females [sec] 4.683 7.8 7.176 9.6 4.575 4.85 x 3.908 10.42 17.558 9.433 5.667 9.6 24.3 21.386 4.4 x 6.65 22.8 12.818 7.667 x x 4.363 20.0 23.178 29.543 x x 13.033 8.625 10.282 7.983 x x x 16.6 8.587 7.492 x 6.219 5.478 3.817 4.508 x x 9.05 12.833 12.633 10.593 x x x 7.215 18.167 x x x 8.2 3.583 22.058 x x 7.783 6.869 9.15 11.642 2.892 5.538 8.007 x 7.025 41.4 6.125 x 22.209 x 0.8 4.7 21.4 x 6.75 10.923 7.823 6.467 6.885 x 10.325 2.285 x 11.0 x x 14.333 10.108 4.825 6.464 8.892 6.84 2.6 9.979 5.124 +12354 Original post publication description: Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during 10 min [beam breaks/sec] None Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during 10 min [beam breaks/sec] 0.42 0.436 0.43 0.417 0.378 0.601 x 0.389 0.538 0.484 0.685 0.451 0.507 0.406 0.438 0.402 x 0.449 0.403 0.483 x x x 0.448 0.509 0.621 0.698 x x 0.488 0.433 0.497 0.505 x x x 0.503 0.532 0.389 x 0.399 0.536 0.587 0.413 x x 0.363 0.746 0.478 0.576 x x x 0.374 0.52 x x x 0.395 0.468 0.51 x x 0.454 0.546 0.512 0.47 0.478 0.51 0.423 x 0.53 0.53 0.452 x 0.537 x 0.361 0.431 x x 0.5 0.573 0.394 0.408 0.518 x 0.508 0.388 x 0.31 x x 0.426 0.509 0.395 0.352 0.404 0.625 0.482 0.593 0.438 +12353 Original post publication description: Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during last 5 min [beam breaks/sec] None Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during last 5 min [beam breaks/sec] 0.462 0.508 0.51 0.484 0.424 0.63 x 0.48 0.629 0.532 0.91 0.576 0.654 0.387 0.494 0.45 x 0.54 0.429 0.553 x x x 0.459 0.719 0.688 0.754 x x 0.54 0.514 0.532 0.578 x x x 0.495 0.719 0.439 x 0.471 0.606 0.656 0.514 x x 0.371 0.914 0.511 0.633 x x x 0.431 0.643 x x x 0.462 0.548 0.531 x x 0.502 0.603 0.454 0.514 0.591 0.546 0.426 x 0.566 0.418 0.434 x 0.544 x 0.394 0.477 x x 0.522 0.695 0.413 0.448 0.596 x 0.575 0.427 x 0.345 x x 0.466 0.684 0.45 0.375 0.418 0.572 0.531 0.915 0.524 +12352 Original post publication description: Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during first 5 min [beam breaks/sec] None Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during first 5 min [beam breaks/sec] 0.384 0.375 0.367 0.37 0.339 0.579 x 0.34 0.48 0.441 0.556 0.368 0.426 0.427 0.401 0.364 x 0.395 0.381 0.442 x x x 0.439 0.367 0.576 0.663 x x 0.447 0.369 0.48 0.465 x x x 0.514 0.412 0.348 x 0.347 0.481 0.535 0.348 x x 0.354 0.657 0.461 0.528 x x x 0.333 0.446 x x x 0.343 0.413 0.528 x x 0.419 0.5 0.587 0.448 0.406 0.48 0.422 x 0.51 0.679 0.48 x 0.537 x 0.336 0.4 x x 0.484 0.505 0.379 0.376 0.473 x 0.462 0.356 x 0.284 x x 0.396 0.403 0.352 0.344 0.399 0.716 0.447 0.453 0.384 +12351 Original post publication description: Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during 10 min [n beam breaks] None Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during 10 min [n beam breaks] 1083.67 946.67 1000.17 1057.0 973.67 851.0 x 933.67 938.2 810.0 761.33 1009.2 1045.33 1263.0 968.57 1129.33 x 852.67 1278.0 898.0 x x x 1000.0 1010.0 741.5 809.0 x x 897.86 937.17 888.33 691.33 x x x 1002.67 848.33 1216.22 x 964.44 805.17 956.0 1265.2 x x 1064.0 727.0 683.83 764.0 x x x 1107.5 1025.5 x x x 806.67 878.17 829.38 x x 1116.5 786.67 892.25 973.33 829.67 841.71 968.12 x 970.0 760.0 878.0 x 973.5 x 1136.0 1157.63 x x 860.33 869.17 1206.14 1028.25 745.67 x 925.67 1020.33 x 792.0 x x 952.8 969.0 1205.4 1106.17 918.89 799.0 977.8 822.33 1040.11 +12350 Original post publication description: Anxiety assay, baseline untreated control (BASE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during last 5 min [n beam breaks] None Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during last 5 min [n beam breaks] 517.67 435.5 451.0 451.14 445.67 397.5 x 400.33 389.0 363.5 336.67 419.4 412.0 674.0 402.14 494.0 x 337.0 591.0 381.83 x x x 470.0 409.0 315.4 378.71 x x 418.14 417.83 396.0 298.83 x x x 525.0 362.0 565.89 x 401.89 359.0 427.5 546.4 x x 520.0 305.67 304.83 356.14 x x x 482.67 428.38 x x x 363.83 407.83 385.75 x x 524.17 364.67 448.5 449.17 335.83 398.86 478.0 x 452.6 434.0 448.0 x 470.67 x 494.0 525.0 x x 423.33 366.17 567.71 473.13 306.5 x 420.33 458.83 x 336.0 x x 439.8 401.0 543.4 503.17 431.67 446.5 431.4 328.44 439.33 +12349 Original post publication description: Anxiety assay, baseline untreated control (BASE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during first 5 min [n beam breaks] None Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during first 5 min [n beam breaks] 566.0 511.17 549.17 605.86 528.0 453.5 x 533.33 549.2 446.5 424.67 589.8 633.33 589.0 566.43 635.33 x 515.67 687.0 516.17 x x x 530.0 601.0 426.1 430.29 x x 479.71 519.33 492.33 392.5 x x x 477.67 486.33 650.33 x 562.56 446.17 528.5 718.8 x x 544.0 421.33 379.0 407.86 x x x 624.83 597.13 x x x 442.83 470.33 443.63 x x 592.33 422.0 443.75 524.17 493.83 442.86 490.13 x 517.4 326.0 430.0 x 502.83 x 642.0 632.63 x x 437.0 503.0 638.43 555.13 439.17 x 505.33 561.5 x 456.0 x x 513.0 568.0 662.0 603.0 487.22 352.5 546.4 493.89 600.78 +12348 Original post publication description: Anxiety assay, baseline untreated control (BASE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males only during 10 min [percentage of time] None Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males only during 10 min [percentage of time] 25.458 32.6 31.231 26.652 40.031 15.333 x 39.233 16.427 34.192 20.819 27.667 13.672 14.583 29.945 24.572 x 36.464 14.183 28.661 x x x 25.267 14.25 25.215 9.131 x x 28.443 32.728 26.881 42.1 x x x 18.128 28.741 21.693 x 37.22 32.158 9.314 16.72 x x 35.175 9.978 46.422 30.836 x x x 32.092 13.7 x x x 46.508 33.161 31.637 x x 17.756 29.083 24.288 26.178 35.147 30.733 31.658 x 16.727 32.867 34.008 x 15.317 x 31.6 18.004 x x 29.156 18.881 21.331 31.019 35.489 x 21.317 34.219 x 59.05 x x 32.223 19.491 22.16 36.494 38.561 18.512 23.657 25.704 26.43 +12347 Original post publication description: Anxiety assay, baseline untreated control (BASE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males only during last 5 min [percentage of time] None Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males only during last 5 min [percentage of time] 22.2 27.539 28.317 28.081 38.433 18.167 x 39.878 20.18 33.617 15.706 24.593 16.533 13.0 34.705 26.128 x 39.533 15.567 31.994 x x x 28.133 2.033 28.577 9.233 x x 27.181 29.167 31.794 43.217 x x x 17.189 22.704 18.33 x 37.911 31.994 8.144 14.747 x x 34.6 10.656 50.761 29.638 x x x 31.833 14.088 x x x 44.978 29.633 31.696 x x 16.528 27.389 34.842 28.994 35.939 28.938 32.604 x 18.487 39.5 37.217 x 17.672 x 35.2 18.4 x x 28.333 20.567 22.738 31.296 38.3 x 20.606 34.933 x 61.333 x x 32.473 15.11 20.933 40.111 41.837 16.875 26.347 24.004 28.496 +12346 Original post publication description: Anxiety assay, baseline untreated control (BASE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males only during first 5 min [percentage of time] None Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males only during first 5 min [percentage of time] 28.717 37.661 34.144 25.224 41.628 12.5 x 38.589 12.673 34.767 25.933 30.74 10.811 16.167 25.186 23.017 x 33.394 12.8 25.328 x x x 22.4 26.467 21.853 9.029 x x 29.705 36.289 21.967 40.983 x x x 19.067 34.778 25.056 x 36.53 32.322 10.483 18.693 x x 35.75 9.3 42.083 32.033 x x x 32.35 13.313 x x x 48.039 36.689 31.579 x x 18.983 30.778 13.733 23.361 34.356 32.529 30.713 x 14.967 26.233 30.8 x 12.961 x 28.0 17.608 x x 29.978 17.194 19.924 30.742 32.678 x 22.028 33.506 x 56.767 x x 31.973 23.871 23.387 32.878 35.285 20.15 20.967 27.404 24.363 +12345 Original post publication description: Anxiety assay, baseline untreated control (BASE group), latency to enter an open quadrant using an elevated zero maze in 60 to 120-day-old males only [sec] None Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), latency to enter an open quadrant using an elevated zero maze in 60 to 120-day-old males only [sec] 6.067 11.517 5.15 5.429 6.0 8.85 x 4.117 10.42 15.317 6.667 3.9 10.183 24.3 22.743 2.75 x 5.1 22.8 8.35 x x x 8.9 20.0 29.9 29.543 x x 14.657 6.883 8.867 10.917 x x x 16.367 8.5 6.556 x 6.2 6.417 4.7 2.46 x x 8.15 17.533 12.65 10.714 x x x 5.217 13.388 x x x 9.55 5.6 29.863 x x 6.2 6.233 12.1 11.067 0.617 3.343 9.4 x 3.76 41.4 16.55 x 31.8 x 0.8 3.625 x x 5.483 20.133 6.386 4.6 6.35 x 14.8 4.15 x 12.4 x x 16.66 11.529 4.84 7.683 8.067 5.425 3.44 8.178 3.911 +12344 Original post publication description: Anxiety assay, baseline untreated control (BASE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during 10 min [beam breaks/sec] None Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during 10 min [beam breaks/sec] 0.56 0.527 0.432 0.8 0.284 0.42 x 0.44 x 0.502 0.773 0.371 0.585 x 0.396 0.77 x 0.396 x 0.506 0.514 x x 0.481 x 0.567 x x x 0.449 0.427 0.43 0.506 x x x 0.608 0.632 0.351 x 0.481 0.501 0.515 0.467 x x 0.454 0.477 0.548 0.458 x x x 0.474 0.566 x x x 0.422 0.524 0.612 x x 0.441 0.65 0.434 0.492 0.376 0.481 0.428 x 0.491 x 0.438 x 0.465 x x 0.477 0.529 x 0.511 0.61 0.472 0.509 0.572 x 0.485 0.428 x 0.483 x x 0.416 0.429 0.443 0.41 0.474 0.564 0.5 0.448 0.477 +12343 Original post publication description: Anxiety assay, baseline untreated control (BASE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during last 5 min [beam breaks/sec] None Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during last 5 min [beam breaks/sec] 0.664 0.702 0.476 1.089 0.301 0.541 x 0.526 x 0.563 0.915 0.423 0.611 x 0.433 1.033 x 0.422 x 0.587 0.626 x x 0.497 x 0.589 x x x 0.556 0.477 0.431 0.593 x x x 0.731 0.86 0.37 x 0.564 0.619 0.588 0.55 x x 0.538 0.524 0.615 0.487 x x x 0.468 0.694 x x x 0.465 0.666 0.566 x x 0.487 0.826 0.451 0.607 0.432 0.548 0.471 x 0.599 x 0.49 x 0.514 x x 0.642 0.665 x 0.615 0.763 0.532 0.618 0.622 x 0.475 0.503 x 0.518 x x 0.491 0.459 0.513 0.429 0.516 0.661 0.528 0.518 0.631 +12342 Original post publication description: Anxiety assay, baseline untreated control (BASE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during first 5 min [beam breaks/sec] None Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during first 5 min [beam breaks/sec] 0.488 0.426 0.399 1.546 0.268 0.334 x 0.38 x 0.457 0.677 0.332 0.572 x 0.369 0.652 x 0.376 x 0.447 0.443 x x 0.469 x 0.551 x x x 0.381 0.389 0.428 0.439 x x x 0.521 0.501 0.337 x 0.422 0.413 0.462 0.412 x x 0.384 0.442 0.507 0.434 x x x 0.49 0.479 x x x 0.39 0.429 0.89 x x 0.405 0.547 0.424 0.457 0.339 0.431 0.393 x 0.419 x 0.416 x 0.427 x x 0.411 0.428 x 0.435 0.519 0.424 0.443 0.535 x 0.511 0.374 x 0.455 x x 0.365 0.408 0.391 0.398 0.442 0.508 0.474 0.397 0.395 +12341 Original post publication description: Anxiety assay, baseline untreated control (BASE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during 10 min [n beam breaks] None Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during 10 min [n beam breaks] 847.83 850.83 1046.36 880.57 1173.5 1053.25 x 1116.86 x 970.17 730.83 1149.71 969.0 x 1084.57 749.8 x 964.5 x 910.2 996.33 x x 843.0 x 884.25 x x x 863.6 970.17 964.0 805.5 x x x 945.5 809.67 1328.0 x 832.71 788.0 901.83 1130.86 x x 1000.33 895.33 616.83 911.71 x x x 929.57 995.86 x x x 772.17 852.33 613.5 x x 964.83 803.14 1077.5 871.0 1058.86 826.67 915.0 x 1059.57 x 795.67 x 972.6 x x 1041.0 764.0 x 922.0 808.57 972.17 1048.25 811.0 x 851.67 999.43 x 1030.67 x x 982.75 1071.4 1244.33 1113.38 908.0 847.0 857.0 913.6 990.13 +12340 Original post publication description: Anxiety assay, baseline untreated control (BASE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during last 5 min [n beam breaks] None Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during last 5 min [n beam breaks] 356.17 361.83 476.55 415.71 552.0 444.25 x 466.43 x 437.83 318.67 504.43 458.5 x 517.43 309.0 x 433.0 x 386.6 419.67 x x 378.0 x 407.88 x x x 345.8 429.83 427.6 362.5 x x x 401.0 310.67 596.67 x 347.29 352.67 418.0 515.86 x x 472.5 382.67 264.5 433.71 x x x 451.29 419.57 x x x 326.67 356.83 340.75 x x 425.33 331.29 486.0 407.33 443.29 377.5 429.83 x 443.86 x 362.0 x 441.2 x x 470.83 324.0 x 406.25 338.86 421.83 463.75 363.0 x 401.17 433.43 x 457.0 x x 395.75 531.0 553.0 522.63 406.5 378.17 402.0 402.8 438.75 +12339 Original post publication description: Anxiety assay, baseline untreated control (BASE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during first 5 min [n beam breaks] None Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during first 5 min [n beam breaks] 491.67 489.0 569.82 464.86 621.5 609.0 x 650.43 x 532.33 412.17 645.29 510.5 x 567.14 440.8 x 531.5 x 523.6 576.67 x x 465.0 x 476.38 x x x 517.8 540.33 536.4 443.0 x x x 544.5 499.0 731.33 x 485.43 435.33 483.83 615.0 x x 527.83 512.67 352.33 478.0 x x x 478.29 576.29 x x x 445.5 495.5 272.75 x x 539.5 471.86 591.5 463.67 615.57 449.17 485.17 x 615.71 x 433.67 x 531.4 x x 570.17 440.0 x 515.75 469.71 550.33 584.5 448.0 x 450.5 566.0 x 573.67 x x 587.0 540.4 691.33 590.75 501.5 468.83 455.0 510.8 551.38 +12338 Original post publication description: Anxiety assay, baseline untreated control (BASE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old females only during 10 min [percentage of time] None Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old females only during 10 min [percentage of time] 22.756 29.683 25.744 19.486 44.625 26.383 x 19.995 x 20.678 13.636 30.559 9.025 x 28.743 8.0 x 35.817 x 25.417 16.017 x x 32.724 x 17.333 x x x 37.087 33.183 32.153 33.431 x x x 4.333 16.708 23.367 x 33.881 34.594 24.194 14.271 x x 26.064 30.594 45.669 32.179 x x x 33.436 8.091 x x x 45.469 25.833 37.962 x x 30.117 17.136 22.1 31.014 34.774 34.178 35.525 x 15.119 x 43.353 x 24.877 x x 22.986 33.9 x 22.785 19.264 23.731 16.125 24.221 x 33.431 29.033 x 19.694 x x 32.471 25.797 10.911 26.819 28.883 21.058 28.733 32.64 24.985 +12337 Original post publication description: Anxiety assay, baseline untreated control (BASE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old females only during last 5 min [percentage of time] None Central nervous system, pharmacology, behavior: Anxiety assay, baseline untreated control (BASE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old females only during last 5 min [percentage of time] 23.283 26.667 25.764 20.986 45.033 20.467 x 19.6 x 20.894 12.061 30.424 12.383 x 26.21 7.007 x 38.133 x 26.38 16.422 x x 37.4 x 21.525 x x x 38.373 33.417 38.867 30.289 x x x 2.467 13.333 26.633 x 34.548 29.478 21.728 11.748 x x 18.839 34.789 49.067 31.981 x x x 33.41 6.629 x x x 49.461 22.922 38.175 x x 31.856 17.686 28.0 31.844 37.905 32.867 33.906 x 14.124 x 41.656 x 25.6 x x 21.65 30.067 x 19.392 18.448 25.439 16.492 26.362 x 37.667 28.776 x 23.078 x x 36.0 22.013 10.522 27.442 31.633 20.078 29.433 31.84 21.25 +12336 Original post publication description: Anxiety assay, baseline untreated control (BASE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old females only during first 5 min [percentage of time] None Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old females only during first 5 min [percentage of time] 22.228 32.7 25.724 17.986 44.217 32.3 x 20.39 x 20.461 15.211 30.695 5.667 x 31.276 8.993 x 33.5 x 24.453 15.611 x x 28.048 x 13.142 x x x 35.8 32.95 25.44 36.572 x x x 6.2 20.083 20.1 x 33.214 39.711 26.661 16.795 x x 33.289 26.4 42.272 32.376 x x x 33.462 9.552 x x x 41.478 28.744 37.75 x x 28.378 16.586 16.2 30.183 31.643 35.489 37.144 x 16.114 x 45.05 x 24.153 x x 24.322 37.733 x 26.179 20.081 22.022 15.758 22.081 x 29.194 29.29 x 16.311 x x 28.942 29.58 11.3 26.196 26.133 22.039 28.033 33.44 28.721 +12335 Original post publication description: Anxiety assay, baseline untreated control (BASE group), latency to enter an open quadrant using an elevated zero maze in 60 to 120-day-old females only [sec] None Central nervous system, behavior: Anxiety assay, baseline untreated control (BASE group), latency to enter an open quadrant using an elevated zero maze in 60 to 120-day-old females only [sec] 3.3 4.083 8.282 14.467 0.3 2.85 x 3.729 x 19.8 12.2 6.929 8.725 x 20.029 6.38 x 11.3 x 18.18 7.667 x x 3.714 x 14.775 x x x 10.76 10.367 11.98 5.05 x x x 17.3 8.717 10.3 x 6.243 3.6 2.933 5.971 x x 9.35 8.133 12.617 10.471 x x x 8.929 23.629 x x x 6.85 1.567 6.45 x x 9.367 7.414 3.25 12.217 4.843 8.1 6.15 x 9.357 x 2.65 x 10.7 x x 6.133 21.4 x 7.7 3.029 9.5 10.2 7.343 x 5.85 0.686 x 10.533 x x 11.425 8.12 4.8 5.55 10.75 7.783 0.5 13.22 6.488 +12296 Original post publication description: Central nervous system, behavior: Central motor pattern generation (CPG), lick rate for 0.1 M sucrose over 20 minutes (Davis MS160 lickometer), male and female adults [MPI] None Central nervous system, behavior: Central motor pattern generation (CPG), mean primary interlick interval (MPI, time between licks) for 0.1 M sucrose over 20 min (Davis MS160 lickometer), male and female adults [mSec] x 103.92 115.59 95.67 131.27 99.83 104.87 116.9 116.75 99.65 106.97 114.46 117.15 123.83 131.27 x 113.13 117.15 x x x x x 102.27 108.87 114.5 x 116.95 x 117.2 99.67 124.23 110.89 x 111.0 x 118.44 103.17 116.54 x 111.32 105.66 113.63 114.7 x x 117.73 x 123.87 128.34 x x x 113.72 118.62 x x x 104.72 107.39 111.74 x x 112.2 122.7 x 111.88 106.39 119.74 98.87 x 102.96 x 100.16 x 102.52 x x 108.39 x x 109.36 106.0 110.05 109.44 125.9 x 113.93 113.38 x 102.78 x x 100.99 120.3 117.57 108.72 114.18 105.5 x 106.7 107.83 +12297 Original post publication description: Central nervous system, behavior: Central motor pattern generation, lick rate [MPI] for water over 20 minutes (MS160 lickometer), male and female adults [66 strains] None Central nervous system, behavior: Central motor pattern generation (CPG), mean primary interlick interval (MPI, time between licks) for water over 20 min (Davis MS160 lickometer), male and female adults [mSec] x 107.51 116.33 95.39 133.27 100.28 107.73 114.6 111.43 97.44 106.57 110.78 116.7 126.08 123.13 x 115.17 116.7 x x x x x 102.97 106.98 115.25 x 117.2 x 117.14 98.95 122.12 111.11 x 106.86 x 118.42 106.43 114.41 x 109.27 106.17 114.41 115.18 x x 113.4 x 119.58 127.31 x x x 114.26 116.07 x x x 103.37 106.78 108.01 x x 110.34 120.49 x 109.99 108.0 113.88 98.43 x 102.83 x 99.02 x 100.32 x x 105.78 x x 105.91 105.67 110.2 110.23 122.4 x 113.31 112.26 x 100.32 x x 101.68 119.49 117.28 108.13 113.88 107.7 x 107.12 107.9 +12555 Original post publication description: Endocrinology, neuroendocrine system, morphology: Adrenal medulla width [um] None Endocrinology, neuroendocrine system, morphology: Adrenal medulla width [um] x x 412.943 483.102 515.23 494.848 x 521.594 495.626 581.21 468.108 438.298 487.31 434.655 598.22 480.206 521.697 438.71 558.266 513.968 x x x 565.082 x 570.283 532.404 468.265 x 507.998 540.992 573.686 548.203 x 561.391 x 539.905 467.68 463.9 x 386.56 578.511 441.6 508.538 x x 648.043 x 617.78 580.872 x x x 556.5 505.992 x x x 510.964 508.153 455.473 679.543 x 463.316 521.813 465.079 516.774 481.956 520.116 546.377 x 547.937 x 483.283 x 462.19 x x 533.548 x x 527.298 525.518 532.253 540.114 542.875 x 562.655 591.617 x 500.007 x x x 541.68 459.975 589.127 586.995 593.204 x x x +12300 Original post publication description: Eye, visual system, physiology: Intraocular pressure (IOP), 1 to 2 months old, both sexes, average of left and right eyes [mmHg] None Eye, visual system, physiology: Intraocular pressure (IOP), 1 to 2 months old, both sexes, average of left and right eyes [mmHg] 15.667 15.111 15.375 16.714 17.5 x 15.6 x x 16.083 14.417 17.429 13.944 18.25 16.875 19.833 16.417 15.625 15.25 x x x x x x 16.75 x 16.833 x 12.5 14.833 12.667 14.3 x 13.75 x 12.5 15.5 15.5 x 16.7 17.25 14.409 13.125 x x 16.539 x 14.885 12.556 x x x 15.3 15.5 x x x 15.375 16.192 19.0 16.071 x 15.7 17.611 16.0 16.167 15.591 11.667 13.056 x 13.75 x 13.111 x 14.208 x x 13.889 x x 17.364 15.0 12.458 16.278 16.688 x 14.167 13.375 x 14.378 x x 15.0 16.533 13.0 11.643 17.0 17.313 12.917 17.333 14.8 +12303 Original post publication description: Eye, visual system, physiology: Intraocular pressure (IOP), 3 to 5 months old, both sexes, average of left and right eyes [mmHg] None Eye, visual system, physiology: Intraocular pressure (IOP), 3 to 5 months old, both sexes, average of left and right eyes [mmHg] 17.375 18.0 15.667 17.183 18.5 x 17.591 17.75 x 17.562 16.864 18.375 13.722 18.0 18.63 17.0 17.3 14.206 16.954 21.75 x x x x x 17.8 x 18.125 x 15.75 15.571 15.4 13.625 x 18.0 x 12.5 13.667 12.6 x 14.938 14.546 14.875 11.75 x x 17.5 x 15.0 14.154 x x x 15.587 13.833 x x x 16.45 17.5 16.455 19.115 x 14.389 20.083 14.062 15.179 16.861 17.235 15.25 x 18.044 x 12.714 x 15.417 x x 18.562 x x 14.875 14.961 15.823 18.321 17.556 x 16.25 14.95 x 14.611 x x 18.0 14.875 14.188 13.5 21.3 14.828 8.85 16.472 16.95 +12306 Original post publication description: Eye, visual system, physiology: Intraocular pressure (IOP), 6 to 9 months old, both sexes, average of left and right eyes [mmHg] None Eye, visual system, physiology: Intraocular pressure (IOP), 6 to 9 months old, both sexes, average of left and right eyes [mmHg] 16.5 20.15 15.1 19.173 17.2 16.125 20.083 16.0 18.929 17.375 15.6 17.0 16.3 18.583 16.5 14.875 17.75 17.964 13.75 13.5 16.5 x x x x 22.125 18.75 x x 15.167 16.25 17.0 17.357 x 14.583 x 13.318 12.611 13.4 x 12.0 15.857 16.667 13.421 x x 10.833 x 13.15 14.818 x x x 17.2 14.0 x x x 17.361 18.167 14.885 19.125 x 13.813 22.5 17.083 18.706 16.864 17.708 14.4 x 20.938 x 15.364 x 15.821 x x 17.393 x x 15.706 15.143 16.737 18.188 21.038 x 17.364 17.812 x 19.0 x 13.5 19.938 15.188 15.389 12.167 18.333 14.182 12.7 20.75 16.5 +12309 Original post publication description: Eye, visual system, physiology: Intraocular pressure (IOP), 10 to 13 months old, both sexes, average of left and right eyes [mmHg] None Eye, visual system, physiology: Intraocular pressure (IOP), 10 to 13 months old, both sexes, average of left and right eyes [mmHg] x 17.625 15.227 16.844 18.5 11.333 13.167 12.5 17.0 14.25 14.75 14.375 13.375 19.375 16.333 16.75 18.125 14.0 9.375 x x x x x x 18.375 x 14.667 x 12.625 13.922 18.0 18.955 x 14.833 x 9.583 13.214 13.75 x 11.75 17.875 21.818 15.063 x x 9.3 x 12.5 17.889 x x x 15.0 18.875 x x x 14.455 18.237 14.611 16.9 x 13.583 18.5 17.5 16.833 17.038 16.458 12.5 x 16.906 x 14.85 x 17.643 x x 19.75 x x 16.208 13.75 16.071 16.667 16.5 x 14.542 15.3 x 14.0 x x 17.75 14.5 13.3 18.688 18.25 16.546 13.25 15.278 17.15 +12312 Original post publication description: Eye, visual system, physiology, aging: Intraocular pressure (IOP), more than 13 months old, both sexes, average of left and right eyes [mmHg] None Eye, visual system, physiology, aging: Intraocular pressure (IOP), more than 13 months old, both sexes, average of left and right eyes [mmHg] x x 13.091 12.5 14.6 15.75 x 12.5 17.75 21.0 15.5 10.3 12.5 x 13.8 14.5 14.143 14.1 8.25 x 16.333 x x x 15.25 18.75 18.25 14.75 x 13.75 14.0 19.125 18.688 x x x 12.75 13.375 11.85 x 10.25 12.25 13.214 15.417 x x 10.375 x 9.7 21.833 x x x 18.25 18.1 x x x 10.6 15.708 14.364 x x 12.727 12.5 17.0 11.583 13.529 14.167 12.944 x 14.083 x 13.667 x 10.688 x x 16.7 x x 0.5 13.5 11.929 16.9 21.717 x 12.222 14.5 x 13.917 x x 16.0 11.583 x 14.1 14.375 16.438 9.5 10.6 18.909 +12315 Original post publication description: Eye, visual system, physiology: Intraocular pressure (IOP), all ages (1 to 30 months old), both sexes, average of left and right eyes [mmHg] None Eye, visual system, physiology: Intraocular pressure (IOP), all ages (1 to 30 months old), both sexes, average of left and right eyes [mmHg] 16.605 17.813 14.727 17.039 17.163 14.444 16.821 14.923 17.938 16.896 15.463 15.635 14.155 18.435 15.936 16.423 16.442 15.394 14.293 19.0 16.4 x x x 13.8 18.776 18.583 16.117 x 14.032 14.833 16.25 16.989 x 15.175 x 12.258 13.586 13.143 x 13.044 15.457 16.432 13.576 x x 15.29 x 13.796 15.667 x x x 16.018 15.909 x x x 15.189 17.215 15.815 18.0 x 14.057 19.32 15.958 16.273 15.886 15.856 13.912 x 17.412 x 13.91 x 14.83 x x 17.517 x x 15.352 14.623 15.145 17.382 19.35 x 14.914 15.119 x 15.0 x x 17.105 14.951 14.121 13.644 18.517 15.493 11.172 16.33 17.157 +12318 Original post publication description: Eye, visual system: Iris pigmentation at 1-2 months in males and females [ordinal scale, 0=full pigmentation, 4=light] None Eye, visual system: Iris pigmentation at 1-2 months in males and females [ordinal scale, 0=full pigmentation, 4=light] 0.0 0.0 0.0 2.021 1.5 x 0.0 x x 1.0 0.0 0.136 1.688 0.0 0.5 0.0 0.0 0.0 0.0 x x x x 1.333 x 0.5 x 0.0 x 0.0 0.0 0.0 0.0 x 0.833 x 0.0 0.0 0.5 x 0.0 0.0 0.909 1.917 x x 0.0 x 0.0 0.0 x x x 2.0 0.0 x x x 0.667 1.0 1.091 x x x 1.333 0.5 1.0 x 1.0 1.583 x 1.75 x 1.857 x 1.786 x x 1.7 x x 1.571 1.286 1.864 0.0 0.0 x 2.4 1.875 x 0.0 x x 1.0 0.0 0.857 1.036 2.167 0.0 0.0 1.0 1.5 +12321 Original post publication description: Eye, visual system: Iris pigmentation at 3-5 months in males and females None Eye, visual system: Iris pigmentation at 3-5 months in males and females [ordinal scale, 0=full pigmentation, 4=light, dispersed] 0.0 0.0 0.0 1.885 2.0 x 0.0 0.0 x 1.727 0.0 0.2 1.5 0.0 0.5 0.0 0.3 0.0 0.0 2.0 x x 0.857 x x 0.75 x 0.0 x 0.0 0.0 0.0 0.0 1.5 1.0 x 0.0 0.0 0.0 x 0.0 0.0 1.083 1.467 x x 0.0 x 0.0 x 0.0 x x 1.875 0.0 x x x 0.205 1.25 1.421 0.625 x 1.5 1.529 0.955 1.306 0.889 1.221 1.762 x 1.483 x 1.471 x 1.889 x x 1.732 x x 1.5 1.1 1.617 0.0 0.0 x 2.182 2.0 x 0.0 x x 1.0 0.0 1.0 1.5 x 0.0 0.0 1.0 1.667 +12324 Original post publication description: Eye, visual system: Iris pigmentation at 6-9 months, males and females [ordinal score, 0=normal, 3=light] None Eye, visual system: Iris pigmentation at 6-9 months, males and females [ordinal score, 0=normal, 4=light, dispersed] 0.0 0.0 0.0 2.455 2.0 0.0 0.0 0.0 0.0 2.0 0.0 0.167 1.5 0.0 0.5 0.0 0.125 0.0 0.0 2.0 0.0 x x 0.0 x 0.5 1.875 x x 0.0 0.0 0.0 0.0 x 1.5 x 0.0 0.0 0.0 x 0.0 0.0 1.83 2.0 x x 0.0 x 0.0 0.0 x x x 1.864 0.0 x x x 0.211 2.938 1.595 0.5 x x 1.816 1.0 1.75 0.397 1.078 1.773 x 1.139 x 1.452 x 2.125 x x 1.667 x x 1.667 1.583 2.0 0.0 0.0 x 2.154 2.0 x 0.0 x 0.0 1.846 0.0 1.0 2.287 2.5 0.0 0.0 1.0 2.0 +12327 Original post publication description: Eye, visual system: Iris pigmentation score at 10-13 months in males and females None Eye, visual system: Iris pigmentation score at 10-13 months in males and females [ordinal scale, 0=full pigmentation, 4=light, dispersed] 0.0 0.0 0.0 2.967 1.75 0.0 0.0 0.0 x 2.0 0.0 0.563 1.5 0.0 0.667 0.0 0.0 0.0 0.0 x x x x x x 0.5 x 0.0 x 0.0 0.0 0.0 0.0 x 1.5 x 0.0 0.0 0.0 x 0.0 0.0 2.824 0.0 x x 0.0 0.5 0.0 0.0 x x x 2.682 0.0 x x x 0.0 2.944 2.808 0.833 x 2.0 3.25 1.5 2.393 0.577 0.955 2.0 x 1.722 x 1.429 x 2.333 x x 1.85 x x 1.643 1.4 1.9 0.0 0.0 x 2.135 2.0 x 0.167 x x 2.306 0.0 1.6 2.917 2.5 0.0 0.125 1.0 1.694 +12330 Original post publication description: Eye, visual system, aging: Iris pigmentation score in old males and females (>13 months) None Eye, visual system, aging: Iris pigmentation score in old males and females (>13 months) [ordinal scale, 0=full pigmentation, 4=light, dispersed] x x 0.0 3.447 1.167 0.0 x x x 2.0 0.0 2.0 x x 0.812 0.0 0.068 0.0 0.0 x 0.0 x x 0.2 1.0 0.5 2.0 0.0 x 0.0 0.0 0.0 0.0 x x x 0.0 0.571 0.857 x 0.429 3.014 3.8 2.222 x x 0.0 0.0 0.0 0.889 x x x 2.778 0.5 x x x 0.375 3.675 3.0 0.666 x 2.15 4.0 2.0 3.0 0.906 1.0 1.5 x 1.6 x 1.333 x 3.5 x x 1.2 2.0 x 2.0 1.7 2.75 0.0 0.0 x 2.385 2.0 x 0.2 x x 3.533 0.0 1.6 3.8 2.75 0.0 0.4 1.1 2.111 +12333 Original post publication description: Eye, visual system: Iris pigmentation (all ages) [ordinal scale, 0=pigmented, 4=light] None Eye, visual system: Iris pigmentation (all ages) [ordinal scale, 0=pigmented, 4=light, dispersed] 0.0 0.0 0.0 2.439 1.619 0.0 0.0 0.0 0.0 1.667 0.0 0.64 1.579 0.0 0.621 0.0 0.092 0.0 0.0 2.0 0.0 x 0.823 0.142 1.0 0.581 1.917 0.0 x 0.0 0.0 0.0 0.0 1.5 1.26 x 0.0 0.095 0.276 x 0.13 0.334 1.865 1.729 x x 0.0 0.375 0.0 0.121 x x x 2.132 0.128 x x x 0.239 2.381 1.773 0.595 x 1.767 2.18 1.056 1.762 0.642 1.11 1.71 x 1.423 x 1.485 x 2.359 x x 1.686 2.0 x 1.62 1.328 1.825 0.0 0.0 x 2.246 1.969 x 0.086 x x 2.066 0.0 1.192 2.037 2.431 0.0 0.155 1.01 1.736 +12394 Original post publication description: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during 10 min [beam breaks/sec] None Central nervous system, behavior: Anxiety assay, ethanol treated [1.8 g/kg i.p] (NOE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during 10 min [beam breaks/sec] 0.438 0.596 0.764 0.976 0.296 0.366 0.989 0.345 0.427 2.886 0.71 0.247 0.733 x 0.532 0.302 x 0.48 0.565 0.344 x x x 1.539 0.462 0.359 0.88 x x 0.344 0.449 0.436 0.583 x 2.272 x 0.476 0.404 0.3 x 0.236 0.643 0.515 0.352 x x 0.507 0.342 0.302 0.402 x 0.786 x 0.83 0.624 x x x 0.638 0.411 0.914 x x 0.382 0.37 0.494 0.288 2.243 0.313 0.305 x 0.319 0.385 0.612 x 0.608 x x 0.324 0.532 x 0.307 0.509 0.775 0.628 0.505 x 5.397 0.305 x 1.418 x x 0.535 0.391 0.552 0.727 0.321 0.647 0.346 21.008 0.375 +12486 Original post publication description: Iron level in dorsal striatum (caudate-putamen) of 120-day-old females fed 3 ppm Fe diet [µg/g] None Iron level in dorsal striatum (caudate-putamen) of 120-day-old females fed 3 ppm Fe diet [µg/g] x x 9.4 8.9 11.4 14.3 x 11.6 12.3 11.7 13.6 9.6 11.5 9.7 x 11.3 11.4 11.6 x 12.6 x x x x x x 13.2 13.9 x 9.0 13.9 10.0 11.9 x x x 10.1 11.4 7.2 x 8.1 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12334 Original post publication description: Endocrinology, neuroendocrine system, morphology: Adrenal X-zone width in males [um] None Endocrinology, neuroendocrine system, morphology: Adrenal X-zone width in males [um] x x x x x x x x x x x x x x 19.25 38.52 12.064 x x x x x x x x x x x x x x 7.3 x x 27.892 x 36.83 x x x x x x x x x x x x 14.148 x x x x 20.99 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12403 Original post publication description: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during last 5 min [beam breaks/sec] None Central nervous system, behavior: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during last 5 min [beam breaks/sec] 0.67 0.665 0.663 0.605 0.472 0.888 1.103 0.734 0.9 0.566 0.99 0.555 1.006 x 0.613 0.644 x 0.546 x 1.076 1.264 x x 0.592 0.795 0.665 1.117 x x 0.833 0.554 0.799 0.523 x x x x 1.528 0.445 x 0.647 0.678 0.607 0.586 x x 0.683 0.649 0.751 0.566 x 0.727 x 0.51 0.531 x x x 0.578 0.827 0.774 x x 0.482 0.909 0.736 0.572 0.64 0.685 0.517 x 1.555 x 0.602 x 1.048 x x 0.652 0.685 x 0.624 0.749 0.654 0.84 0.714 x 0.49 0.491 x 0.532 x x 0.575 0.608 0.657 0.582 0.45 0.695 1.02 0.657 0.77 +12404 Original post publication description: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during 10 min [beam breaks/sec] None Central nervous system, behavior: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during 10 min [beam breaks/sec] 0.573 0.552 0.549 0.558 0.412 0.641 0.749 0.571 0.826 0.508 0.693 0.443 0.736 x 0.505 0.544 x 0.525 x 0.881 0.898 x x 0.573 0.575 0.719 0.924 x x 0.657 0.474 0.638 0.474 x x x x 1.106 0.453 x 0.536 0.597 0.502 0.491 x x 0.556 0.564 0.588 0.498 x 0.519 x 0.445 0.479 x x x 0.453 0.685 0.658 x x 0.429 0.823 0.592 0.546 0.537 0.565 0.499 x 0.795 x 0.47 x 0.737 x x 0.581 0.606 x 0.556 0.547 0.549 0.637 0.587 x 0.499 0.426 x 0.496 x x 0.458 0.508 0.477 0.456 0.436 0.596 0.68 0.512 0.615 +12405 Original post publication description: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), latency to enter an open quadrant using an elevated zero maze in 60 to 120-day-old males only [sec] None Central nervous system, behavior: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), latency to enter an open quadrant using an elevated zero maze in 60 to 120-day-old males only [sec] 8.317 10.1 7.24 8.3 5.833 2.267 7.1 3.257 10.043 19.333 4.125 17.9 10.6 x 0.4 2.68 x 6.625 10.6 13.017 x x x 27.283 x 4.0 32.714 x x 10.7 4.117 10.971 10.85 x 0.2 x 14.129 6.967 3.275 x 5.217 6.175 7.64 3.35 x x 12.4 11.9 4.867 15.567 x 19.1 x 8.543 18.525 x x x 6.35 2.333 4.383 x x 2.033 3.55 14.5 9.617 3.25 6.113 6.7 x 3.0 85.6 7.033 x 15.5 x x 2.317 5.55 x 5.2 6.583 8.167 3.733 6.033 x 2.2 2.967 x 6.167 x x 6.08 4.333 4.267 6.25 8.017 3.417 4.617 6.917 3.4 +12406 Original post publication description: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males only during first 5 min [percentage of time] None Central nervous system, behavior: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males only during first 5 min [percentage of time] 19.817 23.4 21.087 20.667 21.456 14.0 5.833 22.414 16.457 26.967 12.533 5.6 1.778 x 22.7 12.42 x 15.692 31.7 19.45 x x x 8.922 x 19.117 5.6 x x 14.956 29.939 17.51 25.583 x 4.633 x 3.333 28.089 35.542 x 38.989 27.925 28.173 11.389 x x 31.817 5.004 32.294 29.911 x 3.944 x 29.133 8.425 x x x 30.528 23.844 41.244 x x 23.406 37.867 14.219 33.672 25.467 26.142 17.894 x 14.65 1.533 27.472 x 12.144 x x 19.161 32.775 x 26.644 29.05 21.672 12.628 30.85 x 15.883 28.411 x 20.511 x x 22.613 24.978 14.267 23.678 31.083 16.872 27.694 38.983 15.478 +12407 Original post publication description: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males only during last 5 min [percentage of time] None Central nervous system, behavior: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males only during last 5 min [percentage of time] 14.783 16.344 26.86 21.8 22.017 4.433 0.683 20.376 19.819 23.533 9.067 2.033 7.389 x 15.667 10.827 x 20.592 5.833 27.006 x x x 3.694 x 23.25 5.876 x x 15.489 22.528 13.071 22.289 x 4.133 x 5.543 12.111 34.817 x 36.633 26.013 30.393 6.967 x x 16.4 5.081 29.594 26.711 x 3.478 x 30.6 2.7 x x x 37.278 10.956 36.044 x x 12.422 24.733 18.824 34.828 26.139 21.758 25.0 x 5.833 39.033 24.139 x 24.367 x x 16.183 25.025 x 23.522 34.567 25.267 15.583 25.856 x 22.633 26.394 x 15.117 x x 27.687 18.911 11.694 18.806 31.722 11.094 23.772 37.172 11.233 +12408 Original post publication description: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males only during 10 min [percentage of time] None Central nervous system, behavior: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males only during 10 min [percentage of time] 17.3 19.872 23.973 21.233 21.736 9.217 3.258 21.395 18.138 25.25 10.8 3.817 4.583 x 19.183 11.623 x 18.142 18.767 23.228 x x x 6.308 x 21.183 5.738 x x 15.222 26.233 15.29 23.936 x 4.383 x 4.438 20.1 35.179 x 37.811 26.969 29.283 9.178 x x 24.108 5.043 30.944 28.311 x 3.711 x 29.867 5.562 x x x 33.903 17.4 38.644 x x 17.914 31.3 16.521 34.25 25.803 23.95 21.447 x 10.242 20.283 25.806 x 18.256 x x 17.672 28.9 x 25.083 31.808 23.469 14.106 28.353 x 19.258 27.403 x 17.814 x x 25.15 21.944 12.981 21.242 31.403 13.983 25.733 38.078 13.356 +12409 Original post publication description: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during first 5 min [n beam breaks] None Central nervous system, behavior: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during first 5 min [n beam breaks] 572.67 483.33 580.6 616.0 641.5 559.67 445.0 597.43 495.29 487.33 407.0 555.0 408.0 x 391.0 568.6 x 507.75 463.0 457.33 x x x 415.83 x 455.5 412.43 x x 556.33 584.0 404.29 460.83 x 551.0 x 550.71 446.33 563.25 x 584.83 465.62 489.2 639.33 x x 484.5 479.22 398.17 461.0 x 431.67 x 646.57 571.75 x x x 477.17 540.83 392.67 x x 471.83 378.83 506.57 476.5 597.33 550.13 575.33 x 503.83 415.0 512.17 x 526.33 x x 491.83 411.25 x 459.67 474.0 575.67 484.17 480.33 x 369.25 523.5 x 418.33 x x 599.8 566.83 726.33 532.0 458.0 493.67 455.5 400.33 500.17 +12410 Original post publication description: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during last 5 min [n beam breaks] None Central nervous system, behavior: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during last 5 min [n beam breaks] 456.33 351.33 515.8 368.0 529.17 381.0 216.5 444.29 299.14 455.5 374.0 406.0 349.33 x 385.0 401.8 x 453.0 442.0 340.83 x x x 373.67 x 363.5 379.43 x x 460.5 405.67 283.86 359.17 x 329.0 x 411.43 315.67 443.75 x 424.83 397.63 384.8 409.83 x x 472.0 367.0 268.33 353.67 x 254.0 x 478.57 451.25 x x x 388.67 407.17 377.17 x x 489.0 317.33 377.14 365.17 488.5 452.88 566.67 x 392.33 184.0 502.67 x 481.67 x x 376.67 336.0 x 412.83 352.0 508.5 422.83 400.33 x 371.75 452.33 x 362.33 x x 468.0 441.5 536.0 393.83 353.33 391.17 398.17 252.83 426.67 +12411 Original post publication description: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during 10 min [n beam breaks] None Central nervous system, behavior: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during 10 min [n beam breaks] 1029.0 834.67 1096.4 984.0 1170.67 940.67 661.5 1041.71 794.43 942.83 781.0 961.0 757.33 x 776.0 970.4 x 960.75 905.0 798.17 x x x 789.5 x 819.0 791.86 x x 1016.83 989.67 688.14 820.0 x 880.0 x 962.14 762.0 1007.0 x 1009.67 863.25 874.0 1049.17 x x 956.5 846.22 666.5 814.67 x 685.67 x 1125.14 1023.0 x x x 865.83 948.0 769.83 x x 960.83 696.17 883.71 841.67 1085.83 1003.0 1142.0 x 896.17 599.0 1014.83 x 1008.0 x x 868.5 747.25 x 872.5 826.0 1084.17 907.0 880.67 x 741.0 975.83 x 780.67 x x 1067.8 1008.33 1262.33 925.83 811.33 884.83 853.67 653.17 926.83 +12412 Original post publication description: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during first 5 min [beam breaks/sec] None Central nervous system, behavior: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during first 5 min [beam breaks/sec] 0.425 0.498 0.42 0.386 0.38 0.469 0.638 0.401 0.524 0.446 0.65 0.51 0.731 x 0.593 0.478 x 0.5 0.443 0.596 x x x 1.016 x 0.552 0.788 x x 0.478 0.361 0.63 0.495 x 0.519 x 0.643 0.488 0.348 x 0.314 0.48 0.443 0.426 x x 0.422 0.606 0.509 0.464 x 0.704 x 0.336 0.517 x x x 0.472 0.43 0.432 x x 0.605 0.499 0.576 0.418 0.382 0.432 0.441 x 0.663 0.712 0.435 x 0.533 x x 0.508 0.504 x 0.497 0.447 0.415 0.601 0.451 x 0.741 0.418 x 0.632 x x 0.387 0.416 0.361 0.443 0.475 0.532 0.5 0.478 0.519 +12413 Original post publication description: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during last 5 min [beam breaks/sec] None Central nervous system, behavior: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during last 5 min [beam breaks/sec] 0.623 0.798 0.429 0.637 0.461 0.851 1.43 0.563 0.837 0.521 0.735 0.724 0.823 x 0.657 0.781 x 0.535 0.639 0.678 x x x 0.95 x 0.635 0.818 x x 0.593 0.577 0.974 0.693 x 0.874 x 0.953 0.911 0.447 x 0.449 0.563 0.552 0.716 x x 0.565 0.807 0.848 0.636 x 1.255 x 0.443 0.733 x x x 0.492 0.674 0.57 x x 0.545 0.746 0.95 0.556 0.473 0.595 0.402 x 0.892 0.994 0.461 x 0.475 x x 0.698 0.671 x 0.571 0.627 0.455 0.794 0.573 x 0.656 0.491 x 0.762 x x 0.478 0.616 0.543 0.656 0.639 0.71 0.611 0.911 0.706 +12414 Original post publication description: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during 10 min [beam breaks/sec] None Central nervous system, behavior: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during 10 min [beam breaks/sec] 0.499 0.611 0.422 0.48 0.411 0.604 0.889 0.464 0.633 0.477 0.69 0.601 0.762 x 0.625 0.586 x 0.515 0.539 0.636 x x x 0.746 x 0.581 0.793 x x 0.528 0.447 0.755 0.572 x 0.652 x 0.755 0.638 0.391 x 0.371 0.516 0.49 0.533 x x 0.483 0.691 0.628 0.535 x 0.895 x 0.381 0.59 x x x 0.469 0.535 0.461 x x 0.52 0.599 0.686 0.474 0.421 0.498 0.421 x 0.761 0.798 0.447 x 0.503 x x 0.585 0.58 x 0.529 0.5 0.432 0.67 0.503 x 0.673 0.45 x 0.69 x x 0.425 0.495 0.431 0.531 0.531 0.611 0.546 0.59 0.592 +12415 Original post publication description: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), latency to enter an open quadrant using an elevated zero maze in 60 to 120-day-old males and females [sec] None Central nervous system, behavior: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), latency to enter an open quadrant using an elevated zero maze in 60 to 120-day-old males and females [sec] 6.7 9.415 5.857 6.75 4.542 1.3 6.8 2.8 13.315 13.236 5.32 4.0 8.811 x 20.333 4.012 x 3.76 10.6 13.178 12.25 x x 24.029 3.5 4.688 28.88 x x 9.858 3.938 7.65 9.742 x 0.2 x 14.129 6.243 11.3 x 3.621 4.883 6.663 4.5 x x 6.9 10.931 5.314 10.83 x 11.164 x 10.123 15.09 x x x 5.083 4.564 4.121 x x 4.385 3.767 12.636 5.975 4.331 5.779 6.7 x 3.638 85.6 7.25 x 10.225 x x 2.2 5.744 x 6.917 5.1 8.9 4.15 3.642 x 17.31 2.75 x 7.217 x x 5.086 4.433 5.083 8.442 5.575 2.925 3.167 5.258 5.6 +12416 Original post publication description: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males and females during first 5 min [percentage of time] None Central nervous system, behavior: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males and females during first 5 min [percentage of time] 18.361 24.79 20.981 19.211 29.875 18.263 8.407 16.253 15.049 27.245 14.86 19.471 4.059 x 11.256 18.192 x 14.727 31.7 14.611 9.633 x x 10.062 32.078 17.342 5.607 x x 14.997 29.826 19.386 34.581 x 4.633 x 3.333 14.414 31.967 x 38.24 26.558 27.492 14.26 x x 31.8 11.877 38.783 29.477 x 14.55 x 29.697 14.763 x x x 31.889 24.942 30.407 x x 24.467 33.553 11.662 33.472 28.69 27.771 23.4 x 15.726 1.533 32.625 x 24.662 x x 18.358 28.163 x 23.411 27.503 21.264 15.075 26.792 x 20.58 32.183 x 24.381 x x 26.119 24.831 15.906 17.439 32.972 19.133 25.711 32.933 16.082 +12417 Original post publication description: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males and females during last 5 min [percentage of time] None Central nervous system, behavior: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males and females during last 5 min [percentage of time] 16.422 17.105 23.848 20.461 29.339 6.212 2.673 16.425 17.956 24.282 11.8 15.786 4.833 x 8.839 15.679 x 17.083 5.833 19.863 7.233 x x 6.567 18.267 26.275 7.73 x x 14.297 21.879 11.544 30.492 x 4.133 x 5.543 5.9 29.619 x 35.219 27.108 28.542 9.693 x x 19.573 8.777 37.119 23.873 x 15.205 x 28.513 13.423 x x x 34.222 13.258 27.386 x x 16.887 19.697 14.267 32.883 25.995 22.379 28.067 x 9.051 39.033 28.9 x 23.975 x x 13.0 25.381 x 19.894 27.977 21.067 14.786 25.311 x 30.57 27.922 x 18.058 x x 25.819 18.45 14.133 13.172 35.039 13.364 21.833 31.542 10.282 +12418 Original post publication description: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males and females during 10 min [percentage of time] None Central nervous system, behavior: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males and females during 10 min [percentage of time] 17.392 20.947 22.414 19.836 29.607 12.238 5.54 16.339 16.503 25.764 13.33 17.629 4.446 x 10.047 16.935 x 15.905 18.767 17.237 8.433 x x 8.314 25.172 21.808 6.668 x x 14.647 25.853 15.465 32.536 x 4.383 x 4.438 10.157 30.793 x 36.73 26.833 28.017 11.977 x x 25.687 10.327 37.951 26.675 x 14.877 x 29.105 14.093 x x x 33.056 19.1 28.896 x x 20.677 26.625 12.964 33.178 27.342 25.075 25.733 x 12.389 20.283 30.762 x 24.319 x x 15.679 26.772 x 21.653 27.74 21.165 14.931 26.051 x 25.575 30.053 x 21.219 x x 25.969 21.64 15.019 15.306 34.006 16.249 23.772 32.237 13.182 +12419 Original post publication description: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during first 5 min [n beam breaks] None Central nervous system, behavior: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during first 5 min [n beam breaks] 542.33 480.31 562.71 501.17 577.75 510.75 443.2 587.67 444.62 480.18 451.4 645.0 458.0 x 603.17 528.25 x 513.5 463.0 442.89 401.75 x x 420.43 482.67 396.63 402.2 x x 512.58 555.62 435.42 428.5 x 551.0 x 550.71 388.43 526.86 x 499.79 455.92 506.5 616.7 x x 469.8 490.44 374.29 477.1 x 501.29 x 594.46 553.8 x x x 511.42 466.09 401.43 x x 535.15 330.83 532.5 449.75 532.15 499.43 518.5 x 485.31 415.0 498.25 x 453.88 x x 484.5 411.22 x 462.42 485.92 555.92 487.25 472.58 x 429.6 521.25 x 442.25 x x 575.86 546.42 677.33 631.17 463.92 471.92 476.33 456.75 517.0 +12420 Original post publication description: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during last 5 min [n beam breaks] None Central nervous system, behavior: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during last 5 min [n beam breaks] 415.83 374.15 476.86 415.0 469.25 347.5 275.4 440.0 298.46 431.55 338.0 445.71 327.67 x 449.83 378.88 x 466.6 442.0 322.33 239.0 x x 375.43 308.0 339.0 340.0 x x 393.42 421.15 325.33 359.83 x 329.0 x 411.43 254.71 478.0 x 367.14 369.83 384.38 422.4 x x 400.6 386.25 255.43 394.7 x 308.07 x 464.08 465.4 x x x 377.67 367.27 343.79 x x 494.23 305.92 374.14 382.83 425.38 416.36 513.0 x 379.54 184.0 419.92 x 374.63 x x 407.92 332.78 x 418.92 343.31 460.0 385.75 366.5 x 386.9 445.58 x 404.33 x x 435.0 428.5 487.17 451.0 383.58 386.58 355.78 311.25 399.08 +12421 Original post publication description: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during 10 min [n beam breaks] None Central nervous system, behavior: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during 10 min [n beam breaks] 958.17 854.46 1039.57 916.17 1047.0 858.25 718.6 1027.67 743.08 911.73 789.4 1090.71 785.67 x 1053.0 907.13 x 980.1 905.0 765.22 640.75 x x 795.86 790.67 735.63 742.2 x x 906.0 976.77 760.75 788.33 x 880.0 x 962.14 643.14 1004.86 x 866.93 825.75 890.88 1039.1 x x 870.4 876.69 629.71 871.8 x 809.36 x 1058.54 1019.2 x x x 889.08 833.36 745.21 x x 1029.38 636.75 906.64 832.58 957.54 915.79 1031.5 x 864.85 599.0 918.17 x 828.5 x x 892.42 744.0 x 881.33 829.23 1015.92 873.0 839.08 x 816.5 966.83 x 846.58 x x 1010.86 974.92 1164.5 1082.17 847.5 858.5 832.11 768.0 916.08 +12422 Original post publication description: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during first 5 min [beam breaks/sec] None Central nervous system, behavior: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during first 5 min [beam breaks/sec] 0.463 0.483 0.433 0.526 0.373 0.485 0.627 0.439 0.646 0.456 0.589 0.388 0.649 x 0.456 0.473 x 0.505 0.443 0.655 0.696 x x 0.951 0.436 0.723 0.791 x x 0.511 0.387 0.585 0.567 x 0.519 x 0.643 0.711 0.409 x 0.396 0.501 0.437 0.425 x x 0.439 0.559 0.497 0.449 x 0.543 x 0.364 0.478 x x x 0.422 0.503 0.521 x x 0.488 0.629 0.54 0.48 0.423 0.459 0.459 x 0.645 0.712 0.41 x 0.536 x x 0.516 0.533 x 0.507 0.447 0.441 0.566 0.48 x 0.623 0.395 x 0.555 x x 0.387 0.425 0.378 0.411 0.45 0.529 0.499 0.454 0.517 +12423 Original post publication description: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during last 5 min [beam breaks/sec] None Central nervous system, behavior: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during last 5 min [beam breaks/sec] 0.647 0.726 0.496 0.61 0.466 0.874 1.234 0.634 0.866 0.542 0.888 0.579 0.945 x 0.621 0.73 x 0.541 0.639 0.811 1.264 x x 0.899 0.795 0.657 0.908 x x 0.713 0.565 0.901 0.608 x 0.874 x 0.953 1.264 0.446 x 0.562 0.601 0.572 0.664 x x 0.636 0.738 0.793 0.587 x 0.953 x 0.474 0.612 x x x 0.535 0.744 0.686 x x 0.511 0.827 0.843 0.564 0.563 0.633 0.448 x 1.249 0.994 0.532 x 0.833 x x 0.675 0.679 x 0.598 0.693 0.555 0.817 0.643 x 0.557 0.491 x 0.647 x x 0.541 0.612 0.6 0.619 0.545 0.702 0.747 0.784 0.74 +12424 Original post publication description: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during 10 min [beam breaks/sec] None Central nervous system, behavior: Anxiety assay, saline treated [0.18 ml/kg i.p.] (NOS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during 10 min [beam breaks/sec] 0.536 0.579 0.458 0.545 0.412 0.627 0.805 0.509 0.722 0.492 0.692 0.465 0.744 x 0.525 0.57 x 0.521 0.539 0.717 0.898 x x 0.721 0.575 0.685 0.832 x x 0.592 0.462 0.707 0.523 x 0.652 x 0.755 0.906 0.418 x 0.465 0.543 0.494 0.516 x x 0.526 0.636 0.605 0.509 x 0.68 x 0.41 0.524 x x x 0.461 0.603 0.574 x x 0.471 0.711 0.639 0.51 0.484 0.527 0.452 x 0.779 0.798 0.458 x 0.649 x x 0.583 0.595 x 0.543 0.525 0.49 0.653 0.545 x 0.569 0.438 x 0.593 x x 0.446 0.502 0.454 0.493 0.484 0.603 0.591 0.551 0.605 +12425 Original post publication description: Anxiety assay, restraint stress [15 min] + ethanol treated [1.8 g/kg i.p.] (RSE group), latency to enter an open quadrant using an elevated zero maze in 60 to 120-day-old females only [sec] None Central nervous system, behavior: Anxiety assay, restraint stress (15 min) and ethanol (1.8 g/kg ip) (RSE group), latency to enter an open quadrant using an elevated zero maze in 60 to 120-day-old females only [sec] 8.433 1.467 11.517 7.467 14.1 7.533 34.8 15.267 x 36.02 3.8 3.45 3.85 x 12.1 0.7 x 26.2 x 0.2 x x x x x 12.8 x 6.333 x x 2.15 9.0 4.914 x x x x 5.467 5.87 x 2.071 20.85 21.66 1.111 x x 5.333 14.0 1.938 10.8 x x x 8.1 2.275 x x x 13.225 5.983 7.15 x x 15.0 6.617 43.8 4.683 7.583 9.217 2.3 x 5.862 x 5.417 x 7.488 x x 4.343 5.7 x 2.514 2.083 25.675 3.8 6.788 x 31.875 19.4 x 15.4 x x 4.183 9.567 1.6 11.314 1.575 5.189 1.3 4.3 5.683 +12426 Original post publication description: Anxiety assay, restraint stress [15 min] + ethanol treated [1.8 g/kg i.p.] (RSE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old females only during first 5 min [percentage of time] None Central nervous system, behavior: Anxiety assay, restraint stress (15 min) and ethanol (1.8 g/kg ip) (RSE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old females only during first 5 min [% time] 36.889 47.372 42.378 31.844 40.733 54.956 61.633 35.467 x 11.533 41.878 46.333 26.817 x 28.567 50.033 x 39.967 x 44.033 x x x x x 20.333 x 51.167 x x 49.539 29.7 57.114 x x x x 34.844 47.057 x 52.657 54.867 33.387 56.656 x x 50.2 17.383 58.0 28.181 x x x 36.5 23.817 x x x 42.983 55.328 53.95 x x 42.35 44.967 6.8 43.089 66.839 58.378 43.483 x 60.95 x 36.978 x 20.054 x x 49.49 61.467 x 31.39 39.739 20.667 34.867 33.708 x 41.996 50.289 x 36.539 x x 42.45 31.589 38.25 35.019 56.65 40.359 30.733 32.863 66.744 +12427 Original post publication description: Anxiety assay, restraint stress [15 min] + ethanol treated [1.8 g/kg i.p.] (RSE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old females only during last 5 min [percentage of time] None Central nervous system, behavior: Anxiety assay, restraint stress (15 min) and ethanol (1.8 g/kg ip) (RSE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old females only during last 5 min [% time] 24.1 30.372 30.861 25.761 29.05 27.8 2.433 26.078 x 9.2 14.611 42.117 17.15 x 24.633 26.333 x 31.367 x 15.367 x x x x x 17.467 x 42.578 x x 45.306 14.933 43.852 x x x x 14.511 31.927 x 41.805 31.667 30.507 44.07 x x 38.967 10.733 56.759 27.993 x x x 20.967 25.483 x x x 33.008 32.539 36.717 x x 32.722 38.906 6.833 34.65 50.356 63.633 39.689 x 39.642 x 30.217 x 10.763 x x 48.429 70.017 x 24.824 23.544 17.642 19.833 29.688 x 50.919 47.05 x 32.661 x x 33.589 26.5 29.567 21.7 40.55 17.896 21.967 26.497 50.933 +12428 Original post publication description: Anxiety assay, restraint stress [15 min] + ethanol treated [1.8 g/kg i.p.] (RSE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old females only during 10 min [percentage of time] None Central nervous system, behavior: Anxiety assay, restraint stress (15 min) and ethanol (1.8 g/kg ip) (RSE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old females only during 10 min [percentage of time] 30.494 38.872 36.619 28.803 34.892 41.378 32.033 30.772 x 10.367 28.244 44.225 21.983 x 26.6 38.183 x 35.667 x 29.7 x x x x x 18.9 x 46.872 x x 47.422 22.317 50.483 x x x x 24.678 39.492 x 47.231 43.267 31.947 50.363 x x 44.583 14.058 57.38 28.087 x x x 28.733 24.65 x x x 37.996 43.933 45.333 x x 37.536 41.936 6.817 38.869 58.597 61.006 41.586 x 50.296 x 33.597 x 15.408 x x 48.959 65.742 x 28.107 31.642 19.154 27.35 31.698 x 46.457 48.669 x 34.6 x x 38.019 29.044 33.908 28.36 48.6 29.128 26.35 29.68 58.839 +12429 Original post publication description: Anxiety assay, restraint stress [15 min] + ethanol treated [1.8 g/kg i.p.] (RSE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during first 5 min [n beam breaks] None Anxiety assay, restraint stress (15 min) and ethanol (1.8 g/kg ip) (RSE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during first 5 min [n beam breaks] 689.33 603.0 383.17 679.0 618.5 571.67 141.0 631.33 x 396.83 473.67 700.5 484.5 x 631.0 699.0 x 568.0 x 711.0 x x x x x 562.0 x 706.33 x x 828.0 864.0 409.0 x x x x 546.67 457.4 x 739.86 324.88 500.8 619.78 x x 612.67 631.0 550.54 586.78 x x x 663.25 477.25 x x x 498.0 371.83 334.25 x x 518.0 517.0 385.0 702.17 213.17 396.33 689.67 x 418.13 x 526.0 x 523.88 x x 732.43 198.5 x 614.71 487.5 738.5 256.75 235.5 x 272.44 569.67 x 679.0 x x 720.0 653.83 299.0 570.86 459.25 453.44 326.0 385.9 458.0 +12430 Original post publication description: Anxiety assay, restraint stress [15 min] + ethanol treated [1.8 g/kg i.p.] (RSE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during last 5 min [n beam breaks] None Central nervous system, behavior: Anxiety assay, restraint stress (15 min) and ethanol (1.8 g/kg ip) (RSE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during last 5 min [n beam breaks] 601.33 581.0 312.17 664.83 734.0 694.0 65.0 621.33 x 227.5 349.33 652.0 442.0 x 576.0 715.0 x 667.0 x 882.0 x x x x x 512.0 x 605.0 x x 725.67 722.0 364.0 x x x x 474.33 473.2 x 750.0 421.5 410.0 542.0 x x 476.0 423.5 400.77 512.89 x x x 523.0 431.5 x x x 523.25 513.17 458.5 x x 515.5 461.67 435.0 786.17 315.67 309.83 650.67 x 656.63 x 580.0 x 456.38 x x 763.71 204.0 x 453.14 382.67 640.75 398.0 247.13 x 356.78 665.67 x 644.17 x x 585.67 602.67 623.0 582.14 449.0 409.67 421.5 244.0 683.83 +12431 Original post publication description: Anxiety assay, restraint stress [15 min] + ethanol treated [1.8 g/kg i.p.] (RSE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during 10 min [n beam breaks] None Central nervous system, behavior: Anxiety assay, restraint stress (15 min) followed by ethanol (1.8 g/kg ip) (RSE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during 10 min [n beam breaks] 1290.67 1184.0 695.33 1343.83 1352.5 1265.67 206.0 1252.67 x 624.33 823.0 1352.5 926.5 x 1207.0 1414.0 x 1235.0 x 1593.0 x x x x x 1074.0 x 1311.33 x x 1553.67 1586.0 773.0 x x x x 1021.0 930.6 x 1489.86 746.38 910.8 1161.78 x x 1088.67 1054.5 951.31 1099.67 x x x 1186.25 908.75 x x x 1021.25 885.0 792.75 x x 1033.5 978.67 820.0 1488.33 528.83 706.17 1340.33 x 1074.75 x 1106.0 x 980.25 x x 1496.14 402.5 x 1067.86 870.17 1379.25 654.75 482.63 x 629.22 1235.33 x 1323.17 x x 1305.67 1256.5 922.0 1153.0 908.25 863.11 747.5 629.9 1141.83 +12432 Original post publication description: Anxiety assay, restraint stress [15 min] + ethanol treated [1.8 g/kg i.p.] (RSE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during first 5 min [beam breaks/sec] None Anxiety assay, restraint stress (15 min) followed by ethanol (1.8 g/kg ip)(RSE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during first 5 min [n beam breaks/sec] 0.286 0.27 0.48 0.333 0.329 0.243 0.816 0.336 x 0.878 0.412 0.231 0.464 x 0.34 0.214 x 0.317 x 0.236 x x x x x 0.425 x 0.21 x x 0.188 0.244 0.471 x x x x 0.362 0.518 x 0.193 0.58 0.483 0.199 x x 0.249 0.396 0.225 0.397 x x x 0.31 0.514 x x x 0.341 0.561 0.498 x x 0.405 0.359 0.726 0.248 0.493 0.375 0.272 x 0.358 x 0.464 x 0.489 x x 0.206 0.543 x 0.346 0.435 0.328 0.918 1.167 x 5.329 0.298 x 0.325 x x 0.254 0.342 0.665 0.482 0.303 0.426 1.512 0.559 0.231 +12433 Original post publication description: Anxiety assay, restraint stress [15 min] + ethanol treated [1.8 g/kg i.p.] (RSE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during last 5 min [beam breaks/sec] None Central nervous system, behavior: Anxiety assay, restraint stress (15 min) and ethanol (1.8 g/kg ip) (RSE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during last 5 min [beam breaks/sec] 0.384 0.367 0.774 0.392 0.363 0.348 4.503 0.39 x 1.751 0.762 0.265 0.561 x 0.393 0.309 x 0.309 x 0.288 x x x x x 0.484 x 0.285 x x 0.235 0.353 0.528 x x x x 0.588 0.373 x 0.238 0.561 0.537 0.354 x x 0.478 0.648 0.335 0.51 x x x 0.68 0.534 x x x 0.388 0.418 0.417 x x 0.433 0.391 0.643 0.263 0.56 0.382 0.339 x 0.294 x 0.419 x 0.657 x x 0.204 0.592 x 0.613 0.637 0.417 0.635 2.664 x 2.237 0.25 x 0.314 x x 0.368 0.406 0.34 0.848 0.435 0.711 0.551 0.964 0.217 +12434 Original post publication description: Anxiety assay, restraint stress [15 min] + ethanol treated [1.8 g/kg ip] (RSE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females over 10 min [beam breaks/sec] None Central nervous system, behavior: Anxiety assay, restraint stress [15 min] + ethanol treated [1.8 g/kg ip] (RSE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females over 10 min [beam breaks/sec] 0.331 0.317 0.588 0.354 0.346 0.299 1.98 0.361 x 1.024 0.552 0.247 0.507 x 0.365 0.262 x 0.313 x 0.265 x x x x x 0.453 x 0.245 x x 0.209 0.294 0.481 x x x x 0.448 0.5 x 0.215 0.537 0.484 0.247 x x 0.331 0.496 0.258 0.44 x x x 0.439 0.516 x x x 0.362 0.418 0.435 x x 0.384 0.354 0.682 0.255 0.527 0.388 0.296 x 0.305 x 0.423 x 0.561 x x 0.205 0.554 x 0.43 0.512 0.366 0.728 1.204 x 2.349 0.265 x 0.303 x x 0.302 0.369 0.431 0.629 0.374 0.555 0.668 0.788 0.222 +12435 Original post publication description: Anxiety assay, restraint stress [15 min] + ethanol treated [1.8 g/kg i.p.] (RSE group), latency to enter an open quadrant using an elevated zero maze in 60 to 120-day-old males only [sec] None Central nervous system, behavior: Anxiety assay, restraint stress (15 min) and ethanol (1.8 g/kg ip) (RSE group), latency to enter an open quadrant using an elevated zero maze in 60 to 120-day-old males only [sec] 13.1 14.32 10.856 4.25 8.933 1.1 69.4 6.067 7.9 10.9 96.533 3.3 x x 6.3 8.75 x 11.2 1.5 4.067 x x x x x x 17.85 x x 0.85 5.022 3.05 8.367 x 0.5 x 6.1 2.488 2.133 x 6.833 5.425 12.533 5.35 x x 13.55 39.8 1.767 9.475 x x x 8.85 4.425 x x x 5.283 20.35 3.9 x x 11.5 30.486 x 3.433 15.667 12.4 4.3 x 9.117 5.8 10.167 x 17.5 x 3.05 7.733 x x 6.4 8.717 13.563 2.863 21.325 x 4.733 1.467 x 4.029 x x 4.6 10.05 5.78 3.433 6.733 9.729 8.0 7.788 2.283 +12436 Original post publication description: Anxiety assay, restraint stress [15 min] + ethanol treated [1.8 g/kg i.p.] (RSE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males only during first 5 min [percentage of time] None Central nervous system, behavior: Anxiety assay, restraint stress (15 min) and ethanol (1.8 g/kg ip) (RSE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males only during first 5 min [% time] x 55.987 33.133 41.025 30.067 17.3 41.567 42.061 50.3 x 32.522 39.733 x x 51.833 80.083 x 44.6 24.867 39.256 x x x x x x 6.433 x x 46.167 51.511 62.067 42.717 x 45.767 x 62.8 46.892 53.883 x 52.922 65.9 36.928 36.839 x x 49.95 20.433 59.83 56.412 x x x 51.528 23.417 x x x 40.456 54.267 47.333 x x 16.028 43.276 x 44.25 71.061 53.0 60.583 x 52.533 50.433 55.45 x 37.52 x 57.767 41.006 x x 31.61 48.711 32.733 42.9 33.608 x 45.45 42.994 x 35.305 x x 50.767 44.467 33.447 45.867 62.889 34.905 50.142 31.73 40.783 +12437 Original post publication description: Anxiety assay, restraint stress [15 min] + ethanol treated [1.8 g/kg i.p.] (RSE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males only during last 5 min [percentage of time] None Central nervous system, behavior: Anxiety assay, restraint stress (15 min) and ethanol (1.8 g/kg ip) (RSE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males only during last 5 min [% time] 0.533 43.24 15.293 16.583 33.378 1.467 35.233 24.633 35.833 11.433 51.378 30.767 x x 31.8 37.633 x 49.167 25.267 37.156 x x x x x x 5.35 x x 35.133 44.27 59.9 38.55 x 24.533 x 49.133 23.146 47.761 x 59.2 47.65 28.65 34.589 x x 43.35 12.35 64.859 50.7 x x x 38.378 14.725 x x x 27.272 19.783 18.49 x x 9.056 43.376 x 40.889 52.272 60.083 50.633 x 50.672 32.333 35.983 x 14.12 x 45.067 22.178 x x 19.69 25.367 30.083 47.125 39.767 x 50.289 36.183 x 20.476 x x 24.767 22.533 26.3 34.628 61.933 8.681 23.933 42.077 30.639 +12438 Original post publication description: Anxiety assay, restraint stress [15 min] + ethanol treated [1.8 g/kg i.p.] (RSE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males only during 10 min [percentage of time] None Central nervous system, behavior: Anxiety assay, restraint stress (15 min) and ethanol (1.8 g/kg ip) (RSE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males only during 10 min [% time] 1.717 49.613 24.213 28.804 31.722 9.383 38.4 33.347 43.067 6.683 41.95 35.25 x x 41.817 58.858 x 46.883 25.067 38.206 x x x x x x 5.892 x x 40.65 47.891 60.983 40.633 x 35.15 x 55.967 35.019 50.822 x 56.061 56.775 32.789 35.714 x x 46.65 16.392 62.344 53.556 x x x 44.953 19.071 x x x 33.864 37.025 32.912 x x 12.542 43.326 x 42.569 61.667 56.542 55.608 x 51.603 41.383 45.717 x 25.82 x 51.417 31.592 x x 25.65 37.039 31.408 45.013 36.688 x 47.869 39.589 x 27.89 x x 37.767 33.5 29.873 40.247 62.411 21.793 37.038 36.903 35.711 +12439 Original post publication description: Anxiety assay, restraint stress [15 min] + ethanol treated [1.8 g/kg i.p.] (RSE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during first 5 min [n beam breaks] None Central nervous system, behavior: Anxiety assay, restraint stress (15 min) and ethanol (1.8 g/kg ip) (RSE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during first 5 min [n beam breaks] 561.0 549.6 493.44 684.5 936.67 546.0 262.0 532.67 615.0 98.0 381.67 739.0 x x 365.0 288.5 x 903.0 400.0 844.33 x x x x x x 471.5 x x 386.5 703.22 364.0 590.5 x 400.0 x 320.0 508.63 488.5 x 742.67 295.25 523.67 807.0 x x 586.5 607.5 355.89 400.75 x x x 312.83 542.5 x x x 480.5 394.5 400.43 x x 341.17 499.0 x 806.83 143.17 523.63 534.25 x 431.83 375.0 423.17 x 300.6 x 415.5 555.0 x x 626.43 496.5 522.25 337.0 372.0 x 331.5 591.17 x 674.43 x x 537.25 651.67 577.0 439.17 415.0 433.43 482.25 413.8 695.5 +12440 Original post publication description: Anxiety assay, restraint stress [15 min] + ethanol treated [1.8 g/kg i.p.] (RSE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during last 5 min [n beam breaks] None Central nervous system, behavior: Anxiety assay, restraint stress (15 min) and ethanol (1.8 g/kg ip) (RSE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during last 5 min [n beam breaks] 313.0 471.2 446.44 495.75 822.33 467.0 114.0 475.5 566.0 154.0 266.33 783.0 x x 298.0 640.0 x 971.0 408.0 727.0 x x x x x x 354.0 x x 533.0 624.22 510.0 562.0 x 564.0 x 467.0 393.75 502.5 x 463.33 324.0 460.67 695.33 x x 504.5 443.5 328.67 394.88 x x x 287.83 604.25 x x x 510.5 498.17 443.29 x x 422.67 505.0 x 783.17 205.17 319.63 599.0 x 460.33 478.0 599.67 x 209.0 x 771.5 635.0 x x 505.43 590.0 588.13 303.13 337.0 x 407.67 622.0 x 696.0 x x 487.75 664.83 497.6 527.67 540.33 416.43 509.25 267.4 608.83 +12441 Original post publication description: Anxiety assay, restraint stress [15 min] + ethanol treated [1.8 g/kg i.p.] (RSE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during 10 min [n beam breaks] None Anxiety assay, restraint stress (15 min) and ethanol (1.8 g/kg ip) (RSE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during 10 min [n beam breaks] 874.0 1020.8 939.89 1180.25 1759.0 1013.0 376.0 1008.17 1181.0 252.0 648.0 1522.0 x x 663.0 928.5 x 1874.0 808.0 1571.33 x x x x x x 825.5 x x 919.5 1327.44 874.0 1152.5 x 964.0 x 787.0 902.38 991.0 x 1206.0 619.25 984.33 1502.33 x x 1091.0 1051.0 684.56 795.63 x x x 600.67 1146.75 x x x 991.0 892.67 843.71 x x 763.83 1004.0 x 1590.0 348.33 843.25 1133.25 x 892.17 853.0 1022.83 x 509.6 x 1187.0 1190.0 x x 1131.86 1086.5 1110.38 640.13 709.0 x 739.17 1213.17 x 1370.43 x x 1025.0 1316.5 1074.6 966.83 955.33 849.86 991.5 681.2 1304.33 +12442 Original post publication description: Anxiety assay, restraint stress [15 min] + ethanol treated [1.8 g/kg i.p.] (RSE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during first 5 min [beam breaks/sec] None Central nervous system, behavior: Anxiety assay, restraint stress (15 min) and ethanol (1.8 g/kg ip) (RSE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during first 5 min [n beam breaks/sec] 0.519 0.285 0.476 0.268 0.227 0.454 0.669 0.408 0.242 1.3 1.5 0.245 x x 0.396 0.205 x 0.184 0.564 0.222 x x x x x x 0.597 x x 0.468 0.235 0.381 0.299 x 0.407 x 0.349 0.316 0.364 x 0.188 0.348 0.379 0.257 x x 0.255 0.41 0.514 0.328 x x x 0.594 0.475 x x x 0.612 0.364 0.391 x x 1.277 0.5 x 0.21 1.008 0.476 0.236 x 0.402 0.397 0.318 x 1.6 x 0.3 0.325 x x 0.333 0.319 0.468 0.809 0.818 x 0.579 0.428 x 0.317 x x 0.301 0.268 0.416 0.76 0.351 0.495 0.323 1.4 0.257 +12443 Original post publication description: Central nervous system, behavior: Anxiety assay, restraint stress [15 min] + ethanol treated [1.8 g/kg i.p.] (RSE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during last 5 min [beam breaks/sec] None Central nervous system, behavior: Anxiety assay, restraint stress [15 min] + ethanol treated [1.8 g/kg i.p.] (RSE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during last 5 min [beam breaks/sec] 0.953 0.409 0.792 0.623 0.247 0.633 1.704 1.813 0.34 1.725 0.609 0.265 x x 0.687 0.3 x 0.157 0.55 0.261 x x x x x x 0.832 x x 0.385 0.287 0.23 0.363 x 0.401 x 0.327 0.623 0.302 x 0.222 0.528 0.472 0.308 x x 0.334 0.625 0.371 0.39 x x x 0.966 0.476 x x x 0.658 0.722 0.628 x x 0.712 0.361 x 0.228 1.008 0.896 0.248 x 0.418 0.425 0.344 x 4.463 x 0.228 0.375 x x 0.499 0.454 0.374 0.587 0.649 x 0.337 0.573 x 0.367 x x 0.517 0.363 0.461 0.622 0.263 0.736 0.476 1.768 0.366 +12444 Original post publication description: Anxiety assay, restraint stress [15 min] + ethanol treated [1.8 g/kg i.p.] (RSE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during 10 min [beam breaks/sec] None Central nervous system, behavior: Anxiety assay, restraint stress (15 min) and ethanol (1.8 g/kg ip) (RSE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during 10 min [beam breaks/sec] 0.675 0.342 0.599 0.366 0.233 0.537 0.983 0.65 0.289 2.222 32.286 0.255 x x 0.527 0.265 x 0.17 0.556 0.24 x x x x x x 0.692 x x 0.42 0.258 0.275 0.321 x 0.404 x 0.336 0.443 0.332 x 0.212 0.472 0.42 0.278 x x 0.293 0.501 0.441 0.348 x x x 0.736 0.476 x x x 0.587 0.532 0.5 x x 1.634 0.406 x 0.219 0.898 0.571 0.241 x 0.412 0.412 0.33 x 121.035 x 0.25 0.351 x x 0.4 0.372 0.414 0.638 0.734 x 0.456 0.491 x 0.342 x x 0.404 0.314 0.429 0.6 0.313 0.603 0.405 3.756 0.305 +12445 Original post publication description: Anxiety assay, restraint stress [15 min] + ethanol treated [1.8 g/kg i.p.] (RSE group), latency to enter an open quadrant using an elevated zero maze in 60 to 120-day-old males and females [sec] None Central nervous system, behavior: Anxiety assay, restraint stress (15 min) and ethanol (1.8 g/kg ip) (RSE group), latency to enter an open quadrant using an elevated zero maze in 60 to 120-day-old males and females [sec] 9.6 7.309 11.12 6.18 11.0 5.925 52.1 9.133 7.9 31.833 50.167 3.4 3.85 x 9.2 6.067 x 18.7 1.5 3.1 x x x x x 12.8 17.85 6.333 x 0.85 3.873 5.033 6.508 x 0.5 x 6.1 3.3 4.469 x 3.5 15.708 16.682 2.807 x x 8.62 26.9 1.868 10.176 x x x 8.35 3.35 x x x 8.46 13.167 5.082 x x 13.25 19.469 43.8 4.058 11.625 11.036 3.1 x 7.257 5.8 7.792 x 10.825 x 3.05 5.908 5.7 x 4.457 5.4 17.6 3.175 11.633 x 20.243 10.433 x 9.277 x x 4.35 9.808 4.586 7.677 3.786 7.175 5.767 5.85 3.983 +12446 Original post publication description: Anxiety assay, restraint stress [15 min] + ethanol treated [1.8 g/kg i.p.] (RSE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males and females during first 5 min [percentage of time] None Central nervous system, behavior: Anxiety assay, restraint stress [15 min] and ethanol (1.8 g/kg ip) (RSE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males and females during first 5 min [% time] 28.392 51.288 36.831 35.517 34.333 45.542 51.6 39.863 50.3 10.162 37.2 44.133 26.817 x 40.2 70.067 x 42.283 24.867 40.45 x x x x x 20.333 6.433 51.167 x 46.167 50.722 51.278 50.469 x 45.767 x 62.8 43.606 49.617 x 52.737 58.544 35.318 48.729 x x 50.1 18.908 58.748 41.467 x x x 41.509 23.617 x x x 41.467 54.797 49.739 x x 29.189 44.056 6.8 43.669 68.95 55.305 50.323 x 57.343 50.433 46.214 x 26.772 x 57.767 45.574 61.467 x 31.5 44.225 28.711 40.222 33.675 x 43.378 46.642 x 35.874 x x 45.777 38.028 34.819 40.026 59.324 37.973 43.672 32.297 53.764 +12447 Original post publication description: Anxiety assay, restraint stress [15 min] + ethanol treated [1.8 g/kg i.p.] (RSE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males and females during last 5 min [percentage of time] None Central nervous system, behavior: Anxiety assay, restraint stress (15 min) and ethanol (1.8 g/kg ip) (RSE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males and females during last 5 min [% time] 18.208 36.221 21.52 22.09 31.647 21.217 18.833 25.115 35.833 9.519 32.994 38.333 17.15 x 28.217 33.867 x 40.267 25.267 31.708 x x x x x 17.467 5.35 42.578 x 35.133 44.684 44.911 41.405 x 24.533 x 49.133 20.791 37.865 x 47.023 36.994 29.494 40.278 x x 40.72 11.542 60.073 38.678 x x x 26.77 20.104 x x x 29.567 26.161 25.118 x x 20.889 41.313 6.833 37.769 51.314 61.605 44.067 x 44.369 32.333 33.1 x 12.054 x 45.067 36.313 70.017 x 22.257 24.456 25.936 38.028 33.047 x 50.667 41.617 x 26.1 x x 30.06 24.517 27.233 27.667 49.714 13.865 23.278 34.287 40.786 +12448 Original post publication description: Anxiety assay, restraint stress [15 min] + ethanol treated [1.8 g/kg i.p.] (RSE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males and females during 10 min [percentage of time] None Central nervous system, behavior: Anxiety assay, restraint stress (15 min) and ethanol (1.8 g/kg ip) (RSE group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males and females during 10 min [% time] 23.3 43.755 29.176 28.803 32.99 33.379 35.217 32.489 43.067 9.841 35.097 41.233 21.983 x 34.208 51.967 x 41.275 25.067 36.079 x x x x x 18.9 5.892 46.872 x 40.65 47.703 48.094 45.937 x 35.15 x 55.967 32.199 43.741 x 49.88 47.769 32.406 44.503 x x 45.41 15.225 59.411 40.072 x x x 34.14 21.86 x x x 35.517 40.479 37.429 x x 25.039 42.685 6.817 40.719 60.132 58.455 47.195 x 50.856 41.383 39.657 x 19.413 x 51.417 40.944 65.742 x 26.879 34.34 27.324 39.125 33.361 x 47.022 44.129 x 30.987 x x 37.918 31.272 31.026 33.846 54.519 25.919 33.475 33.292 47.275 +12449 Original post publication description: Anxiety assay, restraint stress [15 min] + ethanol treated [1.8 g/kg i.p.] (RSE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during first 5 min [n beam breaks] None Central nervous system, behavior: Anxiety assay, restraint stress (15 min) and ethanol (1.8 g/kg ip) (RSE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during first 5 min [n beam breaks] 657.25 578.73 449.33 681.2 809.4 565.25 201.5 565.56 615.0 354.14 427.67 713.33 484.5 x 498.0 425.33 x 735.5 400.0 811.0 x x x x x 562.0 471.5 706.33 x 386.5 753.13 530.67 492.77 x 400.0 x 320.0 519.0 469.06 x 740.7 315.0 513.27 694.67 x x 602.2 619.25 470.91 499.24 x x x 546.44 509.88 x x x 487.5 383.17 376.36 x x 429.58 507.31 385.0 754.5 178.17 469.07 627.5 x 424.0 375.0 474.58 x 438.0 x 415.5 650.54 198.5 x 620.57 492.0 594.33 310.25 281.0 x 296.07 580.42 x 676.54 x x 646.9 652.75 497.57 510.08 440.29 444.69 430.17 399.85 576.75 +12450 Original post publication description: Anxiety assay, restraint stress [15 min] + ethanol treated [1.8 g/kg i.p.] (RSE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during last 5 min [n beam breaks] None Central nervous system, behavior: Anxiety assay, restraint stress (15 min) and ethanol (1.8 g/kg ip) (RSE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during last 5 min [n beam breaks] 529.25 531.09 392.73 597.2 787.0 637.25 89.5 524.11 566.0 217.0 307.83 695.67 442.0 x 437.0 665.0 x 819.0 408.0 765.75 x x x x x 512.0 354.0 605.0 x 533.0 664.8 580.67 455.38 x 564.0 x 467.0 415.73 484.19 x 664.0 389.0 437.64 603.33 x x 487.4 433.5 371.27 457.35 x x x 444.61 517.88 x x x 515.6 505.67 448.82 x x 469.08 485.0 435.0 784.67 260.42 315.43 630.0 x 572.5 478.0 589.83 x 361.23 x 771.5 704.31 204.0 x 479.29 486.33 605.67 334.75 277.08 x 377.13 643.83 x 672.08 x x 546.5 633.75 533.43 557.0 488.14 412.63 480.0 255.7 646.33 +12451 Original post publication description: Anxiety assay, restraint stress [15 min] + ethanol treated [1.8 g/kg i.p.] (RSE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during 10 min [n beam breaks] None Central nervous system, behavior: Anxiety assay, restraint stress (15 min) and ethanol (1.8 g/kg ip) (RSE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during 10 min [n beam breaks] 1186.5 1109.82 842.07 1278.4 1596.4 1202.5 291.0 1089.67 1181.0 571.14 735.5 1409.0 926.5 x 935.0 1090.33 x 1554.5 808.0 1576.75 x x x x x 1074.0 825.5 1311.33 x 919.5 1417.93 1111.33 948.15 x 964.0 x 787.0 934.73 953.25 x 1404.7 704.0 950.91 1298.0 x x 1089.6 1052.75 842.18 956.59 x x x 991.06 1027.75 x x x 1003.1 888.83 825.18 x x 898.67 992.31 820.0 1539.17 438.58 784.5 1257.5 x 996.5 853.0 1064.42 x 799.23 x 1187.0 1354.85 402.5 x 1099.86 978.33 1200.0 645.0 558.08 x 673.2 1224.25 x 1348.62 x x 1193.4 1286.5 1031.0 1067.08 928.43 857.31 910.17 655.55 1223.08 +12452 Original post publication description: Anxiety assay, restraint stress [15 min] + ethanol treated [1.8 g/kg i.p.] (RSE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during first 5 min [beam breaks/sec] None Central nervous system, behavior: Anxiety assay, restraint stress (15 min) and ethanol (1.8 g/kg ip) (RSE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during first 5 min [beam breaks/sec] 0.344 0.276 0.478 0.307 0.268 0.296 0.743 0.384 0.242 1.181 16.307 0.235 0.464 x 0.368 0.208 x 0.251 0.564 0.226 x x x x x 0.425 0.597 0.21 x 0.468 0.216 0.335 0.391 x 0.407 x 0.349 0.329 0.46 x 0.191 0.503 0.426 0.222 x x 0.252 0.403 0.343 0.365 x x x 0.405 0.495 x x x 0.504 0.463 0.43 x x 0.841 0.435 0.726 0.229 0.751 0.433 0.258 x 0.377 0.397 0.391 x 23.562 x 0.3 0.261 0.543 x 0.34 0.377 0.422 0.846 1.051 x 3.429 0.363 x 0.321 x x 0.273 0.305 0.487 0.61 0.324 0.456 0.719 7.98 0.244 +12453 Original post publication description: Anxiety assay, restraint stress [15 min] + ethanol treated [1.8 g/kg i.p.] (RSE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during last 5 min [beam breaks/sec] None Central nervous system, behavior: Anxiety assay, restraint stress (15 min) and ethanol (1.8 g/kg ip) (RSE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during last 5 min [beam breaks/sec] 0.526 0.386 0.785 0.484 0.293 0.419 3.104 1.339 0.34 1.747 0.701 0.265 0.561 x 0.54 0.303 x 0.233 0.55 0.268 x x x x x 0.484 0.832 0.285 x 0.385 0.266 0.271 0.452 x 0.401 x 0.327 0.613 0.342 x 0.233 0.55 0.501 0.334 x x 0.42 0.637 0.348 0.462 x x x 0.764 0.505 x x x 0.55 0.57 0.551 x x 0.56 0.375 0.643 0.246 0.784 0.682 0.303 x 0.347 0.425 0.381 x 1.926 x 0.228 0.283 0.592 x 0.556 0.546 0.389 0.604 1.992 x 1.36 0.411 x 0.342 x x 0.428 0.385 0.427 0.744 0.361 0.722 0.501 1.416 0.292 +12454 Original post publication description: Anxiety assay, restraint stress [15 min] + ethanol treated [1.8 g/kg i.p.] (RSE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during 10 min [beam breaks/sec] None Central nervous system, behavior: Anxiety assay, restraint stress (15 min) and ethanol (1.8 g/kg ip) (RSE group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during 10 min [beam breaks/sec] 0.417 0.328 0.595 0.359 0.278 0.359 1.481 0.554 0.289 1.195 16.419 0.25 0.507 x 0.446 0.264 x 0.241 0.556 0.246 x x x x x 0.453 0.692 0.245 x 0.42 0.239 0.281 0.407 x 0.404 x 0.336 0.445 0.437 x 0.214 0.515 0.449 0.259 x x 0.316 0.499 0.333 0.397 x x x 0.538 0.496 x x x 0.497 0.475 0.477 x x 1.009 0.382 0.682 0.237 0.713 0.493 0.274 x 0.351 0.412 0.376 x 46.897 x 0.25 0.273 0.554 x 0.415 0.442 0.398 0.668 1.047 x 1.592 0.378 x 0.324 x x 0.343 0.342 0.43 0.615 0.348 0.576 0.493 2.272 0.264 +12455 Original post publication description: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), latency to enter an open quadrant using an elevated zero maze in 60 to 120-day-old females only [sec] None Central nervous system, behavior: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), latency to enter an open quadrant using an elevated zero maze in 60 to 120-day-old females only [sec] 3.767 6.55 6.125 27.75 2.1 5.125 6.4 5.633 5.0 8.663 3.533 2.5 5.7 x 9.45 6.35 x 7.7 x 11.0 x x x 124.3 x 4.8 x 7.65 x 13.6 4.1 10.6 5.3 x x x x 7.0 0.95 x 5.943 4.771 5.417 3.883 x x 11.967 1.4 4.417 6.12 x x x 7.957 5.971 x x x 3.45 4.567 5.45 x x 2.9 5.417 17.9 3.683 7.214 4.433 4.85 x 2.15 x 1.775 x 7.75 x x 1.65 0.95 x 10.075 22.633 12.8 3.489 1.267 x 2.983 1.333 x 6.9 x x 8.471 12.95 3.325 3.483 6.286 2.8 5.625 3.125 5.52 +12456 Original post publication description: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), time in open quadrants using an elevated zero maze in 60 to 120-day-old females only during first 5 min [percentage of time] None Central nervous system, behavior: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), time in open quadrants using an elevated zero maze in 60 to 120-day-old females only during first 5 min [percentage of time] 23.322 24.837 24.733 21.096 40.95 38.342 7.6 29.456 35.033 27.642 13.85 14.117 4.8 x 12.417 5.683 x 31.117 x 10.233 x x x 1.033 x 7.433 x 33.517 x 22.8 37.856 6.833 39.967 x x x x 35.528 55.467 x 39.7 37.49 24.8 18.8 x x 33.867 6.517 41.933 27.64 x x x 22.681 16.057 x x x 39.25 28.233 26.342 x x 27.339 23.933 13.344 43.956 40.343 20.228 24.706 x 24.506 x 14.567 x 10.822 x x 20.833 37.233 x 31.45 23.3 16.494 14.856 35.933 x 31.844 37.067 x 27.867 x x 41.595 35.75 15.042 19.739 36.838 21.883 33.167 31.658 17.453 +12457 Original post publication description: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), time in open quadrants using an elevated zero maze in 60 to 120-day-old females only during last 5 min [percentage of time] None Central nervous system, behavior: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), time in open quadrants using an elevated zero maze in 60 to 120-day-old females only during last 5 min [percentage of time] 17.856 18.087 18.083 10.504 24.517 28.075 0.333 24.189 16.8 18.779 3.128 12.283 0.367 x 4.217 2.517 x 32.7 x 4.667 x x x 0.767 x 6.733 x 13.717 x 29.167 30.278 41.767 39.647 x x x x 12.672 33.161 x 33.033 31.11 18.506 15.772 x x 18.789 1.333 32.006 23.407 x x x 18.652 8.99 x x x 27.533 17.45 20.983 x x 21.528 12.033 13.189 35.572 37.914 12.844 28.761 x 10.894 x 5.875 x 8.306 x x 25.883 34.417 x 23.725 10.583 21.461 12.307 35.167 x 39.706 32.978 x 16.638 x x 29.767 25.667 7.55 10.311 25.829 25.0 16.967 28.246 20.207 +12458 Original post publication description: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), time in open quadrants using an elevated zero maze in 60 to 120-day-old females only during 10 min [percentage of time] None Central nervous system, behavior: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), time in open quadrants using an elevated zero maze in 60 to 120-day-old females only during 10 min [percentage of time] 20.589 21.462 21.408 15.8 32.733 33.208 3.967 26.822 25.917 23.21 8.489 13.2 2.583 x 8.317 4.1 x 31.908 x 7.45 x x x 0.9 x 7.083 x 23.617 x 25.983 34.067 24.3 39.807 x x x x 24.1 44.314 x 36.367 34.3 21.653 17.286 x x 26.328 3.925 36.969 25.523 x x x 20.667 12.524 x x x 33.392 22.842 23.663 x x 24.433 17.983 13.267 39.764 39.129 16.536 26.733 x 17.7 x 10.221 x 9.564 x x 23.358 35.825 x 27.587 16.942 18.978 13.582 35.55 x 35.775 35.022 x 22.252 x x 35.681 30.708 11.296 15.025 31.333 23.442 25.067 29.952 18.83 +12459 Original post publication description: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during first 5 min [n beam breaks] None Central nervous system, behavior: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during first 5 min [n beam breaks] 502.67 558.5 517.25 397.0 673.5 475.5 365.0 552.33 352.0 447.38 348.0 667.5 429.0 x 487.5 388.67 x 516.0 x 726.0 x x x 325.0 x 484.0 x 512.5 x 468.0 499.33 465.0 419.4 x x x x 460.5 326.33 x 572.43 393.71 420.5 553.17 x x 493.33 346.5 397.0 495.6 x x x 586.43 614.14 x x x 438.0 459.5 389.5 x x 580.67 362.83 491.0 373.17 458.86 425.83 559.0 x 412.33 x 513.5 x 491.17 x x 595.0 522.0 x 491.25 423.67 632.0 467.0 435.33 x 458.17 485.33 x 562.5 x x 485.43 536.25 554.75 546.17 429.0 373.75 495.75 389.88 591.2 +12460 Original post publication description: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during last 5 min [n beam breaks] None Central nervous system, behavior: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during last 5 min [n beam breaks] 418.33 420.5 374.5 276.88 600.0 378.75 277.0 434.33 336.0 412.75 194.67 367.5 265.0 x 313.5 256.67 x 313.0 x 271.0 x x x 264.0 x 308.0 x 305.5 x 302.0 380.17 327.0 312.4 x x x x 255.33 409.17 x 430.29 308.86 297.67 435.5 x x 434.33 351.0 273.5 378.2 x x x 414.86 384.86 x x x 291.5 327.17 285.25 x x 393.67 236.0 313.67 356.67 374.57 306.5 469.67 x 339.5 x 331.25 x 375.5 x x 455.67 381.5 x 397.0 276.83 385.67 374.11 277.67 x 408.67 330.0 x 457.75 x x 321.29 436.0 390.25 356.0 399.29 260.25 349.25 330.25 416.6 +12461 Original post publication description: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during 10 min [n beam breaks] None Central nervous system, behavior: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during 10 min [n beam breaks] 921.0 979.0 891.75 673.88 1273.5 854.25 642.0 986.67 688.0 860.13 542.67 1035.0 694.0 x 801.0 645.33 x 829.0 x 997.0 x x x 589.0 x 792.0 x 818.0 x 770.0 879.5 792.0 731.8 x x x x 715.83 735.5 x 1002.71 702.57 718.17 988.67 x x 927.67 697.5 670.5 873.8 x x x 1001.29 999.0 x x x 729.5 786.67 674.75 x x 974.33 598.83 804.67 729.83 833.43 732.33 1028.67 x 751.83 x 844.75 x 866.67 x x 1050.67 903.5 x 888.25 700.5 1017.67 841.11 713.0 x 866.83 815.33 x 1020.25 x x 806.71 972.25 945.0 902.17 828.29 634.0 845.0 720.12 1007.8 +12462 Original post publication description: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during first 5 min [beam breaks/sec] None Central nervous system, behavior: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during first 5 min [beam breaks/sec] 0.46 0.415 0.443 1.117 0.263 0.396 0.759 0.402 0.554 0.492 0.792 0.393 0.666 x 0.54 0.765 x 0.401 x 0.371 x x x 0.914 x 0.574 x 0.389 x 0.495 0.384 0.601 0.434 x x x x 0.421 0.437 x 0.325 0.485 0.543 0.463 x x 0.422 0.829 0.465 0.448 x x x 0.399 0.415 x x x 0.414 0.471 0.581 x x 0.379 0.693 0.559 0.47 0.394 0.581 0.427 x 1.176 x 0.506 x 0.591 x x 0.403 0.361 x 0.437 0.619 0.402 0.72 0.452 x 0.448 0.396 x 0.396 x x 0.386 0.365 0.473 0.44 0.446 0.675 0.41 0.538 0.423 +12463 Original post publication description: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during last 5 min [beam breaks/sec] None Central nervous system, behavior: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during last 5 min [beam breaks/sec] 0.607 0.603 0.671 2.0 0.377 0.575 1.079 0.539 0.743 0.586 1.75 0.806 1.128 x 0.981 1.429 x 0.647 x 1.055 x x x 1.128 x 0.908 x 0.956 x 0.704 0.559 0.534 0.594 x x x x 1.068 0.485 x 0.482 0.705 0.855 0.61 x x 0.561 0.886 0.812 0.654 x x x 0.649 0.744 x x x 0.745 0.779 0.864 x x 0.626 1.179 0.944 0.595 0.531 1.01 0.486 x 0.824 x 0.893 x 0.802 x x 0.505 0.518 x 0.594 1.063 0.631 0.919 0.708 x 0.452 0.61 x 0.561 x x 0.709 0.534 0.846 0.863 0.571 0.896 0.789 0.665 0.579 +12464 Original post publication description: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during 10 min [beam breaks/sec] None Central nervous system, behavior: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old females only during 10 min [beam breaks/sec] 0.525 0.492 0.533 1.944 0.317 0.474 0.898 0.462 0.646 0.535 1.082 0.526 0.842 x 0.7 0.954 x 0.494 x 0.557 x x x 1.01 x 0.704 x 0.573 x 0.577 0.46 0.573 0.498 x x x x 0.647 0.457 x 0.389 0.574 0.656 0.521 x x 0.483 0.856 0.595 0.531 x x x 0.486 0.535 x x x 0.546 0.597 0.691 x x 0.472 0.87 0.698 0.522 0.451 0.702 0.448 x 0.759 x 0.645 x 0.677 x x 0.439 0.426 x 0.507 0.783 0.48 0.805 0.552 x 0.445 0.479 x 0.465 x x 0.511 0.434 0.594 0.578 0.503 0.742 0.545 0.596 0.488 +12465 Original post publication description: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), latency to enter an open quadrant using an elevated zero maze in 60 to 120-day-old males only [sec] None Central nervous system, behavior: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), latency to enter an open quadrant using an elevated zero maze in 60 to 120-day-old males only [sec] 13.5 6.514 8.35 6.86 8.2 2.0 21.6 8.183 12.8 14.429 11.68 4.95 13.5 x 21.4 2.833 x 9.6 10.7 8.25 x x x x x 21.9 28.1 x x 8.3 3.433 8.333 5.567 x 2.0 x 8.2 5.575 2.4 x 2.35 1.2 4.183 6.233 x x 6.533 11.9 3.771 5.783 x x x 4.783 16.1 x x x 2.95 1.8 4.475 x x 4.083 8.16 6.133 13.033 2.067 3.82 16.1 x 4.6 42.4 5.55 x 5.95 x 5.85 7.7 x x 8.483 4.6 15.483 4.633 1.9 x 4.0 1.583 x 5.011 x x 6.4 7.25 7.067 3.767 2.625 28.417 3.283 4.3 8.217 +12466 Original post publication description: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males only during first 5 min [percentage of time] None Central nervous system, behavior: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males only during first 5 min [percentage of time] 21.2 24.405 22.694 24.893 38.775 9.733 3.433 18.006 5.633 30.662 21.78 20.2 36.55 x 22.667 4.456 x 45.267 11.333 25.15 x x x x x 32.933 2.411 x x 17.378 32.222 42.622 36.144 x 11.0 x 1.567 22.858 31.489 x 30.289 22.028 21.633 23.439 x x 56.244 9.567 41.138 28.172 x x x 17.428 8.229 x x x 47.761 28.178 23.158 x x 19.644 22.76 27.356 33.806 20.433 32.467 17.711 x 6.978 2.867 24.95 x 27.625 x 17.133 13.228 x x 29.028 22.106 13.317 21.933 36.533 x 21.433 31.472 x 24.559 x x 27.007 27.172 11.644 22.289 42.842 11.494 24.206 25.639 13.033 +12467 Original post publication description: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males only during last 5 min [percentage of time] None Central nervous system, behavior: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males only during last 5 min [percentage of time] 11.667 18.929 14.711 14.127 32.692 0.5 4.5 15.656 13.433 21.119 23.253 11.467 16.9 x 5.7 1.756 x 41.1 5.7 30.908 x x x x x 0.2 9.333 x x 19.933 27.15 18.933 29.833 x 10.533 x 11.133 6.813 21.717 x 20.85 28.433 16.056 20.511 x x 37.178 6.15 28.843 30.356 x x x 15.089 9.433 x x x 28.95 13.744 17.817 x x 15.144 20.18 26.544 29.233 22.622 31.713 20.572 x 7.483 0.5 24.156 x 26.15 x 13.933 11.556 x x 21.156 22.022 9.8 9.5 35.175 x 22.233 27.061 x 16.967 x x 29.807 11.55 8.706 12.578 43.533 12.378 20.506 21.333 8.633 +12468 Original post publication description: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males only during 10 min [percentage of time] None Central nervous system, behavior: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males only during 10 min [percentage of time] 16.433 21.667 18.703 19.51 35.733 5.117 3.967 16.831 9.533 25.89 22.517 15.833 26.725 x 14.183 3.106 x 43.183 8.517 28.029 x x x x x 16.567 5.872 x x 18.656 29.686 30.778 32.989 x 10.767 x 6.35 14.835 26.603 x 25.569 25.231 18.844 21.975 x x 46.711 7.858 34.99 29.264 x x x 16.258 8.831 x x x 38.356 20.961 20.488 x x 17.394 21.47 26.95 31.519 21.528 32.09 19.142 x 7.231 1.683 24.553 x 26.887 x 15.533 12.392 x x 25.092 22.064 11.558 15.717 35.854 x 21.833 29.267 x 20.763 x x 28.407 19.361 10.175 17.433 43.188 11.936 22.356 23.486 10.833 +12469 Original post publication description: Anxiety assay, restraint stress (15 min) + saline treated (0.018 ml/kg i.p.) for RSS group, activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during first 5 min [n beam breaks] None Central nervous system, behavior: Anxiety assay, restraint stress (15 min) + saline treated (0.018 ml/kg ip) for RSS group, activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during first 5 min [n beam breaks] 624.0 561.14 543.67 551.2 513.25 562.0 679.0 578.67 389.0 480.86 235.2 488.5 465.5 x 779.0 493.67 x 465.0 579.0 448.0 x x x x x 321.0 434.0 x x 450.5 576.5 375.33 415.67 x 697.0 x 553.0 460.5 568.0 x 599.83 421.67 482.0 629.5 x x 453.0 414.5 438.86 454.33 x x x 624.83 636.57 x x x 465.33 462.83 453.5 x x 563.17 425.4 535.0 496.17 533.0 422.0 564.33 x 484.67 453.0 559.0 x 447.75 x 634.5 570.5 x x 457.33 406.33 639.33 394.5 425.25 x 457.25 554.33 x 519.11 x x 576.4 524.33 700.67 562.17 527.75 386.17 505.17 451.17 586.83 +12470 Original post publication description: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during last 5 min [n beam breaks] None Central nervous system, behavior: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during last 5 min [n beam breaks] 500.0 392.57 413.33 383.6 375.75 283.0 502.0 416.5 387.0 368.86 100.8 335.0 400.5 x 522.0 387.0 x 488.0 384.0 269.5 x x x x x 158.0 329.33 x x 350.0 433.83 299.0 287.0 x 363.0 x 363.0 281.13 392.67 x 482.83 316.33 315.67 410.5 x x 423.0 344.0 291.14 321.67 x x x 461.33 382.57 x x x 441.17 352.17 352.25 x x 380.17 205.0 306.67 425.83 478.17 305.0 506.83 x 364.67 334.0 396.83 x 232.0 x 433.0 366.5 x x 352.5 276.83 429.33 289.17 245.5 x 372.75 383.33 x 376.67 x x 420.0 370.0 517.83 456.0 388.5 362.83 413.0 396.17 434.17 +12471 Original post publication description: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during 10 min [n beam breaks] None Central nervous system, behavior: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during 10 min [n beam breaks] 1124.0 953.71 957.0 934.8 889.0 845.0 1181.0 995.17 776.0 849.71 336.0 823.5 866.0 x 1301.0 880.67 x 953.0 963.0 717.5 x x x x x 479.0 763.33 x x 800.5 1010.33 674.33 702.67 x 1060.0 x 916.0 741.63 960.67 x 1082.67 738.0 797.67 1040.0 x x 876.0 758.5 730.0 776.0 x x x 1086.17 1019.14 x x x 906.5 815.0 805.75 x x 943.33 630.4 841.67 922.0 1011.17 727.0 1071.17 x 849.33 787.0 955.83 x 679.75 x 1067.5 937.0 x x 809.83 683.17 1068.67 683.67 670.75 x 830.0 937.67 x 895.78 x x 996.4 894.33 1218.5 1018.17 916.25 749.0 918.17 847.33 1021.0 +12472 Original post publication description: Central nervous system, behavior: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during first 5 min [beam breaks/sec] None Central nervous system, behavior: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during first 5 min [beam breaks/sec] 0.379 0.412 0.434 0.418 0.359 0.482 0.427 0.457 0.728 0.5 1.092 0.49 0.436 x 0.298 0.623 x 0.353 0.459 0.513 x x x x x 0.627 0.679 x x 0.712 0.354 0.472 0.472 x 0.383 x 0.534 0.541 0.362 x 0.356 0.586 0.5 0.372 x x 0.294 0.668 0.416 0.481 x x x 0.397 0.447 x x x 0.356 0.468 0.563 x x 0.441 0.553 0.415 0.404 0.46 0.515 0.46 x 0.613 0.643 0.409 x 0.503 x 0.399 0.494 x x 0.487 0.59 0.41 0.646 0.463 x 0.529 0.38 x 0.445 x x 0.389 0.423 0.395 0.425 0.324 0.723 0.493 0.513 0.46 +12473 Original post publication description: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during last 5 min [beam breaks/sec] None Central nervous system, behavior: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during last 5 min [beam breaks/sec] 0.53 0.65 0.713 0.687 0.613 1.055 0.571 0.687 0.671 0.851 2.788 0.798 0.662 x 0.542 0.878 x 0.362 0.737 0.801 x x x x x 1.895 0.837 x x 0.719 0.508 0.819 0.747 x 0.739 x 0.734 1.13 0.63 x 0.521 0.717 0.954 0.592 x x 0.457 0.818 0.806 0.669 x x x 0.561 0.776 x x x 0.57 0.787 0.705 x x 0.765 1.255 0.725 0.505 0.494 0.682 0.554 x 0.896 0.894 0.634 x 1.081 x 0.623 1.374 x x 0.716 1.022 0.957 1.052 0.802 x 0.627 0.584 x 0.753 x x 0.508 0.79 0.585 0.617 0.422 0.772 0.601 0.623 0.664 +12474 Original post publication description: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during 10 min [beam breaks/sec] None Central nervous system, behavior: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males only during 10 min [beam breaks/sec] 0.446 0.504 0.535 0.524 0.445 0.674 0.488 0.54 0.699 0.641 1.465 0.615 0.549 x 0.396 0.727 x 0.358 0.57 0.62 x x x x x 1.045 0.744 x x 0.664 0.42 0.62 0.581 x 0.505 x 0.613 0.73 0.468 x 0.426 0.639 0.648 0.453 x x 0.373 0.733 0.553 0.557 x x x 0.464 0.562 x x x 0.449 0.594 0.621 x x 0.555 0.772 0.522 0.45 0.475 0.578 0.495 x 0.716 0.75 0.489 x 0.673 x 0.487 0.67 x x 0.579 0.708 0.527 0.796 0.587 x 0.571 0.463 x 0.548 x x 0.434 0.566 0.471 0.503 0.366 0.727 0.535 0.561 0.54 +12475 Original post publication description: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), latency to enter an open quadrant using an elevated zero maze in 60 to 120-day-old males and females [sec] None Central nervous system, behavior: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), latency to enter an open quadrant using an elevated zero maze in 60 to 120-day-old males and females [sec] 5.157 6.535 7.46 19.715 6.167 4.5 14.0 7.333 8.9 11.353 7.236 3.725 10.9 x 13.433 5.178 x 8.333 10.7 8.8 x x x 124.3 x 13.35 28.1 7.65 x 9.057 3.767 8.9 5.445 x 2.0 x 8.2 6.186 1.675 x 4.285 3.123 4.8 5.058 x x 9.25 6.65 4.069 5.936 x x x 6.492 11.036 x x x 3.075 3.183 4.962 x x 3.492 6.664 12.017 8.358 4.838 4.155 10.475 x 3.375 42.4 4.04 x 7.03 x 5.85 4.675 0.95 x 9.12 13.617 14.142 3.947 1.52 x 3.39 1.458 x 5.9 x x 7.608 9.53 5.57 3.625 4.955 18.17 4.22 3.629 6.991 +12476 Original post publication description: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males and females during first 5 min [percentage of time] None Central nervous system, behavior: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males and females during first 5 min [percentage of time] 23.019 24.659 23.51 22.556 39.5 32.62 5.517 21.822 20.333 29.051 17.455 17.158 25.967 x 15.833 5.274 x 35.833 11.333 22.167 x x x 1.033 x 20.183 2.411 33.517 x 18.152 35.039 33.675 37.882 x 11.0 x 1.567 28.288 43.478 x 35.356 30.354 23.217 21.119 x x 45.056 8.042 41.505 27.93 x x x 20.256 12.143 x x x 45.633 28.206 24.75 x x 23.492 23.4 20.35 38.881 31.154 25.791 21.208 x 15.742 2.867 20.797 x 17.543 x 17.133 17.031 37.233 x 29.997 22.703 14.906 17.687 36.173 x 27.68 34.269 x 26.116 x x 35.517 30.603 13.003 21.014 39.021 15.65 27.79 29.079 15.042 +12477 Original post publication description: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males and females during last 5 min [percentage of time] None Central nervous system, behavior: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males and females during last 5 min [percentage of time] 16.971 18.433 16.06 11.897 29.967 22.56 2.417 18.5 15.117 19.871 12.276 11.875 11.389 x 4.711 2.263 x 35.5 5.7 25.66 x x x 0.767 x 3.467 9.333 13.717 x 21.252 28.714 24.642 34.294 x 10.533 x 11.133 9.324 27.439 x 27.41 29.874 17.281 18.142 x x 27.983 3.742 30.303 27.197 x x x 17.008 9.212 x x x 28.596 15.597 19.4 x x 18.336 15.736 19.867 32.403 30.856 21.421 24.667 x 9.189 0.5 16.843 x 15.443 x 13.933 18.719 34.417 x 22.183 16.303 15.631 11.184 35.17 x 32.717 30.019 x 16.812 x x 29.783 17.197 8.243 11.444 32.267 17.427 19.09 25.283 13.894 +12478 Original post publication description: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males and females during 10 min [percentage of time] None Central nervous system, behavior: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), time in open quadrants using an elevated zero maze in 60 to 120-day-old males and females during 10 min [percentage of time] 19.995 21.546 19.785 17.227 34.733 27.59 3.967 20.161 17.725 24.461 14.865 14.517 18.678 x 10.272 3.768 x 35.667 8.517 23.913 x x x 0.9 x 11.825 5.872 23.617 x 19.702 31.876 29.158 36.088 x 10.767 x 6.35 18.806 35.458 x 31.383 30.114 20.249 19.631 x x 36.519 5.892 35.904 27.564 x x x 18.632 10.677 x x x 37.115 21.901 22.075 x x 20.914 19.568 20.108 35.642 31.005 23.606 22.938 x 12.465 1.683 18.82 x 16.493 x 15.533 17.875 35.825 x 26.09 19.503 15.268 14.436 35.672 x 30.198 32.144 x 21.464 x x 32.65 23.9 10.623 16.229 35.644 16.538 23.44 27.181 14.468 +12479 Original post publication description: Anxiety assay, restraint stress (15 min) + saline treated (0.018 ml/kg ip) in the RSS group, activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during first 5 min [n beam breaks] None Central nervous system, behavior: Anxiety assay, restraint stress (15 min) + saline treated (0.018 ml/kg ip) in the RSS group, activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during first 5 min [n beam breaks] 520.0 559.59 533.1 456.31 566.67 492.8 522.0 569.89 370.5 463.0 296.73 578.0 453.33 x 584.67 423.67 x 499.0 579.0 503.6 x x x 325.0 x 402.5 434.0 512.5 x 453.0 537.92 397.75 417.36 x 697.0 x 553.0 460.5 447.17 x 585.08 406.62 451.25 591.33 x x 473.17 380.5 419.54 473.09 x x x 604.15 625.36 x x x 458.5 461.17 421.5 x x 571.92 391.27 513.0 434.67 493.08 424.09 561.67 x 448.5 453.0 540.8 x 473.8 x 634.5 582.75 522.0 x 470.9 415.0 635.67 438.0 431.3 x 457.8 519.83 x 539.53 x x 523.33 529.1 642.3 554.17 464.91 381.2 501.4 416.14 588.82 +12480 Original post publication description: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during last 5 min [n beam breaks] None Central nervous system, behavior: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during last 5 min [n beam breaks] 430.0 409.0 397.8 317.92 450.5 359.6 389.5 422.44 361.5 392.27 152.0 351.25 355.33 x 383.0 300.11 x 371.33 384.0 269.8 x x x 264.0 x 233.0 329.33 305.5 x 343.14 407.0 306.0 298.55 x 363.0 x 363.0 270.07 400.92 x 454.54 312.31 306.67 423.0 x x 428.67 347.5 283.0 347.36 x x x 436.31 383.71 x x x 403.75 339.67 318.75 x x 386.92 221.91 310.17 391.25 422.38 305.82 488.25 x 352.08 334.0 370.6 x 318.1 x 433.0 411.08 381.5 x 370.3 276.83 407.5 340.13 264.8 x 394.3 356.67 x 414.82 x x 362.42 396.4 466.8 406.0 395.36 321.8 387.5 358.5 426.18 +12481 Original post publication description: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during 10 min [n beam breaks] None Central nervous system, behavior: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during 10 min [n beam breaks] 950.0 968.59 930.9 774.23 1017.17 852.4 911.5 992.33 732.0 855.27 448.73 929.25 808.67 x 967.67 723.78 x 870.33 963.0 773.4 x x x 589.0 x 635.5 763.33 818.0 x 796.14 944.92 703.75 715.91 x 1060.0 x 916.0 730.57 848.08 x 1039.62 718.92 757.92 1014.33 x x 901.83 728.0 702.54 820.45 x x x 1040.46 1009.07 x x x 862.25 800.83 740.25 x x 958.83 613.18 823.17 825.92 915.46 729.91 1049.92 x 800.58 787.0 911.4 x 791.9 x 1067.5 993.83 903.5 x 841.2 691.83 1043.17 778.13 696.1 x 852.1 876.5 x 954.35 x x 885.75 925.5 1109.1 960.17 860.27 703.0 888.9 774.64 1015.0 +12482 Original post publication description: Central nervous system, behavior: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during first 5 min [beam breaks/sec] None Central nervous system, behavior: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during first 5 min [beam breaks/sec] 0.449 0.414 0.438 0.848 0.327 0.413 0.593 0.439 0.641 0.496 0.929 0.442 0.513 x 0.46 0.718 x 0.385 0.459 0.485 x x x 0.914 x 0.6 0.679 0.389 x 0.681 0.369 0.504 0.454 x 0.383 x 0.534 0.489 0.4 x 0.339 0.532 0.522 0.418 x x 0.358 0.749 0.439 0.466 x x x 0.398 0.431 x x x 0.371 0.47 0.572 x x 0.41 0.63 0.487 0.437 0.424 0.551 0.443 x 0.894 0.643 0.448 x 0.556 x 0.399 0.448 0.361 x 0.467 0.605 0.406 0.69 0.457 x 0.48 0.388 x 0.422 x x 0.388 0.4 0.426 0.432 0.402 0.704 0.46 0.527 0.443 +12483 Original post publication description: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during last 5 min [beam breaks/sec] None Central nervous system, behavior: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during last 5 min [beam breaks/sec] 0.596 0.622 x x 0.535 0.671 0.825 0.638 0.707 0.71 2.165 0.802 0.817 x 0.835 1.245 x 0.552 0.737 0.852 x x x 1.128 x 1.402 0.837 0.956 x 0.717 0.534 0.748 0.677 x 0.739 x 0.734 1.103 0.557 x 0.5 0.711 0.905 0.601 x x 0.509 0.852 0.809 0.662 x x x 0.609 0.76 x x x 0.614 0.783 0.785 x x 0.696 1.213 0.834 0.55 0.514 0.861 0.52 x 0.86 0.894 0.737 x 0.914 x 0.623 0.94 0.518 x 0.667 1.042 0.794 0.972 0.745 x 0.522 0.597 x 0.663 x x 0.625 0.688 0.69 0.74 0.517 0.821 0.676 0.647 0.625 +12484 Original post publication description: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during 10 min [beam breaks/sec] None Central nervous system, behavior: Anxiety assay, restraint stress [15 min] + saline treated [.018 ml/kg i.p.] (RSS group), activity in closed quadrants using an elevated zero maze in 60 to 120-day-old males and females during 10 min [beam breaks/sec] 0.514 0.497 0.535 1.398 0.402 0.514 0.693 0.514 0.673 0.584 1.256 0.57 0.647 x 0.598 0.878 x 0.449 0.57 0.607 x x x 1.01 x 0.875 0.744 0.573 x 0.652 0.44 0.608 0.543 x 0.505 x 0.613 0.694 0.462 x 0.406 0.604 0.652 0.487 x x 0.428 0.795 0.573 0.545 x x x 0.476 0.549 x x x 0.473 0.595 0.656 x x 0.513 0.825 0.61 0.486 0.462 0.646 0.472 x 0.738 0.75 0.551 x 0.675 x 0.487 0.554 0.426 x 0.55 0.745 0.503 0.802 0.566 x 0.495 0.471 x 0.509 x x 0.479 0.513 0.52 0.54 0.454 0.733 0.539 0.581 0.516 +12485 Original post publication description: Central nervous system, morphology: Cerebellar Purkinje cell number, with Abercrombie correction, for male and females between 30 and 150-days-of-age [n x1000] None Central nervous system, morphology: Cerebellar Purkinje cell number, with Abercrombie correction, for male and females between 30 and 150-days-of-age [n x1000] x x 126.321 109.98 168.102 x x x x 97.728 x 105.892 x x 116.22 117.962 x 140.33 x 146.396 x x x 152.56 x 163.444 x 105.924 x 128.254 x x 131.688 x x x 126.424 x x x 134.708 109.848 141.028 x x x x x 126.432 152.26 x x x 143.384 x x x x 132.198 117.872 127.568 129.804 x 131.574 119.582 129.092 135.8 151.93 129.882 x x x x 147.702 x 118.96 x x 123.264 x x 141.266 126.442 x 133.192 141.718 x x 136.296 x 121.466 x x x 140.372 123.968 151.628 140.446 x x x x +12494 Original post publication description: Iron level in dorsal striatum (caudate-putamen) of 120-day-old males fed 3 ppm Fe diet [µg/g] None Iron level in dorsal striatum (caudate-putamen) of 120-day-old males fed 3 ppm Fe diet [µg/g] x x 9.7 9.1 10.6 14.3 x 14.2 11.3 9.4 10.6 12.2 12.4 x x 12.6 8.4 9.2 x 11.4 x x x x x x 10.9 11.2 x 9.1 14.7 9.8 13.8 x x x 9.4 9.0 9.3 x 10.3 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12495 Original post publication description: Iron level in ventral midbrain of 120-day-old in males fed 3 ppm Fe diet [µg/g] None Central nervous system, metabolism, nutrition: Iron level in ventral midbrain of 120-day-old in males fed 3 ppm Fe diet [µg/g] x x 12.8 11.3 17.3 13.4 x 17.5 13.8 13.0 14.1 10.8 12.0 x x 14.8 12.3 13.9 x 13.6 x x x x x x 13.5 12.3 x 16.7 11.9 12.6 11.5 x x x 10.8 16.6 10.6 x 13.2 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12496 Original post publication description: Spleen weight of 120-day-old males fed 3 ppm Fe diet [g] None Spleen weight of 120-day-old males fed 3 ppm Fe diet [g] x x 0.092 0.215 0.062 0.36 x 0.096 0.139 0.095 0.34 0.273 0.356 x x 0.382 0.289 0.203 x 0.27 x x x x x x 0.28 0.191 x 0.118 0.347 0.131 0.087 x x x 0.252 0.174 0.072 x 0.299 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12497 Original post publication description: Iron level in spleen of 120 day old males fed 3 ppm Fe diet [µg/g] None Iron level in spleen of 120 day old males fed 3 ppm Fe diet [µg/g] x x 107.3 53.8 177.3 58.3 x 68.1 60.5 304.7 51.2 60.2 58.2 x x 47.0 34.3 24.5 x 51.9 x x x x x x 39.0 43.6 x 129.7 50.3 99.9 71.7 x x x 60.9 63.6 166.6 x 36.5 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12498 Original post publication description: Iron level of liver of 120-day-old males fed 3 ppm Fe diet [µg/g] None Iron level of liver of 120-day-old males fed 3 ppm Fe diet [µg/g] x x 27.8 26.9 39.1 29.9 x 32.5 28.2 29.5 34.4 29.1 22.8 x x 36.0 28.1 23.6 x 37.5 x x x x x x 23.1 24.0 x 29.7 28.1 23.0 32.6 x x x 29.3 28.0 28.9 x 22.3 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12499 Original post publication description: Hemoglobin of 120-day-old males fed 3 ppm Fe diet [µg/dl] None Hemoglobin of 120-day-old males fed 3 ppm Fe diet [µg/dl] x x 8.4 8.0 9.6 8.8 x 9.2 7.8 9.5 6.7 5.4 6.4 x x 6.2 4.0 2.3 x 4.9 x x x x x x 2.8 7.0 x 10.3 6.2 6.7 6.5 x x x 5.1 6.6 9.8 x 2.5 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12500 Original post publication description: Cardiovascular system: Hematocrit of 120-day-old males fed 3 parts per million iron (ppm Fe) diet [% packed red blood cells] None Cardiovascular system: Hematocrit of 120-day-old males fed 3 parts per million iron (ppm Fe) diet [% packed red blood cells] x x 36.9 33.6 44.3 36.8 x 37.2 32.1 35.3 28.7 24.6 28.0 x x 32.6 22.5 12.0 x 25.5 x x x x x x 21.5 27.9 x 35.9 31.3 34.4 27.3 x x x 22.8 28.9 37.9 x 13.5 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12501 Original post publication description: Body weight of 120-day-old males fed 3 ppm Fe diet [g] None Body weight of 120-day-old males fed 3 ppm Fe diet [g] x x 26.2 30.9 25.2 30.5 x 26.0 24.8 30.6 27.3 25.8 27.2 x x 32.2 25.0 21.7 x 25.4 x x x x x x 23.5 27.6 x 27.9 28.8 22.1 25.1 x x x 26.2 31.3 28.0 x 26.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12502 Original post publication description: Iron level in dorsal striatum (caudate-putamen) of 120-day-old females fed 270 ppm Fe diet [µg/g] None Central nervous system, metabolism, nutrition: Iron level in dorsal striatum (caudate-putamen) of 120-day-old females fed 270 ppm Fe diet [µg/g] x x 12.9 10.9 11.9 12.3 x 19.0 15.2 12.6 15.9 10.9 x 12.9 x 16.3 17.0 13.4 x 11.9 x x x x x x 13.3 14.2 x 12.4 14.4 13.4 11.3 x x x 11.4 13.5 12.0 x 11.5 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12503 Original post publication description: Iron level in ventral midbrain of 120-day-old in females fed 270 ppm Fe diet [µg/g] None Central nervous system, nutrition: Iron level in ventral midbrain of 120-day-old in females fed 270 ppm Fe diet [µg/g] x x 14.3 14.6 18.0 15.4 x 19.0 13.1 14.7 12.6 15.8 x 15.4 x 16.3 15.7 13.7 x 15.3 x x x x x x 16.7 16.0 x 17.6 13.6 14.6 19.0 x x x 16.5 14.0 15.9 x 15.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12504 Original post publication description: Morphology, immune system, nutrition: Spleen weight of 120-day-old females fed 270 ppm iron (Fe) diet [g] None Morphology, immune system, nutrition: Spleen weight of 120-day-old females fed 270 ppm iron (Fe) diet [g] x x 0.064 0.074 0.062 0.174 x 0.064 0.089 0.074 0.058 0.063 x 0.126 x 0.12 0.086 0.085 x 0.088 x x x x x x 0.074 0.062 x 0.042 0.066 0.066 0.074 x x x 0.067 0.068 0.058 x 0.075 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12505 Original post publication description: Iron level in spleen of 120-day-old females fed 270 ppm Fe diet [µg/g] None Iron level in spleen of 120-day-old females fed 270 ppm Fe diet [µg/g] x x 2239.6 1053.2 831.6 370.2 x 1233.7 478.6 1459.5 1389.1 983.7 x 938.1 x 714.1 1050.9 789.5 x 1399.7 x x x x x x 842.1 1281.3 x 4837.8 1021.6 1116.2 812.5 x x x 793.7 1152.8 1280.6 x 401.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12506 Original post publication description: Iron level of liver of 120-day-old females fed 270 ppm Fe diet [µg/g] None Metabolism, liver, nutrition: Iron level in liver of 120-day-old females fed 270 ppm Fe diet [µg/g] x x 150.4 145.9 221.8 142.1 x 228.9 112.9 174.7 125.8 277.1 x 175.4 x 213.2 231.9 138.4 x 117.1 x x x x x x 126.8 127.2 x 176.4 261.3 150.3 164.1 x x x 105.3 97.6 147.6 x 87.7 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12507 Original post publication description: Hemoglobin of 120-day-old females fed 270 ppm Fe diet [µg/dl] None Hematology, nutrition: Hemoglobin of 120-day-old females fed 270 ppm Fe diet [µg/dl] x x 13.2 11.5 14.2 11.9 x 11.3 10.9 13.6 12.1 12.6 x 13.4 x 10.8 12.5 12.2 x 13.1 x x x x x x 13.2 12.2 x 15.8 12.3 13.3 13.4 x x x 11.8 12.8 11.8 x 11.8 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12508 Original post publication description: Cardiovascular system: Hematocrit of 120-day-old females fed 270 parts per million iron (ppm Fe) diet [% packed red blood cells] None Cardiovascular system: Hematocrit of 120-day-old females fed 270 parts per million iron (ppm Fe) diet [% packed red blood cells] x x 46.4 42.1 50.5 45.4 x 44.1 43.6 46.6 44.2 44.4 x 48.6 x 42.0 44.0 44.5 x 43.0 x x x x x x 50.0 46.0 x 40.8 46.7 48.5 46.1 x x x 45.6 48.3 41.6 x 44.7 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12509 Original post publication description: Musculoskeletal system, morphology: Body weight of 120-day-old females fed 270 ppm Fe diet [g] None Musculoskeletal system, morphology: Body weight of 120-day-old females fed 270 ppm Fe diet [g] x x 21.7 23.7 20.7 25.2 x 22.2 22.8 34.5 23.8 21.1 x 26.1 x 28.7 28.1 24.0 x 28.1 x x x x x x 29.5 23.1 x 25.2 25.9 21.4 28.3 x x x 22.9 30.9 24.3 x 22.3 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12510 Original post publication description: Iron level in dorsal striatum (caudate-putamen) of 120-day-old males fed 270 ppm Fe diet [µg/g] None Central nervous system, pharmacology, nutrition: Iron level in dorsal striatum (caudate-putamen) of 120-day-old males fed 270 ppm Fe diet [µg/g] x x 11.8 12.9 12.5 13.4 x 17.5 14.4 15.9 16.6 14.1 x x x 15.0 x 14.2 x 13.3 x x x x x x 12.9 14.5 x 11.4 13.6 13.3 10.6 x x x 10.4 15.9 12.5 x 12.5 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12511 Original post publication description: Iron level in ventral midbrain of 120-day-old in males fed 270 ppm Fe diet [µg/g] None Iron level in ventral midbrain of 120-day-old in males fed 270 ppm Fe diet [µg/g] x x 16.0 15.1 18.3 13.0 x 19.9 15.0 14.5 15.3 15.6 x 14.3 x 14.9 x 14.5 x 14.9 x x x x x x 15.4 13.1 x 19.0 14.2 17.6 17.6 x x x 16.7 17.8 16.3 x 13.8 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12512 Original post publication description: Spleen weight of 120-day-old males fed 270 ppm Fe diet [g] None Immune system, morphology, nutrition: Spleen weight of 120-day-old males fed 270 ppm Fe diet [g] x x 0.062 0.072 0.12 0.141 x 0.058 0.054 0.099 0.049 0.061 x 0.094 x 0.087 x 0.083 x 0.114 x x x x x x 0.117 0.069 x 0.056 0.059 0.072 0.089 x x x 0.056 0.07 0.055 x 0.084 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12513 Original post publication description: Iron level in spleen of 120 day old males fed 270 ppm Fe diet [µg/g] None Iron level in spleen of 120 day old males fed 270 ppm Fe diet [µg/g] x x 1059.0 793.9 863.5 155.7 x 577.5 1153.6 703.5 916.8 707.2 x 856.8 x 871.2 x 355.4 x 371.6 x x x x x x 375.8 1103.4 x 1982.1 944.4 700.9 588.2 x x x 605.1 890.2 603.0 x 261.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12514 Original post publication description: Iron level of liver of 120-day-old males fed 270 ppm Fe diet [µg/g] None Metabolism, nutrition: Iron level of liver of 120-day-old males fed 270 ppm Fe diet [µg/g] x x 88.4 117.4 132.0 55.3 x 124.6 115.1 84.0 84.2 174.4 x 138.9 x 122.4 x 50.8 x 58.6 x x x x x x 185.1 91.1 x 134.0 180.5 128.0 192.9 x x x 87.6 64.3 90.1 x 47.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12515 Original post publication description: Hemoglobin of 120-day-old males fed 270 ppm Fe diet [µg/dl] None Hemoglobin of 120-day-old males fed 270 ppm Fe diet [µg/dl] x x 13.1 13.4 22.7 11.9 x 11.5 12.7 13.3 13.0 11.3 x 13.4 x 12.5 x 13.1 x 11.1 x x x x x x 11.8 12.6 x 12.2 13.1 12.3 10.4 x x x 12.2 13.7 12.2 x 12.3 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12516 Original post publication description: Cardiovascular system: Hematocrit of 120-day-old males fed 270 parts per million iron (ppm Fe) diet [% packed red blood cells] None Cardiovascular system: Hematocrit of 120-day-old males fed 270 parts per million iron (ppm Fe) diet [% packed red blood cells] x x 44.9 45.8 61.3 45.1 x 43.8 47.7 46.8 44.5 43.6 x 49.7 x 45.9 x 47.9 x 42.4 x x x x x x 47.1 44.3 x 42.6 48.1 46.3 38.7 x x x 43.7 48.7 42.0 x 45.9 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12517 Original post publication description: Body weight of 120-day-old males fed 270 ppm Fe diet [g] None Body weight of 120-day-old males fed 270 ppm Fe diet [g] x x 28.7 32.6 27.0 34.8 x 28.2 26.9 38.5 31.4 27.4 x 33.2 x 45.9 x 37.3 x 31.9 x x x x x x 28.3 29.1 x 32.1 27.7 26.0 28.1 x x x 29.1 42.3 29.1 x 32.3 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12518 Original post publication description: Iron level in caudate-putamen of 120-day-old males and females fed 3 ppm Fe diet [µg/g] None Iron level in caudate-putamen of 120-day-old males and females fed 3 ppm Fe diet [µg/g] x x 9.533 9.003 11.242 14.272 x 12.965 11.709 10.747 12.337 10.817 x 9.65 x 12.132 10.2 10.87 x 11.64 x x x x x x 11.974 12.319 x 9.071 14.296 9.927 12.744 x x x 9.758 10.258 8.355 x 9.037 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12519 Original post publication description: Iron level in ventral midbrain of 120-day-old males and females fed 3 ppm Fe diet [µg/g] None Central nervous system, metabolism, nutrition: Iron level in ventral midbrain of 120-day-old males and females fed 3 ppm Fe diet [µg/g] x x 13.425 11.814 16.564 12.168 x 17.25 12.474 14.913 13.667 11.536 x 14.15 x 13.55 12.84 13.462 x 13.315 x x x x x x 14.304 12.745 x 17.295 12.223 12.463 13.871 x x x 10.445 14.621 10.455 x 13.166 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12520 Original post publication description: Spleen weight of 120-day-old males and females fed 3 ppm Fe diet [g] None Spleen weight of 120-day-old males and females fed 3 ppm Fe diet [g] x x 0.103 0.199 0.066 0.456 x 0.104 0.146 0.18 0.198 0.217 0.272 0.244 x 0.306 0.191 0.295 x 0.3 x x x x x x 0.214 0.169 x 0.091 0.287 0.164 0.077 x x x 0.195 0.14 0.084 x 0.265 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12521 Original post publication description: Iron level in spleen of 120 day old males and females fed 3 ppm Fe diet [µg/g] None Iron level in spleen of 120 day old males and females fed 3 ppm Fe diet [µg/g] x x 109.37 57.51 190.818 67.055 x 72.505 56.452 181.781 65.53 102.448 57.729 54.75 x 52.509 133.35 27.069 x 49.433 x x x x x x 60.108 54.376 x 178.175 67.619 89.361 129.681 x x x 64.217 83.017 139.255 x 40.647 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12522 Original post publication description: Iron level of liver of 120-day-old males and females fed 3 ppm Fe diet [µg/g] None Iron level of liver of 120-day-old males and females fed 3 ppm Fe diet [µg/g] x x 28.426 29.155 33.364 38.214 x 30.886 28.6 28.412 30.209 28.929 24.913 20.5 x 33.057 40.98 23.231 x 36.108 x x x x x x 26.112 25.046 x 33.943 31.53 24.661 80.088 x x x 29.017 25.92 27.289 x 21.336 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12523 Original post publication description: Transferrin saturation in plasma of 120-day-old males and females fed 3 ppm Fe diet [%] None Transferrin saturation in plasma of 120-day-old males and females fed 3 ppm Fe diet [%] x x 25.515 13.118 22.4 14.535 x 16.224 7.167 20.275 18.795 23.256 34.05 25.85 x 21.076 30.22 26.677 x 26.4 x x x x x x 17.652 12.589 x 17.489 23.304 11.294 24.347 x x x 22.013 15.328 14.555 x 16.018 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12524 Original post publication description: Iron binding capacity (total) in plasma of 120-day-old males and females fed 3 ppm Fe diet [ug/dl] None Iron binding capacity (total) in plasma of 120-day-old males and females fed 3 ppm Fe diet [ug/dl] x x 531.721 698.193 668.5 873.932 x 699.281 827.596 983.725 755.437 715.956 448.95 781.95 x 852.523 724.16 914.392 x 1159.67 x x x x x x 839.554 816.944 x 778.716 656.521 853.4 916.765 x x x 686.409 785.62 808.505 x 1026.39 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12525 Original post publication description: Iron level of plasma of 120-day-old males and females fed 3 ppm Fe diet [µg/dl] None Blood chemistry, nutrition: Iron level of plasma of 120-day-old males and females fed 3 ppm Fe diet [µg/dl] x x 130.831 86.914 149.9 136.99 x 92.19 73.146 210.792 143.014 173.436 122.425 246.05 x 192.214 186.48 287.862 x 320.442 x x x x x x 138.983 92.322 x 137.575 144.227 84.912 234.865 x x x 142.173 110.544 119.016 x 149.808 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12526 Original post publication description: Blood chemistry, cardiovascular system, nutrition: Hemoglobin of 120-day-old males and females fed 3 ppm Fe diet [ug/dl] None Blood chemistry, cardiovascular system, nutrition: Hemoglobin of 120-day-old males and females fed 3 ppm Fe diet [ug/dl] x x 8.678 8.463 9.305 8.494 x 8.805 6.402 8.865 8.323 6.176 9.225 9.5 x 6.622 9.13 3.8 x 4.871 x x x x x x 5.634 7.078 x 11.416 7.687 7.589 9.026 x x x 6.824 7.783 9.298 x 4.316 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12527 Original post publication description: Blood chemistry, cardiovascular system: Hematocrit of 120-day-old males and females fed 3 ppm iron (Fe) diet. Blood chemistry, cardiovascular system: Hematocrit of 120-day-old males and females fed 3 ppm iron (Fe) diet [% packed red blood cells] Blood chemistry, cardiovascular system: Hematocrit of 120-day-old males and females fed 3 ppm iron (Fe) diet [% packed red blood cells] x x 37.643 35.345 40.111 35.571 x 36.909 27.963 34.059 34.5 28.346 31.875 41.5 x 32.714 34.4 19.385 x 25.0 x x x x x x 29.115 31.0 x 37.0 34.75 35.722 37.118 x x x 29.2 30.615 36.381 x 20.069 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12528 Original post publication description: Body weight of 120-day-old males and females fed 3 ppm Fe diet [g] None Body weight of 120-day-old males and females fed 3 ppm Fe diet [g] x x 23.756 27.145 21.133 27.838 x 25.477 22.938 27.341 24.508 22.65 25.85 24.9 x 30.667 30.1 23.033 x 24.608 x x x x x x 23.212 24.97 x 26.438 26.839 20.9 25.194 x x x 24.234 26.988 25.345 x 24.203 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12529 Original post publication description: Iron level in caudate-putamen of 120-day-old males and females fed 270 ppm Fe diet [µg/g] None Iron level in caudate-putamen of 120-day-old males and females fed 270 ppm Fe diet [µg/g] x x 12.266 11.897 12.231 12.953 x 18.111 14.695 14.167 16.145 12.578 x 12.867 x 15.716 16.967 13.806 x 12.795 x x x x x x 13.135 14.314 x 11.794 14.0 13.305 11.1 x x x 10.819 14.867 12.227 x 11.93 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12530 Original post publication description: Iron level in ventral midbrain of 120-day-old in males and females fed 270 ppm Fe diet [µg/g] None Iron level in ventral midbrain of 120-day-old in males and females fed 270 ppm Fe diet [µg/g] x x 15.231 14.81 18.162 14.019 x 19.543 14.208 14.645 13.68 15.715 x 15.05 x 15.62 15.7 14.119 x 15.04 x x x x x x 16.215 14.485 x 18.406 13.908 16.342 18.619 x x x 16.616 16.103 16.129 x 14.409 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12531 Original post publication description: Spleen weight of 120-day-old males and females fed 270 ppm Fe diet [g] None Spleen weight of 120-day-old males and females fed 270 ppm Fe diet [g] x x 0.063 0.073 0.093 0.156 x 0.061 0.069 0.086 0.054 0.062 x 0.116 x 0.104 0.086 0.084 x 0.105 x x x x x x 0.092 0.066 x 0.05 0.062 0.07 0.078 x x x 0.06 0.069 0.056 x 0.08 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12532 Original post publication description: Iron level in spleen of 120 day old males and females fed 270 ppm Fe diet [µg/g] None Iron level in spleen of 120 day old males and females fed 270 ppm Fe diet [µg/g] x x 1609.93 932.821 848.785 246.0 x 850.9 877.459 1099.53 1204.27 834.831 x 913.73 x 788.5 1050.87 572.45 x 750.395 x x x x x x 645.737 1199.17 x 3251.32 983.035 873.946 748.433 x x x 685.097 1017.29 921.853 x 326.669 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12533 Original post publication description: Iron level of liver of 120-day-old males and females fed 270 ppm Fe diet [µg/g] None Iron level of liver of 120-day-old males and females fed 270 ppm Fe diet [µg/g] x x 118.334 132.613 173.477 92.481 x 169.909 114.183 131.481 108.479 222.064 x 164.41 x 167.8 231.9 94.588 x 80.163 x x x x x x 150.14 108.47 x 152.839 219.389 136.908 172.348 x x x 95.409 80.96 118.822 x 67.359 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12534 Original post publication description: Transferrin saturation in plasma of 120-day-old males and females fed 270 ppm Fe diet [%] None Blood chemistry, pharmacology, nutrition: Transferrin saturation in plasma of 120-day-old males and females fed 270 ppm Fe diet [%] x x 31.59 40.16 17.64 21.345 x 33.33 27.559 29.968 30.468 27.977 x 32.52 x 34.53 38.233 23.327 x 24.689 x x x x x x 21.805 35.481 x 24.664 42.8 25.121 38.509 x x x 26.964 32.773 27.894 x 28.809 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12535 Original post publication description: Iron binding capacity (total) in plasma of 120-day-old males and females fed 270 ppm Fe diet [ug/dl] None Blood chemistry, metabolism, nutrition: Iron binding capacity (total) in plasma of 120-day-old males and females fed 270 ppm Fe diet [ug/dl] x x 428.359 501.76 818.26 823.275 x 472.914 661.268 733.414 572.005 482.262 x 742.08 x 705.574 523.233 692.933 x 673.787 x x x x x x 934.872 581.262 x 668.24 516.123 687.316 490.79 x x x 462.031 652.662 521.5 x 762.878 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12536 Original post publication description: Iron level of plasma of 120-day-old males and females fed 270 ppm Fe diet [µg/dl] None Iron level of plasma of 120-day-old males and females fed 270 ppm Fe diet [µg/dl] x x 131.737 190.197 188.0 170.665 x 148.326 191.662 204.732 171.64 129.73 x 228.29 x 231.665 199.0 162.7 x 161.325 x x x x x x 197.215 208.982 x 162.143 191.654 173.652 186.041 x x x 121.958 204.114 137.776 x 191.009 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12537 Original post publication description: Hemoglobin of 120-day-old males and females fed 270 ppm Fe diet [µg/dl] None Hemoglobin of 120-day-old males and females fed 270 ppm Fe diet [µg/dl] x x 13.145 12.361 18.419 11.898 x 11.418 11.968 13.452 12.503 11.941 x 13.384 x 11.637 12.547 12.679 x 11.817 x x x x x x 12.617 12.41 x 14.012 12.727 12.71 12.555 x x x 12.037 13.248 12.006 x 12.076 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12538 Original post publication description: Cardiovascular system: Hematocrit of 120-day-old males and females fed 270 parts per million iron (ppm Fe) diet [% packed red blood cells] None Cardiovascular system: Hematocrit of 120-day-old males and females fed 270 parts per million iron (ppm Fe) diet [% packed red blood cells] x x 45.621 43.821 56.308 45.25 x 43.955 46.087 46.714 44.333 43.962 x 48.9 x 43.95 44.0 46.067 x 42.579 x x x x x x 48.789 45.185 x 41.706 47.423 47.192 43.9 x x x 44.562 48.484 41.824 x 45.306 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12539 Original post publication description: Body weight of 120-day-old males and females fed 270 ppm Fe diet [g] None Morphology, nutrition, metabolism: Body weight of 120-day-old males and females fed 270 ppm Fe diet [g] x x 25.436 27.672 24.123 30.686 x 25.6 25.223 36.405 26.824 24.359 x 28.26 x 37.32 28.133 30.612 x 30.58 x x x x x x 29.03 26.096 x 29.212 26.837 24.046 28.227 x x x 26.368 36.769 26.739 x 27.457 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12540 Original post publication description: Transferrin saturation of 120-day-old females fed 3 ppm iron diet [%] None Transferrin saturation of 120-day-old females fed 3 ppm iron diet [%] x x 18.515 13.713 x 15.578 x 9.04 7.018 26.2 15.338 25.985 51.3 25.85 x 23.7 45.4 18.762 x 15.05 x x x x x x 16.446 13.692 x 14.9 20.95 13.289 21.16 x x x 17.964 15.785 12.911 x 11.24 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12541 Original post publication description: Iron binding capacity in plasma of 120-day-old females fed 3 ppm iron diet [µg/dL] None Iron binding capacity in plasma of 120-day-old females fed 3 ppm iron diet [µg/dL] x x 583.086 692.5 x 810.856 x 673.93 890.991 1079.3 718.55 581.577 478.975 781.95 x 738.44 645.033 821.514 x 1112.15 x x x x x x 753.933 818.846 x 825.557 608.55 798.611 904.93 x x x 583.885 795.7 755.889 x 920.894 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12542 Original post publication description: Plasma iron of 120-day-old females fed 3 ppm iron diet [ug/dL] None Blood chemistry, nutrition: Iron level of plasma of 120-day-old females fed 3 ppm Fe diet [ug/dL] x x 106.462 84.493 x 127.456 x 59.49 63.1 273.933 106.354 140.7 177.25 246.05 x 177.24 268.767 195.425 x 209.4 x x x x x x 115.8 94.977 x 120.443 106.7 84.287 198.78 x x x 85.093 100.5 102.211 x 81.386 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12543 Original post publication description: Transferrin saturation of 120-day-old males fed 3 ppm iron diet [%] None Transferrin saturation of 120-day-old males fed 3 ppm iron diet [%] x x 32.515 12.431 22.4 13.682 x 22.755 7.292 14.35 23.789 20.3 16.8 x x 18.691 7.45 39.34 x 28.67 x x x x x x 18.958 11.564 x 19.0 25.838 9.3 28.9 x x x 25.556 14.833 15.9 x 21.531 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12544 Original post publication description: Iron binding capacity in plasma of 120-day-old males fed 3 ppm iron diet [µg/dL] None Iron binding capacity in plasma of 120-day-old males fed 3 ppm iron diet [µg/dL] x x 480.357 703.887 668.5 930.7 x 722.327 777.786 888.15 807.08 861.533 418.925 x x 947.592 842.85 1044.42 x 1168.31 x x x x x x 925.175 815.179 x 751.392 704.493 902.71 933.671 x x x 788.933 774.7 855.86 x 1156.24 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12545 Original post publication description: Metabolism, blood chemistry, nutrition: Plasma iron of 120-day-old males fed 3 ppm iron (Fe) diet [ug/dL] None Metabolism, blood chemistry, nutrition: Plasma iron of 120-day-old males fed 3 ppm iron (Fe) diet [ug/dL] x x 155.2 89.336 149.9 144.142 x 121.918 81.04 147.65 195.967 208.9 67.6 x x 204.692 63.05 435.76 x 342.65 x x x x x x 162.167 89.857 x 146.8 181.754 85.467 286.414 x x x 192.119 121.425 134.14 x 229.633 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12546 Original post publication description: Transferrin saturation of 120-day-old females fed 270 ppm iron diet [%] None Blood chemistry, pharmacology, nutrition: Transferrin saturation of 120-day-old females fed 270 ppm iron diet [%] x x 33.523 43.981 22.45 20.289 x 36.711 31.589 28.592 33.393 27.15 x 33.929 x 39.57 38.233 22.857 x 24.143 x x x x x x 23.183 39.962 x 21.86 49.062 29.17 40.275 x x x 32.087 30.521 26.444 x 31.144 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12547 Original post publication description: Iron binding capacity in plasma of 120-day-old females fed 270 ppm iron diet [µg/dL] None Blood chemistry, metabolism, nutrition: Iron binding capacity in plasma of 120-day-old females fed 270 ppm iron diet [µg/dL] x x 458.971 457.781 835.85 843.222 x 466.289 579.86 636.992 539.386 479.4 x 750.114 x 684.26 523.233 635.071 x 687.257 x x x x x x 931.77 609.683 x 716.28 458.6 696.836 504.96 x x x 403.429 660.236 484.05 x 747.672 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12548 Original post publication description: Plasma iron of 120-day-old females fed 270 ppm iron diet [ug/dL] None Plasma iron of 120-day-old females fed 270 ppm iron diet [ug/dL] x x 150.393 193.869 183.775 157.678 x 163.28 195.01 176.783 177.373 133.6 x 237.571 x 244.12 199.0 160.843 x 161.314 x x x x x x 207.833 239.321 x 156.88 209.2 203.409 202.575 x x x 132.286 187.364 120.238 x 206.212 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12549 Original post publication description: Transferrin saturation of 120-day-old males fed 270 ppm iron diet [%] None Blood chemistry, pharmacology, nutrition: Transferrin saturation of 120-day-old males fed 270 ppm iron diet [%] x x 30.019 35.793 14.433 22.209 x 31.157 24.769 31.62 25.35 28.686 x 29.233 x 29.49 x 23.737 x 25.008 x x x x x x 19.737 31.0 x 26.222 36.538 22.229 33.8 x x x 22.694 34.744 29.344 x 26.335 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12550 Original post publication description: Iron binding capacity in plasma of 120-day-old males fed 270 ppm iron diet [µg/dL] None Iron binding capacity in plasma of 120-day-old males fed 270 ppm iron diet [µg/dL] x x 399.787 552.021 806.533 806.955 x 477.5 729.108 849.12 637.243 484.714 x 723.333 x 729.256 x 743.562 x 666.535 x x x x x x 939.525 556.9 x 644.22 565.429 679.836 455.367 x x x 507.611 645.593 554.789 x 778.083 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12551 Original post publication description: Plasma iron of 120-day-old males fed 270 ppm iron diet [ug/dL] None Plasma iron of 120-day-old males fed 270 ppm iron diet [ug/dL] x x 115.413 185.677 193.633 181.291 x 136.823 189.271 238.27 163.04 126.136 x 206.633 x 219.21 x 164.325 x 161.331 x x x x x x 181.287 178.643 x 165.067 174.108 150.271 141.95 x x x 113.453 219.747 153.367 x 174.856 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12553 Original post publication description: Cocaine and amphetamine-regulated transcript expression level in hypothalamus [relative concentration by PCR cycle count] None Cocaine and amphetamine-regulated transcript expression level in hypothalamus [relative concentration by PCR cycle count] x x 24.85 25.3 x x 24.3 25.2 23.6 x 24.95 23.4 x 26.87 x 25.95 26.1 25.75 x 25.8 22.5 24.55 x 24.05 24.25 23.2 24.6 x x 22.44 24.9 25.0 25.85 x 24.0 x 25.45 24.8 23.9 x 23.3 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12554 Original post publication description: Depression assay, duration of immobility during trial 1 of a tail suspension test (TST) using a 20% mobility threshold over a 5 min test for males [sec] None Central nervous system, behavior: Depression assay, duration of immobility during trial 1 of a tail suspension test (TST) using a 20% mobility threshold over a 5 min test for males [sec] x x 225.0 160.0 155.0 x 180.0 177.0 240.0 110.0 230.0 175.0 x x x 178.0 148.0 210.0 x 105.0 254.0 245.0 x 190.0 x 154.0 160.0 x 176.0 205.0 195.0 184.0 226.0 x x x x 228.0 196.0 x 147.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12557 Original post publication description: Neurexin 1 (Nrxn1) expression in hippocampus, principal component trait 1 (n=74 strains, all coding exons) from hippocampus Exon ST [PC z score] Central nervous system, gene expression: Neurexin 1 (Nrxn1) expression in hippocampus, first principal component generated using all coding exon probe sets and UMUTAffyExon_0209_RMA data [relative residual concentration] Central nervous system, gene expression: Neurexin 1 (Nrxn1) expression in hippocampus, first principal component generated using all coding exon probe sets and UMUTAffyExon_0209_RMA data [relative residual concentration] 1.438 -1.427 -0.33 -2.209 1.487 -3.072 0.675 1.618 1.298 1.543 -1.025 -1.17 2.902 -1.513 -0.279 1.757 1.02 2.134 -2.563 -3.854 0.863 0.368 x 3.06 -1.326 -2.317 -1.264 2.004 x -0.598 -1.462 1.023 1.055 x -3.769 x -2.951 -1.305 -2.059 x 2.37 1.215 x 2.242 x x 3.103 x 2.518 4.93 x x x -1.648 x x x x 3.987 1.462 -0.579 -3.843 0.652 -1.583 1.873 -5.141 1.315 3.806 0.321 x x 0.721 -1.533 -2.434 -3.481 1.193 x -3.984 0.987 x x 1.734 1.795 -0.232 1.559 3.984 x -1.769 0.81 x -0.103 -0.261 -4.213 x 1.008 -0.779 -2.635 0.881 x x x x +13015 Original post publication description: Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), median body weight loss day 11 after infection in 9-14 week-old females [%], file: mm2_weight_median_variantII_hko_180311 Original pre publication description: Infectious disease, immune function: Schughart (kls@helmholtz-hzi.de) WP12, median BWL day 11 [%], file hko_180311_vII Infectious disease, immune function: Schughart (kls@helmholtz-hzi.de) WP12, median BWL day 11 [%] Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), median body weight loss day 11 after infection in 9-14 week-old females [%] x 95.3 95.48 75.0 100.3 90.0 75.85 x 98.35 100.8 89.65 75.0 95.55 75.0 75.0 75.0 75.0 75.0 90.7 90.05 x 89.6 x x x x 75.0 x x 75.0 84.1 x 75.0 x 75.0 x 75.0 92.15 75.0 x 96.85 103.3 75.0 x x x x x x 75.0 x x x 75.0 75.0 x x x 87.57 92.2 75.0 x x 78.95 x 89.35 x 91.3 75.0 89.94 x 75.0 75.0 99.04 x x x 94.62 75.0 x x x 92.93 x x 82.26 x 75.0 x x 91.37 x x x 94.9 99.15 96.8 x 92.94 x 75.0 75.0 +12560 Original post publication description: Infectious disease, immune function: weight loss [percent] None Infectious disease, immune function: Weight loss after Francisella tularensis live vaccine strain (FTLVS) intratracheal [percent] x x 2.159 1.836 x x x x x x x x x x x x x x x x x x x x x x x x x x -6.069 x x x x x x x x x x x x x x x x -0.26 x 3.184 x x x x 1.636 x x x x x x x x x x x x -6.407 2.938 x x 0.796 x x x x x x x -1.577 x x x x x x x -4.355 x x x x x x 4.046 x x x x x x 2.072 +12561 Original post publication description: Infectious disease, immune function: weight loss [slope] None Infectious disease, immune function: Weight loss after Francisella tularensis live vaccine strain (FTLVS) intratracheal [slope] x x 0.396 0.369 x x x x x x x x x x x x x x x x x x x x x x x x x x 0.076 x x x x x x x x x x x x x x x x -0.787 x -0.334 x x x x 0.674 x x x x x x x x x x x x -0.735 0.324 x x -0.363 x x x x x x x 0.837 x x x x x x x 0.356 x x x x x x -0.478 x x x x x x -0.334 +12562 Original post publication description: Infectious disease, immune function: survival [coefficient] None Infectious disease, immune system: Survival after Francisella tularensis live vaccine strain (FTLVS) intratracheal [coefficient] x x 0.469 0.797 x x x x x x x x x x x x x x x x x x x x x x x x x x 0.839 x x x x x x x x x x x x x x x x -0.211 x 0.155 x x x x 0.255 x x x x x x x x x x x x 0.2 -0.197 x x -0.093 x x x x x x x -0.078 x x x x x x x -1.245 x x x x x x -0.245 x x x x x x -0.645 +12563 Original post publication description: Life span, longevity of males on ad libitum diet, 12 hr light cycle [median of 12 animals in days] (BXD13=116 days and BXD31=434 days are deleted outliers) None Life history, aging: Life span, longevity of males on ad libitum diet, 12 hr light cycle [median of 12 animals in days] (BXD13=116 days and BXD31=434 days are deleted outliers) x x 781.0 673.0 x 769.0 x 704.0 722.0 x 845.0 792.0 x 570.0 x 677.0 x 951.0 x x 727.0 x x 814.0 x 832.0 588.0 804.0 700.0 x 561.0 911.0 763.0 x x x 866.0 669.0 796.0 x 760.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12564 Original post publication description: Life history, aging: Life span, longevity of females on ad libitum diet, 12 hr light cycle [median of 12 animals in days] (BXD13=158 days and BXD31=264 days are deleted outliers) None Life history, aging: Life span, longevity of females on ad libitum diet, 12 hr light cycle [median of 12 animals in days] (BXD13=158 days and BXD31=264 days are deleted outliers) x x 704.0 645.0 x 463.0 x 717.0 618.0 x 797.0 671.0 x 428.0 x 681.0 x 893.0 x x 697.0 x x 775.0 x 860.0 798.0 792.0 815.0 x 704.0 821.0 942.0 x x x 689.0 747.0 610.0 x 575.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12565 Original post publication description: Ethanol response (10% in tap water), average daily preference ratio, two-bottle choice in males and females [EtOH/water ratio] None Central nervous system, pharmacology, behavior: Ethanol response (10% in tap water), average daily preference ratio, two-bottle choice in males and females [EtOH/water ratio] x x x x 0.46 x x 0.49 x 0.11 0.24 0.22 0.07 0.2 x 0.43 x 0.2 x x 0.04 x 0.25 0.11 x 0.54 x x x 0.86 0.03 x 0.16 x 0.12 x 0.19 x 0.39 0.21 0.12 0.28 0.17 0.16 x x 0.81 0.67 x 0.21 x x x 0.29 0.25 x x x 0.48 x x x x x 0.19 0.19 0.19 0.23 0.48 0.16 x 0.25 x 0.19 x 0.27 x 0.37 0.46 x x 0.02 0.37 0.18 0.3 0.18 x 0.12 0.31 x 0.2 x x x x x 0.07 x 0.19 x 0.08 0.23 +12566 Original post publication description: Central nervous system, pharmacology, endocrinology: Deoxycorticosterone (DOC) in blood plasma 6 hours after dexamethasone (0.075 mg/kg ip) in adult males [ng/g] None Central nervous system, pharmacology, endocrinology: Deoxycorticosterone (DOC) in blood plasma 6 hours after dexamethasone (0.075 mg/kg ip) in adult males [ng/g] x 1.229 3.113 1.105 x 1.066 5.074 1.446 x 3.97 x 3.15 1.639 2.116 1.21 2.388 2.197 0.874 x 0.714 x x x 2.769 x 2.482 1.773 2.229 x 1.92 4.324 x 3.532 x x x x 2.794 2.188 x x 1.741 2.713 1.287 x x 1.091 x x 0.915 x x x x x x x x 2.571 x 2.059 x x x 1.908 x x 0.766 1.397 x x 1.17 x 1.113 x 2.09 x x 1.117 x x x 0.646 1.319 1.68 0.809 x 0.607 x x 3.571 x x x 1.314 x x x 1.406 x 1.646 1.377 +12567 Original post publication description: Central nervous system, pharmacology, endocrinology: Deoxycorticosterone (DOC) in blood plasma 6 hours after saline control injection (ip) in adult males [ng/g] None Central nervous system, pharmacology, endocrinology: Deoxycorticosterone (DOC) in blood plasma 6 hours after saline control injection (ip) in adult males [ng/g] x 7.616 4.655 4.177 x 5.565 8.757 5.341 x 5.528 x 9.56 5.55 7.574 4.675 10.319 8.456 3.803 x 5.082 x x x 6.623 x 12.13 8.492 5.407 x 6.004 8.905 x 8.155 x x x x 6.178 3.947 x x 4.969 7.042 5.809 x x 5.962 x x 4.596 x x x x x x x x 7.07 x 8.328 x x x 4.484 x x 5.255 3.847 x x 4.149 x 3.642 x 6.266 x x 4.869 x x x 5.695 5.272 8.388 4.802 x 2.841 x x 4.543 x x x 5.24 x x x 7.234 x 4.808 5.27 +12568 Original post publication description: Central nervous system, pharmacology, endocrinology: Deoxycorticosterone (DOC) in cerebral cortex 6 hours after saline control injection (ip) in adult males [ng/g] None Central nervous system, pharmacology, endocrinology: Deoxycorticosterone (DOC) in cerebral cortex 6 hours after saline control injection (ip) in adult males [ng/g] x 5.906 3.369 2.469 x 6.9 8.826 8.284 x 4.488 x 12.192 4.521 8.212 5.786 9.405 8.421 4.305 x 6.137 x x x 3.574 x 9.928 x 7.039 x 7.45 10.216 x x x x x x 4.744 x x x 4.004 6.882 3.933 x x 6.42 x x 1.938 x x x x x x x x x x 6.548 x x x 3.055 x x 4.028 1.431 x x 3.327 x 1.865 x 2.845 x x 1.954 x x x 3.566 2.963 4.663 5.968 x 2.962 x x 3.066 x x x 3.665 x x x x x 2.943 2.942 +12569 Original post publication description: Central nervous system, pharmacology, endocrinology: Deoxycorticosterone (DOC) in cerebral cortex 6 hours after dexamethasone (0.075 mg/kg ip) in adult males [ng/g] None Central nervous system, pharmacology, endocrinology: Deoxycorticosterone (DOC) in cerebral cortex 6 hours after dexamethasone (0.075 mg/kg ip) in adult males [ng/g] x 0.609 1.641 0.481 x 0.589 4.181 1.569 x 3.472 x 4.472 0.467 1.306 0.678 1.607 1.357 0.747 x 0.367 x x x 1.008 x 1.329 x 0.532 x 1.665 2.657 x x x x x x 3.545 x x x 0.871 2.052 0.155 x x 0.368 x x 0.36 x x x x x x x x x x 0.939 x x x 0.331 x x 0.371 0.161 x x 0.824 x 0.384 x 0.386 x x 0.378 x x x 0.225 0.042 0.598 1.783 x 0.502 x x 1.857 x x x 0.032 x x x x x 0.641 0.253 +12574 Original post publication description: Ethanol response, consumption using 2-bottle choice, 2h access, week 6 average [log g/kg/2h] None Central nervous system, pharmacology, behavior: Ethanol response, consumption of 15% ethanol (v/v) using two-bottle choice system (ethanol vs water), 2-hour access, 6th week average, young adult male or female [log g/kg/2h] x 0.391 0.359 0.143 x x 0.14 x x x x 0.294 x 0.094 x 0.255 x 0.004 x x x x x 0.277 x x x x x x 0.099 x 0.246 x 0.23 x 0.329 0.11 x x x 0.255 0.171 0.379 x x x 0.221 0.237 0.224 x x x 0.35 x x x x x 0.071 0.509 x 0.194 x 0.09 x 0.426 0.419 x 0.095 x 0.251 0.147 0.222 x 0.041 x x 0.199 0.744 x -0.037 0.085 0.291 x 0.111 x 0.028 -0.035 x x x x x x x x 0.508 0.222 0.225 0.269 0.228 +12575 Original post publication description: Ethanol response, consumption using 2-bottle choice, 2h access, week 5 average [log g/kg/2h] None Central nervous system, pharmacology, behavior: Ethanol response, consumption of 15% ethanol (v/v) using two-bottle choice system (ethanol vs water), 2-hour access, 5th week average, young adult male or female [log g/kg/2h] x 0.359 0.359 0.2 x x 0.072 x x x x 0.142 x 0.096 x 0.292 x 0.156 x x x x x 0.291 x x x x x x 0.063 x 0.384 x 0.14 x 0.215 -0.033 x x x 0.41 0.059 0.155 x x x 0.214 0.507 -0.015 x x x 0.618 x x x x x 0.09 0.437 x 0.416 x 0.1 x 0.345 0.327 x 0.327 x 0.257 0.316 0.361 x 0.02 x x 0.343 0.656 x 0.136 0.268 0.409 x 0.322 x 0.164 0.07 x x x x x x x x 0.394 0.105 0.225 0.312 0.079 +12576 Original post publication description: Ethanol response, 2-bottle choice 2 h access consumption, week 4 [log transformed g/kg/2h] None Central nervous system, pharmacology, behavior: Ethanol response, consumption of 15% ethanol (v/v) using two-bottle choice system (ethanol vs water), 2-hour access, 4th week average, young adult male or female [log g/kg/2h] x 0.32 0.421 0.198 x x 0.221 x x x x 0.254 x 0.07 x 0.357 x 0.123 x x x x x 0.306 x x x x x x 0.119 x 0.268 x 0.259 x 0.1 -0.239 x x x 0.354 0.113 0.153 x x x 0.361 0.387 0.102 x x x 0.544 x x x x x 0.099 0.61 x 0.06 x 0.216 x 0.398 0.439 x 0.088 x 0.46 0.057 0.156 x 0.113 x x 0.341 0.571 x 0.485 0.131 0.286 x 0.275 x -0.045 0.029 x x x x x x x x 0.488 0.171 0.145 0.161 0.168 +12577 Original post publication description: Ethanol response, consumption using a two-bottle choice, 2 hour access (g/kg/2h), third week average, data log transformed [log ml] None Central nervous system, pharmacology, behavior: Ethanol response, consumption of 15% ethanol (v/v) using two-bottle choice system (ethanol vs water), 2-hour access, 3rd week average, young adult male or female [log g/kg/2h] x 0.349 0.41 0.077 x x 0.105 x x x x 0.166 x 0.166 x 0.283 x 0.09 x x x x x 0.089 x x x x x x 0.136 x 0.289 x 0.098 x 0.023 -0.036 x x x -0.02 -0.112 0.182 x x x 0.183 0.509 0.057 x x x 0.601 x x x x x 0.201 0.681 x 0.108 x 0.327 x 0.382 0.631 x 0.232 x 0.365 0.191 0.375 x 0.22 x x 0.437 0.617 x 0.243 0.286 0.277 x 0.427 x 0.307 0.082 x x x x x x x x 0.596 0.192 0.035 0.033 0.026 +12578 Original post publication description: Ethanol response, consumption using 2-bottle choice, 2h access, week 2 average [log g/kg/2h] None Central nervous system, pharmacology, behavior: Ethanol response, consumption of 15% ethanol (v/v) using two-bottle choice system (ethanol vs water), 2-hour access, 2nd week average, young adult male or female [log g/kg/2h] x 0.312 0.389 0.106 x x 0.075 x x x x 0.073 x -0.02 x 0.132 x 0.017 x x x x x 0.207 x x x x x x 0.113 x 0.364 x 0.203 x 0.213 0.022 x x x 0.262 0.093 0.139 x x x 0.072 0.267 -0.011 x x x 0.39 x x x x x -0.044 0.65 x 0.021 x 0.168 x 0.306 0.413 x 0.421 x 0.27 0.106 0.16 x 0.127 x x 0.357 0.373 x 0.227 0.119 0.26 x 0.116 x -0.057 0.081 x x x x x x x x 0.408 0.179 0.054 0.189 0.091 +12579 Original post publication description: Ethanol response, 2-bottle choice 2 h access consumption, week 1 [log transformed g/kg/2h] None Central nervous system, pharmacology, behavior: Ethanol response, consumption of 15% ethanol (v/v) using two-bottle choice system (ethanol vs water), 2-hour access, 1st week average, young adult male or female [log g/kg/2h] x 0.321 0.445 0.059 x x 0.207 x x x x 0.194 x 0.118 x 0.29 x 0.161 x x x x x 0.064 x x x x x x -0.051 x 0.022 x 0.149 x 0.179 0.092 x x x 0.243 0.093 0.165 x x x 0.281 0.341 0.197 x x x 0.362 x x x x x 0.071 0.526 x 0.013 x 0.176 x 0.04 0.402 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12580 Original post publication description: Ethanol response, 2-bottle choice 2 h access consumption, principal component 1 based on weeks 1-6 [log transformed g/kg/2h] None Central nervous system, pharmacology, behavior: Ethanol response, 2-bottle choice 2 h access consumption, principal component 1 based on weeks 1-6 data [log transformed g/kg/2h] x -1.882 -2.692 1.354 x x 1.233 x x x x 0.429 x 2.055 x -0.712 x 1.996 x x x x x 0.16 x x x x x x 2.178 x -0.563 x 0.542 x 0.488 3.439 x x x -0.592 2.131 0.261 x x x -0.051 -2.184 1.82 x x x -3.742 x x x x x 2.191 -5.24 x 1.302 x 0.735 x -1.428 -3.228 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12974 Original post publication description: Hippocampus dentate gyrus cells positive for Calretinin immunohistochemistry [Number of cells] None Central nervous system, morphology, protein expression: Hippocampus dentate gyrus cells positive for calretinin protein (CALB2) by immunohistochemistry [n total, unilateral] x x x 1065.0 951.0 x 2367.0 3147.0 x 1716.0 648.0 962.0 x 3139.0 x 1834.0 1726.5 3301.0 x x 2691.0 x x x 2781.0 2352.0 1222.0 2461.0 1513.0 1952.0 726.0 1682.0 841.0 x x x 2410.5 1274.0 2110.0 x 2218.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12975 Original post publication description: Hippocampus dentate gyrus cells positive for Doublecortin immunohistochemistry [Number of cells] None Central nervous system, behavior, neurogenesis: Hippocampus dentate gyrus cells positive for doublecortin protein (DCX) by immunohistochemistry [n total, unilateral] x x 1956.0 842.4 1467.0 738.0 1745.0 2926.0 x 1678.0 555.0 1062.0 x 3039.0 1959.0 1220.0 1159.5 2212.0 x x 2099.0 x x 1457.0 2319.0 2433.0 2319.0 3288.0 3052.0 2986.0 1479.0 2784.0 1615.0 x x x 2748.0 1381.0 2930.0 x 2283.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12977 Original post publication description: Blood chemistry, pharmacology: Alanine transaminase (ALT, ALAT, SGPT) level in serum following alcohol concentration at 1-3hr [mg/dl] in males and females [U/L] None Blood chemistry, pharmacology: Alanine transaminase (ALT, ALAT, SGPT) level in serum following alcohol concentration at 1-3hr [mg/dl] in males and females [U/L] x x 520.62 x x x x x x x x x x x x 545.66 x 519.4 x x x x 593.2 x x x x x x x 527.64 x 659.96 x x x 481.76 674.24 609.8 x 642.7 544.12 644.16 512.72 x x 442.72 x 581.32 515.84 x x x 560.54 613.92 x x x 624.08 471.64 605.88 x x x 698.12 x 544.28 600.88 624.6 505.82 x 403.64 x 744.52 x 535.48 x x x x x 507.04 494.96 x 454.18 731.24 x 582.82 587.32 x x x x x 478.0 x 373.2 x 594.34 570.18 473.84 451.48 +12978 Original post publication description: Blood chemistry, pharmacology: Alanine transaminase (ALT, ALAT, SGPT) level in serum following alcohol (6 gm ethanol/kg via gastric gavage) at 24 hours in males and females [U/L] None Blood chemistry, pharmacology: Alanine transaminase (ALT, ALAT, SGPT) level in serum following alcohol (6 gm ethanol/kg via gastric gavage) at 24 hours in males and females [U/L] x x 16.68 19.71 x x x x x x x x x x x 21.3 x 54.6 x x x x 54.84 x x x x x x x 20.62 x 19.2 x x x 71.96 24.08 43.28 x 45.62 28.8 40.56 50.28 x x 35.88 x 32.16 34.76 x x x 33.86 19.38 x x x 15.98 21.3 36.68 x x x 13.28 x 29.6 23.93 19.52 44.56 x 25.88 x 14.2 x 34.24 x x x x x 41.0 51.04 x 26.28 17.64 x 33.0 39.32 x x x x x 17.04 x 25.33 x 22.26 21.32 37.96 31.8 +12979 Original post publication description: Liver distress test activity (serum alanine aminotransferase activity at 24hr post-gavage) [IU/L] None Liver, metabolism, toxicology: Liver distress test, serum alanine aminotransferase activity at 24 hr post-gavage [IU/L] x x 78.58 89.37 x x x x x x x x x x x 107.49 x 45.34 x x x x 61.7 x x x x x x x 57.46 x 59.23 x x x 60.46 56.22 56.05 x 78.62 65.36 66.81 51.98 x x 50.92 x 48.97 51.27 x x x 53.1 61.0 x x x 53.18 68.07 54.28 x x x 57.64 x 52.68 91.05 67.36 52.69 x 47.03 x 54.98 x 52.69 x x x x x 55.16 50.04 x 54.28 69.42 x 52.33 46.67 x x x x x 53.57 x 46.26 x 83.27 62.58 48.44 71.43 +12980 Original post publication description: Liver distress test fold change (serum alanine aminotransferase activity fold change at 24hr post-gavage relative to averaged saline control activity) [ratio] None Liver, metabolism, toxicology: Liver distress test, serum alanine aminotransferase activity fold change at 24 hr post-gavage in adults relative to averaged saline control activity) [ratio] x x 1.58 1.8 x x x x x x x x x x x 2.16 x 0.91 x x x x 1.24 x x x x x x x 1.16 x 1.19 x x x 1.22 1.13 1.13 x 1.58 1.32 1.34 1.05 x x 1.02 x 0.99 1.03 x x x 1.07 1.23 x x x 1.07 1.37 1.09 x x x 1.16 x 1.06 1.83 1.36 1.06 x 0.95 x 1.11 x 1.06 x x x x x 1.11 1.01 x 1.09 1.4 x 1.05 0.94 x x x x x 1.08 x 0.93 x 1.68 1.26 0.97 1.44 +12981 Original post publication description: Blood chemistry, pharmacology: Alanine transaminase (ALT, ALAT, SGPT) level in serum following alcohol concentration at 1-3hr [mg/dl] in females [U/L] None Blood chemistry, pharmacology: Alanine transaminase (ALT, ALAT, SGPT) level in serum following alcohol concentration at 1-3hr [mg/dl] in females [U/L] x x 438.2 507.25 x x x x x x x x x x x 506.27 x 457.07 x x x x 600.6 x x x x x x x 360.93 x 747.2 x x x 544.13 655.0 521.67 x 455.43 514.0 576.0 475.13 x x 453.53 x 600.2 491.4 x x x 521.27 488.6 x x x 604.4 481.4 639.5 x x x 533.33 x 448.8 563.9 531.47 387.6 x 471.93 x 478.53 x 527.27 x x x x x 385.2 364.73 x 421.2 625.0 x 621.07 619.4 x x x x x 411.4 x 375.67 x 618.35 546.9 452.1 483.4 +12983 Original post publication description: Blood chemistry, pharmacology: Alanine transaminase (ALT, ALAT, SGPT) level in serum following alcohol (6 gm ethanol/kg via gastric gavage) at 24 hours in females [U/L] None Blood chemistry, pharmacology: Alanine transaminase (ALT, ALAT, SGPT) level in serum following alcohol (6 gm ethanol/kg via gastric gavage) at 24 hours in females [U/L] x x 21.63 14.7 x x x x x x x x x x x 20.57 x 51.4 x x x x 42.73 x x x x x x x 30.53 x 27.4 x x x 51.47 18.6 47.2 x 25.83 30.0 31.47 27.07 x x 35.4 x 32.33 25.47 x x x 48.13 19.0 x x x 15.05 21.3 18.0 x x x 13.33 x 36.27 14.13 20.67 34.8 x 26.73 x 16.67 x 49.1 x x x x x 54.0 39.07 x 41.93 24.2 x 40.6 50.67 x x x x x 11.4 x 28.4 x 17.15 18.13 15.8 28.07 +12984 Original post publication description: Liver distress test activity in females (serum alanine aminotransferase activity at 24hr post-gavage) [IU/L] None Liver, metabolism, toxicology: Liver distress test, serum alanine aminotransferase activity at 24 hr post-gavage in females [IU/L] x x 81.91 77.34 x x x x x x x x x x x 73.96 x 48.44 x x x x 65.71 x x x x x x x 62.17 x 66.3 x x x 47.14 51.57 49.5 x 74.45 52.74 67.29 54.81 x x 56.28 x 62.47 49.8 x x x 45.47 64.98 x x x 49.95 70.72 52.16 x x x 51.86 x 38.3 80.15 43.91 43.32 x 44.17 x 51.56 x 43.91 x x x x x 60.11 48.03 x 42.14 67.18 x 50.09 48.03 x x x x x 57.91 x 48.32 x 83.1 38.89 68.51 80.74 +12584 Original post publication description: Endocrinology: Thyroxine (T4), free level in serum, control pre-immunization in females 5-8 weeks old, by radioimmunoassay [ng/dL] None Endocrinology: Thyroxine (T4), free level in serum, control pre-immunization in females 5-8 weeks old, by radioimmunoassay [ng/dL] x x 0.57 0.48 x x x x x x 0.49 0.46 0.5 x x 0.6 x x x x x x x x x x x x x x 0.54 x x x x x x x 0.41 x x 0.51 x x x x 0.65 0.62 x x x x x x x x x x x x x x x 0.59 x 0.44 x x 0.58 x x 0.29 x 0.31 x x x x 0.37 x x x x x x 0.39 x x x x x x x x x 0.45 x 0.47 0.5 0.55 x 0.46 +12585 Original post publication description: Endocrinology: Thyroxine (T4), total level in serum, control pre-immunization in females 5-8 weeks old, by radioimmunoassay [ug/dL] None Endocrinology: Thyroxine (T4), total level in serum, control pre-immunization in females 5-8 weeks old, by radioimmunoassay [ug/dL] x x 3.7 3.37 x x x x x x 4.18 3.74 4.64 x x 3.28 x x x x x x x x x x x x x x 4.15 x x x x x x x 4.01 x x 4.15 x x x x 4.19 3.4 x x x x x x x x x x x x x x x 4.11 x 3.97 x x 4.91 x x 3.55 x 2.73 x x x x 3.44 x x x x x x 3.94 x x x x x x x x x 2.96 x 3.5 4.0 3.52 x 3.66 +12586 Original post publication description: Ethanol response (10% in tap water), average daily consumption, two-bottle choice, males and females [g/kg] None Central nervous system, pharmacology, behavior: Ethanol response (10% in tap water), average daily consumption, two-bottle choice, males and females [g/kg] x x x x 2.86 x x 7.6 x 1.85 2.34 1.96 0.94 3.93 x 4.37 x 3.59 x x 0.61 x 4.56 2.33 x 4.76 x x x 4.67 0.7 x 2.76 x 1.7 x 2.16 x 4.25 1.81 3.08 8.38 2.57 3.28 x x 6.4 1.43 x 3.42 x x x 3.86 5.99 x x x 7.04 x 5.62 x x x 2.99 4.0 3.7 4.4 8.07 3.41 x 3.19 x 3.44 x 5.05 x 8.17 5.44 x x 1.24 5.37 3.41 5.75 3.74 x 3.42 3.49 x 3.17 x x x x x 0.68 x 3.96 x x 5.52 +12587 Original post publication description: Hippocampus mossy fiber pathway volume, total without IMF (hilus + SMF) [mm^3] None Central nervous system, morphology: Hippocampus mossy fiber pathway volume, total without IMF (hilus + SMF) [mm^3] x x 0.28 0.308 0.325 0.251 0.298 0.297 x 0.359 0.229 0.22 x 0.251 0.244 0.323 0.311 0.329 x 0.284 0.29 x x 0.173 0.214 0.219 0.177 0.184 0.202 0.234 0.231 0.217 0.2 0.358 x x 0.273 0.312 0.285 x 0.227 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12588 Original post publication description: Hippocampus mossy fiber pathway volume, infrapyramidal (IMF) [mm^3] None Central nervous system, morphology: Hippocampus mossy fiber pathway volume, infrapyramidal (IMF) [mm^3] x x 0.044 0.02 0.036 0.042 0.046 0.024 x 0.028 0.021 0.035 x 0.021 0.024 0.038 0.052 0.029 x 0.037 0.025 x x 0.026 0.021 0.028 0.022 0.015 0.028 0.023 0.021 0.028 0.036 0.037 x x 0.036 0.025 0.03 x 0.029 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12589 Original post publication description: Central nervous system, morphology: Hippocampus mossy fiber pathway volume, suprapyramidal (SMF) [mm^3] None Central nervous system, morphology: Hippocampus mossy fiber pathway volume, suprapyramidal (SMF) [mm^3] x x 0.155 0.217 0.206 0.158 0.163 0.189 x 0.199 0.111 0.136 x 0.162 0.165 0.19 0.166 0.197 x 0.185 0.185 x x 0.107 0.15 0.148 0.112 0.114 0.118 0.145 0.13 0.118 0.114 0.198 x x 0.159 0.158 0.156 x 0.115 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12590 Original post publication description: Hippocampus mossy fiber pathway volume, hilus [mm^3] None Central nervous system, morphology: Hippocampus mossy fiber pathway volume, hilus [mm^3] x x 0.125 0.09 0.119 0.093 0.135 0.108 x 0.16 0.118 0.084 x 0.089 0.08 0.133 0.145 0.132 x 0.099 0.105 x x 0.066 0.064 0.071 0.065 0.07 0.084 0.089 0.1 0.099 0.086 0.161 x x 0.114 0.154 0.129 x 0.112 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12591 Original post publication description: Hippocampus mossy fiber pathway volume, total (hilus + IMF + SMF) [mm^3] None Central nervous system, morphology: Hippocampus mossy fiber pathway volume, total (hilus + IMF + SMF) [mm^3] x x 0.324 0.327 0.361 0.293 0.344 0.321 x 0.387 0.249 0.255 x 0.272 0.269 0.361 0.364 0.358 x 0.322 0.316 x x 0.199 0.236 0.247 0.199 0.199 0.231 0.257 0.252 0.245 0.236 0.395 x x 0.309 0.337 0.314 x 0.256 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12592 Original post publication description: Urogenital system, kidney, morphology: Kidney morphology, number of podocytes per unit glomerular surface area following longterm diabetes (streptozotocin treatment) [n/1000 um2] None Urogenital system, kidney, morphology: Kidney morphology, number of podocytes per unit glomerular surface area following longterm diabetes (streptozotocin treatment) [n/1000 um2] x x 4.508 2.684 x x x 4.911 x 6.174 3.7 2.82 2.899 3.241 x x 5.128 x 5.243 x x x x x x x 3.957 x x x x 4.928 5.099 x 3.455 x x x 5.376 x 3.576 5.214 x x x x x x x 5.854 x x x 6.032 x x x x x 3.737 2.385 5.687 x 5.289 2.927 2.822 5.328 3.313 2.891 4.713 x 5.858 x 6.737 x x x x 6.447 x x 5.941 5.789 x 5.637 6.536 x 4.852 6.448 x x x x x 5.24 x x x 5.536 x x x +12593 Original post publication description: Urogenital system, kidney, morphology: Kidney morphology, total glomerular cell count per glomerular surface area following longterm diabetes (streptozotocin treatment) [n/1000 um2] None Urogenital system, kidney, morphology: Kidney morphology, total glomerular cell count per glomerular surface area following longterm diabetes (streptozotocin treatment) [n/1000 um2] x x 13.73 11.284 x x x 15.589 x 16.916 12.891 11.456 12.073 14.456 x x 15.783 x 16.713 x x x x x x x 13.412 x x x x 15.099 16.886 x 12.435 x x x 15.094 x 14.502 14.83 x x x x x x x 16.729 x x x 16.43 x x x x x 14.315 11.275 16.351 x 15.135 12.614 12.054 16.167 12.601 11.293 16.062 x 17.87 x 19.465 x x x x 18.072 x x 17.183 16.829 x 19.318 17.363 x 17.136 18.136 x x x x x 16.971 x x x 15.967 x x x +12594 Original post publication description: Urogenital system, kidney, morphology: Kidney morphology, podocyte (WT1-positive cells) count per glomerular section following longterm diabetes (streptozotocin treatment) [n] None Urogenital system, kidney, morphology: Kidney morphology, podocyte (WT1-positive cells) count per glomerular section following longterm diabetes (streptozotocin treatment) [n] x x 12.587 9.335 x x x 12.467 x 12.807 11.244 9.896 10.033 9.8 x x 12.527 x 13.057 x x x x x x x 11.384 x x x x 12.3 12.841 x 9.661 x x x 12.583 x 9.443 12.433 x x x x x x x 12.909 x x x 13.997 x x x x x 11.065 9.35 12.533 x 12.244 9.067 9.11 12.684 9.386 8.7 13.25 x 12.68 x 13.4 x x x x 12.34 x x 13.09 12.17 x 12.88 12.22 x 10.33 13.15 x x x x x 11.72 x x x 13.07 x x x +12595 Original post publication description: Urogenital system, kidney, morphology: Kidney morphology, glomerular surface area following longterm diabetes (streptozotocin treatment) [1000 um2] None Urogenital system, kidney, morphology: Kidney morphology, glomerular surface area following longterm diabetes (streptozotocin treatment) [1000 um2] x x 3050.63 3958.44 x x x 2722.64 x 2237.87 3251.71 3937.85 3653.4 3187.0 x x 2544.4 x 2755.01 x x x x x x x 3049.43 x x x x 2785.51 2705.88 x 3136.59 x x x 2478.85 x 2843.48 2517.37 x x x x x x x 2367.36 x x x 2442.37 x x x x x 3191.15 4286.01 2398.83 x 2450.01 3393.94 3487.5 2509.83 3150.41 3239.77 2985.55 x 2235.75 x 2122.05 x x x x 1998.94 x x 2321.1 2268.0 x 2369.2 1975.0 x 2236.63 2195.18 x x x x x 2362.19 x x x 2495.35 x x x +12596 Original post publication description: Kidney morphology, WT1-negative cell count per glomerular section following longterm diabetes (streptozotocin treatment) [units] None Urogenital system, kidney, morphology: WT1-negative cell count per glomerular section following longterm diabetes (streptozotocin treatment) [units] x x 28.042 33.343 x x x 28.967 x 24.226 29.208 33.579 33.367 35.35 x x 27.682 x 31.281 x x x x x x x 28.327 x x x x 27.4 31.272 x 27.706 x x x 24.633 x 30.485 24.467 x x x x x x x 25.812 x x x 25.562 x x x x x 33.96 36.25 25.322 x 24.444 32.533 31.425 27.25 29.024 26.69 34.042 x 27.029 x 27.733 x x x x 23.29 x x 26.24 25.584 x 32.967 21.156 x 27.446 25.744 x x x x x 27.689 x x x 25.91 x x x +12597 Original post publication description: Urogenital system, morphology: Kidney, total glomerular cell count per glomerular section following longterm diabetes (streptozotocin treatment) [units] None Urogenital system, kidney, morphology: Kidney, total glomerular cell count per glomerular section following longterm diabetes (streptozotocin treatment) [units] x x 40.628 42.678 x x x 41.434 x 37.033 40.452 43.475 43.4 45.15 x x 40.209 x 44.338 x x x x x x x 39.711 x x x x 39.7 44.112 x 37.367 x x x 37.217 x 39.928 36.9 x x x x x x x 38.721 x x x 39.559 x x x x x 45.024 45.6 37.856 x 36.689 41.6 40.535 39.934 38.41 35.33 47.29 x 39.71 x 41.13 x x x x 35.63 x x 39.33 37.75 x 45.85 33.38 x 37.77 38.89 x x x x x 39.41 x x x 38.98 x x x +12598 Original post publication description: Kidney morphology, WT1-negative cells per glomerular surface area in longterm diabetes [n/1000 um2] None Urogenital system, kidney, morphology: Wilm's tumor 1 (WT1) -negative cells per glomerular surface area in longterm diabetes [n/1000 um2] x x 9.222 8.6 x x x 10.678 x 10.742 9.191 8.636 9.175 11.215 x x 10.655 x 11.47 x x x x x x x 9.455 x x x x 10.171 11.787 x 8.979 x x x 9.718 x 10.926 9.617 x x x x x x x 10.875 x x x 10.398 x x x x x 10.578 8.89 10.663 x 9.846 9.688 9.232 10.839 9.287 8.42 11.349 x 12.012 x 12.727 x x x x 11.626 x x 11.242 11.04 x 13.681 10.827 x 12.284 11.688 x x x x x 11.731 x x x 10.431 x x x +12599 Original post publication description: Urogenital system, kidney, morphology: Kidney morphology, number of podocytes per 1000 um2 [units] None Urogenital system, kidney, morphology: Kidney morphology, number of podocytes per 1000 um2 [units] x x 4.508 2.684 x x x 4.911 x 6.174 3.7 2.82 2.899 3.241 x x 5.128 x 5.243 x x x x x x x 3.957 x x x x 4.928 5.099 x 3.455 x x x 5.376 x 3.576 5.214 x x x x x x x 5.854 x x x 6.032 x x x x x 3.737 5.462 5.687 x 5.289 2.927 2.822 5.328 3.313 2.891 4.713 x 5.858 x 6.737 x x x x 6.447 x x 5.941 5.789 x 5.637 6.536 x x x x x x x x x x x 4.305 x x x x +12600 Original post publication description: Urogenital system, kidney, morphology: Kidney morphology, podocytes (WT1-positive cells) per glomerular section, 6 months after induction of type I diabetes by streptozotocin treatment [n/section] None Urogenital system, kidney, morphology: Kidney morphology, podocytes (WT1-positive cells) per glomerular section, 6 months after induction of type I diabetes by streptozotocin treatment [n/section] x x 12.59 9.33 x x x 12.47 x 12.81 11.24 9.9 10.03 9.8 x x 12.53 x 13.06 x x x x x x x 11.38 x x x x 12.3 12.84 x 9.66 x x x 12.58 x 9.44 12.43 x x x x x x x 12.91 x x x 14.0 x x x x x 11.06 9.35 12.53 x 12.24 9.07 9.11 12.68 9.39 8.7 13.25 x 12.68 x 13.4 x x x x 12.34 x x 13.09 12.17 x 12.88 12.22 x 10.33 13.15 x x x x x 11.72 x 10.38 8.77 13.07 x x x +12601 Original post publication description: Central motor pattern generator, lick count for water over 20 minutes (MS160 lickometer), male and female adults [66 strainsl] None Central motor pattern generator, lick count for water over 20 minutes (MS160 lickometer), male and female adults [n] x 624.38 679.0 480.29 832.0 885.67 751.83 611.6 906.0 848.88 581.29 1280.2 761.83 621.33 737.67 x 741.0 496.0 x x x x x 343.33 370.67 687.25 x 695.75 x 425.57 818.33 562.67 953.57 x 665.0 x 538.6 620.11 840.78 x 599.17 913.11 614.9 651.5 x x 495.0 x 879.33 682.78 x x x 1024.44 943.11 x x x 590.0 872.0 864.38 x x 502.0 647.29 x 603.5 425.56 656.4 777.0 x 875.67 x 792.33 x 540.2 x x 697.5 x x 814.8 601.5 511.83 447.0 798.17 x 661.6 395.6 x 629.4 x x 603.63 982.5 828.2 705.83 670.67 543.14 x 560.17 617.0 +12602 Original post publication description: Central motor pattern generation, lick count for 0.1 M sucrose over 20 minutes (MS160 lickometer), male and female adults [66 strains] None Central motor pattern generation, lick count for 0.1 M sucrose over 20 minutes (MS160 lickometer), male and female adults [66 strains] x 1082.0 1227.85 865.21 1093.67 1197.33 1417.5 1644.0 1664.5 1621.75 1086.43 2140.6 1223.33 820.17 1298.67 x 1028.33 1219.33 x x x x x 536.0 861.33 1277.5 x 1328.75 x 920.29 1217.17 1164.0 1400.0 x 1193.33 x 1244.0 1043.44 1548.89 x 966.0 1243.33 917.3 952.33 x x 970.67 x 1199.33 1175.56 x x x 2139.33 1834.44 x x x 1595.17 1366.8 1311.63 x x 932.4 1253.14 x 1001.38 891.11 1206.2 1344.5 x 1823.56 x 1471.22 x 898.4 x x 1335.38 x x 1126.1 1152.7 964.5 1025.89 1522.33 x 1452.3 936.6 x 1293.2 x x 1194.5 1627.63 1574.1 1364.67 1322.5 914.43 x 1145.67 1069.33 +12603 Original post publication description: Immune function, blood: Peripheral blood lymphocytes, CD4+/CD8+ T cell ratio, males at 3-5 month [ratio] None Immune system, cardiovascular system: Peripheral blood lymphocytes, CD4+/CD8+ T cell ratio, males at 3-5 month [ratio] x 1.674 1.727 3.102 2.597 1.475 x 2.0 2.188 1.197 2.535 2.254 2.143 2.4 2.133 1.301 1.549 1.563 0.984 1.884 1.9 1.667 x 2.5 2.444 0.815 1.449 1.282 1.368 1.045 2.222 1.429 2.74 1.146 1.667 1.409 1.146 2.111 1.507 x 1.579 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12604 Original post publication description: Central nervous system, behavior: Central motor pattern generation, volume per lick, water over 20 minutes (MS160 lickometer), adults [66 strains] None Central nervous system, behavior: Central motor pattern generation (CPG), volume per lick, water over 20 min (MS160 lickometer), male and female adults [ul] x 1.48 1.26 1.0 1.01 0.94 0.87 0.82 0.62 1.08 0.94 0.9 1.01 1.15 1.21 x 0.6 0.95 x x x x x 1.11 0.71 1.0 x 1.27 x 0.81 0.87 1.02 0.83 x 0.98 x 1.15 1.03 1.2 x 0.91 0.83 0.85 0.86 x x 1.1 x 0.89 0.94 x x x 0.84 0.89 x x x 1.18 0.87 0.75 x x 1.01 0.73 x 1.01 1.04 1.08 0.97 x 0.87 x 0.75 x 1.02 x x 0.86 x x 0.74 0.92 1.06 1.08 0.99 x 1.1 1.01 x 1.1 x x 0.8 1.29 0.91 1.02 1.02 1.16 x 0.95 0.93 +12605 Original post publication description: Central motor pattern generation, volume per lick, 0.1 M sucrose over 20 minutes (MS160 lickometer), adults [66 strains] by Boughter JD Jr., and colleagues None Central motor pattern generation, volume per lick, 0.1 M sucrose over 20 minutes (MS160 lickometer), male and femal adults [ul] x 1.52 1.25 1.17 1.17 0.96 0.83 0.74 0.69 0.8 0.89 0.98 1.2 1.36 1.34 x 0.78 0.96 x x x x x 0.94 0.88 1.04 x 1.28 x 1.06 0.88 1.01 1.0 x 1.16 x 1.0 1.1 1.33 x 1.01 0.97 0.87 0.89 x x 1.42 x 0.99 0.85 x x x 0.88 0.91 x x x 0.94 1.05 0.94 x x 1.2 0.89 x 1.14 1.01 1.03 1.09 0.92 x x 0.8 x 1.11 x x 0.97 x x 0.94 0.91 0.99 0.98 1.08 x 0.96 1.34 x 1.01 x x 0.88 1.37 1.07 1.06 0.99 1.25 x 1.02 1.09 +12727 Original post publication description: Infectious disease, immune function: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) tumor necrosis factor alpha from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control] Infectious disease, immune system: Bix2 Infectious disease, immune system, protein expression: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks), tumor necrosis factor alpha level (TNFA, Chr 17 at 35 Mb) from draining lymph node 3 weeks post infection in females using Luminex assay [% of C57BL/6 control] x 44.215 100.0 46.2 x x x x x x 186.337 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 173.708 107.994 110.056 76.548 x x x 55.379 67.269 x x x x 135.58 18.15 x x x 66.132 122.988 75.666 x x x x x x 57.785 116.947 x x x 46.115 x x 18.446 x x 51.451 x x 124.939 x x x x x 126.409 x x x x x x 93.358 x x x x x x x +12728 Original post publication description: Infectious disease, immune function: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) Vascular endothelial growth factor from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control] None Infectious disease, immune function: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks), vascular endothelial growth factor (VEGF) level from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control] x 73.506 100.0 146.37 x x x x x x 90.218 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 65.77 180.234 68.28 175.427 x x x 135.955 94.594 x x x x 152.576 26.434 x x x 78.516 103.749 63.957 x x x x x x 148.294 79.074 x x x 53.842 x x 79.615 x x 40.204 x x 54.517 x x x x x 115.774 x x x x x x 298.424 x x x x x x x +12726 Original post publication description: Infectious disease, immune function: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) RANTES from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control] None Infectious disease, immune function: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) RANTES from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control] x 35.453 100.0 37.957 x x x x x x 93.351 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 88.456 56.779 48.033 59.889 x x x 58.915 67.386 x x x x 73.501 21.126 x x x 33.392 103.818 106.75 x x x x x x 31.471 48.984 x x x 56.897 x x 32.301 x x 43.13 x x 93.076 x x x x x 83.135 x x x x x x 98.642 x x x x x x x +12751 Original post publication description: Reproduction, urogenital system, morphology: Uterus body width at maturity, unadjusted for body weight, age, or parity [cm] None Reproduction, urogenital system, morphology: Uterus body width at maturity, unadjusted for body weight, age, or parity [cm] 0.265 0.28 0.259 0.305 0.27 x 0.165 x 0.21 0.235 0.257 0.253 0.252 0.34 x 0.227 x 0.313 x x 0.2 x x 0.27 x 0.284 x 0.285 x 0.293 0.324 0.31 0.284 x 0.36 x 0.32 0.254 0.345 x 0.268 0.316 0.247 0.319 x x 0.267 0.337 0.276 0.31 x x x 0.344 0.372 x x x 0.288 0.262 0.275 0.257 x 0.288 0.289 x 0.237 0.28 0.321 0.214 x 0.263 x 0.328 x 0.293 x 0.286 0.258 x x 0.287 0.281 0.352 0.29 0.332 x 0.313 0.273 x 0.28 x x 0.291 0.343 0.293 0.23 0.31 0.299 0.29 0.279 0.248 +12752 Original post publication description: Reproduction, urogenital system, morphology: Ovary weight at maturity, unilateral (average of right and left), unadjusted for body weight, age, or parity [mg] None Reproduction, urogenital system, morphology: Ovary weight at maturity, unilateral (average of right and left), unadjusted for body weight, age, or parity [mg] 3.75 5.0 2.467 9.96 4.667 x 1.5 x 3.5 2.75 5.591 5.125 2.5 x x 4.5 x 2.615 x x 2.5 x x 3.5 x 4.3 x 4.25 x 5.5 8.4 3.5 2.267 x 2.0 x 3.0 3.682 3.5 x 2.5 4.5 3.357 7.3 x x 4.8 5.0 4.188 6.385 x x x 4.071 7.885 x x x 2.37 4.636 5.789 2.25 x 3.6 3.393 x 3.192 2.857 3.348 3.038 x 3.58 x 3.605 x 5.0 x 2.9 3.269 x x 5.357 3.769 4.375 2.556 4.053 x 3.708 7.083 x 6.0 x x 3.0 5.25 5.0 3.0 4.0 6.015 4.5 3.895 2.542 +12730 Original post publication description: Central nervous system, behavior, learning and memory: Learning speed, initial acquisition of task, trials to criterion in naive 4-month adult males (Med Associates nose poke chamber, low values = faster learning) [n] None Central nervous system, behavior, learning and memory: Learning speed, initial acquisition of task, trials to criterion in naive 4-month adult males (Med Associates nose poke chamber, low values = faster learning) [n] x x 103.0 172.0 84.8 40.0 x x x x x 55.5 165.0 114.5 x 200.0 35.0 x x x 76.5 x x 101.4 135.5 x x 97.0 x 103.5 118.75 x 78.33 x 31.0 x 62.5 116.33 118.2 x 135.8 120.75 91.5 44.5 x x x 73.5 77.5 88.67 x x x 135.33 42.0 x x x 54.0 88.0 23.6 x x 71.0 109.0 x 146.33 x 164.67 96.75 x 199.5 x 148.0 x 119.0 x x 91.8 x x 75.25 76.0 123.6 164.25 x x 104.67 157.5 x x x x 129.0 118.25 x 45.0 x 189.6 x 176.0 162.25 +12747 Original post publication description: Reproduction, urogenital system, morphology: Uterus and ovary weight at maturity, bilateral, unadjusted for body weight, age, or parity [mg] None Reproduction, urogenital system, morphology: Uterus and ovary weight at maturity, bilateral, unadjusted for body weight, age, or parity [mg] 100.0 106.2 76.4 129.72 79.5 x 28.5 x 95.0 60.0 81.091 75.0 75.0 x x 59.0 x 64.538 x x 57.5 x x 70.5 x 60.4 x 64.0 x 103.5 138.8 175.0 100.267 x 110.0 x 98.0 82.091 127.5 x 65.0 91.818 61.114 112.857 x x 94.4 187.5 96.75 114.308 x x x 94.857 145.077 x x x 109.13 82.546 91.053 78.5 x 84.8 90.571 x 75.538 75.476 156.794 79.75 x 90.04 x 119.105 x 112.714 x 71.8 71.462 x x 100.571 81.0 151.625 75.722 97.895 x 126.417 119.5 x 88.0 x x 110.5 93.182 97.333 51.0 102.0 107.941 145.0 94.389 80.208 +12622 Original post publication description: Catechol-o-methyl transferase expression level by RNA-seq, distal 3' UTR, whole brain [normalized RNA-seq counts] None Central nervous system, gene expression: Catechol-o-methyl transferase expression level by RNA-seq, distal 3' UTR, whole brain [normalized RNA-seq counts] x x x x x x x 38.0 13.0 34.0 x x 68.0 34.0 35.0 92.0 66.0 x x x x x x 74.0 x x x 121.0 x x 96.0 x x x 23.0 x 104.0 49.0 104.0 x 12.0 9.0 x 66.0 x x x 39.0 44.0 10.0 x x x 14.0 80.0 x x x 66.0 x x x x 69.0 79.0 x x 100.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12635 Original post publication description: Anxiety assay (E5_NR), restraint stress (15 min) + ethanol treated (1.8 g/kg i.p.), number of rears in the light side using a light-dark box in 8-12 week-old males during 5 min session [n beam breaks]. None Anxiety assay (E5_NR), restraint stress (15 min) + ethanol treated (1.8 g/kg i.p.), number of rears in the light side using a light-dark box in 8-12 week-old males during 5 min session [n beam breaks]. x x 9.75 18.769 14.625 11.125 3.143 12.25 13.375 11.333 6.833 35.143 x 18.429 7.625 13.0 15.0 8.625 19.857 15.0 6.75 7.5 x x x 6.5 2.375 x x 6.0 10.25 14.75 13.25 x 8.833 x 1.75 8.667 x x 33.25 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12636 Original post publication description: Anxiety assay (E10_PTS), restraint stress (15 min) + ethanol treated (1.8 g/kg i.p.), percent time spent in light side (sec) using a light-dark box in 8-12 week-old males during 10 min session [n %]. None Central nervous system, pharmacology, behavior: Anxiety assay (E10_PTS), restraint stress (15 min) + ethanol treated (1.8 g/kg i.p.), percent time spent in light side (sec) using a light-dark box in 8-12 week-old males during 10 min session [%] x x 38.627 31.226 46.442 58.51 40.138 46.542 29.81 26.386 28.708 61.21 x 41.171 42.419 59.183 56.248 35.683 43.04 42.998 28.192 36.964 x x x 23.544 16.667 x x 38.395 29.363 55.615 45.425 x 18.697 x 29.417 23.653 x x 48.527 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12637 Original post publication description: Anxiety assay (E10_TS), restraint stress (15 min) + ethanol treated (1.8 g/kg i.p.), time spent in light side using a light-dark box in 8-12 week-old males during 10 min [n sec]. None Central nervous system, pharmacology, behavior: Anxiety assay (E10_TS), restraint stress (15 min) + ethanol treated (1.8 g/kg i.p.), time spent in light side using a light-dark box in 8-12 week-old males during 10 min [n sec] x x 231.762 187.354 278.65 351.062 240.829 279.25 178.863 158.317 172.25 367.257 x 247.029 254.512 355.1 337.488 214.1 258.243 257.986 169.15 221.783 x x x 141.262 100.0 x x 230.371 176.175 333.688 272.55 x 112.183 x 176.5 141.917 x x 291.163 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12621 Original post publication description: Catechol-o-methyl transferase expression level by RNA-seq, last two coding exons and entire 3' UTR, whole brain [normalized RNA-seq counts] None Central nervous system, gene expression: Catechol-o-methyl transferase expression level by RNA-seq, last two coding exons and entire 3' UTR, whole brain [normalized RNA-seq counts] x x x x x x x 243.0 262.0 266.0 x x 235.0 276.0 278.0 317.0 241.0 x x x x x x 268.0 x x x 354.0 x x 316.0 x x x 136.0 x 331.0 160.0 327.0 x 180.0 188.0 x 191.0 x x x 316.0 149.0 160.0 x x x 149.0 253.0 x x x 304.0 x x x x 254.0 303.0 x x 302.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12713 Original post publication description: Infectious disease, immune function: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) interleukin-6 from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control] None Infectious disease, immune function: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) interleukin-6 from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control] x 19.971 100.0 23.245 x x x x x x 81.251 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 98.327 85.862 52.17 100.395 x x x 42.487 58.416 x x x x 125.259 7.163 x x x 18.151 80.431 77.566 x x x x x x 49.064 49.979 x x x 22.597 x x 14.356 x x 29.19 x x 81.169 x x x x x 95.613 x x x x x x 159.626 x x x x x x x +12714 Original post publication description: Infectious disease, immune function: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) interleukin-10 from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control] None Infectious disease, immune function: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) interleukin-10 from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control] x 128.087 100.0 194.383 x x x x x x 56.941 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 55.697 16.826 57.13 86.512 x x x 110.427 99.783 x x x x 194.625 93.595 x x x 43.793 65.611 209.812 x x x x x x 261.063 35.782 x x x 66.245 x x 71.064 x x 167.936 x x 18.817 x x x x x 30.834 x x x x x x 38.807 x x x x x x x +12715 Original post publication description: Infectious disease, immune function: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) interleukin-13 from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control] None Infectious disease, immune function: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) interleukin-13 from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control] x 29.37 100.0 124.109 x x x x x x 9.128 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 14.864 6.7 25.975 106.279 x x x 93.729 190.183 x x x x 83.991 37.998 x x x 34.869 43.322 175.793 x x x x x x 341.497 9.723 x x x 90.573 x x 22.812 x x 268.859 x x 14.503 x x x x x 28.288 x x x x x x 65.287 x x x x x x x +12718 Original post publication description: Infectious disease, immune function: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) macrophage inflammatory protein-2 from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control] None Infectious disease, immune function: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) macrophage inflammatory protein-2 from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control] x 22.482 100.0 25.396 x x x x x x 203.397 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 204.694 218.63 233.681 92.433 x x x 34.644 103.963 x x x x 221.283 6.782 x x x 20.714 156.605 59.961 x x x x x x 57.606 64.526 x x x 42.526 x x 11.004 x x 47.447 x x 196.774 x x x x x 268.943 x x x x x x 261.055 x x x x x x x +12624 Original post publication description: Ethanol response (10% EtOH in tap water), average daily consumption using two-bottle choice method in females [g/kg] None Central nervous system, pharmacology, behavior: Ethanol response (10% EtOH in tap water), average daily consumption using two-bottle choice method in females [g/kg] x x x x x x x 10.71 x x 3.15 x 1.96 4.84 x 4.07 x 4.9 x x 0.04 x 5.84 0.66 x 11.17 x x x 4.47 1.11 x 2.9 x x x 1.07 x 4.94 1.81 3.46 x 2.13 3.28 x x 6.28 x x 2.95 x x x x 8.15 x x x 6.97 x x x x x 4.04 4.0 x 4.13 10.94 4.46 x 2.8 x 2.82 x 2.73 x x 4.63 x x 2.01 4.63 3.14 7.65 3.7 x 3.23 2.44 x 3.17 x x x x x x x x x x 9.33 +12644 Original post publication description: Anxiety assay (S10_PTR), restraint stress (15 min) + saline treated (0.018 mL/g i.p.), percent time spent (sec) without locomotion in the light side of light-dark box in 8-12 week-old males during 10 min session [n %]. None Central nervous system, pharmacology, behavior: Anxiety assay (S10_PTR), percent time spent without locomotion in the light side of light-dark box after restraint stress (15 min) and saline control injection (0.018 ml/g ip) in 8-12 week-old males during 10 min test [n %] x x 17.153 28.012 9.737 14.138 2.867 14.05 25.981 28.79 1.4 27.104 x 8.367 24.121 56.438 8.186 22.915 21.881 42.624 14.452 11.99 x x x 6.719 1.715 x x 18.121 15.004 12.008 17.7 x 6.752 x 16.11 4.783 x x 19.93 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12645 Original post publication description: Anxiety assay (S10_PTS), restraint stress (15 min) + saline treated (0.018 mL/g i.p.), percent time spent in light side (sec) using a light-dark box in 8-12 week-old males during 10 min session [n %]. None Central nervous system, pharmacology, behavior: Anxiety assay (S10_PTS), restraint stress (15 min) + saline treated (0.018 mL/g i.p.), percent time spent in light side (sec) using a light-dark box in 8-12 week-old males during 10 min session [n %]. x x 22.266 28.832 14.578 20.517 3.352 17.779 26.41 28.362 1.794 33.108 x 11.856 25.994 45.343 12.179 23.741 11.471 40.398 14.388 12.802 x x x 6.955 1.783 x x 18.89 16.127 14.477 19.826 x 9.08 x 18.683 4.665 x x 29.454 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12646 Original post publication description: Anxiety assay (S10_TR), restraint stress (15 min) + saline treated (0.018 mL/g i.p.), time spent without locomotion in the light side of light-dark box in 8-12 week-old males during 10 min session [n sec]. Central nervous system, pharmacology, behavior: Anxiety assay (S10_TR), restraint stress (15 min) + saline treated (0.018 mL/g i.p.), time spent without locomotion in the light side of light-dark box in 8-12 week-old males during 10 min session [n sec] Central nervous system, pharmacology, behavior: Anxiety assay (S10_TR), restraint stress (15 min) + saline treated (0.018 mL/g i.p.), time spent without locomotion in the light side of light-dark box in 8-12 week-old males during 10 min session [n sec] x x 51.46 84.037 29.211 42.414 8.6 42.15 77.943 86.371 4.2 81.312 x 25.1 72.362 169.314 24.557 68.744 65.643 127.871 43.357 35.971 x x x 20.157 5.144 x x 54.362 45.013 36.025 53.1 x 20.256 x 48.329 14.35 x x 59.789 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12647 Original post publication description: Anxiety assay (S10_TS), restraint stress (15 min) + saline treated (0.018 mL/g i.p.), time spent in light side using a light-dark box in 8-12 week-old males during 10 min [n sec]. None Central nervous system, pharmacology, behavior: Anxiety assay (S10_TS), restraint stress (15 min) + saline treated (0.018 mL/g i.p.), time spent in light side using a light-dark box in 8-12 week-old males during 10 min [n sec]. x x 133.593 172.994 87.467 123.1 20.111 106.675 158.457 170.171 10.767 198.65 x 71.133 155.963 272.057 73.071 142.444 68.829 242.386 86.329 76.814 x x x 41.729 10.7 x x 113.338 96.763 86.862 118.956 x 54.478 x 112.1 27.988 x x 176.722 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12709 Original post publication description: Infectious disease, immune function: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) interleukin-2 from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control] None Infectious disease, immune function: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) interleukin-2 from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control] x 404.145 100.0 424.758 x x x x x x 222.835 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 127.202 335.749 939.916 211.589 x x x 232.172 239.918 x x x x 370.11 480.583 x x x 327.209 75.757 179.74 x x x x x x 210.778 304.227 x x x 159.672 x x 1054.02 x x 439.931 x x 93.846 x x x x x 122.027 x x x x x x 95.469 x x x x x x x +12710 Original post publication description: Infectious disease, immune function: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) interleukin-3 from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control] None Infectious disease, immune function: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) interleukin-3 from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control] x 64.683 100.0 149.71 x x x x x x 96.465 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 108.179 103.375 161.814 81.4 x x x 132.112 297.066 x x x x 110.957 114.781 x x x 82.924 47.956 127.062 x x x x x x 166.438 130.568 x x x 136.652 x x 45.766 x x 302.37 x x 69.518 x x x x x 172.826 x x x x x x 64.107 x x x x x x x +12708 Original post publication description: Infectious disease, immune function: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) interleukin-1 beta from draining lymph node, 3 weeks post infection in females [%of C57BL/6 control] entered at October/25 13:43:35 from IP 172.2 None Infectious disease, immune function: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks), interleukin-1 beta level (IL1B, Chr 2 at 129 Mb) from draining lymph node 3 weeks post infection in females [%of C57BL/6 control] x 44.495 100.0 47.312 x x x x x x 235.124 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 201.142 177.814 138.743 89.64 x x x 68.021 137.325 x x x x 165.831 16.832 x x x 76.548 189.606 75.285 x x x x x x 75.347 83.784 x x x 31.469 x x 44.947 x x 39.608 x x 183.611 x x x x x 284.835 x x x x x x 196.864 x x x x x x x +12705 Original post publication description: Infectious disease, immune function: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) G-CSF from draining lymph node, 3 weeks post infection in females [%of C57BL/6 control] None Infectious disease, immune function: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks), granulocyte colony-stimulating factor (G-CSF, CSF3, Chr 11 at 98.6 Mb) from draining lymph node 3 weeks post infection in females [%of C57BL/6 control] x 28.434 100.0 55.754 x x x x x x 155.468 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 145.985 81.161 69.705 41.138 x x x 38.232 76.646 x x x x 174.311 9.88 x x x 11.707 178.677 49.044 x x x x x x 46.236 32.142 x x x 33.141 x x 10.617 x x 32.821 x x 35.797 x x x x x 87.751 x x x x x x 65.91 x x x x x x x +12703 Original post publication description: Infectious disease, immune function: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) Parasite Burden in feet, 3 weeks post infection in females [% of C57BL/6 control] None Infectious disease, immune function: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks), parasite burden in feet 3 weeks post infection in females [% of C57BL/6 control] x 64.3 100.0 46.4 x x x x x x 100.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 111.6 65.1 76.7 64.3 x x x 82.1 46.4 x x x x 82.1 46.4 x x x 53.5 100.0 64.3 x x x x x x 64.3 76.7 x x x 28.6 x x 46.4 x 64.3 82.1 x x 76.7 x x x x x 53.5 x x x x x x 28.6 x x x x x x x +12702 Original post publication description: Infectious disease, immune function: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) footpad swelling, 3 weeks post infection in females (BXD80 winsorized from 196 to 120) [% of C57BL/6 control] None Infectious disease, immune system: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) footpad swelling, 3 weeks post infection in females (BXD80 winsorized from 196 to 120) [% of C57BL/6 control] x 91.2 100.0 44.2 x x x x x x 66.1 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 95.2 78.3 52.2 57.9 x x 117.7 57.2 65.1 x x x x 49.7 68.2 x x x 40.1 84.9 82.6 x x x x x x 78.6 40.0 x x x 68.0 x x 49.2 x 65.6 120.0 x x 55.8 x x x 33.8 x 71.4 x x x x x x 65.4 x x x x x x x +12659 Original post publication description: Central nervous system, morphology: Brain weight, corrected only for dissection error [mg] None Central nervous system, morphology: Brain weight, corrected only for dissection error [mg] x 460.121 470.253 400.692 470.588 432.944 514.051 389.764 436.857 435.807 444.262 444.003 398.062 421.972 455.929 448.976 428.546 425.081 391.707 437.124 449.665 421.082 385.6 409.5 408.762 367.645 402.813 395.046 372.922 416.129 430.71 428.577 420.545 417.244 415.869 424.187 420.67 416.726 436.781 x 442.56 421.38 438.364 442.016 x x 412.269 405.833 417.544 440.517 x x x 469.816 434.81 x x x 448.498 457.539 437.164 408.1 446.6 424.386 410.231 408.775 444.11 451.167 429.748 443.741 x 439.678 390.75 421.067 436.1 453.04 417.172 374.017 439.776 406.688 x 439.462 409.604 431.285 484.774 429.752 x 446.717 434.574 462.85 434.901 415.322 x 442.48 416.705 443.842 412.735 452.074 445.842 378.333 402.891 452.84 +12660 Original post publication description: Central nervous system, morphology: Brain weight, repeat measurement prior to dissection, corrected only for initial dissection errors [mg] None Central nervous system, morphology: Brain weight, repeat measurement prior to dissection, corrected only for initial dissection errors [mg] x 469.31 485.055 410.091 483.953 444.595 525.3 399.5 445.898 443.584 453.038 456.622 406.734 433.693 466.823 461.849 440.3 436.898 404.593 448.585 464.446 435.918 385.6 422.906 421.032 378.007 410.553 408.068 386.165 428.674 440.238 441.843 426.309 429.194 423.973 438.875 431.658 423.244 444.022 x 448.86 430.715 447.31 452.188 x x 426.145 405.833 418.835 450.949 x x x 470.787 434.81 x x x 458.608 462.095 446.616 418.356 463.25 430.269 414.089 408.775 448.166 459.29 432.61 443.741 x 447.399 390.75 426.632 452.333 462.698 432.592 376.25 443.226 410.863 x 439.462 409.604 442.554 493.732 433.656 x 452.848 442.911 480.033 447.012 425.9 x 442.48 422.709 452.41 418.7 452.074 446.227 378.333 402.891 452.84 +12661 Original post publication description: Central nervous system, morphology: Brain weight, repeat measurement prior to dissection, statistically adjusted for variation in sex, age, body weight and for dissection error [mg] None Central nervous system, morphology: Brain weight, repeat measurement prior to dissection, statistically adjusted for variation in sex, age, body weight and for dissection error (Hager et al., 2012) [mg] x 465.968 488.776 414.383 492.576 438.697 530.186 400.747 445.859 437.196 452.583 461.049 411.334 438.413 462.643 466.364 442.305 442.403 415.123 450.265 469.971 442.154 389.581 417.29 427.953 381.942 412.801 415.167 398.138 430.899 437.842 449.352 421.077 436.49 427.587 429.919 438.688 420.157 446.549 x 448.954 432.182 446.894 457.649 x x 426.057 405.682 419.602 450.419 x x x 470.528 429.871 x x x 447.543 458.602 446.437 424.192 454.906 428.059 416.054 412.731 443.091 455.804 429.612 444.027 x 450.786 396.589 427.256 452.429 447.104 434.523 386.006 444.4 418.587 x 448.472 411.292 439.863 487.895 432.278 x 446.726 441.078 483.377 437.93 423.064 x 438.51 420.545 443.171 419.56 450.869 436.924 382.171 397.68 444.23 +12662 Original post publication description: Central nervous system, morphology: Brain weight, statistically adjusted for variation in sex, age, body weight, and dissection error [mg] None Central nervous system, morphology: Brain weight, statistically adjusted for variation in sex, age, body weight, and dissection error [mg] x 457.375 474.438 404.971 478.054 427.536 519.353 390.511 437.676 429.642 443.651 448.963 403.899 426.136 452.669 454.554 431.124 430.41 402.79 438.8 455.448 427.6 390.801 403.73 415.684 372.155 406.136 402.946 385.661 418.728 428.894 436.37 415.725 425.596 419.859 410.872 428.497 414.214 439.594 x 443.02 423.284 437.138 446.642 x x 412.671 407.057 418.391 439.887 x x x 469.944 429.454 x x x 437.122 454.284 437.106 414.111 436.282 421.458 411.204 412.544 437.758 447.899 426.008 443.397 x 442.63 397.488 421.741 433.432 437.88 419.535 382.556 440.205 412.357 x 448.101 411.322 429.114 478.721 426.975 x 439.92 432.472 464.823 426.579 413.024 x 438.914 414.948 434.971 412.886 449.968 436.52 383.553 398.186 443.996 +12663 Original post publication description: Gastrointestinal system, morphology: Small intestine length, statistically adjusted for variation in sex and age [cm] None Gastrointestinal system, morphology: Small intestine length, statistically adjusted for variation in sex and age [cm] x 33.236 29.27 29.527 32.957 40.752 34.008 x x 33.221 36.99 32.807 32.038 x x 34.425 x 30.357 x x x x 30.918 x x 38.272 x 31.226 x 34.323 x x 36.822 x 32.236 x x 30.429 28.558 x 31.756 32.651 32.665 32.61 x x 36.878 x x 32.178 x x x 39.078 38.437 x x x 31.025 32.294 31.632 x x x 27.772 x 33.477 30.301 29.291 35.699 x 31.625 x 31.002 x 34.69 x x 31.485 x x 28.192 31.764 33.551 36.669 29.186 x 34.984 34.622 x x x x 36.233 33.775 x 35.665 36.369 38.719 x 33.616 33.098 +12664 Original post publication description: Gastrointestinal system, morphology: small intestine length, without statistical adjustment [cm] None Gastrointestinal system, morphology: small intestine length, without statistical adjustment [cm] x 32.962 29.492 30.613 33.25 43.833 33.81 x x 31.833 37.1 34.25 30.65 x x 35.0 x 30.03 x x x x 29.75 x x 39.714 x 29.85 x 34.667 x x 37.3 x 31.333 x x 30.19 29.0 x 32.34 32.42 33.123 32.567 x x 36.0 x x 31.682 x x x 38.5 38.9 x x x 31.382 32.17 31.309 x x x 27.333 x 34.39 31.333 28.454 36.29 x 30.991 x 30.742 x 35.664 x x 30.96 x x 28.21 31.409 33.4 37.182 29.03 x 35.936 35.667 x x x x 35.083 32.975 x 36.0 37.75 38.136 x 32.314 32.47 +12667 Original post publication description: Infectious disease, immune function: Ectromelia virus survival over two weeks after a 90 pfu injection into the footpad, males and females between 40 and 150 days of age, residuals corrected for sex, age, and body weight [~2.7 days/unit] None Infectious disease, immune function: Ectromelia virus survival over two weeks after a 90 pfu injection into the footpad, males and females between 40 and 150 days of age, residuals corrected for sex, age, and body weight [~2.7 days/unit] x x 0.915 -1.395 x x x -0.548 x x x 0.745 x x x x x x x x x x x x x x x x x x -1.323 x -1.759 x x x x x -1.079 x x x -1.15 0.721 x x 0.896 0.941 0.523 0.101 x x x x x x x x x x 0.774 x 0.479 x 0.75 x 0.943 -1.385 -0.385 x x -0.737 x 0.544 x 0.244 x x -1.026 -1.606 x 0.03 0.957 x 0.857 -1.208 x -1.14 0.947 x x x x 0.949 0.948 x 0.949 -1.259 0.869 0.741 0.953 -0.737 +12668 Original post publication description: Infectious disease, immune function: Ectromelia virus formation of secondary dermal lesions over two weeks after 90 pfu injection into the footpad, males and females between 40 and 150 days of age, residuals corrected for sex, age and body weight [presence of lesions where -0.4 is no lesions and 0.8 is all animals present with lesions] None Infectious disease, immune function: Ectromelia virus formation of secondary dermal lesions over two weeks after 90 pfu injection into the footpad, males and females between 40 and 150 days of age, residuals corrected for sex, age and body weight [presence of lesions where -0.4 is no lesions and 0.8 is all animals present with lesions] x x -0.309 -0.284 x x x -0.0675 x x x -0.1586 x x x x x x x x x x x x x x x x x x -0.305 x -0.03311 x x x x x -0.3542 x x x -0.1771 -0.1886 x x -0.0791 -0.2781 -0.1299 0.2298 x x x x x x x x x x 0.0806 x 0.7233 x 0.1801 x -0.052 -0.2963 -0.1222 x x 0.3579 x 0.4935 x 0.1538 x x -0.0509 -0.3481 x 0.0572 -0.0503 x -0.0261 -0.3832 x -0.2086 0.6191 x x x x 0.6673 0.4587 x 0.1712 -0.1809 0.2758 0.078 0.0309 -0.1965 +12669 Original post publication description: Infectious disease, immune function: Ectromelia virus euthanasia scale over two weeks after a 90 pfu injection into the footpad, males and females between 40 and 150 days of age, residuals corrected for sex, age and body weight [-1 is survival, +2 is rapid unpredictable death] None Infectious disease, immune function: Ectromelia virus euthanasia scale over two weeks after a 90 pfu injection into the footpad, males and females between 40 and 150 days of age, residuals corrected for sex, age and body weight [-1 is survival, +2 is rapid unpredictable death] x x -1.183 1.108 x x x 0.003 x x x -0.716 x x x x x x x x x x x x x x x x x x 0.819 x 2.772 x x x x x 1.405 x x x 0.394 -1.095 x x -1.147 -1.139 -0.366 0.015 x x x x x x x x x x -1.055 x -0.667 x -1.092 x -1.174 2.119 1.033 x x 1.402 x -0.451 x 0.909 x x 1.318 2.088 x 0.361 -1.15 x -0.935 1.098 x 1.212 -1.158 x x x x -1.137 -1.131 x -1.141 0.564 -1.135 -0.982 -1.158 1.391 +12670 Original post publication description: Infectious disease, immune function: Ectromelia virus measure of disease onset measured by the day of maximum clinical score over two weeks after a 90 pfu injection into the footpad, males and females between 40 and 150 days of age, residuals corrected for sex, age, and body weight [scaled days where -0.83 is early onset (before day 8) and 0.9 is late onset (<11 days)] None Infectious disease, immune function: Ectromelia virus measure of disease onset measured by the day of maximum clinical score over two weeks after a 90 pfu injection into the footpad, males and females between 40 and 150 days of age, residuals corrected for sex, age, and body weight [scaled days where -0.83 is early onset (before day 8) and 0.9 is late onset (<11 days)] x x 0.256 -0.73 x x x -0.558 x x x 0.294 x x x x x x x x x x x x x x x x x x -0.833 x -0.357 x x x x x -0.616 x x x -0.544 -0.031 x x 0.277 0.117 -0.053 0.262 x x x x x x x x x x 0.648 x 0.352 x 0.669 x 0.012 -0.331 -0.065 x x -0.341 x 0.623 x 0.389 x x -0.361 -0.651 x -0.267 0.182 x 0.275 -0.465 x -0.682 0.425 x x x x 0.817 0.943 x 0.555 -0.656 0.539 -0.14 0.415 -0.369 +12671 Original post publication description: Infectious disease, immune function: Ectromelia virus measure of severity of disease measured by the maximum clinical score over two weeks after a 90 pfu injection into the footpad, males and females between 40 and 150 days of age, residuals corrected for sex, age, and body weight [scaled days where -0.93 is unaffected animal to 0.65 is severe disease] None Infectious disease, immune function: Ectromelia virus measure of severity of disease measured by the maximum clinical score over two weeks after a 90 pfu injection into the footpad, males and females between 40 and 150 days of age, residuals corrected for sex, age, and body weight [scaled days where -0.93 is unaffected animal to 0.65 is severe disease] x x -0.641 0.179 x x x 0.128 x x x -0.61 x x x x x x x x x x x x x x x x x x 0.119 x 0.556 x x x x x 0.457 x x x 0.65 -0.353 x x -0.096 -0.78 -0.236 0.426 x x x x x x x x x x -0.345 x 0.245 x -0.309 x -0.93 0.387 0.446 x x 0.65 x 0.374 x 0.311 x x 0.395 0.279 x 0.205 -0.679 x -0.628 0.172 x 0.52 -0.315 x x x x 0.123 -0.197 x -0.474 -0.136 0.067 0.101 -0.702 0.643 +12672 Original post publication description: Infectious disease, immune function: Ectromelia virus survival over two weeks after a 90 pfu intranasal inoculation, males and females between 40 and 150 days of age, residuals corrected for sex, age, and body weight [~2.33 days/unit] None Infectious disease, immune function: Ectromelia virus survival over two weeks after a 90 pfu intranasal inoculation, males and females between 40 and 150 days of age, residuals corrected for sex, age, and body weight [~2.33 days/unit] x x 0.504 -1.397 x x x x x -1.12 x 0.697 x x x x x x x x x x x x x x x x x x -1.386 x -1.738 x x x x x -0.677 x x 0.657 -1.602 0.756 x x 0.765 0.604 0.796 -0.054 x x x 1.119 0.593 x x x -0.487 0.905 0.482 x 0.466 x 0.716 x 0.467 x 0.484 -0.733 x -1.108 x -0.086 x 0.822 x -0.255 -0.784 -0.852 x 0.156 0.51 0.702 0.237 -1.133 x 0.401 0.849 x x x x 0.481 0.781 0.83 -1.526 -1.39 0.428 -0.046 0.166 x +12673 Original post publication description: Infectious disease, immune function: Ectromelia virus formation of secondary dermal lesions over two weeks after 90 pfu intranasal inoculation, males and females between 40 and 150 days of age, residuals corrected for sex, age and body weight [presence of lesions where -0.3 is where no lesions present on animals and 0.7 is where all animals present with lesions] None Infectious disease, immune function: Ectromelia virus formation of secondary dermal lesions over two weeks after 90 pfu intranasal inoculation, males and females between 40 and 150 days of age, residuals corrected for sex, age and body weight [presence of lesions where -0.3 is where no lesions present on animals and 0.7 is where all animals present with lesions] x x 0.575 -0.273 x x x x x -0.325 x -0.103 x x x x x x x x x x x x x x x x x x 0.059 x 0.008 x x x x x -0.039 x x 0.175 -0.325 0.675 x x 0.362 0.175 -0.325 0.402 x x x 0.075 0.425 x x x -0.125 0.275 -0.047 x 0.508 x 0.3 x 0.05 x -0.013 -0.2 x -0.025 x -0.004 x 0.29 x -0.159 -0.103 -0.325 x -0.075 -0.325 -0.325 0.059 -0.325 x 0.342 0.425 x x x x -0.325 0.087 -0.325 -0.225 -0.325 -0.075 -0.325 -0.225 x +12674 Original post publication description: Infectious disease, immune function: Ectromelia virus measure of severity of disease measured by the maximum clinical score over two weeks after a 90 pfu intranasal inoculation, males and females between 40 and 150 days of age, residuals corrected for sex, age, and body weight [scaled days where -1.1 is unaffected animal to 1.2 is severe disease] None Infectious disease, immune function: Ectromelia virus measure of severity of disease measured by the maximum clinical score over two weeks after a 90 pfu intranasal inoculation, males and females between 40 and 150 days of age, residuals corrected for sex, age, and body weight [scaled days where -1.1 is unaffected animal to 1.2 is severe disease] x x 0.015 -0.349 x x x x x 0.99 x -0.503 x x x x x x x x x x x x x x x x x x 0.985 x 0.803 x x x x x -0.233 x x -0.622 0.178 -0.104 x x 0.06 -0.221 -1.01 -0.243 x x x -0.022 -0.26 x x x 1.003 0.203 -0.232 x -0.531 x -0.525 x -0.682 x -0.104 1.193 x 0.734 x 0.106 x -0.217 x 0.449 0.4 0.278 x 0.131 -0.372 0.142 -0.265 0.383 x -0.156 -0.401 x x x x -0.547 -0.253 -0.916 0.278 1.017 -0.135 -0.147 -0.297 x +12675 Original post publication description: Infectious disease, immune function: Ectromelia virus measure of disease onset measured by the day of maximum clinical score over two weeks after a 90 pfu intranasal inoculation, males and females between 40 and 150 days of age, residuals corrected for sex, age, and body [scaled days where -1.1 is >8 days and 0.96 is <11 days] None Infectious disease, immune function: Ectromelia virus measure of disease onset measured by the day of maximum clinical score over two weeks after a 90 pfu intranasal inoculation, males and females between 40 and 150 days of age, residuals corrected for sex, age, and body [scaled days where -1.1 is >8 days and 0.96 is <11 days] x x 0.346 -0.087 x x x x x -0.666 x 0.459 x x x x x x x x x x x x x x x x x x -0.743 x -0.75 x x x x x -0.291 x x -0.329 -0.274 0.646 x x 0.318 0.505 -1.041 0.095 x x x -0.566 0.177 x x x -0.466 -0.016 0.313 x -0.333 x -0.182 x -0.494 x 0.162 -0.573 x 0.115 x 0.057 x 0.401 x 0.292 -0.166 -0.129 x 0.24 0.434 0.298 0.526 -0.131 x 0.209 0.193 x x x x -0.229 0.429 -0.838 -0.091 -0.166 0.959 0.759 0.634 x +12676 Original post publication description: Infectious disease, immune function: Cowpox virus survival over two weeks after 10^6 pfu intranasal inoculation, males and females between 40 and 152 days of age, residuals corrected for sex, age and body weight [~2.67/unit] None Infectious disease, immune system: Cowpox virus survival over two weeks after 10^6 pfu intranasal inoculation, males and females between 40 and 152 days of age, residuals corrected for sex, age and body weight [~2.67/unit] x x 0.052 0.045 x x x 0.205 x x x 0.311 x x x x x x x x x x x x x x x x x x 0.098 x 0.382 x x x x x x x x x -0.176 -0.019 x x -0.109 0.105 x -0.041 x x x x 0.285 x x x x x 0.264 x 0.21 x 0.295 x -1.608 x 0.145 x x 0.172 x 0.442 x 0.132 x x -0.301 -0.784 x 0.334 0.097 x -0.346 0.332 x 0.014 x x x x x 0.163 0.295 x x 0.329 0.486 -0.446 -0.749 -0.613 +12677 Original post publication description: Infectious disease, immune function: Cowpox virus severity of disease measured by the maximum clinical score over two weeks after a 10^6 pfu intranasal inoculation, males and females between 40 and 152 days of age, residuals corrected for sex, age, and body [ordinal scale where -0.5 = relatively unaffected and +0.5 is most severe disease] None Infectious disease, immune system: Cowpox virus severity of disease measured by the maximum clinical score over two weeks after a 10^6 pfu intranasal inoculation, males and females between 40 and 152 days of age, residuals corrected for sex, age, and body [ordinal scale where -0.5 = relatively unaffected and +0.5 is most severe disease] x x 0.16 0.072 x x x -0.098 x x x 0.023 x x x x x x x x x x x x x x x x x x -0.056 x 0.021 x x x x x x x x x -0.148 -0.029 x x 0.003 0.488 x 0.023 x x x x 0.085 x x x x x -0.319 x -0.3 x 0.083 x -0.073 x 0.391 x x -0.198 x -0.309 x 0.023 x x -0.132 0.223 x -0.001 0.32 x 0.205 0.221 x 0.088 x x x x x -0.26 0.114 x x -0.486 0.07 -0.126 0.139 -0.217 +12678 Original post publication description: Infectious disease, immune function: Cowpox virus measure of disease onset measured by the day of maximum clinical score over two weeks after 10^6 pfu intranasal inoculation, males and females between 40 and 152 days of age, residuals corrected for sex, age and body weight [scaled days where -0.40 is early onset (6 days) and +0.5 is late onset (>10 days)] None Infectious disease, immune system: Cowpox virus measure of disease onset measured by the day of maximum clinical score over two weeks after 10^6 pfu intranasal inoculation, males and females between 40 and 152 days of age, residuals corrected for sex, age and body weight [scaled days where -0.40 is early onset (6 days) and +0.5 is late onset (>10 days)] x x 0.092 -0.034 x x x 0.037 x x x -0.325 x x x x x x x x x x x x x x x x x x -0.424 x -0.426 x x x x x x x x x 0.127 0.266 x x 0.507 0.274 x -0.299 x x x x 0.009 x x x x x -0.208 x -0.105 x 0.504 x 0.004 x -0.276 x x 0.265 x -0.301 x -0.223 x x 0.174 0.196 x 0.177 0.134 x 0.091 -0.223 x 0.068 x x x x x -0.02 0.044 x x -0.144 -0.203 -0.083 0.072 0.25 +12679 Original post publication description: Infectious disease, immune function: Cowpox virus maximum body temperature over two weeks after 10^6 pfu intranasal inoculation, males and females between 40 and 152 days of age, residuals corrected for sex, age and body weight [scaled deg C where -0.5 is >34.5 and 0.5 is <38] None Infectious disease, immune system: Cowpox virus maximum body temperature over two weeks after 10^6 pfu intranasal inoculation, males and females between 40 and 152 days of age, residuals corrected for sex, age and body weight [scaled deg C where -0.5 is >34.5 and 0.5 is <38] x x 0.303 0.357 x x x 0.035 x x x 0.453 x x x x x x x x x x x x x x x x x x -0.006 x -0.234 x x x x x x x x x 0.075 0.22 x x 0.025 -0.289 x -0.245 x x x x 0.365 x x x x x 0.191 x 0.298 x -0.475 x 0.149 x -0.004 x x 0.243 x 0.103 x -0.441 x x -0.072 -0.15 x 0.119 0.101 x -0.179 0.052 x -0.014 x x x x x -0.079 -0.284 x x -0.041 -0.029 -0.112 -0.343 -0.09 +12680 Original post publication description: Infectious disease, immune function: Cowpox virus measure of disease onset measured by the day of maximum body temperature over two weeks after 10^6 pfu intranasal inoculation, males and females between 40 and 152 days of age, residuals corrected for sex, age and body weight [scaled days where -0.6 is >5 days and 0.6 is <10 days] None Infectious disease, immune system: Cowpox virus measure of disease onset measured by the day of maximum body temperature over two weeks after 10^6 pfu intranasal inoculation, males and females between 40 and 152 days of age, residuals corrected for sex, age and body weight [scaled days where -0.6 is >5 days and 0.6 is <10 days] x x -0.248 0.377 x x x -0.211 x x x -0.27 x x x x x x x x x x x x x x x x x x 0.076 x 0.57 x x x x x x x x x 0.418 0.132 x x -0.532 -0.05 x 0.151 x x x x 0.199 x x x x x 0.047 x 0.51 x 0.231 x 0.01 x 0.072 x x -0.125 x -0.096 x -0.156 x x 0.041 -0.003 x -0.186 -0.196 x 0.073 0.078 x -0.02 x x x x x -0.242 -0.452 x x 0.28 0.023 -0.213 -0.329 0.041 +12681 Original post publication description: infectious disease, immune function: Cowpox virus maximum weight loss over two weeks after 10^6 pfu intranasal inoculation, males and females between 40 and 152 days of age, residuals corrected for sex, age and body weight at time of inoculation [scaled % loss where -0.6 = minimal weight loss of 3% and +0.7 is maximal weight loss of 34%] None infectious disease, immune system: Cowpox virus maximum weight loss over two weeks after 10^6 pfu intranasal inoculation, males and females between 40 and 152 days of age, residuals corrected for sex, age and body weight at time of inoculation [scaled % loss where -0.6 = minimal weight loss of 3% and +0.7 is maximal weight loss of 34%] x x 0.18 0.318 x x x 0.21 x x x -0.024 x x x x x x x x x x x x x x x x x x 0.242 x -0.044 x x x x x x x x x 0.124 -0.287 x x -0.28 -0.371 x 0.006 x x x x -0.085 x x x x x -0.274 x -0.208 x 0.668 x 0.609 x -0.598 x x 0.292 x -0.484 x 0.321 x x 0.44 0.193 x -0.494 -0.564 x 0.44 0.235 x -0.035 x x x x x -0.539 -0.377 x x 0.159 -0.392 0.342 0.191 0.086 +12682 Original post publication description: Infectious disease, immune function: Cowpox virus measure of disease onset measured by the day of maximum weight loss over two weeks after 10^6 pfu intranasal inoculation, males and females between 40 and 152 days of age, residuals corrected for sex, age and body weight [scaled days in which -0.8 is >5 days and 1.7 is <13 days] None Infectious disease, immune system: Cowpox virus measure of disease onset measured by the day of maximum weight loss over two weeks after 10^6 pfu intranasal inoculation, males and females between 40 and 152 days of age, residuals corrected for sex, age and body weight [scaled days in which -0.8 is >5 days and 1.7 is <13 days] x x 0.63 0.394 x x x -0.115 x x x 0.019 x x x x x x x x x x x x x x x x x x -0.269 x -0.378 x x x x x x x x x 0.049 0.012 x x 0.224 0.084 x 0.23 x x x x -0.275 x x x x x -0.304 x 0.533 x 1.721 x 0.022 x -0.51 x x -0.093 x 0.126 x -0.761 x x -0.199 0.122 x 0.248 -0.292 x 0.251 -0.029 x 0.055 x x x x x -0.097 -0.142 x x -0.582 -0.433 -0.153 -0.052 -0.037 +12683 Original post publication description: Infectious disease, immune function: Ectromelia virus mortality score (combined data from Brownstein 1999 and Rice et al. 2010) [3 = resistant, 2 = intermediate, 1 = susceptible, table 1 column 1, ordinal scale] None Infectious disease, immune function: Ectromelia virus mortality score (combined data from Brownstein 1999 and Rice et al. 2010) [3 = resistant, 2 = intermediate, 1 = susceptible, table 1 column 1, ordinal scale] x 3.0 3.0 1.0 2.0 3.0 1.0 2.5 3.0 1.0 2.0 3.0 2.0 2.0 3.0 2.0 3.0 3.0 x 3.0 2.0 3.0 x 1.0 2.0 3.0 3.0 3.0 3.0 2.0 1.0 x 1.0 x x x x x 1.0 x x x 1.0 3.0 x x 3.0 3.0 3.0 2.0 x x x x x x x x x x 3.0 x 2.0 x 3.0 x 3.0 1.0 2.0 x x 1.0 x 2.0 x 2.0 x x 2.0 1.0 x 2.0 3.0 x 3.0 1.0 x 1.0 3.0 x x x x 3.0 3.0 x 3.0 2.0 3.0 3.0 3.0 2.0 +12684 Original post publication description: Radiation biology: Rad6.5 (contact Ryan Yates at cyates4@uthsc.edu) Radiation biology: Rad6.5 (contact Ryan Yates at cyates4@uthsc.edu) Radiation biology, environmental genetics: High-dose total body gamma-irradiation survival for 12-week-old females, mean survival time (MST) after a 137-Cesium 6 Gy single exposure (LD80/30) evaluated over a 30 day post-exposure, no supportive care [residual days] x x x x 1.984 x x x x x -5.516 3.484 x x x x x x x x -7.016 x x -2.266 x -4.516 x 0.1842 x -0.3492 -1.349 x -5.516 x x x 9.184 8.234 2.484 x x 2.484 -0.3492 -3.016 x x 6.984 x x -5.516 x x x x x x x x 0.2342 5.984 -2.266 x x -5.349 x x -1.216 -2.682 -0.0158 x x 0.4842 x -6.682 x 9.984 x -1.682 -2.349 x x x 0.2342 -4.266 x -4.616 x 0.9842 x x x x x x -0.5158 3.784 x 9.318 2.784 0.6508 -2.416 x +12685 Original post publication description: Musculoskeletal system, morphology: Body weight, statistically adjusted for variation in sex and age, and corrected for pregnancy [g] None Musculoskeletal system, morphology: Body weight, statistically adjusted for variation in sex and age, and corrected for pregnancy (Hager et al., 2012) [g] 32.214 29.154 24.273 22.755 24.076 26.971 23.559 22.986 24.495 25.206 24.37 23.698 25.696 24.092 27.645 26.3 25.281 22.033 20.848 23.991 22.911 22.509 24.021 26.648 21.688 24.622 24.476 23.14 20.878 24.64 25.778 21.534 27.948 23.71 24.095 x 23.21 27.484 24.651 x 24.708 24.878 26.165 22.757 x x 26.954 28.464 24.637 25.796 x x x 26.225 26.877 x x x 31.705 28.106 25.455 23.609 24.574 24.462 21.328 26.315 27.245 27.515 26.571 23.913 x 22.523 24.805 24.62 18.693 34.962 24.259 23.516 24.097 22.267 x 21.018 24.55 27.498 28.368 22.683 x 25.556 27.504 20.392 31.262 27.293 x 27.686 27.992 31.93 24.836 24.363 29.085 26.419 27.895 24.029 +12686 Original post publication description: Musculoskeletal system, morphology: Body weight (no statistical adjustment) [g] None Musculoskeletal system, morphology: Body weight (no statistical adjustment) [g] 31.298 28.897 23.343 23.465 23.487 27.74 21.58 23.263 24.576 25.678 23.633 23.323 23.035 23.652 27.111 23.832 23.51 22.444 19.928 24.426 22.162 21.88 22.375 27.948 21.047 22.562 22.597 20.086 18.117 23.995 25.878 21.413 28.19 21.572 22.73 x 21.328 26.442 23.523 x 23.997 24.491 26.656 21.874 x x 26.625 26.033 24.172 26.276 x x x 26.924 27.894 x x x 32.786 27.488 25.596 22.544 30.6 26.453 23.072 26.988 30.879 28.007 28.027 26.45 x 23.049 21.2 24.806 24.533 36.483 24.392 19.9 25.798 24.6 x 21.093 25.121 27.274 29.852 23.751 x 27.637 27.331 22.733 31.29 28.483 x 28.94 27.52 32.328 25.467 24.809 30.027 23.55 27.504 22.5 +12687 Original post publication description: Bovine spongioform encephalopathy (prion disease, mouse-adapted scrapie strain ME7), primary transmission incubation period in females [days] None Bovine spongioform encephalopathy (prion disease, mouse-adapted scrapie strain ME7), primary transmission incubation period in females [days] x x 454.0 278.0 x x x 516.0 x x x x x x x x x x x 274.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12711 Original post publication description: Infectious disease, immune function: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) interleukin-4 from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control] None Infectious disease, immune function: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) interleukin-4 from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control] x 585.976 100.0 1778.71 x x x x x x 72.257 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 90.412 33.252 88.84 258.032 x x x 483.745 398.74 x x x x 385.872 895.398 x x x 57.165 83.886 476.484 x x x x x x 1191.08 68.244 x x x 385.853 x x 455.644 x x 1110.81 x x 45.155 x x x x x 44.675 x x x x x x 60.112 x x x x x x x +12688 Original post publication description: BXD epoch batch trait 1 [-1 = Taylor BXD series BXD1 to 32, 0 = Taylor series BXD33 to 42, 1 = UTHSC BXD series BXD43 and higher] None Genetics, statistics, cofactors: BXD epoch batch trait 1 [-1 = Taylor BXD series BXD1 to 32, 0 = Taylor series BXD33 to 42, 1 = UTHSC BXD series BXD43 and higher] x x x x -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.0 1.0 x x 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 x x 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 x 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 +12689 Original post publication description: BXD epoch batch trait 2 [-1 = Taylor BXD series BXD1 to 42, 1 = UTHSC BXD series BXD43 and higher] None Genetics, statistics, cofactors: BXD epoch batch trait 2 [-1 = Taylor BXD series BXD1 to 42, 1 = UTHSC BXD series BXD43 and higher] x x x x -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 1.0 1.0 1.0 x x 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 x x 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 x 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 +12690 Original post publication description: BXD epoch batch trait 3 [-1 = Taylor BXD series BXD1 to 32, 1 = Taylor series BXD33 to 42 and all UTHSC BXD series BXD43 and higher] None Genetics, statistics, cofactors: BXD epoch batch trait 3 [-1 = Taylor BXD series BXD1 to 32, 1 = Taylor series BXD33 to 42 and all UTHSC BXD series BXD43 and higher] x x x x -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 x x 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 x x 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 x 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 +12717 Original post publication description: Infectious disease, immune function: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) IP-10 from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control] None Infectious disease, immune function: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) IP-10 from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control] x 38.225 100.0 52.081 x x x x x x 207.908 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 98.339 99.589 85.412 66.698 x x x 62.542 39.591 x x x x 118.556 20.952 x x x 51.195 147.18 61.076 x x x x x x 37.512 114.35 x x x 44.901 x x 47.614 x x 94.918 x x 129.057 x x x x x 79.522 x x x x x x 119.363 x x x x x x x +12748 Original post publication description: Reproduction, urogenital system, morphology: Uterus weight at maturity, bilateral, unadjusted for body weight, age, or parity [mg] None Reproduction, urogenital system, morphology: Uterus weight at maturity, bilateral, unadjusted for body weight, age, or parity [mg] 72.5 88.75 63.8 97.16 58.667 x 24.5 x 81.5 49.5 65.636 58.75 64.667 101.0 x 42.333 x 54.462 x x 48.0 x x 53.667 x 49.6 x 47.25 x 70.0 112.4 158.0 89.533 x 99.0 x 85.0 66.909 113.25 x 57.333 74.083 48.714 90.643 x x 66.333 174.667 79.5 95.923 x x x 80.286 119.154 x x x 96.783 66.454 72.158 68.5 x 69.0 77.714 x 62.538 63.809 139.147 68.0 x 76.16 x 104.368 x 94.714 x 56.8 59.923 x x 85.857 66.692 131.625 65.444 82.842 x 109.25 100.333 x 67.0 x x 94.286 76.182 81.667 42.0 90.0 87.177 118.5 80.556 69.846 +12749 Original post publication description: Reproduction, urogenital system, morphology: Uterus horn length at maturity (average of right and left sides), unadjusted for body weight, age, or parity [mg] None Reproduction, urogenital system, morphology: Uterus horn length at maturity (average of right and left sides), unadjusted for body weight, age, or parity [mg] 1.395 1.486 1.583 1.681 1.26 x 1.36 x 2.09 2.1 1.314 1.228 1.675 1.01 x 1.233 x 1.66 x x 1.335 x x 1.1 x 1.47 x 1.445 x 1.34 1.2 1.78 1.623 x 1.47 x 1.41 1.491 1.295 x 1.737 1.879 1.663 1.706 x x 1.638 1.432 1.724 1.758 x x x 1.854 1.515 x x x 1.732 1.775 1.555 1.624 x 1.506 1.602 x 1.945 1.797 1.909 1.721 x 1.753 x 1.851 x 2.124 x 0.772 1.681 x x 1.869 1.875 1.791 1.861 1.592 x 1.807 1.572 x 1.97 x x 1.977 1.825 1.463 1.535 1.77 1.894 1.212 2.182 1.708 +12741 Original post publication description: T4_EtPerchangebas entered at December/14 16:45:32 from IP 128.172.54.246 Central nervous system, pharmacology, behavior: Ethanol response (chronic intermittent ethanol CIE cycles), consumption of 15% ethanol (v/v) using two-bottle choice system (ethanol vs water) and 2-hour access from day 3 to day 8 after the 4th cycle of ethanol vapor chamber treatment, young adult males or females [% change from baseline] Central nervous system, pharmacology, behavior: Ethanol response (chronic intermittent ethanol CIE cycles), consumption of 15% ethanol (v/v) using two-bottle choice system (ethanol vs water) and 2-hour access from day 3 to day 8 after the 4th cycle of ethanol vapor chamber treatment, young adult males or females [% change from baseline] -52.941 x 54.034 48.063 x x 59.247 x x x x -9.524 x -20.032 x -4.721 x x x x x x x x x x x x x x x x 59.859 x x x x -4.829 x x x -52.714 x -40.815 x x x 232.241 54.635 x x x x 87.057 x x x x x x -7.359 x x x 136.328 x x x x 14.43 x x 4.621 16.739 x 88.907 x x -0.467 -22.834 x 118.698 x -22.775 x x x x x x x x x x x x x x -6.811 24.703 -33.069 -32.946 +12721 Original post publication description: Infectious disease, immune function: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) monocyte chemoattractant protein-1 from draining lymph node, 3 weeks post infection in females [%of C57BL/6 control] entered at October/25 13:43: None Infectious disease, immune system: Leishmania major response (footpad injection, 5 million promastigotes at 7 weeks), monocyte chemoattractant protein-1 (MCP1) level from draining lymph nodes 3 weeks after infection in females [% of C57BL/6 control] x 63.925 100.0 105.434 x x x x x x 56.884 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 118.692 160.797 103.141 185.247 x x x 165.307 132.888 x x x x 134.849 88.703 x x x 32.467 196.178 99.984 x x x x x x 187.658 29.996 x x x 84.863 x x 48.206 x x 146.373 x x 81.64 x x x x x 237.805 x x x x x x 415.571 x x x x x x x +12704 Original post publication description: Infectious disease, immune function: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) Interferon-gamma from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control] None Infectious disease, immune function: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) Interferon-gamma from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control] x 39.33 100.0 49.031 x x x x x x 167.9 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 122.1 49.3 41.9 72.0 x x x 52.1 104.3 x x x x 93.9 8.4 x x x 43.4 73.5 94.2 x x x x x x 73.3 144.7 x x x 25.1 x x 7.5 x x 39.1 x x 76.8 x x x x x 77.8 x x x x x x 81.7 x x x x x x x +12725 Original post publication description: Infectious disease, immune function: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) MIG alpha from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control] None Infectious disease, immune function: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) MIG alpha from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control] x 47.697 100.0 71.666 x x x x x x 283.788 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 119.086 166.411 129.236 95.292 x x x 95.097 83.179 x x x x 125.017 30.504 x x x 52.537 105.035 124.839 x x x x x x 56.295 70.545 x x x 62.808 x x 40.4 x x 75.889 x x 124.378 x x x x x 200.42 x x x x x x 164.616 x x x x x x x +12743 Original post publication description: T2_EtPerchangebas Central nervous system, pharmacology, behavior: Ethanol response (chronic intermittent ethanol CIE cycles), consumption of 15% ethanol (v/v) using two-bottle choice system (ethanol vs water) and 2-hour access from day 3 to day 8 after the 2nd cycle of ethanol vapor chamber treatment, young adult males or females [% change from baseline] Central nervous system, pharmacology, behavior: Ethanol response (chronic intermittent ethanol CIE cycles), consumption of 15% ethanol (v/v) using two-bottle choice system (ethanol vs water) and 2-hour access from day 3 to day 8 after the 2nd cycle of ethanol vapor chamber treatment, young adult males or females [% change from baseline] 25.12 x 29.322 12.106 x x 66.351 x x x x -12.088 x 17.538 x -37.212 x 4.825 x x x x x x x x x x x x -1.639 x -19.855 x x x x -12.457 x x x -24.544 x -59.219 x x x 65.657 75.499 28.046 x x x 81.158 x x x x x x 67.635 x 33.884 x 31.829 x x 32.666 x 3.67 x 17.208 17.857 -15.265 x -25.0 x x 25.001 -5.971 x 166.821 46.728 -13.535 x x x 91.48 x x x x x x x x x -29.644 -32.438 93.524 -5.34 -22.32 +12744 Original post publication description: T1_Etchangebas entered at December/14 16:45:32 from IP 128.172.54.246 None Central nervous system, pharmacology, behavior: Ethanol response (chronic intermittent ethanol CIE cycles), consumption of 15% ethanol (v/v) using two-bottle choice system (ethanol vs water) and 2-hour access from day 3 to day 8 after the 1st cycle of ethanol vapor chamber treatment, young adult males or females [% change from baseline] -0.91 x 0.54 -0.305 x x 0.05 x x x x 0.19 x -0.32 x -1.19 x -0.12 x x x x x x x x x x x x -0.21 x 0.13 x -0.2 x x -0.695 x x x -1.0 x -1.35 x x x 0.16 -0.31 0.83 x x x 1.18 x x x x x x 1.37 x -0.06 x 0.57 x x 0.68 x 0.21 x -0.48 -0.15 -0.13 x -0.44 x x 0.05 0.08 x 0.99 -0.08 -0.24 x x x -0.07 x x x x x x x x x x x x x x +12745 Original post publication description: Base_w6_Etgkg_ave entered at December/14 16:45:32 from IP 128.172.54.246 Central nervous system, pharmacology, behavior: Ethanol response (chronic intermittent ethanol CIE cycles), consumption of 15% ethanol (v/v) using two-bottle choice system (ethanol vs water) and 2-hour access from day 3 to day 8 before any ethanol vapor chamber treatment (baseline consumption), young adult males or females [g/kg] Central nervous system, pharmacology, behavior: Ethanol response (chronic intermittent ethanol CIE cycles), consumption of 15% ethanol (v/v) using two-bottle choice system (ethanol vs water) and 2-hour access from day 3 to day 8 before any ethanol vapor chamber treatment (baseline consumption), young adult males or females [g/kg] 1.69 x 2.435 1.375 x x 1.66 x x x x 2.05 x 1.1 x 1.68 x 1.76 x x x x x x x x x x x x 1.46 x 2.02 x 1.36 x x 1.44 x x x 1.98 x 2.42 x x x 1.14 1.55 1.64 x x x 1.84 x x x x x x 2.59 x 1.19 x 0.97 x x 3.06 x 1.55 x 1.64 1.5 1.84 x 1.44 x x 1.7 5.8 x 0.76 1.07 1.645 x x x 1.14 x x x x x x x x x 3.275 1.57 1.38 2.16 1.55 +12706 Original post publication description: Infectious disease, immune function: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) GM-CSF from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control] Infectious disease, immune function: Leishmania major (footpad injection of 5 million promastigotes at 7 weeks) granulocyte macrophage colony-stimulating factor (GM-CSF) level from draining lymph node, 3 weeks after infection in females (Luminex assay) [% of C57BL/6 control] Infectious disease, immune function: Leishmania major (footpad injection of 5 million promastigotes at 7 weeks) granulocyte macrophage colony-stimulating factor (GM-CSF) level from draining lymph node, 3 weeks after infection in females (Luminex assay) [% of C57BL/6 control] x 77.509 100.0 137.731 x x x x x x 91.452 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 142.127 132.701 141.659 81.406 x x x 125.5 139.319 x x x x 93.38 51.459 x x x 102.549 68.936 104.99 x x x x x x 136.904 309.576 x x x 95.847 x x 34.699 x x 217.279 x x 174.556 x x x x x 225.295 x x x x x x 119.077 x x x x x x x +12707 Original post publication description: Infectious disease, immune function: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) interleukin-1 alpha from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control] None Infectious disease, immune function: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) interleukin-1 alpha from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control] x 41.424 100.0 92.671 x x x x x x 186.976 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 223.0 136.656 88.363 136.094 x x x 131.21 79.368 x x x x 219.335 20.84 x x x 84.758 190.276 142.043 x x x x x x 137.928 116.049 x x x 42.752 x x 21.007 x x 49.527 x x 140.971 x x x x x 176.818 x x x x x x 204.109 x x x x x x x +12742 Original post publication description: T3_EtPerchangebas entered at December/14 16:45:32 from IP 128.172.54.246 Central nervous system, pharmacology, behavior: Ethanol response (chronic intermittent ethanol CIE cycles), consumption of 15% ethanol (v/v) using two-bottle choice system (ethanol vs water) and 2-hour access from day 3 to day 8 after the 3rd cycle of ethanol vapor chamber treatment, young adult males or females [% change from baseline] Central nervous system, pharmacology, behavior: Ethanol response (chronic intermittent ethanol CIE cycles), consumption of 15% ethanol (v/v) using two-bottle choice system (ethanol vs water) and 2-hour access from day 3 to day 8 after the 3rd cycle of ethanol vapor chamber treatment, young adult males or females [% change from baseline] -5.976 x 58.766 15.022 x x 47.292 x x x x -16.715 x 21.088 x -29.975 x x x x x x x x x x x x x x 76.707 x 57.288 x x x x 5.147 x x x -31.645 x -28.571 x x x 121.622 153.927 115.704 x x x 91.931 x x x x x x 37.425 x 18.732 x 67.918 x x -100.0 x -2.164 x 8.686 13.793 27.063 x 90.519 x x 14.877 14.31 x 171.7 -100.0 27.87 x x x 86.954 x x x x x x x x x -100.0 5.145 125.323 15.35 6.296 +12750 Original post publication description: Reproduction, urogenital system, morphology: Uterus body length, unadjusted for body weight, age, or parity [cm] None Reproduction, urogenital system, morphology: Uterus body length, unadjusted for body weight, age, or parity [cm] 0.205 0.297 0.304 0.436 0.313 x 0.29 x 0.42 0.215 0.408 0.325 0.358 0.265 x 0.533 x 0.355 x x 0.375 x x 0.32 x 0.354 x 0.28 x 0.293 0.418 0.31 0.44 x 0.33 x 0.39 0.37 0.378 x 0.3 0.418 0.384 0.383 x x 0.337 0.403 0.331 0.489 x x x 0.473 0.359 x x x 0.505 0.471 0.429 0.267 x 0.35 0.454 x 0.315 0.463 0.443 0.368 x 0.41 x 0.335 x 0.461 x 0.38 0.362 x x 0.399 0.345 0.419 0.465 0.384 x 0.422 0.397 x 0.4 x x 0.474 0.43 0.3 0.29 0.49 0.379 0.372 0.321 0.357 +12720 Original post publication description: Infectious disease, immune function: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) LIF from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control] None Infectious disease, immune function: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) LIF from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control] x 137.739 100.0 323.238 x x x x x x 51.298 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 44.516 17.626 61.482 95.444 x x x 184.204 81.386 x x x x 225.91 111.072 x x x 60.783 44.934 282.44 x x x x x x 161.229 35.496 x x x 99.916 x x 186.197 x x 210.85 x x 24.359 x x x x x 45.467 x x x x x x 64.277 x x x x x x x +12724 Original post publication description: Infectious disease, immune function: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) macrophage inflammatory protein-1 beta from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control] None Infectious disease, immune function: Leishmania major response (footpad injection, 5 million promastigotes at 7 weeks), macrophage inflammatory protein-1 beta (MIP1B) from draining lymph nodes 3 weeks after infection in females [% of C57BL/6 control] x 59.523 100.0 86.965 x x x x x x 100.436 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 69.874 73.572 59.952 125.137 x x x 95.716 180.706 x x x x 105.703 85.767 x x x 81.095 85.262 103.587 x x x x x x 82.8 92.53 x x x 110.16 x x 55.449 x x 100.21 x x 69.92 x x x x x 107.984 x x x x x x 87.187 x x x x x x x +12723 Original post publication description: Infectious disease, immune function: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) macrophage inflammatory protein-1 alpha from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control] None Infectious disease, immune function: Leishmania major (footpad injection, 5 million promastigotes at 7 weeks) macrophage inflammatory protein-1 alpha from draining lymph node, 3 weeks post infection in females [% of C57BL/6 control] x 54.613 100.0 77.667 x x x x x x 226.531 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 78.96 69.189 66.375 80.611 x x x 79.6 223.961 x x x x 73.327 77.584 x x x 180.382 126.273 96.971 x x x x x x 77.174 191.574 x x x 114.373 x x 33.214 x x 138.564 x x 77.72 x x x x x 214.245 x x x x x x 74.52 x x x x x x x +12731 Original post publication description: Central nervous system, behavior, learning and memory: Reversal learning, impulsivity, trials to criterion after acquisition in 4-month adult males (Med Associates nose poke chamber, low values = faster learning) [n] None Central nervous system, behavior, learning and memory: Reversal learning, impulsivity, trials to criterion after acquisition in 4-month adult males (Med Associates nose poke chamber, low values = faster learning) [n] x x 183.2 233.75 150.8 296.5 x x x x x 196.0 180.0 164.5 x 310.5 138.0 x x x 235.5 x x 205.8 220.0 x x 220.0 x 110.75 229.0 x 180.83 x 137.0 x 118.5 211.33 132.0 x 259.8 168.75 202.0 205.5 x x x 77.0 136.0 206.67 x x x 157.33 210.0 x x x 97.0 164.0 117.0 x x 123.0 91.0 x 255.0 x 128.33 203.5 x 80.5 x 213.8 x 211.0 x x 115.2 x x 102.5 144.33 172.4 110.25 x x 197.67 102.5 x x x x 122.5 166.0 x 141.0 x 251.0 x 252.8 210.25 +12732 Original post publication description: Central nervous system, behavior, learning and memory: Reversal learning, impulsivity, residual trials to criterion after acquisition in 4-month adult males corrected for variation in acquisition learning (Med Associates nose poke chamber) [residual n] None Central nervous system, behavior, learning and memory: Reversal learning, impulsivity, residual trials to criterion after acquisition in 4-month adult males corrected for variation in acquisition learning (Med Associates nose poke chamber) [residual n] x x 9.77 24.27 -13.13 155.97 x x x x x 47.38 -25.82 -14.94 x 86.4 0.09 x x x 75.91 x x 33.2 29.59 x x 49.7 x -62.95 47.34 x 20.28 x 1.18 x -33.78 30.93 -49.37 x 69.23 -13.96 34.57 62.62 x x x -81.02 -24.11 40.72 x x x -32.99 68.43 x x x -50.84 -1.6 -14.96 x x -33.72 -85.57 x 58.93 x -77.31 33.33 x -143.34 x 16.86 x 29.21 x x -52.38 x x -56.44 -15.0 -11.79 -95.18 x x 23.36 -99.4 x x x x -64.52 -15.4 x -2.14 x 32.33 x 41.23 5.87 +12733 Original post publication description: Ethanol response (10% v/v ethanol), average daily consumption at 2 hr, males and females combined [g/kg] None Ethanol response (10% v/v ethanol), average daily consumption at 2 hr, males and females combined [g/kg] x x x x 0.1 x x 1.15 x 0.18 0.6 0.06 0.11 0.9 x 0.4 x 0.53 x x 0.06 x 1.54 0.54 x 0.52 x x x 0.74 0.12 x 0.51 x 0.21 x 0.3 x 0.45 0.7 0.26 1.21 0.87 0.43 x x 2.25 x x 1.08 x x x 1.95 0.81 x x x 1.35 x 0.22 x x x 0.21 0.52 0.2 0.55 1.36 0.59 x 0.41 x 0.4 x 0.98 x 1.38 0.79 x x 0.16 1.09 0.65 0.72 0.66 x 0.41 0.49 x 0.42 x x x x x 0.07 x 1.54 x 0.06 1.09 +12735 Original post publication description: 3alpha,5alpha-tetrahydroprogesterone (THP) levels 6 hrs after saline injection, afternoon sample collection (preliminary) [pg/g] Central nervous system, pharmacology, endocrinology: 3alpha,5alpha-tetrahydroprogesterone (THP, allopregnanolone) level in the olfactory bulb and tubercle 6 hrs after saline injection, afternoon sample collection (control for dexamethasone injection) [pg/g] Central nervous system, pharmacology, endocrinology: 3alpha,5alpha-tetrahydroprogesterone (THP, allopregnanolone) level in the olfactory bulb and tubercle 6 hrs after saline injection, afternoon sample collection (control for dexamethasone injection) [pg/g] x 127.68 465.39 229.94 x 120.82 547.85 17.9 x 90.06 x 394.97 63.36 369.97 147.88 255.92 299.92 205.45 x 81.87 x x x 199.62 x 175.34 x x x x 158.09 x x x x x x x x x x x 139.8 x x x 291.39 x x x x x x x x x x x x x 259.87 x x x x x x 197.76 x x x x x x x x x x x x x x x x x 150.53 x 189.48 x x x x x x x x x x x x x x +12736 Original post publication description: 3alpha,5alpha-tetrahydroprogesterone (THP) levels 1 hrs after saline injection, morning sample collection (preliminary) [pg/g] None Central nervous system, pharmacology, endocrinology: 3alpha,5alpha-tetrahydroprogesterone (THP) level in the olfactory bulb and tubercle 1 hrs after saline injection, morning sample collection (control for ethanol experiments) [pg/g] x x 1440.0 1234.8 x x x x x x x 1489.4 947.0 x x 850.7 x x x 1371.7 x x x x x 595.5 x x x x x x x x x x x x x x x x 1802.7 x x x x x x x x x x x x x x x x x x x x x x x x 805.7 x x x 1174.8 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12737 Original post publication description: Central nervous system: level of allopregnanolone in the olfactory bulb and tubercle 1 hour after control saline injection ((3alpha,5alpha) 3-hydroxy-5-pregnane-20-one (3alpha,5alpha-THP)) [pg/g] None Central nervous system, pharmacology, endocrinology: 3a,5a-pregnane-3a,21-diol-20-one (THDOC) level in the olfactory bulb and tubercle 1 hour after saline injection, morning sample collection (control for dexamethasone injection) [pg/g] x 112.05 136.52 216.0 x 122.96 2301.4 974.32 x 278.2 x 475.07 85.32 359.75 647.61 147.41 464.25 3502.93 x 175.22 x x x 1000.0 x 2034.15 x 612.11 x 314.09 245.99 x x x x x x x x x x x 270.0 x x x 141.72 x x x x x x x x x x x x x 605.45 x x x x x x 55.12 x x x x x x x x x x x x x x x x x 522.33 x 1369.68 x x x x x x x x x x x x x x +12738 Original post publication description: Pregnenolone levels X hrs after saline injection, XX sample collection (preliminary) [pg/g] None Pregnenolone levels X hrs after saline injection, XX sample collection (preliminary) [pg/g] x 1573.81 1464.92 1266.92 x 1402.71 1066.2 1141.1 x 1119.54 x 1596.29 3832.29 4067.29 940.1 1678.94 6381.52 1286.82 x 1348.52 x x x 1921.86 x 1759.52 x x x 1262.06 x x x x x x x x x x x x 1303.63 x x x 1227.8 x x x x x x x x x x x x x 1128.8 x x x x x x 1479.66 x x x x x x x x x x x x x x x x x 1784.28 x 133.83 x x x x x x x x x x x x x x +12746 Original post publication description: Nowak2_Dec2010 None Nowak2_Dec2010 x x 19.0 0.0 x x x x x x x 0.0 10.0 x x 1.0 x x x x x x x x x x x x x x x x x x 7.0 x 7.0 17.0 6.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13007 Original post publication description: Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), median body weight loss day 3 after infection in 9-14 week-old females [%], file: mm2_weight_median_variantII_hko_180311 Original pre publication description: Infectious disease, immune function: Schughart (kls@helmholtz-hzi.de) WP12, median BWL day 3 [%], file hko_180311_vII Infectious disease, immune function: Schughart (kls@helmholtz-hzi.de) WP12, median BWL day 3 [%] Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), median body weight loss day 3 after infection in 9-14 week-old females [%] x 90.3 95.4 86.75 90.6 89.8 91.35 x 96.95 99.5 97.1 92.3 97.05 89.0 92.5 90.5 85.4 89.1 88.4 94.35 x 95.0 x x x x 79.45 x x 87.8 87.9 x 85.0 x 85.4 x 85.0 88.7 90.25 x 96.85 100.6 89.85 x x x x x x 89.45 x x x 93.5 94.44 x x x 88.9 94.75 86.63 x x 95.1 x 90.17 x 89.62 91.63 93.81 x 90.7 92.72 93.64 x x x 95.39 86.49 x x x 92.87 x x 96.72 x 90.09 x x 96.51 x x x 96.65 101.45 93.1 x 89.23 x 91.93 90.89 +13008 Original post publication description: Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), median body weight loss day 4 after infection in 9-14 week-old females [%], file: mm2_weight_median_variantII_hko_180311 Original pre publication description: Infectious disease, immune function: Schughart (kls@helmholtz-hzi.de) WP12, median BWL day 4 [%], file hko_180311_vII Infectious disease, immune function: Schughart (kls@helmholtz-hzi.de) WP12, median BWL day 4 [%] Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), median body weight loss day 4 after infection in 9-14 week-old females [%] x 88.1 92.73 82.35 89.5 86.5 89.8 x 92.3 100.5 91.05 86.3 95.1 83.4 86.0 86.0 81.2 85.0 87.0 91.15 x 95.6 x x x x 76.05 x x 85.1 85.0 x 84.3 x 82.8 x 82.6 87.75 85.35 x 94.1 102.2 82.81 x x x x x x 82.25 x x x 88.2 88.56 x x x 83.89 90.6 82.83 x x 93.85 x 85.76 x 86.46 84.1 88.47 x 87.8 85.69 91.38 x x x 94.25 80.32 x x x 87.09 x x 92.69 x 85.31 x x 95.28 x x x 94.7 99.8 93.8 x 85.63 x 81.64 83.23 +13009 Original post publication description: Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), median body weight loss day 5 after infection in 9-14 week-old females [%], file: mm2_weight_median_variantII_hko_180311 Original pre publication description: Infectious disease, immune function: Schughart (kls@helmholtz-hzi.de) WP12, median BWL day 5 [%], file hko_180311_vII Infectious disease, immune function: Schughart (kls@helmholtz-hzi.de) WP12, median BWL day 5 [%] Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), median body weight loss day 5 after infection in 9-14 week-old females [%] x 87.5 90.1 78.0 89.0 87.3 89.4 x 89.4 100.7 89.95 80.0 93.5 80.1 81.3 84.4 76.2 83.2 85.0 89.0 x 91.7 x x x x 75.0 x x 81.7 83.7 x 80.6 x 78.1 x 77.9 88.5 82.3 x 93.2 99.5 80.71 x x x x x x 77.85 x x x 86.7 82.24 x x x 83.47 88.3 77.9 x x 90.72 x 85.13 x 87.18 78.77 86.69 x 82.9 83.39 89.46 x x x 94.28 78.13 x x x 85.41 x x 90.31 x 81.16 x x 93.42 x x x 92.35 97.5 94.15 x 82.84 x 81.55 79.71 +13000 Original post publication description: Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), percent survival day 11 after infection in 9-14 week-old females [%], file: mm2_survival_per4_per13_hko_180311 Original pre publication description: Infectious disease, immune function: Schughart (kls@helmholtz-hzi.de) WP12, perc sur day 11 [%], file: hko_180311 Infectious disease, immune function: Schughart (kls@helmholtz-hzi.de) WP12, perc sur day 11 [%] Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), percent survival day 11 after infection in 9-14 week-old females [%] x 82.8 100.0 3.3 100.0 60.0 50.0 x 100.0 100.0 100.0 0.0 100.0 0.0 0.0 0.0 0.0 20.0 80.0 100.0 x 88.8 x x x x 0.0 x x 0.0 57.1 x 0.0 x 0.0 x 0.0 100.0 25.0 x 100.0 100.0 0.0 x x x x x x 0.0 x x x 20.0 20.0 x x x 80.0 80.0 20.0 x x 50.0 x 80.0 x 80.0 0.0 80.0 x 20.0 0.0 100.0 x x x 100.0 0.0 x x x 80.0 x x 100.0 x 0.0 x x 80.0 x x x 100.0 100.0 100.0 x 100.0 x 40.0 0.0 +13012 Original post publication description: Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), median body weight loss day 8 after infection in 9-14 week-old females [%], file: mm2_weight_median_variantII_hko_180311 Original pre publication description: Infectious disease, immune function: Schughart (kls@helmholtz-hzi.de) WP12, median BWL day 8 [%], file hko_180311_vII Infectious disease, immune function: Schughart (kls@helmholtz-hzi.de) WP12, median BWL day 8 [%] Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), median body weight loss day 8 after infection in 9-14 week-old females [%] x 84.2 85.8 75.0 89.2 87.8 77.0 x 90.4 99.2 85.8 75.0 93.95 75.0 75.0 75.0 75.0 77.7 85.5 78.55 x 79.7 x x x x 75.0 x x 75.0 77.5 x 75.0 x 75.0 x 75.0 85.6 75.0 x 89.05 95.8 75.0 x x x x x x 75.0 x x x 75.7 75.0 x x x 81.77 82.35 75.0 x x 78.01 x 82.64 x 83.57 75.0 80.13 x 75.0 75.0 87.46 x x x 85.85 75.0 x x x 86.55 x x 79.07 x 75.0 x x 79.84 x x x 78.9 98.05 91.1 x 81.66 x 75.0 75.0 +13013 Original post publication description: Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), median body weight loss day 9 after infection in 9-14 week-old females [%], file: mm2_weight_median_variantII_hko_180311 Original pre publication description: Infectious disease, immune function: Schughart (kls@helmholtz-hzi.de) WP12, median BWL day 9 [%], file hko_180311_vII Infectious disease, immune function: Schughart (kls@helmholtz-hzi.de) WP12, median BWL day 9 [%] Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), median body weight loss day 9 after infection in 9-14 week-old females [%] x 90.6 90.0 75.0 93.3 88.0 76.5 x 93.8 100.0 87.35 75.0 94.45 75.0 75.0 75.0 75.0 75.0 87.0 82.05 x 82.9 x x x x 75.0 x x 75.0 77.1 x 75.0 x 75.0 x 75.0 87.95 75.0 x 94.0 101.1 75.0 x x x x x x 75.0 x x x 75.0 75.0 x x x 83.38 85.1 75.0 x x 76.06 x 83.99 x 84.6 75.0 81.0 x 75.0 75.0 91.01 x x x 86.63 75.0 x x x 88.38 x x 78.64 x 75.0 x x 83.91 x x x 81.4 97.45 94.45 x 85.54 x 75.0 75.0 +12994 Original post publication description: Infectious disease, immune function: Malaria lethality, Plasmodium yoelii (PY17XL subclone, 10^6 PRBC i.p.) in 7-10 week old males (1=resistant and 0= susceptible)[survival fraction] None Infectious disease, immune function: Malaria lethality, Plasmodium yoelii (PY17XL subclone, 10^6 PRBC i.p.) in 7-10 week old males (1=resistant and 0= susceptible)[survival fraction] x 0.5 0.87 0.0 x x 0.0 x x x 0.0 x 0.67 x x x x 1.0 x x x x x 0.0 x 0.0 x x x 0.0 x x x x 0.0 x 0.0 x 0.0 x x 0.0 x x x x 0.22 1.0 x x x x x 1.0 0.0 x x x x 0.0 0.33 x x 0.5 0.0 1.0 0.46 x 0.0 x x 0.0 0.4 0.0 x 0.0 x x x x x 0.0 0.0 0.25 0.0 0.0 x 0.0 0.62 x x x x 1.0 0.5 0.0 x 0.0 0.0 x 1.0 0.0 +12969 Original post publication description: Infectious disease, immune function: Malaria lethality, Plasmodium yoelii (PY17X subclone, 10^6 PRBC i.p.) in 7-12 week-old females (1 = 100% susceptible and 0 = 100% resistant) [fraction of cohort that survives] None Infectious disease, immune function: Malaria lethality, Plasmodium yoelii (PY17X subclone, 10^6 PRBC i.p.) in 7-12 week-old females (1 = 100% susceptible and 0 = 100% resistant) [fraction of cohort that survives] x x 0.0 0.4 x x 1.0 x x 1.0 1.0 0.0 1.0 x x 1.0 x x x x x x x 1.0 x 1.0 x x x 1.0 0.5 x 0.571 x x x 1.0 1.0 1.0 x 1.0 1.0 1.0 0.0 x x 1.0 0.0 1.0 0.5 x 0.0 x 0.0 0.5 x x x 0.0 x 0.0 1.0 x 0.0 1.0 0.0 0.47 0.0 0.0 x x 1.0 0.75 1.0 x 1.0 x 1.0 1.0 x x x 1.0 0.0 1.0 x 0.333 x 0.1 1.0 x x x 0.2 0.69 x x 1.0 x 0.0 0.08 1.0 +12967 Original post publication description: Ethanol response (post vapor inhalation chamber treatment), 2-bottle choice consumption, 2h access after cycle 3 of ethanol exposure in chambers, average intake over 5 days [g/kg/2h] None Central nervous system, pharmacology, behavior: Ethanol response (ethanol vapor inhalation chronic intermittent ethanol (CIE) inhalation chamber), two-bottle choice consumption, 2 hr access after third cycle of exposure, intake over 5 days [g/kg/2h] 1.585 x 3.88 1.557 x x 2.446 x x x x 1.705 x 1.335 x 1.174 x x x x x x x x x x x x x x 2.584 x 3.173 x x x x 1.518 x x x 1.353 x 1.727 x x x 2.53 3.941 3.548 x x x 3.574 x x x x x x 3.556 x 1.415 x 1.624 x x x x 1.519 x 1.785 1.703 2.323 x 2.735 x x 1.96 6.625 x 2.059 x 2.033 x x x 2.136 x x x x x x x x x x 1.655 3.114 2.489 1.645 +12964 Original post publication description: Ethanol Response, 2-bottle choice consumption, 2h access after cycle 1 of Air exposure in vapor chambers. Average of 5 days ethanol intake [g/kg/2h]. Air_T1_Etgkgave. None Central nervous system, pharmacology: Ethanol response, ethanol intake using a 2-bottle choice test, 2 hr access after cycle 1 of air exposure only (control for CIE) in vapor chambers (average of 5 days ethanol intake, 16 to 18 weeks males or females [g/kg/2h] 3.276 x 2.492 1.369 x x 1.21 x x x x 2.274 x 0.794 x 1.753 x 1.554 x x x x x x x x x x x x 1.387 x 2.12 x 2.349 x x 1.145 x x x 1.775 x 1.036 x x x 3.343 2.863 1.462 x x x 3.426 x x x x x x 3.175 x 1.134 x 1.813 x x 1.895 x 1.262 x 1.25 1.193 1.282 x 1.148 x x 1.927 4.721 x 1.141 1.152 2.026 x x x 1.541 x x x x x x x x x 2.541 0.962 2.737 1.2 1.236 +12971 Original post publication description: Infectious disease, immune function: H5N1 influenza A virus (Boon-Webby Trait 3) None Infectious disease, immune system: TNFa cytokine expression level two days after infection with H5N1 influenza A virus (10^4 EID-50 of HK213 virus in 30 microliters saline) [pg/mL] x 49.0 21.0 301.0 x x x 83.0 x 168.0 x 183.0 148.0 85.0 x x 58.0 x x x 165.0 x x x x 233.0 100.0 x x 55.0 102.0 x x x x x x x x x x 37.0 191.0 73.0 x x 97.0 x 207.0 11.0 x x x 79.0 77.0 x x x 179.0 45.0 180.0 131.0 x 51.0 51.0 88.0 45.0 133.0 29.0 15.0 x 118.0 x 21.0 x x x x 44.0 x x 34.0 120.0 39.0 269.0 63.0 x 53.0 x x 25.0 x x x 77.0 x 126.0 78.0 27.0 x x x +12960 Original post publication description: Metabolism, behavior: Activity level of 13-week old males [total counts of fine movements and ambulatory activity/unit time] None Central nervous system, metabolism, behavior: Activity of 13-week old males, total counts of fine movements and ambulatory activity [counts/unit time] x x 724.205 x x x x 700.643 1304.79 x x x x x x 905.607 1189.39 x 682.321 x x x x x x x 661.333 x x 467.071 x x x x x x x x x x x x 487.857 557.786 x x 636.107 x x x x x x x 674.464 x x x x 768.286 x x x 942.0 782.071 x 836.821 451.81 x 424.786 x 797.071 x 1244.36 x x x x x x x x 755.786 x 1155.79 x x 907.054 x x 570.5 x x 525.393 362.0 x 765.048 x 579.286 691.286 x 567.929 +12958 Original post publication description: Blood chemistry, cardiovascular system: White blood cell count of 14-week old males [x10^3/ul] None Blood chemistry, cardiovascular system: White blood cell count of 14-week old males [x10^3/ul] x x 8.924 x 13.6 x x 6.425 7.775 x 10.2 x x x x 9.125 9.825 x 6.95 x x x x x x x 12.267 x x 8.775 x x 9.45 x x x x x x x 10.925 6.9 14.1 8.85 x x 11.475 x x x x x x 13.15 15.425 x x x x 9.9 7.85 x x 5.8 7.65 x 8.975 7.45 x 10.8 x 5.1 x 11.65 x x x x 8.067 7.4 x 6.95 8.5 x 11.35 9.15 x 6.75 9.0 x 5.05 x x 9.225 11.8 8.05 12.933 x 7.0 9.45 x 6.4 +12956 Original post publication description: Metabolism: Volume oxygen consumption of 13-week old males [ml/kg/h] None Respiratory system, metabolism: Volume oxygen consumption of 13-week old males [ml/kg/h] x x 937.619 x x x x 1197.62 1110.54 x x x x x x 966.95 1202.79 x 1038.79 x x x x x x x 899.0 x x 913.161 x x x x x x x x x x x x 827.238 965.429 x x 882.071 x x x x x x x 938.464 x x x x 831.85 x x x 731.536 752.524 x 983.202 843.662 x 930.214 x 886.357 x 952.417 x x x x x x x x 668.071 x 978.143 x x 823.696 x x 825.571 x x 867.929 746.786 x 855.571 x 659.429 782.071 x 684.214 +12954 Original post publication description: Blood chemistry: Urea of 14-week old males [mM] None Blood chemistry: Urea of 14-week old males [mM] x x 7.496 x 6.6 x x 8.325 5.375 x 6.833 x x x x 6.725 5.5 x 7.6 x x x x x x x 6.067 x x 6.4 x x 9.2 x x x x x x x 8.325 10.0 8.133 8.0 x x 7.925 x x x x x x 7.55 7.6 x x x x x 5.85 x x 8.25 x x x x x 7.05 x x x 7.85 x x x x 9.325 7.25 x 9.05 7.05 x x 8.625 x 7.55 11.9 x 7.65 x x 7.775 8.3 7.433 7.867 x x 9.6 x 7.4 +12952 Original post publication description: Blood chemistry: Triglyceride of 14-week old males [mM] None Blood chemistry: Triglyceride of 14-week old males [mM] x x 0.912 x 1.523 x x 0.773 1.06 x 1.463 x x x x 1.233 1.445 x 1.743 x x x x x x x 0.773 x x 1.278 x x 0.89 x x x x x x x 1.753 1.27 1.353 0.975 x x 1.123 x x x x x x 1.31 0.628 x x x x 1.665 1.555 x x 1.43 1.15 x 0.903 0.83 x 0.89 x 0.955 x 0.95 x x x x 0.955 1.635 x 1.3 1.36 x 1.06 2.433 x 1.295 1.26 x 1.74 x x 1.078 0.805 1.198 0.58 x 1.415 1.745 x 0.765 +12948 Original post publication description: Metabolism: Respiratory exchange ratio (RER) of 13-week old males [ratio] None Respiratory system, metabolism: Respiratory exchange ratio (RER) of 13-week old males [ratio] x x 0.905 x x x x 0.761 0.918 x x x x x x 0.835 0.864 x 0.838 x x x x x x x 0.927 x x 0.828 x x x x x x x x x x x x 0.924 0.94 x x 0.85 x x x x x x x 0.872 x x x x 1.037 x x x 0.921 1.005 x 0.981 0.946 x 0.899 x 0.869 x 0.988 x x x x x x x x 0.889 x 0.912 x x 0.88 x x 0.967 x x 0.836 0.777 x 0.851 x 0.951 0.959 x 0.892 +12946 Original post publication description: Cardiovascular system: Posterior wall thickness by echocardiography of 17-week old males [mm] None Cardiovascular system: Posterior wall thickness by echocardiography of 17-week old males [mm] x x 0.608 x 0.62 x x x x x 0.607 x x x x x x x x x x x x x x x 0.667 x x x x x 0.638 x x x x x x x 0.605 0.62 0.605 x x x 0.645 x x x x x x 0.625 0.585 x x x x 0.585 0.643 x x 0.62 0.58 x 0.618 0.57 x 0.61 x 0.605 x 0.58 x x x x 0.601 0.58 x 0.635 0.72 x 0.618 0.623 x 0.62 0.48 x 0.685 x x 0.615 0.625 0.633 0.555 x 0.585 0.74 x 0.695 +12944 Original post publication description: Blood chemistry: Phosphorus of 14-week old males [mM] None Blood chemistry: Phosphorus of 14-week old males [mM] x x 2.338 x 2.325 x x 2.738 2.173 x 1.597 x x x x 2.29 2.063 x 2.24 x x x x x x x 1.617 x x 2.043 x x 1.923 x x x x x x x 2.238 2.71 2.56 1.98 x x 2.04 x x x x x x 2.79 1.89 x x x x x 1.308 x x 2.385 x x x x x 2.045 x x x 2.86 x x x x 2.813 2.595 x 3.13 2.245 x x 1.883 x 2.213 3.35 x 2.46 x x 2.59 2.365 1.438 2.66 x x 2.73 x 2.09 +12931 Original post publication description: Blood chemistry, cardiovascular system: Hematocrit of 14-week old males [%] None Blood chemistry, cardiovascular system: Hematocrit of 14-week old males [%] x x 42.18 x 41.975 x x 40.2 37.3 x 40.733 x x x x 42.55 52.825 x 44.2 x x x x x x x 46.4 x x 34.725 x x 45.95 x x x x x x x 50.025 43.3 43.4 41.4 x x 42.875 x x x x x x 45.6 49.6 x x x x 54.1 47.65 x x 38.15 57.6 x 48.3 45.2 x 39.4 x 41.35 x 42.8 x x x x 40.5 46.85 x 42.35 50.8 x 48.8 44.625 x 46.875 39.9 x 52.4 x x 43.6 46.0 42.55 38.3 x 44.5 45.25 x 48.6 +12926 Original post publication description: Metabolism: Blood glucose level (intraperitoneal glucose tolerance test) at time=0 min of 18-week old males [mg/dl] None Metabolism: Blood glucose level (intraperitoneal glucose tolerance test) at time=0 min of 18-week old males [mg/dl] x x 97.88 x 108.75 x x 131.75 70.0 x 92.667 x x x x 76.75 83.0 x 95.0 x x x x x x x 119.0 x x 120.25 x x 96.5 x x x x x x x 123.75 101.0 113.5 x x x 94.5 x x x x x x 78.0 91.0 x x x x 98.5 86.667 x x 109.5 88.5 x 98.0 130.5 x 82.5 x 118.0 x 149.0 x x x x 105.0 77.5 x 125.5 79.0 x 116.0 83.667 x 85.75 x x 104.0 x x 108.25 93.0 137.0 97.667 x 86.0 80.5 x 132.0 +12924 Original post publication description: Morphology, musculoskeletal system: Gastrocnemius muscle mass of 20-week old males [g] None Muscloskeletal system, morphology: Gastrocnemius muscle mass of 20-week old males [g] x x 0.171 x 0.181 x x 0.152 0.141 x 0.147 x x x x 0.157 0.193 x 0.183 x x x x x x x 0.333 x x 0.137 x x 0.223 x x x x x x x 0.149 0.14 0.105 x x x 0.173 x x x x x x 0.132 0.12 x x x x 0.149 0.133 x x 0.118 0.157 x 0.167 0.145 x 0.143 x 0.127 x 0.109 x x x x 0.116 0.092 x 0.11 0.107 x 0.167 0.183 x 0.117 0.062 x x x x 0.131 0.155 0.154 0.111 x 0.186 0.112 x 0.125 +12914 Original post publication description: Blood chemistry: Calcium of 14-week old males [mM] None Blood chemistry: Calcium of 14-week old males [mM] x x 2.351 x 2.32 x x 2.275 2.338 x 2.49 x x x x 2.378 2.398 x 2.29 x x x x x x x 2.273 x x 2.295 x x 2.438 x x x x x x x 2.473 2.3 2.367 2.33 x x 2.393 x x x x x x 2.505 2.423 x x x x x 2.4 x x 2.36 x x x x x 2.285 x x x 2.365 x x x x 2.585 2.56 x 2.625 2.375 x x 2.47 x 2.29 2.68 x 2.385 x x 2.4 2.35 2.497 2.33 x x 2.35 x 2.295 +12912 Original post publication description: Morphology: Body weight of 20-week old males [g] None Musculoskeletal system, morphology: Body weight of 20-week old males [g] x x 28.456 x 33.625 x x 26.9 27.5 x 26.633 x x x x 34.6 28.575 x 30.225 x x x x x x x 36.1 x x 30.3 x x 33.475 x x x x x x x 27.5 28.2 28.15 x x x 29.4 x x x x x x 29.15 26.825 x x x x 24.55 28.233 x x 24.25 24.25 x 28.075 25.45 x 29.05 x 26.55 x 24.45 x x x x 27.625 23.85 x 26.45 25.5 x 26.85 26.0 x 26.5 26.4 x 38.65 x x 27.2 31.6 34.575 26.9 x 27.25 27.05 x 27.3 +12905 Original post publication description: Morphology, metabolism: Body weight of 16-week old males, normal diet [g] None Musculoskeletal system, morphology, metabolism: Body weight of 16-week old males, normal diet [g] x x 27.152 x 30.25 x x 26.125 23.825 x 26.0 x x x x 29.575 26.85 x 29.025 x x x x x x x 30.433 x x 28.15 x x 29.575 x x x x x x x 25.25 25.9 27.214 24.05 x x 30.05 x x x x x x 28.2 26.775 x x x x 24.15 25.325 x x 23.2 22.95 x 27.575 25.95 x 28.55 x 25.7 x 23.7 x x x x 26.875 23.8 x 25.95 23.85 x 28.26 23.875 x 25.038 25.9 x 34.5 x x 26.925 31.0 30.1 27.033 x 26.95 25.2 x 26.0 +12903 Original post publication description: Morphology: Body weight of 14-week old males [g] None Musculoskeletal system, morphology: Body weight of 14-week old males [g] x x 27.132 x 30.25 x x 25.275 22.625 x 25.067 x x x x 29.3 26.275 x 29.9 x x x x x x x 29.133 x x 27.575 x x 29.9 x x x x x x x 25.325 24.7 26.714 24.5 x x 27.425 x x x x x x 28.25 26.875 x x x x 23.9 26.825 x x 22.6 22.8 x 26.988 26.217 x 27.8 x 24.9 x 23.55 x x x x 26.325 23.75 x 24.75 22.1 x 27.04 24.425 x 24.088 25.7 x 31.05 x x 26.425 29.55 30.175 26.067 x 27.4 25.15 x 25.65 +12901 Original post publication description: Cardiovascular system: Blood pressure by tail cuff system of 16-week old males [mmHg] None Cardiovascular system: Systolic blood pressure by tail cuff system of 16-week old males [mmHg] x x 103.242 x 92.781 x x 98.611 93.67 x 97.853 x x x x 106.699 99.526 x 96.274 x x x x x x x 87.658 x x 96.356 x x 95.061 x x x x x x x 98.629 83.042 109.426 103.342 x x 104.655 x x x x x x 98.355 107.73 x x x x 101.008 95.922 x x 111.014 102.093 x 90.335 97.031 x 107.988 x 95.536 x 106.821 x x x x 91.585 81.667 x 89.986 91.752 x 105.179 96.584 x 127.95 94.79 x 98.399 x x 102.915 99.812 92.29 96.073 x 100.545 99.594 x 112.782 +12899 Original post publication description: Musculoskeletal system, metabolism: Bone mineral density by peripheral dual energy X-ray absorptiometer (PDEXA) of 19-week old males [g/cm2] None Musculoskeletal system, metabolism: Bone mineral density for whole body by peripheral dual energy X-ray absorptiometer (PDEXA) of 19-week old males [g/cm2] x x 0.05 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.054 x x x x x x x x x x x 0.051 x x x x 0.055 x x x 0.05 0.046 x 0.049 0.048 x 0.053 x 0.052 x 0.048 x x x x x x x x 0.045 x 0.051 x x 0.047 x x 0.05 x x 0.055 0.057 x 0.051 x 0.056 0.051 x 0.049 +12897 Original post publication description: Morphology, metabolism: Brown adipose tissue mass of 20-week old males [g] None Morphology, metabolism: Brown adipose tissue mass of 20-week old males [g] x x 0.124 x 0.105 x x 0.094 0.155 x 0.104 x x x x 0.209 0.136 x 0.108 x x x x x x x 0.349 x x 0.156 x x 0.281 x x x x x x x 0.126 0.156 0.171 x x x 0.169 x x x x x x 0.065 0.102 x x x x 0.131 0.179 x x 0.093 0.119 x 0.16 0.249 x 0.154 x 0.116 x 0.123 x x x x 0.091 0.095 x 0.105 0.13 x 0.249 0.135 x 0.114 0.108 x x x x 0.154 0.132 0.183 0.144 x 0.136 0.157 x 0.119 +12880 Original post publication description: Cardiovascular system: Septum thickness by echocardiography of 17-week old females [mm] None Cardiovascular system: Septum thickness by echocardiography of 17-week old females [mm] x x 0.614 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.615 0.615 x x x x x x x x x x 0.575 0.585 x x x 0.655 0.59 x x x 0.62 0.535 x 0.61 0.605 x x x 0.62 x 0.62 x x x x 0.61 0.625 x x 0.62 x 0.6 x x 0.62 0.565 x x x x 0.6 x x 0.59 x 0.575 0.645 x 0.605 +12877 Original post publication description: Blood chemistry, cardiovascular system: Red blood cell count of 14-week old females [x10^6/ul] None Blood chemistry, cardiovascular system: Red blood cell count of 14-week old females [x10^6/ul] x x 9.31 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 8.895 9.43 x x x x x x x x x x 9.005 6.605 x x x 10.78 9.47 x x x 9.605 10.255 x 9.675 10.915 x x x 11.31 x 9.205 x x x x 8.84 8.13 x x 10.43 x 11.3 x x 10.32 8.85 x x x x 9.02 x x 9.37 x 9.64 10.145 x 9.505 +12875 Original post publication description: Blood chemistry, cardiovascular system: Platelet count of 14-week old females [x10^3/ul] None Blood chemistry, cardiovascular system: Platelet count of 14-week old females [x10^3/ul] x x 1098.5 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 1000.5 982.0 x x x x x x x x x x 1080.0 690.5 x x x 1242.0 1125.5 x x x 1323.0 875.5 x 898.5 1092.5 x x x 1020.5 x 1040.0 x x x x 1290.0 843.0 x x 1227.5 x 978.0 x x 1242.5 1267.5 x x x x 966.0 x x 1202.0 x 916.0 1178.5 x 1278.5 +12873 Original post publication description: Blood chemistry: Sodium of 14-week old females [mM] None Blood chemistry: Sodium of 14-week old females [mM] x x 150.8 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 149.0 149.0 x x x x x x x x x x 148.5 149.5 x x x 149.0 x x x x 152.5 x x x x x x x x x 151.5 x x x x 151.0 149.0 x x 149.5 x x x x 149.0 150.0 x x x x 151.0 x x 149.0 x x 149.5 x 153.5 +12871 Original post publication description: Blood chemistry, cardiovascular system: Mean cell hemoglobin concentration of 14-week old females [g/dl] None Blood chemistry, cardiovascular system: Mean cell hemoglobin concentration of 14-week old females [g/dl] x x 34.113 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 34.55 33.8 x x x x x x x x x x 32.25 32.6 x x x 32.7 30.55 x x x 33.7 30.8 x 33.3 33.15 x x x 32.55 x 33.4 x x x x 34.6 32.7 x x 31.6 x 30.8 x x 31.35 34.45 x x x x 33.6 x x 32.9 x 32.95 34.7 x 34.35 +12869 Original post publication description: Cardiovascular system: Left ventricular mass/body weight ratio by echocardiography of 17-week old females [ratio] None Cardiovascular system: Left ventricular mass/body weight ratio by echocardiography of 17-week old females [ratio] x x 3.572 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 3.616 3.523 x x x x x x x x x x 3.488 3.278 x x x 3.39 3.932 x x x 3.1 3.461 x 3.495 3.564 x x x 4.18 x 3.465 x x x x 3.735 3.486 x x 4.184 x 3.532 x x 3.464 2.688 x x x x 3.011 x x 2.938 x 2.991 3.655 x 4.229 +12867 Original post publication description: Morphology, gastrointestinal system: Liver mass of 20-week old females [g] None Liver, morphology, gastrointestinal system: Liver mass of 20-week old females [g] x x 1.082 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 1.135 0.896 x x x x x x x x x x 1.052 1.32 x x x 1.512 1.27 x x x 1.287 1.416 x 1.441 1.221 x x x 1.019 x 1.178 x x x x 1.112 1.035 x x 1.211 x 1.195 x x 1.072 1.216 x x x x 1.081 x x 0.932 x 1.844 1.254 x 1.064 +12865 Original post publication description: Morphology, metabolism: Body lean mass of 19-week old females [g] None Morphology, metabolism: Body lean mass of 19-week old females [g] x x 16.467 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 16.746 15.56 x x x x x x x x x x 17.456 18.04 x x x 18.303 17.39 x x x 16.876 16.95 x 18.307 18.777 x x x 16.674 x 17.42 x x x x 16.553 14.608 x x 17.094 x 19.197 x x 17.961 16.575 x x x x 18.197 x x 19.01 x 20.347 16.817 x 15.832 +12863 Original post publication description: Cardiovascular system: Heart rate during echocardiography of 17-week old females [beat/min] None Cardiovascular system: Heart rate during echocardiography of 17-week old females [beat/min] x x 574.148 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 626.798 582.035 x x x x x x x x x x 627.468 583.109 x x x 595.813 577.687 x x x 572.504 517.822 x 643.769 613.106 x x x 685.573 x 591.408 x x x x 616.109 507.007 x x 544.445 x 604.007 x x 568.162 632.1 x x x x 538.684 x x 545.539 x 690.352 540.981 x 630.877 +12861 Original post publication description: Blood chemistry, cardiovascular system: Hematocrit of 14-week old females [%] None Blood chemistry, cardiovascular system: Hematocrit of 14-week old females [%] x x 43.588 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 39.35 43.35 x x x x x x x x x x 46.95 33.6 x x x 51.6 47.2 x x x 43.3 48.5 x 45.0 49.9 x x x 49.25 x 39.7 x x x x 40.6 39.4 x x 48.9 x 55.95 x x 49.25 39.1 x x x x 42.7 x x 41.9 x 41.2 44.6 x 42.55 +12855 Original post publication description: Blood chemistry, metabolism: Glucose after 4 hour fast of 14-week old females [mMl] None Blood chemistry, metabolism: Glucose after 4 hour fast of 14-week old females [mMl] x x 16.581 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 17.985 16.27 x x x x x x x x x x 17.57 13.55 x x x 19.71 15.36 x x x 15.94 14.04 x 14.655 16.88 x x x 15.725 x 13.155 x x x x 15.35 17.685 x x 14.75 x 18.115 x x 16.625 17.62 x x x x 13.975 x x 14.16 x 17.315 16.61 x 15.69 +12853 Original post publication description: Cardiovascular system: Shortening fraction by echocardiography of 17-week old females [%] None Cardiovascular system: Shortening fraction by echocardiography of 17-week old females [%] x x 31.55 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 33.05 31.65 x x x x x x x x x x 31.8 29.9 x x x 39.1 33.5 x x x 34.95 30.25 x 26.75 30.0 x x x 29.5 x 42.6 x x x x 38.9 33.65 x x 32.55 x 31.25 x x 32.45 33.6 x x x x 34.6 x x 31.7 x 33.5 31.25 x 35.2 +12851 Original post publication description: Cardiovascular system: Ejection Fraction by echocardiography of 17-week old females [%] None Cardiovascular system: Ejection fraction by echocardiography of 17-week old females [%] x x 66.313 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 68.4 66.55 x x x x x x x x x x 66.65 63.95 x x x 76.15 68.5 x x x 70.65 64.75 x 59.5 63.0 x x x 62.75 x 78.9 x x x x 75.9 69.4 x x 67.45 x 66.0 x x 67.8 69.5 x x x x 70.6 x x 74.7 x 69.0 65.75 x 71.35 +12849 Original post publication description: Morphology, metabolism: Body fat mass percentage of 19-week old females [%] None Morphology, metabolism: Body fat mass percentage of 19-week old females [%] x x 14.75 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 15.74 21.68 x x x x x x x x x x 12.62 13.605 x x x 16.645 15.885 x x x 16.35 19.21 x 17.095 17.515 x x x 16.04 x 13.44 x x x x 18.28 15.045 x x 12.09 x 16.675 x x 16.89 21.82 x x x x 14.34 x x 14.37 x 14.07 15.62 x 17.71 +12847 Original post publication description: Cardiovascular system: End-diastolic diameter by echocardiography of 17-week old females [mm] None Cardiovascular system: End-diastolic diameter by echocardiography of 17-week old females [mm] x x 3.74 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 3.97 3.685 x x x x x x x x x x 3.685 3.795 x x x 3.62 3.91 x x x 3.44 3.865 x 3.845 3.95 x x x 3.9 x 3.76 x x x x 3.83 3.69 x x 4.15 x 3.865 x x 3.83 3.585 x x x x 3.65 x x 3.76 x 3.83 3.655 x 4.115 +12845 Original post publication description: Blood chemistry: Chloride of 14-week old females [mM] None Blood chemistry: Chloride of 14-week old females [mM] x x 118.2 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 114.0 113.0 x x x x x x x x x x 115.5 112.0 x x x 112.0 x x x x 116.5 x x x x x x x x x 115.0 x x x x 112.0 110.5 x x 115.0 x x x x 115.5 114.0 x x x x 113.0 x x 115.0 x x 116.5 x 118.5 +12843 Original post publication description: Morphology: Body weight of 20-week old females at necropsy [g] None Musculoskeletal system, morphology: Body weight of 20-week old females at necropsy [g] x x 20.805 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 22.647 19.476 x x x x x x x x x x 21.581 22.171 x x x 24.865 20.385 x x x 22.507 20.781 x 22.993 22.759 x x x 20.221 x 22.541 x x x x 21.597 18.467 x x 20.71 x 20.393 x x 22.122 23.613 x x x x 21.772 x x 18.745 x 24.014 22.353 x 19.766 +12841 Original post publication description: Morphology, metabolism: Body weight at bone densitometry assay (peripheral dual energy X-ray absorptiometer (PDEXA)) of 19-week old females [g] None Morphology, metabolism: Body weight at bone densitometry assay (peripheral dual energy X-ray absorptiometer (PDEXA)) of 19-week old females [g] x x 21.05 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 23.6 21.25 x x x x x x x x x x 22.95 22.55 x x x 23.65 21.4 x x x 22.3 21.4 x 22.95 23.4 x x x 20.35 x 21.8 x x x x 23.1 19.6 x x 20.9 x 23.65 x x 23.25 24.45 x x x x 23.25 x x 24.4 x 24.8 21.55 x 20.6 +12835 Original post publication description: Morphology: Body weight of 16-week old females [g] None Musculoskeletal system, morphology: Body weight of 16-week old females [g] x x 19.688 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 22.65 21.8 x x x x x x x x x x 21.4 22.9 x x x 21.75 19.5 x x x 21.45 18.8 x 21.25 22.8 x x x 18.05 x 21.1 x x x x 21.5 19.35 x x 20.3 x 21.65 x x 22.85 23.65 x x x x 22.5 x x 22.0 x 22.9 21.35 x 19.4 +12831 Original post publication description: Cardiovascular system: Blood pressure by tail cuff system of 16-week old females [mmHg] None Cardiovascular system: Systolic blood pressure by tail cuff system of 16-week old females [mmHg] x x 98.863 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 95.02 110.996 x x x x x x x x x x 101.924 103.788 x x x 99.494 96.503 x x x 104.532 95.544 x 93.53 92.879 x x x 108.771 x 105.771 x x x x 90.971 80.291 x x 89.234 x 108.246 x x 123.23 101.578 x x x x 107.024 x x 94.463 x 95.515 100.702 x 115.071 +12829 Original post publication description: Musculoskeletal system, metabolism: Bone mineral density by peripheral dual energy X-ray absorptiometer (PDEXA) of 19-week old females [g/cm2] None Musculoskeletal system, metabolism: Bone mineral density for whole body by peripheral dual energy X-ray absorptiometer (PDEXA) of 19-week old females [g/cm2] x x 0.05 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.054 x x x x x x x x x x x 0.054 x x x 0.055 0.053 x x x 0.05 0.047 x 0.049 0.052 x x x 0.048 x 0.054 x x x x x x x x 0.047 x 0.049 x x 0.048 x x x x x 0.055 x x 0.055 x 0.054 0.053 x 0.047 +12827 Original post publication description: Morphology, metabolism: Brown adipose tissue mass of 20-week old females [g] None Morphology, metabolism: Brown adipose tissue mass of 20-week old females [g] x x 0.088 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.1 0.089 x x x x x x x x x x 0.053 0.093 x x x 0.105 0.161 x x x 0.142 0.189 x 0.143 0.17 x x x 0.163 x 0.118 x x x x 0.089 0.074 x x 0.126 x 0.137 x x 0.09 0.068 x x x x 0.145 x x 0.066 x 0.091 0.129 x 0.12 +12825 Original post publication description: Blood chemistry: Aspartate transaminase of 14-week old females [U/l] None Blood chemistry: Aspartate transaminase of 14-week old females [U/l] x x 86.25 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 60.5 90.0 x x x x x x x x x x 49.0 83.0 x x x 55.0 152.0 x x x 56.5 74.0 x 126.0 158.5 x x x 91.0 x 64.0 x x x x 133.0 149.0 x x 44.5 x 61.0 x x 63.5 67.5 x x x x 55.0 x x 65.0 x 72.0 68.5 x 63.0 +12823 Original post publication description: Blood chemistry: Albumin of 14-week old females [g/l] None Blood chemistry: Albumin of 14-week old females [g/l] x x 30.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 27.0 27.5 x x x x x x x x x x 29.0 29.0 x x x 29.0 x x x x 30.0 x x x x x x x x x 25.5 x x x x 29.0 27.5 x x 27.0 x x x x 29.0 30.5 x x x x 30.0 x x 30.0 x x 25.5 x 28.0 +12821 Original post publication description: Blood chemistry: Alpha-amylase of 14-week old females [U/l] None Blood chemistry: Alpha-amylase of 14-week old females [U/l] x x 554.167 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 593.5 492.0 x x x x x x x x x x 531.0 518.0 x x x 577.0 x x x x 455.5 x x x x x x x x x 380.5 x x x x 723.0 489.5 x x 383.5 x x x x 635.0 516.0 x x x x 500.5 x x 514.0 x x 413.5 x 557.0 +12973 Original post publication description: Infectious disease, immune function: H5N1 influenza A virus (Boon-Webby Trait 5) Boon-Webby Trait 5 Infectious disease, immune system: Interferon alpha (IFNa) cytokine expression level two days after infection with H5N1 influenza A virus (10^4 EID-50 of HK213 virus in 30 microliters saline) [pg/mL] x 378.0 185.0 1024.0 x x x 716.0 x 982.0 x 537.0 494.0 868.0 x x 279.0 x x x 703.0 x x x x 844.0 495.0 x x 368.0 616.0 x x x x x x x x x x 349.0 789.0 353.0 x x 748.0 x 844.0 186.0 x x x 397.0 248.0 x x x 652.0 411.0 651.0 545.0 x 418.0 159.0 514.0 230.0 635.0 274.0 127.0 x 594.0 x 501.0 x x x x 199.0 x x x 623.0 199.0 677.0 628.0 x 482.0 x x 394.0 x x x 531.0 x 525.0 358.0 412.0 x x x +12972 Original post publication description: Infectious disease, immune function: H5N1 influenza A virus (Boon-Webby Trait 4) None Infectious disease, immune system: MCP1 cytokine expression level two days after infection with H5N1 influenza A virus (10^4 EID-50 of HK213 virus in 30 microliters saline) [pg/mL] x 2597.0 1982.0 8270.0 x x x 3880.0 x 4147.0 x 5609.0 6128.0 4365.0 x x 2064.0 x x x 5453.0 x x x x 6068.0 2945.0 x x 2143.0 4504.0 x x x x x x x x x x 1548.0 4632.0 3341.0 x x 3503.0 x 3961.0 1147.0 x x x 2744.0 2195.0 x x x 2637.0 2181.0 5063.0 3343.0 x 2554.0 1611.0 1703.0 1845.0 5081.0 2040.0 728.0 x 4125.0 x 2523.0 x x x x 2360.0 x x 1005.0 4348.0 1173.0 2986.0 3081.0 x 2668.0 x x 1503.0 x x x 2364.0 x 2024.0 3098.0 1627.0 x x x +12970 Original post publication description: 3a,5a-THP_CIE Ethanol vapor, from plasma entered at February/03/2011 Endocrinology, pharmacology: 3a,5a-THP_CIE Ethanol vapor, from plasma entered at February/03/2011 Endocrinology, blood chemistry, pharmacology: Ethanol response (chronic intermittent ethanol CIE cycles), 3a,5a-tetrahydroprogesterone (THP, allopregnanolone) in plasma 72 h after the 5th cycle of ethanol vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [units] 53.0 x 177.171 x x x 290.2 x x x x 198.3 x 205.1 x 125.6 x x x x x x x x x x x x x x x x 404.2 x x x x 75.5 x x x x x x x x x x 83.9 x x x x 31.65 x x x x x x x x x x x x x x x x x x 172.2 x x 19.1 x x 59.95 5.8 x 92.7 x 49.85 x x x x x x x x x x x x x x 66.5 126.4 241.9 46.2 +13057 Original post publication description: Urogenital system, renal system, morphology: Kidney weight of females (raw data) [mg] Original pre publication description: Urogenital system, renal system, morphology: Kidney weight of females (raw data) [mg] Urogenital system, renal system, morphology: Kidney weight of females (raw data) [mg] Urogenital system, renal system, morphology: Kidney weight of females (raw data) [mg] 164.889 x 152.86 211.403 214.75 224.42 x 141.63 254.64 151.78 176.38 209.33 x 159.97 x x x 146.31 x x x 122.99 x 162.85 132.4 141.85 x x x 128.61 164.54 144.26 194.76 x 131.94 x 202.23 158.18 161.11 x x 143.11 136.13 166.91 x x 155.39 x 182.2 197.63 x x x 205.12 236.08 x x x 164.07 166.01 152.17 140.12 198.08 176.3 149.79 x 180.84 177.67 173.13 144.14 x 144.37 x 181.0 x 293.0 x x 159.66 x x 156.09 204.62 134.86 152.71 148.74 x 172.72 193.81 x x x x x x x x x x x x x +12753 Original post publication description: Central nervous system, behavior: Total distance in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and female C57BL/6J-R6/2 Huntington model, wildtype cases only [cm] None Central nervous system, behavior: Total distance in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and female C57BL/6J-R6/2 Huntington model, wildtype cases only [cm] x 4458.0 5917.1 x x 3979.1 6354.7 5134.2 x 4402.9 3526.4 5251.2 x 5204.3 x x 5363.0 x 5829.1 x 4066.2 x x x x x 3718.0 x x 3622.3 x x 4555.8 x x x x 4224.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12754 Original post publication description: Central nervous system, behavior: Total distance in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, R6/2 cases only [cm] None Central nervous system, behavior: Total distance in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, R6/2 cases only [cm] x 4229.0 3165.7 x x 3603.3 3121.9 4617.1 x 3132.7 3673.0 4501.9 x 3571.5 x x 5016.2 x 2634.5 x 2975.0 x x x x x 2909.9 x x 3121.8 x x 3298.4 x x x x 3484.8 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12755 Original post publication description: Central nervous system, behavior: Total distance in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model [% WT] None Central nervous system, behavior: Total distance in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model [% WT] x 94.8 53.5 x x 90.5 49.1 89.9 x 71.1 104.1 83.6 x 68.6 x x 93.5 x 45.1 x 73.2 x x x x x 78.2 x x 86.1 x x 72.4 x x x x 82.5 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12756 Original post publication description: Central nervous system, behavior: Rearing behavior in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, wildtype cases only [n vertical beam breaks] None Central nervous system, behavior: Rearing behavior in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, wildtype cases only [n vertical beam breaks] x 466.7 430.2 x x 422.2 426.4 436.7 x 408.2 265.2 453.0 x 378.1 x x 496.5 x 411.5 x 424.6 x x x x x 357.8 x x 327.1 x x 419.7 x x x x 342.6 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12757 Original post publication description: Central nervous system, behavior: Rearing behavior in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, R6/2 cases only [n vertical beam breaks] None Central nervous system, behavior: Rearing behavior in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, R6/2 cases only [n vertical beam breaks] x 294.0 105.7 x x 195.2 115.5 171.0 x 254.7 243.3 190.7 x 112.0 x x 235.4 x 104.3 x 177.6 x x x x x 138.3 x x 218.9 x x 177.2 x x x x 150.8 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12758 Original post publication description: Central nervous system, behavior: Rearing behavior in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model [% WT] None Central nervous system, behavior: Rearing behavior in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model [% WT] x 62.9 24.5 x x 46.2 27.0 39.1 x 62.3 91.7 42.0 x 29.7 x x 47.4 x 25.3 x 41.8 x x x x x 38.6 x x 66.9 x x 42.2 x x x x 44.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12759 Original post publication description: Central nervous system, behavior: Rotarod, average time walking for day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, wildtype cases only [sec] None Central nervous system, behavior: Rotarod, average time walking for day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, wildtype cases only [sec] x 214.6 206.4 x x 216.1 188.8 211.2 x 191.1 267.9 240.0 x 221.2 x x 218.4 x 242.2 x 170.7 x x x x x 175.9 x x 177.4 x x 202.2 x x x x 208.8 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12760 Original post publication description: Central nervous system, behavior: Anxiety measured as center-distance:total distance ratio in the open-field (OFA) in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, wildtype cases only [ratio] None Central nervous system, behavior: Anxiety measured as center-distance:total distance ratio in the open-field (OFA) in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, wildtype cases only [ratio] x 0.15 0.275 x x 0.246 0.319 0.234 x 0.175 0.19 0.273 x 0.28 x x 0.248 x 0.235 x 0.244 x x x x x 0.217 x x 0.184 x x 0.225 x x x x 0.294 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12761 Original post publication description: Central nervous system, behavior: Anxiety measured as center-distance to total distance ratio in open-field (OFA) in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, R6/2 mutant cases only [ratio] None Central nervous system, behavior: Anxiety measured as center-distance to total distance ratio in open-field (OFA) in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, R6/2 mutant cases only [ratio] x 0.136 0.244 x x 0.232 0.245 0.225 x 0.184 0.18 0.223 x 0.3 x x 0.241 x 0.241 x 0.178 x x x x x 0.185 x x 0.243 x x 0.217 x x x x 0.193 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12762 Original post publication description: Central nervous system, behavior: Anxiety (center-distance ratio) in open-field (OFA) in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model [% of WT] None Central nervous system, behavior: Anxiety (center-distance ratio) in open-field (OFA) in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model [% of WT] x 90.6 88.7 x x 94.3 76.8 96.1 x 105.1 94.7 81.6 x 107.1 x x 97.1 x 102.5 x 72.9 x x x x x 85.2 x x 132.6 x x 96.4 x x x x 65.6 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12763 Original post publication description: Central nervous system, behavior: Rotarod, average time walking for day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, R6/2 cases only [sec] None Central nervous system, behavior: Rotarod, average time walking for day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, R6/2 cases only [sec] x 61.2 131.1 x x 100.9 111.2 122.7 x 95.1 155.0 142.0 x 88.3 x x 95.6 x 131.1 x 95.0 x x x x x 80.6 x x 97.2 x x 110.9 x x x x 87.1 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12764 Original post publication description: Central nervous system, behavior: Rotarod, average time walking for day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model [% WT] None Central nervous system, behavior: Rotarod, average time walking for day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model [% WT] x 28.5 63.5 x x 46.6 58.8 58.0 x 49.7 57.8 59.1 x 39.9 x x 43.7 x 54.1 x 55.6 x x x x x 45.8 x x 54.7 x x 54.8 x x x x 41.7 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12765 Original post publication description: Central nervous system, behavior: Body weight in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, wildtype cases only [gm] None Central nervous system, behavior: Body weight in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, wildtype cases only [gm] x 24.76 21.5 x x 25.21 22.2 22.2 x 24.18 20.8 21.4 x 22.99 x x 24.31 x 21.1 x 21.6 x x x x x 23.5 x x 25.7 x x 23.88 x x x x 25.9 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12766 Original post publication description: Central nervous system, behavior: Body weight in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, R6/2 cases only [gm] None Central nervous system, behavior: Body weight in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, R6/2 cases only [gm] x 25.37 19.0 x x 23.62 19.6 19.5 x 24.18 19.7 20.3 x 21.04 x x 22.0 x 19.8 x 20.6 x x x x x 22.1 x x 24.0 x x 22.03 x x x x 25.2 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12767 Original post publication description: Central nervous system, behavior: Body weight in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model [% wildtype] None Central nervous system, behavior: Body weight in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model [% wildtype] x 102.4 88.3 x x 93.6 88.2 87.8 x 99.9 94.7 94.8 x 91.5 x x 90.4 x 93.8 x 95.3 x x x x x 94.0 x x 93.3 x x 92.2 x x x x 97.2 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12768 Original post publication description: Central nervous system, behavior: Acoustic startle response (ASR) in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, wildtype cases only [arbitrary units] None Central nervous system, behavior: Acoustic startle response (ASR) in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, wildtype cases only [arbitrary units] x 187.4 1254.4 x x 197.6 864.8 320.2 x 157.8 469.3 434.6 x 606.1 x x 571.8 x 661.4 x 203.0 x x x x x 556.3 x x 1447.4 x x 177.9 x x x x 470.2 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12769 Original post publication description: Central nervous system, behavior: Acoustic startle response (ASR) in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, R6/2 cases only [arbitrary units] None Central nervous system, behavior: Acoustic startle response (ASR) in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, R6/2 cases only [arbitrary units] x 189.7 1076.4 x x 234.7 876.2 291.2 x 143.6 272.4 614.2 x 810.4 x x 691.3 x 1212.9 x 293.3 x x x x x 463.3 x x 794.0 x x 257.6 x x x x 242.1 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12770 Original post publication description: Central nervous system, behavior: Acoustic startle response (ASR) in 8 week old F1 hybrids between male BXD strains and female C57BL/6J-R6/2 Huntington model mouse [% of WT] None Central nervous system, behavior: Acoustic startle response (ASR) in 8 week old F1 hybrids between male BXD strains and female C57BL/6J-R6/2 Huntington model mouse [% of WT] x 101.2 85.8 x x 118.7 101.3 90.9 x 91.0 58.0 141.3 x 133.7 x x 120.8 x 183.3 x 144.4 x x x x x 83.2 x x 54.8 x x 144.8 x x x x 51.4 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12771 Original post publication description: Central nervous system, behavior: Prepulse inhibition (PPI), average inhibition for 4, 8, and 12 dB above background in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, wildtype cases only [%] None Central nervous system, behavior: Prepulse inhibition (PPI), average inhibition for 4, 8, and 12 dB above background in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, wildtype cases only [%] x 38.5 13.5 x x 37.9 22.4 36.8 x 27.8 43.1 17.0 x 17.5 x x 47.3 x 28.5 x 37.0 x x x x x 30.1 x x 21.9 x x 37.5 x x x x 52.6 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12772 Original post publication description: Central nervous system, behavior: Prepulse inhibition, average inhibition for 4, 8, and 12 dB above background in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, R6/2 cases only [%] None Central nervous system, behavior: Prepulse inhibition, average inhibition for 4, 8, and 12 dB above background in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, R6/2 cases only [%] x 21.6 1.4 x x 19.8 4.4 15.5 x 18.5 22.4 11.5 x 6.1 x x 8.3 x 22.3 x 16.8 x x x x x 4.9 x x 6.5 x x 21.1 x x x x 22.3 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12773 Original post publication description: Central nervous system, behavior: Prepulse inhibition, average inhibition for 4, 8, and 12 dB above background in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model [% WT] None Central nervous system, behavior: Prepulse inhibition, average difference in inhibition for 4, 8, and 12 dB above background in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode (all R6/2 hybrids, including the B6-R6/2 and F1-R6/2 had less PPI than wildtype) [% of WT PPI%] x 56.1 10.3 x x 52.2 19.6 42.1 x 66.5 51.9 67.6 x 34.8 x x 17.5 x 78.2 x 45.4 x x x x x 16.2 x x 29.6 x x 56.2 x x x x 42.9 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12774 Original post publication description: Central nervous system, behavior: Passive avoidance, latency to enter dark on day 1 in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, wildtype cases only [sec] None Central nervous system, behavior: Passive avoidance, latency to enter dark on day 1 in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, wildtype cases only [sec] x 13.0 7.4 x x 10.4 8.5 9.4 x 14.0 17.9 5.0 x 8.3 x x 8.6 x 9.9 x 9.5 x x x x x 12.9 x x 6.0 x x 21.0 x x x x 11.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12775 Original post publication description: Central nervous system, behavior: Passive avoidance, latency to enter dark on day 1 in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, R6/2 cases only [sec] None Central nervous system, behavior: Passive avoidance, latency to enter dark on day 1 in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, R6/2 cases only [sec] x 36.0 25.2 x x 27.7 26.3 24.7 x 20.4 22.5 9.9 x 17.6 x x 26.8 x 19.2 x 19.2 x x x x x 28.1 x x 21.0 x x 56.1 x x x x 29.3 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12776 Original post publication description: Central nervous system, behavior: Passive avoidance, latency to enter dark on day 2 in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, wildtype cases only [sec] None Central nervous system, behavior: Passive avoidance, latency to enter dark on day 2 in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, wildtype cases only [sec] x 211.8 147.8 x x 81.3 228.2 135.6 x 225.7 227.0 227.0 x 192.7 x x 167.1 x 196.0 x 157.1 x x x x x 149.8 x x 272.0 x x 221.6 x x x x 205.6 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12777 Original post publication description: Central nervous system, behavior: Passive avoidance, latency to enter dark on day 2 in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, R6/2 cases only [sec] None Central nervous system, behavior: Passive avoidance, latency to enter dark on day 2 in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, R6/2 cases only [sec] x 127.7 78.9 x x 108.7 177.1 94.1 x 132.9 117.8 56.5 x 139.2 x x 143.4 x 192.7 x 97.6 x x x x x 145.1 x x 159.5 x x 107.6 x x x x 105.5 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12778 Original post publication description: Central nervous system, behavior: Passive avoidance, latency to enter dark on day 3 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, wildtype cases only [sec] None Central nervous system, behavior: Passive avoidance, latency to enter dark on day 3 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, wildtype cases only [sec] x 201.1 263.5 x x 228.1 274.5 230.4 x 292.6 283.1 129.7 x 249.9 x x 212.4 x 283.0 x 211.2 x x x x x 278.2 x x 198.1 x x 224.9 x x x x 250.1 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12779 Original post publication description: Central nervous system, behavior: Passive avoidance, latency to enter dark on day 3 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, R6/2 cases only [sec] None Central nervous system, behavior: Passive avoidance, latency to enter dark on day 3 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, R6/2 cases only [sec] x 223.7 197.8 x x 121.9 292.1 168.3 x 209.7 235.5 132.7 x 203.3 x x 240.5 x 240.3 x 166.7 x x x x x 235.9 x x 191.1 x x 179.7 x x x x 225.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12879 Original post publication description: Metabolism: Body temperature (rectal) of 13-week old females [deg C] None Metabolism: Body temperature (rectal) of 13-week old females [deg C] x x 37.25 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 37.15 38.45 x x x x x x x x x x 37.65 38.55 x x x 36.6 36.95 x x x 37.1 37.65 x 36.5 37.25 x x x 36.3 x 37.75 x x x x 37.6 37.0 x x 37.4 x 36.6 x x 37.2 37.55 x x x x 38.25 x x 38.4 x 37.25 36.8 x 37.1 +12780 Original post publication description: Cau_E_Dopac[ng/mg] entered at January/05 10:15:55 from IP 128.172.53.136 None Central nervous system, pharmacology: Ethanol response (chronic intermittent ethanol CIE cycles), 3,4-dihydroxyphenylacetic acid (DOPAC) level in the striatum (caudate putamen) 72 h after the 5th cycle of ethanol vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg] 68.54 x 78.53 32.63 x x 98.94 x x x x x x 97.47 x 110.25 x x x x x x x x x x x x x x x x 54.22 x x x x 102.28 x x x 47.92 x 46.39 x x x 80.02 44.82 x x x x 108.55 x x x x x x 177.65 x x x 87.13 x x x x 39.31 x x 41.19 193.1 x 101.32 x x 80.16 42.03 x 114.23 x 105.36 x x x x x x x x x x x x x x x 145.15 177.44 63.23 +12781 Original post publication description: Cau_E_NE[ng/mg] entered at January/05 10:15:55 from IP 128.172.53.136 None Central nervous system, pharmacology: Ethanol response (chronic intermittent ethanol CIE cycles), norepinephrine (NE) level in the striatum (caudate putamen) 72 h after the 5th cycle of ethanol vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg] 18.44 x 19.94 24.81 x x 13.34 x x x x x x 20.11 x 46.95 x x x x x x x x x x x x x x x x 8.57 x x x x 22.88 x x x 22.17 x 18.92 x x x 14.02 7.8 x x x x 15.07 x x x x x x 17.99 x x x 21.19 x x x x 21.32 x x 15.48 45.92 x 13.32 x x 15.97 19.04 x 14.26 x 47.23 x x x x x x x x x x x x x x x 18.83 14.74 19.27 +12782 Original post publication description: Cau_E_DA[ng/mg] entered at January/05 10:15:55 from IP 128.172.53.136 None Central nervous system, pharmacology: Ethanol response (chronic intermittent ethanol CIE cycles), dopamine (DA) level in the striatum (caudate putamen) 72 h after the 5th cycle of ethanol vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg] 1001.9 x 533.72 175.01 x x 304.86 x x x x x x 255.54 x 355.3 x x x x x x x x x x x x x x x x 618.94 x x x x 664.63 x x x 475.23 x 186.15 x x x 342.13 445.71 x x x x 870.19 x x x x x x 450.07 x x x 632.73 x x x x 284.95 x x 264.0 841.8 x 309.54 x x 647.63 401.66 x 386.26 x 476.44 x x x x x x x x x x x x x x x 453.11 956.68 130.22 +12783 Original post publication description: Cau_E_5HIAA[ng/mg] entered at January/05 10:15:55 from IP 128.172.53.136 Central nervous system, pharmacology: Control for ethanol response, 5-hydroxytryptamine (5-HT, serotonin) level in the medial septal nucleus 72 h after the 5th air control cycle of vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg] Central nervous system, pharmacology: Ethanol response (chronic intermittent ethanol CIE cycles), 5-hydroxyindoleacetic acid (5-HIAA) level in the striatum (caudate putamen) 72 h after the 5th cycle of ethanol vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg] 30.18 x 23.55 28.37 x x 21.45 x x x x x x 33.25 x 25.04 x x x x x x x x x x x x x x x x 18.06 x x x x 20.09 x x x 12.17 x 15.6 x x x 11.5 9.31 x x x x 26.86 x x x x x x 21.59 x x x 37.79 x x x x 29.4 x x 20.15 36.59 x 11.9 x x 28.91 25.59 x 16.3 x 36.23 x x x x x x x x x x x x x x x 36.35 30.07 22.68 +12784 Original post publication description: Cau_E_HVA[ng/mg] entered at January/05 10:15:55 from IP 128.172.53.136 Central nervous system, pharmacology: Ethanol response (chronic intermittent ethanol CIE cycles), homovanillic acid (HVA) level in the striatum (caudate putamen) 72 h after the 5th cycle of ethanol vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg] Central nervous system, pharmacology: Ethanol response (chronic intermittent ethanol CIE cycles), homovanillic acid (HVA) level in the striatum (caudate putamen) 72 h after the 5th cycle of ethanol vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg] 87.68 x 60.9 21.15 x x 45.89 x x x x x x 32.85 x 42.48 x x x x x x x x x x x x x x x x 46.26 x x x x 65.02 x x x 53.36 x 17.43 x x x 45.5 30.92 x x x x 92.1 x x x x x x 63.86 x x x 69.71 x x x x 24.18 x x 26.69 90.35 x 36.81 x x 48.55 34.65 x 42.26 x 49.49 x x x x x x x x x x x x x x x 42.35 84.4 24.54 +12785 Original post publication description: Cau_E_5HT[ng/mg] entered at January/05 10:15:55 from IP 128.172.53.136 Central nervous system, pharmacology: Ethanol response (chronic intermittent ethanol CIE cycles), 5-hydroxytryptamine (5-HT, serotonin) level in the striatum (caudate putamen) 72 h after the 5th cycle of ethanol vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg] Central nervous system, pharmacology: Ethanol response (chronic intermittent ethanol CIE cycles), 5-hydroxytryptamine (5-HT, serotonin) level in the striatum (caudate putamen) 72 h after the 5th cycle of ethanol vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg] 35.47 x 17.54 8.95 x x 6.41 x x x x x x 4.56 x 16.53 x x x x x x x x x x x x x x x x 16.63 x x x x 19.77 x x x 14.0 x 13.68 x x x 8.83 8.49 x x x x 26.67 x x x x x x 8.02 x x x 3.66 x x x x 39.43 x x 12.32 37.55 x 0.0 x x 28.73 23.78 x 13.62 x 53.86 x x x x x x x x x x x x x x x 4.32 19.74 12.14 +12786 Original post publication description: Cau_C_NE[ng/mg] entered at January/05 10:15:55 from IP 128.172.53.136 Central nervous system, pharmacology: Control for ethanol response, norepinephrine (NE) level in striatum (caudate putamen) tissue 72 h after the 5th air control cycle of vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg] Central nervous system, pharmacology: Control for ethanol response, norepinephrine (NE) level in striatum (caudate putamen) tissue 72 h after the 5th air control cycle of vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg] 20.85 x 16.25 27.3 x x 21.39 x x x x 13.14 x 16.3 x 23.91 x x x x x x x x x x x x x x x x 17.53 x x x x x x x x 20.91 x 21.4 x x x 14.08 10.1 x x x x 19.95 x x x x x x 12.05 x x x 19.53 x x x x 13.55 x x 19.77 39.31 x 9.64 x x 19.13 18.58 x 20.76 x x x x x x x x x x x x x x x x x 14.76 10.34 22.32 +12787 Original post publication description: Cau_C_Dopac[ng/mg] entered at January/05 10:15:55 from IP 128.172.53.136 Central nervous system, pharmacology: Control for ethanol response, 3,4-dihydroxyphenylacetic acid (DOPAC) level in striatum (caudate putamen) tissue 72 h after the 5th air control cycle of vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg] Central nervous system, pharmacology: Control for ethanol response, 3,4-dihydroxyphenylacetic acid (DOPAC) level in striatum (caudate putamen) tissue 72 h after the 5th air control cycle of vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg] 68.82 x 58.74 58.36 x x 125.86 x x x x 119.71 x 116.11 x 107.83 x x x x x x x x x x x x x x x x 135.84 x x x x x x x x 94.3 x 59.19 x x x 91.05 37.69 x x x x 67.09 x x x x x x 55.1 x x x 54.54 x x x x 125.19 x x 59.74 205.66 x 61.87 x x 19.67 27.5 x 73.41 x x x x x x x x x x x x x x x x x 117.2 36.47 99.66 +12788 Original post publication description: Cau_C_5HIAA[ng/mg] entered at January/05 10:15:55 from IP 128.172.53.136 Central nervous system, pharmacology: Control for ethanol response, 5-hydroxyindoleacetic acid (5-HIAA) level in striatum (caudate putamen) tissue 72 h after the 5th air control cycle of vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg] Central nervous system, pharmacology: Control for ethanol response, 5-hydroxyindoleacetic acid (5-HIAA) level in striatum (caudate putamen) tissue 72 h after the 5th air control cycle of vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg] 29.86 x 18.29 31.98 x x 20.18 x x x x 13.59 x 28.98 x 14.07 x x x x x x x x x x x x x x x x 30.54 x x x x x x x x 13.14 x 16.24 x x x 14.37 11.59 x x x x 25.92 x x x x x x 11.98 x x x 32.09 x x x x 34.77 x x 31.85 70.27 x 11.44 x x 17.63 28.94 x 15.11 x x x x x x x x x x x x x x x x x 29.82 17.73 16.23 +12789 Original post publication description: Cau_C_HVA[ng/mg] entered at January/05 10:15:55 from IP 128.172.53.136 Central nervous system, pharmacology: Control for ethanol response, homovanilic acid (HVA) level in striatum (caudate putamen) tissue 72 h after the 5th air control cycle of vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg] Central nervous system, pharmacology: Control for ethanol response, homovanilic acid (HVA) level in striatum (caudate putamen) tissue 72 h after the 5th air control cycle of vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg] 61.07 x 51.45 65.02 x x 62.22 x x x x 42.21 x 65.04 x 31.97 x x x x x x x x x x x x x x x x 58.66 x x x x x x x x 75.14 x 36.06 x x x 40.0 13.45 x x x x 46.81 x x x x x x 52.21 x x x 33.4 x x x x 77.66 x x 50.97 64.25 x 31.2 x x 12.75 17.07 x 51.89 x x x x x x x x x x x x x x x x x 69.44 24.47 30.64 +12790 Original post publication description: Cau_C_5HT[ng/mg] entered at January/05 10:15:55 from IP 128.172.53.136 Central nervous system, pharmacology: Control for ethanol response, 5-hydroxytryptamine (5-HT, serotonin) level in striatum (caudate putamen) tissue 72 h after the 5th air control cycle of vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg] Central nervous system, pharmacology: Control for ethanol response, 5-hydroxytryptamine (5-HT, serotonin) level in striatum (caudate putamen) tissue 72 h after the 5th air control cycle of vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg] 26.25 x 16.88 18.28 x x 9.04 x x x x 11.72 x 24.41 x 13.54 x x x x x x x x x x x x x x x x 4.63 x x x x x x x x 17.68 x 23.39 x x x 2.43 7.04 x x x x 9.83 x x x x x x 11.8 x x x 34.18 x x x x 52.13 x x 4.97 32.16 x 10.08 x x 6.57 7.04 x 28.75 x x x x x x x x x x x x x x x x x 20.48 15.0 14.11 +12791 Original post publication description: Sep_E_NE[ng/mg] entered at January/05 10:15:55 from IP 128.172.53.136 None Central nervous system, pharmacology: Ethanol response (chronic intermittent ethanol CIE cycles), norepinephrine levels (NE) in the medial septal nucleus 72 h after the 5th cycle of ethanol vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg] 69.16 x 22.65 19.02 x x 31.35 x x x x 19.17 x 12.84 x 6.34 x x x x x x x x x x x x x x x x 85.53 x x x x 43.56 x x x 22.0 x 11.08 x x x 33.48 32.51 x x x x 38.64 x x x x x x 8.38 x x x 68.45 x x x x 3.7 x x 10.3 76.58 x 16.12 x x 42.53 23.09 x 22.26 x 13.73 x x x x x x x x x x x x x x 39.97 28.68 45.26 10.28 +12792 Original post publication description: Sep_E_Dopac[ng/mg] entered at January/05 10:15:55 from IP 128.172.53.136 None Central nervous system, pharmacology: Ethanol response (chronic intermittent ethanol CIE cycles), 3,4-dihydroxyphenylacetic acid levels (DOPAC) in the medial septal nucleus 72 h after the 5th cycle of ethanol vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg] 177.84 x 136.19 114.84 x x 132.54 x x x x 138.65 x 120.61 x 133.44 x x x x x x x x x x x x x x x x 262.46 x x x x 136.78 x x x 134.36 x 135.53 x x x 98.72 97.52 x x x x 213.6 x x x x x x 151.43 x x x 194.23 x x x x 55.19 x x 35.28 199.09 x 177.89 x x 117.27 141.36 x 148.77 x 150.85 x x x x x x x x x x x x x x 12.05 104.19 126.01 85.79 +12793 Original post publication description: Sep_E_DA[ng/mg] entered at January/05 10:15:55 from IP 128.172.53.136 Sep_E_DA[ng/mg] entered at January/05 10:15:55 from IP 128.172.53.136 Central nervous system, pharmacology: Ethanol response (chronic intermittent ethanol CIE cycles), dopamine (DA) level in the medial septal nucleus 72 h after the 5th cycle of ethanol vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg] 962.92 x 361.51 75.32 x x 364.41 x x x x 289.96 x 218.18 x 246.17 x x x x x x x x x x x x x x x x 399.37 x x x x 307.01 x x x 268.03 x 204.67 x x x 314.78 175.27 x x x x 602.02 x x x x x x 335.55 x x x 291.29 x x x x 81.36 x x 33.45 367.61 x 359.99 x x 123.44 314.76 x 351.07 x 91.57 x x x x x x x x x x x x x x 11.5 252.08 168.55 244.21 +12794 Original post publication description: Sep_E_5HIAA[ng/mg] entered at January/05 10:15:55 from IP 128.172.53.136 None Central nervous system, pharmacology: Ethanol response (chronic intermittent ethanol CIE cycles), 5-hydroxyindoleacetic acid levels (5-HIAA) in the medial septal nucleus 72 h after the 5th cycle of ethanol vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg] 47.48 x 54.49 34.24 x x 79.32 x x x x 41.44 x 41.53 x 38.07 x x x x x x x x x x x x x x x x 61.81 x x x x 56.05 x x x 67.13 x 39.24 x x x 43.65 37.94 x x x x 61.65 x x x x x x 40.95 x x x 51.89 x x x x 24.42 x x 36.49 84.31 x 49.33 x x 63.68 51.77 x 79.03 x 71.61 x x x x x x x x x x x x x x 35.69 51.07 65.58 44.26 +12795 Original post publication description: Sep_E_HVA[ng/mg] entered at January/05 10:15:55 from IP 128.172.53.136 None Central nervous system, pharmacology: Ethanol response (chronic intermittent ethanol CIE cycles), homovanillic acid (HVA) in the medial septal nucleus 72 h after the 5th cycle of ethanol vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg] 74.81 x 56.16 30.89 x x 59.28 x x x x 41.56 x 36.82 x 38.53 x x x x x x x x x x x x x x x x 62.96 x x x x 43.01 x x x 62.78 x 33.47 x x x 43.61 34.68 x x x x 91.75 x x x x x x 59.35 x x x 67.63 x x x x 11.64 x x 24.85 50.52 x 48.2 x x 36.48 40.41 x 38.64 x 34.94 x x x x x x x x x x x x x x 14.46 44.76 44.75 28.53 +12796 Original post publication description: Sep_E_5HT[ng/mg] entered at January/05 10:15:55 from IP 128.172.53.136 Sep_E_5HT [ng/mg] Central nervous system, pharmacology: Ethanol response (chronic intermittent ethanol CIE cycles), 5-hydroxytryptamine (5-HT, serotonin) in the medial septal nucleus 72 h after the 5th cycle of ethanol vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg] 87.27 x 89.05 58.08 x x 133.45 x x x x 82.37 x 74.81 x 66.44 x x x x x x x x x x x x x x x x 72.2 x x x x 84.47 x x x 94.45 x 70.28 x x x 86.09 72.32 x x x x 59.18 x x x x x x 74.52 x x x 62.53 x x x x 52.59 x x 39.98 112.69 x 66.88 x x 50.57 82.1 x 100.86 x 62.06 x x x x x x x x x x x x x x 75.44 38.64 91.04 72.17 +12797 Original post publication description: Sep_C_NE[ng/mg] entered at January/05 10:15:55 from IP 128.172.53.136 Central nervous system, pharmacology: Control for ethanol response, norepinephrine (NE) level in the medial septal nucleus 72 h after the 5th cycle of ethanol vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg] Central nervous system, pharmacology: Control for ethanol response, norepinephrine (NE) level in the medial septal nucleus 72 h after the 5th cycle of ethanol vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg] 12.24 x 26.97 18.32 x x 18.22 x x x x 4.87 x 60.64 x 34.72 x x x x x x x x x x x x x x x x 12.12 x x x x x x x x 68.14 x 71.6 x x x 12.43 11.1 x x x x 9.08 x x x x x x 16.85 x x x 14.65 x x x x 96.66 x x 7.2 13.58 x 105.33 x x 3.65 6.72 x 11.85 x x x x x x x x x x x x x x x x 59.67 0.0 7.91 78.66 +12798 Original post publication description: Dopac concentration in medial septum of air control for CIE 72 hr after 4th cycle [ng/mg] Central nervous system, pharmacology: Ethanol response, 3,4-dihydroxyphenylacetic acid levels (DOPAC, a dopamine metabolite) in the medial septal nucleus 72 h after the 5th cycle of chronic intermittent ethanol (CIE) vapor chamber treatment, 15 to 17 weeks males or females (Dec 2009 Cohort 1) [ng/mg] Central nervous system, pharmacology: Ethanol response, 3,4-dihydroxyphenylacetic acid levels (DOPAC, a dopamine metabolite) in the medial septal nucleus 72 h after the 5th cycle of chronic intermittent ethanol (CIE) vapor chamber treatment, 15 to 17 weeks males or females (Dec 2009 Cohort 1) [ng/mg] 158.98 x 120.12 67.93 x x 154.02 x x x x 77.93 x 264.98 x 85.14 x x x x x x x x x x x x x x x x 215.57 x x x x x x x x 151.13 x 167.74 x x x 169.25 159.44 x x x x 201.25 x x x x x x 110.46 x x x 112.46 x x x x 179.04 x x 268.9 105.51 x 145.91 x x 92.45 139.38 x 208.14 x x x x x x x x x x x x x x x x 159.87 142.9 95.24 145.67 +12799 Original post publication description: Sep_C_DA[ng/mg] entered at January/05 10:15:55 from IP 128.172.53.136 Central nervous system, pharmacology: Control for ethanol response, dopamine (DA) level in the medial septal nucleus 72 h after the 5th cycle of ethanol vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg] Central nervous system, pharmacology: Control for ethanol response, dopamine (DA) level in the medial septal nucleus 72 h after the 5th cycle of ethanol vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg] 114.28 x 387.37 228.09 x x 285.57 x x x x 227.09 x 382.73 x 126.31 x x x x x x x x x x x x x x x x 406.16 x x x x x x x x 597.8 x 309.11 x x x 312.26 287.59 x x x x 187.29 x x x x x x 166.8 x x x 53.52 x x x x 508.64 x x 441.07 529.12 x 322.19 x x 158.59 181.78 x 656.52 x x x x x x x x x x x x x x x x 224.13 227.14 188.12 402.34 +12800 Original post publication description: Sep_C_5HIAA[ng/mg] entered at January/05 10:15:55 from IP 128.172.53.136 Central nervous system, pharmacology: Control for ethanol response, 5-hydroxyindoleacetic acid levels (5-HIAA, a serotonin metabolite) in the medial septal nucleus 72h after the 5th air control cycle of vapor chamber treatment, 16 to 18 weeks males or females (Dec 2009 Cohort 1) [ng/mg] Central nervous system, pharmacology: Control for ethanol response, 5-hydroxyindoleacetic acid levels (5-HIAA, a serotonin metabolite) in the medial septal nucleus 72h after the 5th air control cycle of vapor chamber treatment, 16 to 18 weeks males or females (Dec 2009 Cohort 1) [ng/mg] 69.53 x 41.31 29.18 x x 68.96 x x x x 20.84 x 62.82 x 29.3 x x x x x x x x x x x x x x x x 66.37 x x x x x x x x 58.38 x 46.7 x x x 47.59 36.84 x x x x 54.94 x x x x x x 61.22 x x x 64.4 x x x x 61.27 x x 62.0 47.24 x 16.77 x x 43.52 41.69 x 53.79 x x x x x x x x x x x x x x x x 101.16 31.93 43.2 56.67 +12801 Original post publication description: Sep_C_HVA[ng/mg] entered at January/05 10:15:55 from IP 128.172.53.136 Central nervous system, pharmacology: Control for ethanol response, homovanillic acid (HVA) level in the medial septal nucleus 72 h after the 5th air control cycle of vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg] Central nervous system, pharmacology: Control for ethanol response, homovanillic acid (HVA) level in the medial septal nucleus 72 h after the 5th air control cycle of vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg] 56.61 x 49.98 27.36 x x 55.06 x x x x 29.88 x 72.41 x 27.22 x x x x x x x x x x x x x x x x 58.51 x x x x x x x x 73.75 x 42.33 x x x 47.61 41.52 x x x x 63.65 x x x x x x 51.78 x x x 36.43 x x x x 53.25 x x 52.25 37.49 x 47.07 x x 27.54 30.47 x 50.31 x x x x x x x x x x x x x x x x 50.02 37.92 37.95 40.77 +12802 Original post publication description: Sep_C_5HT[ng/mg] entered at January/05 10:15:55 from IP 128.172.53.136 Central nervous system, pharmacology: Control for ethanol response, 5-hydroxytryptamine (5-HT, serotonin) level in the medial septal nucleus 72 h after the 5th air control cycle of vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg] Central nervous system, pharmacology: Control for ethanol response, 5-hydroxytryptamine (5-HT, serotonin) level in the medial septal nucleus 72 h after the 5th air control cycle of vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg] 70.58 x 81.17 88.93 x x 118.15 x x x x 55.09 x 84.73 x 63.09 x x x x x x x x x x x x x x x x 76.46 x x x x x x x x 106.12 x 59.15 x x x 59.12 80.87 x x x x 83.99 x x x x x x 100.07 x x x 32.67 x x x x 99.01 x x 59.6 147.79 x 69.74 x x 35.17 54.13 x 87.21 x x x x x x x x x x x x x x x x 130.72 48.22 49.19 136.28 +12803 Original post publication description: BrS_E_NE[ng/mg] entered at January/05 10:15:55 from IP 128.172.53.136 Central nervous system, pharmacology: Ethanol response (chronic intermittent vapor exposure CIE), norepinephrine (NE) level in hindbrain tissue 72 h after the 5th cycle of treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg] Central nervous system, pharmacology: Ethanol response (chronic intermittent vapor exposure CIE), norepinephrine (NE) level in hindbrain tissue 72 h after the 5th cycle of treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg] 102.49 x 122.39 98.7 x x 121.27 x x x x 104.54 x 90.58 x 141.38 x x x x x x x x x x x x x x x x 121.64 x x x x 115.68 x x x 123.82 x 148.83 x x x 86.45 143.47 x x x x 106.18 x x x x x x 143.8 x x x 153.16 x x x x 65.65 x x 45.48 154.64 x 91.94 x x 105.88 97.34 x 105.4 x 129.76 x x x x x x x x x x x x x x 112.85 94.47 76.67 142.59 +12804 Original post publication description: BrS_E_Dopac[ng/mg] entered at January/05 10:15:55 from IP 128.172.53.136 BrS_E_Dopac [ng/mg] Central nervous system, pharmacology: Control for ethanol response, 3,4-dihydroxyphenylacetic acid (DOPAC) level in hindbrain tissue 72 h after the 5th air control cycle of vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg] 7.12 x 6.74 8.7 x x 7.66 x x x x 6.81 x 6.17 x 8.71 x x x x x x x x x x x x x x x x 9.07 x x x x 9.34 x x x 8.68 x 9.76 x x x 7.31 11.47 x x x x 8.38 x x x x x x 7.85 x x x 10.06 x x x x 8.9 x x 9.42 10.3 x 8.88 x x 8.71 10.8 x 9.24 x 6.95 x x x x x x x x x x x x x x 9.03 11.09 8.5 11.98 +12805 Original post publication description: BrS_E_DA[ng/mg] entered at January/05 10:15:55 from IP 128.172.53.136 Central nervous system, pharmacology: Ethanol response (5 cycles of chronic intermittent vapor exposure CIE), dopamine level in hindbrain tissue 72h after the 5th cycle of treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg] Central nervous system, pharmacology: Ethanol response (5 cycles of chronic intermittent vapor exposure CIE), dopamine level in hindbrain tissue 72h after the 5th cycle of treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg] 10.51 x 9.68 14.49 x x 8.75 x x x x 9.78 x 10.29 x 9.28 x x x x x x x x x x x x x x x x 14.19 x x x x 13.3 x x x 10.45 x 12.82 x x x 6.27 14.81 x x x x 10.57 x x x x x x 9.2 x x x 17.58 x x x x 8.01 x x 10.72 14.07 x 12.6 x x 12.61 12.49 x 20.44 x 8.68 x x x x x x x x x x x x x x 12.23 12.01 11.92 16.41 +12806 Original post publication description: BrS_E_5HIAA[ng/mg] entered at January/05 10:15:55 from IP 128.172.53.136 Central nervous system, pharmacology: Ethanol response, 5-hydroxyindoleacetic acid levels (5-HIAA, a serotonin metabolite) in hindbrain tissue 72h after the 5th cycle of chronic intermittent ethanol (CIE) vapor chamber treatment, 16 to 18 weeks males or females (Dec 2009 Cohort 1) [ng/mg] Central nervous system, pharmacology: Ethanol response, 5-hydroxyindoleacetic acid levels (5-HIAA, a serotonin metabolite) in hindbrain tissue 72h after the 5th cycle of chronic intermittent ethanol (CIE) vapor chamber treatment, 16 to 18 weeks males or females (Dec 2009 Cohort 1) [ng/mg] 94.55 x 74.22 72.07 x x 83.12 x x x x 52.25 x 69.53 x 75.55 x x x x x x x x x x x x x x x x 47.84 x x x x 103.61 x x x 102.26 x 91.29 x x x 85.24 97.84 x x x x 81.01 x x x x x x 46.17 x x x 108.95 x x x x 112.91 x x 46.73 88.76 x 67.19 x x 86.89 41.95 x 58.98 x 81.23 x x x x x x x x x x x x x x 73.94 63.47 109.91 114.17 +12807 Original post publication description: BrS_E_HVA[ng/mg] entered at January/05 10:15:55 from IP 128.172.53.136 Central nervous system, pharmacology: Ethanol response (5 cycles of chronic intermittent vapor exposure CIE), homovanillic (HVA) level in hindbrain tissue 72 h after the 5th cycle of treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg] Central nervous system, pharmacology: Ethanol response (5 cycles of chronic intermittent vapor exposure CIE), homovanillic (HVA) level in hindbrain tissue 72 h after the 5th cycle of treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg] 21.06 x 13.67 15.13 x x 17.33 x x x x 22.58 x 21.44 x 13.79 x x x x x x x x x x x x x x x x 10.9 x x x x 21.18 x x x 18.49 x 19.82 x x x 12.54 24.22 x x x x 18.38 x x x x x x 14.86 x x x 8.93 x x x x 17.67 x x 11.94 21.04 x 19.49 x x 18.21 4.97 x 10.13 x 13.41 x x x x x x x x x x x x x x 18.33 17.94 17.1 23.04 +12808 Original post publication description: BrS_E_5HT[ng/mg] entered at January/05 10:15:55 from IP 128.172.53.136 Central nervous system, pharmacology: Ethanol response, 5-hydroxytrptamine levels (5-HT, serotonin) in hindbrain tissue 72h after the 5th cycle of chronic intermittent ethanol (CIE) vapor chamber treatment, 16 to 18 weeks males or females (Dec 2009 Cohort 1) [ng/mg] Central nervous system, pharmacology: Ethanol response, 5-hydroxytrptamine levels (5-HT, serotonin) in hindbrain tissue 72h after the 5th cycle of chronic intermittent ethanol (CIE) vapor chamber treatment, 16 to 18 weeks males or females (Dec 2009 Cohort 1) [ng/mg] 100.37 x 79.53 88.06 x x 28.34 x x x x 31.1 x 85.5 x 35.79 x x x x x x x x x x x x x x x x 117.62 x x x x 45.38 x x x 42.15 x 61.69 x x x 23.24 34.68 x x x x 95.88 x x x x x x 36.16 x x x 136.59 x x x x 85.5 x x 59.0 52.92 x 36.12 x x 125.83 112.25 x 36.78 x 117.5 x x x x x x x x x x x x x x 35.03 95.8 106.65 60.09 +12809 Original post publication description: BrS_C_NE[ng/mg] entered at January/05 10:15:55 from IP 128.172.53.136 Central nervous system, pharmacology: Control for ethanol response, 5-hydroxytryptamine (5-HT, serotonin) level in the medial septal nucleus 72 h after the 5th air control cycle of vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg] Central nervous system, pharmacology: Control for ethanol response, norepinephrine (NE) level in hindbrain tissue 72 h after the 5th air control cycle of vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg] 122.77 x 137.7 106.39 x x 129.77 x x x x 121.16 x 91.65 x 172.43 x x x x x x x x x x x x x x x x 119.07 x x x x x x x x 131.95 x 144.37 x x x 96.5 141.96 x x x x 121.63 x x x x x x 142.87 x x x 119.34 x x x x 106.09 x x 46.96 162.2 x 85.95 x x 105.67 131.81 x 131.39 x x x x x x x x x x x x x x x x 109.48 82.16 0.0 136.92 +12810 Original post publication description: BrS_C_Dopac[ng/mg] entered at January/05 10:15:55 from IP 128.172.53.136 Central nervous system, pharmacology: Control for ethanol response, 3,4-dihydroxyphenylacetic acid levels (DOPAC) in hindbrain tissue 72 h after the 5th air control cycle of vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg] Central nervous system, pharmacology: Control for ethanol response, 3,4-dihydroxyphenylacetic acid levels (DOPAC) in hindbrain tissue 72 h after the 5th air control cycle of vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg] 8.64 x 6.46 8.93 x x 8.74 x x x x 8.12 x 5.65 x 8.36 x x x x x x x x x x x x x x x x 6.62 x x x x x x x x 6.43 x 8.82 x x x 6.19 10.72 x x x x 6.95 x x x x x x 10.49 x x x 7.1 x x x x 8.35 x x 8.38 10.35 x 6.78 x x 5.89 8.13 x 7.77 x x x x x x x x x x x x x x x x 9.16 6.17 6.37 9.42 +12811 Original post publication description: BrS_C_DA[ng/mg] entered at January/05 10:15:55 from IP 128.172.53.136 Central nervous system, pharmacology: Control for ethanol response, dopamine levels (DA) in hindbrain tissue 72 h after the 5th air control cycle of vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg] Central nervous system, pharmacology: Control for ethanol response, dopamine levels (DA) in hindbrain tissue 72 h after the 5th air control cycle of vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg] 11.69 x 12.4 12.08 x x 13.89 x x x x 12.26 x 7.88 x 8.03 x x x x x x x x x x x x x x x x 9.66 x x x x x x x x 9.16 x 14.6 x x x 8.55 15.93 x x x x 10.04 x x x x x x 13.87 x x x 11.81 x x x x 14.48 x x 7.55 15.62 x 5.95 x x 12.45 12.93 x 7.64 x x x x x x x x x x x x x x x x 12.3 9.52 9.16 14.3 +12812 Original post publication description: BrS_C_5HIAA[ng/mg] entered at January/05 10:15:55 from IP 128.172.53.136 Central nervous system, pharmacology: Control for ethanol response, 5-hydroxyindoleacetic acid levels (5-HIAA, a serotonin metabolite) in hindbrain tissue 72h after the 5th air control cycle of vapor chamber treatment, 16 to 18 weeks males or females (Dec 2009 Cohort 1) [ng/mg] Central nervous system, pharmacology: Control for ethanol response, 5-hydroxyindoleacetic acid levels (5-HIAA, a serotonin metabolite) in hindbrain tissue 72h after the 5th air control cycle of vapor chamber treatment, 16 to 18 weeks males or females (Dec 2009 Cohort 1) [ng/mg] 50.28 x 60.33 109.84 x x 99.72 x x x x 71.71 x 78.16 x 81.79 x x x x x x x x x x x x x x x x 95.84 x x x x x x x x 78.81 x 89.63 x x x 72.59 109.06 x x x x 97.2 x x x x x x 145.33 x x x 96.19 x x x x 124.76 x x 46.19 107.17 x 81.21 x x 100.79 94.16 x 52.56 x x x x x x x x x x x x x x x x 68.08 31.21 32.86 108.14 +12813 Original post publication description: BrS_C_HVA[ng/mg] entered at January/05 10:15:55 from IP 128.172.53.136 Central nervous system, pharmacology: Control for ethanol response, homovanillic acid (HVA, a dopamine metabolite) level in hindbrain tissue 72 h after the 5th air control cycle of vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg] Central nervous system, pharmacology: Control for ethanol response, homovanillic acid (HVA, a dopamine metabolite) level in hindbrain tissue 72 h after the 5th air control cycle of vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg] 10.5 x 16.27 24.55 x x 19.59 x x x x 35.72 x 21.63 x 15.56 x x x x x x x x x x x x x x x x 16.61 x x x x x x x x 12.91 x 19.88 x x x 18.97 25.67 x x x x 22.4 x x x x x x 26.94 x x x 17.02 x x x x 21.83 x x 5.45 25.58 x 10.27 x x 18.7 22.77 x 11.45 x x x x x x x x x x x x x x x x 17.63 4.56 5.9 23.21 +12814 Original post publication description: BrS_C_5HT[ng/mg] entered at January/05 10:15:55 from IP 128.172.53.136 Central nervous system, pharmacology: Control for ethanol response, 5-hydroxytryptamine levels (5-HT, serotonin) in hindbrain tissue 72h after the 5th air control cycle of vapor chamber treatment, 16 to 18 weeks males or females (Dec 2009 Cohort 1) [ng/mg] Central nervous system, pharmacology: Control for ethanol response, 5-hydroxytryptamine levels (5-HT, serotonin) in hindbrain tissue 72h after the 5th air control cycle of vapor chamber treatment, 16 to 18 weeks males or females (Dec 2009 Cohort 1) [ng/mg] 107.61 x 73.1 79.95 x x 41.17 x x x x 45.07 x 94.52 x 47.51 x x x x x x x x x x x x x x x x 100.52 x x x x x x x x 40.53 x 57.49 x x x 26.65 43.57 x x x x 117.0 x x x x x x 44.53 x x x 89.41 x x x x 132.29 x x 36.59 60.97 x 34.39 x x 120.65 98.7 x 32.19 x x x x x x x x x x x x x x x x 34.14 76.81 86.31 41.74 +12815 Original post publication description: Cau_C_DA[ng/mg] entered at January/05 11:10:32 from IP 128.172.53.136 Central nervous system, pharmacology: Control for ethanol response, 5-hydroxytryptamine (5-HT, serotonin) level in the medial septal nucleus 72 h after the 5th air control cycle of vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg] Central nervous system, pharmacology: Control for ethanol response, dopamine (DA) level in hindbrain tissue 72 h after the 5th air control cycle of vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [ng/mg] 587.93 x 471.75 133.58 x x 437.56 x x x x 392.16 x 673.49 x 290.26 x x x x x x x x x x x x x x x x 727.0 x x x x x x x x 687.97 x 361.97 x x x 197.25 146.89 x x x x 419.51 x x x x x x 488.49 x x x 235.08 x x x x 841.35 x x 573.63 447.73 x 458.24 x x 131.03 112.08 x 564.22 x x x x x x x x x x x x x x x x x 789.0 245.93 354.25 +12816 Original post publication description: Ethanol response, 2-bottle choice consumption 2 h access, 3 days after cycle 1 of chronic intermittent ethanol vapor (CIE). Expressed as percent change from baseline intake prior to CIE. Central nervous system, pharmacology: Ethanol response, 2-bottle choice consumption 2 h access, 3 days after cycle 1 of chronic intermittent ethanol vapor (CIE) [% from baseline] Central nervous system, pharmacology: Ethanol response, 2-bottle choice consumption 2 h access, 3 days after cycle 1 of chronic intermittent ethanol vapor (CIE) [% from baseline] -53.92 x 22.033 -19.345 x x 3.1 x x x x 9.42 x -28.61 x -71.22 x -6.82 x x x x x x x x x x x x -14.05 x 6.62 x -14.81 x x -48.49 x x x -50.57 x -55.84 x x x 14.29 -20.23 50.26 x x x 68.58 x x x x x x 52.91 x -4.68 x 59.34 x x 22.31 x 13.84 x -29.05 -9.82 -11.335 x -30.98 x x 6.585 1.42 x 130.6 -7.22 -9.725 x x x -6.13 x x x x x x x x x -26.05 -48.1 -19.37 -42.93 -25.65 +12817 Original post publication description: Ethanol response, 2-bottle choice consumption 2 h access, 3 days after cycle 4 of chronic intermittent Ethanol vapor (CIE). Average of 5 days ethanol intake [g/kg/2h]. CIE_T4_Etgkgave. None Central nervous system, pharmacology, behavior: Ethanol response, ethanol consumption using a 2-bottle choice with 2 h access/day from day 3 to day 8 after the fourth cycle of treatment in a chronic intermittent ethanol vapor chamber (CIE) [g/kg/2h/day] 0.793 x 3.685 2.451 x x 2.645 x x x x 1.853 x 0.882 x 1.597 x x x x x x x x x x x x x x x x 3.225 x x x x 1.369 x x x 0.936 x 1.431 x x x 3.792 2.4 x x x x 3.652 x x x x x x 2.397 x x x 2.285 x x x x 1.777 x x 1.566 2.185 x 2.712 x x 1.692 4.472 x 1.657 x 1.271 x x x x x x x x x x x x x x 1.467 1.723 1.444 1.038 +12819 Original post publication description: Central nervous system, behavior: Passive avoidance, latency to enter dark on day 2 in 8-weeK-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model [% WT] None Central nervous system, behavior: Passive avoidance, latency to enter dark on day 2 in 8-weeK-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model [% WT] x 60.2 53.3 x x 133.7 77.6 69.3 x 58.8 51.8 82.6 x 72.2 x x 85.8 x 98.3 x 62.1 x x x x x 96.8 x x 58.6 x x 48.5 x x x x 51.3 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +12820 Original post publication description: Central nervous system, behavior: Passive avoidance, latency to enter dark on day 3 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model [% WT] None Central nervous system, behavior: Passive avoidance, latency to enter dark on day 3 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model [% WT] x 111.2 75.0 x x 53.4 106.4 73.0 x 71.6 83.1 102.6 x 81.3 x x 113.2 x 84.9 x 78.9 x x x x x 84.7 x x 96.4 x x 79.9 x x x x 89.9 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13018 Original post publication description: Ethanol response (3 day exposure to 8-11 g/kg ethanol in vapor chamber with pyrazole 1 mM/kg/day),handling-induced convulsion (HIC) withdrawal severity score (15x 1 hour measurements) in 24-28 week-old males, all three experiments averaged (not in Table 4) [area under curve] None Ethanol response (3 day exposure to 8-11 g/kg ethanol in vapor chamber with pyrazole 1 mM/kg/day),handling-induced convulsion (HIC) withdrawal severity score (15x 1 hour measurements) in 24-28 week-old males, all three experiments averaged (not in Table 4) [area under curve] x x 13.0 28.5 24.415 32.165 x 12.735 x x 32.375 21.13 x 24.355 13.375 x 8.0 x x 7.5 x 15.0 25.46 x 7.5 33.9 9.83 4.5 24.5 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13019 Original post publication description: Central nervous system, endocrinology: 3a,5b-THP in blood plasma 3 days after cycle 5 of chronic intermittent ethanol vapor [pg/g]. None Endocrinology, blood chemistry: Ethanol response (CIE), 3a,5b-THP in blood plasma 3 days after cycle 5 of chronic intermittent ethanol (CIE) vapor treatment [pg/g] 50.7 x 39.417 12.9 x x 48.9 x x x x 14.6 x 11.7 x 5.4 x x x x x x x x x x x x x x x x 9.1 x x x x 5.5 x x x 5.7 x x x x x 10.7 11.8 x x x x 50.2 x x x x x x 23.5 x x x 2.7 x x x x 42.3 x x 9.2 20.0 x 2.6 x x 43.15 14.9 x 38.9 x 62.05 x x x x x x x x x x x x x x 41.0 45.1 56.4 38.1 +13020 Original post publication description: Central nervous system, endocrinology: 3a,5a-THDOC in blood plasma 3 days after cycle 5 of chronic intermittent ethanol vapor [pg/g]. None Endocrinology, blood chemistry: Ethanol response (CIE), 3a,5a-tetrahydrodeoxycorticosterone (THDOC) in blood plasma 3 days after cycle 5 of chronic intermittent ethanol (CIE) vapor treatment [pg/g] 5.2 x 243.9 12.8 x x 153.7 x x x x 125.2 x 192.0 x 82.4 x x x x x x x x x x x x x x x x 160.0 x x x x 79.75 x x x 131.0 x x x x x 52.7 43.8 x x x x 22.95 x x x x x x 154.1 x x x 27.6 x x x x 68.3 x x 294.4 14.85 x 169.1 x x 107.65 62.9 x 81.2 x 17.8 x x x x x x x x x x x x x x 94.4 308.8 75.6 32.0 +13021 Original post publication description: Central nervous system, endocrinology: 3a,5b-THDOC in blood plasma 3 days after cycle 5 of chronic intermittent ethanol vapor [pg/g]. None Endocrinology, blood chemistry: Ethanol response (CIE), 3a,5b-tetrahydrodeoxycorticosterone (THDOC) neurosteroid in blood plasma 3 days after cycle 5 of chronic intermittent ethanol (CIE) vapor treatment [pg/g] x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 78.3 x x x x 167.5 x x x x x x 540.8 x x x x x x x x 277.1 x x x 314.9 x x x x x x x x x 140.35 x x x x x x x x x x x x x x x x x x +13022 Original post publication description: Central nervous system, endocrinology: 3a,5a-Androsterone in blood plasma 3 days after cycle 5 of chronic intermittent ethanol vapor [pg/g]. None Endocrinology, blood chemistry: Ethanol response (CIE), 3a,5a-androsterone in blood plasma 3 days after cycle 5 of chronic intermittent ethanol vapor [pg/g] 31.4 x 29.717 70.8 x x 41.4 x x x x 136.4 x 93.6 x 95.0 x x x x x x x x x x x x x x x x 41.7 x x x x 77.2 x x x 71.3 x x x x x 75.2 37.2 x x x x 26.25 x x x x x x 52.3 x x x 42.6 x x x x 32.7 x x x 34.2 x 34.8 x x 28.3 38.0 x 44.7 x 28.05 x x x x x x x x x x x x x x x 29.6 36.3 37.1 +13023 Original post publication description: Central nervous system, endocrinology: Corticosterone in blood plasma 3 days after cycle 5 of chronic intermittent ethanol vapor [ng/g]. None Endocrinology, blood chemistry: Ethanol response (CIE), corticosterone in blood plasma 3 days after cycle 5 of chronic intermittent ethanol (CIE) vapor chamber treatment [ng/g] 39.6 x 101.058 39.0 x x 49.7 x x x x 93.2 x 31.3 x 25.6 x x x x x x x x x x x x x x x x 46.2 x x x x 31.753 x x x 93.7 x 34.1 x x x 69.6 56.4 x x x x 281.737 x x x x x x 214.0 x x x 39.5 x x x x 190.3 x x 62.6 212.182 x 154.7 x x 140.27 90.8 x 56.8 x 122.683 x x x x x x x x x x x x x x 100.8 166.1 57.6 49.5 +13024 Original post publication description: Central nervous system, endocrinology: Corticosterone in blood plasma 3 days after cycle 5 of chronic intermittent air vapor (control) [ng/g]. None Endocrinology, blood chemistry: Control for ethanol response, corticosterone in blood plasma 3 days after cycle 5 of chronic intermittent air vapor [ng/g] 383.5 x 102.632 63.7 x x 53.1 x x x x 26.4 x 41.3 x 45.1 x x x x x x x x x x x x x x x x 33.6 x x x x x x x x 112.9 x 57.9 x x x 108.0 540.9 x x x x 299.1 x x x x x x 495.6 x x x 154.8 x x x x 190.7 x x 77.1 76.5 x 54.3 x x 74.6 249.2 x 95.9 x x x x x x x x x x x x x x x x 92.6 128.1 117.2 71.8 +13025 Original post publication description: Central nervous system, endocrinology: 3a,5a-THP in blood plasma 3 days after cycle 5 of chronic intermittent air vapor (control) [pg/g]. None Endocrinology, blood chemistry: Control for ethanol response, 3a,5a-THP (3a-hydroxy-5a-pregnan-20-one) neurosteroid in blood plasma 3 days after cycle 5 of chronic intermittent air vapor [pg/g] 66.1 x 109.3 x x x 343.2 x x x x 187.6 x 133.8 x 226.1 x x x x x x x x x x x x x x x x 106.2 x x x x x x x x x x x x x x x x x x x x 26.8 x x x x x x x x x x x x x x x x x x 158.6 x x 24.8 x x 114.5 161.8 x 117.7 x x x x x x x x x x x x x x x x 124.3 94.5 51.3 49.4 +13026 Original post publication description: Central nervous system, endocrinology: 3a,5b-THP in blood plasma 3 days after cycle 5 of chronic intermittent air vapor (control) [pg/g]. None Endocrinology, blood chemistry: Control for ethanol response, 3a,5b-THP in blood plasma 3 days after cycle 5 of chronic intermittent air vapor [pg/g] 78.9 x 37.967 32.3 x x 39.6 x x x x 25.3 x 17.5 x 15.7 x x x x x x x x x x x x x x x x 99.7 x x x x x x x x 4.9 x 1.6 x x x 11.6 x x x x x 52.8 x x x x x x x x x x 6.5 x x x x 52.6 x x 4.8 6.4 x 3.6 x x 55.9 3.3 x 42.3 x x x x x x x x x x x x x x x x 42.6 38.7 45.5 40.6 +13027 Original post publication description: Central nervous system, endocrinology: 3a,5a-THDOC in blood plasma 3 days after cycle 5 of chronic intermittent air vapor (control) [pg/g]. None Endocrinology, blood chemistry: Control for ethanol response, 3a,5a-tetrahydrodeoxycorticosterone (THDOC) in blood plasma 3 days after cycle 5 of chronic intermittent air vapor [pg/g] x x 169.76 81.3 x x 152.6 x x x x 127.6 x 251.6 x 634.2 x x x x x x x x x x x x x x x x 470.4 x x x x x x x x 115.8 x 126.2 x x x 26.7 x x x x x 21.9 x x x x x x x x x x 217.8 x x x x 56.8 x x 258.6 4.1 x 156.0 x x 9.1 353.0 x 135.9 x x x x x x x x x x x x x x x x 97.1 155.7 58.8 9.2 +13028 Original post publication description: Central nervous system, endocrinology: 3a,5b-THDOC in blood plasma 3 days after cycle 5 of chronic intermittent air vapor (control) [pg/g]. None Endocrinology, blood chemistry: Control for ethanol response, 3a,5b-tetrahydrodeoxycorticosterone (THDOC) neurosteroid in blood plasma 3 days after cycle 5 of chronic intermittent air vapor [pg/g] 814.2 x x 69.7 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 43.1 x x x x x 204.9 x x x x x x x x x x x x x x x 563.4 x x x 29.5 x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13029 Original post publication description: Central nervous system, endocrinology: 3a,5a-Androsterone in blood plasma 3 days after cycle 5 of chronic intermittent air vapor (control) [pg/g]. None Endocrinology, blood chemistry: Control for ethanol response, 3a,5a-androsterone in blood plasma 3 days after 5th air control cycle of vapor chamber treatment, 16 to 18 week-old males or females (Dec 2009 Cohort 1) [pg/g] 62.7 x 30.029 36.1 x x x x x x x 39.3 x 56.7 x 453.8 x x x x x x x x x x x x x x x x 55.9 x x x x x x x x 54.5 x 51.3 x x x 34.3 x x x x x 21.5 x x x x x x x x x x 36.9 x x x x 30.2 x x 51.6 32.6 x 39.8 x x 31.9 51.9 x 36.0 x x x x x x x x x x x x x x x x x 28.7 25.0 31.6 +13030 VGX hepatocytes [n +/- 2x via] Liver, metabolism, toxicology: CQ-0 Liver, metabolism, toxicology: Vials of hepatocyte obtained per strain from first run of spring 2011 by Piedmont and Varigenix, one vial of approximately 1 million cells (the error term is 2 times the percentage of non-viable cells) [n] x x 80.0 75.0 88.0 x 74.0 73.0 19.0 x 61.0 x 76.0 x 70.0 85.0 44.0 92.0 70.0 42.0 73.0 x x x x 64.0 x 60.0 x 74.0 74.0 x 53.0 x x x 76.0 65.0 75.0 x 42.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13034 Original post publication description: Transthyretin protein serum band (prealbumin, Pre locus) detected by acylamide electrophoresis in adult males [a-genotype of DBA/2J with band is coded as 1, o-genotype without band is coded as -1] None Hematology: Transthyretin protein serum band (prealbumin, Pre locus) detected by acylamide electrophoresis in adult males [a-genotype of DBA/2J with band is coded as 1, o-genotype without band is coded as -1] x x -1.0 1.0 -1.0 -1.0 -1.0 1.0 1.0 1.0 1.0 -1.0 -1.0 -1.0 1.0 1.0 -1.0 1.0 1.0 -1.0 -1.0 -1.0 x 1.0 1.0 1.0 1.0 -1.0 1.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13031 Original post publication description: Central nervous system, morphology: Hippocampus bilateral weight [mg] with adjustment for age, sex, body weight, and brain minus hippocampus weight. None Central nervous system, morphology: Hippocampus bilateral weight [mg] with adjustment for age, sex, body weight, and brain minus hippocampus weight. x x 27.4 26.4 27.5 25.8 25.2 28.3 26.5 25.1 25.9 25.7 25.5 26.7 25.8 27.1 25.8 28.1 26.0 25.9 24.0 24.7 x 23.8 24.8 25.6 24.9 24.8 23.9 24.7 23.5 27.4 25.0 27.3 27.6 25.1 28.5 26.7 30.8 x 27.5 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13032 Original post publication description: Gastrointestinal system, biochemistry: electrophoretic band variant of Lap-1 protein (ANPEP) that maps to proximal Chr 9 (this is not the Anpep locus, but is a possible trans-effect) [-1 band present, 1 band absent] None Gastrointestinal system, biochemistry: electrophoretic band variant of Lap-1 protein (ANPEP) that maps to proximal Chr 9 (this is not the Anpep locus, but is a possible trans-effect) [-1 band present, 1 band absent] x x -1.0 1.0 -1.0 1.0 -1.0 1.0 1.0 1.0 1.0 1.0 -1.0 -1.0 -1.0 1.0 1.0 1.0 -1.0 1.0 1.0 x x 1.0 1.0 -1.0 -1.0 1.0 1.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13033 Original post publication description: BXD epoch batch trait 4 [-1 = Taylor BXD series BXD1 to 30, 0 = BXD31 and higher] None Genetics, statistics, cofactors: BXD epoch batch trait 4 [-1 = Taylor BXD series BXD1 to 30, 0 = BXD31 and higher] x x x x -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 x -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 x x 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 x x 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 x 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 +13037 Original post publication description: Liver function, hepatocyte phase I metabolic activity measured by 7-ethoxycoumarin-O-deethylase (ECOD) consumption at 0 and 30 minutes (25 uM/sample) using cryorederived hepatocytes from young adult male liver [ECOD pmol/million cells/min] Original pre publication description: CQ-1 Liver, metabolism, toxicology: CQ-1 Liver, metabolism, toxicology: Hepatocyte phase I (CYP1A) metabolic activity measured by 7-ethoxycoumarin-o-deethylase (ECOD, 7EC) consumption at 0 and 30 minutes (25 uM/sample) using cryorederived hepatocytes from young adult male liver (BXD31 winsorized from 1394 to 1250) [ECOD pmol/million cells/min] x x 465.0 589.0 736.0 854.0 791.0 787.0 x x 676.0 x 1079.0 325.0 1081.0 432.0 548.0 407.0 x 631.0 1046.0 x x x x 488.0 466.0 573.0 x 1250.0 724.0 x x x x x 967.0 644.0 659.0 x 357.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13038 Original post publication description: Liver function: hepatocyte metabolic activity measured by production of 7-hydroxycoumarin glucouronide at 30 minutes (100 uM 7-EC/sample) using cryorederived hepatocytes from young adult male liver [pmol/million cells/min] Original pre publication description: CQ-2 Liver, metabolism, toxicology: CQ-2 Liver, metabolism, toxicology: Hepatocyte phase II metabolic activity (7HC, glucuronidation and sulfation) measured by production of 7-hydroxycoumarin glucouronide at 30 minutes (100 uM 7-EC/sample) using cryorederived hepatocytes from young adult male liver (BXD15 and BXD13 winsorized from 4125 and 4485 to 3300 and 3500) [7-HCG pmol/million cells/min] x x 2526.0 2085.0 2929.0 1614.0 1255.0 1687.0 x x 2040.0 x 3500.0 2016.0 3300.0 795.0 1852.0 1551.0 x 2877.0 1789.0 x x x x 2613.0 1103.0 2400.0 x 2319.0 2662.0 x x x x x 1280.0 3103.0 2208.0 x 1552.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13040 Original post publication description: Liver function: Hepatocyte viability, fraction of viable cells after rederivation relative to viable cells immediately after isolation , data from first run of spring 2011 by Piedmont and Varigenix [ratio] Original pre publication description: CQ-4 Liver, metabolism, toxicology: CQ-4 Liver, metabolism, toxicology: Hepatocyte viability, fraction of viable cells after rederivation relative to viable cells immediately after isolation in suspension (data from first run of spring 2011 by Piedmont and Varigenix) [ratio] x x 1.02 0.98 1.0 0.99 0.95 0.96 x x 0.94 x 0.92 0.95 0.96 0.92 0.97 0.94 x 0.95 0.96 x x x x 0.94 1.01 1.0 x 0.97 0.91 x x x x x 0.94 0.97 0.98 x 0.96 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13042 Original post publication description: Liver function: Hepatocyte phase II metabolic activity measured by 7-HCS sulfation assay at 30 minutes (100 uM 7-EC/sample) using cryorederived hepatocytes from young adult male liver [7-HCS pmol/million cells/min] Original pre publication description: CQ-3 Liver, metabolism, toxicology: CQ-3 Liver, metabolism, toxicology: Hepatocyte phase II metabolic activity measured by 7-HCS sulfation assay at 30 minutes (100 uM 7-EC/sample) using cryorederived hepatocytes from young adult male liver [7-HCS pmol/million cells/min] x x 87.0 71.0 123.0 67.0 84.0 133.0 x x 180.0 x 281.0 100.0 154.0 71.0 96.0 102.0 x 98.0 191.0 x x x x 119.0 164.0 101.0 x 96.0 100.0 x x x x x 131.0 119.0 174.0 x 69.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13043 Original post publication description: Infectious disease, immune function: Coccidioides immitis (Valley fever, San Joaquin California disease fungus, Coccidioidomycosis) susceptibility after an IP injection (500 - 800 CFU of the RS strain) [median CFU per lung 15 days after infection] None Infectious disease, immune system: Coccidioides immitis (Valley fever, San Joaquin California disease fungus, Coccidioidomycosis) susceptibility after an IP injection (500 - 800 CFU of the RS strain) in 7 to 12-week-old females, 10 per strain [log10 median CFU per lung 15 days after infection] x x 6.3 4.0 3.8 6.2 5.9 5.9 5.7 6.2 4.8 3.5 2.7 2.5 2.9 6.2 6.6 6.0 6.6 5.1 3.9 5.0 x 6.2 5.6 6.3 7.0 3.2 5.6 6.0 3.8 4.3 6.3 x x x 5.1 3.0 5.7 x 5.3 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13044 Original post publication description: Central nervous system, behavior, metabolism: Activity level (running wheel) in 3-4 month old females, average restriction day 2 and 3, 2-hour daily scheduled food restriction paradigm [revolutions/day] Original pre publication description: Kas01 Kas01 Central nervous system, behavior, metabolism: Body weight in 3-4 month old test naive females [g]. x x 20.6 19.8 19.144 25.8 x x 21.6 x 20.04 x 31.0 23.76 25.8 27.79 x x x x x x x 25.7 x x x 21.13 x x 21.5 x 24.65 x x x x x x x 21.8 21.3 x x x x x x x x x x x 20.5 x x x x x x x x x x x x x x x x x 19.04 x x x x x x x x x x x x 26.6 x x x x x x x x x 24.9 x 21.1 x x x x x +13045 Original post publication description: Musculoskeletal system, morphology: BMD (Bone Mineral Density) of femur of 70 days old male mice Original pre publication description: BMD of femur of male mice Musculoskeletal system, morphology, metabolism: Age adjusted Bone mineral density (BMD) of femur of males (dual energy X-ray absorptiometry PIXImus) [mg/cm2] Musculoskeletal system, morphology, metabolism: Age adjusted Bone mineral density (BMD) of femur of males (dual energy X-ray absorptiometry PIXImus) [mg/cm2] 469.459 424.186 360.993 384.392 469.952 x x x x x 444.064 401.15 x 331.03 x x x x x x x x x 401.285 x 353.768 x 373.348 x 368.018 419.57 x 405.397 x x x 420.659 344.65 389.159 x 381.662 389.779 412.199 341.774 x x 412.188 461.409 344.897 x x x x x 366.797 x x x 396.389 x 425.656 348.397 x 377.332 x x 372.521 346.903 440.532 360.188 x 389.282 x 388.667 x x x 433.828 315.521 x x 401.903 322.521 381.768 x 450.323 x 359.279 431.779 x x x x 414.521 x 332.139 x 328.897 420.656 338.914 331.495 314.817 +13046 Original post publication description: Musculoskeletal system, morphology: BMD (Bone Mineral Density) of tibia of 70 days old male mice Original pre publication description: BMD of tibia of male mice Musculoskeletal system, morphology, metabolism: Age adjusted bone mineral density (BMD) of tibia in adult males (dual energy X-ray absorptiometry DEXA using PIXIimus) [mg/cm2] Musculoskeletal system, morphology, metabolism: Age adjusted bone mineral density (BMD) of tibia in adult males (dual energy X-ray absorptiometry DEXA using PIXIimus) [mg/cm2] 408.732 368.749 317.44 314.567 393.991 x x x x x 375.517 342.339 x 318.469 x x x x x x x x x 289.324 x 288.971 x 296.996 x 315.221 353.38 x 357.517 x x x 331.192 290.993 319.17 x 319.228 296.706 322.848 310.089 x x 342.28 360.42 297.184 x x x x x 301.784 x x x 293.758 x 359.361 292.184 x 290.315 x x 346.78 278.002 371.715 291.28 x 355.015 x 349.569 x x x 392.895 275.341 x x 333.302 268.78 287.971 x 364.278 x 301.456 349.039 x x x x 371.28 x 250.758 x 322.184 354.944 293.704 317.502 287.66 +13047 Original post publication description: Musculoskeletal system, morphology: BMD (Bone Mineral Density) of femur of 70 days old female mice Original pre publication description: BMD of femur of female mice Musculoskeletal system, morphology, metabolism: Age adjusted Bone mineral density (BMD) of femur females (dual energy X-ray absorptiometry DEXA using PIXImus) [mg/cm2] Musculoskeletal system, morphology, metabolism: Age adjusted one mineral density (BMD) of femur females (dual energy X-ray absorptiometry DEXA using PIXImus) [mg/cm2] 405.796 378.48 301.046 378.701 405.406 x x x x x 332.764 318.978 x 324.519 x x x x x x x x x 345.563 x 334.308 x 376.073 x 327.357 382.786 x 341.284 x x x x 313.902 361.588 x 322.038 335.661 360.712 351.759 x x 357.058 365.888 380.284 x x x x x 393.612 x x x 334.098 x 378.337 328.043 x 360.362 x x 345.975 300.955 359.03 327.932 x 304.445 x 369.975 x x x 343.038 288.857 x x 364.936 320.311 331.857 x 340.637 x 313.661 371.494 x x x x 381.131 x 369.764 x 331.784 369.47 355.322 397.656 281.235 +13048 Original post publication description: Musculoskeletal system, morphology: BMD (Bone Mineral Density) of tibia of 70 days old female mice Original pre publication description: BMD of tibia of female mice Musculoskeletal system, morphology, metabolism: Age adjusted Bone mineral density (BMD) of tibia of females (dual energy X-ray absorptiometry DEXA using PIXImus) [mg/cm2] Musculoskeletal system, morphology, metabolism: Age adjusted Bone mineral density (BMD) of tibia females (dual energy X-ray absorptiometry DEXA using PIXImus) [mg/cm2] 339.49 317.175 255.989 315.869 337.221 x x x x x 300.314 248.783 x 289.757 x x x x x x x x x 293.166 x 278.682 x 287.221 x 232.451 313.157 x 291.797 x x x x 253.86 290.218 x 298.115 274.373 288.403 279.412 x x 282.932 276.218 314.297 x x x x x 283.603 x x x 263.606 x 304.988 295.188 x 259.435 x x 318.349 265.74 297.65 302.092 x 267.936 x 324.349 x x x 284.048 247.451 x x 330.007 262.625 292.951 x 252.988 x 269.373 298.706 x x x x 328.349 x 309.939 x 296.297 315.321 284.679 323.346 238.527 +13049 Original post publication description: Musculoskeletal system, morphology: BMC (Bone Mineral Content) of femur of 70 days old male mice Original pre publication description: BMC of femur of male mice Musculoskeletal system, morphology, metabolism: Bone mineral content (BMC) of femur of 10-week-old males (dual energy X-ray absorptiometry DEXA PIXImus) [g hydroxyapatite] Musculoskeletal system, morphology, metabolism: Bone mineral content (BMC) of femur of 10-week-old males (dual energy X-ray absorptiometry DEXA PIXImus) [g hydroxyapatite] 0.018 0.014 0.012 0.01 0.017 x x x x x 0.015 0.013 x 0.01 x x x x x x x x x 0.011 x 0.01 x 0.012 x 0.011 0.013 x 0.013 x x x 0.014 0.01 0.009 x 0.011 0.012 0.013 0.008 x x 0.014 0.014 0.009 x x x x x 0.011 x x x 0.013 x 0.016 0.01 x 0.011 x x 0.01 0.008 0.013 0.01 x 0.012 x 0.011 x x x 0.016 0.007 x x 0.014 0.006 0.012 x 0.014 x 0.01 0.016 x x x x 0.013 x 0.011 x 0.007 0.016 0.008 0.013 0.008 +13050 Original post publication description: Musculoskeletal system, morphology: BMC (Bone Mineral Content) of tibia of 70 days old male mice Original pre publication description: BMC of tibia of male mice Musculoskeletal system, morphology, metabolism: Bone mineral content (BMC) of tibia of 10-week-old males (dual energy X-ray absorptiometry DEXA using PIXImus) [g hydroxyapatite] Musculoskeletal system, morphology, metabolism: Bone mineral content (BMC) of tibia of 10-week-old males (dual energy X-ray absorptiometry DEXA using PIXImus) [g hydroxyapatite] 0.015 0.01 0.008 0.007 0.012 x x x x x 0.011 0.009 x 0.007 x x x x x x x x x 0.006 x 0.006 x 0.007 x 0.007 0.01 x 0.01 x x x 0.009 0.006 0.008 x 0.007 0.005 0.009 0.008 x x 0.01 0.01 0.007 x x x x x 0.006 x x x 0.007 x 0.011 0.004 x 0.006 x x 0.01 0.006 0.009 0.006 x 0.01 x 0.009 x x x 0.012 0.005 x x 0.009 0.004 0.007 x 0.009 x 0.007 0.01 x x x x 0.012 x 0.003 x 0.007 0.01 0.005 0.007 0.004 +13051 Original post publication description: Musculoskeletal system, morphology: BMC (Bone Mineral Content) of femur of 70 days old female mice entered at July/08 13:52:42 from IP 172.23.19.221 Original pre publication description: BMC of femur of female mice Musculoskeletal system, morphology, metabolism: Bone mineral content (BMC) of femur of 10-week-old females (dual energy X-ray absorptiometry PIXImus) [mg] Musculoskeletal system, morphology, metabolism: Bone mineral content (BMC) of femur of 10-week-old females (dual energy X-ray absorptiometry PIXImus) [mg] 0.013 0.009 0.008 0.01 0.012 x x x x x 0.008 0.008 x 0.008 x x x x x x x x x 0.009 x 0.009 x 0.01 x x 0.011 x 0.009 x x x x 0.005 0.007 x 0.01 0.007 0.01 0.009 x x 0.009 0.011 0.011 x x x x x 0.012 x x x 0.006 x 0.011 0.008 x 0.01 x x 0.009 0.005 0.01 0.008 x 0.007 x 0.009 x x x 0.008 0.005 x x 0.011 0.008 0.009 x 0.008 x 0.009 0.011 x x x x 0.011 x 0.01 x 0.006 0.012 0.01 0.008 0.004 +13052 Original post publication description: Musculoskeletal system, morphology: BMC (Bone Mineral Content) of tibia of 70 days old female mice Original pre publication description: BMC of tibia of female mice Musculoskeletal system, morphology, metabolism: Bone mineral content (BMC) of tibia of 10-week-old females (dual energy X-ray absorptiometry DEXA using PIXImus) [g hydroxyapatite] Musculoskeletal system, morphology, metabolism: Bone mineral content (BMC) of tibia of 10-week-old females (dual energy X-ray absorptiometry DEXA using PIXImus) [g hydroxyapatite] 0.009 0.007 0.005 0.007 0.008 x x x x x 0.008 0.004 x 0.005 x x x x x x x x x 0.006 x 0.005 x 0.005 x x 0.008 x 0.006 x x x x 0.004 0.007 x 0.008 0.007 0.005 0.006 x x 0.005 0.006 0.008 x x x x x 0.007 x x x 0.004 x 0.007 0.003 x 0.006 x x 0.008 0.003 0.007 0.007 x 0.004 x 0.008 x x x 0.006 0.005 x x 0.009 0.005 0.005 x 0.004 x 0.005 0.007 x x x x 0.008 x 0.008 x 0.007 0.009 0.007 0.007 0.001 +13053 Original post publication description: Musculoskeletal system, morphology: Area of femur of 70 days old male mice Original pre publication description: Area of femur of male mice Musculoskeletal system, morphology: Surface area of femur of 10-week-old males (dual energy X-ray absorptiometry DEXA using PIXImus) [cm2] Musculoskeletal system, morphology: Surface area of femur of 10-week-old males (dual energy X-ray absorptiometry DEXA using PIXImus) [cm2] 0.388 0.328 0.329 0.268 0.363 x x x x x 0.333 0.313 x 0.278 x x x x x x x x x 0.283 x 0.265 x 0.32 x 0.293 0.323 x 0.313 x x x 0.325 0.285 0.23 x 0.285 0.3 0.317 0.28 x x 0.34 0.32 0.225 x x x x x 0.288 x x x 0.33 x 0.358 0.285 x 0.292 x x 0.273 0.244 0.326 0.273 x 0.315 x 0.28 x x x 0.353 0.209 x x 0.333 0.195 0.32 x 0.31 x 0.28 0.37 x 0.285 x x 0.32 x 0.32 x 0.205 0.39 0.257 0.313 0.24 +13054 Original post publication description: Musculoskeletal system, morphology: Area of tibia of 70 days old male mice Original pre publication description: Area of tibia of male mice Musculoskeletal system, morphology: Surface area of tibia of 10-week-old males (dual energy X-ray absorptiometry DEXA using PIXImus) [cm2] Musculoskeletal system, morphology: Surface area of tibia of 10-week-old males (dual energy X-ray absorptiometry DEXA using PIXImus) [cm2] 0.357 0.278 0.258 0.212 0.303 x x x x x 0.293 0.255 x 0.21 x x x x x x x x x 0.203 x 0.21 x 0.25 x 0.215 0.277 x 0.293 x x x 0.265 0.2 0.26 x 0.22 0.18 0.26 0.24 x x 0.283 0.283 0.215 x x x x x 0.214 x x x 0.21 x 0.298 0.23 x 0.208 x x 0.265 0.194 0.266 0.193 x 0.268 x 0.264 x x x 0.303 0.178 x x 0.27 0.145 0.232 x 0.263 x 0.235 0.29 x 0.175 x x 0.315 x 0.125 x 0.21 0.28 0.193 0.22 0.143 +13055 Original post publication description: Musculoskeletal system, morphology: Area of femur of 70 days old female mice Original pre publication description: Area of femur of female mice Musculoskeletal system, morphology: Surface area of femur of 10-week-old females (dual energy X-ray absorptiometry DEXA using PIXImus) [cm2] Musculoskeletal system, morphology: Surface area of femur of 10-week-old females (dual energy X-ray absorptiometry DEXA using PIXImus) [cm2] 0.313 0.256 0.268 0.263 0.31 x x x x x 0.235 0.248 x 0.243 x x x x x x x x x 0.26 x 0.257 x 0.283 x 0.22 0.286 x 0.265 x x x x 0.24 0.27 x 0.28 0.29 0.264 0.267 x x 0.29 0.278 0.29 x x x x x 0.317 x x x 0.207 x 0.288 0.25 x 0.265 x x 0.27 0.178 0.27 0.226 x 0.227 x 0.25 x x x 0.23 0.23 x x 0.298 0.234 0.265 x 0.235 x 0.275 0.29 x x x x 0.287 x 0.3 x 0.17 0.323 0.273 0.25 0.12 +13056 Original post publication description: Musculoskeletal system, morphology: Area of tibia of 70 days old female mice Original pre publication description: Area of tibia of female mice Musculoskeletal system, morphology: Surface area of tibia of 10-week-old females (dual energy X-ray absorptiometry DEXA using PIXImus) [cm2] Musculoskeletal system, morphology: Surface area of tibia of 10-week-old females (dual energy X-ray absorptiometry DEXA using PIXImus) [cm2] 0.273 0.227 0.188 0.218 0.255 x x x x x 0.24 0.173 x 0.173 x x x x x x x x x 0.217 x 0.197 x 0.187 x 0.21 0.238 x 0.21 x x x x 0.153 0.215 x 0.24 0.23 0.178 0.21 x x 0.17 0.196 0.25 x x x x x 0.218 x x x 0.153 x 0.223 0.133 x 0.215 x x 0.247 0.118 0.216 0.213 x 0.17 x 0.24 x x x 0.218 0.125 x x 0.265 0.166 0.15 x 0.145 x 0.185 0.24 x x x x 0.25 x 0.247 x 0.225 0.27 0.25 0.223 0.06 +13058 Original post publication description: Urogenital system, renal system, morphology: Kidney weight of males (raw data, unadjusted) [mg] Original pre publication description: Urogenital system, renal system, morphology: Kidney weight of males (raw data, unadjusted) [mg] Urogenital system, renal system, morphology: Kidney weight of males (raw data, unadjusted) [mg] Urogenital system, renal system, morphology: Kidney weight of males (raw data, unadjusted) [mg] 257.46 208.34 158.09 289.2 217.24 243.83 x 179.25 262.61 189.37 208.61 206.45 x 192.16 x x x 203.23 x 269.77 x 182.07 x 236.79 161.4 200.42 x x x 172.9 240.9 157.29 278.19 x 212.25 230.53 212.84 188.0 213.84 x x 178.01 195.83 260.2 x x 184.32 x 209.4 237.6 x x x 262.97 x x x x 218.54 241.96 238.66 163.95 252.23 203.82 215.6 x 229.69 267.51 233.25 233.81 x 201.03 x 242.76 x 359.19 x x 218.84 x x 198.51 211.76 170.49 217.0 176.34 x 224.33 239.84 x 241.66 x x 265.7 203.69 240.27 247.1 226.84 202.06 x x x +13059 Original post publication description: Skeletal system, morphology: Cortical tissue mineral density (TMD) of femur of 16-week-old females measured by microcomputed tomography (uCT) [mg/ml] Original pre publication description: Skeletal system, morphology: VDavid1 Musculoskeletal system, morphology: VDavid1. Musculoskeletal system, morphology: Femur length (FL) of 12-week-old males measured by microcomputed tomography (µCT) [mm] 13.8 13.002 13.11 12.66 13.288 x x x x x 12.393 12.44 x 12.946 x x x x x x x x x x x x x 12.67 x 12.0 12.568 x 12.889 x x x 14.29 12.304 x x x x 13.091 x x x 12.728 13.258 x x x x x x 13.066 x x x 12.52 x 13.6 x x 13.7 x x 12.46 12.545 14.09 12.67 x 13.38 x 13.27 x x x 13.378 12.796 x x 13.33 x x x 12.48 x 12.785 13.85 x x x x x x x 12.773 x 13.951 x 12.15 x +13060 Original post publication description: Central nervous system, morphology, stereology: Neuron number in cerebral neocortex of adults, unilateral (disector method) [millions] Original pre publication description: Cortex 1: Glenn Rosen Cortex 1: Glenn Rosen Central nervous system, morphology, stereology: Neuron number in cerebral neocortex of adults, bilateral (direct 3D counting method) [millions] x x 12.05 11.343 10.763 11.324 13.15 10.782 11.856 10.878 12.353 11.698 11.404 11.666 12.337 11.333 12.24 11.752 11.38 10.688 13.085 10.899 x 11.468 11.399 11.127 11.444 10.514 10.187 12.132 11.966 10.903 11.979 12.581 11.224 x 10.467 11.407 10.863 x 10.363 11.136 x 10.122 x x 11.996 x 12.07 10.617 x x x 11.294 11.503 x x x x 10.965 x 10.86 10.106 10.864 11.473 10.17 10.246 11.563 10.963 10.577 x 11.335 10.87 10.236 11.619 10.053 x 11.73 12.23 x x 11.056 12.24 10.073 11.775 11.549 x 9.953 12.177 x 10.782 12.574 x x 10.975 11.694 x x x x x x +13061 Original post publication description: Central nervous system, morphology, stereology: Non-neuronal cell number in cerebral neocortex of adults, unilateral (disector method) [millions] Original pre publication description: Cortex 2: Glenn Rosen Cortex 2: Glenn Rosen Central nervous system, morphology, stereology: Non-neuronal cell number in cerebral neocortex of adults, bilateral (direct 3D counting method) [millions] x x 8.309 7.024 6.74 7.139 7.949 7.299 7.091 6.963 8.081 8.13 7.606 7.631 8.215 7.327 7.21 7.208 7.352 7.155 8.132 7.379 x 6.859 7.019 6.995 7.95 6.404 6.718 8.32 7.078 6.873 7.124 7.899 6.592 x 6.405 6.944 7.105 x 6.743 8.139 x 6.985 x x 6.34 x 5.864 7.226 x x x 8.161 7.699 x x x x 7.152 x 7.161 6.856 7.142 7.251 6.676 7.587 7.25 7.245 7.98 x 7.868 6.251 7.152 5.766 7.256 x 6.178 7.781 x x 7.022 6.817 6.887 6.962 7.882 x 6.442 7.152 x 6.995 6.452 x x 4.856 7.849 x x x x x x +13062 Original post publication description: Central nervous system, morphology, stereology: Total cell number in cerebral neocortex of adults (neurons, glial cells, endothelial cells), unilateral (disector method) [millions] Original pre publication description: Cortex 3: Glenn Rosen Cortex 3: Glenn Rosen Central nervous system, morphology, stereology: Total cell number in cerebral neocortex of adults (neurons, glial cells, endothelial cells), bilateral (direct 3D counting method) [millions] x x 20.359 18.367 17.503 18.462 21.099 18.082 18.947 17.841 20.434 19.828 19.01 19.297 20.552 18.66 19.45 18.96 18.732 17.844 21.218 18.278 x 18.327 18.418 18.122 19.394 16.919 16.905 20.452 19.044 17.776 19.103 20.48 17.816 x 16.872 18.351 17.969 x 17.106 19.275 x 17.107 x x 18.336 x 17.934 17.843 x x x 19.455 19.202 x x x x 18.117 x 18.02 16.962 18.005 18.723 16.846 17.833 18.813 18.207 18.557 x 19.202 17.121 17.388 17.385 17.309 x 17.908 20.011 x x 18.078 19.057 16.959 18.737 19.431 x 16.395 19.329 x 17.777 19.026 x x 15.831 19.543 x x x x x x +15178 Original post publication description: Trait 4 Original pre publication description: Trait 4 Trait 4 Reproduction, development: Trait 4, SCNT Blastocysts/ 4 cell; lathamk1@msu.edu x 0.363 0.379 0.0 0.0 0.295 0.179 0.25 0.168 0.319 0.43 0.0 0.345 0.273 0.0 0.0 0.254 0.091 x 0.312 0.193 x x x x 0.379 0.329 0.058 x 0.556 0.215 0.0 0.266 x 0.544 x 0.069 0.278 0.242 x 0.107 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +15177 Original post publication description: Trait 3 Original pre publication description: Trait 3 Trait 3 Reproduction, development: Trait 3, SCNT Blastocysts/2 cell; lathamk1@msu.edu x 0.274 0.209 0.0 0.0 0.076 0.119 0.012 0.068 0.045 0.275 0.0 0.165 0.057 0.0 0.0 0.104 0.046 x 0.045 0.11 x x x x 0.237 0.087 0.01 x 0.052 0.08 0.0 0.139 x 0.175 x 0.043 0.012 0.161 x 0.07 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +15176 Original post publication description: Trait 2 Original pre publication description: Trait 2, klatham@temple.edu Reproduction, development: Trait 2 klatham@temple.edu Reproduction, development: Trait 2, SCNT 4cell/2cell; lathamk1@msu.edu x 0.66 0.536 0.43 0.0 0.205 0.523 0.012 0.281 0.15 0.642 0.153 0.539 0.174 0.04 0.152 0.421 0.497 x 0.147 0.545 x x x x 0.59 0.298 0.107 x 0.073 0.506 0.0 0.489 x 0.372 x 0.458 0.03 0.66 x 0.392 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +15175 Original post publication description: Trait1 entered at July/30 09:53:36 from IP 155.247.231.93 Original pre publication description: Trait 1, klatham@temple.edu Reproduction, development: Trait 1, lathamk1@msu.edu Reproduction, development: Trait 1, SCNT 2 cell/constructs; lathamk1@msu.edu x 0.873 0.683 0.647 0.596 0.754 0.774 0.382 0.807 0.977 0.798 0.116 0.571 0.712 0.806 0.82 0.66 0.844 x 0.852 0.774 x x x x 0.51 0.821 0.785 x 0.438 0.701 0.156 0.848 x 0.863 x 0.569 0.724 0.935 x 0.231 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +14803 Original post publication description: Nicotine Place Preference Scores for 0.5mg/kg nicotine on Day 5 of CPP Original pre publication description: Nicotine Place Preference Scores for 0.5mg/kg nicotine on Day 5 of CPP Central nervous system, pharmacology, behavior: Nicotine response (0.5 mg/kg nicotine), conditioned place preference (CPP) on day 5 Central nervous system, pharmacology, behavior: Nicotine response (0.5mg/kg, s.c., b.i.d., on days 2-4), conditioned place preference (CPP) on day 5 in 7-8-week old males [sec] x 4.4 96.82 -140.42 75.94 51.28 88.65 x -66.12 -36.37 -26.25 108.87 x 16.1 27.16 152.16 74.12 x -5.14 12.27 x x x x x 131.882 57.62 x x -25.15 -146.61 63.23 22.2 x -35.52 x 0.68 109.96 x x 24.15 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +14804 Original post publication description: Saline Place Preference Scores for 0.9% saline on Day 5 of CPP Original pre publication description: Saline Place Preference Scores for 0.9% saline on Day 5 of CPP Central nervous system, pharmacology, behavior: Saline control response (3 days of 0.9% sc) for nicotine experiment, conditioned place preference (CPP) on day 5 Central nervous system, pharmacology, behavior: Saline control response (0.9%, s.c., b.i.d., on days 2-4) for nicotine experiment, conditioned place preference (CPP) on day 5 in 7-8-week old males [sec] x x 47.25 -20.37 50.17 76.58 55.48 x 15.27 29.99 31.91 79.48 x -0.29 20.69 61.51 22.92 x 51.73 34.93 x x x x x 43.586 36.03 x x 80.23 90.8 61.64 72.4 x 15.1 x 23.32 98.67 x x 7.95 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +14805 Original post publication description: Nicotine Post-Conditioning Scores for 0.5mg/kg nicotine on Day 5 of CPP Original pre publication description: Nicotine Post-Conditioning Scores for 0.5mg/kg nicotine on Day 5 of CPP Central nervous system, pharmacology, behavior: Nicotine response (0.5mg/kg), post-conditioning conditioned place preference (CPP) scores on day 5 of conditioning [units] Central nervous system, pharmacology, behavior: Nicotine response (0.5mg/kg, s.c., b.i.d., on days 2-4), post-conditioning scores on day 5 in 7-8-week old males [sec] x 56.3 91.47 -203.74 77.74 68.24 5.46 x 20.66 -114.89 -37.58 124.87 x 22.84 -125.73 141.22 126.49 x -57.71 16.9 x x x x x 34.832 42.3 x x -146.82 -128.21 64.6 24.32 x -1.5 x 6.91 90.17 x x 52.37 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +14806 Original post publication description: Saline Post-Conditioning Scores for 0.9% saline on Day 5 of CPP Original pre publication description: Saline Post-Conditioning Scores for 0.9% saline on Day 5 of CPP Post-Conditioning Scores for 0.9% saline on Day 5 of CPP Post-Conditioning Scores for 0.9% saline on Day 5 of CPP x x 137.36 -41.56 87.0 -80.29 48.34 x -60.83 -100.75 -62.75 -138.73 x -29.4 49.88 -108.77 36.72 x -92.52 61.95 x x x x x -32.018 -151.41 x x -92.98 -35.55 -23.83 182.51 x -6.81 x -65.04 -15.73 x x -59.91 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +14801 Original post publication description: Musculoskeletal system: Hip cartilage matrix metallopeptidase 13 (Mmp13) mRNA transcript abundance in adult males and females (100 - 300-days-old) corrected for age and sex and normalized to beta actin, measured initially as 2^(–delta delta) cycle time [log residuals] entered at May/15 14:16:42 from IP 172.21.163.249 Original pre publication description: Musculoskeletal system: Hip cartilage matrix metallopeptidase 13 (Mmp13) Musculoskeletal system: Hip cartilage matrix metallopeptidase 13 (Mmp13) Musculoskeletal system: Hip cartilage matrix metallopeptidase 13 (Mmp13) mRNA transcript abundance in adult males and females (100 - 300-days-old) corrected for age and sex and normalized to beta actin, measured initially as 2^(–delta delta) cycle time [log residuals] x x 0.403 0.416 0.344 x x x x -0.207 -0.11 x x x x x x x x x x x x 0.027 x -0.618 x 0.11 x x x x x x x x 0.906 x x x 0.221 -0.091 x -0.269 x x -0.142 -0.05 -0.322 0.452 x x x -0.093 0.208 x x x 0.082 -0.039 -0.077 0.207 x -0.035 -0.093 0.107 -0.852 0.045 0.147 -0.203 x -0.292 x -0.128 x -0.102 -0.785 -0.209 0.001 x x 0.042 -0.101 0.073 0.115 x x 0.231 0.425 x 0.152 x x x 0.418 x 0.064 0.145 -0.083 0.049 0.029 -0.127 +14800 Original post publication description: Musculoskeletal system: Hip cartilage endothelial PAS domain protein 1 (Epas1) mRNA transcript abundance in adult males and females (100 - 300-days-old) corrected for age and sex and normalized to beta actin, measured initially as 2^(–delta delta) cycle time [log residuals] entered at May/15 14:16:42 from IP 172.21.163.249 Original pre publication description: Musculoskeletal system: Hip cartilage endothelial PAS domain protein 1 (Epas1) Musculoskeletal system: Hip cartilage endothelial PAS domain protein 1 (Epas1) Musculoskeletal system: Hip cartilage endothelial PAS domain protein 1 (Epas1) mRNA transcript abundance in adult males and females (100 - 300-days-old) corrected for age and sex and normalized to beta actin, measured initially as 2^(–delta delta) cycle time [log residuals] x x 0.018 0.354 0.174 x x x x 0.042 -0.078 x x x x x x x x x x x x 0.261 x -0.328 x 0.033 x x x x x x x x x x x x 0.157 -0.205 x -0.038 x x -0.105 -0.104 -0.123 0.072 x x x -0.114 0.121 x x x 0.036 -0.116 -0.096 0.151 x -0.017 -0.112 0.166 -0.384 0.098 -0.153 -0.048 x 0.063 x -0.16 x 0.017 -0.371 -0.039 0.041 x x 0.027 -0.01 0.218 0.225 x x 0.045 0.014 x 0.093 x x x 0.201 x -0.205 -0.033 -0.086 -0.094 0.033 0.03 +14799 Original post publication description: Musculoskeletal system: Hip cartilage cartilage oligomeric matrix protein (Comp) mRNA transcript abundance in adult males and females (100 - 300-days-old) corrected for age and sex and normalized to beta actin, measured initially as 2^(–delta delta) cycle time [log residuals] entered at May/15 14:16:42 from IP 172.21.163.249 Original pre publication description: Musculoskeletal system: Hip cartilage cartilage oligomeric matrix protein (Comp) Musculoskeletal system: Hip cartilage cartilage oligomeric matrix protein (Comp), Chr8: 72.905142 Musculoskeletal system: Hip cartilage cartilage oligomeric matrix protein (Comp) mRNA transcript abundance in adult males and females (100 - 300-days-old) corrected for age and sex and normalized to beta actin, measured initially as 2^(–delta delta) cycle time [log residuals] x x 0.233 0.606 0.062 x x x x -0.391 -0.569 x x x x x x x x x x x x 0.311 x -0.306 x 0.412 x x x x x x x x x x x x -0.077 -0.726 x 0.32 x x -0.196 -0.656 -0.247 -0.232 x x x -0.081 0.284 x x x -0.128 -0.304 0.246 0.724 x 0.331 -0.304 0.818 -0.71 -0.025 -0.268 -0.097 x -0.133 x -0.39 x 0.152 -0.318 0.039 0.364 x x -0.195 -0.399 0.327 0.722 x x 0.007 0.502 x 0.46 x x x 0.397 x 0.098 -0.118 -0.416 -0.308 -0.29 0.199 +14797 Original post publication description: Musculoskeletal system: Hip cartilage aggrecan 1 (Agc1) mRNA transcript abundance in adult males and females (100 - 300-days-old) corrected for age and sex and normalized to beta actin, measured initially as 2^(–delta delta) cycle time [log residuals] Original pre publication description: Musculoskeletal system: Hip cartilage aggrecan 1 (Agc1) Musculoskeletal system: Hip cartilage aggrecan 1 (Acan) Musculoskeletal system: Hip cartilage aggrecan 1 (Acan, Agc1, Chr7 at 86.2 Mb) mRNA transcript abundance in adult males and females (100 - 300-days-old) corrected for age and sex and normalized to beta actin, measured initially as 2^(–delta delta) cycle time [log residuals] x x -0.208 0.873 0.234 x x x x 0.222 -0.426 x x x x x x x x x x x x 0.728 x -0.854 x 0.1 x x x x x x x x -0.079 x x x 0.101 -0.712 x -0.096 x x -0.293 -0.969 -0.243 -0.309 x x x -0.492 -0.029 x x x -0.055 -0.317 0.227 0.681 x 0.264 -0.191 0.72 -0.864 -0.005 -0.428 -0.031 x -0.123 x -0.191 x 0.036 -0.972 -0.03 0.621 x x 0.143 -0.26 0.42 0.52 x x 0.272 0.528 x 0.372 x x x 0.46 x -0.072 0.147 -0.439 -0.462 -0.253 0.514 +14794 Original post publication description: Central nervous system, behavior, sleep: Sleep percent in 10-14 week-old males [% day] Original pre publication description: Central nervous system, behavior, sleep: Bruce 1, Contact Bruce O'Hara Central nervous system, behavior, sleep: Bruce 1, Contact Bruce O'Hara Central nervous system, behavior, sleep: Sleep percent in 10-14 week-old males [% day] x x 10.0 20.0 20.0 30.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +14793 Original post publication description: Central nervous system, behavior: R6 soluble minus WT soluble protein by FRET ratio in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, [FRETT florescence ratio] Original pre publication description: Central nervous system, behavior: R6 soluble minus WT soluble protein by FRET ratio in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, [FRETT florescence ratio] Central nervous system, behavior: R6 soluble minus WT soluble protein by FRET ratio in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, [FRETT florescence ratio] Central nervous system, behavior: R6 soluble minus WT soluble protein by FRET ratio in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, [FRETT florescence ratio] x 1485.5 1357.4 x x 1741.5 1447.7 1420.1 x 1368.3 1337.0 1489.6 x 1458.6 x x 1411.6 x 1527.7 x 1451.4 x x x x x 1482.7 x x 1358.7 x x 1447.2 x x x x 1516.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +14792 Original post publication description: Central nervous system, behavior: R62 aggregate/WT aggregate protein by FRET ratio in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, [FRETT florescence ratio] Original pre publication description: Central nervous system, behavior: R62 aggregate/WT aggregate protein by FRET ratio in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, [FRETT florescence ratio] Central nervous system, behavior: R62 aggregate/WT aggregate protein by FRET ratio in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, [FRETT florescence ratio] Central nervous system, behavior: R62 aggregate/WT aggregate protein by FRET ratio in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, [FRETT florescence ratio] x 372.0 161.4 x x 134.6 127.2 150.1 x 145.6 188.1 133.6 x 137.6 x x 145.6 x 155.7 x 237.9 x x x x x 267.6 x x 133.1 x x 119.3 x x x x 98.3 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +14791 Original post publication description: Central nervous system, behavior: R62 soluble/WT soluble protein by FRET ratio in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, [FRETT florescence ratio] Original pre publication description: Central nervous system, behavior: R62 soluble/WT soluble protein by FRET ratio in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, [FRETT florescence ratio] Central nervous system, behavior: R62 soluble/WT soluble protein by FRET ratio in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, [FRETT florescence ratio] Central nervous system, behavior: R62 soluble/WT soluble protein by FRET ratio in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, [FRETT florescence ratio] x 190.1 163.1 x x 95.4 102.0 106.7 x 190.1 125.1 123.8 x 163.7 x x 141.4 x 171.2 x 152.6 x x x x x 104.9 x x 131.3 x x 154.5 x x x x 113.4 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +14802 Original post publication description: Musculoskeletal system, dentition: Malocclusion of incisors in females on high and low fat diet [percent cases] Original pre publication description: Musculoskeletal system, dentition: Malocclusion of incisors in females on 60% high fat diet [percent cases] Musculoskeletal system, orofacial system, dentition: Malocclusion of incisors in females on 60% high fat diet [% cases] Musculoskeletal system, orofacial system, dentition: Malocclusion of incisors in females on 60% high fat diet [% cases] x x x x x x x x x 0.0 0.0 50.0 33.3 x x x x x x x x x x x x 0.0 x x x x x x x x x x x x x x x 0.0 x x x x 100.0 x x x x x x x 100.0 x x x 0.0 75.0 x 0.0 x x 25.0 100.0 x x 100.0 x x 0.0 100.0 x x 0.0 x x x 0.0 x 0.0 x 0.0 0.0 60.0 x 0.0 0.0 x 33.3 x x x 0.0 x 50.0 x x x 100.0 0.0 +14796 Original post publication description: Liver, metabolism, toxicology: Acetaminophen hepatocyte viability response 9 hr after treatment (0.5 mM in vehicle), lactate dehydrogenase (LDH) release assay adjusted for DNA content, young adult male liver [log2 LDH/DNA ratio treated/control] Original pre publication description: Liver, metabolism, toxicology: CQ-14b(Log2) Liver, metabolism, toxicology: Acetaminophen hepatocyte viability response 9 hr after treatment (0.5 mM in vehicle), lactate dehydrogenase (LDH) release assay adjusted for DNA content, young adult male liver [log2 LDH/DNA ratio treated/control] Liver, metabolism, toxicology: Acetaminophen hepatocyte viability response 9 hr after treatment (0.5 mM in vehicle), lactate dehydrogenase (LDH) release assay adjusted for DNA content, young adult male liver [log2 LDH/DNA ratio treated/control] x x -0.934 0.701 0.302 -0.361 0.97 -0.04 x x 0.307 x 0.98 -0.632 0.593 -0.463 -0.682 0.934 x -0.633 -1.193 x x x x -0.614 -1.425 0.754 x 1.282 -0.186 x x x x x -0.518 0.516 -0.596 x -0.468 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +14798 Original post publication description: Musculoskeletal system: Hip cartilage collagen, type II, alpha 1 (Col2a1) mRNA transcript abundance in adult males and females (100 - 300-days-old) corrected for age and sex and normalized to beta actin, measured initially as 2^(–delta delta) cycle time [log residuals] entered at May/15 14:16:42 from IP 172.21.163.249 Original pre publication description: Musculoskeletal system: Hip cartilage collagen, type II alpha 1 (Col2a1) Musculoskeletal system: Hip cartilage collagen, type II alpha 1 (Col2a1) Musculoskeletal system: Hip cartilage collagen, type II, alpha 1 (Col2a1) mRNA transcript abundance in adult males and females (100 - 300-days-old) corrected for age and sex and normalized to beta actin, measured initially as 2^(–delta delta) cycle time [log residuals] x x 0.244 0.377 0.782 x x x x 0.633 0.188 x x x x x x x x x x x x 0.429 x -0.298 x 0.64 x x x x x x x x -0.275 x x x 0.821 -0.202 x -0.314 x x -0.15 0.113 0.065 0.139 x x x -0.254 0.341 x x x -0.478 -0.452 -0.067 0.972 x 0.31 -0.153 0.359 -1.185 -0.257 -0.308 -0.102 x -0.706 x -0.637 x -0.428 -0.746 0.311 0.37 x x 0.031 -0.655 0.264 0.828 x x -0.054 0.212 x 0.465 x x x 0.035 x -0.145 0.798 0.186 0.206 -0.23 -0.151 +14790 Original post publication description: un-named trait Morphology, development, lung: Metzger 1 Morphology, development, lung: Metzger 1 0.0 0.0 1.0 0.0 1.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +14789 Original post publication description: Central nervous system, behavior: R6/2 soluble/WT soluble protein by FRET ratio in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, [FRETT florescence ratio] Original pre publication description: Central nervous system, behavior: R6/2 soluble/WT soluble protein by FRET ratio in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, [FRETT florescence ratio] Central nervous system, behavior: R6/2 soluble/WT soluble protein by FRET ratio in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, [FRETT florescence ratio] Central nervous system, behavior: R6/2 soluble/WT soluble protein by FRET ratio in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, [FRETT florescence ratio] x 190.1 163.1 x x 95.4 x x x x 125.1 123.8 x 162.7 x x 141.4 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +14788 Original post publication description: Central nervous system, morphology:Midsagittal area of the corpus callosum corrected for shrinkage [mm2] Original pre publication description: Central nervous system, morphology: MSACC corrected for shrinkage [mm2] Central nervous system, morphology: MSACC corrected for shrinkage [mm2] Central nervous system, morphology:Midsagittal area of the corpus callosum corrected for shrinkage [mm2] x x 1.251 0.767 1.136 0.884 0.967 0.907 0.92 1.242 1.346 0.994 0.975 1.027 1.338 0.998 0.801 0.809 1.013 1.201 0.875 1.19 x 0.885 0.788 0.776 0.74 0.905 0.767 1.105 0.974 1.28 0.773 1.045 0.888 x 0.695 1.072 1.242 x 1.167 1.2 1.191 1.135 x x 1.078 x 1.08 0.996 x x x 1.748 1.128 x x x 1.244 1.235 1.16 1.177 1.294 0.993 1.105 1.32 1.119 1.279 0.993 1.168 x 1.147 0.83 1.171 0.998 1.349 0.825 1.439 1.261 x x 1.244 0.925 1.118 1.47 1.215 x 1.125 1.203 1.322 1.237 1.386 x x 1.177 1.124 1.008 1.573 x x x x +13346 Original post publication description: Central nervous system, behavior: Acoustic startle response for males, 100 db white noise pulse, average of 10 trials, 40 ms pulse duration, 75 dB background noise, Med Associates startle chamber [force] None Central nervous system, behavior: Acoustic startle response for males, 100 db white noise pulse, average of 10 trials, 40 ms pulse duration, 75 dB background noise, Med Associates startle chamber [force] 382.208 307.731 715.778 192.722 755.056 269.952 260.45 755.262 214.943 x x x 725.781 420.837 212.783 132.163 x x x x x 65.3449 x 128.663 x x 469.234 157.92 x x 415.435 265.03 328.229 x x x 564.831 173.372 232.206 x 167.226 395.191 x x x x x x x 324.938 x x x 205.192 x x x x x 565.839 779.044 x x 821.047 x x 308.621 98.5673 x x x 112.399 x 145.904 x x x x x x x x x x 145.5 295.366 x x 327.841 x x x x x 919.682 1414.75 x x x x x x +13347 Original post publication description: Central nervous system, behavior: Acoustic startle response for males, 105 db white noise pulse, average of 10 trials, 40 ms pulse duration, 75 dB background noise, Med Associates startle chamber [force] None Central nervous system, behavior: Acoustic startle response for males, 105 db white noise pulse, average of 10 trials, 40 ms pulse duration, 75 dB background noise, Med Associates startle chamber [force] 441.519 400.113 925.86 281.122 1189.67 383.699 364.523 991.012 224.71 x x x 913.212 695.937 319.273 282.871 x x x x x 65.1949 x 280.743 x x 552.576 323.508 x x 568.935 426.465 416.247 x x x 588.431 329.131 266.576 x 235.696 461.684 x x x x x x x 647.43 x x x 263.979 x x x x x 637.903 959.98 x x 984.797 x x 410.298 169.155 x x x 157.806 x 239.784 x x x x x x x x x x 152.409 502.957 x x 457.414 x x x x x 1130.7 1619.9 x x x x x x +13348 Original post publication description: Central nervous system, behavior: Acoustic startle response for males, 110 db white noise pulse, average of 10 trials, 40 ms pulse duration, 75 dB background noise, Med Associates startle chamber [force] None Central nervous system, behavior: Acoustic startle response for males, 110 db white noise pulse, average of 10 trials, 40 ms pulse duration, 75 dB background noise, Med Associates startle chamber [force] 396.163 407.886 1091.17 378.0 1434.66 444.332 463.523 1139.57 272.563 x x x 1124.55 863.103 459.663 425.038 x x x x x 58.6699 x 523.383 x x 684.919 670.633 x x 597.96 559.037 372.811 x x x 560.948 349.489 323.206 x 243.696 624.316 x x x x x x x 710.672 x x x 279.142 x x x x x 754.384 1014.39 x x 1160.4 x x 571.752 305.305 x x x 267.045 x 276.874 x x x x x x x x x x 176.745 696.741 x x 510.159 x x x x x 1083.22 1764.63 x x x x x x +13349 Original post publication description: Central nervous system, behavior: Acoustic startle response for males, 115 db white noise pulse, average of 10 trials, 40 ms pulse duration, 75 dB background noise, Med Associates startle chamber [force] None Central nervous system, behavior: Acoustic startle response for males, 115 db white noise pulse, average of 10 trials, 40 ms pulse duration, 75 dB background noise, Med Associates startle chamber [force] 381.086 421.895 1199.87 344.622 1469.93 492.879 473.341 1135.33 343.457 x x x 1237.26 1063.55 550.233 546.138 x x x x x 78.0824 x 809.383 x x 609.819 891.858 x x 910.548 759.48 447.756 x x x 510.465 467.797 386.496 x 267.656 750.928 x x x x x x x 834.938 x x x 357.885 x x x x x 757.212 1096.24 x x 1297.08 x x 637.452 490.93 x x x 344.306 x 322.164 x x x x x x x x x x 246.5 911.232 x x 699.741 x x x x x 1156.02 1797.17 x x x x x x +13350 Original post publication description: Central nervous system, behavior: Acoustic startle response for males, 120 db white noise pulse, average of 10 trials, 40 ms pulse duration, 75 dB background noise, Med Associates startle chamber [force] None Central nervous system, behavior: Acoustic startle response for males, 120 db white noise pulse, average of 10 trials, 40 ms pulse duration, 75 dB background noise, Med Associates startle chamber [force] 377.626 429.34 1102.62 542.593 1563.14 558.821 539.614 1237.38 318.997 x x x 1201.9 1097.68 634.476 614.366 x x x x x 79.2866 x 811.679 x x 709.572 1139.87 x x 852.731 802.303 482.268 x x x 477.654 522.722 443.316 x 253.626 856.447 x x x x x x x 860.494 x x x 333.8 x x x x x 796.754 1191.14 x x 1435.31 x x 704.264 547.326 x x x 427.332 x 320.75 x x x x x x x x x x 255.354 819.196 x x 842.49 x x x x x 1219.68 1782.98 x x x x x x +13351 Original post publication description: Central nervous system, behavior: Acoustic startle response for males, 65 db white noise pulse, average of 10 trials, 40 ms pulse duration, 75 dB background noise, Med Associates startle chamber [force] None Central nervous system, behavior: Acoustic startle response for males, 65 db white noise pulse, average of 10 trials, 40 ms pulse duration, 75 dB background noise, Med Associates startle chamber [force] -2.78095 3.44026 9.09647 0.911111 14.0096 -10.7147 5.57774 4.03674 -3.3566 x x x 21.9559 9.4034 -1.61714 0.021429 x x x x x -6.8551 x -0.147347 x x -0.523615 14.3202 x x 2.2602 4.92959 7.61058 x x x 8.99796 0.539116 19.4559 x -4.76429 -2.54681 x x x x x x x 14.8551 x x x -1.97717 x x x x x 4.18442 0.152876 x x 5.55493 x x 15.7516 -0.032653 x x x -0.508948 x -1.82633 x x x x x x x x x x -2.57291 -0.967517 x x 24.0503 x x x x x -9.05935 12.3663 x x x x x x +13352 Original post publication description: Central nervous system, behavior: Acoustic startle response for males, 70 db white noise pulse, average of 10 trials, 40 ms pulse duration, 75 dB background noise, Med Associates startle chamber [force] None Central nervous system, behavior: Acoustic startle response for males, 70 db white noise pulse, average of 10 trials, 40 ms pulse duration, 75 dB background noise, Med Associates startle chamber [force] 18.4302 9.3948 5.07829 4.01111 13.0403 -3.75469 0.032282 13.6451 -3.60993 x x x 25.3746 21.4617 8.80286 -1.8869 x x x x x 7.9574 x -3.01735 x x 0.790671 1.79515 x x 5.21645 7.67245 -1.3167 x x x -10.8187 -1.26922 24.5359 x -1.02429 0.596939 x x x x x x x 6.02177 x x x 6.77908 x x x x x 30.5481 -0.374397 x x 7.95493 x x 26.244 1.64235 x x x -0.424333 x -5.07633 x x x x x x x x x x -0.34564 3.65748 x x 29.8321 x x x x x -3.67602 12.583 x x x x x x +13353 Original post publication description: Central nervous system, behavior: Acoustic startle response for males, 75 db white noise pulse, average of 10 trials, 40 ms pulse duration, 75 dB background noise, Med Associates startle chamber [force] None Central nervous system, behavior: Acoustic startle response for males, 75 db white noise pulse, average of 10 trials, 40 ms pulse duration, 75 dB background noise, Med Associates startle chamber [force] 26.0968 32.0039 18.9328 1.46667 4.64804 10.4253 -3.82226 35.1867 0.370068 x x x 51.6934 24.0284 12.9029 2.60476 x x x x x 29.2324 x -3.11735 x x 16.7478 16.2827 x x 18.6352 21.3224 16.3924 x x x -6.56871 6.32245 20.8859 x -7.18429 23.0719 x x x x x x x 21.7051 x x x -0.027168 x x x x x 70.6844 14.7438 x x 20.2133 x x 34.0516 9.37985 x x x 1.99874 x 9.00367 x x x x x x x x x x 17.5271 12.6325 x x 42.4776 x x x x x 20.024 14.8163 x x x x x x +13354 Original post publication description: Central nervous system, behavior: Acoustic startle response for males, 80 db white noise pulse, average of 10 trials, 40 ms pulse duration, 75 dB background noise, Med Associates startle chamber [force] None Central nervous system, behavior: Acoustic startle response for males, 80 db white noise pulse, average of 10 trials, 40 ms pulse duration, 75 dB background noise, Med Associates startle chamber [force] 62.6857 52.813 37.8056 11.0556 12.5711 17.012 19.0414 102.453 2.1834 x x x 89.8434 25.8201 10.7129 -8.27024 x x x x x 27.2074 x 2.74265 x x 17.9907 9.09515 x x 17.3665 17.7939 25.3378 x x x 3.03129 19.5808 37.6059 x -2.04429 59.5219 x x x x x x x 44.1218 x x x 0.847832 x x x x x 101.83 33.0711 x x 55.2466 x x 59.444 14.3423 x x x 6.29874 x 24.4737 x x x x x x x x x x 19.3089 14.4158 x x 57.0866 x x x x x 47.499 98.4997 x x x x x x +13355 Original post publication description: Central nervous system, behavior: Acoustic startle response for males, 85 db white noise pulse, average of 10 trials, 40 ms pulse duration, 75 dB background noise, Med Associates startle chamber [force] None Central nervous system, behavior: Acoustic startle response for males, 85 db white noise pulse, average of 10 trials, 40 ms pulse duration, 75 dB background noise, Med Associates startle chamber [force] 85.3079 78.2494 77.9419 31.5222 16.1019 54.2786 25.2414 244.353 29.8301 x x x 115.162 47.9951 28.0129 -11.0286 x x x x x 36.8949 x -1.45735 x x 23.505 15.7202 x x 65.6165 60.7367 56.0288 x x x 16.0313 49.1058 81.0159 x 25.1857 82.1594 x x x x x x x 65.3134 x x x 13.7728 x x x x x 181.812 57.0529 x x 146.872 x x 104.813 19.7548 x x x 16.368 x 28.8037 x x x x x x x x x x 61.2907 38.0075 x x 88.4957 x x x x x 158.024 150.666 x x x x x x +13356 Original post publication description: Central nervous system, behavior: Acoustic startle response for males, 90 db white noise pulse, average of 10 trials, 40 ms pulse duration, 75 dB background noise, Med Associates startle chamber [force] None Central nervous system, behavior: Acoustic startle response for males, 90 db white noise pulse, average of 10 trials, 40 ms pulse duration, 75 dB background noise, Med Associates startle chamber [force] 192.752 197.304 216.042 63.2 72.048 55.2453 50.5959 427.112 72.7034 x x x 262.156 88.3034 74.0829 3.88809 x x x x x 48.1824 x 3.04265 x x 96.7764 44.1702 x x 100.173 100.565 124.265 x x x 82.2313 57.7225 134.886 x 99.2457 152.141 x x x x x x x 116.605 x x x 63.6103 x x x x x 266.03 226.017 x x 390.663 x x 180.09 35.4548 x x x 27.8218 x 68.1937 x x x x x x x x x x 114.791 95.4492 x x 165.505 x x x x x 344.382 428.416 x x x x x x +13357 Original post publication description: Central nervous system, behavior: Acoustic startle response for males, 95 db white noise pulse, average of 10 trials, 40 ms pulse duration, 75 dB background noise, Med Associates startle chamber [force] None Central nervous system, behavior: Acoustic startle response for males, 95 db white noise pulse, average of 10 trials, 40 ms pulse duration, 75 dB background noise, Med Associates startle chamber [force] 283.397 243.595 436.015 143.111 214.202 140.852 169.123 640.045 127.03 x x x 473.8 194.345 115.133 26.8131 x x x x x 65.7074 x 18.7327 x x 312.162 76.0077 x x 209.548 169.18 242.438 x x x 176.981 122.422 176.276 x 135.436 266.047 x x x x x x x 241.872 x x x 133.435 x x x x x 446.366 470.098 x x 617.622 x x 268.359 73.9548 x x x 60.1526 x 88.2337 x x x x x x x x x x 128.618 191.216 x x 276.214 x x x x x 612.257 922.616 x x x x x x +13358 Original post publication description: Central nervous system, behavior: Prepulse inhibition of acoustic starte response for males, prepulse intensity 10 dB below startle threshold, 20 ms white noise prepulse, 40 ms 120 dB white noise pulse, 60 ms prepulse-pulse onset interval, 75 dB background noise, Med Associates startle chamber [%] None Central nervous system, behavior: Prepulse inhibition of acoustic starte response for males, prepulse intensity 10 dB below startle threshold, 20 ms white noise prepulse, 40 ms 120 dB white noise pulse, 60 ms prepulse-pulse onset interval, 75 dB background noise, Med Associates startle chamber [%] 65.9778 68.6224 54.6888 53.1348 x 79.1614 57.8942 x 80.4647 x x x 52.7166 52.9969 75.8969 60.1899 x x x x x 62.2352 x 68.3288 x x 64.468 74.3049 x x 60.246 61.6684 72.9968 x x x 50.1803 62.5145 63.0393 x 58.1836 78.0346 x x x x x x x 67.3539 x x x 79.8955 x x x x x 70.7585 52.169 x x 74.792 x x 82.1751 67.3598 x x x 82.5733 x 62.0206 x x x x x x x x x x 70.8317 78.7242 x x 58.1782 x x x x x 87.4171 x x x x x x x +13359 Original post publication description: Central nervous system, behavior: Prepulse inhibition of acoustic starte response for males, prepulse intensity 65 dB, 20 ms white noise prepulse, 40 ms 120 dB white noise pulse, 60 ms prepulse-pulse onset interval, 75 dB background noise, Med Associates startle chamber [%] None Central nervous system, behavior: Prepulse inhibition of acoustic starte response for males, prepulse intensity 65 dB, 20 ms white noise prepulse, 40 ms 120 dB white noise pulse, 60 ms prepulse-pulse onset interval, 75 dB background noise, Med Associates startle chamber [%] 43.117 57.5775 32.6451 19.5275 x 55.162 28.4076 x 69.9467 x x x 39.4635 31.7891 33.4971 6.98185 x x x x x 45.5609 x 20.3974 x x 30.5944 48.3531 x x 11.8689 28.3759 55.5333 x x x 34.302 43.2264 45.6141 x 47.3866 57.8806 x x x x x x x 25.9346 x x x 61.9751 x x x x x 60.8657 30.9863 x x 56.5985 x x 62.5242 47.3231 x x x 43.4051 x 57.2907 x x x x x x x x x x 52.184 59.8378 x x 40.5147 x x x x x 45.9218 x x x x x x x +13360 Original post publication description: Central nervous system, behavior: Prepulse inhibition of acoustic starte response for males, prepulse intensity 70 dB, 20 ms white noise prepulse, 40 ms 120 dB white noise pulse, 60 ms prepulse-pulse onset interval, 75 dB background noise, Med Associates startle chamber [%] None Central nervous system, behavior: Prepulse inhibition of acoustic starte response for males, prepulse intensity 70 dB, 20 ms white noise prepulse, 40 ms 120 dB white noise pulse, 60 ms prepulse-pulse onset interval, 75 dB background noise, Med Associates startle chamber [%] 56.5044 65.8379 46.2731 31.4974 x 58.5375 35.2957 x 74.976 x x x 49.3294 32.6946 53.8192 8.02341 x x x x x 23.1303 x 27.9424 x x 33.4863 50.6034 x x 22.5011 46.3026 60.3252 x x x 41.4239 46.7399 52.2273 x 51.0168 57.9787 x x x x x x x 33.5521 x x x 66.2089 x x x x x 65.3252 42.6441 x x 58.3317 x x 73.2073 53.5126 x x x 61.3865 x 62.9406 x x x x x x x x x x 63.9713 68.4832 x x 50.0048 x x x x x 63.7027 x x x x x x x +13361 Original post publication description: Central nervous system, behavior: Prepulse inhibition of acoustic starte response for males, prepulse intensity 75 dB, 20 ms white noise prepulse, 40 ms 120 dB white noise pulse, 60 ms prepulse-pulse onset interval, 75 dB background noise, Med Associates startle chamber [%] None Central nervous system, behavior: Prepulse inhibition of acoustic starte response for males, prepulse intensity 75 dB, 20 ms white noise prepulse, 40 ms 120 dB white noise pulse, 60 ms prepulse-pulse onset interval, 75 dB background noise, Med Associates startle chamber [%] 75.2453 72.6888 46.8179 42.4904 x 79.8942 52.4181 x 76.6211 x x x 55.7052 40.2159 65.6251 13.4468 x x x x x 21.183 x 32.8933 x x 48.1406 59.8987 x x 36.2659 57.1702 74.0278 x x x 48.5587 58.6324 60.7314 x 68.7968 76.8194 x x x x x x x 44.2997 x x x 75.4393 x x x x x 78.6096 55.5403 x x 67.2861 x x 77.7321 62.5809 x x x 64.6551 x 69.3516 x x x x x x x x x x 70.4359 70.2635 x x 53.1137 x x x x x 80.7338 x x x x x x x +13362 Original post publication description: Central nervous system, behavior: Prepulse inhibition of acoustic starte response for males, prepulse intensity 80 dB, 20 ms white noise prepulse, 40 ms 120 dB white noise pulse, 60 ms prepulse-pulse onset interval, 75 dB background noise, Med Associates startle chamber [%] None Central nervous system, behavior: Prepulse inhibition of acoustic starte response for males, prepulse intensity 80 dB, 20 ms white noise prepulse, 40 ms 120 dB white noise pulse, 60 ms prepulse-pulse onset interval, 75 dB background noise, Med Associates startle chamber [%] 72.4039 66.4171 56.0335 40.9981 x 81.9604 51.3066 x 79.279 x x x 62.6147 52.7366 64.4486 11.7144 x x x x x 39.1047 x 45.0939 x x 53.8586 59.7833 x x 46.1477 60.2431 73.6666 x x x 45.0398 57.1598 50.2924 x 61.7846 78.5572 x x x x x x x 56.3207 x x x 77.9137 x x x x x 78.6219 58.4722 x x 78.6582 x x 80.3017 69.0673 x x x 68.3489 x 64.9978 x x x x x x x x x x 66.2297 80.676 x x 62.8885 x x x x x 83.8537 x x x x x x x +13363 Original post publication description: Central nervous system, behavior, cognition: Response accuracy, measure of attention in the 5-choice serial reaction time task (5CSRT), Med Associates 5-hole operant chambers, high value = good performance [%] None Central nervous system, behavior, cognition: Response accuracy, measure of attention in the 5-choice serial reaction time task (5CSRT), Med Associates 5-hole operant chambers, high value = good performance [%] 88.024 88.03 85.4002 84.0182 81.0886 77.2932 x 80.2533 x 88.8599 86.8307 x 83.6821 87.5787 81.5931 73.1448 x 78.6071 x 85.4253 x 84.7057 x 82.9782 x 81.595 86.1814 83.9659 x 86.9866 73.2228 87.2761 88.8636 x x x 81.2007 89.6141 83.0772 x 88.8617 83.0561 x x x x x x x 84.2119 x x x 90.2168 x x x x x 88.3626 91.5259 x x 87.0317 x x 77.6037 80.7893 x x x 86.3884 x 86.4651 x x x x x x x x x x 88.153 89.3044 x x 69.0123 x x x x x 81.0584 88.5034 x x x x x x +13364 Original post publication description: Central nervous system, behavior, cognition: Errors of omission, measure of attention/motivation in the 5-choice serial reaction time task (5CSRT), Med Associates 5-hole operant chambers, low value = good performance [%] None Central nervous system, behavior, cognition: Errors of omission, measure of attention/motivation in the 5-choice serial reaction time task (5CSRT), Med Associates 5-hole operant chambers, low value = good performance [%] 55.5575 45.4849 50.0506 49.0978 41.6667 53.15 x 51.2636 x 58.295 38.5841 x 49.5547 50.8488 56.8234 53.5191 x 43.5916 x 43.6575 x 58.0978 x 57.3426 x 35.0188 47.8876 60.5648 x 44.1828 58.4305 54.6428 54.7703 x x x 37.3168 57.8335 56.8533 x 52.8864 51.4022 x x x x x x x 42.2218 x x x 57.3249 x x x x x 40.4303 52.8256 x x 40.1452 x x 45.3682 43.2294 x x x 52.6427 x 53.2198 x x x x x x x x x x 59.5597 48.7437 x x 58.615 x x x x x 43.3469 45.625 x x x x x x +13365 Original post publication description: Central nervous system, behavior, cognition: Mean correct response latency, measure of attention/motivation/motor function in the 5-choice serial reaction time task (5CSRT), Med Associates 5-hole operant chambers, low value = faster [s] None Central nervous system, behavior, cognition: Mean correct response latency, measure of attention/motivation/motor function in the 5-choice serial reaction time task (5CSRT), Med Associates 5-hole operant chambers, low value = faster [s] 0.994983 0.846152 0.826474 0.917111 0.980806 1.07461 x 0.892184 x 0.914058 0.961635 x 0.930905 0.9295 1.01717 1.01419 x 1.22608 x 0.897747 x 1.0888 x 0.968544 x 1.04714 1.16037 1.01618 x 1.00293 1.13263 0.996089 1.14303 x x x 1.01652 0.943766 0.911038 x 0.853759 0.876475 x x x x x x x 0.887883 x x x 0.831325 x x x x x 0.833536 0.789666 x x 1.01108 x x 0.871041 0.917328 x x x 1.16945 x 0.952281 x x x x x x x x x x 1.1703 0.862446 x x 1.29953 x x x x x 0.971128 0.998622 x x x x x x +13366 Original post publication description: Central nervous system, behavior, cognition: Mode of correct response latencies, measure of processing speed/motor function in the 5-choice serial reaction time task (5CSRT), Med Associates 5-hole operant chambers, low value = faster [s] None Central nervous system, behavior, cognition: Mode of correct response latencies, measure of processing speed/motor function in the 5-choice serial reaction time task (5CSRT), Med Associates 5-hole operant chambers, low value = faster [s] 0.661533 0.584194 0.538814 0.6554 0.711909 0.723596 x 0.616229 x 0.665185 0.731738 x 0.646379 0.695606 0.802273 0.689444 x 0.853571 x 0.583104 x 0.86074 x 0.635917 x 0.716944 0.923667 0.729929 x 0.718 0.774903 0.72231 0.867256 x x x 0.749852 0.7025 0.674508 x 0.634528 0.601178 x x x x x x x 0.613944 x x x 0.623667 x x x x x 0.562233 0.595917 x x 0.768667 x x 0.589639 0.633472 x x x 0.888048 x 0.716236 x x x x x x x x x x 0.893083 0.624778 x x 0.876714 x x x x x 0.68825 0.769389 x x x x x x +13367 Original post publication description: Central nervous system, behavior, cognition: Standard deviation of correct response latencies, measure of lapses in attention/motivation in the 5-choice serial reaction time task (5CSRT), Med Associates 5-hole operant chambers, low value = better performance [s] None Central nervous system, behavior, cognition: Standard deviation of correct response latencies, measure of lapses in attention/motivation in the 5-choice serial reaction time task (5CSRT), Med Associates 5-hole operant chambers, low value = better performance [s] 0.611188 0.541374 0.528164 0.569068 0.506052 0.687859 x 0.568218 x 0.457572 0.51579 x 0.576225 0.470685 0.492817 0.708137 x 0.632652 x 0.569075 x 0.599769 x 0.651596 x 0.658887 0.619917 0.603861 x 0.591735 0.723933 0.530922 0.582113 x x x 0.597666 0.518896 0.480044 x 0.485109 0.550638 x x x x x x x 0.522143 x x x 0.425338 x x x x x 0.494154 0.400127 x x 0.575321 x x 0.573143 0.610262 x x x 0.630086 x 0.52968 x x x x x x x x x x 0.590415 0.485964 x x 0.824235 x x x x x 0.557196 0.566831 x x x x x x +13368 Original post publication description: Central nervous system, behavior, cognition: Mean latency to retrieve food pellet, measure of motivation in the 5-choice serial reaction time task (5CSRT), Med Associates 5-hole operant chambers, high value = low motivation [s] None Central nervous system, behavior, cognition: Mean latency to retrieve food pellet, measure of motivation in the 5-choice serial reaction time task (5CSRT), Med Associates 5-hole operant chambers, high value = low motivation [s] 3.23107 2.28585 2.34962 2.51732 2.49107 3.1134 x 2.40557 x 2.33016 2.15208 x 2.36702 2.71318 2.59887 2.48233 x 4.20857 x 2.85759 x 3.3886 x 3.56041 x 2.21289 2.685 4.47298 x 2.46307 2.38549 2.18486 2.67439 x x x 2.27875 2.92457 2.87834 x 2.22727 3.52675 x x x x x x x 2.25333 x x x 3.14587 x x x x x 2.18931 2.31359 x x 2.40142 x x 2.66319 2.04977 x x x 3.31886 x 2.4524 x x x x x x x x x x 3.16395 2.10292 x x 4.19956 x x x x x 2.50386 2.17456 x x x x x x +13369 Original post publication description: Central nervous system, behavior, cognition: Number of completed trials in a 25 min session, measure of motivation in the 5-choice serial reaction time task (5CSRT), Med Associates 5-hole operant chambers, low value = low motivation [n] None Central nervous system, behavior, cognition: Number of completed trials in a 25 min session, measure of motivation in the 5-choice serial reaction time task (5CSRT), Med Associates 5-hole operant chambers, low value = low motivation [n] 53.24 58.7333 59.3588 57.63 57.3045 52.5895 x 57.25 x 57.4444 58.1286 x 56.1333 58.8909 51.7818 47.4476 x 51.7143 x 57.6 x 55.2156 x 54.8667 x 58.7667 54.3556 57.8571 x 59.2167 54.8083 57.4143 55.4 x x x 56.8667 59.2714 57.1619 x 57.8 54.8533 x x x x x x x 54.9 x x x 58.7889 x x x x x 55.84 59.5667 x x 57.5556 x x 55.3833 56.5333 x x x 55.5571 x 53.3333 x x x x x x x x x x 56.7 59.4333 x x 53.9714 x x x x x 56.9667 59.6 x x x x x x +13370 Original post publication description: Central nervous system, behavior, cognition: Response accuracy during a session with variable stimulus duration (1, 0.5, 0.25 s), measure of attention in the 5-choice serial reaction time task (5CSRT), Med Associates 5-hole operant chambers, high value = good performance [%] None Central nervous system, behavior, cognition: Response accuracy during a session with variable stimulus duration (1, 0.5, 0.25 s), measure of attention in the 5-choice serial reaction time task (5CSRT), Med Associates 5-hole operant chambers, high value = good performance [%] 86.2968 81.9455 77.0523 71.7341 67.0815 70.037 x 66.1383 x 68.8566 79.0151 x 79.106 81.3237 71.1187 64.6684 x 69.4884 x 82.3538 x 76.4564 x 79.349 x 74.7884 72.0212 78.8787 x 76.0999 66.5549 73.7938 80.0532 x x x 76.1884 80.7254 68.0892 x 82.2518 73.6082 x x x x x x x 74.5352 x x x 82.7415 x x x x x 76.3257 85.0286 x x 77.5208 x x 68.9687 75.4859 x x x 68.5767 x 76.4432 x x x x x x x x x x 75.0752 82.5418 x x 57.9245 x x x x x 76.8109 80.8792 x x x x x x +13371 Original post publication description: Central nervous system, behavior, cognition: Errors of omission during a session with variable stimulus duration (1, 0.5, 0.25 s), measure of attention in the 5-choice serial reaction time task (5CSRT), Med Associates 5-hole operant chambers, low value = good performance [%] None Central nervous system, behavior, cognition: Errors of omission during a session with variable stimulus duration (1, 0.5, 0.25 s), measure of attention in the 5-choice serial reaction time task (5CSRT), Med Associates 5-hole operant chambers, low value = good performance [%] 60.9464 45.1515 52.6619 52.5572 38.6842 57.96 x 52.7994 x 67.7113 45.8708 x 55.303 53.4782 60.3362 51.0831 x 45.8077 x 51.0531 x 59.0913 x 69.6741 x 39.0207 50.0117 66.8076 x 47.5 59.5133 59.2213 53.8254 x x x 43.6508 61.8315 59.5962 x 58.3359 57.358 x x x x x x x 40.5666 x x x 58.3488 x x x x x 46.5333 55.4167 x x 41.2011 x x 43.515 51.5682 x x x 52.9317 x 66.1916 x x x x x x x x x x 59.967 51.3867 x x 54.7868 x x x x x 51.5094 48.2341 x x x x x x +13372 Original post publication description: Central nervous system, behavior: Acoustic startle threshold for males, lowest sound pressure level at which startle response can be detected [dB] None Central nervous system, behavior: Acoustic startle threshold for males, lowest sound pressure level at which startle response can be detected [dB] 82.2222 83.6364 85.4545 101.667 93.0769 92.6667 94.5455 83.75 100.0 x x x 77.8125 88.3333 96.5 104.583 x x x x x 96.25 x 104.0 x x 93.5714 98.75 x x 95.9375 86.4286 89.0909 x x x 93.3333 89.1667 90.0 x 101.5 89.0625 x x x x x x x 95.8333 x x x 97.5 x x x x x 80.0 85.9091 x x 84.5833 x x 88.0769 94.375 x x x 100.0 x 95.5 x x x x x x x x x x 90.4545 94.1667 x x 77.7273 x x x x x 92.0833 85.8333 x x x x x x +13396 Original post publication description: Musculoskeletal system, morphology:Femur mineralized volume (FMV) of 12-week-old females measured by microcomputed tomography (µCT) [mm3] Original pre publication description: Musculoskeletal system, morphology:VDavid102 Musculoskeletal system, morphology:VDavid102 Musculoskeletal system, morphology:Femur mineralized volume (FMV) of 12-week-old females measured by microcomputed tomography (µCT) [mm3] 16.48 13.787 13.758 13.33 x x x x x x 13.423 11.558 x 11.943 x x x x x x x x x x x 11.977 x x x x 14.435 x x x x x x x x x 12.774 x 12.825 x x x x 15.216 14.147 x x x x x 16.226 x x x 10.75 x 14.039 11.597 x 13.626 x x 13.15 9.898 12.99 12.346 x x x x x x x 10.976 x x x 14.158 11.78 x x x x x 13.78 x 14.51 x x 13.92 x 14.478 x x 16.028 15.077 x x +13397 Original post publication description: Musculoskeletal system, morphology:Femur material bone mineral density (FBMDmat) of 12-week-old females measured by microcomputed tomography (µCT) [mg/cm3] Original pre publication description: Musculoskeletal system, morphology:VDavid103 Musculoskeletal system, morphology:VDavid103 Musculoskeletal system, morphology:Femur material bone mineral density (FBMDmat) of 12-week-old females measured by microcomputed tomography (µCT) [mg/cm3] 1034.94 1046.29 1002.38 1079.5 x x x x x x 1020.93 1047.85 x 1020.93 x x x x x x x x x x x 1036.52 x x x x 1060.16 x x x x x x x x x 1087.33 x 1079.74 x x x x 1053.94 1064.75 x x x x x 1075.17 x x x 999.114 x 1070.72 1053.18 x 1078.2 x x 1054.76 1016.62 1039.7 1065.56 x x x x x x x 1098.45 x x x 1073.05 1046.26 x x x x x 1054.48 x 1050.4 x x 1039.8 x 1057.62 x x 1048.3 1042.46 x x +13398 Original post publication description: Musculoskeletal system, morphology: Femur length (FL) of 12-week-old females measured by microcomputed tomography (µCT) [mm] Original pre publication description: Musculoskeletal system, morphology: VDavid104 Musculoskeletal system, morphology: VDavid104 Musculoskeletal system, morphology: Femur length (FL) of 12-week-old females measured by microcomputed tomography (µCT) [mm] 13.365 12.896 12.776 12.524 x x x x x x 12.264 12.41 x 12.228 x x x x x x x x x x x 12.0 x x x x 12.401 x x x x x x x x x 12.753 x 12.575 x x x x 13.3 12.764 x x x x x 13.447 x x x 11.736 x 12.518 12.765 x 13.73 x x 13.18 12.1 12.8 12.63 x x x x x x x 11.754 x x x 13.358 12.84 x x x x x 12.87 x 13.6 x x 12.362 x 13.735 x x 13.238 13.381 x x +13399 Original post publication description: Central nervous system, morphology, Septum volume, corrected for shrinkage, age, sex, plane of section, brain weight, and epoch [mm3] Original pre publication description: Central nervous system, morphology, Sept Corr Resid [mm3] Central nervous system, morphology: Sept Corr Resid [mm3] Central nervous system, morphology: Septum volume corrected for shrinkage, age, sex, plane of section, brain weight, and epoch [mm3] x x 2.537 3.006 3.239 3.349 3.393 2.735 3.528 3.764 3.111 3.037 2.987 2.948 2.727 2.674 3.154 3.571 3.236 3.206 3.991 3.097 x 3.714 3.794 3.313 3.045 x 3.285 3.21 3.782 2.746 3.067 2.768 3.128 x 2.826 3.579 3.479 x 3.218 3.281 x 3.148 x x 3.33 x 3.134 x x x x 2.751 3.07 x x x 3.101 3.767 x 3.171 3.394 3.172 3.263 3.225 3.17 3.381 3.083 3.495 x 3.173 3.321 3.418 2.842 3.311 x 2.881 3.096 x x 3.385 2.774 3.556 3.477 3.198 x 3.289 3.248 x 3.48 3.188 x x 3.001 2.913 2.991 x x x x x +13405 Original post publication description: Musculoskeletal system, morphology: Tibia length (TL) of 12-week-old females measured by microcomputed tomography (µCT) [mm] Original pre publication description: Musculoskeletal system, morphology: VDavid115. Musculoskeletal system, morphology: VDavid115. Musculoskeletal system, morphology: Tibia length (TL) of 12-week-old females measured by microcomputed tomography (µCT) [mm] 16.631 16.316 15.63 15.773 x x x x x x x 15.609 x 15.43 x x x x x x x x x x x x x x x x 15.934 x x x x x x x x x x x x 15.347 x x 15.527 15.705 16.32 x x x x x x x x x 15.05 x 16.04 x x x x x 16.088 x 16.279 15.137 x 16.255 x x x x x 16.163 x x x 16.559 15.67 x x x x x 15.98 x 16.024 x x 15.48 x 16.43 x x 16.614 16.255 15.84 x +13385 Original post publication description: Central nervous system, morphology:Midsagittal area of the corpus callosum, corrected for shrinkage, age, sex, brain weight, epoch [mm2] Original pre publication description: Central nervous system, morphology:MSACC Corr Resid [mm2] Central nervous system, morphology: MSACC Corr Resid [mm2] Central nervous system, morphology: Midsagittal area of the corpus callosum, corrected for shrinkage, age, sex, brain weight, epoch [mm2] x x 1.115 0.761 1.099 0.978 0.84 1.064 1.084 1.283 1.313 1.052 1.114 1.055 1.281 1.053 0.933 1.0 1.242 1.228 0.877 1.251 x 1.051 1.019 1.061 0.988 1.142 1.152 1.159 1.008 1.412 0.915 1.227 1.027 x 0.835 1.207 1.385 x 1.163 1.139 1.172 1.064 x x 1.047 x 0.989 0.904 x x x 1.515 0.989 x x x 1.096 1.041 1.082 1.119 1.198 0.897 1.045 1.01 0.916 1.172 0.925 1.117 x 1.093 0.837 1.117 0.974 1.237 0.842 1.347 1.101 x x 1.111 0.944 0.99 1.163 1.162 x 1.058 1.116 1.427 1.181 1.324 x x 1.189 0.943 1.007 1.481 x x x x +13406 Original post publication description: Musculoskeletal system, morphology: Femur Cortical Thickness (F.Ct.Th) of 12-week-old males measured at midshaft by microcomputed tomography (µCT) [mm] Original pre publication description: Musculoskeletal system, morphology: VDavid120. Musculoskeletal system, morphology: VDavid120 Musculoskeletal system, morphology: Femur cortical thickness (F.Ct.Th) of 12-week-old males measured at midshaft by microcomputed tomography (µCT) [mm] x 0.248 x x 0.236 x x x x x x 0.222 x 0.195 x x x x x x x x x 0.261 x 0.192 x 0.217 x 0.236 x x 0.218 x x x x 0.202 x x x x 0.233 x x x 0.224 0.235 x x x x x x 0.217 x x x 0.208 x 0.257 x x 0.229 x x 0.233 0.225 x 0.224 x 0.235 x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.184 x 0.209 +13404 Original post publication description: Musculoskeletal system, morphology: Tibia material bone mineral density (TBMDmat) of 12-week-old females measured by microcomputed tomography (µCT) [mg/cm3] Original pre publication description: Musculoskeletal system, morphology: VDavid114. Musculoskeletal system, morphology: VDavid114. Musculoskeletal system, morphology: Tibia material bone mineral density (TBMDmat) of 12-week-old females measured by microcomputed tomography (µCT) [mg/cm3] 1033.7 1033.46 1024.51 1040.86 x x x x x x x 1046.17 x 1026.1 x x x x x x x x x x x x x x x x 1040.5 x x x x x x x x x x x x 1000.77 x x 980.96 1024.69 1082.26 x x x x x x x x x 980.737 x 1038.59 x x x x x 1029.63 x 1057.75 1064.5 x 1030.77 x x x x x 1051.0 x x x 1054.76 1044.54 x x x x x 1031.7 x 1020.55 x x 1027.28 x 1013.6 x x 1015.14 1025.96 1019.43 x +13384 Original post publication description: Central nervous system, morphology:Lateral Septum Volume Raw values (no residual, no correction) [mm3] Original pre publication description: Central nervous system, morphology:Sept Raw [mm3] Central nervous system, morphology: Sept Raw [mm3] Central nervous system, morphology: Lateral septum volume, adult both sexes (MBL samples), morphometric point counting estimate from serial sections (without corrections) [mm3] x x 0.966 1.159 1.314 1.353 1.372 1.032 1.3 1.536 1.298 1.065 1.094 1.3 1.175 1.124 1.321 1.324 1.06 1.18 1.748 1.161 x 1.536 1.474 1.144 1.197 x 1.216 1.279 1.46 1.085 1.072 1.007 1.067 x 1.037 1.19 1.207 x 1.242 1.003 x 0.946 x x 1.046 x 1.011 x x x x 0.979 0.977 x x x 0.953 1.185 x 0.91 1.027 0.955 0.934 0.954 0.98 0.991 0.95 1.032 x 1.028 0.994 0.985 0.866 1.017 x 0.853 0.977 x x 1.034 0.816 1.026 1.098 0.961 x 1.073 0.978 x 1.027 0.96 x x 0.892 0.93 0.896 x x x x x +13400 Original post publication description: Musculoskeletal system, morphology:Tibia mineralized volume (TMV) of 12-week-old males measured by microcomputed tomography (µCT) [mm3] Original pre publication description: Musculoskeletal system, morphology: VDavid110 Musculoskeletal system, morphology: VDavid110 Musculoskeletal system, morphology: Tibia mineralized volume (TMV) of 12-week-old males measured by microcomputed tomography (µCT) [mm3] 18.313 14.803 14.33 11.468 15.67 x x x x x 12.237 12.73 x x x x x x x x x x x x x 10.073 x 12.667 x x 12.98 x 14.381 x x x x x 12.561 x x x x x x x 14.536 14.65 x x x x x x 11.566 x x x 12.78 x 14.53 x x x x x x 11.49 13.97 x x x x 13.36 x x x 14.355 9.94 x x 13.97 x x x 13.66 x 12.298 14.76 x x x x x x x x x 14.68 x 12.54 x +13401 Original post publication description: Musculoskeletal system, morphology: Tibia material bone mineral density (TBMDmat) of 12-week-old males measured by microcomputed tomography (µCT) [mg/cm3] Original pre publication description: Musculoskeletal system, morphology: VDavid111. Musculoskeletal system, morphology: VDavid111. Musculoskeletal system, morphology: Tibia material bone mineral density (TBMDmat) of 12-week-old males measured by microcomputed tomography (µCT) [mg/cm3] 1052.49 1035.63 1011.48 1071.06 1009.46 x x x x x x 1043.39 x x x x x x x x x x x x x 1034.93 x 1028.49 x x 1011.63 x 1035.06 x x x x x 1060.32 x x x x x x x 1000.86 1009.5 x x x x x x 1052.19 x x x 1004.99 x 1063.59 x x x x x x 1026.72 1016.2 x x x x 1069.29 x x x 1054.82 1018.58 x x 1028.1 x x x 1067.95 x 1045.66 1041.55 x x x x x x x x x 1014.8 x 1026.88 x +13402 Original post publication description: Musculoskeletal system, morphology: Tibia length (TL) of 12-week-old males measured by microcomputed tomography (µCT) [mm] Original pre publication description: Musculoskeletal system, morphology: VDavid112. Musculoskeletal system, morphology: VDavid112. Musculoskeletal system, morphology: Tibia length (TL) of 12-week-old males measured by microcomputed tomography (µCT) [mm] 16.921 16.478 16.24 15.325 15.92 x x x x x x 15.732 x x x x x x x x x x x x x 15.317 x 16.268 x x 15.69 x 15.956 x x x x x 15.946 x x x x x x x 16.214 16.668 x x x x x x 16.726 x x x 15.93 x 16.443 x x x x x x 15.74 15.682 x x x x 15.928 x x x 16.659 16.076 x x 16.48 x x x 15.227 x 16.028 16.6 x x x x x x x x x 16.51 x 15.366 x +13403 Original post publication description: Musculoskeletal system, morphology:Tibia mineralized volume (TMV) of 12-week-old females measured by microcomputed tomography (µCT) [mm3] Original pre publication description: Musculoskeletal system, morphology:VDavid113 Musculoskeletal system, morphology:VDavid113 Musculoskeletal system, morphology: Tibia mineralized volume (TMV) of 12-week-old females measured by microcomputed tomography (µCT) [mm3] 13.534 11.68 12.74 12.093 x x x x x x x 9.845 x 10.0 x x x x x x x x x x x x x x x x 12.252 x x x x x x x x x x x x 10.885 x x 10.558 11.75 11.83 x x x x x x x x x 9.63 x 11.89 x x x x x 11.84 x 12.297 11.256 x 11.56 x x x x x 10.898 x x x 13.066 10.32 x x x x x 11.93 x 11.489 x x 12.79 x 12.22 x x 13.38 11.898 12.195 x +13426 Original post publication description: Central nervous system, morphology: Striatal Non-neuron Number corrected for age, sex, plane of section, and brain weight Original pre publication description: Central nervous system, morphology:Str NN Resid Central nervous system, morphology:Str NN Resid Central nervous system, morphology: Striatal Non-neuron Number corrected for age, sex, plane of section, and brain weight x x 1457230.0 1374880.0 1383470.0 1464340.0 1599320.0 1523880.0 1282930.0 1384450.0 1591630.0 1593970.0 1423940.0 1499750.0 1643880.0 1400400.0 1492800.0 1463970.0 1457360.0 1325860.0 1597330.0 1360440.0 x 1389670.0 1382210.0 1322690.0 1572750.0 1491460.0 1476010.0 1692130.0 1460540.0 1364040.0 1369820.0 1683460.0 1261700.0 x 1299250.0 1339050.0 1437650.0 x 1366520.0 x x 1441910.0 x x 1450810.0 x 1364900.0 x x x x 1499410.0 1610670.0 x x x 1599540.0 1451980.0 x 1299830.0 1364430.0 1517320.0 1488500.0 1430670.0 1574700.0 1354470.0 1275740.0 1470440.0 x 1483210.0 1374600.0 1460190.0 x 1542520.0 x 1254800.0 1532390.0 x x 1741490.0 1234300.0 1486870.0 1479170.0 1521950.0 x 1287520.0 1463250.0 x 1596070.0 1385870.0 x x 1251420.0 1524240.0 1412130.0 x x x x x +13425 Original post publication description: Central nervous system, morphology:Striatal Neuron Number corrected for age, sex, plane of section, and brain weight Original pre publication description: Central nervous system, morphology:Str Neur Resid Central nervous system, morphology: Str Neur Resid Central nervous system, morphology: Neurons in the dorsal striatum (caudate-putamen) of adults corrected for age, sex, plane of section, and brain weight [n] x x 2157160.0 2355930.0 2184800.0 2183760.0 2246080.0 2246090.0 2384020.0 2287210.0 2563510.0 2212650.0 2242510.0 2491740.0 2466720.0 2178600.0 2328050.0 2390850.0 2291920.0 2087130.0 2446620.0 1930790.0 x 2325900.0 2250800.0 2010080.0 2321390.0 2135860.0 2272030.0 2375900.0 2275920.0 2394360.0 2339490.0 2334250.0 2282690.0 x 2089120.0 2189860.0 2296580.0 x 2393110.0 x x 2583710.0 x x 2170540.0 x 2267540.0 x x x x 2315800.0 2783840.0 x x x 2453920.0 2309070.0 x 2377520.0 2275460.0 2102480.0 2352960.0 2102220.0 2059780.0 2293550.0 1993630.0 2248530.0 x 2392760.0 2176760.0 2348460.0 x 2224700.0 x 1910920.0 2135650.0 x x 2400380.0 1969980.0 2210230.0 2463570.0 2287730.0 x 2221140.0 2204350.0 x 2463940.0 2303040.0 x x 1926430.0 2391080.0 2245770.0 x x x x x +13424 Original post publication description: Central nervous system, morphology; Neocortical Total Cell number (neurons and non-neurons), corrected for age, sex, plane of section, brain weight, and epoch. Original pre publication description: Central nervous system, morphology; CX Tot Cell Resid Epoch Central nervous system, morphology: CX tot cell resid Epoch Central nervous system, morphology: Neocortex total cell number (neurons and non-neurons) in adults (bilateral) corrected for age, sex, plane of section, brain weight, and epoch [n million] x x 20020800.0 18080300.0 17254300.0 18215400.0 21383600.0 18585500.0 19154600.0 18232800.0 20212500.0 19556900.0 18795300.0 19034000.0 20208900.0 18420300.0 19212200.0 18757200.0 18552900.0 17528500.0 20840000.0 17995400.0 x 18116800.0 18270800.0 17970000.0 19220200.0 16800700.0 16763100.0 20271200.0 18725000.0 17558700.0 18919600.0 20307800.0 17637600.0 x 16688000.0 18222100.0 17767000.0 x 16883400.0 19301500.0 x 17393300.0 x x 18707000.0 x 18055900.0 17867100.0 x x x 19403000.0 19199700.0 x x x x 18388300.0 x 18313700.0 17233600.0 18344000.0 19020400.0 17088600.0 18065200.0 19115100.0 18474200.0 18841300.0 x 19557800.0 17567700.0 17739500.0 17490700.0 17528900.0 x 18006700.0 20052300.0 x x 18340300.0 19402200.0 17314500.0 18781000.0 19722100.0 x 16651700.0 19625000.0 x 17860400.0 19172600.0 x x 16021000.0 19815100.0 x x x x x x +13427 Original post publication description: Central nervous system, morphology:Striatal Tot Cell Number corrected for age, sex, plane of section, and brain weight Original pre publication description: Central nervous system, morphology:Str Tot Cell Resid Central nervous system, morphology:Str Tot Cell Resid Central nervous system, morphology:Striatal Tot Cell Number corrected for age, sex, plane of section, and brain weight x x 3614390.0 3730810.0 3568280.0 3648110.0 3845390.0 3769970.0 3666950.0 3671660.0 4155140.0 3806620.0 3666460.0 3991490.0 4110600.0 3578990.0 3820860.0 3854820.0 3749280.0 3412990.0 4043950.0 3291230.0 x 3715570.0 3633010.0 3332770.0 3894140.0 3627320.0 3748030.0 4068020.0 3736470.0 3758400.0 3709310.0 4017710.0 3544390.0 x 3388370.0 3528910.0 3734230.0 x 3759630.0 x x 4025630.0 x x 3621360.0 x 3632440.0 x x x x 3815220.0 4394510.0 x x x 4053460.0 3761050.0 x 3677340.0 3639890.0 3619800.0 3841460.0 3532880.0 3634470.0 3648010.0 3269370.0 3718980.0 x 3875970.0 3551360.0 3808650.0 x 3767220.0 x 3165720.0 3668040.0 x x 4141860.0 3204280.0 3697100.0 3942740.0 3809680.0 x 3508660.0 3667600.0 x 4060010.0 3688910.0 x x 3177850.0 3915310.0 3657900.0 x x x x x +13428 Original post publication description: Central nervous system, morphology:Striatal Volume corrected for age, sex, plane of section, and brain weight Original pre publication description: Central nervous system, morphology:Str Vol Resid Central nervous system, morphology: Str vol resid Central nervous system, morphology: Striatal volume, adult both sexes (MBL samples), morphometric point counting estimate from serial sections corrected for age, sex, plane of section, and brain weight [mm3] x x 21.865 22.151 22.265 21.312 23.105 21.924 24.203 23.309 22.558 20.691 20.278 21.173 20.774 22.063 22.251 23.765 21.471 22.369 25.774 19.325 x 22.734 22.871 23.467 21.335 20.292 23.329 21.966 23.853 22.094 24.85 21.424 22.386 x 21.159 22.667 21.296 x 21.576 x x 22.523 x x 21.123 x 24.28 x x x x 23.241 23.428 x x x 23.698 23.063 x 22.558 22.569 22.358 23.416 19.775 21.483 22.405 19.7 23.667 x 22.698 23.624 22.714 x 21.866 x 19.045 20.43 x x 22.336 21.868 21.068 24.397 21.469 x 20.818 21.776 x 22.46 23.843 x x 20.452 21.468 23.738 x x x x x +13429 Original post publication description: Central nervous system, morphology; Neocortical Neuron Number corrected for age, sex, plane of section, and brain weight Original pre publication description: Central nervous system, morphology; CX Neuron Resid Central nervous system, morphology; CX Neuron Resid Central nervous system, morphology; Neocortical Neuron Number corrected for age, sex, plane of section, and brain weight x x 12050300.0 11343100.0 10763000.0 11323600.0 13149700.0 10782300.0 11856400.0 10878000.0 12353100.0 11697500.0 11404200.0 11666200.0 12336900.0 11333100.0 12239900.0 11751800.0 11380100.0 10688300.0 13085200.0 10898500.0 x 11468000.0 11398500.0 11126800.0 11443800.0 10514300.0 10187400.0 12131700.0 11966200.0 10903100.0 11978600.0 12580600.0 11224300.0 x 10466600.0 11406700.0 10863300.0 x 10362900.0 11135600.0 x 10121700.0 x x 11996400.0 x 12070400.0 10617300.0 x x x 11293700.0 11503500.0 x x x x 10965300.0 x 10859600.0 10106200.0 10863700.0 11472800.0 10170300.0 10246400.0 11562700.0 10962500.0 10577200.0 x 11334600.0 10870100.0 10235600.0 11619000.0 10053100.0 x 11730300.0 12229600.0 x x 11055500.0 12240400.0 10072800.0 11774700.0 11549300.0 x 9953010.0 12176900.0 x 10782000.0 12573900.0 x x 10974900.0 11693700.0 x x x x x x +13430 Original post publication description: Central nervous system, morphology; Neocortical Non-Neuron Number corrected for age, sex, plane of section, and brain weight Original pre publication description: Central nervous system, morphology; CX NonNeuron Resid Central nervous system, morphology; CX NonNeuron Resid Central nervous system, morphology; Neocortical Non-Neuron Number corrected for age, sex, plane of section, and brain weight x x 8308930.0 7023870.0 6740080.0 7138890.0 7948800.0 7299220.0 7091080.0 6962850.0 8080620.0 8130190.0 7605760.0 7630570.0 8215350.0 7326700.0 7210140.0 7207740.0 7351870.0 7155370.0 8132480.0 7379140.0 x 6858870.0 7019480.0 6995200.0 7949900.0 6404380.0 6717680.0 8320050.0 7078250.0 6872560.0 7124320.0 7899300.0 6591960.0 x 6405400.0 6944430.0 7105190.0 x 6743160.0 8139170.0 x 6984900.0 x x 6339610.0 x 5863790.0 7226090.0 x x x 8161150.0 7698580.0 x x x x 7152020.0 x 7160850.0 6855600.0 7141500.0 7250710.0 6675650.0 7587050.0 7250140.0 7244530.0 7979860.0 x 7867880.0 6251360.0 7152100.0 5765780.0 7255550.0 x 6177530.0 7781270.0 x x 7022030.0 6816790.0 6886610.0 6962440.0 7881640.0 x 6442400.0 7152020.0 x 6995390.0 6452280.0 x x 4855740.0 7848950.0 x x x x x x +13431 Original post publication description: Central nervous system, morphology; Neocortical Tot Cell Number corrected for age, sex, plane of section, and brain weight Original pre publication description: Central nervous system, morphology; CX Tot Cell Resid Central nervous system, morphology; CX Tot Cell Resid Central nervous system, morphology; Neocortical Tot Cell Number corrected for age, sex, plane of section, and brain weight x x 20359200.0 18366900.0 17503100.0 18462500.0 21098500.0 18081600.0 18947500.0 17840800.0 20433700.0 19827700.0 19010000.0 19296800.0 20552200.0 18659800.0 19450000.0 18959500.0 18732000.0 17843700.0 21217700.0 18277700.0 x 18326900.0 18418000.0 18122000.0 19393800.0 16918700.0 16905100.0 20451800.0 19044500.0 17775700.0 19102900.0 20479900.0 17816200.0 x 16872000.0 18351100.0 17968500.0 x 17106000.0 19274800.0 x 17106600.0 x x 18336000.0 x 17934100.0 17843400.0 x x x 19454900.0 19202000.0 x x x x 18117400.0 x 18020500.0 16961800.0 18005200.0 18723500.0 16845900.0 17833500.0 18812900.0 18207100.0 18557100.0 x 19202400.0 17121500.0 17387700.0 17384800.0 17308600.0 x 17907800.0 20010900.0 x x 18077500.0 19057200.0 16959400.0 18737100.0 19430900.0 x 16395400.0 19329000.0 x 17777400.0 19026200.0 x x 15830600.0 19542700.0 x x x x x x +13432 Original post publication description: Central nervous system, morphology; Neocortical volume, shrinkage corrected, corrected for age, sex, plane of section, and brain weight Original pre publication description: Central nervous system, morphology; CX Vol Resid Central nervous system, morphology; CX Vol Resid Central nervous system, morphology; Neocortical volume, shrinkage corrected, corrected for age, sex, plane of section, and brain weight x x 97.174 95.527 99.262 90.148 104.306 90.571 109.36 102.22 102.624 93.478 103.837 89.945 105.722 96.918 96.826 97.577 94.067 98.262 103.285 97.872 x 96.313 99.901 101.936 93.254 91.949 90.33 95.779 98.879 98.844 106.738 96.11 102.452 x 92.365 103.643 96.342 x 90.194 98.68 x 97.095 x x 83.727 x 94.118 96.844 x x x 91.948 102.55 x x x x 95.024 x 97.42 86.307 90.59 99.979 96.287 85.953 88.818 95.522 93.958 x 100.745 92.214 92.945 87.894 91.826 x 100.431 99.927 x x 94.327 87.491 93.007 94.006 91.927 x 97.436 98.654 x 93.279 89.883 x x 91.972 96.574 x x x x x x +13433 Original post publication description: Central nervous system, morphology; Neocortical neuron number, raw data Original pre publication description: Central nervous system, morphology; CX Neuron Raw Central nervous system, morphology; CX Neuron Raw Central nervous system, morphology; Neocortical neuron number, raw data x x 12394000.0 11256300.0 11112700.0 11532700.0 13735900.0 10740400.0 11699900.0 11040200.0 12511900.0 11843600.0 11385100.0 11837800.0 12539800.0 11590800.0 12379800.0 11915100.0 11386900.0 10812300.0 13259500.0 10972400.0 x 11479800.0 11429200.0 10800300.0 11418700.0 10213100.0 9987910.0 12211000.0 12177100.0 10993900.0 12113400.0 12683700.0 11248500.0 x 10560900.0 11515100.0 11078300.0 x 10732500.0 10566200.0 x 10302200.0 x x 12153700.0 x 11534700.0 9899770.0 x x x 10835700.0 10956900.0 x x x x 11136400.0 x 10791700.0 10236800.0 10980200.0 11360500.0 10022000.0 10371500.0 11523700.0 11021500.0 10705200.0 x 11501200.0 10996500.0 10242000.0 11317500.0 10197400.0 x 11440700.0 11825000.0 x x 11310000.0 11997500.0 10268300.0 11597900.0 11414300.0 x 10212400.0 12272900.0 x 10355100.0 12483700.0 x x 10653200.0 11927300.0 x x x x x x +13434 Original post publication description: Central nervous system, morphology; Neocortical non-neuron number, raw data Original pre publication description: Central nervous system, morphology; CX NonNeuron Raw Central nervous system, morphology; CX NonNeuron Raw Central nervous system, morphology; Neocortical non-neuron number, raw data x x 8988280.0 6680530.0 7050750.0 7407130.0 9136880.0 6722810.0 6803510.0 7167730.0 8045810.0 8039780.0 7139460.0 7799380.0 8661420.0 7527680.0 7302380.0 7299270.0 7121640.0 7274270.0 8341560.0 7343430.0 x 6748510.0 6629140.0 5991360.0 7582570.0 5437620.0 5830430.0 8329390.0 7515160.0 6595460.0 7029930.0 7723950.0 6236690.0 x 6194090.0 6726010.0 7196900.0 x 7266670.0 8042290.0 x 7333890.0 x x 6160770.0 x 5571500.0 7096120.0 x x x 8716330.0 7678450.0 x x x x 7662850.0 x 7021300.0 7129800.0 7206920.0 7057760.0 6498580.0 7856160.0 7215700.0 7356570.0 8253840.0 x 8113500.0 6376960.0 7083450.0 5395420.0 7607540.0 x 6236600.0 7883350.0 x x 7529820.0 6178630.0 6825830.0 7624770.0 7298180.0 x 6986220.0 7140070.0 x 6914680.0 6580860.0 x x 4562950.0 8098750.0 x x x x x x +13435 Original post publication description: Central nervous system, morphology; Neocortical total cell number, raw data Original pre publication description: Central nervous system, morphology; CX Tot Cell Raw Central nervous system, morphology; CX Tot Cell Raw Central nervous system, morphology; Neocortical total cell number, raw data x x 21382300.0 17936800.0 18163400.0 18939800.0 22872800.0 17463200.0 18503400.0 18207900.0 20557700.0 19883400.0 18524500.0 19637100.0 21201200.0 19118500.0 19682100.0 19214400.0 18508600.0 18086600.0 21601100.0 18315900.0 x 18228300.0 18058300.0 16791700.0 19001200.0 15650700.0 15818300.0 20540400.0 19692300.0 17589400.0 19143400.0 20407600.0 17485200.0 x 16755000.0 18241100.0 18275200.0 x 17999200.0 18608500.0 x 17636100.0 x x 18314500.0 x 17106200.0 16995900.0 x x x 19552000.0 18635400.0 x x x x 18799200.0 x 17813000.0 17366600.0 18187100.0 18418300.0 16520600.0 18227700.0 18739400.0 18378100.0 18959000.0 x 19614700.0 17373500.0 17325400.0 16712900.0 17804900.0 x 17677300.0 19708400.0 x x 18839800.0 18176100.0 17094100.0 19222700.0 18712500.0 x 17198600.0 19412900.0 x 17269700.0 19064500.0 x x 15216100.0 20026000.0 x x x x x x +13436 Original post publication description: Central nervous system, morphology; Neocortical Volume, corrected for shrinkage. Original pre publication description: Central nervous system, morphology; CX Vol Raw Central nervous system, morphology; CX Vol Raw Central nervous system, morphology; Neocortical Volume, corrected for shrinkage. x x 104.812 86.225 107.435 90.323 120.157 82.025 102.751 103.039 104.728 95.342 103.074 91.762 108.937 102.306 95.196 97.03 86.114 99.303 109.929 96.716 x 91.176 93.447 87.013 87.055 78.922 77.178 90.384 100.6 101.206 106.107 94.234 100.297 x 91.382 99.215 98.695 x 96.922 97.843 x 101.792 x x 86.531 x 91.749 96.147 x x x 101.974 102.761 x x x x 104.303 x 93.635 84.484 90.693 96.546 89.456 89.183 90.91 98.125 97.126 x 104.995 91.635 90.278 84.235 95.24 x 103.814 103.22 x x 96.74 81.552 93.958 107.69 86.333 x 101.076 100.905 x 93.72 95.054 x x 90.111 102.26 x x x x x x +13437 Original post publication description: Central nervous system, morphology; Striatal neuron number, raw data Original pre publication description: Central nervous system, morphology; Str Neuron Raw Central nervous system, morphology; Str Neuron Raw Central nervous system, morphology; Striatal neuron number, raw data x x 2291360.0 2364870.0 2302900.0 2246530.0 2445980.0 2216540.0 2381630.0 2357720.0 2605120.0 2268900.0 2246240.0 2563990.0 2557040.0 2264230.0 2381500.0 2437920.0 2298470.0 2151370.0 2518740.0 1974330.0 x 2352140.0 2245440.0 1925310.0 2324310.0 2048850.0 2203370.0 2413290.0 2379030.0 2428960.0 2375380.0 2359280.0 2294210.0 x 2133480.0 2197420.0 2357440.0 x 2496720.0 x x 2578000.0 x x 2120020.0 x 2196420.0 x x x x 2359990.0 2731590.0 x x x 2442450.0 2334480.0 x 2304010.0 2200980.0 2048960.0 2268770.0 2038670.0 2033890.0 2271560.0 1949750.0 2215930.0 x 2357380.0 2093210.0 2247530.0 x 2196090.0 x 1866700.0 2127780.0 x x 2372550.0 1909750.0 2165320.0 2496410.0 2211670.0 x 2166890.0 2160960.0 x 2406490.0 2274960.0 x x 1853470.0 2362240.0 2165160.0 x x x x x +13438 Original post publication description: Central nervous system, morphology; Striatal non-neuron number, raw data Original pre publication description: Central nervous system, morphology; Str NonNeuron Raw Central nervous system, morphology; Str NonNeuron Raw Central nervous system, morphology; Striatal non-neuron number, raw data x x 1595730.0 1396460.0 1468600.0 1538520.0 1829180.0 1436630.0 1309740.0 1456660.0 1587460.0 1622550.0 1348010.0 1556290.0 1750880.0 1450480.0 1544150.0 1483710.0 1450030.0 1387410.0 1649120.0 1390820.0 x 1391150.0 1322960.0 1181090.0 1535920.0 1339880.0 1338630.0 1735030.0 1598530.0 1316160.0 1360870.0 1660110.0 1208280.0 x 1290640.0 1288580.0 1459420.0 x 1455440.0 x x 1469090.0 x x 1408610.0 x 1264400.0 x x x x 1489240.0 1494550.0 x x x 1567860.0 1525090.0 x 1246660.0 1346080.0 1499230.0 1434270.0 1421490.0 1608520.0 1372100.0 1247620.0 1512830.0 x 1472720.0 1296200.0 1372580.0 x 1584720.0 x 1135300.0 1475350.0 x x 1718680.0 1111650.0 1475550.0 1550540.0 1491230.0 x 1285130.0 1456690.0 x 1470450.0 1319730.0 x x 1075370.0 1537580.0 1258850.0 x x x x x +13439 Original post publication description: Central nervous system, morphology; Striatal total cell number, raw data Original pre publication description: Central nervous system, morphology; Str Tot Cell Raw Central nervous system, morphology; Str Tot Cell Raw Central nervous system, morphology; Striatal total cell number, raw data x x 3887100.0 3761330.0 3771500.0 3785060.0 4275160.0 3653170.0 3691370.0 3814380.0 4192590.0 3891450.0 3594250.0 4120290.0 4307920.0 3714710.0 3925650.0 3921630.0 3748500.0 3538790.0 4167860.0 3365140.0 x 3743280.0 3568410.0 3106410.0 3860230.0 3388730.0 3542000.0 4148320.0 3977560.0 3745120.0 3736250.0 4019400.0 3502490.0 x 3424130.0 3486000.0 3816860.0 x 3952160.0 x x 4047100.0 x x 3528640.0 x 3460830.0 x x x x 3849220.0 4226140.0 x x x 4010310.0 3859570.0 x 3550670.0 3547060.0 3548190.0 3703040.0 3460160.0 3642410.0 3643660.0 3197370.0 3728760.0 x 3830100.0 3389410.0 3620110.0 x 3780820.0 x 3002000.0 3603130.0 x x 4091230.0 3021390.0 3640870.0 4046960.0 3702900.0 x 3452020.0 3617650.0 x 3876940.0 3594690.0 x x 2928840.0 3899820.0 3424010.0 x x x x x +13440 Original post publication description: Central nervous system, morphology; Striatal volume, shrinkage corrected. Original pre publication description: Central nervous system, morphology; Str Vol Raw Central nervous system, morphology: Str Vol Raw Central nervous system, morphology: Striatal volume (caudate putamen), both sexes, shrinkage corrected [mm^3] x x 23.949 21.012 24.047 21.728 27.095 19.248 23.259 23.637 22.549 21.012 19.611 21.671 21.885 23.015 21.923 23.342 19.785 22.824 27.144 19.164 x 21.602 20.884 19.889 19.75 16.894 19.868 20.877 24.846 22.052 24.262 20.527 21.425 x 20.77 20.989 21.403 x 22.798 x x 23.867 x x 20.897 x 25.088 x x x x 26.441 23.941 x x x 25.098 25.265 x 21.897 22.411 22.413 22.622 19.872 22.623 23.309 20.09 24.619 x 23.146 22.822 21.363 x 23.199 x 19.842 22.229 x x 22.515 22.493 21.403 26.849 20.998 x 21.01 22.436 x 23.121 25.328 x x 19.843 22.211 23.662 x x x x x +13441 Original post publication description: unpublished Original pre publication description: Central nervous system, behavior: Rotarod, average time walking for day 1 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model , R6/2 cases only Central nervous system, behavior: Rotarod, average time walking for day 1 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model , R6/2 cases only [sec] Central nervous system, behavior: Rotarod, average time walking for day 1 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model , R6/2 cases only [sec] x 55.0 104.5 x x 78.2 93.5 91.1 x 73.6 113.7 107.0 x 65.0 x x 81.9 x 99.3 x 86.9 x x x x x 72.6 x x 72.1 x x 81.0 x x x x 75.8 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13442 Original post publication description: Central nervous system, behavior: OFA, boli produced in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, R6/2 cases only None Central nervous system, behavior: OFA, boli produced in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, R6/2 cases only x 10.6 7.2 x x 9.1 7.5 8.1 x 11.1 9.0 7.8 x 8.6 x x 5.5 x 9.0 x 7.2 x x x x x 9.4 x x 8.1 x x 9.2 x x x x 10.1 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13443 Original post publication description: Central nervous system, behavior: OFA, boli produced in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, R6/2 cases only Original pre publication description: Central nervous system, behavior: OFA, boli produced in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, R6/2 cases only Central nervous system, behavior: OFA, boli produced in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, wildtype cases only Central nervous system, behavior: anxiety assay, number of fecal boli produced in an open field activity (OFA) test in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, wildtype cases only x 7.8 5.0 x x 7.1 4.5 5.4 x 7.7 6.4 6.8 x 6.3 x x 6.2 x 5.3 x 5.7 x x x x x 7.6 x x 7.1 x x 6.6 x x x x 8.5 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13444 Original post publication description: Central nervous system, behavior: OFA, boli produced in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, [% WT only] Original pre publication description: Central nervous system, behavior: OFA, boli produced in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, [% WT only] Central nervous system, behavior: OFA, boli produced in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, [% WT only] Central nervous system, behavior: OFA, boli produced in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, [% WT only] x 135.8 144.0 x x 128.1 166.6 150.0 x 144.1 140.6 114.7 x 136.5 x x 88.7 x 169.8 x 126.3 x x x x x 123.6 x x 114.0 x x 139.3 x x x x 118.8 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13446 Original post publication description: Central nervous system, behavior: Rotarod, average time walking for day 1 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model , wildtype cases only Original pre publication description: Central nervous system, behavior: Rotarod, average time walking for day 1 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model , wildtype cases only Central nervous system, behavior: Rotarod, average time walking for day 1 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model , wildtype cases only Central nervous system, behavior: Rotarod, average time walking for day 1 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model , wildtype cases only x 130.2 138.1 x x 119.8 126.7 163.4 x 108.9 191.6 163.3 x 156.1 x x 176.4 x 173.4 x 121.5 x x x x x 104.7 x x 129.8 x x 139.5 x x x x 121.6 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13447 Original post publication description: Central nervous system, behavior: Rotarod, average time walking for day 1 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model [% WT] Original pre publication description: Central nervous system, behavior: Rotarod, average time walking for day 1 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model [% WT] Central nervous system, behavior: Rotarod, average time walking for day 1 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model [% WT] Central nervous system, behavior: Rotarod, average time walking for day 1 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model [% WT] x 42.2 75.6 x x 65.2 73.7 55.7 x 67.5 59.3 65.5 x 41.6 x x 46.4 x 57.2 x 71.5 x x x x x 69.3 x x 55.5 x x 58.0 x x x x 62.3 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13448 Original post publication description: Central nervous system, behavior: Rotarod, improvement from day 1 to day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model , R6/2 cases only [percentage improvement] Original pre publication description: Central nervous system, behavior: Rotarod, improvement from day 1 to day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model , R6/2 cases only [percentage improvement] Central nervous system, behavior: Rotarod, improvement from day 1 to day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model , R6/2 cases only [percentage improvement] Central nervous system, behavior: Rotarod, improvement from day 1 to day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model , R6/2 cases only [percentage improvement] x 16.5 32.5 x x 33.8 26.2 27.7 x 31.9 39.8 68.2 x 44.6 x x 24.4 x 31.0 x 3.2 x x x x x 17.3 x x 43.7 x x 44.1 x x x x 17.6 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13449 Original post publication description: Central nervous system, behavior: Rotarod, improvement from day 1 to day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model , R6/2 cases only [day 2 - day 1, sec] Original pre publication description: Central nervous system, behavior: Rotarod, improvement from day 1 to day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model , R6/2 cases only [day 2 - day 1, sec] Central nervous system, behavior: Rotarod, improvement from day 1 to day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model , R6/2 cases only [day 2 - day 1, sec] Central nervous system, behavior: Rotarod, improvement from day 1 to day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model , R6/2 cases only [day 2 - day 1, sec] x 6.2 26.6 x x 22.7 17.7 24.5 x 21.5 41.3 34.9 x 23.3 x x 13.7 x 31.8 x 8.0 x x x x x 8.0 x x 25.1 x x 29.9 x x x x 11.2 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13450 Original post publication description: Central nervous system, behavior: Rotarod, improvement from day 1 to day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model , wildtype cases only [day 2 - day 1, sec] Original pre publication description: Central nervous system, behavior: Rotarod, improvement from day 1 to day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model , wildtype cases only [day 2 - day 1, sec] Central nervous system, behavior: Rotarod, improvement from day 1 to day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model , wildtype cases only [day 2 - day 1, sec] Central nervous system, behavior: Rotarod, improvement from day 1 to day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model , wildtype cases only [day 2 - day 1, sec] x 84.3 68.3 x x 96.3 62.1 47.8 x 82.2 76.2 76.7 x 65.0 x x 42.0 x 68.7 x 49.2 x x x x x 71.1 x x 47.6 x x 62.7 x x x x 87.2 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13451 Original post publication description: Central nervous system, behavior: Rotarod, improvement from day 1 to day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model , wildtype cases only [percentage improvement] Original pre publication description: Central nervous system, behavior: Rotarod, improvement from day 1 to day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model , wildtype cases only [percentage improvement] Central nervous system, behavior: Rotarod, improvement from day 1 to day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model , wildtype cases only [percentage improvement] Central nervous system, behavior: Rotarod, improvement from day 1 to day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model , wildtype cases only [percentage improvement] x 79.6 57.1 x x 96.2 74.3 41.7 x 85.4 45.0 62.9 x 42.6 x x 46.6 x 41.9 x 41.9 x x x x x 87.1 x x 37.7 x x 47.7 x x x x 96.7 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13452 Original post publication description: Central nervous system, behavior: Rotarod, improvement from day 1 to day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model [% WT] [percentage improvement] Original pre publication description: Central nervous system, behavior: Rotarod, improvement from day 1 to day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model [% WT] [percentage improvement] Central nervous system, behavior: Rotarod, improvement from day 1 to day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model [% WT] [percentage improvement] Central nervous system, behavior: Rotarod, improvement from day 1 to day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model [% WT] [percentage improvement] x 20.7 56.9 x x 35.1 35.2 66.4 x 37.3 88.4 108.4 x 104.6 x x 52.3 x 73.9 x 7.6 x x x x x 19.8 x x 115.9 x x 92.4 x x x x 18.2 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13453 Original post publication description: Central nervous system, behavior: Rotarod, improvement from day 1 to day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model [% WT] [day 2 - day 1] Original pre publication description: Central nervous system, behavior: Rotarod, improvement from day 1 to day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model [% WT] [day 2 - day 1] Central nervous system, behavior: Rotarod, improvement from day 1 to day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model [% WT] [day 2 - day 1] Central nervous system, behavior: Rotarod, improvement from day 1 to day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model [% WT] [day 2 - day 1] x 7.3 38.9 x x 23.5 28.5 51.2 x 26.1 54.1 45.5 x 35.8 x x 32.6 x 46.2 x 16.2 x x x x x 11.2 x x 52.7 x x 47.6 x x x x 12.8 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13454 Original post publication description: Central nervous system, behavior: Total distance in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, Female R6/2 cases only [cm Original pre publication description: Central nervous system, behavior: Total distance in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, Female R6/2 cases only [cm] Central nervous system, behavior: Total distance in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, Female R6/2 cases only [cm] Central nervous system, behavior: Total distance in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, Female R6/2 cases only [cm x 4445.3 3492.0 x x 3228.1 2936.7 4372.5 x 3032.6 3225.8 4857.8 x 3911.0 x x 5327.2 x 3025.2 x 3056.0 x x x x x 3192.8 x x 2058.2 x x 3309.7 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13455 Original post publication description: Central nervous system, behavior: Total distance in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, Male R6/2 cases only [cm] Original pre publication description: Central nervous system, behavior: Total distance in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, Male R6/2 cases only [cm] Central nervous system, behavior: Total distance in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, Male R6/2 cases only [cm] Central nervous system, behavior: Total distance in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, Male R6/2 cases only [cm] x 4089.1 2730.3 x x 4032.1 3325.7 4749.6 x 3318.5 3986.0 4012.6 x 3300.0 x x 4808.9 x 2411.2 x x x x x x x 2740.2 x x 3820.8 x x 3277.2 x x x x 3437.6 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13456 Original post publication description: Central nervous system, behavior: Total distance in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, Female wildtype cases only [cm] Original pre publication description: Central nervous system, behavior: Total distance in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, Female wildtype cases only [cm] Central nervous system, behavior: Total distance in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, Female wildtype cases only [cm] Central nervous system, behavior: Total distance in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, Female wildtype cases only [cm] x 4281.9 6435.2 x x 4436.6 6579.0 5293.1 x 4507.0 3643.0 x x 5045.9 x x 6075.2 x 7352.5 x 4144.4 x x x x x 3672.0 x x 4486.6 x x 4580.8 x x x x 3931.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13457 Original post publication description: Central nervous system, behavior: Total distance in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, male wildtype cases only [cm] Original pre publication description: Central nervous system, behavior: Total distance in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, male wildtype cases only [cm] Central nervous system, behavior: Total distance in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, male wildtype cases only [cm] Central nervous system, behavior: Total distance in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, male wildtype cases only [cm] x 4657.7 5235.5 x x 3729.5 6186.5 5020.8 x 4239.4 3363.2 4434.7 x 5461.8 x x 4864.4 x 4305.8 x 3847.2 x x x x x 3696.0 x x 2758.0 x x 4526.3 x x x x 4282.6 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13458 Original post publication description: Central nervous system, behavior: Total distance in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model Females only [% WT] Original pre publication description: Central nervous system, behavior: Total distance in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model Females only [% WT] Central nervous system, behavior: Open field activity (OFA), total distance by 8-week-old F1 hybrids generated by crossing male BXDs with female C57BL/6J-R6/2 Huntington carriers [% of wildtype control] Central nervous system, behavior: Open field activity (OFA), total distance by 8-week-old F1 hybrids generated by crossing male BXDs with female C57BL/6J-R6/2 Huntington carriers [% of wildtype control] x 103.8 54.1 x x 72.8 44.6 82.6 x 67.3 88.5 x x 77.5 x x 87.7 x 41.1 x 73.7 x x x x x 86.9 x x 45.9 x x 72.3 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13459 Original post publication description: Central nervous system, behavior: Total distance in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model males only [% WT] Original pre publication description: Central nervous system, behavior: Total distance in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model males only [% WT] Central nervous system, behavior: Total distance in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model males only [% WT] Central nervous system, behavior: Total distance in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model males only [% WT] x 87.8 52.1 x x 108.1 53.8 94.6 x 78.3 118.5 90.5 x 60.4 x x 98.9 x 55.9 x x x x x x x 74.1 x x 138.5 x x 72.4 x x x x 80.3 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13460 Original post publication description: Central nervous system, behavior: Rearing behavior in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, R6/2 cases only [n vertical beam breaks] Original pre publication description: Central nervous system, behavior: Rearing behavior in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, female R6/2 cases only [n vertical beam breaks] Central nervous system, behavior: Rearing in open field test by 8-week-old F1 hybrids generated by crossing male BXDs with female C57BL/6J-R6/2 Huntington carriers [n beam breaks] Central nervous system, behavior: Rearing in open field test by 8-week-old F1 hybrids generated by crossing male BXDs with female C57BL/6J-R6/2 Huntington carriers [n beam breaks] x 301.6 104.9 x x 162.1 92.7 133.7 x 232.5 133.1 184.0 x 131.2 x x 251.7 x 89.7 x 177.0 x x x x x 295.6 x x 142.0 x x 162.1 x x x x 170.5 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13461 Original post publication description: Central nervous system, behavior: Rearing behavior in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, male R6/2 cases only [n vertical beam breaks] Original pre publication description: Central nervous system, behavior: Rearing behavior in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, male R6/2 cases only [n vertical beam breaks] Central nervous system, behavior: Rearing behavior in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, male R6/2 cases only [n vertical beam breaks] Central nervous system, behavior: Rearing behavior in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, male R6/2 cases only [n vertical beam breaks] x 289.1 106.7 x x 233.1 140.7 191.2 x 295.4 32.4 200.0 x 97.8 x x 224.5 x 112.7 x x x x x x x 126.3 x x 270.1 x x 205.2 x x x x 144.3 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13462 Original post publication description: Central nervous system, behavior: Rearing behavior in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, female wildtype cases only [n vertical beam breaks] Original pre publication description: Central nervous system, behavior: Rearing behavior in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, female wildtype cases only [n vertical beam breaks] Central nervous system, behavior: Rearing behavior in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, female wildtype cases only [n vertical beam breaks] Central nervous system, behavior: Rearing behavior in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, female wildtype cases only [n vertical beam breaks] x 396.6 376.2 x x 448.1 369.1 388.6 x 362.1 263.0 405.0 x 319.3 x x 495.4 x 439.6 x 377.8 x x x x x 295.6 x x 329.0 x x 387.1 x x x x 350.5 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13463 Original post publication description: Central nervous system, behavior: Rearing behavior in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, male wildtype cases only [n vertical beam breaks] Original pre publication description: Central nervous system, behavior: Rearing behavior in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, male wildtype cases only [n vertical beam breaks] Central nervous system, behavior: Rearing behavior in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, male wildtype cases only [n vertical beam breaks] Central nervous system, behavior: Rearing behavior in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, male wildtype cases only [n vertical beam breaks] x 546.1 501.3 x x 408.1 469.3 471.2 x 480.7 268.4 489.0 x 473.6 x x 497.3 x 383.3 x 555.6 x x x x x 389.0 x x 325.3 x x 458.1 x x x x 341.1 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13464 Original post publication description: Central nervous system, behavior: Rearing behavior in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model female only [% WT] Original pre publication description: Central nervous system, behavior: Rearing behavior in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model female only [% WT] Central nervous system, behavior: Rearing behavior in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model female only [% WT] Central nervous system, behavior: Rearing behavior in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model female only [% WT] x 76.0 27.9 x x 36.2 25.1 34.4 x 64.2 50.6 45.4 x 41.1 x x 50.8 x 20.4 x 46.9 x x x x x 53.6 x x 43.2 x x 41.9 x x x x 48.6 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13465 Original post publication description: Central nervous system, behavior: Rearing behavior in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model male only [% WT] Original pre publication description: Central nervous system, behavior: Rearing behavior in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model male only [% WT] Central nervous system, behavior: Rearing behavior in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model male only [% WT] Central nervous system, behavior: Rearing behavior in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model male only [% WT] x 52.9 21.3 x x 57.1 29.9 40.6 x 61.5 119.4 40.9 x 20.7 x x 45.1 x 29.4 x x x x x x x 32.5 x x 83.0 x x 44.8 x x x x 42.3 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13466 Original post publication description: Central nervous system, behavior: Body weight in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, female R6/2 cases only [gm] Original pre publication description: Central nervous system, behavior: Body weight in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, female R6/2 cases only [gm] Central nervous system, behavior: Body weight in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, female R6/2 cases only [gm] Central nervous system, behavior: Body weight in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, female R6/2 cases only [gm] x 21.9 17.0 x x 21.0 17.7 17.5 x 22.8 17.5 18.3 x 18.8 x x 20.2 x 15.9 x 19.9 x x x x x 18.7 x x 20.8 x x 20.4 x x x x 22.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13467 Original post publication description: Central nervous system, behavior: Body weight in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, male R6/2 cases only [gm] Original pre publication description: Central nervous system, behavior: Body weight in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, male R6/2 cases only [gm] Central nervous system, behavior: Body weight in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, male R6/2 cases only [gm] Central nervous system, behavior: Body weight in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, male R6/2 cases only [gm] x 27.5 21.6 x x 26.5 24.5 25.0 x 26.5 21.3 23.1 x 22.8 x x 24.6 x 20.6 x x x x x x x 24.1 x x 26.2 x x 26.8 x x x x 26.2 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13468 Original post publication description: Central nervous system, behavior: Body weight in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model female only [% wildtype] Original pre publication description: Central nervous system, behavior: Body weight in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model female only [% wildtype] Central nervous system, behavior: Body weight in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model female only [% wildtype] Central nervous system, behavior: Body weight in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model female only [% wildtype] x 100.5 89.5 x x 99.1 92.2 87.5 x 105.1 93.1 97.9 x 92.6 x x 99.5 x 85.5 x 98.0 x x x x x 93.0 x x 92.4 x x 95.8 x x x x 109.5 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13469 Original post publication description: Central nervous system, behavior: Body weight in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model male only [% wildtype] Original pre publication description: Central nervous system, behavior: Body weight in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model male only [% wildtype] Central nervous system, behavior: Body weight in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model male only [% wildtype] Central nervous system, behavior: Body weight in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model male only [% wildtype] x 98.2 86.7 x x 96.7 88.9 86.8 x 94.6 90.3 98.7 x 83.5 x x 90.8 x 86.9 x x x x x x x 95.6 x x 90.7 x x 92.9 x x x x 96.7 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13470 Original post publication description: Central nervous system, behavior: Body weight in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, female wildtype cases only [gm] Original pre publication description: Central nervous system, behavior: Body weight in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, female wildtype cases only [gm] Central nervous system, behavior: Body weight in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, female wildtype cases only [gm] Central nervous system, behavior: Body weight in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, female wildtype cases only [gm] x 21.8 19.0 x x 21.2 19.2 20.0 x 21.7 18.8 18.7 x 20.3 x x 20.3 x 18.6 x 20.3 x x x x x 20.1 x x 22.5 x x 21.3 x x x x 20.1 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13471 Original post publication description: Central nervous system, behavior: Body weight in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, male wildtype cases only [gm] Original pre publication description: Central nervous system, behavior: Body weight in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, male wildtype cases only [gm] Central nervous system, behavior: Body weight in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, male wildtype cases only [gm] Central nervous system, behavior: Body weight in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, male wildtype cases only [gm] x 28.0 24.9 x x 27.4 24.5 25.0 x 28.0 23.6 23.4 x 27.3 x x 27.1 x 23.7 x 25.2 x x x x x 25.2 x x 28.9 x x 26.8 x x x x 27.1 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13472 Original post publication description: Central nervous system, behavior: Rotarod, average time walking for day 1 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model , female R6/2 cases only [sec] Original pre publication description: Central nervous system, behavior: Rotarod, average time walking for day 1 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model , female R6/2 cases only [sec] Central nervous system, behavior: Rotarod, average time walking for day 1 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model , female R6/2 cases only [sec] Central nervous system, behavior: Rotarod, average time walking for day 1 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model , female R6/2 cases only [sec] x 59.8 113.8 x x 118.7 167.8 174.2 x 117.0 206.3 187.4 x 168.2 x x 222.8 x 180.3 x 89.6 x x x x x 110.5 x x 156.3 x x 142.3 x x x x 159.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13473 Original post publication description: Central nervous system, behavior: Rotarod, average time walking for day 1 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model , male R6/2 cases only [sec] Original pre publication description: Central nervous system, behavior: Rotarod, average time walking for day 1 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model , male R6/2 cases only [sec] Central nervous system, behavior: Rotarod, average time walking for day 1 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, male R6/2 cases only [sec] Central nervous system, behavior: Rotarod, average time walking for day 1 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, male R6/2 cases only [sec] x 51.8 92.0 x x 72.4 90.6 94.1 x 74.2 108.3 75.6 x 61.3 x x 68.0 x 99.7 x x x x x x x 76.7 x x 58.2 x x 75.3 x x x x 76.2 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13474 Original post publication description: Central nervous system, behavior: Rotarod, average time walking for day 1 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model , female wildtype cases only [sec] Original pre publication description: Central nervous system, behavior: Rotarod, average time walking for day 1 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model , female wildtype cases only [sec] Central nervous system, behavior: Rotarod, average time walking for day 1 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model , female wildtype cases only [sec] Central nervous system, behavior: Rotarod, average time walking for day 1 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model , female wildtype cases only [sec] x 135.66 x x x 118.79 158.8 174.2 x 117.0 206.39 187.42 x 168.29 x x 222.82 x 180.33 x 122.07 x x x x x 110.55 x x 156.33 x x 142.31 x x x x 159.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13475 Original post publication description: Central nervous system, behavior: Rotarod, average time walking for day 1 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model , male wildtype cases only [sec] Original pre publication description: Central nervous system, behavior: Rotarod, average time walking for day 1 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model , male wildtype cases only [sec] Central nervous system, behavior: Rotarod, average time walking for day 1 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model , male wildtype cases only [sec] Central nervous system, behavior: Motor performance, accelerating rotarod test, average time walking for day 1 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, male wildtype cases only [sec] x 124.1 138.3 x x 120.4 95.8 155.7 x 96.2 171.0 145.2 x 136.5 x x 143.9 x 166.5 x 119.9 x x x x x 101.9 x x 103.3 x x 136.2 x x x x 114.1 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13476 Original post publication description: Central nervous system, behavior: Rotarod, average time walking for day 1 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model female only [% WT] Original pre publication description: Central nervous system, behavior: Rotarod, average time walking for day 1 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model female only [% WT] Central nervous system, behavior: Rotarod, average time walking for day 1 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model female only [% WT] Central nervous system, behavior: Rotarod, average time walking for day 1 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model female only [% WT] x 44.1 82.5 x x 70.1 57.2 60.5 x 62.6 58.8 69.3 x 41.4 x x 46.1 x 54.7 x 73.4 x x x x x 59.5 x x 59.4 x x 59.0 x x x x 46.9 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13477 Original post publication description: Central nervous system, behavior: Rotarod, average time walking for day 1 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model male only [% WT] Original pre publication description: Central nervous system, behavior: Rotarod, average time walking for day 1 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model male only [% WT] Central nervous system, behavior: Rotarod, average time walking for day 1 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model male only [% WT] Central nervous system, behavior: Rotarod, average time walking for day 1 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model male only [% WT] x 41.7 66.5 x x 60.1 94.6 60.4 x 77.1 63.3 52.1 x 44.9 x x 47.3 x 59.9 x x x x x x x 75.3 x x 56.3 x x 55.3 x x x x 66.8 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13478 Original post publication description: Central nervous system, behavior: Rotarod, average time walking for day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model male only [% WT] Original pre publication description: Central nervous system, behavior: Rotarod, average time walking for day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model male only [% WT] Central nervous system, behavior: Rotarod, average time walking for day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model male only [% WT] Central nervous system, behavior: Rotarod, average time walking for day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model male only [% WT] x 27.6 62.6 x x 48.4 73.9 60.4 x 48.5 56.5 53.0 x 48.4 x x 41.5 x 60.1 x x x x x x x 45.3 x x 49.5 x x 50.3 x x x x 38.8 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13479 Original post publication description: Central nervous system, behavior: Rotarod, average time walking for day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model female only [% WT] Original pre publication description: Central nervous system, behavior: Rotarod, average time walking for day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model female only [% WT] Central nervous system, behavior: Rotarod, average time walking for day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model female only [% WT] Central nervous system, behavior: Rotarod, average time walking for day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model female only [% WT] x 30.5 64.2 x x 44.7 45.9 60.5 x 50.2 57.9 62.7 x 34.9 x x 46.9 x 47.2 x 58.9 x x x x x 47.6 x x 63.6 x x 58.0 x x x x 50.4 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13480 Original post publication description: Central nervous system, behavior: Rotarod, average time walking for day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, female R6/2 cases only [sec] Original pre publication description: Central nervous system, behavior: Rotarod, average time walking for day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, female R6/2 cases only [sec] Central nervous system, behavior: Rotarod, average time walking for day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, female R6/2 cases only [sec] Central nervous system, behavior: Rotarod, average time walking for day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, female R6/2 cases only [sec] x 67.9 133.3 x x 98.9 98.8 105.4 x 98.0 150.2 154.5 x 83.9 x x 109.2 x 121.1 x 98.1 x x x x x 76.0 x x 121.9 x x 114.4 x x x x 106.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13481 Original post publication description: Central nervous system, behavior: Rotarod, average time walking for day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, male R6/2 cases only [sec] Original pre publication description: Central nervous system, behavior: Rotarod, average time walking for day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, male R6/2 cases only [sec] Central nervous system, behavior: Rotarod, average time walking for day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, male R6/2 cases only [sec] Central nervous system, behavior: Rotarod, average time walking for day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, male R6/2 cases only [sec] x 56.8 128.2 x x 103.2 124.9 94.1 x 89.6 158.4 124.8 x 91.9 x x 86.5 x 136.8 x x x x x x x 83.3 x x 80.8 x x 104.6 x x x x 80.8 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13482 Original post publication description: Central nervous system, behavior: Rotarod, average time walking for day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, female wildtype cases only [sec] Original pre publication description: Central nervous system, behavior: Rotarod, average time walking for day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, female wildtype cases only [sec] Central nervous system, behavior: Rotarod, average time walking for day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, female wildtype cases only [sec] Central nervous system, behavior: Rotarod, average time walking for day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, female wildtype cases only [sec] x 222.3 207.5 x x 221.5 215.1 174.2 x 195.2 259.0 246.3 x 240.5 x x 232.8 x 256.7 x 166.6 x x x x x 159.7 x x 191.8 x x 197.2 x x x x 210.3 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13483 Original post publication description: Central nervous system, behavior: Rotarod, average time walking for day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, male wildtype cases only [sec] Original pre publication description: Central nervous system, behavior: Rotarod, average time walking for day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, male wildtype cases only [sec] Central nervous system, behavior: Rotarod, average time walking for day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, male wildtype cases only [sec] Central nervous system, behavior: Rotarod, average time walking for day 2 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, male wildtype cases only [sec] x 205.7 204.9 x x 213.2 169.0 155.7 x 184.7 280.3 235.3 x 189.7 x x 208.3 x 227.7 x 182.4 x x x x x 184.0 x x 163.1 x x 208.1 x x x x 208.5 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13484 Original post publication description: Central nervous system, electrophysiology: Hippocampus network activity in vitro, spontaneous activity, integrated (1-45 Hz) local field potential amplitude, both sexes at 2 weeks-of-age [ln(uV)] None Central nervous system, electrophysiology: Hippocampus network activity in vitro, spontaneous activity, integrated (1-45 Hz) local field potential amplitude, both sexes at 2 weeks-of-age [ln(uV)] x x 0.562 0.702 0.602 0.585 x x 0.629 x 0.572 0.539 0.653 x x 0.561 x x x x x x x x x 0.585 0.786 0.701 x 0.555 0.591 0.608 0.561 x x x x 0.658 0.519 x 0.562 0.881 x x x x x x x 0.759 x x x 0.726 x x x x x 0.814 x x x 0.855 x x 0.831 0.669 x x x 0.737 x 0.648 x x x x x x x x x x x 0.622 x x 0.711 x x x x x 0.776 x x x x x x x +13485 Original post publication description: Central nervous system, behavior: Prepulse inhibition, average inhibition for 4, 8, and 12 dB above background in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, female R6/2 cases only [%] Original pre publication description: Central nervous system, behavior: Prepulse inhibition, average inhibition for 4, 8, and 12 dB above background in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, female R6/2 cases only [%] Central nervous system, behavior: Prepulse inhibition, average inhibition for 4, 8, and 12 dB above background in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, female R6/2 cases only [%] Central nervous system, behavior: Prepulse inhibition, average inhibition for 4, 8, and 12 dB above background in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, female R6/2 cases only [%] x 25.6 2.5 x x 14.5 1.7 12.8 x 20.9 28.6 5.7 x 25.1 x x 5.8 x 39.9 x 14.7 x x x x x 9.1 x x 8.2 x x 19.7 x x x x 34.2 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13486 Original post publication description: Central nervous system, electrophysiology: Hippocampus network activity in vitro, spontaneous activity, mean correlation of local field potentials, both sexes at 2 weeks-of-age [ln(r)] None Central nervous system, electrophysiology: Hippocampus network activity in vitro, spontaneous activity, mean correlation of local field potentials, both sexes at 2 weeks-of-age [ln(r)] x x -1.863 -1.254 -1.655 -1.839 x x -1.737 x -1.74 -1.922 -1.727 x x -1.715 x x x x x x x x x -1.686 -1.683 -1.596 x -1.842 -1.788 -1.7 -1.804 x x x x -1.747 -1.848 x -1.857 -1.282 x x x x x x x -1.603 x x x -1.898 x x x x x -1.763 x x x -1.514 x x -1.344 -1.574 x x x -1.742 x -1.762 x x x x x x x x x x x -1.604 x x -1.362 x x x x x -1.711 x x x x x x x +13487 Original post publication description: Central nervous system, electrophysiology: Hippocampus network activity in vitro, carbachol (25 uM) induced oscillations, normalized local field potential peak amplitude, both sexes at 2 weeks-of-age [ln(uV)] None Central nervous system, electrophysiology: Hippocampus network activity in vitro, carbachol (25 uM) induced oscillations, normalized local field potential peak amplitude, both sexes at 2 weeks-of-age [ln(uV)] x x 1.088 1.028 0.934 1.146 x x 1.492 x 1.42 0.907 1.638 x x 1.412 x x x x x x x x x 1.239 1.713 1.278 x 1.131 1.153 1.257 1.519 x x x x 1.563 0.933 x 1.116 1.269 x x x x x x x 2.03 x x x 1.333 x x x x x 1.35 x x x 1.255 x x 1.715 1.38 x x x 1.751 x 0.838 x x x x x x x x x x x 1.476 x x 1.084 x x x x x 1.693 x x x x x x x +13488 Original post publication description: Central nervous system, electrophysiology: Hippocampus network activity in vitro, carbachol (25 uM) induced oscillations, normalized local field potential peak frequency, both sexes at 2 weeks-of-age [Hz] None Central nervous system, electrophysiology: Hippocampus network activity in vitro, carbachol (25 uM) induced oscillations, normalized local field potential peak frequency, both sexes at 2 weeks-of-age [Hz] x x 18.933 20.396 20.616 18.697 x x 22.418 x 19.745 17.061 19.468 x x 20.594 x x x x x x x x x 18.824 22.052 21.3 x 17.438 16.964 16.142 18.35 x x x x 20.356 18.958 x 18.457 21.252 x x x x x x x 22.048 x x x 21.225 x x x x x 21.213 x x x 19.611 x x 21.025 20.334 x x x 21.713 x 17.384 x x x x x x x x x x x 20.206 x x 20.409 x x x x x 21.624 x x x x x x x +13489 Original post publication description: Central nervous system, behavior: Prepulse inhibition, average inhibition for 4, 8, and 12 dB above background in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, male R6/2 cases only [%] Original pre publication description: Central nervous system, behavior: Prepulse inhibition, average inhibition for 4, 8, and 12 dB above background in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, male R6/2 cases only [%] Central nervous system, behavior: Prepulse inhibition, average inhibition for 4, 8, and 12 dB above background in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, male R6/2 cases only [%] Central nervous system, behavior: Prepulse inhibition, average inhibition for 4, 8, and 12 dB above background in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, male R6/2 cases only [%] x 19.1 0.01 x x 25.9 7.4 17.0 x 14.0 18.0 19.6 x 9.0 x x 9.9 x 12.3 x x x x x x x 2.5 x x 5.6 x x 23.6 x x x x 18.4 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13490 Original post publication description: Central nervous system, electrophysiology: Hippocampus network activity in vitro, carbachol (25 uM) induced oscillations, normalized integrated (1-45 Hz) local field potential amplitude, both sexes at 2 weeks-of-age [ln(uV)] None Central nervous system, electrophysiology: Hippocampus network activity in vitro, carbachol (25 uM) induced oscillations, normalized integrated (1-45 Hz) local field potential amplitude, both sexes at 2 weeks-of-age [ln(uV)] x x 0.194 0.16 0.167 0.263 x x 0.359 x 0.303 0.243 0.366 x x 0.4 x x x x x x x x x 0.327 0.533 0.367 x 0.213 0.221 0.364 0.452 x x x x 0.39 0.202 x 0.257 0.23 x x x x x x x 0.524 x x x 0.294 x x x x x 0.386 x x x 0.33 x x 0.318 0.382 x x x 0.402 x 0.237 x x x x x x x x x x x 0.379 x x 0.27 x x x x x 0.42 x x x x x x x +13491 Original post publication description: Central nervous system, electrophysiology: Hippocampus network activity in vitro, carbachol (25 uM) induced oscillations, normalized mean correlation of local field potentials, both sexes at 2 weeks-of-age [ln(r)] None Central nervous system, electrophysiology: Hippocampus network activity in vitro, carbachol (25 uM) induced oscillations, normalized mean correlation of local field potentials, both sexes at 2 weeks-of-age [ln(r)] x x -0.757 -0.882 -0.925 -0.581 x x 0.02 x -0.284 -0.729 -0.041 x x -0.137 x x x x x x x x x -0.359 0.407 -0.63 x -0.494 -0.686 -0.574 -0.072 x x x x -0.225 -0.822 x -0.78 -0.673 x x x x x x x 0.441 x x x -0.225 x x x x x -0.367 x x x -0.442 x x -0.249 -0.274 x x x 0.324 x -0.803 x x x x x x x x x x x -0.251 x x -0.659 x x x x x 0.4 x x x x x x x +13492 Original post publication description: Central nervous system, behavior: Prepulse inhibition, average inhibition for 4, 8, and 12 dB above background in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, female wildtype cases only [%] Original pre publication description: Central nervous system, behavior: Prepulse inhibition, average inhibition for 4, 8, and 12 dB above background in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, female wildtype cases only [%] Central nervous system, behavior: Prepulse inhibition, average inhibition for 4, 8, and 12 dB above background in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, female wildtype cases only [%] Central nervous system, behavior: Prepulse inhibition, average inhibition for 4, 8, and 12 dB above background in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, female wildtype cases only [%] x 32.0 15.1 x x 30.0 18.4 22.6 x 31.7 47.9 27.8 x 20.8 x x 43.6 x 24.8 x 37.3 x x x x x 17.6 x x 14.9 x x 40.2 x x x x 56.8 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13493 Original post publication description: Central nervous system, behavior: Prepulse inhibition, average inhibition for 4, 8, and 12 dB above background in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, male wildtype cases only [%] Original pre publication description: Central nervous system, behavior: Prepulse inhibition, average inhibition for 4, 8, and 12 dB above background in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, male wildtype cases only [%] Central nervous system, behavior: Prepulse inhibition, average inhibition for 4, 8, and 12 dB above background in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, male wildtype cases only [%] Central nervous system, behavior: Prepulse inhibition, average inhibition for 4, 8, and 12 dB above background in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, male wildtype cases only [%] x 45.8 11.4 x x 42.2 25.3 46.9 x 21.6 36.4 8.9 x 12.0 x x 49.9 x 32.1 x 36.0 x x x x x 36.3 x x 29.0 x x 34.2 x x x x 51.8 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13494 Original post publication description: Central nervous system, behavior: Prepulse inhibition, average difference in inhibition for 4, 8, and 12 dB above background in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model female only [% of WT PPI%] Original pre publication description: Central nervous system, behavior: Prepulse inhibition, average difference in inhibition for 4, 8, and 12 dB above background in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model female only [% of WT PPI%] Central nervous system, behavior: Prepulse inhibition, average difference in inhibition for 4, 8, and 12 dB above background in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model female only [% of WT PPI%] Central nervous system, behavior: Prepulse inhibition, average difference in inhibition for 4, 8, and 12 dB above background in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model female only [% of WT PPI%] x 80.0 16.6 x x 48.3 9.2 56.6 x 65.9 59.7 20.5 x 120.7 x x 13.3 x 160.9 x 39.4 x x x x x 51.7 x x 55.0 x x 49.0 x x x x 60.2 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13495 Original post publication description: Central nervous system, behavior: Prepulse inhibition, average difference in inhibition for 4, 8, and 12 dB above background in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model male only [% of WT PPI%] Original pre publication description: Central nervous system, behavior: Prepulse inhibition, average difference in inhibition for 4, 8, and 12 dB above background in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model male only [% of WT PPI%] Central nervous system, behavior: Prepulse inhibition, average difference in inhibition for 4, 8, and 12 dB above background in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model male only [% of WT PPI%] Central nervous system, behavior: Prepulse inhibition, average difference in inhibition for 4, 8, and 12 dB above background in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model male only [% of WT PPI%] x 41.7 0.09 x x 61.4 29.2 36.2 x 64.8 49.5 220.2 x 75.0 x x 19.8 x 38.3 x x x x x x x 6.9 x x 19.3 x x 69.0 x x x x 35.5 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13496 Original post publication description: Musculoskeletal system, morphology: Femur Cortical Thickness (F.Ct.Th) of 12-week-old females measured at midshaft by microcomputed tomography (µCT) [mm] Original pre publication description: Musculoskeletal system, morphology: VDavid201 Musculoskeletal system, morphology: VDavid201 Musculoskeletal system, morphology: Femur cortical thickness (F.Ct.Th) of 12-week-old females measured at midshaft by microcomputed tomography (µCT) [mm] x 0.202 x x x x x x x x 0.202 x x 0.186 x x x x x x x x x 0.23 x x x x x x 0.226 x x x x x x x x x 0.192 x 0.201 0.196 x x 0.188 0.211 0.196 x x x x x 0.204 x x x 0.166 x 0.215 0.194 x x x x 0.225 0.177 0.193 x x 0.197 x x x x x 0.226 x x x x x x x x x x x x x x x x x x x x 0.202 0.193 0.188 0.154 +13497 Original post publication description: Musculoskeletal system, morphology: Femur cortical apparent bone mineral density (F.Ct.BMDapp) of 12-week-old females measured at midshaft by microcomputed tomography (µCT) [mg/cm3] Original pre publication description: Musculoskeletal system, morphology: VDavid202 Musculoskeletal system, morphology: VDavid202 Musculoskeletal system, morphology: Femur cortical apparent bone mineral density (F.Ct.BMDapp) of 12-week-old females measured at midshaft by microcomputed tomography (µCT) [mg/cm3] x 1039.45 x x x x x x x x 1024.02 x x 1009.8 x x x x x x x x x 1059.34 x x x x x x 1066.59 x x x x x x x x x 1060.39 x 1075.65 1038.89 x x 993.089 1038.68 1049.82 x x x x x 1082.08 x x x 979.418 x 1066.01 1060.34 x x x x 1073.98 1000.84 1039.83 x x 1055.58 x x x x x 1108.27 x x x x x x x x x x x x x x x x x x x x 1063.14 1037.64 1046.76 995.721 +13498 Original post publication description: Musculoskeletal system, morphology: Femur cortical material bone mineral density (F.Ct.BMDmat) of 12-week-old males measured at midshaft by microcomputed tomography (µCT) [mg/cm3] Original pre publication description: Musculoskeletal system, morphology: VDavid203. Musculoskeletal system, morphology: VDavid203. Musculoskeletal system, morphology: Femur cortical material bone mineral density (F.Ct.BMDmat) of 12-week-old females measured at midshaft by microcomputed tomography (µCT) [mg/cm3] x 1116.35 x x x x x x x x 1096.27 x x 1090.33 x x x x x x x x x 1130.19 x x x x x x 1140.08 x x x x x x x x x 1146.15 x 1158.63 1118.38 x x 1069.31 1114.82 1131.13 x x x x x 1163.83 x x x 1062.87 x 1140.75 1147.19 x x x x 1149.39 1085.53 1120.75 x x 1140.85 x x x x x 1188.38 x x x x x x x x x x x x x x x x x x x x 1092.21 1116.62 1128.83 1086.33 +13499 Original post publication description: Musculoskeletal system, morphology: Femur cross-sectional volume (F.CSV) of 12-week-old females measured at midshaft by microcomputed tomography (µCT) [mm3] Original pre publication description: Musculoskeletal system, morphology: VDavid204 Musculoskeletal system, morphology: VDavid204 Musculoskeletal system, morphology: Femur cross-sectional volume (F.CSV) of 12-week-old females measured at midshaft by microcomputed tomography (µCT) [mm3] x 1.517 x x x x x x x x 1.633 x x 1.526 x x x x x x x x x 1.285 x x x x x x 1.505 x x x x x x x x x 1.725 x 2.355 2.023 x x 1.772 2.195 1.646 x x x x x 1.762 x x x 1.491 x 1.992 1.663 x x x x 1.791 1.483 1.66 x x 1.715 x x x x x 1.515 x x x x x x x x x x x x x x x x x x x x 2.014 1.591 1.506 1.131 +13500 Original post publication description: Musculoskeletal system, morphology: Femur cortical volume (F.Ct.V) of 12-week-old females measured at midshaft by microcomputed tomography (µCT) [mm3] Original pre publication description: Musculoskeletal system, morphology: VDavid205. Musculoskeletal system, morphology: VDavid205. Musculoskeletal system, morphology: Femur cortical volume (F.Ct.V) of 12-week-old females measured at midshaft by microcomputed tomography (µCT) [mm3] x 0.55 x x x x x x x x 0.574 x x 0.516 x x x x x x x x x 0.535 x x x x x x 0.579 x x x x x x x x x 0.565 x 0.547 0.579 x x 0.564 0.652 0.559 x x x x x 0.583 x x x 0.434 x 0.639 0.498 x x x x 0.573 0.447 0.502 x x 0.496 x x x x x 0.552 x x x x x x x x x x x x x x x x x x x x 0.645 0.535 0.519 0.37 +13501 Original post publication description: Musculoskeletal system, morphology: Femur cortical marrow volume (F.MaV) of 12-week-old females measured at midshaft by microcomputed tomography (µCT) [mm3] Original pre publication description: Musculoskeletal system, morphology: VDavid206 Musculoskeletal system, morphology: VDavid206 Musculoskeletal system, morphology: Femur cortical marrow volume (F.MaV) of 12-week-old females measured at midshaft by microcomputed tomography (µCT) [mm3] x 0.967 x x x x x x x x 1.059 x x 1.011 x x x x x x x x x 0.75 x x x x x x 0.926 x x x x x x x x x 1.16 x 1.808 1.444 x x 1.208 1.542 1.087 x x x x x 1.179 x x x 1.057 x 1.353 1.165 x x x x 1.218 1.036 1.158 x x 1.219 x x x x x 0.963 x x x x x x x x x x x x x x x x x x x x 1.369 1.055 0.987 0.76 +13502 Original post publication description: Musculoskeletal system, morphology: Femur cross-sectional area (F.CSAr) of 12-week-old females measured at midshaft by microcomputed tomography (µCT) [mm2] Original pre publication description: Musculoskeletal system, morphology: VDavid207. Musculoskeletal system, morphology: VDavid207. Musculoskeletal system, morphology: Femur cross-sectional area (F.CSAr) of 12-week-old females measured at midshaft by microcomputed tomography (µCT) [mm2] x 1.935 x x x x x x x x 2.082 x x 1.947 x x x x x x x x x 1.639 x x x x x x 1.919 x x x x x x x x x 2.2 x 3.004 2.581 x x 2.26 2.799 2.099 x x x x x 2.248 x x x 1.902 x 2.541 2.121 x x x x 2.284 1.892 2.117 x x 2.188 x x x x x 1.932 x x x x x x x x x x x x x x x x x x x x 2.569 2.029 1.921 1.443 +13503 Original post publication description: Musculoskeletal system, morphology: Femur cortical area (F.Ct.Ar) of 12-week-old females measured at midshaft by microcomputed tomography (µCT) [mm2] Original pre publication description: Musculoskeletal system, morphology: VDavid208 Musculoskeletal system, morphology: VDavid208 Musculoskeletal system, morphology: Femur cortical area (F.Ct.Ar) of 12-week-old females measured at midshaft by microcomputed tomography (µCT) [mm2] x 0.702 x x x x x x x x 0.732 x x 0.658 x x x x x x x x x 0.683 x x x x x x 0.738 x x x x x x x x x 0.721 x 0.698 0.739 x x 0.719 0.832 0.713 x x x x x 0.744 x x x 0.554 x 0.815 0.635 x x x x 0.73 0.57 0.64 x x 0.632 x x x x x 0.704 x x x x x x x x x x x x x x x x x x x x 0.822 0.683 0.662 0.473 +13504 Original post publication description: Musculoskeletal system, morphology: Femur marrow area (F.Ma.Ar) of 12-week-old females measured at midshaft by microcomputed tomography (µCT) [mm2] Original pre publication description: Musculoskeletal system, morphology: VDavid209. Musculoskeletal system, morphology: VDavid209. Musculoskeletal system, morphology: Femur marrow area (F.Ma.Ar) of 12-week-old females measured at midshaft by microcomputed tomography (µCT) [mm2] x 1.233 x x x x x x x x 1.351 x x 1.289 x x x x x x x x x 0.956 x x x x x x 1.181 x x x x x x x x x 1.479 x 2.306 1.842 x x 1.541 1.967 1.386 x x x x x 1.504 x x x 1.349 x 1.726 1.486 x x x x 1.554 1.321 1.477 x x 1.555 x x x x x 1.229 x x x x x x x x x x x x x x x x x x x x 1.747 1.346 1.259 0.97 +13505 Original post publication description: Musculoskeletal system, morphology: Femur polar moment of inertia (F.pMOI) of 12-week-old females measured at midshaft by microcomputed tomography (µCT) [g*mm2] Original pre publication description: Musculoskeletal system, morphology: VDavid210 Musculoskeletal system, morphology: VDavid210 Musculoskeletal system, morphology: Femur polar moment of inertia (F.pMOI) of 12-week-old females measured at midshaft by microcomputed tomography (µCT) [g*mm2] x 0.228 x x x x x x x x 0.249 x x 0.22 x x x x x x x x x 0.174 x x x x x x 0.217 x x x x x x x x x 0.265 x 0.222 0.278 x x 0.277 0.367 0.249 x x x x x 0.257 x x x 0.163 x 0.312 0.188 x x x x 0.217 0.16 0.187 x x 0.187 x x x x x 0.193 x x x x x x x x x x x x x x x x x x x x 0.342 0.224 0.21 0.113 +13506 Original post publication description: Musculoskeletal system, morphology: Femur moment of inertia around the shorter axis (F.Imax) of 12-week-old females measured at midshaft by microcomputed tomography (µCT) [g*mm2] Original pre publication description: Musculoskeletal system, morphology: VDavid211. Musculoskeletal system, morphology: VDavid211. Musculoskeletal system, morphology: Femur moment of inertia around the shorter axis (F.Imax) of 12-week-old females measured at midshaft by microcomputed tomography (µCT) [g*mm2] x 0.149 x x x x x x x x 0.165 x x 0.133 x x x x x x x x x 0.119 x x x x x x 0.141 x x x x x x x x x 0.173 x 0.15 0.19 x x 0.181 0.236 0.156 x x x x x 0.168 x x x 0.108 x 0.217 0.13 x x x x 0.146 0.104 0.122 x x 0.132 x x x x x 0.127 x x x x x x x x x x x x x x x x x x x x 0.231 0.147 0.13 0.073 +13507 Original post publication description: Infectious disease, immune function: Burkholderia pseudomallei (126b) infection response (50 CFU intranasal), survival in males, [1=resistant, 0=sensitive] Original pre publication description: Infectious disease, immune function: Burkholderia pseudomallei (126b) infection response (50 CFU intranasal), survival in males, [1=resistant, 0=sensitive] Infectious disease, immune system: Burkholderia pseudomallei (126b) infection response (50 CFU intranasal), survival in males, [1=resistant, 0=sensitive] Infectious disease, immune system: Burkholderia pseudomallei (126b) infection response (50 CFU intranasal), survival in males, [1=resistant, 0=sensitive] x x 1.0 0.0 0.0 x x x x 0.0 x x 0.0 x x x x x x x 1.0 x x x x x x x x x x x x x x x 1.0 x x x x 0.25 x 1.0 x x x 1.0 1.0 x x x x 1.0 x x x x x 0.75 0.0 0.0 0.5 1.0 0.75 x 0.0 0.0 1.0 x x 0.0 x 0.6 x x x x 1.0 x x 1.0 x x 0.2 1.0 x x 1.0 x x x x x 1.0 x x x x x x 0.833 +13508 Original post publication description: Musculoskeletal system, morphology: Femur moment of inertia around the longer axis (F.Imin) of 12-week-old females measured at midshaft by microcomputed tomography (µCT) [g*mm2] Original pre publication description: Musculoskeletal system, morphology: VDavid212 Musculoskeletal system, morphology: VDavid212 Musculoskeletal system, morphology: Femur moment of inertia around the longer axis (F.Imin) of 12-week-old females measured at midshaft by microcomputed tomography (µCT) [g*mm2] x 0.08 x x x x x x x x 0.085 x x 0.086 x x x x x x x x x 0.055 x x x x x x 0.075 x x x x x x x x x 0.092 x 0.072 0.088 x x 0.096 0.131 0.093 x x x x x 0.089 x x x 0.055 x 0.095 0.058 x x x x 0.071 0.056 0.065 x x 0.055 x x x x x 0.065 x x x x x x x x x x x x x x x x x x x x 0.111 0.077 0.079 0.04 +13509 Original post publication description: Musculoskeletal system, morphology: Femur moment of inertia around the shorter axis divided by the maximum radius perpendicular to Imax direction (F.Imax/Cmax) of 12-week-old females measured at midshaft by microcomputed tomography (µCT) [mm3] Original pre publication description: Musculoskeletal system, morphology: VDavid213. Musculoskeletal system, morphology: VDavid213. Musculoskeletal system, morphology: Femur moment of inertia around the shorter axis divided by the maximum radius perpendicular to Imax direction (F.Imax/Cmax) of 12-week-old females measured at midshaft by microcomputed tomography (µCT) [mm3] x 0.189 x x x x x x x x 0.2 x x 0.173 x x x x x x x x x 0.155 x x x x x x 0.186 x x x x x x x x x 0.21 x 0.184 0.217 x x 0.213 0.264 0.189 x x x x x 0.204 x x x 0.146 x 0.233 0.165 x x x x 0.183 0.142 0.16 x x 0.16 x x x x x 0.168 x x x x x x x x x x x x x x x x x x x x 0.248 0.184 0.171 0.108 +13510 Original post publication description: Musculoskeletal system, morphology: Femur moment of inertia around the longer axis divided by the maximum radius perpendicular to Imin direction (F.Imin/Cmin) of 12-week-old females measured at midshaft by microcomputed tomography (µCT) [mm3] Original pre publication description: Musculoskeletal system, morphology: VDavid214. Musculoskeletal system, morphology: VDavid214. Musculoskeletal system, morphology: Femur moment of inertia around the longer axis divided by the maximum radius perpendicular to Imin direction (F.Imin/Cmin) of 12-week-old females measured at midshaft by microcomputed tomography (µCT) [mm3] x 0.142 x x x x x x x x 0.15 x x 0.143 x x x x x x x x x 0.11 x x x x x x 0.136 x x x x x x x x x 0.158 x 0.136 0.15 x x 0.159 0.192 0.153 x x x x x 0.154 x x x 0.102 x 0.163 0.116 x x x x 0.129 0.105 0.121 x x 0.108 x x x x x 0.123 x x x x x x x x x x x x x x x x x x x x 0.187 0.138 0.14 0.084 +13511 Original post publication description: Central nervous system, behavior: Left hemisphere brain weight in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, wildtype cases only [mg] Original pre publication description: Central nervous system, behavior: Left hemisphere brain weight in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, wildtype cases only [mg] Central nervous system, behavior: Left hemisphere brain weight in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, wildtype cases only [mg] Central nervous system, behavior: Left hemisphere brain weight in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, wildtype cases only [mg] x 232.6 229.9 x x 229.5 254.9 223.6 x 238.8 239.4 229.6 x 231.7 x x 230.6 x 223.9 x 239.6 x x x x x 247.7 x x 212.5 x x 234.0 x x x x 235.8 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13512 Original post publication description: Central nervous system, behavior: Left hemisphere brain weight in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, R6/2 cases only [mg] Original pre publication description: Central nervous system, behavior: Left hemisphere brain weight in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, R6/2 cases only [mg] Central nervous system, behavior: Left hemisphere brain weight in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, R6/2 cases only [mg] Central nervous system, behavior: Left hemisphere brain weight in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, R6/2 cases only [mg] x 190.8 205.6 x x 195.4 221.3 181.7 x 205.8 191.5 206.6 x 193.0 x x 197.7 x 208.7 x 196.9 x x x x x 197.4 x x 198.7 x x 195.9 x x x x 195.9 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13513 Original post publication description: Central nervous system, behavior: Left hemisphere brain weight in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model [% WT] Original pre publication description: Central nervous system, behavior: Left hemisphere brain weight in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model [% WT] Central nervous system, behavior: Left hemisphere brain weight in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model [% WT] Central nervous system, behavior: Left hemisphere brain weight in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model [% WT] x 82.0 89.4 x x 85.1 86.8 81.2 x 86.1 79.9 89.9 x 83.2 x x 85.7 x 93.2 x 82.1 x x x x x 79.6 x x 93.5 x x 83.0 x x x x 83.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13514 Original post publication description: Central nervous system, behavior: Brain:body weight ratio in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, wildtype cases only [ratio, left hemisphere:brain weight] Original pre publication description: Central nervous system, behavior: Brain:body weight ratio in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, wildtype cases only [ratio, left hemisphere:brain weight] Central nervous system, behavior: Brain:body weight ratio in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, wildtype cases only [ratio, left hemisphere:brain weight] Central nervous system, behavior: Brain:body weight ratio in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, wildtype cases only [ratio, left hemisphere:brain weight] x 0.0097 0.0106 x x 0.0092 0.0116 0.0098 x 0.0099 0.0116 0.0109 x 0.0103 x x 0.0096 x 0.0107 x 0.0111 x x x x x 0.0105 x x 0.0083 x x 0.0099 x x x x 0.0092 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13515 Original post publication description: Central nervous system, behavior: Brain:body weight ratio in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, R6/2 cases only [ratio, left hemisphere:brain weight] Original pre publication description: Central nervous system, behavior: Brain:body weight ratio in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, R6/2 cases only [ratio, left hemisphere:brain weight] Central nervous system, behavior: Brain:body weight ratio in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, R6/2 cases only [ratio, left hemisphere:brain weight] Central nervous system, behavior: Brain:body weight ratio in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, R6/2 cases only [ratio, left hemisphere:brain weight] x 0.0077 0.0107 x x 0.0084 0.0114 0.0091 x 0.0085 0.0098 0.0103 x 0.0092 x x 0.009 x 0.0113 x 0.0096 x x x x x 0.0093 x x 0.0083 x x 0.009 x x x x 0.0078 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13516 Original post publication description: Central nervous system, behavior: Brain:body weight ratio in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, [% WT] [ratio, left hemisphere:brain weight] Original pre publication description: Central nervous system, behavior: Brain:body weight ratio in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, [% WT] [ratio, left hemisphere:brain weight] Central nervous system, behavior: Brain:body weight ratio in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, [% WT] [ratio, left hemisphere:brain weight] Central nervous system, behavior: Brain:body weight ratio in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, [% WT] [ratio, left hemisphere:brain weight] x 79.3 100.9 x x 91.3 98.2 92.8 x 85.8 84.4 94.4 x 89.3 x x 93.7 x 105.6 x 86.4 x x x x x 88.5 x x 100.0 x x 90.9 x x x x 84.7 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13518 Original post publication description: Central nervous system, behavior: Body weight in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, corrected female R6/2 cases only [gm] Original pre publication description: Central nervous system, behavior: Body weight in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, corrected female R6/2 cases only [gm] Central nervous system, behavior: Body weight in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, corrected female R6/2 cases only [gm] Central nervous system, behavior: Body weight in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, corrected female R6/2 cases only [gm] x 2.83 0.05 x x -4.17 -0.54 -1.26 x 0.236 0.48 1.72 x -0.19 x x 0.29 x -1.39 x x x x x x x 0.61 x x 0.52 x x -1.1 x x x x -0.32 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13519 Original post publication description: Central nervous system, behavior: Body weight in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, CORRECTED female R6/2 cases [gm] Original pre publication description: Central nervous system, behavior: Body weight in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, CORRECTED female R6/2 cases [gm] Central nervous system, behavior: Body weight in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, CORRECTED female R6/2 cases [gm] Central nervous system, behavior: Body weight in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, CORRECTED female R6/2 cases [gm] x -2.82 -4.47 x x -4.17 -4.64 -5.4 x -1.3 -3.33 -3.11 x -4.14 x x -4.09 x -5.24 x -1.7 x x x x x -4.83 x x -4.95 x x -3.44 x x x x -3.9 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13520 Original post publication description: Central nervous system, behavior: Body weight in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, CORRECTED R6/2 cases only [gm] Original pre publication description: Central nervous system, behavior: Body weight in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, CORRECTED R6/2 cases only [gm] Central nervous system, behavior: RROD day 1 in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, CORRECTED R6/2 cases only [sec] Central nervous system, behavior: RROD day 1 in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, CORRECTED R6/2 cases only [sec] x -75.25 -33.63 x x -41.64 -27.32 -65.34 x -35.33 -77.94 -56.23 x -91.12 x x -94.51 x -74.37 x -34.54 x x x x x -32.17 x x -57.76 x x -58.52 x x x x -45.78 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13521 Original post publication description: Central nervous system, behavior: Body weight in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, CORRECTED R6/2 cases [gm] Original pre publication description: Central nervous system, behavior: Body weight in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, CORRECTED R6/2 cases [gm] Central nervous system, behavior: Body weight in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, CORRECTED R6/2 cases [gm] Central nervous system, behavior: Body weight in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, CORRECTED R6/2 cases [gm] x 0.61 -2.54 x x -1.59 -2.69 -2.72 x x -1.09 -1.08 x x x x -14.46 x -3.1 x -0.99 x x x x x -1.43 x x -1.67 x x -1.85 x x x x -0.74 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13522 Original post publication description: Central nervous system, behavior: RROD day 2 in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, CORRECTED R6/2 cases only [sec] Original pre publication description: Central nervous system, behavior: RROD day 2 in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, CORRECTED R6/2 cases only [sec] Central nervous system, behavior: RROD day 2 in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, CORRECTED R6/2 cases only [sec] Central nervous system, behavior: RROD day 2 in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, CORRECTED R6/2 cases only [sec] x 153.4 -75.28 x x -115.23 -75.36 -88.58 x -96.04 -112.87 -98.03 x -132.85 x x -122.81 x 123.06 x -75.78 x x x x x -95.31 x x -80.18 x x -91.24 x x x x -121.75 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13523 Original post publication description: Central nervous system, behavior: RROD day 1 in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, CORRECTED Female R6/2 cases only [sec] Original pre publication description: Central nervous system, behavior: RROD day 1 in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, CORRECTED Female R6/2 cases only [sec] Central nervous system, behavior: Motor performance measured by the rotarod test on day 1 (first test) in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model (corrected female R6/2 cases only) [sec] Central nervous system, behavior: Motor performance measured by the rotarod test on day 1 (first test) in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model (corrected female R6/2 cases only) [sec] x -70.39 -24.28 x x x -24.81 -57.97 x -35.66 -70.25 -33.37 x -86.49 x x -73.72 x -74.77 x -31.83 x x x x x -38.99 x x -36.95 x x -55.46 x x x x -47.13 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13524 Original post publication description: Central nervous system, behavior: RROD day 1 in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, CORRECTED male R6/2 cases only [sec] Original pre publication description: Central nervous system, behavior: RROD day 1 in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, CORRECTED male R6/2 cases only [sec] Central nervous system, behavior: RROD day 1 in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, CORRECTED male R6/2 cases only [sec] Central nervous system, behavior: RROD day 1 in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, CORRECTED male R6/2 cases only [sec] x -78.39 -46.1 x x -47.39 -30.1 -69.33 x -34.72 -83.32 -87.66 x -94.83 x x -108.37 x -74.06 x x x x x x x -28.08 x x -71.63 x x 64.2 x x x x -45.33 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13525 Original post publication description: Central nervous system, behavior: RROD day 2 in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, CORRECTED female R6/2 cases only [sec] Original pre publication description: Central nervous system, behavior: RROD day 2 in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, CORRECTED female R6/2 cases only [sec] Central nervous system, behavior: RROD day 2 in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, CORRECTED female R6/2 cases only [sec] Central nervous system, behavior: RROD day 2 in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, CORRECTED female R6/2 cases only [sec] x -146.65 -73.06 x x -117.27 -83.3 -74.3 x -93.12 -117.7 85.53 x -137.28 x x -109.19 x -121.06 x -72.6 x x x x x -99.85 x x -55.49 x x -87.82 x x x x -102.88 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13526 Original post publication description: Central nervous system, behavior: RROD day 2 in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, CORRECTED male R6/2 cases only [sec] Original pre publication description: Central nervous system, behavior: RROD day 2 in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, CORRECTED male R6/2 cases only [sec] Central nervous system, behavior: day 2 in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, CORRECTED male R6/2 cases only [sec] Central nervous system, behavior: motor performance, accelerating rotarod test, day 2 in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington mode, CORRECTED male R6/2 cases only [sec] x -157.76 -78.23 x x -112.89 -66.53 -96.31 x -101.46 -109.49 -115.23 x -129.31 x x -131.89 x -124.65 x x x x x x x 92.58 x x 96.64 x x -97.61 x x x x -128.04 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13527 Original post publication description: Central nervous system, behavior: Total distance in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED Female R6/2 cases only [cm] Original pre publication description: Central nervous system, behavior: Total distance in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED Female R6/2 cases only [cm] Central nervous system, behavior: Total distance in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED Female R6/2 cases only [cm] Central nervous system, behavior: Total distance in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED Female R6/2 cases only [cm] x -12.73 -2425.18 x x -750.99 -3213.52 -761.75 x -1370.32 -300.53 -393.47 x -1293.38 x x -35.75 x -2803.92 x -1010.21 x x x x x -525.17 x x -1564.08 x x -1246.11 x x x x -597.5 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13528 Original post publication description: Central nervous system, behavior: Total distance in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED male R6/2 cases only [cm] Original pre publication description: Central nervous system, behavior: Total distance in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED male R6/2 cases only [cm] Central nervous system, behavior: Total distance in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED male R6/2 cases only [cm] Central nervous system, behavior: Total distance in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED male R6/2 cases only [cm] x -368.91 -3186.45 x x 53.02 -2855.36 -384.62 x -1084.37 459.58 -1238.67 x -1904.38 x x -554.08 x -3444.97 x x x x x x x -997.8 x x 208.5 x x -1278.59 x x x x -786.33 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13529 Original post publication description: Central nervous system, behavior: Rearing behavior in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED female R6/2 cases only [n vertical beam breaks] Original pre publication description: Central nervous system, behavior: Rearing behavior in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED female R6/2 cases only [n vertical beam breaks] Central nervous system, behavior: Rearing behavior in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED female R6/2 cases only [n vertical beam breaks] Central nervous system, behavior: Rearing behavior in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED female R6/2 cases only [n vertical beam breaks] x -165.08 -325.32 x x -260.17 -316.47 -303.02 x -175.43 -132.11 -268.91 x -246.89 x x -244.78 x -321.75 x -247.63 x x x x x -199.37 x x -185.17 x x -252.56 x x x x -172.17 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13530 Original post publication description: Central nervous system, behavior: Rearing behavior in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED male R6/2 cases only [n vertical beam breaks] Original pre publication description: Central nervous system, behavior: Rearing behavior in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED male R6/2 cases only [n vertical beam breaks] Central nervous system, behavior: Rearing behavior in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED male R6/2 cases only [n vertical beam breaks] Central nervous system, behavior: Rearing behavior in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED male R6/2 cases only [n vertical beam breaks] x -177.6 -323.54 x x -189.15 -272.95 -245.54 x -112.85 55.21 -253.0 x -280.34 x x -272.03 x -309.5 x x x x x x x -231.57 x x -57.0 x x -214.42 x x x x -198.34 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13531 Original post publication description: Central nervous system, behavior: Prepulse inhibition, average inhibition for 4, 8, and 12 dB above background in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED Female R6/2 cases only [%] Original pre publication description: Central nervous system, behavior: Prepulse inhibition, average inhibition for 4, 8, and 12 dB above background in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED Female R6/2 cases only [%] Central nervous system, behavior: Prepulse inhibition, average inhibition for 4, 8, and 12 dB above background in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED Female R6/2 cases only [%] Central nervous system, behavior: Prepulse inhibition, average inhibition for 4, 8, and 12 dB above background in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED Female R6/2 cases only [%] x -12.9 -10.9 x x -23.3 -22.1 -23.9 x -6.91 -14.4 -11.3 x -15.0 x x -41.4 x 11.44 x -22.2 x x x x x -21.0 x x -15.7 x x -17.7 x x x x 18.4 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13532 Original post publication description: Central nervous system, behavior: Prepulse inhibition, average inhibition for 4, 8, and 12 dB above background in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED male R6/2 cases only [%] Original pre publication description: Central nervous system, behavior: Prepulse inhibition, average inhibition for 4, 8, and 12 dB above background in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED male R6/2 cases only [%] Central nervous system, behavior: Prepulse inhibition, average inhibition for 4, 8, and 12 dB above background in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED male R6/2 cases only [%] Central nervous system, behavior: Prepulse inhibition, average inhibition for 4, 8, and 12 dB above background in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED male R6/2 cases only [%] x -19.3 -13.5 x x -11.9 -11.7 -19.8 x -13.7 -25.0 2.55 x -8.49 x x -37.3 x -16.0 x x x x x x x -27.6 x x -163.3 x x -13.8 x x x x -34.2 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13533 Original post publication description: Central nervous system, behavior: OFA, boli produced in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTEd R6/2 cases only Original pre publication description: Central nervous system, behavior: OFA, boli produced in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTEd R6/2 cases only Central nervous system, behavior: OFA, boli produced in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTEd R6/2 cases only Central nervous system, behavior: OFA, boli produced in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTEd R6/2 cases only x 2.83 2.2 x x 2.01 2.49 2.73 x 3.38 2.58 0.98 x 2.34 x x -0.69 x 3.56 x 1.51 x x x x x 1.84 x x 0.93 x x 2.58 x x x x 1.54 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13534 Original post publication description: Central nervous system, behavior: Total distance in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED R6/2 cases only [cm] Original pre publication description: Central nervous system, behavior: Total distance in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED R6/2 cases only [cm] Central nervous system, behavior: Total distance in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED R6/2 cases only [cm] Central nervous system, behavior: Total distance in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED R6/2 cases only [cm] x -228.98 -2751.44 x x -375.79 -3043.87 -517.13 x -1270.24 146.58 -749.34 x -1632.82 x x -346.75 x -3160.06 x -1091.21 x x x x x -808.06 x x -500.53 x x -1257.48 x x x x -739.13 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13535 Original post publication description: Central nervous system, behavior: Rearing behavior in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED R6/2 cases only [n vertical beam breaks] Original pre publication description: Central nervous system, behavior: Rearing behavior in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED R6/2 cases only [n vertical beam breaks] Central nervous system, behavior: Rearing behavior in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED R6/2 cases only [n vertical beam breaks] Central nervous system, behavior: Rearing behavior in open-field (OFA) in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED R6/2 cases only [n vertical beam breaks] x -172.68 -324.56 x x -227.02 -295.85 -265.74 x -153.53 -21.92 -262.21 x -265.47 x x 261.13 x -314.94 x -247.0 x x x x x -219.5 x x -108.27 x x -242.46 x x x x -191.8 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13536 Original post publication description: Central nervous system, behavior: Anxiety measured as center-distance to total distance ratio in open-field (OFA) in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED R6/2 mutant cases only [ratio] Original pre publication description: Central nervous system, behavior: Anxiety measured as center-distance to total distance ratio in open-field (OFA) in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED R6/2 mutant cases only [ratio] Central nervous system, behavior: Anxiety measured as center-distance to total distance ratio in open-field (OFA) in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED R6/2 mutant cases only [ratio] Central nervous system, behavior: Anxiety measured as center-distance to total distance ratio in open-field (OFA) in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED R6/2 mutant cases only [ratio] x -0.01 -0.04 x x -0.02 -0.06 0.0 x 0.0 0.0 -0.05 x 0.02 x x 0.0 x 0.0 x -0.06 x x x x x -0.03 x x 0.06 x x -0.01 x x x x -0.1 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13537 Original post publication description: Central nervous system, behavior: Passive avoidance, latency to enter dark on day 1 in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, R6/2 cases only [sec] Original pre publication description: Central nervous system, behavior: Passive avoidance, latency to enter dark on day 1 in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED R6/2 cases only [sec] Central nervous system, behavior: Passive avoidance, latency to enter dark on day 1 in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED R6/2 cases only [sec] Central nervous system, behavior: Passive avoidance, latency to enter dark on day 1 in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, R6/2 cases only [sec] x 22.94 17.74 x x 17.36 17.53 15.3 x 6.34 4.67 4.95 x 9.3 x x 18.15 x 12.64 x 9.67 x x x x x 15.26 x x 15.0 x x 35.1 x x x x 18.3 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13538 Original post publication description: Central nervous system, behavior: Passive avoidance, latency to enter dark on day 2 in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED R6/2 cases only [sec] Original pre publication description: Central nervous system, behavior: Passive avoidance, latency to enter dark on day 2 in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED R6/2 cases only [sec] Central nervous system, behavior: Passive avoidance, latency to enter dark on day 2 in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED R6/2 cases only [sec] Central nervous system, behavior: Passive avoidance, latency to enter dark on day 2 in 8-week F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED R6/2 cases only [sec] x -84.09 -68.86 x x 27.43 -70.45 -41.49 x -92.82 -109.12 -11.85 x -53.46 x x -23.78 x 7.7 x -59.49 x x x x x -4.68 x x -112.5 x x -113.97 x x x x -100.17 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13539 Original post publication description: Central nervous system, behavior: Passive avoidance, latency to enter dark on day 3 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED R6/2 cases only [sec] Original pre publication description: Central nervous system, behavior: Passive avoidance, latency to enter dark on day 3 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED R6/2 cases only [sec] Central nervous system, behavior: Passive avoidance, latency to enter dark on day 3 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED R6/2 cases only [sec] Central nervous system, behavior: Passive avoidance, latency to enter dark on day 3 in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED R6/2 cases only [sec] x 22.7 -65.78 x x -106.22 12.83 -62.1 x -82.91 -47.64 3.03 x -46.58 x x 28.09 x -55.97 x -44.51 x x x x x -42.26 x x -7.07 x x -45.26 x x x x -25.17 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13540 Original post publication description: Central nervous system, behavior: Acoustic startle response (ASR) in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED R6/2 cases only [arbitrary units] Original pre publication description: Central nervous system, behavior: Acoustic startle response (ASR) in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED R6/2 cases only [arbitrary units] Central nervous system, behavior: Acoustic startle response (ASR) in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED R6/2 cases only [arbitrary units] Central nervous system, behavior: Acoustic startle response (ASR) in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED R6/2 cases only [arbitrary units] x 2.26 177.0 x x 37.11 63.82 -29.0 x -14.2 196.0 179.6 x 204.2 x x 119.4 x 575.3 x 90.29 x x x x x -92.9 x x -653.0 x x 79.61 x x x x -228.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13541 Original post publication description: Central nervous system, behavior: Prepulse inhibition, average inhibition for 4, 8, and 12 dB above background in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED R6/2 cases only [%] Original pre publication description: Central nervous system, behavior: Prepulse inhibition, average inhibition for 4, 8, and 12 dB above background in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED R6/2 cases only [%] Central nervous system, behavior: Prepulse inhibition, average inhibition for 4, 8, and 12 dB above background in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED R6/2 cases only [%] Central nervous system, behavior: Prepulse inhibition, average inhibition for 4, 8, and 12 dB above background in 8-week-old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, CORRECTED R6/2 cases only [%] x -16.8 -12.0 x x -18.0 -17.2 -21.2 x -9.32 -20.7 -5.5 x -11.3 x x -38.9 x -3.84 x -20.1 x x x x x -25.1 x x -16.0 x x -16.4 x x x x -30.3 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13542 Original post publication description: Liver, metabolism, toxicology: Hepatocyte plating efficiency at time point 0 hours using cryorederived hepatocytes from young adult male liver [attached cells/cell] Original pre publication description: CQ-5 Liver, metabolism, toxicology: CQ-5 Liver, metabolism, toxicology: Hepatocyte general viability at 0 hr post-thaw in suspension, young adult male pool, Promega CellTiter-Blue fluorometric assay (5 replicates) [RFU/20000 cells/well] x x 47450.0 35508.0 38367.0 45022.0 51008.0 54457.0 x x 35930.0 x 40045.0 55541.0 50044.0 42710.0 47937.0 42486.0 x 39821.0 28721.0 x x x x 43031.0 43016.0 51463.0 x 34848.0 34293.0 x x x x x 35437.0 42140.0 48097.0 x 38398.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13543 Original post publication description: Liver, metabolism, toxicology: Hepatocyte plating efficiency at time point 4 hours using cryorederived hepatocytes from young adult male liver [attached cells/cell] Original pre publication description: CQ-6 Liver, metabolism, toxicology: CQ-6 Liver, metabolism, toxicology: Hepatocyte general viability at 4 hr post-thaw on plates, young adult male pool, Promega CellTiter-Blue fluorometric assay (5 replicates) [RFU/20000 cells/well] x x 53497.0 44332.0 21059.0 32272.0 20508.0 32795.0 x x 49123.0 x 39624.0 50016.0 37801.0 46734.0 34950.0 48402.0 x 25099.0 21079.0 x x x x 41726.0 27329.0 45056.0 x 47401.0 36261.0 x x x x x 35772.0 36958.0 51124.0 x 40556.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13546 Original post publication description: Central nervous system, morphology: Cerebellum residual weight, repeat measurement prior to dissection, statistically adjusted for variation in sex, age, bodyweight and epoch (Hager et al., 2012) [residual mg] Original pre publication description: Central nervous system, morphology: Cerebellum, repeat measurement prior to dissection, statistically adjusted for variation in sex, age, bodyweight and epoch [mg] Central nervous system, morphology: Cerebellum residual weight, repeat measurement prior to dissection, statistically adjusted for variation in sex, age, and body weight [residual mg] Central nervous system, morphology: Cerebellum residual weight, repeat measurement prior to dissection, statistically adjusted for variation in sex, age, and body weight [residual mg] 6.109 5.671 4.59 -2.9 5.57 -5.14 8.17 -2.32 2.84 -1.34 -0.61 -6.15 -5.41 -4.34 -6.4 -0.66 -0.77 -2.34 -2.83 -5.44 0.99 -2.51 x -2.63 -0.64 -4.25 -1.75 -2.89 2.27 -4.52 -1.37 -0.99 -0.8 -1.7 -7.83 5.68 -2.56 0.56 -0.6 x 5.18 2.98 2.51 11.06 x x 4.82 x -0.1 1.44 x x x 1.94 -3.25 x x x -0.42 6.88 3.48 x x -0.73 -2.55 x x 8.69 1.47 x x 0.65 x 1.38 x 1.42 x x -4.63 x x 6.38 x -0.76 5.89 -3.71 x -3.13 -1.93 x -0.59 x x x -0.39 0.15 0.89 2.15 3.75 x x x +13545 Original post publication description: BrdU+ cells/mm of RMS length in BXD RI Original pre publication description: BrdU+ cells/mm of RMS length in BXD RI Central nervous system, adult neurogenesis: Newly generated BrdU-labeled cells in young adult rostral migratory stream (RMS), unadjusted data [N per mm of RMS length] Central nervous system, adult neurogenesis: Newly generated BrdU-labeled cells in young adult rostral migratory stream (RMS), unadjusted data [N per mm of RMS length] x x 43.17 73.34 61.91 61.0 x 63.35 46.7 68.35 54.38 66.93 47.35 65.09 74.18 73.89 54.55 40.23 84.87 63.27 x x x 54.62 x 58.82 96.09 96.67 x 58.29 62.03 48.81 69.02 x x x 84.91 103.21 58.94 x 59.81 64.3 58.32 60.86 x x 68.75 x 44.29 57.16 x x x 36.79 60.72 x x x 52.71 65.48 52.55 40.56 x 53.66 62.32 82.46 111.83 x x 67.67 x 58.07 x 77.79 x 63.83 x x 68.1 x x 64.37 90.27 66.43 68.7 70.34 x 74.8 76.06 x 60.5 x x x 64.52 53.44 74.21 89.23 68.77 x x x +13548 Original post publication description: Central nervous system, morphology: Dorsal striatum (caudate putamen) residual volume, repeat measurement prior to dissection, statistically adjusted for variation in sex, age, bodyweight (Hager et al., 2012) [residual mm^3] Central nervous system, morphology: Dorsal striatum (caudate putamen) residual volume, statistically adjusted for variation in sex, age, body weight, and epoch (Hager et al., 2012) [residual mm^3] Central nervous system, morphology: Dorsal striatum (caudate putamen) residual volume, statistically adjusted for variation in sex, age, body weight, and epoch (Hager et al., 2012) [residual mm^3] x x 0.492 -0.738 3.69 -2.444 5.776 -2.58 -0.891 2.093 2.646 -0.89 -3.049 -0.73 -0.595 -1.201 -0.84 1.202 -1.659 1.983 3.761 -2.325 x 0.658 -1.486 -1.656 -1.639 -2.458 -2.026 -1.388 4.309 1.856 0.445 -1.526 -0.188 x -1.842 0.036 1.573 x 2.129 -0.836 3.583 -0.809 x x x x x 1.689 x x x x x x x x 0.402 x 2.065 0.408 x x x x x -0.775 x x x 0.911 x -0.652 x -0.157 x x x x x 1.211 x -1.507 3.059 -1.705 x -3.585 -1.652 x -1.588 x x x x -1.559 x x x x x x +13549 Original post publication description: Central nervous system, morphology: Basolateral amygdala residual volume, statistically adjusted for variation in sex, age, bodyweight (Hager et al., 2012) [residual mm^3] Original pre publication description: Central nervous system, morphology: Basolateral amygdala residual volume, statistically adjusted for variation in sex, age, bodyweight (Hager et al., 2012) [residual mm^3] Central nervous system, morphology: Basolateral amygdala residual volume, statistically adjusted for variation in sex, age, body weight (Hager et al., 2012, data from Mozhui et al. 2007) [residual mm^3] Central nervous system, morphology: Basolateral amygdala residual volume, statistically adjusted for variation in sex, age, body weight (Hager et al., 2012, data from Mozhui et al. 2007) [residual mm^3] 0.244 0.363 0.158 0.085 0.071 -0.088 0.104 -0.218 0.03 0.057 0.057 -0.022 -0.124 -0.035 -0.072 0.04 -0.013 0.316 0.032 -0.004 0.102 -0.009 x 0.017 -0.039 -0.032 -0.091 -0.378 -0.283 0.04 0.211 -0.201 0.016 -0.008 0.001 0.083 -0.046 -0.133 0.027 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13550 Original post publication description: Central nervous system, morphology: Cerebral cortex (neocortex) residual volume, statistically adjusted for variation in sex, age, bodyweight and epoch (Hager et al., 2012) [residual mm^3] Original pre publication description: Central nervous system, morphology: Cerebral cortex (neocortex) residual volume, statistically adjusted for variation in sex, age, bodyweight and epoch (Hager et al., 2012) [residual mm^3] Central nervous system, morphology: Cerebral cortex (neocortex) residual volume, statistically adjusted for variation in sex, age, body weight, and epoch (Hager et al., 2012) [residual mm^3] Central nervous system, morphology: Cerebral cortex (neocortex) residual volume, statistically adjusted for variation in sex, age, body weight, and epoch (Hager et al., 2012) [residual mm^3] x x 10.901 -10.901 9.828 -11.162 25.348 -20.623 6.966 10.256 7.86 -4.389 -0.234 -1.469 8.674 -2.024 -4.873 3.076 -3.614 5.01 6.013 9.543 x -0.559 1.746 -8.595 -2.957 -11.075 -27.757 -12.506 8.058 -0.875 1.139 -3.006 -0.319 x -3.698 5.88 7.524 x -0.403 -1.346 9.195 -0.165 x x -18.728 x x 9.658 x x x x x x x x -5.824 x 6.727 4.659 x x x x x -3.906 x x x 4.393 x -3.857 x -3.189 x x x x x 11.074 x -3.244 15.296 -8.499 x 8.545 -0.383 x -11.737 x x x x -5.94 x x x x x x +13551 Original post publication description: Central nervous system, morphology: Hippocampus residual weight, repeat measurement prior to dissection, statistically adjusted for variation in sex, age, bodyweight and epoch (Hager et al., 2012) [residual mg] Original pre publication description: Central nervous system, morphology: Hippocampus residual weight, repeat measurement prior to dissection, statistically adjusted for variation in sex, age, bodyweight and epoch (Hager et al., 2012) [residual mg] Central nervous system, morphology: Hippocampus residual weight, repeat measurement prior to dissection, statistically adjusted for variation in sex, age, body weight, and epoch (Hager et al., 2012) [residual mg] Central nervous system, morphology: Hippocampus residual weight, repeat measurement prior to dissection, statistically adjusted for variation in sex, age, body weight, and epoch (Hager et al., 2012) [residual mg] 1.253 1.231 2.082 -3.107 2.044 -1.959 0.994 0.722 1.333 -0.612 0.492 0.785 -0.461 0.955 1.509 2.089 0.586 2.253 -0.676 0.338 -0.046 -1.08 x -2.263 -0.71 -2.396 -2.531 -3.871 -3.793 -1.69 -1.411 1.422 -1.795 0.1 0.991 -1.378 2.167 -0.715 5.152 x 1.946 1.627 1.565 -1.14 x x x x -0.464 0.733 x x x 1.181 1.993 x x x 0.2 -1.121 1.211 x x -1.725 -2.229 x x -0.12 -0.616 x x 2.213 x 0.107 x 2.718 x x -0.836 x x 1.903 x 1.405 0.891 -4.487 x 1.154 -0.727 x -0.661 x x x -1.11 0.995 x 0.557 -1.996 x x x +13552 Original post publication description: Liver, metabolism, toxicology: Hepatocyte injury assay, lactate dehydrogenase (LDH) release in culture medium from control wells corrected for DNA content 33 hours after seeding with 20,000 cells, young adult male liver [ratio LDH/DNA] Original pre publication description: Liver, metabolism, toxicology: CQ-11 Liver, metabolism, toxicology: CQ-11 Liver, metabolism, toxicology: Hepatocyte injury assay, lactate dehydrogenase (LDH) release in culture medium from control wells corrected for DNA content 31.5 hr after seeding with 20,000 cells, young adult male liver (BXD15 winsorized from 223 to 160) [ratio LDH/DNA] x x 82.09 101.01 107.6 124.69 123.49 137.57 x x 110.6 x 102.09 107.16 160.0 104.72 86.26 128.55 x 91.63 56.05 x x x x 97.94 47.04 146.39 x 73.31 58.1 x x x x x 62.08 99.02 102.15 x 83.73 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13553 Original post publication description: Liver, metabolism, toxicology: Hepatocyte plating efficiency, cells per control wells (DNA content assay) 33 hours after seeding with 20,000 cells/well, young adult male liver [DNA units] Original pre publication description: CQ-12 Liver, metabolism, toxicology: CQ-12 Liver, metabolism, toxicology: Hepatocyte plating efficiency, cells per control wells (DNA assay) 31.5 hr after seeding with 20,000 cells/well, young adult male liver [ng/ml] x x 95.7 80.82 45.42 47.09 44.8 43.94 x x 48.4 x 53.68 58.72 52.1 55.03 50.9 51.55 x 43.04 72.76 x x x x 62.2 86.62 74.04 x 74.76 80.16 x x x x x 66.92 68.76 77.32 x 69.48 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13554 Original post publication description: Liver, metabolism, toxicology: Hepatocyte injury assay, lactate dehydrogenase (LDH) release in culture medium from control wells (uncorrected for viable cell number) 33 hours after seeding with 20,000 cells, young adult male liver [LDH units] Original pre publication description: Liver, metabolism, toxicology: CQ-13 Liver, metabolism, toxicology: CQ-13 Liver, metabolism, toxicology: Hepatocyte injury assay, lactate dehydrogenase (LDH) release in culture medium from control wells (uncorrected for viable cell number) 33 hours after seeding with 20,000 cells, young adult male liver (BXD29 and BXD15 winsorized from 10821 and 11658 to 8500 and 9000) [LDH units] x x 7754.0 8157.0 4650.0 5835.0 5540.0 5967.0 x x 5340.0 x 5473.0 6297.0 9000.0 5744.0 4382.0 6658.0 x 3919.0 4082.0 x x x x 6098.0 4074.0 8500.0 x 5470.0 4666.0 x x x x x 4135.0 6773.0 7902.0 x 5803.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13555 Original post publication description: Liver, metabolism, toxicology: Acetaminophen hepatocyte cytotoxicity response 9 hr after treatment (0.5 mM in vehicle), lactate dehydrogenase (LDH) release assay adjusted for DNA content, young adult male liver [LDH/DNA ratio] Original pre publication description: Liver, metabolism, toxicology: CQ-14 Liver, metabolism, toxicology: Acetaminophen hepatocyte viability response 9 hr after treatment (0.5 mM in vehicle), lactate dehydrogenase (LDH) release assay adjusted for DNA content, young adult male liver (BXD31 winsorized from 243 to 200) [LDH/DNA ratio] Liver, metabolism, toxicology: Acetaminophen hepatocyte viability response 9 hr after treatment (0.5 mM in vehicle), lactate dehydrogenase (LDH) release assay adjusted for DNA content, young adult male liver (BXD31 winsorized from 243 to 200) [LDH/DNA ratio] x x 52.34 162.55 123.31 77.87 195.87 97.29 x x 123.73 x 197.28 64.51 150.79 72.56 62.51 191.03 x 64.48 43.75 x x x x 65.33 37.25 168.67 x 200.0 87.92 x x x x x 69.83 142.95 66.16 x 72.32 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13556 Original post publication description: Liver, metabolism, toxicology: Ethanol hepatocyte cytotoxicity response 9 hr after treatment (1.0 M), lactate dehydrogenase (LDH) release assay adjusted for DNA content, young adult male liver [LDH/DNA ratio] Original pre publication description: Liver, metabolism, toxicology: CQ-15 Liver, metabolism, toxicology: CQ-15 Liver, metabolism, toxicology: Ethanol hepatocyte cytotoxicity response 9 hr after treatment (2.0 M), lactate dehydrogenase (LDH) release assay adjusted for DNA content, young adult male liver (BXD15 deleted due to bad LDH control, BXD21 winsorized from 1223 to 900) [LDH/DNA ratio] x x 615.05 322.22 368.88 352.73 528.23 853.37 x x 593.12 x 564.19 889.59 x 570.01 624.49 827.58 x 900.0 300.6 x x x x 210.83 491.16 449.61 x 529.7 388.67 x x x x x 280.33 308.99 587.68 x 508.95 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13557 Original post publication description: Liver, metabolism, toxicology: Maximal hepatocyte cytotoxicity response 9 hr after treatment with lysis buffer, lactate dehydrogenase (LDH) release assay, young adult male liver [LDH] Original pre publication description: Liver, metabolism, toxicology: CQ-16 Liver, metabolism, toxicology: CQ-16 Liver, metabolism, toxicology: Maximal hepatocyte cytotoxicity response 9 hr after treatment with lysis buffer, lactate dehydrogenase (LDH) release assay, young adult male liver [LDH] x x 31865.0 21537.0 15429.0 15998.0 17958.0 23778.0 x x 21932.0 x 23427.0 40841.0 40062.0 29188.0 29289.0 33391.0 x 33991.0 22450.0 x x x x 16769.0 27856.0 19771.0 x 29081.0 21438.0 x x x x x 19616.0 20263.0 29022.0 x 24299.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13558 Original post publication description: Liver, metabolism, toxicology: Acetaminophen hepatocyte cytotoxicity response 9 hr after treatment (0.5 mM in vehicle), lactate dehydrogenase (LDH) assay adjusted for DNA content minus Control LDH/DNA background ratio, young adult male liver [LDH/DNA ratio difference] Original pre publication description: Liver, metabolism, toxicology: CQ-17 Liver, metabolism, toxicology: CQ-17 Liver, metabolism, toxicology: Acetaminophen hepatocyte viability response 9 hr after treatment (0.5 mM in vehicle), lactate dehydrogenase (LDH) assay adjusted for DNA content minus Control LDH/DNA background ratio, young adult male liver (BXD15 deleted due to bad control LDH, BXD31 winsorized from 169.8 to 100) to [LDH/DNA ratio difference] x x -29.75 61.53 15.71 -46.82 72.37 -40.29 x x 13.13 x 95.18 -42.65 x -32.15 -23.92 62.47 x -27.15 -12.3 x x x x -32.61 -9.79 22.28 x 100.0 29.82 x x x x x 7.75 43.94 -35.99 x -11.41 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13559 Original post publication description: Liver, metabolism, toxicology: Ethanol hepatocyte cytotoxicity response 9 hrs after treatment (1.0 M), lactate dehydrogenase (LDH) assay adjusted for DNA content minus Control LDH/DNA background ratio, young adult male liver [LDH/DNA ratio difference] Original pre publication description: Liver, metabolism, toxicology: CQ-18 Liver, metabolism, toxicology: CQ-18 Liver, metabolism, toxicology: Ethanol hepatocyte cytotoxicity response 9 hr after treatment (2.0 M), lactate dehydrogenase (LDH) assay adjusted for DNA content minus Control LDH/DNA background ratio, young adult male liver (BXD15 deleted due to bad LDH control, BXD21 winsorized from 1131 to 800) [LDH/DNA ratio difference] x x 532.96 221.2 261.28 228.05 404.74 715.8 x x 482.52 x 462.1 782.43 x 465.3 538.23 699.03 x 800.0 244.54 x x x x 112.89 444.12 303.23 x 456.4 330.57 x x x x x 218.25 209.97 485.53 x 425.22 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13560 Original post publication description: Liver, metabolism, toxicology: Ethanol hepatocyte cytotoxicity response 9 hr after treatment (1.0 M), lactate dehydrogenase (LDH) release assay, young adult male liver [LDH] Original pre publication description: Liver, metabolism, toxicology: CQ-19 Liver, metabolism, toxicology: CQ-19 Liver, metabolism, toxicology: Ethanol hepatocyte cytotoxicity response 9 hr after treatment (2.0 M), lactate dehydrogenase (LDH) release assay (relative fluorescent units), young adult male liver [RFU] x x 35405.0 20184.0 13528.0 13729.0 18219.0 23972.0 x x 20769.0 x 21166.0 39807.0 42347.0 26870.0 25016.0 33619.0 x 34045.0 20677.0 x x x x 15562.0 33108.0 30980.0 x 29743.0 19803.0 x x x x x 16243.0 19259.0 31913.0 x 23654.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13561 Original post publication description: Liver, metabolism, toxicology: Ethanol hepatocyte cytotoxicity response 9 hr after treatment (1.0 M), ratio of ethanol-induced release to maximal (lysis) lactate dehydrogenase (LDH) release, young adult male liver [ratio] Original pre publication description: Liver, metabolism, toxicology: CQ-20 Liver, metabolism, toxicology: CQ-20 Liver, metabolism, toxicology: Ethanol hepatocyte cytotoxicity response 9 hr after treatment (2.0 M), ratio of ethanol-induced release to maximal (lysis) lactate dehydrogenase (LDH) release, young adult male liver (BXD15 deleted due to bad LDH control, BXD29 winsorized from 1.57 to 1.20) [ratio] x x 1.11 0.94 0.88 0.86 1.01 1.01 x x 0.95 x 0.9 0.97 x 0.92 0.85 1.01 x 1.0 0.92 x x x x 0.93 1.19 1.2 x 1.02 0.92 x x x x x 0.83 0.95 1.1 x 0.97 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +13562 Original post publication description: Endocrine system: Serum coricosterone 15 min following 15 min restraint in normally housed controls [ng/ml] Original pre publication description: Trait 1 for Byron Jones Endocrine system: Corticosterone in serum 15 min following 15 min restraint in females (6-8 months) for normally housed control group for chronic mild stress (CMS) [ng/ml] Endocrine system: Corticosterone in serum 15 min following 15 min restraint in females (6-8 months) for normally housed control group for chronic mild stress (CMS) [ng/ml] x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 353.21 162.11 x x x x x 586.39 x x x x 355.64 x x x x x x 267.94 x x x 330.04 x x x 246.48 272.36 x x x x x x x x 352.44 x x 382.06 x x 200.73 345.46 x x 157.2 x x x x x x x 240.99 x 266.11 x x x +13563 Original post publication description: Endocrine system: Serum coricosterone 15 min following 15 min restraint following 7 weeks of chronic mild stress (CMS) [ng/ml] Original pre publication description: Trait 2 for Byron Jones Endocrine system: Corticosterone in serum 15 min following 15 min of restraint in adult females (6-8 months) following 7 weeks of chronic mild stress (CMS) [ng/ml] Endocrine system: Corticosterone in serum 15 min following 15 min of restraint in adult females (6-8 months) following 7 weeks of chronic mild stress (CMS) [ng/ml] x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 311.0 235.77 x x x x x 577.09 x x x x 310.97 x x x x x x 543.51 x x x 256.44 x x x 330.5 450.75 x x x x x x x x 472.77 x x 555.5 x x 209.07 369.9 x x 166.61 x x x x x x x 187.88 x 281.86 x x x +13564 Original post publication description: Endocrine system: Serum coricosterone difference, 15 min following 15 min restraint, chronic mild stress (CMS) cases minus contro casesl [ng/ml] Original pre publication description: Trait 3 for Byron Jones Endocrine system: Corticosterone difference in serum 15 min following 15 min of restraint in adult females (6-8 months) following 7 weeks of chronic mild stress (CMS), CMS group minus control [ng/ml] Endocrine system: Corticosterone difference in serum 15 min following 15 min of restraint in adult females (6-8 months) following 7 weeks of chronic mild stress (CMS), CMS group minus control [ng/ml] x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x -42.21 73.66 x x x x x -9.3 x x x x -44.67 x x x x x x 275.57 x x x -73.6 x x x 84.02 178.39 x x x x x x x x 120.32 x x 173.44 x x 8.35 24.44 x x 9.41 x x x x x x x -53.11 x 15.75 x x x +13565 Original post publication description: Ethanol response, EtOH consumed ( 20%v/v), drinking in the dark paradigm, 4h on day 4, at baseline in normally housed controls [g/kg] Original pre publication description: Trait 4 for Byron Jones Central nervous system, pharmacology, behavior: Ethanol response (20% v/v), consumption using drinking in the dark (DID) method (4 hr access on day 4 of DID) in females, baseline in normally housed group, control for chronic mild stress (CMS) group (Phase 1) [g/kg] Central nervous system, pharmacology, behavior: Ethanol response (20% v/v), consumption using drinking in the dark (DID) method (4 hr access on day 4 of DID) in females, baseline in normally housed group, control for chronic mild stress (CMS) group (Phase 1) [g/kg] x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 5.98 7.63 x x x x x 7.6 x x x x 7.97 x x x x x x 17.89 x x x 10.2 x x x 8.79 5.1 x x x x x x x x 4.06 x x 4.75 x x 10.81 4.32 x x 10.54 x x x x x x x 15.73 x 7.21 x x x +13566 Original post publication description: Ethanol response, EtOH consumed (20%v/v), drinking in the dark paradigm, 4h on day 4,at baseline in chronic mild stress (CMS) cases but prior to CMS [g/kg] Original pre publication description: Trait 5 for Byron Jones Central nervous system, pharmacology, behavior: Ethanol response (20% v/v), consumption using drinking in the dark (DID) method (4 hr access on day 4 of DID) in females, baseline in chronic mild (CMS) stress group 1 week before start of 7 weeks of CMS (Phase 1) [g/kg] Central nervous system, pharmacology, behavior: Ethanol response (20% v/v), consumption using drinking in the dark (DID) method (4 hr access on day 4 of DID) in females, baseline in chronic mild (CMS) stress group 1 week before start of 7 weeks of CMS (Phase 1) [g/kg] x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 5.3 3.79 x x x x x 5.68 x x x x 12.05 x x x x x x 5.3 x x x 4.44 x x x 8.36 5.27 x x x x x x x x 5.51 x x 4.99 x x 7.56 7.61 x x 4.63 x x x x x x x 10.51 x 8.31 x x x +13567 Original post publication description: Ethanol response, difference in EtOH consumed (20%v/v), drinking in the dark paradigm, 4h on day 4,at baseline in chronic mild stress (CMS) cases vs control, but prior to chronic mild stress [g/kg] Original pre publication description: Trait 6 for Byron Jones Central nervous system, pharmacology, behavior: Ethanol response (20% v/v), consumption using drinking in the dark (DID) method (4 hr access on day 4 of DID, first DID) in females, difference between chronic mild stress (CMS) and control groups one week before the start of 7 weeks of CMS (Phase 1) [g/kg] Central nervous system, pharmacology, behavior: Ethanol response (20% v/v), consumption using drinking in the dark (DID) method (4 hr access on day 4 of DID, first DID), difference between chronic mild stress (CMS) and control groups one week before the start of 7 weeks of CMS (Phase 1) [g/kg] x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x -0.68 -3.84 x x x x x -1.92 x x x x 4.08 x x x x x x -12.59 x x x -5.76 x x x -0.44 0.17 x x x x x x x x 1.45 x x 0.24 x x -3.25 3.29 x x -5.91 x x x x x x x -5.22 x 1.11 x x x +13568 Original post publication description: Ethanol response, EtOH consumed (20%v/v), drinking in the dark paradigm, 4h on day 4, week 6 or 7 in normally housed controls [g/kg] Original pre publication description: Trait 7 for Byron Jones Central nervous system, pharmacology, behavior: Ethanol response (20% v/v), consumption using drinking in the dark (DID) method (4 hr access on day 4 of DID, second DID phase) in females, control group for chronic mild stress (CMS) group (Phase 1) [g/kg] Central nervous system, pharmacology, behavior: Ethanol response (20% v/v), consumption using drinking in the dark (DID) method (4 hr access on day 4 of DID, second DID phase) in females, control group for chronic mild stress (CMS) group (Phase 1) [g/kg][g/kg] x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 3.18 3.76 x x x x x 4.24 x x x x 5.36 x x x x x x 3.69 x x x 7.44 x x x 6.38 5.4 x x x x x x x x 3.54 x x 2.15 x x 7.15 4.67 x x 4.13 x x x x x x x 8.35 x 4.7 x x x +13569 Original post publication description: Ethanol response, EtOH consumed (20%v/v), drinking in the dark paradigm, 4h on day 4, in CMS animals during chronic mild stress [g/kg] Original pre publication description: Trait 8 for Byron Jones Central nervous system, pharmacology, behavior: Ethanol response (20% v/v), consumption using drinking in the dark (DID) method (4 hr access on day 4 of DID, second DID) in females, chronic mild stress (CMS) group (Phase 2) [g/kg] Central nervous system, pharmacology, behavior: Ethanol response (20% v/v), consumption using drinking in the dark (DID) method (4 hr access on day 4 of DID, second DID) in females, chronic mild stress (CMS) group (Phase 2) [g/kg] x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 3.99 3.78 x x x x x 3.54 x x x x 6.38 x x x x x x 6.43 x x x 6.76 x x x 6.49 4.83 x x x x x x x x 2.5 x x 3.42 x x 6.86 6.96 x x 4.78 x x x x x x x 10.5 x 5.51 x x x +13570 Original post publication description: Ethanol response, difference in EtOH consumed (20%v/v), drinking in the dark paradigm, 4h on day 4,at baseline CMS vs control, during chronic mild stress [g/kg] Original pre publication description: Trait 9 for Byron Jones Central nervous system, pharmacology, behavior: Ethanol response (20% v/v), consumption using drinking in the dark (DID) method (4 hr access on day 4 of DID, second DID) in females, difference between chronic mild stress (CMS) group and control group (Phase 2) [g/kg] Central nervous system, pharmacology, behavior: Ethanol response (20% v/v), consumption using drinking in the dark (DID) method (4 hr access on day 4 of DID, second DID) in females, difference between chronic mild stress (CMS) group and control group (Phase 2) [g/kg] x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.81 0.02 x x x x x -0.69 x x x x 1.02 x x x x x x 2.75 x x x -0.68 x x x 0.11 -0.57 x x x x x x x x -1.05 x x 1.27 x x -0.29 2.29 x x 0.65 x x x x x x x 2.16 x 0.82 x x x +13571 Original post publication description: Ethanol response, EtOH consumed (20%v/v), drinking in the dark paradigm, 4h on day 4, week 7 or 8 in normally housed controls [g/kg] Original pre publication description: Trait 10 for Byron Jones Central nervous system, pharmacology, behavior: Ethanol response (20% v/v), consumption using drinking in the dark (DID) method (4 hr access on day 4 of DID, third DID)in females, in the control group for the chronic mild stress (CMS) group (Phase 3) [g/kg] Central nervous system, pharmacology, behavior: Ethanol response (20% v/v), consumption using drinking in the dark (DID) method (4 hr access on day 4 of DID, third DID)in females, in the control group for the chronic mild stress (CMS) group (Phase 3) [g/kg] x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 4.03 4.8 x x x x x 3.44 x x x x 4.09 x x x x x x 5.51 x x x 8.25 x x x 5.22 5.03 x x x x x x x x 2.87 x x 2.6 x x 7.23 4.25 x x -6.01 x x x x x x x 10.6 x 4.62 x x x +13572 Original post publication description: Ethanol response, EtOH consumed (20%v/v), drinking in the dark paradigm, 4h on day 4, in chronic mild stress (CMS) cases one week following CMS [g/kg] Original pre publication description: Trait 11 for Byron Jones Central nervous system, pharmacology, behavior: Ethanol response (20% v/v), consumption using drinking in the dark (DID) method (4 hr access on day 4 of DID, third DID) in females, chronic mild stress (CMS) group following CMS (Phase 3) [g/kg] Central nervous system, pharmacology, behavior: Ethanol response (20% v/v), consumption using drinking in the dark (DID) method (4 hr access on day 4 of DID, third DID) in females, chronic mild stress (CMS) group following CMS (Phase 3) [g/kg] x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 4.14 4.62 x x x x x 4.32 x x x x 8.02 x x x x x x 6.12 x x x 6.49 x x x 4.22 4.63 x x x x x x x x 4.26 x x 3.3 x x 7.27 7.03 x x -0.31 x x x x x x x 10.31 x 4.17 x x x +13573 Original post publication description: Ethanol response, difference in EtOH consumed (20%v/v), drinking in the dark paradigm, 4h on day 4,at baseline CMS vs control, following chronic mild stress [g/kg] Original pre publication description: Trait 12 for Byron Jones Central nervous system, pharmacology, behavior: Ethanol response (20% v/v), consumption using drinking in the dark (DID) method (4 hr access on day 4 of DID, third DID) in females, difference between chronic mild stress (CMS) group and control group following CMS (Phase 3) [g/kg] Central nervous system, pharmacology, behavior: Ethanol response (20% v/v), consumption using drinking in the dark (DID) method (4 hr access on day 4 of DID, third DID) in females, difference between chronic mild stress (CMS) group and control group following CMS (Phase 3) [g/kg] x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.12 -0.18 x x x x x 0.88 x x x x 3.93 x x x x x x 0.62 x x x -1.76 x x x -1.0 -0.4 x x x x x x x x 1.4 x x 0.71 x x 0.04 2.78 x x 5.7 x x x x x x x -0.29 x -0.45 x x x +13574 Original post publication description: Ethanol response, difference in EtOH consumed (20%v/v), drinking in the dark paradigm, 4h on day 4, week 8-9 vs week 6-7 [g/kg] Original pre publication description: Trait 13 for Byron Jones Central nervous system, pharmacology, behavior: Ethanol response (20% v/v), consumption using drinking in the dark (DID) method (4 hr access on day 4 of DID) in females, within-group change (phase 3 minus phase 2) in the control group [g/kg] Central nervous system, pharmacology, behavior: Ethanol response (20% v/v), consumption using drinking in the dark (DID) method (4 hr access on day 4 of DID) in females, within-group change (phase 3 minus phase 2) in the control group [g/kg] x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.85 1.05 x x x x x -0.79 x x x x -1.27 x x x x x x 1.83 x x x 0.81 x x x -1.15 -0.37 x x x x x x x x -0.68 x x 0.45 x x 0.08 -0.42 x x 0.4 x x x x x x x 2.26 x -0.07 x x x +13575 Original post publication description: Ethanol response, difference in EtOH consumed (g/kg, 20%v/v), drinking in the dark paradigm, 4h on day 4, post stress vs chronic mild stress (CMS) [g/kg] Original pre publication description: Trait 14 for Byron Jones Central nervous system, pharmacology, behavior: Ethanol response (20% v/v), consumption using drinking in the dark (DID) method (4 hr access on day 4 of DID) in females, within-group change (phase 3 minus phase 2) in the chronic mild stress (CMS) group [g/kg] Central nervous system, pharmacology, behavior: Ethanol response (20% v/v), consumption using drinking in the dark (DID) method (4 hr access on day 4 of DID) in females, within-group change (phase 3 minus phase 2) in the chronic mild stress (CMS) group [g/kg] x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.16 0.84 x x x x x 0.78 x x x x 1.64 x x x x x x -0.31 x x x -0.27 x x x -2.27 -0.19 x x x x x x x x 1.77 x x -1.68 x x 0.41 0.07 x x -0.46 x x x x x x x -0.19 x -1.34 x x x +13576 Original post publication description: Ethanol response, difference in EtOH consumed ( 20%v/v), drinking in the dark paradigm, 4h on day 4, week 6 or 7 vs basseline [g/kg] Original pre publication description: Trait 15 for Byron Jones Central nervous system, pharmacology, behavior: Ethanol response (20% v/v), consumption using drinking in the dark (DID) method (4 hr access on day 4 of DID) in females, within-group change (phase 2 minus phase 1) in the control group for chronic mild stress (CMS) group [g/kg] Central nervous system, pharmacology, behavior: Ethanol response (20% v/v), consumption using drinking in the dark (DID) method (4 hr access on day 4 of DID) in females, within-group change (phase 2 minus phase 1) in the control group for chronic mild stress (CMS) group [g/kg] x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x -2.8 -3.87 x x x x x -3.36 x x x x -2.61 x x x x x x -14.21 x x x -2.76 x x x -2.41 0.29 x x x x x x x x -0.53 x x -2.6 x x -3.66 0.36 x x -6.41 x x x x x x x -7.38 x -2.51 x x x +13577 Original post publication description: Ethanol response, difference in EtOH consumed (20%v/v), drinking in the dark paradigm, 4h on day 4, chronic mild stress (CMS) vs baseline [g/kg] Original pre publication description: Trait 16 for Byron Jones Central nervous system, pharmacology, behavior: Ethanol response (20% v/v), consumption using drinking in the dark (DID) method (4 hr access on day 4 of DID) in females, within-group change (phase 2 minus phase 1) for the chronic mild stress (CMS) group [g/kg] Central nervous system, pharmacology, behavior: Ethanol response (20% v/v), consumption using drinking in the dark (DID) method (4 hr access on day 4 of DID) in females, within-group change (phase 2 minus phase 1) for the chronic mild stress (CMS) group [g/kg] x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x -1.31 -0.01 x x x x x -2.13 x x x x -5.67 x x x x x x 1.13 x x x 2.32 x x x -1.87 -0.44 x x x x x x x x -3.02 x x -1.57 x x -0.7 -0.65 x x 0.15 x x x x x x x 0.0 x -2.8 x x x +13578 Original post publication description: Ethanol response, difference in EtOH consumed (20%v/v), drinking in the dark paradigm, 4h on day 4, week 8-9 vs baseline [g/kg] Original pre publication description: Trait 17 for Byron Jones Central nervous system, pharmacology, behavior: Ethanol response (20% v/v), consumption using drinking in the dark (DID) method (4 hr access on day 4 of DID) in females, within-group change (phase 3 minus phase 1) for the control group for chronic mild stress (CMS) [g/kg] Central nervous system, pharmacology, behavior: Ethanol response (20% v/v), consumption using drinking in the dark (DID) method (4 hr access on day 4 of DID) in females, within-group change (phase 3 minus phase 1) for the control group for chronic mild stress (CMS) [g/kg] x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x -1.95 -2.83 x x x x x -4.16 x x x x -3.88 x x x x x x -12.38 x x x -1.95 x x x -3.57 -0.07 x x x x x x x x -1.2 x x -2.15 x x -3.58 -0.06 x x -6.01 x x x x x x x -5.13 x -2.59 x x x +13579 Original post publication description: Ethanol response, difference in EtOH consumed (20%v/v), drinking in the dark paradigm, 4h on day 4, post stress stress vs baseline [g/kg] Original pre publication description: Trait 18 for Byron Jones Central nervous system, pharmacology, behavior: Ethanol response (20% v/v), consumption using drinking in the dark (DID) method (4 hr access on day 4 of DID) in females, within-group change (phase 3 minus phase 1) for the chronic mild stress (CMS) group [g/kg] Central nervous system, pharmacology, behavior: Ethanol response (20% v/v), consumption using drinking in the dark (DID) method (4 hr access on day 4 of DID) in females, within-group change (phase 3 minus phase 1) for the chronic mild stress (CMS) group [g/kg] x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x -1.15 0.84 x x x x x -1.36 x x x x -4.03 x x x x x x 0.82 x x x 2.05 x x x -4.14 -0.64 x x x x x x x x -1.25 x x -1.68 x x -0.29 -0.58 x x -0.31 x x x x x x x -0.19 x -4.14 x x x +13580 Original post publication description: Endocrine system: Adrenal gland weights in normally housed controls [mg] Original pre publication description: Trait 19 for Byron Jones Endocrinology, neuroendocrine system, morphology: Adrenal gland weight in normally housed females (6–8 months) [mg x 10] Endocrinology, neuroendocrine system, morphology: Adrenal gland weight in normally housed females (6–8 months) [mg x 10] x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 15.0 10.0 x x x x x 22.0 x x x x 23.0 x x x x x x 12.0 x x x 12.0 x x x 18.0 28.0 x x x x x x x x 15.0 x x 17.0 x x 15.0 19.0 x x 13.0 x x x x x x x 11.0 x 29.0 x x x +13581 Original post publication description: Endocrine system: Adrenal gland weights in chronic mild stress (CMS) cases following CMS [mg] Original pre publication description: Trait 20 for Byron Jones Endocrinology, neuroendocrine system, morphology: Adrenal gland weights in chronic mild stress (CMS) cases following CMS in adult females (6-8 months) [mg x 10] Endocrinology, neuroendocrine system, morphology: Adrenal gland weights in chronic mild stress (CMS) cases following CMS in adult females (6-8 months) [mg x 10] x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 16.0 26.0 x x x x x 13.0 x x x x 16.0 x x x x x x 12.0 x x x 19.0 x x x 10.0 10.0 x x x x x x x x 12.0 x x 12.0 x x 12.0 16.0 x x 8.0 x x x x x x x 11.0 x 14.0 x x x +13582 Original post publication description: Endocrine system: Thymus gland weight differences, chronic mild stress (CMS) vs control [mg] Original pre publication description: Trait 21 for Byron Jones Endocrinology, neuroendocrine system, morphology: Adrenal weight difference in adult females (6-8 months) between chronic mild stress group (CMS for 7 weeks) and control group [mg x 10] Endocrinology, neuroendocrine system, morphology: Adrenal weight difference in adult females (6-8 months) between chronic mild stress group (CMS for 7 weeks) and control group [mg x 10] x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 1.0 16.0 x x x x x -9.0 x x x x -7.0 x x x x x x 0.0 x x x 7.0 x x x -8.0 -18.0 x x x x x x x x -3.0 x x -5.0 x x -3.0 -3.0 x x -5.0 x x x x x x x 0.0 x -15.0 x x x +13583 Original post publication description: Endocrine system: Thymus gland weights in normally housed controls [mg] Original pre publication description: Trait 22 for Byron Jones Endocrine system, immune system: Thymus weight in normally housed adult female controls (6–8 months) for chronic mild stress (CMS) [mg x 10] Endocrine system, immune system: Thymus weight in normally housed adult female controls (6–8 months) for chronic mild stress (CMS) [mg x 10] x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 36.0 40.0 x x x x x 32.0 x x x x 41.0 x x x x x x 27.0 x x x 21.0 x x x 35.0 37.0 x x x x x x x x 39.0 x x 21.0 x x 25.0 38.0 x x 45.0 x x x x x x x 20.0 x 43.0 x x x +13584 Original post publication description: Endocrine system: Thymus gland weights in chronic mild stress (CMS) cases following CMS [mg] Original pre publication description: Trait 23 for Byron Jones Endocrine system, immune system: Thymus weight in adult females (6–8 months) following 7 weeks of chronic mild stress (CMS) [mg x 10] Endocrine system, immune system: Thymus weight in adult females (6–8 months) following 7 weeks of chronic mild stress (CMS) [mg x 10] x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 33.0 24.0 x x x x x 36.0 x x x x 31.0 x x x x x x 26.0 x x x 24.0 x x x 26.0 33.0 x x x x x x x x 34.0 x x 27.0 x x 17.0 36.0 x x 35.0 x x x x x x x 24.0 x 43.0 x x x +13585 Original post publication description: Endocrine system: Thymus gland weight differences, chronic mild stress (CMS) vs control [mg] Original pre publication description: Trait 24 for Byron Jones Endocrine system: Thymus gland weight difference in adult females (6-8 months), chronic mild stress (CMS) group minus control group [mg x 10] Endocrine system: Thymus gland weight difference in adult females (6-8 months), chronic mild stress (CMS) group minus control group [mg x 10] x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x -3.0 -16.0 x x x x x 4.0 x x x x -10.0 x x x x x x -1.0 x x x 3.0 x x x -9.0 -4.0 x x x x x x x x -5.0 x x 6.0 x x -8.0 -2.0 x x -10.0 x x x x x x x 4.0 x 0.0 x x x +13586 Original post publication description: BrdU+ cells/mm of RMS length in BXD RI (adjusted for differences in age) Original pre publication description: BrdU+ cells/mm of RMS length in BXD RI (adjusted for differences in age) Central nervous system, adult neurogenesis: Newly generated BrdU-labeled cells in the rostral migratory stream of adult mouse brain, data corrected for age effects [N cells per mm of RMS length] Central nervous system, adult neurogenesis: Newly generated BrdU-labeled cells in the rostral migratory stream of adult mouse brain, data corrected for age effects [N cells per mm of RMS length] x x x x 54.32 57.46 x 60.65 27.18 69.15 42.63 70.58 29.31 64.05 83.25 83.76 47.64 15.14 103.52 62.95 x x x 45.49 x 52.63 130.5 128.41 x 47.45 57.76 35.41 71.72 x x x 102.85 138.25 53.81 x 54.48 61.89 49.17 56.58 x x 71.78 x 25.03 47.66 x x x 8.47 59.45 x x x 42.1 63.06 40.92 14.95 x 41.45 56.57 97.01 157.35 x x 67.43 x 53.15 x 87.95 x 63.86 x x 72.22 x x 62.69 114.56 67.47 72.76 74.28 x 86.33 85.59 x 54.43 x x x 65.46 45.75 85.21 117.19 73.06 x x x +13587 Original post publication description: Central nervous system, morphology: Cerebellum residual weight, repeat measurement prior to dissection, statistically adjusted for variation in sex, age, body weight, and epoch (Hager et al., 2012) [residual mg] Original pre publication description: Central nervous system, morphology: Cerebellum residual weight, repeat measurement prior to dissection, statistically adjusted for variation in sex, age, body weight, and epoch (Hager et al., 2012) [residual mg] Central nervous system, morphology: Cerebellum residual weight, repeat measurement prior to dissection, statistically adjusted for variation in sex, age, body weight, and epoch (Hager et al., 2012) [residual mg] Central nervous system, morphology: Cerebellum residual weight, repeat measurement prior to dissection, statistically adjusted for variation in sex, age, body weight, and epoch (Hager et al., 2012) [residual mg] 7.844 6.948 5.487 -2.234 6.382 -3.908 9.07 -1.901 3.422 -0.252 -0.039 -5.693 -4.862 -3.508 -5.451 0.636 0.37 -1.556 -2.507 -4.864 1.79 -1.85 x -2.63 -0.137 -3.542 -0.619 -1.859 2.706 -3.747 -0.487 -0.673 0.582 -0.761 -7.355 5.435 -2.161 1.606 0.054 x 6.132 0.956 0.527 8.447 x x 3.143 x -2.476 -0.456 x x x 0.257 -5.786 x x x -1.987 5.694 1.869 x x -2.725 -5.306 x x 6.743 -1.254 x x -1.171 x -0.853 x -0.261 x x -6.109 x x 3.633 x -1.917 4.611 -6.091 x -4.777 -3.334 x -2.223 x x x -1.69 -1.241 -0.429 0.673 3.136 x x x +13588 Original post publication description: Central nervous system, morphology: Lateral geniculate nucleus residual volume, repeat measurement prior to dissection, statistically adjusted for variation in sex, age, and body weight (Hager et al., 2012, data from Seecharan et al., 2003) [mm^3] Original pre publication description: Central nervous system, morphology: Lateral geniculate nucleus residual volume, repeat measurement prior to dissection, statistically adjusted for variation in sex, age, and body weight (Hager et al., 2012, data from Seecharan et al., 2003) [mm^3] Central nervous system, morphology: Lateral geniculate nucleus residual volume, repeat measurement prior to dissection, statistically adjusted for variation in sex, age, and body weight (Hager et al., 2012, data from Seecharan et al., 2003) [mm^3] Central nervous system, morphology: Lateral geniculate nucleus residual volume, repeat measurement prior to dissection, statistically adjusted for variation in sex, age, and body weight (Hager et al., 2012, data from Seecharan et al., 2003) [mm^3] 0.313 0.334 0.303 0.261 0.291 0.228 0.356 x 0.207 0.267 0.327 0.224 0.247 0.251 0.276 0.256 0.239 0.302 0.239 x 0.341 0.358 x 0.242 0.254 0.243 0.221 0.256 0.235 0.261 0.266 0.225 0.265 0.266 0.265 x 0.258 0.294 0.338 x 0.298 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +15731 None Trait_170_AUW-BXD Metabolism: Body temperature loss between 3 to 6 hours after being placed in 4 deg C chamber, high fat diet, males [%] x x 1.3355 2.6927 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 2.525 1.1043 2.2636 x x -0.4 0.1 0.4 -0.446 x x x 1.0762 1.6 x x x x 0.9258 2.39 5.27 2.2 0.27 10.0 x -1.8 -0.44 -1.2276 1.3 x -2.7547 x 0.1024 x x x -0.5 0.4817 -0.9 x -3.86 1.315 0.455 x 0.8088 x 0.908 0.764 x x x x -1.78 -1.04 3.3 2.61 0.98 1.96 2.1 x -0.5 +15732 None Trait_171_AUW-BXD Metabolism: Body temperature, high fat diet / chow diet, basal, males [ratio] x x 1.0016 1.0061 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 1.0136 1.0065 1.0011 x x 1.011 1.005 1.0823 0.9847 x x x 1.0012 0.9843 x x x x 0.9781 0.984 0.9906 0.998 0.9882 1.0091 x 0.9925 0.9861 1.0066 1.0114 x 1.0148 x 0.9948 x x x 1.0335 1.0143 0.996 x 0.9887 0.9881 0.9997 x 1.008 x 1.0107 0.9928 x x x x 0.9711 1.0082 1.013 1.0257 1.0 0.9992 1.0137 x 1.0309 +15733 None Trait_172_AUW-BXD Metabolism: Body temperature after 6 hours in 4 deg C chamber, high fat diet / chow diet, males [ratio] x x 1.0227 0.9913 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.9944 0.9613 1.0101 x x 1.065 1.003 1.0152 0.9863 x x x 1.0017 1.0322 x x x x 0.9993 0.999 0.9971 0.9838 1.0337 0.956 x 1.0077 1.0234 1.0372 1.0525 x 1.0393 x 1.0032 x x x 0.9803 1.0177 1.047 x 1.013 1.0973 1.0021 x 1.005 x 1.054 1.0205 x x x x 0.9926 1.0503 0.9474 1.0125 0.96 1.0076 0.9829 x 1.0315 +15734 None Trait_173_AUW-BXD Central nervous system, metabolism, behavior: Activity (movement) during full day (24 hours), in standard housing cage, chow diet, males [counts/hour] x x 4764.0 4471.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 4423.0 2753.0 5237.0 x x 3893.0 3090.0 3224.0 3342.0 x x x 4129.0 6964.0 x x x 3972.0 2958.0 3006.0 3114.0 4080.0 3526.0 3045.0 x 4241.0 4524.0 4427.0 2906.0 x 3742.0 x 3554.0 x x x 2659.0 3398.0 3186.0 x 3072.0 3619.0 2585.0 x 3148.0 x 3388.0 2563.0 x 4003.0 x x 3406.0 3462.0 3572.0 3785.0 4548.0 4149.0 5817.0 x 2829.0 +15735 None Trait_174_AUW-BXD Central nervous system, metabolism, behavior: Activity (movement) during light phase (day), in standard housing cage, chow diet, males [counts/hour] x x 3644.0 2058.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 3209.0 2220.0 2334.0 x x 2475.0 1892.0 1937.0 2084.0 x x x 2033.0 4126.0 x x x 2881.0 1407.0 2416.0 2104.0 3068.0 2435.0 2557.0 x 2845.0 3031.0 3512.0 2240.0 x 1982.0 x 2979.0 x x x 1776.0 1966.0 2658.0 x 2039.0 1793.0 1814.0 x 1262.0 x 3156.0 1526.0 x 2886.0 x x 2481.0 1827.0 3372.0 2372.0 2688.0 1981.0 3302.0 x 1741.0 +15709 None Trait_148_AUW-BXD Respiratory system, metabolism: Oxygen intake (VO2) light phase (day) average, lean mass corrected, metabolic cage, high fat diet, males [ml/kg/h] x x 4197.0 4368.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 3769.0 x 4414.0 x x x x x 4740.0 x x x 5001.0 x x x x x 3592.0 3589.0 4238.0 x 4432.0 4620.0 x x 4693.0 4670.0 x x 4478.0 x 4192.0 x x x x 4490.0 x x 4613.0 3832.0 x x 4440.0 x 4179.0 4175.0 x x x x x 4044.0 x x x 4202.0 x x x +15707 None Trait_146_AUW-BXD Central nervous system, metabolism, behavior: Water intake in 24 h, metabolic cage, high fat diet, males [ml] x x 1.535 1.533 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 1.447 0.895 1.79 x x 1.17 2.55 0.548 0.81 x x x 3.44 1.535 x x x x 1.632 1.695 1.79 1.365 1.395 2.432 x 2.05 1.24 3.0 2.785 x 0.764 x 1.148 x x x 1.464 1.62 0.985 x 1.08 2.01 3.27 x 1.845 x 2.645 1.48 x x x x 0.652 0.275 1.53 1.184 1.148 2.512 1.335 x 1.77 +15705 None Trait_144_AUW-BXD Central nervous system, metabolism, behavior: Food intake in 24 h, metabolic cage, high fat diet, males [kCal] x x 9.4962 11.1333 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 11.2863 15.7335 8.2722 x x x x x 9.231 x x x 15.5448 6.7218 x x x x 13.3926 8.67 11.4852 9.0882 11.6688 11.1996 x x 8.0376 13.5558 11.6127 x 5.763 x 5.0592 x x x 10.9446 x 10.4295 x 6.8187 22.2207 17.748 x 10.2255 x 10.8477 x x x x x 7.4766 5.814 11.8575 9.0372 x 9.8328 6.885 x 16.2435 +15703 None Trait_142_AUW-BXD Central nervous system, metabolism, behavior: Food intake in 24 h, metabolic cage, high fat diet, males [g] x x 1.862 2.183 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 2.213 3.085 1.622 x x x x x 1.81 x x x 3.048 1.318 x x x x 2.626 1.7 2.252 1.782 2.288 2.196 x x 1.576 2.658 2.277 x 1.13 x 0.992 x x x 2.146 x 2.045 x 1.337 4.357 3.48 x 2.005 x 2.127 x x x x x 1.466 1.14 2.325 1.772 x 1.928 1.35 x 3.185 +15701 None Trait_140_AUW-BXD Metabolism, behavior: Activty (rearing) at night, metabolic cage, high fat diet, males [AUC] x x 525.4 241.9 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 436.02 302.4 141.0 x x 438.99 336.5 571.9 111.2 x x x 167.32 178.0 x x x x 267.4 268.15 316.99 4010.5 470.4 97.82 x 323.4 372.13 207.5 352.0 x 27.5 x 115.8 x x x 331.8 208.74 284.14 x 191.38 490.86 356.7 x 309.32 x 577.64 61.115 x x x x 411.7 148.99 409.9 614.9 1417.8 513.84 1004.8 x 337.47 +15699 None Trait_138_AUW-BXD Metabolism, behavior: Activty (ambulations) at night, metabolic cage, high fat diet, males [AUC] x x 607.708 460.07 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 671.2 296.2 302.8 x x 415.07 505.86 677.5 223.4 x x x 370.3 481.0 x x x x 408.4 501.2 534.3 685.03 794.7 203.66 x 585.92 475.5 352.115 610.0 x 101.3 x 306.6 x x x 611.99 434.3 378.2 x 378.76 697.35 499.9 x 537.2 x 871.3 236.4 x x x x 426.5 273.8 645.6 788.4 965.6 563.9 1272.4 x 567.2 +15697 None Trait_136_AUW-BXD Metabolism, behavior: Activity (movement) at night, metabolic cage, high fat diet, males [AUC] x x 1488.0 1245.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 1655.1 775.03 774.4 x x 1062.0 1142.0 1436.2 570.7 x x x 833.0 1277.0 x x x x 1138.0 1328.6 1201.9 1723.1 1619.0 805.6 x 1501.3 1213.4 790.9 1610.0 x 395.08 x 763.6 x x x 1501.4 1150.4 1050.6 x 1159.95 1640.2 1319.7 x 1379.6 x 1911.97 773.6 x x x x 1083.7 994.0 1557.8 1709.7 1869.8 1375.8 2453.4 x 1212.2 +15695 None Trait_128_AUW-BXD Respiratory system, metabolism: Carbon dioxide output (VCO2) over 24 hours, metabolic cage, high fat diet, males [mL/kg/h] x x 2529.0 2226.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 2282.0 1696.0 2563.0 x x 1421.0 1692.0 1923.0 1957.0 x x x 3471.0 1776.0 x x x x 1925.0 1924.0 1999.0 2084.0 1973.0 1920.0 x 2605.0 2153.0 2775.0 1547.0 x 2400.0 x 2013.0 x x x 2141.0 2438.0 1418.0 x 2534.0 1939.0 1935.0 x 2634.0 x 2196.0 1909.0 x x x x 1858.0 1805.0 1975.0 1796.0 2040.0 2316.0 1826.0 x 2020.0 +15693 None Trait_126_AUW-BXD Respiratory system, metabolism: Carbon dioxide output (VCO2) dark phase (night) average, metabolic cage, high fat diet, males [mL/kg/h] x x 2701.0 2376.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 2543.0 1772.0 2764.0 x x 1481.0 1832.0 2086.0 2083.0 x x x 3710.0 1920.0 x x x x 2080.0 2099.0 2223.0 2239.0 2129.0 2067.0 x 2812.0 2340.0 2887.0 1656.0 x 2588.0 x 2127.0 x x x 2289.0 2669.0 1477.0 x 2729.0 2128.0 1898.0 x 2816.0 x 2378.0 2076.0 x x x x 1955.0 1863.0 2111.5 1975.0 2136.0 2468.0 1927.0 x 2225.0 +15691 None Trait_124_AUW-BXD Respiratory system, metabolism: Carbon dioxide output (VCO2) light phase (day) average, metabolic cage, high fat diet, males [mL/kg/h] x x 2256.0 1988.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 1988.0 1576.0 2244.0 x x 1353.0 1524.0 1629.0 1758.0 x x x 3092.0 1536.0 x x x x 1680.0 1749.0 1769.0 1910.0 1786.0 1689.0 x 2385.0 1951.0 2599.0 1387.0 x 2101.0 x 1834.0 x x x 1924.0 2073.0 1322.0 x 2225.0 1711.0 1963.0 x 2346.0 x 1978.0 1707.0 x x x x 1710.0 1713.0 1808.0 1580.0 1932.0 2074.0 1643.0 x 1789.0 +15689 None Trait_122_AUW-BXD Respiratory system, metabolism: Oxygen intake (VO2) over 24 hours, metabolic cage, high fat diet, males [mL/kg/h] x x 3246.0 2845.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 2971.0 2155.0 3280.0 x x 1832.0 2089.0 2856.0 2533.0 x x x 4268.0 3118.0 x x x x 2401.0 2491.0 2566.0 2728.0 2581.0 2476.0 x 3445.0 2840.0 3462.0 2817.0 x 3142.0 x 2681.0 x x x 3116.0 3179.0 2574.0 x 3393.0 2502.0 2418.0 x 3374.0 x 2910.0 2502.0 x x x x 2862.0 2405.0 2860.0 2417.0 2664.0 2983.0 2784.0 x 2642.0 +15687 None Trait_120_AUW-BXD Respiratory system, metabolism: Oxygen intake (VO2) dark phase (night) average, metabolic cage, high fat diet, males [mL/kg/h] x x 3441.0 3023.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 3257.0 2247.0 3511.0 x x 1935.0 2257.0 3079.0 2689.0 x x x 4518.0 3331.0 x x x x 2573.0 2673.0 2814.0 2891.0 2772.0 2646.0 x 3668.0 3069.0 3594.0 3003.0 x 3391.0 x 2811.0 x x x 3309.0 3470.0 2665.0 x 3645.0 2693.0 2391.0 x 3603.0 x 3145.0 2698.0 x x x x 2986.0 2488.0 3068.0 2621.0 2771.0 3156.0 2942.0 x 2861.0 +15685 None Trait_118_AUW-BXD Respiratory system, metabolism: Oxygen intake (VO2) light phase (day) average, metabolic cage, high fat diet, males [mL/kg/h] x x 2936.0 2565.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 2649.0 2010.0 2914.0 x x 1716.0 1887.0 2452.0 2287.0 x x x 3871.0 2760.0 x x x x 2129.0 2309.0 2312.0 2490.0 2353.0 2208.0 x 3208.0 2593.0 3253.0 2545.0 x 2748.0 x 2474.0 x x x 2834.0 2718.0 2422.0 x 2996.0 2271.0 2435.0 x 3011.0 x 2646.0 2282.0 x x x x 2674.0 2274.0 2604.0 2173.0 2544.0 2709.0 2498.0 x 2395.0 +15683 None Trait_116_AUW-BXD Respiratory system, metabolism: Respiratory exchange ratio (RER) over 24 hours, metabolic cage, high fat diet, males [ratio] x x 0.776875 0.7821 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.765 0.7838 0.7796 x x 0.774 0.808 0.67 0.771175 x x x 0.81082 0.568 x x x x 0.79982 0.77 0.776 0.761 0.763 0.77366 x 0.755 0.757 0.799 0.545 x 0.76188 x 0.74754 x x x 0.688 0.76736 0.55 x 0.7459 0.773 0.7925 x 0.78015 x 0.75 0.758 x x x x 0.649 0.748325 0.69 0.74 0.764 0.77494 0.654 x 0.764 +15681 None Trait_114_AUW-BXD Respiratory system, metabolism: Respiratory exchange ratio (RER) dark phase (night), metabolic cage, high fat diet, males [ratio] x x 0.7833 0.78555 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.779 0.78628 0.78605 x x 0.764 0.809 0.674 0.773325 x x x 0.81788 0.576 x x x x 0.80688 0.784 0.788 0.768 0.767 0.77864 x 0.766 0.762 0.8011 0.548 x 0.76286 x 0.75422 x x x 0.693 0.76986 0.553 x 0.748875 0.789 0.80261 x 0.780125 x 0.755 0.766 x x x x 0.654 0.7466 0.688 0.751 0.769 0.78026 0.653 x 0.778 +15679 None Trait_112_AUW-BXD Respiratory system, metabolism: Respiratory exchange ratio (RER) light phase (day), metabolic cage, high fat diet, males [ratio] x x 0.76725 0.776925 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.749 0.7803 0.769975 x x 0.786 0.806 0.664 0.768 x x x 0.79976 0.556 x x x x 0.78924 0.757 0.763 0.753 0.758 0.76622 x 0.743 0.751 0.7958 0.541 x 0.7604 x 0.7373 x x x 0.68 0.76364 0.544 x 0.74145 0.753 0.78247 x 0.780175 x 0.744 0.749 x x x x 0.64 0.750875 0.693 0.726 0.758 0.767 0.657 x 0.748 +15677 None Trait_108_AUW-BXD Musculoskeletal system, morphology: Soleus muscle mass, percentage of body, high fat diet, males [%] x x 0.049 0.038 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.038 0.027 0.044 x x 0.05 0.051 0.041 0.031 x x x 0.034 0.046 x x x x 0.028 0.037 0.034 0.045 0.035 0.026 x 0.053 0.049 0.037 0.048 x 0.042 x 0.033 x x x 0.028 0.038 0.038 x 0.042 0.033 0.034 x 0.042 x 0.038 0.029 x x x x 0.05 0.038 0.041 0.047 0.045 0.037 0.038 x 0.046 +15675 None Trait_106_AUW-BXD Musculoskeletal system, morphology: Gastrocnemius muscle mass, percentage of body, high fat diet, males [%] x x 0.735 0.634 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.71 0.457 0.749 x x 0.617 0.743 0.615 0.528 x x x 0.71 0.783 x x x x 0.582 0.634 0.567 0.61 0.519 0.437 x 0.755 0.756 0.728 0.636 x 0.747 x 0.646 x x x 0.584 0.614 0.587 x 0.706 0.561 0.657 x 0.713 x 0.672 0.52 x x x x 0.789 0.567 0.615 0.601 0.658 0.664 0.627 x 0.643 +15673 None Trait_104_AUW-BXD Morphology: Epididymal white adipose mass, percentage of body, high fat diet, males [%] x x 4.114 5.229 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 5.853 5.67 4.6 x x 3.584 6.147 6.213 4.791 x x x 4.267 2.822 x x x x 7.521 4.73 4.382 4.963 3.408 6.891 x 3.41 1.863 2.798 2.681 x 4.401 x 4.747 x x x 4.115 3.565 3.88 x 4.109 5.48 2.61 x 5.187 x 2.634 4.455 x x x x 5.228 3.487 4.796 4.735 5.129 5.936 6.344 x 3.337 +15671 None Trait_102_AUW-BXD Urogenital system, morphology: Kidney mass, percentage of body, high fat diet, males [%] x x 0.945 1.455 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.796 0.778 1.25 x x 0.763 1.034 1.099 0.837 x x x 1.325 1.437 x x x x 0.962 0.945 0.905 1.012 0.754 0.882 x 1.013 1.484 1.533 1.237 x 1.512 x 1.14 x x x 1.255 1.037 0.969 x 1.309 1.276 0.954 x 1.138 x 1.308 0.974 x x x x 1.03 0.897 1.11 1.087 0.996 0.922 0.977 x 1.091 +15669 None Trait_100_AUW-BXD Morphology: Perirenal white adipose mass, percentage of body, high fat diet, males [%] x x 3.39 3.393 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 2.918 5.491 3.354 x x 3.807 2.987 3.088 7.13 x x x 1.236 1.915 x x x x 4.15 5.22 3.73 6.35 6.303 4.924 x 3.61 3.308 4.18 4.814 x 3.16 x 3.071 x x x 5.63 3.082 3.778 x 2.093 4.927 3.41 x 3.675 x 3.041 3.375 x x x x 5.97 4.694 4.65 5.179 4.887 4.35 3.395 x 3.347 +15667 None Trait_98_AUW-BXD Morphology: Subcutaneous white adipose mass, percentage of body, high fat diet, males [%] x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 4.477 7.792 2.954 x x 5.234 2.725 4.533 7.272 x x x 3.832 2.225 x x x x 4.031 3.4 3.462 5.737 3.884 5.036 x 5.171 5.008 5.095 5.097 x 3.791 x 4.366 x x x 3.141 x 7.53 x 3.257 4.071 4.34 x 3.492 x 3.66 5.515 x x x x 4.01 4.047 4.14 5.155 5.219 4.1 7.002 x 5.201 +15665 None Trait_96_AUW-BXD Cardiovascular systen, morphology: Heart mass, percentage of body, high fat diet, males [%] x x 0.489 0.485 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.289 0.308 0.481 x x 0.302 0.393 0.37 0.32 x x x 0.449 0.491 x x x x 0.343 x 0.508 0.373 0.336 0.347 x 0.419 0.435 0.479 0.416 x 0.51 x 0.356 x x x 0.42 0.516 0.389 x 0.534 0.356 0.372 x 0.552 x 0.396 0.328 x x x x 0.342 0.329 0.442 0.364 0.41 0.436 0.37 x 0.432 +15663 None Trait_94_AUW-BXD Gastrointestinal system, morphology: Liver mass, percentage of body, high fat diet, males [%] x x 4.745 4.023 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 2.69 4.014 3.942 x x 3.44 5.106 2.574 3.901 x x x 4.621 3.728 x x x x 6.167 3.405 2.796 4.083 5.898 2.671 x 3.059 4.394 4.841 4.264 x 2.816 x 5.664 x x x 4.043 3.646 4.157 x 4.678 4.709 5.396 x 3.216 x 4.075 2.588 x x x x 3.264 5.311 5.361 6.9 4.121 5.396 5.075 x 3.483 +15661 None Trait_90_AUW-BXD Musculoskeletal system, morphology: Soleus muscle mass, high fat diet, males [g] x x 0.0232 0.0185 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.0187 0.017 0.0198 x x 0.0279 0.0234 0.0195 0.0197 x x x 0.015 0.0189 x x x x 0.0149 0.017 0.0165 0.02 0.0223 0.0158 x 0.0231 0.0179 0.0186 0.0258 x 0.0188 x 0.0153 x x x 0.0136 0.0178 0.0187 x 0.0154 0.0188 0.0194 x 0.0164 x 0.0174 0.0141 x x x x 0.0267 0.0231 0.0207 0.0248 0.0233 0.0209 0.0195 x 0.0222 +15659 None Trait_88_AUW-BXD Musculoskeletal system, morphology: Gastrocnemius muscle mass, high fat diet, males [g] x x 0.346 0.306 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.35 0.294 0.335 x x 0.342 0.343 0.295 0.338 x x x 0.313 0.323 x x x x 0.306 0.289 0.275 0.302 0.333 0.265 x 0.333 0.297 0.367 0.337 x 0.326 x 0.299 x x x 0.279 0.287 0.291 x 0.259 0.317 0.372 x 0.279 x 0.306 0.258 x x x x 0.418 0.348 0.315 0.315 0.339 0.376 0.324 x 0.312 +15657 None Trait_86_AUW-BXD Morphology: Epididymal white adipose mass, high fat diet, males [g] x x 1.914 2.527 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 2.896 3.66 2.077 x x 1.951 2.97 2.98 3.041 x x x 1.864 1.164 x x x x 4.013 2.14 2.13 2.478 2.173 4.19 x 1.342 1.288 1.406 1.417 x 1.923 x 2.193 x x x 2.023 1.664 1.923 x 1.511 3.106 1.48 x 2.002 x 1.199 2.86 x x x x 2.8 2.13 2.498 2.504 2.65 3.364 3.344 x 1.613 +15655 None Trait_84_AUW-BXD Urogenital system, morphology: Kidney mass, high fat diet, males [g] x x 0.446 0.704 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.392 0.502 0.556 x x 0.424 0.486 0.527 0.538 x x x 0.576 0.593 x x x x 0.506 0.43 0.439 0.504 0.483 0.535 x 0.466 0.452 0.796 0.659 x 0.663 x 0.528 x x x 0.616 0.484 0.479 x 0.482 0.722 0.542 x 0.444 x 0.596 0.483 x x x x 0.537 0.551 0.565 0.57 0.513 0.523 0.505 x 0.53 +15653 None Trait_82_AUW-BXD Morphology: Perirenal white adipose mass, high fat diet, males [g] x x 1.618 1.64 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 1.43 3.541 1.417 x x 2.17 1.241 1.483 4.595 x x x 0.54 0.79 x x x x 2.255 2.374 1.81 3.245 4.046 3.012 x 1.359 0.951 0.213 2.588 x 1.397 x 1.424 x x x 2.744 1.444 1.868 x 0.785 2.864 1.95 x 1.451 x 1.39 1.74 x x x x 3.28 2.899 2.543 2.74 2.533 2.496 1.766 x 1.622 +15651 None Trait_80_AUW-BXD Morphology: Subcutaneous white adipose mass, high fat diet, males [g] x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 2.197 5.025 1.33 x x 2.934 1.396 2.176 4.672 x x x 1.677 0.919 x x x x 2.159 1.55 1.68 2.905 2.496 3.163 x 1.848 0.876 2.556 2.738 x 1.692 x 2.045 x x x 1.554 x 3.727 x 1.229 2.366 2.47 x 1.38 x 1.67 2.89 x x x x 2.202 2.493 2.223 2.72 2.71 2.35 3.642 x 2.536 +15649 None Trait_76_AUW-BXD Cardiovascular system, morphology: Heart mass, high fat diet, males [g] x x 0.231 0.234 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.142 0.199 0.218 x x 0.168 0.181 0.178 0.205 x x x 0.2 0.203 x x x x 0.18 x 0.246 0.185 0.215 0.21 x 0.17 0.178 0.24 0.221 x 0.223 x 0.167 x x x 0.206 0.242 0.192 x 0.197 0.201 0.211 x 0.215 x 0.181 0.162 x x x x 0.179 0.204 0.231 0.192 0.212 0.247 0.191 x 0.209 +15647 None Trait_74_AUW-BXD Gastrointestinal system, liver, morphology, metabolism: Liver mass, high fat diet, males [g] x x 2.271 1.947 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 1.33 2.585 1.749 x x 1.968 2.37 1.235 2.275 x x x 2.02 1.539 x x x x 3.245 1.56 1.35 2.051 3.783 1.623 x 1.294 1.207 2.455 2.302 x 1.24 x 2.627 x x x 1.989 1.716 2.054 x 1.735 2.693 3.054 x 1.498 x 1.857 1.289 x x x x 1.753 3.315 2.817 3.648 2.138 3.104 2.634 x 1.692 +15645 None Trait_72_AUW-BXD Central nervous system, metabolism, behavior: Locomotor activity, 24 h running distance, activity wheel, high fat diet, males [km] x x 4.07342 8.47794 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 7.839 0.58742 6.92763 x x 2.41702 0.343074 1.876 1.37038 x x x 7.43505 1.434 x x x x 1.74106 0.436 2.525 3.1639 0.661 0.07354 x 7.94 2.41 6.56752 2.25 x 1.8023 x 4.50654 x x x 0.34705 0.79265 3.231 x 2.3104 5.402 1.224 x 1.5181 x 5.202 3.142 x x x x 3.42 0.9941 0.48 1.75 7.19 5.9094 4.781 x 2.221 +15644 None Trait_71_AUW-BXD Central nervous system, metabolism, behavior: Locomotor activity, dark phase (night) running distance, activity wheel, high fat diet, males [km] x x 3.81538 7.37066 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 7.6368 0.58448 6.39895 x x 2.40864 0.33061 1.876 1.24505 x x x 7.1339 1.351 x x x x 1.73806 0.373 2.396 3.105 0.658 0.06072 x 7.851 2.377 5.62775 2.2485 x 1.80218 x 4.47518 x x x 0.34535 0.78425 3.215 x 2.2919 4.8732 1.21 x 1.515 x 5.137 3.109 x x x x 2.93 0.968 0.43 1.65 7.01 5.74158 4.744 x 2.213 +15642 None Trait_69_AUW-BXD Central nervous system, metabolism, behavior: Locomotor activity, 24 h running distance, activity wheel, chow diet, males [km] x x 6.87665 3.65133 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 8.303 2.88284 5.10822 x x 3.0462 0.657987 2.075 5.0758 x x x 4.10118 5.45 x x x 1.23443 3.18617 2.664 2.18 3.8823 0.8544 0.27982 x 7.38 3.363 4.2289 5.81 x 1.8 x 4.38496 x x x 0.8729 1.05327 6.685 x 1.7471 7.12 1.44 x 1.17795 x 6.096 3.274 x 1.45 x x 2.8 3.47655 3.91 5.22 6.42 2.82097 8.46 x 2.678 +15640 None Trait_67_AUW-BXD Central nervous system, metabolism, behavior: Locomotor actvity, light phase (day) running distance, activity wheel, chow diet, males [km] x x 0.1108 0.0008 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.382 0.2998 0.3963 x x 0.1098 0.0121 0.001 1.0126 x x x 0.1365 0.032 x x x 0.001 0.0973 0.156 0.181 0.02 0.0043 0.0134 x 0.641 0.111 0.3269 0.256 x 0.0001 x 0.0364 x x x 0.0019 0.0004 0.1243 x 0.0395 1.02 0.056 x 0.0104 x 0.247 0.029 x 0.063 x x 0.35 0.0204 0.253 0.053 1.02 0.3769 0.114 x 0.025 +15638 None Trait_65_AUW-BXD Cardiovascular system, physiology: Systolic blood pressure, high fat diet, males [mmHg] x x 111.5 108.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 101.7 126.875 101.857 x x 107.2 107.175 105.6 98.625 x x x 116.0 119.9 x x x x 110.375 101.54 105.625 121.8 101.0 106.5 x 109.1 110.65 131.25 107.3 x 104.75 x 100.625 x x x 100.6 123.375 115.6 x 104.875 99.61 104.7 x 112.875 x 123.0 98.25 x x x x 120.8 111.333 111.3 103.6 117.655 99.385 105.886 x 128.8 +15636 None Trait_63_AUW-BXD Cardiovascular system, physiology: Heart rate, chow diet, males [bpm] x x 716.125 702.25 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 758.0 625.375 763.125 x x 714.887 712.0 657.0 691.0 x x x 682.25 726.6 x x x 663.43 743.0 628.59 694.625 674.55 644.72 698.25 x 750.33 700.0 671.875 680.2 x 639.75 x 711.625 x x x 753.929 673.0 648.287 x 626.2 667.9 700.538 x 735.28 x 708.375 705.0 x 652.41 x x 680.959 676.0 643.2 661.2 676.58 792.8 702.2 x 672.6 +15634 None Trait_61_AUW-BXD Cardiovascular system, physiology: Diastolic blood pressure, chow diet, males [mmHg] x x 93.5 87.5 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 68.5 79.625 88.875 x x 77.9 68.3 58.6 75.625 x x x 93.0 73.6 x x x 91.58 79.857 74.281 93.11 89.84 80.9 75.75 x 78.1 83.17 73.625 100.3 x 80.125 x 91.875 x x x 65.6571 92.75 76.1 x 91.5 83.4 69.28 x 80.14 x 78.875 84.625 x 73.411 x x 94.739 77.83 83.4 74.6 85.475 68.67 80.9 x 89.6 +15632 None Trait_59_AUW-BXD Metabolism, morphology: Body weight loss pre-sacrifice, chow diet, males [g] x x x 1.3275 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 3.22 3.884 1.7 x x 2.15 2.0 2.62 1.81 x x x 1.96 2.39 x x x 2.57 x 2.75 1.3 2.26 2.07 2.2 x 1.52 0.79 1.91 2.32 x 2.8 x 2.52 x x x 1.92 2.6 1.64 x 1.72 1.94 3.88 x 0.392 x 2.08 1.29 x 3.1 x x 0.95 2.85 2.72 2.1 2.43 2.82 0.94 x 2.54 +15631 None Trait_58_AUW-BXD Metabolism, morphology: Body weight fat loss percentage after exercise, high fat diet, males [%] x x 16.59 51.73 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 48.13 2.65 x x x 18.94 5.57 x x x x x x 68.94 x x x x 2.54 5.56 25.33 17.65 -2.61 1.47 x 42.7 13.89 x 7.96 x x x 24.92 x x x -2.63 x 14.0 x 14.38 37.71 3.98 x 19.4 x 15.73 39.09 x x x x 26.61 12.11 9.0 6.46 38.42 23.78 16.83 x 7.83 +15629 None Trait_50_AUW-BXD Metabolism, morphology: Body weight loss percentage after exercise, high fat diet, males [%] x x 8.16 19.7 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 15.37 2.19 17.75 x x 10.02 2.38 8.32 9.19 x x x 14.88 2.78 x x x x 0.91 2.49 10.64 7.93 -1.53 0.74 x 19.37 5.96 22.81 5.54 x 3.87 x 10.82 x x x -1.67 3.17 9.09 x 5.4 16.2 -1.27 x 5.57 x 5.7 17.21 x x x x 10.94 9.23 4.21 2.66 19.58 10.26 8.8 x 3.23 +15627 None Trait_48_AUW-BXD Metabolism, morphology: Body weight gain 8-28 weeks, high fat diet, males [g] x x 22.18 18.34 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 27.59 39.94 22.72 x x 30.83 20.75 20.75 31.83 x x x 19.98 18.73 x x x x 26.21 19.67 19.09 24.67 35.24 29.03 x 19.33 15.4 19.5 23.47 x 16.12 x 19.34 x x x 29.62 22.46 28.09 x 13.35 32.94 27.15 x 14.87 x 19.52 26.03 x x x x 26.9 28.34 24.16 26.84 26.0 25.53 22.67 x 21.28 +15625 None Trait_46_AUW-BXD Metabolism, morphology: Body weight gain 8-16 weeks, high fat diet, males [g] x x 9.48 17.7 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 13.59 26.56 13.89 x x 21.64 10.67 16.45 23.48 x x x 11.36 13.55 x x x x 18.51 12.91 15.7 17.85 22.08 17.43 x 19.37 17.77 12.32 16.91 x 14.65 x 15.76 x x x 21.21 17.52 21.24 x 10.26 21.14 20.4 x 10.2 x 14.95 21.31 x x x x 19.17 20.14 17.97 17.51 18.86 16.76 16.58 x 16.96 +15623 None Trait_44_AUW-BXD Metabolism, morphology: Body weight gain percentage 8-28 weeks, chow diet, males [%] x x 39.45 46.7 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 44.82 50.25 34.68 x x 39.54 26.92 36.47 34.88 x x x 25.49 26.26 x x x 68.42 31.07 26.1 36.23 37.64 72.89 55.99 x 52.22 43.43 31.62 43.79 x 21.51 x 28.22 x x x 54.74 47.92 34.84 x 27.28 43.3 59.67 x 25.39 x 34.43 46.4 x 78.12 x x 43.34 47.69 43.51 47.15 30.64 51.12 43.48 x 34.44 +15621 None Trait_42_AUW-BXD Metabolism, morphology: Body weight percentage gain 8-16 weeks, chow diet, males [%] x x 30.53 34.62 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 32.5 41.52 25.38 x x 27.87 13.79 15.73 21.46 x x x 22.22 19.52 x x x 16.66 24.01 17.48 22.05 35.03 42.9 33.64 x 64.97 60.65 31.98 52.84 x 22.75 x 29.62 x x x 98.23 71.05 94.56 x 43.57 87.5 69.92 x 16.47 x 11.6 21.31 x 46.08 x x 72.28 66.78 60.15 62.4 75.68 58.65 61.13 x 59.23 +15619 None Trait_40_AUW-BXD Metabolism, morphology: Lean mass percentage after activity wheel, high fat diet, males [%] x x 62.189 75.596 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 74.99 40.62 x x x 54.211 61.0697 61.85 x x x x x 73.66 x x x x 55.25 59.16 63.6 59.34 48.45 45.263 x 70.67 61.84 74.405 58.7 x x x 62.42 x x x 59.86 58.1 53.62 x 67.8 66.38 59.89 x 69.59 x 70.48 62.12 x x x x 64.33 56.3 57.5 58.3 63.67 62.412 58.6 x 58.13 +15617 None Trait_38_AUW-BXD Metabolism, morphology: Lean mass after activity wheel, high fat diet, males [g] x x 26.63 26.94 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 27.756 25.269 x x x 26.9638 30.8532 26.17 x x x x x 29.486 x x x x 29.36 25.313 26.15 25.767 28.975 25.4526 x 24.52 23.5 26.997 29.9 x x x 24.0294 x x x 28.48 26.44 24.14 x 23.85 28.61 32.01 x 23.48 x 26.86 26.13 x x x x 28.895 31.713 29.17 29.4 26.454 30.186 27.23 x 27.25 +15615 None Trait_36_AUW-BXD Metabolism, morphology: Fat mass after activity wheel, high fat diet, males [%] x x 35.4 20.96 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 20.04 57.36 x x x 43.067 35.567 34.71 x x x x x 22.6 x x x x 41.732 37.77 33.65 37.986 48.66 51.94 x 25.7 35.17 21.4975 38.4 x x x 33.682 x x x 37.15 39.1 43.29 x 29.54 30.39 37.4 x 26.39 x 26.54 34.75 x x x x 32.79 41.02 38.95 39.02 33.1 32.91 38.2 x 38.82 +15613 None Trait_34_AUW-BXD Metabolism, morphology: Fat mass after activity wheel, high fat diet, males [g] x x 15.296 7.7 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 7.504 35.74 x x x 21.6498 19.2298 14.758 x x x x x 9.045 x x x x 22.25 16.14 13.9 16.66 29.1 29.855 x 9.169 13.5514 8.236 19.72 x x x 13.361 x x x 17.74 17.83 19.51 x 10.62 15.24 20.1 x 9.09 x 10.18 15.77 x x x x 15.762 23.192 20.1 19.74 14.279 16.5 18.06 x 18.21 +15611 None Trait_32_AUW-BXD Metabolism, morphology: Body weight after activity wheel, high fat diet, males [g] x x 35.866 41.94 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 37.1 62.245 39.486 x x 49.97 51.72 42.39 55.378 x x x 35.125 40.0 x x x x 53.21 42.77 41.18 43.58 59.805 56.876 x 34.94 38.172 36.7325 51.1 x 41.82 x 38.896 x x x 47.65 45.558 45.04 x 35.38 45.25 53.5 x 33.935 x 38.55 43.26 x x x x 45.97 56.4 51.03 50.494 42.112 49.046 46.783 x 46.886 +15609 None Trait_30_AUW-BXD Metabolism, morphology: Lean mass percentage before activity wheel, high fat diet, males [%] x x 58.035 59.99 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 63.44 39.59 x x x 49.65 60.665 x x x x x 77.845 69.83 x x x x 55.388 58.44 57.05 54.5 49.03 44.464 x 60.2 58.57 x 57.4 x x x 56.358 x x x 60.15 56.382 51.99 x 64.6 54.6 57.91 x 65.6075 x 66.0 48.29 x x x x 56.32 55.55 55.45 56.95 54.08 56.44 54.77 x 56.56 +15607 None Trait_28_AUW-BXD Metabolism, morphology: Lean mass before activity wheel, high fat diet, males [g] x x 27.074 26.8646 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 27.79 24.73 x x x 27.51 31.291 x x x x x 27.2925 28.77 x x x x 29.7338 25.65 26.3 25.7 28.887 25.2768 x 26.14 23.772 x 30.97 x x x 24.4252 x x x 28.1772 26.511 25.89 x 24.05 28.891 30.995 x 23.4695 x 27.0 25.051 x x x x 28.84 34.45 29.43 29.497 28.1304 30.913 28.05 x 27.42 +15605 None Trait_26_AUW-BXD Metabolism, morphology: Fat mass percentage before activity wheel, high fat diet, males [%] x x 39.09 36.898 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 32.3 58.68 x x x 47.92 36.545 x x x x x 16.5825 26.41 x x x x 42.42 39.01 40.3 42.77 48.15 52.505 x 36.82 38.94 x 39.4 x x x 40.306 x x x 36.79 40.161 45.5 x 32.65 42.36 38.87 x 30.8025 x 31.1 48.34 x x x x 41.07 42.36 41.04 40.63 43.23 40.01 42.09 x 40.81 +15603 None Trait_24_AUW-BXD Metabolism, morphology: Fat mass before activity wheel, high fat diet, males [g] x x 18.275 16.7448 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 14.23 36.77 x x x 26.57 19.954 x x x x x 5.877 10.9 x x x x 22.7954 17.1 18.57 20.41 28.37 30.177 x 15.99 15.848 x 21.4 x x x 17.9242 x x x 17.2818 18.908 22.68 x 12.25 22.686 20.87 x 11.1217 x 12.7 25.16 x x x x 21.27 26.32 21.96 21.1176 22.637 21.5514 21.58 x 19.78 +15601 None Trait_22_AUW-BXD Metabolism, morphology: Body weight before activity wheel, high fat diet, males [g] x x 46.7 44.99 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 43.87 62.57 44.958 x x 55.414 52.69 46.07 61.973 x x x 41.908 41.18 x x x x 53.706 43.86 46.1 47.4 58.913 57.166 x 43.43 40.644 47.583 54.1 x 42.736 x 43.814 x x x 46.898 47.0475 49.85 x 37.32 53.187 53.593 x 35.905 x 40.84 51.96 x x x x 51.46 62.08 53.245 51.884 52.156 54.396 51.24 x 48.48 +15599 None Trait_20_AUW-BXD Metabolism, morphology: Lean mass percentage pre-metabolic caging, high fat diet, males [%] x x 70.855 58.44 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 70.77 45.0816 66.4 x x 53.46 68.14 x 48.285 x x x 77.718 70.0 x x x x 59.442 64.47 54.64 57.4 53.22 48.686 x 67.56 40.88 69.89 59.48 x 61.548 x 58.428 x x x 60.96 60.192 55.055 x 65.319 59.45 59.34 x 69.614 x 63.53 54.52 x x x x 58.797 56.312 59.94 57.8 59.24 63.712 58.98 x 58.05 +15597 None Trait_18_AUW-BXD Metabolism, morphology: Lean mass pre-metabolic caging, high fat diet, males [g] x x 24.337 24.7945 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 25.52 23.2312 24.5798 x x 26.3398 30.023 x 25.2878 x x x 26.132 27.46 x x x x 28.994 25.778 24.8 24.83 27.3 23.7436 x 24.228 22.54 26.912 29.07 x 25.9488 x 25.073 x x x 26.06 25.4716 24.14 x 22.49 26.86 29.55 x 22.411 x 25.9 24.58 x x x x 26.869 28.217 28.63 26.9 25.94 28.7404 25.73 x 26.478 +15595 None Trait_16_AUW-BXD Metabolism, morphology: Fat mass percentage pre-metabolic caging, high fat diet, males [%] x x 26.025 38.8475 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 24.56 52.8775 30.62 x x 43.71 29.1 x 48.8175 x x x 18.422 26.8 x x x x 38.546 32.54 42.82 39.73 44.14 48.218 x 29.11 41.99 27.3425 37.46 x 36.098 x 38.468 x x x 36.03 37.334 41.62 x 31.963 37.78 38.1 x 28.35 x 33.76 42.83 x x x x 38.361 41.158 37.91 39.7 38.1 33.368 37.7 x 39.33 +15593 None Trait_14_AUW-BXD Metabolism, morphology: Fat mass pre-metabolic caging, high fat diet, males [g] x x 9.0395 16.4597 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 9.017 28.0572 11.391 x x 21.6 12.92 x 25.7155 x x x 6.2582 10.5 x x x x 18.827 13.0 19.376 17.34 22.63 23.6828 x 10.67 17.17 10.8695 18.44 x 15.3182 x 16.5952 x x x 15.43 15.903 18.26 x 11.112 17.16 18.98 x 9.1762 x 13.766 19.25 x x x x 17.68 20.698 18.16 18.49 16.7 15.2578 16.48 x 17.949 +15591 None Trait_12_AUW-BXD Metabolism, morphology: Body weight pre-metabolic caging, high fat diet, males [g] x x 34.4525 42.4075 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 36.21 52.46 37.08 x x 49.3 44.17 43.82 52.523 x x x 33.694 39.22 x x x x 48.8 39.97 45.45 43.42 51.28 48.936 x 36.11 40.88 38.815 49.0 x 42.262 x 43.002 x x x 42.78 42.422 43.855 x 34.538 45.28 49.82 x 32.246 x 38.96 45.13 x x x x 45.856 50.185 47.81 46.55 43.816 45.32 43.67 x 45.62 +15589 None Trait_10_AUW-BXD Metabolism, morphology: Body weight at blood pressure measurement, high fat diet, males [g] x x 37.7 43.8 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 39.2 56.2 38.1 x x 50.49 46.18 40.956 54.5 x x x 36.7 39.88 x x x x 50.5 41.57 48.47 44.25 52.65 50.77 x 37.52 41.42 42.7 48.48 x 40.0 x 40.6 x x x 44.252 44.0 45.36 x 35.56 x 51.57 x 32.36 x 39.07 47.0 x x x x 45.844 54.3 47.09 46.074 48.168 50.7 45.14 x 47.95 +15587 None Trait_8_AUW-BXD Metabolism, morphology: Body weight at sacrifice, high fat diet, males [g] x x 47.228 48.328 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 49.24 64.536 44.6 x x 49.1 47.02 48.02 64.07 x x x 43.6475 41.285 x x x x 53.032 45.54 48.5 50.065 64.05 60.922 x 41.49 33.72 50.2833 53.4 x 43.915 x 46.39 x x x 49.036 46.844 49.5 x 36.94 53.59 56.78 x 39.14 x 45.535 50.1 x x x x 53.43 61.386 52.24 52.64 51.67 56.956 51.87 x 48.51 +15585 None Trait_6_AUW-BXD Metabolism, morphology: Body weight at 28 weeks, high fat diet, males [g] x x 43.9 40.6 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 50.22 65.79 43.7 x x 56.52 52.64 48.116 59.6 x x x 41.7 44.79 x x x x 53.2 45.51 47.87 50.24 64.44 54.4 x 41.23 41.05 49.6 56.3 x 44.8 x 46.6 x x x 51.192 47.1 51.08 x 36.8 53.09 56.58 x 36.56 x 45.35 49.85 x x x x 53.59 58.7 54.0 54.88 50.95 54.1 49.905 x 49.94 +15583 None Trait_4_AUW-BXD Metabolism, morphology: Body weight at 16 weeks, high fat diet, males [g] x x 31.196 39.914 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 36.21 50.36 34.886 x x 47.32 44.17 43.818 51.2275 x x x 32.964 39.22 x x x x 45.514 38.75 46.45 43.42 51.28 42.84 x 36.11 40.88 39.57 49.0 x 41.648 x 43.002 x x x 40.64 42.186 43.85 x 33.71 45.28 49.82 x 31.886 x 40.78 45.13 x x x x 45.856 50.3 47.81 45.55 43.82 45.32 43.82 x 45.62 +15581 None Trait_2_AUW-BXD Metabolism, morphology: Body weight at 8 weeks, high fat diet, males [g] x x 21.718 22.214 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 22.364 23.8 21.0 x x 25.69 32.1 27.37 27.75 x x x 21.6 25.87 x x x x 27.0 25.84 30.75 25.01 29.2 25.414 x 21.91 25.65 26.8 36.08 x 27.0 x 27.246 x x x 21.57 24.664 22.61 x 23.45 24.14 29.42 x 21.69 x 25.825 23.82 x x x x 26.69 30.2 29.85 28.04 24.95 28.558 27.24 x 28.66 +15579 None Trait_387_AUW-BXD Metadata: Cohort study order, high fat diet, males [weeks] x x 34.0 34.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 78.0 22.0 25.0 x x 92.0 92.0 134.0 25.0 x x x 27.0 112.0 x x x x 31.0 53.0 51.0 94.0 84.0 38.0 x 109.0 94.0 28.0 110.0 x 26.0 x 29.0 x x x 127.0 35.0 98.0 x 45.0 84.0 106.0 x 31.0 x 80.0 54.0 x x x x 140.0 45.0 123.0 116.0 101.0 37.0 136.0 x 107.0 +15577 None Trait_385_AUW-BXD Metadata: Cohort study order, high fat diet, males [rank] x x 10.0 10.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 19.0 1.0 2.0 x x 23.0 23.0 38.0 3.0 x x x 5.0 32.0 x x x x 8.0 16.0 15.0 24.0 21.0 13.0 x 30.0 24.0 6.0 31.0 x 4.0 x 7.0 x x x 37.0 11.0 25.0 x 14.0 21.0 28.0 x 9.0 x 20.0 17.0 x x x x 40.0 14.0 35.0 33.0 26.0 12.0 39.0 x 29.0 +15711 None Trait_150_AUW-BXD Respiratory system, metabolism: Oxygen intake (VO2) dark phase (night) average, lean mass corrected, metabolic cage, high fat diet, males [ml/kg/h] x x 4872.0 5201.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 4739.0 x 5290.0 x x x x x 5632.0 x x x 5828.0 x x x x x 4359.0 4154.0 5151.0 x 4941.0 5470.0 x x 5281.0 5140.0 x x 5554.0 x 4891.0 x x x x 5821.0 x x 5651.0 4542.0 x x 5336.0 x 4957.0 4924.0 x x x x x 4438.0 x x x 4968.0 x x x +15712 None Trait_151_AUW-BXD Metabolism: Body temperature, basal, chow diet, males [Celsius] x x 38.16 37.85 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 36.9 36.78 36.32 x x 36.8 37.8 36.575 37.22 x x x 37.18 38.3 x x x 37.5 38.6667 37.125 37.3 37.35 38.15 37.0 x 37.28 37.3 37.65 36.78 x 36.4 x 38.44 x x x 35.8 37.64 36.9 x 37.93 37.75 37.46 x 37.66 x 37.53 37.55 x 37.5 x x 38.0 36.8 37.02 36.15 37.68 37.93 36.6 x 35.6 +15713 None Trait_152_AUW-BXD Metabolism: Body temperature after 1 hour in 4 deg C chamber, chow diet, males [deg C] x x 36.84 36.95 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 37.5 36.32 36.58 x x 35.6 36.0 35.25 36.64 x x x 36.48 35.8 x x x 35.6 37.2333 36.45 35.35 35.5 36.77 35.7 x 35.1 35.4 36.825 34.44 x 35.775 x 36.72 x x x 35.7 36.42 36.7 x 35.8 36.15 36.38 x 36.96 x 36.28 35.9 x 35.4 x x 36.0 36.3 36.46 35.15 36.6 38.03 36.9 x 35.4 +15714 None Trait_153_AUW-BXD Metabolism: Body temperature after 2 hours in 4 deg C chamber, chow diet, males [deg C] x x 36.36 36.75 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 37.4 36.3 36.78 x x 34.1 35.7 34.28 35.92 x x x 36.46 35.7 x x x 33.8 36.4 35.83 35.8 34.725 35.6 34.9 x 35.1 35.0 36.4 34.34 x 34.75 x 36.68 x x x 35.2 36.46 35.93 x 36.63 35.275 35.98 x 36.76 x 35.55 35.5 x 35.2 x x 35.4 36.1 35.88 34.8 35.6 36.63 36.0 x 35.1 +15715 None Trait_154_AUW-BXD Metabolism: Body temperature after 3 hours in 4 deg C chamber, chow diet, males [deg C] x x 36.66 36.825 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 36.3 35.76 36.82 x x 33.3 34.5 35.03 35.4 x x x 36.08 35.1 x x x 33.6 35.73 36.0 36.68 34.05 35.48 33.9 x 34.98 35.5 36.2 34.66 x 35.375 x 36.24 x x x 34.9 35.68 35.675 x 35.7 34.95 35.02 x 36.34 x 34.9 35.03 x 35.0 x x 35.2 35.9 35.84 34.43 35.18 36.47 35.3 x 35.4 +15716 None Trait_155_AUW-BXD Metabolism: Body temperature after 4 hours in 4 deg C chamber, chow diet, males [deg C] x x 36.24 36.5 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 36.7 35.16 36.38 x x 33.7 35.0 34.45 35.78 x x x 35.56 34.5 x x x 34.8 35.53 35.7 35.83 33.9 35.6 32.8 x 35.08 34.7 36.275 33.92 x 35.075 x 36.62 x x x 35.4 36.16 35.475 x 35.6 34.425 35.5 x 36.62 x 34.58 35.18 x 34.7 x x 35.5 35.2 35.08 34.4 35.4 36.13 34.9 x 35.1 +15717 None Trait_156_AUW-BXD Metabolism: Body temperature after 5 hours in 4 deg C chamber, chow diet, males [deg C] x x 36.46 36.325 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 35.4 35.44 36.16 x x 32.5 34.2 34.35 35.64 x x x 35.74 34.2 x x x 32.9 35.87 36.23 35.43 33.5 34.98 34.1 x 34.85 34.5 35.7 32.88 x 34.55 x 36.74 x x x 35.6 35.58 33.6 x 35.77 33.8 34.32 x 36.02 x 34.9 35.13 x 34.7 x x 35.5 34.5 35.82 33.45 35.08 35.3 34.7 x 35.2 +15718 None Trait_157_AUW-BXD Metabolism: Body temperature after 6 hours in 4 deg C chamber, chow diet, males [deg C] x x 35.32 36.275 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 36.0 35.14 35.52 x x 32.5 34.4 34.28 35.46 x x x 36.14 34.2 x x x 33.8 35.87 35.55 34.15 33.85 34.1 32.8 x 34.93 33.3 36.25 32.78 x 34.6 x 37.18 x x x 35.6 36.24 32.1 x 36.23 32.05 35.0 x 36.28 x 33.8 35.18 x 34.9 x x 34.9 33.8 34.2 31.98 35.78 35.63 35.0 x 34.9 +15719 None Trait_158_AUW-BXD Metabolism: Body temperature, basal, high fat diet, males [deg C] x x 38.22 38.08 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 37.4 37.02 36.36 x x 37.2 37.9 37.1 36.65 x x x 37.225 37.7 x x x x 37.82 36.53 36.95 37.275 37.7 37.3 x 37.0 36.78 37.9 37.2 x 36.94 x 38.24 x x x 37.0 38.18 36.8 x 37.5 37.3 37.45 x 37.96 x 37.93 37.28 x x x x 36.9 37.1 37.5 37.08 37.8 37.9 37.1 x 36.7 +15720 None Trait_159_AUW-BXD Metabolism: Body temperature after 1 hour in 4 deg C chamber, high fat diet, males [deg C] x x 37.0 37.38 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 36.3 35.8 36.52 x x 35.6 35.3 35.7 35.4 x x x 37.025 37.1 x x x x 36.42 36.28 33.6 34.625 36.03 35.6 x 35.4 33.8 36.95 35.0 x 35.56 x 37.42 x x x 35.5 37.22 34.9 x 36.0 36.2 35.6 x 37.16 x 36.85 36.48 x x x x 35.18 35.9 34.7 35.24 36.32 37.0 35.7 x 35.9 +15721 None Trait_160_AUW-BXD Metabolism: Body temperature after 2 hours in 4 deg C chamber, high fat diet, males [deg C] x x 37.02 37.04 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 36.4 35.4 36.54 x x 35.5 35.9 35.3 35.025 x x x 36.85 36.6 x x x x 36.56 36.5 35.4 33.975 36.05 34.6 x 34.5 33.88 37.225 34.6 x 35.04 x 37.48 x x x 35.0 37.52 33.98 x 35.7 36.2 35.45 x 37.18 x 36.125 36.63 x x x x 34.78 35.4 33.9 33.84 35.5 37.0 34.6 x 35.6 +15722 None Trait_161_AUW-BXD Metabolism: Body temperature after 3 hours in 4 deg C chamber, high fat diet, males [deg C] x x 36.62 36.96 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 36.7 34.16 36.72 x x 34.4 34.8 34.9 34.825 x x x 36.6 35.9 x x x x 36.18 36.38 35.95 34.05 35.35 33.6 x 34.5 33.92 37.15 35.0 x 35.0 x 37.34 x x x 34.7 37.06 33.3 x 35.4 35.63 35.25 x 36.76 x 35.95 36.18 x x x x 34.04 35.1 33.5 33.24 34.76 36.6 35.1 x 35.8 +15723 None Trait_162_AUW-BXD Metabolism: Body temperature after 4 hours in 4 deg C chamber, high fat diet, males [deg C] x x 36.3 36.76 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 35.5 34.08 36.88 x x 35.2 35.5 34.5 35.425 x x x 36.275 35.7 x x x x 36.06 35.9 35.35 33.65 35.18 30.7 x 34.6 33.66 37.1 34.7 x 35.28 x 36.98 x x x 35.1 36.24 33.6 x 35.9 35.47 35.15 x 36.74 x 36.0 35.48 x x x x 34.46 35.0 32.9 32.8 34.48 36.1 34.5 x 35.6 +15724 None Trait_163_AUW-BXD Metabolism: Body temperature after 5 hours in 4 deg C chamber, high fat diet, males [deg C] x x 36.54 36.64 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 35.1 33.6 36.32 x x 34.4 34.6 34.5 34.975 x x x 36.5 35.2 x x x x 35.9 36.28 34.1 33.3 35.2 30.4 x 34.9 33.82 37.3 34.5 x 35.26 x 37.12 x x x 35.5 36.7 33.65 x 36.0 35.47 35.4 x 36.58 x 36.125 36.1 x x x x 33.96 35.6 32.6 32.2 35.04 35.7 34.9 x 35.6 +15725 None Trait_164_AUW-BXD Metabolism: Body temperature after 6 hours in 4 deg C chamber, high fat diet, males [deg C] x x 36.12 35.96 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 35.8 33.78 35.88 x x 34.6 34.7 34.8 34.975 x x x 36.2 35.3 x x x x 35.84 35.5 34.05 33.3 35.25 30.2 x 35.2 34.08 37.6 34.5 x 35.96 x 37.3 x x x 34.9 36.88 33.6 x 36.7 35.17 35.075 x 36.46 x 35.625 35.9 x x x x 34.64 35.5 32.4 32.38 34.48 35.9 34.4 x 36.0 +15726 None Trait_165_AUW-BXD Metabolism: Body temperature loss after 3 hours in 4 deg C chamber, chow diet, males [%] x x 3.9239 2.6934 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 1.768 2.7694 -1.3737 x x 9.6 8.7 4.235 4.8911 x x x 2.8897 8.3 x x x 10.6 7.5794 3.02 1.67 8.84 7.011 8.27 x 6.17 4.92 3.8486 5.7716 x 2.8138 x 5.721 x x x 2.4 5.2001 2.64 x 5.89 6.55 6.51 x 3.5082 x 6.99 6.71 x 6.52 x x 7.47 2.45 3.177 4.77 6.99 3.9 3.6 x 0.6 +15727 None Trait_166_AUW-BXD Metabolism: Body temperature loss after 6 hours in 4 deg C chamber, chow diet, males [%] x x 7.4276 4.1486 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 2.558 4.4468 2.2048 x x 8.6 4.2 6.284 4.7189 x x x 2.7362 10.7 x x x 10.0 7.2429 4.2 8.45 9.36 10.61 11.1 x 6.27 10.71 3.7114 10.8856 x 4.9401 x 3.2745 x x x 0.5 3.719 13.1 x 4.49 15.1 6.5414 x 3.6632 x 9.86 6.31 x 6.85 x x 8.14 8.09 7.65 11.55 5.47 6.055 4.5 x 2.1 +15728 None Trait_167_AUW-BXD Metabolism: Body temperature loss between 3 to 6 hours after being placed in 4 deg C chamber, chow diet, males [%] x x 3.6498 1.487 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.792 1.7077 3.5285 x x 2.3 0.3 2.127 -0.1897 x x x -0.1789 2.7 x x x -0.7 -0.3709 1.2 6.89 0.526 3.87 3.01 x 0.11 6.09 -0.1393 5.422 x 2.1793 x -2.6022 x x x -1.9 -1.6059 10.1 x -1.51 8.35 0.0399 x 0.1465 x 3.06 -0.44 x 0.363 x x 0.714 5.8 4.62 7.13 -1.66 2.29 0.9 x 1.6 +15729 None Trait_168_AUW-BXD Metabolism: Body temperature loss after 3 hours in 4 deg C chamber, high fat diet, males [%] x x 4.1888 2.9287 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 1.755 7.7195 -0.9958 x x 7.4 8.3 5.8 4.9816 x x x 1.6573 4.7 x x x x 4.3377 0.403 2.68 8.65 6.23 9.72 x 6.6 7.76 1.9959 5.9 x 5.2442 x 2.3526 x x x 6.2 2.9335 7.55 x 5.67 4.45 5.3 x 3.1484 x 5.211 2.95 x x x x 7.744 5.3 10.9 10.35 8.07 3.48 5.3 x 2.4 +14787 Original post publication description: Central nervous system, behavior: soluble/aggregate protein by FRET ratio in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, 2B7/4C9 R6/2 cases only [FRETT florescence ratio] Original pre publication description: Central nervous system, behavior: soluble/aggregate protein by FRET ratio in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, 2B7/4C9 R6/2 cases only [FRETT florescence ratio] Central nervous system, behavior: soluble/aggregate protein by FRET ratio in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, 2B7/4C9 R6/2 cases only [FRETT florescence ratio] Central nervous system, behavior: soluble/aggregate protein by FRET ratio in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, 2B7/4C9 R6/2 cases only [FRETT florescence ratio] x 1.491 1.292 x x 1.933 1.682 1.44 x 1.481 1.314 1.495 x 1.453 x x 1.37 x 1.511 x 1.484 x x x x x 1.301 x x 1.371 x x 1.414 x x x x 1.416 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +14786 Original post publication description: Central nervous system, adult neurogenesis: Proliferation of BrdU-labeled cells in subgranular zone, 1h BrdU injection [n cells] None Central nervous system, adult neurogenesis: Proliferation of BrdU-labeled cells in subgranular zone, 1h BrdU injection, unadjusted data [n cells] x x 54.8 15.83 22.0 15.0 x 34.33 42.0 30.33 15.0 29.0 21.63 28.4 29.75 32.5 24.0 44.67 20.0 20.0 x x x 17.67 x 28.38 25.5 37.6 x 31.25 18.67 23.14 23.25 x x x 17.0 28.5 22.0 x 25.75 23.5 28.75 22.5 x x 25.25 x 11.5 16.0 x x x 18.75 20.5 x x x 22.67 23.25 25.5 29.0 x 34.67 27.0 21.5 36.0 x x 36.0 x 20.0 x 25.0 x 36.4 x x 28.75 x x 19.4 28.2 26.5 24.75 23.67 x 18.25 34.6 x 33.5 x x x 18.75 22.67 24.83 26.33 13.17 x x x +14785 Original post publication description: Chlamydia muridarum upper genital tract disease severity (oviduct) after primary and secondary intravaginal infection by with 5 x 10^3 C. muridarum. Ordinal scale 0 = no disease, 4 = severe disease. Original pre publication description: Chlamydia muridarum upper genital tract disease severity (oviduct) after primary and secondary intravaginal infection by with 5 x 10^3 C. muridarum. Ordinal scale 0 = no disease, 4 = severe disease. Infectious disease, immune system, urogenital system: Chlamydia muridarum upper genital tract disease severity (oviduct) after primary and secondary intravaginal infection by with 5x10^3 C. muridarum [ordinal scale 0 = no disease, 4 = severe disease] Infectious disease, immune function: Chlamydia muridarum upper genital tract disease severity (oviduct) after primary and secondary intravaginal infection by with 5x10^3 C. muridarum [ordinal scale 0 = no disease, 4 = severe disease] x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +14783 Original post publication description: Chlamydia muridarum upper genital tract disease severity (endometrium; uterine horn) after primary and secondary intravaginal infection by with 5 x 10^3 C. muridarum. Original pre publication description: Chlamydia muridarum upper genital tract disease severity (endometrium) after primary and secondary intravaginal infection by with 5 x 10^3 C. muridarum. Infectious disease, immune system, urogenital system: Chlamydia muridarum upper genital tract disease severity (endometrium, uterine horn) after primary and secondary intravaginal infection by with 5x10^3 C. muridarum [ordinal scale 0 = no disease, 4 = severe] Infectious disease, immune function: Chlamydia muridarum upper genital tract disease severity (endometrium, uterine horn) after primary and secondary intravaginal infection by with 5x10^3 C. muridarum [ordinal scale 0 = no disease, 4 = severe] x x 2.67 3.3 1.5 x x x x x 4.0 x 3.0 x x x x x x x x x x 3.2 x x x x x 2.0 3.3 x 2.5 x x x 3.5 3.3 2.5 x 4.0 x x x x x 2.75 x x 3.67 x x x x x x x x x 3.0 x 4.0 x x 3.3 x 3.67 x 4.0 2.5 x x 4.0 3.0 x 4.0 x 3.4 2.5 x x x 2.25 x 2.3 x x 3.0 x x 4.0 x x x x 2.4 x x 3.0 x 2.75 2.75 +14781 Original post publication description: Reproductive system: Breeding performance at the Regional Biocontainment Facility, Memphis (UTHSC 2010-2012) [ordinal scale, 0=poor, 1=fair, 2=good] Original pre publication description: Reproductive system: Breeding performance at the Regional Biocontainment Facility, Memphis (UTHSC 2010-2011) [ordinal scale, 0=poor, 1=fair, 2=good] Reproductive system: Breeding performance at the Regional Biocontainment Facility, Memphis (UTHSC 2010-2011) [ordinal scale, 0=poor, 1=fair, 2=good] Reproductive system: Breeding performance at the Regional Biocontainment Facility, Memphis (UTHSC 2010-2011) [ordinal scale, 0=poor, 1=fair, 2=good] x x 2.0 2.0 2.0 x x 1.0 x 0.0 1.0 1.0 0.0 1.0 x 2.0 x 1.0 1.0 x 1.0 x x 1.0 x 1.0 x 1.0 x 1.0 1.0 x 2.0 x 2.0 x 2.0 2.0 2.0 x 2.0 1.0 2.0 1.0 x x 1.0 1.0 1.0 2.0 x x x 2.0 2.0 x x x 2.0 2.0 1.0 1.0 1.0 2.0 2.0 1.0 1.0 2.0 2.0 1.0 x 2.0 2.0 2.0 x 1.0 x 2.0 1.0 1.0 x 1.0 1.0 1.0 1.0 1.0 x 2.0 2.0 x 1.0 x x 2.0 1.0 1.0 1.0 2.0 2.0 1.0 2.0 x +14779 Original post publication description: Central nervous system, adult neurogenesis: In vitro proliferation rate of adult hippocampal precursor cells (AHPC) measured by BrdU incorporation (Hoechst) after rederivation by cyropreservation [% positive cells] Original pre publication description: Kempermann 2012 Kempermann 2012 Central nervous system, adult neurogenesis: In vitro proliferation rate of adult hippocampal precursor cells (AHPC) measured by BrdU incorporation (Hoechst) after rederivation by cyropreservation [% positive cells] x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +15737 None Trait_176_AUW-BXD Central nervous system, metabolism, behavior: Activity (movement) during full day (24 hours), in standard housing cage, high fat diet, males [counts/hour] x x 2704.0 4114.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 4375.0 2012.0 3714.0 x x 2216.0 1876.0 2943.0 1910.0 x x x 3611.0 3115.0 x x x x 2258.0 2021.0 2757.0 3072.0 2310.0 1974.0 x 3308.0 4223.0 3069.0 2916.0 x 3130.0 x 2649.0 x x x 3272.0 2552.0 2790.0 x 2677.0 2648.0 2486.0 x 2462.0 x 3742.0 1739.0 x x x x 2851.0 2921.0 3579.0 2931.0 3905.0 3302.0 3666.0 x 2689.0 +15738 None Trait_177_AUW-BXD Central nervous system, metabolism, behavior: Activity (movement) during light phase (day), in standard housing cage, high fat diet, males [counts/hour] x x 2212.0 1938.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 3261.0 1905.0 1617.0 x x 2007.0 1215.0 1852.0 1517.0 x x x 1426.0 2706.0 x x x x 1472.0 1595.0 1442.0 2371.0 1797.0 1439.0 x 2067.0 2760.0 2544.0 2606.0 x 1666.0 x 2135.0 x x x 2537.0 1582.0 2244.0 x 2089.0 1611.0 1643.0 x 1447.0 x 2397.0 1126.0 x x x x 2053.0 2257.0 2564.0 2196.0 2900.0 2303.0 2100.0 x 1752.0 +15739 None Trait_178_AUW-BXD Central nervous system, metabolism, behavior: Activity (movement) during dark phase (night), in standard housing cage, high fat diet, males [counts/hour] x x 3195.0 6291.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 5489.0 2055.0 5811.0 x x 2425.0 2537.0 4034.0 2302.0 x x x 5696.0 3524.0 x x x x 3045.0 2446.0 4072.0 3773.0 2823.0 2509.0 x 4548.0 5686.0 3594.0 3226.0 x 4594.0 x 3162.0 x x x 4007.0 3521.0 3333.0 x 3266.0 3685.0 3328.0 x 3478.0 x 5087.0 2351.0 x x x x 3515.0 3586.0 4594.0 3552.0 4826.0 4302.0 5233.0 x 3626.0 +15740 None Trait_179_AUW-BXD Central nervous system, metabolism, behavior: Activity (rearing) during full day (24 hours), in standard housing cage, chow diet, males [counts/hour] x x 537.0 749.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 695.0 374.0 808.0 x x 451.0 524.0 403.0 405.0 x x x 503.0 236.0 x x x 332.0 399.0 339.0 334.0 293.0 373.0 294.0 x 538.0 603.0 327.0 904.0 x 438.0 x 263.0 x x x 225.0 334.0 388.0 x 221.0 710.0 886.0 x 308.0 x 553.0 256.0 x 438.0 x x 505.0 427.0 433.0 421.0 692.0 504.0 790.0 x 265.0 +15741 None Trait_180_AUW-BXD Central nervous system, metabolism, behavior: Activity (rearing) during light phase (day), in standard housing cage, chow diet, males [counts/hour] x x 299.0 179.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 421.0 279.0 383.0 x x 291.0 269.0 201.0 184.0 x x x 141.0 115.0 x x x 171.0 92.0 143.0 125.0 150.0 204.0 220.0 x 147.0 334.0 193.0 755.0 x 125.0 x 125.0 x x x 72.0 92.0 402.0 x 98.0 223.0 739.0 x 61.0 x 245.0 45.0 x 195.0 x x 315.0 88.0 325.0 266.0 202.0 250.0 245.0 x 44.0 +15742 None Trait_181_AUW-BXD Central nervous system, metabolism, behavior: Activity (rearing) during dark phase (night), in standard housing cage, chow diet, males [counts/hour] x x 774.0 1320.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 968.0 462.0 1233.0 x x 608.0 779.0 573.0 626.0 x x x 865.0 356.0 x x x 493.0 706.0 536.0 543.0 435.0 541.0 368.0 x 898.0 872.0 462.0 1052.0 x 750.0 x 400.0 x x x 378.0 575.0 374.0 x 344.0 1197.0 1032.0 x 556.0 x 673.0 466.0 x 681.0 x x 695.0 765.0 541.0 552.0 1142.0 759.0 1335.0 x 486.0 +15743 None Trait_182_AUW-BXD Central nervous system, metabolism, behavior: Activity (rearing) during full day (24 hours), in standard housing cage, high fat diet, males [counts/hour] x x 276.0 416.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 517.0 100.0 436.0 x x 189.0 244.0 393.0 280.1 x x x 459.0 167.0 x x x x 115.0 196.0 253.0 176.0 303.0 129.0 x 244.0 314.0 219.0 140.0 x 188.0 x 126.0 x x x 191.0 340.0 133.0 x 196.0 233.0 124.0 x 215.0 x 288.0 147.0 x x x x 132.0 258.0 233.0 231.0 541.0 246.0 290.0 x 185.0 +15744 None Trait_183_AUW-BXD Central nervous system, metabolism, behavior: Activity (rearing) during light phase (day), in standard housing cage, high fat diet, males [counts/hour] x x 180.0 114.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 307.0 67.0 306.0 x x 141.0 85.0 151.0 225.0 x x x 91.0 119.0 x x x x 33.0 68.0 93.0 71.0 195.0 61.0 x 81.0 119.0 162.0 91.0 x 43.0 x 61.0 x x x 64.0 213.0 88.0 x 192.0 66.0 54.0 x 49.0 x 168.0 34.0 x x x x 43.0 89.0 136.0 164.0 218.0 151.0 127.0 x 26.0 +15745 None Trait_184_AUW-BXD Central nervous system, metabolism, behavior: Activity (rearing) during dark phase (night) in standard housing cage, high fat diet, males [counts/hour] x x 372.0 719.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 728.0 129.0 567.0 x x 238.0 403.0 636.0 335.0 x x x 828.0 215.0 x x x x 198.0 324.0 413.0 280.0 411.0 198.0 x 408.0 509.0 276.0 189.0 x 333.0 x 192.0 x x x 319.0 468.0 178.0 x 200.0 399.0 193.0 x 380.0 x 408.0 261.0 x x x x 210.0 427.0 330.0 287.0 837.0 342.0 453.0 x 345.0 +15746 None Trait_185_AUW-BXD Central nervous system, metabolism, behavior: Food intake in 24 h, standard housing cage, chow diet, males [g] x x 4.5175 4.75667 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 4.48 3.36 3.43 x x 1.66 3.71 3.0 4.72 x x x 3.752 3.86 x x x 4.73 5.07333 4.08 3.02 3.73 4.59 5.838 x 4.51 3.27 4.4875 2.68 x 2.7425 x 3.044 x x x 3.64 2.916 1.67 x 3.64 2.71 3.54 x 3.6575 x 3.05 3.2 x 4.53 x x 2.34 4.2775 4.54 3.99 2.75 5.34 2.18 x 2.98 +15747 None Trait_186_AUW-BXD Central nervous system, metabolism, behavior: Food intake in 24 h, standard housing cage, high fat diet, males [g] x x 4.5925 3.364 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 2.71 3.874 2.965 x x 1.73 2.86 7.56 5.99 x x x 2.695 2.6 x x x x 2.696 3.32 7.0 2.26 5.23 3.736 x 10.0 10.0 3.18667 2.93 x 2.618 x 1.928 x x x 2.88 2.634 2.31 x 2.8 3.09 2.98 x 1.84333 x 2.57 1.87 x x x x x 2.435 x 3.41 3.19 3.685 3.85 x 2.61 +15748 None Trait_187_AUW-BXD Central nervous system, metabolism, behavior: Food intake in 24 h, standard housing cage, chow diet, males [kCal] x x 14.0042 14.7457 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 13.9 10.416 10.633 x x 5.13 11.49 9.3 14.632 x x x 11.6312 11.97 x x x 14.66 15.7273 12.66 9.35 11.57 14.23 18.0978 x 13.98 13.39 13.9113 8.3 x 8.50175 x 9.4364 x x x 11.29 9.0396 5.18 x 11.284 8.4 10.99 x 11.3383 x 9.46 9.913 x 14.05 x x 7.24 13.2603 14.08 12.38 8.51 16.554 6.77 x 9.24 +15749 None Trait_188_AUW-BXD Central nervous system, metabolism, behavior: Food intake in 24 h, standard housing cage, high fat diet, males [kCal] x x 23.4217 17.1564 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 13.5 19.7574 15.1215 x x 5.35 14.62 38.55 30.549 x x x 13.7445 13.27 x x x x 13.7496 16.93 35.0 11.54 26.0 19.0536 x 40.0 40.0 16.252 14.96 x 13.3518 x 9.8328 x x x 14.7 13.4334 11.78 x 14.28 15.77 15.22 x 9.401 x 13.12 9.52 x x x x x 12.4185 x 17.38 16.27 18.7935 19.64 x 13.32 +15750 None Trait_189_AUW-BXD Central nervous system, metabolism, behavior: Food intake/body weight g, standard housing cage, chow diet, males [g/g] x x 14.12 14.48 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 13.95 11.98 14.64 x x 4.2 6.22 x 9.94 x x x 12.18 x x x x 11.92 15.13 x x 6.2 4.59 5.84 x 11.6 8.06 14.93 6.66 x 8.41 x 3.04 x x x x 2.92 5.76 x x x 7.46 x 13.82 x 8.42 10.48 x 9.73 x x 6.65 10.16 x x 6.92 14.33 x x 7.1 +15751 None Trait_190_AUW-BXD Central nervous system, metabolism, behavior: Food intake/body weight g, standard housing cage, high fat diet, males [g/g] x x 9.79 7.76 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 6.7 6.23 19.31 x x 3.03 8.03 x 4.71 x x x 6.43 x x x x x 4.96 x x 6.36 4.06 3.74 x x x 6.98 x x 6.12 x 1.93 x x x x 2.63 4.59 x x 3.09 x x 5.22 x 6.25 3.57 x x x x x x x x 5.59 6.547 x x 5.24 +15752 None Trait_191_AUW-BXD Morphology, metabolism: Body weight in home cage, chow diet, males [g] x x 32.08 33.09 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 32.6 31.3 32.116 x x 39.72 37.53 38.29 35.36 x x x 30.858 33.71 x x x 40.43 33.44 32.0 37.42 34.71 44.69 44.81 x 40.91 40.61 31.5 39.42 x 33.45 x 38.68 x x x 37.262 44.66 28.47 x 28.6 37.1 47.27 x 26.6 x 36.25 30.77 x 46.59 x x 35.32 42.2 44.7 35.6 39.91 39.4 33.83 x 42.54 +15753 None Trait_192_AUW-BXD Morphology, metabolism: Body weight in home cage, high fat diet, males [g] x x 46.66 44.53 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 43.62 41.52 44.96 x x 57.22 53.04 47.5 61.97 x x x 41.91 41.52 x x x x 54.39 44.48 46.11 48.52 59.58 56.47 x 43.94 41.62 47.33 50.09 x 42.29 x 45.23 x x x 47.5 46.33 50.57 x 37.188 53.96 53.8 x 35.08 x 41.35 53.51 x x x x x 61.79 53.55 51.77 52.42 55.1 52.24 x 49.51 +15754 None Trait_193_AUW-BXD Metabolism: Glycemia after overnight fast, chow diet, males [mg/mL] x x 103.5 86.5 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 82.3 120.6 154.75 x x 93.0 89.0 91.0 119.0 x x x 91.2 82.0 x x x 110.8 96.3333 137.0 122.0 79.0 143.0 113.5 x 95.4 171.5 83.25 79.2 x 157.75 x 96.2 x x x 91.6 128.0 87.75 x 106.0 81.6 97.2 x 96.0 x 117.0 94.0 x 156.3 x x 123.0 124.6 146.4 107.2 84.8 121.0 68.0 x 103.4 +15755 None Trait_194_AUW-BXD Metabolism: Glycemia during oral glucose tolerance test (OGTT), 15min, chow diet, males [mg/mL] x x 294.5 186.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 367.3 356.4 320.0 x x 317.0 311.0 258.0 215.75 x x x 183.4 267.0 x x x 210.6 207.333 272.0 344.0 246.0 302.5 234.3 x 389.0 461.0 225.0 295.0 x 217.25 x 240.0 x x x 163.6 284.0 295.0 x 229.0 221.2 363.4 x 267.8 x 269.0 252.0 x 292.0 x x 270.0 326.8 343.0 324.0 214.0 362.0 310.0 x 298.0 +15756 None Trait_195_AUW-BXD Metabolism: Glycemia during oral glucose tolerance test (OGTT), 30 min, chow diet, males [mg/mL] x x 260.5 179.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 431.5 447.0 280.25 x x 340.0 266.0 280.0 222.25 x x x 217.8 295.0 x x x 235.6 221.333 189.0 380.0 263.0 327.88 223.6 x 385.0 490.0 201.0 373.0 x 189.0 x 272.6 x x x 196.2 271.0 228.0 x 201.0 262.2 429.0 x 252.8 x 222.0 238.0 x 243.0 x x 285.0 304.4 365.0 381.0 260.0 439.0 302.8 x 322.0 +15757 None Trait_196_AUW-BXD Metabolism: Glycemia during oral glucose tolerance test (OGTT), 45min, chow diet, males [mg/mL] x x 225.5 166.5 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 390.3 521.6 237.75 x x 310.0 239.0 262.0 202.0 x x x 197.4 305.4 x x x 219.8 201.667 186.0 359.0 268.0 331.25 224.8 x 317.0 479.0 165.25 367.0 x 200.5 x 277.4 x x x 214.5 261.0 191.0 x 175.0 244.2 431.4 x 247.6 x 198.0 197.0 x 279.0 x x 273.0 285.8 361.0 363.0 267.0 404.0 264.0 x 308.0 +15758 None Trait_197_AUW-BXD Metabolism: Glycemia during oral glucose tolerance test (OGTT), 60 min, chow diet, males [mg/mL] x x 205.5 143.5 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 343.0 554.2 223.0 x x 264.0 212.0 268.0 179.0 x x x 172.6 284.6 x x x 201.8 191.0 168.0 348.0 254.0 307.25 207.8 x 261.0 474.0 137.5 354.8 x 218.25 x 235.4 x x x 193.4 233.0 168.8 x 165.0 237.6 405.6 x 224.6 x 177.0 166.0 x 265.0 x x 261.0 260.2 350.0 332.0 243.0 355.33 228.0 x 298.0 +15759 None Trait_198_AUW-BXD Metabolism: Glycemia during oral glucose tolerance test (OGTT), 90 min, chow diet, males [mg/mL] x x 155.5 105.5 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 245.5 379.8 x x x 180.0 159.0 229.0 x x x x 133.8 221.4 x x x 150.2 159.667 142.0 295.0 213.0 244.75 147.0 x 197.0 454.0 109.0 250.2 x 196.5 x 159.4 x x x 182.2 180.0 127.5 x 148.0 207.4 325.6 x 165.2 x 122.0 122.0 x 213.0 x x 193.0 199.6 297.0 258.0 174.0 243.33 195.8 x 231.2 +15760 None Trait_199_AUW-BXD Metabolism: Glycemia during oral glucose tolerance test (OGTT), 120 min, chow diet, males [mg/mL] x x 142.0 99.75 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 180.0 211.6 155.25 x x 145.0 144.0 179.0 142.5 x x x 118.4 176.2 x x x 136.2 135.667 134.0 221.0 195.0 210.0 127.3 x 163.0 425.0 94.5 174.4 x 170.75 x 133.8 x x x 181.4 155.0 117.8 x 142.0 199.6 262.4 x 134.6 x 103.0 104.0 x 206.0 x x 174.0 182.0 263.0 208.0 148.0 196.66 167.0 x 200.0 +15761 None Trait_200_AUW-BXD Metabolism: Glycemia during oral glucose tolerance test (OGTT), 150 min, chow diet, males [mg/mL] x x 122.75 95.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 144.5 144.0 142.0 x x 125.0 130.0 157.0 125.25 x x x 108.4 139.0 x x x 119.6 108.667 127.0 187.0 180.0 181.25 118.0 x 141.0 360.0 87.25 144.6 x 157.0 x 118.0 x x x 156.8 137.0 104.0 x 128.0 189.5 236.2 x 114.8 x 84.0 102.0 x 195.0 x x 148.0 158.6 219.0 176.0 127.0 157.66 133.3 x 168.2 +15762 None Trait_201_AUW-BXD Metabolism: Glycemia during oral glucose tolerance test (OGTT), 180 min, chow diet, males [mg/mL] x x 112.0 96.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 125.3 136.2 x x x 113.0 127.0 150.0 x x x x 109.0 127.8 x x x 110.2 103.0 121.0 168.0 168.0 169.75 111.3 x 126.0 294.0 90.25 122.2 x x x 105.0 x x x 146.0 134.0 100.8 x 117.0 160.4 203.4 x 108.4 x 79.3 96.0 x 189.0 x x 138.0 147.6 189.0 155.0 118.0 144.333 116.5 x 169.6 +15763 None Trait_202_AUW-BXD Metabolism: Glycemia after overnight fast, high fat diet, males [mg/mL] x x 163.0 132.7 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 89.3 238.4 163.25 x x 145.0 113.0 144.2 178.25 x x x 77.5 118.8 x x x x 144.4 132.0 198.0 138.0 198.5 146.5 x 78.5 202.0 122.0 161.0 x 125.8 x 163.4 x x x 133.4 162.0 158.5 x 186.0 127.5 134.75 x 191.0 x 95.3 157.0 x x x x 131.6 159.3 149.25 158.0 111.6 163.0 94.0 x 102.0 +15764 None Trait_203_AUW-BXD Metabolism: Glycemia during oral glucose tolerance test (OGTT), 15min, high fat diet, males [mg/mL] x x 349.5 256.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 344.7 370.0 277.5 x x 390.0 267.0 327.8 313.0 x x x 199.5 311.3 x x x x 250.8 315.0 440.0 358.0 379.75 243.3 x 406.8 465.0 333.5 472.0 x 299.8 x 294.6 x x x 275.8 244.0 433.3 x 340.0 357.7 466.5 x 359.0 x 261.0 318.0 x x x x 329.6 417.7 326.5 439.0 319.0 352.4 213.0 x 241.0 +15765 None Trait_204_AUW-BXD Metabolism: Glycemia during oral glucose tolerance test (OGTT), 30 min, high fat diet, males [mg/mL] x x 302.0 251.3 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 487.0 566.0 286.75 x x 477.0 273.0 290.2 358.25 x x x 251.25 421.3 x x x x 293.8 364.0 506.0 468.0 396.5 246.1 x 468.5 555.0 340.0 528.0 x 312.6 x 339.6 x x x 337.6 286.0 493.5 x 373.0 443.0 404.5 x 366.2 x 296.0 335.0 x x x x 430.6 445.3 398.0 536.0 419.0 378.4 260.0 x 279.0 +15766 None Trait_205_AUW-BXD Metabolism: Glycemia during oral glucose tolerance test (OGTT), 45min, high fat diet, males [mg/mL] x x 302.5 223.67 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 492.0 600.0 288.5 x x 473.0 237.0 294.4 382.25 x x x 251.5 425.3 x x x x 321.0 371.0 546.0 511.0 392.25 257.8 x 432.0 587.0 328.0 547.0 x 330.6 x 380.2 x x x 370.8 301.0 534.0 x 343.0 500.0 460.0 x 325.8 x 285.0 291.0 x x x x 425.4 454.7 459.8 591.0 482.0 381.4 300.0 x 302.0 +15767 None Trait_206_AUW-BXD Metabolism: Glycemia during oral glucose tolerance test (OGTT), 60 min, high fat diet, males [mg/mL] x x 295.625 205.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 462.8 572.6 283.0 x x 464.0 220.0 291.2 367.0 x x x 231.0 420.3 x x x x 332.0 361.0 547.0 511.0 350.75 250.8 x 406.8 591.0 301.0 544.0 x 319.0 x 386.8 x x x 367.2 284.0 508.8 x 318.0 560.0 512.0 x 328.8 x 231.0 254.0 x x x x 433.2 451.0 472.3 597.0 502.0 348.6 253.0 x 289.0 +15768 None Trait_207_AUW-BXD Metabolism: Glycemia during oral glucose tolerance test (OGTT), 90 min, high fat diet, males [mg/mL] x x 266.5 197.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 353.7 543.8 x x x 371.0 196.0 223.2 x x x x 173.75 324.5 x x x x 243.4 313.0 529.0 476.0 325.5 178.3 x 315.0 577.0 248.5 504.0 x 255.4 x 316.6 x x x 366.2 244.0 430.0 x 257.0 498.0 440.0 x 277.6 x 149.0 208.0 x x x x 358.2 390.7 383.5 585.0 396.0 292.6 196.0 x 235.8 +15769 None Trait_208_AUW-BXD Metabolism: Glycemia during oral glucose tolerance test (OGTT), 120 min, high fat diet, males [mg/mL] x x 229.75 197.33 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 262.3 370.0 219.5 x x 271.0 187.0 187.0 193.5 x x x 144.25 271.8 x x x x 207.0 253.0 444.0 437.0 292.75 153.0 x 231.0 489.0 170.75 440.0 x 215.6 x 234.8 x x x 348.4 198.0 375.8 x 231.0 472.3 423.5 x 227.6 x 143.0 184.0 x x x x 286.2 341.7 289.8 543.0 331.0 233.4 171.0 x 225.2 +15770 None Trait_209_AUW-BXD Metabolism: Glycemia during oral glucose tolerance test (OGTT), 150 min, high fat diet, males [mg/mL] x x 227.5 195.33 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 190.0 349.0 182.0 x x 206.0 172.0 161.8 191.25 x x x 133.0 219.5 x x x x 180.2 213.0 365.0 390.0 247.75 147.0 x 162.0 404.0 145.0 384.3 x 190.6 x 180.4 x x x 333.8 176.0 303.3 x 211.0 416.3 392.0 x 192.2 x 141.0 158.0 x x x x 234.0 276.7 221.5 489.0 286.0 176.6 151.0 x 208.4 +15771 None Trait_210_AUW-BXD Metabolism: Glycemia during oral glucose tolerance test (OGTT), 180 min, high fat diet, males [mg/mL] x x 196.5 180.33 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 154.0 276.6 x x x 175.0 166.0 156.6 x x x x 131.25 188.3 x x x x 160.6 178.0 281.0 340.0 208.25 136.3 x 125.5 278.0 141.5 357.7 x x x 150.6 x x x 292.8 173.0 250.0 x 191.3 334.33 329.3 x 157.6 x 123.0 151.0 x x x x 204.8 240.7 178.0 407.0 230.0 155.4 151.0 x 197.2 +15772 None Trait_211_AUW-BXD Metabolism: Glycemia during oral glucose tolerance test (OGTT), chow diet, males [AUC] x x 31387.0 22298.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 45148.0 70698.0 35661.0 x x 36359.0 33064.0 37750.0 28369.0 x x x 25999.8 38051.0 x x x 29195.0 28140.3 28389.8 48595.8 38095.0 44016.0 29202.0 x 39899.0 78779.0 22663.2 43011.0 x 33566.0 x 31779.2 x x x 31234.6 34552.8 27156.0 x 27893.0 37191.2 55989.0 x 31360.0 x 25617.0 26027.0 x 40575.0 x x 36717.0 38964.2 51219.0 45876.0 32448.0 47073.0 35419.0 x 41913.0 +15773 None Trait_212_AUW-BXD Metabolism: Glycemia during oral glucose tolerance test (OGTT), increase rate, chow diet, males [mg/mL/min] x x 12.283 4.98 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 7.84111 11.0167 x x x x x 4.55 x x x 4.73778 x x x x x 5.26667 x x x x 6.55 x x x 7.875 x x 3.48194 x 5.86667 x x x x x x x x x x x 5.20444 x x x x x x x x 7.022 x x x 10.6 x x x +15774 None Trait_213_AUW-BXD Metabolism: Glycemia during oral glucose tolerance test (OGTT), decrease rate, chow diet, males [mg/mL/min] x x 1.24 0.627 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 3.44593 1.31852 x x x x x 0.991766 x x x 0.734707 x x x x x 0.79899 x x x x 0.967 x x x 0.866212 x x 0.873611 x 1.26885 x x x x x x x x x x x 1.13452 x x x x x x x x 1.16 x x x x x x x +15775 None Trait_214_AUW-BXD Metabolism: Glycemia during oral glucose tolerance test (OGTT), high fat diet, males [AUC] x x 46844.3 36968.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 57433.0 88299.0 41125.0 x x 59689.0 36531.0 41021.0 46108.0 x x x 31811.5 55009.0 x x x x 42864.4 50864.0 80500.0 76776.0 56012.0 34339.0 x 52472.0 87212.0 41760.2 81873.0 x 44394.0 x 49357.8 x x x 59870.0 41217.0 71567.0 x 48199.0 81533.0 78105.0 x 47882.0 x 33370.0 39758.0 x x x x 57942.0 64988.0 59021.0 92703.0 63851.0 49158.0 35706.0 x 42630.0 +15776 None Trait_215_AUW-BXD Metabolism: Glycemia during oral glucose tolerance test (OGTT), increase rate, high fat diet, males [mg/mL/min] x x 10.17 7.033 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 8.72889 4.81667 x x x x x 7.775 x x x 6.80278 x x x x x 3.58889 x x x x 2.85 x x x 10.0583 x x 4.15778 x 5.74444 x x x x x x x x x x x 4.70889 x x x x x x x x 9.19 x x x 8.66 x x x +15777 None Trait_216_AUW-BXD Metabolism: Glycemia during oral glucose tolerance test (OGTT), decrease rate, high fat diet, males [mg/mL/min] x x 1.02 0.5178 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 2.34281 1.15093 x x x x x 1.87212 x x x 0.85798 x x x x x 1.41444 x x x x 0.995 x x x 1.57977 x x 1.64413 x 1.92879 x x x x x x x x x x x 1.56993 x x x x x x x x 1.82 x x x 1.78 x x x +15778 None Trait_217_AUW-BXD Metabolism: Insulin response from oral glucose tolerance test (OGTT), chow diet, males [AUC] x x 40.93 68.335 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 16.61 37.346 28.095 x x 29.86 13.03 48.02 29.8975 x x x 41.034 20.914 x x x 47.03 28.84 22.38 44.3 25.42 79.25 153.645 x 25.39 44.538 50.16 34.29 x 49.1333 x 68.328 x x x 45.11 121.728 22.48 x 35.75 23.558 52.886 x 28.96 x 37.22 7.435 x 54.72 x x 24.73 73.06 91.992 12.559 33.562 43.096 20.633 x 44.87 +15779 None Trait_218_AUW-BXD Metabolism: Insulin response from oral glucose tolerance test (OGTT), high fat diet, males [AUC] x x 127.2 192.675 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 26.69 57.96 97.5425 x x 105.45 54.24 122.05 82.7875 x x x 45.9625 58.92 x x x x 263.5 103.1 100.17 28.34 156.45 215.575 x 25.3295 48.51 104.773 72.15 x 82.66 x 172.06 x x x 70.73 141.495 118.9 x 205.675 61.58 68.87 x 100.464 x 93.66 59.25 x x x x 98.02 331.1 120.55 56.82 63.872 129.266 99.52 x 70.854 +15781 None Trait_220_AUW-BXD Metabolism: Insulin after overnight fast, high fat diet, males [ug/mL] x x 3.3 3.7855 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.007 1.9148 2.114 x x 1.418 0.606 1.896 1.8715 x x x 0.43275 0.729 x x x x 4.805 1.57 2.46 1.048 4.35 4.175 x 0.0975 1.733 1.32325 3.32 x 1.3462 x 2.4586 x x x 0.971 4.743 2.723 x 3.82975 2.105 2.277 x 2.0186 x 1.401 1.188 x x x x 1.44 9.79333 2.275 1.39 0.8936 2.561 0.9775 x 1.2394 +15782 None Trait_221_AUW-BXD Metabolism: Insulin during oral glucose tolerance test (OGTT), 15min, chow diet, males [ug/mL] x x 1.999 1.85225 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.77 1.1992 0.88925 x x 1.307 0.795 2.0735 1.09125 x x x 1.0912 0.872 x x x 1.762 1.06233 1.36 1.79 1.072 3.13 6.98925 x 1.2442 1.7 2.597 1.098 x 1.89775 x 2.9756 x x x 1.918 4.593 0.9503 x 1.77767 0.9452 2.0616 x 0.834 x 1.822 0.395 x 1.9068 x x 1.14125 3.5046 3.766 0.601 1.4468 1.67933 0.895 x 1.7078 +15783 None Trait_222_AUW-BXD Metabolism: Insulin during oral glucose tolerance test (OGTT), 15min, high fat diet, males [ug/mL] x x 4.98 7.42825 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 1.175 1.33733 4.2285 x x 3.878 2.3535 5.084 2.802 x x x 2.172 2.49 x x x x 10.1946 4.11 3.32 0.9523 4.44 8.774 x 1.153 1.604 3.8255 1.745 x 3.56325 x 7.3964 x x x 3.11 4.84 4.564 x 8.70325 1.9197 2.504 x 3.8362 x 3.7155 2.151 x x x x 3.886 11.7487 4.74 1.815 2.6132 5.2104 4.375 x 2.7762 +15784 None Trait_223_AUW-BXD Metabolism: Insulin during oral glucose tolerance test (OGTT), 30min, chow diet, males [ug/mL] x x 1.072 2.68625 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.521 1.0418 1.4595 x x 1.018 0.344 2.11 0.81375 x x x 0.9934 0.72 x x x 1.547 1.03033 0.256 1.372 0.919 3.12 4.22725 x 0.6898 1.06 1.22367 1.3486 x 1.41133 x 1.7996 x x x 1.99 3.6885 0.617 x 1.08233 0.7782 1.711 x 0.559 x 1.008 0.181 x 2.154 x x 0.665 1.8986 3.65 0.462 1.413 1.10867 0.622 x 1.5648 +15785 None Trait_224_AUW-BXD Metabolism: Insulin during oral glucose tolerance test (OGTT), 30min, high fat diet, males [ug/mL] x x 3.694 7.0495 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 1.2 1.6365 2.43375 x x 3.242 1.995 4.22 3.56375 x x x 1.3515 2.15 x x x x 9.9428 3.45 4.267 1.019 5.17 7.02125 x 0.9735 1.625 3.08433 2.02 x 2.2222 x 5.6896 x x x 2.236 4.43975 3.856 x 6.1865 2.267 1.898 x 3.703 x 3.6548 2.41 x x x x 4.144 10.8543 4.33 2.02 2.3962 4.2542 3.535 x 2.6552 +15786 None Trait_225_AUW-BXD Blood chemistry, metabolism: Basal glucose, fasted state, chow diet, males [mmol/L] x x 15.1 15.35 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 7.83 15.425 15.54 x x 16.28 13.825 14.23 14.9 x x x 15.0 13.1 x x x 20.75 14.0 14.25 17.05 14.975 18.525 18.14 x 16.6 21.08 17.375 16.1 x 14.725 x 19.2 x x x 18.8 15.7 15.075 x 13.733 12.2 14.12 x 14.12 x 12.8 16.775 x 18.35 x x 15.9 19.85 x 19.03 14.3 16.6333 17.4 x 15.54 +15787 None Trait_226_AUW-BXD Blood chemistry, metabolism: Cholesterol, fasted state, chow diet, males [mmol/L] x x 3.66667 3.55 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 2.5 3.375 4.26 x x 3.16 2.88 3.225 3.0 x x x 3.46 2.87 x x x 5.15 3.58 3.775 3.35 4.7 4.25 3.84 x 3.83 3.24 3.55 3.55 x 2.825 x 4.5 x x x 2.96 3.1 3.075 x 3.033 3.37 3.12 x 3.52 x 2.675 3.55 x 4.48 x x 4.075 3.6 x 3.0 3.3 4.6 3.48 x 3.02 +15788 None Trait_227_AUW-BXD Blood chemistry, metabolism: High-density lipoprotein (HDL), fasted state, chow diet, males [mmol/L] x x 2.07 1.925 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 2.26 1.5125 1.92 x x 2.914 2.805 3.205 1.46333 x x x 1.75 2.73 x x x 4.525 1.366 3.77 3.305 4.12 3.4975 3.73 x 3.72 2.802 1.61 3.563 x 1.315 x 2.154 x x x 2.936 1.31 2.69 x 2.993 3.32 3.09 x 1.954 x 2.8 3.52 x 3.9275 x x 3.72 1.695 x 2.943 3.31 2.05333 3.303 x 2.964 +15789 None Trait_228_AUW-BXD Blood chemistry, metabolism: Low-density lipoprotein (LDL), fasted state, chow diet, males [mmol/L] x x 0.0666667 0.03 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.01 0.0133333 0.1 x x 0.102 0.095 0.1175 0.035 x x x 0.054 0.1433 x x x 0.2425 0.148 0.135 0.07 0.23 0.1675 0.046 x 0.13 0.084 0.23 0.1175 x 0.095 x 0.138 x x x 0.136 0.124 0.2325 x 0.0733 0.2 0.112 x 0.054 x 0.075 0.095 x 0.2175 x x 0.115 0.105 x 0.1033 0.09 0.123333 0.135 x 0.148 +15790 None Trait_229_AUW-BXD Blood chemistry, metabolism: Triglycerides, fasted state, chow diet, males [mmol/L] x x 1.28 1.66667 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 1.36 0.5625 1.318 x x 0.652 1.13 0.635 0.916667 x x x 0.92 0.797 x x x 0.66 0.418 0.32 1.96 1.1925 0.6725 1.622 x 1.297 1.484 1.0175 1.125 x 0.6425 x 0.932 x x x 0.926 0.864 0.8375 x 0.9533 1.483 0.728 x 1.51 x 1.083 1.428 x 0.79 x x 1.8 0.95 x 0.963 0.844 1.46667 1.883 x 1.06 +15791 None Trait_230_AUW-BXD Blood chemistry, metabolism: Free fatty acids (FFA), fasted state, chow diet, males [mmol/L] x x 2.34333 3.475 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.76 0.735 1.69 x x 0.752 1.3875 0.555 1.42667 x x x 1.486 0.897 x x x 0.75 0.888 0.6425 1.1733 0.7125 0.475 0.79 x 0.807 0.618 1.22 0.6325 x 1.22 x 1.4925 x x x 0.662 1.388 0.4775 x 0.513 0.8133 0.662 x 1.652 x 0.865 0.99 x 1.0975 x x 0.875 1.695 x 0.72 0.66 1.27333 1.025 x 0.636 +15792 None Trait_231_AUW-BXD Blood chemistry, metabolism: Bile acids, fasted state, chow diet, males [umol/L] x x x 5.43333 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 9.6 8.86 x x x x x 8.6 x x x 4.5 x x x x x 377.533 x x x x x x x x 13.7 x x 5.53333 x 12.3 x x x 11.18 119.2 x x x x x x 1.1 x x x x x x x x 11.6 x x x 15.7 x x x +15793 None Trait_232_AUW-BXD Blood chemistry, metabolism: Lactic acid, fasted state, chow diet, males [mmol/L] x x 8.73333 6.425 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 4.7 8.5 x x x x x 5.3 x x x 4.04 x x x x x 5.22 5.325 7.7 x x 5.62 x x x 4.7 x x 6.05 x 7.7 x x x x 6.54 x x 4.2 x x x 7.02 x 4.95 5.325 x x x x x 4.5 x x x 2.7 x x x +15794 None Trait_233_AUW-BXD Blood chemistry, metabolism: Total protein, fasted state, chow diet, males [g/L] x x 59.7 56.625 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 47.76 53.05 53.06 x x 51.14 51.225 51.225 52.4333 x x x 56.04 50.2 x x x 55.675 49.94 54.775 57.25 50.275 51.95 59.4 x 51.667 47.24 58.7 57.125 x 50.425 x 58.22 x x x 45.25 48.46 45.625 x 51.467 52.67 53.48 x 45.52 x 50.48 54.8 x 52.225 x x 55.05 54.45 x 56.4 52.38 53.8 48.93 x 50.02 +15795 None Trait_234_AUW-BXD Blood chemistry, metabolism: Alanine transaminase (ALAT), fasted state, chow diet, males [U/L] x x 26.0 30.5 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 123.3 44.25 29.2 x x 48.8 45.25 51.0 38.0 x x x 26.4 47.33 x x x 149.75 146.6 34.75 44.0 168.25 139.0 44.0 x 73.67 81.0 27.5 55.75 x 32.3333 x 26.6 x x x 84.0 31.2 53.0 x 67.33 52.0 63.4 x 34.6 x 28.25 30.0 x 118.25 x x 66.0 22.0 x 76.33 51.4 24.3333 58.5 x 67.4 +15796 None Trait_235_AUW-BXD Blood chemistry, metabolism: Aspartate transaminase (ASAT), fasted state, chow diet, males [U/L] x x 48.3333 43.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 118.7 43.0 35.25 x x 35.6 93.25 71.5 84.0 x x x 62.0 65.0 x x x 147.25 348.8 31.0 48.0 191.0 143.0 33.8 x 105.3 148.2 50.25 55.75 x 72.75 x 56.6 x x x 84.6 78.6 115.25 x 75.33 48.33 76.4 x 175.8 x 28.5 28.5 x 156.0 x x 91.75 110.0 x 92.33 67.4 33.6667 81.0 x 91.6 +15797 None Trait_236_AUW-BXD Blood chemistry, metabolism: Lactate dehydrogenase (LDH), fasted state, chow diet, males [U/L] x x 193.333 55.3333 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 2.33 336.0 231.0 x x 130.0 196.5 170.0 95.3333 x x x 163.0 296.0 x x x 622.5 326.75 273.25 218.0 539.0 444.5 211.6 x 396.3 435.8 179.75 236.3 x 84.25 x 177.0 x x x 350.0 168.0 239.0 x 302.3 290.7 233.8 x 194.0 x 249.25 169.0 x 411.0 x x 237.75 16.0 x 242.0 280.2 107.0 296.0 x 353.8 +15798 None Trait_237_AUW-BXD Blood chemistry, metabolism: Bilirubin, fasted state, chow diet, males [umol/L] x x 1.2 1.975 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.9 0.7 x x x 0.35 x 0.55 x x x 0.4 x x x x x 10.28 2.15 3.25 x x 2.92 x x x 0.6 x x 0.733333 x 1.1 x x x x 3.475 0.0 x 1.6 x x x 3.33333 x x x x x x x x 0.85 x x x 1.55 x x x +15799 None Trait_238_AUW-BXD Blood chemistry, metabolism: Alkaline phosphatase (ALPL), fasted state, chow diet, males [U/L] x x 63.3333 95.5 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 88.0 82.25 106.6 x x 94.2 82.0 73.0 110.0 x x x 77.6 67.67 x x x 91.0 104.67 52.75 51.0 124.75 93.5 78.6 x 70.67 141.6 94.75 117.25 x 57.25 x 78.0 x x x 109.8 74.2 198.5 x 126.67 62.67 129.2 x 78.6 x 100.25 137.25 x 95.25 x x 111.75 78.5 x 70.33 95.4 94.3333 77.3 x 64.0 +15800 None Trait_239_AUW-BXD Blood chemistry, metabolism: Amylase, fasted state, chow diet, males [U/L] x x 1199.67 1021.5 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 1120.7 1045.75 924.2 x x 1104.4 923.5 1047.5 1079.33 x x x 1086.6 995.3 x x x 1154.5 1272.0 1059.5 1122.0 1083.5 1266.0 1396.0 x 1127.3 1207.6 1341.5 1192.3 x 1047.5 x 1265.4 x x x 939.0 1181.0 889.0 x 1052.3 881.0 1377.0 x 1260.0 x 1257.5 977.25 x 1299.75 x x 1057.75 1135.5 x 941.0 928.0 1051.0 878.3 x 1180.0 +15801 None Trait_240_AUW-BXD Blood chemistry, metabolism: Creatine kinase (CPK), fasted state, chow diet, males [U/L] x x 148.667 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 122.3 55.6667 203.0 x x 88.0 62.5 56.5 14.5 x x x 53.0 147.67 x x x 164.0 36.5 171.5 122.5 79.0 201.5 113.0 x 339.0 157.0 62.75 130.0 x 87.3333 x 53.75 x x x 158.6 34.2 181.75 x 145.67 112.7 179.2 x 82.25 x 684.0 37.0 x 327.5 x x 101.5 189.5 x 62.7 173.6 57.6667 256.8 x 273.4 +15802 None Trait_241_AUW-BXD Blood chemistry, metabolism: Creatinine, fasted state, chow diet, males [umol/L] x x 24.3333 21.25 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 11.33 24.25 29.2 x x 11.25 10.5 13.5 22.3333 x x x 21.0 10.3 x x x 7.5 26.2 x x 7.5 12.5 x x x 11.6 20.75 32.3 x 23.5 x 29.4 x x x 19.4 27.8 2.5 x x 20.0 22.2 x 23.2 x x x x 4.0 x x 15.25 22.0 x 9.0 7.4 29.0 9.25 x 14.8 +15803 None Trait_242_AUW-BXD Blood chemistry, metabolism: Iron (Fe) level in serum, fasted state, chow diet, males [umol/L] x x 21.8667 40.85 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 16.5 29.1 26.4 x x 20.62 27.6 20.075 26.7667 x x x 28.86 29.6 x x x 31.3 34.68 20.85 30.8 32.075 27.1 25.22 x 38.2 32.3 29.875 27.85 x 28.6 x 30.36 x x x 26.85 25.7 47.85 x 19.73 29.4 25.5 x 29.02 x 26.95 26.8 x 25.2 x x 30.625 20.15 x 26.83 22.76 26.5 26.05 x 28.38 +15804 None Trait_243_AUW-BXD Blood chemistry, metabolism: Basal glucose, fasted state, high fat diet, males [mmol/L] x x 21.46 16.38 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 11.53 16.2 17.975 x x 21.28 13.825 11.98 18.45 x x x 16.575 13.6 x x x x 14.4 13.925 14.0 10.325 15.55 15.55 x 13.75 16.72 20.8667 12.3 x 14.2 x 18.2 x x x 12.72 15.54 13.35 x 14.625 15.1 14.7 x 16.74 x 14.625 16.7 x x x x x 19.3667 11.85 15.76 19.66 17.92 11.83 x 17.78 +15805 None Trait_244_AUW-BXD Blood chemistry, metabolism: Cholesterol, fasted state, high fat diet, males [mmol/L] x x 5.6 4.44 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 3.7 6.0 5.1 x x 4.72 4.375 4.46 5.175 x x x 5.3 3.85 x x x x 4.13333 6.125 2.6 2.925 7.1 4.3 x 4.55 3.98 5.5 3.47 x 3.575 x 6.06 x x x 4.16 4.54 5.2 x 4.3 6.3 4.3 x 5.54 x 3.45 4.2 x x x x x 3.83333 6.025 6.8 5.12 6.52 5.03 x 4.3 +15806 None Trait_245_AUW-BXD Blood chemistry, metabolism: High-density lipoprotein (HDL), fasted state, high fat diet, males [mmol/L] x x 2.168 2.318 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 3.29 1.875 1.91 x x 4.248 3.645 4.35 1.8025 x x x 2.1375 3.675 x x x x 2.09667 5.708 2.8 2.8275 5.225 4.8125 x 4.1975 3.554 2.29333 3.4 x 1.485 x 2.438 x x x 4.208 1.582 4.36 x 4.048 5.38 x x 2.556 x 3.26 4.37 x x x x x 1.79667 5.59 5.884 4.68 2.59 4.783 x 4.184 +15807 None Trait_246_AUW-BXD Blood chemistry, metabolism: Low-density lipoprotein (LDL), fasted state, high fat diet, males [mmol/L] x x 0.372 0.14 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.14 0.285 0.2075 x x 0.198 0.265 0.238 0.2425 x x x 0.1975 0.23 x x x x 0.06 0.395 0.11 0.045 0.57 0.125 x 0.305 0.132 0.323333 0.303 x 0.17 x 0.222 x x x 0.21 0.234 0.466 x 0.2125 0.447 0.2575 x 0.182 x 0.0825 0.2175 x x x x x 0.185 0.0433 0.566 0.194 0.334 0.348 x 0.226 +15808 None Trait_247_AUW-BXD Blood chemistry, metabolism: Triglycerides, fasted state, high fat diet, males [mmol/L] x x 0.91 1.855 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 1.29 0.85 1.49 x x 1.052 1.855 0.904 0.93 x x x 1.29 1.2 x x x x 0.783333 0.8925 1.68 1.1875 0.655 1.2575 x 0.8525 1.06 1.68333 1.593 x 1.41 x 0.868 x x x 0.888 1.128 1.353 x 1.025 1.147 1.785 x 2.34 x 2.2275 1.41 x x x x x 0.733333 0.628 0.798 1.502 1.324 0.83 x 1.392 +15809 None Trait_248_AUW-BXD Blood chemistry, metabolism: Free fatty acids (FFA), fasted state, high fat diet, males [mmol/L] x x 2.182 2.428 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.847 1.065 1.5075 x x 0.86 0.695 0.848 1.4575 x x x 1.6775 1.02 x x x x 1.49667 0.475 0.885 0.93 0.63 0.9775 x 0.67 0.632 1.79 0.74 x 1.3225 x 0.45 x x x 0.598 1.608 0.743 x 0.395 0.51 0.4267 x 2.354 x 0.775 0.875 x x x x x 1.61333 0.493 0.638 0.54 1.224 0.715 x 0.63 +15810 None Trait_249_AUW-BXD Blood chemistry, metabolism: Bile acids, fasted state, high fat diet, males [umol/L] x x 7.4 6.23333 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 12.0 9.75 x x x x x 12.225 x x x 13.1333 x x x x x x x x x x x x x x 22.2 x x 74.55 x 20.55 x x x x 13.7 x x x x x x x x x x x x x x x 21.0 8.525 x x 5.8 x x x +15811 None Trait_250_AUW-BXD Blood chemistry, metabolism: Lactic acid, fasted state, high fat diet, males [mmol/L] x x 3.66 5.64 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 4.95 6.35 x x x x x 2.35 x x x 4.9 x x x x x 6.06667 6.175 10.63 x x 5.775 x x x 5.86667 x x 5.475 x 4.34 x x x x 3.96 x x x x x x 6.16 x x 4.6 x x x x x 3.23333 x x x 3.7 x x x +15812 None Trait_251_AUW-BXD Blood chemistry, metabolism: Total protein, fasted state, high fat diet, males [g/L] x x 64.32 59.76 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 50.8 55.35 51.4 x x 50.0 57.0 54.34 54.85 x x x 60.2 52.7 x x x x 52.7667 56.7 54.67 48.525 56.55 61.525 x 47.675 46.68 62.8 53.5 x 50.65 x 52.96 x x x 49.58 49.24 53.03 x 49.43 49.8 51.125 x 53.22 x 51.4 55.38 x x x x x 58.4 58.45 61.38 53.74 50.22 52.73 x 55.38 +15813 None Trait_252_AUW-BXD Blood chemistry, metabolism: Alanine transaminase (ALAT), fasted state, high fat diet, males [U/L] x x 32.0 32.2 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 74.33 89.0 31.75 x x 86.2 85.5 123.6 81.0 x x x 36.75 78.5 x x x x 31.5 67.5 40.0 60.75 243.25 68.0 x 90.25 103.4 54.3333 132.67 x 37.25 x 72.0 x x x 132.8 39.0 88.67 x 61.25 87.67 139.0 x 41.0 x 63.0 39.5 x x x x x 32.6667 176.3 373.4 77.6 52.4 279.5 x 97.8 +15814 None Trait_253_AUW-BXD Blood chemistry, metabolism: Aspartate transaminase (ASAT), fasted state, high fat diet, males [U/L] x x 54.0 50.4 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 73.33 197.0 38.0 x x 113.4 129.5 157.0 119.25 x x x 73.0 94.0 x x x x 23.5 80.25 40.0 86.75 247.25 77.5 x 123.5 191.6 45.3333 156.0 x 93.0 x 117.6 x x x 134.0 90.4 133.0 x 73.0 121.7 112.5 x 110.0 x 103.25 23.0 x x x x x 63.0 162.75 496.0 79.0 52.4 281.0 x 105.4 +15815 None Trait_254_AUW-BXD Blood chemistry, metabolism: Lactate dehydrogenase (LDH), fasted state, high fat diet, males [U/L] x x 146.8 87.25 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 214.33 819.0 296.0 x x 280.2 303.8 270.2 338.0 x x x 181.333 406.5 x x x x 277.667 891.0 201.0 251.25 707.0 235.0 x 281.8 503.6 400.0 445.0 x 237.75 x 262.5 x x x 426.2 214.25 614.3 x 535.0 330.67 688.8 x 485.0 x 480.25 355.5 x x x x x 236.0 398.0 1392.0 354.4 200.8 479.5 x 386.4 +15816 None Trait_255_AUW-BXD Blood chemistry, metabolism: Bilirubin, fasted state, high fat diet, males [umol/L] x x 0.45 0.3 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.6 0.3 x x x x x 1.2 x x x 0.5 x x x x x 1.8 2.167 2.93 x x 3.5 x x x x x x 0.65 x 1.3 x x x x 2.28 0.01 x x x x x x x x x x x x x x 0.5 x x x 2.4 x x x +15817 None Trait_256_AUW-BXD Blood chemistry, metabolism: Alkaline phosphatase (ALPL), fasted state, high fat diet, males [U/L] x x 61.6 62.4 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 79.0 76.5 83.25 x x 71.8 97.5 69.6 117.25 x x x 66.5 59.5 x x x x 104.667 50.5 73.3 109.75 115.0 61.5 x 54.25 119.8 104.333 122.3 x 45.75 x 68.0 x x x 122.0 56.6 160.67 x 82.5 58.7 96.0 x 62.8 x 81.5 96.75 x x x x x 77.3333 95.3 161.4 93.2 68.0 79.75 x 59.0 +15818 None Trait_257_AUW-BXD Blood chemistry, metabolism: Amylase, fasted state, high fat diet, males [U/L] x x 1169.2 1145.8 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 1155.0 1014.5 858.5 x x 945.0 1077.0 973.8 1048.75 x x x 1173.25 1181.0 x x x x 1189.0 897.0 912.0 1048.0 981.0 1113.0 x 1078.0 1142.2 1467.67 1228.0 x 1168.5 x 1065.4 x x x 863.4 1234.4 842.3 x 1229.0 928.3 1309.0 x 1375.0 x 1488.0 1037.3 x x x x x 1178.67 116.0 952.0 925.4 1099.6 919.75 x 1326.4 +15819 None Trait_258_AUW-BXD Blood chemistry, metabolism: Creatine kinase (CPK), fasted state, high fat diet, males [U/L] x x 146.4 11.2 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 131.67 225.0 117.0 x x 106.2 71.3 72.8 26.5 x x x 149.75 83.0 x x x x 30.0 208.25 92.3 243.25 127.3 77.25 x 110.0 157.0 29.3333 117.67 x 17.0 x 55.0 x x x 113.6 41.8 251.67 x 237.0 77.67 267.3 x 77.4 x 602.5 68.75 x x x x x 50.67 100.75 88.0 74.4 65.6 55.8 x 103.2 +15820 None Trait_259_AUW-BXD Blood chemistry, metabolism: Creatinine, fasted state, high fat diet, males [umol/L] x x 26.0 25.8 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 8.67 32.5 26.0 x x 4.4 15.25 15.4 19.25 x x x 28.75 3.0 x x x x 26.2 x x 11.0 10.5 x x 21.5 6.0 24.3333 8.0 x 27.5 x 22.2 x x x 18.2 41.8 3.33 x x 7.33 23.25 x 28.8 x x x x x x x x x 20.5 22.2 17.6 25.2 16.3 x 19.8 +15821 None Trait_260_AUW-BXD Blood chemistry, metabolism: Iron (Fe) level in serum, fasted state, high fat diet, males [umol/L] x x 22.94 43.24 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 20.37 22.5 25.5 x x 25.3 26.65 15.9 25.25 x x x 28.5 22.9 x x x x 32.0333 16.775 31.37 26.95 33.73 29.2 x 21.7 27.4 31.7333 23.1 x 22.25 x 38.22 x x x 15.3 24.5 60.5 x 27.13 35.0 27.63 x 35.42 x 33.22 25.63 x x x x x 20.4 9.05 21.86 35.02 24.22 21.4 x 29.64 +15822 None Trait_377_AUW-BXD Blood chemistry, metabolism: Interferon-gamma (IFN-g) cytokine level in plasma after 12 h fast, Luminex assay, high fat diet, males [pg/mL] x x 16.476 18.1325 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 11.0567 8.74 8.995 x x 14.29 x x 8.87 x x x 12.04 x x x x x 9.86 11.11 x 11.94 13.93 15.42 78.705 8.85 13.87 9.74 10.56 x 12.55 x 8.08 x x x x 19.46 9.23 x 14.84 11.87 11.03 x 15.18 x 32.1 21.6 x x x x x 16.32 x 8.88 7.29 14.22 x x 20.71 +15823 None Trait_378_AUW-BXD Blood chemistry, metabolism: Tumer necrosis factor-alpha (TNF, cachexin) cytokine level in plasma after 12 h fast, Luminex assay, high fat diet, males [pg/mL] x x 85.1 116.4 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 70.6 67.5 68.2 x x 62.98 x x 58.6 x x x 70.82 78.36 x x x x 61.81 79.52 x 79.28 78.57 78.71 x 43.75 69.98 58.85 63.94 x 70.05 x 58.52 x x x x 104.7 60.85 x 61.71 70.6 103.8 x 87.3 x 101.55 98.66 x x x x x 78.53 x 73.22 57.13 65.2 x x 92.1 +15824 None Trait_379_AUW-BXD Blood chemistry, metabolism: Interleukin 15 (IL15) cytokine level in plasma after 12 h fast, Luminex assay, high fat diet, males [pg/mL] x x 276.92 298.03 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 298.77 234.36 324.135 x x 328.192 x x 234.36 x x x 234.36 339.3 x x x x 234.36 263.11 x 262.98 234.36 277.392 x 234.36 234.36 234.36 269.85 x 236.07 x 327.4 x x x x 327.396 234.36 x 271.88 234.36 234.36 x 234.36 x 325.99 234.36 x x x x x 322.79 x 600.0 234.36 292.848 x x 339.674 +15825 None Trait_380_AUW-BXD Blood chemistry, metabolism: Monocyte chemotactic protein 1 (MCP1, CCL2) cytokine level in plasma after 12 h fast, Luminex assay, high fat diet, males [pg/mL] x x 139.24 84.99 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 50.5767 48.08 53.06 x x 59.268 x x 61.7925 x x x 74.8025 55.72 x x x x 245.024 59.39 x 53.27 80.36 35.11 x 44.9 109.397 49.17 55.5633 x 82.88 x 33.786 x x x x 141.292 50.8867 x 43.81 84.08 93.43 x 81.2175 x 105.582 71.005 x x x x x 124.985 x 84.91 48.924 59.585 x x 113.25 +15826 None Trait_381_AUW-BXD Blood chemistry, metabolism: Interleukin 10 (IL10) cytokine level in plasma after 12 h fast, Luminex assay, high fat diet, males [pg/mL] x x 177.15 105.64 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 51.7067 65.8 33.6675 x x 104.416 x x 50.775 x x x 68.2975 83.02 x x x x 296.694 132.97 x 94.46 181.337 131.415 x 58.625 108.07 44.83 91.3667 x 61.91 x 46.438 x x x x 139.21 75.4667 x 111.92 77.36 72.2167 x 77.69 x 75.755 153.31 x x x x x 151.705 x 127.78 41.476 80.9075 x x 158.896 +15827 None Trait_382_AUW-BXD Blood chemistry, metabolism: Macrophage inflammatory protein 1-beta (MIP1B, CCL4) cytokine level in plasma after 12 h fast, Luminex assay, high fat diet, males [pg/mL] x x 32.462 26.8425 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 27.5967 30.8 28.4275 x x 17.818 x x 26.2175 x x x 32.66 36.7 x x x x 46.294 34.15 x 39.14 17.2825 17.855 x 34.1275 47.31 35.0867 40.6033 x 36.0725 x 31.286 x x x x 33.126 40.48 x 30.8 51.15 38.83 x 15.9175 x 75.47 27.54 x x x x x 28.44 x 51.58 32.974 16.2875 x x 61.828 +15828 None Trait_383_AUW-BXD Blood chemistry, metabolism: Macrophage inflammatory protein 1-alpha (MIP1A, CCL3) cytokine level in plasma after 12 h fast, Luminex assay, high fat diet, males [pg/mL] x x 13.732 16.1 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 12.0633 8.12 15.9975 x x 7.416 x x 5.6825 x x x 12.8825 12.94 x x x x 19.09 18.58 x 11.95 4.685 6.6 x 16.635 11.3725 8.53 5.79 x 13.42 x 8.796 x x x x 14.648 7.73667 x 8.21 19.28 10.16 x 16.275 x 28.8525 11.94 x x x x x 6.125 x 14.26 9.338 8.5175 x x 10.196 +15829 None Trait_388_AUW-BXD Blood chemistry, metabolism: Interleukin 6 (IL6) cytokine level in plasma after 12 h fast, Luminex assay, high fat diet, males [pg/mL] x x 6.92 6.95 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 2.97 2.8 2.8 x x 4.456 x x 3.59 x x x 3.15 2.8 x x x x 13.51 4.97 x 3.98 8.65 4.99 x 6.63 4.59 5.28 2.8 x 3.32 x 6.46 x x x x 5.93 3.45 x 4.22 5.12 4.04 x 4.44 x 8.81 10.39 x x x x x 6.16 x 4.37 2.8 3.38 x x 4.25 +15830 None Trait_389_AUW-BXD Blood chemistry, metabolism: Interleukin 18 (IL18) cytokine level in plasma after 12 h fast, Luminex assay, high fat diet, males [pg/mL] x x 351.28 724.5 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 430.2 493.5 862.2 x x 481.9 x x 771.6 x x x 922.1 1333.4 x x x x 175.6 692.2 x 679.5 318.8 506.6 x 508.1 940.5 776.3 669.2 x 828.0 x 579.5 x x x x 748.6 396.0 x 657.0 790.7 1032.3 x 565.5 x 820.3 741.3 x x x x x 425.5 x 1008.8 643.4 434.2 x x 1361.0 +15831 None Trait_390_AUW-BXD Blood chemistry, metabolism: Regulated and normal T cell expressed and secreted (RANTES, CCL5) cytokine level in plasma after 12 h fast, Luminex assay, high fat diet, males [pg/mL] x x 9.312 11.35 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 8.61 22.3 7.06 x x 10.01 x x 8.48 x x x 9.65 22.12 x x x x 25.6 11.79 x 11.81 5.55 3.14 x 13.77 8.73 5.52 1.04 x 16.6 x 30.2 x x x x 26.32 7.33 x 10.29 7.19 10.4 x 9.92 x 12.98 10.33 x x x x x 5.98 x 12.69 8.17 6.89 x x 19.2 +15832 None Trait_261_AUW-BXD Hematology: Red blood cells, chow diet, males [10^6/uL] x x 9.38 10.185 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 9.91 10.45 x x x 10.43 10.02 11.26 x x x x x x x x x 9.99 x 10.94 9.97 10.23 11.11 11.356 x 11.92 9.01 x 9.98 x x x x x x x 10.86 10.4275 11.5 x 9.34 10.94 9.92 x x x 9.23 10.11 x 9.71 x x 8.85 9.71 11.22 9.71 10.51 9.89 11.37 x 10.15 +15833 None Trait_262_AUW-BXD Hematology: Mature red blood cells, chow diet, males [%] x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 97.2 97.05 x x x 97.54 96.4 97.13 x x x x x x x x x 97.05 x 97.225 97.3 97.4 97.65 x x 97.43 97.5 x 97.83 x x x x x x x 97.6 x 97.73 x 96.97 98.3 97.85 x x x 97.8 97.73 x 97.73 x x 97.57 x 97.6 97.97 97.62 x 97.45 x 97.98 +15834 None Trait_263_AUW-BXD Hematology: Mature red blood cells, chow diet, males [10^9/L] x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 85338.0 83480.0 x x x 87986.0 83825.0 91285.0 x x x x x x x x x 89340.5 x 84852.0 83385.7 88042.0 92663.0 x x 96587.0 78346.0 x 82654.0 x x x x x x x 91570.0 x 94505.5 x 87109.0 90312.0 73112.0 x x x 76277.0 82496.5 x 82706.0 x x 77880.7 x 92389.0 83473.0 87668.0 x 91682.0 x 85200.4 +15835 None Trait_264_AUW-BXD Hematology: Hemoglobin, chow diet, males [g/dL] x x 13.63 13.4 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 14.33 13.8 x x x 13.64 14.0 14.95 x x x x x x x x x 14.1 x 14.4 13.5 13.0 14.8 13.86 x 17.73 12.95 x 14.3 x x x x x x x 15.0 13.8 15.65 x 12.44 15.4 13.95 x x x 13.6 13.35 x 13.07 x x 12.13 12.825 14.72 13.13 14.48 13.95 15.75 x 14.2 +15836 None Trait_265_AUW-BXD Hematology: Hematocrit, chow diet, males [%] x x 45.47 44.3 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 45.67 x x x x 42.64 43.7 51.55 x x x x x x x x x 43.75 x 23.85 47.67 42.33 47.75 48.86 x 55.0 41.7 x 45.4 x x x x x x x 48.44 47.2 47.5 x 13.27 47.7 45.1 x x x 42.5 46.2 x 41.87 x x 39.73 44.325 50.44 45.02 44.16 46.95 51.0 x 44.68 +15837 None Trait_266_AUW-BXD Hematology: Mean corpuscular volume (MCV), chow diet, males [fL/RBC] x x 48.37 43.5 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 46.13 47.4 x x x 40.84 43.58 45.8 x x x x x x x x x 43.85 x 43.625 47.8 41.4 43.03 43.06 x 46.13 46.3 x 45.5 x x x x x x x 44.6 45.25 41.28 x 44.17 43.5 45.53 x x x 46.1 45.65 x 43.13 x x 44.9 45.65 44.94 46.33 42.02 47.5 44.88 x 43.96 +15838 None Trait_267_AUW-BXD Hematology: Mean corpuscular hemoglobin (MCH), chow diet, males [pg/RBC] x x 15.5 13.175 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 14.47 13.4 x x x 13.04 14.0 13.3 x x x x x x x x x 14.1 x 13.175 13.5 12.67 13.33 12.22 x 14.83 14.35 x 14.38 x x x x x x x 13.85 13.25 13.6 x 13.37 14.05 14.1 x x x 14.85 13.175 x 13.47 x x 13.8 13.225 13.12 13.6 13.78 13.3 13.85 x 14.0 +15839 None Trait_268_AUW-BXD Hematology: Mean corpuscular hemoglobin concentration (MCHC), chow diet, males [g/dL] x x 29.98 30.275 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 31.4 28.266 x x x 31.88 32.08 28.98 x x x x x x x x x 32.15 x 30.15 28.26 30.63 31.0 28.98 x 32.17 30.98 x 31.5 x x x x x x x 31.0 29.25 32.98 x 30.27 32.3 30.88 x x x 32.25 28.85 x 31.2 x x 30.67 28.95 29.18 29.27 32.76 27.95 30.88 x 31.84 +15840 None Trait_269_AUW-BXD Hematology: Red blood cell hemoglobin content, chow diet, males [pg/RBC] x x 12.52 12.05 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 14.37 12.1667 x x x 12.86 14.23 12.85 x x x x x x x x x 14.65 x 12.35 12.47 12.63 13.8 11.6 x 14.3 14.1 x 14.38 x x x x x x x 13.6 12.05 13.75 x 11.97 14.2 14.05 x x x 12.75 12.2 x 13.3 x x 14.0 12.125 12.38 13.0 13.84 12.35 13.38 x 14.06 +15841 None Trait_270_AUW-BXD Hematology: Red blood cell distribution width, chow diet, males [%] x x 12.666 13.525 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 14.27 12.55 x x x 12.92 14.13 12.63 x x x x x x x x x 13.55 x 12.8 14.4 16.87 13.83 13.02 x 13.5 14.93 x 12.75 x x x x x x x 13.7 14.03 14.43 x 13.1 12.9 14.38 x x x 12.0 12.575 x 13.97 x x 13.27 12.625 13.12 14.03 13.84 14.3 12.48 x 13.18 +15842 None Trait_271_AUW-BXD Hematology: Hemoglobin concentration distribution width, chow diet, males [g/dL] x x 1.657 1.86 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 2.11 1.885 x x x 2.03 2.11 1.61 x x x x x x x x x 2.24 x 1.9325 2.097 2.36 2.02 1.922 x 2.15 2.09 x 2.09 x x x x x x x 1.83 1.898 2.16 x 1.91 2.08 2.1 x x x 1.855 1.8575 x 2.13 x x 2.08 1.82 1.76 1.81 2.22 2.0 1.85 x 2.09 +15843 None Trait_272_AUW-BXD Hematology: Reticulocytes, chow diet, males [%] x x 3.0 1.9 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 2.8 2.7667 x x x 2.46 3.6 2.88 x x x x x x x x x 2.95 x 2.775 2.67 2.6 2.35 3.08 x 2.57 2.5 x 2.18 x x x x x x x 2.4 2.7 2.28 x 3.03 1.7 2.15 x x x 2.2 2.275 x 2.27 x x 2.43 3.175 2.4 2.03 2.38 2.95 2.55 x 2.02 +15844 None Trait_273_AUW-BXD Hematology: Reticulocytes, chow diet, males [10^9/L] x x 297.166 193.4 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 279.0 282.7 x x x 256.36 363.35 320.4 x x x x x x x x x 294.25 x 303.6 266.3 263.93 263.65 347.0 x 305.0 224.9 x 217.95 x x x x x x x 261.87 282.4 262.05 x 283.0 186.7 213.3 x x x 202.3 231.1 x 219.13 x x 215.73 307.5 269.64 200.47 252.2 294.1 290.3 x 205.52 +15845 None Trait_274_AUW-BXD Hematology: Mean corpuscular volume reticulocytes, chow diet, males [fL/RTC] x x 58.3667 53.1 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 54.93 55.4 x x x 50.26 56.05 56.38 x x x x x x x x x 57.0 x 52.375 55.4 53.93 51.13 54.54 x 56.4 56.9 x 54.13 x x x x x x x 57.3 57.45 52.78 x 53.3 51.25 58.5 x x x 54.3 53.975 x 52.83 x x 54.37 56.075 55.74 59.67 52.48 57.35 55.53 x 51.6 +15846 None Trait_275_AUW-BXD Hematology: Mean corpuscular hemoglobin concentration reticulocytes, chow diet, males [g/dL] x x 29.98 26.825 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 28.77 25.7667 x x x 29.22 29.38 24.95 x x x x x x x x x 29.6 x 27.575 27.2 27.43 29.7 25.4 x 29.13 28.7 x 30.78 x x x x x x x 27.15 25.35 30.23 x 27.0 31.85 29.95 x x x 27.8 27.25 x 28.63 x x 28.97 25.375 25.22 24.67 30.5 24.95 27.63 x 31.36 +15847 None Trait_276_AUW-BXD Hematology: Red cell hemoglobin content reticulocytes, chow diet, males [pg/RTC] x x 14.667 14.15 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 15.73 14.233 x x x 14.5 16.33 13.98 x x x x x x x x x 16.6 x 14.35 15.03 14.67 15.03 13.74 x 16.33 16.2 x 16.53 x x x x x x x 15.3 14.45 15.75 x 14.33 16.15 17.4 x x x 14.95 14.6 x 15.03 x x 15.63 14.18 13.86 14.57 15.78 14.3 15.15 x 16.02 +15848 None Trait_277_AUW-BXD Hematology: Low mature reticulocytes, chow diet, males [%] x x 42.566 56.95 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 51.6 51.3666 x x x 63.98 54.4 74.53 x x x x x x x x x 37.0 x 53.275 56.97 59.57 65.45 50.54 x 61.4 47.0 x 62.2 x x x x x x x 74.2 61.98 55.13 x 47.2 64.95 65.85 x x x 53.45 56.15 x 63.83 x x 48.4 58.35 67.82 73.2 60.88 58.15 75.63 x 71.26 +15849 None Trait_278_AUW-BXD Hematology: Low mature reticulocytes, chow diet, males [10^9/L] x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 637.67 598.3 x x x 708.8 848.0 996.75 x x x x x x x x x 411.5 x 646.25 583.7 688.0 736.0 x x 781.0 469.0 x 573.75 x x x x x x x 796.5 x 601.25 x 141.0 511.5 522.5 x x x 457.5 542.0 x 609.67 x x 472.0 x 771.8 623.0 655.2 x 908.3 x 626.2 +15850 None Trait_279_AUW-BXD Hematology: Medium mature reticulocytes, chow diet, males [%] x x 41.8 325.03 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 39.77 42.4 x x x 33.28 39.88 24.43 x x x x x x x x x 42.65 x 41.3 38.3 33.53 31.9 41.52 x 33.43 37.45 x 33.45 x x x x x x x 23.7 33.25 39.55 x 40.67 31.8 29.2 x x x 39.65 37.375 x 32.8 x x 41.2 37.4 30.02 24.5 34.02 35.8 22.45 x 26.22 +15851 None Trait_280_AUW-BXD Hematology: Medium mature reticulocytes, chow diet, males [10^9/L] x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 491.0 498.7 x x x 370.4 634.25 326.5 x x x x x x x x x 476.5 x 498.25 395.7 395.67 359.5 x x 420.67 374.25 x 307.5 x x x x x x x 254.5 x 439.0 x 353.0 248.5 239.0 x x x 339.0 361.0 x 315.0 x x 401.0 x 339.6 210.0 367.0 x 269.0 x 231.4 +15852 None Trait_281_AUW-BXD Hematology: High mature reticulocytes, chow diet, males [%] x x 15.633 8.025 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 8.63 6.233 x x x 2.74 5.65 1.08 x x x x x x x x x 20.4 x 5.4 4.7 6.83 2.68 7.96 x 5.13 15.55 x 4.35 x x x x x x x 2.05 4.75 5.38 x 12.2 3.25 4.98 x x x 6.95 6.45 x 3.33 x x 10.43 4.225 2.18 2.3 5.14 6.05 1.95 x 2.52 +15853 None Trait_282_AUW-BXD Hematology: High mature reticulocytes, chow diet, males [10^9/L] x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 106.7 75.0 x x x 29.8 93.5 14.25 x x x x x x x x x 227.0 x 64.75 46.0 83.67 30.25 x x 65.67 157.75 x 40.25 x x x x x x x 22.5 x 60.75 x 104.3 25.5 37.25 x x x 59.5 62.25 x 32.0 x x 99.33 x 24.6 20.33 55.4 x 23.25 x 22.2 +15854 None Trait_283_AUW-BXD Hematology: Platelets, chow diet, males [10^3/uL] x x 931.333 1239.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 1410.7 1387.0 x x x 1284.0 1267.0 1827.5 x x x x x x x x x 1469.5 x 1772.0 1162.0 1126.0 1327.0 1095.4 x 830.0 946.0 x 1412.5 x x x x x x x 1532.36 1024.3 1186.5 x 1585.5 1325.0 1249.0 x x x 1061.0 1686.0 x 1178.0 x x 1319.33 917.5 1546.4 1197.33 1558.4 899.0 1228.5 x 1497.6 +15855 None Trait_284_AUW-BXD Hematology: Mean platelet volume, chow diet, males [fL/PLT] x x 5.66 4.2 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 5.47 4.1 x x x 5.26 5.28 7.1 x x x x x x x x x 5.55 x 4.325 4.57 5.73 5.35 3.9 x 6.4 6.1 x 6.0 x x x x x x x 4.95 3.98 4.93 x 4.7 6.65 5.93 x x x 11.95 4.45 x 6.23 x x 5.4 3.925 4.94 7.4 5.36 4.45 4.5 x 4.88 +15856 None Trait_285_AUW-BXD Hematology: Platelet distribution width, chow diet, males [%] x x 83.8 58.425 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 64.47 48.35 x x x 51.02 50.98 49.1 x x x x x x x x x 58.25 x 49.3 66.63 56.47 56.53 52.76 x 64.27 67.73 x 49.55 x x x x x x x 53.85 55.7 54.0 x 64.8 57.35 48.7 x x x 71.3 47.4 x 61.6 x x 57.07 47.725 45.14 53.7 48.98 65.75 44.5 x 42.28 +15857 None Trait_286_AUW-BXD Hematology: Plateletcrit, chow diet, males [%] x x 0.5233 0.52 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.38 0.28 x x x 0.34 0.34 0.65 x x x x x x x x x 0.32 x 0.385 0.243 0.32 0.36 0.428 x 0.27 0.29 x 0.43 x x x x x x x 0.37 0.403 0.29 x 0.21 0.44 0.37 x x x 0.265 0.375 x 0.37 x x 0.36 0.3575 0.38 0.43 0.43 0.385 0.28 x 0.36 +15858 None Trait_287_AUW-BXD Hematology: Platelet component concentration, chow diet, males [g/dL] x x 226.0 271.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 237.3 272.0 x x x 239.4 257.5 195.25 x x x x x x x x x 232.0 x 255.75 264.0 227.0 232.0 291.2 x 227.0 223.5 x 226.8 x x x x x x x 252.0 288.0 243.75 x 261.0 192.5 234.5 x x x 202.5 254.25 x 205.0 x x 226.0 294.25 238.8 190.67 247.6 295.5 256.0 x 256.8 +15859 None Trait_288_AUW-BXD Hematology: Platelet component distribution width, chow diet, males [g/dL] x x 72.866 75.825 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 82.17 73.75 x x x 76.82 74.9 69.68 x x x x x x x x x 80.75 x 69.98 81.0 77.87 79.1 68.62 x 78.1 78.15 x 75.2 x x x x x x x 75.25 70.4 80.05 x 79.0 76.35 75.8 x x x 68.95 75.45 x 76.43 x x 75.97 68.325 64.6 69.73 75.38 66.95 74.73 x 72.32 +15860 None Trait_289_AUW-BXD Hematology: Platelet mass, chow diet, males [pg/PLT] x x 1.08667 1.04 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 1.11 1.025 x x x 1.12 1.22 1.2 x x x x x x x x x 1.13 x 1.0225 1.05 1.14 1.09 1.074 x 1.25 1.16 x 1.21 x x x x x x x 1.14 1.07 1.06 x 1.1 1.08 1.23 x x x 1.52 1.0325 x 1.09 x x 1.07 1.0875 1.1 1.22 1.19 1.225 1.06 x 1.15 +15861 None Trait_290_AUW-BXD Hematology: White blood cells, chow diet, males [10^3/uL] x x 7.948 3.89 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 4.14 8.74 x x x 7.78 11.33 5.99 x x x x x x x x x 18.19 x 5.21 5.447 7.95 8.32 7.536 x 8.42 6.84 x 5.96 x x x x x x x 12.97 7.783 7.03 x 3.61 5.96 8.54 x x x 4.81 6.37 x 3.41 x x 3.97 3.68 9.28 6.75 9.9 5.135 9.08 x 4.34 +15862 None Trait_291_AUW-BXD Hematology: Neutrophils, chow diet, males [%] x x 9.933 15.5 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 18.33 19.85 x x x 9.4 14.3 14.63 x x x x x x x x x 13.75 x 11.85 12.67 13.03 19.05 13.9 x 5.7 15.2 x 10.23 x x x x x x x 15.55 12.55 10.88 x 9.0 10.2 17.7 x x x 10.9 7.75 x 32.9 x x 19.53 30.8 12.9 12.67 12.68 10.85 7.98 x 9.4 +15863 None Trait_292_AUW-BXD Hematology: Lymphocytes, chow diet, males [%] x x 80.833 79.23 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 78.23 74.65 x x x 84.78 79.08 76.1 x x x x x x x x x 81.75 x 80.85 81.4 77.6 60.83 80.34 x 87.97 80.15 x 84.55 x x x x x x x 79.7 76.88 84.8 x 83.87 83.75 75.8 x x x 84.1 87.275 x 62.47 x x 73.87 73.975 81.06 82.03 77.52 84.25 86.58 x 83.82 +15864 None Trait_293_AUW-BXD Hematology: Monocytes, chow diet, males [%] x x 1.3 1.7 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 1.37 1.75 x x x 1.42 3.6 6.4 x x x x x x x x x 2.55 x 1.625 1.67 2.1 3.08 2.58 x 1.53 2.83 x 1.15 x x x x x x x 1.8 1.35 0.95 x 3.47 1.3 1.95 x x x 0.8 1.45 x 2.7 x x 3.07 2.375 3.7 2.7 1.4 2.05 3.25 x 1.74 +15865 None Trait_294_AUW-BXD Hematology: Eosinophils, chow diet, males [%] x x 7.2 2.5 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 1.6 2.95 x x x 3.94 1.6 2.13 x x x x x x x x x 1.1 x 5.2 3.53 5.27 12.73 1.32 x 3.67 1.45 x 2.83 x x x x x x x 2.2 7.73 2.9 x 3.33 3.0 2.95 x x x 3.3 3.05 x 1.4 x x 3.2 7.375 1.38 1.97 7.3 2.2 1.45 x 3.4 +15866 None Trait_295_AUW-BXD Hematology: Basophils, chow diet, males [%] x x 0.2 0.07 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.2 0.2 x x x 0.1 0.13 0.13 x x x x x x x x x 0.1 x 0.1 0.0667 0.33 0.23 0.24 x 0.23 0.1 x 0.1 x x x x x x x 0.15 0.2 0.08 x 0.13 0.05 0.1 x x x 0.2 0.025 x 0.17 x x 0.03 0.125 0.16 0.13 0.24 0.15 0.05 x 0.16 +15867 None Trait_296_AUW-BXD Hematology: Large unknown cells, chow diet, males [%] x x 0.6 0.15 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.23 0.55 x x x 0.34 1.25 0.7 x x x x x x x x x 0.7 x 0.375 0.633 1.63 4.18 1.62 x 0.83 0.23 x 1.2 x x x x x x x 0.6 1.275 0.4 x 0.2 1.6 1.5 x x x 0.7 0.425 x 0.37 x x 0.23 0.3 0.78 0.53 0.86 0.8 0.7 x 1.46 +15868 None Trait_297_AUW-BXD Hematology: Nucleated red blood cells, chow diet, males [%] x x 0.0 0.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.0 0.0 x x x 0.0 0.0 0.0 x x x x x x x x x 0.0 x 0.0 0.0 0.0 0.0 0.0 x 0.0 0.0 x 0.0 x x x x x x x 0.0 0.0 0.0 x 0.0 0.0 0.0 x x x 0.0 0.0 x 0.0 x x 0.0 0.0 0.0 0.0 0.0 0.0 0.0 x 0.0 +15869 None Trait_298_AUW-BXD Hematology: Neutrophils, chow diet, males [10^3/uL] x x 0.71667 0.6175 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.75 1.69 x x x 0.73 1.62 0.87 x x x x x x x x x 2.54 x 0.665 0.743 1.01 1.59 1.09 x 0.49 1.0 x 0.63 x x x x x x x 2.01 0.938 0.76 x 0.32 0.59 1.5 x x x 0.54 0.49 x 1.13 x x 0.76 0.58 1.19 0.85 1.13 0.525 0.72 x 0.42 +15870 None Trait_299_AUW-BXD Hematology: Lymphocytes, chow diet, males [10^3/uL] x x 5.92 3.01 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 3.25 6.58 x x x 6.61 8.97 4.59 x x x x x x x x x 14.86 x 4.15 4.397 6.23 5.08 6.0 x 7.39 5.5 x 5.02 x x x x x x x 10.33 6.18 5.96 x 3.03 5.02 6.46 x x x 4.03 5.565 x 2.13 x x 2.97 2.7325 7.53 5.52 7.8 4.355 7.88 x 3.62 +15871 None Trait_300_AUW-BXD Hematology: Monocytes, chow diet, males [10^3/uL] x x 0.0933 0.0825 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.05 0.15 x x x 0.1 0.4 0.35 x x x x x x x x x 0.42 x 0.08 0.103 0.16 0.26 0.188 x 0.13 0.22 x 0.08 x x x x x x x 0.23 0.113 0.08 x 0.12 0.08 0.17 x x x 0.04 0.09 x 0.1 x x 0.11 0.088 0.34 0.2 0.16 0.105 0.29 x 0.08 +15872 None Trait_301_AUW-BXD Hematology: Eosinophils, chow diet, males [10^3/uL] x x 0.547 0.1 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.06 0.24 x x x 0.3 0.18 0.12 x x x x x x x x x 0.22 x 0.29 0.177 0.41 1.04 0.098 x 0.31 0.11 x 0.16 x x x x x x x 0.29 0.42 0.2 x 0.12 0.18 0.26 x x x 0.16 0.185 x 0.05 x x 0.13 0.2575 0.13 0.12 0.7 0.11 0.13 x 0.16 +15873 None Trait_302_AUW-BXD Hematology: Basophils, chow diet, males [10^3/uL] x x 0.016 0.03 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.01 0.02 x x x 0.01 0.02 0.01 x x x x x x x x x 0.01 x 0.005 0.0 0.03 0.03 0.018 x 0.02 0.0 x 0.01 x x x x x x x 0.02 0.02 0.0 x 0.0 0.0 0.01 x x x 0.04 0.03 x 0.0 x x 0.0 0.0075 0.02 0.0 0.02 0.01 0.01 x 0.0 +15874 None Trait_303_AUW-BXD Hematology: Large unknown cells, chow diet, males [10^3/uL] x x 0.046 0.005 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.01 0.05 x x x 0.03 0.15 0.04 x x x x x x x x x 0.12 x 0.02 0.033 0.12 0.36 0.132 x 0.07 0.02 x 0.07 x x x x x x x 0.08 0.11 0.03 x 0.01 0.1 0.13 x x x 0.01 0.0 x 0.01 x x 0.01 0.0125 0.08 0.05 0.08 0.07 0.07 x 0.06 +15875 None Trait_304_AUW-BXD Hematology: Nucleated red blood cells, chow diet, males [10^3/uL] x x 0.0 0.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.0 0.0 x x x 0.0 0.0 0.0 x x x x x x x x x 0.0 x 0.0 0.0 0.0 0.0 0.0 x 0.0 0.0 x 0.0 x x x x x x x 0.0 0.0 0.0 x 0.0 0.0 0.0 x x x 4.32 4.345 x 0.0 x x 0.0 0.0 0.0 0.0 0.0 0.0 0.0 x 0.0 +15876 None Trait_305_AUW-BXD Hematology: Red blood cells, high fat diet, males [10^6/uL] x x 8.88 9.256 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 9.76 10.22 x x x 10.44 9.62 11.01 x x x x x x x x x x x 9.91 9.3 9.96 10.21 11.46 x 11.04 10.32 x 10.64 x x x x x x x 10.17 10.27 12.35 x 9.95 x 9.61 x x x 8.45 9.62 x x x x 11.1 8.33 10.22 10.72 11.11 9.55 10.11 x 10.34 +15877 None Trait_306_AUW-BXD Hematology: Mature red blood cells, high fat diet, males [%] x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 96.93 96.0 x x x 96.9 95.6 96.94 x x x x x x x x x x x 94.75 96.15 97.67 96.1 x x 97.33 97.98 x 96.8 x x x x x x x 94.22 x 96.95 x 96.67 97.45 97.1 x x x 96.57 97.1 x x x x 97.14 96.2 89.65 97.44 96.18 x 96.65 x 97.74 +15878 None Trait_307_AUW-BXD Hematology: Mature red blood cells, high fat diet, males [10^9/L] x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 82614.0 82544.0 x x x 87539.6 80426.5 89280.0 x x x x x x x x x x x 77783.0 75007.0 85756.0 84951.5 x x 91030.0 92576.0 x 87899.0 x x x x x x x 81424.8 x 98997.0 x 84443.0 x 80161.0 x x x 72666.0 77017.0 x x x x 91306.0 74388.0 79314.0 88916.0 89609.0 x 85242.0 x 86238.4 +15879 None Trait_308_AUW-BXD Hematology: Hemoglobin, high fat diet, males [g/dL] x x 13.03 12.58 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 14.13 13.6 x x x 14.32 13.05 14.4 x x x x x x x x x x x 13.2 12.7 12.47 13.75 14.74 x 15.65 14.63 x 15.6 x x x x x x x 14.88 13.7 18.2 x 12.43 x 13.7 x x x 12.07 12.8 x x x x 15.44 11.84 11.9 14.68 16.32 12.7 14.45 x 14.4 +15880 None Trait_309_AUW-BXD Hematology: Hematocrit, high fat diet, males [%] x x 44.4 41.4 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 45.33 x x x x 45.2 41.95 49.56 x x x x x x x x x x x x 45.8 40.07 46.0 50.2 x 51.65 46.53 x 51.47 x x x x x x x 50.16 46.15 54.1 x 15.6 x 46.4 x x x 39.27 43.86 x x x x 51.0 44.33 46.4 51.2 49.96 45.5 48.05 x 45.48 +15881 None Trait_310_AUW-BXD Hematology: Mean corpuscular volume (MCV), high fat diet, males [fL/RBC] x x 50.0 44.82 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 46.53 50.25 x x x 43.3 43.48 45.08 x x x x x x x x x x x 45.35 49.25 40.2 45.05 43.82 x 46.83 45.08 x 48.37 x x x x x x x 49.48 44.95 43.85 x 45.8 44.2 48.35 x x x 46.47 45.6 x x x x 45.98 46.93 45.58 47.8 45.0 47.65 47.53 x 43.96 +15882 None Trait_311_AUW-BXD Hematology: Mean corpuscular hemoglobin (MCH), high fat diet, males [pg/RBC] x x 14.7 13.6 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 14.53 13.85 x x x 13.74 13.5 13.16 x x x x x x x x x x x 13.35 13.65 12.47 13.43 12.86 x 14.15 14.15 x 14.73 x x x x x x x 14.7 13.35 14.8 x 13.53 14.1 14.25 x x x 14.33 13.33 x x x x 13.86 14.17 11.65 13.68 14.7 13.3 14.28 x 13.94 +15883 None Trait_312_AUW-BXD Hematology: Mean corpuscular hemoglobin concentration (MCHC), high fat diet, males [g/dL] x x 29.4 30.28 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 31.27 27.65 x x x 31.72 31.05 29.16 x x x x x x x x x x x 29.35 27.7 31.03 29.85 29.38 x 30.25 31.38 x 30.43 x x x x x x x 29.7 29.7 33.7 x 29.6 31.9 29.45 x x x 30.8 29.2 x x x x 30.2 30.1 25.58 28.64 32.68 27.95 30.08 x 31.66 +15884 None Trait_313_AUW-BXD Hematology: Red blood cell hemoglobin content, high fat diet, males [pg/RBC] x x x 12.1 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 14.53 12.6 x x x 13.36 13.73 12.92 x x x x x x x x x x x 12.4 12.6 12.47 13.23 11.74 x 13.7 13.98 x 14.3 x x x x x x x 14.4 12.2 14.6 x 12.15 13.95 14.0 x x x 14.5 12.367 x x x x 13.6 12.47 11.53 13.18 14.74 x 13.8 x 13.94 +15885 None Trait_314_AUW-BXD Hematology: Red blood cell distribution width, high fat diet, males [%] x x 14.87 15.62 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 16.47 15.0 x x x 14.14 17.3 13.1 x x x x x x x x x x x 14.15 15.4 15.2 15.65 13.72 x 14.48 15.93 x 14.27 x x x x x x x 14.98 14.25 15.1 x 14.1 15.5 15.05 x x x 14.63 14.5 x x x x 14.44 14.93 19.83 15.4 15.34 14.3 13.35 x 14.72 +15886 None Trait_315_AUW-BXD Hematology: Hemoglobin concentration distribution width, high fat diet, males [g/dL] x x 1.91 2.102 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 2.27 2.06 x x x 2.17 2.36 1.74 x x x x x x x x x x x 2.305 2.48 2.2 2.16 2.0 x 2.06 2.31 x 2.03 x x x x x x x 1.99 2.035 2.3 x 1.96 2.13 2.13 x x x 2.1 2.15 x x x x 2.21 2.09 2.52 2.01 2.37 1.97 2.0 x 2.25 +15887 None Trait_316_AUW-BXD Hematology: Reticulocytes, high fat diet, males [%] x x 4.0 3.46 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 3.07 5.3 x x x 3.1 4.4 3.06 x x x x x x x x x x x 5.25 3.85 2.33 3.9 2.76 x 2.68 2.03 x 3.2 x x x x x x x 5.78 2.4 3.05 x 3.53 2.55 2.9 x x x 3.43 2.9 x x x x 2.86 3.8 10.35 2.56 3.82 3.4 3.35 x 2.26 +15888 None Trait_317_AUW-BXD Hematology: Reticulocytes, high fat diet, males [10^9/L] x x 355.0 304.8 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 300.8 512.5 x x x 320.1 418.7 336.2 x x x x x x x x x x x 521.2 355.7 229.93 399.05 316.16 x 293.85 209.1 x 342.3 x x x x x x x 570.12 244.05 378.9 x 321.57 499.85 278.1 x x x 292.4 276.4 x x x x 315.5 315.3 1005.65 273.8 149.6 321.9 336.3 x 233.0 +15889 None Trait_318_AUW-BXD Hematology: Mean corpuscular volume reticulocytes, high fat diet, males [fL/RTC] x x 60.6 55.92 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 56.17 58.4 x x x 53.28 55.43 58.2 x x x x x x x x x x x 52.2 56.0 52.07 52.6 55.46 x 57.8 55.38 x 59.37 x x x x x x x 56.44 57.8 54.25 x 53.88 53.05 55.55 x x x 56.83 53.933 x x x x 56.5 56.2 52.78 61.1 57.34 59.15 60.7 x 52.32 +15890 None Trait_319_AUW-BXD Hematology: Mean corpuscular hemoglobin concentration reticulocytes, high fat diet, males [g/dL] x x 25.13 26.24 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 28.67 25.4 x x x 29.06 28.1 24.12 x x x x x x x x x x x 26.35 26.85 27.4 28.88 25.36 x 26.18 28.1 x 26.87 x x x x x x x 27.12 25.6 30.35 x 26.95 30.6 29.7 x x x 29.8 27.233 x x x x 26.78 26.63 22.8 24.2 30.56 24.55 25.2 x 31.12 +15891 None Trait_320_AUW-BXD Hematology: Red cell hemoglobin content reticulocytes, high fat diet, males [pg/RTC] x x 15.17 14.6 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 16.07 14.8 x x x 15.28 15.5 13.92 x x x x x x x x x x x 13.7 15.0 14.17 15.15 13.94 x 15.03 15.38 x 15.8 x x x x x x x 15.22 14.7 16.4 x 14.45 16.1 16.4 x x x 16.77 14.633 x x x x 15.06 14.87 12.0 14.68 17.26 14.4 15.1 x 16.14 +15892 None Trait_321_AUW-BXD Hematology: Low mature reticulocytes, high fat diet, males [%] x x 41.2 45.1 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 47.73 44.45 x x x 56.62 56.38 67.2 x x x x x x x x x x x 47.9 51.6 60.93 52.35 51.46 x 65.65 56.1 x 74.7 x x x x x x x 79.86 65.4 47.3 x 46.95 49.7 58.4 x x x 40.77 57.633 x x x x 35.66 44.83 65.7 68.78 52.44 53.05 57.1 x 68.44 +15893 None Trait_322_AUW-BXD Hematology: Low mature reticulocytes, high fat diet, males [10^9/L] x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 628.0 944.5 x x x 777.6 1033.25 944.6 x x x x x x x x x x x 1000.5 779.0 616.67 896.75 x x 823.3 443.3 x 1070.0 x x x x x x x 1925.4 x 741.0 x 493.0 596.0 702.0 x x x 521.67 660.0 x x x x 475.8 458.0 2782.25 801.6 910.8 x 841.3 x 677.6 +15894 None Trait_323_AUW-BXD Hematology: Medium mature reticulocytes, high fat diet, males [%] x x 37.7 35.94 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 40.03 43.8 x x x 36.54 37.8 30.3 x x x x x x x x x x x 42.65 41.0 34.03 38.53 40.32 x 29.15 34.53 x 21.9 x x x x x x x 19.1 30.4 44.6 x 42.3 42.15 34.5 x x x 40.0 35.866 x x x x 33.5 38.6 31.7 28.1 38.44 37.75 37.8 x 28.08 +15895 None Trait_324_AUW-BXD Hematology: Medium mature reticulocytes, high fat diet, males [10^9/L] x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 526.0 961.0 x x x 512.2 693.0 428.4 x x x x x x x x x x x 928.0 606.5 344.67 669.5 x x 358.75 268.75 x 338.0 x x x x x x x 484.6 x 698.5 x 445.0 505.0 407.0 x x x 521.67 408.0 x x x x 445.2 394.0 1481.0 328.2 693.8 x 554.3 x 280.6 +15896 None Trait_325_AUW-BXD Hematology: High mature reticulocytes, high fat diet, males [%] x x 21.2 18.96 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 12.27 11.8 x x x 6.86 5.83 2.5 x x x x x x x x x x x 9.45 7.4 5.0 9.1 8.2 x 5.18 9.35 x 3.33 x x x x x x x 1.02 4.15 8.15 x 10.75 8.15 7.1 x x x 19.23 6.433 x x x x 30.8 16.6 2.58 3.08 9.12 9.15 5.1 x 3.48 +15897 None Trait_326_AUW-BXD Hematology: High mature reticulocytes, high fat diet, males [10^9/L] x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 160.33 265.0 x x x 98.4 107.0 35.2 x x x x x x x x x x x 232.5 106.0 51.0 160.25 x x 62.75 71.5 x 53.67 x x x x x x x 25.0 x 127.5 x 116.5 98.0 82.5 x x x 255.67 72.33 x x x x 413.0 167.0 121.0 35.6 159.6 x 73.5 x 35.4 +15898 None Trait_327_AUW-BXD Hematology: Platelets, high fat diet, males [10^3/uL] x x 917.0 946.2 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 1055.33 1222.0 x x x 1045.6 1366.0 1404.8 x x x x x x x x x x x 1424.0 899.0 1453.33 1121.5 854.8 x 835.5 896.5 x 958.7 x x x x x x x 1528.8 774.5 950.0 x 1350.7 2142.5 974.0 x x x 1320.0 1467.33 x x x x 1240.0 1141.0 1400.0 1211.0 1331.0 909.5 997.0 x 1342.8 +15899 None Trait_328_AUW-BXD Hematology: Platelet volume, high fat diet, males [fL/PLT] x x 5.3 4.8 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 5.83 4.0 x x x 5.28 5.45 5.22 x x x x x x x x x x x 4.55 4.15 5.63 5.53 3.84 x 5.73 5.73 x 5.1 x x x x x x x 6.78 3.9 5.55 x 4.77 5.25 6.15 x x x 5.43 4.4667 x x x x 7.54 5.07 7.53 7.72 6.18 4.2 6.56 x 4.82 +15900 None Trait_329_AUW-BXD Hematology: Platelet distribution width, high fat diet, males [%] x x 82.5 72.28 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 66.03 54.2 x x x 55.74 54.18 47.92 x x x x x x x x x x x 55.0 54.6 53.53 57.0 45.5 x 52.28 62.5 x 47.87 x x x x x x x 47.72 55.5 58.65 x 66.87 52.9 63.95 x x x 60.7 46.333 x x x x 57.16 56.57 60.1 50.58 51.64 54.15 46.73 x 42.4 +15901 None Trait_330_AUW-BXD Hematology: Plateletcrit, high fat diet, males [%] x x 0.487 0.448 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.31 0.24 x x x 0.28 0.37 0.37 x x x x x x x x x x x 0.325 0.185 0.41 0.31 0.33 x 0.24 0.22 x 0.24 x x x x x x x 0.51 0.295 0.27 x 0.26 0.32 0.3 x x x 0.36 0.327 x x x x 0.47 0.2 0.53 0.47 0.42 0.38 0.33 x 0.33 +15902 None Trait_331_AUW-BXD Hematology: Platelet component concentration, high fat diet, males [g/dL] x x 248.3 258.4 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 232.67 284.0 x x x 242.2 247.5 228.8 x x x x x x x x x x x 249.5 282.0 223.67 239.25 295.2 x 234.5 237.75 x 254.3 x x x x x x x 210.2 290.5 234.5 x 258.0 233.0 218.5 x x x 229.33 257.67 x x x x 184.8 250.33 198.5 190.2 226.8 295.0 209.75 x 258.4 +15903 None Trait_332_AUW-BXD Hematology: Platelet component distribution width, high fat diet, males [g/dL] x x 71.8 77.4 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 82.2 68.8 x x x 78.2 78.15 77.1 x x x x x x x x x x x 70.7 74.1 78.77 79.43 67.34 x 77.18 80.68 x 78.6 x x x x x x x 72.1 69.75 80.8 x 75.4 79.15 84.35 x x x 78.73 78.8 x x x x 72.14 77.13 74.95 68.96 74.9 68.0 68.9 x 74.78 +15904 None Trait_333_AUW-BXD Hematology: Mean platelet mass, high fat diet, males [pg/PLT] x x 1.15 1.094 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 1.17 1.06 x x x 1.13 1.2 1.06 x x x x x x x x x x x 1.04 1.075 1.09 1.16 1.082 x 1.2 1.18 x 1.18 x x x x x x x 1.25 1.055 1.14 x 1.11 1.08 1.12 x x x 1.08 1.0433 x x x x 1.18 1.14 1.28 1.27 1.22 1.18 1.23 x 1.15 +15905 None Trait_334_AUW-BXD Hematology: White blood cells, high fat diet, males [10^3/uL] x x 6.927 5.382 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 6.47 12.8 x x x 12.74 10.91 7.27 x x x x x x x x x x x 8.79 6.03 4.85 6.29 7.244 x 10.41 7.03 x 10.9 x x x x x x x 12.67 8.565 9.32 x 6.68 12.05 7.77 x x x 7.23 4.113 x x x x 7.04 8.59 8.43 8.88 19.04 8.155 9.37 x 7.55 +15906 None Trait_335_AUW-BXD Hematology: Neutrophils, high fat diet, males [%] x x x 30.06 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 13.47 17.2 x x x 9.92 15.55 18.88 x x x x x x x x x x x 8.9 8.4 13.6 37.33 11.2 x 8.95 12.75 x 7.87 x x x x x x x 20.92 10.05 9.3 x 16.8 23.25 16.45 x x x 13.4 20.033 x x x x 12.86 5.77 9.58 18.32 10.92 8.55 9.15 x 10.68 +15907 None Trait_336_AUW-BXD Hematology: Lymphocytes, high fat diet, males [%] x x 78.3 61.16 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 82.43 77.6 x x x 84.02 75.15 75.5 x x x x x x x x x x x 84.15 87.05 77.2 27.75 81.84 x 86.23 80.53 x 87.03 x x x x x x x 74.08 83.15 86.05 x 78.2 42.9 69.4 x x x 81.97 74.33 x x x x 80.88 89.23 84.78 74.66 82.76 84.1 83.53 x 80.06 +15908 None Trait_337_AUW-BXD Hematology: Monocytes, high fat diet, males [%] x x 1.77 3.24 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 1.63 2.2 x x x 1.24 4.75 2.4 x x x x x x x x x x x 2.85 1.15 3.0 2.73 3.06 x 1.58 1.68 x 2.53 x x x x x x x 1.92 1.9 1.1 x 2.1 1.1 1.5 x x x 1.47 1.933 x x x x 2.92 2.17 1.88 3.6 0.86 1.55 3.68 x 2.54 +15909 None Trait_338_AUW-BXD Hematology: Eosinophils, high fat diet, males [%] x x 4.7 5.18 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 1.93 1.8 x x x 3.46 2.05 2.04 x x x x x x x x x x x 3.1 2.8 5.13 29.7 2.18 x 2.33 4.08 x 1.37 x x x x x x x 1.82 3.35 2.85 x 2.53 30.75 3.55 x x x 2.63 3.133 x x x x 2.66 1.97 0.78 1.56 3.26 4.85 1.33 x 3.62 +15910 None Trait_339_AUW-BXD Hematology: Basophils, high fat diet, males [%] x x 0.5 0.14 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.13 0.1 x x x 0.16 0.15 0.1 x x x x x x x x x x x 0.15 0.25 0.17 0.15 0.22 x 0.23 0.08 x 0.13 x x x x x x x 0.14 0.25 0.1 x 0.18 0.1 0.15 x x x 0.07 0.066 x x x x 0.14 0.1 0.38 0.2 0.22 0.2 0.15 x 0.12 +15911 None Trait_340_AUW-BXD Hematology: Large unknown cells, high fat diet, males [%] x x 1.2 0.26 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.47 1.2 x x x 1.18 2.35 1.14 x x x x x x x x x x x 0.9 0.3 0.97 2.38 1.5 x 0.73 0.85 x 1.0 x x x x x x x 1.1 1.25 0.6 x 0.23 1.95 8.9 x x x 0.47 0.5 x x x x 0.54 0.77 2.63 1.62 1.98 0.8 2.18 x 3.0 +15912 None Trait_341_AUW-BXD Hematology: Nucleated red blood cells, high fat diet, males [%] x x 0.0 0.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.0 0.0 x x x 0.0 0.0 0.0 x x x x x x x x x x x 0.0 0.0 0.0 0.0 0.0 x 0.0 0.0 x 0.0 x x x x x x x 0.0 0.0 0.0 x 0.0 0.0 0.0 x x x 0.0 0.0 x x x x 0.0 0.0 0.0 0.0 0.0 0.0 0.0 x 0.0 +15913 None Trait_342_AUW-BXD Hematology: Neutrophils, high fat diet, males [10^3/uL] x x 0.94 1.548 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.78 2.2 x x x 1.19 1.63 1.32 x x x x x x x x x x x 0.78 0.47 0.61 2.35 0.816 x 0.93 0.88 x 0.81 x x x x x x x 2.59 0.875 0.87 x 1.01 3.01 1.27 x x x 0.95 0.7866 x x x x 0.83 0.5 0.78 1.58 2.02 0.67 0.85 x 0.76 +15914 None Trait_343_AUW-BXD Hematology: Lymphocytes, high fat diet, males [10^3/uL] x x 5.42 3.386 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 5.45 9.94 x x x 10.79 8.34 5.52 x x x x x x x x x x x 7.39 5.29 3.81 1.62 5.916 x 8.99 5.7 x 9.54 x x x x x x x 9.43 7.115 8.01 x 5.35 4.7 5.41 x x x 5.95 3.093 x x x x 5.74 7.65 7.16 6.67 15.82 6.845 7.85 x 6.1 +15915 None Trait_344_AUW-BXD Hematology: Monocytes, high fat diet, males [10^3/uL] x x 0.13 0.164 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.09 0.28 x x x 0.15 0.48 0.17 x x x x x x x x x x x 0.25 0.05 0.13 0.18 0.222 x 0.16 0.12 x 0.27 x x x x x x x 0.26 0.165 0.1 x 0.13 0.14 0.12 x x x 0.1 0.08667 x x x x 0.22 0.19 0.17 0.32 0.17 0.12 0.35 x 0.18 +15916 None Trait_345_AUW-BXD Hematology: Eosinophils, high fat diet, males [10^3/uL] x x 0.3 0.262 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.11 0.24 x x x 0.42 0.22 0.15 x x x x x x x x x x x 0.27 0.18 0.25 1.97 0.156 x 0.24 0.28 x 0.15 x x x x x x x 0.23 0.275 0.27 x 0.18 3.95 0.27 x x x 0.2 0.12667 x x x x 0.21 0.17 0.07 0.14 0.6 0.43 0.12 x 0.27 +15917 None Trait_346_AUW-BXD Hematology: Basophils, high fat diet, males [10^3/uL] x x 0.3 0.006 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.0 0.01 x x x 0.02 0.2 0.0 x x x x x x x x x x x 0.01 0.01 0.01 0.01 0.014 x 0.02 0.0 x 0.01 x x x x x x x 0.01 0.025 0.02 x 0.0 0.0 0.01 x x x 0.01 0.0 x x x x 0.01 0.02 0.04 0.02 0.04 0.015 0.01 x 0.01 +15918 None Trait_347_AUW-BXD Hematology: Large unknown cells, high fat diet, males [10^3/uL] x x 0.093 0.016 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.03 0.14 x x x 0.16 0.25 0.1 x x x x x x x x x x x 0.08 0.02 0.05 0.16 0.118 x 0.07 0.06 x 0.11 x x x x x x x 0.14 0.105 0.05 x 0.01 0.24 0.69 x x x 0.03 0.02 x x x x 0.04 0.08 0.23 0.14 0.38 0.07 0.21 x 0.23 +15919 None Trait_348_AUW-BXD Hematology: Nucleated red blood cells, high fat diet, males [10^3/uL] x x 0.0 0.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.0 0.0 x x x 0.0 0.0 0.0 x x x x x x x x x x x 0.0 0.0 0.0 0.0 0.0 x 0.0 0.0 x 0.0 x x x x x x x 0.0 0.0 0.0 x 0.0 0.0 0.0 x x x 0.0 0.0 x x x x 0.0 0.0 0.0 0.0 0.0 0.0 0.0 x 0.0 +15920 None Trait_349_AUW-BXD Cardiovascular system, behavior: Run distance untrained, treadmill at 10 degree incline, chow diet, treadmill at 10 degree incline, males [m] x x 437.25 648.667 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 828.3 272.25 661.775 x x 318.0 227.0 233.4 529.22 x x x 237.8 286.0 x x x 312.0 391.33 587.75 497.3 380.3 239.0 107.2 x 309.7 481.8 546.75 263.4 x 442.5 x 535.6 x x x 218.4 219.8 629.0 x 503.66 398.75 156.2 x 245.0 x 452.5 233.3 x 195.0 x x 562.0 389.0 228.0 585.0 413.6 552.2 321.0 x 225.2 +15921 None Trait_350_AUW-BXD Cardiovascular system, behavior: Run distance untrained, treadmill at 0 degree incline, high fat diet, treadmill at 0 degree incline, males [m] x x 236.25 395.8 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 759.67 85.25 501.45 x x 234.5 85.0 106.0 135.025 x x x 212.5 170.0 x x x x 154.8 224.0 276.0 130.75 101.3 38.0 x 377.0 593.4 317.125 325.0 x 403.0 x 395.2 x x x 88.8 124.0 219.8 x 168.25 207.0 76.5 x 251.25 x 359.5 165.5 x x x x 213.6 96.33 85.8 207.0 358.8 441.08 245.0 x 216.0 +15922 None Trait_351_AUW-BXD Cardiovascular system, behavior: Run distance trained, treadmill at 10 degree incline, chow diet, treadmill at 10 degree incline, males [m] x x 614.25 1024.33 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 1184.33 746.5 864.25 x x 509.2 366.5 418.0 1000.5 x x x 815.2 454.0 x x x 330.2 915.33 613.75 761.3 706.5 352.3 150.48 x 707.3 599.4 768.3 446.6 x 600.575 x 563.6 x x x 322.2 404.3 1086.5 x 816.33 885.3 177.0 x 582.0 x 709.3 560.75 x 407.3 x x 946.0 539.0 449.6 897.0 1158.6 1016.9 989.0 x 414.4 +15923 None Trait_352_AUW-BXD Cardiovascular system, behavior: Run distance trained, treadmill at 0 degree incline, high fat diet, treadmill at 0 degree incline, males [m] x x 478.75 1215.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 1148.67 132.0 954.5 x x 442.0 109.3 282.4 314.75 x x x 600.5 461.0 x x x x 252.4 429.75 617.0 336.0 161.0 25.92 x 791.5 684.0 700.525 263.0 x 519.75 x 588.4 x x x 162.2 340.3 312.0 x 607.75 678.0 249.0 x 473.75 x 703.0 437.75 x x x x 807.4 259.33 244.5 399.0 929.6 686.84 790.8 x 325.6 +15924 None Trait_353_AUW-BXD Cardiovascular system, behavior: Run distance improvement, treadmill at 10 degree incline, chow diet, treadmill at 10 degree incline, males [m] x x 177.0 375.663 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 356.0 474.25 202.475 x x 191.2 139.5 184.0 471.28 x x x 577.4 169.0 x x x 18.2 524.0 26.0 264.0 326.3 113.3 43.28 x 397.7 117.6 221.55 183.2 x 158.075 x 28.0 x x x 103.8 184.5 457.5 x 312.67 486.5 20.8 x 337.0 x 256.8 327.45 x 212.3 x x 384.0 148.775 221.6 312.0 745.0 464.7 669.0 x 189.2 +15925 None Trait_354_AUW-BXD Cardiovascular system, behavior: Run distance improvement, treadmill at 0 degree incline, high fat diet, treadmill at 0 degree incline, males [m] x x 242.5 832.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 389.0 46.75 453.05 x x 209.0 13.0 176.5 179.725 x x x 388.0 283.0 x x x x 97.6 205.75 340.5 205.3 59.5 -12.08 x 414.8 90.6 383.4 63.3 x 116.75 x 193.2 x x x 73.4 216.3 92.3 x 439.5 471.0 53.6 x 222.5 x 343.5 272.25 x x x x 593.8 163.0 159.0 192.0 571.0 245.76 546.0 x 109.4 +15926 None Trait_355_AUW-BXD Respiratory system, metabolism: Oxygen intake (VO2) basal untrained, treadmill at 10 degree incline, chow diet, males [mL/kg/min] x x 96.285 80.25 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 87.4 64.8525 108.585 x x 56.61 66.73 72.1 107.295 x x x 89.8874 73.67 x x x 80.4 91.83 81.75 74.77 75.6 61.98 65.838 x 73.97 72.6 98.655 72.53 x 79.54 x 79.414 x x x 66.08 67.44 75.25 x 77.96 67.7 63.72 x 96.7525 x 81.2917 72.92 x 57.6 x x 59.1 71.04 57.8 71.1675 66.484 93.1933 77.9 x 64.684 +15927 None Trait_356_AUW-BXD Respiratory system, metabolism: Oxygen intake (VO2) basal untrained, treadmill at 0 degree incline, high fat diet, males [mL/kg/min] x x 73.0417 72.4046 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 75.6 48.9875 87.2115 x x 50.19 51.9 58.23 63.375 x x x 87.895 63.6 x x x x 64.038 63.3575 61.25 62.2 52.99 52.5846 x 67.4 73.5 82.005 61.1 x 69.8125 x 71.516 x x x 63.24 66.3783 59.63 x 74.3975 57.8 55.71 x 86.275 x 68.7 71.1 x x x x 58.78 55.0267 57.84 54.98 54.624 70.216 57.5 x 55.92 +15928 None Trait_357_AUW-BXD Respiratory system, metabolism: Oxygen intake (VO2) max untrained, treadmill at 10 degree incline, chow diet, males [mL/kg/min] x x 129.0 130.333 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 122.3 87.25 128.0 x x 86.8 98.3 102.5 126.5 x x x 112.6 125.0 x x x 103.4 120.0 111.75 103.5 105.5 82.5 87.8 x 95.0 96.6 120.25 94.4 x 123.0 x 123.6 x x x 90.6 96.0 99.5 x 103.667 101.5 84.0 x 131.0 x 114.75 95.0 x 82.5 x x 94.25 97.5 83.8 95.0 91.0 117.0 92.5 x 93.0 +15929 None Trait_358_AUW-BXD Respiratory system, metabolism: Oxygen intake (VO2) max untrained, treadmill at 0 degree incline, high fat diet, males [mL/kg/min] x x 87.25 100.6 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 88.7 60.75 98.0 x x 64.2 68.5 75.0 69.25 x x x 96.0 81.7 x x x x 80.4 74.25 85.0 77.3 65.5 65.8 x 83.3 91.6 93.75 74.67 x 108.25 x 95.0 x x x 72.6 80.75 76.0 x 89.25 72.33 70.75 x 106.25 x 99.5 87.75 x x x x 71.6 69.3333 65.75 67.6 75.4 85.0 67.0 x 79.6 +15930 None Trait_359_AUW-BXD Respiratory system, metabolism: Respiratory exchange ratio (RER) basal untrained, treadmill at 10 degree incline, chow diet, males [ratio] x x 0.83675 0.826333 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.825 0.78825 0.830075 x x 0.783 0.7977 0.763 0.821 x x x 0.83026 0.8 x x x 0.8404 0.807667 0.8235 0.796125 0.8398 0.845 0.8484 x 0.8476 0.765 0.81225 0.8132 x 0.796475 x 0.7735 x x x 0.6195 0.789813 0.8353 x 0.836 0.798 0.84477 x 0.78675 x 0.8145 0.79605 x 0.825 x x 0.757 0.8168 0.8984 0.86525 0.82774 0.818 0.841 x 0.7968 +15931 None Trait_360_AUW-BXD Respiratory system, metabolism: Respiratory exchange ratio (RER) basal untrained, treadmill at 0 degree incline, high fat diet, males [ratio] x x 0.76875 0.7976 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.769 0.759 0.774 x x 0.7706 0.7595 0.909 0.76635 x x x 0.821 0.7697 x x x x 0.771 0.78825 0.7635 0.7885 0.7853 0.7928 x 0.776 0.778 0.7815 0.794 x 0.760188 x 0.7626 x x x 0.797 0.79375 0.808975 x 0.7885 0.785 0.7958 x 0.79175 x 0.773 0.80675 x x x x 0.7659 0.768667 0.7963 0.7986 0.8124 0.8098 0.7978 x 0.7754 +15932 None Trait_361_AUW-BXD Respiratory system, metabolism: Respiratory exchange ratio (RER) max untrained, treadmill at 10 degree incline, chow diet, males [ratio] x x 0.97975 0.969333 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.9343 0.9365 0.94325 x x 0.9292 0.99225 0.887 0.95275 x x x 0.912 0.93 x x x 9824.0 0.98 1.01825 0.92125 0.9755 0.939 1.0262 x 0.9827 0.911 0.98825 0.9914 x 1.03425 x 0.9712 x x x 0.7343 0.93575 1.026 x 0.976667 0.951 0.9966 x 0.97575 x 0.95425 0.93725 x 0.922 x x 0.931 0.93425 0.9972 1.003 0.9822 0.955333 0.9593 x 0.9562 +15933 None Trait_362_AUW-BXD Respiratory system, metabolism: Respiratory exchange ratio (RER) max untrained, treadmill at 0 degree incline, high fat diet, males [ratio] x x 0.96075 0.9472 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.9153 0.9145 0.941 x x 0.9136 0.9625 0.9898 0.909 x x x 0.90825 0.931 x x x x 0.9728 0.9565 0.928 0.945 0.959 0.9836 x 0.911 0.9338 0.98725 0.966 x 0.968 x 0.9246 x x x 0.894 0.92675 0.97425 x 0.9585 0.992 0.941 x 0.97075 x 0.944 0.96125 x x x x 0.933 0.908333 0.93325 0.918 0.979 0.9416 0.9573 x 0.9306 +15934 None Trait_363_AUW-BXD Respiratory system, metabolism: Oxygen intake (VO2) basal trained, treadmill at 10 degree incline, chow diet, males [mL/kg/min] x x 90.9425 100.193 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 94.8333 97.94 98.8975 x x 66.73 63.5 78.28 108.868 x x x 93.716 74.4 x x x 73.67 90.75 85.7125 83.915 61.9 61.91 67.14 x 87.77 81.82 99.505 x x 90.9782 x 78.78 x x x 74.7 72.6465 90.9 x 93.64 83.5 x x 100.702 x 91.19 89.145 x 53.83 x x 70.83 71.395 62.6 74.245 90.368 93.39 91.03 x 64.3333 +15935 None Trait_364_AUW-BXD Respiratory system, metabolism: Oxygen intake (VO2) basal trained, treadmill at 0 degree incline, high fat diet, males [mL/kg/min] x x 81.2958 96.318 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 73.6 66.13 93.8175 x x 51.9 55.3 71.134 59.525 x x x 92.8118 77.6 x x x x 69.172 64.7325 66.0415 55.35 52.988 55.7166 x 79.7 76.95 103.395 68.75 x 82.9782 x 76.884 x x x 61.85 63.935 62.54 x 74.9175 69.5 56.4 x 86.9607 x 77.3 74.9225 x x x x 66.076 59.6667 60.3 55.68 65.202 76.166 72.21 x 64.14 +15936 None Trait_365_AUW-BXD Respiratory system, metabolism: Oxygen intake (VO2) max trained, treadmill at 10 degree incline, chow diet, males [mL/kg/min] x x 138.25 153.667 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 128.333 120.5 138.5 x x 98.3 93.0 98.0 143.5 x x x 141.0 124.0 x x x 85.8 148.0 115.0 110.0 85.33 82.5 76.6 x 121.3 103.6 126.75 x x 129.25 x 133.6 x x x 92.8 110.0 116.75 x 131.667 139.8 x x 138.25 x 132.5 127.0 x 88.0 x x 117.8 104.25 98.6 111.5 138.8 117.333 114.5 x 101.333 +15937 None Trait_366_AUW-BXD Respiratory system, metabolism: Oxygen intake (VO2) max trained, treadmill at 0 degree incline, high fat diet, males [mL/kg/min] x x 99.25 135.8 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 110.0 63.0 116.25 x x 68.5 73.8 79.8 75.0 x x x 124.25 100.5 x x x x 81.4 76.5 88.0 68.3 65.5 62.4 x 106.5 99.33 120.25 77.33 x 109.0 x 106.6 x x x 71.0 96.25 77.0 x 98.75 92.67 77.0 x 120.0 x 105.0 98.5 x x x x 84.4 74.6667 0.826 71.6 101.6 93.2 82.75 x 88.4 +15938 None Trait_367_AUW-BXD Respiratory system, metabolism: Respiratory exchange ratio (RER) basal trained, treadmill at 10 degree incline, chow diet, males [ratio] x x 0.8277 0.850333 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.85 0.84825 0.83 x x 0.7977 0.8199 0.797 0.835 x x x 0.81498 0.802 x x x 0.8468 0.812067 0.87675 0.850025 0.8543 0.844 0.84336 x 0.8423 0.801 0.88 x x 0.89075 x 0.85118 x x x 0.8534 0.81 0.8572 x 0.856 0.798 x x 0.825125 x 0.871 0.795125 x 0.8183 x x 0.793 0.8645 0.8722 0.8489 0.83446 0.8352 0.8081 x 0.829333 +15939 None Trait_368_AUW-BXD Respiratory system, metabolism: Respiratory exchange ratio (RER) basal trained, treadmill at 0 degree incline, high fat diet, males [ratio] x x 0.7725 0.80022 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.767333 0.778175 0.76475 x x 0.7595 0.7699 0.775 0.78175 x x x 0.78125 0.774 x x x x 0.7728 0.791 0.8025 0.7952 0.785 0.8139 x 0.7735 0.763 0.813 0.825 x 0.800375 x 0.7656 x x x 0.8203 0.77775 0.7954 x 0.7905 0.7596 0.7883 x 0.79525 x 0.786 0.79995 x x x x 0.7701 0.7981 0.826 0.7974 0.781 0.78218 0.7822 x 0.7791 +15940 None Trait_369_AUW-BXD Respiratory system, metabolism: Respiratory exchange ratio (RER) max trained, treadmill at 10 degree incline, chow diet, males [ratio] x x 0.9545 0.941 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.930333 0.97575 1.00225 x x 0.99225 0.97275 0.9313 0.9505 x x x 0.9684 0.957 x x x 0.9885 0.961667 0.996 0.92775 1.0 0.9393 1.08 x 0.9147 0.939 1.021 x x 1.118 x 0.987 x x x 0.9744 0.97675 0.987 x 0.981333 0.914 x x 0.97725 x 0.978 0.96475 x 0.973 x x 0.95 1.0 0.973 0.946 0.9428 1.005 0.943 x 0.971 +15941 None Trait_370_AUW-BXD Respiratory system, metabolism: Respiratory exchange ratio (RER) max trained, treadmill at 0 degree incline, high fat diet, males [ratio] x x 0.964 0.9486 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.91 0.92825 0.9435 x x 0.9625 0.961 0.8616 0.92425 x x x 0.89625 0.902 x x x x 0.9554 0.9505 0.912 0.9695 0.959 1.0048 x 0.9045 0.902 0.9705 0.97 x 1.0145 x 0.9342 x x x 0.906 0.98725 0.94 x 0.96675 0.947 0.985 x 0.95125 x 0.97 0.96875 x x x x 0.9456 0.940667 1.0025 0.882 0.9246 0.917 0.917 x 0.9464 +15942 None Trait_371_AUW-BXD Respiratory system, metabolism: Oxygen intake (VO2) basal improvement after 10 days of voluntary exercise, treadmill at 10 degree incline, chow diet, males [mL/kg/min] x x -5.3425 19.94 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 7.46 20.67 -9.6875 x x 6.34 -3.25 6.2 1.573 x x x 3.8286 14.89 x x x -6.7 -1.1 3.96 9.145 10.83 -0.595 1.302 x 13.8 9.26 0.85 x x 11.4382 x -0.634 x x x 8.62 5.2065 15.65 x 15.68 15.82 x x 3.95 x 9.89825 16.225 x -3.79 x x 11.73 0.355 4.76 3.08 23.884 0.19667 13.15 x -0.061 +15943 None Trait_372_AUW-BXD Respiratory system, metabolism: Oxygen intake (VO2) basal improvement after 10 days of voluntary exercise, treadmill at 0 degree incline, high fat diet, males [mL/kg/min] x x 8.254 23.9134 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x -2.0 7.053 6.606 x x 10.3 3.36 12.9 -3.85 x x x 4.91675 13.59 x x x x 5.134 1.375 4.7915 5.78 2.37 3.132 x 12.3 -0.82 26.5 7.67 x 13.1657 x 5.368 x x x -1.39 -2.44325 3.26 x 0.52 14.71 0.693 x 0.68575 x x 3.8225 x x x x 10.11 4.64 2.46 -0.75 10.578 5.95 14.76 x 8.22 +15944 None Trait_373_AUW-BXD Respiratory system, metabolism: Oxygen intake (VO2) max improvement after 10 days of voluntary exercise, treadmill at 10 degree incline, chow diet, males [mL/kg/min] x x 9.25 23.33 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 6.0 33.25 10.5 x x -7.8 -5.25 -4.5 17.0 x x x 28.4 2.5 x x x -17.6 28.0 3.25 6.5 -1.0 2.5 -11.2 x 26.33 7.0 6.5 x x 6.25 x 10.0 x x x 2.2 14.0 17.25 x 28.0 38.3 x x 7.25 x 17.75 32.0 x 5.5 x x 23.55 6.75 14.8 16.5 47.8 0.333 22.0 x 9.3 +15945 None Trait_374_AUW-BXD Respiratory system, metabolism: Oxygen intake (VO2) max improvement after 10 days of voluntary exercise, treadmill at 0 degree incline, high fat diet, males [mL/kg/min] x x 12.0 35.2 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 21.33 2.25 18.25 x x 19.0 5.25 4.8 7.66667 x x x 28.25 19.5 x x x x 1.0 2.25 3.0 5.5 2.75 -3.4 x 23.2 3.25 26.5 2.66 x 1.0 x 11.6 x x x -1.6 15.5 5.25 x 9.5 20.34 6.25 x 13.75 x 5.5 10.75 x x x x 16.5 5.33333 4.0 4.5 26.2 8.2 15.8 x 8.8 +15946 None Trait_375_AUW-BXD Respiratory system, metabolism: Respiratory exchange ratio (RER) improvement after 10 days of voluntary exercise, treadmill at 10 degree incline, chow diet, males [ratio] x x -0.00905 0.024 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.0253 0.06 -7.5e-05 x x 0.043 0.02218 -0.0523 0.014 x x x -0.01528 0.0075 x x x 0.0064 0.0044 0.0533 0.0539 -0.0003 0.0263 -0.00504 x -0.00525 0.036 0.0678 x x 0.094275 x 0.078 x x x 0.242 0.0201875 0.02185 x 0.02 0.0004 x x 0.0384 x 0.0565 -0.000925 x -0.00675 x x 0.0363 0.0477 -0.0262 -0.0163 0.00672 0.0172 -0.0331 x 0.033 +15947 None Trait_376_AUW-BXD Respiratory system, metabolism: Respiratory exchange ratio (RER) improvement after 10 days of voluntary exercise, treadmill at 0 degree incline, high fat diet, males [ratio] x x 0.00375 0.00262 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x -0.0017 0.019175 -0.00925 x x 0.0415 0.0104 -0.1344 0.0154 x x x -0.03975 -0.001 x x x x 0.00225 0.00275 0.039 0.014 0.00995 0.0211 x -0.0028 -0.0065 0.0315 0.031 x 0.0401875 x 0.003 x x x 0.0235 -0.016 -0.001575 x 0.002 -0.0253 -0.00755 x 0.0035 x 0.0133 -0.0068 x x x x -0.002 0.0294333 0.0298 0.00525 -0.03172 -0.02762 -0.028 x 0.0037 +15966 Original post publication description: Somite counts; embryonic development None Somite counts; embryonic development x x 18.091 15.929 13.923 19.0 x x x x x x x x x x x x 17.478 x x x x x x x x 15.083 x x 16.054 x x x x x x 20.161 x x x x x x x x x x x 19.3 x x x x x x x x 20.438 x x 17.667 x x x x x x x 15.526 x 15.841 x x x x x x 17.4 x x x x x x x x x x x x x x x 19.955 x x x 25.381 x 18.909 18.204 +13966 Original post publication description: Central nervous system, protein: Aggregate (4C9/4C9) FRET in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, R62 only [ratio] Original pre publication description: Central nervous system, protein: Aggregate (4C9/4C9) FRET in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, R62 only [ratio] Central nervous system, protein expression: Aggregate (4C9/4C9) FRET in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, R62 only [ratio] Central nervous system, protein: Aggregate (4C9/4C9) FRET in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, R62 only [ratio] x 1013.0 1059.0 x x 920.9 894.8 1002.0 x 927.0 1033.0 1006.0 x 1008.0 x x 1044.0 x 1018.0 x 1163.0 x x x x x 1163.0 x x 997.4 x x 1033.0 x x x x 1105.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +15173 Original post publication description: Central nervous system, behavior, learning and memory: Spatial navigation, latency to reach platform using Morris water maze (test 3, Trait Lat3 Table 1), males and females combined [sec] None Central nervous system, behavior, learning and memory: Spatial navigation, latency to reach hidden platform using Morris water maze (test 3, Trait Lat3 Table 1), males and females combined [sec] x x 17.75 20.361 38.805 19.305 11.694 17.666 17.666 22.694 12.944 22.111 23.416 22.388 32.972 29.222 22.5 29.36 26.888 25.472 13.361 25.666 x 28.861 13.611 17.194 21.861 29.777 17.527 39.222 13.972 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +15174 Original post publication description: Central nervous system, behavior, learning and memory: Spatial navigation, latency to reach platform using Morris water maze (test 4, Trait Lat4 Table 1), males and females combined [sec] Original pre publication description: Central nervous system, behavior, learning and memory: Spatial navigation, latency to reach platform using Morris water maze (test 4, Trait Lat4 Table 1), males and females combined [sec] Central nervous system, behavior, learning and memory: Spatial navigation, latency to reach platform using Morris water maze (test 4, Trait Lat4 Table 1), males and females combined [sec] Central nervous system, behavior, learning and memory: Spatial navigation, latency to reach hidden platform using Morris water maze (test 4, Trait Lat4 Table 1), males and females combined [sec] x x 12.972 12.055 36.194 10.527 14.805 12.611 21.611 11.75 14.75 20.444 24.277 21.805 28.0 17.777 23.694 26.972 22.805 23.25 10.055 26.472 x 22.305 12.027 21.111 17.416 24.25 13.083 40.472 13.138 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +15169 Original post publication description: Central nervous system, behavior, learning and memory: Spatial navigation, escape latency to reach platform using Morris water maze, training session (test 3) [log sec] Original pre publication description: Central nervous system, behavior, learning and memory: Spatial navigation, crossing over trained platform location Morris water maze, final test [n annulus crossings] Central nervous system, behavior, learning and memory: Spatial navigation, crossing events over location of trained platform in Morris water maze, final probe trial, males and females combined [n annulus crossings] Central nervous system, behavior, learning and memory: Spatial navigation, crossing events over location of trained platform in Morris water maze, final probe trial, males and females combined [n annulus crossings] x x 4.166 4.666 2.333 3.416 3.916 3.166 3.083 3.0 3.833 3.166 3.166 3.333 2.0 2.833 3.583 3.333 2.333 3.583 5.0 2.416 x 3.333 3.75 2.166 2.5 2.833 2.75 2.416 4.333 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +15133 Original post publication description: malaria lethality entered at June/16 17:55:21 from IP 75.66.47.130 Original pre publication description: Infectious disease, immune function: Malaria lethality, Plasmodium yoelii (PY17X subclone, 10^6 PRBC i.p.) in 7-12 week-old males and females (1 = 100% susceptible and 0 = 100% resistant) [fraction of cohort that survives] Infectious disease, immune system: Malaria infection lethality, Plasmodium yoelii (PY17X subclone, 10^6 PRBC i.p.) in 7-12 week-old males and females (0 = resistant, 1 = susceptible) [fraction of cohort that survives] Infectious disease, immune system: Malaria infection lethality, Plasmodium yoelii (PY17X subclone, 10^6 PRBC i.p.) in 7-12 week-old males and females (0 = 100% resistant, 1 = 100% susceptible) [fraction of cohort that survives] x 0.5 0.15 0.85 x x 1.0 x x 1.0 1.0 0.0 0.71 x x 1.0 x 0.0 x x x x x 1.0 x 1.0 x x x 1.0 0.71 x 0.57 x 1.0 x 1.0 1.0 1.0 x 1.0 1.0 1.0 0.0 x x 0.88 0.0 1.0 0.5 x 0.17 x 0.0 0.78 x x x 0.625 1.0 0.36 1.0 x 0.55 1.0 0.0 0.51 0.125 0.4 x x 1.0 0.67 1.0 x 1.0 x 1.0 1.0 x x 1.0 1.0 0.46 1.0 1.0 0.67 1.0 0.22 1.0 x x x 0.125 0.63 1.0 x 1.0 1.0 0.22 0.05 1.0 +15134 None Central nervous system, pharmacology, toxicology: Saline response, control for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine), dihydroxyphenylacetic acid (DOPAC, a dopamine metabolite) in caudate-putamen (striatum) in 2-4 month-old males 48 h after saline injection (sc) [ug/mg wet weight] Central nervous system, pharmacology, toxicology: Saline response, control for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine), dihydroxyphenylacetic acid (DOPAC, a dopamine metabolite) in caudate-putamen (striatum) in 2-4 month-old males 48 h after saline injection (sc) [ug/mg wet weight] x x x x x x x x x 0.57 x x x x x x x x x x x x x x x 0.56 x 0.61 x x 0.47 x x x x x x x 0.54 x x x x x x x 0.41 x x x x x x x x x x x 0.6 x 0.5 x x x x x x 0.6 x x x x x x x x x x x x x x 0.42 x x x x x x x x x x x x x x x x x x x +15135 None Central nervous system, pharmacology toxicology: MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) response (12.5 mg/kg sc), dihydroxyphenylacetic acid (DOPAC, a dopamine metabolite) level in caudate-putamen (striatum) in males 48 h after injection (MPTP group) [ug/mg wet weight] Central nervous system, pharmacology toxicology: MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) response (12.5 mg/kg ip), dihydroxyphenylacetic acid (DOPAC, a dopamine metabolite) level in caudate-putamen (striatum) in males 48 h after injection (MPTP group) [ug/mg total protein] x x x x x x x x x 0.24 x x x x x x x x x x x x x x x 0.25 x 0.35 x x 0.35 x x x x x x x 0.02 x x x x x x x 0.11 x x x x x x x x x x x 0.3 x 0.38 x x x x x x 0.43 x x x x x x x x x x x x x x 0.34 x x x x x x x x x x x x x x x x x x x +15136 None Central nervous system, toxicology; Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on dihydroxyphenylacetic acid (DOPAC, a dopamine metabolite) concentration in Caudate-putamen (ug/mg wet weight) in males 48h after injection (Saline-MPTP group) Central nervous system, pharmacology toxicology: MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) response (12.5 mg/kg ip), dihydroxyphenylacetic acid (DOPAC, a dopamine metabolite) in caudate-putamen (striatum) concentration in males 48 h after injection (saline-MPTP group) [ug/mg total protein] x x x x x x x x x 0.33 x x x x x x x x x x x x x x x 0.31 x 0.26 x x 0.12 x x x x x x x 0.52 x x x x x x x 0.3 x x x x x x x x x x x 0.3 x 0.12 x x x x x x 0.17 x x x x x x x x x x x x x x 0.08 x x x x x x x x x x x x x x x x x x x +15137 None Central nervous system, pharmacology, toxicology: Saline response, control for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine), dopamine (DA) in caudate-putamen (striatum) in 2-4 month-old males 48 h after saline injection (sc) [ug/mg wet weight] Central nervous system, pharmacology, toxicology: Saline response, control for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine), dopamine (DA) in caudate-putamen (striatum) in 2-4 month-old males 48 h after saline injection (sc) [ug/mg wet weight] x x x x x x x x x 19.64 x x x x x x x x x x x x x x x 12.86 x 11.0 x x 12.47 x x x x x x x 13.06 x x x x x x x 15.31 x x x x x x x x x x x 13.69 x 12.68 x x x x x x 16.51 x x x x x x x x x x x x x x 11.95 x x x x x x x x x x x x x x x x x x x +15138 None Central nervous system, pharmacology, toxicology: MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) response (12.5 mg/kg sc), dopamine (DA) concentration in caudate-putamen (striatum) in males 48 h after injection (MPTP group) [ug/mg wet weight] Central nervous system, pharmacology, toxicology: MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) response (12.5 mg/kg sc), dopamine (DA) concentration in caudate-putamen (striatum) in males 48 h after injection (MPTP group) [ug/mg wet weight] x x x x x x x x x 7.74 x x x x x x x x x x x x x x x 6.42 x 8.75 x x 7.0 x x x x x x x 1.16 x x x x x x x 4.08 x x x x x x x x x x x 2.82 x 8.06 x x x x x x 8.85 x x x x x x x x x x x x x x 6.48 x x x x x x x x x x x x x x x x x x x +15139 None Central nervous system, toxicology: Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on dopamine concentration in caudate-putamen (striatum) in males 48 h after injection (saline-MPTP group) [ug/mg wet weight] Central nervous system, toxicology: Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on dopamine concentration in caudate-putamen (striatum) in males 48 h after injection (saline-MPTP group) [ug/mg wet weight] x x x x x x x x x 11.9 x x x x x x x x x x x x x x x 6.44 x 2.25 x x 5.47 x x x x x x x 11.9 x x x x x x x 11.23 x x x x x x x x x x x 10.87 x 4.62 x x x x x x 7.66 x x x x x x x x x x x x x x 5.47 x x x x x x x x x x x x x x x x x x x +15140 None Central nervous system, pharmacology, toxicology: Saline response, control for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine), homovanillic acid (HVA, a dopamine metabolite) in caudate-putamen (striatum) in 2-4 month-old males 48 h after saline injection (sc) [ug/mg wet weight] Central nervous system, pharmacology, toxicology: Saline response, control for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine), homovanillic acid (HVA, a dopamine metabolite) in caudate-putamen (striatum) in 2-4 month-old males 48 h after saline injection (sc) [ug/mg wet weight] x x x x x x x x x 0.74 x x x x x x x x x x x x x x x 0.41 x 0.52 x x 0.12 x x x x x x x 0.72 x x x x x x x 0.68 x x x x x x x x x x x 0.62 x 0.63 x x x x x x 0.81 x x x x x x x x x x x x x x 0.47 x x x x x x x x x x x x x x x x x x x +15141 None Central nervous system, pharmacology, toxicology: MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) response (12.5 mg/kg sc), homovanillic acid (HVA) concentration in caudate-putamen (striatum) in males 48 h after injection (MPTP group) [ug/mg wet weight] Central nervous system, pharmacology, toxicology: MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) response (12.5 mg/kg sc), homovanillic acid (HVA) concentration in caudate-putamen (striatum) in males 48 h after injection (MPTP group) [ug/mg wet weight] x x x x x x x x x 0.38 x x x x x x x x x x x x x x x 0.24 x 0.34 x x 0.34 x x x x x x x 0.28 x x x x x x x 0.34 x x x x x x x x x x x 0.31 x 0.54 x x x x x x 0.51 x x x x x x x x x x x x x x 0.43 x x x x x x x x x x x x x x x x x x x +15142 None Central nervous system, toxicology: Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on homovanilic acid (HVA) concentration in caudate-putamen in males 48h after injection (saline-MPTP group) [ug/mg wet weight] Central nervous system, toxicology: Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on homovanilic acid (HVA) concentration in caudate-putamen in males 48h after injection (saline-MPTP group) [ug/mg wet weight] x x x x x x x x x 0.36 x x x x x x x x x x x x x x x 0.17 x 0.18 x x -0.22 x x x x x x x 0.44 x x x x x x x 0.34 x x x x x x x x x x x 0.31 x 0.09 x x x x x x 0.3 x x x x x x x x x x x x x x 0.04 x x x x x x x x x x x x x x x x x x x +15143 None Central nervous system, pharmacology, toxicology: Saline response, control for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine), 3-methoxytyramine (3-MT, a dopamine metabolite) in caudate-putamen (striatum) in 2-4 month-old males 48 h after saline injection (sc) [ug/mg wet weight] Central nervous system, pharmacology, toxicology: Saline response, control for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine), 3-methoxytyramine (3-MT, a dopamine metabolite) in caudate-putamen (striatum) in 2-4 month-old males 48 h after saline injection (sc) [ug/mg wet weight] x x x x x x x x x 0.45 x x x x x x x x x x x x x x x 0.44 x 0.4 x x 0.35 x x x x x x x 0.46 x x x x x x x 0.39 x x x x x x x x x x x 0.36 x 0.46 x x x x x x 0.32 x x x x x x x x x x x x x x 0.31 x x x x x x x x x x x x x x x x x x x +15144 None Central nervous system, pharmacology, toxicology: MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) response (12.5 mg/kg sc), 3-methoxytyramine (3-MT, a dopamine metabolite) concentration in caudate-putamen (striatum) in males 48 h after injection (MPTP group) [ug/mg wet weight] Central nervous system, pharmacology, toxicology: MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) response (12.5 mg/kg sc), 3-methoxytyramine (3-MT, a dopamine metabolite) concentration in caudate-putamen (striatum) in males 48 h after injection (MPTP group) [ug/mg wet weight] x x x x x x x x x 0.36 x x x x x x x x x x x x x x x 0.22 x 0.33 x x 0.26 x x x x x x x 0.1 x x x x x x x 0.24 x x x x x x x x x x x 0.15 x 0.44 x x x x x x 0.36 x x x x x x x x x x x x x x 0.23 x x x x x x x x x x x x x x x x x x x +15145 None Central nervous system, pharmacology, toxicology: MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) response (12.5 mg/kg sc) on 3-methoxytyramine (3-MT, a dopamine metabolite) concentration in caudate-putamen (striatum) in 2-4 month-old males 48 h after injection (saline-MPTP group) [ug/mg total protein] Central nervous system, pharmacology, toxicology: MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) response (12.5 mg/kg sc) on 3-methoxytyramine (3-MT, a dopamine metabolite) concentration in caudate-putamen (striatum) in 2-4 month-old males 48 h after injection (saline-MPTP group) [ug/mg total protein] x x x x x x x x x 0.09 x x x x x x x x x x x x x x x 0.22 x 0.07 x x 0.09 x x x x x x x 0.36 x x x x x x x 0.15 x x x x x x x x x x x 0.21 x 0.02 x x x x x x -0.04 x x x x x x x x x x x x x x 0.08 x x x x x x x x x x x x x x x x x x x +15146 None Central nervous system, pharmacology, toxicology: Saline response, control for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine), DOPAC/DA ratio (index of presynaptic dopamine utilization) in caudate-putamen (striatum) in 2-4 month-old males 48 h after saline injection (sc) [ratio of ug/mg] Central nervous system, pharmacology, toxicology: Saline response, control for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine), DOPAC/DA ratio (index of presynaptic dopamine utilization) in caudate-putamen (striatum) in 2-4 month-old males 48 h after saline injection (sc) [ratio of ug/mg] x x x x x x x x x 2.9 x x x x x x x x x x x x x x x 4.35 x 5.53 x x 3.74 x x x x x x x 4.13 x x x x x x x 2.69 x x x x x x x x x x x 4.37 x 3.96 x x x x x x 3.6 x x x x x x x x x x x x x x 3.5 x x x x x x x x x x x x x x x x x x x +15147 None Central nervous system, toxicology; Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on DOPAC/DA (index of presynaptic dopamine utilization) in caudate-putamen (ug/mg wet weight) in males 48h after injection (MPTP group) Central nervous system, pharmacology, toxicology: MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) response (12.5 mg/kg ip), DOPAC/DA ratio (index of presynaptic dopamine utilization) in caudate-putamen (striatum) in males 48 h after injection (MPTP group) [ug/mg total protein] x x x x x x x x x 3.22 x x x x x x x x x x x x x x x 4.06 x 3.34 x x 5.06 x x x x x x x 1.33 x x x x x x x 2.77 x x x x x x x x x x x 5.32 x 4.81 x x x x x x 4.92 x x x x x x x x x x x x x x 5.24 x x x x x x x x x x x x x x x x x x x +15148 None Central nervous system, toxicology; Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on DOPAC/DA (index of presynaptic dopamine utilization) in caudate-putamen (ug/mg wet weight) in males 48h after injection (Saline-MPTP group) Central nervous system, pharmacology toxicology: MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) response (12.5 mg/kg ip), DOPAC/DA ratio (index of presynaptic dopamine utilization) in caudate-putamen (striatum) in males 48 h after injection (saline-MPTP group) [ug/mg total protein] x x x x x x x x x -0.32 x x x x x x x x x x x x x x x 0.29 x 2.19 x x -1.32 x x x x x x x 2.8 x x x x x x x -0.08 x x x x x x x x x x x -9.55 x -0.85 x x x x x x -1.32 x x x x x x x x x x x x x x -1.74 x x x x x x x x x x x x x x x x x x x +15149 None Central nervous system, pharmacology, toxicology: Saline response, control for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine), HVA/DA concentration ratio (index of postsynaptic dopamine utilization) in caudate-putamen (striatum) in 2-4 month-old males 48 h after saline injection (sc) [ratio of ug/mg] Central nervous system, pharmacology, toxicology: Saline response, control for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine), HVA/DA concentration ratio (index of postsynaptic dopamine utilization) in caudate-putamen (striatum) in 2-4 month-old males 48 h after saline injection (sc) [ratio of ug/mg] x x x x x x x x x 3.77 x x x x x x x x x x x x x x x 3.21 x 4.78 x x 1.02 x x x x x x x 5.58 x x x x x x x 4.46 x x x x x x x x x x x 4.52 x 4.98 x x x x x x 4.79 x x x x x x x x x x x x x x 3.94 x x x x x x x x x x x x x x x x x x x +15150 None Central nervous system, toxicology; Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on HVA/DA (index of postsynaptic dopamine utilization) in caudate-putamen (ug/mg wet weight) in males 48h after injection (MPTP group) Central nervous system, pharmacology, toxicology: MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) response (dose and route here), HVA/DA (index of postsynaptic dopamine utilization) in caudate-putamen (striatum) in males 48 h after injection (MPTP group) [ug/mg wet weight] x x x x x x x x x 5.42 x x x x x x x x x x x x x x x 3.93 x 3.92 x x 5.18 x x x x x x x 25.45 x x x x x x x 8.46 x x x x x x x x x x x 8.01 x 6.84 x x x x x x 5.78 x x x x x x x x x x x x x x 6.67 x x x x x x x x x x x x x x x x x x x +15151 None Central nervous system, toxicology; Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on HVA/DA (index of postsynaptic dopamine utilization) in caudate-putamen (ug/mg wet weight) in males 48h after injection (Saline-MPTP group) Central nervous system, pharmacology, toxicology: MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) response (dose and route here), HVA/DA (index of postsynaptic dopamine utilization) in caudate-putamen (striatum) in males 48 h after injection (saline minus MPTP group) [ug/mg wet weight] x x x x x x x x x -1.65 x x x x x x x x x x x x x x x -0.72 x 0.86 x x -4.16 x x x x x x x -19.87 x x x x x x x -4.0 x x x x x x x x x x x -3.49 x -1.86 x x x x x x -0.99 x x x x x x x x x x x x x x -2.73 x x x x x x x x x x x x x x x x x x x +15152 None Central nervous system, pharmacology, toxicology: Saline response, control for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine), serotonin (5-HT) concentration in caudate-putamen (striatum) in 2-4 month-old males 48 h after saline injection (sc) [ug/mg of wet weight] Central nervous system, pharmacology, toxicology: Saline response, control for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine), serotonin (5-HT) concentration in caudate-putamen (striatum) in 2-4 month-old males 48 h after saline injection (sc) [ug/mg of wet weight] x x x x x x x x x 0.59 x x x x x x x x x x x x x x x 0.42 x 0.44 x x 0.63 x x x x x x x 0.43 x x x x x x x 0.71 x x x x x x x x x x x 0.51 x 0.64 x x x x x x 0.51 x x x x x x x x x x x x x x 0.59 x x x x x x x x x x x x x x x x x x x +15153 None Central nervous system, toxicology; Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) 5-HT Concentration in Caudate-putamen (ug/mg wet weight) in males 48h after injection (MPTP group) Central nervous system, pharmacology, toxicology: MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) response (12.5 mg/kg s.c.), 5-HT concentration in caudate-putamen (striatum) in males 48 h after injection (MPTP group) [ug/g wet weight] x x x x x x x x x 0.49 x x x x x x x x x x x x x x x 0.51 x 0.53 x x 0.44 x x x x x x x 0.4 x x x x x x x 0.71 x x x x x x x x x x x 0.36 x 0.45 x x x x x x 0.52 x x x x x x x x x x x x x x 0.42 x x x x x x x x x x x x x x x x x x x +15154 None Central nervous system, toxicology; Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) 5-HT Concentration in Caudate-putamen (ug/mg wet weight) in males 48h after injection (Saline-MPTP group) Central nervous system, pharmacology toxicology: MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) response (dose and route here), serotonin (5-HT) concentration in caudate-putamen (striatum) in males 48 h after injection (saline-MPTP group) [ug/mg total protein] x x x x x x x x x 0.1 x x x x x x x x x x x x x x x -0.09 x -0.09 x x 0.19 x x x x x x x 0.03 x x x x x x x 0.0 x x x x x x x x x x x 0.15 x 0.19 x x x x x x -0.01 x x x x x x x x x x x x x x 0.17 x x x x x x x x x x x x x x x x x x x +15155 None Central nervous system, pharmacology, toxicology: Saline response, control for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine), 5-HIAA (serotonin metabolite) concentration in caudate-putamen (striatum) in 2-4 month-old males 48 h after saline injection (sc) [ug/mg of wet weight] Central nervous system, pharmacology, toxicology: Saline response, control for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine), 5-HIAA (serotonin metabolite) concentration in caudate-putamen (striatum) in 2-4 month-old males 48 h after saline injection (sc) [ug/mg of wet weight] x x x x x x x x x 0.17 x x x x x x x x x x x x x x x 0.14 x 0.13 x x 0.06 x x x x x x x 0.09 x x x x x x x 0.18 x x x x x x x x x x x 0.14 x 0.13 x x x x x x 0.1 x x x x x x x x x x x x x x 0.13 x x x x x x x x x x x x x x x x x x x +15156 None Central nervous system, toxicology; Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) 5-HIAA (5-HT metabolite) concentration in caudate-putamen (ug/mg wet weight) in males 48h after injection (MPTP group) Central nervous system, toxicology: Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on 5-HIAA (5-HT metabolite) concentration in caudate-putamen (striatum) in males 48 h after injection (MPTP group) [ug/mg total protein] x x x x x x x x x 0.15 x x x x x x x x x x x x x x x 0.14 x 0.07 x x 0.06 x x x x x x x 0.17 x x x x x x x 0.18 x x x x x x x x x x x 0.34 x 0.11 x x x x x x 0.11 x x x x x x x x x x x x x x 0.12 x x x x x x x x x x x x x x x x x x x +15157 None Central nervous system, pharmacology, toxicology: MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) response (12.5 mg/kg sc), 5-HIAA (5-HT metabolite) level in caudate-putamen (striatum) in males 48 h after injection (saline-MPTP group) [ug/mg total protein] Central nervous system, pharmacology, toxicology: MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) response (12.5 mg/kg sc), 5-HIAA (5-HT metabolite) level in caudate-putamen (striatum) in males 48 h after injection (saline-MPTP group) [ug/mg total protein] x x x x x x x x x 0.02 x x x x x x x x x x x x x x x 0.0 x 0.06 x x 0.0 x x x x x x x -0.08 x x x x x x x 0.0 x x x x x x x x x x x -0.2 x 0.02 x x x x x x -0.01 x x x x x x x x x x x x x x 0.01 x x x x x x x x x x x x x x x x x x x +15158 None Central nervous system, pharmacology, toxicology: Saline response, control for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine), glial acidic fibrillary protein (GFAP, a marker of neurotoxicity) in caudate-putamen (striatum) in 2-4 month-old males 48 h after saline injection (sc) [ug/mg total protein] Central nervous system, pharmacology, toxicology: Saline response, control for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine), glial acidic fibrillary protein (GFAP, a marker of neurotoxicity) in caudate-putamen (striatum) in 2-4 month-old males 48 h after saline injection (sc) [ug/mg total protein] x x x x x x x x x 0.17 x x x x x x x x x x x x x x x 0.1 x 0.12 x x 0.08 x x x x x x x 0.17 x x x x x x x 0.16 x x x x x x x x x x x 0.16 x 0.17 x x x x x x 0.08 x x x x x x x x x x x x x x 0.11 x x x x x x x x x x x x x x x x x x x +15159 None Central nervous system, toxicology; Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on glial acidic fibrillary protein (GFAP, a marker of neurotoxicity) concentration in caudate-putamen (ug/mg total protein) in males 48h after injection (MPTP group) Central nervous system, pharmacology, toxicology: MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) response (12.5 mg/kg s.c.), glial fibrillary acidic protein (GFAP, a marker of neurotoxicity) in caudate-putamen (striatum) in males 48 h after injection (MPTP group) [ug/g total protein] x x x x x x x x x 0.61 x x x x x x x x x x x x x x x 0.33 x 0.2 x x 0.16 x x x x x x x 0.48 x x x x x x x 0.47 x x x x x x x x x x x 0.28 x 0.27 x x x x x x 0.3 x x x x x x x x x x x x x x 0.25 x x x x x x x x x x x x x x x x x x x +15160 None Central nervous system, toxicology; Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on glial acidic fibrillary protein (GFAP, a marker of neurotoxicity) concentration in caudate-putamen (ug/mg total protein) in males 48h after injection (Saline-MPTP group) Central nervous system, pharmacology, toxicology: MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) response (12.5 mg/kg s.c.), glial fibrillary acidic protein (GFAP, a marker of neurotoxicity) in caudate-putamen (striatum) in males 48 h after injection (saline-MPTP group) [ug/g total protein] x x x x x x x x x -0.44 x x x x x x x x x x x x x x x -0.23 x -0.08 x x -0.08 x x x x x x x -0.31 x x x x x x x -0.31 x x x x x x x x x x x -0.12 x -0.1 x x x x x x -0.22 x x x x x x x x x x x x x x -0.14 x x x x x x x x x x x x x x x x x x x +15161 None Central nervous system, pharmacology, toxicology: Saline response, control for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine), tyrosine hydroxylase (TH, rate limiting enzyme for catecholamine synthesis) in caudate-putamen (striatum) in 2-4 month-old males 48 h after saline injection (sc) [ug/mg total protein] Central nervous system, pharmacology, toxicology: Saline response, control for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine), tyrosine hydroxylase (TH, rate limiting enzyme for catecholamine synthesis) in caudate-putamen (striatum) in 2-4 month-old males 48 h after saline injection (sc) [ug/mg total protein] x x x x x x x x x 1.78 x x x x x x x x x x x x x x x 1.31 x 1.06 x x 1.5 x x x x x x x 1.22 x x x x x x x 1.51 x x x x x x x x x x x 1.48 x 1.3 x x x x x x 1.6 x x x x x x x x x x x x x x 1.03 x x x x x x x x x x x x x x x x x x x +15162 None Central nervous system, toxicology: Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Tyrosine Hydroxylase (TH, rate limiting enzyme for catecholamine synthesis) Concentration in Caudate-putamen (ug/mg total protein) in males 48h after injection (MPTP group) Central nervous system, pharmacology, toxicology: MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) response (12.5 mg/kg s.c.), tyrosine hydroxylase (TH, rate limiting enzyme for catecholamine synthesis) in caudate-putamen (striatum) in males 48 h after injection (MPTP group) [ug/g total protein] x x x x x x x x x 0.92 x x x x x x x x x x x x x x x 0.8 x 0.83 x x 0.87 x x x x x x x 0.31 x x x x x x x 0.61 x x x x x x x x x x x 0.55 x 1.08 x x x x x x 0.98 x x x x x x x x x x x x x x 0.73 x x x x x x x x x x x x x x x x x x x +15163 None Central nervous system, toxicology: Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on tyrosine hydroxylase (TH, rate limiting enzyme for catecholamine synthesis) concentration in caudate-putamen (striatum) in males 48 h after injection (saline-MPTP group) [ug/mg total protein] Central nervous system, pharmacology, toxicology: MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) response (12.5 mg/kg s.c.), tyrosine hydroxylase (TH, rate limiting enzyme for catecholamine synthesis) in caudate-putamen (striatum) in males 48 h after injection (saline-MPTP group) [ug/g total protein] x x x x x x x x x 0.86 x x x x x x x x x x x x x x x 0.51 x 0.23 x x 0.63 x x x x x x x 0.91 x x x x x x x 0.9 x x x x x x x x x x x 0.93 x 0.22 x x x x x x 0.62 x x x x x x x x x x x x x x 0.3 x x x x x x x x x x x x x x x x x x x +15164 None Central nervous system, pharmacology, toxicology: Saline response, control for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine), iron concentration in ventral midbrain (SN and VTA) in 2-4 month-old males 48 h after saline injection (sc) [ug/mg wet weight] Central nervous system, pharmacology, toxicology: Saline response, control for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine), iron concentration in ventral midbrain (SN and VTA) in 2-4 month-old males 48 h after saline injection (sc) [ug/mg wet weight] x x x x x x x x x 30.54 x x x x x x x x x x x x x x x 21.74 x 25.14 x x 26.13 x x x x x x x 24.41 x x x x x x x 24.02 x x x x x x x x x x x 34.43 x 24.95 x x x x x x 29.77 x x x x x x x x x x x x x x 28.02 x x x x x x x x x x x x x x x x x x x +15165 None Central nervous system, pharmacology, toxicology: MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) response (12.5 mg/kg sc), iron concentration in ventral midbrain (SN and VTA) in 2-4 month-old males 48 h after injection (MPTP group) [ug/mg wet weight] Central nervous system, pharmacology, toxicology: MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) response (12.5 mg/kg sc), iron concentration in ventral midbrain (SN and VTA) in 2-4 month-old males 48 h after injection (MPTP group) [ug/mg wet weight] x x x x x x x x x 25.12 x x x x x x x x x x x x x x x 23.56 x 29.89 x x 24.96 x x x x x x x 33.46 x x x x x x x 28.1 x x x x x x x x x x x 29.24 x 24.98 x x x x x x 24.86 x x x x x x x x x x x x x x 27.73 x x x x x x x x x x x x x x x x x x x +15166 None Central nervous system, pharmacology, toxicology: MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) response difference (12.5 mg/kg sc vs saline), iron concentration in ventral midbrain (SN and VTA) in 2-4 month-old males 48 h after injection [difference ug/mg] Central nervous system, pharmacology, toxicology: MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) response difference (12.5 mg/kg sc vs saline), iron concentration in ventral midbrain (SN and VTA) in 2-4 month-old males 48 h after injection [difference ug/mg] x x x x x x x x x -5.42 x x x x x x x x x x x x x x x 1.82 x 4.75 x x -1.17 x x x x x x x 9.05 x x x x x x x 4.08 x x x x x x x x x x x -5.19 x 0.03 x x x x x x -4.91 x x x x x x x x x x x x x x -0.29 x x x x x x x x x x x x x x x x x x x +15167 Original post publication description: Infectious disease, immune function: Ectromelia virus formation of secondary dermal lesions over two weeks after 90 pfu injection into the footpad, males and females between 40 and 150 days of age, residuals corrected for sex, age and body weight [presence of lesions where -0.4 is no lesions and 0.6 is all animals present with lesions] None Infectious disease, immune function: Ectromelia virus formation of secondary dermal lesions over two weeks after 90 pfu injection into the footpad, females between 40 and 150 days of age, residuals corrected for age and body weight [presence of lesions where -0.4 is no lesions and 0.6 is all animals present with lesions] x x -0.271 -0.37 x x x 0.065 x x x -0.081 x x x x x x x x x x x x x x x x x x -0.527 x x x x x x x -0.28 x x x -0.154 -0.228 x x -0.691 -0.333 0.024 0.199 x x x x x x x x x x 0.134 x 0.736 x 0.482 x 0.062 -0.579 -0.117 x x 0.16 x 0.436 x 0.332 x x 0.142 -0.354 x 0.311 -0.17 x -0.282 -0.492 x -0.116 0.439 x x x x 0.523 0.293 x 0.612 0.027 0.315 -0.29 0.054 -0.011 +15168 Original post publication description: Infectious disease, immune function: Ectromelia virus formation of secondary dermal lesions over two weeks after 90 pfu injection into the footpad, males only between 40 and 150 days of age, residuals corrected for age and body weight [presence of lesions where -0.4 is no lesions and 0.7 is all animals present with lesions] None Infectious disease, immune function: Ectromelia virus formation of secondary dermal lesions over two weeks after 90 pfu injection into the footpad, males only between 40 and 150 days of age, residuals corrected for age and body weight [presence of lesions where -0.4 is no lesions and 0.7 is all animals present with lesions] x x -0.3339 -0.2218 x x x -0.3265 x x x 0.0409 x x x x x x x x x x x x x x x x x x -0.2807 x -0.3065 x x x x x x x x x -0.2528 -0.1256 x x 0.3892 -0.2945 -0.2744 0.1892 x x x x x x x x x x 0.00911 x 0.7142 x -0.0476 x -0.1816 -0.2808 -0.1698 x x 0.71 x 0.4406 x 0.0135 x x -0.1213 -0.3378 x -0.1262 0.0596 x 0.0054 -0.3454 x -0.3158 0.698 x x x x 0.7261 0.5237 x -0.279 -0.2449 0.2604 0.3179 0.0621 -0.2928 +15022 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW119_17, males Morphology, metabolism: Body weight at 119 days (17 weeks) in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 4.885 5.124 4.8 4.769 4.944 x 4.917 4.946 x 5.166 x x 5.374 4.915 5.329 x x x x x x 4.825 x x 5.221 x x x 5.14 4.878 4.793 x x x x 5.081 5.374 4.769 x 5.194 4.844 x x x x x x x 5.004 x x x x x x x x x 4.769 5.374 x x x x x 5.053 5.024 x x x 4.959 x 4.989 x x x x x x x x x x 5.374 4.769 x x 5.125 x x x x x 5.043 x x x x x x x +15023 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW126_18, males Morphology, metabolism: Body weight at 126 days (18 weeks) in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 4.944 5.144 4.843 4.818 4.956 x 4.946 4.966 x 5.254 x x 5.406 x 5.369 x x x x x x 4.869 x x 5.27 x x x 5.177 4.878 4.823 x x x x 5.083 5.406 4.818 x 5.24 4.901 x x x x x x x 5.052 x x x x x x x x x 4.818 5.406 x x x x x 5.11 5.097 x x x 4.971 x 5.02 x x x x x x x x x x 5.406 4.818 x x 5.182 x x x x x 5.109 x x x x x x x +15024 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW133_19, males Morphology, metabolism: Body weight at 133 days (19 weeks) in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 4.959 5.165 4.853 4.853 4.983 x 4.967 5.035 x 5.323 x x 5.439 x 5.439 x x x x x x 4.899 x x 5.275 x x x 5.236 4.898 4.881 x x x x 5.11 5.439 4.858 x 5.261 4.931 x x x x x x x 5.106 x x x x x x x x x 4.853 5.439 x x x x x 5.121 5.11 x x x 4.999 x 5.044 x x x x x x x x x x 5.388 4.853 x x 5.195 x x x x x 5.163 x x x x x x x +15025 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW140_20, males Morphology, metabolism: Body weight at 140 days (20 weeks) in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 5.011 5.262 4.931 4.854 4.998 x 4.987 5.1 x 5.363 x x 5.467 x 5.467 x x x x x x 4.934 x x 5.307 x x x 5.297 4.93 4.854 x x x x 5.087 5.467 4.945 x 5.274 4.964 x x x x x x x 5.153 x x x x x x x x x 4.854 5.467 x x x x x 5.15 5.175 x x x 5.049 x 5.083 x x x x x x x x x x 5.394 4.854 x x 5.251 x x x x x 5.19 x x x x x x x +15026 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW4.5, males Morphology, metabolism: Body weight gain between 4 and 5 weeks in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 2.585 2.62 2.479 2.055 2.677 x 2.493 2.491 x x x x 2.911 2.641 2.911 x x x x x x 2.857 x x 2.804 x x x 2.423 2.707 2.139 x x x x 2.055 2.911 2.578 x 2.657 2.055 x x x x x x x 2.491 x x x x x x x x x 2.332 2.897 x x x x x 2.457 2.558 x x x 2.723 x 2.538 x x x x x x x x x x 2.489 2.055 x x 2.403 x x x x x 2.911 x x x x x x x +15027 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW5.6, males Morphology, metabolism: Body weight gain between 5 and 6 weeks in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 2.244 2.502 2.252 2.176 2.176 x 2.547 2.475 x 2.554 x x 2.24 2.176 2.629 x x x x x x 2.689 x x 2.689 x x x 2.505 2.629 2.468 x x x x 2.428 2.627 2.323 x 2.269 2.176 x x x x x x x 2.689 x x x x x x x x x 2.287 2.689 x x x x x 2.205 2.327 x x x 2.485 x 2.239 x x x x x x x x x x 2.604 2.184 x x 2.671 x x x x x 2.575 x x x x x x x +15028 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW6.7, males Morphology, metabolism: Body weight gain between 6 and 7 weeks in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.638 1.91 1.803 1.585 1.585 x 2.01 1.853 x 1.595 x x 1.774 1.623 1.82 x x x x x x 1.921 x x 2.043 x x x 1.869 1.966 1.988 x x x x 1.886 1.991 1.585 x 1.726 1.93 x x x x x x x 1.756 x x x x x x x x x 2.043 1.955 x x x x x 1.976 1.652 x x x 2.043 x 1.585 x x x x x x x x x x 2.043 1.873 x x 2.019 x x x x x 1.812 x x x x x x x +15029 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW7.8, males Morphology, metabolism: Body weight gain between 7 and 8 weeks in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.644 1.91 1.968 1.434 1.626 x 1.491 1.434 x 1.7 x x 2.221 1.56 1.728 x x x x x x 1.727 x x 1.695 x x x 1.719 1.816 1.742 x x x x 2.221 2.221 1.434 x 1.593 1.599 x x x x x x x 1.655 x x x x x x x x x 1.434 1.849 x x x x x 1.873 1.658 x x x 1.815 x 1.758 x x x x x x x x x x 2.221 1.757 x x 1.736 x x x x x 1.669 x x x x x x x +15030 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW8.9, males Morphology, metabolism: Body weight gain between 8 and 9 weeks in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.332 1.511 1.631 1.332 1.344 x 1.643 1.388 x 1.872 x x 1.872 1.705 1.714 x x x x x x 1.604 x x 1.852 x x x 1.636 1.744 1.501 x x x x 1.753 1.872 1.353 x 1.561 1.397 x x x x x x x 1.332 x x x x x x x x x 1.483 1.581 x x x x x 1.463 1.763 x x x 1.586 x 1.747 x x x x x x x x x x 1.872 1.332 x x 1.504 x x x x x 1.369 x x x x x x x +15031 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW9.10, males Morphology, metabolism: Body weight gain between 9 and 10 weeks in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.664 1.61 1.605 1.238 1.491 x 1.701 1.238 x 1.786 x x 1.786 1.526 1.73 x x x x x x 1.238 x x 1.786 x x x 1.5 1.63 1.515 x x x x 1.336 1.688 1.393 x 1.52 1.239 x x x x x x x 1.583 x x x x x x x x x 1.445 1.776 x x x x x 1.654 1.698 x x x 1.49 x 1.479 x x x x x x x x x x 1.786 1.238 x x 1.752 x x x x x 1.245 x x x x x x x +15032 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW10.11, males Morphology, metabolism: Body weight gain between 10 and 11 weeks in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.388 1.8 1.3 1.3 1.487 x 1.335 1.581 x 1.963 x x 2.038 1.512 1.913 x x x x x x 1.345 x x 1.999 x x x 1.418 1.451 1.468 x x x x 1.778 2.038 1.585 x 1.627 1.633 x x x x x x x 1.3 x x x x x x x x x 1.362 2.038 x x x x x 1.54 1.409 x x x 1.3 x 1.7 x x x x x x x x x x 2.038 1.493 x x 1.608 x x x x x 1.49 x x x x x x x +15033 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW11.12, males Morphology, metabolism: Body weight gain between 11 and 12 weeks in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.46 1.913 1.443 1.287 1.407 x 1.551 1.651 x 1.987 x x 1.987 1.37 1.709 x x x x x x 1.611 x x 1.709 x x x 1.857 1.309 1.331 x x x x 1.621 1.987 1.286 x 1.286 1.429 x x x x x x x 1.434 x x x x x x x x x 1.455 1.91 x x x x x 1.805 1.715 x x x 1.526 x 1.688 x x x x x x x x x x 1.987 1.286 x x 1.931 x x x x x 1.286 x x x x x x x +15034 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW12.13, males Morphology, metabolism: Body weight gain between 12 and 13 weeks in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.151 1.469 1.328 1.151 1.432 x 1.543 1.205 x 1.942 x x 1.961 1.895 1.629 x x x x x x 1.151 x x 1.877 x x x 1.897 1.181 1.422 x x x x 1.567 1.961 1.637 x 1.272 1.525 x x x x x x x 1.531 x x x x x x x x x 1.151 1.961 x x x x x 1.223 1.408 x x x 1.259 x 1.516 x x x x x x x x x x 1.961 1.367 x x 1.49 x x x x x 1.673 x x x x x x x +15035 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW13.14, males Morphology, metabolism: Body weight gain between 13 and 14 weeks in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.458 1.577 1.448 1.517 1.245 x 1.55 1.7 x 1.907 x x 1.669 1.28 1.832 x x x x x x 1.243 x x 1.243 x x x 1.423 1.243 1.533 x x x x 1.568 1.907 1.508 x 1.629 1.458 x x x x x x x 1.358 x x x x x x x x x 1.406 1.907 x x x x x 1.818 1.907 x x x 1.459 x 1.523 x x x x x x x x x x 1.564 1.243 x x 1.554 x x x x x 1.397 x x x x x x x +15036 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW14.15, males Morphology, metabolism: Body weight gain between 14 and 15 weeks in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.585 1.51 1.398 1.39 1.418 x 1.201 1.824 x 1.95 x x 1.871 1.592 1.688 x x x x x x 1.291 x x 1.713 x x x 1.742 1.282 1.281 x x x x 1.274 1.73 1.512 x 1.941 1.234 x x x x x x x 1.706 x x x x x x x x x 1.452 1.95 x x x x x 1.696 1.625 x x x 1.438 x 1.201 x x x x x x x x x x 1.95 1.201 x x 1.95 x x x x x 1.201 x x x x x x x +15037 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW15.16, males Morphology, metabolism: Body weight gain between 15 and 16 weeks in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.302 1.502 1.382 1.21 1.665 x 1.428 1.403 x 1.535 x x 1.907 1.597 1.907 x x x x x x 1.21 x x 1.706 x x x 1.561 1.404 1.432 x x x x 1.21 1.826 1.571 x 1.907 1.474 x x x x x x x 1.514 x x x x x x x x x 1.21 1.907 x x x x x 1.279 1.624 x x x 1.329 x 1.55 x x x x x x x x x x 1.373 1.24 x x 1.646 x x x x x 1.636 x x x x x x x +15038 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW16.17, males Morphology, metabolism: Body weight gain between 16 and 17 weeks in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.751 1.62 1.368 1.247 1.485 x 1.535 1.92 x 2.001 x x 1.677 1.247 2.001 x x x x x x 1.421 x x 1.377 x x x 1.929 1.37 1.592 x x x x 1.524 2.001 1.247 x 1.699 1.408 x x x x x x x 1.668 x x x x x x x x x 1.366 1.845 x x x x x 1.651 2.001 x x x 1.247 x 1.49 x x x x x x x x x x 1.817 1.399 x x 1.46 x x x x x 1.8 x x x x x x x +15039 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW17.18, males Morphology, metabolism: Body weight gain between 17 and 18 weeks in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.696 1.309 1.51 1.428 1.179 x 1.399 1.286 x 1.821 x x 1.276 x 1.65 x x x x x x 1.528 x x 1.726 x x x 1.547 1.179 1.367 x x x x 1.179 1.821 1.588 x 1.677 1.662 x x x x x x x 1.623 x x x x x x x x x 1.331 1.776 x x x x x 1.748 1.821 x x x 1.179 x 1.43 x x x x x x x x x x 1.474 1.318 x x 1.775 x x x x x 1.821 x x x x x x x +15040 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW18.19, males Morphology, metabolism: Body weight gain between 18 and 19 weeks in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.519 1.616 1.45 1.506 1.641 x 1.566 2.016 x 2.016 x x 1.45 x 2.016 x x x x x x 1.657 x x 1.45 x x x 2.011 1.561 1.882 x x x x 1.664 1.782 1.732 x 1.624 1.654 x x x x x x x 1.924 x x x x x x x x x 1.609 2.016 x x x x x 1.472 1.513 x x x 1.655 x 1.62 x x x x x x x x x x 1.45 1.634 x x 1.502 x x x x x 1.938 x x x x x x x +15041 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW19.20, males Morphology, metabolism: Body weight gain between 19 and 20 weeks in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.889 1.758 2.032 1.584 1.559 x 1.593 2.032 x 1.886 x x 1.598 x 1.818 x x x x x x 1.721 x x 1.782 x x x 2.032 1.688 1.459 x x x x 1.459 1.784 1.882 x 1.535 1.708 x x x x x x x 1.886 x x x x x x x x x 1.621 1.459 x x x x x 1.712 2.032 x x x 1.883 x 1.794 x x x x x x x x x x 1.459 1.612 x x 2.014 x x x x x 1.705 x x x x x x x +15042 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BL42_6, males Morphology, metabolism: Body length from the nose until the tail at 42 days in males on high fat diet (45% energy from fat) feeding from 4 weeks on [cm] x 6.487 6.488 6.366 6.403 6.488 x 6.421 6.43 x 6.384 x x 6.488 6.392 6.484 x x x x x x 6.406 x x 6.366 x x x 6.415 6.399 6.38 x x x x 6.443 6.438 6.375 x 6.462 6.314 x x x x x x x 6.473 x x x x x x x x x 6.314 6.426 x x x x x 6.402 6.314 x x x 6.34 x 6.426 x x x x x x x x x x 6.488 6.314 x x 6.413 x x x x x 6.452 x x x x x x x +15043 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BL70_10, males Morphology, metabolism: Body length from the nose until the tail at 70 days in males on high fat diet (45% energy from fat) feeding from 4 weeks on [cm] x 6.592 6.61 6.478 6.489 6.55 x 6.583 6.533 x 6.5 x x 6.61 6.566 6.597 x x x x x x 6.542 x x 6.539 x x x 6.577 6.518 6.508 x x x x 6.607 6.559 6.492 x 6.478 6.508 x x x x x x x 6.605 x x x x x x x x x 6.478 6.543 x x x x x 6.508 6.498 x x x 6.57 x 6.567 x x x x x x x x x x 6.61 6.478 x x 6.573 x x x x x 6.61 x x x x x x x +15044 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BL140_20, males Morphology, metabolism: Body length from the nose until the tail at 140 days in males on high fat diet (45% energy from fat) feeding from 4 weeks on [cm] x 6.647 6.672 6.611 6.577 6.647 x 6.687 6.577 x 6.658 x x 6.707 x 6.707 x x x x x x 6.632 x x 6.607 x x x 6.615 6.607 6.596 x x x x 6.707 6.674 6.58 x 6.689 6.579 x x x x x x x 6.646 x x x x x x x x x 6.577 6.665 x x x x x 6.658 6.607 x x x 6.649 x 6.624 x x x x x x x x x x 6.707 6.577 x x 6.67 x x x x x 6.702 x x x x x x x +15045 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Gluc70_10, males Morphology, metabolism: Serum glucose level at 70 days in males on high fat diet (45% energy from fat) feeding from 4 weeks on [mmol/l] x 6.511 6.579 6.408 6.681 6.747 x 6.389 6.389 x 6.409 x x 6.618 6.389 6.71 x x x x x x 6.389 x x 6.409 x x x 6.465 6.778 6.861 x x x x 6.592 6.822 6.495 x 6.473 6.634 x x x x x x x 6.861 x x x x x x x x x 6.79 6.43 x x x x x 6.766 6.861 x x x 6.861 x 6.524 x x x x x x x x x x 6.52 6.806 x x 6.545 x x x x x 6.757 x x x x x x x +15046 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Gluc140_20, males Morphology, metabolism: Serum glucose level at 140 days in males on high fat diet (45% energy from fat) feeding from 4 weeks on [mmol/l] x 6.778 6.594 6.426 6.931 6.664 x 6.392 6.833 x 6.392 x x 7.006 x 6.392 x x x x x x 6.667 x x 6.94 x x x 6.777 6.508 6.421 x x x x 7.017 7.025 6.52 x 6.392 6.448 x x x x x x x 6.714 x x x x x x x x x 6.458 6.392 x x x x x 6.618 7.025 x x x 7.025 x 6.866 x x x x x x x x x x 7.025 6.888 x x 6.618 x x x x x 6.691 x x x x x x x +15047 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FoodIntake7.10, males Morphology, metabolism: Food Intake between 7 and 10 weeks in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.511 1.549 1.433 1.504 1.679 x 1.475 1.611 x 1.724 x x 1.75 1.891 1.743 x x x x x x 1.469 x x 1.672 x x x 1.668 1.549 1.634 x x x x 1.729 1.891 1.433 x 1.889 1.48 x x x x x x x 1.664 x x x x x x x x x 1.433 1.629 x x x x x 1.692 1.891 x x x 1.79 x 1.676 x x x x x x x x x x 1.803 1.541 x x 1.433 x x x x x 1.891 x x x x x x x +15048 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FoodIntake17.20, males Metabolism: Food intake between 17 and 20 weeks in males on a high fat diet (45% energy from fat, Ssniff(R) diet S8074-E010, Germany) initiated at 4 weeks [g/day] x 1.485 1.67 1.592 1.473 1.79 x 1.735 1.708 x 1.876 x x 2.06 x 1.791 x x x x x x 1.473 x x 1.928 x x x 1.723 1.588 1.626 x x x x 1.774 1.815 1.548 x 1.783 1.601 x x x x x x x 1.794 x x x x x x x x x 1.473 1.792 x x x x x 1.585 2.06 x x x 1.996 x 1.712 x x x x x x x x x x 2.06 1.473 x x 2.06 x x x x x 1.844 x x x x x x x +15049 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Brain, males Morphology, metabolism: Brain weight at 20 weeks in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.287 1.289 1.257 1.279 1.268 x 1.257 1.273 x 1.267 x x 1.282 1.282 1.289 x x x x x x 1.257 x x 1.257 x x x 1.277 1.259 1.274 x x x x 1.286 1.271 1.276 x 1.289 1.268 x x x x x x x 1.286 x x x x x x x x x 1.26 1.28 x x x x x 1.279 1.284 x x x 1.279 x 1.271 x x x x x x x x x x 1.289 1.261 x x 1.267 x x x x x 1.271 x x x x x x x +15050 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Liver, males Morphology, metabolism: Liver weight at 20 weeks in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 0.345 0.614 0.466 0.202 0.793 x 0.562 0.586 x 0.601 x x 1.082 0.202 0.952 x x x x x x 0.202 x x 0.902 x x x 0.564 0.503 0.202 x x x x 0.35 1.082 0.435 x 1.082 0.445 x x x x x x x 0.685 x x x x x x x x x 0.425 1.082 x x x x x 0.541 0.842 x x x 0.596 x 0.817 x x x x x x x x x x 1.019 0.225 x x 0.935 x x x x x 0.588 x x x x x x x +15051 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Kidney, males Morphology, metabolism: Kidney weight at 20 weeks in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.286 1.235 1.327 1.235 1.286 x 1.241 1.302 x 1.252 x x 1.335 1.242 1.264 x x x x x x 1.246 x x 1.286 x x x 1.245 1.335 1.268 x x x x 1.307 1.308 1.252 x 1.323 1.235 x x x x x x x 1.32 x x x x x x x x x 1.258 1.302 x x x x x 1.27 1.335 x x x 1.335 x 1.296 x x x x x x x x x x 1.322 1.235 x x 1.31 x x x x x 1.273 x x x x x x x +15052 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Spleen, males Morphology, metabolism: Spleen weight at 20 weeks in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.041 1.074 1.049 1.059 1.081 x 1.081 1.052 x 1.041 x x 1.081 1.041 1.081 x x x x x x 1.045 x x 1.067 x x x 1.065 1.067 1.05 x x x x 1.045 1.08 1.041 x 1.062 1.066 x x x x x x x 1.064 x x x x x x x x x 1.044 1.057 x x x x x 1.067 1.048 x x x 1.056 x 1.065 x x x x x x x x x x 1.059 1.041 x x 1.059 x x x x x 1.072 x x x x x x x +15053 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Heart, males Morphology, metabolism: Heart weight at 20 weeks in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.101 1.101 1.103 1.089 1.097 x 1.098 1.104 x 1.099 x x 1.125 1.089 1.11 x x x x x x 1.089 x x 1.125 x x x 1.096 1.096 1.092 x x x x 1.125 1.12 1.116 x 1.109 1.097 x x x x x x x 1.098 x x x x x x x x x 1.089 1.103 x x x x x 1.095 1.109 x x x 1.116 x 1.097 x x x x x x x x x x 1.125 1.092 x x 1.112 x x x x x 1.108 x x x x x x x +15054 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Lung, males Morphology, metabolism: Lung weight at 20 weeks in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.156 1.132 1.119 1.119 1.146 x 1.142 1.124 x 1.126 x x 1.147 1.142 1.144 x x x x x x 1.123 x x 1.134 x x x 1.134 1.149 1.132 x x x x 1.157 1.157 1.141 x 1.157 1.134 x x x x x x x 1.119 x x x x x x x x x 1.132 1.136 x x x x x 1.157 1.138 x x x 1.139 x 1.139 x x x x x x x x x x 1.132 1.119 x x 1.135 x x x x x 1.155 x x x x x x x +15055 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Pancreas, males Morphology, metabolism: Pancreas weight at 20 weeks in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.145 1.169 1.151 1.145 1.163 x 1.163 1.239 x 1.181 x x 1.24 1.19 1.206 x x x x x x 1.166 x x 1.153 x x x 1.166 1.164 1.159 x x x x 1.202 1.24 1.145 x 1.148 1.193 x x x x x x x 1.203 x x x x x x x x x 1.153 1.24 x x x x x 1.189 1.183 x x x 1.161 x 1.162 x x x x x x x x x x 1.24 1.16 x x 1.145 x x x x x 1.233 x x x x x x x +15056 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Testis, males Urogenital system, reproduction, morphology, metabolism: Testis weight at 20 weeks in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.175 1.143 1.154 1.107 1.157 x 1.175 1.145 x 1.138 x x 1.107 1.164 1.165 x x x x x x 1.156 x x 1.143 x x x 1.126 1.165 1.163 x x x x 1.107 1.175 1.107 x 1.108 1.163 x x x x x x x 1.122 x x x x x x x x x 1.154 1.124 x x x x x 1.135 1.175 x x x 1.143 x 1.147 x x x x x x x x x x 1.171 1.115 x x 1.124 x x x x x 1.145 x x x x x x x +15057 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Muscle.femoralis, males Morphology, metabolism: The quadriceps (musculus rectus femulus, musculus vastus intermedius, musculus vastus lateralis, musculus vastus medialis) weight at 20 weeks in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.229 1.241 1.212 1.212 1.245 x 1.25 1.22 x 1.231 x x 1.27 1.27 1.27 x x x x x x 1.204 x x 1.225 x x x 1.211 1.204 1.259 x x x x 1.259 1.254 1.233 x 1.233 1.249 x x x x x x x 1.259 x x x x x x x x x 1.204 1.27 x x x x x 1.258 1.217 x x x 1.235 x 1.245 x x x x x x x x x x 1.235 1.204 x x 1.212 x x x x x 1.254 x x x x x x x +15058 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); M.longissimus.dorsi, males Morphology, metabolism: Muscle, Longissmus dorsi weight at 20 weeks in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.381 1.38 1.313 1.313 1.387 x 1.402 1.366 x 1.423 x x 1.423 1.38 1.366 x x x x x x 1.337 x x 1.321 x x x 1.39 1.321 1.37 x x x x 1.385 1.402 1.395 x 1.379 1.368 x x x x x x x 1.377 x x x x x x x x x 1.313 1.423 x x x x x 1.39 1.332 x x x 1.356 x 1.362 x x x x x x x x x x 1.367 1.313 x x 1.343 x x x x x 1.423 x x x x x x x +15059 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); RepF, males Morphology, metabolism: Reproductive adipose tissue weight at 20 weeks (epididymal adipose tissue in males and the periuterine and the periovarian adipose tissues in females) in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.716 1.868 1.744 1.479 1.496 x 1.479 1.969 x 2.234 x x 1.864 1.683 2.234 x x x x x x 1.846 x x 1.991 x x x 2.011 1.767 1.618 x x x x 1.799 2.234 1.771 x 1.738 1.699 x x x x x x x 2.005 x x x x x x x x x 1.479 2.234 x x x x x 1.877 1.966 x x x 1.626 x 1.811 x x x x x x x x x x 2.08 1.479 x x 2.081 x x x x x 1.753 x x x x x x x +15060 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); PerF, males Morphology, metabolism: Retroperitoneal adipose tissue weight at 20 weeks in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.172 1.245 1.229 1.13 1.13 x 1.135 1.295 x 1.341 x x 1.271 1.185 1.341 x x x x x x 1.242 x x 1.302 x x x 1.341 1.156 1.143 x x x x 1.17 1.341 1.157 x 1.185 1.215 x x x x x x x 1.298 x x x x x x x x x 1.136 1.335 x x x x x 1.229 1.25 x x x 1.137 x 1.13 x x x x x x x x x x 1.289 1.13 x x 1.161 x x x x x 1.225 x x x x x x x +15061 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); RenF, males Morphology, metabolism: Peritoneal adipose tissue weight at 20 weeks in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.068 1.077 1.07 1.053 1.053 x 1.053 1.147 x 1.316 x x 1.316 1.065 1.296 x x x x x x 1.096 x x 1.156 x x x 1.094 1.114 1.12 x x x x 1.06 1.204 1.053 x 1.058 1.056 x x x x x x x 1.185 x x x x x x x x x 1.057 1.316 x x x x x 1.181 1.108 x x x 1.149 x 1.067 x x x x x x x x x x 1.316 1.065 x x 1.141 x x x x x 1.15 x x x x x x x +15062 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Total.RenF, males Morphology, metabolism: Total retroperitoneal and peritneal adipose tissue weight at 20 weeks in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.233 1.309 1.288 1.175 1.175 x 1.175 1.416 x 1.599 x x 1.546 1.242 1.599 x x x x x x 1.323 x x 1.43 x x x 1.416 1.259 1.252 x x x x 1.223 1.599 1.19 x 1.236 1.263 x x x x x x x 1.45 x x x x x x x x x 1.188 1.599 x x x x x 1.385 1.341 x x x 1.273 x 1.175 x x x x x x x x x x 1.555 1.188 x x 1.287 x x x x x 1.355 x x x x x x x +15063 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); MesF, males Morphology, metabolism: Adipose tissue hanging at the intestine in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.296 1.275 1.258 1.208 1.247 x 1.231 1.379 x 1.527 x x 1.585 1.214 1.585 x x x x x x 1.286 x x 1.49 x x x 1.462 1.292 1.208 x x x x 1.274 1.585 1.222 x 1.288 1.208 x x x x x x x 1.535 x x x x x x x x x 1.236 1.479 x x x x x 1.482 1.457 x x x 1.382 x 1.236 x x x x x x x x x x 1.585 1.208 x x 1.478 x x x x x 1.436 x x x x x x x +15064 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); IngF, males Morphology, metabolism: Inguinal adipose tissue weight at 20 weeks in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.309 1.437 1.424 1.255 1.382 x 1.333 1.44 x 1.791 x x 1.781 1.293 1.791 x x x x x x 1.487 x x 1.63 x x x 1.631 1.317 1.255 x x x x 1.359 1.791 1.367 x 1.565 1.314 x x x x x x x 1.401 x x x x x x x x x 1.255 1.67 x x x x x 1.683 1.535 x x x 1.339 x 1.346 x x x x x x x x x x 1.791 1.255 x x 1.599 x x x x x 1.464 x x x x x x x +15065 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); GlutF, males Morphology, metabolism: Subcutaneous adipose tissue upon the gluteal Mucsculus maximus between the legs, left and right of the tail in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.197 1.344 1.34 1.16 1.225 x 1.19 1.368 x 1.311 x x 1.392 1.335 1.41 x x x x x x 1.402 x x 1.507 x x x 1.507 1.249 1.16 x x x x 1.228 1.337 1.303 x 1.485 1.31 x x x x x x x 1.187 x x x x x x x x x 1.16 1.507 x x x x x 1.366 1.398 x x x 1.215 x 1.264 x x x x x x x x x x 1.421 1.16 x x 1.507 x x x x x 1.299 x x x x x x x +15066 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); SubF, males Morphology, metabolism: Total subcutaneous adipose tissue weight at 20 weeks in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.926 2.173 2.103 1.749 2.008 x 1.908 2.242 x 2.753 x x 2.729 1.903 2.753 x x x x x x 2.182 x x 2.609 x x x 2.534 1.945 1.749 x x x x 1.99 2.753 2.106 x 2.475 1.86 x x x x x x x 2.132 x x x x x x x x x 1.749 2.699 x x x x x 2.458 2.375 x x x 1.963 x 2.066 x x x x x x x x x x 2.753 1.749 x x 2.663 x x x x x 2.22 x x x x x x x +15067 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); WAT, males Morphology, metabolism: White adipose weight, total of whole body, at 20 weeks in males on a high fat diet (45% energy from fat) initiated at 4 weeks [g] x 2.073 2.428 2.267 1.716 1.927 x 1.738 2.706 x 3.293 x x 3.194 1.941 3.293 x x x x x x 2.437 x x 3.005 x x x 2.97 2.17 1.716 x x x x 2.165 3.293 2.238 x 2.608 2.036 x x x x x x x 2.702 x x x x x x x x x 1.716 3.293 x x x x x 2.828 2.784 x x x 2.128 x 2.195 x x x x x x x x x x 3.287 1.716 x x 3.044 x x x x x 2.539 x x x x x x x +15068 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BAT, males Morphology, metabolism: Brown adipose tissue located on the back, along the upper half of the spine and toward the shoulders in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.149 1.143 1.154 1.106 1.183 x 1.138 1.312 x 1.313 x x 1.384 1.106 1.384 x x x x x x 1.158 x x 1.212 x x x 1.233 1.198 1.106 x x x x 1.117 1.384 1.158 x 1.193 1.197 x x x x x x x 1.197 x x x x x x x x x 1.132 1.298 x x x x x 1.181 1.218 x x x 1.169 x 1.143 x x x x x x x x x x 1.384 1.106 x x 1.195 x x x x x 1.25 x x x x x x x +15069 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Carcass, males Morphology, metabolism: Skeleton with muscle (excluding the Longissmus dorsi and femoral muscle) weight at 20 weeks in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 3.338 3.506 3.106 3.092 3.337 x 3.425 3.284 x 3.311 x x 3.517 3.396 3.44 x x x x x x 3.091 x x 3.394 x x x 3.36 3.172 3.261 x x x x 3.488 3.517 3.091 x 3.498 3.281 x x x x x x x 3.344 x x x x x x x x x 3.091 3.517 x x x x x 3.343 3.248 x x x 3.273 x 3.32 x x x x x x x x x x 3.507 3.091 x x 3.374 x x x x x 3.517 x x x x x x x +15070 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Hor_Resistin, males Morphology, metabolism: Serum level of resistin at 20 weeks in males on high fat diet (45% energy from fat) feeding from 4 weeks on [pg/ml] x 2725.88 2423.4 1868.42 2485.18 2610.99 x 1880.06 2113.04 x 3703.85 x x 2630.38 2258.24 3448.68 x x x x x x 2823.34 x x 3194.58 x x x 3137.04 1568.2 3703.85 x x x x 2136.98 3135.45 3185.19 x 2544.43 2417.36 x x x x x x x 2576.26 x x x x x x x x x 1568.2 2139.48 x x x x x 3703.85 1982.69 x x x 2102.79 x 1568.2 x x x x x x x x x x 3703.85 1568.2 x x 2273.27 x x x x x 2622.8 x x x x x x x +15071 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Hor_Insulin, males Morphology, metabolism: Serum level of insulin at 20 weeks in males on high fat diet (45% energy from fat) feeding from 4 weeks on [pg/ml] x 1678.25 1013.47 1254.75 1013.47 2317.6 x 1959.96 2383.44 x 2393.53 x x 3977.62 2219.9 3067.39 x x x x x x 2120.35 x x 4213.13 x x x 1313.71 1574.32 2027.41 x x x x 1831.03 4213.13 1509.44 x 1599.43 1820.81 x x x x x x x 1335.32 x x x x x x x x x 1396.92 3305.29 x x x x x 1425.11 4213.13 x x x 1726.51 x 1013.47 x x x x x x x x x x 4213.13 1013.47 x x 1898.41 x x x x x 1980.55 x x x x x x x +15072 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Hor_Leptin, males Morphology, metabolism: Serum level of leptin at 20 weeks in males on high fat diet (45% energy from fat) feeding from 4 weeks on [pg/ml] x 4894.75 13548.2 5880.08 3538.04 7614.48 x 3538.04 7985.99 x 15455.4 x x 11927.5 3902.77 16119.4 x x x x x x 8604.11 x x 16119.4 x x x 14856.0 4234.93 4388.05 x x x x 3538.04 16119.4 6311.42 x 7823.96 5657.44 x x x x x x x 6314.4 x x x x x x x x x 9088.7 14889.8 x x x x x 14755.1 16119.4 x x x 5336.81 x 8059.42 x x x x x x x x x x 13773.7 3538.04 x x 9077.01 x x x x x 6597.1 x x x x x x x +15073 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Hor_IL1B, males Morphology, metabolism: Serum level of Interleukin 1 beta at 20 weeks in males on high fat diet (45% energy from fat) feeding from 4 weeks on [pg/ml] x 2.84 67.233 4.924 1.982 18.758 x 22.695 1.982 x 33.24 x x 1.982 8.293 23.486 x x x x x x 6.254 x x 67.233 x x x 1.982 12.946 9.896 x x x x 4.165 2.72 12.368 x 6.58 24.032 x x x x x x x 12.736 x x x x x x x x x 67.233 7.362 x x x x x 67.233 4.618 x x x 6.17 x 62.332 x x x x x x x x x x 2.765 9.436 x x 8.872 x x x x x 5.626 x x x x x x x +15074 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Hor_IL6, males Morphology, metabolism: Serum level of Interleukin 6 at 20 weeks in males on high fat diet (45% energy from fat) feeding from 4 weeks on [pg/ml] x 1.7 1.7 5.814 1.754 5.232 x 2.92 4.414 x 3.39 x x 1.7 1.7 2.706 x x x x x x 1.7 x x 1.7 x x x 1.7 3.758 4.88 x x x x 1.7 15.692 1.7 x 1.7 15.692 x x x x x x x 1.7 x x x x x x x x x 15.692 3.595 x x x x x 1.7 1.7 x x x 6.548 x 15.692 x x x x x x x x x x 4.27 1.7 x x 4.272 x x x x x 1.7 x x x x x x x +15075 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Hor_IL10, males Morphology, metabolism: Serum level of Interleukin 10 at 20 weeks in males on high fat diet (45% energy from fat) feeding from 4 weeks on [pg/ml] x 2.7 21.472 3.158 2.7 16.625 x 9.682 3.064 x 21.472 x x 2.7 2.7 3.284 x x x x x x 2.7 x x 4.303 x x x 3.178 5.144 2.7 x x x x 3.315 10.056 3.572 x 3.826 10.298 x x x x x x x 2.946 x x x x x x x x x 21.472 7.163 x x x x x 2.7 3.562 x x x 3.074 x 21.472 x x x x x x x x x x 2.7 3.058 x x 2.7 x x x x x 8.938 x x x x x x x +15076 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Hor_IL17, males Morphology, metabolism: Serum level of Interleukin 17 at 20 weeks in males on high fat diet (45% energy from fat) feeding from 4 weeks on [pg/ml] x 0.4 15.165 2.192 1.51 4.708 x 0.4 4.386 x 3.66 x x 0.4 0.4 0.4 x x x x x x 0.4 x x 4.362 x x x 9.214 1.244 0.4 x x x x 2.805 1.486 0.4 x 15.165 7.327 x x x x x x x 7.394 x x x x x x x x x 15.165 5.425 x x x x x 1.167 6.534 x x x 9.592 x 15.165 x x x x x x x x x x 0.4 2.464 x x 8.208 x x x x x 5.294 x x x x x x x +15077 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Hor_MCP1, males Morphology, metabolism: Serum level of monocyte chemoattractant protein 1 at 20 weeks in males on high fat diet (45% energy from fat) feeding from 4 weeks on [pg/ml] x 9.723 69.007 9.723 12.136 61.678 x 34.855 9.723 x 69.007 x x 24.162 23.988 38.392 x x x x x x 11.37 x x 69.007 x x x 36.952 17.048 30.512 x x x x 54.31 64.074 13.0 x 23.546 49.797 x x x x x x x 55.838 x x x x x x x x x 69.007 22.64 x x x x x 23.315 19.754 x x x 62.882 x 46.268 x x x x x x x x x x 9.723 43.748 x x 37.116 x x x x x 51.056 x x x x x x x +15078 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Hor_TNFa, males Morphology, metabolism: Serum level of tumor necrosis factor alpha at 20 weeks in males on high fat diet (45% energy from fat) feeding from 4 weeks on [pg/ml] x 0.9 6.392 2.898 1.842 1.475 x 4.407 1.736 x 6.392 x x 0.9 0.9 2.69 x x x x x x 1.518 x x 3.882 x x x 3.552 4.11 0.9 x x x x 4.075 5.3 0.9 x 2.93 3.69 x x x x x x x 4.35 x x x x x x x x x 6.392 2.0 x x x x x 2.215 2.11 x x x 5.478 x 6.392 x x x x x x x x x x 0.9 4.546 x x 3.592 x x x x x 4.468 x x x x x x x +15079 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); NeckF, males Morphology, metabolism: Fat weight around the neck at 20 weeks in males on a high fat diet (45% energy from fat, Ssniff(R) diet S8074-E010, Germany) initiated at 4 weeks [g] x 1.091 1.127 1.105 1.085 1.088 x 1.1 1.215 x 1.239 x x 1.227 1.093 1.187 x x x x x x 1.121 x x 1.239 x x x 1.239 1.09 1.085 x x x x 1.1 1.177 1.136 x 1.192 1.097 x x x x x x x 1.128 x x x x x x x x x 1.085 1.207 x x x x x 1.134 1.195 x x x 1.121 x 1.114 x x x x x x x x x x 1.231 1.085 x x 1.239 x x x x x 1.146 x x x x x x x +15080 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); AbdominalF, males Morphology, metabolism: Fat weight in the visceral organs (liver, lung) at 20 weeks in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.041 1.027 1.041 1.027 1.027 x 1.039 1.058 x 1.067 x x 1.092 1.027 1.102 x x x x x x 1.027 x x 1.029 x x x 1.102 1.048 1.033 x x x x 1.04 1.102 1.053 x 1.027 1.062 x x x x x x x 1.073 x x x x x x x x x 1.059 1.087 x x x x x 1.102 1.081 x x x 1.045 x 1.055 x x x x x x x x x x 1.07 1.031 x x 1.084 x x x x x 1.057 x x x x x x x +15081 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Res.SubF, males Morphology, metabolism: Residual subcutaneous fat weight at 20 weeks in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.329 1.323 1.372 1.274 1.409 x 1.287 1.526 x 1.904 x x 1.904 1.301 1.884 x x x x x x 1.411 x x 1.569 x x x 1.753 1.291 1.296 x x x x 1.424 1.904 1.429 x 1.425 1.274 x x x x x x x 1.581 x x x x x x x x x 1.274 1.904 x x x x x 1.731 1.585 x x x 1.386 x 1.495 x x x x x x x x x x 1.775 1.274 x x 1.657 x x x x x 1.44 x x x x x x x +15082 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FTIR_RepF_UnsatF, males Morphology, metabolism: Unsaturated fat content measured by Fourier Transform Infrared Spectroscopy (FTIR) in reproductive adipose tissue at 140 days in males on high fat diet (45% energy from fat) feeding from 4 weeks on [arbitrary unit] x 4.362 1.231 0.486 4.679 4.044 x 2.848 5.686 x 3.807 x x x 5.611 5.73 x x x x x x 5.04 x x 1.926 x x x 5.829 0.71 3.049 x x x x 5.571 0.845 0.86 x 1.599 2.049 x x x x x x x 5.557 x x x x x x x x x 5.798 2.69 x x x x x 5.493 0.236 x x x 5.305 x 1.492 x x x x x x x x x x 1.604 1.198 x x 6.262 x x x x x 6.735 x x x x x x x +15083 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FTIR_RepF_SatF, males Morphology, metabolism: Saturated fat content measured by Fourier Transform Infrared Spectroscopy (FTIR) in reproductive adipose tissue at 140 days in males on high fat diet (45% energy from fat) feeding from 4 weeks on [arbitrary unit] x 197.621 51.471 22.001 214.716 170.7 x 117.907 247.761 x 159.489 x x x 251.299 254.804 x x x x x x 219.035 x x 80.805 x x x 278.074 31.409 133.131 x x x x 244.641 35.758 36.398 x 65.636 89.993 x x x x x x x 268.285 x x x x x x x x x 250.695 116.944 x x x x x 245.671 10.801 x x x 235.027 x 62.718 x x x x x x x x x x 66.254 53.899 x x 278.587 x x x x x 295.375 x x x x x x x +15084 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FTIR_RepF_TotF, males Morphology, metabolism: Total fat content measured by Fourier Transform Infrared Spectroscopy (FTIR) in reproductive adipose tissue at 140 days in males on high fat diet (45% energy from fat) feeding from 4 weeks on [arbitrary unit] x 675.789 178.696 77.739 726.826 586.846 x 405.022 848.798 x 561.865 x x x 874.999 883.9 x x x x x x 756.547 x x 272.278 x x x 954.17 109.445 461.076 x x x x 849.712 124.605 126.146 x 224.75 308.771 x x x x x x x 923.461 x x x x x x x x x 873.463 400.136 x x x x x 848.967 38.493 x x x 795.886 x 216.189 x x x x x x x x x x 226.061 190.064 x x 956.162 x x x x x 1019.08 x x x x x x x +15085 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FTIR_RepF_acylchainlength, males Morphology, metabolism: Acyl chain length measured by Fourier Transform Infrared Spectroscopy (FTIR) in reproductive adipose tissue at 140 days in males on high fat diet (45% energy from fat) feeding from 4 weeks on [arbitrary unit] x 21.615 20.665 19.669 21.677 21.372 x 20.915 21.464 x 20.645 x x x 21.439 21.54 x x x x x x 21.359 x x 21.033 x x x 21.674 19.919 20.987 x x x x 21.373 20.24 20.693 x 20.223 20.772 x x x x x x x 21.841 x x x x x x x x x 21.498 20.976 x x x x x 21.67 19.418 x x x 21.405 x 20.484 x x x x x x x x x x 20.828 20.555 x x 21.648 x x x x x 21.528 x x x x x x x +15086 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FTIR_RepF_SatF.unsatF, males Morphology, metabolism: Ratio of saturated to unsaturated fat content measured by Fourier Transform Infrared Spectroscopy (FTIR) in reproductive adipose tissue at 140 days in males on high fat diet (45% energy from fat) feeding from 4 weeks on [arbitrary unit] x 45.305 41.806 45.264 45.887 42.216 x 41.398 43.577 x 41.895 x x x 44.789 44.468 x x x x x x 43.459 x x 41.964 x x x 47.704 44.221 43.659 x x x x 43.916 42.3 42.308 x 41.053 43.916 x x x x x x x 48.278 x x x x x x x x x 43.242 43.472 x x x x x 44.725 45.738 x x x 44.301 x 42.05 x x x x x x x x x x 41.305 44.99 x x 44.489 x x x x x 43.855 x x x x x x x +15087 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FTIR_RepF_lipid.prot, males Morphology, metabolism: Ratio of lipid to protein content measured by Fourier Transform Infrared Spectroscopy (FTIR) in reproductive adipose tissue at 140 days in males on high fat diet (45% energy from fat) feeding from 4 weeks on [arbitrary unit] x 200.454 12.598 5.615 71.244 56.64 x 41.585 344.076 x 39.421 x x x 449.242 423.808 x x x x x x 93.835 x x 19.003 x x x 294.583 7.121 33.561 x x x x 110.579 8.257 10.105 x 19.187 32.669 x x x x x x x 501.377 x x x x x x x x x 526.98 46.303 x x x x x 446.915 2.75 x x x 89.672 x 18.165 x x x x x x x x x x 14.735 20.604 x x 169.359 x x x x x 442.823 x x x x x x x +15088 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FTIR_RepF_Tot_lipid.Tot_prot, males Morphology, metabolism: Ratio of total lipid to total protein content measured by Fourier Transform Infrared Spectroscopy (FTIR) spectroscopy in reproductive adipose tissue at 140 days in males on high fat diet (45% energy from fat) feeding from 4 weeks on [arbitrary unit] x 264.241 37.798 17.987 154.153 130.753 x 102.647 317.003 x 99.082 x x x 387.808 348.275 x x x x x x 183.612 x x 54.369 x x x 315.125 22.33 87.43 x x x x 200.54 25.405 30.836 x 54.536 86.368 x x x x x x x 416.191 x x x x x x x x x 425.689 111.518 x x x x x 380.042 9.164 x x x 177.461 x 52.208 x x x x x x x x x x 43.407 58.577 x x 253.013 x x x x x 373.354 x x x x x x x +15089 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FTIR_RepF_collagen, males Morphology, metabolism: Collagen content measured by Fourier Transform Infrared Spectroscopy (FTIR) in reproductive adipose tissue at 140 days in males on high fat diet (45% energy from fat) feeding from 4 weeks on [arbitrary unit] x 1.277 0.345 0.174 1.345 1.076 x 0.799 1.597 x 1.028 x x x 1.528 1.563 x x x x x x 1.358 x x 0.532 x x x 1.682 0.237 0.872 x x x x 1.544 0.255 0.249 x 0.449 0.579 x x x x x x x 1.634 x x x x x x x x x 1.541 0.797 x x x x x 1.513 0.094 x x x 1.462 x 0.414 x x x x x x x x x x 0.438 0.362 x x 1.688 x x x x x 1.833 x x x x x x x +15090 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FTIR_RepF_collagenintegrity, males Morphology, metabolism: Collagen integrity measured by Fourier Transform Infrared Spectroscopy (FTIR) in reproductive adipose tissue at 140 days in males on high fat diet (45% energy from fat) feeding from 4 weeks on [arbitrary unit] x 0.806 12.488 19.586 2.297 2.967 x 3.741 0.475 x 4.298 x x x 0.259 0.41 x x x x x x 1.823 x x 8.209 x x x 0.587 19.466 4.839 x x x x 1.535 18.002 15.213 x 7.985 4.968 x x x x x x x 0.143 x x x x x x x x x 0.121 3.308 x x x x x 0.265 19.913 x x x 1.858 x 8.79 x x x x x x x x x x 10.695 7.75 x x 1.027 x x x x x 0.278 x x x x x x x +15091 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de), FTIR_liver_SatF, males Metabolism, liver: Saturated fat content measured by Fourier Transform Infrared Spectroscopy (FTIR) in liver at 140 days in males on high fat diet (45% energy from fat) feeding from 4 weeks on [arbitrary unit] x 0.986 1.254 0.946 1.205 0.951 x 0.927 0.898 x 0.911 x x 1.056 x 1.088 x x x x x x 0.873 x x 1.568 x x x 1.023 0.811 0.898 x x x x 0.771 1.395 1.209 x 1.29 0.913 x x x x x x x 1.428 x x x x x x x x x 1.397 0.965 x x x x x 0.943 1.716 x x x 0.903 x 1.374 x x x x x x x x x x 1.622 0.981 x x 1.32 x x x x x 1.32 x x x x x x x +15092 None Metabolism, liver: Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de), FTIR_liver_TotF, males Metabolism, liver: Total fat content measured by Fourier Transform Infrared Spectroscopy (FTIR) in liver at 140 days in males on high fat diet (45% energy from fat) feeding from 4 weeks on [arbitrary unit] x 2.228 2.746 2.199 2.592 2.279 x 2.139 2.183 x 2.193 x x 2.722 x 2.527 x x x x x x 2.128 x x 3.329 x x x 2.414 1.973 2.12 x x x x 1.988 3.072 2.665 x 2.812 2.091 x x x x x x x 3.138 x x x x x x x x x 3.124 2.208 x x x x x 2.238 3.785 x x x 2.153 x 2.994 x x x x x x x x x x 3.555 2.172 x x 2.833 x x x x x 2.833 x x x x x x x +15093 None Morphology, biochemistry: FTIR_liver_acylchainlength, males (contact Gudrun Brockmann at gudrun.brockmann@agrar.hu-berlin.de) Morphology, biochemistry: Acyl chain length measured by Fourier transform infrared spectroscopy (FTIR) in liver at 140 days in males on a high fat diet (45% energy from far) feeding from 4 weeks [arbitrary unit] x 7.701 11.015 9.621 12.957 10.758 x 9.844 10.524 x 9.765 x x 13.578 x 11.586 x x x x x x 9.344 x x 13.716 x x x 10.592 9.661 9.1 x x x x 9.077 13.646 12.202 x 10.328 9.012 x x x x x x x 13.759 x x x x x x x x x 12.996 9.264 x x x x x 9.472 14.752 x x x 9.165 x 11.762 x x x x x x x x x x 14.581 9.306 x x 10.325 x x x x x 10.325 x x x x x x x +15094 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de), FTIR_liver_lipid.prot, males Metabolism, liver: Ratio of lipid to protein content measured by Fourier Transform Infrared Spectroscopy (FTIR) in liver at 140 days in males on high fat diet (45% energy from fat) feeding from 4 weeks on [arbitrary unit] x 2.112 4.583 2.695 2.683 2.507 x 1.978 2.414 x 2.435 x x 5.442 x 4.407 x x x x x x 2.43 x x 6.032 x x x 3.218 1.989 1.8 x x x x 2.107 6.533 3.789 x 5.106 1.944 x x x x x x x 5.237 x x x x x x x x x 6.535 2.402 x x x x x 2.64 8.482 x x x 2.449 x 5.235 x x x x x x x x x x 7.109 2.058 x x 4.679 x x x x x 4.679 x x x x x x x +15095 None Metabolism, liver: Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de), FTIR_liver_Tot_lipid.Tot_prot, males Metabolism, liver: Ratio of total lipid to total protein content measured by Fourier Transform Infrared Spectroscopy (FTIR) in liver at 140 days in males on high fat diet (45% energy from fat) feeding from 4 weeks on [ratio] x 0.329 0.428 0.351 0.379 0.358 x 0.344 0.347 x 0.346 x x 0.448 x 0.423 x x x x x x 0.323 x x 0.51 x x x 0.366 0.318 0.335 x x x x 0.291 0.516 0.415 x 0.446 0.339 x x x x x x x 0.487 x x x x x x x x x 0.506 0.357 x x x x x 0.333 0.592 x x x 0.34 x 0.463 x x x x x x x x x x 0.551 0.339 x x 0.452 x x x x x 0.452 x x x x x x x +15096 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FTIR_liver_collagen, males Morphology, metabolism: Collagen content measured by Fourier Transform Infrared Spectroscopy (FTIR) in liver at 140 days in males on high fat diet (45% energy from fat) feeding from 4 weeks on [arbitrary unit] x 0.849 0.899 0.689 0.844 1.108 x 0.737 0.886 x 0.983 x x 0.977 x 1.17 x x x x x x 1.064 x x 0.722 x x x 0.731 0.606 1.124 x x x x 1.195 0.863 0.856 x 0.841 0.81 x x x x x x x 0.972 x x x x x x x x x 0.927 0.908 x x x x x 1.181 0.954 x x x 0.768 x 0.824 x x x x x x x x x x 1.204 0.857 x x 0.872 x x x x x 0.872 x x x x x x x +15097 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FTIR_liver_collagenintegrity, males Morphology, metabolism: Collagen integrity measured by Fourier Transform Infrared Spectroscopy (FTIR) in liver at 140 days in males on high fat diet (45% energy from fat) feeding from 4 weeks on [arbitrary unit] x 796.691 712.683 906.2 809.549 573.395 x 842.167 707.849 x 642.127 x x 619.983 x 509.584 x x x x x x 617.29 x x 901.257 x x x 900.579 1020.86 561.792 x x x x 545.778 687.567 749.413 x 746.889 759.493 x x x x x x x 660.556 x x x x x x x x x 663.385 679.4 x x x x x 548.141 641.78 x x x 822.573 x 782.529 x x x x x x x x x x 507.475 745.537 x x 717.526 x x x x x 717.526 x x x x x x x +15098 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FTIR_liver_glycogen, males Morphology, metabolism: Glycogen content measured by Fourier Transform Infrared Spectroscopy (FTIR) in liver at 140 days in males on high fat diet (45% energy from fat) feeding from 4 weeks on [arbitrary unit] x 1.491 2.134 1.916 1.885 2.355 x 2.219 2.215 x 2.798 x x 2.867 x 2.581 x x x x x x 2.071 x x 2.033 x x x 1.524 1.885 2.126 x x x x 1.248 2.249 2.37 x 1.828 2.262 x x x x x x x 2.732 x x x x x x x x x 2.271 2.649 x x x x x 1.819 2.464 x x x 2.246 x 1.6 x x x x x x x x x x 2.709 2.355 x x 2.19 x x x x x 2.19 x x x x x x x +15099 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FTIR_muscle_SatF, males Morphology, metabolism: Saturated fat content measured by Fourier Transform Infrared Spectroscopy (FTIR) in Muscle Femoralis at 140 days in males on high fat diet (45% energy from fat) feeding from 4 weeks on [arbitrary unit] x 1.946 0.807 1.022 1.91 1.234 x 1.559 2.349 x 3.41 x x 1.905 1.508 1.803 x x x x x x 1.485 x x 5.362 x x x 2.621 1.777 1.262 x x x x 1.556 2.299 1.716 x 1.918 1.27 x x x x x x x 3.951 x x x x x x x x x 2.364 1.144 x x x x x 2.635 1.789 x x x 1.692 x 2.594 x x x x x x x x x x 1.98 1.22 x x 3.406 x x x x x 1.673 x x x x x x x +15100 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FTIR_muscle_TotF, males Morphology, metabolism: Total fat content measured by Fourier Transform Infrared Spectroscopy (FTIR) in Muscle Femoralis at 140 days in males on high fat diet (45% energy from fat) feeding from 4 weeks on [arbitrary unit] x 3.12 1.483 1.796 2.965 1.988 x 2.581 3.768 x 5.572 x x 3.157 2.372 2.911 x x x x x x 2.38 x x 8.543 x x x 4.279 2.992 2.06 x x x x 2.57 3.643 2.911 x 3.042 2.124 x x x x x x x 6.262 x x x x x x x x x 3.843 1.894 x x x x x 4.186 2.882 x x x 2.744 x 4.105 x x x x x x x x x x 3.159 1.974 x x 5.441 x x x x x 2.663 x x x x x x x +15101 None Morphology, metabolism: Acyl chain length measured by Fourier transform infrared spectroscopy (FTIR) in Muscle Femoralis at 140 days in males on high fat diet (45% energy from fat) feeding from 4 weeks on [arbitrary unit] Morphology, metabolism: Acyl chain length measured by Fourier Transform Infrared Spectroscopy (FTIR) in Muscle Femoralis at 140 days in males on high fat diet (45% energy from fat) feeding from 4 weeks on [arbitrary unit] x 11.829 9.876 12.454 16.459 14.466 x 14.483 19.28 x 16.997 x x 19.926 14.469 15.72 x x x x x x 16.19 x x 20.423 x x x 16.643 15.405 12.06 x x x x 15.52 15.233 18.354 x 12.012 11.435 x x x x x x x 19.554 x x x x x x x x x 17.529 11.707 x x x x x 17.429 14.838 x x x 13.273 x 16.362 x x x x x x x x x x 15.657 11.092 x x 20.33 x x x x x 11.643 x x x x x x x +15102 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FTIR_muscle_lipid.prot, males Morphology, metabolism: Ratio of lipid to protein content measured by Fourier Transform Infrared Spectroscopy (FTIR) in Muscle Femoralis at 140 days in males on high fat diet (45% energy from fat) feeding from 4 weeks on [arbitrary unit] x 0.091 0.058 0.065 0.076 0.055 x 0.09 0.115 x 0.194 x x 0.105 0.061 0.088 x x x x x x 0.064 x x 0.292 x x x 0.16 0.114 0.056 x x x x 0.081 0.107 0.103 x 0.091 0.075 x x x x x x x 0.206 x x x x x x x x x 0.128 0.065 x x x x x 0.129 0.105 x x x 0.088 x 0.126 x x x x x x x x x x 0.089 0.052 x x 0.169 x x x x x 0.08 x x x x x x x +15103 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FTIR_muscle_Tot_lipid.Tot_prot, males Morphology, metabolism: Ratio of total lipid to total protein content measured by Fourier Transform Infrared Spectroscopy (FTIR) in Muscle Femoralis at 140 days in males on high fat diet (45% energy from fat) feeding from 4 weeks on [arbitrary unit] x 0.451 0.249 0.301 0.398 0.296 x 0.41 0.525 x 0.788 x x 0.451 0.315 0.408 x x x x x x 0.318 x x 1.193 x x x 0.672 0.492 0.286 x x x x 0.373 0.501 0.441 x 0.445 0.352 x x x x x x x 0.883 x x x x x x x x x 0.544 0.33 x x x x x 0.57 0.486 x x x 0.426 x 0.589 x x x x x x x x x x 0.427 0.276 x x 0.733 x x x x x 0.406 x x x x x x x +15104 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FTIR_muscle_collagen, males Morphology, metabolism: Collagen content measured by Fourier Transform Infrared Spectroscopy (FTIR) in Muscle Femoralis at 140 days in males on high fat diet (45% energy from fat) feeding from 4 weeks on [arbitrary unit] x 9.794 7.436 7.637 6.02 4.594 x 6.113 7.21 x 6.734 x x 3.652 2.779 5.329 x x x x x x 4.2 x x 8.987 x x x 7.602 8.404 4.114 x x x x 5.393 4.456 7.783 x 5.658 5.788 x x x x x x x 8.114 x x x x x x x x x 5.999 5.55 x x x x x 4.69 6.337 x x x 7.219 x 6.349 x x x x x x x x x x 5.537 5.033 x x 8.831 x x x x x 6.013 x x x x x x x +15105 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FTIR_muscle_collagenintegrity, males Morphology, metabolism: Collagen integrity measured by Fourier Transform Infrared Spectroscopy (FTIR) in Muscle Femoralis at 140 days in males on high fat diet (45% energy from fat) feeding from 4 weeks on [arbitrary unit] x 69.572 78.909 77.102 122.609 145.155 x 101.81 98.538 x 103.946 x x 190.453 204.086 132.905 x x x x x x 177.059 x x 78.557 x x x 82.741 71.358 173.799 x x x x 126.647 161.944 83.794 x 119.626 103.332 x x x x x x x 86.335 x x x x x x x x x 116.751 102.465 x x x x x 155.444 92.477 x x x 88.11 x 108.664 x x x x x x x x x x 132.407 140.767 x x 82.924 x x x x x 108.001 x x x x x x x +15106 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FTIR_muscle_glycogen, males Morphology, metabolism: Glycogen content measured by Fourier Transform Infrared Spectroscopy (FTIR) in Muscle Femoralis at 140 days in males on high fat diet (45% energy from fat) feeding from 4 weeks on [arbitrary unit] x 0.622 0.71 0.728 1.375 1.475 x 0.816 1.583 x 1.148 x x 2.674 1.694 1.561 x x x x x x 1.797 x x 1.226 x x x 0.718 0.7 1.23 x x x x 1.699 1.174 0.678 x 0.778 0.7 x x x x x x x 1.547 x x x x x x x x x 1.661 0.684 x x x x x 1.559 0.794 x x x 0.727 x 1.11 x x x x x x x x x x 1.188 0.792 x x 1.507 x x x x x 0.811 x x x x x x x +15107 None Immunophenotyping, Adler (thure.adler@helmholtz-muenchen.de), CD3+, frequency of CD45+ Immune function: CD45 cells as a percentage of CD3 cells in peripheral blood measured by fluorescence activated cell sorting (FACS) [%] x 24.0 21.5333 24.775 24.3 11.566 x x 21.625 x 33.0545 x 15.6075 10.7267 28.6375 25.7125 x x x 23.8667 x x x 21.4333 x x x x x 16.9833 22.5667 27.2 x x x x x 25.1444 20.875 x 32.6 19.425 x x x x x x x 33.0 x x x 12.8889 x x x x x 24.025 44.025 x x x x x x 19.55 x x x 23.15 x 21.025 x x x x x x x x x x 10.99 21.85 x x 15.0333 x x x x x 13.96 x x x x x x x +15108 None Immunophenotyping, Adler (thure.adler@helmholtz-muenchen.de), CD3+ CD4+, frequency of CD45+ Immune system: CD45-positive cells as a percentage of CD3 CD4-positive cells in peripheral blood measured by fluorescence activated cell sorting (FACS) [%] x 13.3 11.2867 18.15 16.8625 8.536 x x 9.52 x 18.9545 x 12.4 8.17833 17.7875 13.8875 x x x 17.7667 x x x 11.975 x x x x x 8.75 14.1 16.7333 x x x x x 16.1667 12.3575 x 22.86 13.525 x x x x x x x 23.2 x x x 8.63556 x x x x x 16.8875 22.85 x x x x x x 11.5533 x x x 15.0 x 12.15 x x x x x x x x x x 6.1425 15.0 x x 8.89 x x x x x 8.68 x x x x x x x +15109 None Immunophenotyping, Adler (thure.adler@helmholtz-muenchen.de), CD3+ CD8a+, frequency of CD45+ Immune function: CD45 cells as a percentage of CD3 CD8a cells in peripheral blood measured by fluorescence activated cell sorting (FACS) [%] x 10.4 9.53 8.1525 7.785 5.29 x x 11.265 x 14.3182 x 6.3975 2.975 10.5375 12.255 x x x 8.34 x x x 9.395 x x x x x 8.68667 9.21 10.0467 x x x x x 9.78 8.05125 x 11.698 5.035 x x x x x x x 9.35 x x x 5.70778 x x x x x 7.31 19.075 x x x x x x 7.80667 x x x 7.9975 x 7.235 x x x x x x x x x x 4.77 7.06167 x x 6.60333 x x x x x 5.504 x x x x x x x +15110 None Immunophenotyping, Adler (thure.adler@helmholtz-muenchen.de), CD25+, frequency of CD4+CD3+ Immune function: CD4 CD3 cells as a percentage of CD25 cell in peripheral blood measured by fluorescence activated cell sorting (FACS) [%] x 5.31 5.81667 6.1575 2.98875 8.886 x x 3.9425 x 3.08818 x 8.2325 5.29833 3.76875 4.7575 x x x 6.21 x x x 5.345 x x x x x 6.39167 9.63 2.75 x x x x x 4.10444 3.0175 x 3.138 4.0825 x x x x x x x 3.11 x x x 5.63 x x x x x 5.30875 6.2775 x x x x x x 8.625 x x x 3.6525 x 4.5925 x x x x x x x x x x 7.3625 8.38667 x x 6.73 x x x x x 8.112 x x x x x x x +15111 None Immunophenotyping, Adler (thure.adler@helmholtz-muenchen.de), CD3+ gammadelta TCR+, frequency of CD45+ Immune function: CD45 cells as a percentage of CD3gammadelta TCR cells peripheral blood measured by fluorescence activated cell sorting (FACS) [%] x 0.711 0.559333 0.67225 0.494 0.5372 x x 1.3225 x 0.549182 x 0.754 0.712167 0.80975 0.824375 x x x 0.402 x x x 0.988167 x x x x x 0.656 0.921333 0.595 x x x x x 0.728889 0.685625 x 0.9504 0.75525 x x x x x x x 1.23 x x x 0.451444 x x x x x 1.27625 1.86 x x x x x x 0.437333 x x x 0.64975 x 1.675 x x x x x x x x x x 0.57875 0.668167 x x 0.697 x x x x x 0.4862 x x x x x x x +15112 None Immunophenotyping, Adler (thure.adler@helmholtz-muenchen.de), Ly6C+, frequency of CD4+CD3+ Immune system: CD4 CD3 cells as a percentage of Ly6C cells in peripheral blood measured by fluorescence activated cell sorting (FACS) [%] x 16.0 27.3667 22.6 32.9625 7.028 x x 11.75 x 2.95909 x 14.2875 13.6667 14.125 9.51125 x x x 7.29 x x x 10.32 x x x x x 11.55 26.1 5.04 x x x x x 19.2889 21.4125 x 21.48 8.9375 x x x x x x x 11.6 x x x 21.5333 x x x x x 28.7 32.675 x x x x x x 20.0833 x x x 6.1775 x 28.125 x x x x x x x x x x 12.325 25.2833 x x 18.5667 x x x x x 13.06 x x x x x x x +15113 None Immunophenotyping, Adler (thure.adler@helmholtz-muenchen.de), CD62L+, frequency of CD4+CD3+ Immune function: CD4 CD3 cells as a percentage of CD62L cells in peripheral blood measured by fluorescence activated cell sorting (FACS) [%] x 64.4 58.8667 42.675 75.05 36.98 x x 32.1 x 60.8727 x 26.3 45.95 70.7125 57.3 x x x 38.7 x x x 27.3333 x x x x x 61.4333 33.0 45.5333 x x x x x 61.0778 74.9875 x 54.24 44.175 x x x x x x x 61.9 x x x 31.9222 x x x x x 43.8625 64.3 x x x x x x 44.1 x x x 48.9 x 49.475 x x x x x x x x x x 16.6 56.15 x x 53.3333 x x x x x 40.94 x x x x x x x +15114 None Immunophenotyping, Adler (thure.adler@helmholtz-muenchen.de), CD44+, frequency of CD4+CD3+ Immune function: CD4 CD3 cells as a percentage of CD44 cells in peripheral blood measured by fluorescence activated cell sorting (FACS) [%] x 78.0 79.4333 68.525 66.9375 80.22 x x 81.925 x 79.4273 x 83.525 78.3167 65.25 79.95 x x x 74.2 x x x 78.65 x x x x x 75.3167 79.3 67.7667 x x x x x 66.2556 84.2875 x 75.24 60.775 x x x x x x x 58.6 x x x 86.5889 x x x x x 79.475 68.35 x x x x x x 73.45 x x x 72.25 x 65.4 x x x x x x x x x x 75.8 81.8 x x 79.0 x x x x x 65.44 x x x x x x x +15115 None Immunophenotyping, Adler (thure.adler@helmholtz-muenchen.de), CD44+CD62L-, frequency of CD4+CD3+ Immune function: CD4 CD3 cells as a percentage of CD44 cells without CD62L cells in peripheral blood measured by fluorescence activated cell sorting (FACS) [%] x 28.6 33.4 41.3 18.5125 51.5 x x 56.3 x 31.4545 x 60.825 44.4167 20.2375 35.4125 x x x 46.7 x x x 57.2333 x x x x x 31.35 53.3 38.5333 x x x x x 27.9778 21.825 x 34.8 35.85 x x x x x x x 24.6 x x x 58.5 x x x x x 44.975 26.15 x x x x x x 42.75 x x x 39.3 x 34.7 x x x x x x x x x x 62.65 36.7833 x x 38.8333 x x x x x 39.84 x x x x x x x +15116 None Immunophenotyping, Adler (thure.adler@helmholtz-muenchen.de), CD44-CD62L+, frequency of CD4+CD3+ Immune function: CD4 CD3 cells as a percentage of CD62L cells without CD44 cells in peripheral blood measured by fluorescence activated cell sorting (FACS) [%] x 15.4 13.4633 16.1 27.3375 8.444 x x 6.575 x 12.91 x 3.7775 12.3217 25.7 12.9062 x x x 11.4733 x x x 5.94 x x x x x 17.85 7.53667 16.3667 x x x x x 23.2889 12.9625 x 14.076 19.325 x x x x x x x 28.2 x x x 4.17111 x x x x x 9.87375 23.0 x x x x x x 13.8817 x x x 15.9 x 19.54 x x x x x x x x x x 3.66 11.62 x x 13.6033 x x x x x 15.94 x x x x x x x +15117 None Immunophenotyping, Adler (thure.adler@helmholtz-muenchen.de), Ly6C+, frequency of CD8+CD3+ Immune function: CD8 CD3 cells as a percentage of Ly6C cells in peripheral blood measured by fluorescence activated cell sorting (FACS) [%] x 28.0 34.3 48.025 39.1625 64.26 x x 36.35 x 10.4955 x 46.375 49.5667 34.0625 28.425 x x x 49.1333 x x x 44.2 x x x x x 38.5 54.3333 20.8667 x x x x x 41.3333 36.6125 x 25.34 40.0 x x x x x x x 29.0 x x x 59.4222 x x x x x 25.55 43.65 x x x x x x 47.3667 x x x 37.925 x 21.65 x x x x x x x x x x 64.725 26.1833 x x 40.7333 x x x x x 52.58 x x x x x x x +15118 None Immunophenotyping, Adler (thure.adler@helmholtz-muenchen.de), CD62L+, frequency of CD8+CD3+ Immune function: CD8 CD3 cells as a percentage of CD62L cells in peripheral blood measured by fluorescence activated cell sorting (FACS) [%] x 83.1 74.5667 71.55 88.7875 73.18 x x 57.075 x 75.9273 x 61.825 72.6 89.0125 79.15 x x x 65.0333 x x x 42.0833 x x x x x 73.65 69.4 62.1 x x x x x 76.0556 87.8375 x 79.34 68.2 x x x x x x x 84.0 x x x 61.9 x x x x x 68.6375 76.55 x x x x x x 69.75 x x x 74.85 x 70.0 x x x x x x x x x x 56.5 79.45 x x 84.9333 x x x x x 75.72 x x x x x x x +15119 None Immunophenotyping, Adler (thure.adler@helmholtz-muenchen.de), CD44+, frequency of CD8+CD3+ Immune function: CD8 CD3 cells as a percentage of CD44 cells in peripheral blood measured by fluorescence activated cell sorting (FACS) [%] x 67.8 65.1667 59.1 61.675 79.32 x x 73.6 x 64.5545 x 68.925 74.1333 57.95 70.2375 x x x 65.8 x x x 58.4833 x x x x x 64.0333 69.0333 54.7333 x x x x x 61.0333 68.6125 x 61.4 58.5 x x x x x x x 53.4 x x x 72.1222 x x x x x 64.9125 59.675 x x x x x x 68.7 x x x 62.775 x 58.8 x x x x x x x x x x 70.175 67.2167 x x 70.9 x x x x x 76.56 x x x x x x x +15120 None Immune function: CD8+ CD3+ T cel lymphocytes as a percentage of CD44+ Ly6C+ cells in peripheral blood measured by fluorescence activated cell sorting (FACS) [%] Immune function: CD8+ CD3+ T cel lymphocytes as a percentage of CD44+ Ly6C+ cells in peripheral blood measured by fluorescence activated cell sorting (FACS) [%] x 21.2 25.5667 29.2 25.9875 52.36 x x 32.3 x 8.11727 x 32.8 41.7333 24.65 21.5 x x x 36.4333 x x x 30.0833 x x x x x 28.9 39.2333 13.8667 x x x x x 28.5889 27.9375 x 18.56 28.7 x x x x x x x 18.7 x x x 42.6556 x x x x x 17.7875 28.075 x x x x x x 34.8167 x x x 26.375 x 17.1 x x x x x x x x x x 49.475 17.21 x x 33.2667 x x x x x 39.8 x x x x x x x +15121 None Immunophenotyping, Adler (thure.adler@helmholtz-muenchen.de), CD44+62L-, frequency of CD8+CD3+ Immune function: CD8 CD3 cells as a percentage of CD44 cells excluding CD62L cells in peripheral blood measured by fluorescence activated cell sorting (FACS) [%] x 11.0 16.5967 16.65 6.61375 22.14 x x 28.875 x 14.6145 x 24.125 19.7333 6.675 13.4838 x x x 21.88 x x x 31.0167 x x x x x 16.7833 19.9667 20.4533 x x x x x 14.3011 8.7375 x 12.604 18.875 x x x x x x x 11.5 x x x 25.6333 x x x x x 21.225 15.4025 x x x x x x 20.005 x x x 15.4 x 17.59 x x x x x x x x x x 26.725 13.6633 x x 10.88 x x x x x 17.44 x x x x x x x +15122 None Immunophenotyping, Adler (thure.adler@helmholtz-muenchen.de), CD44-62L+, frequency of CD8+CD3+ Immune function: CD8 CD3 cells as a percentage of CD62L cells excluding CD44 cells in peripheral blood measured by fluorescence activated cell sorting (FACS) [%] x 26.0 25.7667 28.8 33.475 15.84 x x 12.1875 x 25.6364 x 16.9 18.25 37.475 22.175 x x x 20.9 x x x 14.6217 x x x x x 26.05 20.0667 27.7 x x x x x 29.1556 27.625 x 30.08 28.5 x x x x x x x 41.6 x x x 15.4 x x x x x 24.725 32.25 x x x x x x 20.95 x x x 27.3 x 28.75 x x x x x x x x x x 13.0475 25.7167 x x 24.7 x x x x x 16.64 x x x x x x x +15123 None Immunophenotyping, Adler (thure.adler@helmholtz-muenchen.de), GR-1++ CD11b+, frequency of CD45+ Immune function: CD45 cells as a percentage of GR-1 CD11b cells in peripheral blood measured by fluorescence activated cell sorting (FACS) [%] x 8.54 9.51 26.35 7.0825 24.34 x x 14.825 x 15.2836 x 23.125 22.0833 13.575 18.4375 x x x 24.4667 x x x 15.1 x x x x x 16.6267 16.5667 13.3667 x x x x x 15.9656 11.0312 x 18.34 10.21 x x x x x x x 14.7 x x x 13.7344 x x x x x 14.6 19.3 x x x x x x 11.7117 x x x 13.625 x 13.525 x x x x x x x x x x 14.0025 14.145 x x 14.3 x x x x x 16.23 x x x x x x x +15124 None Immunophenotyping, Adler (thure.adler@helmholtz-muenchen.de), CD11b+, not Gr-1++, not NKp46+, frequency of CD45+ Immune function: CD45 cells as a percentage of CD11b cells, not Gr-1, not Nkp46, in peripheral blood measured by fluorescence activated cell sorting (FACS) [%] x 1.91 1.94333 3.055 1.58125 6.934 x x 2.355 x 3.22727 x 3.585 2.53167 1.85125 2.98625 x x x 2.21333 x x x 3.94167 x x x x x 4.155 2.15333 3.76333 x x x x x 3.13556 3.5325 x 2.468 1.8075 x x x x x x x 4.08 x x x 2.39667 x x x x x 3.1525 3.435 x x x x x x 1.78 x x x 2.1825 x 2.565 x x x x x x x x x x 2.1875 2.20333 x x 2.02667 x x x x x 3.31 x x x x x x x +15125 None Immunophenotyping, Adler (thure.adler@helmholtz-muenchen.de), CD5-NKp46+cells, frequency of CD45+ Immune function: CD45 cells as a percentage of Nkp46 cells in peripheral blood measured by fluorescence activated cell sorting (FACS) [%] x 4.09 4.46 7.64 5.9125 6.478 x x 4.955 x 4.39545 x 13.875 7.31167 6.64125 4.24 x x x 3.66333 x x x 1.92 x x x x x 6.88667 7.5 5.54 x x x x x 7.11778 4.225 x 4.686 3.1625 x x x x x x x 8.1 x x x 3.32556 x x x x x 9.3375 4.885 x x x x x x 6.51 x x x 3.8775 x 4.1825 x x x x x x x x x x 4.8525 5.54167 x x 4.04333 x x x x x 4.572 x x x x x x x +15126 None Immunophenotyping, Adler (thure.adler@helmholtz-muenchen.de), B (=CD19+OR(B220+AND IgD+), frequency of CD45+ Immune function: CD45 cells as a percentage of B cells (CD19 or B220 and IgD) in peripheral blood measured by fluorescence activated cell sorting (FACS) [%] x 54.7 56.7333 27.125 54.6875 35.48 x x 43.775 x 31.8091 x 26.225 48.7833 33.8875 36.3625 x x x 31.7667 x x x 48.1833 x x x x x 41.8 45.8333 42.8 x x x x x 36.3 54.7 x 26.16 57.65 x x x x x x x 30.8 x x x 54.6889 x x x x x 35.0 21.25 x x x x x x 51.3167 x x x 44.325 x 46.15 x x x x x x x x x x 60.35 43.7667 x x 59.5667 x x x x x 51.24 x x x x x x x +15127 None Immunophenotyping, Adler (thure.adler@helmholtz-muenchen.de), CD5+, frequency of B cells Immune system: B cells as a percentage of CD5 cells in peripheral blood measured by fluorescence activated cell sorting (FACS) [%] x 2.59 1.88667 4.675 3.1725 3.696 x x 2.37 x 3.22182 x 4.5775 2.79833 2.4375 3.155 x x x 3.09667 x x x 2.47333 x x x x x 3.03167 4.68667 2.89667 x x x x x 4.31667 4.13375 x 6.762 1.7925 x x x x x x x 5.34 x x x 2.77778 x x x x x 4.17875 4.33 x x x x x x 2.36 x x x 2.445 x 2.0575 x x x x x x x x x x 1.21275 3.7 x x 1.72 x x x x x 1.608 x x x x x x x +15128 None Immunophenotyping, Adler (thure.adler@helmholtz-muenchen.de), IgD+, frequency of B cells Immune function: B cells as a percentage of IgD cells in peripheral blood measured by fluorescence activated cell sorting (FACS) [%] x 94.0 90.6 89.75 90.35 91.74 x x 94.175 x 88.6 x 89.475 85.4667 89.025 88.25 x x x 95.0333 x x x 95.5167 x x x x x 90.2 93.1 94.6333 x x x x x 90.0444 90.5 x 88.4 91.0 x x x x x x x 93.4 x x x 90.3111 x x x x x 92.875 86.1 x x x x x x 90.0333 x x x 93.15 x 86.975 x x x x x x x x x x 92.875 92.4 x x 91.5 x x x x x 84.54 x x x x x x x +15129 None Immunophenotyping, Adler (thure.adler@helmholtz-muenchen.de), MHC class II (I/A-E)+, frequency Of B cells Immune function: B cells as a percentage of MHC class II (I/A-E) cells in peripheral blood measured by fluorescence activated cell sorting (FACS) [%] x 63.6 72.1 82.65 62.7 79.82 x x 72.75 x 76.3 x 67.225 61.8667 79.675 73.25 x x x 61.2 x x x 71.5333 x x x x x 75.55 75.1667 62.0333 x x x x x 71.4778 72.0625 x 75.6 72.75 x x x x x x x 75.3 x x x 68.5222 x x x x x 74.225 81.25 x x x x x x 64.7333 x x x 79.625 x 69.125 x x x x x x x x x x 79.375 75.4167 x x 76.4 x x x x x 70.86 x x x x x x x +15130 None Immunophenotyping, Adler (thure.adler@helmholtz-muenchen.de), CD11b+, frequency of NKp46+ CD5-cell Immune system, hematology: NKp46 as a percentage of CD11b cells in peripheral blood measured by fluorescence activated cell sorting (FACS) [%] x 59.4 77.7667 61.8 70.675 63.76 x x 57.55 x 53.7 x 81.55 53.8333 47.7125 61.2875 x x x 81.4667 x x x 57.5667 x x x x x 68.8 63.5333 63.3667 x x x x x 69.9556 54.325 x 54.92 71.2 x x x x x x x 71.3 x x x 74.5667 x x x x x 58.8375 59.025 x x x x x x 71.1167 x x x 76.275 x 80.825 x x x x x x x x x x 68.0 76.8833 x x 81.1333 x x x x x 78.76 x x x x x x x +14902 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); RenF, females Morphology, metabolism: Peritoneal adipose tissue weight at 20 weeks in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.036 1.034 1.039 1.038 1.038 x 1.029 1.043 x 1.178 x 1.178 1.032 1.05 1.169 x x x x x x 1.094 x x 1.055 x x x 1.068 1.041 1.037 x x x x 1.029 1.13 1.032 x 1.029 1.037 x x x x x x x 1.059 x x x x x x x x x 1.146 1.046 x x x x x 1.036 1.178 x x x 1.04 x 1.046 x x x x x x x x x x 1.178 1.057 x x 1.05 x x x x x 1.029 x x x x x x x +14903 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Total.RenF, females Morphology, metabolism: Total retroperitoneal and peritneal adipose tissue weight at 20 weeks in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.075 1.119 1.088 1.07 1.083 x 1.056 1.084 x 1.315 x 1.315 1.056 1.108 1.315 x x x x x x 1.209 x x 1.109 x x x 1.193 1.094 1.089 x x x x 1.059 1.291 1.056 x 1.068 1.132 x x x x x x x 1.116 x x x x x x x x x 1.282 1.153 x x x x x 1.061 1.253 x x x 1.064 x 1.124 x x x x x x x x x x 1.315 1.102 x x 1.1 x x x x x 1.056 x x x x x x x +14904 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); MesF, females Morphology, metabolism: Adipose tissue hanging at the intestine in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.209 1.18 1.134 1.112 1.163 x 1.1 1.136 x 1.334 x 1.334 1.1 1.143 1.26 x x x x x x 1.212 x x 1.1 x x x 1.266 1.171 1.103 x x x x 1.115 1.334 1.106 x 1.149 1.138 x x x x x x x 1.21 x x x x x x x x x 1.231 1.205 x x x x x 1.1 1.19 x x x 1.109 x 1.149 x x x x x x x x x x 1.334 1.11 x x 1.294 x x x x x 1.108 x x x x x x x +14905 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); IngF, females Morphology, metabolism: Inguinal adipose tissue weight at 20 weeks in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.14 1.25 1.198 1.14 1.196 x 1.173 1.151 x 1.458 x 1.458 1.14 1.226 1.385 x x x x x x 1.411 x x 1.143 x x x 1.406 1.186 1.143 x x x x 1.143 1.443 1.151 x 1.212 1.247 x x x x x x x 1.192 x x x x x x x x x 1.458 1.232 x x x x x 1.14 1.256 x x x 1.142 x 1.252 x x x x x x x x x x 1.458 1.159 x x 1.347 x x x x x 1.18 x x x x x x x +14906 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); GlutF, females Morphology, metabolism: Subcutaneous adipose tissue upon the gluteal Mucsculus maximus between the legs, left and right of the tail in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.063 1.237 1.079 1.061 1.092 x 1.058 1.095 x 1.428 x 1.428 1.089 1.218 1.218 x x x x x x 1.253 x x 1.094 x x x 1.42 1.092 1.058 x x x x 1.136 1.058 1.088 x 1.166 1.188 x x x x x x x 1.106 x x x x x x x x x 1.161 1.131 x x x x x 1.06 1.114 x x x 1.058 x 1.143 x x x x x x x x x x 1.428 1.06 x x 1.428 x x x x x 1.116 x x x x x x x +14907 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); SubF, females Morphology, metabolism: Total subcutaneous adipose tissue weight at 20 weeks in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.431 1.772 1.566 1.41 1.46 x 1.406 1.469 x 2.312 x 2.312 1.406 1.68 2.187 x x x x x x 2.031 x x 1.481 x x x 2.201 1.573 1.406 x x x x 1.534 2.312 1.542 x 1.685 1.685 x x x x x x x 1.596 x x x x x x x x x 2.26 1.704 x x x x x 1.406 1.773 x x x 1.414 x 1.802 x x x x x x x x x x 2.312 1.538 x x 2.184 x x x x x 1.487 x x x x x x x +14908 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); WAT, females Morphology, metabolism: Total white adipose weight at 20 weeks in the whole body in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 0.682 1.446 0.885 0.413 0.62 x 0.359 0.7 x 2.502 x 2.502 0.359 1.244 2.211 x x x x x x 2.056 x x 0.655 x x x 2.16 0.962 0.379 x x x x 0.664 2.502 0.511 x 1.007 1.276 x x x x x x x 1.186 x x x x x x x x x 2.435 1.439 x x x x x 0.359 1.645 x x x 0.359 x 1.429 x x x x x x x x x x 2.502 0.873 x x 2.111 x x x x x 0.508 x x x x x x x +14909 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BAT, females Morphology, metabolism: Brown adipose tissue located on the back, along the upper half of the spine and toward the shoulders in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.067 1.074 1.079 1.049 1.092 x 1.066 1.087 x 1.147 x 1.147 1.065 1.058 1.14 x x x x x x 1.107 x x 1.059 x x x 1.14 1.089 1.068 x x x x 1.055 1.147 1.049 x 1.072 1.112 x x x x x x x 1.075 x x x x x x x x x 1.112 1.102 x x x x x 1.049 1.099 x x x 1.049 x 1.097 x x x x x x x x x x 1.147 1.057 x x 1.105 x x x x x 1.077 x x x x x x x +14910 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Carcass, females Morphology, metabolism: Skeleton with muscle (excluding the Longissmus dorsi and femoral muscle) weight at 20 weeks in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 3.115 3.233 2.903 2.864 3.103 x 3.193 3.025 x 3.051 x 3.238 3.072 3.158 3.158 x x x x x x 2.933 x x 2.864 x x x 3.068 2.973 3.161 x x x x 3.16 3.238 2.864 x 3.238 3.025 x x x x x x x 3.052 x x x x x x x x x 3.147 3.034 x x x x x 2.868 2.996 x x x 3.004 x 3.137 x x x x x x x x x x 3.238 2.864 x x 3.047 x x x x x 3.221 x x x x x x x +14911 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); NeckF, females Morphology, metabolism: Fat weight around the neck at 20 weeks in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.032 1.087 1.066 1.042 1.036 x 1.032 1.049 x 1.08 x 1.125 1.052 1.065 1.094 x x x x x x 1.103 x x 1.057 x x x 1.125 1.048 1.032 x x x x 1.048 1.039 1.098 x 1.074 1.056 x x x x x x x 1.045 x x x x x x x x x 1.075 1.083 x x x x x 1.032 1.051 x x x 1.043 x 1.069 x x x x x x x x x x 1.125 1.043 x x 1.125 x x x x x 1.042 x x x x x x x +14912 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); AbdominalF, females Morphology, metabolism: Fat weight in the visceral organs (liver, lung) at 20 weeks in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.015 1.016 1.014 1.01 1.014 x 1.068 1.024 x 1.074 x 1.074 1.011 1.025 1.063 x x x x x x 1.028 x x 1.013 x x x 1.039 1.034 1.01 x x x x 1.024 1.074 1.01 x 1.014 1.026 x x x x x x x 1.021 x x x x x x x x x 1.062 1.03 x x x x x 1.022 1.04 x x x 1.019 x 1.04 x x x x x x x x x x 1.074 1.026 x x 1.011 x x x x x 1.01 x x x x x x x +14913 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Res.SubF, females Morphology, metabolism: Residual subcutaneous fat weight at 20 weeks in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.139 1.19 1.245 1.173 1.12 x 1.142 1.287 x 1.879 x 1.879 1.12 1.246 1.696 x x x x x x 1.327 x x 1.134 x x x 1.514 1.131 1.12 x x x x 1.172 1.879 1.177 x 1.236 1.198 x x x x x x x 1.257 x x x x x x x x x 1.85 1.307 x x x x x 1.13 1.397 x x x 1.164 x 1.436 x x x x x x x x x x 1.879 1.285 x x 1.314 x x x x x 1.12 x x x x x x x +14914 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FAT42 in females + males Morphology, metabolism: Total fat weight measured by Magnetic Resonance Interference (MRI) at 42 days in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.669 1.826 2.173 1.812 1.767 x 1.715 1.688 x 2.182 x x 2.131 1.669 2.132 x x x x x x 2.284 x x 2.181 x x x 2.179 2.284 1.669 x x x x 2.284 2.226 1.967 x 1.977 2.153 x x x x x x x 2.003 x x x x x x x x x 2.284 2.106 x x x x x 2.084 1.944 x x x 1.914 x 1.988 x x x x x x x x x x 2.05 1.669 x x 2.256 x x x x x 1.991 x x x x x x x +14915 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FAT56 in females + males Morphology, metabolism: Total fat weight measured by Magnetic Resonance Interference (MRI) at 56 days in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.705 1.967 2.407 1.705 1.874 x 1.759 1.793 x 2.325 x x 2.452 1.89 2.317 x x x x x x 2.523 x x 2.31 x x x 2.24 2.523 1.705 x x x x 2.507 2.523 1.831 x 1.94 2.101 x x x x x x x 1.993 x x x x x x x x x 2.307 2.103 x x x x x 2.266 1.705 x x x 2.197 x 2.005 x x x x x x x x x x 2.523 1.708 x x 2.247 x x x x x 2.056 x x x x x x x +14916 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FAT70 in females + males Morphology, metabolism: Total fat weight measured by Magnetic Resonance Interference (MRI) at 70 days in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.865 2.192 2.545 1.794 1.968 x 1.868 1.794 x 2.788 x x 2.853 1.964 2.572 x x x x x x 2.853 x x 2.693 x x x 2.5 2.667 1.794 x x x x 2.311 2.853 1.807 x 2.147 2.031 x x x x x x x 2.089 x x x x x x x x x 2.341 2.182 x x x x x 2.457 2.047 x x x 2.331 x 2.201 x x x x x x x x x x 2.853 1.794 x x 2.411 x x x x x 1.977 x x x x x x x +14917 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FAT84 in females + males Morphology, metabolism: Total fat weight measured by magnetic resonance interference analysis at 84 days in females and males on a high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.984 2.474 2.51 1.872 2.02 x 2.025 1.872 x 3.067 x x 3.067 2.024 2.85 x x x x x x 2.974 x x 2.994 x x x 2.684 2.656 1.872 x x x x 2.324 3.067 1.961 x 2.236 2.2 x x x x x x x 2.159 x x x x x x x x x 2.66 2.297 x x x x x 2.599 2.176 x x x 2.278 x 2.327 x x x x x x x x x x 3.067 1.872 x x 2.709 x x x x x 2.146 x x x x x x x +14918 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FAT112 in females + males Morphology, metabolism: Total fat weight measured by magnetic resonance interference analysis (EchoMRI-100 system) at 112 days in females and males on a high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.442 2.385 1.929 1.222 1.784 x 1.222 1.604 x 3.242 x x 3.157 1.956 2.915 x x x x x x 2.627 x x 2.92 x x x 2.798 2.104 1.222 x x x x 1.818 3.242 1.57 x 2.15 1.708 x x x x x x x 1.882 x x x x x x x x x 3.242 1.913 x x x x x 2.382 2.068 x x x 1.663 x 2.13 x x x x x x x x x x 3.242 1.222 x x 2.772 x x x x x 1.757 x x x x x x x +14919 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FAT140 in females + males Morphology, metabolism: Total fat weight measured by Magnetic Resonance Interference (MRI) at 140 days in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 2.056 2.838 2.237 1.685 1.98 x 1.773 2.411 x 3.608 x x 3.123 2.08 3.582 x x x x x x 2.892 x x 3.097 x x x 3.171 2.222 1.685 x x x x 2.102 3.608 2.111 x 2.692 2.196 x x x x x x x 2.586 x x x x x x x x x 3.608 2.138 x x x x x 2.61 2.882 x x x 1.685 x 2.543 x x x x x x x x x x 3.608 1.685 x x 3.168 x x x x x 2.416 x x x x x x x +14920 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FatGain7.10 in females + males Morphology, metabolism: Fat gain between 7 and 10 weeks in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.644 1.827 1.966 1.207 1.6 x 1.532 1.468 x 2.284 x x 2.284 1.7 2.032 x x x x x x 2.234 x x 2.155 x x x 1.869 1.789 1.236 x x x x 1.207 2.284 1.207 x 1.593 1.207 x x x x x x x 1.47 x x x x x x x x x 1.438 1.464 x x x x x 1.916 1.49 x x x 1.921 x 1.656 x x x x x x x x x x 2.284 1.503 x x 1.614 x x x x x 1.314 x x x x x x x +14921 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FatGain17.20 in females + males Morphology, metabolism: Fat gain between 17 and 20 weeks in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 2.065 2.078 1.598 1.535 1.535 x 1.746 2.516 x 3.165 x x 2.152 2.052 3.093 x x x x x x 1.812 x x 2.203 x x x 2.721 1.535 1.882 x x x x 1.704 3.165 2.039 x 2.521 2.005 x x x x x x x 2.47 x x x x x x x x x 3.165 1.836 x x x x x 2.017 2.781 x x x 1.535 x 2.237 x x x x x x x x x x 3.165 1.747 x x 2.687 x x x x x 2.222 x x x x x x x +14922 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); LEAN42 in females + males Morphology, metabolism: Total lean weight measured by Magnetic Resonance Interference (MRI) at 42 days in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 4.091 4.11 3.844 3.94 4.131 x 4.007 4.008 x 3.844 x x 4.172 4.156 4.172 x x x x x x 3.844 x x 3.961 x x x 4.093 3.888 3.883 x x x x 4.064 4.047 3.928 x 4.172 3.899 x x x x x x x 4.119 x x x x x x x x x 4.01 3.882 x x x x x 3.944 3.845 x x x 4.062 x 4.104 x x x x x x x x x x 4.006 3.844 x x 3.898 x x x x x 4.172 x x x x x x x +14923 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); LEAN56 in females + males Morphology, metabolism: Total lean weight measured by Magnetic Resonance Interference (MRI) at 56 days in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 4.16 4.275 3.971 4.08 4.227 x 4.185 4.125 x 3.971 x x 4.275 4.232 4.272 x x x x x x 3.971 x x 4.086 x x x 4.202 4.041 4.138 x x x x 4.231 4.237 4.003 x 4.275 4.099 x x x x x x x 4.234 x x x x x x x x x 4.2 4.023 x x x x x 4.055 4.046 x x x 4.21 x 4.218 x x x x x x x x x x 4.177 3.971 x x 4.115 x x x x x 4.275 x x x x x x x +14924 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); LEAN70 in females + males Morphology, metabolism: Total lean weight measured by Magnetic Resonance Interference (MRI) at 70 days in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 4.269 4.337 4.045 4.102 4.3 x 4.331 4.203 x 4.045 x x 4.35 4.343 4.35 x x x x x x 4.045 x x 4.155 x x x 4.261 4.119 4.231 x x x x 4.343 4.348 4.069 x 4.35 4.173 x x x x x x x 4.324 x x x x x x x x x 4.279 4.138 x x x x x 4.154 4.112 x x x 4.286 x 4.284 x x x x x x x x x x 4.283 4.045 x x 4.196 x x x x x 4.35 x x x x x x x +14925 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); LEAN84 in females + males Morphology, metabolism: Total lean weight measured by Magnetic Resonance Interference (MRI) at 84 days in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 4.297 4.402 4.124 4.148 4.373 x 4.367 4.277 x 4.124 x x 4.423 4.398 4.419 x x x x x x 4.124 x x 4.216 x x x 4.319 4.197 4.294 x x x x 4.423 4.423 4.149 x 4.423 4.23 x x x x x x x 4.336 x x x x x x x x x 4.368 4.157 x x x x x 4.19 4.228 x x x 4.329 x 4.361 x x x x x x x x x x 4.366 4.124 x x 4.263 x x x x x 4.394 x x x x x x x +14926 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); LEAN112 in females + males Morphology, metabolism: Total lean weight measured by Magnetic Resonance Interference (MRI) at 112 days in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 4.368 4.44 4.215 4.211 4.424 x 4.457 4.365 x 4.213 x x 4.517 4.458 4.517 x x x x x x 4.211 x x 4.297 x x x 4.358 4.278 4.375 x x x x 4.507 4.517 4.211 x 4.517 4.312 x x x x x x x 4.373 x x x x x x x x x 4.494 4.234 x x x x x 4.235 4.284 x x x 4.374 x 4.411 x x x x x x x x x x 4.515 4.211 x x 4.344 x x x x x 4.471 x x x x x x x +14927 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); LEAN140 in females + males Morphology, metabolism: Total lean weight measured by Magnetic Resonance Interference (MRI) at 140 days in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 4.401 4.499 4.299 4.266 4.45 x 4.481 4.442 x 4.305 x x 4.58 4.528 4.58 x x x x x x 4.266 x x 4.375 x x x 4.451 4.334 4.397 x x x x 4.506 4.58 4.266 x 4.58 4.388 x x x x x x x 4.415 x x x x x x x x x 4.542 4.306 x x x x x 4.312 4.388 x x x 4.501 x 4.466 x x x x x x x x x x 4.54 4.266 x x 4.43 x x x x x 4.544 x x x x x x x +14928 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); LeanGain7.10 in females + males Morphology, metabolism: Lean gain between 7 and 10 weeks in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.169 1.558 1.427 0.967 1.122 x 1.928 1.214 x 1.254 x x 1.377 1.303 1.175 x x x x x x 0.967 x x 1.164 x x x 1.077 1.361 1.928 x x x x 1.84 1.928 0.967 x 1.928 1.643 x x x x x x x 1.407 x x x x x x x x x 1.721 1.516 x x x x x 1.27 1.55 x x x 1.488 x 1.195 x x x x x x x x x x 1.763 0.967 x x 1.776 x x x x x 1.1 x x x x x x x +14929 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); LeanGain17.20 in females + males Morphology, metabolism: Lean gain between 17 and 20 weeks in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.797 1.831 2.132 1.707 1.719 x 1.886 2.119 x 2.123 x x 2.192 1.999 2.119 x x x x x x 1.926 x x 2.056 x x x 1.972 1.94 1.785 x x x x 1.707 2.192 1.762 x 2.192 2.059 x x x x x x x 1.707 x x x x x x x x x 2.179 1.984 x x x x x 1.848 2.069 x x x 2.184 x 1.804 x x x x x x x x x x 2.192 1.707 x x 2.124 x x x x x 2.097 x x x x x x x +14930 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW28_4 in females + males Morphology, metabolism: Body weight at 28 days (4 weeks) in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 3.73 3.815 3.48 3.599 3.782 x 3.561 3.588 x x x x 3.833 3.514 3.675 x x x x x x x x x 3.544 x x x 3.8 3.674 3.48 x x x x 3.857 3.55 3.485 x 3.857 3.851 x x x x x x x 3.764 x x x x x x x x x 3.497 3.62 x x x x x 3.703 3.48 x x x 3.642 x 3.799 x x x x x x x x x x 3.56 3.537 x x 3.563 x x x x x 3.857 x x x x x x x +14931 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW35_5 in females + males Morphology, metabolism: Body weight at 35 days (5 weeks) in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 4.187 4.244 3.957 4.131 4.281 x 4.083 4.055 x 3.98 x x 4.294 4.089 4.294 x x x x x x 3.957 x x 4.058 x x x 4.206 4.084 3.957 x x x x 4.257 4.222 4.019 x 4.294 4.164 x x x x x x x 4.227 x x x x x x x x x 4.15 4.087 x x x x x 4.164 3.987 x x x 4.154 x 4.291 x x x x x x x x x x 4.095 3.957 x x 4.061 x x x x x 4.294 x x x x x x x +14932 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW42_6 in females + males Morphology, metabolism: Body weight at 42 days (6 weeks) in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 4.309 4.382 4.159 4.208 4.385 x 4.252 4.227 x 4.176 x x 4.46 4.344 4.46 x x x x x x 4.24 x x 4.278 x x x 4.389 4.3 4.159 x x x x 4.46 4.392 4.201 x 4.442 4.251 x x x x x x x 4.394 x x x x x x x x x 4.361 4.181 x x x x x 4.249 4.159 x x x 4.306 x 4.401 x x x x x x x x x x 4.307 4.159 x x 4.28 x x x x x 4.46 x x x x x x x +14834 None Bacterial infection, Ehlers (sehlers@fz-borstel.de), median survival Infectious disease, immune function: Median survival time in log10 after aerosol infection with 1000 colony forming units (CFU) Mycobacterium tuberculosis H37Rv in 12-48 week-old females [days in log10 * 100] x 234.138 235.773 209.5 225.954 x x x x x x x x x x x x x x x x x 197.469 x x x x x x 221.206 201.408 149.136 x x x x x 212.385 x x 222.42 207.188 x x x x x x x x x x x 212.385 x x x x x 217.894 x x x 180.426 x x x x x x x 226.476 x x x x x x x x x x x x x x x x x x x x x x 228.33 x x x x x x x +14835 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FAT42, females Morphology, metabolism: Total fat weight measured by Magnetic Resonance Interference (MRI) at 42 days in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.572 1.903 2.149 1.786 1.822 x 1.572 1.58 x 2.415 x 2.415 1.958 1.658 2.144 x x x x x x 2.215 x x 1.668 x x x 2.352 2.41 1.572 x x x x 2.415 1.953 1.936 x 1.841 2.345 x x x x x x x 1.883 x x x x x x x x x 2.415 2.082 x x x x x 1.944 1.953 x x x 1.806 x 1.933 x x x x x x x x x x 2.145 1.572 x x 2.214 x x x x x 1.938 x x x x x x x +14836 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FAT56, females Morphology, metabolism: Total fat weight measured by Magnetic Resonance Interference (MRI) at 56 days in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.48 1.872 2.254 1.785 1.867 x 1.471 1.654 x 2.4 x 2.4 1.932 1.895 2.117 x x x x x x 2.4 x x 1.471 x x x 2.4 2.292 1.471 x x x x 2.294 1.824 1.489 x 1.645 2.174 x x x x x x x 1.728 x x x x x x x x x 2.208 1.979 x x x x x 1.826 1.471 x x x 1.76 x 1.914 x x x x x x x x x x 2.374 1.663 x x 2.095 x x x x x 1.896 x x x x x x x +14837 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FAT70, females Morphology, metabolism: Total fat weight measured by Magnetic Resonance Interference (MRI) at 70 days in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.654 1.937 2.275 1.704 1.911 x 1.62 1.731 x 2.695 x 2.695 1.888 1.811 2.35 x x x x x x 2.695 x x 1.739 x x x 2.689 2.276 1.62 x x x x 2.102 1.993 1.62 x 1.95 2.059 x x x x x x x 1.84 x x x x x x x x x 1.972 2.059 x x x x x 1.828 1.62 x x x 1.85 x 1.965 x x x x x x x x x x 2.695 1.723 x x 2.22 x x x x x 1.78 x x x x x x x +14838 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FAT84, females Morphology, metabolism: Total fat weight measured by Magnetic Resonance Interference (MRI) at 84 days in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.695 2.046 2.179 1.775 1.785 x 1.642 1.713 x 2.874 x 2.874 1.587 1.863 2.613 x x x x x x 2.874 x x 1.702 x x x 2.755 2.256 1.587 x x x x 2.001 2.053 1.587 x 2.026 2.192 x x x x x x x 1.847 x x x x x x x x x 2.058 2.149 x x x x x 1.996 1.587 x x x 1.805 x 1.981 x x x x x x x x x x 2.874 1.78 x x 2.528 x x x x x 1.853 x x x x x x x +14839 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FAT112, females Morphology, metabolism: Total fat weight measured by Magnetic Resonance Interference (MRI) at 112 days in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.887 2.35 2.07 1.79 2.095 x 1.727 1.863 x 3.065 x 3.065 1.727 2.345 2.72 x x x x x x 2.954 x x 2.198 x x x 3.065 2.33 1.727 x x x x 2.082 2.623 1.727 x 2.028 2.266 x x x x x x x 1.976 x x x x x x x x x 3.026 2.514 x x x x x 2.046 1.877 x x x 1.741 x 2.449 x x x x x x x x x x 3.065 2.039 x x 2.932 x x x x x 1.906 x x x x x x x +14840 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FAT140, females Morphology, metabolism: Total fat weight measured by Magnetic Resonance Interference (MRI) at 140 days in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.008 2.183 1.251 0.781 1.371 x 0.85 0.949 x 3.2 x 3.2 0.781 1.622 2.907 x x x x x x 2.735 x x 1.52 x x x 2.567 1.715 0.781 x x x x 1.474 2.929 0.781 x 1.921 1.936 x x x x x x x 1.99 x x x x x x x x x 3.2 2.113 x x x x x 0.865 1.879 x x x 0.838 x 2.13 x x x x x x x x x x 3.2 1.505 x x 2.812 x x x x x 1.256 x x x x x x x +14841 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FatGain7.10, females Morphology, metabolism: Fat gain between 7 and 10 weeks in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.882 1.847 1.968 1.73 1.901 x 1.791 1.94 x 2.391 x 2.391 1.732 1.949 2.065 x x x x x x 2.391 x x 1.875 x x x 2.278 1.603 1.793 x x x x 1.463 1.855 1.463 x 1.921 1.602 x x x x x x x 1.766 x x x x x x x x x 1.463 1.782 x x x x x 1.683 1.463 x x x 1.855 x 1.846 x x x x x x x x x x 2.391 2.022 x x 1.818 x x x x x 1.637 x x x x x x x +14842 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FatGain17.20, females Morphology, metabolism: Fat gain between 17 and 20 weeks in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.557 2.196 1.31 1.31 1.731 x 1.511 1.496 x 3.017 x 3.017 1.589 1.851 2.144 x x x x x x 1.664 x x 1.919 x x x 1.742 1.42 1.564 x x x x 1.557 2.933 1.611 x 1.957 1.777 x x x x x x x 2.184 x x x x x x x x x 3.017 2.059 x x x x x 1.31 2.284 x x x 1.31 x 2.178 x x x x x x x x x x 3.017 1.838 x x 2.439 x x x x x 1.348 x x x x x x x +14843 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); LEAN42, females Morphology, metabolism: Total lean weight measured by Magnetic Resonance Interference (MRI) at 42 days in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 3.949 3.94 3.674 3.807 3.903 x 3.852 3.812 x 3.674 x 4.051 4.051 4.051 4.001 x x x x x x 3.674 x x 3.705 x x x 3.941 3.745 3.708 x x x x 3.967 3.815 3.789 x 3.956 3.702 x x x x x x x 3.94 x x x x x x x x x 3.778 3.762 x x x x x 3.757 3.694 x x x 3.892 x 4.007 x x x x x x x x x x 3.913 3.674 x x 3.715 x x x x x 4.051 x x x x x x x +14844 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); LEAN56, females Morphology, metabolism: Total lean weight measured by Magnetic Resonance Interference (MRI) at 56 days in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 4.014 4.098 3.832 3.912 3.994 x 4.054 3.966 x 3.816 x 4.134 4.134 4.129 4.089 x x x x x x 3.816 x x 3.816 x x x 3.994 3.874 3.981 x x x x 4.092 4.047 3.861 x 4.134 3.908 x x x x x x x 4.068 x x x x x x x x x 3.967 3.91 x x x x x 3.849 3.927 x x x 4.006 x 4.094 x x x x x x x x x x 4.059 3.816 x x 3.925 x x x x x 4.134 x x x x x x x +14845 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); LEAN70, females Morphology, metabolism: Total lean weight measured by Magnetic Resonance Interference (MRI) at 70 days in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 4.12 4.176 3.935 3.951 4.124 x 4.217 4.051 x 3.901 x 4.256 4.256 4.256 4.184 x x x x x x 3.901 x x 3.901 x x x 4.042 3.939 4.05 x x x x 4.164 4.223 3.919 x 4.256 4.01 x x x x x x x 4.18 x x x x x x x x x 4.061 4.052 x x x x x 3.985 3.985 x x x 4.094 x 4.158 x x x x x x x x x x 4.164 3.901 x x 3.988 x x x x x 4.243 x x x x x x x +14846 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); LEAN84, females Morphology, metabolism: Total lean weight measured by magnetic resonance interference analysis at 84 days in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 4.15 4.225 3.999 3.986 4.209 x 4.236 4.123 x 3.958 x 4.274 4.274 4.274 4.26 x x x x x x 3.958 x x 3.973 x x x 4.114 4.031 4.158 x x x x 4.23 4.247 4.007 x 4.274 4.07 x x x x x x x 4.186 x x x x x x x x x 4.147 4.062 x x x x x 3.958 4.109 x x x 4.118 x 4.229 x x x x x x x x x x 4.258 3.958 x x 4.054 x x x x x 4.263 x x x x x x x +14847 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); LEAN112, females Morphology, metabolism: Total lean weight measured by Magnetic Resonance Interference (MRI) at 112 days in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 4.238 4.267 4.121 4.044 4.301 x 4.339 4.222 x 4.039 x 4.315 4.362 4.343 4.353 x x x x x x 4.037 x x 4.032 x x x 4.144 4.124 4.274 x x x x 4.336 4.362 4.032 x 4.362 4.191 x x x x x x x 4.212 x x x x x x x x x 4.282 4.168 x x x x x 4.032 4.135 x x x 4.159 x 4.261 x x x x x x x x x x 4.362 4.032 x x 4.103 x x x x x 4.358 x x x x x x x +14848 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); LEAN140, females Morphology, metabolism: Total lean weight measured by magnetic resonance interference analysis at 140 days in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 4.25 4.299 4.172 4.065 4.302 x 4.367 4.304 x 4.137 x 4.354 4.426 4.396 4.424 x x x x x x 4.087 x x 4.065 x x x 4.251 4.191 4.29 x x x x 4.341 4.426 4.075 x 4.426 4.255 x x x x x x x 4.237 x x x x x x x x x 4.26 4.246 x x x x x 4.065 4.226 x x x 4.249 x 4.315 x x x x x x x x x x 4.426 4.065 x x 4.206 x x x x x 4.375 x x x x x x x +14849 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); LeanGain7.10, females Morphology, metabolism: Lean gain between 7 and 10 weeks in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 0.961 1.446 1.365 0.551 1.306 x 1.771 1.341 x 1.077 x 1.265 0.546 1.294 1.112 x x x x x x 0.513 x x 0.882 x x x 0.513 0.948 1.771 x x x x 1.193 1.771 0.513 x 1.771 1.631 x x x x x x x 1.474 x x x x x x x x x 1.572 1.596 x x x x x 1.207 1.534 x x x 1.16 x 0.833 x x x x x x x x x x 1.516 0.513 x x 1.454 x x x x x 0.792 x x x x x x x +14850 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); LeanGain17.20, females Morphology, metabolism: Lean gain between 17 and 20 weeks in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.71 1.574 2.012 1.523 1.722 x 1.923 2.112 x 2.142 x 1.911 1.949 1.718 1.779 x x x x x x 1.994 x x 1.566 x x x 1.898 1.97 1.893 x x x x 1.809 2.142 1.523 x 2.142 2.102 x x x x x x x 1.523 x x x x x x x x x 1.807 2.075 x x x x x 1.681 1.786 x x x 1.869 x 1.602 x x x x x x x x x x 2.142 1.523 x x 1.944 x x x x x 1.797 x x x x x x x +14851 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW28_4, females Morphology, metabolism: Body weight at 28 days (4 weeks) in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 3.691 3.816 3.388 3.388 3.567 x 3.493 3.539 x 3.467 x 3.684 3.692 3.497 3.588 x x x x x x x x x 3.559 x x x 3.768 3.604 3.388 x x x x 3.816 3.423 3.399 x 3.816 3.816 x x x x x x x 3.739 x x x x x x x x x 3.48 3.629 x x x x x 3.564 3.388 x x x 3.694 x 3.756 x x x x x x x x x x 3.577 3.49 x x 3.482 x x x x x 3.801 x x x x x x x +14852 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW35_5, females Morphology, metabolism: Body weight at 35 days (5 weeks) in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 4.075 4.183 3.809 4.051 4.077 x 3.997 3.914 x 3.986 x 4.057 4.215 4.021 4.142 x x x x x x 3.809 x x 3.849 x x x 4.115 4.005 3.809 x x x x 4.178 4.065 3.869 x 4.215 4.095 x x x x x x x 4.172 x x x x x x x x x 4.057 4.065 x x x x x 4.013 3.876 x x x 4.053 x 4.215 x x x x x x x x x x 4.08 3.809 x x 3.959 x x x x x 4.215 x x x x x x x +14853 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW42_6, females Morphology, metabolism: Body weight at 42 days (6 weeks) in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 4.17 4.249 4.024 4.085 4.197 x 4.087 4.031 x 4.112 x 4.37 4.37 4.257 4.332 x x x x x x 4.048 x x 4.024 x x x 4.277 4.173 4.024 x x x x 4.37 4.134 4.061 x 4.224 4.13 x x x x x x x 4.222 x x x x x x x x x 4.209 4.076 x x x x x 4.038 4.036 x x x 4.124 x 4.299 x x x x x x x x x x 4.246 4.024 x x 4.124 x x x x x 4.37 x x x x x x x +14854 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW49_7, females Morphology, metabolism: Body weight at 49 days (7 weeks) in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 4.179 4.3 4.123 4.15 4.254 x 4.172 4.089 x 4.162 x 4.338 4.317 4.33 4.326 x x x x x x 4.246 x x 4.072 x x x 4.308 4.205 4.084 x x x x 4.338 4.245 4.069 x 4.329 4.222 x x x x x x x 4.268 x x x x x x x x x 4.28 4.151 x x x x x 4.069 4.069 x x x 4.228 x 4.332 x x x x x x x x x x 4.338 4.069 x x 4.178 x x x x x 4.338 x x x x x x x +14855 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW56_8, females Morphology, metabolism: Body weight at 56 days (8 weeks) in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 4.236 4.368 4.209 4.17 4.287 x 4.276 4.196 x 4.225 x 4.406 4.363 4.37 4.4 x x x x x x 4.333 x x 4.149 x x x 4.394 4.281 4.186 x x x x 4.406 4.314 4.149 x 4.406 4.262 x x x x x x x 4.328 x x x x x x x x x 4.306 4.221 x x x x x 4.16 4.149 x x x 4.288 x 4.397 x x x x x x x x x x 4.405 4.149 x x 4.248 x x x x x 4.406 x x x x x x x +14856 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW63_9, females Morphology, metabolism: Body weight at 63 days (9 weeks) in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 4.313 4.403 4.249 4.227 4.361 x 4.349 4.268 x 4.325 x 4.496 4.396 4.454 4.474 x x x x x x 4.355 x x 4.19 x x x 4.462 4.291 4.26 x x x x 4.437 4.37 4.19 x 4.496 4.326 x x x x x x x 4.367 x x x x x x x x x 4.317 4.303 x x x x x 4.19 4.24 x x x 4.326 x 4.437 x x x x x x x x x x 4.496 4.19 x x 4.277 x x x x x 4.496 x x x x x x x +14857 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW70_10, females Morphology, metabolism: Body weight at 70 days (10 weeks) in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 4.352 4.446 4.304 4.211 4.399 x 4.429 4.309 x 4.456 x 4.549 4.446 4.483 4.549 x x x x x x 4.342 x x 4.211 x x x 4.514 4.331 4.258 x x x x 4.476 4.494 4.211 x 4.549 4.342 x x x x x x x 4.43 x x x x x x x x x 4.332 4.354 x x x x x 4.246 4.266 x x x 4.358 x 4.444 x x x x x x x x x x 4.549 4.211 x x 4.324 x x x x x 4.5 x x x x x x x +14858 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW77_11, females Morphology, metabolism: Body weight at 77 days (11 weeks) in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 21.101 22.583 20.411 19.074 21.792 x 21.782 20.613 x 22.905 x 24.271 21.645 23.152 24.271 x x x x x x 22.424 x x 19.074 x x x 23.544 20.279 20.472 x x x x 22.557 22.372 19.074 x 24.271 21.133 x x x x x x x 21.623 x x x x x x x x x 20.87 20.921 x x x x x 19.491 20.063 x x x 20.896 x 22.749 x x x x x x x x x x 24.271 19.074 x x 21.552 x x x x x 23.418 x x x x x x x +14859 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW84_12, females Morphology, metabolism: Body weight at 84 days (12 weeks) in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 4.423 4.527 4.359 4.258 4.462 x 4.464 4.406 x 4.568 x 4.608 4.521 4.561 4.608 x x x x x x 4.527 x x 4.258 x x x 4.59 4.389 4.4 x x x x 4.547 4.549 4.258 x 4.608 4.441 x x x x x x x 4.468 x x x x x x x x x 4.433 4.418 x x x x x 4.294 4.35 x x x 4.415 x 4.539 x x x x x x x x x x 4.608 4.258 x x 4.477 x x x x x 4.573 x x x x x x x +14860 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW91_13, females Morphology, metabolism: Body weight at 91 days (13 weeks) in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 4.433 4.536 4.405 4.282 4.521 x 4.506 4.45 x 4.654 x 4.659 4.506 4.581 4.659 x x x x x x 4.535 x x 4.282 x x x 4.637 4.435 4.418 x x x x 4.542 4.631 4.282 x 4.659 4.447 x x x x x x x 4.455 x x x x x x x x x 4.494 4.467 x x x x x 4.33 4.405 x x x 4.376 x 4.554 x x x x x x x x x x 4.659 4.282 x x 4.507 x x x x x 4.572 x x x x x x x +14861 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW98_14, females Morphology, metabolism: Body weight at 98 days (14 weeks) in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 4.461 4.553 4.419 4.307 4.529 x 4.539 4.454 x 4.729 x 4.729 4.506 4.611 4.729 x x x x x x 4.602 x x 4.309 x x x 4.708 4.404 4.47 x x x x 4.585 4.7 4.307 x 4.64 4.5 x x x x x x x 4.504 x x x x x x x x x 4.561 4.512 x x x x x 4.307 4.472 x x x 4.397 x 4.597 x x x x x x x x x x 4.729 4.307 x x 4.549 x x x x x 4.606 x x x x x x x +14862 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW105_15, females Morphology, metabolism: Body weight at 105 days (15 weeks) in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 4.486 4.577 4.443 4.345 4.576 x 4.546 4.495 x 4.809 x 4.809 4.545 4.611 4.809 x x x x x x 4.583 x x 4.363 x x x 4.733 4.5 4.432 x x x x 4.573 4.648 4.345 x 4.685 4.505 x x x x x x x 4.504 x x x x x x x x x 4.66 4.549 x x x x x 4.345 4.455 x x x 4.438 x 4.6 x x x x x x x x x x 4.809 4.345 x x 4.614 x x x x x 4.596 x x x x x x x +14863 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW112_16, females Morphology, metabolism: Body weight at 112 days (16 weeks) in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 4.509 4.607 4.432 4.331 4.582 x 4.575 4.487 x 4.832 x 4.832 4.522 4.674 4.832 x x x x x x 4.612 x x 4.389 x x x 4.702 4.502 4.506 x x x x 4.621 4.755 4.331 x 4.69 4.547 x x x x x x x 4.516 x x x x x x x x x 4.79 4.578 x x x x x 4.331 4.48 x x x 4.432 x 4.652 x x x x x x x x x x 4.832 4.331 x x 4.627 x x x x x 4.629 x x x x x x x +14864 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW119_17, females Morphology, metabolism: Body weight at 119 days (17 weeks) in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 4.503 4.688 4.45 4.324 4.608 x 4.564 4.511 x 4.951 x 4.951 4.582 4.641 4.951 x x x x x x 4.604 x x 4.345 x x x 4.725 4.481 4.532 x x x x 4.615 4.794 4.324 x 4.725 4.547 x x x x x x x 4.558 x x x x x x x x x 4.863 4.565 x x x x x 4.324 4.529 x x x 4.446 x 4.624 x x x x x x x x x x 4.951 4.324 x x 4.666 x x x x x 4.637 x x x x x x x +14865 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW126_18, females Morphology, metabolism: Body weight at 126 days (18 weeks) in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 4.529 4.733 4.457 4.375 4.627 x 4.593 4.499 x 4.892 x 4.892 4.567 4.796 4.892 x x x x x x 4.614 x x 4.415 x x x 4.739 4.549 4.54 x x x x 4.601 4.879 4.375 x 4.752 4.609 x x x x x x x 4.57 x x x x x x x x x 4.848 4.607 x x x x x 4.375 4.574 x x x 4.458 x 4.661 x x x x x x x x x x 4.892 4.375 x x 4.683 x x x x x 4.64 x x x x x x x +14866 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW133_19, females Morphology, metabolism: Body weight at 133 days (19 weeks) in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 4.52 4.732 4.444 4.392 4.637 x 4.604 4.542 x 4.968 x 4.968 4.601 4.841 4.968 x x x x x x 4.668 x x 4.453 x x x 4.8 4.558 4.531 x x x x 4.688 4.831 4.392 x 4.777 4.637 x x x x x x x 4.586 x x x x x x x x x 4.878 4.621 x x x x x 4.392 4.528 x x x 4.474 x 4.688 x x x x x x x x x x 4.968 4.392 x x 4.749 x x x x x 4.649 x x x x x x x +14867 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW140_20, females Morphology, metabolism: Body weight at 140 days (20 weeks) in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 4.541 4.738 4.483 4.386 4.618 x 4.63 4.58 x 4.981 x 4.981 4.609 x 4.977 x x x x x x 4.686 x x 4.459 x x x 4.781 4.541 4.548 x x x x 4.672 4.981 4.386 x 4.818 4.651 x x x x x x x 4.655 x x x x x x x x x 4.959 4.664 x x x x x 4.386 4.636 x x x 4.507 x 4.728 x x x x x x x x x x 4.981 4.386 x x 4.756 x x x x x 4.679 x x x x x x x +14868 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW4.5, females Morphology, metabolism: Body weight gain between 4 and 5 weeks in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.979 1.85 1.924 2.507 2.33 x 2.236 1.788 x 2.26 x 1.924 2.507 2.305 2.494 x x x x x x x x x 1.598 x x x 1.889 1.959 2.23 x x x x 1.598 2.507 2.023 x 2.024 1.598 x x x x x x x 2.225 x x x x x x x x x 2.456 2.127 x x x x x 2.109 2.11 x x x 1.872 x 2.369 x x x x x x x x x x 2.315 1.598 x x 2.13 x x x x x 2.507 x x x x x x x +14869 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW5.6, females Morphology, metabolism: Body weight gain between 5 and 6 weeks in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.736 1.605 2.175 1.372 1.864 x 1.683 1.789 x 1.859 x 2.317 2.065 2.317 2.223 x x x x x x 2.317 x x 1.703 x x x 2.085 2.061 2.18 x x x x 2.317 1.587 2.089 x 1.372 1.38 x x x x x x x 1.5 x x x x x x x x x 2.012 1.372 x x x x x 1.372 1.963 x x x 1.594 x 1.679 x x x x x x x x x x 2.084 1.797 x x 2.025 x x x x x 1.86 x x x x x x x +14870 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW6.7, females Morphology, metabolism: Body weight gain between 6 and 7 weeks in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.596 1.842 2.026 1.886 1.87 x 1.976 1.839 x 1.816 x 2.111 1.516 1.962 1.516 x x x x x x 2.111 x x 2.087 x x x 1.736 1.726 2.111 x x x x 1.516 2.111 1.516 x 2.11 2.025 x x x x x x x 1.81 x x x x x x x x x 1.942 1.928 x x x x x 1.708 1.702 x x x 2.073 x 1.749 x x x x x x x x x x 2.067 1.973 x x 1.837 x x x x x 1.795 x x x x x x x +14871 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW7.8, females Morphology, metabolism: Body weight gain between 7 and 8 weeks in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.524 1.638 1.691 1.338 1.378 x 1.766 1.766 x 1.557 x 1.766 1.482 1.442 1.683 x x x x x x 1.737 x x 1.338 x x x 1.752 1.659 1.765 x x x x 1.766 1.62 1.338 x 1.706 1.42 x x x x x x x 1.569 x x x x x x x x x 1.338 1.603 x x x x x 1.7 1.639 x x x 1.563 x 1.623 x x x x x x x x x x 1.629 1.46 x x 1.609 x x x x x 1.636 x x x x x x x +14872 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW8.9, females Morphology, metabolism: Body weight gain between 8 and 9 weeks in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.806 1.567 1.576 1.667 1.801 x 1.791 1.764 x 1.92 x 1.92 1.552 1.891 1.838 x x x x x x 1.469 x x 1.785 x x x 1.795 1.389 1.769 x x x x 1.389 1.699 1.533 x 1.92 1.732 x x x x x x x 1.59 x x x x x x x x x 1.389 1.83 x x x x x 1.437 1.866 x x x 1.57 x 1.609 x x x x x x x x x x 1.92 1.426 x x 1.506 x x x x x 1.389 x x x x x x x +14873 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW9.10, females Morphology, metabolism: Body weight gain between 9 and 10 weeks in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.513 1.558 1.606 1.211 1.513 x 1.799 1.518 x 1.848 x 1.531 1.611 1.455 1.848 x x x x x x 1.211 x x 1.531 x x x 1.641 1.517 1.211 x x x x 1.535 1.848 1.515 x 1.782 1.34 x x x x x x x 1.695 x x x x x x x x x 1.336 1.589 x x x x x 1.66 1.407 x x x 1.465 x 1.273 x x x x x x x x x x 1.848 1.392 x x 1.562 x x x x x 1.211 x x x x x x x +14874 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW10.11, females Morphology, metabolism: Body weight gain between 10 and 11 weeks in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.503 1.561 1.494 1.441 1.511 x 1.258 1.561 x 1.636 x 1.897 1.216 1.563 1.897 x x x x x x 1.897 x x 1.342 x x x 1.515 1.216 1.806 x x x x 1.303 1.216 1.396 x 1.5 1.592 x x x x x x x 1.216 x x x x x x x x x 1.529 1.398 x x x x x 1.417 1.576 x x x 1.353 x 1.648 x x x x x x x x x x 1.897 1.422 x x 1.881 x x x x x 1.56 x x x x x x x +14875 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW11.12, females Morphology, metabolism: Body weight gain between 11 and 12 weeks in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 0.348 0.473 0.139 0.139 0.244 x 0.287 0.587 x 0.81 x 0.991 0.991 0.45 0.567 x x x x x x 0.63 x x 0.27 x x x 0.532 0.669 0.638 x x x x 0.813 0.991 0.518 x 0.139 0.581 x x x x x x x 0.512 x x x x x x x x x 0.735 0.451 x x x x x 0.139 0.336 x x x 0.43 x 0.492 x x x x x x x x x x 0.991 0.211 x x 0.717 x x x x x 0.388 x x x x x x x +14876 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW12.13, females Morphology, metabolism: Body weight gain between 12 and 13 weeks in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.443 1.441 1.693 1.397 1.802 x 1.685 1.688 x 1.944 x 1.944 1.259 1.538 1.259 x x x x x x 1.431 x x 1.575 x x x 1.751 1.701 1.503 x x x x 1.314 1.944 1.551 x 1.764 1.415 x x x x x x x 1.259 x x x x x x x x x 1.808 1.725 x x x x x 1.616 1.744 x x x 1.259 x 1.495 x x x x x x x x x x 1.944 1.606 x x 1.6 x x x x x 1.352 x x x x x x x +14877 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW13.14, females Morphology, metabolism: Body weight gain between 13 and 14 weeks in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.525 1.446 1.408 1.453 1.372 x 1.576 1.336 x 1.912 x 1.912 1.305 1.566 1.912 x x x x x x 1.831 x x 1.577 x x x 1.893 1.305 1.696 x x x x 1.664 1.871 1.372 x 1.305 1.71 x x x x x x x 1.685 x x x x x x x x x 1.814 1.659 x x x x x 1.305 1.791 x x x 1.466 x 1.664 x x x x x x x x x x 1.912 1.5 x x 1.648 x x x x x 1.596 x x x x x x x +14878 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW14.15, females Morphology, metabolism: Body weight gain between 14 and 15 weeks in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.728 1.73 1.715 1.591 1.881 x 1.601 1.827 x 2.125 x 2.11 1.826 1.539 2.082 x x x x x x 1.425 x x 1.879 x x x 1.754 2.125 1.425 x x x x 1.447 1.425 1.51 x 1.893 1.585 x x x x x x x 1.543 x x x x x x x x x 2.125 1.811 x x x x x 1.758 1.425 x x x 1.819 x 1.569 x x x x x x x x x x 2.125 1.69 x x 1.999 x x x x x 1.453 x x x x x x x +14879 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW15.16, females Morphology, metabolism: Body weight gain between 15 and 16 weeks in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.54 1.615 1.258 1.5 1.408 x 1.6 1.281 x 1.506 x 1.696 1.185 1.868 1.185 x x x x x x 1.609 x x 1.552 x x x 1.185 1.371 1.879 x x x x 1.748 1.879 1.388 x 1.408 1.692 x x x x x x x 1.455 x x x x x x x x x 1.879 1.604 x x x x x 1.185 1.55 x x x 1.303 x 1.783 x x x x x x x x x x 1.879 1.49 x x 1.471 x x x x x 1.644 x x x x x x x +14880 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW16.17, females Morphology, metabolism: Body weight gain between 16 and 17 weeks in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.347 2.011 1.54 1.391 1.623 x 1.293 1.588 x 2.078 x 2.078 1.851 1.221 2.078 x x x x x x 1.318 x x 1.221 x x x 1.606 1.221 1.607 x x x x 1.341 1.753 1.535 x 1.708 1.393 x x x x x x x 1.732 x x x x x x x x x 2.024 1.508 x x x x x 1.419 1.769 x x x 1.512 x 1.221 x x x x x x x x x x 2.078 1.468 x x 1.727 x x x x x 1.495 x x x x x x x +14881 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW17.18, females Morphology, metabolism: Body weight gain between 17 and 18 weeks in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 2.017 2.156 1.905 2.051 1.983 x 2.046 1.789 x 2.284 x 2.18 1.769 2.284 1.769 x x x x x x 1.93 x x 2.218 x x x 1.963 2.238 1.917 x x x x 1.769 2.284 1.986 x 2.044 2.224 x x x x x x x 1.938 x x x x x x x x x 1.769 2.114 x x x x x 2.097 2.128 x x x 1.932 x 2.094 x x x x x x x x x x 2.284 1.795 x x 1.976 x x x x x 1.882 x x x x x x x +14882 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW18.19, females Morphology, metabolism: Body weight gain between 18 and 19 weeks in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.635 1.8 1.721 1.635 1.873 x 1.877 2.064 x 2.211 x 2.008 2.015 2.067 2.298 x x x x x x 2.143 x x 2.018 x x x 2.217 1.822 1.743 x x x x 2.298 1.635 1.946 x 1.984 1.988 x x x x x x x 1.905 x x x x x x x x x 2.03 1.901 x x x x x 1.884 1.635 x x x 1.898 x 1.99 x x x x x x x x x x 2.298 2.056 x x 2.298 x x x x x 1.861 x x x x x x x +14883 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW19.20, females Morphology, metabolism: Body weight gain between 19 and 20 weeks in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 4.953 4.944 4.966 4.94 4.954 x 4.959 4.967 x 5.009 x 4.924 4.946 4.924 4.925 x x x x x x 4.954 x x 4.943 x x x 4.924 4.926 4.952 x x x x 4.926 5.009 4.965 x 4.976 4.95 x x x x x x x 4.993 x x x x x x x x x 5.009 4.973 x x x x x 4.924 5.009 x x x 4.963 x 4.963 x x x x x x x x x x 4.975 4.956 x x 4.945 x x x x x 4.963 x x x x x x x +14884 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BL42_6, females Morphology, metabolism: Body length from the nose until the tail at 42 days in females on high fat diet (45% energy from fat) feeding from 4 weeks on [cm] x 6.41 6.439 6.295 6.362 6.34 x 6.402 6.322 x 6.304 x 6.439 6.384 6.347 6.437 x x x x x x 6.248 x x 6.235 x x x 6.392 6.332 6.226 x x x x 6.432 6.308 6.276 x 6.387 6.232 x x x x x x x 6.375 x x x x x x x x x 6.384 6.256 x x x x x 6.304 6.226 x x x 6.226 x 6.399 x x x x x x x x x x 6.439 6.226 x x 6.372 x x x x x 6.439 x x x x x x x +14885 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BL70_10, females Morphology, metabolism: Body length from the nose until the tail at 70 days in females on high fat diet (45% energy from fat) feeding from 4 weeks on [cm] x 6.537 6.548 6.448 6.459 6.456 x 6.546 6.454 x 6.426 x 6.545 6.531 6.536 6.508 x x x x x x 6.485 x x 6.41 x x x 6.548 6.487 6.44 x x x x 6.544 6.496 6.445 x 6.41 6.436 x x x x x x x 6.526 x x x x x x x x x 6.484 6.428 x x x x x 6.41 6.412 x x x 6.476 x 6.537 x x x x x x x x x x 6.548 6.41 x x 6.489 x x x x x 6.548 x x x x x x x +14363 Original post publication description: Liver, toxicology, Fibrosis susceptibility after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, Days 1 and 4), mean liver to body weight ratio in females_data, trimmed [g] Original pre publication description: Hall trait 9 Hall trait 9 Liver, toxicology: Fibrosis susceptibility in adult females after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), mean liver to body weight ratio, data trimmed [g] x 0.07 0.048 0.057 0.053 0.058 x x x x 0.049 x 0.066 x x x x 0.082 x x x x 0.051 x x x x x x 0.045 0.07 0.064 x x x x 0.062 0.06 0.078 x 0.054 0.062 x x x x x x x 0.046 x x x 0.069 x x x x x 0.067 0.049 x x 0.052 x x x x x x x 0.062 x 0.053 x x x x x x x x x x x x x x 0.054 x x x x x 0.062 x 0.066 x x x x x +14359 Original post publication description: Liver, toxicology, Fibrosis susceptibility aftercarbon tetrachloride challenge (12 x 0.7 mg/kg ip, Days 1 and 4), mean hepatic collagen in males and females_data, trimmed [ug hydroxyproline/g liver] Original pre publication description: Hall trait 5 Hall trait 5 Liver, toxicology: Fibrosis susceptibility in adult males and females after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), mean hepatic collagen, data, trimmed [ug hydroxyproline/g liver] x 325.87 419.3 570.89 462.29 478.58 x 335.81 x x 403.13 472.41 368.24 357.81 x x x 403.06 x x x 181.2 334.27 x x 327.64 282.62 253.97 x 333.13 406.14 373.12 273.19 x x x 394.81 298.07 283.1 x 385.05 408.5 x x x x x x x 421.34 x x x 391.98 x x x x x 351.17 402.27 x x 507.9 x x x 380.88 x x 257.72 547.9 x 416.88 x x x x x x x x x x x 335.07 x x 307.36 x x x x x 296.23 x 559.49 x x x x x +14360 Original post publication description: Liver, toxicology, Fibrosis susceptibility aftercarbon tetrachloride challenge (12 x 0.7 mg/kg ip, Days 1 and 4), median hepatic collagen in males and females_data, trimmed [ug hydroxyproline/g liver] Original pre publication description: Hall trait 6 Hall trait 6 Liver, toxicology: Fibrosis susceptibility in adult males and females after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), median hepatic collagen data, trimmed [ug hydroxyproline/g liver] x 337.37 425.12 542.4 476.38 445.79 x 325.96 x x 414.98 475.42 380.33 361.7 x x x 351.92 x x x 181.2 326.41 x x 331.86 292.31 289.35 x 337.0 472.87 356.72 280.62 x x x 409.63 294.83 294.4 x 387.36 396.56 x x x x x x x 415.07 x x x 405.38 x x x x x 330.27 385.58 x x 489.62 x x x 366.11 x x 257.72 482.38 x 410.68 x x x x x x x x x x x 331.31 x x 320.06 x x x x x 275.53 x 538.41 x x x x x +14361 Original post publication description: Liver, toxicology, Fibrosis susceptibility after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, Days 1 and 4), mean liver to body weight ratio in males_data, trimmed [g] Original pre publication description: Hall trait 7 Hall trait 7 Liver, toxicology: Fibrosis susceptibility in adult males after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), mean liver to body weight ratio, trimmed [g] x 0.051 0.046 0.049 0.068 0.061 x x x x 0.063 x x 0.074 x x x 0.081 x x x x 0.064 x x x x x x x 0.064 0.064 x x x x 0.052 x 0.08 x x 0.063 x x x x x x x 0.047 x x x 0.075 x x x x x 0.058 0.049 x x 0.054 x x x 0.044 x x 0.061 0.049 x 0.051 x x x x x x x x x x x x x x 0.063 x x x x x 0.055 x 0.072 x x x x x +15171 Original post publication description: Central nervous system, behavior, learning and memory: Spatial navigation, latency to reach platform using Morris water maze (test 1, Trait Lat1 Table 1), males and females combined [sec] Original pre publication description: Central nervous system, behavior, learning and memory: Spatial navigation, latency to reach platform using Morris water maze (test 1, Trait Lat1 Table 1), males and females combined [sec] Central nervous system, behavior, learning and memory: Spatial navigation, latency to reach hidden platform using Morris water maze (test 1, Trait Lat1 Table 1), males and females combined [sec] Central nervous system, behavior, learning and memory: Spatial navigation, latency to reach hidden platform using Morris water maze (test 1, Trait Lat1 Table 1), males and females combined [sec] x x 34.916 25.027 70.138 38.916 22.138 49.277 33.111 24.555 29.027 54.166 51.555 30.0 75.583 41.277 46.805 51.0 61.194 74.25 27.138 24.444 x 38.555 30.916 55.166 56.611 70.722 47.194 47.444 25.583 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +15172 Original post publication description: Central nervous system, behavior, learning and memory: Spatial navigation, latency to reach platform using Morris water maze (test 2, Trait Lat2 Table 1), males and females combined [sec] Central nervous system, behavior, learning and memory: Spatial navigation, latency to reach platform using Morris water maze (test 2, Trait Lat2 Table 1), males and females combined [sec] Central nervous system, behavior, learning and memory: Spatial navigation, latency to reach hidden platform using Morris water maze (test 2, Trait Lat2 Table 1), males and females combined [sec] x x 17.388 17.333 36.388 24.194 13.5 33.75 34.25 30.0 17.416 31.416 36.861 28.805 45.194 34.416 32.416 44.638 41.222 40.111 17.444 24.388 x 23.388 18.388 28.638 31.916 47.944 21.222 42.944 20.638 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +15131 Original post publication description: Cardiovascular system: Systolic blood pressure of adult males raised in Memphis measured using a tail cuff system [mm Hg] None Cardiovascular system: Systolic blood pressure of adult males raised in Memphis measured using a tail cuff system (originally known as GN Trait 11017) [mm Hg] x x 100.3 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 83.0 112.8 103.3 x x x x x x x x x 98.4 107.7 x x x x 101.0 x x x 111.0 102.1 x 89.9 91.9 x 108.0 x 95.5 x 106.8 x x x x 91.6 81.7 x 90.0 91.8 x 112.4 x x 128.3 94.8 x 98.4 x x 102.9 99.8 x 96.1 x 100.5 99.6 x 112.8 +15132 Original post publication description: Cardiovascular system: Systolic blood pressure of adult females raised in Memphis measured using a tail cuff system [mm Hg] None Cardiovascular system: Systolic blood pressure of adult females raised in Memphis measured using a tail cuff system (originally known as GN Trait 12076) [mm Hg] x x 98.9 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 95.0 111.0 x x x x x x x x x x 101.9 103.8 x x x 99.5 96.5 x x x 104.5 95.5 x 93.5 92.9 x x x 108.8 x 105.8 x x x x 91.0 80.3 x x 89.2 x 108.2 x x 123.2 101.6 x x x x 107.0 x x 94.5 x 95.5 x x x +14933 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW49_7 in females + males Morphology, metabolism: Body weight at 49 days (7 weeks) in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 4.353 4.464 4.242 4.271 4.441 x 4.363 4.313 x 4.24 x x 4.529 4.419 4.529 x x x x x x 4.401 x x 4.419 x x x 4.46 4.383 4.232 x x x x 4.507 4.501 4.232 x 4.529 4.358 x x x x x x x 4.46 x x x x x x x x x 4.457 4.297 x x x x x 4.333 4.232 x x x 4.466 x 4.45 x x x x x x x x x x 4.443 4.232 x x 4.376 x x x x x 4.529 x x x x x x x +14934 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW56_8 in females + males Morphology, metabolism: Body weight at 56 days (8 weeks) in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 4.417 4.55 4.353 4.297 4.492 x 4.435 4.374 x 4.315 x x 4.622 4.469 4.618 x x x x x x 4.486 x x 4.46 x x x 4.539 4.468 4.323 x x x x 4.622 4.622 4.297 x 4.598 4.412 x x x x x x x 4.523 x x x x x x x x x 4.52 4.34 x x x x x 4.429 4.297 x x x 4.542 x 4.525 x x x x x x x x x x 4.564 4.297 x x 4.451 x x x x x 4.622 x x x x x x x +14935 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW63_9 in females + males Morphology, metabolism: Body weight at 63 days (9 weeks) in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 4.471 4.591 4.41 4.384 4.538 x 4.505 4.423 x 4.421 x x 4.678 4.55 4.678 x x x x x x 4.526 x x 4.544 x x x 4.603 4.518 4.384 x x x x 4.639 4.678 4.384 x 4.669 4.46 x x x x x x x 4.551 x x x x x x x x x 4.555 4.406 x x x x x 4.462 4.387 x x x 4.59 x 4.579 x x x x x x x x x x 4.678 4.384 x x 4.49 x x x x x 4.654 x x x x x x x +14936 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW70_10 in females + males Morphology, metabolism: Body weight at 70 days (10 weeks) in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 4.525 4.641 4.469 4.418 4.579 x 4.579 4.449 x 4.53 x x 4.752 4.589 4.752 x x x x x x 4.528 x x 4.612 x x x 4.65 4.569 4.418 x x x x 4.674 4.752 4.418 x 4.726 4.477 x x x x x x x 4.609 x x x x x x x x x 4.605 4.454 x x x x x 4.526 4.442 x x x 4.627 x 4.603 x x x x x x x x x x 4.752 4.418 x x 4.553 x x x x x 4.663 x x x x x x x +14937 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW77_11 in females + males Morphology, metabolism: Body weight at 77 days (11 weeks) in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 4.566 4.705 4.503 4.481 4.623 x 4.602 4.506 x 4.616 x x 4.837 4.638 4.837 x x x x x x 4.619 x x 4.686 x x x 4.688 4.596 4.481 x x x x 4.717 4.837 4.481 x 4.773 4.539 x x x x x x x 4.622 x x x x x x x x x 4.694 4.488 x x x x x 4.57 4.489 x x x 4.641 x 4.667 x x x x x x x x x x 4.837 4.481 x x 4.631 x x x x x 4.708 x x x x x x x +14938 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW84_12 in females + males Morphology, metabolism: Body weight at 84 days (12 weeks) in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 4.6 4.766 4.53 4.515 4.648 x 4.638 4.56 x 4.696 x x 4.881 4.669 4.881 x x x x x x 4.668 x x 4.731 x x x 4.748 4.629 4.515 x x x x 4.769 4.881 4.515 x 4.783 4.576 x x x x x x x 4.657 x x x x x x x x x 4.762 4.526 x x x x x 4.618 4.541 x x x 4.678 x 4.713 x x x x x x x x x x 4.881 4.515 x x 4.702 x x x x x 4.729 x x x x x x x +14939 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW91_13 in females + males Morphology, metabolism: Body weight at 91 days (13 weeks) in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 4.599 4.784 4.558 4.538 4.685 x 4.676 4.577 x 4.779 x x 4.902 4.717 4.902 x x x x x x 4.671 x x 4.784 x x x 4.81 4.648 4.538 x x x x 4.783 4.902 4.538 x 4.811 4.601 x x x x x x x 4.67 x x x x x x x x x 4.83 4.548 x x x x x 4.636 4.577 x x x 4.671 x 4.735 x x x x x x x x x x 4.902 4.538 x x 4.73 x x x x x 4.757 x x x x x x x +14940 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW98_14 in females + males Morphology, metabolism: Body weight at 98 days (14 weeks) in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 4.632 4.814 4.584 4.584 4.696 x 4.714 4.619 x 4.861 x x 4.989 4.742 4.989 x x x x x x 4.713 x x 4.803 x x x 4.855 4.633 4.584 x x x x 4.825 4.989 4.584 x 4.825 4.642 x x x x x x x 4.705 x x x x x x x x x 4.899 4.587 x x x x x 4.668 4.657 x x x 4.699 x 4.777 x x x x x x x x x x 4.989 4.584 x x 4.772 x x x x x 4.785 x x x x x x x +14941 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW105_15 in females + males Morphology, metabolism: Body weight at 105 days (15 weeks) in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 4.669 4.844 4.61 4.583 4.73 x 4.714 4.682 x 4.954 x x 5.043 4.765 5.043 x x x x x x 4.706 x x 4.852 x x x 4.898 4.682 4.583 x x x x 4.828 5.043 4.583 x 4.888 4.651 x x x x x x x 4.737 x x x x x x x x x 5.003 4.624 x x x x x 4.713 4.68 x x x 4.73 x 4.785 x x x x x x x x x x 5.043 4.583 x x 4.856 x x x x x 4.784 x x x x x x x +14942 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW112_16 in females + males Morphology, metabolism: Body weight at 112 days (16 weeks) in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 4.686 4.87 4.617 4.617 4.759 x 4.738 4.691 x 4.975 x x 5.103 4.815 5.089 x x x x x x 4.723 x x 4.887 x x x 4.903 4.693 4.621 x x x x 4.85 5.103 4.617 x 4.938 4.682 x x x x x x x 4.758 x x x x x x x x x 5.103 4.638 x x x x x 4.709 4.713 x x x 4.734 x 4.829 x x x x x x x x x x 5.103 4.617 x x 4.882 x x x x x 4.821 x x x x x x x +14943 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW119_17 in females + males Morphology, metabolism: Body weight at 119 days (17 weeks) in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 4.71 4.922 4.63 4.63 4.782 x 4.749 4.746 x 5.076 x x 5.17 4.792 5.17 x x x x x x 4.728 x x 4.88 x x x 4.949 4.691 4.653 x x x x 4.86 5.17 4.63 x 4.975 4.691 x x x x x x x 4.798 x x x x x x x x x 5.159 4.631 x x x x x 4.732 4.8 x x x 4.736 x 4.825 x x x x x x x x x x 5.17 4.63 x x 4.91 x x x x x 4.855 x x x x x x x +14944 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW126_18 in females + males Morphology, metabolism: Body weight at 126 days (18 weeks) in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 4.754 4.953 4.659 4.659 4.796 x 4.778 4.753 x 5.15 x x 5.185 x 5.184 x x x x x x 4.756 x x 4.935 x x x 4.977 4.718 4.673 x x x x 4.856 5.185 4.659 x 5.012 4.749 x x x x x x x 4.831 x x x x x x x x x 5.185 4.664 x x x x x 4.785 4.862 x x x 4.745 x 4.861 x x x x x x x x x x 5.185 4.659 x x 4.949 x x x x x 4.899 x x x x x x x +14945 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW133_19 in females + males Morphology, metabolism: Body weight at 133 days (19 weeks) in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 4.758 4.965 4.659 4.659 4.816 x 4.794 4.814 x 5.21 x x 5.259 x 5.259 x x x x x x 4.799 x x 4.949 x x x 5.037 4.728 4.705 x x x x 4.914 5.259 4.659 x 5.035 4.777 x x x x x x x 4.869 x x x x x x x x x 5.231 4.686 x x x x x 4.797 4.853 x x x 4.767 x 4.89 x x x x x x x x x x 5.259 4.659 x x 4.989 x x x x x 4.936 x x x x x x x +14946 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW140_20 in females + males Morphology, metabolism: Body weight at 140 days (20 weeks) in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 4.796 5.014 4.722 4.692 4.815 x 4.817 4.871 x 5.262 x x 5.254 x 5.262 x x x x x x 4.826 x x 4.973 x x x 5.067 4.741 4.692 x x x x 4.898 5.262 4.692 x 5.062 4.802 x x x x x x x 4.925 x x x x x x x x x 5.246 4.719 x x x x x 4.806 4.934 x x x 4.812 x 4.929 x x x x x x x x x x 5.262 4.692 x x 5.025 x x x x x 4.964 x x x x x x x +14947 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW4.5 in females + males Morphology, metabolism: Body weight gain between 4 and 5 weeks in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 2.305 2.285 2.231 2.202 2.509 x 2.365 2.204 x x x x 2.744 2.483 2.744 x x x x x x x x x 2.323 x x x 2.182 2.356 1.943 x x x x 1.929 2.744 2.327 x 2.368 1.929 x x x x x x x 2.364 x x x x x x x x x 2.694 2.233 x x x x x 2.293 2.351 x x x 2.413 x 2.497 x x x x x x x x x x 2.405 1.929 x x 2.282 x x x x x 2.74 x x x x x x x +14948 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW5.6 in females + males Morphology, metabolism: Body weight gain between 5 and 6 weeks in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.848 1.965 2.044 1.629 1.795 x 2.037 2.041 x 2.104 x x 1.933 1.629 2.26 x x x x x x 2.26 x x 2.247 x x x 2.17 2.245 2.179 x x x x 2.26 2.121 2.063 x 1.629 1.648 x x x x x x x 2.102 x x x x x x x x x 2.26 1.654 x x x x x 1.629 1.997 x x x 1.997 x 1.82 x x x x x x x x x x 2.235 1.811 x x 2.245 x x x x x 2.128 x x x x x x x +14949 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW6.7 in females + males Morphology, metabolism: Body weight gain between 6 and 7 weeks in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.433 1.685 1.723 1.495 1.496 x 1.82 1.655 x 1.493 x x 1.433 1.621 1.508 x x x x x x 1.978 x x 1.978 x x x 1.611 1.666 1.934 x x x x 1.433 1.868 1.433 x 1.763 1.793 x x x x x x x 1.579 x x x x x x x x x 1.768 1.812 x x x x x 1.654 1.455 x x x 1.978 x 1.452 x x x x x x x x x x 1.978 1.731 x x 1.737 x x x x x 1.604 x x x x x x x +14950 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW7.8 in females + males Morphology, metabolism: Body weight gain between 7 and 8 weeks in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.55 1.748 1.811 1.391 1.476 x 1.611 1.519 x 1.595 x x 1.948 1.465 1.655 x x x x x x 1.711 x x 1.391 x x x 1.695 1.707 1.707 x x x x 1.948 1.948 1.391 x 1.625 1.475 x x x x x x x 1.576 x x x x x x x x x 1.575 1.391 x x x x x 1.757 1.609 x x x 1.677 x 1.658 x x x x x x x x x x 1.948 1.594 x x 1.639 x x x x x 1.613 x x x x x x x +14951 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW8.9 in females + males Morphology, metabolism: Body weight gain between 8 and 9 weeks in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.499 1.421 1.499 1.343 1.446 x 1.614 1.44 x 1.802 x x 1.802 1.708 1.674 x x x x x x 1.396 x x 1.735 x x x 1.612 1.473 1.518 x x x x 1.299 1.802 1.32 x 1.69 1.438 x x x x x x x 1.299 x x x x x x x x x 1.361 1.559 x x x x x 1.324 1.718 x x x 1.484 x 1.528 x x x x x x x x x x 1.802 1.299 x x 1.378 x x x x x 1.299 x x x x x x x +14952 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW9.10 in females + males Morphology, metabolism: Body weight gain between 9 and 10 weeks in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 0.839 0.844 0.886 0.208 0.669 x 1.202 0.386 x 1.389 x x 1.389 0.651 1.258 x x x x x x 0.208 x x 1.125 x x x 0.802 0.83 0.461 x x x x 0.599 1.389 0.587 x 1.022 0.271 x x x x x x x 0.962 x x x x x x x x x 0.82 0.711 x x x x x 0.998 0.81 x x x 0.628 x 0.395 x x x x x x x x x x 1.389 0.208 x x 0.989 x x x x x 0.208 x x x x x x x +14953 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW10.11 in females + males Morphology, metabolism: Body weight gain between 10 and 11 weeks in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.415 1.649 1.344 1.28 1.454 x 1.28 1.531 x 1.776 x x 1.828 1.502 1.828 x x x x x x 1.804 x x 1.717 x x x 1.42 1.295 1.578 x x x x 1.475 1.705 1.452 x 1.522 1.576 x x x x x x x 1.28 x x x x x x x x x 1.828 1.336 x x x x x 1.438 1.447 x x x 1.28 x 1.634 x x x x x x x x x x 1.828 1.42 x x 1.73 x x x x x 1.481 x x x x x x x +14954 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW11.12 in females + males Morphology, metabolism: Body weight gain between 11 and 12 weeks in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.355 1.641 1.274 1.261 1.286 x 1.385 1.52 x 1.757 x x 1.757 1.344 1.56 x x x x x x 1.511 x x 1.487 x x x 1.634 1.35 1.335 x x x x 1.57 1.757 1.309 x 1.261 1.379 x x x x x x x 1.382 x x x x x x x x x 1.699 1.377 x x x x x 1.49 1.497 x x x 1.403 x 1.497 x x x x x x x x x x 1.757 1.261 x x 1.696 x x x x x 1.261 x x x x x x x +14955 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW12.13 in females + males Morphology, metabolism: Body weight gain between 12 and 13 weeks in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.13 1.299 1.36 1.13 1.466 x 1.475 1.259 x 1.767 x x 1.67 1.572 1.323 x x x x x x 1.13 x x 1.636 x x x 1.718 1.293 1.31 x x x x 1.248 1.767 1.453 x 1.408 1.337 x x x x x x x 1.231 x x x x x x x x x 1.767 1.31 x x x x x 1.274 1.434 x x x 1.13 x 1.332 x x x x x x x x x x 1.767 1.326 x x 1.4 x x x x x 1.39 x x x x x x x +14956 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW13.14 in females + males Morphology, metabolism: Body weight gain between 13 and 14 weeks in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.491 1.511 1.43 1.49 1.356 x 1.562 1.578 x 1.875 x x 1.562 1.441 1.862 x x x x x x 1.587 x x 1.398 x x x 1.657 1.356 1.605 x x x x 1.62 1.875 1.44 x 1.356 1.569 x x x x x x x 1.529 x x x x x x x x x 1.875 1.536 x x x x x 1.5 1.859 x x x 1.467 x 1.609 x x x x x x x x x x 1.875 1.356 x x 1.603 x x x x x 1.493 x x x x x x x +14957 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW14.15 in females + males Morphology, metabolism: Body weight gain between 14 and 15 weeks in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.444 1.407 1.332 1.255 1.432 x 1.061 1.662 x 1.874 x x 1.704 1.323 1.654 x x x x x x 1.061 x x 1.608 x x x 1.558 1.546 1.061 x x x x 1.092 1.301 1.275 x 1.734 1.153 x x x x x x x 1.41 x x x x x x x x x 1.874 1.429 x x x x x 1.526 1.308 x x x 1.395 x 1.147 x x x x x x x x x x 1.874 1.191 x x 1.874 x x x x x 1.061 x x x x x x x +14958 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW15.16 in females + males Morphology, metabolism: Body weight gain between 15 and 16 weeks in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.255 1.392 1.131 1.131 1.388 x 1.339 1.171 x 1.348 x x 1.577 1.605 1.627 x x x x x x 1.253 x x 1.488 x x x 1.137 1.2 1.482 x x x x 1.321 1.627 1.305 x 1.627 1.405 x x x x x x x 1.307 x x x x x x x x x 1.627 1.226 x x x x x 1.131 1.428 x x x 1.131 x 1.551 x x x x x x x x x x 1.566 1.158 x x 1.382 x x x x x 1.483 x x x x x x x +14959 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW16.17 in females + males Morphology, metabolism: Body weight gain between 16 and 17 weeks in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.519 1.812 1.425 1.236 1.528 x 1.402 1.783 x 1.963 x x 1.713 1.236 1.963 x x x x x x 1.345 x x 1.236 x x x 1.772 1.268 1.575 x x x x 1.399 1.91 1.32 x 1.687 1.375 x x x x x x x 1.682 x x x x x x x x x 1.906 1.411 x x x x x 1.52 1.963 x x x 1.309 x 1.236 x x x x x x x x x x 1.963 1.401 x x 1.595 x x x x x 1.659 x x x x x x x +14960 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW17.18 in females + males Morphology, metabolism: Body weight gain between 17 and 18 weeks in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.525 1.45 1.367 1.418 1.235 x 1.402 1.176 x 1.696 x x 1.176 x 1.284 x x x x x x 1.376 x x 1.696 x x x 1.427 1.365 1.292 x x x x 1.176 1.696 1.458 x 1.543 1.661 x x x x x x x 1.444 x x x x x x x x x 1.456 1.418 x x x x x 1.625 1.696 x x x 1.176 x 1.485 x x x x x x x x x x 1.639 1.184 x x 1.541 x x x x x 1.576 x x x x x x x +14961 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW18.19 in females + males Morphology, metabolism: Body weight gain between 18 and 19 weeks in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.407 1.552 1.416 1.407 1.607 x 1.57 1.932 x 1.952 x x 1.407 x 1.952 x x x x x x 1.799 x x 1.56 x x x 1.952 1.534 1.698 x x x x 1.952 1.501 1.699 x 1.674 1.672 x x x x x x x 1.777 x x x x x x x x x 1.947 1.606 x x x x x 1.532 1.407 x x x 1.625 x 1.7 x x x x x x x x x x 1.669 1.696 x x 1.839 x x x x x 1.785 x x x x x x x +14962 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW19.20 in females + males Morphology, metabolism: Body weight gain between 19 and 20 weeks in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.602 1.474 1.787 1.358 1.413 x 1.469 1.79 x 1.803 x x 1.391 x 1.517 x x x x x x 1.519 x x 1.506 x x x 1.599 1.355 1.355 x x x x 1.355 1.803 1.666 x 1.556 1.486 x x x x x x x 1.803 x x x x x x x x x 1.435 1.556 x x x x x 1.355 1.803 x x x 1.666 x 1.614 x x x x x x x x x x 1.495 1.453 x x 1.649 x x x x x 1.545 x x x x x x x +14963 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BL42_6 in females + males Morphology, metabolism: Body length from the nose until the tail at 42 days in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [cm] x 6.448 6.464 6.331 6.381 6.445 x 6.41 6.382 x 6.344 x x 6.464 6.371 6.459 x x x x x x 6.321 x x 6.307 x x x 6.402 6.366 6.292 x x x x 6.442 6.384 6.326 x 6.425 6.275 x x x x x x x 6.425 x x x x x x x x x 6.405 6.275 x x x x x 6.354 6.275 x x x 6.29 x 6.419 x x x x x x x x x x 6.464 6.275 x x 6.394 x x x x x 6.464 x x x x x x x +14964 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BL70_10 in females + males Morphology, metabolism: Body length from the nose until the tail at 70 days in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [cm] x 6.564 6.579 6.45 6.473 6.508 x 6.565 6.498 x 6.464 x x 6.579 6.552 6.56 x x x x x x 6.513 x x 6.481 x x x 6.562 6.502 6.476 x x x x 6.574 6.53 6.468 x 6.449 6.474 x x x x x x x 6.566 x x x x x x x x x 6.514 6.449 x x x x x 6.449 6.457 x x x 6.53 x 6.555 x x x x x x x x x x 6.579 6.449 x x 6.53 x x x x x 6.579 x x x x x x x +14965 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BL140_20 in females + males Morphology, metabolism: Body length from the nose until the tail at 140 days in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [cm] x 6.626 6.651 6.596 6.55 6.635 x 6.662 6.55 x 6.618 x x 6.67 x 6.67 x x x x x x 6.616 x x 6.559 x x x 6.604 6.573 6.558 x x x x 6.635 6.634 6.55 x 6.67 6.565 x x x x x x x 6.627 x x x x x x x x x 6.632 6.555 x x x x x 6.598 6.572 x x x 6.608 x 6.614 x x x x x x x x x x 6.67 6.55 x x 6.638 x x x x x 6.67 x x x x x x x +14966 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Gluc70_10 in females + males Morphology, metabolism: Serum glucose level at 70 days in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [mmol/l] x 6.447 6.546 6.502 6.468 6.621 x 6.416 6.454 x 6.665 x x 6.477 6.416 6.641 x x x x x x 6.612 x x 6.416 x x x 6.445 6.565 6.774 x x x x 6.521 6.727 6.419 x 6.432 6.625 x x x x x x x 6.774 x x x x x x x x x 6.416 6.726 x x x x x 6.705 6.774 x x x 6.774 x 6.461 x x x x x x x x x x 6.539 6.742 x x 6.489 x x x x x 6.724 x x x x x x x +14967 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Gluc140_20 in females + males Morphology, metabolism: Serum glucose level at 140 days in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [mmol/l] x 6.668 6.574 6.429 6.607 6.612 x 6.367 6.618 x 6.527 x x 6.885 x 6.342 x x x x x x 6.531 x x 6.704 x x x 6.619 6.342 6.56 x x x x 6.961 6.961 6.478 x 6.342 6.434 x x x x x x x 6.768 x x x x x x x x x 6.342 6.424 x x x x x 6.662 6.961 x x x 6.961 x 6.673 x x x x x x x x x x 6.919 6.797 x x 6.518 x x x x x 6.596 x x x x x x x +14968 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FoodIntake7.10 in females + males Morphology, metabolism: Food Intake between 7 and 10 weeks in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.504 1.485 1.402 1.43 1.592 x 1.613 1.704 x 1.58 x x 1.687 1.767 1.641 x x x x x x 1.454 x x 1.57 x x x 1.639 1.491 1.634 x x x x 1.846 1.83 1.402 x 1.856 1.444 x x x x x x x 1.724 x x x x x x x x x 1.484 1.402 x x x x x 1.613 1.856 x x x 1.856 x 1.566 x x x x x x x x x x 1.818 1.505 x x 1.402 x x x x x 1.856 x x x x x x x +14969 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FoodIntake17.20 in females + males Morphology, metabolism: Food Intake between 17 and 20 weeks in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.497 1.75 1.534 1.497 1.847 x 1.743 1.735 x 1.775 x x 2.003 x 1.758 x x x x x x 1.497 x x 1.964 x x x 1.614 1.591 1.703 x x x x 1.642 1.887 1.566 x 1.777 1.682 x x x x x x x 1.767 x x x x x x x x x 1.754 1.537 x x x x x 1.648 2.003 x x x 2.003 x 1.653 x x x x x x x x x x 1.99 1.497 x x 2.003 x x x x x 1.764 x x x x x x x +14970 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Brain in females + males Morphology, metabolism: Brain weight at 20 weeks in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.292 1.294 1.259 1.28 1.262 x 1.259 1.274 x 1.267 x x 1.283 1.282 1.294 x x x x x x 1.259 x x 1.259 x x x 1.281 1.268 1.277 x x x x 1.289 1.274 1.277 x 1.294 1.272 x x x x x x x 1.286 x x x x x x x x x 1.287 1.265 x x x x x 1.276 1.287 x x x 1.283 x 1.274 x x x x x x x x x x 1.294 1.259 x x 1.267 x x x x x 1.275 x x x x x x x +14971 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Liver in females + males Morphology, metabolism: Liver weight at 20 weeks in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.692 1.755 1.714 1.611 1.811 x 1.741 1.725 x 1.737 x x 1.969 1.611 1.885 x x x x x x 1.631 x x 1.822 x x x 1.718 1.708 1.611 x x x x 1.665 1.969 1.68 x 1.969 1.705 x x x x x x x 1.796 x x x x x x x x x 1.969 1.741 x x x x x 1.675 1.82 x x x 1.735 x 1.811 x x x x x x x x x x 1.969 1.611 x x 1.889 x x x x x 1.75 x x x x x x x +14972 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Kidney in females + males Morphology, metabolism: Kidney weight at 20 weeks in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.25 1.22 1.264 1.205 1.239 x 1.22 1.261 x 1.217 x x 1.272 1.225 1.228 x x x x x x 1.21 x x 1.235 x x x 1.205 1.257 1.225 x x x x 1.258 1.262 1.21 x 1.272 1.205 x x x x x x x 1.272 x x x x x x x x x 1.244 1.222 x x x x x 1.22 1.272 x x x 1.271 x 1.252 x x x x x x x x x x 1.267 1.205 x x 1.254 x x x x x 1.242 x x x x x x x +14973 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Spleen in females + males Morphology, metabolism: Spleen weight at 20 weeks in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.052 1.076 1.06 1.061 1.089 x 1.076 1.059 x 1.05 x x 1.089 1.05 1.089 x x x x x x 1.055 x x 1.073 x x x 1.066 1.077 1.052 x x x x 1.068 1.077 1.05 x 1.087 1.089 x x x x x x x 1.075 x x x x x x x x x 1.055 1.05 x x x x x 1.064 1.063 x x x 1.059 x 1.058 x x x x x x x x x x 1.061 1.05 x x 1.061 x x x x x 1.074 x x x x x x x +14974 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Heart in females + males Morphology, metabolism: Heart weight at 20 weeks in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.098 1.092 1.094 1.085 1.096 x 1.092 1.096 x 1.09 x x 1.109 1.085 1.101 x x x x x x 1.085 x x 1.109 x x x 1.085 1.085 1.092 x x x x 1.109 1.107 1.104 x 1.102 1.093 x x x x x x x 1.09 x x x x x x x x x 1.088 1.085 x x x x x 1.089 1.099 x x x 1.107 x 1.09 x x x x x x x x x x 1.109 1.085 x x 1.102 x x x x x 1.103 x x x x x x x +14975 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Lung in females + males Cardiovascular pulmonary system, morphology, metabolism: Lung weight at 20 weeks in females and males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.153 1.128 1.121 1.121 1.157 x 1.144 1.134 x 1.134 x x 1.143 1.141 1.138 x x x x x x 1.131 x x 1.141 x x x 1.121 1.136 1.124 x x x x 1.138 1.157 1.145 x 1.157 1.138 x x x x x x x 1.126 x x x x x x x x x 1.127 1.134 x x x x x 1.157 1.138 x x x 1.143 x 1.143 x x x x x x x x x x 1.134 1.121 x x 1.136 x x x x x 1.153 x x x x x x x +14976 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Pancreas in females + males Morphology, metabolism: Pancreas weight at 20 weeks in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.133 1.155 1.153 1.133 1.183 x 1.181 1.223 x 1.162 x x 1.223 1.183 1.2 x x x x x x 1.161 x x 1.16 x x x 1.16 1.154 1.155 x x x x 1.179 1.223 1.133 x 1.153 1.184 x x x x x x x 1.206 x x x x x x x x x 1.204 1.163 x x x x x 1.163 1.192 x x x 1.162 x 1.158 x x x x x x x x x x 1.223 1.158 x x 1.133 x x x x x 1.209 x x x x x x x +14977 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Muscle.femoralis in females + males Morphology, metabolism: The quadriceps (musculus rectus femulus, musculus vastus intermedius, musculus vastus lateralis, musculus vastus medialis) weight at 20 weeks in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.218 1.231 1.202 1.202 1.22 x 1.238 1.223 x 1.197 x x 1.253 1.253 1.253 x x x x x x 1.197 x x 1.204 x x x 1.2 1.196 1.243 x x x x 1.245 1.243 1.207 x 1.231 1.231 x x x x x x x 1.233 x x x x x x x x x 1.253 1.196 x x x x x 1.214 1.214 x x x 1.217 x 1.238 x x x x x x x x x x 1.227 1.196 x x 1.196 x x x x x 1.238 x x x x x x x +14978 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); M.longissimus.dorsi in females + males Morphology, metabolism: Muscle, Longissmus dorsi weight at 20 weeks in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.34 1.343 1.294 1.294 1.341 x 1.375 1.336 x 1.368 x x 1.375 1.347 1.339 x x x x x x 1.305 x x 1.294 x x x 1.363 1.302 1.352 x x x x 1.348 1.375 1.353 x 1.36 1.332 x x x x x x x 1.34 x x x x x x x x x 1.375 1.309 x x x x x 1.341 1.303 x x x 1.322 x 1.35 x x x x x x x x x x 1.34 1.294 x x 1.309 x x x x x 1.375 x x x x x x x +14979 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); RepF in females + males Morphology, metabolism: Reproductive adipose tissue weight at 20 weeks (epididymal adipose tissue in males and the periuterine and the periovarian adipose tissues in females) in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.494 1.664 1.529 1.371 1.371 x 1.371 1.688 x 2.043 x x 1.626 1.56 2.025 x x x x x x 1.779 x x 1.688 x x x 1.792 1.539 1.437 x x x x 1.516 2.043 1.483 x 1.499 1.533 x x x x x x x 1.724 x x x x x x x x x 2.043 1.45 x x x x x 1.511 1.754 x x x 1.414 x 1.607 x x x x x x x x x x 2.043 1.371 x x 1.84 x x x x x 1.494 x x x x x x x +14980 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); PerF in females + males Morphology, metabolism: Retroperitoneal adipose tissue weight at 20 weeks in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.108 1.168 1.143 1.082 1.082 x 1.082 1.188 x 1.285 x x 1.185 1.126 1.285 x x x x x x 1.185 x x 1.192 x x x 1.244 1.104 1.094 x x x x 1.103 1.285 1.092 x 1.119 1.155 x x x x x x x 1.184 x x x x x x x x x 1.245 1.123 x x x x x 1.122 1.167 x x x 1.082 x 1.12 x x x x x x x x x x 1.285 1.083 x x 1.109 x x x x x 1.132 x x x x x x x +14981 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); RenF in females + males Morphology, metabolism: Peritoneal adipose tissue weight at 20 weeks in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.054 1.055 1.055 1.04 1.048 x 1.04 1.102 x 1.252 x x 1.252 1.059 1.252 x x x x x x 1.099 x x 1.11 x x x 1.079 1.079 1.081 x x x x 1.046 1.169 1.04 x 1.04 1.043 x x x x x x x 1.123 x x x x x x x x x 1.245 1.052 x x x x x 1.098 1.139 x x x 1.104 x 1.063 x x x x x x x x x x 1.252 1.057 x x 1.094 x x x x x 1.093 x x x x x x x +14982 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Total.RenF in females + males Morphology, metabolism: Total retroperitoneal and peritneal adipose tissue weight at 20 weeks in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.158 1.217 1.192 1.127 1.127 x 1.127 1.279 x 1.47 x x 1.413 1.18 1.47 x x x x x x 1.272 x x 1.289 x x x 1.312 1.178 1.171 x x x x 1.146 1.47 1.127 x 1.156 1.194 x x x x x x x 1.293 x x x x x x x x x 1.455 1.171 x x x x x 1.212 1.292 x x x 1.175 x 1.167 x x x x x x x x x x 1.47 1.137 x x 1.197 x x x x x 1.217 x x x x x x x +14983 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); MesF in females + males Morphology, metabolism: Adipose tissue hanging at the intestine in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.258 1.228 1.198 1.164 1.21 x 1.164 1.273 x 1.511 x x 1.46 1.185 1.511 x x x x x x 1.257 x x 1.323 x x x 1.369 1.231 1.164 x x x x 1.197 1.511 1.165 x 1.222 1.164 x x x x x x x 1.381 x x x x x x x x x 1.361 1.22 x x x x x 1.273 1.337 x x x 1.268 x 1.21 x x x x x x x x x x 1.511 1.164 x x 1.387 x x x x x 1.287 x x x x x x x +14984 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); IngF in females + males Morphology, metabolism: Inguinal adipose tissue weight at 20 weeks in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.226 1.347 1.316 1.226 1.293 x 1.254 1.313 x 1.66 x x 1.621 1.268 1.66 x x x x x x 1.465 x x 1.427 x x x 1.527 1.25 1.226 x x x x 1.255 1.66 1.263 x 1.393 1.268 x x x x x x x 1.3 x x x x x x x x x 1.572 1.247 x x x x x 1.388 1.411 x x x 1.241 x 1.318 x x x x x x x x x x 1.66 1.226 x x 1.476 x x x x x 1.332 x x x x x x x +14985 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); GlutF in females + males Morphology, metabolism: Subcutaneous adipose tissue upon the gluteal Mucsculus maximus between the legs, left and right of the tail in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.132 1.292 1.215 1.112 1.161 x 1.112 1.254 x 1.37 x x 1.296 1.279 1.331 x x x x x x 1.328 x x 1.354 x x x 1.37 1.172 1.112 x x x x 1.188 1.226 1.199 x 1.328 1.249 x x x x x x x 1.147 x x x x x x x x x 1.345 1.127 x x x x x 1.199 1.28 x x x 1.139 x 1.208 x x x x x x x x x x 1.37 1.112 x x 1.37 x x x x x 1.212 x x x x x x x +14986 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); SubF in females + males Morphology, metabolism: Total subcutaneous adipose tissue weight at 20 weeks in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.701 1.987 1.859 1.679 1.757 x 1.679 1.945 x 2.557 x x 2.45 1.81 2.557 x x x x x x 2.128 x x 2.202 x x x 2.377 1.768 1.679 x x x x 1.783 2.557 1.851 x 2.118 1.748 x x x x x x x 1.889 x x x x x x x x x 2.496 1.688 x x x x x 1.921 2.12 x x x 1.719 x 1.968 x x x x x x x x x x 2.557 1.679 x x 2.435 x x x x x 1.91 x x x x x x x +14987 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); WAT in females + males Morphology, metabolism: Total white adipose weight at 20 weeks in the whole body in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.546 2.019 1.736 1.216 1.433 x 1.216 2.116 x 3.058 x x 2.739 1.669 3.058 x x x x x x 2.298 x x 2.339 x x x 2.627 1.685 1.216 x x x x 1.598 3.058 1.619 x 2.002 1.66 x x x x x x x 2.135 x x x x x x x x x 2.927 1.484 x x x x x 1.873 2.343 x x x 1.517 x 1.923 x x x x x x x x x x 3.058 1.216 x x 2.64 x x x x x 1.878 x x x x x x x +14988 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BAT in females + males Morphology, metabolism: Brown adipose tissue located on the back, along the upper half of the spine and toward the shoulders in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.11 1.108 1.117 1.081 1.139 x 1.101 1.219 x 1.249 x x 1.303 1.081 1.303 x x x x x x 1.138 x x 1.141 x x x 1.187 1.145 1.081 x x x x 1.092 1.303 1.102 x 1.133 1.153 x x x x x x x 1.137 x x x x x x x x x 1.208 1.117 x x x x x 1.108 1.161 x x x 1.111 x 1.131 x x x x x x x x x x 1.303 1.081 x x 1.151 x x x x x 1.169 x x x x x x x +14989 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Carcass in females + males Morphology, metabolism: Skeleton with muscle (excluding the Longissmus dorsi and femoral muscle) weight at 20 weeks in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 3.233 3.376 3.008 3.008 3.225 x 3.313 3.161 x 3.187 x x 3.399 3.282 3.318 x x x x x x 3.008 x x 3.168 x x x 3.223 3.073 3.199 x x x x 3.324 3.399 3.008 x 3.399 3.158 x x x x x x x 3.205 x x x x x x x x x 3.345 3.03 x x x x x 3.096 3.126 x x x 3.146 x 3.242 x x x x x x x x x x 3.399 3.008 x x 3.216 x x x x x 3.388 x x x x x x x +14990 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); NeckF in females + males Morphology, metabolism: Fat weight around the neck at 20 weeks in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.062 1.107 1.085 1.062 1.064 x 1.064 1.147 x 1.185 x x 1.174 1.081 1.147 x x x x x x 1.116 x x 1.176 x x x 1.185 1.068 1.062 x x x x 1.076 1.121 1.116 x 1.132 1.075 x x x x x x x 1.087 x x x x x x x x x 1.143 1.084 x x x x x 1.07 1.131 x x x 1.084 x 1.096 x x x x x x x x x x 1.185 1.062 x x 1.185 x x x x x 1.096 x x x x x x x +14991 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); AbdominalF in females + males Morphology, metabolism: Fat weight in the visceral organs (liver, lung) at 20 weeks in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.029 1.017 1.028 1.017 1.021 x 1.045 1.041 x 1.074 x x 1.068 1.027 1.074 x x x x x x 1.029 x x 1.017 x x x 1.073 1.039 1.019 x x x x 1.034 1.074 1.03 x 1.017 1.045 x x x x x x x 1.048 x x x x x x x x x 1.074 1.045 x x x x x 1.059 1.061 x x x 1.031 x 1.048 x x x x x x x x x x 1.073 1.027 x x 1.059 x x x x x 1.034 x x x x x x x +14992 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Res.SubF in females + males Morphology, metabolism: Residual subcutaneous fat weight at 20 weeks in females + males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.236 1.258 1.31 1.216 1.263 x 1.216 1.43 x 1.881 x x 1.738 1.28 1.811 x x x x x x 1.376 x x 1.388 x x x 1.638 1.216 1.216 x x x x 1.295 1.881 1.309 x 1.333 1.225 x x x x x x x 1.428 x x x x x x x x x 1.881 1.256 x x x x x 1.399 1.498 x x x 1.288 x 1.48 x x x x x x x x x x 1.881 1.262 x x 1.486 x x x x x 1.292 x x x x x x x +14993 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FAT42, males Morphology, metabolism: Total fat weight measured by Magnetic Resonance Interference (MRI) at 42 days in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.675 1.745 2.196 1.838 1.734 x 1.839 1.76 x 1.675 x x 2.219 1.675 2.137 x x x x x x 2.384 x x 2.384 x x x 2.02 2.384 1.675 x x x x 2.384 2.37 1.997 x 2.117 2.034 x x x x x x x 2.113 x x x x x x x x x 2.13 2.115 x x x x x 2.211 1.943 x x x 1.981 x 2.072 x x x x x x x x x x 1.947 1.723 x x 2.302 x x x x x 2.038 x x x x x x x +14994 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FAT56, males Morphology, metabolism: Total fat weight measured by Magnetic Resonance Interference (MRI) at 56 days in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.904 2.056 2.542 1.848 1.926 x 1.999 1.937 x 1.989 x x 2.703 1.848 2.464 x x x x x x 2.731 x x 2.731 x x x 2.109 2.724 1.848 x x x x 2.731 2.731 2.107 x 2.199 2.092 x x x x x x x 2.218 x x x x x x x x x 2.217 2.399 x x x x x 2.603 1.917 x x x 2.444 x 2.029 x x x x x x x x x x 2.711 1.848 x x 2.387 x x x x x 2.199 x x x x x x x +14995 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FAT70, males Morphology, metabolism: Total fat weight measured by Magnetic Resonance Interference (MRI) at 70 days in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 2.029 2.41 2.761 1.945 2.075 x 2.131 1.945 x 2.488 x x 3.152 2.077 2.748 x x x x x x 3.014 x x 3.152 x x x 2.354 2.955 1.945 x x x x 2.492 3.152 2.103 x 2.315 2.083 x x x x x x x 2.301 x x x x x x x x x 2.297 2.635 x x x x x 2.893 2.354 x x x 2.615 x 2.406 x x x x x x x x x x 3.152 1.945 x x 2.578 x x x x x 2.159 x x x x x x x +14996 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FAT84, males Morphology, metabolism: Total fat weight measured by Magnetic Resonance Interference (MRI) at 84 days in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.381 2.316 2.272 1.164 1.465 x 1.596 1.164 x 2.623 x x 3.204 1.241 2.639 x x x x x x 2.584 x x 3.204 x x x 2.11 2.526 1.164 x x x x 2.014 3.204 1.572 x 1.722 1.534 x x x x x x x 1.737 x x x x x x x x x 1.764 2.696 x x x x x 2.615 1.968 x x x 2.01 x 2.075 x x x x x x x x x x 3.204 1.164 x x 2.4 x x x x x 1.704 x x x x x x x +14997 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FAT112, males Morphology, metabolism: Total fat weight measured by Magnetic Resonance Interference (MRI) at 112 days in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.849 2.878 2.43 1.762 2.221 x 1.762 2.156 x 3.53 x x 3.626 2.176 3.284 x x x x x x 2.68 x x 3.545 x x x 2.933 2.483 1.762 x x x x 2.246 3.626 2.264 x 2.797 2.008 x x x x x x x 2.443 x x x x x x x x x 1.934 3.626 x x x x x 3.053 2.687 x x x 2.27 x 2.252 x x x x x x x x x x 3.626 1.762 x x 2.997 x x x x x 2.317 x x x x x x x +14998 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FAT140, males Morphology, metabolism: Total fat weight measured by Magnetic Resonance Interference (MRI) at 140 days in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 2.669 3.325 2.805 2.234 2.44 x 2.342 3.026 x 3.87 x x 3.822 2.37 3.87 x x x x x x 2.99 x x 3.735 x x x 3.574 2.614 2.234 x x x x 2.479 3.87 2.809 x 3.21 2.513 x x x x x x x 3.007 x x x x x x x x x 2.234 3.87 x x x x x 3.377 3.411 x x x 2.28 x 2.773 x x x x x x x x x x 3.845 2.234 x x 3.454 x x x x x 3.002 x x x x x x x +14999 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FatGain7.10, males Morphology, metabolism: Fat gain between 7 and 10 weeks in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.86 2.21 2.331 1.572 1.829 x 1.795 1.635 x 2.372 x x 2.588 1.889 2.318 x x x x x x 2.345 x x 2.588 x x x 1.897 2.294 1.572 x x x x 1.616 2.588 1.572 x 1.724 1.572 x x x x x x x 1.709 x x x x x x x x x 1.68 2.184 x x x x x 2.45 1.975 x x x 2.277 x 1.911 x x x x x x x x x x 2.588 1.583 x x 1.889 x x x x x 1.598 x x x x x x x +15000 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FatGain17.20, males Morphology, metabolism: Fat gain between 17 and 20 weeks in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 2.525 2.012 2.056 1.648 1.648 x 2.017 2.985 x 3.337 x x 2.539 2.265 3.337 x x x x x x 1.98 x x 2.478 x x x 3.262 1.648 2.196 x x x x 1.822 3.337 2.415 x 2.992 2.267 x x x x x x x 2.746 x x x x x x x x x 1.719 3.337 x x x x x 2.647 3.125 x x x 1.648 x 2.209 x x x x x x x x x x 2.442 1.844 x x 2.941 x x x x x 2.756 x x x x x x x +15001 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); LEAN42, males Morphology, metabolism: Total lean weight measured by Magnetic Resonance Interference (MRI) at 42 days in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 4.22 4.263 3.993 4.066 4.308 x 4.147 4.167 x 4.001 x x 4.315 4.236 4.315 x x x x x x 4.018 x x 4.159 x x x 4.229 4.02 4.038 x x x x 4.133 4.219 4.055 x 4.315 4.061 x x x x x x x 4.278 x x x x x x x x x 3.993 4.211 x x x x x 4.11 3.993 x x x 4.205 x 4.157 x x x x x x x x x x 4.093 3.993 x x 4.063 x x x x x 4.315 x x x x x x x +15002 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); LEAN56, males Morphology, metabolism: Total lean weight measured by Magnetic Resonance Interference (MRI) at 56 days in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 4.29 4.431 4.128 4.231 4.409 x 4.308 4.268 x 4.128 x x 4.431 4.317 4.418 x x x x x x 4.128 x x 4.295 x x x 4.376 4.191 4.279 x x x x 4.354 4.391 4.131 x 4.431 4.262 x x x x x x x 4.382 x x x x x x x x x 4.128 4.401 x x x x x 4.235 4.161 x x x 4.37 x 4.312 x x x x x x x x x x 4.286 4.148 x x 4.287 x x x x x 4.431 x x x x x x x +15003 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); LEAN70, males Morphology, metabolism: Total lean weight measured by Magnetic Resonance Interference (MRI) at 70 days in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 4.406 4.483 4.206 4.241 4.45 x 4.438 4.34 x 4.223 x x 4.488 4.411 4.486 x x x x x x 4.206 x x 4.355 x x x 4.442 4.276 4.384 x x x x 4.488 4.467 4.206 x 4.488 4.317 x x x x x x x 4.454 x x x x x x x x x 4.218 4.468 x x x x x 4.306 4.233 x x x 4.438 x 4.385 x x x x x x x x x x 4.392 4.206 x x 4.386 x x x x x 4.488 x x x x x x x +15004 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); LEAN84, males Morphology, metabolism: Total lean weight measured by Magnetic Resonance Interference (MRI) at 84 days in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 4.429 4.559 4.25 4.296 4.517 x 4.489 4.417 x 4.299 x x 4.58 4.475 4.555 x x x x x x 4.25 x x 4.409 x x x 4.491 4.345 4.422 x x x x 4.58 4.58 4.278 x 4.58 4.374 x x x x x x x 4.472 x x x x x x x x x 4.25 4.56 x x x x x 4.393 4.343 x x x 4.491 x 4.468 x x x x x x x x x x 4.468 4.25 x x 4.452 x x x x x 4.517 x x x x x x x +15005 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); LEAN112, males Morphology, metabolism: Total lean weight measured by Magnetic Resonance Interference (MRI) at 112 days in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 4.483 4.594 4.319 4.361 4.541 x 4.568 4.497 x 4.368 x x 4.673 4.559 4.652 x x x x x x 4.319 x x 4.507 x x x 4.536 4.418 4.481 x x x x 4.673 4.673 4.356 x 4.673 4.432 x x x x x x x 4.518 x x x x x x x x x 4.319 4.664 x x x x x 4.438 4.421 x x x 4.539 x 4.552 x x x x x x x x x x 4.631 4.319 x x 4.564 x x x x x 4.58 x x x x x x x +15006 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); LEAN140, males Morphology, metabolism: Total lean weight measured by Magnetic Resonance Interference (MRI) at 140 days in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 23.174 25.824 21.444 20.819 24.023 x 24.09 23.846 x 21.922 x x 26.915 25.038 26.374 x x x x x x 20.819 x x 24.39 x x x 24.624 22.133 22.795 x x x x 25.24 26.915 21.52 x 26.915 22.922 x x x x x x x 23.815 x x x x x x x x x 20.819 26.915 x x x x x 23.003 23.186 x x x 25.683 x 24.192 x x x x x x x x x x 24.947 20.819 x x 24.796 x x x x x 25.833 x x x x x x x +15007 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); LeanGain7.10, males Morphology, metabolism: Lean gain between 7 and 10 weeks in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.359 1.662 1.486 1.115 1.115 x 1.985 1.197 x 1.411 x x 1.719 1.277 1.283 x x x x x x 1.115 x x 1.38 x x x 1.574 1.66 1.985 x x x x 1.985 1.807 1.115 x 1.742 1.697 x x x x x x x 1.336 x x x x x x x x x 1.431 1.856 x x x x x 1.331 1.579 x x x 1.693 x 1.61 x x x x x x x x x x 1.974 1.36 x x 1.985 x x x x x 1.34 x x x x x x x +15008 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); LeanGain17.20, males Morphology, metabolism: Lean gain between 17 and 20 weeks in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.862 2.086 2.242 1.745 1.746 x 1.864 2.166 x 2.083 x x 2.374 2.263 2.285 x x x x x x 1.814 x x 2.362 x x x 2.051 1.929 1.745 x x x x 1.745 2.374 2.014 x 2.144 2.064 x x x x x x x 1.858 x x x x x x x x x 1.913 2.374 x x x x x 1.996 2.29 x x x 2.374 x 2.02 x x x x x x x x x x 2.27 1.745 x x 2.294 x x x x x 2.306 x x x x x x x +15009 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW28_4, males Morphology, metabolism: Body weight at 28 days (4 weeks) in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 3.769 3.765 3.523 3.751 3.928 x 3.624 3.634 x x x x 3.917 3.532 3.736 x x x x x x 3.556 x x 3.544 x x x 3.832 3.751 3.523 x x x x 3.928 3.691 3.565 x 3.928 3.885 x x x x x x x 3.788 x x x x x x x x x 3.61 3.523 x x x x x 3.829 3.523 x x x 3.632 x 3.846 x x x x x x x x x x 3.542 3.583 x x 3.645 x x x x x 3.928 x x x x x x x +15010 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW35_5, males Morphology, metabolism: Body weight at 35 days (5 weeks) in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 4.295 4.303 4.088 4.212 4.406 x 4.167 4.173 x 4.036 x x 4.406 4.154 4.406 x x x x x x 4.036 x x 4.221 x x x 4.293 4.162 4.036 x x x x 4.325 4.342 4.154 x 4.406 4.238 x x x x x x x 4.281 x x x x x x x x x 4.108 4.238 x x x x x 4.3 4.089 x x x 4.248 x 4.335 x x x x x x x x x x 4.11 4.036 x x 4.154 x x x x x 4.404 x x x x x x x +15011 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW42_6, males Morphology, metabolism: Body weight at 42 days (6 weeks) in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 4.436 4.504 4.254 4.326 4.539 x 4.398 4.384 x 4.254 x x 4.606 4.416 4.606 x x x x x x 4.425 x x 4.51 x x x 4.496 4.417 4.254 x x x x 4.505 4.569 4.328 x 4.606 4.369 x x x x x x x 4.547 x x x x x x x x x 4.279 4.499 x x x x x 4.433 4.272 x x x 4.452 x 4.472 x x x x x x x x x x 4.366 4.254 x x 4.423 x x x x x 4.606 x x x x x x x +15012 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW49_7, males Morphology, metabolism: Body weight at 49 days (7 weeks) in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 4.509 4.611 4.362 4.392 4.6 x 4.531 4.491 x 4.362 x x 4.695 4.488 4.695 x x x x x x 4.54 x x 4.666 x x x 4.598 4.541 4.37 x x x x 4.609 4.684 4.396 x 4.695 4.491 x x x x x x x 4.63 x x x x x x x x x 4.429 4.614 x x x x x 4.557 4.362 x x x 4.641 x 4.527 x x x x x x x x x x 4.539 4.362 x x 4.555 x x x x x 4.695 x x x x x x x +15013 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW56_8, males Morphology, metabolism: Body weight at 56 days (8 weeks) in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 4.578 4.711 4.489 4.434 4.663 x 4.58 4.535 x 4.434 x x 4.771 4.547 4.771 x x x x x x 4.619 x x 4.735 x x x 4.673 4.632 4.461 x x x x 4.763 4.771 4.434 x 4.771 4.555 x x x x x x x 4.695 x x x x x x x x x 4.451 4.706 x x x x x 4.655 4.434 x x x 4.727 x 4.611 x x x x x x x x x x 4.706 4.434 x x 4.634 x x x x x 4.761 x x x x x x x +15014 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW63_9, males Morphology, metabolism: Body weight at 63 days (9 weeks) in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 4.609 4.757 4.558 4.503 4.693 x 4.647 4.573 x 4.51 x x 4.833 4.623 4.833 x x x x x x 4.679 x x 4.82 x x x 4.734 4.709 4.514 x x x x 4.833 4.833 4.503 x 4.821 4.593 x x x x x x x 4.715 x x x x x x x x x 4.503 4.76 x x x x x 4.698 4.524 x x x 4.78 x 4.689 x x x x x x x x x x 4.817 4.503 x x 4.682 x x x x x 4.791 x x x x x x x +15015 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW70_10, males Morphology, metabolism: Body weight at 70 days (10 weeks) in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 4.676 4.812 4.62 4.549 4.738 x 4.717 4.594 x 4.599 x x 4.911 4.674 4.911 x x x x x x 4.694 x x 4.898 x x x 4.778 4.768 4.567 x x x x 4.86 4.911 4.549 x 4.864 4.615 x x x x x x x 4.769 x x x x x x x x x 4.549 4.833 x x x x x 4.76 4.6 x x x 4.822 x 4.732 x x x x x x x x x x 4.911 4.549 x x 4.757 x x x x x 4.81 x x x x x x x +15016 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW77_11, males Morphology, metabolism: Body weight at 77 days (11 weeks) in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 4.711 4.887 4.647 4.585 4.781 x 4.745 4.652 x 4.708 x x 4.994 4.721 4.994 x x x x x x 4.723 x x 4.992 x x x 4.813 4.806 4.613 x x x x 4.93 4.994 4.585 x 4.917 4.678 x x x x x x x 4.788 x x x x x x x x x 4.585 4.95 x x x x x 4.808 4.639 x x x 4.832 x 4.799 x x x x x x x x x x 4.994 4.585 x x 4.812 x x x x x 4.851 x x x x x x x +15017 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW84_12, males Morphology, metabolism: Body weight at 84 days (12 weeks) in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 4.752 4.97 4.688 4.628 4.814 x 4.794 4.716 x 4.814 x x 5.051 4.753 5.051 x x x x x x 4.78 x x 5.048 x x x 4.894 4.831 4.643 x x x x 4.98 5.051 4.628 x 4.934 4.717 x x x x x x x 4.824 x x x x x x x x x 4.628 5.029 x x x x x 4.883 4.711 x x x 4.876 x 4.861 x x x x x x x x x x 5.051 4.628 x x 4.902 x x x x x 4.873 x x x x x x x +15018 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW91_13, males Morphology, metabolism: Body weight at 91 days (13 weeks) in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 4.739 4.995 4.703 4.652 4.838 x 4.83 4.72 x 4.894 x x 5.109 4.83 5.088 x x x x x x 4.776 x x 5.109 x x x 4.965 4.832 4.669 x x x x 5.013 5.109 4.652 x 4.943 4.752 x x x x x x x 4.857 x x x x x x x x x 4.652 5.101 x x x x x 4.888 4.734 x x x 4.884 x 4.892 x x x x x x x x x x 5.109 4.652 x x 4.93 x x x x x 4.92 x x x x x x x +15019 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW98_14, males Morphology, metabolism: Body weight at 98 days (14 weeks) in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 4.775 5.035 4.739 4.696 4.853 x 4.872 4.783 x 4.977 x x 5.171 4.848 5.149 x x x x x x 4.785 x x 5.122 x x x 4.993 4.828 4.714 x x x x 5.052 5.171 4.696 x 4.99 4.787 x x x x x x x 4.881 x x x x x x x x x 4.696 5.171 x x x x x 4.956 4.823 x x x 4.916 x 4.929 x x x x x x x x x x 5.171 4.696 x x 4.97 x x x x x 4.946 x x x x x x x +15020 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW105_15, males Morphology, metabolism: Body weight at 105 days (15 weeks) in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 4.823 5.069 4.769 4.734 4.882 x 4.868 4.858 x 5.069 x x 5.272 4.894 5.195 x x x x x x 4.805 x x 5.171 x x x 5.049 4.846 4.734 x x x x 5.067 5.272 4.736 x 5.068 4.802 x x x x x x x 4.938 x x x x x x x x x 4.734 5.272 x x x x x 5.01 4.874 x x x 4.946 x 4.936 x x x x x x x x x x 5.272 4.734 x x 5.071 x x x x x 4.953 x x x x x x x +15021 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BW112_16, males Morphology, metabolism: Body weight at 112 days (16 weeks) in males on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 4.833 5.093 4.786 4.759 4.922 x 4.889 4.876 x 5.096 x x 5.328 4.931 5.253 x x x x x x 4.807 x x 5.21 x x x 5.079 4.865 4.759 x x x x 5.057 5.328 4.774 x 5.157 4.828 x x x x x x x 4.965 x x x x x x x x x 4.759 5.328 x x x x x 5.017 4.913 x x x 4.958 x 4.967 x x x x x x x x x x 5.328 4.759 x x 5.107 x x x x x 4.991 x x x x x x x +14886 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); BL140_20, females Morphology, metabolism: Body length from the nose until the tail at 140 days in females on high fat diet (45% energy from fat) feeding from 4 weeks on [cm] x 6.603 6.628 6.583 6.512 6.626 x 6.637 6.512 x 6.577 x 6.643 6.607 x 6.643 x x x x x x 6.597 x x 6.512 x x x 6.597 6.537 6.514 x x x x 6.575 6.581 6.52 x 6.643 6.557 x x x x x x x 6.607 x x x x x x x x x 6.595 6.564 x x x x x 6.55 6.535 x x x 6.555 x 6.596 x x x x x x x x x x 6.643 6.512 x x 6.607 x x x x x 6.637 x x x x x x x +14887 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Gluc70_10, females Morphology, metabolism: Serum glucose level at 70 days in females on high fat diet (45% energy from fat) feeding from 4 weeks on [mmol/l] x 6.379 6.513 6.619 6.288 6.453 x 6.456 6.682 x 6.745 x 6.495 6.288 6.288 6.56 x x x x x x 6.745 x x 6.328 x x x 6.436 6.288 6.745 x x x x 6.448 6.592 6.338 x 6.385 6.64 x x x x x x x 6.745 x x x x x x x x x 6.29 6.658 x x x x x 6.642 6.678 x x x 6.524 x 6.392 x x x x x x x x x x 6.558 6.672 x x 6.429 x x x x x 6.696 x x x x x x x +14888 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Gluc140_20, females Morphology, metabolism: Serum glucose level at 140 days in females on high fat diet (45% energy from fat) feeding from 4 weeks on [mmol/l] x 6.555 6.53 6.453 6.225 6.57 x 6.377 6.31 x 6.651 x 6.225 6.7 x 6.358 x x x x x x 6.389 x x 6.352 x x x 6.426 6.225 6.768 x x x x 6.819 6.581 6.435 x 6.317 6.459 x x x x x x x 6.819 x x x x x x x x x 6.225 6.399 x x x x x 6.648 6.819 x x x 6.819 x 6.509 x x x x x x x x x x 6.804 6.696 x x 6.412 x x x x x 6.495 x x x x x x x +14889 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FoodIntake7.10, females Morphology, metabolism: Food Intake between 7 and 10 weeks in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.489 1.418 1.372 1.369 1.48 x 1.757 1.87 x 1.42 x 1.901 1.596 1.651 1.458 x x x x x x 1.43 x x 1.394 x x x 1.611 1.429 1.65 x x x x 1.901 1.69 1.403 x 1.901 1.411 x x x x x x x 1.781 x x x x x x x x x 1.369 1.369 x x x x x 1.528 1.584 x x x 1.901 x 1.484 x x x x x x x x x x 1.833 1.472 x x 1.369 x x x x x 1.444 x x x x x x x +14890 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); FoodIntake17.20, females Morphology, metabolism: Food Intake between 17 and 20 weeks in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.455 1.826 1.455 1.455 1.907 x 1.748 1.755 x 1.667 x 2.107 1.871 2.107 1.575 x x x x x x 1.59 x x 2.001 x x x 1.463 1.571 1.79 x x x x 1.561 1.98 1.584 x 1.777 1.775 x x x x x x x 1.74 x x x x x x x x x 1.69 1.599 x x x x x 1.708 2.107 x x x 2.107 x 1.642 x x x x x x x x x x 1.912 1.455 x x 1.959 x x x x x 1.628 x x x x x x x +14891 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Brain, females Morphology, metabolism: Brain weight at 20 weeks in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.296 1.296 1.262 1.28 1.259 x 1.256 1.274 x 1.265 x 1.282 1.279 1.282 1.293 x x x x x x 1.256 x x 1.256 x x x 1.285 1.276 1.281 x x x x 1.292 1.279 1.28 x 1.296 1.276 x x x x x x x 1.285 x x x x x x x x x 1.294 1.27 x x x x x 1.275 1.292 x x x 1.286 x 1.276 x x x x x x x x x x 1.296 1.256 x x 1.268 x x x x x 1.28 x x x x x x x +14892 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Liver, females Morphology, metabolism: Liver weight at 20 weeks in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.658 1.688 1.67 1.57 1.719 x 1.685 1.633 x 1.656 x 1.78 1.627 1.57 1.741 x x x x x x 1.599 x x 1.61 x x x 1.632 1.644 1.574 x x x x 1.605 1.801 1.613 x 1.801 1.676 x x x x x x x 1.739 x x x x x x x x x 1.718 1.74 x x x x x 1.57 1.698 x x x 1.655 x 1.719 x x x x x x x x x x 1.801 1.57 x x 1.801 x x x x x 1.693 x x x x x x x +14893 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Kidney, females Morphology, metabolism: Kidney weight at 20 weeks in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.212 1.205 1.197 1.175 1.189 x 1.204 1.219 x 1.181 x 1.219 1.181 1.201 1.202 x x x x x x 1.173 x x 1.177 x x x 1.169 1.169 1.181 x x x x 1.209 1.213 1.169 x 1.219 1.172 x x x x x x x 1.219 x x x x x x x x x 1.183 1.185 x x x x x 1.171 1.197 x x x 1.189 x 1.209 x x x x x x x x x x 1.21 1.169 x x 1.198 x x x x x 1.211 x x x x x x x +14894 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Spleen, females Morphology, metabolism: Spleen weight at 20 weeks in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.061 1.077 1.071 1.061 1.111 x 1.066 1.069 x 1.055 x 1.087 1.101 1.055 1.111 x x x x x x 1.062 x x 1.079 x x x 1.065 1.087 1.055 x x x x 1.085 1.068 1.062 x 1.111 1.111 x x x x x x x 1.085 x x x x x x x x x 1.055 1.056 x x x x x 1.065 1.081 x x x 1.059 x 1.057 x x x x x x x x x x 1.063 1.055 x x 1.064 x x x x x 1.076 x x x x x x x +14895 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Heart, females Morphology, metabolism: Heart weight at 20 weeks in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.094 1.083 1.085 1.074 1.093 x 1.087 1.089 x 1.081 x 1.087 1.085 1.082 1.089 x x x x x x 1.081 x x 1.094 x x x 1.074 1.075 1.094 x x x x 1.096 1.091 1.091 x 1.096 1.09 x x x x x x x 1.083 x x x x x x x x x 1.074 1.081 x x x x x 1.082 1.087 x x x 1.096 x 1.083 x x x x x x x x x x 1.096 1.074 x x 1.092 x x x x x 1.096 x x x x x x x +14896 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Lung, females Morphology, metabolism: Lung weight at 20 weeks in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.151 1.124 1.112 1.13 1.153 x 1.146 1.151 x 1.142 x 1.112 1.128 1.141 1.122 x x x x x x 1.136 x x 1.151 x x x 1.112 1.122 1.114 x x x x 1.124 1.153 1.149 x 1.153 1.143 x x x x x x x 1.132 x x x x x x x x x 1.118 1.136 x x x x x 1.153 1.137 x x x 1.15 x 1.145 x x x x x x x x x x 1.137 1.112 x x 1.136 x x x x x 1.149 x x x x x x x +14897 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Pancreas, females Morphology, metabolism: Pancreas weight at 20 weeks in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.131 1.141 1.156 1.131 1.198 x 1.202 1.208 x 1.144 x 1.208 1.175 1.175 1.196 x x x x x x 1.155 x x 1.171 x x x 1.154 1.143 1.153 x x x x 1.162 1.208 1.131 x 1.156 1.174 x x x x x x x 1.208 x x x x x x x x x 1.165 1.174 x x x x x 1.146 1.205 x x x 1.17 x 1.153 x x x x x x x x x x 1.204 1.158 x x 1.131 x x x x x 1.181 x x x x x x x +14898 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); Muscle.femoralis, females Morphology, metabolism: Quadriceps (musculus rectus femulus, musculus vastus intermedius, musculus vastus lateralis, musculus vastus medialis) weight at 20 weeks in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.207 1.221 1.192 1.193 1.196 x 1.225 1.235 x 1.18 x 1.225 1.21 1.235 1.235 x x x x x x 1.189 x x 1.18 x x x 1.19 1.18 1.227 x x x x 1.231 1.233 1.18 x 1.227 1.211 x x x x x x x 1.206 x x x x x x x x x 1.235 1.197 x x x x x 1.182 1.215 x x x 1.194 x 1.228 x x x x x x x x x x 1.219 1.18 x x 1.18 x x x x x 1.22 x x x x x x x +14899 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); M.longissimus.dorsi, females Morphology, metabolism: Muscle, Longissmus dorsi weight at 20 weeks in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.301 1.306 1.268 1.268 1.298 x 1.338 1.306 x 1.298 x 1.332 1.278 1.314 1.314 x x x x x x 1.271 x x 1.268 x x x 1.337 1.285 1.338 x x x x 1.313 1.338 1.31 x 1.338 1.292 x x x x x x x 1.301 x x x x x x x x x 1.337 1.305 x x x x x 1.299 1.274 x x x 1.283 x 1.329 x x x x x x x x x x 1.312 1.268 x x 1.275 x x x x x 1.338 x x x x x x x +14900 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); RepF, females Morphology, metabolism: Reproductive adipose tissue weight at 20 weeks (epididymal adipose tissue in males and the periuterine and the periovarian adipose tissues in females) in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.236 1.427 1.275 1.213 1.172 x 1.178 1.238 x 1.786 x 1.786 1.167 1.407 1.483 x x x x x x 1.672 x x 1.241 x x x 1.521 1.263 1.247 x x x x 1.202 1.709 1.167 x 1.219 1.364 x x x x x x x 1.375 x x x x x x x x x 1.786 1.435 x x x x x 1.167 1.487 x x x 1.174 x 1.376 x x x x x x x x x x 1.786 1.306 x x 1.567 x x x x x 1.167 x x x x x x x +14901 None Obesity, Brockmann (gudrun.brockmann@agrar.hu-berlin.de); High Fat Diet between 4 and 20 weeks (Ssniff(R) diet S8074-E010, Germany: The diet contained 20.7% crude protein, 25.1% crude fat, 5.0% crude fiber, 5.9% crude ash, 39.7% N-free extract, 20.0% starch, 17.5% sugar, vitamins, trace elements, amino acids, and minerals (19.1 MJ/kg metabolizable energy; thereof 45% energy from fat, 31% from carbohydrates, and 24% from proteins). The fat in the diet derived from coconut oil and suet.); PerF, females Morphology, metabolism: Retroperitoneal adipose tissue weight at 20 weeks in females on high fat diet (45% energy from fat) feeding from 4 weeks on [g] x 1.039 1.087 1.05 1.033 1.045 x 1.029 1.041 x 1.175 x 1.175 1.026 1.061 1.17 x x x x x x 1.123 x x 1.055 x x x 1.131 1.054 1.054 x x x x 1.032 1.175 1.026 x 1.049 1.097 x x x x x x x 1.059 x x x x x x x x x 1.15 1.109 x x x x x 1.026 1.075 x x x 1.026 x 1.08 x x x x x x x x x x 1.175 1.048 x x 1.051 x x x x x 1.027 x x x x x x x +14807 None bacterial infection, Eva Medina (Eva.Medina@helmholtz-hzi.de), blood Infectious disease, immune function: Susceptibility to Staphylococcus aureus, colony forming units (CFU) in blood 48h after infection of 10E5 CFU per mouse in 10-14 old females [CFU (log10)] x 1.1 1.1 2.0 1.8 1.3 x 0.0 x x 1.4 x 1.7 x x 0.5 x x x 0.7 x x x x x x 0.0 x x 1.3 1.2 x 1.1 x x x x 0.0 1.0 x x 3.0 x x x x x x x 0.0 x x x x x x x x x x 1.0 x x x x x 1.6 0.7 x x x 0.9 x 0.7 x x x x x x x x x x 0.5 0.0 x x 0.7 x x x x x 0.9 x x x x x x x +14808 None bacterial infection, Eva Medina (Eva.Medina@helmholtz-hzi.de), kidney Infectious disease, immune function: Susceptibility to Staphylococcus aureus, colony forming units (CFU) in kidney 48h after infection of 10E5 CFU per mouse in 10-14 old females [CFU (log10)] x 5.6 4.9 8.3 7.3 5.7 x 7.6 x x 7.6 x 8.1 x x 6.8 x x x 6.6 x x x x x x 6.3 x x 6.3 7.2 x 6.6 x x x x 5.1 6.0 x x 6.8 x x x x x x x 6.3 x x x x x x x x x x 5.9 x x x x x 5.8 7.5 x x x 6.2 x 5.9 x x x x x x x x x x 6.8 6.4 x x 6.5 x x x x x 7.3 x x x x x x x +14809 None bacterial infection, Eva Medina (Eva.Medina@helmholtz-hzi.de), liver Infectious disease, immune function: Susceptibility to Staphylococcus aureus, colony forming units (CFU) in liver 48h after infection of 10E5 CFU per mouse in 10-14 old females [CFU (log10)] x 5.3 5.6 6.3 7.0 6.0 x 3.2 x x 5.8 x 6.7 x x 5.4 x x x 5.5 x x x x x x 5.3 x x 5.4 5.8 x 5.4 x x x x 5.4 5.8 x x 6.5 x x x x x x x 5.7 x x x x x x x x x x 6.3 x x x x x 7.6 5.8 x x x 5.8 x 5.8 x x x x x x x x x x 4.9 6.0 x x 5.9 x x x x x 5.9 x x x x x x x +14810 None bacterial infection, Eva Medina (Eva.Medina@helmholtz-hzi.de), heart Infectious disease, immune function: Susceptibility to Staphylococcus aureus, colony forming units (CFU) in heart 48h after infection of 10E5 CFU per mouse in 10-14 old females [CFU (log10)] x 3.2 4.9 7.9 6.1 5.7 x 0.0 x x 7.9 x 7.4 x x 5.1 x x x 5.6 x x x x x x 2.0 x x 5.6 7.0 x 5.3 x x x x 2.9 6.1 x x 5.2 x x x x x x x 5.6 x x x x x x x x x x 1.8 x x x x x 3.2 6.9 x x x 4.2 x 5.3 x x x x x x x x x x 6.6 6.8 x x 3.6 x x x x x 7.3 x x x x x x x +14811 None bacterial infection, Eva Medina (Eva.Medina@helmholtz-hzi.de), death Infectious disease, immune function: Susceptibility to Staphylococcus aureus, mean time of death in days of mice infected with 10E5 colony forming units (CFU) per mouse in 10-14 old females [days] x 10.0 10.0 3.8 4.22 4.75 x 9.78 x x 2.11 x 2.56 x x x x x x 6.2 x x x x x x 10.0 x x 3.44 7.0 x 8.2 x x x x 5.89 7.56 x x 6.5 x x x x x x x 3.22 x x x x x x x x x x 8.0 x x x x x 5.89 7.89 x x x 6.56 x 9.78 x x x x x x x x x x x 6.44 x x 9.25 x x x x x 8.33 x x x x x x x +14812 None bacterial infection, Eva Medina (Eva.Medina@helmholtz-hzi.de), survival 10d Infectious disease, immune function: Susceptibility to Staphylococcus aureus, survival 10 days after infection with 10E5 colony forming units (CFU) in 10 to 14 day-old females [%] x 100.0 100.0 0.0 0.0 25.0 x 88.9 x x 0.0 x 11.1 x x x x x x 40.0 x x x x x x 100.0 x x 0.0 11.1 x 0.0 x x x x 33.3 44.4 x x 0.0 x x x x x x x 0.0 x x x x x x x x x x 44.4 x x x x x 44.4 55.6 x x x 44.4 x 88.9 x x x x x x x x x x x 44.4 x x 75.0 x x x x x 55.6 x x x x x x x +14813 None bacterial infection, Eva Medina (Eva.Medina@helmholtz-hzi.de), suvival 4d Infectious disease, immune function: Susceptibility to Staphylococcus aureus, % survival after 4 days of mice infected with 10E5 colony forming units (CFU) per mouse in 10-14 old females [%] x 100.0 100.0 20.0 33.3 50.0 x 100.0 x x 0.0 x 11.1 x x x x x x 40.0 x x x x x x 100.0 x x 0.0 100.0 x 100.0 x x x x 50.0 88.9 x x 100.0 x x x x x x x 0.0 x x x x x x x x x x 44.4 x x x x x 44.4 77.8 x x x 66.7 x 100.0 x x x x x x x x x x x 55.6 x x 100.0 x x x x x 88.9 x x x x x x x +14814 None Bacterial infection, Ehlers (sehlers@fz-borstel.de), lung 21d Infectious disease, immune system, pulmonary system: Mycobacterium tuberculosis (H37Rv, 100 colony forming units (CFU)) response, bacterial load in lung 21 days after aerosol infection in 12-23 week-old females [linear CFU/lung/1000] x 3815.7 3052.54 2899.6 1944.88 302.995 x 3644.5 x x 8785.86 x x x x x x x x 4302.47 x x 8068.37 x x x x x x x 4092.5 6201.75 3600.68 x x x x 8605.99 742.283 x 1103.78 4449.75 x x x x x x x x x x x 2652.86 x x x x x 5165.71 x x x x x x x x x x x 1706.8 x x x x x x x x x x x x 6363.21 2615.45 x x x x x x x x 4845.04 x x x x x x x +14815 None Bacterial infection, Ehlers (sehlers@fz-borstel.de), lung 90d Infectious disease, immune function: Linear bacterial load in lung 90 days after aerosol infection with 100 colony forming units (CFU) Mycobacterium tuberculosis H37Rv in 18-30 week-old females [linear CFU / lung / 10000] x 2599.04 125.19 2325.1 x 53.1012 x 602.82 x x 140.865 x x x x x x x x 423.281 x x 2580.67 x x x x x x x 1931.55 1029.45 826.57 x x x x 80.925 454.5 x 252.428 x x x x x x x x x x x x 2095.66 x x x x x 77.3545 x x x x x x x x x x x 500.638 x x x x x x x x x x x x 1028.05 1382.8 x x x x x x x x 1460.81 x x x x x x x +14816 None Bacterial infection, Ehlers (sehlers@fz-borstel.de), spleen 21d Infectious disease, immune function: Linear bacterial load in spleen 21 days after aerosol infection with 100 colony forming units (CFU) Mycobacterium tuberculosis H37Rv in 12-23 week-old females [linear CFU / spleen / 100] x 116.893 439.905 40.3 97.7333 107.572 x 30.3333 x x 71.1111 x x x x x x x x 348.503 x x 1499.6 x x x x x x x 370.893 50.194 247.315 x x x x 814.514 245.0 x 148.043 122.362 x x x x x x x x x x x 460.5 x x x x x 958.242 x x x x x x x x x x x 271.389 x x x x x x x x x x x x 210.04 807.667 x x x x x x x x 3043.38 x x x x x x x +14817 None Bacterial infection, Ehlers (sehlers@fz-borstel.de), spleen 90d Infectious disease, immune function: Linear bacterial load in spleen 90 days after aerosol infection with 100 colony forming units (CFU) Mycobacterium tuberculosis H37Rv in 18-30 week-old females [linear CFU / spleen / 1000] x 757.251 360.192 924.4 x 42.7435 x 292.347 x x 124.373 x x x x x x x x 1169.83 x x 621.409 x x x x x x x 93.4875 419.429 94.0667 x x x x 37.888 49.0 x 83.9314 x x x x x x x x x x x x 1220.17 x x x x x 77.71 x x x x x x x x x x x 69.0917 x x x x x x x x x x x x 218.369 215.156 x x x x x x x x 636.438 x x x x x x x +14818 None Bacterial infection, Ehlers (sehlers@fz-borstel.de), liver 21d Infectious disease, immune function: Linear bacterial load in liver 21 days after aerosol infection with 100 colony forming units (CFU) Mycobacterium tuberculosis H37Rv in 12-23 week-old females [linear CFU / liver / 10] x 1403.1 943.362 391.17 877.319 671.584 x 262.218 x x 981.274 x x x x x x x x 1795.62 x x 4790.37 x x x x x x x 5625.05 651.831 5591.72 x x x x 8558.57 2403.92 x 1154.51 802.874 x x x x x x x x x x x 2572.85 x x x x x 8672.05 x x x x x x x x x x x 1397.81 x x x x x x x x x x x x 2067.79 4939.65 x x x x x x x x 8781.86 x x x x x x x +14819 None Bacterial infection, Ehlers (sehlers@fz-borstel.de), liver 90d Infectious disease, immune function: Linear bacterial load in liver 90 days after aerosol infection with 100 colony forming units (CFU) Mycobacterium tuberculosis H37Rv in 18-30 week-old females [linear CFU / liver / 100] x 346.499 61.3661 394.058 x 32.38 x 70.9128 x x 56.7719 x x x x x x x x 124.022 x x 3037.59 x x x x x x x 355.56 195.514 49.3084 x x x x 49.185 807.266 x 18.6884 x x x x x x x x x x x x 185.705 x x x x x 36.7999 x x x x x x x x x x x 74.3727 x x x x x x x x x x x x 316.042 213.446 x x x x x x x x 650.922 x x x x x x x +14820 None Bacterial infection, Ehlers (sehlers@fz-borstel.de), pathology 21d Infectious disease, immune function: Quantity of lung pathology 21 days after aerosol infection with 100 colony forming units (CFU) Mycobacterium tuberculosis H37Rv in 12-23 week-old females [quantitative score (10 lowest - 70 highest)] x 26.0 18.0 14.0 16.0 15.0 x 12.5 x x 18.0 x x x x x x x x 20.0 x x 12.0 x x x x x x x 16.0 20.0 18.0 x x x x 20.0 25.0 x 18.0 x x x x x x x x x x x x 22.0 x x x x x 10.0 x x x x x x x x x x x 24.0 x x x x x x x x x x x x x 26.0 x x x x x x x x 26.0 x x x x x x x +14821 None Bacterial infection, Ehlers (sehlers@fz-borstel.de), pathology 90d Infectious disease, immune function: Quantity of lung pathology 90 days after aerosol infection with 100 colony forming units (CFU) Mycobacterium tuberculosis H37Rv in 18-30 week-old females [quantitative score (10 lowest - 70 highest)] x 56.0 32.0 46.0 x 30.0 x 28.0 x x 24.0 x x x x x x x x 26.6667 x x 40.0 x x x x x x x 44.0 63.3333 36.0 x x x x 44.0 40.0 x 34.0 x x x x x x x x x x x x 48.0 x x x x x 36.0 x x x x x x x x x x x 32.5 x x x x x x x x x x x x 40.0 58.0 x x x x x x x x 42.5 x x x x x x x +14822 None Bacterial infection, Ehlers (sehlers@fz-borstel.de), weight 21d Infectious disease, immune function: Lung weight/body weight 21 days after aerosol infection with 100 colony forming units (CFU) Mycobacterium tuberculosis H37Rv in 12-23 week-old females [lung weight/body weight * 10000] x 68.76 83.3757 66.7694 75.0141 58.2149 x 79.7307 x x 81.2873 x x x x x x x x 88.219 x x 62.8335 x x x x x x x 71.2147 69.0492 64.682 x x x x 73.6894 59.9548 x 81.5543 90.1594 x x x x x x x x x x x 75.4202 x x x x x 63.5377 x x x x x x x x x x x 67.1041 x x x x x x x x x x x x 82.1231 69.2244 x x x x x x x x 90.9621 x x x x x x x +14823 None Bacterial infection, Ehlers (sehlers@fz-borstel.de), weight 90d Infectious disease, immune function: Lung weight/body weight 90 days after aerosol infection with 100 colony forming units (CFU) Mycobacterium tuberculosis H37Rv in 18-30 week-old females [lung weight/body weight * 10000] x 133.877 111.627 101.865 x 107.626 x 95.8023 x x 125.566 x x x x x x x x 88.093 x x 132.617 x x x x x x x 104.785 230.425 91.4527 x x x x 118.21 85.2689 x 114.229 x x x x x x x x x x x x 188.651 x x x x x 104.237 x x x x x x x x x x x 80.8601 x x x x x x x x x x x x 174.533 126.451 x x x x x x x x 102.651 x x x x x x x +14824 None Bacterial infection, Ehlers (sehlers@fz-borstel.de), survival Infectious disease, immune function: Linear median survival time after aerosol infection with 1000 colony forming units (CFU) Mycobacterium tuberculosis H37Rv in 12-48 week-old females [days] x 219.5 228.0 124.5 182.0 x x x x x x x x x x x x x x x x x 94.5 x x x x x x x 103.5 31.0 x x x x x 133.0 x x 168.0 118.0 x x x x x x x x x x x 133.0 x x x x x 151.0 x x x 64.0 x x x x x x x 184.0 x x x x x x x x x x x x x x x x x x x x x x 192.0 x x x x x x x +14825 None Bacterial infection, Ehlers (sehlers@fz-borstel.de), lung 21d, log10 Infectious disease, immune function: Bacterial load in lungs 21 days after aerosol infection with 100 colony forming units (CFU) Mycobacterium tuberculosis H37Rv in 12-23 week-old females [log10 CFU / lung * 100] x 643.885 642.7 644.233 603.378 506.369 x 645.042 x x 686.054 x x x x x x x x 660.329 x x 681.727 x x x x x x x 651.001 665.416 648.18 x x x x 677.573 584.762 x 601.933 663.208 x x x x x x x x x x x 640.108 x x x x x 670.253 x x x x x x x x x x x 609.675 x x x x x x x x x x x x 673.872 636.497 x x x x x x x x 664.464 x x x x x x x +14826 None Bacterial infection, Ehlers (sehlers@fz-borstel.de), lung 90d, log10 Infectious disease, immune function: Bacterial load in lungs 90 days after aerosol infection with 100 colony forming units (CFU) Mycobacterium tuberculosis H37Rv in 18-30 week-old females [log10 CFU / lung * 100] x 733.103 604.956 732.976 x 567.713 x 653.158 x x 605.038 x x x x x x x x 657.305 x x 724.6 x x x x x x x 720.448 701.001 689.637 x x x x 573.486 665.58 x 624.704 x x x x x x x x x x x x 729.18 x x x x x 584.392 x x x x x x x x x x x 653.33 x x x x x x x x x x x x 693.723 711.895 x x x x x x x x 651.423 x x x x x x x +14827 None Bacterial infection, Ehlers (sehlers@fz-borstel.de), normalized CFU lung 90d, log10 Infectious disease, immune function: Normalized bacterial load in lungs 90 days after aerosol infection with 100 colony forming units (CFU) Mycobacterium tuberculosis H37Rv in 18-30 week-old females [ratio CFU BXD / CFU C57BL/6J * 100] x 223.473 100.0 1000.0 x 78.3158 x 159.679 x x 112.521 x x x x x x x x 112.122 x x 2061.4 x x x x x x x 1542.89 1518.28 218.947 x x x x 78.06 120.391 x 21.7045 x x x x x x x x x x x x 555.114 x x x x x 20.4902 x x x x x x x x x x x 132.613 x x x x x x x x x x x x 404.546 366.286 x x x x x x x x 386.948 x x x x x x x +14828 None Bacterial infection, Ehlers (sehlers@fz-borstel.de), histology lung 90d Infectious disease, immune function: Quality of lung pathology 90 days after aerosol infection with 100 colony forming units (CFU) Mycobacterium tuberculosis H37Rv in 18-30 week-old females [ordinal scale (10 = normal, 20 = intermediate, 30 = severe)] x 20.0 10.0 20.0 x 12.5 x 18.0 x x 30.0 x x x x x x x x 20.0 x x 22.0 x x x x x x x 22.0 30.0 20.0 x x x x 24.0 20.0 x 20.0 x x x x x x x x x x x x 20.0 x x x x x 14.0 x x x x x x x x x x x 20.0 x x x x x x x x x x x x 21.6667 22.0 x x x x x x x x 22.5 x x x x x x x +14829 None Bacterial infection, Ehlers (sehlers@fz-borstel.de), body weight 13 weeks pi, 1000 CFU Infectious disease, immune system, morphology: Body weight 13 weeks after aerosol infection with 1000 colony forming units (CFU) Mycobacterium tuberculosis H37Rv in 13-30 week-old females [g] x 26.24 22.442 23.078 21.607 x x x x x x x x x x x x x x x x x 21.572 x x x x x x 21.51 22.224 x x x x x x 19.05 x x 23.8 14.218 x x x x x x x x x x x 22.922 x x x x x 23.854 x x x 19.68 x x x x x x x 22.646 x x x x x x x x x x x x x x x x x x x x x x 26.431 x x x x x x x +14830 None Bacterial infection, Ehlers (sehlers@fz-borstel.de), moribund body weight 1000 CFU Infectious disease, immune function: Mean moribund body weight after aerosol infection with 1000 colony forming units (CFU) Mycobacterium tuberculosis H37Rv in 12-48 week-old females [g * 10] x 177.95 165.978 176.6 171.45 x x x x x x x x x x x x x x x x x 183.03 x x x x x x 184.0 185.69 141.133 x x x x x 151.367 x x 185.1 127.322 x x x x x x x x x x x 168.778 x x x x x 190.76 x x x 170.83 x x x x x x x 169.411 x x x x x x x x x x x x x x x x x x x x x x 207.15 x x x x x x x +14831 None Bacterial infection, Ehlers (sehlers@fz-borstel.de), temperature 13 week pi 1000 CFU Infectious disease, immune function: Mean temperature 13 weeks after aerosol infection with 1000 colony forming units (CFU) Mycobacterium tuberculosis H37Rv in 13-30 week-old females [deg C * 10] x 369.4 358.5 359.33 354.456 x x x x x x x x x x x x x x x x x 341.612 x x x x x x 355.79 361.06 x x x x x x 347.914 x x 365.444 338.778 x x x x x x x x x x x 362.111 x x x x x 355.7 x x x 354.833 x x x x x x x 353.8 x x x x x x x x x x x x x x x x x x x x x x 353.133 x x x x x x x +14832 None Bacterial infection, Ehlers (sehlers@fz-borstel.de), moribund temperature 1000 CFU Infectious disease, immune function: Mean moribund temperature after aerosol infection with 1000 colony forming units (CFU) Mycobacterium tuberculosis H37Rv in 12-48 week-old females [deg C * 10] x 336.0 316.7 335.3 333.556 x x x x x x x x x x x x x x x x x 329.625 x x x x x x 340.3 349.8 348.222 x x x x x 330.111 x x 334.0 329.5 x x x x x x x x x x x 304.222 x x x x x 336.1 x x x 351.556 x x x x x x x 328.0 x x x x x x x x x x x x x x x x x x x x x x 345.333 x x x x x x x +14833 None Bacterial infection, Ehlers (sehlers@fz-borstel.de), normalized median survival Infectious disease, immune function: Normalized median survival time after aerosol infection with 1000 colony forming units (CFU) Mycobacterium tuberculosis H37Rv in 12-48 week-old females [ratio survival time BXD / survival time C57BL/6J * 100] x 76.8827 100.885 49.0157 71.6535 x x x x x x x x x x x x x x x x x 33.0998 x x x x x x 57.0928 36.2522 13.7168 x x x x x 58.8496 x x 58.8441 52.2124 x x x x x x x x x x x 46.5849 x x x x x 66.8142 x x x 22.4168 x x x x x x x 72.4409 x x x x x x x x x x x x x x x x x x x x x x 67.2504 x x x x x x x +14393 Original post publication description: Liver, toxicology, fibrosis susceptibility after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), mean area of Sirius red stained collagen (100x magnification, laboratory homburg) in females, data trimmed [%] Original pre publication description: Hall trait 39 Hall trait 39 Liver, toxicology: Fibrosis susceptibility in adult females after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), mean area of Sirius red stained collagen (100x magnification, laboratory homburg), data trimmed [%] x 2.24 x 5.776 2.129 1.55 x 1.393 x x 2.474 2.375 2.534 2.055 x x x x x x x x 1.928 x x 2.088 x x x 2.417 2.521 1.877 2.063 x x x x 1.639 1.566 x 2.089 1.839 x x x x x x x 2.192 x x x x x x x x x 1.877 2.202 x x 5.185 x x x 2.727 x x x 3.226 x 3.485 x x x x x x x x x x x 1.949 x x 2.077 x x x x x 2.271 x 2.391 x x x x x +14392 Original post publication description: Liver, toxicology, fibrosis susceptibility after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), median area of Sirius red stained collagen (100x magnification, laboratory homburg) in males, data trimmed [%] Original pre publication description: Hall trait 38 Hall trait 38 Liver, toxicology: Fibrosis susceptibility in adult males after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), median area of Sirius red stained collagen (100x magnification, Homburg Laboratory), trimmed [%] x 1.707 2.554 5.449 2.57 1.792 x 0.397 x x 0.968 2.027 1.063 2.788 x x x 1.642 x x x x x x x x x x x 1.63 2.321 1.261 x x x x x 1.571 0.899 x x 2.63 x x x x x x x 2.752 x x x 3.021 x x x x x 2.583 1.29 x x x x x x x x x x 3.298 x 3.38 x x x x x x x x x x x 1.517 x x 1.596 x x x x x 2.281 x 0.976 x x x x x +14391 Original post publication description: Liver, toxicology, fibrosis susceptibility after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), mean area of Sirius red stained collagen (100x magnification, laboratory homburg) in males, data trimmed [%] Original pre publication description: Hall trait 37 Hall trait 37 Liver, toxicology: Fibrosis susceptibility in adult males after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), mean area of Sirius red stained collagen (100x magnification, laboratory homburg), data trimmed [%] x 1.87 2.72 4.91 2.59 1.73 x 0.4 x x 0.96 1.74 1.81 2.44 x x x 1.58 x x x x x x x x x x x 1.78 2.2 1.21 x x x x x 1.48 1.14 x x 2.66 x x x x x x x 2.56 x x x 3.02 x x x x x 2.36 1.33 x x x x x x x x x x 3.61 x 3.38 x x x x x x x x x x x 1.52 x x 1.71 x x x x x 2.22 x 0.97 x x x x x +14390 Original post publication description: Liver, toxicology, fibrosis susceptibility after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), median area of Sirius red stained collagen (100x magnification, pathology Bonn) in males and females [%] Original pre publication description: Hall trait 36 Hall trait 36 Liver, toxicology: Fibrosis susceptibility in adult males and females after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), median area of Sirius red stained collagen (100x magnification, pathology Bonn) [%] x 2.03 0.28 2.23 2.14 2.69 x 1.22 x x 2.02 1.9 1.87 1.77 x x x 2.64 x x x x 1.29 x x 2.57 x x x 2.43 2.54 1.78 x x x x x 1.81 1.3 x 2.05 1.81 x x x x x x x 1.76 x x x 1.44 x x x x x 1.49 1.07 x x 2.62 x x x 2.09 x x x 2.0 x 2.38 x x x x x x x x x x x 2.07 x x 1.56 x x x x x 1.56 x 1.77 x x x x x +14389 Original post publication description: Liver, toxicology, fibrosis susceptibility after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), mean area of Sirius red stained collagen (100x magnification, pathology Bonn) in males and females [%] Original pre publication description: Hall trait 35 Hall trait 35 Liver, toxicology: Fibrosis susceptibility in adult males and females after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), mean area of Sirius red stained collagen (100x magnification, pathology Bonn) [%] x 1.87 0.89 1.76 2.09 2.59 x 1.13 x x 2.0 2.05 1.7 1.73 x x x 2.15 x x x x 1.19 x x 2.44 x x x 2.81 2.33 1.86 x x x x x 1.84 1.3 x 2.08 1.95 x x x x x x x 1.9 x x x 1.81 x x x x x 1.54 1.12 x x 2.49 x x x 2.21 x x x 2.03 x 2.1 x x x x x x x x x x x 2.15 x x 1.6 x x x x x 1.93 x 1.9 x x x x x +14387 Original post publication description: Liver, toxicology, fibrosis susceptibility after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), mean area of Sirius red stained collagen (100x magnification, pathology Bonn) in females [%] Original pre publication description: Hall trait 33 Hall trait 33 Liver, toxicology: Fibrosis susceptibility in adult females after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), mean area of Sirius red stained collagen (100x magnification, pathology Bonn) [%] x 2.59 1.06 2.21 2.36 2.72 x 1.1 x x 2.38 2.31 1.75 2.46 x x x x x x x x 1.4 x x 2.51 0.9 x x 3.24 2.28 2.06 x x x x x 1.87 1.02 x 2.76 1.99 x x x x x x x 2.44 x x x 2.21 x x x x x 1.78 0.88 x x 2.63 x x x 2.03 x x x 2.08 x 1.61 x x x x x x x x x x x 2.42 x x 1.6 x x x x x 2.44 x 2.68 x x x x x +14384 Original post publication description: Liver, toxicology, Fibrosis susceptibility after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, Days 1 and 4), median Fibrosis score, semiquantitative histology score, in males and females Original pre publication description: Hall trait 30 Hall trait 30 Liver, toxicology: Fibrosis susceptibility in adult males and females after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), median fibrosis score, semi-quantitative ordinal histology score, 1=mild, 4=severe [severety] x 2.0 2.0 3.5 3.0 2.5 x 1.0 x x 2.0 2.5 3.0 3.0 x x x 2.0 x x x x 2.0 x x 2.0 x x x 3.0 3.0 2.0 x x x x x 2.0 1.0 x 3.0 2.0 x x x x x x x 2.0 x x x 2.0 x x x x x 2.0 1.0 x x 4.0 x x x 2.0 x x x 2.0 x 2.75 x x x x x x x x x x x 2.0 x x 1.5 x x x x x 1.13 x 2.0 x x x x x +14383 Original post publication description: Liver, toxicology, Fibrosis susceptibility after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, Days 1 and 4), mean Fibrosis score, semiquantitative histology score, in males and females Original pre publication description: Hall trait 29 Hall trait 29 Liver, toxicology: Fibrosis susceptibility in adult males and females after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), mean fibrosis score, semi-quantitative ordinal histology score, 1=mild, 4=severe [severity] x 2.0 1.93 3.43 2.82 2.75 x 1.14 x x 1.97 2.55 2.63 2.58 x x x 2.07 x x x x 1.56 x x 2.57 x x x 3.0 3.25 2.4 x x x x x 2.06 1.43 x 2.43 2.06 x x x x x x x 1.67 x x x 1.88 x x x x x 1.88 1.23 x x 3.86 x x x 2.43 x x x 2.0 x 2.6 x x x x x x x x x x x 2.29 x x 1.6 x x x x x 1.31 x 1.86 x x x x x +14381 Original post publication description: Liver, toxicology, Fibrosis susceptibility after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, Days 1 and 4), mean Fibrosis score, semiquantitative histology score, males Original pre publication description: Hall trait 27 Hall trait 27 Liver, toxicology: Fibrosis susceptibility in males after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), mean fibrosis score, semi-quantitative ordinal histology score, 1=mild, 4=severe [severity] x 2.0 1.71 3.31 2.71 3.0 x 1.33 x x 2.25 2.71 2.25 2.45 x x x 2.5 x x x x 1.5 x x 2.67 x x x 3.25 3.75 2.33 x x x x x 2.1 1.25 x 2.0 1.8 x x x x x x x 1.6 x x x 1.5 x x x x x 2.0 1.07 x x 3.67 x x x 2.25 x x x 2.0 x 3.1 x x x x x x x x x x x 2.0 x x 1.56 x x x x x 1.25 x 1.75 x x x x x +14378 Original post publication description: Liver, toxicology, Liver injury aftercarbon tetrachloride challenge (12 x 0.7 mg/kg ip, Days 1 and 4), median Alaninaminotransferase aktivity in males and females_data, trimmed [U/l] Original pre publication description: Hall trait 24 Hall trait 24 Liver, toxicology: Liver injury in adult males and females after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), median alanine aminotransferase (ALT) aktivity, trimmed [U/l] x 435.0 107.0 585.0 370.0 83.6 x 212.0 x x 82.1 131.0 87.0 83.6 x x x 737.4 x x x x 672.0 x x 149.0 x x x 171.0 318.5 575.0 x x x x x 130.0 1080.0 x 58.5 799.0 x x x x x x x 314.0 x x x 390.0 x x x x x 294.5 1560.0 x x 438.0 x x x 185.0 x x 80.15 146.0 x 160.0 x x x x x x x x x x x 325.0 x x 55.6 x x x x x 372.0 x 168.0 x x x x x +14377 Original post publication description: Liver, toxicology, Liver injury aftercarbon tetrachloride challenge (12 x 0.7 mg/kg ip, Days 1 and 4), mean Alaninaminotransferase aktivity in males and females_data, trimmed [U/l] Original pre publication description: Hall trait 23 Hall trait 23 Liver, toxicology: Liver injury in adult males and females after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), mean alanine aminotransferase (ALT) aktivity, trimmed [U/l] x 475.91 93.67 710.85 431.93 91.65 x 223.86 x x 225.39 257.89 88.59 135.8 x x x 721.88 x x x x 626.0 x x 165.86 x x x 189.86 316.5 730.83 x x x x x 161.81 1096.33 x 60.39 879.93 x x x x x x x 427.45 x x x 361.64 x x x x x 326.17 1547.33 x x 479.78 x x x 220.46 x x 80.15 161.33 x 227.88 x x x x x x x x x x x 312.71 x x 106.62 x x x x x 353.33 x 192.8 x x x x x +14375 Original post publication description: Liver, toxicology, Liver injury aftercarbon tetrachloride challenge (12 x 0.7 mg/kg ip, Days 1 and 4), mean Alaninaminotransferase aktivity in females_data, trimmed [U/l] Original pre publication description: Hall trait 21 Hall trait 21 Liver, toxicology: Liver injury in adult females after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), mean alanine aminotransferase (ALT) activity, trimmed [U/l] x 463.24 108.0 565.33 459.67 75.93 x 242.5 x x 484.67 362.42 100.02 83.5 x x x 781.54 x x x x 546.8 x x 125.65 x x x 180.34 300.0 663.0 x x x x x 142.87 970.0 x 96.3 473.8 x x x x x x x 308.86 x x x 251.2 x x x x x 325.44 x x x 451.5 x x x 214.33 x x x 161.33 x 233.6 x x x x x x x x x x x 298.0 x x 48.95 x x x x x 341.0 x 186.89 x x x x x +14372 Original post publication description: Liver, toxicology, Liver injury day 0, beforecarbon tetrachloride challenge (12 x 0.7 mg/kg ip, Days 1 and 4), median of Alaninaminotransferase aktivity in males and females_data, trimmed [U/l] Original pre publication description: Hall trait 18 Hall trait 18 Liver, toxicology: Liver injury day 0 in adult males and females before carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), median of alanine aminotransferase (ALT) aktivity, trimmed [U/l] x 23.915 34.01 22.615 30.1 24.75 x 19.05 x x 35.48 23.5 18.2 25.85 x x x 24.15 x x x x 17.65 x x 32.8 x x x 22.85 27.865 30.0 x x x x 33.3 20.2 52.9 x 20.45 27.3 x x x x x x x 34.78 x x x 16.0 x x x x x 23.95 54.445 x x x x x x 27.05 x x 27.6 32.35 x 33.33 x x x x x x x x x x x 20.35 x x 30.385 x x x x x 27.085 x 30.0 x x x x x +14371 Original post publication description: Liver, toxicology, Liver injury day 0, beforecarbon tetrachloride challenge (12 x 0.7 mg/kg ip, Days 1 and 4), mean Alaninaminotransferase aktivity in males and females_data, trimmed [U/l] Original pre publication description: Hall trait 17 Hall trait 17 Liver, toxicology: Liver injury day 0 in adult males and females before carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), mean alanine aminotransferase (ALT) aktivity, trimmed [U/l] x 25.264 34.3 24.504 29.815 23.67 x 18.7 x x 33.942 24.036 20.318 27.685 x x x 28.388 x x x x 17.03 x x 32.491 x x x 22.863 28.574 30.16 x x x x 33.3 20.807 50.271 x 23.74 30.254 x x x x x x x 34.28 x x x 16.436 x x x x x 24.44 54.49 x x x x x x 25.538 x x 27.6 32.257 x 32.573 x x x x x x x x x x x 20.988 x x 31.006 x x x x x 26.429 x 30.151 x x x x x +14370 Original post publication description: Liver, toxicology, Liver injury day 0, beforecarbon tetrachloride challenge (12 x 0.7 mg/kg ip, Days 1 and 4), median of Alaninaminotransferase aktivity in females_data, trimmed [U/l] Original pre publication description: Hall trait 16 Hall trait 16 Liver, toxicology: Liver injury day 0 in adult females before carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), median of alanine aminotransferase (ALT) aktivity, trimmed [U/l] x 25.0 33.005 14.2 26.67 22.5 x 18.8 x x 40.835 20.95 17.6 23.45 x x x 35.05 x x x x x x x 32.85 x x x 23.05 25.66 30.0 x x x x x 20.7 52.9 x 22.7 39.475 x x x x x x x x x x x 20.0 x x x x x 26.9 57.14 x x x x x x 24.0 x x x 25.71 x 34.2 x x x x x x x x x x x 22.6 x x 27.55 x x x x x 26.67 x 30.555 x x x x x +14369 Original post publication description: Liver, toxicology, Liver injury day 0, beforecarbon tetrachloride challenge (12 x 0.7 mg/kg ip, Days 1 and 4), mean Alaninaminotransferase aktivity in females_data, trimmed [U/l] Original pre publication description: Hall trait 15 Hall trait 15 Liver, toxicology: Liver injury day 0 in adult females before carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), mean alanine aminotransferase (ALT) aktivity, trimmed [U/l] x 24.429 33.07 23.536 28.429 22.283 x 17.32 x x 41.885 22.233 18.613 21.495 x x x 35.05 x x x x x x x 32.9 x x x 22.975 25.898 31.1 x x x x x 22.383 48.733 x 23.725 38.992 x x x x x x x x x x x 20.173 x x x x x 27.5 55.366 x x x x x x 24.0 x x x 24.833 x 34.798 x x x x x x x x x x x 22.54 x x 28.213 x x x x x 26.714 x 33.502 x x x x x +14368 Original post publication description: Liver, toxicology, Liver injury day 0, beforecarbon tetrachloride challenge (12 x 0.7 mg/kg ip, Days 1 and 4), median of Alaninaminotransferase aktivity in males_data, trimmed [U/l] Original pre publication description: Hall trait 14 Hall trait 14 Liver, toxicology: Liver injury day 0 in adult males before carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), median of alanine aminotransferase (ALT) aktivity, trimmed [U/l] x 23.33 37.57 31.03 33.85 28.4 x 21.6 x x 25.0 26.8 28.3 29.0 x x x 24.15 x x x x 16.515 x x 26.6 x x x 22.7 32.5 28.75 x x x x 33.3 18.7 49.55 x 18.9 25.0 x x x x x x x 34.78 x x x 15.0 x x x x x 20.5 54.05 x x x x x x 27.05 x x 27.6 34.89 x 30.635 x x x x x x x x x x x 18.0 x x 36.725 x x x x x 27.5 x 28.335 x x x x x +14367 Original post publication description: Liver, toxicology, Liver injury day 0, beforecarbon tetrachloride challenge (12 x 0.7 mg/kg ip, Days 1 and 4), mean Alaninaminotransferase aktivity in males_data, trimmed [U/l] Original pre publication description: Hall trait 13 Hall trait 13 Liver, toxicology: Liver injury day 0 in adult males before carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), mean alanine aminotransferase (ALT) aktivity, trimmed [U/l] x 25.913 34.847 26.117 31.433 25.75 x 21.0 x x 29.609 26.2 24.867 31.221 x x x 26.167 x x x x 16.927 x x 31.4 x x x 22.75 31.25 28.75 x x x x 33.3 19.625 51.425 x 23.75 26.222 x x x x x x x 34.28 x x x 14.301 x x x x x 19.85 53.614 x x x x x x 26.05 x x 27.6 35.968 x 29.793 x x x x x x x x x x x 18.4 x x 34.732 x x x x x 26.144 x 26.8 x x x x x +14366 Original post publication description: Liver, toxicology, Fibrosis susceptibility after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, Days 1 and 4), median liver to body weight ratio in males and females_data, trimmed [g] Original pre publication description: Hall trait 12 Hall trait 12 Liver, toxicology: Fibrosis susceptibility in adult males and females after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), median liver to body weight ratio, data trimmed [g] x 0.054 0.047 0.054 0.062 0.06 x x x x 0.054 x 0.067 0.076 x x x 0.081 x x x x 0.061 x x x x x x 0.044 0.068 0.066 x x x x 0.058 0.061 0.078 x 0.053 0.065 x x x x x x x 0.046 x x x 0.071 x x x x x 0.062 0.05 x x 0.054 x x x 0.041 x x 0.061 0.054 x 0.053 x x x x x x x x x x x x x x 0.057 x x x x x 0.058 x 0.066 x x x x x +14364 Original post publication description: Liver, toxicology, Fibrosis susceptibility after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, Days 1 and 4), median liver to body weight ratio in females_data, trimmed [g] Original pre publication description: Hall trait 10 Hall trait 10 Liver, toxicology: Fibrosis susceptibility in adult females after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, Days 1 and 4), median liver to body weight ratio, data trimmed [g] x 0.071 0.049 0.056 0.05 0.059 x x x x 0.045 x 0.065 x x x x 0.082 x x x x 0.048 x x x x x x 0.044 0.071 0.066 x x x x 0.062 0.06 0.077 x 0.053 0.065 x x x x x x x 0.046 x x x 0.069 x x x x x 0.068 0.052 x x 0.052 x x x x x x x 0.062 x 0.054 x x x x x x x x x x x x x x 0.055 x x x x x 0.06 x 0.064 x x x x x +14358 Original post publication description: Liver, toxicology, Fibrosis susceptibility aftercarbon tetrachloride challenge (12 x 0.7 mg/kg ip, Days 1 and 4), median hepatic collagen in females_data, trimmed [ug hydroxyproline/g liver] Original pre publication description: Hall trait 4 Hall trait 4 Liver, toxicology: Fibrosis susceptibility in adult females after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), median hepatic collagen, data trimmed [ug hydroxyproline/g liver] x 325.1 356.05 518.42 403.16 451.82 x 327.98 x x 414.98 493.7 403.68 385.36 x x x 319.71 x x x x 316.02 x x 346.76 299.4 198.75 x 332.9 391.55 400.69 289.75 x x x 409.63 289.87 273.16 x 457.63 416.4 x x x x x x x 494.17 x x x 475.68 x x x x x 354.85 385.58 x x 554.26 x x x 359.93 x x x 717.63 x 408.3 x x x x x x x x x x x 347.41 x x 288.63 x x x x x 295.05 x 573.88 x x x x x +14394 Original post publication description: Liver, toxicology, fibrosis susceptibility after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), median area of Sirius red stained collagen (100x magnification, laboratory homburg) in males and females, data Original pre publication description: Hall trait 40 Hall trait 40 Liver, toxicology: Fibrosis susceptibility in adult males and females after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), median area of Sirius red stained collagen (100x magnification, laboratory homburg), data trimmed [%] x 2.246 x 5.768 2.133 1.36 x 0.929 x x 2.4 2.404 2.494 1.668 x x x x x x x x 1.826 x x 1.606 x x x 2.558 2.738 2.017 1.865 x x x x 1.781 1.566 x 2.082 1.878 x x x x x x x 2.187 x x x x x x x x x 1.511 2.084 x x 4.55 x x x 2.817 x x x 3.227 x 3.461 x x x x x x x x x x x 1.878 x x 2.14 x x x x x 2.427 x 2.188 x x x x x +14357 Original post publication description: Liver, toxicology, Fibrosis susceptibility aftercarbon tetrachloride challenge (12 x 0.7 mg/kg ip, Days 1 and 4), mean hepatic collagen in females_data, trimmed [ug hydroxyproline/g liver] Original pre publication description: Hall trait 3 Hall trait 3 Liver, toxicology: Fibrosis susceptibility in adult females after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), mean hepatic collagen, trimmed [ug hydroxyproline/g liver] x 313.8 371.086 539.484 426.63 491.355 x 341.325 x x 410.687 488.662 413.672 414.365 x x x 354.934 x x x x 330.707 x x 361.439 295.013 218.575 x 284.597 355.033 393.882 269.902 x x x 404.304 288.89 282.837 x 455.838 412.678 x x x x x x x 472.84 x x x 508.316 x x x x x 376.668 417.256 x x 536.31 x x x 377.564 x x x 691.782 x 393.322 x x x x x x x x x x x 338.768 x x 282.924 x x x x x 300.26 x 625.432 x x x x x +14356 Original post publication description: Liver, toxicology, Fibrosis susceptibility aftercarbon tetrachloride challenge (12 x 0.7 mg/kg ip, Days 1 and 4), median hepatic collagen in males_data, trimmed [ug hydroxyproline/g liver] Original pre publication description: Hall trait 2 Hall trait 2 Liver, toxicology: Fibrosis susceptibility in adult males after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), median hepatic collagen, data trimmed [ug hydroxyproline/g liver] x 352.03 441.275 577.47 497.915 430.275 x 297.33 x x 384.59 457.13 298.35 342.7 x x x 454.39 x x x x 331.1 x x 256.425 270.14 324.75 x 337.0 574.235 345.22 277.14 x x x 405.785 299.78 294.87 x 321.07 396.56 x x x x x x x 359.69 x x x 285.78 x x x x x 311.01 370.7 x x 422.42 x x x 373.835 x x 257.715 417.46 x 457.35 x x x x x x x x x x x 325.36 x x 321.28 x x x x x 273.54 x 472.435 x x x x x +14355 Original post publication description: Liver, toxicology, Fibrosis susceptibility after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, Days 1 and 4), mean hepatic collagen in males_data, trimmed [ug hydroxyproline/g liver] Original pre publication description: Hall trait 1 Hall trait 1 Liver, toxicology: Fibrosis susceptibility in adult males after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), mean hepatic collagen, data trimmed [ug hydroxyproline/g liver] x 332.569 461.485 605.794 497.95 459.418 x 324.787 x x 397.468 453.194 300.093 327.646 x x x 451.177 x x x x 338.544 x x 276.932 266.51 324.75 x 365.479 559.475 343.13 275.383 x x x 383.732 304.432 283.257 x 334.493 406.225 x x x x x x x 369.836 x x x 308.88 x x x x x 330.299 392.909 x x 441.617 x x x 383.635 x x 257.715 404.013 x 459.27 x x x x x x x x x x x 330.13 x x 335.289 x x x x x 293.54 x 460.58 x x x x x +15170 Original post publication description: Central nervous system, behavior, learning and memory: Spatial navigation, latency to reach platform using Morris water maze (test 4, Trait Llat4 Table 1), males and females combined [log sec] Original pre publication description: Central nervous system, behavior, learning and memory: Spatial navigation, latency to reach platform using Morris water maze (test 4, Trait Llat4 Table 1), males and females combined [log sec] Central nervous system, behavior, learning and memory: Spatial navigation, latency to reach platform using Morris water maze (test 4, Trait Llat4 Table 1), males and females combined [log sec] Central nervous system, behavior, learning and memory: Spatial navigation, latency to reach hidden platform using Morris water maze (test 4, Trait Llat4 Table 1), males and females combined [log sec] x x 1.043 1.014 1.457 0.997 1.12 1.031 1.246 1.017 1.143 1.21 1.278 1.198 1.373 1.149 1.295 1.347 1.294 1.318 0.936 1.329 x 1.258 0.97 1.193 1.189 1.347 1.035 1.478 1.011 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +14308 Original post publication description: Blood [serum] urea nitrogen (BUN), expressed in mg/dL, measured at 72 hours after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus; Light phase: h 0-12; dark phase: h 12-24; inoculation performed immediately after light onset None Blood chemistry, infectious disease, immune system: Blood [serum] urea nitrogen (BUN) at 72 h after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinusimmediately after light onset [mg/dl serum] x x x x 39.0 31.0 250.0 32.0 x x 32.0 31.0 172.0 x x 250.0 24.0 174.0 x x 75.0 x x 57.0 x x 42.0 35.0 37.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +14309 Original post publication description: Serum glucose (unfasted), expressed in mg/dL, measured at 72 hours after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus; Light phase: h 0-12; dark phase: h 12-24; inoculation performed immediately after light onset None Infectious disease, immune function: Serum glucose (unfasted) at 72 h after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [mg/dL serum) x x x x 144.0 140.0 101.0 116.0 x x 141.0 99.0 55.0 x x 83.0 125.0 66.0 x x 70.0 x x 102.0 x x 137.0 137.0 45.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +14310 Original post publication description: Brain Candida albicans titer, expressed as colony-forming units (CFU) x 10^4 per gram tissue weight, measured at 72 hours after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus; Light phase: h 0-12; dark phase: h 12-24; inoculation performed immediately after light onset None Infectious disease, immune system, central nervous system: Candida albicans titer in brain at 72 h after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [CFU x 10^4 per gram tissue] x x x x 0.2 0.1 3.2 1.0 x x 0.6 0.5 6.6 x x 2.1 0.6 5.1 x x 1.0 x x 1.5 x x 1.3 1.1 0.4 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +14311 Original post publication description: Kidney Candida albicans titer, expressed as colony-forming units (CFU) x 10^4 per gram tissue weight, measured at 72 hours after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus; Light phase: h 0-12; dark phase: h 12-24; inoculation performed immediately after light onset None Infectious disease, immune system, urogenital system: Candida albicans titer, renal, at 72 h after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus performed immediately after light onset [CFU x 10^4 per gram tissue weight] x x x x 1.0 x 191.0 1.0 x x 2.0 3.0 863.0 x x 26.0 x 277.0 x x 9.0 x x 98.0 x x 25.0 3.0 1.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +14312 Original post publication description: Log kidney Candida albicans titer, expressed as colony-forming units (CFU) x 10^4 per gram tissue weight, measured at 72 hours after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus; Light phase: h 0-12; dark phase: h 12-24; inoculation performed immediately after light onset None Infectious disease, immune system, urogenital system: Candida albicans titer in kidney (log) at 72 h after inoculation with 1 x 10^6 cfu (ATCC 10231) IV via retroorbital sinus immediately after light onset [CFU x 10^4 per gram tissue] x x x x -0.22 -0.52 2.28 0.0 x x 0.36 0.4 2.94 x x 1.41 -0.4 2.44 x x 0.97 x x 1.99 x 1.4 0.4 0.15 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +14313 Original post publication description: White blood cell count (number per ul of whole blood), measured at 72 hours after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus; Light phase: h 0-12; dark phase: h 12-24; inoculation performed immediately after light onset None Blood chemistry, infectious disease, immune system: White blood cell (WBC) count 72 h after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [number per ul of whole blood] x x x x x x x x x x x 6.9 5.1 x x x x x x x 8.2 x x 9.4 x x 8.5 10.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +14314 Original post publication description: Ratio of number of neutrophils to lymphocytes in whole blood, measured at 72 hours after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus; Light phase: h 0-12; dark phase: h 12-24; inoculation performed immediately after light onset None Infectious disease, immune system: Ratio of number of neutrophil to lymphocyte ratio at 72 h after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [neutrophil to lymphocyte ratio, whole blood] x x x x x x x x x x x 1.44 4.72 x x x x x x x 1.94 x x 2.3 x x 2.27 1.75 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +14315 Original post publication description: Hematocrit (proportional packed cell volume of RBCs in whole blood), measured at 72 hours after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus; Light phase: h 0-12; dark phase: h 12-24; inoculation performed immediately after light onset None Infectious disease, immune system: Hematocrit 72 h after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [proportional packed cell volume of RBCs in whole blood] x x x x x x x x x x x 66.0 66.0 x x x x x x x 44.0 x x 57.0 x x 44.0 66.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +14316 Original post publication description: Lipocalin-2 (pg/mg protein), measured at 72 hours after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus; Light phase: h 0-12; dark phase: h 12-24; inoculation performed immediately after light onset None Infectious disease, immune system: lipocalin-2 (LCN-2) at 72 h after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [pg/mg protein, kidney] x x x x 159.0 105.0 2720.0 95.0 x x 82.0 158.0 1282.0 x x 3852.0 66.0 1130.0 x x 1397.0 x x 1013.0 x x 123.0 90.0 124.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +14317 Original post publication description: Interleukin-6 (pg/mg protein), measured at 72 hours after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus; Light phase: h 0-12; dark phase: h 12-24; inoculation performed immediately after light onset None Infectious disease, immune system: Interleukin-6 (IL-6) protein level in kidney 72 h after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [pg/mg protein] x x x x 39.0 31.0 135.0 49.0 x x 23.0 25.0 92.0 x x 58.0 28.0 123.0 x x 20.0 x x 18.0 x x 18.0 16.0 19.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +14318 Original post publication description: G-CSF (granulocyte colony stimulating factor; pg/mg protein), measured at 72 hours after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus; Light phase: h 0-12; dark phase: h 12-24; inoculation performed immediately after light onset None Infectious disease, immune system: G-CSF (granulocyte colony stimulating factor) at 72 h after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [pg/mg protein, kidney] x x x x 22.0 12.0 197.0 9.0 x x 4.0 9.0 120.0 x x 220.0 6.0 194.0 x x 110.0 x x 88.0 x x 12.0 5.0 3.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +14319 Original post publication description: IP-10 (Interferon gamma-induced protein 10 or CXLC10; pg/mg protein), measured at 72 hours after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus; Light phase: h 0-12; dark phase: h 12-24; inoculation performed immediately after light onset None Infectious disease, immune system: IP-10 (Interferon gamma-induced protein 10 or CXLC10) at 72 h after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinusimmediately after light onset [pg/mg protein, kidney] x x x x 38.0 17.0 51.0 23.0 x x 17.0 22.0 60.0 x x 43.0 15.0 34.0 x x 28.0 x x 29.0 x x 36.0 19.0 18.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +14320 Original post publication description: MIP2 (macrophage inflammatory protein 2-alpha or CXCL2; pg/mg protein), measured at 72 hours after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus; Light phase: h 0-12; dark phase: h 12-24; inoculation performed immediately after light onset None Infectious disease, immune function: MIP-2 (macrophage inflammatory protein 2-alpha or CXCL2) at 72 h after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [pg/mg protein, kidney] x x x x 33.0 20.0 584.0 29.0 x x 14.0 6.0 390.0 x x 180.0 16.0 710.0 x x 75.0 x x 103.0 x x 33.0 15.0 16.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +14321 Original post publication description: KC (CXCL1; keratinocyte-derived chemokine; pg/mg protein), measured at 72 hours after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus; Light phase: h 0-12; dark phase: h 12-24; inoculation performed immediately after light onset None Infectious disease, immune function: KC (CXCL1; keratinocyte-derived chemokine at 72 h after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [pg/mg protein, kidney] x x x x 39.0 23.0 248.0 28.0 x x 12.0 18.0 161.0 x x 153.0 17.0 121.0 x x 106.0 x x 147.0 x x 27.0 17.0 13.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +14322 Original post publication description: MCP-1 (CCL2 or monocyte chemotactic protein-1; pg/mg protein), measured at 72 hours after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus; Light phase: h 0-12; dark phase: h 12-24; inoculation performed immediately after light onset None Infectious disease, immune function: MCP-1 (CCL2 or monocyte chemotactic protein-1) at 72 h after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [pg/mg protein, kidney] x x x x 18.0 6.0 311.0 12.0 x x 6.0 12.0 138.0 x x 222.0 4.0 100.0 x x 65.0 x x 131.0 x x 9.0 8.0 6.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +14323 Original post publication description: TNF-alpha (pg/mg protein), measured at 72 hours after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus; Light phase: h 0-12; dark phase: h 12-24; inoculation performed immediately after light onset None Infectious disease, immune system, urogenital system: TNF-a at 72 h after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [pg/mg protein, kidney] x x x x 0.6 0.6 7.9 0.7 x x 0.6 0.4 4.3 x x 7.6 0.4 2.0 x x 3.1 x x 5.2 x x 0.6 0.3 0.6 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +14324 Original post publication description: Temperature (difference from baseline, C) during hours 0-12 after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus; Light phase: h 0-12; dark phase: h 12-24; inoculation performed immediately after light onset None Infectious disease, immune function: temperature during h 0-12 after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset (difference from baseline, C) x x x x 0.2 0.3 0.8 0.1 x x 0.2 0.2 -0.3 x x 0.1 0.1 -0.9 x x 0.5 x x 0.8 x x -1.0 -0.7 -0.1 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +14325 Original post publication description: Temperature (difference from baseline, C) during hours 12-24 after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus; Light phase: h 0-12; dark phase: h 12-24; inoculation performed immediately after light onset None Infectious disease, immune function: Temperature during h 12-24 after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset (difference from baseline, C) x x x x 0.5 -0.1 -0.8 x x x -0.1 x -1.0 x x -1.1 -0.7 -3.2 x x -3.7 x x -0.5 x x -2.7 -1.2 -1.2 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +14326 Original post publication description: Temperature (difference from baseline, C) during hours 24-36 after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus; Light phase: h 0-12; dark phase: h 12-24; inoculation performed immediately after light onset None Infectious disease, immune function: Temperature during h 24-36 after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [difference from baseline, C] x x x x 1.8 0.9 0.7 1.7 x x 1.1 1.0 0.8 x x 1.4 1.1 -1.8 x x -1.2 x x 1.7 x x 0.9 1.2 1.1 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +14327 Original post publication description: Temperature (difference from baseline, C) during hours 36-48 after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus; Light phase: h 0-12; dark phase: h 12-24; inoculation performed immediately after light onset None Infectious disease, immune function: Temperature during h 36-48 after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [difference from baseline, C] x x x x -0.2 0.4 -0.8 0.3 x x 0.2 x -0.6 x x 0.7 -0.3 -3.5 x x -3.8 x x 0.5 x x -0.5 -0.5 -0.3 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +14328 Original post publication description: Temperature (difference from baseline, C) during hours 48-60 after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus; Light phase: h 0-12; dark phase: h 12-24; inoculation performed immediately after light onset None Infectious disease, immune function: Temperature during h 48-60 after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [difference from baseline, C] x x x x 0.6 0.7 0.8 0.9 x x 0.6 0.3 0.3 x x 1.1 0.8 -1.9 x x -3.3 x x 1.5 x x 0.7 0.8 0.6 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +14329 Original post publication description: Temperature (difference from baseline, C) during hours 60-72 after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus; Light phase: h 0-12; dark phase: h 12-24; inoculation performed immediately after light onset None Infectious disease, immune function: Temperature during h 60-72 after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus ; immediately after light onset [difference from baseline, C] x x x x 0.2 x -0.8 -0.3 x x -0.2 -0.3 -1.3 x x -0.2 -0.3 -4.2 x x -5.3 x x x x x -0.7 -0.6 -0.6 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +14330 Original post publication description: Activity (ratio to baseline) during hours 0-12 after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus; Light phase: h 0-12; dark phase: h 12-24; inoculation performed immediately after light onset None Infectious disease, immune function: locomotor activity during h 0-12 after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus performed immediately after light onset [ratio to baseline] x x x x 0.97 0.93 1.72 0.81 x x 1.49 0.75 0.85 x x 1.02 0.89 1.05 x x 1.0 x x 1.63 x x 0.67 0.72 0.8 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +14331 Original post publication description: Activity (ratio of baseline) during hours 12-24 after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus; Light phase: h 0-12; dark phase: h 12-24; inoculation performed immediately after light onset None Infectious disease, immune function: locomotor activity during h 12-24 after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus performed immediately after light onset [ratio to baseline] x x x x 0.25 0.42 0.16 0.42 x x 0.24 0.31 0.12 x x 0.03 0.13 0.35 x x 0.07 x x 0.2 x x 0.15 0.21 0.27 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +14332 Original post publication description: Activity (ratio to baseline) during hours 24-36 after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus; Light phase: h 0-12; dark phase: h 12-24; inoculation performed immediately after light onset None Infectious disease, immune function: locomotor activity during h 24-36 after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [ratio to baseline] x x x x 0.76 0.64 0.37 0.76 x x 1.18 0.55 0.54 x x 0.27 0.49 0.31 x x 0.22 x x 0.75 x x 0.52 0.58 0.75 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +14333 Original post publication description: Activity (ratio to baseline) during hours 36-48 after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus; Light phase: h 0-12; dark phase: h 12-24; inoculation performed immediately after light onset None Infectious disease, immune function: locomotor activity during h 36-48 after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [ratio to baseline] x x x x 0.29 0.77 0.19 0.69 x x 0.44 0.44 0.19 x x 0.15 0.41 0.12 x x 0.14 x x 0.57 x x 0.34 0.34 0.4 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +14334 Original post publication description: Activity (ratio to baseline) during hours 48-60 after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus; Light phase: h 0-12; dark phase: h 12-24; inoculation performed immediately after light onset None Infectious disease, immune function: locomotor activity during h 48-60 after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [ratio to baseline] x x x x 0.81 0.77 0.35 0.8 x x 0.68 0.61 0.77 x x 0.27 0.79 0.49 x x 0.47 x x 0.89 x x 0.75 0.58 0.79 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +14335 Original post publication description: Activity (ratio to baseline) during hours 60-72 after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus; Light phase: h 0-12; dark phase: h 12-24; inoculation performed immediately after light onset None Infectious disease, immune system: locomotor activity during h 60-72 after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [ratio to baseline] x x x x 0.34 0.81 0.11 0.64 x x 0.63 0.53 0.21 x x 0.2 0.78 0.17 x x 0.21 x x 0.37 x x 0.45 0.52 0.53 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +14386 Original post publication description: Liver, toxicology, fibrosis susceptibility after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), median area of Sirius red stained collagen (100x magnification, pathology Bonn) in males [%] Original pre publication description: Hall trait 32 Hall trait 32 Liver, toxicology: Fibrosis susceptibility in adult males after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), median area of Sirius red stained collagen (100x magnification, pathology Bonn) [%] x 1.2 0.51 2.37 2.03 2.46 x x x x 1.62 1.73 1.6 1.12 x x x 2.64 x x x x 0.85 x x 2.69 x x x 2.16 2.47 1.65 x x x x x 1.74 1.52 x 1.31 1.72 x x x x x x x 1.37 x x x 1.36 x x x x x 1.32 1.28 x x 2.26 x x x 2.35 x x x 2.0 x 2.65 x x x x x x x x x x x 1.73 x x 1.53 x x x x x 1.42 x 1.37 x x x x x +14365 Original post publication description: Liver, toxicology, Fibrosis susceptibility after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, Days 1 and 4), mean liver to body weight ratio in males and females_data, trimmed [g] Original pre publication description: Hall trait 11 Hall trait 11 Liver, toxicology: Fibrosis susceptibility in adult males and females after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), mean liver to body weight ratio, data trimmed [g] x 0.059 0.047 0.053 0.061 0.06 x x x x 0.052 x 0.067 0.074 x x x 0.081 x x x x 0.057 x x x x x x 0.045 0.067 0.064 x x x x 0.055 0.063 0.079 x 0.054 0.063 x x x x x x x 0.047 x x x 0.073 x x x x x 0.063 0.049 x x 0.053 x x x 0.044 x x 0.061 0.056 x 0.052 x x x x x x x x x x x x x x 0.057 x x x x x 0.058 x 0.069 x x x x x +14362 Original post publication description: Liver, toxicology, Fibrosis susceptibility after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, Days 1 and 4), median liver to body weight ratio in males_data, trimmed [g] Original pre publication description: Hall trait 8 Hall trait 8 Liver, toxicology: Fibrosis susceptibility in adult males after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), median liver to body weight ratio, data trimmed [g] x 0.052 0.046 0.049 0.07 0.061 x x x x 0.063 x x 0.076 x x x 0.081 x x x x 0.064 x x x x x x x 0.064 0.064 x x x x 0.056 x 0.08 x x 0.064 x x x x x x x 0.047 x x x 0.076 x x x x x 0.058 0.05 x x 0.055 x x x 0.041 x x 0.061 0.049 x 0.051 x x x x x x x x x x x x x x 0.063 x x x x x 0.057 x 0.07 x x x x x +14388 Original post publication description: Liver, toxicology, fibrosis susceptibility after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), median area of Sirius red stained collagen (100x magnification, pathology Bonn) females [%] Original pre publication description: Hall trait 34 Hall trait 34 Liver, toxicology: Fibrosis susceptibility in females after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), median area of Sirius red stained collagen (100x magnification, pathology Bonn) [%] x 2.61 0.21 2.16 2.22 2.71 x 1.22 x x 2.17 2.17 1.87 2.55 x x x x x x x x 1.47 x x 2.57 x x x 2.58 2.67 2.06 x x x x x 1.81 1.1 x 2.8 1.96 x x x x x x x 2.46 x x x 2.3 x x x x x 1.98 0.65 x x 2.66 x x x 2.03 x x x 2.07 x 1.88 x x x x x x x x x x x 2.56 x x 1.58 x x x x x 1.71 x 2.5 x x x x x +14385 Original post publication description: Liver, toxicology, fibrosis susceptibility after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), mean area of Sirius red stained collagen (100x magnification, pathology Bonn) in males [%] Original pre publication description: Hall trait 31 Hall trait 31 Liver, toxicology: Fibrosis susceptibility in adult males after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), mean area of Sirius red stained collagen (100x magnification, pathology Bonn) [%] x 1.14 0.74 1.5 1.81 2.41 x x x x 1.63 1.85 1.6 1.18 x x x 2.15 x x x x 0.92 x x 2.35 x x x 2.24 2.37 1.72 x x x x x 1.81 1.52 x 1.57 1.91 x x x x x x x 1.35 x x x 1.27 x x x x x 1.3 1.3 x x 2.32 x x x 2.3 x x x 1.99 x 2.58 x x x x x x x x x x x 1.78 x x 1.6 x x x x x 1.42 x 1.31 x x x x x +14382 Original post publication description: Liver, toxicology, Fibrosis susceptibility after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, Days 1 and 4), median Fibrosis score, semiquantitative histology score, males Original pre publication description: Hall trait 28 Hall trait 28 Liver, toxicology: Fibrosis susceptibility in adult males after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), median fibrosis score, semi-quantitative ordinal histology score, 1=mild, 4=severe [severity] x 2.0 1.63 3.13 3.0 3.0 x 1.0 x x 2.5 2.5 2.0 3.0 x x x 2.5 x x x x 1.5 x x 2.0 x x x 3.0 4.0 2.0 x x x x x 2.0 1.0 x 2.0 2.0 x x x x x x x 1.75 x x x 1.5 x x x x x 2.0 1.0 x x 4.0 x x x 2.0 x x x 2.0 x 3.0 x x x x x x x x x x x 2.0 x x 1.5 x x x x x 1.0 x 2.0 x x x x x +14379 Original post publication description: Liver, toxicology, Fibrosis susceptibility after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, Days 1 and 4), mean Fibrosis score, semiquantitative histology score, females Original pre publication description: Hall trait 25 Hall trait 25 Liver, toxicology: Fibrosis susceptibility in adult females after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), mean fibrosis score, semi-quantitative ordinal histology score, 1=mild, 4=severe [severity] x 2.0 2.25 3.57 3.0 2.5 x 1.0 x x 1.69 2.25 3.0 3.0 x x x 1.0 x x x x 1.6 x x 2.5 x x x 2.75 2.75 2.5 x x x x x 2.0 1.67 x 3.0 2.38 x x x x x x x 1.75 x x x 2.25 x x x x x 1.75 1.5 x x 4.0 x x x 2.67 x x x 2.0 x 2.1 x x x x x x x x x x x 2.5 x x 1.69 x x x x x 1.38 x 2.0 x x x x x +14380 Original post publication description: Liver, toxicology, Fibrosis susceptibility after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, Days 1 and 4), median Fibrosis score, semiquantitative histology score, females Original pre publication description: Hall trait 26 Hall trait 26 Liver, toxicology: Fibrosis susceptibility in adult females after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), median fibrosis score, semi-quantitative ordinal histology score, 1=mild, 4=severe [severity] x 2.0 2.0 3.75 3.0 2.5 x 1.0 x x 1.88 2.0 3.0 3.0 x x x 1.0 x x x x 2.0 x x 2.5 x x x 3.0 3.0 2.5 x x x x x 2.0 2.0 x 3.0 2.25 x x x x x x x 2.0 x x x 2.0 x x x x x 2.0 1.5 x x 4.0 x x x 3.0 x x x 2.0 x 2.0 x x x x x x x x x x x 2.5 x x 1.75 x x x x x 1.38 x 2.0 x x x x x +14376 Original post publication description: Liver, toxicology, Liver injury aftercarbon tetrachloride challenge (12 x 0.7 mg/kg ip, Days 1 and 4), median Alaninaminotransferase aktivity in females_data, trimmed [U/l] Original pre publication description: Hall trait 22 Hall trait 22 Liver, toxicology: Liver injury in adult females after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), median alanine aminotransferase (ALT) activity, trimmed [U/l] x 520.0 110.0 523.0 411.0 78.7 x 251.5 x x 448.0 206.0 87.0 90.5 x x x 815.8 x x x x 514.0 x x 110.5 x x x 207.0 266.0 551.0 x x x x x 158.0 970.0 x 74.0 438.0 x x x x x x x 304.0 x x x 218.0 x x x x x 289.0 x x x 413.0 x x x 166.0 x x x 146.0 x 179.0 x x x x x x x x x x x 301.0 x x 40.5 x x x x x 341.0 x 152.0 x x x x x +14373 Original post publication description: Liver, toxicology, Liver injury aftercarbon tetrachloride challenge (12 x 0.7 mg/kg ip, Days 1 and 4), mean Alaninaminotransferase aktivity in males_data, trimmed [U/l] Original pre publication description: Hall trait 19 Hall trait 19 Liver, toxicology: Liver injury in adult males after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), mean alanine aminotransferase (ALT) aktivity, trimmed [U/l] x 487.0 79.33 856.38 390.33 115.23 x 199.0 x x 69.82 106.91 74.3 163.7 x x x 638.34 x x x x 824.0 x x 286.5 x x x 199.38 333.0 798.67 x x x x x 172.63 1159.5 x 33.45 1105.56 x x x x x x x 635.0 x x x 453.67 x x x x x 326.89 1547.33 x x x x x x 224.14 x x 80.15 x x 219.3 x x x x x x x x x x x 349.5 x x 221.97 x x x x x 359.5 x 201.67 x x x x x +14374 Original post publication description: Liver, toxicology, Liver injury aftercarbon tetrachloride challenge (12 x 0.7 mg/kg ip, Days 1 and 4), median Alaninaminotransferase aktivity in males_data, trimmed [U/l] Original pre publication description: Hall trait 20 Hall trait 20 Liver, toxicology: Liver injury in adult males after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), median alanine aminotransferase (ALT) aktivity, trimmed [U/l] x 417.5 48.0 674.5 88.85 115.0 x 196.0 x x 71.5 89.1 75.95 83.6 x x x 281.0 x x x x 824.0 x x 286.5 x x x 135.0 349.0 599.0 x x x x x 100.0 1096.0 x 28.55 1024.0 x x x x x x x 687.0 x x x 418.5 x x x x x 300.0 1560.0 x x x x x x 204.0 x x 80.15 x x 142.0 x x x x x x x x x x x 349.5 x x 249.0 x x x x x 372.0 x 205.0 x x x x x +14336 Original post publication description: Infectious disease, immune function: Candida titer brain (log) None Infectious disease, immune system, central nervous system: Candida albicans titer in brain (log) at 72 h after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [CFU x 10^4 per gram tissue weight] x x x x -0.7 -1.0 0.51 x x x -0.22 -0.3 0.82 x x 0.32 -0.22 0.71 x x x x x 0.18 x x 0.11 0.04 -0.4 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +14337 Original post publication description: BUN (log) Blood chemistry, infectious disease, immune system: Blood [serum] urea nitrogen (BUN) (log) at 72 h after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinusimmediately after light onset [mg/dl serum, log] Blood chemistry, infectious disease, immune system: Blood [serum] urea nitrogen (BUN) (log) at 72 h after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinusimmediately after light onset [mg/dl serum, log] x x x x 1.59 1.49 2.4 1.51 x x 1.51 1.49 2.24 x x 2.4 1.38 2.24 x x 1.88 x x 1.76 x x 1.62 1.54 1.57 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +14338 Original post publication description: G-CSF (log) candida None Infectious disease, immune function: G-CSF (granulocyte colony stimulating factor) (log) at 72 h after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [pg/mg protein, log, kidney] x x x x 1.34 1.07 2.29 0.97 x x 0.54 0.95 2.08 x x 2.34 0.78 2.29 x x 2.04 x x 1.94 x x 1.08 0.7 0.52 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +14339 Original post publication description: IL-6 (log) candida None Infectious disease, immune system: IL-6 (interleukin-6) protein level in kidney 72 h after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [log pg/mg protein] x x x x 1.59 1.49 2.13 1.69 x x 1.35 1.39 1.96 x x 1.77 1.45 2.09 x x 1.29 x x 1.26 x x 1.26 1.19 1.29 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +14340 Original post publication description: KC (log) candida None Infectious disease, immune function: KC (CXCL1; keratinocyte-derived chemokine) (log) at 72 h after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [pg/mg protein, log, kidney] x x x x 1.59 1.36 2.39 1.44 x x 1.06 1.27 2.21 x x 2.18 1.23 2.08 x x 2.02 x x 2.17 x x 1.43 1.23 1.1 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +14341 Original post publication description: Infectious disease, immune function, IP-10 (log) None Infectious disease, immune system: IP-10 (Interferon gamma-induced protein 10 or CXLC10) (log) at 72 h after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinusimmediately after light onset [pg/mg protein, log, kidney] x x x x 1.58 1.22 1.71 1.35 x x 1.22 1.35 1.78 x x 1.64 1.19 1.53 x x 1.44 x x 1.46 x x 1.56 1.28 1.25 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +14342 Original post publication description: LCN-2 candida log None Infectious disease, immune system, protein expression: Lipocalin-2 (LCN-2) level in kidney 72 h after inoculation with 1 x 10^6 CFU Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [log pg/mg protein] x x x x 2.2 2.02 3.43 1.98 x x 1.91 2.2 3.11 x x 3.59 1.82 3.05 x x 3.15 x x 3.01 x x 2.09 1.95 2.1 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +14343 Original post publication description: MCP-1 (log) candida None Infectious disease, immune function: MCP-1 (CCL2 or monocyte chemotactic protein-1) (log) at 72 h after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [pg/mg protein, log, kidney] x x x x 1.26 0.8 2.49 1.08 x x 0.75 1.06 2.14 x x 2.35 0.6 2.0 x x 1.81 x x 2.12 x x 0.95 0.9 0.77 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +14344 Original post publication description: MIP-2 (log) candida None Infectious disease, immune function: MIP-2 (macrophage inflammatory protein 2-alpha or CXCL2) (log) at 72 h after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [pg/mg protein, log, kidney] x x x x 1.52 1.31 2.77 1.46 x x 1.15 0.78 2.59 x x 2.25 1.21 2.85 x x 1.87 x x 2.01 x x 1.52 1.17 1.21 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +14345 Original post publication description: TNF-a (log) candida None Infectious disease, immune system, urogenital system: TNF-a (log) at 72 h after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [pg/mg protein, log, kidney] x x x x -0.21 -0.21 0.9 -0.14 x x -0.23 -0.35 0.64 x x 0.88 -0.39 0.29 x x 0.5 x x 0.71 x x -0.22 -0.49 -0.21 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +14348 Original post publication description: Log activity candida 0-12 None Infectious disease, immune function: locomotor activity (log) during h 0-12 after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus performed immediately after light onset [ratio to baseline, log] x x x x -0.01 -0.03 0.24 -0.09 x x 0.17 -0.12 -0.07 x x 0.01 -0.05 0.02 x x x x x 0.21 x x -0.18 -0.15 -0.09 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +14349 Original post publication description: Log, activity candida 12-24 None Infectious disease, immune function: locomotor activity (log) during h 12-24 after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus performed immediately after light onset [ratio to baseline. log] x x x x -0.61 -0.38 -0.78 -0.38 x x -0.61 -0.5 -0.94 x x -1.52 -0.89 -0.45 x x -1.16 x x -0.7 x x -0.82 -0.67 -0.56 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +14350 Original post publication description: Log activity candida h 24-36 None Infectious disease, immune function: locomotor activity (log) during h 24-36 after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [ratio to baseline, log] x x x x -0.12 -0.19 -0.43 -0.12 x x 0.07 -0.26 -0.27 x x -0.57 -0.31 -0.51 x x -0.66 x x -0.12 x x -0.28 -0.24 -0.12 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +14351 Original post publication description: Log activity candida 36-48 None Infectious disease, immune function: locomotor activity (log) during h 36-48 after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [ratio to baseline, log] x x x x -0.54 -0.11 -0.71 -0.16 x x -0.36 -0.36 -0.73 x x -0.81 -0.39 -0.93 x x -0.86 x x -0.24 x x -0.47 -0.47 -0.39 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +14352 Original post publication description: Log candida activity 48-60 None Infectious disease, immune function: locomotor activity (log) during h 48-60 after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [ratio to baseline, log] x x x x -0.09 -0.12 -0.45 -0.1 x x -0.17 -0.21 -0.11 x x -0.57 -0.1 -0.31 x x -0.33 x x -0.05 x x -0.13 -0.23 -0.1 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +14353 Original post publication description: Activity candida log 60-72 None Infectious disease, immune system: Locomotor activity (log) during h 60-72 after inoculation with 1 x 10^6 cfu Candida albicans (ATCC 10231) IV via retroorbital sinus immediately after light onset [ratio to baseline, log] x x x x -0.46 -0.09 -0.94 -0.2 x x -0.2 -0.27 -0.69 x x -0.71 -0.11 -0.76 x x -0.67 x x -0.43 x x -0.34 -0.28 -0.28 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +14395 Original post publication description: Liver, toxicology, fibrosis susceptibility after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), mean area of Sirius red stained collagen (100x magnification, laboratory homburg) in males and females, data Original pre publication description: Hall trait 41 Hall trait 41 Liver, toxicology: Fibrosis susceptibility in adult males and females after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), mean area of Sirius red stained collagen (100x magnification, laboratory homburg), data trimmed [%] x 2.057 2.721 5.225 2.405 1.642 x 0.995 x x 1.827 2.105 2.174 2.275 x x x 1.44 x x x x 1.642 x x 2.088 x x x 2.178 2.384 1.626 2.063 x x x x 1.57 1.307 x 2.089 2.249 x x x x x x x 2.435 x x x 3.021 x x x x x 2.009 1.706 x x 5.185 x x x 2.489 x x x 3.416 x 3.459 x x x x x x x x x x x 1.805 x x 1.921 x x x x x 2.248 x 1.821 x x x x x +14396 Original post publication description: Liver, toxicology, fibrosis susceptibility after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), median area of Sirius red stained collagen (100x magnification, laboratory homburg) in males and females, data Original pre publication description: Hall trait 42 Hall trait 42 Liver, toxicology: fibrosis susceptibility in adult males and females after carbon tetrachloride challenge (12 x 0.7 mg/kg ip, days 1 and 4), median area of Sirius red stained collagen (100x magnification, laboratory homburg), data trimmed [%] x 2.153 2.554 5.766 2.412 1.618 x 0.763 x x 2.001 2.027 1.977 2.655 x x x 1.353 x x x x 1.578 x x 1.606 x x x 2.297 2.72 1.42 1.865 x x x x 1.781 1.519 x 2.082 2.579 x x x x x x x 2.257 x x x 3.021 x x x x x 1.514 1.882 x x 4.55 x x x 2.307 x x x 3.298 x 3.38 x x x x x x x x x x x 1.712 x x 2.091 x x x x x 2.281 x 1.908 x x x x x +14397 Original post publication description: Visual system, eye: Corneal neovascular response to FGF2 (10 ng in corneal micro pocket assay), vessel length five days postoperatively measured by slit lamp (from Fig 1) [mm] None Visual system, eye: Corneal neovascular response to FGF2 (10 ng in corneal micro pocket assay), vessel length five days postoperatively measured by slit lamp (from Fig 1) [mm] x 0.57 0.47 0.61 0.33 0.49 0.17 0.52 0.18 0.51 0.32 0.34 0.25 0.48 0.51 0.63 0.61 0.68 0.46 0.56 0.53 0.24 x 0.77 0.43 0.4 0.56 0.06 0.73 0.41 0.52 0.43 0.64 0.55 0.48 x 0.78 0.56 0.53 x 0.51 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +14398 Original post publication description: Visual system, eye: Corneal neovascular response to FGF2 (10 ng, corneal micro pocket assay), vessel area five days postoperatively measured by slit lamp (from Fig 2) [mm2] None Visual system, eye: Corneal neovascular response to FGF2 (10 ng, corneal micro pocket assay), vessel area five days postoperatively measured by slit lamp (from Fig 2) [mm2] x x x x 0.43 0.76 0.15 0.79 0.17 0.73 0.31 0.31 0.24 0.56 0.61 1.8 0.75 1.03 0.5 0.79 0.83 0.24 x 1.45 0.41 0.44 0.68 0.61 1.2 0.57 0.73 0.45 0.97 0.7 0.58 x 1.15 0.62 0.76 x 0.7 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +14399 Original post publication description: Visual system, eye: Central corneal thickness measured by ocular coherence tomography (OCT) in 60 to 100-day-old males and females [um] Original pre publication description: Geisert Eye 1 Visual system, eye: Eldon Geisert trait, contact <egeisert@uthsc.edu> Visual system, eye: Central corneal thickness measured by ocular coherence tomography (OCT) in 60 to 100-day-old males and females [um] x x 102.0 125.0 89.0 x x x x 98.0 98.0 x 94.0 110.0 x 94.0 x x x x 88.0 x x 106.0 x 85.0 x 104.0 x 91.0 121.0 x x x x x x 105.0 75.0 x x 83.0 85.0 86.0 x x 117.0 96.0 107.0 102.0 x x x x 100.0 x x x 89.0 111.0 91.0 x x x 109.0 91.0 97.0 85.0 109.0 103.0 x 100.0 128.0 100.0 x 108.0 x 97.0 96.0 x x 104.0 97.0 111.0 96.0 101.0 x 102.0 95.0 x x x x 96.0 109.0 x 109.0 x 92.0 87.0 97.0 89.0 +14400 Original post publication description: Gene expression, retina: Hspa5 expression from denoised Original pre publication description: Hspa5 denoised Hspa5 denoised Gene expression, retina: Hspa5 expression from denoised -0.582 -0.384 -0.007 -0.188 -0.068 0.06 -0.217 0.139 0.023 0.291 -0.442 -0.397 0.533 -0.206 0.342 -0.473 0.546 -0.281 -0.2 0.069 -0.278 x 0.267 0.311 x 0.202 -0.098 0.302 x 0.339 0.274 0.469 -0.319 x -0.285 x 0.02 -0.465 0.319 x 0.179 -0.501 -0.498 -0.14 x x -0.124 -0.094 -0.186 -0.437 x -0.499 x -0.229 0.07 x x x 0.226 -0.52 -0.19 0.411 x 0.81 0.094 0.03 -0.136 0.401 0.356 -0.128 x -0.079 0.473 -0.225 x -0.193 x x -0.66 0.166 x 0.057 0.099 -0.05 0.094 0.294 x -0.05 0.69 x -0.556 x x 0.059 -0.18 0.057 -0.175 0.413 0.511 -0.071 0.743 0.069 +14401 Original post publication description: Immune function, infectious disease: Bronchoalveolar lavage (BAL) lung lymphocyte cell number following infection with Acinetobacter baumannii [units/ul] Original pre publication description: Immune function infectious disease: MA Miller Trait 1 Immune function infectious disease: MA Miller Trait 1 Infectious disease, immune system: Bronchoalveolar lavage (BAL) lung lymphocyte cell number following infection with Acinetobacter baumannii (BXD65 winsorized from 47.5 to 26.0) [units/ul] x x 5.065 23.699 x x x x x x x 4.764 x x x x x x x x 10.478 x x x x x x x x 7.67 x x x x x x 5.107 x 1.463 x x 11.371 x 3.682 x x x 5.091 5.531 x x x x 10.222 x x x x x 7.185 9.492 x x 26.0 12.512 x 12.774 19.377 11.654 x x x x 25.002 x x x x x x x 6.871 x x 11.293 8.708 x x 15.358 x 11.739 x x 9.509 3.001 x x x x 12.865 22.495 x +14402 Original post publication description: Immune function, infectious disease: Bronchoalveolar lavage (BAL) lung lymphocyte cell number following infection with Acinetobacter baumannii [units/ul] Original pre publication description: Immune function infectious disease: MA Miller Trait 1 Immune function infectious disease: MA Miller Trait 1 Infectious disease, immune system: Bronchoalveolar lavage (BAL) lung lymphocyte cell number following infection with Acinetobacter baumannii [units/ul] x x 5.065 23.699 x x x x x x x 4.764 x x x x x x x x 10.478 x x x x x x x x 7.67 x x x x x x 5.107 x 1.463 x x 11.371 x 3.682 x x x 5.091 5.531 x x x x 10.222 x x x x x 7.185 9.492 x x 47.517 12.512 x 12.774 19.377 11.654 x x x x 25.002 x x x x x x x 6.871 x x 11.293 8.708 x x 15.358 x 11.739 x x 9.509 3.001 x x x x 12.865 22.495 x +15179 Original post publication description: un-named trait Original pre publication description: Orofacial system, dentition: incisor malocclusion frequency scale (3 = very common problem, 2 = occasional, 1 = rare, 0 =none) Musculoskeletal system, orofacial system, dentition: Malocclusion of incisors in adults of both sexes [frequency scale: 3 = common, 2 = occasional, 1 = rare, 0 =none] Musculoskeletal system, orofacial system, dentition: Malocclusion of incisors in adults of both sexes [frequency scale: 3 = common, 2 = occasional, 1 = rare, 0 =none] x x 1.0 1.0 2.0 2.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +15180 Original post publication description: Infectious disease, immune function: Burkholderia pseudomallei (strain 1026b, 100 CFU intranasal under isoflurane) survival to 11-days in 12–13 week-old males and females [%] Original pre publication description: Infectious disease, immune function: UTHSC RBL Trait 1 Infectious disease, immune system: UTHSC RBL Trait 1 Infectious disease, immune system: Burkholderia pseudomallei (strain 1026b, 100 CFU intranasal under isoflurane) survival to 11-days in 12–13 week-old males and females [%] x x 100.0 0.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 26.0 45.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +15181 Original post publication description: Central nervous system, gene expression, learning and memory: Kcnq5 expression level (potassium voltage-gated channel, subfamily Q, member 5 (M-current, slowly activating muscarinic acetylcholine receptor sensitive), first principal component generated on exon probes using UMUTAffyExon_0209_RMA data set [log2 relative concentration] Original pre publication description: Central nervous system, gene expression, learning and memory: Kcnq5 expression level (potassium voltage-gated channel, subfamily Q, member 5 (M-current, slowly activating muscarinic acetylcholine receptor sensitive), first principal component generated on exon probes using UMUTAffyExon_0209_RMA data set [log2 relative concentration] Central nervous system, gene expression, learning and memory: Kcnq5 mRNA expression in hippocampus (potassium voltage-gated channel, subfamily Q, member 5 (M-current, slowly activating muscarinic acetylcholine receptor sensitive), first principal component generated on exon probes using UMUTAffyExon_0209_RMA data set [relative residual concentration] Central nervous system, gene expression: Kcnq5 mRNA expression in hippocampus (Kv7.5, potassium voltage-gated channel, subfamily Q, member 5, M-current, slowly activating muscarinic acetylcholine receptor sensitive), first principal component generated using exon probe sets and UMUTAffyExon_0209_RMA data [relative residual concentration] 2.285 0.682 -2.162 -0.638 0.207 -1.006 -0.105 1.995 1.836 2.353 2.709 -1.639 0.819 -1.262 1.203 1.985 2.474 1.504 0.546 -5.373 -0.622 -3.078 x 3.41 -0.305 2.661 5.371 -0.176 x -3.716 1.712 1.256 2.888 x 0.493 x -5.468 0.259 -2.573 x -2.474 2.389 x 0.653 x x 0.844 x -2.485 4.861 x x x -3.056 x x x x -0.243 -0.858 -1.767 1.926 1.278 -2.836 1.268 0.418 -2.213 2.55 -0.397 x x 0.998 -4.961 -0.809 -1.242 0.58 x -3.669 2.161 x x -4.095 1.844 2.399 1.91 4.439 x 1.554 -4.238 x 3.099 -5.187 -1.999 x -1.074 -2.071 -2.21 2.187 x x x x +15183 Original post publication description: Central nervous system, gene expression: Prodynorphin (Pdyn, dynorphin, D1 medium spiny neuron expression signature) mRNA expression in striatum (caudate-putamen), first principal component generated using five Affymetrix exon-level Penk probe sets and Striatum_Exon_0209 data [relative residual concentration] Original pre publication description: Central nervous system, gene expression: Prodynorphin (Pdyn, dynorphin, D1 medium spiny neuron expression signature) mRNA expression in striatum (caudate-putamen), first principal component generated using five Affymetrix exon-level Penk probe sets and Striatum_Exon_0209 data [relative residual concentration] Central nervous system, gene expression: Prodynorphin (Pdyn, dynorphin, D1 medium spiny neuron expression signature) mRNA expression in striatum (caudate-putamen), first principal component generated using five Affymetrix exon-level Pdyn probe sets and Striatum_Exon_0209 data [relative residual concentration] Central nervous system, gene expression: Prodynorphin (Pdyn, dynorphin, D1 medium spiny neuron expression signature) mRNA expression in striatum (caudate-putamen), first principal component generated using five Affymetrix exon-level Pdyn probe sets and Striatum_Exon_0209 data [relative residual concentration] x -0.733 2.638 2.303 -1.281 -1.264 x x 1.85 0.041 0.495 -0.136 0.183 -1.57 -1.057 1.654 2.51 -1.575 -0.383 0.378 1.256 -0.941 x -1.436 x -0.056 -2.405 -1.144 x -2.222 0.894 -2.207 3.0 x 0.249 x -1.6 1.958 -0.72 x -0.133 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +15184 Original post publication description: Central nervous system, gene expression: Substance P (tachykinin 1, Tac1, D1 medium spiny neuron expression signature) mRNA expression in striatum (caudate-putamen), first principal component generated using ten Affymetrix exon-level Penk probe sets and Striatum_Exon_0209 data [relative residual concentration] Original pre publication description: Central nervous system, gene expression: Substance P (tachykinin 1, Tac1, D1 medium spiny neuron expression signature) mRNA expression in striatum (caudate-putamen), first principal component generated using ten Affymetrix exon-level Penk probe sets and Striatum_Exon_0209 data [relative residual concentration] Central nervous system, gene expression: Substance P (tachykinin 1, Tac1, substance P, D1 medium spiny neuron expression signature) mRNA expression in striatum (caudate-putamen), first principal component generated using ten Affymetrix exon-level Tac1 probe sets and Striatum_Exon_0209 data [relative residual concentration] Central nervous system, gene expression: Substance P (tachykinin 1, Tac1, substance P, D1 medium spiny neuron expression signature) mRNA expression in striatum (caudate-putamen), first principal component generated using ten Affymetrix exon-level Tac1 probe sets and Striatum_Exon_0209 data [relative residual concentration] x 0.089 -2.022 3.178 0.677 1.236 x x -3.856 -2.913 0.114 -2.861 0.778 -0.621 0.155 -2.661 -0.039 -1.361 -0.835 0.37 0.781 -3.154 x 1.001 x 1.403 -0.954 1.056 x 2.206 5.0 2.757 0.018 x -1.769 x -2.335 4.485 -0.088 x -0.693 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +15185 Original post publication description: Central nervous system, gene expression: Dopamine D1 receptor (Drd1a, D1 medium spiny neuron expression signature) mRNA expression in striatum (caudate-putamen), first principal component generated using three Affymetrix exon-level Drd1a probe sets and Striatum_Exon_0209 data [relative residual concentration] Original pre publication description: Central nervous system, gene expression: Dopamine D1 receptor (Drd1a, D1 medium spiny neuron expression signature) mRNA expression in striatum (caudate-putamen), first principal component generated using three Affymetrix exon-level Drd1a probe sets and Striatum_Exon_0209 data [relative residual concentration] Central nervous system, gene expression: Dopamine D1 receptor (Drd1a, D1 medium spiny neuron expression signature) mRNA expression in striatum (caudate-putamen), first principal component generated using three Affymetrix exon-level Drd1a probe sets and Striatum_Exon_0209 data [relative residual concentration] Central nervous system, gene expression: Dopamine D1 receptor (Drd1a, D1 medium spiny neuron expression signature) mRNA expression in striatum (caudate-putamen), first principal component generated using three Affymetrix exon-level Drd1a probe sets and Striatum_Exon_0209 data [relative residual concentration] x 0.729 0.517 -1.322 -0.794 1.033 x x 1.394 1.331 1.512 0.482 0.7 0.165 1.547 0.554 1.39 0.921 1.619 1.175 0.964 -2.5 x -2.826 x -1.85 -2.9 -1.78 x -3.617 -0.789 -1.565 0.521 x 1.204 x 1.801 -1.452 0.374 x 1.463 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +15186 Original post publication description: Central nervous system, gene expression: Dopamine D2 receptor (Drd2, D2 medium spiny neuron expression signature) mRNA expression in striatum (caudate-putamen), first principal component generated using eight Affymetrix exon-level Drd1a probe sets and Striatum_Exon_0209 data [relative residual concentration] Original pre publication description: Central nervous system, gene expression: Dopamine D2 receptor (Drd2, D2 medium spiny neuron expression signature) mRNA expression in striatum (caudate-putamen), first principal component generated using eight Affymetrix exon-level Drd1a probe sets and Striatum_Exon_0209 data [relative residual concentration] Central nervous system, gene expression: Dopamine D2 receptor (Drd2, D2 medium spiny neuron expression signature) mRNA expression in striatum (caudate-putamen), first principal component generated using eight Affymetrix exon-level Drd2 probe sets and Striatum_Exon_0209 data [relative residual concentration] Central nervous system, gene expression: Dopamine D2 receptor (Drd2, D2 medium spiny neuron expression signature) mRNA expression in striatum (caudate-putamen), first principal component generated using eight Affymetrix exon-level Drd2 probe sets and Striatum_Exon_0209 data [relative residual concentration] x -0.463 -2.059 2.978 1.728 -1.374 x x -2.722 -2.785 -0.954 -1.597 1.567 0.404 0.358 -1.208 -0.608 -0.826 -0.476 -3.734 -1.494 2.768 x 1.726 x 2.757 4.065 1.863 x 5.634 0.828 4.17 -0.171 x -2.571 x -3.265 -2.501 -0.003 x -2.037 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +15736 None Trait_175_AUW-BXD Central nervous system, metabolism, behavior: Activity (movement) during dark phase (night), in standard housing cage, chow diet, males [counts/hour] x x 5883.0 6884.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 5637.0 3147.0 8139.0 x x 5311.0 4288.0 4312.0 4599.0 x x x 6226.0 9801.0 x x x 5063.0 4510.0 3596.0 4125.0 5092.0 4618.0 3533.0 x 5520.0 6017.0 5343.0 3573.0 x 5502.0 x 4128.0 x x x 3542.0 4829.0 3714.0 x 4105.0 5446.0 3356.0 x 5033.0 x 5012.0 3601.0 x 5120.0 x x 4331.0 5098.0 3371.0 4980.0 6253.0 6316.0 8332.0 x 3917.0 +15730 None Trait_169_AUW-BXD Metabolism: Body temperature loss after 6 hours in 4 deg C chamber, high fat diet, males [%] x x 5.4922 5.5658 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 4.2657 8.7561 1.3186 x x 2.8 1.7 6.2 4.5712 x x x 2.7384 6.2 x x x x 5.2348 2.8 7.84 10.66 6.5 18.8 x 4.9 7.34 0.8011 7.1 x 2.6549 x 2.4576 x x x 5.7 3.4042 8.62 x 2.07 5.71 6.33 x 3.9478 x 6.07 3.67 x x x x 6.119 4.31 13.8 12.65 9.01 5.38 7.3 x 1.9 +15710 None Trait_149_AUW-BXD Respiratory system, metabolism: Oxygen intake (VO2) dark phase (night) average, lean mass corrected, metabolic cage, chow diet, males [ml/kg/h] x x 3776.0 5159.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 3927.0 x 3893.0 x x x x x 4531.0 x x x 4190.0 x x x x x 4249.0 3542.0 4266.0 x 4129.0 4043.0 x x 2508.0 3899.0 x x 4233.0 x 3779.0 x x x x 4203.0 x x 3857.0 4363.0 x x 4611.0 x 4288.0 4530.0 x 3681.0 x x 3861.0 3652.0 x x x 4045.0 x x x +15708 None Trait_147_AUW-BXD Respiratory system, metabolism: Oxygen intake (VO2) light phase (day) average, lean mass corrected, metabolic cage, chow diet, males [ml/kg/h] x x 3172.0 4568.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 3244.0 x 3192.0 x x x x x 3675.0 x x x 3366.0 x x x x x 3490.0 2851.0 3620.0 x 3525.0 3232.0 x x 2177.0 3208.0 x x 3400.0 x 3105.0 x x x x 3639.0 x x 3471.0 3276.0 x x 3987.0 x 3519.0 3573.0 x 3297.0 x x 3431.0 3135.0 x x x 3423.0 x x x +15706 None Trait_145_AUW-BXD Central nervous system, metabolism, behavior: Water intake in 24 h, metabolic cage, chow diet, males [ml] x x 1.82 2.295 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 1.99 0.69 2.85 x x 1.42 3.16 1.176 2.0 x x x 2.224 2.132 x x x 3.596 2.487 2.775 2.588 1.315 1.3 2.648 x 1.656 1.325 3.045 0.632 x 3.044 x 2.392 x x x 1.236 1.128 1.665 x 0.347 1.37 1.776 x 3.215 x 2.205 3.935 x 1.155 x x 1.57 1.464 2.04 1.032 1.356 1.793 1.53 x 1.388 +15704 None Trait_143_AUW-BXD Central nervous system, metabolism, behavior: Food intake in 24 h, metabolic cage, chow diet, males [kCal] x x 10.9337 9.6348 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 9.2938 4.2625 12.8433 x x x x 5.9148 8.7265 x x x 8.1778 7.5144 x x x 13.4044 11.3677 10.416 9.8952 6.2403 10.8872 9.7216 x x 10.4315 11.8482 2.1886 x 8.7854 x 4.6562 x x x 7.8244 x 8.0817 x 6.1163 5.3692 4.1292 x 10.0688 x 6.5472 x x 8.8412 x x 10.6702 7.099 8.9156 5.4436 x 11.3677 5.5552 x 4.1788 +15702 None Trait_141_AUW-BXD Central nervous system, metabolism, behavior: Food intake in 24 h, metabolic cage, chow diet, males [g] x x 3.527 3.108 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 2.998 1.375 4.143 x x x x 1.908 2.815 x x x 2.638 2.424 x x x 4.324 3.667 3.36 3.192 2.013 3.512 3.136 x x 3.365 3.822 0.706 x 2.834 x 1.502 x x x 2.524 x 2.607 x 1.973 1.732 1.332 x 3.248 x 2.112 x x 2.852 x x 3.442 2.29 2.876 1.756 x 3.667 1.792 x 1.348 +15700 None Trait_139_AUW-BXD Metabolism, behavior: Activty (rearing) at night, metabolic cage, chow diet, males [AUC] x x 689.0 155.13 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 760.92 234.8 154.14 x x 381.5 353.2 680.7 322.141 x x x 129.93 258.0 x x x 575.2 287.7 153.63 436.2 266.7 362.3 264.42 x 463.97 281.67 224.2 420.86 x 137.3 x 155.01 x x x 395.65 239.34 175.76 x 302.68 536.5 219.6 x 117.9 x 693.15 60.08 x 434.3 x x 301.3 321.884 480.4 717.1 1455.03 483.06 1094.0 x 191.8 +15698 None Trait_137_AUW-BXD Metabolism, behavior: Activty (ambulations) at night, metabolic cage, chow diet, males [AUC] x x 887.5 507.4 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 1091.47 463.76 378.6 x x 501.5 674.08 829.0 565.95 x x x 335.98 626.0 x x x 901.97 638.2 409.1 785.6 574.97 644.4 351.55 x 949.089 510.97 348.6 792.6 x 206.7 x 383.4 x x x 626.65 475.4 455.8 x 395.8 804.4 501.1 x 365.65 x 977.2 366.5 x 708.5 x x 472.64 443.67 829.3 1060.34 1032.26 646.0 978.0 x 525.5 +15696 None Trait_135_AUW-BXD Metabolism, behavior: Activity (movement) at dark phase (night), metabolic cage, chow diet, males [AUC] x x 1892.0 1407.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 2224.0 1082.7 815.2 x x 1268.0 1398.0 1621.8 1094.2 x x x 740.05 1539.0 x x x 1991.8 1606.0 1269.4 1609.4 1503.5 1517.6 1125.0 x 1986.2 1257.86 759.4 1827.06 x 552.6 x 994.1 x x x 1522.0 1118.6 1115.7 x 1063.8 1678.2 1315.99 x 1090.6 x 1973.0 1080.5 x 1582.6 x x 1216.6 1279.8 1975.0 2141.02 2019.3 1491.2 2018.0 x 1339.5 +15694 None Trait_127_AUW-BXD Respiratory system, metabolism: Carbon dioxide output (VCO2) over 24 hours, metabolic cage, chow diet, males [mL/kg/h] x x 2741.0 2969.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 2532.0 2180.0 3031.0 x x 1740.0 1899.0 2139.0 2830.0 x x x 2805.0 1853.0 x x x 2460.0 2794.0 2421.0 2303.0 2108.0 2113.0 2052.0 x 2363.0 1964.0 2683.0 1878.0 x 2722.0 x 2162.0 x x x 2067.0 2049.0 1772.0 x 2652.0 2051.0 1766.0 x 3296.0 x 2226.0 3048.0 x 1923.0 x x 2398.0 2196.0 2066.0 2204.0 2334.0 2533.0 1898.0 x 2048.0 +15692 None Trait_125_AUW-BXD Respiratory system, metabolism: Carbon dioxide output (VCO2) dark phase (night) average, metabolic cage, chow diet, males [mL/kg/h] x x 2972.0 3185.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 2841.0 2307.0 3358.0 x x 1967.0 2240.0 2330.0 3113.0 x x x 3133.0 2082.0 x x x 2769.0 3098.0 2793.0 2631.0 2327.0 2289.0 2268.0 x 2607.0 2133.0 2964.0 1991.0 x 2990.0 x 2360.0 x x x 2224.0 2182.0 1896.0 x 2785.0 2335.0 1978.0 x 3549.0 x 2483.0 3489.0 x 2086.0 x x 2640.0 2382.0 2324.0 2494.0 2513.0 2710.0 2100.0 x 2288.0 +15690 None Trait_123_AUW-BXD Respiratory system, metabolism: Carbon dioxide output (VCO2) light phase (day) average, metabolic cage, chow diet, males [mL/kg/h] x x 2376.0 2629.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 2108.0 1978.0 2514.0 x x 1499.0 1491.0 1909.0 2382.0 x x x 2286.0 1519.0 x x x 2112.0 2311.0 2049.0 1975.0 1870.0 1902.0 1710.0 x 2102.0 1762.0 2239.0 1751.0 x 2298.0 x 1847.0 x x x 1799.0 1839.0 1544.0 x 2443.0 1767.0 1539.0 x 2894.0 x 1919.0 2518.0 x 1750.0 x x 2126.0 1902.0 1756.0 1855.0 2132.0 2253.0 1571.0 x 1793.0 +15688 None Trait_121_AUW-BXD Respiratory system, metabolism: Oxygen intake (VO2) over 24 hours, metabolic cage, chow diet, males [mL/kg/h] x x 3000.0 3466.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 2943.0 2521.0 3163.0 x x 1985.0 2149.0 2762.0 3263.0 x x x 3160.0 3181.0 x x x 2920.0 3088.0 2751.0 2738.0 2584.0 2529.0 2364.0 x 2699.0 2358.0 2809.0 2450.0 x 3072.0 x 2639.0 x x x 2947.0 2543.0 3076.0 x 3160.0 2528.0 2251.0 x 3705.0 x 2800.0 3413.0 x 2328.0 x x 2792.0 2598.0 2746.0 2817.0 2852.0 2854.0 3102.0 x 2554.0 +15686 None Trait_119_AUW-BXD Respiratory system, metabolism: Oxygen intake (VO2) dark phase (night) average, metabolic cage, chow diet, males [mL/kg/h] x x 3205.0 3616.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 3230.0 2633.0 3394.0 x x 2195.0 2487.0 2923.0 3490.0 x x x 3417.0 3452.0 x x x 3198.0 3322.0 3049.0 2967.0 2730.0 2649.0 2563.0 x 2870.0 2508.0 3013.0 2563.0 x 3301.0 x 2831.0 x x x 3125.0 2672.0 3196.0 x 3277.0 2768.0 2444.0 x 3899.0 x 3059.0 3815.0 x 2453.0 x x 2946.0 2772.0 2976.0 3103.0 3012.0 2997.0 3333.0 x 2790.0 +15684 None Trait_117_AUW-BXD Respiratory system, metabolism: Oxygen intake (VO2) light phase (day) average, metabolic cage, chow diet, males [mL/kg/h] x x 2675.0 3227.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 2621.0 2344.0 2799.0 x x 1762.0 1744.0 2569.0 2904.0 x x x 2753.0 2786.0 x x x 2608.0 2716.0 2452.0 2508.0 2336.0 2385.0 2054.0 x 2515.0 2177.0 2487.0 2323.0 x 2710.0 x 2334.0 x x x 2640.0 2338.0 2858.0 x 2974.0 2289.0 2045.0 x 3399.0 x 2509.0 2982.0 x 2196.0 x x 2618.0 2322.0 2469.0 2473.0 2673.0 2545.0 2722.0 x 2303.0 +15682 None Trait_115_AUW-BXD Respiratory system, metabolism: Respiratory exchange ratio (RER) over 24 hours, metabolic cage, chow diet, males [ratio] x x 0.9128 0.85645 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.851 0.8609 0.956675 x x 0.874 0.88 0.769 0.86715 x x x 0.88288 0.574 x x x 0.834 0.9005 0.874 0.836 0.812 0.834 0.86352 x 0.872 0.832 0.95135 0.764 x 0.87586 x 0.81496 x x x 0.701 0.80198 0.57 x 0.838 0.8034 0.78 x 0.8841 x 0.785 0.871 x 0.825 x x 0.853 0.84154 0.749 0.777 0.816 0.874467 0.605 x 0.796 +15680 None Trait_113_AUW-BXD Respiratory system, metabolism: Respiratory exchange ratio (RER) dark phase (night), metabolic cage, chow diet, males [ratio] x x 0.93275 0.88225 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.896 0.87498 0.992625 x x 0.895 0.899 0.793 0.895775 x x x 0.91928 0.598 x x x 0.861 0.936033 0.915 0.886 0.839 0.866 0.88416 x 0.908 0.851 0.987475 0.775 x 0.90668 x 0.83306 x x x 0.711 0.81672 0.588 x 0.8501 0.8453 0.806 x 0.909975 x 0.805 0.924 x 0.85 x x 0.892 0.85586 0.781 0.801 0.834 0.889433 0.626 x 0.816 +15678 None Trait_111_AUW-BXD Respiratory system, metabolism: Respiratory exchange ratio (RER) light phase (day), metabolic cage, chow diet, males [ratio] x x 0.88285 0.81775 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.8 0.84006 0.90285 x x 0.851 0.857 0.741 0.824175 x x x 0.82776 0.538 x x x 0.805 0.847233 0.834 0.786 0.782 0.797 0.83262 x 0.833 0.808 0.89735 0.752 x 0.82964 x 0.78882 x x x 0.685 0.77986 0.537 x 0.819833 0.762 0.752 x 0.84525 x 0.763 0.814 x 0.798 x x 0.809 0.8201 0.71 0.748 0.796 0.852 0.573 x 0.775 +15676 None Trait_107_AUW-BXD Musculoskeletal system, morphology: Soleus muscle mass, percentage of body, chow diet, males [%] x x 0.054 0.044 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.052 0.043 0.052 x x 0.062 0.05 0.039 0.048 x x x 0.041 0.046 x x x 0.033 0.047 0.059 0.04 0.052 0.046 0.037 x 0.058 0.041 0.039 0.052 x 0.049 x 0.047 x x x 0.042 0.038 0.061 x 0.051 0.048 0.044 x 0.042 x 0.043 0.039 x 0.035 x x 0.054 0.045 0.052 0.055 0.065 0.045 0.045 x 0.046 +15674 None Trait_105_AUW-BXD Musculoskeletal system, Musculoskeletal system, morphology: Gastrocnemius muscle mass, percentage of body, chow diet, males [%] x x 1.061 0.81 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 1.071 0.674 0.951 x x 0.828 0.916 0.777 1.132 x x x 0.949 0.812 x x x 0.654 0.836 0.88 0.775 0.916 0.755 0.549 x 0.829 0.769 0.926 0.833 x 0.902 x 0.908 x x x 0.787 0.714 1.067 x 0.867 0.793 0.763 x 0.896 x 0.813 0.674 x 0.619 x x 0.882 0.754 0.715 0.813 0.909 0.799 0.855 x 0.751 +15672 None Trait_103_AUW-BXD Morphology: Epididymal white adipose mass, percentage of body, chow diet, males [%] x x 2.38 3.865 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 2.468 6.299 1.782 x x 4.347 2.801 4.062 3.157 x x x 2.275 2.27 x x x 3.96 3.731 3.185 3.643 4.337 3.996 5.608 x 2.862 4.016 2.813 3.229 x 2.124 x 3.44 x x x 5.64 3.505 3.289 x 3.572 3.57 3.101 x 3.219 x 4.235 3.917 x 4.039 x x 3.469 5.241 5.01 5.007 2.964 5.145 3.284 x 2.985 +15670 None Trait_101_AUW-BXD Urogenital system, morphology: Kidney mass, percentage of body, chow diet, males [%] x x 1.208 1.99 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 1.115 1.228 1.675 x x 1.005 1.3 1.216 1.646 x x x 1.678 1.997 x x x 1.189 1.38 1.507 1.023 1.302 1.076 1.216 x 1.085 1.406 1.849 1.25 x 1.724 x 1.67 x x x 1.347 1.196 1.484 x 1.592 1.73 0.95 x 1.282 x 1.258 1.395 x 0.921 x x 1.331 1.014 1.278 1.465 1.322 1.075 1.229 x 1.316 +15668 None Trait_99_AUW-BXD Morphology: Perirenal white adipose mass, percentage of body, chow diet, males [%] x x 0.855 1.625 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 1.179 2.311 0.953 x x 2.581 1.722 1.86 1.813 x x x 0.864 1.159 x x x 2.628 1.592 1.825 2.455 2.658 2.881 3.722 x 2.297 2.654 1.571 1.74 x 1.489 x 1.324 x x x 2.33 2.412 1.28 x 1.224 1.95 1.881 x 1.653 x 2.084 1.007 x 2.924 x x 2.427 2.489 1.025 2.93 1.54 2.399 1.244 x 2.997 +15666 None Trait_97_AUW-BXD Morphology: Subcutaneous white adipose mass, percentage of body, chow diet, males [%] x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.843 3.282 0.724 x x 2.079 1.586 1.685 1.241 x x x 1.081 0.923 x x x 2.565 1.37 1.028 1.531 1.835 3.027 3.243 x 1.976 3.193 1.912 2.375 x 1.007 x 1.649 x x x 1.76 x 2.073 x 1.008 1.404 2.361 x 0.923 x 1.862 1.862 x 2.895 x x 1.483 1.862 1.905 2.088 1.525 2.499 2.196 x 2.937 +15664 None Trait_95_AUW-BXD Cardiovascular systen, morphology: Heart mass, percentage of body, chow diet, males [%] x x 0.763 0.616 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.465 0.486 0.638 x x 0.429 0.455 0.471 0.658 x x x 0.595 0.583 x x x 0.392 0.49 x 0.548 0.556 0.398 0.473 x 0.502 0.429 0.585 0.59 x 0.681 x 0.519 x x x 0.505 0.566 0.486 x 0.609 0.578 0.451 x 0.718 x 0.478 0.488 x 0.356 x x 0.433 0.431 0.504 0.465 0.641 0.529 0.554 x 0.59 +15662 None Trait_93_AUW-BXD Gastrointestinal system, morphology: Liver mass, percentage of body, chow diet, males [%] x x 5.024 4.11 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 3.403 4.257 5.1 x x 3.207 4.479 3.31 4.287 x x x 4.901 3.972 x x x 6.94 4.787 3.814 2.942 3.524 5.929 4.009 x 4.715 4.622 4.487 3.802 x 3.678 x 4.238 x x x 4.03 3.322 4.513 x 3.721 4.105 4.06 x 4.24 x 3.216 3.908 x 5.242 x x 3.777 4.142 5.748 3.748 4.137 4.117 4.152 x 3.382 +15660 None Trait_89_AUW-BXD Musculoskeletal system, morphology: Soleus muscle mass, chow diet, males [g] x x 0.017 0.0148 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.0162 0.016 0.0157 x x 0.0227 0.0193 0.018 0.0154 x x x 0.0123 0.0149 x x x 0.0152 0.0161 0.018 0.0142 0.0181 0.0215 0.0176 x 0.0238 0.0161 0.0116 0.019 x 0.0147 x 0.0152 x x x 0.0158 0.0158 0.0155 x 0.0145 0.0172 0.0191 x 0.0119 x 0.0179 0.013 x 0.0167 x x 0.0182 0.0201 0.0233 0.0197 0.0205 0.0158 0.0141 x 0.0172 +15658 None Trait_87_AUW-BXD Musculoskeletal system, morphology: Gastrocnemius muscle mass, chow diet, males [g] x x 0.331 0.271 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.325 0.231 0.305 x x 0.305 0.363 0.277 0.365 x x x 0.283 0.262 x x x 0.297 0.287 0.273 0.274 0.288 0.354 0.276 x 0.34 0.303 0.27 0.304 x 0.275 x 0.298 x x x 0.294 0.293 0.265 x 0.247 0.282 0.334 x 0.25 x 0.276 0.221 x 0.3 x x 0.303 0.33 0.317 0.291 0.286 0.322 0.267 x 0.281 +15656 None Trait_85_AUW-BXD Morphology: Epididymal white adipose mass, chow diet, males [g] x x 0.753 1.299 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.789 2.149 0.602 x x 1.612 1.115 1.482 1.017 x x x 0.698 0.732 x x x 1.787 1.288 1.01 1.297 0.693 1.88 2.666 x 1.214 1.583 0.887 1.192 x 0.694 x 1.166 x x x 2.13 1.444 0.932 x 1.029 1.29 1.37 x 0.91 x 1.438 1.311 x 1.956 x x 1.214 2.355 2.224 1.866 0.937 2.147 1.04 x 1.128 +15654 None Trait_83_AUW-BXD Urogenital system, morphology: Kidney mass, chow diet, males [g] x x 0.378 0.666 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.342 0.417 0.535 x x 0.371 0.514 0.438 0.528 x x x 0.501 0.648 x x x 0.538 0.475 0.468 0.362 0.567 0.508 0.57 x 0.451 0.554 0.586 0.459 x 0.448 x 0.547 x x x 0.506 0.492 0.385 x 0.453 0.62 0.418 x 0.359 x 0.426 0.459 x 0.445 x x 0.457 0.449 0.567 0.527 0.417 0.426 0.383 x 0.496 +15652 None Trait_81_AUW-BXD Morphology: Perirenal white adipose mass, chow diet, males [g] x x 0.273 0.555 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.377 0.789 0.324 x x 0.954 0.686 0.685 0.584 x x x 0.266 0.377 x x x 1.19 0.553 0.575 0.872 1.266 1.367 1.782 x 0.986 1.047 0.565 0.659 x 0.49 x 0.45 x x x 0.875 0.998 0.362 x 0.35 0.701 0.833 x 0.467 x 0.709 0.337 x 1.42 x x 0.858 1.114 0.456 1.096 0.488 1.011 0.393 x 1.193 +15650 None Trait_79_AUW-BXD Morphology: Subcutaneous white adipose mass, chow diet, males [g] x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.264 1.112 0.261 x x 0.778 0.632 0.612 0.401 x x x 0.331 0.299 x x x 1.17 0.474 0.328 0.546 1.897 1.417 1.564 x 0.871 1.26 0.659 0.886 x 0.338 x 0.558 x x x 0.688 x 0.582 x 0.288 0.515 1.044 x 0.261 x 0.437 0.525 x 1.403 x x 0.528 0.835 0.845 0.778 0.484 1.089 0.697 x 1.146 +15648 None Trait_75_AUW-BXD Cardiovascular system, morphology: Heart mass, chow diet, males [g] x x 0.239 0.206 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.142 0.165 0.204 x x 0.158 0.18 0.168 0.21 x x x 0.178 0.188 x x x 0.177 0.168 x 0.194 0.165 0.188 0.223 x 0.205 0.169 0.174 0.216 x 0.207 x 0.17 x x x 0.189 0.233 0.124 x 0.173 0.205 0.197 x 0.201 x 0.162 0.16 x 0.169 x x 0.146 0.191 0.224 0.168 0.201 0.214 0.172 x 0.22 +15646 None Trait_73_AUW-BXD Gastrointestinal system, liver, morphology, metabolism: Liver mass, chow diet, males [g] x x 1.579 1.382 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 1.04 1.458 1.648 x x 1.187 1.773 1.186 1.379 x x x 1.46 1.285 x x x 3.164 1.661 1.191 1.04 1.742 2.81 1.898 x 1.972 1.824 1.384 1.4 x 1.13 x 1.397 x x x 1.523 1.369 1.18 x 1.061 1.46 1.793 x 1.193 x 1.091 1.29 x 2.54 x x 1.293 1.846 2.553 1.361 1.302 1.699 1.299 x 1.278 +15643 None Trait_70_AUW-BXD Central nervous system, metabolism, behavior: Locomotor activity, light phase (day) running distance, activity wheel, high fat diet, males [km] x x 0.258075 0.8074 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.203 0.00292 0.52865 x x 0.00838 0.012464 0.0006 0.125325 x x x 0.30115 0.083 x x x x 0.00298 0.063 0.13 0.059 0.0028 0.01282 x 0.086 0.037 0.939775 0.0043 x 0.000125 x 0.03132 x x x 0.00169 0.0084 0.016 x 0.01847 0.529 0.02 x 0.0031 x 0.065 0.033 x x x x 0.4881 0.02595 0.05 0.095 0.26 0.16782 0.04 x 0.0072 +15641 None Trait_68_AUW-BXD Central nervous system, metabolism, behavior: Locomotor actvity, dark phase (night) running distance, activity wheel, chow diet, males [km] x x 6.7659 3.39047 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 7.92 2.58306 4.71195 x x 2.9364 0.645839 2.074 4.06325 x x x 3.96468 5.417 x x x 1.2339 3.08883 2.508 1.999 3.8623 0.85 0.26638 x 6.738 3.252 3.902 5.55 x 1.79995 x 4.34858 x x x 0.8711 1.05288 6.56 x 1.7076 6.1 1.38 x 1.1676 x 5.849 3.245 x 1.392 x x 2.45 3.45613 3.655 5.17 5.49 2.44407 8.347 x 2.653 +15639 None Trait_66_AUW-BXD Cardiovascular system, physiology: Heart rate, high fat diet, males [bpm] x x 697.25 688.25 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 709.5 584.0 760.143 x x 737.0 736.919 655.3 660.75 x x x 624.75 719.1 x x x x 683.625 691.88 661.375 636.37 637.0 678.125 x 774.5 681.31 706.75 690.9 x 644.5 x 685.0 x x x 724.9 658.5 621.0 x 633.875 706.53 700.9 x 714.25 x 687.0 708.75 x x x x 666.3 685.167 622.3 621.0 643.89 756.5 691.4 x 664.0 +15637 None Trait_64_AUW-BXD Cardiovascular system, physiology: Diastolic blood pressure, high fat diet, males [mmHg] x x 77.125 80.25 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 67.3 82.625 78.7143 x x 73.8 73.8225 73.75 62.5 x x x 87.75 85.2 x x x x 79.75 74.0 76.0 97.3 79.5 76.75 x 83.8 82.43 104.5 76.3 x 82.25 x 72.75 x x x 62.7 97.25 91.3 x 80.05 71.6 72.7 x 80.5 x 90.52 80.75 x x x x 90.85 74.0 81.4 76.8 98.49 59.7625 82.99 x 105.5 +15635 None Trait_62_AUW-BXD Cardiovascular system, physiology: Systolic blood pressure, chow diet, males [mmHg] x x 117.0 115.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 97.3 107.75 111.875 x x 110.0 97.0 96.0 101.625 x x x 122.0 104.0 x x x 117.22 111.0 103.504 114.125 120.0 109.489 105.125 x 106.64 115.467 100.625 124.1 x 102.75 x 119.125 x x x 95.0714 115.25 101.93 x 115.5 108.1 101.025 x 108.86 x 116.0 109.375 x 102.61 x x 123.019 109.67 108.3 104.6 105.01 104.3 103.2 x 120.6 +15633 None Trait_60_AUW-BXD Metabolism, morphology: Body weight loss pre-sacrifice, high fat diet, males [g] x x x 1.072 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 3.46 1.86 1.3 x x 1.29 1.103 2.71 2.375 x x x 1.65 3.22 x x x x x 1.96 -0.6 1.41 1.58 1.58 x 2.44 2.52 0.617 2.92 x 1.69 x 1.31 x x x 2.156 2.16 2.82 x 1.66 0.02 1.3 x -0.74 x 0.94 1.5 x x x x 2.22 1.61 2.76 3.16 1.79 1.24 x x 2.59 +15630 None Trait_57_AUW-BXD Metabolism, morphology: Body weight fat loss percentage after exercise, chow diet, males [%] x x 52.11 40.43 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 43.77 44.17 x x x 24.51 -24.41 14.49 x x x x x 41.16 x x x 5.49 50.15 -33.7 25.66 30.17 -4.52 -4.88 x 49.07 25.02 x 49.83 x x x 39.26 x x x 13.35 x 45.62 x 10.56 61.2 7.87 x 17.77 x 15.73 16.75 x -3.89 x x 41.38 22.06 32.11 37.9 66.23 -3.86 28.17 x 20.39 +15628 None Trait_49_AUW-BXD Metabolism, morphology: Body weight gain percentage 8-28 weeks, high fat diet, males [%] x x 102.1 83.3 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 121.95 170.36 108.17 x x 120.23 64.19 76.66 115.26 x x x 92.31 72.34 x x x x 97.5 76.12 66.31 96.53 122.6 114.16 x 89.55 61.44 66.4 71.26 x 59.55 x 71.07 x x x 137.15 91.18 123.01 x 56.8 137.35 93.12 x 68.49 x 75.51 109.9 x x x x 100.94 93.24 80.73 95.71 104.26 89.22 88.52 x 74.39 +15626 None Trait_47_AUW-BXD Metabolism, morphology: Body weight gain percentage 8-16 weeks, high fat diet, males [%] x x 43.65 80.1 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 59.9 112.2 66.12 x x 83.97 33.06 60.72 84.72 x x x 52.79 52.84 x x x x 68.59 49.94 51.23 70.01 76.63 68.58 x 64.97 60.65 31.98 52.84 x 54.7 x 57.92 x x x 98.23 71.05 94.56 x 43.57 87.5 69.92 x 46.99 x 57.9 89.64 x x x x 72.28 66.78 60.15 62.4 75.68 58.65 61.13 x 59.23 +15624 None Trait_45_AUW-BXD Metabolism, morphology: Body weight loss percentage after exercise, chow diet, males [%] x x 3.78 8.54 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 5.9 7.44 1.96 x x 5.5 -5.68 2.62 6.46 x x x 4.55 5.09 x x x 2.99 11.13 -0.78 5.67 6.38 -0.88 0.2 x 17.88 8.23 6.91 14.69 x 0.38 x 9.32 x x x 3.73 7.03 8.45 x 0.14 15.78 0.12 x -0.52 x 4.86 -2.32 x -0.55 x x 5.27 5.01 9.67 10.92 20.31 1.12 3.51 x 4.95 +15622 None Trait_43_AUW-BXD Metabolism, morphology: Body weight gain 8-28 weeks, chow diet, males [g] x x 8.42 10.33 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 10.17 12.058 8.376 x x 10.9 8.668 10.22 9.284 x x x 6.222 7.15 x x x 19.25 8.27 6.64 9.41 9.19 20.12 16.016 x 14.1 11.828 7.4 11.66 x 5.67 x 7.77 x x x 13.62 13.616 7.25 x 6.23 10.89 17.72 x 5.58 x 9.19 10.75 x 21.56 x x 10.13 14.23 13.314 11.94 7.63 14.15 9.81 x 10.388 +15620 None Trait_41_AUW-BXD Metabolism, morphology: Body weight gain 8-16 weeks, chow diet, males [g] x x 6.54 7.73 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 7.62 9.95 6.07 x x 7.7 4.44 4.48 5.63 x x x 5.43 5.27 x x x 4.68 6.3 4.4 5.96 8.59 11.9 9.71 x 11.53 11.81 6.52 12.4 x 6.12 x 8.07 x x x 10.69 12.93 5.04 x 2.53 10.87 15.33 x 3.62 x 5.33 4.92 x 13.4 x x 10.36 8.44 11.52 7.17 10.55 8.87 6.13 x 11.01 +15618 None Trait_39_AUW-BXD Metabolism, morphology: Lean mass percentage after activity wheel, chow diet, males [%] x x 89.64 82.06 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 85.22 70.2 x x x 75.1799 80.6278 34.72 x x x x x 87.87 x x x 72.31 84.29 83.5 75.95 80.01 63.5 64.036 x 79.83 66.98 82.64 79.13 x x x 77.304 x x x 70.99 65.4 83.23 x 82.85 85.97 68.2 x 84.05 x 82.66 85.05 x 61.5 x x 85.63 76.14 75.212 76.62 82.858 75.35 79.15 x 70.33 +15616 None Trait_37_AUW-BXD Metabolism, morphology: Lean mass after activity wheel, chow diet, males [g] x x 27.24 24.83 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 25.761 24.32 x x x 26.223 32.2195 26.49 x x x x x 27.95 x x x 27.779 26.04 26.54 26.33 25.44 28.884 28.0416 x 26.47 24.0 23.7245 25.1 x x x 25.847 x x x 24.72 26.64 20.9 x 23.35 25.97 31.22 x 22.571 x 27.1 26.35 x 28.4 x x 26.94 29.899 30.385 24.48 25.1796 28.14 23.7 x 27.145 +15614 None Trait_35_AUW-BXD Metabolism, morphology: Fat mass after activity wheel, chow diet, males [%] x x 6.633 13.81 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 9.75 26.23 x x x 21.288 16.42 17.36 x x x x x 7.48 x x x 23.37 10.85 13.59 20.79 17.18 33.201 32.2216 x 15.67 30.34 11.575 16.52 x x x 15.626 x x x 25.76 30.73 13.04 x 13.99 9.93 28.0 x 10.7 x 13.37 11.14 x 34.63 x x 10.65 20.59 20.85 19.34 13.23 18.82 17.0 x 26.04 +15612 None Trait_33_AUW-BXD Metabolism, morphology: Fat mass after activity wheel, chow diet, males [g] x x 1.998 4.281 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 3.065 9.13 x x x 7.56 6.564 6.15 x x x x x 2.38 x x x 9.44 3.36 4.35 7.43 5.47 15.11 14.596 x 5.33 10.9 3.74825 5.27 x x x 5.343 x x x 9.0252 12.57 3.43 x 3.98 2.97 12.82 x 2.89 x 4.38 3.45 x 15.96 x x 3.49 8.2 8.556 6.31 4.03 7.62 5.19 x 10.26 +15610 None Trait_31_AUW-BXD Metabolism, morphology: Body weight after activity wheel, chow diet, males [g] x x 30.357 30.18 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 30.37 34.685 30.288 x x 35.02 39.97 34.72 32.896 x x x 29.45 31.8 x x x 38.858 30.917 31.81 34.9 31.8 45.49 44.298 x 33.31 35.51 29.155 31.74 x 32.015 x 33.554 x x x 34.872 40.765 25.26 x 28.22 30.2 45.8 x 26.868 x 32.78 30.98 x 46.1 x x 31.6 41.4 40.538 32.08 30.4 37.973 30.05 x 38.798 +15608 None Trait_29_AUW-BXD Metabolism, morphology: Lean mass before activity wheel, chow diet, males [%] x x 84.132 72.18 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 79.81 56.1 x x x 69.98 82.521 74.49 x x x x 86.676 82.99 x x x 72.1 78.2033 83.45 70.11 73.52 60.59 63.801 x 71.32 61.9 x 66.95 x x x 72.128 x x x 67.7 60.718 74.58 x 81.53 73.84 66.49 x 83.2825 x 74.66 81.06 x 63.1 x x 78.16 71.833 68.52 69.1 64.82 75.09 73.8 x 65.56 +15606 None Trait_27_AUW-BXD Metabolism, morphology: Lean mass before activity wheel, chow diet, males [g] x x 26.555 23.963 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 25.67 22.55 x x x 25.84 31.2085 26.3 x x x x 25.4842 27.8 x x x 28.056 27.2063 26.29 25.81 25.03 28.003 28.009 x 28.8 23.83 x 24.91 x x x 26.654 x x x 24.48 26.591 20.52 x 23.01 25.996 30.135 x 22.2447 x 25.73 24.525 x 28.92 x x 25.97 29.822 30.755 24.7927 24.73 28.468 24.5 x 26.72 +15604 None Trait_25_AUW-BXD Metabolism, morphology: Fat mass percentage before activity wheel, chow diet, males [%] x x 12.1 23.53 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 15.4 40.699 x x x 26.87 14.1037 22.03 x x x x 7.01 12.1 x x x 24.32 19.22 13.1 26.32 23.52 31.26 31.737 x 24.9 35.7 x 29.0449 x x x 23.248 x x x 28.76 35.522 21.5 x 15.61 22.75 30.777 x 13.26 x 21.69 14.86 x 33.5 x x 18.17 25.29 27.96 27.46 31.548 20.865 22.2 x 31.13 +15602 None Trait_23_AUW-BXD Metabolism, morphology: Fat mass before activity wheel, chow diet, males [g] x x 3.79 7.97 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 5.08 16.44 x x x 10.22 5.33575 8.26 x x x x 2.105 4.1 x x x 9.88 6.68467 4.23 9.89 8.06 14.47 14.66 x 10.5 13.8 x 10.995 x x x 8.6312 x x x 10.44 15.57 6.28 x 4.45 8.125 13.904 x 3.57575 x 7.474 4.56 x 15.4 x x 6.11 10.567 12.5536 9.9845 12.047 9.058 7.55 x 12.74 +15600 None Trait_21_AUW-BXD Metabolism, morphology: Body weight before activity wheel, chow diet, males [g] x x 31.55 33.36 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 32.29 40.27 32.116 x x 37.228 37.82 35.83 35.364 x x x 30.858 33.52 x x x 38.46 34.7833 31.63 37.01 34.1 46.43 44.656 x 40.8 38.71 30.735 37.38 x 33.398 x 36.978 x x x 36.21 43.8075 27.91 x 28.27 35.31 45.27 x 26.7475 x 34.47 30.32 x 45.86 x x 33.31 41.567 44.886 36.015 38.164 39.1133 33.4 x 40.81 +15598 None Trait_19_AUW-BXD Metabolism, morphology: Lean mass percentage pre-metabolic caging, chow diet, males [%] x x 85.1725 70.17 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 77.96 63.884 87.555 x x 77.07 83.94 70.26 77.975 x x x 82.532 79.823 x x x 73.76 78.41 86.32 69.59 73.6 67.66 64.332 x 71.1 60.65 78.625 67.3 x 79.7125 x 75.18 x x x 67.15 63.702 78.48 x 84.81 73.1 64.54 x 84.822 x 71.23 84.33 x 66.7 x x 76.2 75.67 70.23 71.8 69.87 74.3167 79.562 x 64.61 +15596 None Trait_17_AUW-BXD Metabolism, morphology: Lean mass pre-metabolic caging, chow diet, males [g] x x 25.2083 22.062 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 23.801 21.8926 26.392 x x 26.086 30.73 25.6 24.4735 x x x 24.887 25.7 x x x 26.67 25.7263 25.36 24.0 24.36 27.17 27.145 x 26.1 23.59 23.4923 25.93 x 26.9755 x 26.5004 x x x 23.95 26.5004 19.698 x 22.06 25.64 29.215 x 21.81 x 24.36 23.59 x 28.53 x x 25.3 28.8072 29.675 23.3 24.75 26.061 22.69 x 26.42 +15594 None Trait_15_AUW-BXD Metabolism, morphology: Fat mass percentage pre-metabolic caging, chow diet, males [%] x x 10.87 26.0375 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 17.32 33.4962 8.7275 x x 19.1 12.91 25.7 17.6525 x x x 12.736 16.31 x x x 22.04 19.4867 9.91 27.34 23.22 29.03 32.354 x 25.885 36.7 17.7775 29.01 x 16.88 x 21.552 x x x 29.14 33.4 17.15 x 12.076 24.3 31.41 x 12.636 x 24.67 12.1 x 30.32 x x 20.62 21.952 26.41 24.3 27.1 21.8367 17.57 x 31.98 +15592 None Trait_13_AUW-BXD Metabolism, morphology: Fat mass pre-metabolic caging, chow diet, males [g] x x 3.21375 8.22625 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 5.529 13.7978 2.61975 x x 6.48 4.76 9.8 5.69225 x x x 3.8924 5.27 x x x 8.15 6.38067 2.88 9.467 7.71 11.6 14.0626 x 9.8698 14.3 5.92975 11.21 x 6.0055 x 7.6118 x x x 10.402 13.884 4.604 x 3.171 8.56 14.228 x 3.2676 x 8.54 3.34 x 12.96 x x 7.04 8.508 11.15 7.97 9.66 8.77333 5.058 x 13.15 +15590 None Trait_11_AUW-BXD Metabolism, morphology: Body weight pre-metabolic caging, chow diet, males [g] x x 29.5925 31.4775 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 30.75 36.8325 29.7 x x 33.88 36.64 36.93 31.545 x x x 30.198 32.22 x x x 36.34 32.7967 29.48 34.56 33.12 40.07 42.632 x 37.064 38.91 30.503 38.586 x 34.145 x 35.264 x x x 35.67 41.588 25.3875 x 26.036 35.124 45.282 x 25.728 x 34.31 28.04 x 42.75 x x 33.34 38.216 42.246 32.53 35.498 36.1767 28.57 x 40.97 +15588 None Trait_9_AUW-BXD Metabolism, morphology: Body weight at blood pressure measurement, chow diet, males [g] x x 30.0 32.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 27.52 34.4 31.3 x x 35.51 37.1 35.0225 33.0 x x x 30.6 31.22 x x x 37.94 32.0 30.5 34.98 32.6 39.46 42.41 x 35.41 38.78 30.6 36.01 x 33.2 x 35.2 x x x 34.516 41.6 26.54 x 27.24 34.64 44.2 x 26.51 x 33.97 28.85 x 42.16 x x 32.78 39.4 40.91 31.752 38.018 36.6 30.21 x 40.85 +15586 None Trait_7_AUW-BXD Metabolism, morphology: Body weight at sacrifice, chow diet, males [g] x x 31.302 33.5725 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 30.78 34.116 32.4375 x x 37.01 39.62 35.96 32.09 x x x 30.044 32.32 x x x 45.38 34.39 31.15 35.4 32.49 47.113 47.298 x 41.72 39.45 30.09 36.86 x 30.8025 x 32.876 x x x 37.606 41.2 26.15 x 28.48 35.61 43.98 x 28.008 x 33.92 33.01 x 48.38 x x 34.49 44.354 44.406 36.32 31.43 40.976 31.305 x 37.69 +15584 None Trait_5_AUW-BXD Metabolism, morphology: Body weight at 28 weeks, chow diet, males [g] x x 30.0 32.3 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 32.78 37.32 32.6 x x 38.44 40.87 38.58 35.5 x x x 30.6 34.38 x x x 45.34 34.8 31.96 36.95 33.72 48.3 44.3 x 40.95 39.61 31.4 38.16 x 31.9 x 35.0 x x x 38.596 41.4 27.6 x 29.0 36.02 47.68 x 27.51 x 35.96 33.87 x 49.21 x x 33.7 44.0 44.04 37.14 32.58 41.5 32.24 x 40.35 +15582 None Trait_3_AUW-BXD Metabolism, morphology: Body weight at 16 weeks, chow diet, males [g] x x 28.084 30.146 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 30.75 33.954 30.266 x x 35.24 36.64 33.89 31.828 x x x 29.828 32.22 x x x 34.48 32.7967 29.72 33.21 33.12 40.07 38.0 x 37.06 38.91 30.0775 38.59 x 32.37 x 35.264 x x x 35.67 40.9 25.39 x 25.32 28.92 45.28 x 25.556 x 32.23 28.04 x 41.62 x x 33.91 38.216 41.87 32.53 35.5 36.1767 28.57 x 40.97 +15580 None Trait_1_AUW-BXD Metabolism, morphology: Body weight at 8 weeks, chow diet, males [g] x x 21.548 22.414 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 23.13 24.0 24.2 x x 27.53 32.0 27.65 26.2 x x x 24.4 26.95 x x x 27.94 26.5 25.32 27.25 25.57 28.18 28.29 x 25.35 27.7 24.0 26.18 x 27.0 x 27.198 x x x 24.98 27.982 20.348 x 22.8 22.17 29.95 x 21.932 x 27.0 23.12 x 28.4 x x 23.8 29.78 30.72 25.37 24.95 27.3067 22.44 x 29.96 +15578 None Trait_386_AUW-BXD Metadata: Cohort study order, chow diet, males [weeks] x x 34.0 34.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 78.0 22.0 25.0 x x 92.0 92.0 116.0 25.0 x x x 27.0 112.0 x x x 86.0 31.0 53.0 51.0 94.0 84.0 38.0 x 101.0 80.0 28.0 103.0 x 26.0 x 29.0 x x x 125.0 35.0 98.0 x 45.0 106.0 103.0 x 31.0 x 56.0 54.0 x 80.0 x x 80.0 37.0 121.0 116.0 101.0 37.0 110.0 x 107.0 +15576 None Trait_384_AUW-BXD Metadata: Cohort study order, chow diet, males [rank] x x 10.0 10.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 19.0 1.0 2.0 x x 23.0 23.0 33.0 3.0 x x x 5.0 32.0 x x x 22.0 8.0 16.0 15.0 24.0 21.0 13.0 x 26.0 20.0 6.0 27.0 x 4.0 x 7.0 x x x 36.0 11.0 25.0 x 14.0 28.0 27.0 x 9.0 x 18.0 17.0 x 20.0 x x 20.0 12.0 34.0 33.0 26.0 12.0 31.0 x 29.0 +15552 Original post publication description: Central nervous system, gene expression: Early B-cell factor 1 (Ebf1, D1 medium spiny neuron expression signature) mRNA expression in striatum (caudate-putamen), first principal component generated using 8 Affymetrix exon-level probe sets (exons 4 to 11) and Striatum_Exon_0209 data [relative residual concentration] Original pre publication description: Central nervous system, gene expression: Early B-cell factor 1 (Ebf1, D1 medium spiny neuron developmental expression signature) mRNA expression in adult striatum (caudate-putamen), first principal component generated using 8 Affymetrix exon-level probe sets (exons 4 to 11) and Striatum_Exon_0209 data [relative residual concentration] Central nervous system, gene expression: Early B-cell factor 1 (Ebf1, D1 medium spiny neuron developmental expression signature) mRNA expression in adult striatum (caudate-putamen), first principal component generated using 8 Affymetrix exon-level probe sets (exons 4 to 11) and Striatum_Exon_0209 data [relative residual concentration] Central nervous system, gene expression: Early B-cell factor 1 (Ebf1, D1 medium spiny neuron expression signature) mRNA expression in striatum (caudate-putamen), first principal component generated using 8 Affymetrix exon-level probe sets (exons 4 to 11) and Striatum_Exon_0209 data [relative residual concentration] x 0.533 2.824 0.265 -1.376 0.208 x x 2.689 2.71 -0.148 -1.108 -0.412 -0.994 2.845 -3.033 0.038 0.247 1.64 0.657 1.111 -4.648 x -3.353 x -1.585 -4.415 -2.342 x -2.203 1.307 -1.55 4.134 x 3.141 x 3.265 -3.662 0.385 x 2.83 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +15553 Original post publication description: Central nervous system, gene expression: Dock1 (D2 medium spiny neuron expression signature) mRNA expression in striatum (caudate-putamen), first principal component generated using four Affymetrix exon-level Dock1 probe sets and Striatum_Exon_0209 data [relative residual concentration] Original pre publication description: Central nervous system, gene expression: Dock1 (D2 medium spiny neuron expression signature) mRNA expression in striatum (caudate-putamen), first principal component generated using four Affymetrix exon-level Dock1 probe sets and Striatum_Exon_0209 data [relative residual concentration] Central nervous system, gene expression: Dock1 (D2 medium spiny neuron expression signature) mRNA expression in striatum (caudate-putamen), first principal component generated using six Affymetrix exon-level Dock1 probe sets (exon 45 to 50) and Striatum_Exon_0209 data [relative residual concentration] Central nervous system, gene expression: Dock1 (D2 medium spiny neuron expression signature) mRNA expression in striatum (caudate-putamen), first principal component generated using six Affymetrix exon-level Dock1 probe sets (exon 45 to 50) and Striatum_Exon_0209 data [relative residual concentration] x -0.978 0.287 3.192 -1.084 -2.207 x x -2.19 -1.503 -1.926 -0.695 -0.409 0.016 -1.753 -0.406 -1.026 -0.36 -2.939 -3.398 -2.423 4.039 x 3.551 x 2.974 4.882 3.182 x 3.678 2.005 2.707 -1.72 x -0.564 x -1.331 0.265 -1.776 x -2.089 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +15554 Original post publication description: ROY Original pre publication description: gy6ye6bjhu56IUM'P P'JH Central nervous system, gene expression: Dopamine-associated trait (rwilliams@uthsc.edu) Central nervous system, gene expression: Dopamine receptor ratio in striatum based on relative expression using Affymetrix Exon array probe sets for Drd1 and Drd2 [ratio] x 0.939 0.948 0.885 0.901 0.946 x x 0.962 0.964 0.946 0.939 0.922 0.92 0.942 0.941 0.948 0.942 0.954 0.966 0.945 0.867 x 0.875 x 0.88 0.854 0.878 x 0.844 0.909 0.877 0.941 x 0.959 x 0.968 0.905 0.933 x 0.96 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +15555 Original post publication description: Infectious disease, immune system: Kramer1 Original pre publication description: Infectious disease, immune system: Kramer1 TAFI1 TAFI1 x x -4.879 3.121 x x x x x x x x x x x x x x x x x x x x x x x x x x x x -5.212 x x x x x x x x x -9.212 8.121 x x 3.454 4.121 x 4.121 x x x 4.121 6.788 x x x 1.454 -5.212 x x -2.99 x 2.521 x 3.454 0.121 5.454 -0.879 x 4.121 x 5.454 x x x x 5.454 -11.88 x -6.546 -1.546 x -11.88 -9.212 x -5.212 -5.212 x x x x x -6.546 -1.212 -2.736 x 1.454 x -3.879 10.79 +15556 Original post publication description: Infectious disease, immune system: Kramer3 Original pre publication description: Infectious disease, immune system: Kramer3 TAFI3 TAFI3 x x -1.004 11.753 x x x x x x x x x x x x x x x x x x x x x x x x x x x x -1.754 x x x x x x x x x -10.028 6.604 x x 5.459 -0.695 x -15.848 x x x 5.575 4.218 x x x 6.408 6.964 x x -1.479 x -3.114 21.642 1.895 -2.388 0.301 -13.842 x -9.161 x 8.109 x x x x -6.158 -7.552 x 0.404 -0.949 x -7.81 -9.029 x -5.32 -3.316 x x x x x -1.284 -0.586 4.671 x 16.118 x 3.902 -2.7 +15557 Original post publication description: Infectious disease, immune system: Kramer2 Original pre publication description: Infectious disease, immune system: Kramer2 TAFI2 TAFI2 x x -2.797 -8.797 x x x x x x x x x x x x x x x x x x x x x x x x x x x x -3.63 x x x x x x x x x 0.56 1.703 x x 0.37 3.989 x 17.7 x x x -0.297 3.036 x x x -4.697 -12.3 x x 1.703 x 7.036 -0.964 4.37 3.303 5.703 3.703 x 13.7 x -2.297 x x x x 12.37 -5.097 x -8.297 -0.583 x -3.63 -3.63 x 0.37 -0.964 x x x x x -8.297 -0.297 x x -15.63 x -7.63 14.5 +15558 Original post publication description: Infectious disease, immune system: Kramer4 Original pre publication description: Infectious disease, immune system: Kramer4 TAFI4 TAFI4 x x 0.233 -0.076 x x x x x x x x x x x x x x x x x x x x x x x x x x -0.017 -0.119 -0.321 x x x x x x x x x 0.504 0.174 x x 0.055 x x 0.649 x x x x -0.241 x x x -0.034 0.465 -0.206 x -0.45 x 0.54 -0.367 -0.242 0.423 0.518 0.131 x -0.326 x -0.535 x x x x x x x -0.068 0.883 x 0.331 -0.451 x -0.23 -0.41 x x x x x -0.735 0.418 -0.072 x -0.327 x -0.004 -0.091 +15559 Original post publication description: Infectious disease, immune system: Kramer5 Original pre publication description: Infectious disease, immune system: Kramer5 TAFI5 TAFI5 x x 6.176 -8.023 x x x x x x x x x x x x x x x x x x x x x x x x x x x -16.67 -7.526 x x x x x x x x x -14.24 3.902 x x 10.03 6.759 x -16.67 x x x 13.62 1.159 x x x -12.24 -8.641 -2.241 x 11.76 x -0.241 -8.669 2.759 10.76 18.76 21.85 x -7.241 x 7.759 x x x x 4.359 x x -1.241 -2.574 x x 8.759 x -5.241 -5.241 x x x x x -4.491 1.759 x x -14.24 -3.241 x 9.305 +15560 Original post publication description: Infectious disease, immune system: Kramer6 Original pre publication description: Infectious disease, immune system: Kramer6 TAFI6 TAFI6 x x -0.608 -0.38 x x x x x x x x x x x x x x x x x x x x x x x x x x x x -0.475 x x x x x x x x x -0.545 1.208 x x -0.084 0.002 x 0.465 x x x 0.318 0.028 x x x 0.118 -0.649 0.464 x 0.275 x -0.292 -0.623 0.975 -0.269 -0.034 0.101 x 1.072 x -0.275 x x x x 0.297 -1.525 x -0.703 -0.096 x -0.149 0.714 x 0.501 -0.283 x x x x x 0.647 -0.313 0.055 x -0.559 -0.37 0.406 0.589 +15561 Original post publication description: Infectious disease, immune system: Kramer7 Original pre publication description: Infectious disease, immune system: Kramer7 TAFI7 TAFI7 x x 0.575 -0.084 x x x x x x x x x x x x x x x x x x x x x x x x x x x x -0.557 x x x x x x x x x -0.215 0.493 x x 0.202 -0.029 x 0.077 x x x 0.406 0.654 x x x -0.277 -0.709 0.064 x 0.09 x 0.039 -0.559 0.674 0.107 0.077 0.429 x 0.029 x -0.355 x x x x 0.515 -0.974 x -0.3 0.501 x -0.42 -0.069 x 0.239 -0.191 x x x x x 0.33 -0.444 0.271 x -0.539 0.104 -0.34 0.188 +15562 Original post publication description: Infectious disease, immune system: Kramer8 Original pre publication description: Infectious disease, immune system: Kramer8 TAFI8 TAFI8 x x 1.701 -2.306 x x x x x x x x x x x x x x x x x x x x x x x x x x x x -2.401 x x x x x 3.493 x x x -1.605 -0.559 x x -2.354 -1.965 x -2.255 x x x -1.951 -2.107 x x x -2.293 -2.225 -2.126 x 0.575 x -1.739 -2.011 -2.748 -1.811 10.3 -2.377 x 0.716 x -1.624 x x x x -1.509 -1.342 x 6.355 -2.19 x -1.254 6.224 x 4.613 x x x x x -2.518 -0.305 2.682 -0.192 14.55 -2.16 -1.337 -1.505 -0.449 +15563 Original post publication description: Infectious disease, immune system: Kramer9 Original pre publication description: Infectious disease, immune system: Kramer9 TAFI9 TAFI9 x x 4.699 -3.488 x x x x x x x x x x x x x x x x x x x x x x x x x x x x -4.379 x x x x x 13.0 x x x -1.684 -2.38 x x -4.341 4.141 x -3.725 x x x -3.467 -3.519 x x x -3.796 -3.545 -2.742 x 4.151 x -3.179 -3.604 -4.087 -3.592 12.68 1.644 x 1.779 x -3.121 x x x x -2.447 -1.999 x 10.07 -2.976 x -3.52 4.688 x 2.199 x x x x x -3.969 -1.855 11.04 -2.223 10.18 -3.341 -2.707 -1.299 0.718 +15564 Original post publication description: Infectious disease, immune system: Kramer10 Original pre publication description: Infectious disease, immune system: Kramer10 TAFI10 TAFI10 x x 6.688 -2.457 x x x x x x x x x x x x x x x x x x x x x x x x x x x x -5.193 x x x x x x x x x 2.992 2.266 x x -3.314 7.232 x -4.704 x x x 2.028 -4.222 x x x -4.443 -3.459 -3.045 x -0.582 x -4.473 -4.873 -5.234 -5.051 10.49 1.455 x 4.057 x -5.087 x x x x 6.366 0.945 x 7.949 2.52 x 3.491 3.491 x 12.62 4.116 x x x x -4.551 1.588 -3.522 -3.704 x -5.329 -4.384 -5.084 2.422 +15565 Original post publication description: Infectious disease, immune system: Kramer11 Original pre publication description: Infectious disease, immune system: Kramer11 TAFI11 TAFI11 x x 7.305 -1.729 x x x x x x x x x x x x x x x x x x x x x x x x x x x x -5.499 x x x x x x x x x -2.378 3.714 x x 2.8 9.139 x -5.006 x x x -3.828 -4.336 x x x -5.036 -4.54 0.025 x 1.14 x -2.745 -5.317 -5.045 -5.211 6.876 -4.733 x -2.881 x -4.911 x x x x -0.119 -3.229 x 8.589 -1.411 x 0.692 5.839 x 10.42 12.42 x x x x -4.578 2.843 2.214 3.046 x -4.111 -5.278 -5.003 -2.562 +15566 Original post publication description: Infectious disease, immune system: Kramer12 Original pre publication description: Infectious disease, immune system: Kramer12 TAFI12 TAFI12 x x -0.277 -0.444 x x x x x x x x x x x x x x x x x x x x x x x x x x x x -0.374 x x x x x x x x x 1.8 1.181 x x 0.542 1.042 x -1.863 x x x -1.541 0.042 x x x -1.791 -1.125 1.25 x -1.416 x -1.25 -1.458 -1.583 -1.5 0.233 -1.291 x -0.27 x 1.783 x 6.042 x x -0.791 -1.958 x 2.709 0.042 x -1.583 -1.166 x -1.75 -1.625 x x x x 1.709 0.5 -1.333 2.264 1.542 0.576 0.167 0.126 2.837 +15567 Original post publication description: Infectious disease, immune system: Kramer13 Original pre publication description: Infectious disease, immune system: Kramer13 TAFI13 TAFI13 x x 0.019 -0.453 x x x x x x x x x x x x x x x x x x x x x x x x x x x x -1.759 x x x x x 3.783 x x x -0.753 1.239 x x 0.533 0.566 x -1.675 x x x -1.384 -0.277 x x x -2.05 -1.181 -1.023 x -1.562 x -1.675 -1.3 -2.092 -1.675 -1.086 0.255 x 0.111 x -1.4 x 1.616 x x 1.325 -0.324 x 1.116 -1.009 x -1.175 3.283 x -1.8 -1.759 x x x x 6.45 1.394 -1.675 3.866 -0.05 -1.217 2.408 -0.495 2.89 +15568 Original post publication description: Infectious disease, immune system: Kramer13 Original pre publication description: Infectious disease, immune system: Kramer13 Infectious disease, immune system: Kramerxxx3 Infectious disease, immune system: Kramerxxx3 x x 0.019 -0.453 x x x x x x x x x x x x x x x x x x x x x x x x x x x x -1.759 x x x x x 3.783 x x x -0.753 1.239 x x 0.533 0.566 x -1.675 x x x -1.384 -0.277 x x x -2.05 -1.181 -1.023 x -1.562 x -1.675 -1.3 -2.092 -1.675 -1.086 0.255 x 0.111 x -1.4 x 1.616 x x 1.325 -0.324 x 1.116 -1.009 x -1.175 3.283 x -1.8 -1.759 x x x x 6.45 1.394 -1.675 3.866 -0.05 -1.217 2.408 -0.495 2.89 +15569 Original post publication description: Kramer14 Original pre publication description: Kramer14 TAFI14 TAFI14 x x -3.091 7.47 x x x x x x x x x x x x x x x x x x x x x x x x x x x x -3.068 x x x x x x x x x -8.856 7.989 x x 3.891 3.013 x -2.839 x x x 4.842 6.087 x x x 4.053 0.632 x x -3.122 x 0.113 x 2.184 -0.694 3.615 -1.865 x -1.131 x 7.029 x x x x 0.769 -9.11 x -2.41 -0.703 x -9.736 -7.068 x -4.775 -4.206 x x x x x -2.41 -0.491 x x 8.719 x -0.028 5.196 +15570 Original post publication description: Infectious disease, immune system: Kramer15 (F=Y axis) Original pre publication description: Infectious disease, immune system: Kramer15 TAFI15 TAFI15 (F=Y axis) x x 0.017 -11.448 x x x x x x x x x x x x x x x x x x x x x x x x x x x x -0.589 x x x x x x x x x 6.334 -4.363 x x -2.508 0.655 x 14.366 x x x -3.631 -2.12 x x x -6.209 -9.259 x x 3.227 x 4.795 x 1.492 2.702 1.459 3.785 x 10.366 x -6.541 x x x x 8.126 2.499 x -4.344 -0.046 x 3.966 2.144 x 3.411 2.077 x x x x x -4.344 0.012 x x -17.142 x -5.499 6.611 +15571 Original post publication description: Skin, pigmentation: Hair coat color, ordinal scale version 2 where black=2, grey=1, brown=4, dba dilute=3 [color intensity] None Skin, pigmentation: Hair coat color, ordinal scale version 3 where grey=1, black=2, brown=3, dba dilute=4 [color intensity] 2.0 2.0 2.0 4.0 4.0 2.0 1.0 1.0 1.0 4.0 2.0 1.0 3.0 2.0 3.0 1.0 1.0 1.0 2.0 4.0 1.0 2.0 3.0 3.0 3.0 3.0 3.0 1.0 4.0 2.0 2.0 1.0 2.0 2.0 3.0 x 1.0 1.0 1.0 x 2.0 2.0 4.0 4.0 x x 2.0 1.0 2.0 2.0 4.0 3.0 x 3.0 2.0 x x 3.0 3.0 4.0 3.0 4.0 4.0 3.0 4.0 3.0 3.0 4.0 4.0 4.0 3.0 4.0 3.0 4.0 1.0 4.0 3.0 1.0 4.0 4.0 x 4.0 4.0 4.0 2.0 2.0 3.0 4.0 4.0 4.0 4.0 4.0 2.0 4.0 2.0 4.0 2.0 4.0 2.0 1.0 3.0 4.0 +15572 Original post publication description: Withdrawal anxiety assay (Nic_Mec_Som), 7-day nicotine-treated (24mg/kg/day, s.c. minipump) + day 8 mecamylamine (2.0mg/kg, s.c.), number of somatic signs observedin 8-12 week old males during 20 minute session [n total number]. None Central nervous system, pharmacology, behavior: Withdrawal anxiety assay, 7-day nicotine-treated (24 mg/kg/day, s.c. minipump) + day 8 mecamylamine (2.0 mg/kg, s.c.), number of somatic signs observed in 8- to 12-week-old males during 20 min session [n] x x 7.333 8.75 18.143 5.571 13.167 4.25 8.625 3.429 6.25 11.833 x 6.375 4.286 8.5 7.5 9.0 11.833 10.714 x x x x x 17.4 8.125 x x 9.625 7.143 13.4 5.875 x 2.714 x 12.714 4.167 x x 13.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +15573 Original post publication description: Withdrawal anxiety assay (Nic_Sal_Som), 7-day nicotine-treated (24mg/kg/day, s.c. minipump) + day 8 saline (0.01mL/g, s.c.), number of somatic signs observedin 8-12 week old males during 20 minute session [n total number]. None Central nervous system, pharmacology, behavior: withdrawal anxiety assay (Nic_Sal_Som), 7-day nicotine-treated (24mg/kg/day, s.c. minipump) + day 8 saline (0.01mL/g, s.c.), number of somatic signs observedin 8-12 week old males during 20 minute session [n total number]. x x 3.667 4.625 5.25 2.0 2.75 1.25 3.857 2.0 3.25 4.0 x 7.5 1.8 3.143 6.143 2.143 2.6 2.875 x x x x x 2.5 6.875 x x 3.0 4.429 4.0 1.375 x 1.5 x 4.875 1.4 x x 4.5 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +15574 Original post publication description: Withdrawal anxiety assay (Nic_Mec_PTO), 7-day nicotine-treated (24mg/kg/day, s.c. minipump) + day 8 mecamylamine (2mg/kg, s.c.), percent time spent in open arms of the elevated plus maze in 8-12 week old males during 5 minute session [n %]. Original pre publication description: Nic (24mg/kg/day) + Mec (2mg/kg), percent time in open arms of the EPM [%] Nic (24mg/kg/day) + Mec (2mg/kg), percent time in open arms of the EPM [%] Central nervous system, pharmacology, behavior: Withdrawal anxiety assay, 7-day nicotine-treated (24 mg/kg/day, s.c. minipump) + day 8 mecamylamine (2 mg/kg, s.c.), percent time spent in open arms of the elevated plus maze in 8-12 week old males during 5 minute session (Nic_Mec_PTO) [n %]. x x 4.529 2.92 10.431 5.223 3.601 1.954 2.042 1.836 1.373 2.966 x 5.825 5.134 1.523 2.297 2.233 14.736 6.443 x x x x x 4.635 12.208 x x 8.287 3.375 5.467 4.851 x 0.794 x 1.178 1.802 x x 6.372 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +15575 Original post publication description: Withdrawal anxiety assay (Nic_Sal_PTO), 7-day nicotine-treated (24mg/kg/day, s.c. minipump) + day 8 saline (0.01mL/g, s.c.), percent time spent in open arms of the elevated plus maze in 8-12 week old males during 5 minute session [n %]. Original pre publication description: Nic (24mg/kg/day) + Sal (0.01mL/g), percent time in open arms of the EPM [%] Nic (24mg/kg/day) + Sal (0.01mL/g), percent time in open arms of the EPM [%] Central nervous system, pharmacology, behavior: Nicotine response (nicotine at 24 mg/kg/day for 7 days, s.c. by minipump followed by s.c. saline injection on day 8), withdrawal anxiety, percentage of time spent in open arms of an elevated plus maze in 8-12 week old males during 5 minute session (Nic_Sal_PTO) [%] x x 5.089 2.264 7.369 2.899 2.174 2.751 3.26 1.866 1.967 4.449 x 4.51 0.929 3.863 2.536 2.023 13.798 5.468 x x x x x 9.867 5.929 x x 2.558 2.989 7.997 5.106 x 1.061 x 4.488 1.974 x x 5.837 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +15948 Original post publication description: Central nervous system; embryonic neurogenesis; Cell death in brainstem following exposure to ethanol at E9 (TUNEL+ cells/mm2) None Central nervous system; embryonic neurogenesis; Cell death in brainstem following exposure to ethanol at E9 (TUNEL+ cells/mm2) x x 4073.6 725.616 306.716 2561.82 x x x x x x x x x x x x 4706.39 x x x x x x x x 850.617 x x 563.284 x x x x x x 397.657 x x x x x x x x x x x 6020.52 x x x x x x x x 677.627 x x x x x x x x x x 732.251 x 1972.58 x x x x x x 589.189 x x x x x x x x x x x x x x x 2133.11 x x x 1797.23 x 3939.37 513.065 +15949 Original post publication description: Central nervous system; embryonic neurogenesis; Cell death in the forebrain following ethanol exposure at E9 (TUNEL+ cells/mm2) None Central nervous system; embryonic neurogenesis; Cell death in the forebrain following ethanol exposure at E9 (TUNEL+ cells/mm2) x x 3172.6 1892.73 842.364 3859.58 x x x x x x x x x x x x 2011.71 x x x x x x x x 1934.4 x x 2306.93 x x x x x x 1048.45 x x x x x x x x x x x 3815.18 x x x x x x x x 444.812 x x x x x x x x x x 1235.32 x 4940.97 x x x x x x 2626.86 x x x x x x x x x x x x x x x 1359.66 x x x 858.692 x 2159.83 1664.57 +15950 Original post publication description: un-named trait Original pre publication description: Trait 5 Trait 5 Reproduction, development: Trait 5, Parthenote 2 cell/constructs; lathamk1@msu.edu x 1.0 0.84 0.726 0.854 0.974 0.919 0.982 0.917 0.977 0.957 0.227 0.974 0.784 0.975 0.992 0.802 1.0 x 0.986 0.957 x x x x 0.667 0.975 0.912 x 0.951 0.943 0.194 1.0 x 0.901 x 0.663 0.844 0.957 x 0.396 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +15951 Original post publication description: Trait 6 Original pre publication description: Trait 6 Trait 6 Reproduction, development: Trait 6, Parthenote 4cell/2cell; lathamk1@msu.edu x 0.996 1.0 0.59 0.053 1.0 0.593 0.831 0.529 0.864 0.95 0.795 0.778 0.55 0.492 0.094 0.736 0.814 x 0.793 0.78 x x x x 1.0 0.971 0.317 x 0.852 0.613 0.467 0.898 x 0.601 x 0.135 0.846 1.0 x 0.8 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +15952 Original post publication description: Trait 7 Original pre publication description: Trait 7 Trait 7 Reproduction, development: Trait 7, Parthenote Blastocyst/2cell; lathamk1@msu.edu x 0.723 0.368 0.021 0.0 0.915 0.056 0.0 0.025 0.388 0.836 0.073 0.387 0.117 0.337 0.0 0.409 0.188 x 0.575 0.126 x x x x 0.771 0.647 0.033 x 0.399 0.225 0.125 0.486 x 0.147 x 0.038 0.615 0.745 x 0.083 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +15953 Original post publication description: Trait 8 Original pre publication description: Trait 8 Trait 8 Reproduction, development: Trait 8, Parthenote Blastocyst/4cell; lathamk1@msu.edu x 0.726 0.368 0.025 0.0 0.915 0.079 0.061 0.036 0.446 0.888 0.075 0.469 0.167 0.628 0.0 0.548 0.234 x 0.72 0.164 x x x x 0.771 0.664 0.067 x 0.467 0.395 0.17 0.547 x 0.263 x 0.35 0.738 0.745 x 0.083 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +15954 Original post publication description: Trait 9 Original pre publication description: Trait 9 Trait 9 Reproduction, development: Trait 9, SCNT:Parthenote 2 cell/constructs; lathamk1@msu.edu x 0.873 0.813 0.89 0.698 0.775 0.842 0.389 0.88 1.0 0.834 0.509 0.587 0.908 0.826 0.827 0.823 0.844 x 0.864 0.809 x x x x 0.765 0.842 0.861 x 0.461 0.743 0.803 0.848 x 0.957 x 0.858 0.859 0.977 x 0.584 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +15955 Original post publication description: Trait 10 Original pre publication description: Trait 10 Trait 10 Reproduction, development: Trait 10, SCNT:Parthenote 4cell/2cell; lathamk1@msu.edu x 0.663 0.536 0.729 0.0 0.205 0.882 0.014 0.532 0.174 0.675 0.192 0.693 0.317 0.08 1.628 0.572 0.611 x 0.186 0.699 x x x x 0.59 0.307 0.337 x 0.086 0.825 0.0 0.544 x 0.619 x 3.394 0.036 0.66 x 0.491 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +15956 Original post publication description: Trait 11 Original pre publication description: Trait 11 Trait 11 Reproduction, development: Trait 11, SCNT:Parthenote Blastocyst/2cell; lathamk1@msu.edu x 0.379 0.568 0.0 0.0 0.083 2.149 0.0 2.733 0.115 0.329 0.0 0.427 0.489 0.0 0.0 0.254 0.247 x 0.079 0.877 x x x x 0.307 0.134 0.289 x 0.13 0.357 0.0 0.286 x 1.191 x 1.145 0.02 0.216 x 0.845 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +15957 Original post publication description: Trait 12 Original pre publication description: Trait 12 Trait 12 Reproduction, development: Trait 12 SCNT:Parthenote Blastocyst/4cell; lathamk1@msu.edu x 0.499 1.03 0.0 0.0 0.323 2.27 4.083 4.693 0.714 0.484 0.0 0.735 1.636 0.0 0.0 0.462 0.391 x 0.434 1.177 x x x x 0.492 0.496 0.877 x 1.189 0.545 0.0 0.487 x 2.069 x 0.198 0.377 0.325 x 1.286 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +15958 Original post publication description: Metabolism, pancreas, visual system: Alloxan response (80 mg/kg iv to induce diabetes by killing pancretic beta cells), retinopathy severity score, males and females from 7 to 17 weeks of age [ordinal scale, 1=normal, 2=slight retinopathy, 3=moderate, 4=severe retinopathy] Original pre publication description: Metabolism, pancreas, visual system: Lucki 1 Metabolism, pancreas, visual system: Lucki 1 Metabolism, pancreas, visual system: Alloxan response (80 mg/kg iv to induce diabetes by killing pancretic beta cells), retinopathy severity score, males and females from 7 to 17 weeks of age [ordinal scale, 1=normal, 2=slight retinopathy, 3=moderate, 4=severe retinopathy] x x 2.0 4.0 1.0 1.0 1.0 3.0 3.0 3.0 4.0 4.0 4.0 4.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +15959 Original post publication description: Central nervous system, toxicology: 3-NP response (dose and route here), short description of trait here [-1 = sensitive, +1 = resistant] Original pre publication description: Central nervous system, toxicology: I.Dragatsis 1 Central nervous system, toxicology: Dietrich and Dragatsis trait 1 (contact idragatsis@uthsc.edu) Central nervous system, toxicology: 3-nitropropionic acid neurodegeneration in striatum (caudate putamen) (50 mg/kg ip) in young adults, presence or absence of lesions [-1 = lesions, +1 = no lesions] x x -1.0 1.0 x x x x x 1.0 x x x x x x x x x x x x x -1.0 x 1.0 x 1.0 x x 1.0 x x x x x x x 1.0 x x -1.0 x x x x 1.0 x x 1.0 x x x x 1.0 x x x 1.0 1.0 x x x x x x x x x x x x x x x 1.0 x 1.0 x x x x x x x -1.0 x 1.0 x x x x x x x x x x -1.0 x -1.0 1.0 +15960 Original post publication description: Central nervous system; embryonic neurogenesis; Cell death in brainstem following exposure to ethanol at E9 (TUNEL+ cells/mm2) None Central nervous system; embryonic neurogenesis; Cell death in brainstem following exposure to ethanol at E9 (TUNEL+ cells/mm2) x x 3510.35 302.783 x 1722.8 x x x x x x x x x x x x 3379.48 x x x x x x x x x x x 321.561 x x x x x x 196.63 x x x x x x x x x x x 5488.26 x x x x x x x x -115.188 x x x x x x x x x x x x 1814.31 x x x x x x 130.77 x x x x x x x x x x x x x x x 1764.4 x x x 1504.88 x x 115.628 +15961 Original post publication description: Central nervous system; embryonic neurogenesis; Cell death in forebrain following exposure to ethanol at E9 (TUNEL+ cells/mm2) None Central nervous system; embryonic neurogenesis; Cell death in forebrain following exposure to ethanol at E9 (TUNEL+ cells/mm2) x x 2807.34 1130.68 x 2921.76 x x x x x x x x x x x x 670.908 x x x x x x x x x x x 1548.51 x x x x x x 532.978 x x x x x x x x x x x 2830.62 x x x x x x x x 144.004 x x x x x x x x x x x x 3693.12 x x x x x x 258.192 x x x x x x x x x x x x x x x 885.807 x x x 729.545 x x 272.43 +15962 Original post publication description: Infectious disease, immune system: Tuberculosis, bacterial load in lung [CFU] Original pre publication description: Infectious disease, immune system: Sassetti, Christopher Infectious disease, immune system: Sassetti, Christopher, Trait 1 Infectious disease, immune system: Tuberculosis, bacterial load in lung [CFU] x x 704667.0 219000.0 x x x x x 2646670.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x 6253330.0 1760000.0 x x x x x x x 596000.0 x x 130667.0 x x 354000.0 x 2753330.0 x x x 123500.0 x 183333.0 x x x x 1153330.0 x 2380000.0 x x x 3513330.0 x x x 15080.0 x 983600.0 x x x x x x x x x x 1578000.0 x x 101000.0 x x x x x x x x 393333.0 513000.0 +15963 Original post publication description: Infectious disease, immune system: Tuberculosis, bacterial load in lung [log CFU] Original pre publication description: Infectious disease, immune system: Sassetti, Christopher, Trait 2 Infectious disease, immune system: Sassetti, Christopher, Trait 2 Infectious disease, immune system: Tuberculosis, bacterial load in lung (BXD71 winsorized from 4.18 to 4.98) [log CFU] x x 5.85 5.34 x x x x x 6.42 x x x x x x x x x x x x x x x x x 6.45 x x x x x x x x x 6.8 6.25 x x x x x x x x x x 5.12 x x 5.55 x 6.44 x x x 5.09 x 5.26 x x x x 6.06 x 6.38 x x x 6.55 x x x 4.98 x 5.99 x x x x x x x x x x 6.2 x x 5.0 x x 5.78 x x x x x 5.59 5.71 +15964 Original post publication description: malaria susceptibility entered at November/13 14:57:41 from IP 192.55.208.10 None Infectious disease, immune system: Malaria susceptibility 0.5 0.5 1.0 0.0 x x 1.0 x x 1.0 1.0 0.0 1.0 x x 1.0 x 0.0 x x x x x 1.0 x 1.0 x x x 1.0 1.0 x x x 1.0 x 1.0 1.0 1.0 x 1.0 1.0 1.0 0.0 x x 1.0 0.0 1.0 1.0 x 0.0 x 0.0 1.0 x x x 1.0 1.0 0.0 1.0 x 1.0 1.0 0.0 x 0.0 x x x 1.0 1.0 1.0 x 1.0 x 1.0 1.0 x x 1.0 1.0 x 1.0 1.0 1.0 1.0 0.0 1.0 x x x 0.0 0.0 1.0 x 1.0 1.0 0.0 0.0 1.0 +15965 Original post publication description: Central nervous system, gene expression: Vasopressin receptor expression gene family mapping to Avpr1a using Hypothalamus data set (BXD84 winsorized from 6.26 to 3.7) None Central nervous system, gene expression: Vasopressin receptor expression gene family mapping to Avpr1a using Hypothalamus data set (BXD84 winsorized from 6.26 to 3.7) -0.8 0.69 -0.217 -0.745 -2.505 x x x x x -0.329 -2.272 x -1.094 x x x x x x x x x 2.597 x -1.3 x -3.307 x 3.19 0.361 x -2.108 x x x x -2.828 0.001 x 2.474 2.649 2.155 1.159 x x -1.549 2.17 -0.753 x x x x x -2.62 x x x 1.34 x 2.987 -0.948 x -0.271 x x -2.132 1.448 -1.076 -0.704 x 1.453 x -1.154 x x x 0.345 2.635 x x -1.654 3.7 -0.198 x 1.409 x -0.391 -2.712 x -0.752 x x -0.304 x -2.159 x -0.922 -3.085 0.697 3.645 1.219 +15967 Original post publication description: un-named trait Original pre publication description: age_gender adjusted_ femur_BMD age_gender adjusted_ femur_BMD un-named trait 437.606 401.376 334.809 387.543 432.844 x x x x x 388.178 361.868 x 337.781 x x x x x x x x x 365.093 x 349.577 x 374.015 x 356.624 404.699 x 374.11 x x x 395.925 325.386 372.01 x 350.798 362.355 383.123 357.651 x x 382.292 400.995 368.538 x x x x x 379.438 x x x 367.478 x 401.183 338.532 x 367.075 x x 358.495 314.85 378.341 348.01 x 349.851 x 372.68 x x x 382.912 295.69 x x 382.918 331.491 355.88 x x x 337.757 401.016 x x x x 400.284 x 355.287 x 329.441 394.454 347.549 365.437 297.369 +15968 Original post publication description: un-named trait Original pre publication description: age_gender adjusted_BMD_Tibia Musculoskeletal system, morphology, metabolism: Bone mineral density of the tibia in young adults corrected for sex and age [units] Musculoskeletal system, morphology, metabolism: Bone mineral density of the tibia in young adults corrected for sex and age [units] 373.936 343.086 290.81 320.534 362.124 x x x x x 338.342 290.625 x 301.176 x x x x x x x x x 291.11 x 285.222 x 291.154 x 282.611 336.192 x 327.417 x x x 310.545 271.867 302.358 310.576 x 285.207 304.032 294.237 x x 309.947 304.76 310.039 x x x x x 293.581 x x x 278.135 x 325.378 274.745 x 281.124 x x 328.752 266.745 322.442 311.97 x 314.262 x 332.069 x x x 329.922 256.743 x x 331.069 273.668 289.604 x 315.261 x 284.66 323.301 x x x x 358.052 x 287.291 x 308.673 334.448 289.273 320.483 263.527 +15969 Original post publication description: Central nervous system, adult neurogenesis: Newly generated BrdU-labeled cells in the rostral migratory stream of adult mouse brain, data corrected for age, sex, body weight, and strain epoch effects [N cells per mm of RMS length] None Central nervous system, adult neurogenesis: Newly generated BrdU-labeled cells in the rostral migratory stream of adult mouse brain, data corrected for age, sex, body weight, and strain epoch effects [N cells per mm of RMS length] x x x x 59.88 57.92 x 61.74 27.92 72.88 44.5 68.9 32.34 68.31 84.67 84.53 45.53 16.73 105.38 62.88 x x x 45.96 x 54.19 127.77 129.55 x 53.03 61.78 49.07 63.68 x x x 90.24 120.24 57.7 x 52.6 60.51 49.27 55.57 x x 72.22 x 24.61 47.58 x x x 7.39 56.16 x x x 41.71 64.68 38.72 14.05 x 40.7 54.85 97.72 156.58 x x 67.1 x 50.48 x 88.45 x 67.57 x x 69.62 x x 61.41 113.51 70.84 70.81 72.32 x 83.91 85.97 x 54.83 x x x 65.11 42.99 82.31 114.18 72.1 x x x +15970 Original post publication description: David J. Reiner, Taha A. Jan, John D. Boughter Jr, Cheng-Xiang Li, Lu Lu, Robert W. Williams and Robert S. Waters. Genetic Analysis of Tongue Size and Taste Papillae Number and Size in Recombinant Inbred Strains of Mice. Chem. Senses 33: 693–707, 2008 Original pre publication description: This is a set of data published by Reiner et al. in 2008. W. Gu put the data for his analysis with other traits. Gustation: Filiform papillae number [adjusted n] Gustation: Filiform papillae number [adjusted n] x x 242.61 336.87 344.3 x x x x x x 328.78 x 258.01 x x x x x x x x x x x x x x x x 385.13 x 317.13 x 273.36 x x x x x 267.11 x x 299.78 x x x x 288.67 394.69 x x x x x x x x x x 346.58 x x 287.64 314.17 x x 332.97 387.74 227.94 x x x x x 321.85 x x x x x x 361.44 326.7 355.05 341.27 x 223.39 x x x x x 264.85 x x x x x x x x +15971 None Eye, visual system, physiology: Intraocular pressure (IOP), 1 to 2 months old, both sexes, average of left and right eyes Eye, visual system, physiology: Intraocular pressure (IOP), 1 to 2 months old, both sexes, average of left and right eyes [mmHg] 15.6667 15.1111 15.375 16.7143 17.5 x 15.6 x x 16.0833 14.4167 17.4286 13.9444 18.25 16.875 18.0714 16.4167 15.625 15.25 x x x x 13.75 x 16.75 x 16.8333 x 12.5 14.8333 12.6667 14.3 x 13.75 x 12.5 15.5 15.5 x 16.7 17.25 14.4091 13.125 x x 16.5385 x 14.8846 12.5556 x x x 15.3 15.5 x x x 15.375 16.1923 19.0 16.0714 x 15.7 17.6111 16.0 16.1667 15.5909 11.6667 13.0556 x 13.75 x 13.1111 x 14.2083 x x 13.8889 x x 17.3636 15.0 12.4583 16.2778 16.6875 x 14.1667 13.375 x 15.1667 x x 15.0 16.5333 13.0 11.6429 17.0 17.3125 12.9167 17.3333 14.8 +15972 None Eye, visual system, physiology: Intraocular pressure (IOP), 2.1 to 5 months old, both sexes, average of left and right eyes Eye, visual system, physiology: Intraocular pressure (IOP), 2.1 to 5 months old, both sexes, average of left and right eyes 17.375 18.0 15.6667 17.1833 18.5 x 17.5909 17.75 x 17.5625 16.8636 18.375 13.7222 18.0 18.3 17.0 17.3 14.2059 16.9545 21.75 x x x 16.9286 x 17.8 x 18.125 x 15.75 15.5714 15.4 13.625 16.25 18.0 x 12.5 13.6667 12.6 x 14.9375 14.5455 14.875 11.75 x x 17.5 x 15.0 14.1538 x x x 15.587 13.8333 x x x 16.45 17.5 16.4545 19.1154 x 14.3889 20.0833 14.0625 15.1786 16.8611 17.2353 15.0714 x 18.0435 x 12.7143 x 15.4167 x x 18.5625 x x 14.875 14.9615 15.8235 18.3214 17.5556 x 16.25 14.95 x 14.4 x x 18.0 14.875 14.1875 13.5 21.3 14.8889 8.75 16.9688 17.3824 +15973 None Eye, visual system, physiology: Intraocular pressure (IOP), 5.1 to 9 months old, both sexes, average of left and right eyes Eye, visual system, physiology: Intraocular pressure (IOP), 5.1 to 9 months old, both sexes, average of left and right eyes 16.5 20.15 15.1 19.1731 17.25 16.125 20.0833 16.0 18.9286 17.375 15.6 17.0 16.3 18.5833 16.5 14.875 17.75 17.9643 13.5 13.5 16.5 x 19.125 18.625 x 22.125 18.75 15.0833 x 15.1667 16.25 17.0 17.3571 x 14.5833 x 13.3182 12.6111 13.4 x 12.0 15.8571 16.6667 13.4211 x x 10.8333 x 13.15 14.8182 x x x 17.2 14.0 x x x 17.3611 18.1667 14.8846 19.125 x 13.3571 22.5 17.0833 18.7059 16.8636 17.7083 14.75 x 20.9375 x 15.3636 x 15.8214 x x 17.3929 x x 15.7059 15.1429 16.7368 18.1875 21.0385 x 17.3636 17.8125 x 19.0 x x 19.9375 15.1875 15.3889 12.1667 18.3333 14.1538 12.7 18.6875 15.75 +15974 None Eye, visual system, physiology: Intraocular pressure (IOP), 9.1 to 13 months old, both sexes, average of left and right eyes Eye, visual system, physiology: Intraocular pressure (IOP), 9 to 13 months old, both sexes, average of left and right eyes (BXD44 winsorized from 21.8 to 19.4, BXD38 winsorized from 9.58 to 10.9, BXD48 outlier deleted (9.300 +/- 0.768 SE), BXD80/73a and BXD103/73b merged with BXD73 (original values BXD73=16.906 +/- 0.8, BXD73a=19.750 +/- 1.37, BXD73b=17.150+/- 0.48), BXD65 merged with BXD92/65b and with BXD97/65a (original values BXD65=14.071 +/- 0.834, BXD65b=14.0 +/- 1.618, BXD65a=12.833 +/- 0.928) [mmHg] x 17.625 15.227 16.844 18.2 11.333 13.167 12.5 17.0 14.25 14.75 14.375 13.375 19.375 16.333 16.75 18.125 14.167 11.0 x x x 17.0 x x 18.375 x 14.667 x 12.625 13.9 18.0 18.954 x 14.833 x 10.9 13.214 13.75 x 11.75 17.875 19.4 16.5 x x x x 12.5 17.889 x x x 15.0 18.875 x x x 14.454 18.237 14.611 17.333 x 13.635 18.5 17.5 16.833 17.038 16.458 12.5 x 17.935 x 14.85 x 17.643 x x x x x 16.208 13.75 16.071 16.667 16.5 x 14.542 15.3 x x x x 17.75 14.5 x 18.688 18.25 16.546 13.25 15.278 x +15975 None Eye, visual system, physiology, aging: Intraocular pressure (IOP), more than 13 months old, both sexes, average of left and right eyes Eye, visual system, physiology, aging: Intraocular pressure (IOP), more than 13 months old, both sexes, average of left and right eyes x x 13.0909 12.5 14.6 15.75 x 12.5 17.75 21.0 15.5 10.3 13.25 x 13.8 14.5 14.1429 12.5 8.25 x 16.3333 x 18.0 12.6667 13.8 18.75 18.25 14.75 x 13.75 14.0 19.125 18.6875 x x x 12.75 13.375 11.85 x 10.25 12.25 13.2143 14.25 x x 10.375 x 9.7 21.8333 x x x 18.25 18.1 x x x 10.6 15.7083 14.3636 16.25 x 12.7273 12.5 17.0 11.5833 13.5294 14.1667 12.9444 x 14.0833 x 13.6667 x 10.6875 x x 16.7 x x 11.5 13.5 11.9286 16.9 21.7174 x 12.2222 14.5 x 13.9167 x x 16.0 11.5833 14.0 14.1 14.375 16.4375 9.5 10.6 18.9091 +15976 None Eye, visual system, physiology: Intraocular pressure (IOP), all ages (1 to 30 months old), both sexes, average of left and right eyes Eye, visual system, physiology: Intraocular pressure (IOP), all ages (1 to 30 months old), both sexes, average of left and right eyes 16.6053 17.8125 14.7273 17.0385 17.1364 14.4444 16.8214 14.9231 17.9375 16.8958 15.4634 15.6346 14.1552 18.4348 15.9355 16.4231 16.4423 15.3942 14.2931 19.0 16.4 x 16.1562 18.05 13.8 18.7763 18.5833 16.1167 x 14.0323 14.8333 16.25 16.9891 16.25 15.175 x 12.2581 13.5857 13.1429 x 13.0435 15.4574 16.4322 13.5755 x x 14.2895 x 13.7959 15.6667 x x x 16.0175 15.9091 x x x 15.1885 17.2154 15.8148 18.0 x 14.0568 19.32 15.9583 16.2727 15.8857 15.8559 13.9118 x 17.4123 x 13.91 x 14.8302 x x 17.5172 x x 15.3516 14.6228 15.1449 17.3824 19.35 x 14.9135 15.119 x 15.0 x x 17.1047 14.951 14.1207 13.6444 18.5167 15.4925 11.1724 16.3298 17.1569 +16012 None Blood Chemistry: AMC Trait 186 contact <c.a.argmann@amc.uva.nl> Blood chemistry, metabolism: Ratio of lysoGb3(noSmase)/Cer levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks x x 0.155108 0.267777 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.365803 x 0.148832 x x 0.309468 0.0724903 0.238557 0.293197 x x x 0.0937477 0.204429 x x x x 0.534185 0.912412 0.250145 0.341112 0.207595 0.0779967 x 0.266411 0.0496962 0.184132 0.0576657 x 0.457957 x 0.191647 x x x 0.0696836 0.0568522 0.0452565 x 0.441061 0.346879 0.141076 x 0.198179 x 0.0707373 0.09654 x x x x 0.258673 0.165997 0.0666198 0.0781471 0.13501 0.174553 0.426706 x 0.158838 +16011 None Blood Chemistry: AMC Trait 185 contact <c.a.argmann@amc.uva.nl> Blood chemistry, metabolism: Ratio of lysoGb3(noSmase)/Cer levels in pooled plasma of young adult males on a normal chow diet x x 0.154372 0.148613 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.0615432 0.0875224 0.0637467 x x 0.495506 0.145948 0.0878838 0.0965124 x x x 0.260126 0.368497 x x x 0.0 0.304686 0.370375 0.160103 0.311237 0.0680125 0.231786 x 0.163177 0.0339353 0.110893 0.0526276 x 0.132119 x 0.193074 x x x 0.276088 0.0329535 0.0372791 x 0.304108 0.434445 0.221706 x 0.129337 x 0.270025 0.133848 x 0.090848 x x 0.164171 0.277335 x 0.0820764 0.123088 0.233484 0.1416 x 0.0784866 +16010 None Blood Chemistry: AMC Trait 184 contact <c.a.argmann@amc.uva.nl> Blood chemistry, metabolism: Ratio of GM2-gl/GlcCer levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks x x 3.60375 10.7349 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 11.9126 x 5.44204 x x 4.68577 8.20116 16.1485 8.79258 x x x 9.33104 7.67861 x x x x 8.72621 4.23032 6.25358 6.25943 6.92834 8.44527 x 6.32065 3.58809 4.39816 9.16663 x 6.42687 x 2.49028 x x x x 13.54 x x 7.88031 5.70207 x x 9.17102 x 8.36986 x x x x x x x 4.52619 7.31891 6.94779 x 6.72985 x 8.55274 +16009 None Blood Chemistry: AMC Trait 183 contact <c.a.argmann@amc.uva.nl> Blood chemistry, metabolism: Ratio of GM2-gl/GlcCer levels in pooled plasma of young adult males on a normal chow diet x x 6.14798 14.0691 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 5.54281 4.80155 9.48394 x x 12.3696 14.805 8.99453 17.9217 x x x 29.8512 14.8391 x x x 8.33594 9.08991 7.29957 21.2709 13.0005 7.77509 9.27902 x 9.45795 9.58734 11.2096 13.0434 x 8.49512 x 5.90177 x x x x 12.814 x x x 17.3122 14.2613 x 14.4736 x 21.048 20.2444 x x x x x x x 11.417 12.359 12.9172 9.38688 x 10.2172 +16008 None Blood Chemistry: AMC Trait 32 contact <c.a.argmann@amc.uva.nl> Blood chemistry, metabolism: Ratio of GM2-gl/Cer levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks x x 3.59286 4.48077 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 7.14758 x 5.63123 x x 4.58977 5.3796 7.42923 9.42062 x x x 10.861 4.92066 x x x x 7.84375 4.53553 2.72316 3.79501 3.08 6.63673 x 6.80745 4.40078 3.82938 6.81376 x 9.40102 x 2.40265 x x x x 13.8116 x x 6.16653 5.48822 x x 5.62594 x 6.30479 x x x x x x x 4.39743 5.90595 5.41901 x 9.03293 x 9.03257 +16007 None Blood Chemistry: AMC Trait 31 contact <c.a.argmann@amc.uva.nl> Blood chemistry, metabolism: Ratio of GM2-gl/Cer levels in pooled plasma of young adult males on a normal chow diet x x 5.44243 3.72044 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 4.80801 7.2372 6.3846 x x 8.72378 9.4706 8.24976 7.97551 x x x 15.6702 6.52054 x x x 4.95983 5.63239 5.74075 8.72726 6.52532 3.67409 5.78348 x 3.69279 4.86389 4.99809 8.56081 x 10.3479 x 4.74243 x x x x 10.8739 x x x 7.71403 7.79451 x 8.02846 x 10.2794 8.77325 x x x x x x x 7.46696 9.42981 7.02157 4.97206 x 7.86657 +16006 None Blood Chemistry: AMC Trait 30 contact <c.a.argmann@amc.uva.nl> Blood chemistry, metabolism: Ratio of totalSM/Cer levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks x x 40.9188 63.7285 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 103.184 x 92.089 x x 75.1719 29.4489 83.54 134.099 x x x 102.86 92.7186 x x x x 78.9296 84.363 34.6735 64.9284 28.1273 99.3822 x 69.4868 109.291 56.9369 89.5225 x 109.563 x 37.0935 x x x 53.5134 100.915 76.9016 x 44.8658 69.1727 51.7555 x 31.1651 x 52.0868 70.3182 x x x x 70.1362 31.9398 49.6217 64.6421 41.5531 38.4138 108.863 x 90.6997 +16005 None Blood Chemistry: AMC Trait 29 contact <c.a.argmann@amc.uva.nl> Blood chemistry, metabolism: Ratio of totalSM/Cer levels in pooled plasma of young adult males on a normal chow diet x x 42.5918 61.4163 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 49.2213 85.8082 61.6624 x x 83.4514 45.4668 73.8458 53.7325 x x x 97.448 72.9689 x x x 50.5008 50.3689 70.1437 44.5358 61.0518 42.3642 69.6853 x 36.6306 45.9545 37.4907 59.3526 x 78.5021 x 65.6446 x x x 45.3858 72.5452 39.683 x 51.8406 65.3484 57.1143 x 64.9961 x 56.5212 56.2746 x 46.488 x x 60.0647 75.4802 x 64.247 42.0869 71.2327 55.9205 x 85.4141 +16004 None Blood Chemistry: AMC Trait 28 contact <c.a.argmann@amc.uva.nl> Blood chemistry, metabolism: Ratio of GlcCer/Cer levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks x x 0.996979 0.417401 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.600001 x 1.03477 x x 0.979512 0.655956 0.460058 1.07143 x x x 1.16397 0.640826 x x x x 0.898872 1.07215 0.435457 0.606288 0.444551 0.785851 x 1.07702 1.2265 0.870677 0.743322 x 1.46277 x 0.964812 x x x 1.03518 1.02006 1.23352 x 0.782523 0.962495 1.13568 x 0.613448 x 0.753273 0.573687 x x x x 0.940763 0.567621 0.971552 0.806944 0.779962 0.956349 1.34222 x 1.0561 +16003 None Blood Chemistry: AMC Trait 27 contact <c.a.argmann@amc.uva.nl> Blood chemistry, metabolism: Ratio of GlcCer/Cer levels in pooled plasma of young adult males on a normal chow diet x x 0.88524 0.264441 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.867431 1.50726 0.673202 x x 0.70526 0.639689 0.917198 0.44502 x x x 0.524944 0.439417 x x x 0.594993 0.619631 0.786451 0.410292 0.501927 0.472546 0.623285 x 0.390443 0.507324 0.445876 0.656333 x 1.2181 x 0.80356 x x x 0.734845 0.84859 0.574079 x 0.641833 0.445584 0.546548 x 0.554696 x 0.488377 0.433367 x 0.332603 x x 0.510515 0.770421 x 0.654019 0.762994 0.543581 0.529682 x 0.769931 +16002 None Blood Chemistry: AMC Trait 26 contact <c.a.argmann@amc.uva.nl> Blood chemistry, metabolism: Ceramide (d18:1) levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml] x x 5.56514 3.24193 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 2.98252 x 3.06209 x x 3.636 4.3715 2.63198 2.31252 x x x 2.58112 3.48527 x x x x 2.28586 3.58786 5.49278 3.99795 9.44685 2.63565 x 3.27115 3.01753 4.91869 2.1856 x 1.81858 x 8.43291 x x x 2.94748 2.1285 4.20008 x 4.24871 4.95804 3.75202 x 5.14474 x 4.29267 2.97984 x x x x 3.57144 5.56653 5.06445 5.0365 5.28772 6.52647 2.84124 x 2.59007 +16001 None Blood Chemistry: AMC Trait 25 contact <c.a.argmann@amc.uva.nl> Blood chemistry, metabolism: Gluco(galacto)sylceramide levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml] x x 5.54833 1.35318 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 1.78951 x 3.16855 x x 3.56151 2.86751 1.21086 2.4777 x x x 3.00434 2.23345 x x x x 2.0547 3.84672 2.39187 2.42391 4.1996 2.07123 x 3.52309 3.70099 4.28259 1.6246 x 2.66015 x 8.13618 x x x 3.05116 2.17121 5.1809 x 3.32472 4.77209 4.26111 x 3.15603 x 3.23355 1.70949 x x x x 3.35988 3.15968 4.92037 4.06417 4.12422 6.24158 3.81357 x 2.73538 +16000 None Blood Chemistry: AMC Trait 24 contact <c.a.argmann@amc.uva.nl> Blood chemistry, metabolism: Unknown lipid (16minRT) levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml] x x 1.56651 0.776809 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.771129 x 1.15316 x x 0.906502 0.744311 0.611137 0.863067 x x x 0.863348 0.62246 x x x x 0.453403 0.841625 0.830902 0.930096 1.00356 0.850837 x 0.87014 0.962472 1.03404 0.487266 x 0.563704 x 2.07126 x x x 0.70045 0.38586 0.634337 x 0.912325 0.842501 0.602052 x 0.881615 x 0.726571 0.537518 x x x x 0.719745 0.58018 0.702087 1.10033 1.05791 1.04615 0.564843 x 0.595122 +15999 None Blood Chemistry: AMC Trait 23 contact <c.a.argmann@amc.uva.nl> Blood chemistry, metabolism: Ceramide (d18:1) levels in pooled plasma of young adult males on a normal chow diet [nmol/ml] x x 3.06387 3.257 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 3.45277 3.20497 2.69901 x x 1.78927 2.36855 2.26594 2.60214 x x x 1.75218 2.6373 x x x 4.11832 2.65481 2.54967 3.22987 2.51154 4.6892 2.50186 x 4.23769 3.19964 4.02113 3.57028 x 1.87896 x 3.06888 x x x 2.39272 1.61926 3.49081 x 2.90234 2.60031 2.40846 x 2.37453 x 2.36994 2.7266 x 4.47033 x x 3.1234 1.8017 x 2.17826 3.23433 2.69502 2.7763 x 1.87711 +15998 None Blood Chemistry: AMC Trait 22 contact <c.a.argmann@amc.uva.nl> Blood chemistry, metabolism: Gluco(galacto)sylceramide levels in pooled plasma of young adult males on a normal chow diet [nmol/ml] x x 2.71226 0.861283 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 2.99504 x 1.81698 x x 1.2619 1.51513 2.07831 1.158 x x x 0.919798 1.15887 x x x 2.45037 1.645 2.0052 1.32519 1.26061 2.21586 1.55937 x 1.65457 1.62325 1.79292 2.34329 x 2.28877 x 2.46603 x x x 1.75828 1.37409 2.004 x 1.86282 1.15866 1.31634 x 1.31714 x 1.15742 1.18162 x 1.48684 x x 1.59454 1.38807 x 1.42462 2.46777 1.46496 1.47056 x 1.44525 +15997 None Blood Chemistry: AMC Trait 21 contact <c.a.argmann@amc.uva.nl> Blood chemistry, metabolism: Unknown lipid (16minRT) levels in pooled plasma of young adult males on a normal chow diet [nmol/ml] x x 0.837553 0.471368 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.52387 0.749601 0.592535 x x 0.406074 0.464238 0.547141 0.492687 x x x 0.401813 0.410858 x x x 0.595942 0.541271 0.623336 0.529768 0.446967 0.564448 0.506163 x 0.647668 0.606059 0.449488 0.819465 x 0.540631 x 0.666303 x x x 0.491658 0.267113 0.452561 x 0.583173 0.452609 0.462888 x 0.545704 x 0.320743 0.427205 x 0.388019 x x 0.503471 0.316916 x 0.446191 0.560253 0.506938 0.511883 x 0.319714 +15996 None Blood Chemistry: AMC Trait 20 contact <c.a.argmann@amc.uva.nl> Blood chemistry, metabolism: N-glycolyl ganglioside GM2 levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml] x x 19.9948 14.5263 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 21.3178 x 17.2434 x x 16.6884 23.5169 19.5536 21.7854 x x x 28.0336 17.1498 x x x x 17.9297 16.2728 14.9577 15.1723 29.0963 17.4921 x 22.2682 13.2795 18.8355 14.8921 x 17.0965 x 20.2614 x x x x 29.3981 x x 26.1998 27.2108 x x 28.944 x 27.0644 x x x x x x x 22.2706 29.7453 28.6542 x 25.6647 x 23.395 +15995 None Blood Chemistry: AMC Trait 19 contact <c.a.argmann@amc.uva.nl> Blood chemistry, metabolism: N-glycolyl ganglioside GM2 levels in pooled plasma of young adult males on a normal chow diet [nmol/ml] x x 16.6749 12.1175 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 16.6009 23.195 17.2321 x x 15.6092 22.4316 18.6935 20.7534 x x x 27.4571 17.1966 x x x 20.4262 14.9529 14.6371 28.1879 16.3886 17.2285 14.4694 x 15.6489 15.5627 20.098 30.5644 x 19.4434 x 14.554 x x x x 17.6076 x x x 20.0588 18.7727 x 19.0638 x 24.3615 23.9211 x x x x x x x 16.265 30.4991 18.9232 13.8039 x 14.7664 +15994 None Blood Chemistry: AMC Trait 18 contact <c.a.argmann@amc.uva.nl> Blood chemistry, metabolism: Globotriaosylsphingosine levels measured with sphingomyelinase in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml] x x 1.38445 1.41488 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 1.09481 x 0.63225 x x 0.722969 0.135937 0.89351 0.571093 x x x 0.355449 1.28927 x x x x 1.05828 3.225 1.12202 1.44396 1.44148 0.634122 x 0.807727 0.346213 2.05096 0.516168 x 1.14335 x 3.15986 x x x 0.970696 0.578668 0.519078 x 1.82576 1.62378 0.582272 x 1.06147 x 0.870234 0.929146 x x x x 0.940048 0.744537 0.135388 0.417064 0.440303 0.985202 0.869348 x 0.208715 +15993 None Blood Chemistry: AMC Trait 17 contact <c.a.argmann@amc.uva.nl> Blood chemistry, metabolism: Gluco(galacto)sylsphingosine levels measured with sphingomyelinase in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml] x x 0.237365 0.16489 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.368463 x 0.802144 x x 0.122188 0.0 0.175001 0.81038 x x x 0.0 0.0 x x x x 0.0 0.457431 0.39596 0.00947024 0.0 0.487123 x 0.635972 0.112106 0.189443 0.160348 x 0.0 x 0.00440551 x x x 0.0 0.957429 0.232911 x 0.411214 0.3306 0.0 x 0.0 x 0.459384 0.253594 x x x x 0.0 0.0 0.479808 0.172845 0.0 0.18934 0.846982 x 0.0 +15992 None Blood Chemistry: AMC Trait 16 contact <c.a.argmann@amc.uva.nl> Blood chemistry, metabolism: Globotriaosylsphingosine levels measured without sphingomyelinase in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml] x x 0.863201 0.868115 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 1.09101 x 0.455739 x x 1.12522 0.316891 0.627877 0.678025 x x x 0.241974 0.712491 x x x x 1.22107 x 1.37399 1.36375 1.96112 0.205572 x 0.871473 0.14996 0.905686 0.126034 x 0.83283 x 1.61614 x x x 0.205391 0.12101 0.190081 x 1.87394 1.71984 0.529321 x 1.01958 x 0.303652 0.287673 x x x x 0.923836 0.924027 0.337392 0.393587 0.713897 1.13921 1.21237 x 0.411401 +15991 None Blood Chemistry: AMC Trait 15 contact <c.a.argmann@amc.uva.nl> Blood chemistry, metabolism: Gluco(galacto)sylsphingosine levels measured without sphingomyelinase in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml] x x 0.375718 0.306835 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.0 x 0.403665 x x 0.0 1.23157 0.207471 0.41094 x x x 0.197817 0.0968738 x x x x 0.811978 0.0 0.521789 0.0 0.556245 0.0 x 0.257244 0.317355 1.15608 0.154402 x 0.227199 x 0.0576161 x x x 0.0 0.142236 0.080884 x 0.0 0.53578 0.267229 x 0.0170099 x 0.0910954 0.295086 x x x x 0.0 0.0 0.0 0.45464 0.0 0.0 0.533734 x 0.492763 +15990 None Blood Chemistry: AMC Trait 14 contact <c.a.argmann@amc.uva.nl> Blood chemistry, metabolism: Globotriaosylsphingosine levels mesaured with sphingomyelinase in pooled plasma of young adult males on a normal chow diet [nmol/ml] x x 0.597553 0.416822 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.225424 0.121534 0.109931 x x 0.549402 0.556443 0.352988 0.579273 x x x 0.523802 0.741169 x x x 0.455955 0.893569 1.13714 0.603848 1.40228 1.06872 0.509372 x 1.1104 0.431484 0.555801 0.0 x 0.0 x 0.825922 x x x 0.511999 0.189321 0.647277 x 0.654106 0.519485 0.683867 x 0.420211 x 0.391526 0.446482 x 0.448502 x x 0.46438 0.171525 x 1.22008 0.416815 1.17531 0.378831 x 0.336236 +15989 None Blood Chemistry: AMC Trait 13 contact <c.a.argmann@amc.uva.nl> Blood chemistry, metabolism: Gluco(galacto)sylsphingosine levels measured with sphingomyelinase in pooled plasma of young adult males on a normal chow diet [nmol/ml] x x 1.1909 0.305256 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.0871082 0.0 0.339091 x x 0.271791 0.266327 0.0 0.0 x x x 0.0 0.328363 x x x 0.339052 0.0918689 0.0 0.0 0.370662 0.0 0.156274 x 0.277142 0.0889031 0.0 0.165369 x 0.0 x 0.0571129 x x x 0.0 0.0 0.244763 x 0.515216 0.0 0.0 x 0.170414 x 0.246824 0.0 x 0.769041 x x 0.560106 0.647522 x 0.0 0.0 0.0 0.265087 x -0.03483 +15988 None Blood Chemistry: AMC Trait 12 contact <c.a.argmann@amc.uva.nl> Blood chemistry, metabolism: Globotriaosylsphingosine levels measured without sphingomyelinase in pooled plasma of young adult males on a normal chow diet [nmol/ml] x x 0.472975 0.484034 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.212494 0.280506 0.172053 x x 0.886596 0.345685 0.199139 0.251138 x x x 0.455789 0.971837 x x x 0.0 0.808885 0.944336 0.517112 0.781684 0.318924 0.579894 x 0.691494 0.108581 0.445914 0.187895 x 0.248247 x 0.592521 x x x 0.660601 0.0533601 0.130134 x 0.882626 1.12969 0.53397 x 0.307113 x 0.639942 0.364949 x 0.40612 x x 0.512774 0.499674 x 0.178784 0.398107 0.629242 0.393123 x 0.147328 +15987 None Blood Chemistry: AMC Trait 11 contact <c.a.argmann@amc.uva.nl> Blood chemistry, metabolism: Gluco(galacto)sylsphingosine levels measured without sphingomyelinase in pooled plasma of young adult males on a normal chow diet [nmol/ml] x x 0.628469 0.175789 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.697978 0.621789 0.0373505 x x 0.363173 0.0 0.0 0.0 x x x 0.156859 0.0 x x x 1.74051 0.0 0.0 0.0 0.323365 0.20012 0.0 x x 0.0 0.061498 0.0997759 x 0.377981 x 0.0 x x x 0.310748 0.0 0.343429 x 0.693611 0.456131 0.0333046 x 0.120073 x 0.121931 0.405994 x 0.0 x x 0.381194 0.0633987 x 0.0 0.0 0.279074 0.59026 x 0.0 +15986 None Blood Chemistry: AMC Trait 10 contact <c.a.argmann@amc.uva.nl> Blood chemistry, metabolism: Total sphingomyelin levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml] x x 227.719 206.603 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 307.748 x 281.985 x x 273.325 128.736 219.876 310.107 x x x 265.494 323.149 x x x x 180.422 302.683 190.454 259.58 265.715 261.937 x 227.302 329.788 280.055 195.66 x 199.25 x 312.806 x x x 157.729 214.799 322.993 x 190.622 342.961 194.188 x 160.336 x 223.592 209.537 x x x x 250.487 177.794 251.307 325.57 219.721 250.707 309.306 x 234.919 +15985 None Blood Chemistry: AMC Trait 09 contact <c.a.argmann@amc.uva.nl> Blood chemistry, metabolism: Sphingomyelin (d18:1) levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml] x x 166.538 136.935 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 224.36 x 203.103 x x 204.437 110.355 158.614 235.33 x x x 197.651 250.451 x x x x 124.276 225.164 127.491 194.421 204.632 185.396 x 173.893 249.745 195.373 149.861 x 134.626 x 220.925 x x x 111.216 153.993 257.919 x 133.529 247.601 144.903 x 112.599 x 160.367 147.721 x x x x 178.59 137.572 200.055 275.818 161.755 179.109 249.065 x 172.317 +15984 None Blood Chemistry: AMC Trait 08 contact <c.a.argmann@amc.uva.nl> Blood chemistry, metabolism: Sphingomyelin (d16:0) levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml] x x 14.276 16.7836 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 20.0347 x 18.1281 x x 18.6325 2.72951 14.4644 19.6077 x x x 14.8138 15.8457 x x x x 13.9024 21.0653 15.5997 17.6184 16.229 19.634 x 11.8972 19.8832 19.8546 10.9291 x 16.2405 x 25.3475 x x x 10.3597 16.2135 13.4979 x 16.1042 22.0731 11.7922 x 11.0063 x 13.1718 14.5875 x x x x 19.5507 11.1158 11.4466 12.3707 11.3947 18.9473 15.6352 x 14.0783 +15983 None Blood Chemistry: AMC Trait 07 contact <c.a.argmann@amc.uva.nl> Blood chemistry, metabolism: Sphingomyelin (d18:2) levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml] x x 41.7432 45.9173 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 56.5765 x 54.0538 x x 43.5548 14.692 42.5234 47.381 x x x 47.9461 52.0359 x x x x 40.2471 50.6531 40.1967 42.1485 38.5775 49.1542 x 37.3207 55.1643 56.8759 31.6166 x 42.9254 x 56.2218 x x x 33.0599 39.9762 47.4703 x 36.6075 63.631 33.3665 x 32.2534 x 44.698 41.7951 x x x x 43.945 25.7568 36.4182 34.3522 42.2595 45.4048 39.8712 x 44.1489 +15982 None Blood Chemistry: AMC Trait 06 contact <c.a.argmann@amc.uva.nl> Blood chemistry, metabolism: Sphingomyelin (d16:1) levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml] x x 5.16169 6.96722 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 6.77745 x 6.70048 x x 6.70078 0.959885 4.27432 7.78848 x x x 5.08258 4.81636 x x x x 1.99641 5.80034 7.16639 5.3921 6.27653 7.75308 x 4.19064 4.99533 7.9513 3.25282 x 5.45714 x 10.3112 x x x 3.09394 4.61661 4.10572 x 4.38115 9.65642 4.12659 x 4.47784 x 5.35528 5.43294 x x x x 8.401 3.3495 3.3872 3.02891 4.31162 7.24557 4.7349 x 4.37445 +15981 None Blood Chemistry: AMC Trait 05 contact <c.a.argmann@amc.uva.nl> Blood chemistry, metabolism: Total sphingomyelin levels in pooled plasma of young adult males on a normal chow diet [nmol/ml] x x 130.496 200.033 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 169.95 275.012 166.428 x x 149.317 107.69 167.33 139.819 x x x 170.747 192.441 x x x 207.979 133.72 178.844 143.845 153.334 198.654 174.342 x 155.229 147.038 150.755 211.905 x 147.502 x 201.456 x x x 108.596 117.469 138.525 x 150.459 169.926 137.557 x 154.335 x 133.952 153.438 x 207.817 x x 187.606 135.993 x 139.947 136.123 191.973 155.252 x 160.332 +15980 None Blood Chemistry: AMC Trait 04 contact <c.a.argmann@amc.uva.nl> Blood chemistry, metabolism: Sphingomyelin (d18:1) levels in pooled plasma of young adult males on a normal chow diet [nmol/ml] x x 98.8667 135.635 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 130.723 x 123.311 x x 114.585 86.2414 118.624 100.572 x x x 124.168 142.986 x x x 161.967 106.502 130.826 104.928 113.051 147.822 123.33 x 115.161 102.722 117.543 152.685 x 104.439 x 140.82 x x x 73.9013 85.7081 106.815 x 102.075 123.266 104.75 x 107.097 x 99.8944 111.77 x 158.245 x x 137.706 106.327 x 98.1681 103.214 145.575 117.178 x 114.105 +15979 None Blood Chemistry: AMC Trait 03 contact <c.a.argmann@amc.uva.nl> Blood chemistry, metabolism: Sphingomyelin (d16:0) levels in pooled plasma of young adult males on a normal chow diet [nmol/ml] x x 7.23526 14.08 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 9.05345 13.3682 8.41062 x x 8.45901 4.24063 11.7893 7.50615 x x x 9.9686 9.40388 x x x 12.9876 7.53178 10.2157 10.587 9.37767 14.1416 12.0628 x 8.18091 10.5243 6.95301 13.9747 x 11.0258 x 12.6216 x x x 9.31586 8.54172 6.99506 x 11.2566 9.07188 7.70672 x 13.282 x 4.66825 8.09724 x 12.9248 x x 13.6989 5.89396 x 9.11979 6.04789 8.67687 8.99341 x 11.2527 +15978 None Blood Chemistry: AMC Trait 02 contact <c.a.argmann@amc.uva.nl> Blood chemistry, metabolism: Sphingomyelin (d18:2) levels in pooled plasma of young adult males on a normal chow diet [nmol/ml] x x 23.3064 48.4583 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 28.9196 45.1203 33.421 x x 25.23 16.5164 35.5091 30.5538 x x x 35.1135 38.6335 x x x 31.7206 17.182 36.2703 26.6925 29.5627 34.9038 37.6086 x 30.4926 32.2449 25.1958 43.3493 x 30.5416 x 46.4304 x x x 24.4657 22.1925 23.6356 x 35.8174 36.2587 24.0508 x 32.1698 x 28.3696 32.5965 x 35.3705 x x 34.1986 22.9219 x 31.5308 25.7975 36.3645 27.6077 x 33.3637 +15977 None Blood Chemistry: AMC Trait 01 contact <c.a.argmann@amc.uva.nl> Blood chemistry, metabolism: Sphingomyelin (d16:1) levels in pooled plasma of young adult males on a normal chow diet [nmol/ml] x x 1.08748 1.85997 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 1.25399 x 1.28458 x x 1.04338 0.6918 1.40723 1.18697 x x x 1.49661 1.41731 x x x 1.30325 2.50426 1.53187 1.63754 1.34245 1.78674 1.34121 x 1.39429 1.54675 1.06304 1.89571 x 1.49549 x 1.58408 x x x 0.912691 1.02695 1.08001 x 1.31054 1.32935 1.04984 x 1.78629 x 1.01944 0.974135 x 1.27681 x x 2.00293 0.850016 x 1.12812 1.06389 1.35703 1.47322 x 1.6105 +16013 None Blood Chemistry: AMC Trait 187 contact <c.a.argmann@amc.uva.nl> Blood chemistry, metabolism: Ratio of lysoGb3(noSmase)/GlcCer levels in pooled plasma of young adult males on a normal chow diet x x 0.174384 0.561992 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.0709488 0.0580671 0.0946918 x x 0.702587 0.228155 0.0958177 0.216872 x x x 0.495532 0.838606 x x x 0.0 0.491722 0.470944 0.390218 0.620084 0.143928 0.371877 x 0.417929 0.0668908 0.248708 0.0801843 x 0.108463 x 0.240273 x x x 0.375709 0.0388332 0.0649372 x 0.473813 0.975 0.405648 x 0.233167 x 0.552901 0.308856 x 0.273142 x x 0.32158 0.359978 x 0.125495 0.161323 0.429529 0.267329 x 0.10194 +16014 None Blood Chemistry: AMC Trait 188 contact <c.a.argmann@amc.uva.nl> Blood chemistry, metabolism: Ratio of lysoGb3(noSmase)/GlcCer levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks x x 0.155579 0.641535 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.609671 x 0.143832 x x 0.315941 0.110511 0.518537 0.273651 x x x 0.0805414 0.319009 x x x x 0.594284 0.851012 0.574442 0.562624 0.466976 0.0992512 x 0.24736 0.0405188 0.211481 0.0775784 x 0.313076 x 0.198636 x x x 0.0673157 0.0557339 0.0366888 x 0.563639 0.360396 0.124221 x 0.323058 x 0.0939066 0.16828 x x x x 0.274961 0.292443 0.0685705 0.0968433 0.173099 0.18252 0.317911 x 0.1504 +16015 None Blood Chemistry: AMC Trait 189 contact <c.a.argmann@amc.uva.nl> Blood chemistry, metabolism: Ratio of lysoGlcCer(noSmase)/GlcCer levels in pooled plasma of young adult males on a normal chow diet x x 0.231714 0.204101 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.233045 0.128715 0.0205564 x x 0.287798 0.0 0.0 0.0 x x x 0.170536 0.0 x x x 0.710306 0.0 0.0 0.0 0.256515 0.0903127 0.0 x 1.76238 0.0 0.0343004 0.0425794 x 0.165146 x 0.0 x x x 0.176734 0.0 0.171372 x 0.372345 0.393673 0.0253009 x 0.0911622 x 0.105347 0.343592 x 0.0 x x 0.239062 0.045674 x 0.0 0.0 0.190499 0.401386 x 0.0 +16016 None Blood Chemistry: AMC Trait 190 contact <c.a.argmann@amc.uva.nl> Blood chemistry, metabolism: Ratio of lysoGlcCer(noSmase)/GlcCer levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks x x 0.0677173 0.22675 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.0 x 0.127397 x x 0.0 0.429492 0.171341 0.165855 x x x 0.0658437 0.0433741 x x x x 0.395181 0.0 0.218151 0.0 0.132452 0.0 x 0.0730166 0.0857487 0.26995 0.0950397 x 0.0854082 x 0.00708147 x x x 0.0 0.0655101 0.0156119 x 0.0 0.112274 0.0627133 x 0.00538965 x 0.0281719 0.172616 x x x x 0.0 0.0 0.0 0.111865 0.0 0.0 0.139957 x 0.180144 +16017 None Blood Chemistry: AMC Trait 33 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: Phenylalanine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml] x x 86.0 73.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 70.0 85.0 87.0 x x 67.0 69.0 72.0 64.0 x x x 74.0 71.0 x x x 72.0 74.0 69.0 84.0 73.0 84.0 73.0 x 87.0 109.0 84.0 83.0 x 119.0 x 79.0 x x x 98.0 84.0 74.0 x 88.0 75.0 96.0 x 114.0 x 70.0 74.0 x 70.0 x x 58.0 64.0 x 62.0 66.0 74.0 74.0 x 73.0 +16018 None Blood Chemistry: AMC Trait 34 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: Tyrosine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml] x x 79.0 87.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 56.0 62.0 83.0 x x 65.0 83.0 58.0 80.0 x x x 80.0 72.0 x x x 67.0 65.0 73.0 92.0 79.0 74.0 57.0 x 64.0 92.0 60.0 59.0 x 61.0 x 62.0 x x x 71.0 59.0 47.0 x 66.0 61.0 70.0 x 72.0 x 71.0 75.0 x 56.0 x x 54.0 52.0 x 61.0 63.0 56.0 75.0 x 64.0 +16019 None Blood Chemistry: AMC Trait 35 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: Tryptophan levels in pooled plasma of young adult males on a normal chow diet [nmol/ml] x x 75.0 65.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 57.0 96.0 70.0 x x 75.0 71.0 79.0 77.0 x x x 75.0 66.0 x x x 97.0 80.0 76.0 60.0 66.0 84.0 75.0 x 54.0 64.0 63.0 73.0 x 78.0 x 68.0 x x x 69.0 71.0 51.0 x 82.0 49.0 70.0 x 67.0 x 79.0 72.0 x 83.0 x x 49.0 65.0 x 82.0 61.0 78.0 65.0 x 76.0 +16020 None Blood Chemistry: AMC Trait 36 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: Alanine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml] x x 750.0 549.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 355.0 571.0 633.0 x x 425.0 653.0 512.0 542.0 x x x 480.0 518.0 x x x 711.0 514.0 491.0 935.0 704.0 762.0 465.0 x 739.0 964.0 452.0 847.0 x 583.0 x 801.0 x x x 858.0 573.0 683.0 x 658.0 862.0 775.0 x 863.0 x 529.0 595.0 x 487.0 x x 690.0 414.0 x 565.0 563.0 333.0 578.0 x 518.0 +16021 None Blood Chemistry: AMC Trait 37 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: Methionine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml] x x 89.0 72.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 60.0 53.0 74.0 x x 54.0 69.0 62.0 74.0 x x x 73.0 74.0 x x x 67.0 58.0 55.0 83.0 68.0 52.0 34.0 x 54.0 56.0 36.0 45.0 x 54.0 x 48.0 x x x 53.0 41.0 40.0 x 54.0 52.0 55.0 x 79.0 x 56.0 49.0 x 39.0 x x 48.0 39.0 x 45.0 51.0 40.0 60.0 x 49.0 +16022 None Blood Chemistry: AMC Trait 38 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: Glycine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml] x x 187.0 147.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 195.0 101.0 184.0 x x 147.0 171.0 118.0 174.0 x x x 196.0 151.0 x x x 193.0 124.0 84.0 228.0 151.0 387.0 233.0 x 246.0 319.0 241.0 407.0 x 301.0 x 347.0 x x x 298.0 237.0 244.0 x 216.0 267.0 299.0 x 385.0 x 254.0 302.0 x 271.0 x x 253.0 178.0 x 244.0 214.0 242.0 236.0 x 255.0 +16023 None Blood Chemistry: AMC Trait 39 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: Valine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml] x x 230.0 211.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 212.0 212.0 240.0 x x 185.0 194.0 198.0 201.0 x x x 199.0 231.0 x x x 207.0 176.0 188.0 201.0 173.0 217.0 179.0 x 191.0 247.0 209.0 187.0 x 280.0 x 212.0 x x x 250.0 196.0 187.0 x 198.0 203.0 235.0 x 251.0 x 216.0 230.0 x 218.0 x x 183.0 200.0 x 189.0 201.0 231.0 238.0 x 264.0 +16024 None Blood Chemistry: AMC Trait 40 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: Leucine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml] x x 191.0 151.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 170.0 171.0 201.0 x x 156.0 152.0 169.0 162.0 x x x 168.0 190.0 x x x 165.0 158.0 159.0 176.0 139.0 188.0 170.0 x 175.0 215.0 182.0 148.0 x x x 168.0 x x x 215.0 175.0 153.0 x 160.0 166.0 204.0 x 225.0 x 158.0 196.0 x 194.0 x x 142.0 158.0 x 146.0 173.0 196.0 193.0 x 230.0 +16025 None Blood Chemistry: AMC Trait 41 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: Isoleucine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml] x x 156.0 145.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 161.0 177.0 184.0 x x 149.0 152.0 163.0 151.0 x x x 151.0 183.0 x x x 168.0 135.0 151.0 159.0 126.0 126.0 123.0 x 120.0 141.0 128.0 112.0 x 202.0 x 130.0 x x x 152.0 135.0 116.0 x 133.0 124.0 152.0 x 144.0 x 110.0 134.0 x 129.0 x x 95.0 116.0 x 111.0 117.0 140.0 142.0 x 182.0 +16026 None Blood Chemistry: AMC Trait 42 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: Glutamine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml] x x 662.0 565.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 474.0 558.0 604.0 x x 451.0 541.0 469.0 547.0 x x x 532.0 477.0 x x x 445.0 573.0 443.0 704.0 471.0 582.0 571.0 x 552.0 497.0 431.0 529.0 x 500.0 x 527.0 x x x 465.0 506.0 587.0 x 367.0 441.0 536.0 x 514.0 x 471.0 556.0 x 558.0 x x 437.0 519.0 x 459.0 429.0 530.0 440.0 x 368.0 +16027 None Blood Chemistry: AMC Trait 43 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: Asparagine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml] x x 36.0 24.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 24.0 14.0 24.0 x x 21.0 26.0 24.0 27.0 x x x 26.0 27.0 x x x 31.0 19.0 18.0 39.0 24.0 24.0 14.0 x 22.0 24.0 17.0 19.0 x 18.0 x 25.0 x x x 20.0 21.0 14.0 x 22.0 18.0 18.0 x 23.0 x 24.0 22.0 x 20.0 x x 32.0 21.0 x 24.0 24.0 21.0 27.0 x 24.0 +16028 None Blood Chemistry: AMC Trait 44 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: Citrulline levels in pooled plasma of young adult males on a normal chow diet [nmol/ml] x x 61.0 48.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 30.0 53.0 51.0 x x 44.0 59.0 36.0 32.0 x x x 43.0 35.0 x x x 33.0 50.0 34.0 66.0 55.0 53.0 48.0 x 59.0 42.0 36.0 34.0 x 45.0 x 42.0 x x x 52.0 36.0 36.0 x 46.0 35.0 50.0 x x x 47.0 45.0 x 48.0 x x 39.0 48.0 x 41.0 43.0 37.0 48.0 x 36.0 +16029 None Blood Chemistry: AMC Trait 45 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: Ornithine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml] x x 117.0 90.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 55.0 120.0 109.0 x x 52.0 87.0 48.0 103.0 x x x 89.0 58.0 x x x 124.0 136.0 41.0 88.0 100.0 163.0 144.0 x 154.0 230.0 94.0 199.0 x 150.0 x 94.0 x x x 193.0 132.0 116.0 x 142.0 178.0 154.0 x 243.0 x 104.0 127.0 x 143.0 x x 181.0 95.0 x 121.0 155.0 80.0 149.0 x 152.0 +16030 None Blood Chemistry: AMC Trait 46 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: Lysine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml] x x 296.0 243.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 190.0 195.0 243.0 x x 177.0 244.0 197.0 224.0 x x x 258.0 258.0 x x x 209.0 238.0 182.0 301.0 230.0 241.0 178.0 x 194.0 252.0 171.0 271.0 x 288.0 x 236.0 x x x 264.0 203.0 176.0 x 231.0 242.0 265.0 x 287.0 x 265.0 230.0 x 209.0 x x 257.0 188.0 x 186.0 233.0 166.0 240.0 x 243.0 +16031 None Blood Chemistry: AMC Trait 47 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: Arginine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml] x x 92.0 105.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 63.0 30.0 68.0 x x 68.0 54.0 83.0 47.0 x x x 68.0 80.0 x x x 22.0 42.0 66.0 108.0 66.0 5.0 19.0 x 11.0 14.0 29.0 26.0 x 101.0 x 64.0 x x x 10.0 26.0 7.0 x 18.0 39.0 24.0 x 31.0 x 56.0 47.0 x 9.0 x x 6.0 46.0 x 5.0 34.0 45.0 20.0 x 16.0 +16032 None Blood Chemistry: AMC Trait 48 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: Serine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml] x x 169.0 125.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 119.0 103.0 131.0 x x 108.0 147.0 115.0 128.0 x x x 131.0 148.0 x x x 144.0 103.0 100.0 x 131.0 136.0 98.0 x 140.0 151.0 86.0 161.0 x 120.0 x 134.0 x x x 132.0 98.0 88.0 x 133.0 156.0 142.0 x 155.0 x 129.0 129.0 x 117.0 x x 139.0 97.0 x 131.0 128.0 124.0 142.0 x 123.0 +16033 None Blood Chemistry: AMC Trait 49 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: Proline levels in pooled plasma of young adult males on a normal chow diet [nmol/ml] x x x 75.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 72.0 65.0 79.0 x x 61.0 93.0 58.0 73.0 x x x 61.0 74.0 x x x 72.0 67.0 56.0 104.0 78.0 99.0 54.0 x 105.0 x 71.0 83.0 x 82.0 x 77.0 x x x 86.0 58.0 56.0 x 71.0 71.0 94.0 x x x 87.0 87.0 x 68.0 x x 83.0 63.0 x 75.0 92.0 62.0 99.0 x 74.0 +16034 None Blood Chemistry: AMC Trait 50 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: Glutamate levels in pooled plasma of young adult males on a normal chow diet [nmol/ml] x x 49.0 58.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 31.0 41.0 48.0 x x 27.0 51.0 30.0 74.0 x x x 50.0 38.0 x x x 59.0 47.0 31.0 46.0 30.0 72.0 35.0 x 42.0 60.0 38.0 41.0 x 48.0 x 45.0 x x x 49.0 55.0 52.0 x 35.0 40.0 46.0 x 72.0 x 45.0 41.0 x 67.0 x x 38.0 59.0 x 33.0 49.0 56.0 40.0 x 48.0 +16035 None Blood Chemistry: AMC Trait 51 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: Aspartate levels in pooled plasma of young adult males on a normal chow diet [nmol/ml] x x 15.0 12.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 10.0 27.0 11.0 x x 10.0 14.0 15.0 14.0 x x x 13.0 15.0 x x x 28.0 12.0 13.0 20.0 16.0 24.0 11.0 x 15.0 24.0 10.0 21.0 x 12.0 x 11.0 x x x 16.0 11.0 11.0 x 12.0 14.0 17.0 x 19.0 x 11.0 12.0 x 20.0 x x 14.0 14.0 x 10.0 13.0 15.0 12.0 x 14.0 +16036 None Blood Chemistry: AMC Trait 52 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: C0-carnitine_free carnitine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml] x x 59.2376 69.4798 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 40.5504 x 73.6438 x x 47.5177 54.2582 46.5409 55.9957 x x x 53.2618 53.6643 x x x 61.8974 68.435 49.4491 75.2234 49.3457 62.971 52.524 x 54.4082 67.7503 47.8849 57.074 x 57.7203 x x x x x 53.8184 44.2612 38.076 x 44.4127 58.4286 55.7503 x 52.4179 x 56.8498 56.83 x 59.2726 x x 43.4842 52.4112 x 67.0863 52.3442 49.0809 49.2264 x 46.5937 +16037 None Blood Chemistry: AMC Trait 53 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: C2-carnitine_acetylcarnitine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml] x x 25.6869 38.099 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 50.7096 x 46.5 x x 37.707 34.287 21.8906 39.3744 x x x 42.4185 44.6954 x x x 41.2118 39.2562 42.5583 38.1022 34.9569 31.8307 35.6117 x 25.8681 33.8898 37.0945 35.7493 x 54.0636 x 35.345 x x x 36.9552 36.8733 28.479 x 30.0106 31.6896 42.453 x 25.506 x 31.263 36.4584 x 36.1993 x x 25.3089 33.6983 x 32.615 39.2476 33.6748 30.8656 x 37.4545 +16038 None Blood Chemistry: AMC Trait 54 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: C3-carnitine_propionylcarnitine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml] x x 1.0111 1.23926 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.513217 0.35569 1.17799 x x 0.801992 0.920865 0.517603 0.891594 x x x 0.718422 0.804187 x x x 0.862003 0.920116 0.913295 1.13585 0.831362 0.767327 0.604338 x 0.609514 0.861498 0.705084 1.02412 x 1.04177 x 1.16275 x x x 0.756388 0.818464 0.436337 x 0.706718 0.711361 0.757618 x 0.606191 x 0.764695 0.766239 x 0.669429 x x 0.599696 0.595128 x 0.642084 1.05996 0.579247 0.847644 x 0.791438 +16039 None Blood Chemistry: AMC Trait 55 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: C4-carnitine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml] x x 0.625631 0.908038 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.710315 0.339409 0.950612 x x 0.475166 0.542004 0.366578 0.713857 x x x 0.562021 0.708624 x x x 0.579219 0.653529 0.558812 0.901365 0.416209 0.689425 0.460233 x 0.527825 0.733512 0.579434 0.51623 x 0.918553 x 0.675517 x x x 0.626094 0.618148 0.288087 x 0.468853 0.452073 0.515643 x 0.635957 x 0.562348 0.464417 x 0.408932 x x 0.320844 0.5287 x 0.480629 0.48314 0.459512 0.495002 x 0.608389 +16040 None Blood Chemistry: AMC Trait 56 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: C5-carnitine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml] x x 0.13798 0.201298 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.133324 0.0575821 0.175231 x x 0.0927413 0.134488 0.0599981 0.13073 x x x 0.0959635 0.136256 x x x 0.127 0.193499 0.135985 0.204038 0.103531 0.12014 0.0923092 x 0.0950895 0.17774 0.122688 0.136514 x 0.208474 x 0.215635 x x x 0.149438 0.131663 0.0531473 x 0.0943484 0.0892563 0.166992 x 0.14356 x 0.126925 0.15662 x 0.0848122 x x 0.0791336 0.0859795 x 0.0911961 0.104707 0.0829709 0.11837 x 0.0910037 +16041 None Blood Chemistry: AMC Trait 57 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: C4hydroxy-carnitine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml] x x 0.181332 0.234818 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.570621 0.155218 0.479179 x x 0.446694 0.445088 0.190805 0.472492 x x x 0.560745 0.551887 x x x 0.286363 0.345965 0.517129 0.357659 0.282824 0.24658 0.3894 x 0.159091 0.257989 0.501821 0.375264 x x x 0.461847 x x x 0.295152 0.496979 0.249319 x 0.284684 0.275779 0.483621 x 0.194359 x 0.309843 0.57942 x 0.297606 x x 0.20372 0.416176 x 0.284042 0.284669 0.386333 0.271938 x 0.490368 +16042 None Blood Chemistry: AMC Trait 58 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: C6-carnitine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml] x x 0.0479489 0.168154 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.213177 0.0289184 0.100847 x x 0.0693108 0.0855967 0.0496767 0.100517 x x x 0.0900533 0.159158 x x x 0.0619366 0.106929 0.0994334 0.0824717 0.0584567 0.0594947 0.0572769 x 0.0403708 0.0429981 0.0797469 0.099357 x 0.115603 x 0.0780349 x x x 0.0830841 0.0837578 0.0490691 x 0.0847708 0.0959621 0.0691614 x 0.0526463 x 0.0853916 0.090194 x 0.0845947 x x 0.0425243 0.0650707 x 0.0787591 0.071737 0.055301 0.0510094 x 0.0987516 +16043 None Blood Chemistry: AMC Trait 59 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: C5hydroxy-carnitine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml] x x 0.0878644 0.0980409 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.0963722 0.0 0.124171 x x 0.0 0.074765 0.0546858 0.116701 x x x 0.0927526 0.0839052 x x x 0.0953569 0.122979 0.0814434 0.136179 0.0670168 0.090386 0.100832 x 0.075652 0.109981 0.102217 0.0877428 x 0.1081 x 0.141726 x x x 0.0855166 0.0975749 0.0 x 0.0 0.0868555 0.113326 x 0.0708311 x 0.0846399 0.0801398 x 0.106188 x x 0.0 0.0733813 x 0.0772489 0.10097 0.0687667 0.10622 x 0.0709472 +16044 None Blood Chemistry: AMC Trait 60 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: C8-carnitine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml] x x 0.0231702 0.0469644 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.0355373 0.0276258 0.0392384 x x 0.0308488 0.0248848 0.0197768 0.0288607 x x x 0.0224547 0.0446965 x x x 0.0238735 0.0254726 0.0273812 0.0359847 0.0255028 0.033211 0.0214373 x 0.0246314 0.0292101 0.0321557 0.0289852 x 0.0382469 x 0.0350051 x x x 0.0280344 0.0263746 0.0239005 x 0.0347802 0.0268263 0.0290377 x 0.0272657 x 0.025981 0.0336114 x 0.0205841 x x 0.025984 0.0299357 x 0.0282566 0.0234227 0.02159 0.020906 x 0.0262019 +16045 None Blood Chemistry: AMC Trait 61 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: C3 dicarboxylylcarnitine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml] x x 0.0068433 0.0590135 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.0275243 0.20921 0.0253876 x x 0.0181887 0.0173493 0.0852996 0.0173498 x x x 0.0220461 0.0214023 x x x 0.0295761 0.074889 0.0664593 0.069462 0.067797 0.215178 0.0199914 x 0.0160963 0.0884412 0.0181902 0.0250495 x 0.0322478 x 0.109726 x x x 0.121639 0.0314844 0.0129527 x 0.0682598 0.0293473 0.0239535 x 0.0571791 x 0.0736304 0.0160051 x 0.203534 x x 0.0344284 0.0248036 x 0.0796194 0.0468902 0.0121659 0.0183953 x 0.0329326 +16046 None Blood Chemistry: AMC Trait 62 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: C10:1-carnitine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml] x x 0.00828746 0.0221405 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.0603748 0.00300191 0.0231658 x x 0.0159938 0.0140166 0.0132655 0.0215886 x x x 0.01199 0.0198788 x x x 0.0103246 0.0116234 0.0252659 0.0208332 0.0164659 0.0117574 0.0158136 x 0.0108945 0.0 0.0147349 0.0172399 x 0.0246159 x 0.0172426 x x x 0.0143863 0.0203059 0.0117888 x 0.0177067 0.0185857 0.0201438 x 0.0122669 x 0.0129239 0.0128864 x 0.014102 x x 0.0117205 0.0109557 x 0.0111199 0.0236842 0.0182568 0.0105737 x 0.0135756 +16047 None Blood Chemistry: AMC Trait 63 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: C10-carnitine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml] x x 0.0150004 0.0252527 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.0299477 0.0179673 0.0235287 x x 0.0213626 0.0180078 0.0158702 0.0263831 x x x 0.0153764 0.0250647 x x x 0.0216692 0.0218127 0.0212238 0.0233017 0.0146897 0.0213138 0.0245704 x 0.0159896 0.0164696 0.0215183 0.0174341 x 0.0256081 x 0.0186071 x x x 0.0153744 0.0176981 0.0160221 x 0.016396 0.0190022 0.0271493 x 0.0160893 x 0.0162066 0.0268656 x 0.0204871 x x 0.0160072 0.0174575 x 0.0149755 0.0194862 0.014073 0.0151407 x 0.0135679 +16048 None Blood Chemistry: AMC Trait 64 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: C4 dicarboxylylcarnitine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml] x x 0.0 0.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.033798 0.045786 0.0507752 x x 0.0481011 0.0 0.0 0.0 x x x 0.0 0.0399091 x x x 0.0436652 0.0408731 0.0 0.0472332 0.0423078 0.046003 0.0385065 x 0.044734 0.0410284 0.0 0.0 x 0.0 x 0.0 x x x 0.0379445 0.0340322 0.0 x 0.0432447 0.0 0.0 x 0.0403284 x 0.0 0.0 x 0.0495571 x x 0.0346079 0.0400426 x 0.0 0.041382 0.0 0.0 x 0.0 +16049 None Blood Chemistry: AMC Trait 65 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: C5 dicarboxylylcarnitine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml] x x 0.0159964 0.0175068 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.0210882 0.0208941 0.0214302 x x 0.0168328 0.0134341 0.0173862 0.0152265 x x x 0.0160401 0.0167666 x x x 0.0263861 0.0119756 0.0130236 0.0207719 0.0138674 0.0231699 0.015395 x 0.0163972 0.0142509 0.0197908 0.0142611 x 0.0234861 x 0.0228792 x x x 0.0185639 0.0231828 0.0091307 x 0.0142589 0.0145395 0.0254415 x 0.0125118 x 0.0132184 0.0126195 x 0.0207071 x x 0.00940179 0.0239234 x 0.0119705 0.0186245 0.0109988 0.0153053 x 0.0205419 +16050 None Blood Chemistry: AMC Trait 66 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: C12:1-carnitine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml] x x 0.00825853 0.0210746 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.00762712 0.0148737 x x 0.0192674 0.0128811 0.0126128 0.0146123 x x x 0.00847982 0.0257926 x x x 0.0100502 0.0187129 0.0230105 0.0212396 0.0147969 0.0233865 0.0181346 x 0.0101344 0.0119767 0.0141991 0.0150945 x 0.0244774 x 0.0187046 x x x 0.0168442 0.0153012 0.00922831 x 0.021932 0.0129789 0.0166717 x 0.00747797 x 0.00910212 0.0117427 x 0.0161397 x x 0.0102545 0.0143823 x 0.0090881 0.0228621 0.00895254 x x 0.016345 +16051 None Blood Chemistry: AMC Trait 67 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: C12-carnitine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml] x x 0.0190409 0.0519005 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.0791146 0.0163854 0.0442606 x x 0.0360178 0.0260645 0.0354555 0.0358749 x x x 0.0284169 0.0642503 x x x 0.0250054 0.0367363 0.054416 0.0324575 0.0406457 0.028407 0.0351429 x 0.0235309 0.0283433 0.0301498 0.0410238 x 0.0616966 x 0.0414538 x x x 0.0394444 0.0333463 0.0173453 x 0.0313531 0.0356107 0.0318209 x 0.0222992 x 0.0232672 0.0306986 x 0.037139 x x 0.0217356 0.0336766 x 0.0289575 0.033004 0.0277609 0.0302324 x 0.0303774 +16052 None Blood Chemistry: AMC Trait 68 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: C6 dicarboxylylcarnitine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml] x x 0.0114477 0.0147402 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.0421493 0.015274 0.0116122 x x 0.0242716 0.0103521 0.00931162 0.0201175 x x x 0.0162956 0.0157774 x x x 0.0142435 0.0137068 0.0247426 0.0121534 0.012402 0.00992882 0.0180357 x 0.00678769 0.00554004 0.0224904 0.0118379 x 0.0223854 x 0.0194437 x x x 0.013224 0.019179 0.00828972 x 0.0175209 0.0130001 0.0138609 x 0.00867788 x 0.0138145 0.00914249 x 0.0104958 x x 0.00627459 0.0142487 x 0.0111436 0.0180042 0.00917635 0.0107829 x 0.010692 +16053 None Blood Chemistry: AMC Trait 69 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: C12:1hydroxy-carnitine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml] x x 0.0 0.0103106 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.0170952 0.00626644 0.0143371 x x 0.00696908 0.00499244 0.00636939 0.00886445 x x x 0.00543745 0.00895374 x x x 0.00976722 0.0106417 0.00702698 0.0103821 0.0114318 0.00575278 0.00640913 x 0.00802837 0.00529491 0.0 0.00881286 x 0.0125376 x 0.00594274 x x x 0.0102557 0.0130613 0.0 x 0.0 0.00907392 0.00954144 x 0.00831821 x 0.0 0.00739558 x 0.0 x x 0.00633219 0.00859795 x 0.00614038 0.00772036 0.00283284 0.00626132 x 0.00776565 +16054 None Blood Chemistry: AMC Trait 70 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: C12hydroxy-carnitine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml] x x 0.02688 0.0233953 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.0274769 x 0.0264356 x x 0.0270133 0.0351705 0.0262653 0.033054 x x x 0.0281104 0.0198715 x x x 0.0387602 0.0218454 0.0225683 0.0266607 0.0183994 0.0338847 0.0405841 x 0.0202293 0.0473849 0.0400899 0.0297955 x 0.0329768 x 0.0493645 x x x 0.0389026 0.0300354 0.0315069 x 0.0259028 0.0215515 0.0414037 x 0.0277784 x 0.0213388 0.0374011 x 0.0334404 x x 0.0288935 0.0380699 x 0.0337851 0.0337588 0.033636 0.0373378 x 0.0267872 +16055 None Blood Chemistry: AMC Trait 71 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: C14:2-carnitine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml] x x 0.038885 0.0652938 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.0832848 0.0187849 0.0519736 x x 0.0491348 0.0448148 0.0452188 0.0496418 x x x 0.0327734 0.0541387 x x x 0.0303111 0.0601183 0.0608963 0.0523908 0.0447205 0.0383262 0.0330165 x 0.0232863 0.0372196 0.0425188 0.0438832 x 0.0642125 x 0.0522253 x x x 0.0410267 0.0353878 0.0307455 x 0.0567085 0.0412127 0.0425103 x 0.0289145 x 0.0341645 0.0448751 x 0.0487749 x x 0.0324416 0.0286138 x 0.0302006 0.0488467 0.0327005 0.0291845 x 0.0344792 +16056 None Blood Chemistry: AMC Trait 72 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: C14:1-carnitine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml] x x 0.0273196 0.168399 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.208993 0.0654487 0.0948342 x x 0.135224 0.108013 0.157093 0.109221 x x x 0.0717206 0.175414 x x x 0.0943377 0.148124 0.194085 0.101697 0.101159 0.0994792 0.0847762 x 0.056666 0.0657063 0.127652 0.0812967 x 0.16489 x 0.107987 x x x 0.129558 0.104888 0.0714909 x 0.15508 0.0667959 0.0903455 x 0.0558504 x 0.0852575 0.117087 x 0.136122 x x 0.0608269 0.118673 x 0.0879547 0.112397 0.0879332 0.0419615 x 0.087456 +16057 None Blood Chemistry: AMC Trait 73 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: C14-carnitine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml] x x 0.0382878 0.177661 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.397966 0.0923823 0.115682 x x 0.165699 0.125969 0.194894 0.185986 x x x 0.132908 0.288217 x x x 0.096796 0.204121 0.265337 0.133905 0.210588 0.102294 0.110149 x 0.0793787 0.0708785 0.188393 0.131547 x 0.248353 x 0.127167 x x x 0.168622 0.154407 0.106545 x 0.151394 0.120925 0.126792 x 0.0696905 x 0.131665 0.162052 x 0.126992 x x 0.101646 0.106725 x 0.139506 0.183469 0.100495 0.08834 x 0.109409 +16058 None Blood Chemistry: AMC Trait 74 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: C8 dicarboxylylcarnitine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml] x x 0.0048975 0.00739361 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.0364598 0.0 0.0 x x 0.00672765 0.00961047 0.00725249 0.0135569 x x x 0.00736867 0.0148203 x x x 0.0 0.00811773 0.0179141 0.0105406 0.017237 0.0 0.00609904 x 0.00750012 0.0 0.0149898 0.0106267 x 0.013462 x 0.0 x x x 0.00747805 0.00827841 0.00481546 x 0.013682 0.00573499 0.0 x 0.00872135 x 0.00628316 0.0107139 x 0.0 x x 0.00717857 0.0 x 0.00679659 0.00961119 0.00492584 0.0 x 0.00593553 +16059 None Blood Chemistry: AMC Trait 75 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: C14:1hydroxy-carnitine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml] x x 0.00311308 0.0242965 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.0450172 0.0122681 0.0187047 x x 0.0261727 0.0281709 0.023203 0.0189815 x x x 0.0201408 0.0378213 x x x 0.0135047 0.0232397 0.0455276 0.0155181 0.0181859 0.0207208 0.015804 x 0.0191 0.0151222 0.0329514 0.0214969 x 0.0333232 x 0.0146047 x x x 0.020268 0.0260605 0.0191545 x 0.0269097 0.0152051 0.024847 x 0.00973023 x 0.0152954 0.0304406 x 0.0241219 x x 0.0274208 0.0180862 x 0.0264424 0.0185634 0.0159941 0.0153183 x 0.0211907 +16060 None Blood Chemistry: AMC Trait 76 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: C14hydroxy-carnitine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml] x x 0.0 0.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.0262382 0.0108916 0.00617837 x x 0.0111265 0.0 0.0109794 0.0107033 x x x 0.0132108 0.0211518 x x x 0.00433736 0.00944373 0.0143949 0.00434215 0.0124315 0.0140144 0.00588494 x 0.0116331 0.0 0.0101583 0.0081175 x 0.0163474 x 0.00401679 x x x 0.00881486 0.00676316 0.00292909 x 0.010433 0.00920462 0.0126305 x 0.0 x 0.00750235 0.00959974 x 0.00934502 x x 0.00645807 0.0 x 0.0 0.00886658 0.0 0.0 x 0.00653262 +16061 None Blood Chemistry: AMC Trait 77 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: C16:2-carnitine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml] x x 0.0115215 0.0384594 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.117928 0.0226904 0.0330089 x x 0.0450714 0.0381535 0.0476978 0.0431231 x x x 0.0186285 0.0424885 x x x 0.0175778 0.0340326 0.0570782 0.0286158 0.044085 0.0281647 0.0293073 x 0.0122168 0.0144574 0.0443958 0.0330692 x 0.06685 x 0.0276111 x x x 0.0302891 0.0333966 0.0217455 x 0.0548653 0.021888 0.0328426 x 0.0136149 x 0.02022 0.0346784 x 0.0200131 x x 0.0163201 0.0330765 x 0.0198149 0.0544665 0.0332247 0.0190294 x 0.0391745 +16062 None Blood Chemistry: AMC Trait 78 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: C16:1-carnitine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml] x x 0.0339409 0.153856 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.279953 0.152057 0.110064 x x 0.163304 0.144204 0.200878 0.129278 x x x 0.138068 0.237583 x x x 0.115299 0.160414 0.236894 0.117411 0.16114 0.124713 0.121793 x 0.0600775 0.0589565 0.166061 0.124525 x 0.171617 x 0.118176 x x x 0.152231 0.138949 0.108455 x 0.187142 0.116181 0.115996 x 0.0687012 x 0.122859 0.201744 x 0.151868 x x 0.097202 0.139312 x 0.125015 0.136025 0.136895 0.0723158 x 0.120925 +16063 None Blood Chemistry: AMC Trait 79 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: C16-carnitine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml] x x 0.164655 0.433687 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.923322 0.343845 0.395524 x x 0.532749 0.467034 0.604343 0.620955 x x x 0.471139 0.826962 x x x 0.342607 0.583904 0.816932 0.343351 0.643341 0.326195 0.383878 x 0.253392 0.251061 0.634176 0.508491 x 0.703284 x 0.387394 x x x 0.424205 0.475622 0.409182 x 0.46867 0.445001 0.450997 x 0.270828 x 0.505116 0.620551 x 0.451971 x x 0.361671 0.374668 x 0.395815 0.615549 0.428489 0.335813 x 0.41655 +16064 None Blood Chemistry: AMC Trait 80 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: C10 dicarboxylylcarnitine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml] x x 0.0 0.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.0461238 0.0 0.0270271 x x 0.0 0.0 0.0457982 0.0 x x x 0.026119 0.0 x x x 0.0317202 0.0 0.0 0.0 0.0367462 0.0 0.0 x 0.0 0.0 0.0408677 0.0383779 x 0.0405632 x 0.0276311 x x x 0.0 0.0 0.0 x 0.0 0.0266568 0.0 x 0.0242717 x 0.0381743 0.0419006 x 0.0 x x 0.033633 0.0 x 0.0349925 0.0308763 0.0 0.0242633 x 0.0351879 +16065 None Blood Chemistry: AMC Trait 81 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: C16:1hydroxy-carnitine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml] x x 0.00564921 0.0201745 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.0503561 0.027924 0.0173211 x x 0.0219176 0.025752 0.0284268 0.0187991 x x x 0.0146697 0.0317101 x x x 0.0135356 0.025864 0.036262 0.0229161 0.0268305 0.0122966 0.0106487 x 0.0105362 0.0108064 0.0244094 0.0227608 x 0.033633 x 0.0187404 x x x 0.0205526 0.0151962 0.0118818 x 0.0214832 0.0215884 0.0257237 x 0.00829332 x 0.0148337 0.0245913 x 0.0205721 x x 0.0145047 0.0193173 x 0.017873 0.0245975 0.0171613 0.00884711 x 0.0217488 +16066 None Blood Chemistry: AMC Trait 82 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: C16hydroxy-carnitine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml] x x 0.0 0.0148206 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.0081915 0.0153133 x x 0.0143274 0.0152763 0.0213605 0.0184618 x x x 0.0113782 0.0343959 x x x 0.0128773 0.0188967 0.0372937 0.00927673 0.0181946 0.0102876 0.00881567 x 0.00929138 0.00682867 0.0290845 0.0192498 x 0.0378902 x 0.0118276 x x x 0.0246946 0.0206633 0.0104727 x 0.0167939 0.0176602 0.0167054 x 0.00292279 x 0.0117387 0.0188712 x 0.0182987 x x 0.0078414 0.0109621 x 0.0164915 0.0201826 0.0148665 0.00836608 x 0.0138555 +16067 None Blood Chemistry: AMC Trait 83 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: C18:2-carnitine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml] x x 0.072501 0.192204 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.468672 0.11379 0.215239 x x 0.258181 0.241425 0.238394 0.230659 x x x 0.166803 0.268228 x x x 0.138853 0.21715 0.305735 0.157036 0.280319 0.12151 0.174191 x 0.0919779 0.0924801 0.234275 0.216279 x 0.349695 x 0.192498 x x x 0.210924 0.206633 0.192818 x 0.2889 0.141898 0.202932 x 0.129292 x 0.180142 0.217561 x 0.162769 x x 0.113371 0.183668 x 0.139796 0.245598 0.209793 0.144006 x 0.201276 +16068 None Blood Chemistry: AMC Trait 84 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: C18:1-carnitine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml] x x 0.151307 0.366809 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.754708 0.797765 0.406655 x x 0.529203 0.502015 0.512024 0.447642 x x x 0.461442 0.625835 x x x 0.425816 0.476807 0.730254 0.357893 0.54697 0.394326 0.38632 x 0.206799 0.212297 0.598895 0.374323 x 0.570522 x 0.365817 x x x 0.44089 0.456583 0.418182 x 0.554226 0.333064 0.437279 x 0.222833 x 0.372681 0.516794 x 0.481879 x x 0.329144 0.442197 x 0.413399 0.491761 0.463702 0.301728 x 0.416993 +16069 None Blood Chemistry: AMC Trait 85 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: C18-carnitine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml] x x 0.0523911 0.0992051 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.128065 0.147105 0.113913 x x 0.0901332 0.0953605 0.103051 0.121164 x x x 0.0948328 0.183603 x x x 0.0873848 0.1253 0.160243 0.0759315 0.11944 0.0707224 0.0837902 x 0.053476 0.0531419 0.141469 0.116941 x 0.122406 x 0.0831629 x x x 0.0767043 0.101395 0.0774636 x 0.103816 0.103781 0.116402 x 0.0769583 x 0.0884038 0.11848 x 0.0906179 x x 0.0829999 0.0884755 x 0.0936644 0.119552 0.0980223 0.0681005 x 0.0697735 +16070 None Blood Chemistry: AMC Trait 86 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: C18:2hydroxy-carnitine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml] x x 0.0 0.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.0416635 0.010617 0.0169154 x x 0.0109636 0.0228679 0.0172954 0.018088 x x x 0.0103907 0.0222613 x x x 0.00735509 0.0128812 0.0228988 0.0172749 0.0105947 0.00465174 0.010536 x 0.00571994 0.00914321 0.0210291 0.0112072 x 0.0256938 x 0.0 x x x 0.0203465 0.0163839 0.0179909 x 0.0137078 0.00912139 0.0169814 x 0.00516092 x 0.00981504 0.0183639 x 0.0107519 x x 0.00875952 0.0107811 x 0.0118445 0.0159653 0.0108705 0.00764605 x 0.0136694 +16071 None Blood Chemistry: AMC Trait 87 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: C18:1hydroxy-carnitine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml] x x 0.00493 0.0156172 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.058508 0.0395056 0.0235109 x x 0.0285781 0.0292036 0.0246182 0.026275 x x x 0.0251583 0.0393448 x x x 0.0251375 0.0227223 0.0370237 0.0229747 0.0270917 0.018508 0.0189779 x 0.0128205 0.0139503 0.0433009 0.0255322 x 0.0361997 x 0.0249139 x x x 0.0266281 0.0233968 0.0198182 x 0.0270555 0.0228035 0.0254396 x 0.00618546 x 0.0114737 0.0356931 x 0.0356285 x x 0.0171995 0.0243502 x 0.0215539 0.0193353 0.0157864 0.010387 x 0.0214122 +16072 None Blood Chemistry: AMC Trait 88 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: C18hydroxy-carnitine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml] x x 0.00519081 0.0161359 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.00982455 0.0145304 0.0123172 x x 0.0113373 0.0205327 0.0251026 0.0185074 x x x 0.011645 0.0313226 x x x 0.0116019 0.0211329 0.0271411 0.0118094 0.0106904 0.0135874 0.0102167 x 0.00869966 0.0145476 0.0187177 0.0120686 x 0.0191443 x 0.0242246 x x x 0.0344997 0.00397109 0.00812636 x 0.0156452 0.0113352 0.011697 x 0.00886828 x 0.00927641 0.0340716 x 0.0130532 x x 0.0198659 0.0104281 x 0.0181242 0.0177162 0.0131158 0.00838625 x 0.0118445 +16073 None Blood Chemistry: AMC Trait 89 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: Total amino acid levels in pooled plasma of young adult males on a normal chow diet [nmol/ml] x x 3488.0 2845.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 2404.0 2734.0 3124.0 x x 2342.0 2930.0 2506.0 2794.0 x x x 2767.0 2766.0 x x x 2914.0 2671.0 2330.0 3693.0 2780.0 3373.0 2581.0 x 3024.0 3632.0 2438.0 3345.0 x 3320.0 x 3170.0 x x x 3351.0 2717.0 2738.0 x 2732.0 3093.0 3302.0 x 3779.0 x 2782.0 3023.0 x 2806.0 x x 2798.0 2436.0 x 2590.0 2709.0 2526.0 2878.0 x 2809.0 +16074 None Blood Chemistry: AMC Trait 90 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: Total branched chain amino acid levels in pooled plasma of young adult males on a normal chow diet [nmol/ml] x x 577.0 507.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 543.0 560.0 625.0 x x 490.0 498.0 530.0 514.0 x x x 518.0 604.0 x x x 540.0 469.0 498.0 536.0 438.0 531.0 472.0 x 486.0 603.0 519.0 447.0 x 760.0 x 510.0 x x x 617.0 506.0 456.0 x 491.0 493.0 591.0 x 620.0 x 484.0 560.0 x 541.0 x x 420.0 474.0 x 446.0 491.0 567.0 573.0 x 676.0 +16075 None Blood Chemistry: AMC Trait 91 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: Ratio of BCAA/Total AA levels in pooled plasma of young adult males on a normal chow diet x x 0.165424 0.178207 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.225874 0.204828 0.200064 x x 0.209223 0.169966 0.211492 0.183966 x x x 0.187206 0.218366 x x x 0.185312 0.17559 0.213734 0.145139 0.157554 0.157427 0.182875 x 0.160714 0.166024 0.212879 0.133632 x 0.228916 x 0.160883 x x x 0.184124 0.186235 0.166545 x 0.179722 0.159392 0.178982 x 0.164065 x 0.173976 0.185246 x 0.192801 x x 0.150107 0.194581 x 0.172201 0.181248 0.224466 0.199097 x 0.240655 +16076 None Blood Chemistry: AMC Trait 92 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: Ratio of BCAA/Gln levels in pooled plasma of young adult males on a normal chow diet x x 0.871601 0.897345 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 1.14557 1.00358 1.03477 x x 1.08647 0.920518 1.13006 0.939671 x x x 0.973684 1.26625 x x x 1.21348 0.818499 1.12415 0.761364 0.929936 0.912371 0.82662 x 0.880435 1.21328 1.20418 0.844991 x 1.52 x 0.967742 x x x 1.32688 1.0 0.776831 x 1.33787 1.11791 1.10261 x 1.20623 x 1.0276 1.00719 x 0.969534 x x 0.961098 0.913295 x 0.971678 1.14452 1.06981 1.30227 x 1.83696 +16077 None Blood Chemistry: AMC Trait 93 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: Ratio of BCAA/Ala levels in pooled plasma of young adult males on a normal chow diet x x 0.769333 0.923497 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 1.52958 0.980736 0.987362 x x 1.15294 0.762634 1.03516 0.948339 x x x 1.07917 1.16602 x x x 0.759494 0.912451 1.01426 0.573262 0.622159 0.69685 1.01505 x 0.657645 0.625519 1.14823 0.527745 x 1.3036 x 0.636704 x x x 0.719114 0.883072 0.667643 x 0.746201 0.571926 0.762581 x 0.718424 x 0.914934 0.941176 x 1.11088 x x 0.608696 1.14493 x 0.789381 0.872114 1.7027 0.991349 x 1.30502 +16078 None Blood Chemistry: AMC Trait 94 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: Ratio of BCAA/C3 levels in pooled plasma of young adult males on a normal chow diet x x 570.664 409.117 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 1058.03 1574.41 530.564 x x 610.979 540.796 1023.95 576.496 x x x 721.024 751.069 x x x 626.448 509.718 545.278 471.894 526.846 692.013 781.02 x 797.356 699.943 736.083 436.473 x 729.528 x 438.617 x x x 815.719 618.231 1045.06 x 694.76 693.037 780.076 x 1022.78 x 632.932 730.843 x 808.151 x x 700.355 796.468 x 694.613 463.224 978.856 675.991 x 854.141 +16079 None Blood Chemistry: AMC Trait 95 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: Ratio of Val/C3 levels in pooled plasma of young adult males on a normal chow diet x x 227.474 170.264 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 413.08 x 203.737 x x 230.676 210.672 382.533 225.439 x x x 276.996 287.246 x x x 240.138 191.28 205.848 176.96 208.092 282.8 296.192 x 313.364 286.71 296.419 182.596 x 268.774 x 182.327 x x x 330.518 239.473 428.568 x 280.168 285.368 310.183 x 414.061 x 282.466 300.168 x 325.651 x x 305.155 336.062 x 294.354 189.629 398.793 280.778 x 333.57 +16080 None Blood Chemistry: AMC Trait 96 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: Ratio of Ile/C3 levels in pooled plasma of young adult males on a normal chow diet x x 154.287 117.006 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 313.707 x 156.198 x x 185.788 165.062 314.913 169.36 x x x 210.183 227.559 x x x 194.895 146.721 165.335 139.983 151.559 164.206 203.528 x 196.878 163.668 181.539 109.362 x 193.901 x 111.804 x x x 200.955 164.943 265.85 x 188.194 174.314 200.629 x 237.549 x 143.848 174.88 x 192.702 x x 158.414 194.916 x 172.874 110.381 241.693 167.523 x 229.961 +16081 None Blood Chemistry: AMC Trait 97 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: Ratio of C0/C2 levels in pooled plasma of young adult males on a normal chow diet x x 2.30614 1.82367 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.79966 2.20312 1.58374 x x 1.26018 1.58247 2.12607 1.42213 x x x 1.25563 1.20067 x x x 1.50193 1.74329 1.16191 1.97425 1.41162 1.97831 1.47491 x 2.10329 1.99914 1.29089 1.59651 x 1.06764 x 2.65102 x x x 1.45631 1.20036 1.33698 x 1.4799 1.84378 1.31322 x 2.05512 x 1.81844 1.55876 x 1.6374 x x 1.71814 1.55531 x 2.05692 1.33369 1.4575 1.59487 x 1.24401 +16082 None Blood Chemistry: AMC Trait 98 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: Ratio of C18/C18:1 levels in pooled plasma of young adult males on a normal chow diet x x 0.346257 0.270455 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.169689 0.184396 0.280123 x x 0.170319 0.189956 0.201261 0.270672 x x x 0.205514 0.293373 x x x 0.205217 0.262791 0.219435 0.212163 0.218367 0.17935 0.216894 x 0.258589 0.250318 0.236216 0.312406 x 0.214552 x 0.227335 x x x 0.173976 0.222073 0.185239 x 0.187316 0.311594 0.266196 x 0.345363 x 0.23721 0.229259 x 0.188051 x x 0.252169 0.200082 x 0.226572 0.243109 0.211391 0.225702 x 0.167325 +16083 None Blood Chemistry: AMC Trait 99 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: Ratio of C18:2/C18:1 levels in pooled plasma of young adult males on a normal chow diet x x 0.479164 0.52399 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.620998 x 0.529291 x x 0.487867 0.480912 0.465591 0.515275 x x x 0.361481 0.428592 x x x 0.326087 0.455426 0.418669 0.438778 0.512494 0.308147 0.450899 x 0.444769 0.435616 0.391178 0.577789 x 0.612938 x 0.526215 x x x 0.478406 0.452563 0.461087 x 0.521268 0.426037 0.46408 x 0.58022 x 0.483368 0.420982 x 0.33778 x x 0.344441 0.415353 x 0.338163 0.499426 0.452432 0.477273 x 0.482685 +16084 None Blood Chemistry: AMC Trait 100 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: Ratio of C16:2/C16:1 levels in pooled plasma of young adult males on a normal chow diet x x 0.339457 0.24997 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.421243 0.149223 0.299905 x x 0.275998 0.264581 0.237447 0.333568 x x x 0.134923 0.178836 x x x 0.152453 0.212154 0.240944 0.243724 0.273582 0.225837 0.240632 x 0.20335 0.245222 0.267347 0.265564 x 0.389531 x 0.233643 x x x 0.198968 0.240352 0.200503 x 0.293175 0.188395 0.283135 x 0.198175 x 0.164579 0.171893 x 0.131779 x x 0.167899 0.237427 x 0.158501 0.400415 0.242702 0.263143 x 0.323956 +16085 None Blood Chemistry: AMC Trait 101 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: Ratio of C16/C16:1 levels in pooled plasma of young adult males on a normal chow diet x x 4.85123 2.81878 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 3.29813 2.26129 3.59357 x x 3.26232 3.23871 3.00851 4.80324 x x x 3.41237 3.48073 x x x 2.97145 3.63998 3.44851 2.92436 3.99244 2.61556 3.15189 x 4.21776 4.25841 3.81894 4.08346 x 4.09799 x 3.27811 x x x 2.78659 3.423 3.77284 x 2.50435 3.83023 3.88803 x 3.94212 x 4.11134 3.07594 x 2.97607 x x 3.72082 2.68941 x 3.16615 4.52526 3.13006 4.6437 x 3.44469 +16086 None Blood Chemistry: AMC Trait 102 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: Ratio of C14/C14:1 levels in pooled plasma of young adult males on a normal chow diet x x 1.40148 1.05501 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 1.9042 1.41152 1.21983 x x 1.22537 1.16624 1.24063 1.70284 x x x 1.85314 1.64307 x x x 1.02606 1.37804 1.36711 1.3167 2.08176 1.02829 1.29929 x 1.40082 1.07872 1.47583 1.6181 x 1.50617 x 1.17761 x x x 1.30152 1.47211 1.49034 x 0.97623 1.81037 1.40341 x 1.24781 x 1.54432 1.38403 x 0.932923 x x 1.67107 0.899314 x 1.58612 1.63233 1.14286 2.10526 x 1.25101 +16087 None Blood Chemistry: AMC Trait 103 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: Ratio of C14:2/C14:1 levels in pooled plasma of young adult males on a normal chow diet x x 1.42334 0.387734 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.398504 0.287016 0.548047 x x 0.363359 0.414901 0.287848 0.454507 x x x 0.456959 0.308635 x x x 0.321304 0.405864 0.313761 0.515163 0.442083 0.385268 0.389455 x 0.410939 0.566455 0.333084 0.53979 x 0.389426 x 0.483626 x x x 0.316667 0.337386 0.430061 x 0.365672 0.616995 0.47053 x 0.517713 x 0.400722 0.383263 x 0.358316 x x 0.533344 0.241114 x 0.343366 0.43459 0.371879 0.695506 x 0.394246 +16088 None Blood Chemistry: AMC Trait 104 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: Total long chain amino acid levels in pooled plasma of young adult males on a normal chow diet [nmol/ml] x x 0.579288 1.65711 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 3.24496 1.73118 1.50389 x x 1.92363 1.72883 2.0559 1.89455 x x x 1.56969 2.65998 x x x 1.3314 1.97594 2.77038 1.33962 2.10768 1.27756 1.37791 x 0.825054 0.841741 2.13344 1.59728 x 2.39498 x 1.43443 x x x 1.64416 1.67387 1.41488 x 1.96594 1.36886 1.58325 x 0.923069 x 1.52029 1.99914 x 1.65099 x x 1.1793 1.48233 x 1.42535 1.9532 1.55803 1.08145 x 1.45686 +16089 None Blood Chemistry: AMC Trait 105 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: Ratio of total LCAC/C2 levels in pooled plasma of young adult males on a normal chow diet x x 0.0225519 0.043495 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.0639911 0.160494 0.0323416 x x 0.0510151 0.0504224 0.0939169 0.0481163 x x x 0.0370048 0.0595135 x x x 0.0323064 0.0503344 0.065096 0.0351585 0.0602936 0.0401362 0.0386927 x 0.0318946 0.0248376 0.0575137 0.0446802 x 0.0442993 x 0.0405837 x x x 0.0444906 0.045395 0.0496816 x 0.0655081 0.0431958 0.0372943 x 0.0361903 x 0.048629 0.0548335 x 0.0456085 x x 0.0465963 0.0439884 x 0.0437023 0.049766 0.0462669 0.0350374 x 0.0388969 +16090 None Blood Chemistry: AMC Trait 106 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: Ratio of total LCAC/C0 levels in pooled plasma of young adult males on a normal chow diet x x 0.00977906 0.0238503 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.080023 0.0728484 0.0204211 x x 0.0404823 0.0318631 0.0441739 0.0338338 x x x 0.0294712 0.049567 x x x 0.0215099 0.0288732 0.0560248 0.0178085 0.0427124 0.0202881 0.026234 x 0.0151641 0.0124242 0.0445534 0.0279862 x 0.0414928 x 0.0153087 x x x 0.0305502 0.0378179 0.0371594 x 0.0442652 0.0234279 0.028399 x 0.0176098 x 0.0267422 0.0351776 x 0.0278543 x x 0.0271202 0.0282827 x 0.0212465 0.0373145 0.0317441 0.0219689 x 0.0312674 +16091 None Blood Chemistry: AMC Trait 107 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: Ratio of C14:1/C2 levels in pooled plasma of young adult males on a normal chow diet x x 0.00106356 0.00442003 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.00412138 0.00606761 0.00203944 x x 0.00358617 0.00315026 0.00717628 0.00277391 x x x 0.00169079 0.00392464 x x x 0.00228909 0.00377327 0.00456045 0.00266907 0.00289381 0.00312526 0.00238057 x 0.00219057 0.00193882 0.00344127 0.00227408 x 0.00304993 x 0.00305523 x x x 0.00350581 0.00284456 0.0025103 x 0.00516752 0.00210782 0.00212813 x 0.00218969 x 0.00272711 0.00321152 x 0.00376036 x x 0.00240338 0.00352165 x 0.00269676 0.0028638 0.00261124 0.00135949 x 0.002335 +16092 None Blood Chemistry: AMC Trait 108 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: Phenylalanine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml] x x 77.0 88.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 61.0 x 77.0 x x 67.0 65.0 68.0 62.0 x x x 68.0 72.0 x x x x 79.0 66.0 93.0 72.0 87.0 75.0 x 81.0 85.0 82.0 83.0 x 83.0 x 91.0 x x x 94.0 78.0 66.0 x 79.0 84.0 99.0 x 98.0 x 66.0 64.0 x x x x 60.0 53.0 78.0 68.0 62.0 62.0 59.0 x 73.0 +16093 None Blood Chemistry: AMC Trait 109 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: Tyrosine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml] x x 83.0 104.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 52.0 x 87.0 x x 76.0 73.0 59.0 68.0 x x x 72.0 73.0 x x x x 88.0 62.0 106.0 91.0 82.0 65.0 x 49.0 60.0 74.0 59.0 x 62.0 x 71.0 x x x 53.0 50.0 41.0 x 58.0 59.0 72.0 x 95.0 x 78.0 65.0 x x x x 56.0 50.0 73.0 51.0 69.0 77.0 46.0 x 67.0 +16094 None Blood Chemistry: AMC Trait 110 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: Tryptophan levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml] x x 78.0 90.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 71.0 x 66.0 x x 87.0 74.0 89.0 97.0 x x x 81.0 85.0 x x x x 75.0 68.0 67.0 85.0 90.0 94.0 x 68.0 82.0 74.0 102.0 x 67.0 x 76.0 x x x 76.0 70.0 79.0 x 83.0 70.0 78.0 x 68.0 x 64.0 82.0 x x x x 77.0 57.0 112.0 93.0 86.0 67.0 71.0 x 97.0 +16095 None Blood Chemistry: AMC Trait 111 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: Alanine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml] x x 607.0 574.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 276.0 x 554.0 x x 559.0 808.0 272.0 374.0 x x x 528.0 605.0 x x x x 565.0 715.0 1006.0 781.0 867.0 507.0 x 294.0 512.0 746.0 517.0 x 582.0 x 929.0 x x x 360.0 465.0 317.0 x 810.0 1128.0 1165.0 x 900.0 x 910.0 492.0 x x x x 292.0 592.0 466.0 383.0 546.0 662.0 227.0 x 597.0 +16096 None Blood Chemistry: AMC Trait 112 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: Methionine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml] x x 78.0 74.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 56.0 x 75.0 x x 62.0 71.0 54.0 54.0 x x x 76.0 77.0 x x x x 56.0 57.0 x 72.0 60.0 34.0 x 44.0 42.0 44.0 37.0 x 41.0 x 56.0 x x x 41.0 36.0 31.0 x 46.0 53.0 59.0 x 80.0 x 64.0 44.0 x x x x 49.0 42.0 58.0 41.0 39.0 61.0 35.0 x 50.0 +16097 None Blood Chemistry: AMC Trait 113 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: Glycine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml] x x 164.0 124.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 256.0 x 133.0 x x 141.0 163.0 88.0 144.0 x x x 124.0 187.0 x x x x 142.0 134.0 175.0 146.0 330.0 232.0 x 226.0 270.0 279.0 245.0 x 259.0 x 334.0 x x x 200.0 236.0 201.0 x 224.0 282.0 247.0 x 299.0 x 235.0 245.0 x x x x 181.0 173.0 330.0 195.0 153.0 288.0 146.0 x 213.0 +16098 None Blood Chemistry: AMC Trait 114 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: Valine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml] x x 260.0 279.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 169.0 x 225.0 x x 206.0 213.0 157.0 156.0 x x x 188.0 180.0 x x x x 182.0 143.0 364.0 236.0 270.0 157.0 x 180.0 186.0 236.0 196.0 x 189.0 x 299.0 x x x 239.0 180.0 187.0 x 183.0 241.0 297.0 x 323.0 x 256.0 189.0 x x x x 193.0 187.0 249.0 197.0 204.0 289.0 217.0 x 239.0 +16099 None Blood Chemistry: AMC Trait 115 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: Leucine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml] x x 182.0 178.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 127.0 x 146.0 x x 139.0 161.0 127.0 133.0 x x x 147.0 141.0 x x x x 150.0 133.0 x 174.0 204.0 149.0 x 150.0 188.0 176.0 155.0 x 169.0 x 212.0 x x x 210.0 163.0 150.0 x 162.0 188.0 212.0 x 217.0 x 166.0 156.0 x x x x 133.0 148.0 194.0 155.0 157.0 195.0 177.0 x 198.0 +16100 None Blood Chemistry: AMC Trait 116 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: Isoleucine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml] x x 186.0 180.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 122.0 x 152.0 x x 147.0 166.0 133.0 133.0 x x x 144.0 143.0 x x x x 153.0 126.0 x 183.0 153.0 107.0 x 119.0 135.0 132.0 128.0 x 128.0 x 169.0 x x x 148.0 124.0 129.0 x 129.0 142.0 160.0 x 170.0 x 125.0 110.0 x x x x 100.0 107.0 143.0 117.0 118.0 147.0 140.0 x 151.0 +16101 None Blood Chemistry: AMC Trait 117 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: Glutamine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml] x x 563.0 580.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 442.0 x 536.0 x x 514.0 634.0 477.0 527.0 x x x 619.0 533.0 x x x x 626.0 548.0 544.0 604.0 643.0 647.0 x 489.0 567.0 493.0 442.0 x 504.0 x 575.0 x x x 476.0 485.0 651.0 x 436.0 634.0 600.0 x 521.0 x 457.0 556.0 x x x x 438.0 610.0 507.0 553.0 521.0 541.0 464.0 x 540.0 +16102 None Blood Chemistry: AMC Trait 118 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: Asparagine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml] x x 28.0 22.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 24.0 x 22.0 x x 23.0 29.0 16.0 22.0 x x x 25.0 30.0 x x x x 28.0 25.0 45.0 27.0 27.0 18.0 x 20.0 16.0 24.0 14.0 x 23.0 x 20.0 x x x 16.0 14.0 13.0 x 22.0 26.0 22.0 x 32.0 x 37.0 25.0 x x x x 23.0 30.0 28.0 20.0 21.0 42.0 18.0 x 28.0 +16103 None Blood Chemistry: AMC Trait 119 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: Citrulline levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml] x x 53.0 77.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 44.0 x 56.0 x x 50.0 56.0 44.0 41.0 x x x 53.0 55.0 x x x x 45.0 47.0 78.0 68.0 55.0 54.0 x 58.0 40.0 47.0 37.0 x 41.0 x 67.0 x x x 61.0 41.0 51.0 x 51.0 45.0 65.0 x 77.0 x 51.0 45.0 x x x x 50.0 53.0 57.0 46.0 43.0 48.0 39.0 x 47.0 +16104 None Blood Chemistry: AMC Trait 120 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: Ornithine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml] x x 116.0 97.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 61.0 x 113.0 x x 77.0 113.0 73.0 137.0 x x x 101.0 76.0 x x x x 143.0 111.0 182.0 152.0 155.0 158.0 x 110.0 165.0 114.0 160.0 x 155.0 x 164.0 x x x 150.0 148.0 128.0 x 146.0 219.0 198.0 x 195.0 x 140.0 117.0 x x x x 163.0 164.0 129.0 109.0 180.0 139.0 104.0 x 168.0 +16105 None Blood Chemistry: AMC Trait 121 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: Lysine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml] x x 322.0 349.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 166.0 x 292.0 x x 235.0 331.0 160.0 195.0 x x x 308.0 290.0 x x x x 255.0 197.0 x 269.0 352.0 175.0 x 161.0 211.0 244.0 219.0 x 228.0 x 329.0 x x x 189.0 196.0 143.0 x 205.0 335.0 281.0 x 423.0 x 372.0 201.0 x x x x 231.0 205.0 248.0 142.0 226.0 337.0 125.0 x 243.0 +16106 None Blood Chemistry: AMC Trait 122 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: Arginine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml] x x 56.0 86.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 63.0 x 71.0 x x 75.0 42.0 57.0 15.0 x x x 74.0 89.0 x x x x 17.0 85.0 51.0 43.0 0.0 7.0 x 6.0 7.0 23.0 10.0 x 20.0 x 14.0 x x x 5.0 17.0 6.0 x 10.0 27.0 11.0 x 11.0 x 48.0 25.0 x x x x 0.0 3.0 15.0 0.0 13.0 22.0 0.0 x 9.0 +16107 None Blood Chemistry: AMC Trait 123 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: Serine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml] x x 173.0 146.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 131.0 x 141.0 x x 145.0 183.0 115.0 123.0 x x x 154.0 218.0 x x x x 146.0 213.0 257.0 183.0 175.0 117.0 x 115.0 139.0 145.0 115.0 x 120.0 x 157.0 x x x 105.0 102.0 98.0 x 128.0 218.0 165.0 x 167.0 x 194.0 141.0 x x x x 129.0 143.0 166.0 135.0 147.0 187.0 104.0 x 153.0 +16108 None Blood Chemistry: AMC Trait 124 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: Proline levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml] x x 118.0 122.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 56.0 x 97.0 x x 76.0 109.0 44.0 57.0 x x x 85.0 82.0 x x x x 99.0 65.0 272.0 114.0 166.0 54.0 x 63.0 69.0 119.0 62.0 x 61.0 x 161.0 x x x 54.0 46.0 45.0 x 60.0 80.0 126.0 x 198.0 x 163.0 70.0 x x x x 65.0 67.0 99.0 62.0 72.0 154.0 51.0 x 93.0 +16109 None Blood Chemistry: AMC Trait 125 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: Glutamate levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml] x x 41.0 59.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 25.0 x 46.0 x x 33.0 40.0 28.0 58.0 x x x 48.0 29.0 x x x x 54.0 44.0 67.0 43.0 96.0 47.0 x 25.0 44.0 55.0 37.0 x 49.0 x 80.0 x x x 34.0 60.0 68.0 x 40.0 46.0 58.0 x 77.0 x 48.0 52.0 x x x x 46.0 43.0 61.0 55.0 57.0 57.0 46.0 x 48.0 +16110 None Blood Chemistry: AMC Trait 126 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: Aspartate levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml] x x 14.0 15.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 13.0 x 12.0 x x 14.0 16.0 14.0 18.0 x x x 11.0 15.0 x x x x 16.0 37.0 32.0 18.0 30.0 17.0 x 11.0 15.0 14.0 12.0 x 9.0 x 15.0 x x x 12.0 11.0 14.0 x 17.0 18.0 18.0 x 14.0 x 20.0 15.0 x x x x 14.0 17.0 23.0 14.0 15.0 16.0 12.0 x 19.0 +16111 None Blood Chemistry: AMC Trait 127 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: C0-carnitine_free carnitine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml] x x 46.872 57.5257 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 27.1416 x 50.0711 x x 36.5941 39.7748 21.615 24.038 x x x 32.7922 35.3532 x x x x 50.278 32.6556 42.5969 32.3282 40.9566 27.211 x 25.2389 38.0838 39.8934 28.7475 x 35.6411 x 81.9169 x x x 26.5066 28.9124 26.7508 x 30.5938 46.815 40.8492 x 38.0051 x 37.872 40.3888 x x x x 20.8532 33.9476 26.986 41.5341 36.2204 38.5283 19.6596 x 28.1558 +16112 None Blood Chemistry: AMC Trait 128 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: C2-carnitine_acetylcarnitine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml] x x 17.3025 24.4047 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 24.7517 x 20.2441 x x 16.7096 18.7622 12.6428 12.6229 x x x 14.7462 19.0193 x x x x 22.7033 16.7434 23.1327 14.2398 17.7147 16.272 x 20.5944 18.9705 16.2154 15.3895 x 20.5216 x 27.3201 x x x 20.1531 17.2154 23.5852 x 15.0478 21.4474 20.6076 x 16.8627 x 15.1843 20.9421 x x x x 16.4119 17.8401 19.7173 20.0007 18.018 13.9221 22.1954 x 16.7124 +16113 None Blood Chemistry: AMC Trait 129 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: C3-carnitine_propionylcarnitine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml] x x 0.405511 0.879148 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.248598 x 0.626149 x x 0.457881 0.579887 0.327822 0.302233 x x x 0.336397 0.416305 x x x x 0.639659 0.374409 0.942899 0.354771 0.512022 0.332366 x 0.253181 0.410084 0.494666 0.353916 x 0.623967 x 0.774069 x x x 0.403874 0.369784 0.183379 x 0.380143 0.357855 0.683424 x 0.442632 x 0.391779 0.479294 x x x x 0.418358 0.364984 0.369415 0.321998 0.39909 0.350806 0.272948 x 0.446634 +16114 None Blood Chemistry: AMC Trait 130 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: C4-carnitine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml] x x 0.372031 0.794137 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.393434 x 0.546073 x x 0.279763 0.369191 0.237842 0.254017 x x x 0.331425 0.409835 x x x x 0.449578 0.296809 0.669324 0.263842 0.50119 0.29198 x 0.30704 0.265134 0.510946 0.347923 x 0.39541 x 0.793241 x x x 0.336867 0.364049 0.287883 x 0.254368 0.281744 0.508117 x 0.39418 x 0.263118 0.309814 x x x x 0.246738 0.342948 0.382621 0.44677 0.270075 0.358995 0.335718 x 0.381847 +16115 None Blood Chemistry: AMC Trait 131 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: C5-carnitine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml] x x 0.0966913 0.206512 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.0948345 x 0.130355 x x 0.0809191 0.0718048 0.048825 0.0461324 x x x 0.080648 0.0795418 x x x x 0.137685 0.078702 0.194224 0.0601519 0.0935555 0.0502183 x 0.0685319 0.0695783 0.104346 0.0851591 x 0.0955153 x 0.233525 x x x 0.0925341 0.0661903 0.0467828 x 0.0523397 0.0886092 0.124104 x 0.105236 x 0.0796745 0.0828205 x x x x 0.058763 0.0450505 0.0725834 0.0683329 0.0634835 0.0683021 0.0494519 x 0.0690885 +16116 None Blood Chemistry: AMC Trait 132 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: C4hydroxy-carnitine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml] x x 0.146375 0.232481 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.404046 x 0.14692 x x 0.132956 0.171734 0.142995 0.191983 x x x 0.171715 0.230797 x x x x 0.25459 0.232925 0.253905 0.104176 0.228666 0.272139 x 0.292803 0.275568 0.132979 0.182791 x 0.278936 x 0.32366 x x x 0.261522 0.274719 0.305448 x 0.160743 0.21997 0.178843 x 0.125307 x 0.122866 0.431796 x x x x 0.262523 0.132877 0.294735 0.212722 0.120193 0.0927158 0.510989 x 0.283873 +16117 None Blood Chemistry: AMC Trait 133 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: C6-carnitine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml] x x 0.0453345 0.0737519 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.0790899 x 0.061435 x x 0.0409305 0.044 0.0531482 0.0361763 x x x 0.0493847 0.0675953 x x x x 0.0488558 0.049213 0.0708006 0.0301066 0.0437032 0.0475855 x 0.054148 0.0522503 0.0386254 0.0487127 x 0.0535952 x 0.0617025 x x x 0.0528256 0.0666949 0.0561814 x 0.0472705 0.0391294 0.0261803 x 0.0453055 x 0.037541 0.0553627 x x x x 0.0469374 0.0361101 0.0516414 0.0396023 0.0460617 0.0301192 0.0530131 x 0.0643725 +16118 None Blood Chemistry: AMC Trait 134 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: C5hydroxy-carnitine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml] x x 0.0783035 0.0869953 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.0479234 x 0.0914075 x x 0.048905 0.0590579 0.0289159 0.0 x x x 0.0527579 0.0 x x x x 0.101181 0.0 0.107566 0.0459585 0.0645276 0.0 x 0.0418802 0.0 0.0555376 0.0351886 x 0.0596878 x 0.122736 x x x 0.0 0.0487573 0.0515772 x 0.0 0.0 0.066824 x 0.0721939 x 0.0477383 0.0724562 x x x x 0.0 0.0489307 0.0 0.041441 0.0601543 0.0630882 0.0420093 x 0.0462029 +16119 None Blood Chemistry: AMC Trait 135 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: C8-carnitine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml] x x 0.0260695 0.0294549 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.0275113 x 0.0229005 x x 0.0184049 0.0264498 0.0259364 0.0217613 x x x 0.0295736 0.034082 x x x x 0.028993 0.0273906 0.0302947 0.0232992 0.0244537 0.0251206 x 0.0275788 0.0273648 0.0262438 0.0266591 x 0.0247624 x 0.0320836 x x x 0.0325406 0.0271666 0.029243 x 0.0210695 0.0301064 0.0313126 x 0.0294597 x 0.0262535 0.0211028 x x x x 0.0285637 0.0213848 0.0353797 0.0251627 0.0260115 0.022608 0.0243223 x 0.0219808 +16120 None Blood Chemistry: AMC Trait 136 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: C3 dicarboxylylcarnitine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml] x x 0.0180767 0.0679591 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.01922 x 0.0193325 x x 0.0126619 0.0164355 0.265295 0.0189478 x x x 0.016306 0.02571 x x x x 0.0970497 0.114806 0.0527155 0.0610835 0.187277 0.0239885 x 0.018861 0.0699588 0.0119465 0.0288 x 0.0285353 x 0.105191 x x x 0.13321 0.0235434 0.0243518 x 0.088074 0.0400939 0.0211431 x 0.0472603 x 0.0455862 0.0205491 x x x x 0.101665 0.015582 0.181588 0.155968 0.0796268 0.0142694 0.0267714 x 0.0332202 +16121 None Blood Chemistry: AMC Trait 137 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: C10:1-carnitine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml] x x 0.0110689 0.014787 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.0146581 x 0.00864883 x x 0.0 0.00812614 0.009525 0.0 x x x 0.00977236 0.0164509 x x x x 0.00732106 0.00989558 0.0127585 0.0 0.0091981 0.0185039 x 0.0120528 0.0112503 0.00996268 0.00550909 x 0.0139582 x 0.01087 x x x 0.0092861 0.0105726 0.00722959 x 0.00540173 0.00888489 0.00747452 x 0.00712823 x 0.0077537 0.0134447 x x x x 0.0112394 0.00561056 0.00851446 0.0 0.01301 0.0090556 0.0124766 x 0.00680093 +16122 None Blood Chemistry: AMC Trait 138 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: C10-carnitine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml] x x 0.0182263 0.034031 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.024999 x 0.0224853 x x 0.0172478 0.0177309 0.0169504 0.0199026 x x x 0.0180435 0.0259137 x x x x 0.0179435 0.0216853 0.0203549 0.0136115 0.0216065 0.0231291 x 0.0219731 0.0173376 0.0208421 0.0191327 x 0.0199762 x 0.0273042 x x x 0.0164979 0.0129519 0.0191606 x 0.0162013 0.0216748 0.0323337 x 0.0162764 x 0.0263328 0.0214137 x x x x 0.0216267 0.0202475 0.0257087 0.0176741 0.021623 0.0233405 0.0176475 x 0.0167423 +16123 None Blood Chemistry: AMC Trait 139 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: C4 dicarboxylylcarnitine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml] x x 0.0412428 0.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.0 x 0.0 x x 0.0 0.0 0.04095 0.0 x x x 0.0 0.0 x x x x 0.0403302 0.0404648 0.0457935 0.0550238 0.0470098 0.0 x 0.0426205 0.0 0.0461866 0.0 x 0.0 x 0.0514339 x x x 0.0396687 0.0 0.0433582 x 0.0493968 0.0471011 0.0 x 0.0 x 0.0 0.0452159 x x x x 0.0333205 0.0422889 0.0438646 0.0 0.0364076 0.0506777 0.0441464 x 0.0 +16124 None Blood Chemistry: AMC Trait 140 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: C5 dicarboxylylcarnitine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml] x x 0.0145167 0.0143553 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.0157836 x 0.0112427 x x 0.0213907 0.0210642 0.0128864 0.0180843 x x x 0.0220379 0.0138117 x x x x 0.0173985 0.0247004 0.0247874 0.00998076 0.0228627 0.0220226 x 0.0203278 0.0190842 0.0202574 0.0235909 x 0.0154122 x 0.0168439 x x x 0.0195597 0.0200316 0.0150682 x 0.0254626 0.0168589 0.0235328 x 0.0189441 x 0.0131857 0.0156595 x x x x 0.015456 0.0263924 0.0180037 0.0156394 0.0173779 0.0146589 0.0181823 x 0.0162283 +16125 None Blood Chemistry: AMC Trait 141 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: C12:1-carnitine_ levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml] x x 0.0136871 0.0207479 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.0174751 x 0.0149696 x x 0.0175084 0.0110978 0.0133091 0.0118169 x x x 0.0124099 0.0177338 x x x x 0.025451 0.0230811 0.0183815 0.00868456 0.0215948 0.0147022 x 0.0195459 0.012334 0.0185883 0.00942955 x 0.0157552 x 0.0153901 x x x 0.0179771 0.0145002 0.00545477 x 0.0112812 0.0149573 0.00770531 x 0.0137543 x 0.00829175 0.0187477 x x x x 0.0261177 0.0107579 0.0151163 0.00964259 0.0139977 0.00679834 0.0143016 x 0.0102599 +16126 None Blood Chemistry: AMC Trait 142 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: C12-carnitine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml] x x 0.0313663 0.0317395 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.0500878 x 0.0269807 x x 0.0201896 0.0315167 0.0273068 0.0267092 x x x 0.0180376 0.0365819 x x x x 0.0315327 0.0425382 0.0279993 0.0177823 0.0316796 0.0368931 x 0.0423922 0.0326011 0.0324311 0.0300205 x 0.0342021 x 0.0496376 x x x 0.0357253 0.0252139 0.0323995 x 0.0250076 0.0354757 0.02459 x 0.0210232 x 0.0207846 0.031857 x x x x 0.0421064 0.0242513 0.0383114 0.0319773 0.0302602 0.0229267 0.0344854 x 0.0223709 +16127 None Blood Chemistry: AMC Trait 143 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: C6 dicarboxylylcarnitine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml] x x 0.0124774 0.00788837 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.0279575 x 0.00403695 x x 0.0138375 0.0134161 0.00940227 0.0121273 x x x 0.0105179 0.0 x x x x 0.0132808 0.0122602 0.0138439 0.0 0.00675356 0.0198043 x 0.0290318 0.0131695 0.0118241 0.0110932 x 0.0139657 x 0.0132929 x x x 0.00891989 0.0103796 0.00983451 x 0.0118569 0.00910861 0.0077202 x 0.0114992 x 0.00533989 0.0101381 x x x x 0.0125899 0.010522 0.0212234 0.00967666 0.007296 0.00542628 0.022443 x 0.0116794 +16128 None Blood Chemistry: AMC Trait 144 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: C12:1hydroxy-carnitine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml] x x 0.00698441 0.0114456 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.00957669 x 0.0056867 x x 0.00562467 0.0076569 0.00619023 0.00906834 x x x 0.00399633 0.0117003 x x x x 0.00942053 0.0108552 0.00580893 0.0 0.00644696 0.00978359 x 0.00624917 0.0 0.00922858 0.00702273 x 0.0048988 x 0.010636 x x x 0.0 0.00659675 0.00522993 x 0.00546429 0.0 0.0 x 0.00632377 x 0.0 0.0103955 x x x x 0.00737163 0.00806016 0.00567951 0.00674044 0.00542113 0.00606274 0.00721187 x 0.0052055 +16129 None Blood Chemistry: AMC Trait 145 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: C12hydroxy-carnitine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml] x x 0.0355658 0.0177488 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.0286568 x 0.034099 x x 0.0485413 0.027836 0.0263727 0.0514781 x x x 0.027842 0.0240165 x x x x 0.0279026 0.0429751 0.0327592 0.0223757 0.0289864 0.0339557 x 0.0255516 0.0335111 0.0405236 0.023925 x 0.0319205 x 0.0657963 x x x 0.023333 0.0283991 0.0339406 x 0.0389118 0.0245293 0.0209048 x 0.0377843 x 0.0287005 0.0421043 x x x x 0.0534884 0.0588934 0.0308308 0.0338342 0.0489749 0.0477477 0.0299805 x 0.0466677 +16130 None Blood Chemistry: AMC Trait 146 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: C14:2-carnitine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml] x x 0.0402376 0.0373783 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.0373137 x 0.0423172 x x 0.0289745 0.027848 0.030037 0.0264637 x x x 0.0271084 0.0437747 x x x x 0.0360236 0.0355814 0.0414268 0.0317817 0.0321419 0.0428521 x 0.0382368 0.0398022 0.0333924 0.0227345 x 0.0382923 x 0.055179 x x x 0.0316873 0.0243132 0.0222136 x 0.0208721 0.0259516 0.0216952 x 0.0247313 x 0.0220607 0.0424405 x x x x 0.0329337 0.0205717 0.0354506 0.0221374 0.0188977 0.0235776 0.0310051 x 0.0248977 +16131 None Blood Chemistry: AMC Trait 147 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: C14:1-carnitine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml] x x 0.0846289 0.113224 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.164818 x 0.0766422 x x 0.101916 0.0961015 0.136023 0.0905317 x x x 0.0807144 0.176763 x x x x 0.158564 0.166203 0.0729225 0.0767405 0.123631 0.117153 x 0.147779 0.124171 0.0827377 0.0914945 x 0.13453 x 0.16376 x x x 0.134045 0.0896238 0.132912 x 0.119569 0.0950776 0.0585883 x 0.0734786 x 0.0593219 0.108248 x x x x 0.134139 0.107371 0.138732 0.133387 0.0840868 0.0563591 0.121911 x 0.0967386 +16132 None Blood Chemistry: AMC Trait 148 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: C14-carnitine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml] x x 0.106046 0.112364 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.218971 x 0.0863078 x x 0.0940103 0.10848 0.134017 0.11493 x x x 0.0691552 0.168258 x x x x 0.129994 0.162355 0.0754288 0.0771739 0.104397 0.0908668 x 0.19992 0.129969 0.101588 0.0832473 x 0.121151 x 0.135229 x x x 0.126294 0.0900506 0.139236 x 0.0993821 0.114975 0.0698093 x 0.0710911 x 0.0595927 0.108606 x x x x 0.157322 0.083315 0.127657 0.0994454 0.0986301 0.0653683 0.144077 x 0.0848935 +16133 None Blood Chemistry: AMC Trait 149 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: C8 dicarboxylylcarnitine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml] x x 0.00399242 0.00922992 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.0135871 x 0.0 x x 0.00802732 0.00790487 0.0126414 0.00463115 x x x 0.0 0.00615896 x x x x 0.00800217 0.00327597 0.0055389 0.0 0.0 0.00974856 x 0.0136836 0.0 0.0 0.0 x 0.00597267 x 0.0103435 x x x 0.0 0.0 0.00510728 x 0.0 0.00208739 0.011165 x 0.00490294 x 0.00250845 0.0 x x x x 0.0143298 0.0 0.00970836 0.00600347 0.0 0.0 0.0103142 x 0.00428527 +16134 None Blood Chemistry: AMC Trait 150 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: C14:1hydroxy-carnitine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml] x x 0.018126 0.0166253 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.0343784 x 0.021632 x x 0.0179508 0.027753 0.0326104 0.0206589 x x x 0.016351 0.0349273 x x x x 0.0239821 0.0401666 0.019925 0.0200184 0.0219285 0.0216057 x 0.0382 0.0253296 0.012708 0.0319261 x 0.0292313 x 0.0297697 x x x 0.0248713 0.0157577 0.0223887 x 0.0247725 0.0224413 0.0181011 x 0.011595 x 0.00706682 0.0201378 x x x x 0.0296995 0.0196086 0.0148642 0.0146574 0.0219639 0.0163313 0.0256246 x 0.0314239 +16135 None Blood Chemistry: AMC Trait 151 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: C14hydroxy-carnitine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml] x x 0.00600542 0.00721481 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.0116763 x 0.00877389 x x 0.0 0.0132223 0.00543423 0.0 x x x 0.0 0.029593 x x x x 0.00310995 0.0136917 0.0 0.0 0.0126305 0.0113087 x 0.0107041 0.00836521 0.00879577 0.0163425 x 0.00970686 x 0.0135014 x x x 0.0 0.011816 0.00624764 x 0.0106598 0.00707028 0.0 x 0.00890427 x 0.0 0.00804884 x x x x 0.00784989 0.0 0.0153402 0.00524899 0.00970863 0.00821538 0.0 x 0.00985706 +16136 None Blood Chemistry: AMC Trait 152 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: C16:2-carnitine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml] x x 0.0118227 0.014485 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.0315244 x 0.00759156 x x 0.0124496 0.0123886 0.0146801 0.0185043 x x x 0.00731069 0.0231123 x x x x 0.0231502 0.0251389 0.00951345 0.00887928 0.0168475 0.019847 x 0.0213162 0.0210079 0.0202178 0.0187711 x 0.0200135 x 0.0212749 x x x 0.0199594 0.0151765 0.0211628 x 0.0184332 0.0268714 0.00559464 x 0.00778909 x 0.00769145 0.0130435 x x x x 0.020636 0.0180936 0.0262795 0.0148844 0.00778692 0.00881563 0.021978 x 0.0179134 +16137 None Blood Chemistry: AMC Trait 153 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: C16:1-carnitine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml] x x 0.123713 0.0817125 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.197993 x 0.0762459 x x 0.102087 0.109218 0.147052 0.119923 x x x 0.087062 0.124437 x x x x 0.155119 0.186404 0.0690169 0.0718185 0.14307 0.111952 x 0.180333 0.129336 0.0767364 0.104228 x 0.133146 x 0.128661 x x x 0.152918 0.0939106 0.16288 x 0.128886 0.116008 0.0686237 x 0.0682704 x 0.0523354 0.137413 x x x x 0.202639 0.127802 0.173998 0.157707 0.101153 0.058003 0.20244 x 0.111165 +16138 None Blood Chemistry: AMC Trait 154 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: C16-carnitine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml] x x 0.350652 0.28779 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.624226 x 0.326737 x x 0.350504 0.374508 0.479255 0.467804 x x x 0.298861 0.566991 x x x x 0.34822 0.587857 0.328637 0.335978 0.419439 0.377556 x 0.673696 0.540218 0.30191 0.376181 x 0.464582 x 0.370695 x x x 0.473077 0.38091 0.531453 x 0.411413 0.433715 0.258307 x 0.280758 x 0.244527 0.438271 x x x x 0.656193 0.369339 0.596511 0.431615 0.387962 0.286284 0.556644 x 0.398966 +16139 None Blood Chemistry: AMC Trait 155 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: C10 dicarboxylylcarnitine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml] x x 0.0362631 0.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.0363786 x 0.0 x x 0.0 0.0285339 0.0 0.0 x x x 0.0266885 0.0 x x x x 0.0294357 0.0 0.026504 0.0 0.0286551 0.0 x 0.0361769 0.0401395 0.0 0.0 x 0.0 x 0.038523 x x x 0.0 0.0 0.0 x 0.0331761 0.0 0.0207243 x 0.0250335 x 0.0 0.0372249 x x x x 0.0 0.0 0.032983 0.0447504 0.0266165 0.0 0.0 x 0.0 +16140 None Blood Chemistry: AMC Trait 156 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: C16:1hydroxy-carnitine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml] x x 0.0179021 0.0187751 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.0364193 x 0.020399 x x 0.0213133 0.0208306 0.0335796 0.0281494 x x x 0.0195486 0.0440705 x x x x 0.0185118 0.0370563 0.0180766 0.0223091 0.0216405 0.0214639 x 0.0435704 0.0315066 0.0260455 0.0244547 x 0.0385229 x 0.0229437 x x x 0.0252167 0.0321694 0.0372465 x 0.0264623 0.0227417 0.0191 x 0.0185459 x 0.0156338 0.0241725 x x x x 0.0340499 0.0191108 0.0309428 0.0339411 0.0281709 0.0151848 0.0259195 x 0.0246583 +16141 None Blood Chemistry: AMC Trait 157 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: C16hydroxy-carnitine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml] x x 0.0118115 0.00446113 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.0341832 x 0.0175368 x x 0.00915523 0.0141192 0.0143626 0.0178326 x x x 0.0117502 0.0248041 x x x x 0.0122768 0.0161821 0.00748753 0.00726646 0.0164464 0.00889947 x 0.0211967 0.0223255 0.0 0.0184675 x 0.0154738 x 0.0138674 x x x 0.0141038 0.0118069 0.014488 x 0.0139939 0.0205829 0.00789579 x 0.0106078 x 0.0135307 0.0181964 x x x x 0.0141294 0.0174768 0.0177885 0.0152087 0.0144261 0.0 0.0240068 x 0.0110228 +16142 None Blood Chemistry: AMC Trait 158 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: C18:2-carnitine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml] x x 0.0919621 0.0752439 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.162216 x 0.0720076 x x 0.093723 0.107319 0.12491 0.139923 x x x 0.0812967 0.145053 x x x x 0.133692 0.175074 0.0688498 0.0824984 0.115608 0.13786 x 0.160102 0.139982 0.108338 0.106336 x 0.127887 x 0.131353 x x x 0.127895 0.10817 0.154026 x 0.104041 0.123798 0.0607727 x 0.0787573 x 0.0575257 0.10968 x x x x 0.157036 0.115141 0.167586 0.119443 0.0996522 0.079212 0.130491 x 0.117827 +16143 None Blood Chemistry: AMC Trait 159 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: C18:1-carnitine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml] x x 0.490487 0.321136 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.805387 x 0.399724 x x 0.4584 0.541026 0.73601 0.795305 x x x 0.419226 0.687822 x x x x 0.642913 0.890122 0.345763 0.41275 0.662894 0.578201 x 0.83674 0.706342 0.437889 0.601249 x 0.616459 x 0.523043 x x x 0.710584 0.517598 0.890685 x 0.651099 0.584451 0.322814 x 0.340798 x 0.252019 0.572911 x x x x 0.849673 0.580575 0.820445 0.790158 0.454716 0.38373 0.961703 x 0.53938 +16144 None Blood Chemistry: AMC Trait 160 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: C18-carnitine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml] x x 0.160324 0.166444 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.185715 x 0.173166 x x 0.166739 0.149529 0.158916 0.261468 x x x 0.140983 0.213927 x x x x 0.149069 0.256306 0.168235 0.168918 0.176806 0.186367 x 0.247831 0.233374 0.172226 0.118816 x 0.137944 x 0.197137 x x x 0.14702 0.146679 0.195378 x 0.156472 0.176921 0.112117 x 0.166118 x 0.11265 0.163446 x x x x 0.225059 0.169141 0.190028 0.18819 0.184612 0.146657 0.151227 x 0.146138 +16145 None Blood Chemistry: AMC Trait 161 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: C18:2hydroxy-carnitine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml] x x 0.0 0.00390695 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.0086759 x 0.00663381 x x 0.00799646 0.00765055 0.00630567 0.0195436 x x x 0.00567368 0.0110477 x x x x 0.0112432 0.0175823 0.00748753 0.00621704 0.0091715 0.0055078 x 0.0109064 0.0146728 0.0 0.0103132 x 0.0137391 x 0.00727286 x x x 0.00598781 0.00963628 0.00693263 x 0.00891607 0.0102305 0.00840363 x 0.0 x 0.0120864 0.0125425 x x x x 0.00913022 0.0110704 0.0118428 0.0108741 0.016087 0.00870099 0.0103589 x 0.00400423 +16146 None Blood Chemistry: AMC Trait 162 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: C18:1hydroxy-carnitine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml] x x 0.017096 0.0194535 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.0427534 x 0.0160506 x x 0.0221752 0.0259802 0.0339054 0.0405194 x x x 0.0168473 0.0417685 x x x x 0.0228982 0.0444313 0.0170845 0.0164274 0.0285317 0.0271844 x 0.0585598 0.037304 0.0254486 0.047965 x 0.0356902 x 0.0238589 x x x 0.0281992 0.0252033 0.030309 x 0.0323449 0.0286829 0.0218072 x 0.0129147 x 0.0105068 0.0240383 x x x x 0.0412816 0.0216755 0.0388898 0.0357031 0.0219001 0.017813 0.0499442 x 0.0330685 +16147 None Blood Chemistry: AMC Trait 163 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: C18hydroxy-carnitine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml] x x 0.0154838 0.0116568 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.0199294 x 0.0141791 x x 0.008703 0.0234898 0.0100597 0.011133 x x x 0.00657189 0.0171401 x x x x 0.0126381 0.0121633 0.0 0.0111133 0.00796605 0.00929848 x 0.0163872 0.0197957 0.016897 0.0187543 x 0.00812719 x 0.0152455 x x x 0.00900657 0.00395078 0.021046 x 0.011692 0.015815 0.0118838 x 0.0135896 x 0.0112199 0.00791733 x x x x 0.0214947 0.00874488 0.011425 0.024029 0.0162041 0.0124593 0.0112526 x 0.0089515 +16148 None Blood Chemistry: AMC Trait 164 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: Total amino acid levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml] x x 3199.0 3244.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 2215.0 x 2901.0 x x 2726.0 3347.0 2075.0 2414.0 x x x 2906.0 2980.0 x x x x 2919.0 2876.0 4558.0 3361.0 3842.0 2714.0 x 2269.0 2833.0 3121.0 2630.0 x 2790.0 x 3819.0 x x x 2523.0 2522.0 2418.0 x 2889.0 3895.0 3933.0 x 3965.0 x 3494.0 2694.0 x x x x 2300.0 2744.0 3036.0 2436.0 2729.0 3391.0 2081.0 x 3033.0 +16149 None Blood Chemistry: AMC Trait 165 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: Total branched chain amino acid levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml] x x 628.0 637.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 418.0 x 523.0 x x 492.0 540.0 417.0 422.0 x x x 479.0 464.0 x x x x 485.0 402.0 871.0 593.0 627.0 413.0 x 449.0 509.0 544.0 479.0 x 486.0 x 680.0 x x x 597.0 467.0 466.0 x 474.0 571.0 669.0 x 710.0 x 547.0 455.0 x x x x 426.0 442.0 586.0 469.0 479.0 631.0 534.0 x 588.0 +16150 None Blood Chemistry: AMC Trait 166 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: Ratio of BCAA/Total AA levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks x x 0.196311 0.196363 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.188713 x 0.180283 x x 0.180484 0.161339 0.200964 0.174814 x x x 0.164831 0.155705 x x x x 0.166153 0.139777 0.191093 0.176436 0.163196 0.152174 x 0.197885 0.179668 0.174303 0.182129 x 0.174194 x 0.178057 x x x 0.236623 0.185171 0.192721 x 0.164071 0.146598 0.170099 x 0.179067 x 0.156554 0.168894 x x x x 0.185217 0.161079 0.193017 0.192529 0.175522 0.186081 0.256607 x 0.193867 +16151 None Blood Chemistry: AMC Trait 167 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: Ratio of BCAA/Gln levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks x x 1.11545 1.09828 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.945701 x 0.975746 x x 0.957198 0.851735 0.874214 0.800759 x x x 0.773829 0.870544 x x x x 0.77476 0.733577 1.6011 0.981788 0.975117 0.638331 x 0.9182 0.897707 1.10345 1.08371 x 0.964286 x 1.18261 x x x 1.2542 0.962887 0.715822 x 1.08716 0.900631 1.115 x 1.36276 x 1.19694 0.818345 x x x x 0.972603 0.72459 1.15582 0.848101 0.919386 1.16636 1.15086 x 1.08889 +16152 None Blood Chemistry: AMC Trait 168 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: Ratio of BCAA/Ala levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks x x 1.0346 1.10976 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 1.51449 x 0.944043 x x 0.880143 0.668317 1.53309 1.12834 x x x 0.907197 0.766942 x x x x 0.858407 0.562238 0.865805 0.759283 0.723183 0.814596 x 1.52721 0.994141 0.729223 0.926499 x 0.835052 x 0.73197 x x x 1.65833 1.0043 1.47003 x 0.585185 0.506206 0.574249 x 0.788889 x 0.601099 0.924797 x x x x 1.4589 0.746622 1.25751 1.22454 0.877289 0.953172 2.35242 x 0.984925 +16153 None Blood Chemistry: AMC Trait 169 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: Ratio of BCAA/C3 levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks x x 1548.66 724.565 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 1681.43 x 835.264 x x 1074.52 931.216 1272.03 1396.27 x x x 1423.91 1114.57 x x x x 758.216 1073.69 923.747 1671.5 1224.56 1242.6 x 1773.43 1241.21 1099.73 1353.43 x 778.887 x 878.475 x x x 1478.18 1262.9 2541.18 x 1246.9 1595.62 978.895 x 1604.04 x 1396.2 949.314 x x x x 1018.27 1211.01 1586.29 1456.53 1200.23 1798.72 1956.42 x 1316.51 +16154 None Blood Chemistry: AMC Trait 170 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: Ratio of Val/C3 levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks x x 641.166 317.353 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 679.812 x 359.339 x x 449.899 367.313 478.918 516.158 x x x 558.863 432.376 x x x x 284.526 381.935 386.043 665.219 527.321 472.37 x 710.954 453.566 477.09 553.803 x 302.901 x 386.271 x x x 591.768 486.771 1019.74 x 481.398 673.457 434.577 x 729.726 x 653.43 394.33 x x x x 461.328 512.351 674.038 611.806 511.163 823.818 795.023 x 535.114 +16155 None Blood Chemistry: AMC Trait 171 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: Ratio of Ile/C3 levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks x x 458.68 204.744 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 490.752 x 242.754 x x 321.044 286.263 405.708 440.058 x x x 428.065 343.498 x x x x 239.19 336.53 274.685 515.826 298.815 321.934 x 470.019 329.201 266.847 361.667 x 205.139 x 218.327 x x x 366.45 335.331 703.46 x 339.346 396.809 234.115 x 384.066 x 319.058 229.504 x x x x 239.03 293.164 387.098 363.357 295.673 419.035 512.918 x 338.084 +16156 None Blood Chemistry: AMC Trait 172 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: Ratio of C0/C2 levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks x x 2.70897 2.35716 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 1.09655 x 2.47337 x x 2.19001 2.11995 1.70967 1.90431 x x x 2.22378 1.85881 x x x x 2.21457 1.95036 1.84142 2.27026 2.31201 1.67226 x 1.22552 2.00753 2.46022 1.86799 x 1.73676 x 2.99841 x x x 1.31527 1.67945 1.13422 x 2.03311 2.18278 1.98224 x 2.25379 x 2.49415 1.92859 x x x x 1.27061 1.90288 1.36865 2.07664 2.01024 2.76741 0.885751 x 1.68472 +16157 None Blood Chemistry: AMC Trait 173 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: Ratio of C18/C18:1 levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks x x 0.326866 0.518298 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.230591 x 0.433214 x x 0.363742 0.27638 0.215916 0.328765 x x x 0.336293 0.311022 x x x x 0.231865 0.287944 0.48656 0.40925 0.266718 0.322322 x 0.296186 0.330398 0.393309 0.197616 x 0.223769 x 0.376904 x x x 0.206901 0.283383 0.219358 x 0.24032 0.302714 0.347311 x 0.487437 x 0.446991 0.28529 x x x x 0.264878 0.291333 0.231616 0.238167 0.405994 0.382187 0.157249 x 0.270938 +16158 None Blood Chemistry: AMC Trait 174 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: Ratio of C18:2/C18:1 levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks x x 0.187491 0.234305 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.201413 x 0.180143 x x 0.204457 0.198362 0.169713 0.175936 x x x 0.193921 0.210887 x x x x 0.207947 0.196686 0.199124 0.199875 0.174399 0.23843 x 0.19134 0.198179 0.24741 0.176858 x 0.207454 x 0.251132 x x x 0.179986 0.208984 0.17293 x 0.159792 0.211819 0.188259 x 0.231097 x 0.228259 0.191443 x x x x 0.184819 0.198322 0.204263 0.151163 0.219152 0.206426 0.135688 x 0.218448 +16159 None Blood Chemistry: AMC Trait 175 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: Ratio of C16:2/C16:1 levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks x x 0.0955656 0.177268 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.15922 x 0.0995668 x x 0.121951 0.11343 0.0998295 0.154301 x x x 0.0839711 0.185736 x x x x 0.149242 0.134862 0.137842 0.123635 0.117757 0.17728 x 0.118205 0.162429 0.263471 0.180097 x 0.150312 x 0.165356 x x x 0.130523 0.161605 0.129928 x 0.143019 0.231634 0.0815263 x 0.114092 x 0.146964 0.0949219 x x x x 0.101836 0.141575 0.151033 0.0943797 0.0769814 0.151986 0.108565 x 0.161142 +16160 None Blood Chemistry: AMC Trait 176 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: Ratio of C16/C16:1 levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks x x 2.83439 3.52198 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 3.15277 x 4.2853 x x 3.4334 3.42899 3.25909 3.90087 x x x 3.43274 4.55646 x x x x 2.24485 3.15367 4.76169 4.67816 2.9317 3.37247 x 3.73585 4.17685 3.93438 3.60922 x 3.48926 x 2.88117 x x x 3.09366 4.05609 3.26284 x 3.19206 3.73867 3.76411 x 4.11244 x 4.6723 3.18945 x x x x 3.23823 2.88992 3.42825 2.73681 3.83539 4.93567 2.74967 x 3.58895 +16161 None Blood Chemistry: AMC Trait 177 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: Ratio of C14/C14:1 levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks x x 1.25308 0.992405 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 1.32856 x 1.12611 x x 0.922426 1.1288 0.985258 1.26949 x x x 0.856788 0.951883 x x x x 0.81982 0.976849 1.03437 1.00565 0.844426 0.775626 x 1.35283 1.04669 1.22783 0.909862 x 0.900549 x 0.825773 x x x 0.942175 1.00476 1.04758 x 0.831169 1.20928 1.19152 x 0.967508 x 1.00456 1.00331 x x x x 1.17283 0.775952 0.920168 0.745543 1.17296 1.15985 1.18182 x 0.877555 +16162 None Blood Chemistry: AMC Trait 178 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: Ratio of C14:2/C14:1 levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks x x 0.47546 0.330127 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.226394 x 0.55214 x x 0.284297 0.289777 0.220823 0.292314 x x x 0.335856 0.247646 x x x x 0.227186 0.214084 0.568094 0.414145 0.259983 0.365779 x 0.258743 0.320543 0.403594 0.248479 x 0.284636 x 0.336949 x x x 0.236392 0.271281 0.16713 x 0.174561 0.272952 0.3703 x 0.336578 x 0.371881 0.392066 x x x x 0.245519 0.191594 0.255532 0.165964 0.22474 0.418346 0.254326 x 0.25737 +16163 None Blood Chemistry: AMC Trait 179 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: Ratio of total long chain amino acid levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks x x 1.44805 1.19529 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 2.39664 x 1.25315 x x 1.39635 1.51403 1.94622 2.01635 x x x 1.20441 2.12702 x x x x 1.7536 2.4599 1.17028 1.25766 1.77799 1.64281 x 2.48464 2.04319 1.31482 1.50429 x 1.77399 x 1.70506 x x x 1.90352 1.45125 2.22878 x 1.69173 1.6709 0.972728 x 1.104 x 0.860033 1.68101 x x x x 2.415 1.57326 2.25041 1.94208 1.42971 1.09919 2.2995 x 1.52001 +16164 None Blood Chemistry: AMC Trait 180 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: Ratio of total LCAC/C2 levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks x x 0.0836901 0.0489779 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.0968271 x 0.0619018 x x 0.083566 0.0806959 0.153939 0.159737 x x x 0.0816759 0.111835 x x x x 0.0772396 0.146918 0.0505899 0.0883197 0.100368 0.100959 x 0.120646 0.107704 0.0810848 0.0977474 x 0.0864452 x 0.0624104 x x x 0.0944532 0.0842997 0.0944992 x 0.112424 0.0779068 0.0472023 x 0.06547 x 0.0566395 0.0802696 x x x x 0.147149 0.0881863 0.114134 0.0971008 0.0793491 0.0789527 0.103602 x 0.0909507 +16165 None Blood Chemistry: AMC Trait 181 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: Ratio of total LCAC/C0 levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks x x 0.0308937 0.0207784 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.0883012 x 0.0250273 x x 0.0381579 0.038065 0.0900404 0.0838818 x x x 0.0367284 0.060165 x x x x 0.034878 0.0753286 0.0274734 0.0389029 0.0434115 0.0603729 x 0.0984447 0.05365 0.0329583 0.0523276 x 0.0497738 x 0.0208145 x x x 0.071813 0.0501949 0.0833166 x 0.0552967 0.0356915 0.0238126 x 0.0290488 x 0.0227089 0.0416208 x x x x 0.115809 0.0463436 0.0833916 0.0467587 0.0394725 0.0285295 0.116966 x 0.0539856 +16166 None Blood Chemistry: AMC Trait 182 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: Ratio of C14:1/C2 levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks x x 0.00489113 0.00463944 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.00665884 x 0.0037859 x x 0.00609927 0.00512209 0.0107589 0.007172 x x x 0.00547358 0.00929387 x x x x 0.0069842 0.0099265 0.00315236 0.00538914 0.00697898 0.00719967 x 0.00717568 0.00654549 0.00510243 0.00594524 x 0.00655556 x 0.00599414 x x x 0.00665137 0.00520602 0.00563539 x 0.00794596 0.00443306 0.00284304 x 0.00435745 x 0.00390679 0.00516893 x x x x 0.00817327 0.00601852 0.00703607 0.0066691 0.00466683 0.00404816 0.00549262 x 0.00578843 +16167 None Blood Chemistry: AMC Trait 194 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: Ratio of a-NH2-adipate/Lys levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks x x 0.010559 0.0017192 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.00301205 x 0.00239726 x x 0.00808511 0.00453172 0.01125 0.00307692 x x x 0.0012987 0.00586207 x x x x 0.00196078 0.00203046 0.00582192 0.00185874 0.00511364 0.0125714 x 0.00745342 0.0042654 0.00163934 0.00319635 x 0.00614035 x 0.0012158 x x x 0.00634921 0.00153061 0.0020979 x 0.00146341 0.00507463 0.00569395 x 0.00851064 x 0.00430107 0.00696517 x x x x 0.00562771 0.00780488 0.00443548 0.00140845 0.00486726 0.00237389 0.0088 x 0.00164609 +16168 None Blood Chemistry: AMC Trait 198 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: Ratio of Kynurenine/Trp levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks x x 0.0051282 0.00333333 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.0084507 x 0.00454545 x x 0.00574713 0.00540541 0.00898876 0.00206186 x x x 0.00493827 0.00588235 x x x x 0.00533333 0.00735294 0.00447761 0.00705882 0.00444444 0.00531915 x x 0.00731707 0.0027027 0.00490196 x 0.00895522 x 0.00526316 x x x 0.00657895 x 0.00506329 x 0.00481928 0.00571429 0.00897436 x 0.00588235 x 0.0078125 0.00609756 x x x x 0.00909091 0.00350877 0.00625 0.00645161 0.0104651 0.00597015 0.00704225 x x +16169 None Blood Chemistry: AMC Trait 199 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: Kynurenine levels in pooled plasma of young adult males on a normal chow diet [nmol/ml] x x 0.5 0.2 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.6 0.4 0.4 x x 0.6 0.7 0.8 0.4 x x x 0.4 0.1 x x x 0.5 0.4 0.6 0.7 1.1 0.5 0.5 x 1.0 0.3 0.7 0.8 x 1.4 x 0.5 x x x 0.4 1.3 0.4 x 0.6 x 0.8 x 0.6 x 0.5 0.6 x 0.6 x x 0.7 0.7 x 0.6 0.8 0.5 0.5 x 1.9 +16170 None Blood Chemistry: AMC Trait 195 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: Anthranilic acid levels in pooled plasma of young adult males on a normal chow diet [nmol/ml] x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 11.3 5.1 3.4 221.3 x 6.0 9.3 9.8 7.7 x 11.7 x 6.0 x x x 14.1 7.8 27.5 x 4.8 3.5 50.1 x 4.0 x 4.5 30.0 x 3.5 x x 6.5 3.8 x 3.4 3.9 5.6 3.5 x 3.6 +16171 None Blood Chemistry: AMC Trait 191 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: a-NH2-adipate levels in pooled plasma of young adult males on a normal chow diet [nmol/ml] x x 2.8 0.4 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.6 1.3 0.4 x x 1.6 1.7 1.4 0.6 x x x 0.4 1.6 x x x 0.4 0.4 0.5 3.0 0.6 1.2 2.1 x 1.3 1.0 0.3 1.0 x 1.3 x 0.3 x x x 1.4 0.3 0.4 x 0.3 1.3 1.0 x 1.4 x 1.6 1.2 x 0.7 x x 2.9 1.5 x 0.2 1.6 0.4 1.5 x 0.3 +16172 None Blood Chemistry: AMC Trait 200 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: Kynurenine levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml] x x 0.4 0.3 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.6 x 0.3 x x 0.5 0.4 0.8 0.2 x x x 0.4 0.5 x x x x 0.4 0.5 0.3 0.6 0.4 0.5 x 1.0 0.6 0.2 0.5 x 0.6 x 0.4 x x x 0.5 x 0.4 x 0.4 0.4 0.7 x 0.4 x 0.5 0.5 x x x x 0.7 0.2 0.7 0.6 0.9 0.4 0.5 x x +16173 None Blood Chemistry: AMC Trait 196 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: Anthranilic acid levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml] x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 4.1 x x 8.3 8.9 7.7 x x 6.6 x 5.5 x x x 4.2 6.8 4.4 x 4.6 3.7 4.1 x 6.2 x 4.2 3.6 x x x x 3.2 3.1 4.1 4.4 3.4 3.2 3.2 x 3.3 +16174 None Blood Chemistry: AMC Trait 193 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: a-NH2-adipate levels in pooled plasma of young adult males on a high fat diet (60% kCal/fat) for 20 weeks [nmol/ml] x x 3.4 0.6 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.5 x 0.7 x x 1.9 1.5 1.8 0.6 x x x 0.4 1.7 x x x x 0.5 0.4 3.4 0.5 1.8 2.2 x 1.2 0.9 0.4 0.7 x 1.4 x 0.4 x x x 1.2 0.3 0.3 x 0.3 1.7 1.6 x 3.6 x 1.6 1.4 x x x x 1.3 1.6 1.1 0.2 1.1 0.8 1.1 x 0.4 +16175 None Blood Chemistry: AMC Trait 192 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: Ratio of a-NH2-adipate/Lys levels in pooled plasma of young adult males on a normal chow diet x x 0.00945946 0.00164609 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.0031579 0.00666667 0.00164609 x x 0.00903955 0.00696721 0.0071066 0.00267857 x x x 0.00155039 0.00620155 x x x 0.00191388 0.00168067 0.00274725 0.00996678 0.0026087 0.00497925 0.0117978 x 0.00670103 0.00396825 0.00175439 0.00369004 x 0.00451389 x 0.00127119 x x x 0.00530303 0.00147783 0.00227273 x 0.0012987 0.0053719 0.00377358 x 0.00487805 x 0.00603774 0.00521739 x 0.00334928 x x 0.011284 0.00797872 x 0.00107527 0.00686695 0.00240964 0.00625 x 0.00123457 +16176 None Blood Chemistry: AMC Trait 197 contact <s.m.houten@amc.uva.nl> Blood chemistry, metabolism: Ratio of Kynurenine/Trp levels in pooled plasma of young adult males on a normal chow diet x x 0.00666667 0.00307692 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.0105263 0.00416667 0.00571429 x x 0.008 0.00985915 0.0101266 0.00519481 x x x 0.00533333 0.00151515 x x x 0.00515464 0.005 0.00789474 0.0116667 0.0166667 0.00595238 0.00666667 x 0.0185185 0.0046875 0.0111111 0.0109589 x 0.0179487 x 0.00735294 x x x 0.0057971 0.0183099 0.00784314 x 0.00731707 0.283673 0.0114286 x 0.00895522 x 0.00632911 0.00833333 x 0.00722892 x x 0.0142857 0.0107692 x 0.00731707 0.0131148 0.00641026 0.00769231 x 0.025 +16177 Original post publication description: un-named trait Original pre publication description: CA1 Apoptosis; Post-natal CA1 Apoptosis; Post-natal CA1 Apoptosis; Post-natal x x 3.031 2.416 5.796 4.627 x x x x x x x x x x x x 1.958 x x x x x x x x x x x 2.384 x x x x x x 2.512 x x x x x x x x x x x 3.152 x x x x x x x x 2.082 x x x x x x x x x x 1.996 x 3.364 x x x x x x 2.531 x x x x x x x x x x x x x x x 5.871 x x x 5.831 x x 3.722 +16178 Original post publication description: Central nervous system; embryonic neurogenesis; Cell death in brainstem following exposure to maltose dextrin at E9 (TUNEL+ cells/mm2) None Central nervous system; embryonic neurogenesis; Cell death in brainstem following exposure to maltose dextrin at E9 (TUNEL+ cells/mm2) x x 563.251 422.833 x 839.028 x x x x x x x x x x x x 1326.91 x x x x x x x x x x x 241.722 x x x x x x 201.027 x x x x x x x x x x x 532.259 x x x x x x x x 718.987 x x x x x x x x x x x x 158.266 x x x x x x 458.418 x x x x x x x x x x x x x x x 368.717 x x x 292.349 x x 414.908 +16179 Original post publication description: Central nervous system; embryonic neurogenesis; Cell death in forebrain following exposure to maltose dextrin at E9 (TUNEL+ cells/mm2) None Central nervous system; embryonic neurogenesis; Cell death in forebrain following exposure to maltose dextrin at E9 (TUNEL+ cells/mm2) x x 365.258 762.053 x 937.825 x x x x x x x x x x x x 1340.81 x x x x x x x x x x x 758.416 x x x x x x 515.469 x x x x x x x x x x x 984.566 x x x x x x x x 387.084 x x x x x x x x x x x x 1247.85 x x x x x x 2368.67 x x x x x x x x x x x x x x x 473.854 x x x 129.146 x x 1392.14 +16180 None Trait_1_GENEX_CB_BXD Pharmacology, metabolism: Ethanol response (4.0 g/kg ethanol in saline, IP), blood alcohol concentration (BAC) 1 hour after injection, male and females average (associated with GenEx EtOH cerebellum gene expression data) [mg/dl] x 507.92 423.133 442.267 435.167 477.914 x 507.533 x x x 535.971 x x x 549.117 x x 502.9 x x x x x x x x x x 432.867 594.967 x 539.033 x 473.933 x 417.35 610.733 460.733 x 400.425 531.833 545.622 490.8 x x 528.0 577.467 538.967 476.667 x x x 616.625 491.633 x x x 594.067 515.233 409.767 444.814 558.033 469.167 491.467 484.3 583.2 571.267 513.367 525.0 x 502.467 479.4 528.333 x 566.6 x 451.033 473.7 631.733 x 472.933 496.486 478.08 506.3 478.833 x 430.233 604.533 x x x x 460.225 545.15 580.925 459.567 544.229 495.967 487.471 501.067 543.057 +16181 None Trait_2_GENEX_CB_BXD Blood alcohol concentration at 2hr [mg/dl] x 353.4 365.1 365.567 383.933 424.44 x 437.86 x x x 449.114 x x x 619.76 x x 452.8 x x x x x x x x x x 385.917 530.3 x 478.133 x 412.933 x 363.8 463.533 395.467 x 340.5 471.267 573.822 399.733 x x 496.8 524.533 464.533 414.8 x x x 476.88 360.933 x x x 543.267 455.5 297.9 403.017 561.767 426.92 424.833 365.0 441.486 500.067 452.5 459.3 x 420.367 433.933 451.433 x 608.933 x 334.733 376.433 387.444 x 402.4 448.425 397.1 388.0 414.467 x 321.167 285.9 x x x x 372.12 371.525 612.25 412.033 467.433 429.067 500.9 382.8 499.257 +16182 None Trait_3_GENEX_CB_BXD Pharmacology, toxicology: Alcohol response (6 mg/kg ip), blood alcohol concentration (BAC) 3 hr after injection of [mg/dl] x 253.433 318.467 355.7 304.5 345.171 x 364.25 x x x 347.714 x x x 574.367 x x 366.1 x x x x x x x x x x 318.267 450.567 x 436.533 x 267.85 x 294.683 435.911 315.3 x 273.862 403.033 451.622 335.2 x x 382.8 417.833 389.867 304.667 x x x 274.556 221.7 x x x 496.633 398.5 355.633 315.714 426.567 330.733 297.9 279.2 355.686 455.433 374.667 346.914 x 367.8 362.267 362.267 x 469.567 x 249.533 301.967 294.067 x 320.6 365.375 334.5 410.2 324.6 x 333.033 194.8 x x x x 317.675 290.6 485.971 339.0 387.114 346.433 382.814 417.933 384.933 +16183 None Trait_4_GENEX_CB_BXD Blood alcohol concentration at 7hr [mg/dl] x 93.5667 94.7667 74.9333 36.5667 48.2 x 88.1667 x x x 76.2286 x x x 39.1333 x x 65.4 x x x x x x x x x x 29.2833 102.5 x 202.533 x 9.91667 x 70.7 156.489 49.7667 x 13.9625 169.767 81.3333 83.5333 x x 38.0 59.6667 48.0667 83.4 x x x 34.72 64.0333 x x x 223.567 105.6 71.1 41.7429 89.6667 36.9667 50.2333 72.1667 77.1714 231.067 126.467 66.4571 x 66.0333 92.4667 43.5667 x 150.0 x 75.7 49.4 43.3778 x 67.8 58.35 22.9667 105.767 59.5 x 42.1 36.6 x x x x 34.95 43.725 139.457 65.4333 15.3333 137.2 79.4667 151.267 75.8 +16184 None Trait_5_GENEX_CB_BXD Blood alcohol concentration maximum [mg/dl] x 507.92 423.133 442.267 435.167 477.914 x 507.533 x x x 535.971 x x x 619.76 x x 502.9 x x x x x x x x x x 432.867 594.967 x 539.033 x 473.933 x 417.35 610.733 460.733 x 400.425 531.833 573.822 490.8 x x 528.0 577.467 538.967 476.667 x x x 616.625 491.633 x x x 594.067 515.233 409.767 444.814 561.767 469.167 491.467 484.3 583.2 571.267 513.367 525.0 x 502.467 479.4 528.333 x 608.933 x 451.033 473.7 631.733 x 472.933 496.486 478.08 506.3 478.833 x 430.233 604.533 x x x x 460.225 545.15 612.25 459.567 544.229 495.967 500.9 501.067 543.057 +16185 Original post publication description: Infectious disease, immune system: Herpes simplex virus Type 1, virulence following corneal infection, young adult male and female (combined) [percent mortality] Original pre publication description: Infectious disease, immune system: Herpes simplex virus Type 1, virulence following corneal infection, young adult male and female (combined) [percent mortality] Infectious disease, immune system: Herpes simplex virus type 1, virulence following corneal infection, young adult male and female (combined) [percent mortality] Infectious disease, immune system: Herpes simplex virus type 1, virulence following corneal infection, young adult male and female (combined) [percent mortality] x x 0.0 100.0 x x x x x x x 31.0 x x x x x x x x x x x x x x x x x x 100.0 x 70.0 x x x x x x x x x x x x x 100.0 13.0 x 10.0 x x x 0.0 19.0 x x x x 7.0 0.0 x 90.0 x 89.0 x x 0.0 0.0 20.0 x 75.0 x 0.0 70.0 x x x x 49.0 x 0.0 44.0 x 72.0 46.0 x 0.0 20.0 x x x x 0.0 65.0 x 12.0 25.0 36.0 26.0 0.0 94.0 +16186 Original post publication description: Infectious disease, immune system: Herpes simplex virus type 1, stromal keratitis severity following corneal infection, young adult male and female (combined) [ordinal 1 t0 5 scale, 0=none, 5 = penetrating lesions] Original pre publication description: Infectious disease, immune system: Herpes simplex virus type 1, stromal keratitis severity following corneal infection, young adult male and female (combined) [ordinal 1 t0 5 scale, 0=none, 5 = penetrating lesions] Infectious disease, immune system: Herpes simplex virus type 1, stromal keratitis severity following corneal infection, young adult male and female (combined) [ordinal 1 t0 5 scale, 0=none, 5 = penetrating lesions] Infectious disease, immune system: Herpes simplex virus type 1, stromal keratitis severity following corneal infection, young adult male and female (combined) [ordinal 1 t0 5 scale, 0=none, 5 = penetrating lesions] x x 0.01 4.0 x x x x x x x 4.3 x x x x x x x x x x x x x x x x x x 2.25 x 4.5 x x x x x x x x x x x x x 4.5 2.9 x 3.75 x x x 3.6 4.35 x x x x 2.05 0.5 x x x x x x 0.95 0.1 x x x x 1.75 x x x x x x x 1.8 2.75 x 4.0 4.5 x 0.01 2.65 x x x x 2.6 4.75 2.5 3.25 4.2 3.05 x 4.0 4.4 +16187 Original post publication description: Central nervous system, adult neurogenesis: Proliferation of BrdU-labeled cells in subgranular zone, 1h BrdU injection, data corrected for age, sex, body weight, and strain epoch effects [n cells] Original pre publication description: Central nervous system, adult neurogenesis: Proliferation of BrdU-labeled cells in subgranular zone, 1h BrdU injection, data corrected for age, sex, body weight, and strain epoch effects [n cells] Central nervous system, adult neurogenesis: Proliferation of BrdU-labeled cells in subgranular zone, 1h BrdU injection, data corrected for age, sex, body weight, and strain epoch effects [n cells] Central nervous system, adult neurogenesis: Proliferation of BrdU-labeled cells in subgranular zone, 1h BrdU injection, data corrected for age, sex, body weight, and strain epoch effects [n cells] x x x x 12.45 3.9 x 40.7 56.06 31.02 1.88 x 15.41 27.39 32.26 38.39 25.4 61.32 12.48 13.48 x x x 9.26 x 29.56 27.17 48.18 x 35.01 8.57 25.43 21.41 x x x 8.47 30.26 21.2 x 27.97 20.87 30.17 20.07 x x 24.79 x -1.05 5.63 x x x 12.64 19.26 x x x 21.84 18.69 25.74 31.58 x 43.75 26.81 15.36 46.06 x x 44.6 x 18.14 x 22.65 x 47.93 x x 34.17 x x 13.2 30.81 26.9 25.21 21.58 x 13.66 43.12 x 40.6 x x x 13.74 24.32 26.82 31.5 1.97 x x x +16188 Original post publication description: Central nervous system, behavior: soluble/brain weight by FRET ratio in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, 2B7/left hemishere wt R6/2 cases only [FRETT florescence ratio] Original pre publication description: Central nervous system, behavior: soluble/brain weight by FRET ratio in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, 2B7/left hemishere wt R6/2 cases only [FRETT florescence ratio] Central nervous system, behavior: soluble/brain weight by FRET ratio in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, 2B7/left hemishere wt R6/2 cases only [FRETT florescence ratio] Central nervous system, behavior: soluble/brain weight by FRET ratio in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, 2B7/left hemishere wt R6/2 cases only [FRETT florescence ratio] x 10.16 9.55 x x 12.57 8.93 11.49 x 9.49 9.9 11.36 x 10.69 x x 9.98 x 12.0 x 10.36 x x x x x 10.43 x x 8.6 x x 10.88 x x x x 10.31 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +16189 Original post publication description: Central nervous system, behavior: aggregate/brain weight by FRET ratio in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, 4C9/left hemishere wt R6/2 cases only [FRETT florescence ratio] Original pre publication description: Central nervous system, behavior: aggregate/brain weight by FRET ratio in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, 4C9/left hemishere wt R6/2 cases only [FRETT florescence ratio] Central nervous system, behavior: aggregate/brain weight by FRET ratio in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, 4C9/left hemishere wt R6/2 cases only [FRETT florescence ratio] Central nervous system, behavior: aggregate/brain weight by FRET ratio in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, 4C9/left hemishere wt R6/2 cases only [FRETT florescence ratio] x 6.91 7.45 x x 6.56 5.44 8.05 x 6.48 7.67 7.76 x 7.39 x x 7.38 x 7.94 x 7.05 x x x x x 8.31 x x 6.25 x x 7.75 x x x x 7.46 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +16190 Original post publication description: Central nervous system, behavior: soluble:aggregate ratio/brain weight by FRET ratio in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, 2B7:4C9/left hemishere wt R6/2 cases only [FRETT florescence ratio] Original pre publication description: Central nervous system, behavior: soluble:aggregate ratio/brain weight by FRET ratio in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, 2B7:4C9/left hemishere wt R6/2 cases only [FRETT florescence ratio] Central nervous system, behavior: soluble:aggregate ratio/brain weight by FRET ratio in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, 2B7:4C9/left hemishere wt R6/2 cases only [FRETT florescence ratio] Central nervous system, behavior: soluble:aggregate ratio/brain weight by FRET ratio in 8 week old F1 hybrids between male BXD strains and C57BL/6J-R6/2 Huntington model, 2B7:4C9/left hemishere wt R6/2 cases only [FRETT florescence ratio] x 0.01 0.009 x x 0.0138 0.01 0.011 x 0.01 0.009 0.011 x 0.01 x x 0.009 x 0.011 x 0.01 x x x x x 0.008 x x 0.008 x x 0.01 x x x x 0.009 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +16191 Original post publication description: Infectious disease, immune system: Herpes simplex virus type 1, spleen weights following corneal infection, young adult female Original pre publication description: Infectious disease, immune system: Herpes simplex virus type 1, spleen weights following corneal infection, young adult female Infectious disease, immune system: Herpes simplex virus type 1, spleen weight following corneal infection, young adult female [g] Infectious disease, immune system: Herpes simplex virus type 1, spleen weight following corneal infection, young adult female [g] x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x 0.095 x 0.102 x x x x x x x x x x x x x x 0.243 x 0.148 x x x x 0.142 x x x x x 0.064 x x x x x x 0.084 0.124 x x x x 0.082 x 0.201 x x x x x x 0.14 x x 0.9 x 0.107 0.115 x x x x 0.118 x 0.096 0.134 x 0.18 0.138 0.127 x +16192 Original post publication description: Infectious disease, immune system: Herpes simplex virus type 1, spleen weights following corneal infection, young adult male Original pre publication description: Infectious disease, immune system: Herpes simplex virus type 1, spleen weights following corneal infection, young adult Male. Infectious disease, immune system: Herpes simplex virus type 1, spleen weight following corneal infection, young adult male [g] Infectious disease, immune system: Herpes simplex virus type 1, spleen weight following corneal infection, young adult male [g] x x x x x x x x x x x 0.099 x x x x x x x x x x x x x x x x x x 0.188 x x x x x x x x x x x x x x x x 0.188 x 0.111 x x x x 0.129 x x x x x 0.079 x x x x x x 0.068 0.143 x x 0.102 x 0.076 x 0.286 x x x 0.124 x x 0.197 x x 0.064 x 0.09 0.13 x x x x 0.099 x 0.103 0.105 x 0.138 0.109 0.132 x +16193 Original post publication description: Infectious disease, immune system: Herpes simplex virus type 1, spleen weights following corneal infection, young adult male and female combined. Original pre publication description: Infectious disease, immune system: Herpes simplex virus type 1, spleen weights following corneal infection, young adult male and female combined. Infectious disease, immune system: Herpes simplex virus type 1, spleen weight following corneal infection, young adult male and female (combined) [g] Infectious disease, immune system: Herpes simplex virus type 1, spleen weight following corneal infection, young adult male and female (combined) [g] x x x x x x x x x x x 0.099 x x x x x x x x x x x x x x x x x x 0.142 x x 0.102 x x x x x x x x x x x x x 0.215 x 0.13 x x x x 0.136 x x x x x 0.071 x x x x x x 0.076 0.133 x x 0.102 x 0.079 x 0.243 x x x 0.124 x x 0.169 x x 0.482 x 0.099 0.122 x x x x 0.108 x 0.099 0.12 x 0.159 0.124 0.13 x +16194 Original post publication description: Infectious disease, immune system: Herpes simplex virus type 1, percent maximum weight loss following corneal infection, young adult female (combined) [percent maximum weight loss] Original pre publication description: Infectious disease, immune system: Herpes simplex virus type 1, percent maximum weight loss following corneal infection, young adult female (combined) [percent maximum weight loss] Infectious disease, immune system: Herpes simplex virus type 1, percent maximum weight loss following corneal infection, young adult female (combined) [max weight loss %] Infectious disease, immune system: Herpes simplex virus type 1, percent maximum weight loss following corneal infection, young adult female (combined) [max weight loss %] x x x x x x x x x x x 23.37 x x x x x x x x x x x x x x x x x x 35.06 x 26.78 x x x x x x x x x x x x x x 19.67 x 19.38 x x x 11.17 15.55 x x x x 3.57 5.54 x 36.32 x 39.31 x x 6.63 14.34 31.52 x 28.87 x 10.2 x 33.68 x x x x x 10.32 x x x 17.7 x 30.27 x x x x x 14.78 30.56 18.94 20.51 16.79 22.29 14.5 25.48 32.57 +16195 Original post publication description: Infectious disease, immune system: Herpes simplex virus type 1, virulence following corneal infection, young adult male [percent maximum weight loss] Original pre publication description: Infectious disease, immune system: Herpes simplex virus type 1, virulence following corneal infection, young adult male [percent maximum weight loss] Infectious disease, immune system: Herpes simplex virus type 1, percent weight loss following corneal infection, young adult male [max weight loss %] Infectious disease, immune system: Herpes simplex virus type 1, percent weight loss following corneal infection, young adult male [max weight loss %] x x x x x x x x x x x 26.35 x x x x x x x x x x x x x x x x x x 33.85 x 25.22 x x x x x x x x x x x x x 31.91 9.3 x 28.14 x x x 24.26 26.39 x x x x 9.39 8.05 x 34.51 x 38.04 x x 14.12 18.65 28.2 x 28.85 x 20.81 x 36.37 x x x 16.12 x 5.05 x x x 30.71 x 27.31 x x x x x x 33.07 19.18 9.84 24.53 21.27 15.24 24.8 30.51 +16196 Original post publication description: Infectious disease, immune system: Herpes simplex virus type 1, percent weight loss following corneal infection, young adult female and male [percent maximum weight loss combined] Original pre publication description: Infectious disease, immune system: Herpes simplex virus type 1, percent weight loss following corneal infection, young adult female and male [percent maximum weight loss combined] Infectious disease, immune system: Herpes simplex virus type 1, percent weight loss following corneal infection, young adult female and male [max weight loss %] Infectious disease, immune system: Herpes simplex virus type 1, percent weight loss following corneal infection, young adult female and male [max weight loss %] x x 6.4 32.2 x x x x x x x 25.36 x x x x x x x x x x x x x x x x x x 34.21 x 26.0 x x x x x x x x x x x x x 25.79 9.3 x 23.76 x x x 17.72 20.97 x x x x 6.48 6.7 x 35.42 x 38.74 x x 9.96 16.57 29.86 x 28.9 x 13.74 x 34.87 x x x 16.12 x 7.68 x x x 23.48 x 28.96 x x x x x 14.78 31.74 19.13 14.86 20.66 21.47 14.83 25.13 31.54 +16197 Original post publication description: Central nervous system, pharmacology, behavior: Difference in nicotine response (0.5mg/kg, s.c., b.i.d., on days 2-4) and saline response (0.9%, s.c., b.i.d., on days 2-4), conditioned place preference (CPP) on day 5 in 7-8-week old males [sec] Original pre publication description: Nic-Sal Pref Nic-Sal Pref Central nervous system, pharmacology, behavior: Difference in nicotine response (0.5mg/kg, s.c., b.i.d., on days 2-4) and saline response (0.9%, s.c., b.i.d., on days 2-4), conditioned place preference (CPP) on day 5 in 7-8-week old males [sec] x x 49.57 -120.05 25.77 -25.3 33.17 x -81.39 -66.36 -58.16 29.39 x 16.39 6.47 90.65 51.2 x -56.87 -22.66 x x x x x 88.3 21.59 x x -105.38 -237.41 1.59 -50.2 x -50.62 x -22.64 11.29 x x 16.2 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +16198 Original post publication description: Central nervous system; embryonic neurogenesis; Cell death in untreated brainstem at E9 (TUNEL+ cells/mm2) None Central nervous system; embryonic neurogenesis; Cell death in untreated brainstem at E9 (TUNEL+ cells/mm2) x x 533.355 x x 1799.3 x x x x x x x x x x x x x x x x x x x x x x x x 898.985 x x x x x x 713.637 x x x x x x x x x x x 1214.31 x x x x x x x x x x x x x x x x x x x 222.913 x 188.897 x x x x x x 549.402 x x x x x x x x x x x x x x x 1178.27 x x x x x x 299.504 +16199 Original post publication description: Central nervous system; embryonic neurogenesis; Cell death in untreated forebrain at E9 (TUNEL+ cells/mm2) None Central nervous system; embryonic neurogenesis; Cell death in untreated forebrain at E9 (TUNEL+ cells/mm2) x x 498.093 x x 1308.47 x x x x x x x x x x x x x x x x x x x x x x x x 659.24 x x x x x x 400.988 x x x x x x x x x x x 1420.07 x x x x x x x x x x x x x x x x x x x 1134.83 x 763.449 x x x x x x 1106.36 x x x x x x x x x x x x x x x 743.16 x x x x x x 380.748 +16200 Central nervous system, behavior: Touchscreen, discrimination, habituation [sessions] Central nervous system, behavior: Touchscreen, discrimination, habituation [sessions] None x x 1.0 1.0 x x x x x 1.0 x 1.0 1.0 x x x x x x x x x x x x 2.0 x 1.0 x x 1.0 x 1.0 x x x x 1.0 2.0 x x 1.0 x x x x 1.0 x x x x x x 1.0 x x x x 1.0 1.0 1.0 x x x x x x 1.0 x x x 1.0 1.0 x x x x x x x x x x x x 1.0 x x x x x x x 1.0 1.0 x x x 1.0 x 1.0 x +16201 Central nervous system, behavior: Touchscreen, discrimination, pavlovian autoshaping [sessions] Central nervous system, behavior: Touchscreen, discrimination, pavlovian autoshaping [sessions] None x x 1.0 1.0 x x x x x 1.0 x 2.0 1.0 x x x x x x x x x x x x 10.0 x 2.0 x x 1.0 x 1.0 x x x x 1.0 1.0 x x 1.0 x x x x 1.0 x x x x x x 1.0 x x x x 1.0 2.0 1.0 x x x x x x 2.0 x x x 2.0 1.0 x x x x x x x x x x x x 1.0 x x x x x x x 1.0 1.0 x x x 1.0 x 1.0 x +16202 Central nervous system, behavior: Touchscreen, discrimination, touch [sessions] Central nervous system, behavior: Touchscreen, discrimination, touch [sessions] None x x 4.0 3.0 x x x x x 3.0 x 8.0 2.0 x x x x x x x x x x x x 14.0 x 4.0 x x 4.0 x 5.0 x x x x 3.0 3.0 x x 6.0 x x x x 2.0 x x x x x x 3.0 x x x x 5.0 3.0 4.0 x x x x x x 7.0 x x x 4.0 6.0 x x x x x x x x x x x x 3.0 x x x x x x x 3.0 9.0 x x x 4.0 x 6.0 x +16203 Central nervous system, behavior: Touchscreen, discrimination, punish [sessions] Central nervous system, behavior: Touchscreen, discrimination, punish [sessions] None x x 5.0 4.0 x x x x x 2.0 x 11.0 5.0 x x x x x x x x x x x x 20.0 x 5.0 x x 15.0 x 7.0 x x x x 4.0 1.0 x x 14.0 x x x x 2.0 x x x x x x 7.0 x x x x 12.0 1.0 3.0 x x x x x x 7.0 x x x 5.0 13.0 x x x x x x x x x x x x 3.0 x x x x x x x 1.0 7.0 x x x 7.0 x 5.0 x +16204 Central nervous system, behavior: Touchscreen, discrimination, discrimination sessions [sessions] Central nervous system, behavior: Touchscreen, discrimination, discrimination sessions [sessions] None x x 12.0 7.0 x x x x x 10.0 x 31.0 24.0 x x x x x x x x x x x x 18.0 x 8.0 x x 60.0 x 11.0 x x x x 16.0 12.0 x x 38.0 x x x x 12.0 x x x x x x 9.0 x x x x 16.0 10.0 8.0 x x x x x x 16.0 x x x 16.0 51.0 x x x x x x x x x x x x 9.0 x x x x x x x 15.0 10.0 x x x 15.0 x 6.0 x +16205 Central nervous system, behavior: Touchscreen, discrimination, reversal sessions [sessions] Central nervous system, behavior: Touchscreen, discrimination, reversal sessions [sessions] None x x 23.0 9.0 x x x x x 9.0 x 38.0 26.0 x x x x x x x x x x x x 42.0 x 16.0 x x x x 18.0 x x x x 22.0 15.0 x x 24.0 x x x x 20.0 x x x x x x 12.0 x x x x 24.0 14.0 16.0 x x x x x x 22.0 x x x 27.0 60.0 x x x x x x x x x x x x 14.0 x x x x x x x 48.0 21.0 x x x 32.0 x 7.0 x +16206 Central nervous system, behavior: Touchscreen, discrimination, extinction sessions [sessions] Central nervous system, behavior, learning and memory: Extinction learning, mean number of sessions to extinguish a learned response using touchscreen assay (Figure S5 of Graybeal et al, 2014) [n sessions] Central nervous system, behavior, learning and memory: Extinction learning, sessions to extinguish a well learned instrumental response using a touchscreen assay (low value = fast to extinguish unrewarded response, Figure S5 of Graybeal et al, 2014) in 3-month-old male mice [n sessions] x x 27.0 30.0 x x x x x 30.0 x 28.0 9.0 x x x x x x x x x x x x 30.0 x 25.0 x x x x 22.0 x x x x 28.0 23.0 x x 13.0 x x x x 25.0 x x x x x x 30.0 x x x x 25.0 7.0 27.0 x x x x x x 26.0 x x x 26.0 x x x x x x x x x x x x x 25.0 x x x x x x x 30.0 21.0 x x x 16.0 x 27.0 x +16207 Central nervous system, behavior: Touchscreen, discrimination correct responses [responses] Central nervous system, behavior: Touchscreen, discrimination correct responses [responses] None x x 240.75 151.5 x x x x x 239.22 x 517.0 501.0 x x x x x x x x x x x x 312.0 x 162.0 x x 825.0 x 223.0 x x x x 321.0 248.4 x x 814.5 x x x x 244.0 x x x x x x 152.17 x x x x 329.3 167.0 160.4 x x x x x x 329.3 x x x 276.17 853.5 x x x x x x x x x x x x 173.56 x x x x x x x 279.5 203.71 x x x 214.17 x 126.71 x +16208 Central nervous system, behavior: Touchscreen, discrimination errors [responses] Central nervous system, behavior: Touchscreen, discrimination errors [responses] None x x 98.67 43.25 x x x x x 62.11 x 321.25 208.0 x x x x x x x x x x x x 183.0 x 56.44 x x 735.0 x 88.64 x x x x 135.25 90.2 x x 298.5 x x x x 98.2 x x x x x x 52.0 x x x x 128.3 71.5 54.6 x x x x x x 124.5 x x x 133.17 460.0 x x x x x x x x x x x x 63.44 x x x x x x x 136.0 79.71 x x x 106.83 x 43.14 x +16209 Central nervous system, behavior: Touchscreen, discrimination correction errors [errors] Central nervous system, behavior: Touchscreen, discrimination correction errors [errors] None x x 237.58 84.75 x x x x x 108.78 x 843.25 464.0 x x x x x x x x x x x x 491.0 x 131.67 x x 1752.0 x 193.14 x x x x 274.25 183.4 x x 492.0 x x x x 219.4 x x x x x x 204.0 x x x x 244.2 217.0 135.8 x x x x x x 242.5 x x x 284.83 1000.0 x x x x x x x x x x x x 193.78 x x x x x x x 297.5 175.14 x x x 216.67 x 87.57 x +16210 Central nervous system, behavior: Touchscreen, discrimination reaction time [time] Central nervous system, behavior: Touchscreen, discrimination reaction time [time] None x x 7.39 7.57 x x x x x 11.37 x 10.14 6.95 x x x x x x x x x x x x 5.74 x 8.15 x x 20.64 x 6.22 x x x x 7.18 8.74 x x 8.41 x x x x 7.36 x x x x x x 11.37 x x x x 8.11 8.85 6.67 x x x x x x 6.16 x x x 7.96 9.66 x x x x x x x x x x x x 5.86 x x x x x x x 5.31 7.73 x x x 12.78 x 5.31 x +16211 Central nervous system, behavior: Touchscreen, discrimination magazine latency [time] Central nervous system, behavior: Touchscreen, discrimination magazine latency [time] None x x 2.07 1.74 x x x x x 3.13 x 2.19 3.21 x x x x x x x x x x x x 2.25 x 2.76 x x 2.6 x 2.01 x x x x 2.66 2.46 x x 2.15 x x x x 5.72 x x x x x x 1.99 x x x x 2.66 2.1 1.76 x x x x x x 4.01 x x x 3.73 18.78 x x x x x x x x x x x x 2.01 x x x x x x x 1.6 3.89 x x x 2.18 x 1.74 x +16212 Central nervous system, behavior: Touchscreen, reversal correct responses [responses] Central nervous system, behavior: Touchscreen, reversal correct responses [responses] None x x 389.0 159.25 x x x x x 162.89 x 641.67 462.0 x x x x x x x x x x x x 411.0 x 250.44 x x x x 323.64 x x x x 328.75 235.2 x x 453.0 x x x x 298.5 x x x x x x 194.0 x x x x 393.1 262.5 294.4 x x x x x x 344.8 x x x 464.6 840.0 x x x x x x x x x x x x 234.44 x x x x x x x 945.0 298.14 x x x 631.8 x 119.43 x +16213 Central nervous system, behavior: Touchscreen, reversal correct responses <50% [responses] Central nervous system, behavior: Touchscreen, reversal correct responses <50% [responses] None x x 60.33 17.5 x x x x x 16.89 x 76.0 53.0 x x x x x x x x x x x x 102.0 x 39.78 x x x x 40.93 x x x x 87.75 55.0 x x 42.0 x x x x 44.5 x x x x x x 25.33 x x x x 83.2 17.5 36.2 x x x x x x 75.7 x x x 113.0 421.0 x x x x x x x x x x x x 33.78 x x x x x x x 66.5 57.86 x x x 221.2 x 16.57 x +16214 Central nervous system, behavior: Touchscreen, reversal correct responses >50% [responses] Central nervous system, behavior: Touchscreen, reversal correct responses >50% [responses] None x x 328.67 141.75 x x x x x 146.0 x 565.67 409.0 x x x x x x x x x x x x 309.0 x 210.67 x x x x 282.71 x x x x 241.0 180.2 x x 411.0 x x x x 254.0 x x x x x x 168.67 x x x x 309.9 245.0 258.2 x x x x x x 269.1 x x x 351.6 419.0 x x x x x x x x x x x x 200.67 x x x x x x x 878.5 240.29 x x x 410.6 x 102.86 x +16215 Central nervous system, behavior: Touchscreen, reversal errors [errors] Central nervous system, behavior: Touchscreen, reversal errors [errors] None x x 233.0 84.0 x x x x x 79.44 x 394.67 309.0 x x x x x x x x x x x x 266.0 x 149.22 x x x x 168.29 x x x x 215.13 156.6 x x 219.0 x x x x 162.1 x x x x x x 110.33 x x x x 264.8 123.0 153.6 x x x x x x 219.9 x x x 322.2 898.0 x x x x x x x x x x x x 133.11 x x x x x x x 433.0 198.57 x x x 350.6 x 58.57 x +16216 Central nervous system, behavior: Touchscreen, reversal errors <50% [errors] Central nervous system, behavior: Touchscreen, reversal errors <50% [errors] None x x 99.42 33.0 x x x x x 35.44 x 117.67 118.0 x x x x x x x x x x x x 125.0 x 73.22 x x x x 63.36 x x x x 122.63 90.8 x x 59.0 x x x x 74.0 x x x x x x 54.0 x x x x 135.3 38.0 63.8 x x x x x x 111.9 x x x 173.2 627.0 x x x x x x x x x x x x 63.78 x x x x x x x 96.5 93.14 x x x 203.8 x 32.86 x +16217 Central nervous system, behavior: Touchscreen, reversal errors >50% [errors] Central nervous system, behavior: Touchscreen, reversal errors >50% [errors] None x x 133.58 51.0 x x x x x 44.0 x 277.0 191.0 x x x x x x x x x x x x 141.0 x 76.0 x x x x 104.93 x x x x 92.5 65.8 x x 160.0 x x x x 88.1 x x x x x x 56.33 x x x x 129.5 85.0 89.8 x x x x x x 108.0 x x x 149.0 271.0 x x x x x x x x x x x x 69.33 x x x x x x x 336.5 106.14 x x x 146.8 x 25.71 x +16218 Central nervous system, behavior: Touchscreen, reversal correction errors [errors] Central nervous system, behavior: Touchscreen, reversal correction errors [errors] None x x 679.0 280.75 x x x x x 220.0 x 909.67 759.0 x x x x x x x x x x x x 1096.0 x 469.67 x x x x 428.93 x x x x 565.0 500.8 x x 469.0 x x x x 530.3 x x x x x x 333.17 x x x x 667.9 321.0 287.0 x x x x x x 619.9 x x x 751.8 2484.0 x x x x x x x x x x x x 449.11 x x x x x x x 858.5 605.14 x x x 921.6 x 219.43 x +16219 Central nervous system, behavior: Touchscreen, reversal correction errors <50% [errors] Central nervous system, behavior: Touchscreen, reversal correction errors <50% [errors] None x x 440.75 179.5 x x x x x 147.11 x 458.67 437.0 x x x x x x x x x x x x 752.0 x 342.11 x x x x 250.71 x x x x 407.0 381.0 x x 207.0 x x x x 371.9 x x x x x x 236.83 x x x x 448.0 176.0 189.8 x x x x x x 412.1 x x x 483.8 1810.0 x x x x x x x x x x x x 320.0 x x x x x x x 315.5 389.71 x x x 640.6 x 173.29 x +16220 Central nervous system, behavior: Touchscreen, reversal correction errors >50% [errors] Central nervous system, behavior: Touchscreen, reversal correction errors >50% [errors] None x x 238.25 101.25 x x x x x 72.89 x 451.0 322.0 x x x x x x x x x x x x 344.0 x 127.56 x x x x 178.21 x x x x 158.0 119.8 x x 262.0 x x x x 158.4 x x x x x x 96.33 x x x x 219.9 145.0 97.2 x x x x x x 207.8 x x x 268.0 674.0 x x x x x x x x x x x x 129.11 x x x x x x x 543.0 215.43 x x x 294.8 x 46.14 x +16221 Central nervous system, behavior: Touchscreen, reversal reaction time [time] Central nervous system, behavior: Touchscreen, reversal reaction time [time] None x x 5.83 5.37 x x x x x 8.56 x 7.44 4.97 x x x x x x x x x x x x 25.12 x 11.67 x x x x 7.46 x x x x 8.67 6.31 x x 5.54 x x x x 6.08 x x x x x x 8.18 x x x x 7.42 5.62 5.64 x x x x x x 6.5 x x x 6.29 13.21 x x x x x x x x x x x x 5.38 x x x x x x x 4.73 6.88 x x x 10.19 x 6.52 x +16222 Central nervous system, behavior: Touchscreen, reversal magazine latency [time] Central nervous system, behavior: Touchscreen, reversal magazine latency [time] None x x 2.57 1.86 x x x x x 2.03 x 5.2 1.52 x x x x x x x x x x x x 2.3 x 2.52 x x x x 3.47 x x x x 2.66 2.09 x x 2.14 x x x x 2.6 x x x x x x 2.0 x x x x 3.44 1.96 1.81 x x x x x x 5.32 x x x 1.92 3.98 x x x x x x x x x x x x 1.69 x x x x x x x 1.88 2.63 x x x 2.46 x 1.85 x +16223 Central nervous system, behavior: Touchscreen, extinction correct responses[responses] Central nervous system, behavior: Andrew Holmes laboratory unpublished trait Central nervous system, behavior: Extinction, number of correct responses using a touchscreen paradigm [n] x x 201.0 345.25 x x x x x 276.11 x 197.5 95.0 x x x x x x x x x x x x 118.0 x 212.11 x x x x 157.71 x x x x 255.71 228.6 x x 104.0 x x x x 167.2 x x x x x x 265.67 x x x x 194.78 63.0 205.6 x x x x x x 215.22 x x x 211.25 x x x x x x x x x x x x x 240.56 x x x x x x x 149.0 203.29 x x x 124.33 x 189.71 x +16224 Central nervous system, behavior: Touchscreen, discrimination extinction errors [errors] Central nervous system, behavior: Touchscreen, discrimination extinction errors [errors] Central nervous system, behavior: Holmes leaning trait x x 107.83 169.25 x x x x x 194.0 x 107.0 34.0 x x x x x x x x x x x x 90.0 x 123.33 x x x x 78.71 x x x x 126.71 114.6 x x 37.0 x x x x 103.1 x x x x x x 142.0 x x x x 99.67 13.0 124.4 x x x x x x 115.0 x x x 131.75 x x x x x x x x x x x x x 103.0 x x x x x x x 102.0 61.0 x x x 51.67 x 127.57 x +16225 Central nervous system, behavior: Touchscreen, extinction correction errors [errors] Central nervous system, behavior: Touchscreen, extinction correction errors [errors] None x x 236.42 365.0 x x x x x 450.56 x 175.5 45.0 x x x x x x x x x x x x 291.0 x 357.22 x x x x 130.29 x x x x 228.86 229.2 x x 45.0 x x x x 223.6 x x x x x x 440.83 x x x x 253.0 16.0 320.6 x x x x x x 251.78 x x x 357.25 x x x x x x x x x x x x x 234.11 x x x x x x x 178.0 109.0 x x x 113.0 x 281.43 x +16226 Central nervous system, behavior: Touchscreen, extinction reaction time [time] Central nervous system, behavior: Touchscreen, extinction reaction time [time] None x x 120.94 17.24 x x x x x 66.58 x 58.51 148.97 x x x x x x x x x x x x 46.99 x 90.09 x x x x 100.48 x x x x 79.97 40.3 x x 75.22 x x x x 94.99 x x x x x x 64.62 x x x x 66.73 289.64 119.92 x x x x x x 64.92 x x x 32.37 x x x x x x x x x x x x x 93.38 x x x x x x x 49.83 93.29 x x x 45.86 x 51.7 x +16227 Central nervous system, behavior: Touchscreen, extinction magazine latency [time] Central nervous system, behavior: Touchscreen, extinction magazine latency [time] None x x 64.5 57.33 x x x x x 26.08 x 102.77 145.01 x x x x x x x x x x x x 99.21 x 50.32 x x x x 81.78 x x x x 54.75 65.33 x x 94.16 x x x x 88.91 x x x x x x 45.32 x x x x 73.49 101.74 52.78 x x x x x x 81.43 x x x 45.44 x x x x x x x x x x x x x 58.03 x x x x x x x 103.72 65.45 x x x 28.63 x 69.72 x +16228 Original post publication description: un-named trait Original pre publication description: RLT NMS F1 RLT NMS F1 un-named trait x x x x x x x x x x x 300.0 x x x x x x x x x x x x x x x x x x x x 700.0 x x x x x x x x x x x x x x x x x x x x 125.0 x x x x x x x x x x x 500.0 x 175.0 150.0 x x x x x x x x x x x x x 300.0 x x 550.0 x 300.0 425.0 x x x x x 800.0 x 600.0 x 300.0 350.0 x 500.0 +16229 Liver, toxicology, Hepatocyte damage in vitro measured as lactate dehydrogenase (LDH) release after 24 hrs attachment (no treatment) median in males and females [% LDH supernatant of total LDH] Liver, toxicology: Hepatocyte damage in vitro measured as lactate dehydrogenase (LDH) release after 24 hrs attachment (no treatment) median in males and females [% LDH supernatant of total LDH] Liver, toxicology: Hepatocyte damage in vitro measured as lactate dehydrogenase (LDH) release after 24 hrs attachment (no treatment) median in males and females [% LDH supernatant of total LDH] x x 10.99 11.6 13.41 11.54 x 8.525 x x 14.765 10.17 31.29 14.9 16.12 x x 9.665 x x x x 7.72 x x x x x x x 10.56 13.98 x x x x x 13.305 9.73 x x 8.985 x x x x x x x 11.84 x x x 15.435 x x x x x 19.18 x x x x x x x x x x x 11.41 x x x x x x x x x x x x x x x x x x x x x x 9.67 x 11.655 x x x x x +16230 Liver, toxicology, Hepatocyte damage in vitro measured as difference in lactate dehydrogenase (LDH) release relative to untreated hepatocytes, after 48 hrs 0.6% alcohol median in males and females [% LDH increase vs. untreated cells] Liver, toxicology, Hepatocyte damage in vitro measured as difference in lactate dehydrogenase (LDH) release relative to untreated hepatocytes, after 48 hrs 0.6% alcohol median in males and females [% LDH increase vs. untreated cells] None x x 9.485 12.67 3.66 0.6 x 3.465 x x 4.255 8.745 6.15 9.11 7.96 x x -2.62 x x x x 5.51 x x x x x x x 21.45 1.59 x x x x x 4.41 20.62 x x 10.145 x x x x x x x 24.62 x x x 3.21 x x x x x 12.35 x x x x x x x x x x x 5.735 x x x x x x x x x x x x x x x x x x x x x x 12.34 x 7.81 x x x x x +16231 Liver, toxicology, Hepatocyte damage in vitro measured as difference in lactate dehydrogenase (LDH) release relative to untreated hepatocytes, after 48 hrs 5ng/ml TGF-beta median in males and females [% LDH increase vs. untreated cells] Liver, toxicology, Hepatocyte damage in vitro measured as difference in lactate dehydrogenase (LDH) release relative to untreated hepatocytes, after 48 hrs 5ng/ml TGF-beta median in males and females [% LDH increase vs. untreated cells] None x x 51.19 39.5 19.01 58.64 x 25.44 x x 12.99 40.855 -15.55 14.12 20.75 x x 50.835 x x x x 10.26 x x x x x x x 35.59 15.71 x x x x x 6.625 31.04 x x 1.64 x x x x x x x 5.24 x x x 38.42 x x x x x 18.98 x x x x x x x x x x x -0.32 x x x x x x x x x x x x x x x x x x x x x x 8.22 x 10.22 x x x x x +16232 Liver, toxicology, Hepatocyte damage in vitro measured as difference in lactate dehydrogenase (LDH) release relative to untreated hepatocytes, after 48 hrs 5ng/ml TGF-beta + 0.6% ethanol median in males and females [% LDH increase vs. untreated cells] Liver, toxicology, Hepatocyte damage in vitro measured as difference in lactate dehydrogenase (LDH) release relative to untreated hepatocytes, after 48 hrs 5ng/ml TGF-beta + 0.6% ethanol median in males and females [% LDH increase vs. untreated cells] None x x 39.375 60.28 41.17 74.735 x 32.745 x x 31.01 51.17 -18.69 43.78 19.7 x x 84.435 x x x x 35.78 x x x x x x x 63.06 29.47 x x x x x 16.38 44.1 x x 28.58 x x x x x x x 20.0 x x x 46.215 x x x x x 34.76 x x x x x x x x x x x 2.82 x x x x x x x x x x x x x x x x x x x x x x 13.57 x 21.16 x x x x x +16233 Liver, toxicology, Hepatocyte damage in vitro measured as lactate dehydrogenase (LDH) release after 24 hrs attachment (no treatment) median in males [% LDH supernatant of total LDH] Liver, toxicology, Hepatocyte damage in vitro measured as lactate dehydrogenase (LDH) release after 24 hrs attachment (no treatment) median in males [% LDH supernatant of total LDH] None x x 10.99 20.08 14.83 14.425 x 8.63 x x 17.15 15.23 35.0 18.27 17.44 x x 12.505 x x x x 9.915 x x x x x x x 11.06 15.285 x x x x x 15.29 9.73 x x 7.98 x x x x x x x 11.09 x x x 16.6 x x x x x 19.365 x x x x x x x x x x x 13.53 x x x x x x x x x x x x x x x x x x x x x x 10.205 x 13.32 x x x x x +16234 Liver, toxicology, Hepatocyte damage in vitro measured as difference in lactate dehydrogenase (LDH) release relative to untreated hepatocytes, after 48 hrs 0.6% alcohol median in males [% LDH increase vs. untreated cells] Liver, toxicology, Hepatocyte damage in vitro measured as difference in lactate dehydrogenase (LDH) release relative to untreated hepatocytes, after 48 hrs 0.6% alcohol median in males [% LDH increase vs. untreated cells] None x x 9.485 0.91 2.665 2.15 x -4.79 x x -5.675 3.765 3.2 5.93 6.595 x x -12.475 x x x x -6.19 x x x x x x x 21.45 1.615 x x x x x 9.97 17.5 x x 10.64 x x x x x x x 27.54 x x x -3.385 x x x x x 9.185 x x x x x x x x x x x 6.32 x x x x x x x x x x x x x x x x x x x x x x 1.255 x 2.78 x x x x x +16235 Liver, toxicology, Hepatocyte damage in vitro measured as difference in lactate dehydrogenase (LDH) release relative to untreated hepatocytes, after 48 hrs 5ng/ml TGF-beta medianin males [% LDH increase vs. untreated cells] Liver, toxicology, Hepatocyte damage in vitro measured as difference in lactate dehydrogenase (LDH) release relative to untreated hepatocytes, after 48 hrs 5ng/ml TGF-beta medianin males [% LDH increase vs. untreated cells] None x x 42.63 158.03 18.18 76.7 x 26.085 x x 12.99 48.74 -29.98 45.84 14.675 x x 57.205 x x x x 19.11 x x x x x x x 39.64 29.655 x x x x x -3.67 31.04 x x 7.99 x x x x x x x 31.39 x x x 39.56 x x x x x 18.88 x x x x x x x x x x x 0.46 x x x x x x x x x x x x x x x x x x x x x x 2.08 x 2.75 x x x x x +16236 Liver, toxicology, Hepatocyte damage in vitro measured as difference in lactate dehydrogenase (LDH) release relative to untreated hepatocytes, after 48 hrs 5ng/ml TGF-beta + 0.6% ethanol median in males [% LDH increase vs. untreated cells] Liver, toxicology, Hepatocyte damage in vitro measured as difference in lactate dehydrogenase (LDH) release relative to untreated hepatocytes, after 48 hrs 5ng/ml TGF-beta + 0.6% ethanol median in males [% LDH increase vs. untreated cells] None x x 35.23 165.56 24.77 93.34 x 34.105 x x 18.52 30.245 -25.81 115.21 10.435 x x 71.855 x x x x 18.05 x x x x x x x 63.06 34.34 x x x x x 19.96 44.1 x x 27.71 x x x x x x x 36.53 x x x 45.55 x x x x x 35.36 x x x x x x x x x x x 0.14 x x x x x x x x x x x x x x x x x x x x x x 10.47 x 8.66 x x x x x +16237 Liver, toxicology, Hepatocyte damage in vitro measured as lactate dehydrogenase (LDH) release after 24 hrs attachment (no treatment) median in females [% LDH supernatant of total LDH] Liver, toxicology, Hepatocyte damage in vitro measured as lactate dehydrogenase (LDH) release after 24 hrs attachment (no treatment) median in females [% LDH supernatant of total LDH] None x x 10.57 10.625 9.98 9.85 x 8.525 x x 11.745 7.475 11.55 12.79 13.73 x x 7.88 x x x x 7.6 x x x x x x x 10.17 9.69 x x x x x 11.11 10.79 x x 9.44 x x x x x x x 12.88 x x x 11.005 x x x x x 14.4 x x x x x x x x x x x 10.65 x x x x x x x x x x x x x x x x x x x x x x 8.98 x 9.2 x x x x x +16238 Liver, toxicology, Hepatocyte damage in vitro measured as difference in lactate dehydrogenase (LDH) release relative to untreated hepatocytes, after 48 hrs 0.6% alcohol median in females [% LDH increase vs. untreated cells] Liver, toxicology, Hepatocyte damage in vitro measured as difference in lactate dehydrogenase (LDH) release relative to untreated hepatocytes, after 48 hrs 0.6% alcohol median in females [% LDH increase vs. untreated cells] None x x 12.1 13.145 9.19 0.225 x 19.505 x x 5.245 17.56 13.59 13.905 20.315 x x -0.57 x x x x 10.59 x x x x x x x 22.18 1.59 x x x x x -0.02 20.65 x x 9.65 x x x x x x x 3.695 x x x 8.93 x x x x x 13.78 x x x x x x x x x x x 5.15 x x x x x x x x x x x x x x x x x x x x x x 26.29 x 15.21 x x x x x +16239 Liver, toxicology, Hepatocyte damage in vitro measured as difference in lactate dehydrogenase (LDH) release relative to untreated hepatocytes, after 48 hrs 5ng/ml TGF-beta median in females [% LDH increase vs. untreated cells] Liver, toxicology, Hepatocyte damage in vitro measured as difference in lactate dehydrogenase (LDH) release relative to untreated hepatocytes, after 48 hrs 5ng/ml TGF-beta median in females [% LDH increase vs. untreated cells] None x x 81.875 35.725 24.85 42.865 x 25.44 x x 13.935 39.295 21.695 10.6 26.1 x x 50.835 x x x x 10.26 x x x x x x x 28.48 6.06 x x x x x 9.58 32.61 x x -3.44 x x x x x x x 2.27 x x x 38.42 x x x x x 28.18 x x x x x x x x x x x -10.53 x x x x x x x x x x x x x x x x x x x x x x 15.24 x 58.8 x x x x x +16240 Liver, toxicology, Hepatocyte damage in vitro measured as difference in lactate dehydrogenase (LDH) release relative to untreated hepatocytes, after 48 hrs 5ng/ml TGF-beta + 0.6% ethanol median in females [% LDH increase vs. untreated cells] Liver, toxicology: Hepatocyte damage in vitro measured as difference in lactate dehydrogenase (LDH) release relative to untreated hepatocytes, after 48 hrs 5 ng/ml TGF-beta + 0.6% ethanol median in females [% LDH increase vs. untreated cells] Liver, toxicology: Hepatocyte damage in vitro measured as difference in lactate dehydrogenase (LDH) release relative to untreated hepatocytes, after 48 hrs 5 ng/ml TGF-beta + 0.6% ethanol median in females [% LDH increase vs. untreated cells] x x 50.95 59.435 60.15 50.12 x 32.745 x x 38.64 79.87 29.175 26.63 22.185 x x 86.505 x x x x 58.08 x x x x x x x 57.995 19.76 x x x x x 12.8 35.575 x x 29.45 x x x x x x x 4.445 x x x 62.84 x x x x x 27.12 x x x x x x x x x x x 5.5 x x x x x x x x x x x x x x x x x x x x x x 20.95 x 63.64 x x x x x +16241 Original post publication description: Central nervous system, gene expression: Tnik mRNA expression in hippocampus (TRAF2 and NCK interacting kinase), first principal component generated using exon probe sets and UMUTAffyExon_0209_RMA data [relative residual concentration] Original pre publication description: Central nervous system, gene expression: Tnik mRNA expression in hippocampus (TRAF2 and NCK interacting kinase), first principal component generated using exon probe sets and UMUTAffyExon_0209_RMA data [relative residual concentration] Central nervous system, gene expression: Tnik mRNA expression in hippocampus (TRAF2 and NCK interacting kinase), first principal component generated using exon probe sets and UMUTAffyExon_0209_RMA data [relative residual concentration] Central nervous system, gene expression: Tnik mRNA expression in hippocampus (TRAF2 and NCK interacting kinase), first principal component generated using exon probe sets and UMUTAffyExon_0209_RMA data [relative residual concentration] 3.126 -0.084 -1.771 -1.351 -0.889 -2.188 -1.93 1.963 2.904 1.596 1.806 -2.717 2.289 -2.401 2.005 0.231 -0.21 0.394 2.92 -6.76 -1.822 -2.268 x 1.135 0.163 0.168 1.275 1.654 x -1.354 1.792 -2.741 -0.183 x -0.934 x -4.823 -0.702 -2.257 x -3.355 0.021 x 1.077 x x 2.511 x -0.906 1.437 x x x -2.625 x x x x 0.524 -2.662 -3.385 2.089 4.526 -2.003 3.441 2.854 -0.766 5.21 4.853 x x 2.484 -5.394 -4.37 -3.185 1.393 x -2.403 2.727 x x -6.726 2.599 3.26 2.088 6.108 x -0.862 0.015 x 0.333 -3.201 -2.397 x 0.778 0.236 1.828 3.814 x x x x +16242 Original post publication description: un-named trait Original pre publication description: Infectious disease, immune function: Cowpox virus disease onset measured by day of max clinical score over three weeks after 10^5pfu intranasal infection, males and females between XX and XXX days of age, residuals corrected for age, sex and body weight [scaled days where -5.8 is early onset (before day X) and 6.2 is late onset (<XX days)] Infectious disease, immune function: Cowpox virus disease onset measured by day of max clinical score over three weeks after 10^5pfu intranasal infection, males and females between XX and XXX days of age, residuals corrected for age, sex and body weight [scaled days where -5.8 is early onset (before day X) and 6.2 is late onset (<XX days)] Infectious disease, immune function: Cowpox virus disease onset measured by day of max clinical score over three weeks after 10^5pfu intranasal infection, males and females between XX and XXX days of age, residuals corrected for age, sex and body weight [scaled days where -5.8 is early onset (before day X) and 6.2 is late onset (<XX days)] x x 4.538 3.265 x x x -4.145 x x x x x x x -1.82 x x x x x x x x x x x x x x -0.468 x 0.041 x x x x x -0.336 x -1.251 x x 1.624 x x -2.957 -5.793 x -0.72 x x x x 0.33 x x x 1.858 3.475 1.254 x x x x x x 6.157 -4.161 -1.538 x 3.084 -3.563 1.533 x 0.956 x -2.906 -0.826 x x -1.328 2.17 x x x x 1.838 -0.822 x x x x x x -2.088 1.716 0.761 0.122 x x x +16243 Original post publication description: Central nervous system, aging: Age at death (average) of hippocampal samples [days] Original pre publication description: Central nervous system, aging: Age at death (average) of hippocampal samples [days] Metadata, cofactor: Age at death (average) of hippocampal samples (use only with UTHSC BXD Aged Hippocampus Affy expression data sets) [days] Metadata, cofactor: Age at death (average) of hippocampal samples (use only with UTHSC BXD Aged Hippocampus Affy expression data sets) [days] 430.0 x 566.0 622.0 794.0 483.0 x 530.0 454.0 442.0 464.0 506.0 x 561.0 605.0 605.0 536.0 500.5 432.0 415.0 502.0 456.0 493.0 399.0 536.5 652.0 454.0 462.0 x x 464.0 478.0 549.0 x x x 499.0 x 451.0 x 463.0 446.0 415.0 524.0 x x 438.0 x 528.0 498.0 x x x 526.0 501.0 x x x 587.0 425.0 572.0 463.0 747.0 475.0 421.0 415.0 470.0 485.0 471.0 464.0 x 459.0 431.0 515.0 631.0 579.0 x 618.0 614.0 651.0 x 512.0 458.0 425.0 523.0 506.0 x 488.0 651.0 x 526.0 912.0 x 467.0 420.0 715.0 697.0 440.0 772.0 693.0 x x +16244 Original post publication description: Cardiovascular system, morphology: Heart weight raw [mg] Cardiovascular system, morphology: Heart weight, young adult males and females, unadjusted (BXD19 winsorized from 101.4 to 118) [mg] Cardiovascular system, morphology: Heart weight, young adult males and females, unadjusted (BXD19 winsorized from 101.4 to 118) [mg] 118.9 x 122.4 193.2 148.5 165.7 x 131.4 151.5 129.5 156.7 154.3 x 135.0 x x x 118.0 x 169.2 142.5 141.8 x 155.4 x 132.3 x x x 119.4 121.8 156.5 166.5 x 144.0 x 157.2 150.1 170.4 x x 127.5 122.0 127.1 x x 134.6 x 158.9 138.6 x x x 151.1 x x x x 146.2 136.5 128.6 146.7 148.7 151.1 152.9 125.7 140.8 146.8 149.9 175.3 x 149.3 124.0 139.7 138.4 185.6 125.3 161.3 154.8 x x 135.4 146.8 132.8 181.3 151.3 x 142.9 164.6 142.9 150.6 x x 148.9 134.1 149.0 155.5 150.9 x x x x +16245 Original post publication description: Cardiovascular system, morphology: Heart weight adjusted by age, sex and body weight [mg] Cardiovascular system, morphology: Heart weight, young adult males and females, adjusted by age, sex, and body weight (BXD19 winsorized from 80.7 to 118) [mg] Cardiovascular system, morphology: Heart weight, young adult males and females, adjusted by age, sex, and body weight (BXD19 winsorized from 80.7 to 118) [mg] 134.9 x 129.8 181.5 142.4 165.0 x 146.0 141.4 125.9 149.1 143.5 x 140.6 x x x 118.0 x 159.0 134.6 154.1 x 139.9 x 143.8 x x x 129.6 134.2 171.6 158.5 x 147.0 x 166.7 158.7 165.9 x x 130.6 124.2 142.3 x x 133.4 x 146.8 139.0 x x x 151.3 x x x x 131.8 132.5 130.7 156.3 143.4 146.7 155.7 129.5 136.3 146.4 151.6 146.5 x 159.9 134.6 139.1 144.2 164.4 123.6 144.2 147.3 x x 132.5 139.5 133.8 178.8 152.5 x 146.3 163.3 155.2 140.5 x x 118.8 135.9 148.4 146.4 143.7 x x x x +16246 Original post publication description: Cortex L2/3 apoptosis None Central nervous system; post-natal neurogenesis; Apoptosis in cortex L2/3 (% caspase 3+ cells) x x 1.289 19.988 x 6.691 x x x x x x x x x x x x 5.804 x x x x x x x x x x x 5.111 x x x x x x 4.328 x x x x x x x x x x x 3.283 x x x x x x x x 7.775 x x x x x x x x x x 14.938 x 13.842 x x x x x x 18.688 x x x x x x x x x x x x x x x 11.218 x x x 15.786 x x 12.968 +16247 Metagenome, gastrointestinal system: Microbiome, Actinobacteria (class) frequency assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction] None Metagenome, gastrointestinal system: Microbiome, Actinobacteria (class) frequency assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction] -0.518831 x -0.156824 0.31448 x x x x x x -0.689001 0.724981 x x x x x x x x x x -0.0653891 x x x x x x x -0.387328 x x x x x x x x x x x -0.180422 0.0812122 x x -0.0508463 x 0.0557928 0.44173 x x x x -0.203314 x x x -0.364487 -0.0144792 0.068776 x x -0.298034 0.528846 x -0.201443 -0.0057032 -0.0126551 -0.0714455 x x x 0.518153 x 0.36181 x x x x x 0.19999 0.23894 -0.0342155 x -0.113823 x 0.712927 0.107623 x x x x x -0.637051 x x x -0.675143 x 0.325173 x +16248 Metagenome, gastrointestinal system: Microbiome, Actinobacteria (phylum) frequency assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction] None Metagenome, gastrointestinal system: Microbiome, Actinobacteria (phylum) frequency assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction] -0.518831 x -0.156824 0.31448 x x x x x x -0.689001 0.724981 x x x x x x x x x x -0.0653891 x x x x x x x -0.387328 x x x x x x x x x x x -0.180422 0.0812122 x x -0.0508463 x 0.0557928 0.44173 x x x x -0.203314 x x x -0.364487 -0.0144792 0.068776 x x -0.298034 0.528846 x -0.201443 -0.0057032 -0.0126551 -0.0714455 x x x 0.518153 x 0.36181 x x x x x 0.19999 0.23894 -0.0342155 x -0.113823 x 0.712927 0.107623 x x x x x -0.637051 x x x -0.675143 x 0.325173 x +16249 Metagenome, gastrointestinal system: Microbiome, Actinobacteridae (subclass) frequency assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction] None Metagenome, gastrointestinal system: Microbiome, Actinobacteridae (subclass) frequency assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction] -0.493655 x -0.575807 1.07654 x x x x x x -0.131479 -0.298258 x x x x x x x x x x -0.29357 x x x x x x x -0.663642 x x x x x x x x x x x -0.772682 -0.0520093 x x -0.291292 x 0.182453 0.616944 x x x x -0.407057 x x x -0.280671 -0.0437554 -0.256199 x x -0.367829 -0.0698029 x -0.255752 -0.129114 -0.159195 -0.0621979 x x x 0.0656433 x 0.942902 x x x x x -0.202483 0.112618 -0.0431452 x 0.802235 x 0.988803 0.696573 x x x x x -0.372203 x x x -0.147797 x 0.884888 x +16250 Metagenome, gastrointestinal system: Microbiome, Actinomycetales (order) frequency assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction] None Metagenome, gastrointestinal system: Microbiome, Actinomycetales (order) frequency assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction] -0.491175 x -0.573327 1.06929 x x x x x x -0.128999 -0.295778 x x x x x x x x x x -0.29109 x x x x x x x -0.661162 x x x x x x x x x x x -0.770202 -0.0515699 x x -0.291292 x 0.21274 0.616944 x x x x -0.376769 x x x -0.280452 -0.028392 -0.25576 x x -0.337541 -0.0693634 x -0.255313 -0.128675 -0.158755 -0.0617584 x x x 0.0660828 x 0.939736 x x x x x -0.187339 0.112618 -0.0429255 x 0.797181 x 0.999498 0.56028 x x x x x -0.370963 x x x -0.147357 x 0.881593 x +16251 Metagenome, gastrointestinal system: Microbiome, Aerococcaceae (family) frequency assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction] None Metagenome, gastrointestinal system: Microbiome, Aerococcaceae (family) frequency assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction] -0.227958 x -0.311711 0.0205206 x x x x x x -0.0165501 -0.422635 x x x x x x x x x x -0.503894 x x x x x x x -0.398006 x x x x x x x x x x x -0.356322 0.0010337 x x -0.225797 x -0.017287 -0.126996 x x x x -0.0676221 x x x -0.175983 0.121586 -0.112208 x x -0.0283943 0.0719612 x 0.0365271 0.013946 -0.166762 -0.0715648 x x x -0.143623 x 0.668961 x x x x x -0.0759333 -0.210009 -0.0254375 x 0.758159 x 1.36763 0.0103836 x x x x x 0.58762 x x x -0.15473 x 0.181095 x +16252 Metagenome, gastrointestinal system: Microbiome, Aerococcus (genus) frequency assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction] None Metagenome, gastrointestinal system: Microbiome, Aerococcus (genus) frequency assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction] -0.227915 x -0.311667 0.0205641 x x x x x x -0.0165065 -0.422592 x x x x x x x x x x -0.503851 x x x x x x x -0.397962 x x x x x x x x x x x -0.356279 0.0010337 x x -0.225797 x -0.017287 -0.126996 x x x x -0.0676221 x x x -0.175983 0.121586 -0.112208 x x -0.0283943 0.0719612 x 0.0365271 0.013946 -0.166762 -0.0715648 x x x -0.143623 x 0.668983 x x x x x -0.0759333 -0.210009 -0.0254375 x 0.758159 x 1.36722 0.0103836 x x x x x 0.587642 x x x -0.15473 x 0.181116 x +16253 Metagenome, gastrointestinal system: Microbiome, Alistipes (genus) frequency assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction] None Metagenome, gastrointestinal system: Microbiome, Alistipes (genus) frequency assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction] 0.544218 x -0.801056 -0.383372 x x x x x x -0.958986 1.30263 x x x x x x x x x x -1.1453 x x x x x x x -0.0220506 x x x x x x x x x x x 1.03731 -0.144791 x x -1.17637 x -0.0419391 0.640827 x x x x -0.350808 x x x 0.561449 0.264502 -0.440862 x x 0.0332929 0.220489 x 0.238043 -0.241245 0.365953 0.484774 x x x 0.304317 x -0.0268954 x x x x x 0.319757 0.269607 0.657682 x -0.159915 x 0.0095781 0.296614 x x x x x -1.16534 x x x -0.662211 x 0.170111 x +16254 Metagenome, gastrointestinal system: Microbiome, Bacilli (class) frequency assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction] None Metagenome, gastrointestinal system: Microbiome, Bacilli (class) frequency assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction] 0.175631 x 0.0643576 0.0828972 x x x x x x -0.314874 -0.327173 x x x x x x x x x x 0.102037 x x x x x x x 0.137568 x x x x x x x x x x x -0.0310169 0.0888305 x x -0.177407 x -0.025221 -0.0405718 x x x x 0.100843 x x x -0.0458157 -0.239702 0.0611031 x x 0.0770017 -0.0478189 x -0.186117 0.0353056 0.0912961 -0.049865 x x x -0.0579127 x 0.150464 x x x x x -0.0171508 0.0779871 0.0522646 x 0.078666 x -0.0307228 -0.010306 x x x x x 0.105267 x x x 0.0865452 x 0.0336109 x +16255 Metagenome, gastrointestinal system: Microbiome, Bacteroidales (order) frequency assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction] None Metagenome, gastrointestinal system: Microbiome, Bacteroidales (order) frequency assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction] 0.0446889 x -1.21738 -0.115595 x x x x x x 0.186051 0.573394 x x x x x x x x x x 0.331771 x x x x x x x 0.0509353 x x x x x x x x x x x 0.262439 -0.802288 x x -0.319515 x 0.0355208 -0.150273 x x x x -0.362807 x x x 0.446252 0.146154 0.171167 x x -0.106644 0.274185 x 0.421208 0.0962919 -0.202544 0.569655 x x x 0.357818 x -0.711256 x x x x x 0.141332 0.233103 0.490095 x -0.0752507 x 0.347905 0.234137 x x x x x -1.07516 x x x -0.604454 x 0.329057 x +16256 Metagenome, gastrointestinal system: Microbiome, Bacteroidetes (class) frequency assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction] None Metagenome, gastrointestinal system: Microbiome, Bacteroidetes (class) frequency assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction] 0.0446889 x -1.21738 -0.115595 x x x x x x 0.186051 0.573394 x x x x x x x x x x 0.331771 x x x x x x x 0.0509353 x x x x x x x x x x x 0.262439 -0.802288 x x -0.319515 x 0.0355208 -0.150273 x x x x -0.362807 x x x 0.446252 0.146154 0.171167 x x -0.106644 0.274185 x 0.421208 0.0962919 -0.202544 0.569655 x x x 0.357818 x -0.711256 x x x x x 0.141332 0.233103 0.490095 x -0.0752507 x 0.347905 0.234137 x x x x x -1.07516 x x x -0.604454 x 0.329057 x +16257 Metagenome, gastrointestinal system: Microbiome, Bacteroidetes (phylum) frequency assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction] None Metagenome, gastrointestinal system: Microbiome, Bacteroidetes (phylum) frequency assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction] -0.052787 x -0.811083 -0.192092 x x x x x x 0.151683 0.522894 x x x x x x x x x x 0.235884 x x x x x x x -0.035648 x x x x x x x x x x x 0.176051 -0.815211 x x -0.171261 x 0.0275689 -0.240795 x x x x -0.31525 x x x 0.295878 0.137622 0.11389 x x -0.107427 0.282148 x 0.424369 0.099047 -0.145649 0.494136 x x x 0.314976 x -0.720422 x x x x x 0.0640031 0.0478076 0.378928 x -0.15851 x 0.295805 0.17925 x x x x x -0.352205 x x x -0.298157 x 0.174558 x +16258 Metagenome, gastrointestinal system: Microbiome, Clostridia (class) frequency assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction] None Metagenome, gastrointestinal system: Microbiome, Clostridia (class) frequency assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction] -0.426698 x 0.118477 0.120741 x x x x x x 0.499147 0.226502 x x x x x x x x x x -0.452471 x x x x x x x -0.134977 x x x x x x x x x x x 0.117907 0.0783203 x x 0.28546 x -0.056438 0.0613142 x x x x 0.162186 x x x 0.214995 0.420538 -0.033524 x x -0.0420715 0.00078636 x 0.216338 -0.321217 -0.144049 -0.0742876 x x x 0.0208625 x -0.474452 x x x x x 0.180638 -0.0173998 -0.299829 x 0.100176 x -0.129281 -0.470697 x x x x x 0.0991319 x x x 0.0777258 x 0.0761444 x +16259 Metagenome, gastrointestinal system: Microbiome, Clostridiales (order) frequency assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction] None Metagenome, gastrointestinal system: Microbiome, Clostridiales (order) frequency assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction] -0.425997 x 0.117165 0.120251 x x x x x x 0.498538 0.227792 x x x x x x x x x x -0.453562 x x x x x x x -0.13328 x x x x x x x x x x x 0.118188 0.078881 x x 0.285915 x -0.0553559 0.0608066 x x x x 0.162515 x x x 0.215089 0.419817 -0.0324586 x x -0.0436538 0.00086857 x 0.217339 -0.320542 -0.142937 -0.0756874 x x x 0.0214288 x -0.472332 x x x x x 0.179997 -0.0171946 -0.301286 x 0.0980756 x -0.127413 -0.47025 x x x x x 0.0963469 x x x 0.0770432 x 0.0758936 x +16260 Metagenome, gastrointestinal system: Microbiome, Coriobacteriaceae (family) frequency assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction] None Metagenome, gastrointestinal system: Microbiome, Coriobacteriaceae (family) frequency assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction] -0.298915 x 0.112491 -0.321125 x x x x x x -0.596804 1.02431 x x x x x x x x x x 0.164162 x x x x x x x -0.168559 x x x x x x x x x x x 0.102804 0.0949202 x x -0.0372589 x 0.0375579 0.433102 x x x x -0.151018 x x x -0.329621 0.0135206 0.108685 x x -0.237843 0.561269 x -0.167234 0.0480445 0.0271857 -0.0424244 x x x 0.549646 x -0.309732 x x x x x 0.232147 0.243174 -0.0313238 x -0.351518 x 0.288784 -0.0406591 x x x x x -0.511369 x x x -0.774942 x 0.328547 x +16261 Metagenome, gastrointestinal system: Microbiome, Coriobacteriales (order) frequency assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction] None Metagenome, gastrointestinal system: Microbiome, Coriobacteriales (order) frequency assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction] -0.298915 x 0.112491 -0.321125 x x x x x x -0.596804 1.02431 x x x x x x x x x x 0.164162 x x x x x x x -0.168559 x x x x x x x x x x x 0.102804 0.0949202 x x -0.0372589 x 0.0375579 0.433102 x x x x -0.151018 x x x -0.329621 0.0135206 0.108685 x x -0.237843 0.561269 x -0.167234 0.0480445 0.0271857 -0.0424244 x x x 0.549646 x -0.309732 x x x x x 0.232147 0.243174 -0.0313238 x -0.351518 x 0.288784 -0.0406591 x x x x x -0.511369 x x x -0.774942 x 0.328547 x +16262 Metagenome, gastrointestinal system: Microbiome, Coriobacteridaesub (class) frequency assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction] None Metagenome, gastrointestinal system: Microbiome, Coriobacteridaesub (class) frequency assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction] -0.298915 x 0.112491 -0.321125 x x x x x x -0.596804 1.02431 x x x x x x x x x x 0.164162 x x x x x x x -0.168559 x x x x x x x x x x x 0.102804 0.0949202 x x -0.0372589 x 0.0375579 0.433102 x x x x -0.151018 x x x -0.329621 0.0135206 0.108685 x x -0.237843 0.561269 x -0.167234 0.0480445 0.0271857 -0.0424244 x x x 0.549646 x -0.309732 x x x x x 0.232147 0.243174 -0.0313238 x -0.351518 x 0.288784 -0.0406591 x x x x x -0.511369 x x x -0.774942 x 0.328547 x +16263 Metagenome, gastrointestinal system: Microbiome, Coriobacterineae (suborder) proportionassessed by 16S rRNA sequencing of fecal pellets from young adult males andfemales [residuals, log10 of fraction] None Metagenome, gastrointestinal system: Microbiome, Coriobacterineae (suborder) proportionassessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction] -0.298915 x 0.112491 -0.321125 x x x x x x -0.596804 1.02431 x x x x x x x x x x 0.164162 x x x x x x x -0.168559 x x x x x x x x x x x 0.102804 0.0949202 x x -0.0372589 x 0.0375579 0.433102 x x x x -0.151018 x x x -0.329621 0.0135206 0.108685 x x -0.237843 0.561269 x -0.167234 0.0480445 0.0271857 -0.0424244 x x x 0.549646 x -0.309732 x x x x x 0.232147 0.243174 -0.0313238 x -0.351518 x 0.288784 -0.0406591 x x x x x -0.511369 x x x -0.774942 x 0.328547 x +16264 Metagenome, gastrointestinal system: Microbiome, Corynebacteriaceae (family) proportionassessed by 16S rRNA sequencing of fecal pellets from young adult males andfemales [residuals, log10 of fraction] None Metagenome, gastrointestinal system: Microbiome, Corynebacteriaceae (family) proportionassessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction] -0.244724 x -0.326875 0.8252 x x x x x x -0.0323169 -0.588917 x x x x x x x x x x -0.672274 x x x x x x x -0.714803 x x x x x x x x x x x -0.673119 -0.212555 x x -0.250729 x 0.198623 0.236489 x x x x -0.302632 x x x -0.220995 -0.180725 -0.0290138 x x -0.263404 0.00686757 x -0.0285666 -0.0511476 -0.231856 -0.136658 x x x -0.208717 x 1.00014 x x x x x -0.205904 0.218348 -0.0715149 x 0.86199 x 0.907302 0.617009 x x x x x -0.151139 x x x -0.0711263 x 0.997745 x +16265 Metagenome, gastrointestinal system: Microbiome, Corynebacterineae (suborder) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males andfemales [residuals, log10 of fraction] None Metagenome, gastrointestinal system: Microbiome, Corynebacterineae (suborder) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction] -0.276183 x -0.358335 1.05865 x x x x x x -0.0637763 -0.620376 x x x x x x x x x x -0.703734 x x x x x x x -0.746262 x x x x x x x x x x x -0.704579 -0.0764024 x x -0.311146 x 0.198623 0.238459 x x x x -0.302632 x x x -0.257375 -0.186896 -0.0413563 x x -0.263404 -0.00547495 x -0.040909 -0.0634901 -0.244198 -0.149001 x x x -0.221059 x 0.98714 x x x x x -0.083881 0.245397 -0.107895 x 0.855433 x 0.925484 0.617009 x x x x x -0.197077 x x x -0.0834688 x 0.982713 x +16266 Metagenome, gastrointestinal system: Microbiome, Corynebacterium (genus) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males andfemales [residuals, log10 of fraction] None Metagenome, gastrointestinal system: Microbiome, Corynebacterium (genus) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction] -0.244724 x -0.326875 0.8252 x x x x x x -0.0323169 -0.588917 x x x x x x x x x x -0.672274 x x x x x x x -0.714803 x x x x x x x x x x x -0.673119 -0.212555 x x -0.250729 x 0.198623 0.236489 x x x x -0.302632 x x x -0.220995 -0.180725 -0.0290138 x x -0.263404 0.00686757 x -0.0285666 -0.0511476 -0.231856 -0.136658 x x x -0.208717 x 1.00014 x x x x x -0.205904 0.218348 -0.0715149 x 0.86199 x 0.907302 0.617009 x x x x x -0.151139 x x x -0.0711263 x 0.997745 x +16267 Metagenome, gastrointestinal system: Microbiome, Erysipelotrichaceae (family) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males andfemales [residuals, log10 of fraction] None Metagenome, gastrointestinal system: Microbiome, Erysipelotrichaceae (family) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction] -0.666374 x 1.28778 0.587961 x x x x x x 0.153322 0.331 x x x x x x x x x x 0.519012 x x x x x x x 0.0777729 x x x x x x x x x x x -1.0343 0.415382 x x 0.469347 x -0.00773274 -0.160974 x x x x -0.241509 x x x -0.445406 -0.0953455 -0.288817 x x -0.0910713 -0.404969 x -0.289848 0.996801 0.359467 0.0475529 x x x 0.219512 x 0.701748 x x x x x 0.560564 -0.932489 -0.657249 x -0.87568 x -0.362342 -0.161732 x x x x x 0.594353 x x x 0.599039 x -1.20478 x +16268 Metagenome, gastrointestinal system: Microbiome, Erysipelotrichales (order) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males andfemales [residuals, log10 of fraction] None Metagenome, gastrointestinal system: Microbiome, Erysipelotrichales (order) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction] -0.666374 x 1.28778 0.587961 x x x x x x 0.153322 0.331 x x x x x x x x x x 0.519012 x x x x x x x 0.0777729 x x x x x x x x x x x -1.0343 0.415382 x x 0.469347 x -0.00773274 -0.160974 x x x x -0.241509 x x x -0.445406 -0.0953455 -0.288817 x x -0.0910713 -0.404969 x -0.289848 0.996801 0.359467 0.0475529 x x x 0.219512 x 0.701748 x x x x x 0.560564 -0.932489 -0.657249 x -0.87568 x -0.362342 -0.161732 x x x x x 0.594353 x x x 0.599039 x -1.20478 x +16269 Metagenome, gastrointestinal system: Microbiome, Erysipelotrichi (class) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males andfemales [residuals, log10 of fraction] None Metagenome, gastrointestinal system: Microbiome, Erysipelotrichi (class) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction] -0.666374 x 1.28778 0.587961 x x x x x x 0.153322 0.331 x x x x x x x x x x 0.519012 x x x x x x x 0.0777729 x x x x x x x x x x x -1.0343 0.415382 x x 0.469347 x -0.00773274 -0.160974 x x x x -0.241509 x x x -0.445406 -0.0953455 -0.288817 x x -0.0910713 -0.404969 x -0.289848 0.996801 0.359467 0.0475529 x x x 0.219512 x 0.701748 x x x x x 0.560564 -0.932489 -0.657249 x -0.87568 x -0.362342 -0.161732 x x x x x 0.594353 x x x 0.599039 x -1.20478 x +16270 Metagenome, gastrointestinal system: Microbiome, Firmicutes (phylum) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction] None Metagenome, gastrointestinal system: Microbiome, Firmicutes (phylum) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction] 0.0296774 x 0.0815978 0.0553438 x x x x x x 0.0153972 -0.161755 x x x x x x x x x x -0.0137528 x x x x x x x 0.0283285 x x x x x x x x x x x -0.00885991 0.0634745 x x 0.0204117 x -0.0292455 0.0133247 x x x x 0.0943384 x x x -0.0172929 -0.0177875 0.0161917 x x 0.0577529 -0.0650127 x -0.0762745 0.00402869 0.0300363 -0.0728906 x x x -0.0503368 x 0.0487216 x x x x x -0.0169733 0.00625448 -0.0516014 x 0.0481878 x -0.093757 -0.0483435 x x x x x 0.0669109 x x x 0.0528318 x -0.00892617 x +16271 Metagenome, gastrointestinal system: Microbiome, Lachnospiraceae Incertae Sedis (genus) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males andfemales [residuals, log10 of fraction] None Metagenome, gastrointestinal system: Microbiome, Lachnospiraceae Incertae Sedis (genus) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction] 0.291713 x -0.161637 -0.104141 x x x x x x 0.476806 0.86281 x x x x x x x x x x -0.23363 x x x x x x x 0.40317 x x x x x x x x x x x -0.219648 0.457722 x x 0.594979 x 0.591208 0.401855 x x x x -0.173797 x x x 0.172929 0.309742 0.171417 x x -0.338134 -0.386662 x 0.496834 -0.364225 -0.520103 -0.0857305 x x x -0.463669 x -1.48526 x x x x x -0.236941 -0.400222 -0.499692 x 0.419061 x -0.16794 -0.482566 x x x x x -0.0916087 x x x 0.367598 x 0.39776 x +16272 Metagenome, gastrointestinal system: Microbiome, Lachnospiraceae (family) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males andfemales [residuals, log10 of fraction] None Metagenome, gastrointestinal system: Microbiome, Lachnospiraceae (family) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction] -0.428522 x 0.0810765 0.116844 x x x x x x 0.455007 0.31158 x x x x x x x x x x -0.410224 x x x x x x x -0.0995122 x x x x x x x x x x x 0.0605468 0.0671499 x x 0.228891 x -0.0218005 0.0912356 x x x x 0.171946 x x x 0.211844 0.364129 0.0129055 x x -0.102911 0.030296 x 0.196323 -0.319809 -0.10675 -0.157542 x x x 0.0179584 x -0.420778 x x x x x 0.209992 -0.0261196 -0.269106 x 0.0837835 x -0.0849984 -0.473175 x x x x x 0.0260585 x x x 0.113566 x 0.0701148 x +16273 Metagenome, gastrointestinal system: Microbiome, Lactobacillaceae (family) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males andfemales [residuals, log10 of fraction] None Metagenome, gastrointestinal system: Microbiome, Lactobacillaceae (family) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction] 0.166769 x -0.0335204 -0.188119 x x x x x x -0.292566 -0.245628 x x x x x x x x x x 0.197213 x x x x x x x 0.234125 x x x x x x x x x x x 0.0627403 0.0812679 x x -0.153935 x -0.0188299 -0.0221787 x x x x 0.100631 x x x -0.0402408 -0.259882 0.0755088 x x 0.0810103 -0.0458573 x -0.1782 0.0461477 0.108648 -0.0562578 x x x -0.0626443 x 0.177345 x x x x x -0.0194291 0.0193415 0.0692351 x 0.0911389 x -0.0677089 -0.0057351 x x x x x 0.136946 x x x 0.0927899 x -0.050126 x +16274 Metagenome, gastrointestinal system: Microbiome, Lactobacillales (order) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males andfemales [residuals, log10 of fraction] None Metagenome, gastrointestinal system: Microbiome, Lactobacillales (order) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction] 0.163324 x -0.0414604 -0.186893 x x x x x x -0.291532 -0.243622 x x x x x x x x x x 0.187369 x x x x x x x 0.225347 x x x x x x x x x x x 0.0569694 0.0784068 x x -0.15547 x -0.0225379 -0.0219444 x x x x 0.104223 x x x -0.0398604 -0.251663 0.0721055 x x 0.0827533 -0.038353 x -0.179005 0.044831 0.102554 -0.0585214 x x x -0.0480389 x 0.174505 x x x x x -0.0196597 0.0203909 0.0681611 x 0.0876842 x -0.0306362 -0.00948277 x x x x x 0.130958 x x x 0.0877733 x -0.048675 x +16275 Metagenome, gastrointestinal system: Microbiome, Lactobacillus (genus) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction] None Metagenome, gastrointestinal system: Microbiome, Lactobacillus (genus) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction] 0.166257 x -0.0344694 -0.188403 x x x x x x -0.293797 -0.242885 x x x x x x x x x x 0.197666 x x x x x x x 0.234947 x x x x x x x x x x x 0.0620364 0.0811225 x x -0.15617 x -0.019465 -0.0220185 x x x x 0.101186 x x x -0.0400069 -0.258527 0.0749236 x x 0.0819602 -0.0441376 x -0.17922 0.0443007 0.108643 -0.0563982 x x x -0.0609753 x 0.177551 x x x x x -0.020274 0.0199332 0.0700996 x 0.09102 x -0.0676415 -0.00611784 x x x x x 0.136874 x x x 0.0926035 x -0.0506184 x +16276 Metagenome, gastrointestinal system: Microbiome, Marinilabilia (genus) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction] None Metagenome, gastrointestinal system: Microbiome, Marinilabilia (genus) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction] 0.993771 x -0.863711 -0.833092 x x x x x x -0.569295 -0.52309 x x x x x x x x x x -1.05589 x x x x x x x 0.987624 x x x x x x x x x x x 0.965482 -0.457954 x x -0.664574 x -0.561936 -0.0652021 x x x x 0.177632 x x x 0.195705 -0.910036 0.754849 x x 0.0306079 -0.540057 x 0.412223 0.515941 -1.23032 1.29029 x x x -0.605254 x -1.09546 x x x x x 0.199433 1.46076 0.312049 x 0.818112 x 0.967787 0.539845 x x x x x -0.864739 x x x -1.21829 x 1.4368 x +16277 Metagenome, gastrointestinal system: Microbiome, Prevotellaceae (family) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males andfemales [residuals, log10 of fraction] None Metagenome, gastrointestinal system: Microbiome, Prevotellaceae (family) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction] 0.721831 x -1.44635 0.372893 x x x x x x -1.06364 1.38996 x x x x x x x x x x -0.595141 x x x x x x x 0.577361 x x x x x x x x x x x -0.174255 -1.3251 x x -0.958788 x 0.38873 -0.558501 x x x x -0.0725758 x x x 0.528854 0.352648 0.659431 x x -0.159085 0.393057 x 0.726732 0.023064 -0.526339 0.852699 x x x 0.292428 x -0.542555 x x x x x 0.89849 0.933052 0.00708122 x 0.113571 x 0.634882 -0.915458 x x x x x -1.45368 x x x -0.6826 x 0.607313 x +16278 Metagenome, gastrointestinal system: Microbiome, Rikenellaceae (family) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction] None Metagenome, gastrointestinal system: Microbiome, Rikenellaceae (family) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction] 0.8277 x -1.46379 -0.355714 x x x x x x -1.0204 1.02282 x x x x x x x x x x -1.80803 x x x x x x x 0.643781 x x x x x x x x x x x 0.899423 -0.641259 x x -1.36778 x -0.00549038 0.3247 x x x x -0.223113 x x x 0.536495 0.0170183 0.314471 x x -0.173168 -0.122023 x 0.366687 0.218054 -0.255001 0.916512 x x x 0.0963906 x -0.674298 x x x x x 0.310403 0.99694 0.759679 x 0.338541 x 0.793746 0.320277 x x x x x -1.3553 x x x -1.31313 x 1.07487 x +16279 Metagenome, gastrointestinal system: Microbiome, Ruminococcaceae (family) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males andfemales [residuals, log10 of fraction] None Metagenome, gastrointestinal system: Microbiome, Ruminococcaceae (family) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction] -0.414616 x 0.176192 0.225687 x x x x x x 0.375886 0.265788 x x x x x x x x x x -0.462219 x x x x x x x -0.513273 x x x x x x x x x x x 0.155383 0.0130721 x x 0.320702 x -0.210747 0.118105 x x x x 0.13548 x x x -0.00559473 0.581611 -0.212829 x x 0.0542575 0.173474 x 0.250021 -0.306303 -0.150723 0.0776548 x x x -0.00223868 x -0.491184 x x x x x 0.150336 0.106015 -0.336554 x 0.128256 x -0.173121 -0.298541 x x x x x 0.160177 x x x -0.0856468 x 0.195492 x +16280 Metagenome, gastrointestinal system: Microbiome, TM7 genera incertae sedis (genus) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males andfemales [residuals, log10 of fraction] None Metagenome, gastrointestinal system: Microbiome, TM7 genera incertae sedis (genus) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction] 1.05725 x -0.944007 0.686322 x x x x x x -0.949877 -1.05493 x x x x x x x x x x -0.337048 x x x x x x x -0.72779 x x x x x x x x x x x 1.01681 0.0639868 x x -1.45837 x -0.830352 0.933026 x x x x 0.379405 x x x 0.135504 0.626344 -0.54558 x x -0.585176 0.746883 x 0.507109 0.193912 -0.296364 0.162131 x x x -0.428067 x 0.122313 x x x x x 0.722149 0.719246 0.23496 x -0.0839088 x 1.08359 -0.0551184 x x x x x -1.3781 x x x -0.811472 x 1.09523 x +16281 Metagenome, gastrointestinal system: Microbiome, TM7 (phylum) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction] None Metagenome, gastrointestinal system: Microbiome, TM7 (phylum) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction] 1.05725 x -0.944007 0.686322 x x x x x x -0.949877 -1.05493 x x x x x x x x x x -0.337048 x x x x x x x -0.72779 x x x x x x x x x x x 1.01681 0.0639868 x x -1.45837 x -0.830352 0.933026 x x x x 0.379405 x x x 0.135504 0.626344 -0.54558 x x -0.585176 0.746883 x 0.507109 0.193912 -0.296364 0.162131 x x x -0.428067 x 0.122313 x x x x x 0.722149 0.719246 0.23496 x -0.0839088 x 1.08359 -0.0551184 x x x x x -1.3781 x x x -0.811472 x 1.09523 x +16282 Metagenome, gastrointestinal system: Microbiome, Turicibacter (genus) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction] None Metagenome, gastrointestinal system: Microbiome, Turicibacter (genus) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction] -0.837607 x 1.77119 0.525424 x x x x x x -0.927229 -0.0978546 x x x x x x x x x x 1.03085 x x x x x x x -0.119392 x x x x x x x x x x x -0.965971 -0.372315 x x -0.164168 x -0.0995034 -0.366396 x x x x -0.149839 x x x -0.182337 -0.184208 -0.337061 x x -0.110611 -0.00237705 x -0.188326 1.63795 -0.391615 0.53696 x x x -0.368476 x 1.26997 x x x x x 0.141262 -0.298895 -0.331461 x -0.385042 x -0.476425 0.229842 x x x x x 1.21808 x x x -0.379584 x -0.624843 x +16283 Metagenome, gastrointestinal system: Microbiome, Bacillales (order) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction] None Metagenome, gastrointestinal system: Microbiome, Bacillales (order) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction] 0.509227 x 1.34562 0.781456 x x x x x x 0.255585 -0.52288 x x x x x x x x x x -0.159732 x x x x x x x -1.65041 x x x x x x x x x x x -1.38555 0.979671 x x -0.164978 x -0.155753 0.394321 x x x x -0.264295 x x x -0.0911772 0.165594 -0.863361 x x -0.274703 -0.183023 x -0.612316 -0.436189 -0.35259 0.411867 x x x -0.730184 x -0.202938 x x x x x 0.126256 0.358318 -0.151305 x 0.0784648 x 0.564508 0.299649 x x x x x 0.347337 x x x 0.524417 x 1.05909 x +16284 Metagenome, gastrointestinal system: Microbiome, Staphylococcaceae (family) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males andfemales [residuals, log10 of fraction] None Metagenome, gastrointestinal system: Microbiome, Staphylococcaceae (family) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction] 0.515558 x 1.351 0.769464 x x x x x x 0.258365 -0.541316 x x x x x x x x x x -0.153281 x x x x x x x -1.64257 x x x x x x x x x x x -1.37848 0.98483 x x -0.27297 x -0.194812 0.456249 x x x x -0.260157 x x x -0.20223 0.173208 -0.847674 x x -0.258979 -0.229813 x -0.596808 -0.421394 -0.352209 0.40805 x x x -0.753018 x -0.237714 x x x x x 0.164327 0.42348 -0.110376 x 0.0907167 x 0.567059 0.304335 x x x x x 0.382058 x x x 0.536762 x 1.06834 x +16285 Metagenome, gastrointestinal system: Microbiome, Staphylococcus (genus) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction] None Metagenome, gastrointestinal system: Microbiome, Staphylococcus (genus) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction] 0.53052 x 1.38484 0.735944 x x x x x x 0.242675 -0.50985 x x x x x x x x x x -0.18338 x x x x x x x -1.60456 x x x x x x x x x x x -1.34788 0.999303 x x -0.23702 x -0.147351 0.480623 x x x x -0.321241 x x x -0.174319 0.159347 -0.857457 x x -0.318658 -0.209337 x -0.581701 -0.406593 -0.360293 0.427809 x x x -0.719009 x -0.317094 x x x x x 0.207293 0.280525 -0.0937761 x 0.0432627 x 0.550392 0.341859 x x x x x 0.412962 x x x 0.501139 x 1.09102 x +16286 Metagenome, gastrointestinal system: Microbiome, Jeotgalicoccus (genus) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction] None Metagenome, gastrointestinal system: Microbiome, Jeotgalicoccus (genus) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction] 0.39998 x -0.726933 1.17051 x x x x x x 0.397771 -0.834406 x x x x x x x x x x 0.113036 x x x x x x x -1.06839 x x x x x x x x x x x -0.733612 0.108686 x x -0.373887 x -0.327538 0.135225 x x x x 0.310783 x x x -0.15975 0.447092 -0.320143 x x 0.148086 -0.163575 x -0.101514 0.00254179 -0.270905 -0.0378914 x x x -0.913629 x 0.239595 x x x x x -0.258034 0.909799 -0.118824 x 0.481649 x 0.86244 -0.218316 x x x x x 0.0535525 x x x 0.0422198 x 0.804388 x +16287 Metagenome, gastrointestinal system: Microbiome, Bacteroidaceae (family) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males andfemales [residuals, log10 of fraction] None Metagenome, gastrointestinal system: Microbiome, Bacteroidaceae (family) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction] 0.454638 x -1.06418 0.814548 x x x x x x -1.46221 1.26315 x x x x x x x x x x -0.230965 x x x x x x x -1.01865 x x x x x x x x x x x 0.950246 -0.829507 x x -1.42975 x -0.258696 0.39728 x x x x -0.500254 x x x 0.782929 0.3355 -0.00611854 x x 0.480543 0.413909 x 0.177243 0.0746275 -0.141143 0.505859 x x x 0.913007 x -0.86488 x x x x x 0.246317 0.148124 0.907988 x -0.174652 x -0.133395 0.198971 x x x x x -0.932641 x x x -0.454647 x 0.436818 x +16288 Metagenome, gastrointestinal system: Microbiome, Bacteroides (genus) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction] None Metagenome, gastrointestinal system: Microbiome, Bacteroides (genus) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction] 0.454619 x -1.06418 0.814547 x x x x x x -1.46223 1.26318 x x x x x x x x x x -0.230937 x x x x x x x -1.01867 x x x x x x x x x x x 0.95022 -0.829509 x x -1.42968 x -0.258571 0.39736 x x x x -0.500147 x x x 0.782945 0.335544 -0.00610765 x x 0.480129 0.41392 x 0.177242 0.0746193 -0.141126 0.505851 x x x 0.913006 x -0.864893 x x x x x 0.24641 0.148229 0.907645 x -0.174666 x -0.133356 0.199048 x x x x x -0.932585 x x x -0.454655 x 0.436798 x +16289 Metagenome, gastrointestinal system: Microbiome, Proteobacteria (phylum) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males andfemales [residuals, log10 of fraction] None Metagenome, gastrointestinal system: Microbiome, Proteobacteria (phylum) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction] 0.110449 x -0.256438 0.0125445 x x x x x x -0.0442753 0.910501 x x x x x x x x x x -0.107983 x x x x x x x -0.474307 x x x x x x x x x x x 0.0783774 0.265936 x x -0.255395 x 0.360211 0.438629 x x x x -0.384531 x x x -0.000326915 0.0699349 0.13694 x x 0.0716448 0.745071 x 0.224942 0.307481 -0.789893 -0.0254416 x x x 0.182263 x -0.597315 x x x x x 0.0785046 -0.0701852 0.0968717 x -0.373935 x 0.34468 -0.315172 x x x x x -0.717894 x x x -0.286223 x 0.264334 x +16290 Metagenome, gastrointestinal system: Microbiome, Lactobacillus johnsonii (OTU) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction] None Metagenome, gastrointestinal system: Microbiome, Lactobacillus johnsonii (OTU) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction] 0.440476 x 0.511281 0.0547226 x x x x x x 0.244005 -2.47521 x x x x x x x x x x 0.60437 x x x x x x x 0.635076 x x x x x x x x x x x 0.407482 0.479303 x x 1.2792 x 0.831303 1.07773 x x x x 0.182013 x x x -0.254376 -3.15311 0.556686 x x 0.446942 -0.13064 x 0.33951 0.704264 0.514822 0.379683 x x x -4.57336 x 0.39439 x x x x x 0.949019 -0.365074 -2.57964 x 0.574613 x -0.78529 0.84578 x x x x x 1.01271 x x x 0.573006 x 0.278322 x +16291 Metagenome, gastrointestinal system: Microbiome, Lactobacillus murinus (OTU) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction] None Metagenome, gastrointestinal system: Microbiome, Lactobacillus murinus (OTU) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction] 1.50579 x -2.4381 0.960542 x x x x x x -0.338603 1.82928 x x x x x x x x x x -5.24033 x x x x x x x 1.3068 x x x x x x x x x x x 0.931507 -0.0424446 x x -3.01301 x -0.335567 1.44443 x x x x 0.288892 x x x 1.03771 0.242734 -0.319416 x x 0.325059 0.778031 x 0.0946134 0.0233313 0.20098 0.18155 x x x 0.505762 x 0.673257 x x x x x 0.672227 1.42131 1.27604 x -0.401894 x 0.60146 -0.453527 x x x x x -3.02855 x x x -1.30083 x 0.610973 x +16292 Metagenome, gastrointestinal system: Microbiome, Lactobacillus intestinalis (OTU) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction] None Metagenome, gastrointestinal system: Microbiome, Lactobacillus intestinalis (OTU) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction] 1.81682 x -0.367112 -2.68621 x x x x x x -0.542551 -2.85254 x x x x x x x x x x -3.09628 x x x x x x x -0.567343 x x x x x x x x x x x 3.74495 0.755631 x x -3.11009 x 0.272371 0.175533 x x x x 0.225425 x x x -1.38146 -0.647724 0.962051 x x 0.323943 0.472265 x 0.375084 0.739413 0.700516 0.764339 x x x -3.8941 x 2.54968 x x x x x 1.65471 3.74254 -1.29901 x 0.780717 x 1.34902 0.513291 x x x x x -0.83864 x x x -2.54795 x 1.91271 x +16293 Metagenome, gastrointestinal system: Microbiome, Staphylococcus xylosus (OTU) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction] None Metagenome, gastrointestinal system: Microbiome, Staphylococcus xylosus (OTU) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction] 0.934974 x 1.8781 1.12797 x x x x x x 0.710625 -0.104845 x x x x x x x x x x -0.257789 x x x x x x x -4.99798 x x x x x x x x x x x -0.753829 1.31617 x x -1.39833 x -0.398366 1.5167 x x x x -0.263134 x x x -0.693281 0.647897 -1.53654 x x -0.424516 -1.02842 x -0.820257 -3.41658 -1.41836 1.76161 x x x 1.10594 x 0.499455 x x x x x 0.812163 -0.360838 1.15982 x 0.966136 x 0.972458 0.359042 x x x x x 0.887055 x x x -0.754912 x 1.97186 x +16294 Metagenome, gastrointestinal system: Microbiome, Staphylococcus lentus (OTU) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction] None Metagenome, gastrointestinal system: Microbiome, Staphylococcus lentus (OTU) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction] -0.912678 x -2.52861 2.79972 x x x x x x 2.56917 -2.36757 x x x x x x x x x x 0.272821 x x x x x x x -2.99654 x x x x x x x x x x x -2.11249 0.21923 x x -1.6836 x 0.33462 0.923161 x x x x 0.283263 x x x 0.0818799 -0.62505 -2.77466 x x 0.145681 -2.15993 x -0.12598 -1.79644 -0.381589 2.15396 x x x -3.84856 x 1.10337 x x x x x 0.487053 2.61348 -0.0509118 x 2.46408 x 2.57232 -1.98981 x x x x x 2.55709 x x x 2.33023 x 2.44328 x +16295 Metagenome, gastrointestinal system: Microbiome, Barnsiella (OTU) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction] None Metagenome, gastrointestinal system: Microbiome, Barnsiella (OTU) proportion assessed by 16S rRNA sequencing of fecal pellets from young adult males and females [residuals, log10 of fraction] 0.00304035 x -2.64151 0.300188 x x x x x x 0.840267 0.420511 x x x x x x x x x x -0.0688201 x x x x x x x 0.504685 x x x x x x x x x x x 0.923472 -2.66217 x x 0.351238 x 0.17233 0.249233 x x x x -0.978736 x x x 0.518873 0.642998 0.149715 x x -0.626442 1.00393 x 0.610731 0.780141 -0.0834485 0.834213 x x x 0.951121 x -0.310491 x x x x x 0.566277 0.174957 1.27112 x 0.0354868 x 0.453424 0.532845 x x x x x -3.13209 x x x -2.25496 x 0.467885 x +16296 Original post publication description: Delprato_Crusio_1 Original pre publication description: Delprato_Crusio_1 Delprato_Crusio_1 Unpublished x x 4.111 1.894 1.815 2.462 x 1.966 3.171 x 2.378 x 2.071 2.075 1.334 2.129 2.685 1.731 x 2.506 x x x x x 2.497 2.88 x x 2.268 1.678 3.061 2.196 x x x x 2.518 2.573 x 1.831 2.403 2.354 x x x 1.659 2.595 2.548 3.363 x x x x x x x x x 3.816 4.201 x x 2.567 2.578 x 1.899 3.774 3.218 2.829 x 2.167 x 2.643 x 1.434 x x 2.308 1.623 x x 1.832 1.774 1.417 2.35 x 2.601 2.871 x 1.376 x x x 2.16 2.188 2.05 x 2.441 2.139 2.675 x +16297 Original post publication description: Central nervous system, morphology, eye, visual system: Photoreceptor density (rods and cones) in young adults of both sexes (BXD97, BXD92, and BXD65 have been merged together.) [cells/mm^3] None Central nervous system, morphology, eye, visual system: Photoreceptor density (rods and cones) in young adults of both sexes (BXD97, BXD92, and BXD65 merged, BXD96 and BXD48 merged, BXD80 and BXD73 merged) [cells/mm^3] 532285.0 496127.0 454220.0 476437.0 457598.0 x 430738.0 446377.0 495641.0 420529.0 430495.0 450736.0 466350.0 414452.0 446295.0 x x x x x x 433777.0 x x x 440170.0 x x x 412741.0 201980.0 417369.0 459468.0 x 453167.0 x 483159.0 444788.0 425391.0 x x 447714.0 391360.0 476600.0 x x 425658.0 x 464332.0 463797.0 x x x 424639.0 481688.0 x x x 430323.0 496734.0 487072.0 435697.0 465094.0 478381.0 470057.0 417661.0 x 438878.0 439927.0 514277.0 x 465223.0 483608.0 472325.0 x 507147.0 x x x 489766.0 x x 426039.0 466512.0 465378.0 409347.0 x 471576.0 447365.0 x x x x x x x 451449.0 x x x x x +16298 Original post publication description: Central nervous system, morphology, eye, visual system: Photoreceptor number (rods and cones), unilateral per retina in young adults of both sexes (BXD97, BXD92, and BXD65 have been merged together. BXD96 and BXD48 have been merged together. BXD80 and BXD73 have been merged together.) [n x10^6] None Central nervous system, morphology, eye, visual system: Photoreceptor number (rods and cones), unilateral per retina in young adults of both sexes (BXD97, BXD92, and BXD65 merged, BXD96 and BXD48 merged, BXD80 and BXD73 merged ) [n x10^6] 8415350.0 8330980.0 7947670.0 9018000.0 8242460.0 x 7029650.0 7539990.0 7841040.0 6142620.0 7959680.0 7301560.0 7484060.0 6285550.0 8225400.0 x x x x x x 7957070.0 x x x 7126990.0 x x x 7008420.0 3507350.0 6066040.0 7376060.0 x 8656460.0 x 7898080.0 7498950.0 6637860.0 x x 7896080.0 5969000.0 7419700.0 x x 6678710.0 x 7355900.0 7282700.0 x x x 6925380.0 8706560.0 x x x 7406900.0 8189850.0 7637950.0 7291650.0 7827120.0 7936540.0 7283880.0 7051910.0 x 7067820.0 6100370.0 8228570.0 x 7569900.0 7277860.0 7143290.0 x 8119760.0 x x x 7704030.0 x x 6637680.0 7419100.0 7167640.0 6332600.0 x 7440620.0 7315010.0 x x x x x x x 6783890.0 x x x x x +16310 Original post publication description: Central nervous system, gene expression: Tnik mRNA expression in hippocampus (TRAF2 and NCK interacting kinase), first principal component generated using exon probe sets and UMUTAffyExon_0209_RMA data [relative residual concentration] Original pre publication description: Central nervous system, gene expression: Erbb4 mRNA expression in hippocampus (receptor tyrosine-protein kinase erbB-4), first principal component generated using exon probe sets and UMUTAffyExon_0209_RMA data [relative residual concentration] Central nervous system, gene expression: Erbb4 mRNA expression in hippocampus (receptor tyrosine-protein kinase erbB-4), first principal component generated using exon probe sets and UMUTAffyExon_0209_RMA data [relative residual concentration] Central nervous system, gene expression: Erbb4 mRNA expression in hippocampus (receptor tyrosine-protein kinase erbB-4), first principal component generated using exon probe sets and UMUTAffyExon_0209_RMA data [relative residual concentration] 2.197 -1.227 -2.041 -1.217 0.81 -0.779 -2.989 0.976 -0.059 0.337 -3.842 -2.248 1.573 -3.876 0.963 0.429 -1.55 1.31 -1.58 -4.528 0.926 -1.357 x 2.605 2.237 0.704 4.621 0.472 x -6.725 4.665 1.626 0.17 x -0.793 x -9.0 1.081 -2.872 x -2.402 4.062 x 2.161 x x 5.478 x 2.01 1.428 x x x -3.818 x x x x 2.662 0.127 -3.348 0.728 2.767 -0.909 -0.551 -0.059 3.334 8.203 1.584 x x 2.13 -5.027 -4.22 -5.99 2.084 x -3.466 2.186 x x -0.236 5.29 -2.253 3.875 7.865 x 0.928 0.218 x 0.899 -4.638 -1.507 x -0.423 -0.508 -1.64 2.742 x x x x +16300 Original post publication description: Central nervous system, morphology, eye, visual system: Photoreceptor density (rods and cones) without strain merge, unilateral per retina in young adults of both sexes [cells/mm^3] None Central nervous system, morphology, eye, visual system: Photoreceptor density (rods and cones), unilateral per retina in young adults of both sexes [cells/mm^3] 532285.0 496127.0 454220.0 476437.0 457598.0 x 430738.0 446377.0 495641.0 420529.0 430495.0 450736.0 466350.0 414452.0 446295.0 x x x x x x 433777.0 x x x 440170.0 x x x 412741.0 201980.0 417369.0 459468.0 x 453167.0 x 483159.0 444788.0 425391.0 x x 447714.0 391360.0 476600.0 x x 429863.0 x 464332.0 463797.0 x x x 424639.0 481688.0 x x x 430323.0 496734.0 487072.0 435697.0 465094.0 473354.0 470057.0 417661.0 x 438878.0 439927.0 514277.0 x 454852.0 483608.0 472325.0 x 507147.0 x x 475595.0 489766.0 x x 426039.0 466512.0 465378.0 409347.0 x 471576.0 447365.0 x 506701.0 x x x 421453.0 459746.0 451449.0 x x x x x +16301 Original post publication description: Central nervous system, morphology, eye, visual system: Photoreceptor number (rods and cones) without strain mergence, unilateral per retina in young adults of both sexes [n x10^6] None Central nervous system, morphology, eye, visual system: Photoreceptor number (rods and cones), unilateral per retina in young adults of both sexes [n x10^6] 8415350.0 8330980.0 7947670.0 9018000.0 8242460.0 x 7029650.0 7539990.0 7841040.0 6142620.0 7959680.0 7301560.0 7484060.0 6285550.0 8225400.0 x x x x x x 7957070.0 x x x 7126990.0 x x x 7008420.0 3507350.0 6066040.0 7376060.0 x 8656460.0 x 7898080.0 7498950.0 6637860.0 x x 7896080.0 5969000.0 7419700.0 x x 6577300.0 x 7355900.0 7282700.0 x x x 6925380.0 8706560.0 x x x 7406900.0 8189850.0 7637950.0 7291650.0 7827120.0 7941770.0 7283880.0 7051910.0 x 7067820.0 6100370.0 8228570.0 x 7244620.0 7277860.0 7143290.0 x 8119760.0 x x 7895190.0 7704030.0 x x 6637680.0 7419100.0 7167640.0 6332600.0 x 7440620.0 7315010.0 x 8309400.0 x x x 6780120.0 7634070.0 6783890.0 x x x x x +16302 Original post publication description: AVG Baseline TST Immobility (sec) entered at August/28 16:21:00 from IP 172.21.162.34 None AVG Baseline TST Immobility (sec) entered at August/28 16:21:00 from IP 172.21.162.34 x 81.514 110.583 85.0 16.467 x x x x 55.9 x x x x x x x x x x x x x 48.4 x x x 108.8 x x 58.133 x 130.033 x x x x 104.443 102.4 x x x x x x x 139.4 x x 59.763 x x x x x x x x 62.237 x 79.471 66.74 70.0 104.36 151.3 x 73.033 61.975 x x x 37.48 136.914 x x 72.167 x 104.3 x x x x 126.167 x 83.287 124.587 x 46.871 80.267 x x x x 149.457 x x x x 113.933 129.617 142.917 x +16303 Original post publication description: Central nervous system; post-natal neurogenesis; Apoptosis in cortex L5 (% caspase 3+ cells) None Central nervous system; post-natal neurogenesis; Apoptosis in cortex L5 (% caspase 3+ cells) x x 6.674 12.887 x 4.349 x x x x x x x x x x x x 5.287 x x x x x x x x x x x 1.029 x x x x x x 7.112 x x x x x x x x x x x 3.234 x x x x x x x x 2.806 x x x x x x x x x x 2.119 x 6.731 x x x x x x 7.279 x x x x x x x x x x x x x x x 7.733 x x x 7.615 x x 5.96 +16304 Original post publication description: Infectious disease, immune system: Herpes simplex virus type 1, Serum neutralizing antibody titer in males Original pre publication description: Infectious disease, immune system: Herpes simplex virus type 1, Serum neutralizing antibody titer in males Infectious disease, immune system: Herpes simplex virus type 1, serum neutralizing antibody titer in young adult males [unit] Infectious disease, immune system: Herpes simplex virus type 1, serum neutralizing antibody titer in young adult males [unit] x x x x x x x x x x x 250.0 x x x x x x x x x x x x x x x x x x x x 500.0 x x x x x x x x x x x x x x x x x x x x 275.0 x x x x x 225.0 250.0 x x x x x x 175.0 400.0 425.0 x x x 175.0 x x x x x x x 350.0 300.0 x x x x x 250.0 x x x x 350.0 300.0 x 375.0 80.0 200.0 225.0 400.0 x +16305 Original post publication description: Infectious disease, immune system: Herpes simplex virus type 1, Serum neutralizing antibody titer in females Original pre publication description: Infectious disease, immune system: Herpes simplex virus type 1, Serum neutralizing antibody titer in females Infectious disease, immune system: Herpes simplex virus type 1, serum neutralizing antibody titer in young adult females [unit] Infectious disease, immune system: Herpes simplex virus type 1, serum neutralizing antibody titer in young adult females [unit] x x x x x x x x x x x 300.0 x x x x x x x x x x x x x x x x x x x x 700.0 x x x x x x x x x 600.0 x x x x x x x x x x 125.0 x x x x x 150.0 500.0 x x x x x x 175.0 150.0 400.0 x x x x x x x x x x x 225.0 300.0 x x 550.0 x 300.0 425.0 x x x x x 800.0 x 600.0 90.0 300.0 350.0 x 500.0 +16306 Original post publication description: Jamboree: 2013 Birthdays Original pre publication description: Jamboree2013 secret trait Jamboree2013 secret trait Jamboree: 2013 Birthdays x x 11.0 21.0 1.0 27.0 3.0 20.0 7.0 10.0 21.0 21.0 30.0 12.0 10.0 16.0 23.0 28.0 8.0 29.0 11.0 13.0 28.0 5.0 23.0 20.0 27.0 32.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +16307 Original post publication description: I entered at September/15 10:11:36 from IP 109.43.26.119 Delprato A, Crusio W Trait 1 Unpublished x x 4.111 1.894 1.815 2.462 x 1.966 3.171 x 2.378 x 2.071 2.075 1.334 2.129 2.685 1.731 x 2.506 x x x x x 2.497 2.88 x x 2.268 1.678 3.061 2.196 x x x x 2.518 2.573 x 1.831 2.403 2.354 x x x 1.659 2.595 2.548 3.363 x x x x x x x x x 3.816 4.201 x x 2.567 2.578 x 1.899 3.774 3.218 2.829 x 2.167 x 2.643 x 1.434 x x 2.308 1.623 x x 1.832 1.774 1.417 2.35 x 2.601 2.871 x 1.376 x x x 2.16 2.188 2.05 x 2.441 2.139 2.675 x +16308 Original post publication description: H entered at September/15 10:11:36 from IP 109.43.26.119 None H entered at September/15 10:11:36 from IP 109.43.26.119 x x 12.76 8.497 9.941 8.418 x 10.851 9.239 x 9.083 x 12.083 9.854 8.103 8.918 8.724 10.399 x 9.156 x x x x x 10.217 9.832 x x 11.175 9.093 9.499 7.485 x x x x 9.573 11.156 x 10.404 7.597 9.43 x x x 9.346 10.712 10.367 8.53 x x x x x x x x x 11.026 10.652 x x 10.392 9.34 x 9.457 10.361 10.162 8.185 x 9.334 x 8.637 x 8.039 x x 9.64 9.987 x x 9.499 9.51 8.946 8.789 x 8.425 9.167 x 11.03 x x x 8.945 8.448 9.317 x 7.761 9.564 10.817 x +16309 Original post publication description: Neurogenesis entered at September/16 10:24:03 from IP 77.24.242.160 Original pre publication description: New neurons in the dentate gyrus corrected for number of proliferating precursors. Derived from RecordIDs 10797 and 10795. Meta-trait from the Neuroinformatics Jamboree 2013. Central nervous system: New neurons in the dentate gyrus corrected for number of proliferating precursors (data derived from Record IDs 10797 and 10795) [z score] Central nervous system: New neurons in the dentate gyrus corrected for number of proliferating precursors (data derived from Record IDs 10797 and 10795) [z score] x x x x -0.393 -0.461 0.921 0.588 x -0.078 -0.83 0.197 x 0.005 0.273 -0.407 -0.173 0.277 x 0.387 -0.34 x x 0.296 -0.534 0.115 -0.327 -0.75 0.017 0.316 -0.301 -0.039 0.19 0.282 x x 0.324 -0.46 0.879 x 0.025 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +16311 Original post publication description: Central nervous system, behavior: Impulsivity measured by 5-choice serial reaction time task [n] Original pre publication description: SD1_PremPokesTotalPokes entered at September/19 04:49:47 from IP 77.24.69.98 spijker001 spijker001 4.278 5.791 8.772 14.759 9.184 5.787 x 8.833 x 9.546 8.936 x 11.081 8.996 11.911 31.855 x 8.006 x 11.051 x 6.582 11.701 x x 12.597 6.045 5.065 x 5.073 12.507 11.423 5.388 x x x 11.295 2.087 13.135 x 10.415 14.759 x x x x x x x 13.221 x x x 5.685 x x x x x 5.456 3.926 x x 12.435 x x 21.456 17.901 x x x 7.274 x 7.709 x x x x x x x x x x 5.354 5.275 x x 9.33 x x x x x 10.178 7.337 x x x x x x +16312 Original post publication description: Central nervous system, behavior, learning and memory: Fear conditioning, freezing time on first context trial 24 hours after shock training, both sexes at 3-4 months of age [percent time] Original pre publication description: Central nervous system, behavior, learning and memory: Fear conditioning, freezing time on first context trial 24 hours after shock training, both sexes at 3-4 months of age [percent time] Central nervous system, behavior, learning and memory: Fear conditioning, freezing time on first context trial 24 hours after shock training, both sexes at 3-4 months of age [percent time] Central nervous system, behavior, learning and memory: Fear conditioning, freezing time on first context trial 24 hours after shock training, both sexes at 3-4 months of age [percent time] x x 26.0 12.0 x x x x x x x x x x x x x x x x x x x x x x x x x x 18.0 x 37.0 x x x x 30.0 x x x x x x x x 10.0 x x x x x x x x x x x x x x x x x 16.0 x x 6.0 x x x 13.0 x x x 8.0 x x x x x x x x x 22.0 x 4.0 x x x x x 11.0 22.0 x x x 13.0 x x 25.0 +16313 Original post publication description: Pre-immunization weight (grams) Original pre publication description: Response of BXD female mice to immunization with TSHR A-subunit (human) adenovirus Morphology, cofactor : Body weight of young adult females before immunization with TSHR A-subunit (human) adenovirus (see Traits 16314-16323 by McLachlan and colleagues) [g] Morphology, cofactor : Body weight of young adult females before immunization with TSHR A-subunit (human) adenovirus (see Traits 16314 by McLachlan and colleagues) [g] x x x x 18.5 19.3 19.5 17.8 17.9 24.3 18.0 16.4 24.4 24.8 19.8 16.9 20.4 20.5 x 17.7 16.9 x x 17.3 x 16.7 19.2 18.6 x 16.7 18.0 14.8 20.3 x 18.5 x 21.9 17.1 18.5 x 17.8 17.4 16.9 17.7 x x 22.8 22.5 16.5 20.4 x x x 17.3 21.4 x x x 17.4 18.3 17.3 x 21.3 x 19.7 19.5 17.0 15.9 17.0 18.5 x 14.3 16.7 19.1 x 28.3 x 20.5 19.9 15.7 x 19.7 x 22.7 18.3 15.3 x 16.8 18.9 x x x x x 18.7 20.1 16.9 x 18.9 19.5 18.1 15.0 +16314 Original post publication description: TBI-0x Original pre publication description: TBI-0x: Immune system: TBI-0x:serum inhibition of TSH binding to the TSHR before immunization (% inhibition) Immune system: TBI-0x, pre-immunization serum inhibition of TSH binding to the TSHR [% inhibition] Immune system, endocrinology: serum inhibition of TSH binding to the TSHR before immunization [% inhibition] x x x x -0.1 6.2 9.6 5.1 6.9 11.2 12.0 21.8 5.6 3.7 13.9 6.4 14.8 7.4 x 5.6 -0.5 x x 4.9 x 8.8 1.7 1.0 x 3.7 10.2 3.4 8.8 x 1.5 x 4.83 3.0 4.8 x 3.4 3.3 0.5 11.8 x x 0.0 0.71 7.5 6.5 x x x 1.0 -0.1 x x x 5.1 2.7 23.1 x 0.7 x 4.9 4.8 1.8 7.0 3.2 6.5 x 1.9 -1.4 10.6 x 5.3 x 9.7 7.1 0.7 x 20.8 x 5.9 10.8 -1.2 x 9.9 2.5 x x x x x 6.2 8.1 -1.3 x 3.9 1.6 8.36 4.9 +16315 Original post publication description: TBI-2x Original pre publication description: Immune system: TBI-2x, serum inhibition of TSH binding to the TSHR 1 week after 2 immunizations with TSHR A-subunit adenovirus Immune system, endocrine system: TBI-2x, serum inhibition of TSH binding to the TSHR 1 week after 2 immunizations with TSHR A-subunit adenovirus [% inhibition] Immune system, endocrine system: TBI-2x, serum inhibition of TSH binding to the TSHR 1 week after 2 immunizations with TSHR A-subunit adenovirus [% inhibition] x x x x 51.7 67.6 39.5 42.8 69.0 32.5 27.9 57.6 84.8 79.2 55.1 19.3 49.2 58.7 x 46.2 77.0 x x 50.3 x 38.0 21.2 53.2 x 18.2 31.1 26.9 x x 58.4 x 53.5 56.4 43.4 x 75.3 72.7 44.8 59.0 x x 39.9 76.3 30.6 x x x x 79.1 x x x x 56.1 58.3 37.1 x 53.1 x 44.8 68.5 64.7 44.3 31.0 34.5 x 37.6 60.8 67.1 x 62.7 x 10.8 35.9 77.7 x 82.0 x 39.8 57.4 32.6 x 65.7 45.4 x x x x x 59.0 54.3 59.8 x 75.9 63.0 72.2 21.2 +16316 Original post publication description: TBI-3x Original pre publication description: # TBI-3x: Immune system, serum inhibition of TSH binding to the TSHR 4 weeks after 3 immunizations with TSHR A-subunit adenovirus (% inhibition) Immune system, endocrinology: Serum inhibition of TSH binding to the TSHR 4 weeks after 3 immunizations with TSHR A-subunit adenovirus in young adult females [% inhibition] Immune system, endocrinology: Serum inhibition of TSH binding to the TSHR 4 weeks after 3 immunizations with TSHR A-subunit adenovirus in young adult females [% inhibition] x x x x 46.0 87.1 39.9 52.2 62.4 36.8 21.7 33.6 83.6 82.5 55.6 20.8 34.6 59.6 x 39.6 69.0 x x 58.1 x 43.4 24.5 67.3 x 21.8 41.5 24.9 45.7 x 60.0 x 48.8 51.3 32.6 x 71.9 73.5 37.0 67.1 x x 53.1 66.0 33.1 54.8 x x x 82.5 27.0 x x x 47.2 64.9 43.4 x 65.2 x 47.2 83.1 65.7 35.7 25.6 29.8 x 39.7 74.3 83.2 x 52.8 x 8.7 40.0 74.7 x 82.1 x 72.7 56.7 33.4 x 75.2 57.2 x x x x x 56.6 58.5 62.9 x 79.0 77.0 64.3 38.0 +16317 Original post publication description: T4 -0x Original pre publication description: Endocrine system: T4-0x, serum thyroxine (T4) at base-line (micrograms/dL) Endocrine system, thyroid: T4-0x, serum thyroxine (T4) before immunization with TSHR A-subunit adenovirus [micrograms/dL] Endocrine system, thyroid: T4-0x, serum thyroxine (T4) before immunization with TSHR A-subunit adenovirus [micrograms/dL] x x x x 2.9 4.0 4.6 2.5 3.8 2.7 3.4 3.1 2.5 3.5 2.8 2.2 2.6 1.9 x 3.8 2.0 x x 3.7 x 2.7 5.2 4.4 x 3.0 2.8 2.6 3.5 x 3.3 x 3.02 3.4 4.1 x 3.7 3.9 4.3 5.2 x x 2.7 3.33 5.1 4.2 x x x 6.4 4.1 x x x 3.7 3.2 2.3 x 2.7 x 5.7 6.5 3.4 2.4 5.2 3.2 x 2.8 3.2 1.8 x 3.5 x 3.4 2.5 3.2 x 4.66 x 3.0 5.1 3.5 x 4.3 3.8 x x x x x 2.4 4.5 x x 4.1 4.02 3.25 2.6 +16318 Original post publication description: T4 -2x Original pre publication description: Endocrine system: T4-2x: serum thyroxine (T4) 1 week after 2 immunizations with TSHR A-subunit adenovirus (micrograms/dL) Endocrine system, thyroid: T4-2x: serum thyroxine (T4) 1 week after 2 immunizations with TSHR A-subunit adenovirus [micrograms/dL] Endocrine system, thyroid: T4-2x: serum thyroxine (T4) 1 week after 2 immunizations with TSHR A-subunit adenovirus [micrograms/dL] x x x x 2.6 3.2 3.4 2.4 3.1 2.6 3.1 3.0 3.5 4.9 3.4 2.8 4.2 2.4 x 5.0 2.4 x x 2.7 x 3.5 4.3 3.3 x 3.1 2.1 2.4 x x 4.7 x 2.8 3.2 2.2 x 4.3 4.7 3.0 4.8 x x 3.5 5.1 3.3 x x x x 10.4 x x x x 4.5 2.8 2.3 x 2.1 x 4.1 8.4 3.3 2.7 3.6 3.2 x 3.0 1.7 2.3 x 3.6 x 3.9 2.1 7.5 x 4.7 x 3.6 3.9 3.7 x 3.7 4.3 x x x x x 3.2 4.2 x x 6.5 6.0 4.2 2.0 +16319 Original post publication description: T4 -3x Original pre publication description: Endocrine system, thyroid: T4-3x, serum thyroxine (T4) 4 weeks after 3 immunizations of females with TSHR A-subunit adenovirus [micrograms/dL] Endocrine system, thyroid: T4-3x, serum thyroxine (T4) 4 weeks after 3 immunizations of females with TSHR A-subunit adenovirus [micrograms/dL] Endocrine system, thyroid: T4-3x, serum thyroxine (T4) 4 weeks after 3 immunizations of females with TSHR A-subunit adenovirus [micrograms/dL] x x x x 1.9 1.4 2.8 1.9 3.5 3.4 1.8 2.8 3.2 3.9 2.4 1.9 2.7 2.5 x 2.6 2.4 x x 2.1 x 3.1 2.8 4.4 x 1.9 2.0 2.3 2.7 x 4.8 x 3.0 2.5 1.5 x 3.5 2.0 3.6 3.3 x x 3.1 2.4 2.8 3.5 x x x 5.4 3.3 x x x 2.6 2.0 2.0 x 3.3 x 4.3 5.1 2.7 2.7 4.7 2.5 x 2.5 1.4 2.3 x 3.7 x 2.8 1.9 4.6 x 3.82 x 2.0 2.4 3.3 x 3.9 3.1 x x x x x 2.6 2.5 x x 6.0 3.6 3.0 1.9 +16320 Original post publication description: ELISA-2x Original pre publication description: Immune system: ELISA-2x, IgG class antibody binding to TSHR A-subunit protein in ELISA 1 week after 2 immunizations of female mice with TSHR A-subunit adenovirus [OD 490 nm] Immune system: ELISA-2x, IgG class antibody binding to TSHR A-subunit protein in ELISA 1 week after 2 immunizations of female mice with TSHR A-subunit adenovirus [OD 490 nm] Immune system: ELISA-2x, IgG class antibody binding to TSHR A-subunit protein in ELISA 1 week after 2 immunizations of female mice with TSHR A-subunit adenovirus [OD 490 nm] x x x x 1.53 1.17 1.69 0.9 1.48 1.35 0.74 1.3 1.04 1.03 1.23 0.79 1.1 1.55 x 1.41 1.41 x x 1.47 x 0.73 1.81 0.9 x 1.23 0.92 1.12 x x 1.19 x 1.28 1.2 1.37 x 1.46 1.3 2.13 1.62 x x 1.52 1.01 1.84 x x x x 1.53 x x x x 1.32 1.69 1.42 x 1.97 x 1.4 1.52 1.05 1.43 1.38 1.79 x 0.9 1.43 1.57 x 1.63 x 0.85 1.15 1.57 x 1.61 x 1.25 1.56 1.5 x 1.57 1.26 x x x x x 1.38 1.25 1.65 x 1.54 1.42 1.25 0.8 +16321 Original post publication description: ELISA-3x Original pre publication description: ELISA-3x: Immune system, ELISA-3x, IgG class antibody binding to TSHR A-subunit protein in ELISA 4 weeks after 3 immunizations with TSHR A-subunit adenovirus [OD490 nm] Immune system: ELISA-3x, IgG class antibody binding to TSHR A-subunit protein in ELISA 4 weeks after 3 immunizations with TSHR A-subunit adenovirus [OD490 nm] Immune system: ELISA-3x, IgG class antibody binding to TSHR A-subunit protein in ELISA 4 weeks after 3 immunizations with TSHR A-subunit adenovirus [OD490 nm] x x x x 1.22 0.75 1.62 0.68 1.11 1.12 0.56 0.64 0.79 0.37 1.01 0.45 0.44 0.51 x 0.91 0.69 x x 1.33 x 0.63 1.0 1.34 x 0.58 0.38 0.76 0.98 x 0.63 x 0.99 0.854 0.6 x 0.77 1.23 1.08 0.29 x x 1.49 0.48 0.86 1.3 x x x 1.21 1.22 x x x 1.38 1.39 0.99 x 1.06 x 1.16 1.2 0.6 0.77 0.29 1.38 x 0.57 1.35 0.7 x 1.1 x 0.27 0.69 0.87 x 1.06 x 1.12 1.43 1.42 x 1.09 0.92 x x x x x 1.22 1.21 1.27 x 1.2 0.87 1.15 0.29 +16322 Original post publication description: Serum thyroxine (T4) 1 week after 2 immunization of female mice with TSHR A-subunit adenovirus minus baseline T4 [micrograms/dL] Original pre publication description: Endocrine system, thyroid: Del T4-2x, serum thyroxine (T4) 1 week after 2 immunization of female mice with TSHR A-subunit adenovirus minus baseline T4 [micrograms/dL] Endocrine system, thyroid: Del T4-2x, serum thyroxine (T4) 1 week after 2 immunizations of female mice with TSHR A-subunit adenovirus minus baseline T4 [micrograms/dL] Enodocrine system, thyroid: Del T4-2x, serum thyroxine (T4) 1 week after 2 immunizations of female mice with TSHR A-subunit adenovirus minus baseline T4 [micrograms/dL] x x x x -0.3 -0.8 -1.3 -0.1 -0.7 -0.1 -0.3 -0.1 1.1 1.4 0.6 0.7 1.7 0.5 x 1.2 0.4 x x -1.0 x 0.8 -0.9 -1.2 x 0.1 -0.7 -0.2 x x 1.4 x -0.2 -0.2 -1.8 x 0.6 0.9 -1.3 -0.4 x x 0.8 1.8 -1.7 x x x x 4.1 x x x x 0.8 -0.4 0.0 x -0.5 x -1.6 1.9 -0.1 0.3 -1.6 -0.1 x 0.1 -1.5 0.5 x 0.1 x 0.5 -0.3 4.3 x 0.1 x 0.6 -1.2 0.2 x -0.6 0.5 x x x x x 0.8 -0.3 x x 2.4 2.0 1.0 -0.6 +16323 Original post publication description: Del T4-3x, serum thyroxine (T4) 4 weeks after 3 immunizations of female mice with TSHR A-subunit adenovirus minus baseline T4 [micrograms/dL] Original pre publication description: Endocrine system, thyroid: Del T4-3x, serum thyroxine (T4) 4 weeks after 3 immunizations of female mice with TSHR A-subunit adenovirus minus baseline T4 [micrograms/dL] Endocrine system, thyroid: Del T4-3x, serum thyroxine (T4) 4 weeks after 3 immunizations of female mice with TSHR A-subunit adenovirus minus baseline T4 [micrograms/dL] Del T4-3x, serum thyroxine (T4) 4 weeks after 3 immunizations of female mice with TSHR A-subunit adenovirus minus baseline T4 [micrograms/dL] x x x x -1.1 -2.6 -1.8 -0.6 -0.3 0.7 -1.6 -0.3 0.7 0.4 -0.4 -0.3 0.2 0.6 x -1.2 0.4 x x -1.6 x 0.4 -2.4 -0.1 x -1.2 -0.9 -0.4 -0.8 x 1.5 x 0.0 -0.9 -2.6 x -0.2 -1.8 -0.7 -1.9 x x 0.3 -1.0 -2.2 -0.6 x x x -1.0 -0.9 x x x -1.1 -1.2 -0.3 x 0.6 x -1.4 -1.4 -0.7 0.3 -0.5 -0.8 x -0.4 -1.8 0.6 x 0.2 x -0.6 -0.6 1.5 x -0.8 x -1.0 -2.7 -0.2 x -0.4 -0.7 x x x x x 0.3 -2.0 x x 1.9 -0.5 -0.2 -0.7 +16341 None Eye, visual system, physiology, aging: Intraocular pressure (IOP), more than 13 months old, both sexes, average of left and right eyes. Merged. Eye, visual system, physiology, aging: Intraocular pressure (IOP), more than 13 months old, both sexes, average of left and right eyes. (BXD48 and BXD96 are merged; BXD65 and BXD97 are merged; BXD73, BXD80 and BXD103 are merged). [mmHg] x x 13.0909 12.5 14.6 15.75 x 12.5 17.75 21.0 15.5 10.3 13.25 x 13.8 14.5 14.1429 12.5 8.25 x 16.3333 x 12.6667 18.0 13.8 18.75 18.25 14.75 x 13.75 14.0 19.125 18.6875 x x x 12.75 13.375 11.85 x 10.25 12.25 13.2143 14.25 x x 10.9791 x 9.7 21.8333 x x x 18.25 18.1 x x x 10.6 15.7083 14.3636 16.25 x 13.3637 12.5 17.0 11.5833 13.5294 14.1667 12.9444 x 16.5641 x 13.6667 x 10.6875 x x x x x 11.5 13.5 11.9286 16.9 21.7174 x 12.2222 14.5 x 13.9167 x x 16.0 x x 14.1 14.375 16.4375 9.5 10.6 x +16342 None Eye, visual system, physiology: Intraocular pressure (IOP), all ages (1 to 30 months old), both sexes, average of left and right eyes. Merged. Eye, visual system, physiology: Intraocular pressure (IOP), all ages (1 to 30 months old), both sexes, average of left and right eyes. (BXD48 and BXD96 are merged; BXD65 and BXD97 are merged; BXD73, BXD80 and BXD103 are merged). [mmHg] 16.6053 17.8125 14.7273 17.0385 17.1364 14.4444 16.8214 14.9231 17.9375 16.8958 15.4634 15.6346 14.1552 18.4348 15.9355 16.4231 16.4423 15.3942 14.2931 19.0 16.4 x 16.1562 18.05 13.8 18.7763 18.5833 16.1167 x 14.0323 14.8333 16.25 16.9891 16.25 15.175 x 12.2581 13.5857 13.1429 x 13.0435 15.4574 16.4322 13.5755 x x 14.6202 x 13.7959 15.6667 x x x 16.0175 15.9091 x x x 15.1885 17.2154 15.8148 18.0 x 14.0887 19.32 15.9583 16.2727 15.8857 15.8559 13.9118 x 17.3621 x 13.91 x 14.8302 x x x x x 15.3516 14.6228 15.1449 17.3824 19.35 x 14.9135 15.119 x 15.0 x x 17.1047 x x 13.6444 18.5167 15.4925 11.1724 16.3298 x +16338 None Eye, visual system, physiology: Intraocular pressure (IOP), 2.1 to 5 months old, both sexes, average of left and right eyes. Merged. Eye, visual system, physiology: Intraocular pressure (IOP), 2.1 to 5 months old, both sexes, average of left and right eyes. (BXD48 and BXD96 are merged; BXD65 and BXD97 are merged; BXD73, BXD80 and BXD103 are merged). [mmHg] 17.375 18.0 15.6667 17.1833 18.5 x 17.5909 17.75 x 17.5625 16.8636 18.375 13.7222 18.0 18.3 17.0 17.3 14.2059 16.9545 21.75 x x 16.9286 x x 17.8 x 18.125 x 15.75 15.5714 15.4 13.625 16.25 18.0 x 12.5 13.6667 12.6 x 14.9375 14.5455 14.875 11.75 x x 16.1875 x 15.0 14.1538 x x x 15.587 13.8333 x x x 16.45 17.5 16.4545 19.1154 x 14.2882 20.0833 14.0625 15.1786 16.8611 17.2353 15.0714 x 17.9961 x 12.7143 x 15.4167 x x x x x 14.875 14.9615 15.8235 18.3214 17.5556 x 16.25 14.95 x 14.4 x x 18.0 x x 13.5 21.3 14.8889 8.75 16.9688 x +16339 None Eye, visual system, physiology: Intraocular pressure (IOP), 5.1 to 9 months old, both sexes, average of left and right eyes. Merged. Eye, visual system, physiology: Intraocular pressure (IOP), 5.1 to 9 months old, both sexes, average of left and right eyes. (BXD48 and BXD96 are merged; BXD65 and BXD97 are merged; BXD73, BXD80 and BXD103 are merged). [mmHg] 16.5 20.15 15.1 19.1731 17.25 16.125 20.0833 16.0 18.9286 17.375 15.6 17.0 16.3 18.5833 16.5 14.875 17.75 17.9643 13.5 13.5 16.5 x 18.625 19.125 x 22.125 18.75 15.0833 x 15.1667 16.25 17.0 17.3571 x 14.5833 x 13.3182 12.6111 13.4 x 12.0 15.8571 16.6667 13.4211 x x 13.0104 x 13.15 14.8182 x x x 17.2 14.0 x x x 17.3611 18.1667 14.8846 19.125 x 14.373 22.5 17.0833 18.7059 16.8636 17.7083 14.75 x 18.0268 x 15.3636 x 15.8214 x x x x x 15.7059 15.1429 16.7368 18.1875 21.0385 x 17.3636 17.8125 x 19.0 x x 19.9375 x x 12.1667 18.3333 14.1538 12.7 18.6875 x +16330 Original post publication description: Infectious disease, immune system: Burkholderia pseudomallei (1026b) infection response (50-100 CFU intranasal), survival in males, [1=resistant, 0=sensitive] Original pre publication description: Infectious disease, immune system: Burkholderia pseudomallei (1026b) infection response (50-100 CFU intranasal), survival in males, [1=resistant, 0=sensitive] Infectious disease, immune system: Burkholderia pseudomallei (1026b) infection response (50-100 CFU intranasal), survival in males, [1=resistant, 0=sensitive] Infectious disease, immune system: Burkholderia pseudomallei (1026b) infection response (50-100 CFU intranasal), survival in males, [1=resistant, 0=sensitive] x x 1.0 0.0 0.0 x x x x 0.0 x 1.0 0.0 x x x x x x x 1.0 x x x x 0.0 x x x x x x x x x x 1.0 x x x x 0.182 x 1.0 x x x 1.0 1.0 x x x x 1.0 x x x x x x 0.188 0.0 0.211 1.0 0.75 0.25 0.0 0.0 x x x 0.1 0.875 0.5 x x x x 1.0 0.0 x x x x 0.2 1.0 x x 1.0 x x x x 0.5 0.167 x x x x 1.0 x 0.667 +16331 Original post publication description: Infectious disease, immune system: Burkholderia pseudomallei (1026b) infection response (50-100 CFU intranasal), survival in males, Time of Death [1-11 Days] Original pre publication description: Infectious disease, immune system: Burkholderia pseudomallei (1026b) infection response (50-100 CFU intranasal), survival in males, Time of Death [1-11 Days] Infectious disease, immune system: Burkholderia pseudomallei (1026b) infection response (50-100 CFU intranasal), survival in males, Time of Death [1-11 Days] Infectious disease, immune system: Burkholderia pseudomallei (1026b) infection response (50-100 CFU intranasal), survival in males, Time of Death [1-11 Days] x x 11.0 3.13 3.5 x x x x 3.333 x 11.0 3.25 x x x x x x x 11.0 x x x x 7.0 x x x x x x x x x x 11.0 x x x x 5.182 x 11.0 x x x 11.0 11.0 x x x x 11.0 x x x x x x 5.188 3.25 5.737 11.0 9.5 5.625 3.25 4.0 x x x 4.5 10.75 8.0 x x x x 11.0 3.5 x x x x 5.0 11.0 x x 11.0 x x x x 7.5 5.083 x x x x 11.0 x 8.917 +16332 Original post publication description: Infectious disease, immune system: Burkholderia pseudomallei (1026b) infection response (50-100 CFU intranasal), survival in males, weight loss Day 1 [% change in body weight] Original pre publication description: Infectious disease, immune system: Burkholderia pseudomallei (1026b) infection response (50-100 CFU intranasal), survival in males, weight loss Day 1 [% change in body weight] Infectious disease, immune system: Burkholderia pseudomallei (1026b) infection response (50-100 CFU intranasal), survival in males, weight loss Day 1 [% change in body weight] Infectious disease, immune system: Burkholderia pseudomallei (1026b) infection response (50-100 CFU intranasal), survival in males, weight loss Day 1 [% change in body weight] x x 1.592 1.979 4.069 x x x x 1.706 x 3.409 3.314 x x x x x x x -0.108 x x x x -0.434 x x x x x x x x x x x 9.0 x x x 3.458 x 1.936 x x x 0.12 1.95 x x x x -0.02 x x x x x x 4.14 2.015 2.794 2.418 5.44 2.644 6.311 4.442 x x x 0.897 2.453 1.949 x x x x 2.583 0.649 x x x x 2.982 1.008 x x -0.067 x x x x 1.048 2.445 x x x x 2.179 x 1.674 +16333 Original post publication description: Infectious disease, immune system: Burkholderia pseudomallei (1026b) infection response (50-100 CFU intranasal), survival in males, weight loss Day 2 [% change in body weight] Original pre publication description: Infectious disease, immune system: Burkholderia pseudomallei (1026b) infection response (50-100 CFU intranasal), survival in males, weight loss Day 2 [% change in body weight] Infectious disease, immune system: Burkholderia pseudomallei (1026b) infection response (50-100 CFU intranasal), survival in males, weight loss Day 2 [% change in body weight] Infectious disease, immune system: Burkholderia pseudomallei (1026b) infection response (50-100 CFU intranasal), survival in males, weight loss Day 2 [% change in body weight] x x 10.166 13.025 9.853 x x x x 6.585 x 16.265 13.28 x x x x x x x 12.475 x x x x 5.552 x x x x x x x x x x x 17.111 x x x 11.925 x 15.282 x x x 6.782 5.397 x x x x 14.422 x x x x x x 12.432 14.068 9.305 4.264 14.804 10.54 14.991 13.547 x x x 11.679 11.22 13.759 x x x x 12.309 6.706 x x x x 14.666 12.792 x x 7.724 x x x x 11.585 9.973 x x x x 10.105 x 11.767 +16334 Original post publication description: Infectious disease, immune system: Burkholderia pseudomallei (1026b) infection response (50-100 CFU intranasal), survival in males, weight loss Day 3 [% change in body weight] Original pre publication description: Infectious disease, immune system: Burkholderia pseudomallei (1026b) infection response (50-100 CFU intranasal), survival in males, weight loss Day 3 [% change in body weight] Infectious disease, immune system: Burkholderia pseudomallei (1026b) infection response (50-100 CFU intranasal), survival in males, weight loss Day 3 [% change in body weight] Infectious disease, immune system: Burkholderia pseudomallei (1026b) infection response (50-100 CFU intranasal), survival in males, weight loss Day 3 [% change in body weight] x x 7.48 18.326 15.653 x x x x 7.812 x 13.072 19.757 x x x x x x x 12.511 x x x x 16.31 x x x x x x x x x x x 13.278 x x x 15.697 x 13.443 x x x 6.935 5.622 x x x x 12.509 x x x x x x 16.745 17.76 14.635 1.275 20.809 15.154 22.142 18.774 x x x 16.508 11.225 16.47 x x x x 14.169 10.152 x x x x 20.882 10.459 x x 2.508 x x x x 15.408 15.236 x x x x 15.778 x 14.525 +16335 Original post publication description: Infectious disease, immune system: Burkholderia pseudomallei (1026b) infection response (50-100 CFU intranasal), survival in males, weight loss Day 4 [% change in body weight] Original pre publication description: Infectious disease, immune system: Burkholderia pseudomallei (1026b) infection response (50-100 CFU intranasal), survival in males, weight loss Day 4 [% change in body weight] Infectious disease, immune system: Burkholderia pseudomallei (1026b) infection response (50-100 CFU intranasal), survival in males, weight loss Day 4 [% change in body weight] Infectious disease, immune system: Burkholderia pseudomallei (1026b) infection response (50-100 CFU intranasal), survival in males, weight loss Day 4 [% change in body weight] x x 6.79 21.15 16.168 x x x x 9.673 x 11.176 24.646 x x x x x x x 7.121 x x x x 20.995 x x x x x x x x x x x 10.722 x x x 18.125 x 11.889 x x x 3.649 4.242 x x x x 9.274 x x x x x x 20.053 27.717 18.033 -0.835 20.633 19.317 23.614 21.695 x x x 19.114 8.841 17.347 x x x x 14.132 15.123 x x x x 22.493 8.221 x x 0.827 x x x x 17.895 16.672 x x x x 18.069 x 11.51 +16340 None Eye, visual system, physiology: Intraocular pressure (IOP), 9.1 to 13 months old, both sexes, average of left and right eyes. Merged. Eye, visual system, physiology: Intraocular pressure (IOP), 9.1 to 13 months old, both sexes, average of left and right eyes. (BXD48 and BXD96 are merged; BXD65 and BXD97 are merged; BXD73, BXD80 and BXD103 are merged). [mmHg] x 17.625 15.2273 16.8438 18.2 11.3333 13.1667 12.5 17.0 14.25 14.75 14.375 13.375 19.375 16.3333 16.75 18.125 14.1667 11.0 x x x x 17.0 x 18.375 x 14.6667 x 12.625 13.9 18.0 18.9545 x 14.8333 x 9.58333 13.2143 13.75 x 11.75 17.875 21.8182 16.5 x x 11.9 x 12.5 17.8889 x x x 15.0 18.875 x x x 14.4545 18.2368 14.6111 17.3333 x 13.4523 18.5 17.5 16.8333 17.0385 16.4583 12.5 x 17.9354 x 14.85 x 17.6429 x x x x x 16.2083 13.75 16.0714 16.6667 16.5 x 14.5417 15.3 x 14.0 x x 17.75 x x 18.6875 18.25 16.5455 13.25 15.2778 x +16337 None Eye, visual system, physiology: Intraocular pressure (IOP), 1 to 2 months old, both sexes, average of left and right eyes. Merged. Eye, visual system, physiology: Intraocular pressure (IOP), 1 to 2 months old, both sexes, average of left and right eyes. (BXD48 and BXD96 are merged; BXD65 and BXD97 are merged; BXD73, BXD80 and BXD103 are merged). [mmHg] 15.6667 15.1111 15.375 16.7143 17.5 x 15.6 x x 16.0833 14.4167 17.4286 13.9444 18.25 16.875 18.0714 16.4167 15.625 15.25 x x x 13.75 x x 16.75 x 16.8333 x 12.5 14.8333 12.6667 14.3 x 13.75 x 12.5 15.5 15.5 x 16.7 17.25 14.4091 13.125 x x 16.5359 x 14.8846 12.5556 x x x 15.3 15.5 x x x 15.375 16.1923 19.0 16.0714 x 14.35 17.6111 16.0 16.1667 15.5909 11.6667 13.0556 x 14.1463 x 13.1111 x 14.2083 x x x x x 17.3636 15.0 12.4583 16.2778 16.6875 x 14.1667 13.375 x 15.1667 x x 15.0 x x 11.6429 17.0 17.3125 12.9167 17.3333 x +16355 Original post publication description: Duration of call-day-7 Central nervous system, behavior, development, communication: Infant vocalization, Roy 1 Central nervous system, behavior, development, communication: Infant vocalization, duration of call on day 7 (AviSoft analysis software), mixed sexes from 2 to 5 litters [msec] 29.883 29.587 16.434 35.289 33.61 x x x x x x x x x x x x x x x x x x 35.27 x x x 50.252 x x 26.533 x 32.328 x x x x x x x x x 43.761 x x x 29.2 43.65 x x x x x 30.743 x x x x 25.488 x x x x x x x 47.668 27.353 x x x 26.948 23.413 x x 38.97 x x x x x x 30.92 x 46.088 x x x x x x x x x x x x 27.95 34.85 x 24.88 x +16336 Original post publication description: Metabolism: Blood glucose level (intraperitoneal glucose tolerance test) at time = 30 min of XX-week old males after inject of XX mg 2DG (2-deoxyglucose) [mg/dl] Original pre publication description: Metabolism: Thorens Trait 1 Metabolism: Thorens Trait 1 (demo only) Metabolism: Demo data, Blood glucose level (intraperitoneal glucose tolerance test) at time = 30 min of XX-week old males after inject of XX mg 2DG (2-deoxyglucose) [mg/dl] 5.0 6.0 10.0 x x x x x x x x x x 15.0 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +16343 Original post publication description: Infectious disease, immune system, add other information Original pre publication description: Schughart trait RNASeq BWL BWL for RNAseq mice Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), body weight loss day 3 after infection in 9-14 week-old females [%] - individual mice from RNAseq experiment (HZI PR8M-Infected Lungs Females RNAseq (Nov13) RPKM) x x 86.35 81.71 x x x 85.48 x x x x x x x x x x x x 76.5 x x x x x x 91.0 x x x x x x x x x x 97.25 x x x x 80.8 x x 85.71 86.57 81.77 x x x x x x x x x x x 74.25 x 81.76 x 92.42 x x x x x x 80.41 80.4 x x x x x x x x 81.05 x x 83.46 x x x x x x x x x x 90.29 89.59 82.53 x x x 85.09 +16344 Original post publication description: Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), flu HA expression [RPKM plus 1, log2] - individual mice from RNAseq experiment [HZI PR8M-Infected Lungs Females RNAseq (Nov13) RPKM] Original pre publication description: RPKM flu HA expression for RNAseq mice RPKM flu HA expression for RNAseq mice Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), flu HA expression [RPKM] - individual mice from RNAseq experiment (HZI PR8M-Infected Lungs Females RNAseq (Nov13) RPKM) x x 9.4 10.62 x x x 10.71 x x x x x x x x x x x x 11.33 x x x x x x 10.39 x x x x x x x x x x 10.64 x x x x 10.63 x x 10.08 10.19 10.87 x x x x x x x x x x x 10.9 x 10.75 x 10.56 x x x x x x 10.96 10.88 x x x x x x x x 10.7 x x 10.51 x x x x x x x x x x 11.05 10.56 10.8 x x x 10.86 +16345 Original post publication description: Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), flu PB1 expression [RPKM plus 1, log2] - individual mice from RNAseq experiment [HZI PR8M-Infected Lungs Females RNAseq (Nov13) RPKM] Original pre publication description: RPKM flu PB1 expression for RNAseq mice RPKM flu PB1 expression for RNAseq mice Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), flu PB1 expression [RPKM] - individual mice from RNAseq experiment (HZI PR8M-Infected Lungs Females RNAseq (Nov13) RPKM) x x 8.37 10.98 x x x 10.44 x x x x x x x x x x x x 11.77 x x x x x x 9.65 x x x x x x x x x x 9.68 x x x x 9.84 x x 9.24 9.23 10.52 x x x x x x x x x x x 10.88 x 10.2 x 9.82 x x x x x x 10.3 x x x x x x x x x 10.27 x x 9.25 x x x x x x x x x x 10.04 9.69 10.43 x x x 10.22 +16346 Original post publication description: Infectious disease, immune system: Herpes simplex virus type 1, serum neutralization titers following corneal infection, young adult male and female (combined) Original pre publication description: Infectious disease, immune system: Herpes simplex virus type 1, serum neutralization titers following corneal infection, young adult male and female (combined) Infectious disease, immune system: Herpes simplex virus type 1, serum neutralization titer following corneal infection, young adult male and female (combined) [unit] Infectious disease, immune system: Herpes simplex virus type 1, serum neutralization titer following corneal infection, young adult male and female (combined) [unit] x x x x x x x x x x x 275.0 x x x x x x x x x x x x x x x x x x x x 600.0 x x x x x x x x x 600.0 x x x x x x x x x x 200.0 x x x x x 162.0 375.0 x x x x x x 175.0 275.0 412.0 x x x x x x x x x x x 287.0 300.0 x x 550.0 x 300.0 337.0 x x x x x 550.0 x 487.0 85.0 250.0 287.0 x 400.0 +16347 Original post publication description: Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), flu M expression [RPKM] - individual mice from RNAseq experiment (HZI PR8M-Infected Lungs Females RNAseq (Nov13) RPKM) Original pre publication description: RPKM flu M expression for RNAseq mice RPKM flu M expression for RNAseq mice Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), flu M expression [RPKM] - individual mice from RNAseq experiment (HZI PR8M-Infected Lungs Females RNAseq (Nov13) RPKM) x x 7.31 9.17 x x x 8.59 x x x x x x x x x x x x 9.57 x x x x x x 8.43 x x x x x x x x x x 8.66 x x x x 8.61 x x 8.08 8.28 9.18 x x x x x x x x x x x 9.17 x 8.77 x 8.61 x x x x x x 8.89 9.66 x x x x x x x x 8.83 x x 8.63 x x x x x x x x x x 8.99 8.56 8.82 x x x 8.84 +16348 Original post publication description: Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), flu NA expression [RPKM] - individual mice from RNAseq experiment (HZI PR8M-Infected Lungs Females RNAseq (Nov13) RPKM) Original pre publication description: RPKM flu NA expression for RNAseq mice RPKM flu NA expression for RNAseq mice Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), flu NA expression [RPKM] - individual mice from RNAseq experiment (HZI PR8M-Infected Lungs Females RNAseq (Nov13) RPKM) x x 4.63 6.15 x x x 5.51 x x x x x x x x x x x x 6.88 x x x x x x 5.44 x x x x x x x x x x 5.64 x x x x 5.72 x x 5.24 5.24 6.27 x x x x x x x x x x x 6.49 x 6.17 x 5.83 x x x x x x 6.13 6.85 x x x x x x x x 5.69 x x 5.51 x x x x x x x x x x 5.72 5.2 5.89 x x x 6.06 +16349 Original post publication description: Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), flu NA expression [RPKM] - individual mice from RNAseq experiment (HZI PR8M-Infected Lungs Females RNAseq (Nov13) RPKM) Original pre publication description: RPKM flu NA expression for RNAseq mice RPKM flu NS expression for RNAseq mice Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), flu NS expression [RPKM] - individual mice from RNAseq experiment (HZI PR8M-Infected Lungs Females RNAseq (Nov13) RPKM) x x 8.24 9.93 x x x 9.66 x x x x x x x x x x x x 10.18 x x x x x x 9.28 x x x x x x x x x x 9.48 x x x x 9.38 x x 9.13 9.13 10.09 x x x x x x x x x x x 10.03 x 9.59 x 9.66 x x x x x x 9.96 10.43 x x x x x x x x 9.85 x x 9.43 x x x x x x x x x x 10.03 9.56 9.86 x x x 9.81 +16350 Original post publication description: Infectious disease, immune system: Burkholderia pseudomallei (1026b) infection response (50-100 CFU intranasal), survival in males, weight loss, first principal component, days 1-4 [% change in body weight] Original pre publication description: Infectious disease, immune system: Burkholderia pseudomallei (1026b) infection response (50-100 CFU intranasal), survival in males, weight loss, first principal component, days 1-4 [% change in body weight] Infectious disease, immune system: Burkholderia pseudomallei (1026b) infection response (50-100 CFU intranasal), survival in males, weight loss, first principal component, days 1-4 [% change in body weight] Infectious disease, immune system: Burkholderia pseudomallei (1026b) infection response (50-100 CFU intranasal), survival in males, weight loss, first principal component, days 1-4 [% change in body weight] x x -1.649 1.164 0.448 x x x x -1.9 x 0.587 1.897 x x x x x x x -1.05 x x x x -0.669 x x x x x x x x x x x 1.842 x x x 0.777 x 0.238 x x x -2.741 -2.679 x x x x -0.588 x x x x x x 1.254 1.744 0.127 -3.628 2.38 0.433 2.96 1.835 x x x 0.385 -0.734 0.77 x x x x 0.183 -1.425 x x x x 2.005 -0.933 x x -3.362 x x x x 0.185 0.123 x x x x 0.254 x -0.234 +16351 Original post publication description: Hab Activity entered at November/25 14:32:55 from IP 128.125.179.203 None Hab Activity entered at November/25 14:32:55 from IP 128.125.179.203 x x 1.0 0.0 0.5 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +16352 Original post publication description: Central nervous system, neurotoxicology: 3-nitropropionic acid neurodegeneration in striatum (caudate putamen) (50 mg/kg ip) in young adults (mostly females) Original pre publication description: Central nervous system, neurotoxicology: Dietrich and Dragatsis trait 1 (contact idragatsis@uthsc.edu) Central nervous system, neurotoxicology: Dietrich and Dragatsis trait 1 (contact idragatsis@uthsc.edu) Central nervous system, neurotoxicology: 3-nitropropionic acid neurodegeneration in striatum (caudate putamen) (50 mg/kg ip) in young adults (mostly females) x x 1.0 0.0 0.5 x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x x +16353 Original post publication description: Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), flu PB2 expression [RPKM] - individual mice from RNAseq experiment (HZI PR8M-Infected Lungs Females RNAseq (Nov13) RPKM) Original pre publication description: RPKM flu PB2 expression for RNAseq mice RPKM flu PB2 expression for RNAseq mice Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), flu PB2 expression [RPKM] - individual mice from RNAseq experiment (HZI PR8M-Infected Lungs Females RNAseq (Nov13) RPKM) x x 7.02 9.42 x x x 8.7 x x x x x x x x x x x x 10.32 x x x x x x 8.1 x x x x x x x x x x 8.48 x x x x 8.74 x x 8.0 7.93 9.03 x x x x x x x x x x x 9.55 x 9.09 x 8.59 x x x x x x 9.06 9.81 x x x x x x x x 8.71 x x 8.54 x x x x x x x x x x 8.37 8.35 8.67 x x x 8.86 +16354 Original post publication description: Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), flu NP expression [RPKM] - individual mice from RNAseq experiment (HZI PR8M-Infected Lungs Females RNAseq (Nov13) RPKM) Original pre publication description: RPKM flu NP expression for RNAseq mice RPKM flu NP expression for RNAseq mice Infectious disease, immune function: H1N1 (PR8) influenza A virus (2x10E3 FFU), flu NP expression [RPKM] - individual mice from RNAseq experiment (HZI PR8M-Infected Lungs Females RNAseq (Nov13) RPKM) x x 9.55 10.94 x x x 11.02 x x x x x x x x x x x x 11.51 x x x x x x 10.28 x x x x x x x x x x 10.88 x x x x 11.02 x x 10.38 10.3 11.02 x x x x x x x x x x x 11.1 x 10.83 x 10.73 x x x x x x 11.05 11.37 x x x x x x x x 10.8 x x 10.69 x x x x x x x x x x 11.43 11.15 10.96 x x x 10.93 +16356 Original post publication description: Central nervous system, behavior, development, communication: Infant vocalization, duration of call on day 8 [msec] Original pre publication description: Central nervous system, behavior, development, communication: Infant vocalization, Roy 1 Central nervous system, behavior, development, communication: Infant vocalization, Roy 1 Central nervous system, behavior, development, communication: Infant vocalization, duration of call on day 8 (AviSoft analysis software), mixed sexes from 2 to 5 litters [msec] 32.117 32.846 16.289 33.503 36.36 x x x x x x x x x x x x x x x x x x 39.32 x x x 51.45 x x 27.98 x 38.35 x x x x x x x x x 46.603 x x x 31.99 43.783 x x x x x 27.74 x x x x 22.715 x x x x x x x 41.76 26.458 x x x 24.3 26.335 x x 37.47 x x x x x x 30.41 x 41.5 x x x x x x x x x x x x 33.35 31.0 x 26.07 x +16357 Original post publication description: Central nervous system, behavior, development, communication: Infant vocalization, mean peak amplitude of call on day7 (Avisoft analysis software), mixed sexes from 2 to 5 litters [dB] Original pre publication description: Central nervous system, behavior, development, communication: Infant vocalization, Roy1 Central nervous system, behavior, development, communication: Infant vocalization, Roy1 Central nervous system, behavior, development, communication: Infant vocalization, mean peak amplitude of call on day 7 (Avisoft analysis software), mixed sexes from 2 to 5 litters [dB] -40.27 -44.07 -34.57 -22.23 -40.62 x x x x x x x x x x x x x x x x x x -29.06 x x x -19.48 x x -36.317 x -30.736 x x x x x x x x x -29.546 x x x -33.09 -32.349 x x x x x -28.418 x x x x -33.145 x x x x x x x -20.977 -40.186 x x x -35.75 -34.157 x x -28.55 x x x x x x -37.99 x -33.53 x x x x x x x x x x x x -27.871 -35.51 x -29.53 x +16358 Original post publication description: Central nervous system, behavior, development, communication: Infant vocalization, amplitude of call on day8, mixed sexes from 2 to 5 litters [dB] Original pre publication description: Central nervous system, behavior, development, communication: Infant vocalization, Roy1 Central nervous system, behavior, development, communication: Infant vocalization, Roy1 Central nervous system, behavior, development, communication: Infant vocalization, mean peak amplitude of call on day 8 (Avisoft analysis software), mixed sexes from 2 to 5 litters [dB] -35.79 -41.067 -35.777 -15.95 -41.101 x x x x x x x x x x x x x x x x x x -24.998 x x x -20.278 x x -36.752 x -22.12 x x x x x x x x x -27.931 x x x -25.929 -33.673 x x x x x -30.997 x x x x -38.36 x x x x x x x -19.16 -38.79 x x x -39.327 -37.502 x x -30.402 x x x x x x -35.953 x -37.019 x x x x x x x x x x x x -24.299 -31.028 x -24.994 x +16359 Original post publication description: Central nervous system, behavior, development, communication: Infant vocalization, mean peak frequency of call on day 7, mixed sexes from 2 to 5 litters [kHz] Original pre publication description: Central nervous system, behavior, development, communication: Infant vocalization, Roy1 Central nervous system, behavior, development, communication: Infant vocalization, Roy1 Central nervous system, behavior, development, communication: Infant vocalization, mean peak frequency of call on day 7, mixed sexes from 2 to 5 litters [kHz] 64.61 65.36 73.12 63.74 65.428 x x x x x x x x x x x x x x x x x x 65.061 x x x 69.613 x x 70.57 x 66.719 x x x x x x x x x 67.815 x x x 56.193 67.291 x x x x x 70.201 x x x x 87.298 x x x x x x x 64.908 61.116 x x x 70.822 73.331 x x 66.258 x x x x x x 70.348 x 55.419 x x x x x x x x x x x x 74.453 67.347 x 66.629 x +16360 Original post publication description: Central nervous system, behavior, development, communication: Infant vocalization, mean peak frequency of call on day8 (Avisoft analysis software), mixed sexes from 2 to 5 litters [kHz] Original pre publication description: Central nervous system, behavior, development, communication: Infant vocalization, Roy1 Central nervous system, behavior, development, communication: Infant vocalization, Roy1 Central nervous system, behavior, development, communication: Infant vocalization, mean peak frequency of call on day 8 (Avisoft analysis software), mixed sexes from 2 to 5 litters [kHz] 67.78 66.87 67.04 61.38 64.552 x x x x x x x x x x x x x x x x x x 65.018 x x x 69.999 x x 70.841 x 62.317 x x x x x x x x x 67.115 x x x 73.214 68.636 x x x x x 71.434 x x x x 83.701 x x x x x x x 61.365 67.736 x x x 76.232 70.379 x x 66.085 x x x x x x 70.926 x 59.413 x x x x x x x x x x x x 64.151 74.582 x 74.972 x +16361 Original post publication description: Central nervous system, behavior, development, communication: Infant vocalization, duration of call on day 9 (AviSoft analysis software), mixed sexes from 2 to 5 litters [msec] Original pre publication description: Central nervous system, behavior, development, communication: Infant vocalization, Roy 1 Central nervous system, behavior, development, communication: Infant vocalization, Roy 1 Central nervous system, behavior, development, communication: Infant vocalization, duration of call on day 9 (AviSoft analysis software), mixed sexes from 2 to 5 litters [msec] 29.067 25.485 15.526 33.654 35.89 x x x x x x x x x x x x x x x x x x 31.06 x x x 45.533 x x 26.767 x 36.273 x x x x x x x x x 44.913 x x x 30.15 45.615 x x x x x 32.225 x x x x 20.485 x x x x x x x 32.43 26.06 x x x 26.51 21.292 x x 34.6 x x x x x x 30.425 x 41.32 x x x x x x x x x x x x 33.657 30.5 x 27.45 x +16362 Original post publication description: Central nervous system, behavior, development, communication: Infant vocalization, amplitude of call on day 9, mixed sexes from 2 to 5 litters [dB] Original pre publication description: Central nervous system, behavior, development, communication: Infant vocalization, Roy 1 Central nervous system, behavior, development, communication: Infant vocalization, Roy 1 Central nervous system, behavior, development, communication: Infant vocalization, mean peak amplitude of call on day 9 (Avisoft analysis software), mixed sexes from 2 to 5 litters [dB] -36.73 -43.44 -36.22 -22.75 -41.448 x x x x x x x x x x x x x x x x x x -27.323 x x x -20.642 x x -41.986 x -25.05 x x x x x x x x x -25.456 x x x -32.062 -34.865 x x x x x -25.044 x x x x -33.45 x x x x x x x -25.46 -38.86 x x x -37.829 -42.014 x x -34.394 x x x x x x -35.796 x -38.927 x x x x x x x x x x x x -26.064 -29.513 x -29.78 x +16363 Original post publication description: Uterine Weight entered at January/07 11:58:18 from IP 172.23.146.243 Original pre publication description: Reproduction, urogenital system, morphology: uterine weight at maturity, adjusted for age, body weight, dissector, source, and days in fixative [mg] Reproduction, urogenital system, morphology: uterine weight at maturity, adjusted for age, body weight, dissector, source, and days in fixative [mg] Reproduction, urogenital system, morphology: uterine weight at maturity, adjusted for age, body weight, dissector, source, and days in fixative [mg] 84.918 109.317 61.714 98.693 62.152 x 62.247 x x 85.894 68.812 62.88 98.831 x x 48.141 x 72.035 x x 73.579 x x 59.126 x 35.501 x 64.377 x 72.837 89.12 x 85.482 x 92.271 x x 81.025 77.517 x 57.807 75.819 50.241 89.667 x x 63.615 x 84.743 89.833 x x x 102.647 104.061 x x x 86.815 67.38 73.811 93.228 88.368 87.168 82.685 52.414 73.693 67.398 x 69.365 x 75.26 93.96 103.049 x 86.626 x 58.284 63.909 66.743 x 80.206 73.374 113.495 61.452 87.994 x 92.682 85.052 x 77.527 x x 87.431 82.589 76.075 69.69 89.329 90.177 104.606 84.339 73.351 +16364 Original post publication description: Ovarian Weight Original pre publication description: Reproduction, urogenital system, morphology: ovarian weight at maturity, average of unilateral values, adjusted for age, birth weight, dissector, source, and days in fixative [mg] Reproduction, urogenital system, morphology: ovarian weight at maturity, average of unilateral values, adjusted for age, birth weight, dissector, source, and days in fixative [mg] Reproduction, urogenital system, morphology: ovarian weight at maturity, average of unilateral values, adjusted for age, birth weight, dissector, source, and days in fixative [mg] 4.039 4.322 2.813 9.627 3.404 x 3.3 x x 3.446 5.36 4.61 3.851 7.35 x 3.896 x 3.36 x x 3.566 x x 3.46 x 3.044 x 3.908 x 4.029 6.769 x 2.243 x 3.844 x x 3.626 3.179 x 2.647 4.571 3.518 7.121 x x 4.907 4.257 4.409 6.001 x x x 4.845 7.5 x x x 2.422 4.412 5.345 2.552 5.462 2.89 3.978 3.262 4.035 2.893 3.56 3.465 x 3.991 4.593 3.761 x 5.756 x 2.623 3.755 2.404 x 4.431 4.224 4.348 2.841 4.205 x 3.942 5.252 x 3.247 x x 3.331 5.356 2.636 4.247 3.852 5.992 4.693 4.244 2.972 +16365 Original post publication description: Uterine Body Length Original pre publication description: Reproduction, urogenital system, morphology: uterine body length at maturity, adjusted for age, body weight, dissector, source, and days in fixative [cm] Reproduction, urogenital system, morphology: uterine body length at maturity, adjusted for age, body weight, dissector, source, and days in fixative [cm] Reproduction, urogenital system, morphology: uterine body length at maturity, adjusted for age, body weight, dissector, source, and days in fixative [cm] 0.296 0.422 0.298 0.416 0.377 x 0.327 x x 0.334 0.389 0.409 0.384 0.412 x 0.453 x 0.366 x x 0.407 x x 0.41 x 0.375 x 0.35 x 0.36 0.474 x 0.385 x 0.422 x x 0.368 0.374 x 0.348 0.417 0.368 0.404 x x 0.402 0.415 0.377 0.438 x x x 0.442 0.332 x x x 0.438 0.412 0.419 0.352 0.438 0.344 0.432 0.338 0.346 0.379 0.432 0.383 x 0.397 0.382 0.329 x 0.393 x 0.431 0.368 0.532 x 0.424 0.361 0.385 0.333 0.373 x 0.426 0.385 x 0.388 x x 0.474 0.393 0.363 0.35 0.461 0.356 0.432 0.332 0.362 +16366 Original post publication description: Uterine Body Weight Original pre publication description: Reproduction, urogenital system, morphology: uterine body weight at maturity, adjusted for age, body weight, dissector, source, and days in fixative [mg] Reproduction, urogenital system, morphology: uterine body width at maturity, adjusted for age, body weight, dissector, source, and days in fixative [cm] Reproduction, urogenital system, morphology: uterine body width at maturity, adjusted for age, body weight, dissector, source, and days in fixative [cm] 0.28 0.3 0.262 0.3 0.268 x 0.198 x x 0.256 0.258 0.279 0.286 0.348 x 0.239 x 0.326 x x 0.243 x x 0.284 x 0.245 x 0.277 x 0.303 0.304 x 0.282 x 0.375 x x 0.265 0.319 x 0.275 0.283 0.249 0.312 x x 0.277 0.308 0.297 0.286 x x x 0.349 0.364 x x x 0.282 0.26 0.267 0.281 0.3 0.311 0.291 0.253 0.249 0.276 0.312 0.223 x 0.266 0.311 0.322 x 0.29 x 0.294 0.258 0.226 x 0.273 0.274 0.327 0.274 0.326 x 0.305 0.303 x 0.27 x x 0.289 0.328 0.294 0.283 0.314 0.29 0.284 0.282 0.25 +16367 Original post publication description: Reproduction, urogenital system, morphology: uterine horn length at maturity, average of unilateral values, adjusted for age, body weight, dissector, source, and days in fixative [cm] Original pre publication description: Reproduction, urogenital system, morphology: uterine horn length at maturity, average of unilateral values, adjusted for age, body weight, dissector, source, and days in fixative [cm] Reproduction, urogenital system, morphology: uterine horn length at maturity, average of unilateral values, adjusted for age, body weight, dissector, source, and days in fixative [cm] Reproduction, urogenital system, morphology: uterine horn length at maturity, average of unilateral values, adjusted for age, body weight, dissector, source, and days in fixative [cm] 1.778 1.887 1.619 1.602 1.487 x 1.487 x x 2.031 1.388 1.348 1.63 1.61 x 1.426 x 1.655 x x 1.516 x x 1.581 x 1.587 x 1.486 x 1.569 1.695 x 1.459 x 1.42 x x 1.563 1.441 x 1.699 1.809 1.569 1.619 x x 1.778 1.652 1.793 1.538 x x x 1.644 1.586 x x x 1.545 1.69 1.522 1.86 1.575 1.715 1.595 1.58 1.83 1.737 1.831 1.664 x 1.663 1.812 1.912 x 1.846 x 1.295 1.657 1.856 x 1.884 1.786 1.653 1.681 1.573 x 1.821 1.631 x 1.598 x x 1.961 1.648 1.602 1.592 1.743 1.725 1.876 2.037 1.691 diff --git a/wqflask/maintenance/dataset/calculation/__init__.py b/wqflask/maintenance/dataset/calculation/__init__.py deleted file mode 100644 index e69de29b..00000000 --- a/wqflask/maintenance/dataset/calculation/__init__.py +++ /dev/null diff --git a/wqflask/maintenance/dataset/calculation/correlation/__init__.py b/wqflask/maintenance/dataset/calculation/correlation/__init__.py deleted file mode 100644 index e69de29b..00000000 --- a/wqflask/maintenance/dataset/calculation/correlation/__init__.py +++ /dev/null diff --git a/wqflask/maintenance/dataset/calculation/correlation/conf.ini b/wqflask/maintenance/dataset/conf.ini index 9c23bb45..9c23bb45 100644 --- a/wqflask/maintenance/dataset/calculation/correlation/conf.ini +++ b/wqflask/maintenance/dataset/conf.ini diff --git a/wqflask/maintenance/dataset/calculation/correlation/correlations.py b/wqflask/maintenance/dataset/correlations.py index b089e446..b089e446 100644 --- a/wqflask/maintenance/dataset/calculation/correlation/correlations.py +++ b/wqflask/maintenance/dataset/correlations.py diff --git a/wqflask/maintenance/dataset/datastructure/datastructure.py b/wqflask/maintenance/dataset/datastructure.py index 73e1c0d8..73e1c0d8 100644 --- a/wqflask/maintenance/dataset/datastructure/datastructure.py +++ b/wqflask/maintenance/dataset/datastructure.py diff --git a/wqflask/maintenance/dataset/datastructure/__init__.py b/wqflask/maintenance/dataset/datastructure/__init__.py deleted file mode 100644 index e69de29b..00000000 --- a/wqflask/maintenance/dataset/datastructure/__init__.py +++ /dev/null diff --git a/wqflask/maintenance/dataset/utilities/db.py b/wqflask/maintenance/dataset/db.py index 453ee707..453ee707 100644 --- a/wqflask/maintenance/dataset/utilities/db.py +++ b/wqflask/maintenance/dataset/db.py diff --git a/wqflask/maintenance/dataset/utilities/fetch.py b/wqflask/maintenance/dataset/fetch.py index fcb2d2d8..fcb2d2d8 100644 --- a/wqflask/maintenance/dataset/utilities/fetch.py +++ b/wqflask/maintenance/dataset/fetch.py diff --git a/wqflask/maintenance/dataset/genotypes/__init__.py b/wqflask/maintenance/dataset/genotypes/__init__.py deleted file mode 100644 index e69de29b..00000000 --- a/wqflask/maintenance/dataset/genotypes/__init__.py +++ /dev/null diff --git a/wqflask/maintenance/dataset/genotypes/genotypes_load.py b/wqflask/maintenance/dataset/genotypes_load.py index e4988446..e4988446 100644 --- a/wqflask/maintenance/dataset/genotypes/genotypes_load.py +++ b/wqflask/maintenance/dataset/genotypes_load.py diff --git a/wqflask/maintenance/dataset/phenotypes/phenotypes.py b/wqflask/maintenance/dataset/phenotypes.py index 821e5687..821e5687 100644 --- a/wqflask/maintenance/dataset/phenotypes/phenotypes.py +++ b/wqflask/maintenance/dataset/phenotypes.py diff --git a/wqflask/maintenance/dataset/phenotypes/__init__.py b/wqflask/maintenance/dataset/phenotypes/__init__.py deleted file mode 100644 index e69de29b..00000000 --- a/wqflask/maintenance/dataset/phenotypes/__init__.py +++ /dev/null diff --git a/wqflask/maintenance/dataset/probesets/probesets.py b/wqflask/maintenance/dataset/probesets.py index 7fa65786..7fa65786 100644 --- a/wqflask/maintenance/dataset/probesets/probesets.py +++ b/wqflask/maintenance/dataset/probesets.py diff --git a/wqflask/maintenance/dataset/probesets/__init__.py b/wqflask/maintenance/dataset/probesets/__init__.py deleted file mode 100644 index e69de29b..00000000 --- a/wqflask/maintenance/dataset/probesets/__init__.py +++ /dev/null diff --git a/wqflask/maintenance/dataset/calculation/correlation/run.sh b/wqflask/maintenance/dataset/run.sh index eccfa507..eccfa507 100644 --- a/wqflask/maintenance/dataset/calculation/correlation/run.sh +++ b/wqflask/maintenance/dataset/run.sh diff --git a/wqflask/maintenance/dataset/utilities/test.py b/wqflask/maintenance/dataset/test.py index 340377b3..340377b3 100644 --- a/wqflask/maintenance/dataset/utilities/test.py +++ b/wqflask/maintenance/dataset/test.py diff --git a/wqflask/maintenance/dataset/utilities/__init__.py b/wqflask/maintenance/dataset/utilities/__init__.py deleted file mode 100644 index e69de29b..00000000 --- a/wqflask/maintenance/dataset/utilities/__init__.py +++ /dev/null |